molecule_chembl_id	molecule_pref_name	canonical_smiles	standard_inchi_key	standard_inchi	mechanism_of_action	mechanism_action_type	target_chembl_id	target_pref_name	target_organism
CHEMBL19	METHAZOLAMIDE	CC(=O)/N=c1/sc(S(N)(=O)=O)nn1C	FLOSMHQXBMRNHR-QPJJXVBHSA-N	InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12)/b7-4+	Carbonic anhydrase VII inhibitor	INHIBITOR	CHEMBL2326	Carbonic anhydrase VII	Homo sapiens
CHEMBL1201117	METHOCARBAMOL	COc1ccccc1OCC(O)COC(N)=O	GNXFOGHNGIVQEH-UHFFFAOYSA-N	InChI=1S/C11H15NO5/c1-15-9-4-2-3-5-10(9)16-6-8(13)7-17-11(12)14/h2-5,8,13H,6-7H2,1H3,(H2,12,14)	Carbonic anhydrase I inhibitor	INHIBITOR	CHEMBL261	Carbonic anhydrase I	Homo sapiens
CHEMBL1200814	ACETAZOLAMIDE SODIUM	CC(=O)Nc1nnc(S([NH-])(=O)=O)s1.[Na+]	MRSXAJAOWWFZJJ-UHFFFAOYSA-M	InChI=1S/C4H6N4O3S2.Na/c1-2(9)6-3-7-8-4(12-3)13(5,10)11;/h1H3,(H3,5,6,7,9,10,11);/q;+1/p-1	Carbonic anhydrase I inhibitor	INHIBITOR	CHEMBL261	Carbonic anhydrase I	Homo sapiens
CHEMBL17	DICHLORPHENAMIDE	NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1	GJQPMPFPNINLKP-UHFFFAOYSA-N	InChI=1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14)	Carbonic anhydrase I inhibitor	INHIBITOR	CHEMBL261	Carbonic anhydrase I	Homo sapiens
CHEMBL20	ACETAZOLAMIDE	CC(=O)Nc1nnc(S(N)(=O)=O)s1	BZKPWHYZMXOIDC-UHFFFAOYSA-N	InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)	Carbonic anhydrase I inhibitor	INHIBITOR	CHEMBL261	Carbonic anhydrase I	Homo sapiens
CHEMBL19	METHAZOLAMIDE	CC(=O)/N=c1/sc(S(N)(=O)=O)nn1C	FLOSMHQXBMRNHR-QPJJXVBHSA-N	InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12)/b7-4+	Carbonic anhydrase I inhibitor	INHIBITOR	CHEMBL261	Carbonic anhydrase I	Homo sapiens
CHEMBL1450	ATOVAQUONE	O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21	KUCQYCKVKVOKAY-CTYIDZIISA-N	InChI=1S/C22H19ClO3/c23-16-11-9-14(10-12-16)13-5-7-15(8-6-13)19-20(24)17-3-1-2-4-18(17)21(25)22(19)26/h1-4,9-13,15,26H,5-8H2/t13-,15-	Cytochrome b inhibitor	INHIBITOR	CHEMBL1777	Cytochrome b	Plasmodium falciparum
CHEMBL1200771	TRIDIHEXETHYL CHLORIDE	CC[N+](CC)(CC)CCC(O)(c1ccccc1)C1CCCCC1.[Cl-]	XJGONMZLEDGBRM-UHFFFAOYSA-M	InChI=1S/C21H36NO.ClH/c1-4-22(5-2,6-3)18-17-21(23,19-13-9-7-10-14-19)20-15-11-8-12-16-20;/h7,9-10,13-14,20,23H,4-6,8,11-12,15-18H2,1-3H3;1H/q+1;/p-1	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1722209	TOLTERODINE TARTRATE	Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1.O=C(O)C(O)C(O)C(=O)O	TWHNMSJGYKMTRB-VEIFNGETSA-N	InChI=1S/C22H31NO.C4H6O6/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24;5-1(3(7)8)2(6)4(9)10/h6-12,15-17,20,24H,13-14H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t20-;/m1./s1	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1240	PROPANTHELINE BROMIDE	CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C.[Br-]	XLBIBBZXLMYSFF-UHFFFAOYSA-M	InChI=1S/C23H30NO3.BrH/c1-16(2)24(5,17(3)4)14-15-26-23(25)22-18-10-6-8-12-20(18)27-21-13-9-7-11-19(21)22;/h6-13,16-17,22H,14-15H2,1-5H3;1H/q+1;/p-1	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1200906	OXYPHENONIUM BROMIDE	CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1.[Br-]	UKLQXHUGTKWPSR-UHFFFAOYSA-M	InChI=1S/C21H34NO3.BrH/c1-4-22(3,5-2)16-17-25-20(23)21(24,18-12-8-6-9-13-18)19-14-10-7-11-15-19;/h6,8-9,12-13,19,24H,4-5,7,10-11,14-17H2,1-3H3;1H/q+1;/p-1	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1724	MEPENZOLATE BROMIDE	C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1.[Br-]	JRRNZNSGDSFFIR-UHFFFAOYSA-M	InChI=1S/C21H26NO3.BrH/c1-22(2)15-9-14-19(16-22)25-20(23)21(24,17-10-5-3-6-11-17)18-12-7-4-8-13-18;/h3-8,10-13,19,24H,9,14-16H2,1-2H3;1H/q+1;/p-1	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1626570	HEXOCYCLIUM METHYLSULFATE	COS(=O)(=O)[O-].C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1	NSILVESQCSUIAJ-UHFFFAOYSA-M	InChI=1S/C20H33N2O.CH4O4S/c1-22(2)15-13-21(14-16-22)17-20(23,18-9-5-3-6-10-18)19-11-7-4-8-12-19;1-5-6(2,3)4/h3,5-6,9-10,19,23H,4,7-8,11-17H2,1-2H3;1H3,(H,2,3,4)/q+1;/p-1	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1200880	DIPHEMANIL METHYLSULFATE	COS(=O)(=O)[O-].C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1	BREMLQBSKCSNNH-UHFFFAOYSA-M	InChI=1S/C20H24N.CH4O4S/c1-21(2)15-13-19(14-16-21)20(17-9-5-3-6-10-17)18-11-7-4-8-12-18;1-5-6(2,3)4/h3-12H,13-16H2,1-2H3;1H3,(H,2,3,4)/q+1;/p-1	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1200479	DICYCLOMINE HYDROCHLORIDE	CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1.Cl	GUBNMFJOJGDCEL-UHFFFAOYSA-N	InChI=1S/C19H35NO2.ClH/c1-3-20(4-2)15-16-22-18(21)19(13-9-6-10-14-19)17-11-7-5-8-12-17;/h17H,3-16H2,1-2H3;1H	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1768	BETHANECHOL CHLORIDE	CC(C[N+](C)(C)C)OC(N)=O.[Cl-]	XXRMYXBSBOVVBH-UHFFFAOYSA-N	InChI=1S/C7H16N2O2.ClH/c1-6(11-7(8)10)5-9(2,3)4;/h6H,5H2,1-4H3,(H-,8,10);1H	Muscarinic acetylcholine receptor M3 agonist	AGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1578	ANISOTROPINE METHYLBROMIDE	CCCC(CCC)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]2(C)C.[Br-]	QSFKGMJOKUZAJM-CNKDKAJDSA-M	InChI=1S/C17H32NO2.BrH/c1-5-7-13(8-6-2)17(19)20-16-11-14-9-10-15(12-16)18(14,3)4;/h13-16H,5-12H2,1-4H3;1H/q+1;/p-1/t14-,15+,16+;	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL2146146	ATROPINE SULFATE	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2.O=S(=O)(O)O	VJFQPODMEGSXHC-RIMUKSHESA-N	InChI=1S/C17H23NO3.H2O4S/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12;1-5(2,3)4/h2-6,13-16,19H,7-11H2,1H3;(H2,1,2,3,4)/t13-,14+,15+,16?;	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL517712	ATROPINE	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2	RKUNBYITZUJHSG-SPUOUPEWSA-N	InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15+,16?	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1200604	TROPICAMIDE	CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1	BGDKAVGWHJFAGW-UHFFFAOYSA-N	InChI=1S/C17H20N2O2/c1-2-19(12-14-8-10-18-11-9-14)17(21)16(13-20)15-6-4-3-5-7-15/h3-11,16,20H,2,12-13H2,1H3	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1200803	SOLIFENACIN SUCCINATE	O=C(O)CCC(=O)O.O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1	RXZMMZZRUPYENV-VROPFNGYSA-N	InChI=1S/C23H26N2O2.C4H6O4/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19;5-3(6)1-2-4(7)8/h1-9,18,21-22H,10-16H2;1-2H2,(H,5,6)(H,7,8)/t21-,22-;/m0./s1	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1200935	DARIFENACIN HYDROBROMIDE	Br.NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1	UQAVIASOPREUIT-VQIWEWKSSA-N	InChI=1S/C28H30N2O2.BrH/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26;/h1-12,19,25H,13-18,20H2,(H2,29,31);1H/t25-;/m1./s1	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL551466	ACLIDINIUM BROMIDE	O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]	XLAKJQPTOJHYDR-QTQXQZBYSA-M	InChI=1S/C26H30NO4S2.BrH/c28-25(26(29,23-9-4-17-32-23)24-10-5-18-33-24)31-22-19-27(14-11-20(22)12-15-27)13-6-16-30-21-7-2-1-3-8-21;/h1-5,7-10,17-18,20,22,29H,6,11-16,19H2;1H/q+1;/p-1/t20?,22-,27?;/m0./s1	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1200764	METHACHOLINE CHLORIDE	CC(=O)OC(C)C[N+](C)(C)C.[Cl-]	JHPHVAVFUYTVCL-UHFFFAOYSA-M	InChI=1S/C8H18NO2.ClH/c1-7(11-8(2)10)6-9(3,4)5;/h7H,6H2,1-5H3;1H/q+1;/p-1	Muscarinic acetylcholine receptor M3 agonist	AGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL3545181	TIOTROPIUM BROMIDE	C[N+]1(C)[C@H]2C[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@@H]1[C@H]1O[C@@H]21.O.[Br-]	MQLXPRBEAHBZTK-SEINRUQRSA-M	InChI=1S/C19H22NO4S2.BrH.H2O/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15;;/h3-8,11-13,16-17,22H,9-10H2,1-2H3;1H;1H2/q+1;;/p-1/t11-,12-,13+,16-,17+;;	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1201765	FESOTERODINE FUMARATE	CC(C)C(=O)Oc1ccc(CO)cc1[C@H](CCN(C(C)C)C(C)C)c1ccccc1.O=C(O)/C=C/C(=O)O	MWHXMIASLKXGBU-RNCYCKTQSA-N	InChI=1S/C26H37NO3.C4H4O4/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6;5-3(6)1-2-4(7)8/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t23-;/m1./s1	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1200473	CYCLOPENTOLATE HYDROCHLORIDE	CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1.Cl	RHKZVMUBMXGOLL-UHFFFAOYSA-N	InChI=1S/C17H25NO3.ClH/c1-18(2)12-13-21-16(19)15(14-8-4-3-5-9-14)17(20)10-6-7-11-17;/h3-5,8-9,15,20H,6-7,10-13H2,1-2H3;1H	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1184	ACETYLCHOLINE CHLORIDE	CC(=O)OCC[N+](C)(C)C.[Cl-]	JUGOREOARAHOCO-UHFFFAOYSA-M	InChI=1S/C7H16NO2.ClH/c1-7(9)10-6-5-8(2,3)4;/h5-6H2,1-4H3;1H/q+1;/p-1	Muscarinic acetylcholine receptor M3 agonist	AGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL14	CARBACHOL	C[N+](C)(C)CCOC(N)=O.[Cl-]	AIXAANGOTKPUOY-UHFFFAOYSA-N	InChI=1S/C6H14N2O2.ClH/c1-8(2,3)4-5-10-6(7)9;/h4-5H2,1-3H3,(H-,7,9);1H	Muscarinic acetylcholine receptor M3 agonist	AGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL550	PILOCARPINE	CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C	QCHFTSOMWOSFHM-WPRPVWTQSA-N	InChI=1S/C11H16N2O2/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2/h5,7-8,10H,3-4,6H2,1-2H3/t8-,10-/m0/s1	Muscarinic acetylcholine receptor M3 agonist	AGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1200330	PILOCARPINE HYDROCHLORIDE	CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C.Cl	RNAICSBVACLLGM-GNAZCLTHSA-N	InChI=1S/C11H16N2O2.ClH/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2;/h5,7-8,10H,3-4,6H2,1-2H3;1H/t8-,10-;/m0./s1	Muscarinic acetylcholine receptor M3 agonist	AGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1200826	LITHIUM CARBONATE	O=C([O-])[O-].[Li+].[Li+]	XGZVUEUWXADBQD-UHFFFAOYSA-L	InChI=1S/CH2O3.2Li/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2	Inositol-1(or 4)-monophosphatase 1 inhibitor	INHIBITOR	CHEMBL1786	Inositol-1(or 4)-monophosphatase 1	Homo sapiens
CHEMBL344159	TOLVAPTAN	Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1	GYHCTFXIZSNGJT-UHFFFAOYSA-N	InChI=1S/C26H25ClN2O3/c1-16-6-3-4-7-20(16)25(31)28-19-10-11-21(17(2)14-19)26(32)29-13-5-8-24(30)22-15-18(27)9-12-23(22)29/h3-4,6-7,9-12,14-15,24,30H,5,8,13H2,1-2H3,(H,28,31)	Vasopressin V2 receptor antagonist	ANTAGONIST	CHEMBL1790	Vasopressin V2 receptor	Homo sapiens
CHEMBL1201108	CONIVAPTAN HYDROCHLORIDE	Cc1nc2c([nH]1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2.Cl	BTYHAFSDANBVMJ-UHFFFAOYSA-N	InChI=1S/C32H26N4O2.ClH/c1-21-33-28-19-20-36(29-14-8-7-13-27(29)30(28)34-21)32(38)23-15-17-24(18-16-23)35-31(37)26-12-6-5-11-25(26)22-9-3-2-4-10-22;/h2-18H,19-20H2,1H3,(H,33,34)(H,35,37);1H	Vasopressin V2 receptor antagonist	ANTAGONIST	CHEMBL1790	Vasopressin V2 receptor	Homo sapiens
CHEMBL175247	ORLISTAT	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O	AHLBNYSZXLDEJQ-FWEHEUNISA-N	InChI=1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27-/m0/s1	Gastric lipase inhibitor	INHIBITOR	CHEMBL1796	Gastric lipase	Homo sapiens
CHEMBL603	ZAFIRLUKAST	COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12	YEEZWCHGZNKEEK-UHFFFAOYSA-N	InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)	Cysteinyl leukotriene receptor 1 antagonist	ANTAGONIST	CHEMBL1798	Cysteinyl leukotriene receptor 1	Homo sapiens
CHEMBL1200681	MONTELUKAST SODIUM	CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)[O-])CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1.[Na+]	LBFBRXGCXUHRJY-HKHDRNBDSA-M	InChI=1S/C35H36ClNO3S.Na/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29;/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39);/q;+1/p-1/b15-10+;/t32-;/m1./s1	Cysteinyl leukotriene receptor 1 antagonist	ANTAGONIST	CHEMBL1798	Cysteinyl leukotriene receptor 1	Homo sapiens
CHEMBL2103749	BIVALIRUDIN	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O	OIRCOABEOLEUMC-GEJPAHFPSA-N	InChI=1S/C98H138N24O33/c1-5-52(4)82(96(153)122-39-15-23-70(122)92(149)114-60(30-34-79(134)135)85(142)111-59(29-33-78(132)133)86(143)116-64(43-55-24-26-56(123)27-25-55)89(146)118-67(97(154)155)40-51(2)3)119-87(144)61(31-35-80(136)137)112-84(141)58(28-32-77(130)131)113-88(145)63(42-54-18-10-7-11-19-54)117-90(147)66(45-81(138)139)110-76(129)50-107-83(140)65(44-71(100)124)109-75(128)49-106-73(126)47-104-72(125)46-105-74(127)48-108-91(148)68-21-13-38-121(68)95(152)62(20-12-36-103-98(101)102)115-93(150)69-22-14-37-120(69)94(151)57(99)41-53-16-8-6-9-17-53/h6-11,16-19,24-27,51-52,57-70,82,123H,5,12-15,20-23,28-50,99H2,1-4H3,(H2,100,124)(H,104,125)(H,105,127)(H,106,126)(H,107,140)(H,108,148)(H,109,128)(H,110,129)(H,111,142)(H,112,141)(H,113,145)(H,114,149)(H,115,150)(H,116,143)(H,117,147)(H,118,146)(H,119,144)(H,130,131)(H,132,133)(H,134,135)(H,136,137)(H,138,139)(H,154,155)(H4,101,102,103)/t52-,57+,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,82-/m0/s1	Thrombin inhibitor	INHIBITOR	CHEMBL204	Thrombin	Homo sapiens
CHEMBL1615369	DABIGATRAN ETEXILATE MESYLATE	CCCCCCOC(=O)/N=C(\N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1.CS(=O)(=O)O	XETBXHPXHHOLOE-UHFFFAOYSA-N	InChI=1S/C34H41N7O5.CH4O3S/c1-4-6-7-10-21-46-34(44)39-32(35)24-12-15-26(16-13-24)37-23-30-38-27-22-25(14-17-28(27)40(30)3)33(43)41(20-18-31(42)45-5-2)29-11-8-9-19-36-29;1-5(2,3)4/h8-9,11-17,19,22,37H,4-7,10,18,20-21,23H2,1-3H3,(H2,35,39,44);1H3,(H,2,3,4)	Thrombin inhibitor	INHIBITOR	CHEMBL204	Thrombin	Homo sapiens
CHEMBL1166	ARGATROBAN	CC1CNc2c(cccc2S(=O)(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CC[C@@H](C)C[C@@H]2C(=O)O)C1	KXNPVXPOPUZYGB-IOVMHBDKSA-N	InChI=1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15?,17+,18-/m1/s1	Thrombin inhibitor	INHIBITOR	CHEMBL204	Thrombin	Homo sapiens
CHEMBL877	TRANEXAMIC ACID	NC[C@H]1CC[C@H](C(=O)O)CC1	GYDJEQRTZSCIOI-LJGSYFOKSA-N	InChI=1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)/t6-,7-	Plasminogen inhibitor	INHIBITOR	CHEMBL1801	Plasminogen	Homo sapiens
CHEMBL1046	AMINOCAPROIC ACID	NCCCCCC(=O)O	SLXKOJJOQWFEFD-UHFFFAOYSA-N	InChI=1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9)	Plasminogen inhibitor	INHIBITOR	CHEMBL1801	Plasminogen	Homo sapiens
CHEMBL220491	BRINZOLAMIDE	CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21	HCRKCZRJWPKOAR-JTQLQIEISA-N	InChI=1S/C12H21N3O5S3/c1-3-14-10-8-15(5-4-6-20-2)23(18,19)12-9(10)7-11(21-12)22(13,16)17/h7,10,14H,3-6,8H2,1-2H3,(H2,13,16,17)/t10-/m0/s1	Carbonic anhydrase II inhibitor	INHIBITOR	CHEMBL205	Carbonic anhydrase II	Homo sapiens
CHEMBL1201162	DORZOLAMIDE HYDROCHLORIDE	CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21.Cl	OSRUSFPMRGDLAG-QMGYSKNISA-N	InChI=1S/C10H16N2O4S3.ClH/c1-3-12-8-4-6(2)18(13,14)10-7(8)5-9(17-10)19(11,15)16;/h5-6,8,12H,3-4H2,1-2H3,(H2,11,15,16);1H/t6-,8-;/m0./s1	Carbonic anhydrase II inhibitor	INHIBITOR	CHEMBL205	Carbonic anhydrase II	Homo sapiens
CHEMBL17	DICHLORPHENAMIDE	NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1	GJQPMPFPNINLKP-UHFFFAOYSA-N	InChI=1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14)	Carbonic anhydrase II inhibitor	INHIBITOR	CHEMBL205	Carbonic anhydrase II	Homo sapiens
CHEMBL19	METHAZOLAMIDE	CC(=O)/N=c1/sc(S(N)(=O)=O)nn1C	FLOSMHQXBMRNHR-QPJJXVBHSA-N	InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12)/b7-4+	Carbonic anhydrase II inhibitor	INHIBITOR	CHEMBL205	Carbonic anhydrase II	Homo sapiens
CHEMBL220492	TOPIRAMATE	CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1	KJADKKWYZYXHBB-XBWDGYHZSA-N	InChI=1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1	Carbonic anhydrase II inhibitor	INHIBITOR	CHEMBL205	Carbonic anhydrase II	Homo sapiens
CHEMBL20	ACETAZOLAMIDE	CC(=O)Nc1nnc(S(N)(=O)=O)s1	BZKPWHYZMXOIDC-UHFFFAOYSA-N	InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)	Carbonic anhydrase II inhibitor	INHIBITOR	CHEMBL205	Carbonic anhydrase II	Homo sapiens
CHEMBL1200814	ACETAZOLAMIDE SODIUM	CC(=O)Nc1nnc(S([NH-])(=O)=O)s1.[Na+]	MRSXAJAOWWFZJJ-UHFFFAOYSA-M	InChI=1S/C4H6N4O3S2.Na/c1-2(9)6-3-7-8-4(12-3)13(5,10)11;/h1H3,(H3,5,6,7,9,10,11);/q;+1/p-1	Carbonic anhydrase II inhibitor	INHIBITOR	CHEMBL205	Carbonic anhydrase II	Homo sapiens
CHEMBL3039588	PASIREOTIDE DIASPARTATE	NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O.N[C@@H](CC(=O)O)C(=O)O.N[C@@H](CC(=O)O)C(=O)O	NEEFMPSSNFRRNC-PPCPDXGKSA-N	InChI=1S/C58H66N10O9.2C4H7NO4/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45;2*5-2(4(8)9)1-3(6)7/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72);2*2H,1,5H2,(H,6,7)(H,8,9)/t43-,46-,47-,48+,49-,50-,51-;2*2-/m000/s1	Somatostatin receptor 2 agonist	AGONIST	CHEMBL1804	Somatostatin receptor 2	Homo sapiens
CHEMBL1201003	ELETRIPTAN HYDROBROMIDE	Br.CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12	UTINOWOSWSPFLJ-FSRHSHDFSA-N	InChI=1S/C22H26N2O2S.BrH/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20;/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3;1H/t19-;/m1./s1	Serotonin 1f (5-HT1f) receptor agonist	AGONIST	CHEMBL1805	Serotonin 1f (5-HT1f) receptor	Homo sapiens
CHEMBL1200521	ALMOTRIPTAN MALATE	CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12.O=C(O)CC(O)C(=O)O	QHATUKWEVNMHRY-UHFFFAOYSA-N	InChI=1S/C17H25N3O2S.C4H6O5/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20;5-2(4(8)9)1-3(6)7/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3;2,5H,1H2,(H,6,7)(H,8,9)	Serotonin 1f (5-HT1f) receptor agonist	AGONIST	CHEMBL1805	Serotonin 1f (5-HT1f) receptor	Homo sapiens
CHEMBL1200645	ETOPOSIDE PHOSPHATE	COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OP(=O)(O)O	LIQODXNTTZAGID-OCBXBXKTSA-N	InChI=1S/C29H33O16P/c1-11-38-9-20-27(42-11)23(30)24(31)29(43-20)44-25-14-7-17-16(40-10-41-17)6-13(14)21(22-15(25)8-39-28(22)32)12-4-18(36-2)26(19(5-12)37-3)45-46(33,34)35/h4-7,11,15,20-25,27,29-31H,8-10H2,1-3H3,(H2,33,34,35)/t11-,15+,20-,21-,22+,23-,24-,25-,27-,29+/m1/s1	DNA topoisomerase II alpha inhibitor	INHIBITOR	CHEMBL1806	DNA topoisomerase II alpha	Homo sapiens
CHEMBL1200475	DAUNORUBICIN CITRATE	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.O=C(O)CC(O)(CC(=O)O)C(=O)O	VNTHYLVDGVBPOU-QQYBVWGSSA-N	InChI=1S/C27H29NO10.C6H8O7/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t10-,14-,16-,17-,22+,27-;/m0./s1	DNA topoisomerase II alpha inhibitor	INHIBITOR	CHEMBL1806	DNA topoisomerase II alpha	Homo sapiens
CHEMBL1563	DAUNORUBICIN HYDROCHLORIDE	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl	GUGHGUXZJWAIAS-QQYBVWGSSA-N	InChI=1S/C27H29NO10.ClH/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33;/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3;1H/t10-,14-,16-,17-,22+,27-;/m0./s1	DNA topoisomerase II alpha inhibitor	INHIBITOR	CHEMBL1806	DNA topoisomerase II alpha	Homo sapiens
CHEMBL359744	DOXORUBICIN HYDROCHLORIDE	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl	MWWSFMDVAYGXBV-RUELKSSGSA-N	InChI=1S/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,17-,22+,27-;/m0./s1	DNA topoisomerase II alpha inhibitor	INHIBITOR	CHEMBL1806	DNA topoisomerase II alpha	Homo sapiens
CHEMBL1417019	MITOXANTRONE HYDROCHLORIDE	Cl.Cl.O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21	ZAHQPTJLOCWVPG-UHFFFAOYSA-N	InChI=1S/C22H28N4O6.2ClH/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32;;/h1-4,23-30H,5-12H2;2*1H	DNA topoisomerase II alpha inhibitor	INHIBITOR	CHEMBL1806	DNA topoisomerase II alpha	Homo sapiens
CHEMBL1096885	VALRUBICIN	CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O	ZOCKGBMQLCSHFP-KQRAQHLDSA-N	InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22-,27+,33-/m0/s1	DNA topoisomerase II alpha inhibitor	INHIBITOR	CHEMBL1806	DNA topoisomerase II alpha	Homo sapiens
CHEMBL1200976	IDARUBICIN HYDROCHLORIDE	CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O.Cl	JVHPTYWUBOQMBP-RVFAQHLVSA-N	InChI=1S/C26H27NO9.ClH/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31;/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3;1H/t10-,15-,16-,17-,21+,26-;/m0./s1	DNA topoisomerase II alpha inhibitor	INHIBITOR	CHEMBL1806	DNA topoisomerase II alpha	Homo sapiens
CHEMBL1201011	QUINAPRIL HYDROCHLORIDE	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O.Cl	IBBLRJGOOANPTQ-JKVLGAQCSA-N	InChI=1S/C25H30N2O5.ClH/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30;/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30);1H/t17-,21-,22-;/m0./s1	Angiotensin-converting enzyme inhibitor	INHIBITOR	CHEMBL1808	Angiotensin-converting enzyme	Homo sapiens
CHEMBL1519	TRANDOLAPRIL	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21	VXFJYXUZANRPDJ-WTNASJBWSA-N	InChI=1S/C24H34N2O5/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29/h4-6,9-10,16,18-21,25H,3,7-8,11-15H2,1-2H3,(H,28,29)/t16-,18+,19-,20-,21-/m0/s1	Angiotensin-converting enzyme inhibitor	INHIBITOR	CHEMBL1808	Angiotensin-converting enzyme	Homo sapiens
CHEMBL1200534	MOEXIPRIL HYDROCHLORIDE	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(=O)O.Cl	JXRAXHBVZQZSIC-JKVLGAQCSA-N	InChI=1S/C27H34N2O7.ClH/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32;/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32);1H/t17-,21-,22-;/m0./s1	Angiotensin-converting enzyme inhibitor	INHIBITOR	CHEMBL1808	Angiotensin-converting enzyme	Homo sapiens
CHEMBL3989406	ENALAPRILAT	C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O.O	MZYVOFLIPYDBGD-MLZQUWKJSA-N	InChI=1S/C18H24N2O5.2H2O/c1-12(16(21)20-11-5-8-15(20)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13;;/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25);2*1H2/t12-,14-,15-;;/m0../s1	Angiotensin-converting enzyme inhibitor	INHIBITOR	CHEMBL1808	Angiotensin-converting enzyme	Homo sapiens
CHEMBL1168	RAMIPRIL	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21	HDACQVRGBOVJII-JBDAPHQKSA-N	InChI=1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1	Angiotensin-converting enzyme inhibitor	INHIBITOR	CHEMBL1808	Angiotensin-converting enzyme	Homo sapiens
CHEMBL3039596	FOSINOPRIL SODIUM	CCC(=O)O[C@@H](O[P@](=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)[O-])C(C)C.[Na+]	TVTJZMHAIQQZTL-WATAJHSMSA-M	InChI=1S/C30H46NO7P.Na/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24;/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35);/q;+1/p-1/t25-,26+,30+,39-;/m1./s1	Angiotensin-converting enzyme inhibitor	INHIBITOR	CHEMBL1808	Angiotensin-converting enzyme	Homo sapiens
CHEMBL1694	BENAZEPRIL HYDROCHLORIDE	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O.Cl	VPSRQEHTHIMDQM-FKLPMGAJSA-N	InChI=1S/C24H28N2O5.ClH/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28;/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28);1H/t19-,20-;/m0./s1	Angiotensin-converting enzyme inhibitor	INHIBITOR	CHEMBL1808	Angiotensin-converting enzyme	Homo sapiens
CHEMBL1560	CAPTOPRIL	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	FAKRSMQSSFJEIM-RQJHMYQMSA-N	InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1	Angiotensin-converting enzyme inhibitor	INHIBITOR	CHEMBL1808	Angiotensin-converting enzyme	Homo sapiens
CHEMBL1200343	PERINDOPRIL ERBUMINE	CC(C)(C)N.CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC	IYNMDWMQHSMDDE-MHXJNQAMSA-N	InChI=1S/C19H32N2O5.C4H11N/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24;1-4(2,3)5/h12-16,20H,4-11H2,1-3H3,(H,23,24);5H2,1-3H3/t12-,13-,14-,15-,16-;/m0./s1	Angiotensin-converting enzyme inhibitor	INHIBITOR	CHEMBL1808	Angiotensin-converting enzyme	Homo sapiens
CHEMBL419213	LISINOPRIL	NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O.O	CZRQXSDBMCMPNJ-ZUIPZQNBSA-N	InChI=1S/C21H31N3O5.2H2O/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15;;/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29);2*1H2/t16-,17-,18-;;/m0../s1	Angiotensin-converting enzyme inhibitor	INHIBITOR	CHEMBL1808	Angiotensin-converting enzyme	Homo sapiens
CHEMBL1200659	ENALAPRIL MALEATE	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O.O=C(O)/C=C\C(=O)O	OYFJQPXVCSSHAI-QFPUQLAESA-N	InChI=1S/C20H28N2O5.C4H4O4/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25;5-3(6)1-2-4(7)8/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25);1-2H,(H,5,6)(H,7,8)/b;2-1-/t14-,16-,17-;/m0./s1	Angiotensin-converting enzyme inhibitor	INHIBITOR	CHEMBL1808	Angiotensin-converting enzyme	Homo sapiens
CHEMBL1200831	SPIRAPRIL HYDROCHLORIDE	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2.Cl	CLDOLNORSLLQDI-OOAIBONUSA-N	InChI=1S/C22H30N2O5S2.ClH/c1-3-29-21(28)17(10-9-16-7-5-4-6-8-16)23-15(2)19(25)24-14-22(30-11-12-31-22)13-18(24)20(26)27;/h4-8,15,17-18,23H,3,9-14H2,1-2H3,(H,26,27);1H/t15-,17-,18-;/m0./s1	Angiotensin-converting enzyme inhibitor	INHIBITOR	CHEMBL1808	Angiotensin-converting enzyme	Homo sapiens
CHEMBL1472	PROTIRELIN	NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1	XNSAINXGIQZQOO-SRVKXCTJSA-N	InChI=1S/C16H22N6O4/c17-14(24)12-2-1-5-22(12)16(26)11(6-9-7-18-8-19-9)21-15(25)10-3-4-13(23)20-10/h7-8,10-12H,1-6H2,(H2,17,24)(H,18,19)(H,20,23)(H,21,25)/t10-,11-,12-/m0/s1	Thyrotropin-releasing hormone receptor agonist	AGONIST	CHEMBL1810	Thyrotropin-releasing hormone receptor	Homo sapiens
CHEMBL495	ALPROSTADIL	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O	GMVPRGQOIOIIMI-DWKJAMRDSA-N	InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,19+/m0/s1	Prostanoid EP1 receptor agonist	AGONIST	CHEMBL1811	Prostanoid EP1 receptor	Homo sapiens
CHEMBL98	VORINOSTAT	O=C(CCCCCCC(=O)Nc1ccccc1)NO	WAEXFXRVDQXREF-UHFFFAOYSA-N	InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)	Histone deacetylase 1 inhibitor	INHIBITOR	CHEMBL325	Histone deacetylase 1	Homo sapiens
CHEMBL175247	ORLISTAT	CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O	AHLBNYSZXLDEJQ-FWEHEUNISA-N	InChI=1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27-/m0/s1	Pancreatic lipase inhibitor	INHIBITOR	CHEMBL1812	Pancreatic lipase	Homo sapiens
CHEMBL1643	RIBAVIRIN	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1	IWUCXVSUMQZMFG-AFCXAGJDSA-N	InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	INHIBITOR	CHEMBL1822	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens
CHEMBL1201179	LAPATINIB DITOSYLATE	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1.O	XNRVGTHNYCNCFF-UHFFFAOYSA-N	InChI=1S/C29H26ClFN4O4S.2C7H8O3S.H2O/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19;2*1-6-2-4-7(5-3-6)11(8,9)10;/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35);2*2-5H,1H3,(H,8,9,10);1H2	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL3989885	TRIMEPRAZINE TARTRATE	CC(CN(C)C)CN1c2ccccc2Sc2ccccc21.CC(CN(C)C)CN1c2ccccc2Sc2ccccc21.O=C(O)C(O)C(O)C(=O)O	AJZJIYUOOJLBAU-UHFFFAOYSA-N	InChI=1S/2C18H22N2S.C4H6O6/c2*1-14(12-19(2)3)13-20-15-8-4-6-10-17(15)21-18-11-7-5-9-16(18)20;5-1(3(7)8)2(6)4(9)10/h2*4-11,14H,12-13H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200491	EPINASTINE HYDROCHLORIDE	Cl.NC1=NCC2c3ccccc3Cc3ccccc3N12	VKXSGUIOOQPGAF-UHFFFAOYSA-N	InChI=1S/C16H15N3.ClH/c17-16-18-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)19(15)16;/h1-8,15H,9-10H2,(H2,17,18);1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200497	CYCLIZINE LACTATE	CC(O)C(=O)O.CN1CCN(C(c2ccccc2)c2ccccc2)CC1	JOROEVAWQLGPFQ-UHFFFAOYSA-N	InChI=1S/C18H22N2.C3H6O3/c1-19-12-14-20(15-13-19)18(16-8-4-2-5-9-16)17-10-6-3-7-11-17;1-2(4)3(5)6/h2-11,18H,12-15H2,1H3;2,4H,1H3,(H,5,6)	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200618	FEXOFENADINE HYDROCHLORIDE	CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1.Cl	RRJFVPUCXDGFJB-UHFFFAOYSA-N	InChI=1S/C32H39NO4.ClH/c1-31(2,30(35)36)25-17-15-24(16-18-25)29(34)14-9-21-33-22-19-28(20-23-33)32(37,26-10-5-3-6-11-26)27-12-7-4-8-13-27;/h3-8,10-13,15-18,28-29,34,37H,9,14,19-23H2,1-2H3,(H,35,36);1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1716	CYPROHEPTADINE HYDROCHLORIDE	CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1.Cl	ZPMVNZLARAEGHB-UHFFFAOYSA-N	InChI=1S/C21H21N.ClH/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21;/h2-11H,12-15H2,1H3;1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL3544908	AZATADINE MALEATE	CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O	SGHXFFAHXTZRQM-SPIKMXEPSA-N	InChI=1S/C20H22N2.2C4H4O4/c1-22-13-10-16(11-14-22)19-18-7-3-2-5-15(18)8-9-17-6-4-12-21-20(17)19;2*5-3(6)1-2-4(7)8/h2-7,12H,8-11,13-14H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200638	DEXBROMPHENIRAMINE MALEATE	CN(C)CC[C@@H](c1ccc(Br)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O	SRGKFVAASLQVBO-DASCVMRKSA-N	InChI=1S/C16H19BrN2.C4H4O4/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13;5-3(6)1-2-4(7)8/h3-9,11,15H,10,12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t15-;/m0./s1	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200750	PROMETHAZINE HYDROCHLORIDE	CC(CN1c2ccccc2Sc2ccccc21)N(C)C.Cl	XXPDBLUZJRXNNZ-UHFFFAOYSA-N	InChI=1S/C17H20N2S.ClH/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19;/h4-11,13H,12H2,1-3H3;1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200809	AZELASTINE HYDROCHLORIDE	CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1.Cl	YEJAJYAHJQIWNU-UHFFFAOYSA-N	InChI=1S/C22H24ClN3O.ClH/c1-25-13-4-5-18(12-14-25)26-22(27)20-7-3-2-6-19(20)21(24-26)15-16-8-10-17(23)11-9-16;/h2-3,6-11,18H,4-5,12-15H2,1H3;1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200961	BROMPHENIRAMINE MALEATE	CN(C)CCC(c1ccc(Br)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O	SRGKFVAASLQVBO-BTJKTKAUSA-N	InChI=1S/C16H19BrN2.C4H4O4/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13;5-3(6)1-2-4(7)8/h3-9,11,15H,10,12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1201006	PYRILAMINE MALEATE	COc1ccc(CN(CCN(C)C)c2ccccn2)cc1.O=C(O)/C=C\C(=O)O	JXYWFNAQESKDNC-BTJKTKAUSA-N	InChI=1S/C17H23N3O.C4H4O4/c1-19(2)12-13-20(17-6-4-5-11-18-17)14-15-7-9-16(21-3)10-8-15;5-3(6)1-2-4(7)8/h4-11H,12-14H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1607273	CETIRIZINE HYDROCHLORIDE	Cl.Cl.O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	PGLIUCLTXOYQMV-UHFFFAOYSA-N	InChI=1S/C21H25ClN2O3.2ClH/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26;;/h1-9,21H,10-16H2,(H,25,26);2*1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1719	OLOPATADINE HYDROCHLORIDE	CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21.Cl	HVRLZEKDTUEKQH-NOILCQHBSA-N	InChI=1S/C21H23NO3.ClH/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24;/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24);1H/b18-8-;	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200532	METHDILAZINE HYDROCHLORIDE	CN1CCC(CN2c3ccccc3Sc3ccccc32)C1.Cl	IEISBKIVLDXSMZ-UHFFFAOYSA-N	InChI=1S/C18H20N2S.ClH/c1-19-11-10-14(12-19)13-20-15-6-2-4-8-17(15)21-18-9-5-3-7-16(18)20;/h2-9,14H,10-13H2,1H3;1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200927	DEXCHLORPHENIRAMINE MALEATE	CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O	DBAKFASWICGISY-DASCVMRKSA-N	InChI=1S/C16H19ClN2.C4H4O4/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13;5-3(6)1-2-4(7)8/h3-9,11,15H,10,12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t15-;/m0./s1	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL998	LORATADINE	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1	JCCNYMKQOSZNPW-UHFFFAOYSA-N	InChI=1S/C22H23ClN2O2/c1-2-27-22(26)25-12-9-15(10-13-25)20-19-8-7-18(23)14-17(19)6-5-16-4-3-11-24-21(16)20/h3-4,7-8,11,14H,2,5-6,9-10,12-13H2,1H3	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1659	CHLORPHENIRAMINE MALEATE	CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O	DBAKFASWICGISY-BTJKTKAUSA-N	InChI=1S/C16H19ClN2.C4H4O4/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13;5-3(6)1-2-4(7)8/h3-9,11,15H,10,12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200795	CLEMASTINE FUMARATE	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1.O=C(O)/C=C/C(=O)O	PMGQWSIVQFOFOQ-YKVZVUFRSA-N	InChI=1S/C21H26ClNO.C4H4O4/c1-21(17-7-4-3-5-8-17,18-10-12-19(22)13-11-18)24-16-14-20-9-6-15-23(20)2;5-3(6)1-2-4(7)8/h3-5,7-8,10-13,20H,6,9,14-16H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t20-,21-;/m1./s1	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1237102	LEVOCABASTINE HYDROCHLORIDE	C[C@@H]1CN([C@H]2CC[C@](C#N)(c3ccc(F)cc3)CC2)CC[C@]1(C(=O)O)c1ccccc1.Cl	OICFWWJHIMKBCD-VALQNVSPSA-N	InChI=1S/C26H29FN2O2.ClH/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20;/h2-10,19,23H,11-17H2,1H3,(H,30,31);1H/t19-,23-,25-,26-;/m1./s1	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200967	BROMODIPHENHYDRAMINE HYDROCHLORIDE	CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1.Cl	ZQDJSWUEGOYDGT-UHFFFAOYSA-N	InChI=1S/C17H20BrNO.ClH/c1-19(2)12-13-20-17(14-6-4-3-5-7-14)15-8-10-16(18)11-9-15;/h3-11,17H,12-13H2,1-2H3;1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1201068	PROPIOMAZINE HYDROCHLORIDE	CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2.Cl	UGVNGSMLNPWNNA-UHFFFAOYSA-N	InChI=1S/C20H24N2OS.ClH/c1-5-18(23)15-10-11-20-17(12-15)22(13-14(2)21(3)4)16-8-6-7-9-19(16)24-20;/h6-12,14H,5,13H2,1-4H3;1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL3989555	MECLIZINE HYDROCHLORIDE	Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1.Cl.Cl.O	KDLHYOMCWBWLMM-UHFFFAOYSA-N	InChI=1S/C25H27ClN2.2ClH.H2O/c1-20-6-5-7-21(18-20)19-27-14-16-28(17-15-27)25(22-8-3-2-4-9-22)23-10-12-24(26)13-11-23;;;/h2-13,18,25H,14-17,19H2,1H3;2*1H;1H2	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL3989520	HISTAMINE PHOSPHATE	NCCc1c[nH]cn1.O=P(O)(O)O.O=P(O)(O)O	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N	InChI=1S/C5H9N3.2H3O4P/c6-2-1-5-3-7-4-8-5;2*1-5(2,3)4/h3-4H,1-2,6H2,(H,7,8);2*(H3,1,2,3,4)	Histamine H1 receptor agonist	AGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200974	CARBINOXAMINE MALEATE	CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O	GVNWHCVWDRNXAZ-BTJKTKAUSA-N	InChI=1S/C16H19ClN2O.C4H4O4/c1-19(2)11-12-20-16(15-5-3-4-10-18-15)13-6-8-14(17)9-7-13;5-3(6)1-2-4(7)8/h3-10,16H,11-12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1201747	ALCAFTADINE	CN1CCC(=C2c3ccccc3CCn3c(C=O)cnc32)CC1	MWTBKTRZPHJQLH-UHFFFAOYSA-N	InChI=1S/C19H21N3O/c1-21-9-6-15(7-10-21)18-17-5-3-2-4-14(17)8-11-22-16(13-23)12-20-19(18)22/h2-5,12-13H,6-11H2,1H3	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1224	ACRIVASTINE	Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1	PWACSDKDOHSSQD-IUTFFREVSA-N	InChI=1S/C22H24N2O2/c1-17-7-9-18(10-8-17)20(13-16-24-14-2-3-15-24)21-6-4-5-19(23-21)11-12-22(25)26/h4-13H,2-3,14-16H2,1H3,(H,25,26)/b12-11+,20-13+	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL3188034	TRIPROLIDINE HYDROCHLORIDE	Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1.Cl.O	CUZMOIXUFHOLLN-UMVVUDSKSA-N	InChI=1S/C19H22N2.ClH.H2O/c1-16-7-9-17(10-8-16)18(19-6-2-3-12-20-19)11-15-21-13-4-5-14-21;;/h2-3,6-12H,4-5,13-15H2,1H3;1H;1H2/b18-11+;;	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200769	TRIPELENNAMINE CITRATE	CN(C)CCN(Cc1ccccc1)c1ccccn1.O=C(O)CC(O)(CC(=O)O)C(=O)O	GGRBYIUPUOYRLQ-UHFFFAOYSA-N	InChI=1S/C16H21N3.C6H8O7/c1-18(2)12-13-19(16-10-6-7-11-17-16)14-15-8-4-3-5-9-15;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-11H,12-14H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL3186993	HYDROXYZINE HYDROCHLORIDE	Cl.Cl.OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	ANOMHKZSQFYSBR-UHFFFAOYSA-N	InChI=1S/C21H27ClN2O2.2ClH/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25;;/h1-9,21,25H,10-17H2;2*1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1172	DESLORATADINE	Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1	JAUOIFJMECXRGI-UHFFFAOYSA-N	InChI=1S/C19H19ClN2/c20-16-5-6-17-15(12-16)4-3-14-2-1-9-22-19(14)18(17)13-7-10-21-11-8-13/h1-2,5-6,9,12,21H,3-4,7-8,10-11H2	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1620	DIPHENHYDRAMINE HYDROCHLORIDE	CN(C)CCOC(c1ccccc1)c1ccccc1.Cl	PCHPORCSPXIHLZ-UHFFFAOYSA-N	InChI=1S/C17H21NO.ClH/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;/h3-12,17H,13-14H2,1-2H3;1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1653	PHENIRAMINE MALEATE	CN(C)CCC(c1ccccc1)c1ccccn1.O=C(O)/C=C\C(=O)O	SSOXZAQUVINQSA-BTJKTKAUSA-N	InChI=1S/C16H20N2.C4H4O4/c1-18(2)13-11-15(14-8-4-3-5-9-14)16-10-6-7-12-17-16;5-3(6)1-2-4(7)8/h3-10,12,15H,11,13H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200392	DOXYLAMINE SUCCINATE	CN(C)CCOC(C)(c1ccccc1)c1ccccn1.O=C(O)CCC(=O)O	KBAUFVUYFNWQFM-UHFFFAOYSA-N	InChI=1S/C17H22N2O.C4H6O4/c1-17(20-14-13-19(2)3,15-9-5-4-6-10-15)16-11-7-8-12-18-16;5-3(6)1-2-4(7)8/h4-12H,13-14H2,1-3H3;1-2H2,(H,5,6)(H,7,8)	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200446	TRIPELENNAMINE HYDROCHLORIDE	CN(C)CCN(Cc1ccccc1)c1ccccn1.Cl	FSSICIQKZGUEAE-UHFFFAOYSA-N	InChI=1S/C16H21N3.ClH/c1-18(2)12-13-19(16-10-6-7-11-17-16)14-15-8-4-3-5-9-15;/h3-11H,12-14H2,1-2H3;1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200550	ANTAZOLINE PHOSPHATE	O=P(O)(O)O.c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1	DUIGUKRYYAGJAF-UHFFFAOYSA-N	InChI=1S/C17H19N3.H3O4P/c1-3-7-15(8-4-1)13-20(14-17-18-11-12-19-17)16-9-5-2-6-10-16;1-5(2,3)4/h1-10H,11-14H2,(H,18,19);(H3,1,2,3,4)	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1201190	LEVOCETIRIZINE DIHYDROCHLORIDE	Cl.Cl.O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1	PGLIUCLTXOYQMV-GHVWMZMZSA-N	InChI=1S/C21H25ClN2O3.2ClH/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26;;/h1-9,21H,10-16H2,(H,25,26);2*1H/t21-;;/m1../s1	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1201759	BEPOTASTINE BESYLATE	O=C(O)CCCN1CCC(O[C@@H](c2ccc(Cl)cc2)c2ccccn2)CC1.O=S(=O)(O)c1ccccc1	UDGHXQPQKQPSBB-BOXHHOBZSA-N	InChI=1S/C21H25ClN2O3.C6H6O3S/c22-17-8-6-16(7-9-17)21(19-4-1-2-12-23-19)27-18-10-14-24(15-11-18)13-3-5-20(25)26;7-10(8,9)6-4-2-1-3-5-6/h1-2,4,6-9,12,18,21H,3,5,10-11,13-15H2,(H,25,26);1-5H,(H,7,8,9)/t21-;/m0./s1	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1564	DIPHENYLPYRALINE HYDROCHLORIDE	CN1CCC(OC(c2ccccc2)c2ccccc2)CC1.Cl	LPRLDRXGWKXRMQ-UHFFFAOYSA-N	InChI=1S/C19H23NO.ClH/c1-20-14-12-18(13-15-20)21-19(16-8-4-2-5-9-16)17-10-6-3-7-11-17;/h2-11,18-19H,12-15H2,1H3;1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1633	KETOTIFEN FUMARATE	CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1.O=C(O)/C=C/C(=O)O	YNQQEYBLVYAWNX-WLHGVMLRSA-N	InChI=1S/C19H19NOS.C4H4O4/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19;5-3(6)1-2-4(7)8/h2-5,8,11H,6-7,9-10,12H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1+	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL2360580	BUCLIZINE HYDROCHLORIDE	CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1.Cl.Cl	SDBHDSZKNVDKNU-UHFFFAOYSA-N	InChI=1S/C28H33ClN2.2ClH/c1-28(2,3)25-13-9-22(10-14-25)21-30-17-19-31(20-18-30)27(23-7-5-4-6-8-23)24-11-15-26(29)16-12-24;;/h4-16,27H,17-21H2,1-3H3;2*1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200406	DIMENHYDRINATE	CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O	NFLLKCVHYJRNRH-UHFFFAOYSA-N	InChI=1S/C17H21NO.C7H7ClN4O2/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14/h3-12,17H,13-14H2,1-2H3;1-2H3,(H,9,10)	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL2103739	EMEDASTINE DIFUMARATE	CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O	FWLKKPKZQYVAFR-LVEZLNDCSA-N	InChI=1S/C17H26N4O.2C4H4O4/c1-3-22-14-13-21-16-8-5-4-7-15(16)18-17(21)20-10-6-9-19(2)11-12-20;2*5-3(6)1-2-4(7)8/h4-5,7-8H,3,6,9-14H2,1-2H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1+	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200959	METHDILAZINE	CN1CCC(CN2c3ccccc3Sc3ccccc32)C1	HTMIBDQKFHUPSX-UHFFFAOYSA-N	InChI=1S/C18H20N2S/c1-19-11-10-14(12-19)13-20-15-6-2-4-8-17(15)21-18-9-5-3-7-16(18)20/h2-9,14H,10-13H2,1H3	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1201089	DIPHENHYDRAMINE CITRATE	CN(C)CCOC(c1ccccc1)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O	SPCKHVPPRJWQRZ-UHFFFAOYSA-N	InChI=1S/C17H21NO.C6H8O7/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-12,17H,13-14H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1201023	ORPHENADRINE HYDROCHLORIDE	Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl	UQZKYYIKWZOKKD-UHFFFAOYSA-N	InChI=1S/C18H23NO.ClH/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;/h4-12,18H,13-14H2,1-3H3;1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200395	ORPHENADRINE CITRATE	Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O	MMMNTDFSPSQXJP-UHFFFAOYSA-N	InChI=1S/C18H23NO.C6H8O7/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-12,18H,13-14H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1689	TOLAZOLINE HYDROCHLORIDE	Cl.c1ccc(CC2=NCCN2)cc1	RHTNTTODYGNRSP-UHFFFAOYSA-N	InChI=1S/C10H12N2.ClH/c1-2-4-9(5-3-1)8-10-11-6-7-12-10;/h1-5H,6-8H2,(H,11,12);1H	Histamine H1 receptor agonist	AGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200948	TRIMIPRAMINE MALEATE	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21.O=C(O)/C=C\C(=O)O	YDGHCKHAXOUQOS-BTJKTKAUSA-N	InChI=1S/C20H26N2.C4H4O4/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22;5-3(6)1-2-4(7)8/h4-11,16H,12-15H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL779	TADALAFIL	CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3c(c2)OCO3)C1=O	WOXKDUGGOYFFRN-IIBYNOLFSA-N	InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1	Phosphodiesterase 5A inhibitor	INHIBITOR	CHEMBL1827	Phosphodiesterase 5A	Homo sapiens
CHEMBL1339	VARDENAFIL HYDROCHLORIDE	CCCc1nc(C)c2c(O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)nn12.Cl	XCMULUAPJXCOHI-UHFFFAOYSA-N	InChI=1S/C23H32N6O4S.ClH/c1-5-8-20-24-16(4)21-23(30)25-22(26-29(20)21)18-15-17(9-10-19(18)33-7-3)34(31,32)28-13-11-27(6-2)12-14-28;/h9-10,15H,5-8,11-14H2,1-4H3,(H,25,26,30);1H	Phosphodiesterase 5A inhibitor	INHIBITOR	CHEMBL1827	Phosphodiesterase 5A	Homo sapiens
CHEMBL1737	SILDENAFIL CITRATE	CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12.O=C(O)CC(O)(CC(=O)O)C(=O)O	DEIYFTQMQPDXOT-UHFFFAOYSA-N	InChI=1S/C22H30N6O4S.C6H8O7/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28;7-3(8)1-6(13,5(11)12)2-4(9)10/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)	Phosphodiesterase 5A inhibitor	INHIBITOR	CHEMBL1827	Phosphodiesterase 5A	Homo sapiens
CHEMBL1963681	AVANAFIL	COc1ccc(C/N=c2\[nH]c(N3CCC[C@H]3CO)ncc2C(=O)NCc2ncccn2)cc1Cl	WEAJZXNPAWBCOA-INIZCTEOSA-N	InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1	Phosphodiesterase 5A inhibitor	INHIBITOR	CHEMBL1827	Phosphodiesterase 5A	Homo sapiens
CHEMBL98	VORINOSTAT	O=C(CCCCCCC(=O)Nc1ccccc1)NO	WAEXFXRVDQXREF-UHFFFAOYSA-N	InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)	Histone deacetylase 3 inhibitor	INHIBITOR	CHEMBL1829	Histone deacetylase 3	Homo sapiens
CHEMBL2359670	THIETHYLPERAZINE MALATE	CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2.O=C(O)CC(O)C(=O)O.O=C(O)CC(O)C(=O)O	GTHHLZDYRHLACN-UHFFFAOYSA-N	InChI=1S/C22H29N3S2.2C4H6O5/c1-3-26-18-9-10-22-20(17-18)25(19-7-4-5-8-21(19)27-22)12-6-11-24-15-13-23(2)14-16-24;2*5-2(4(8)9)1-3(6)7/h4-5,7-10,17H,3,6,11-16H2,1-2H3;2*2,5H,1H2,(H,6,7)(H,8,9)	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL3989478	THIETHYLPERAZINE MALEATE	CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O	RVBRTNPNFYFDMZ-SPIKMXEPSA-N	InChI=1S/C22H29N3S2.2C4H4O4/c1-3-26-18-9-10-22-20(17-18)25(19-7-4-5-8-21(19)27-22)12-6-11-24-15-13-23(2)14-16-24;2*5-3(6)1-2-4(7)8/h4-5,7-10,17H,3,6,11-16H2,1-2H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1200951	FLUPHENAZINE ENANTHATE	CCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	LRWSFOSWNAQHHW-UHFFFAOYSA-N	InChI=1S/C29H38F3N3O2S/c1-2-3-4-5-11-28(36)37-21-20-34-18-16-33(17-19-34)14-8-15-35-24-9-6-7-10-26(24)38-27-13-12-23(22-25(27)35)29(30,31)32/h6-7,9-10,12-13,22H,2-5,8,11,14-21H2,1H3	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL567	PERPHENAZINE	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1	RGCVKNLCSQQDEP-UHFFFAOYSA-N	InChI=1S/C21H26ClN3OS/c22-17-6-7-21-19(16-17)25(18-4-1-2-5-20(18)27-21)9-3-8-23-10-12-24(13-11-23)14-15-26/h1-2,4-7,16,26H,3,8-15H2	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1200707	BENZQUINAMIDE HYDROCHLORIDE	CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(C)=O.Cl	KZLNXGBVFTWMPS-UHFFFAOYSA-N	InChI=1S/C22H32N2O5.ClH/c1-6-23(7-2)22(26)17-13-24-9-8-15-10-20(27-4)21(28-5)11-16(15)18(24)12-19(17)29-14(3)25;/h10-11,17-19H,6-9,12-13H2,1-5H3;1H	Dopamine D2 receptor modulator	MODULATOR	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL728	PROCHLORPERAZINE	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1	WIKYUJGCLQQFNW-UHFFFAOYSA-N	InChI=1S/C20H24ClN3S/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24/h2-3,5-8,15H,4,9-14H2,1H3	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1448187	FLUPHENAZINE HYDROCHLORIDE	Cl.Cl.OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	MBHNWCYEGXQEIT-UHFFFAOYSA-N	InChI=1S/C22H26F3N3OS.2ClH/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29;;/h1-2,4-7,16,29H,3,8-15H2;2*1H	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1201087	CABERGOLINE	C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21	KORNTPPJEAJQIU-KJXAQDMKSA-N	InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1	Dopamine D2 receptor agonist	AGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1314751	PROCHLORPERAZINE MALEATE	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O	DSKIOWHQLUWFLG-SPIKMXEPSA-N	InChI=1S/C20H24ClN3S.2C4H4O4/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24;2*5-3(6)1-2-4(7)8/h2-3,5-8,15H,4,9-14H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1200854	FLUPHENAZINE DECANOATE	CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1	VIQCGTZFEYDQMR-UHFFFAOYSA-N	InChI=1S/C32H44F3N3O2S/c1-2-3-4-5-6-7-8-14-31(39)40-24-23-37-21-19-36(20-22-37)17-11-18-38-27-12-9-10-13-29(27)41-30-16-15-26(25-28(30)38)32(33,34)35/h9-10,12-13,15-16,25H,2-8,11,14,17-24H2,1H3	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL2360079	ACETOPHENAZINE MALEATE	CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O	NUKVZKPNSKJGBK-SPIKMXEPSA-N	InChI=1S/C23H29N3O2S.2C4H4O4/c1-18(28)19-7-8-23-21(17-19)26(20-5-2-3-6-22(20)29-23)10-4-9-24-11-13-25(14-12-24)15-16-27;2*5-3(6)1-2-4(7)8/h2-3,5-8,17,27H,4,9-16H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL908	CHLORPROTHIXENE	CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21	WSPOMRSOLSGNFJ-AUWJEWJLSA-N	InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7-	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1201102	TRIFLUPROMAZINE HYDROCHLORIDE	CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21.Cl	FTNWXGFYRHWUKG-UHFFFAOYSA-N	InChI=1S/C18H19F3N2S.ClH/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(12-15(17)23)18(19,20)21;/h3-4,6-9,12H,5,10-11H2,1-2H3;1H	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL3544974	ASENAPINE MALEATE	CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1.O=C(O)/C=C\C(=O)O	GMDCDXMAFMEDAG-BTJKTKAUSA-N	InChI=1S/C17H16ClNO.C4H4O4/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19;5-3(6)1-2-4(7)8/h2-8,14-15H,9-10H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1112	ARIPIPRAZOLE	O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1	CEUORZQYGODEFX-UHFFFAOYSA-N	InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)	Dopamine D2 receptor partial agonist	PARTIAL AGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL2107360	PALIPERIDONE PALMITATE	CCCCCCCCCCCCCCCC(=O)OC1CCCn2c1nc(C)c(CCN1CCC(c3noc4cc(F)ccc34)CC1)c2=O	VOMKSBFLAZZBOW-UHFFFAOYSA-N	InChI=1S/C39H57FN4O4/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-18-36(45)47-34-17-16-24-44-38(34)41-29(2)32(39(44)46)23-27-43-25-21-30(22-26-43)37-33-20-19-31(40)28-35(33)48-42-37/h19-20,28,30,34H,3-18,21-27H2,1-2H3	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL14376	ILOPERIDONE	COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1	XMXHEBAFVSFQEX-UHFFFAOYSA-N	InChI=1S/C24H27FN2O4/c1-16(28)18-4-7-21(23(14-18)29-2)30-13-3-10-27-11-8-17(9-12-27)24-20-6-5-19(25)15-22(20)31-26-24/h4-7,14-15,17H,3,8-13H2,1-2H3	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1201052	MESORIDAZINE BESYLATE	CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21.O=S(=O)(O)c1ccccc1	CRJHBCPQHRVYBS-UHFFFAOYSA-N	InChI=1S/C21H26N2OS2.C6H6O3S/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(26(2)24)15-19(21)23;7-10(8,9)6-4-2-1-3-5-6/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1-5H,(H,7,8,9)	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1200940	METOCLOPRAMIDE HYDROCHLORIDE	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC.Cl.O	KJBLQGHJOCAOJP-UHFFFAOYSA-N	InChI=1S/C14H22ClN3O2.ClH.H2O/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3;;/h8-9H,4-7,16H2,1-3H3,(H,17,19);1H;1H2	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1200419	MOLINDONE HYDROCHLORIDE	CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2.Cl	GQWNECFJGBQMBO-UHFFFAOYSA-N	InChI=1S/C16H24N2O2.ClH/c1-3-13-11(2)17-14-5-4-12(16(19)15(13)14)10-18-6-8-20-9-7-18;/h12,17H,3-10H2,1-2H3;1H	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1621	PALIPERIDONE	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O	PMXMIIMHBWHSKN-UHFFFAOYSA-N	InChI=1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1201	THIOTHIXENE	CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1	GFBKORZTTCHDGY-UWVJOHFNSA-N	InChI=1S/C23H29N3O2S2/c1-24(2)30(27,28)18-10-11-23-21(17-18)19(20-7-4-5-9-22(20)29-23)8-6-12-26-15-13-25(3)14-16-26/h4-5,7-11,17H,6,12-16H2,1-3H3/b19-8-	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL3989824	THIOTHIXENE HYDROCHLORIDE	CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1.Cl.Cl.O.O	MEUAAEMCZUPORO-LRSHZYOCSA-N	InChI=1S/C23H29N3O2S2.2ClH.2H2O/c1-24(2)30(27,28)18-10-11-23-21(17-18)19(20-7-4-5-9-22(20)29-23)8-6-12-26-15-13-25(3)14-16-26;;;;/h4-5,7-11,17H,6,12-16H2,1-3H3;2*1H;2*1H2/b19-8-;;;;	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL570	TRIFLUPROMAZINE	CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21	XSCGXQMFQXDFCW-UHFFFAOYSA-N	InChI=1S/C18H19F3N2S/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(12-15(17)23)18(19,20)21/h3-4,6-9,12H,5,10-11H2,1-2H3	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1200948	TRIMIPRAMINE MALEATE	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21.O=C(O)/C=C\C(=O)O	YDGHCKHAXOUQOS-BTJKTKAUSA-N	InChI=1S/C20H26N2.C4H4O4/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22;5-3(6)1-2-4(7)8/h4-11,16H,12-15H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL2103795	AZILSARTAN KAMEDOXOMIL	CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[n-]2)cc1.[K+]	IHWFKDWIUSZLCJ-UHFFFAOYSA-M	InChI=1S/C30H24N4O8.K/c1-3-38-28-31-23-10-6-9-22(27(35)39-16-24-17(2)40-30(37)41-24)25(23)34(28)15-18-11-13-19(14-12-18)20-7-4-5-8-21(20)26-32-29(36)42-33-26;/h4-14H,3,15-16H2,1-2H3,(H,32,33,36);/q;+1/p-1	Type-1 angiotensin II receptor antagonist	ANTAGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL995	LOSARTAN POTASSIUM	CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[n-]n2)cc1.[K+]	OXCMYAYHXIHQOA-UHFFFAOYSA-N	InChI=1S/C22H22ClN6O.K/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22;/h4-7,9-12,30H,2-3,8,13-14H2,1H3;/q-1;+1	Type-1 angiotensin II receptor antagonist	ANTAGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL1513	IRBESARTAN	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1	YOSHYTLCDANDAN-UHFFFAOYSA-N	InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)	Type-1 angiotensin II receptor antagonist	ANTAGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL1069	VALSARTAN	CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C	ACWBQPMHZXGDFX-QFIPXVFZSA-N	InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1	Type-1 angiotensin II receptor antagonist	ANTAGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL1200670	SARALASIN ACETATE	CC(=O)O.CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C.O	YBZYNINTWCLDQA-UHKVWXOHSA-N	InChI=1S/C42H65N13O10.C2H4O2.H2O/c1-22(2)33(53-35(58)28(50-32(57)20-45-6)9-7-15-47-42(43)44)38(61)51-29(17-25-11-13-27(56)14-12-25)36(59)54-34(23(3)4)39(62)52-30(18-26-19-46-21-48-26)40(63)55-16-8-10-31(55)37(60)49-24(5)41(64)65;1-2(3)4;/h11-14,19,21-24,28-31,33-34,45,56H,7-10,15-18,20H2,1-6H3,(H,46,48)(H,49,60)(H,50,57)(H,51,61)(H,52,62)(H,53,58)(H,54,59)(H,64,65)(H4,43,44,47);1H3,(H,3,4);1H2/t24-,28-,29-,30-,31-,33-,34-;;/m0../s1	Type-1 angiotensin II receptor antagonist	ANTAGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL1200692	OLMESARTAN MEDOXOMIL	CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1	UQGKUQLKSCSZGY-UHFFFAOYSA-N	InChI=1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34)	Type-1 angiotensin II receptor antagonist	ANTAGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL1014	CANDESARTAN CILEXETIL	CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1	GHOSNRCGJFBJIB-UHFFFAOYSA-N	InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)	Type-1 angiotensin II receptor antagonist	ANTAGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL1200987	EPROSARTAN MESYLATE	CCCCc1ncc(/C=C(\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1.CS(=O)(=O)O	DJSLTDBPKHORNY-XMMWENQYSA-N	InChI=1S/C23H24N2O4S.CH4O3S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27;1-5(2,3)4/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29);1H3,(H,2,3,4)/b18-12+;	Type-1 angiotensin II receptor antagonist	ANTAGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL1017	TELMISARTAN	CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1	RMMXLENWKUUMAY-UHFFFAOYSA-N	InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)	Type-1 angiotensin II receptor antagonist	ANTAGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL1200843	METHYLERGONOVINE MALEATE	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1.O=C(O)/C=C\C(=O)O	NOFOWWRHEPHDCY-DAUURJMHSA-N	InChI=1S/C20H25N3O2.C4H4O4/c1-3-14(11-24)22-20(25)13-7-16-15-5-4-6-17-19(15)12(9-21-17)8-18(16)23(2)10-13;5-3(6)1-2-4(7)8/h4-7,9,13-14,18,21,24H,3,8,10-11H2,1-2H3,(H,22,25);1-2H,(H,5,6)(H,7,8)/b;2-1-/t13-,14+,18-;/m1./s1	Serotonin 2b (5-HT2b) receptor partial agonist	PARTIAL AGONIST	CHEMBL1833	Serotonin 2b (5-HT2b) receptor	Homo sapiens
CHEMBL3989558	METHYSERGIDE MALEATE	CCC(CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1.O=C(O)/C=C\C(=O)O	LWYXFDXUMVEZKS-TZTNOGQLSA-N	InChI=1S/C21H27N3O2.C4H4O4/c1-4-15(12-25)22-21(26)14-8-17-16-6-5-7-18-20(16)13(10-23(18)2)9-19(17)24(3)11-14;5-3(6)1-2-4(7)8/h5-8,10,14-15,19,25H,4,9,11-12H2,1-3H3,(H,22,26);1-2H,(H,5,6)(H,7,8)/b;2-1-/t14-,15?,19-;/m1./s1	Serotonin 2b (5-HT2b) receptor antagonist	ANTAGONIST	CHEMBL1833	Serotonin 2b (5-HT2b) receptor	Homo sapiens
CHEMBL1515	METHIMAZOLE	Cn1cc[nH]c1=S	PMRYVIKBURPHAH-UHFFFAOYSA-N	InChI=1S/C4H6N2S/c1-6-3-2-5-4(6)7/h2-3H,1H3,(H,5,7)	Thyroid peroxidase inhibitor	INHIBITOR	CHEMBL1839	Thyroid peroxidase	Homo sapiens
CHEMBL1518	PROPYLTHIOURACIL	CCCc1cc(=O)[nH]c(=S)[nH]1	KNAHARQHSZJURB-UHFFFAOYSA-N	InChI=1S/C7H10N2OS/c1-2-3-5-4-6(10)9-7(11)8-5/h4H,2-3H2,1H3,(H2,8,9,10,11)	Thyroid peroxidase inhibitor	INHIBITOR	CHEMBL1839	Thyroid peroxidase	Homo sapiens
CHEMBL1200748	CARBIDOPA	C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O	QTAOMKOIBXZKND-PPHPATTJSA-N	InChI=1S/C10H14N2O4.H2O/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6;/h2-4,12-14H,5,11H2,1H3,(H,15,16);1H2/t10-;/m0./s1	DOPA decarboxylase inhibitor	INHIBITOR	CHEMBL1843	DOPA decarboxylase	Homo sapiens
CHEMBL1201733	PAZOPANIB HYDROCHLORIDE	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O.Cl	MQHIQUBXFFAOMK-UHFFFAOYSA-N	InChI=1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	CHEMBL1844	Macrophage colony stimulating factor receptor	Homo sapiens
CHEMBL1567	SUNITINIB MALATE	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O	LBWFXVZLPYTWQI-IPOVEDGCSA-N	InChI=1S/C22H27FN4O2.C4H6O5/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28;5-2(4(8)9)1-3(6)7/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28);2,5H,1H2,(H,6,7)(H,8,9)/b17-12-;/t;2-/m.0/s1	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	CHEMBL1844	Macrophage colony stimulating factor receptor	Homo sapiens
CHEMBL24778	SILODOSIN	C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F	PNCPYILNMDWPEY-QGZVFWFLSA-N	InChI=1S/C25H32F3N3O4/c1-17(30-8-12-34-21-5-2-3-6-22(21)35-16-25(26,27)28)13-18-14-19-7-10-31(9-4-11-32)23(19)20(15-18)24(29)33/h2-3,5-6,14-15,17,30,32H,4,7-13,16H2,1H3,(H2,29,33)/t17-/m1/s1	Alpha-1a adrenergic receptor antagonist	ANTAGONIST	CHEMBL229	Alpha-1a adrenergic receptor	Homo sapiens
CHEMBL1201044	DAPIPRAZOLE HYDROCHLORIDE	Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1.Cl	ZIODNPFQZIHCOE-UHFFFAOYSA-N	InChI=1S/C19H27N5.ClH/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19;/h2-3,6-7H,4-5,8-15H2,1H3;1H	Alpha-1a adrenergic receptor antagonist	ANTAGONIST	CHEMBL229	Alpha-1a adrenergic receptor	Homo sapiens
CHEMBL1200695	PHENYLPROPANOLAMINE HYDROCHLORIDE	CC(N)C(O)c1ccccc1.Cl	DYWNLSQWJMTVGJ-UHFFFAOYSA-N	InChI=1S/C9H13NO.ClH/c1-7(10)9(11)8-5-3-2-4-6-8;/h2-7,9,11H,10H2,1H3;1H	Alpha-1a adrenergic receptor agonist	AGONIST	CHEMBL229	Alpha-1a adrenergic receptor	Homo sapiens
CHEMBL1079742	ERLOTINIB HYDROCHLORIDE	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1.Cl	GTTBEUCJPZQMDZ-UHFFFAOYSA-N	InChI=1S/C22H23N3O4.ClH/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1H	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL939	GEFITINIB	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1	XGALLCVXEZPNRQ-UHFFFAOYSA-N	InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL1201179	LAPATINIB DITOSYLATE	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1.O	XNRVGTHNYCNCFF-UHFFFAOYSA-N	InChI=1S/C29H26ClFN4O4S.2C7H8O3S.H2O/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19;2*1-6-2-4-7(5-3-6)11(8,9)10;/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35);2*2-5H,1H3,(H,8,9,10);1H2	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL1009	LEVODOPA	N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O	WTDRDQBEARUVNC-LURJTMIESA-N	InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1	Dopamine D3 receptor agonist	AGONIST	CHEMBL234	Dopamine D3 receptor	Homo sapiens
CHEMBL908	CHLORPROTHIXENE	CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21	WSPOMRSOLSGNFJ-AUWJEWJLSA-N	InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7-	Dopamine D3 receptor antagonist	ANTAGONIST	CHEMBL234	Dopamine D3 receptor	Homo sapiens
CHEMBL928	DANTROLENE SODIUM	O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)[N-]1.[Na+]	KSRLIXGNPXAZHD-HAZZGOGXSA-M	InChI=1S/C14H10N4O5.Na/c19-13-8-17(14(20)16-13)15-7-11-5-6-12(23-11)9-1-3-10(4-2-9)18(21)22;/h1-7H,8H2,(H,16,19,20);/q;+1/p-1/b15-7+;	Ryanodine receptor 1 antagonist	ANTAGONIST	CHEMBL1846	Ryanodine receptor 1	Homo sapiens
CHEMBL64	ISONIAZID	NNC(=O)c1ccncc1	QRXWMOHMRWLFEY-UHFFFAOYSA-N	InChI=1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10)	Enoyl-[acyl-carrier-protein] reductase inhibitor	INHIBITOR	CHEMBL1849	Enoyl-[acyl-carrier-protein] reductase	Mycobacterium tuberculosis
CHEMBL1441	ETHIONAMIDE	CCc1cc(C(N)=S)ccn1	AEOCXXJPGCBFJA-UHFFFAOYSA-N	InChI=1S/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11)	Enoyl-[acyl-carrier-protein] reductase inhibitor	INHIBITOR	CHEMBL1849	Enoyl-[acyl-carrier-protein] reductase	Mycobacterium tuberculosis
CHEMBL2103735	CETRORELIX ACETATE	CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O.CC(=O)O	KFEFLCOCAHJBEA-ANRVCLKPSA-N	InChI=1S/C70H92ClN17O14.C2H4O2/c1-39(2)31-52(61(94)82-51(15-9-28-77-69(73)74)68(101)88-30-10-16-58(88)67(100)79-40(3)59(72)92)83-60(93)50(14-8-29-78-70(75)102)81-63(96)54(34-43-20-25-49(91)26-21-43)86-66(99)57(38-89)87-65(98)56(36-45-11-7-27-76-37-45)85-64(97)55(33-42-18-23-48(71)24-19-42)84-62(95)53(80-41(4)90)35-44-17-22-46-12-5-6-13-47(46)32-44;1-2(3)4/h5-7,11-13,17-27,32,37,39-40,50-58,89,91H,8-10,14-16,28-31,33-36,38H2,1-4H3,(H2,72,92)(H,79,100)(H,80,90)(H,81,96)(H,82,94)(H,83,93)(H,84,95)(H,85,97)(H,86,99)(H,87,98)(H4,73,74,77)(H3,75,78,102);1H3,(H,3,4)/t40-,50-,51+,52+,53-,54+,55-,56-,57+,58+;/m1./s1	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL1200671	NAFARELIN ACETATE	CC(=O)O.CC(C)C[C@H](NC(=O)[C@@H](Cc1cccc2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O	FUCZIEGYURIPAY-CFWZQLQRSA-N	InChI=1S/C66H83N17O13.C2H4O2/c1-36(2)26-48(58(89)76-47(16-8-24-71-66(68)69)65(96)83-25-9-17-54(83)64(95)73-33-55(67)86)77-60(91)50(28-39-12-7-11-38-10-3-4-13-43(38)39)79-59(90)49(27-37-18-20-42(85)21-19-37)78-63(94)53(34-84)82-61(92)51(29-40-31-72-45-15-6-5-14-44(40)45)80-62(93)52(30-41-32-70-35-74-41)81-57(88)46-22-23-56(87)75-46;1-2(3)4/h3-7,10-15,18-21,31-32,35-36,46-54,72,84-85H,8-9,16-17,22-30,33-34H2,1-2H3,(H2,67,86)(H,70,74)(H,73,95)(H,75,87)(H,76,89)(H,77,91)(H,78,94)(H,79,90)(H,80,93)(H,81,88)(H,82,92)(H4,68,69,71);1H3,(H,3,4)/t46-,47-,48-,49-,50+,51-,52-,53-,54-;/m0./s1	Gonadotropin-releasing hormone receptor agonist	AGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL1200511	GONADORELIN ACETATE	CC(=O)O.CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O	NGCGMRBZPXEPOZ-HBBGHHHDSA-N	InChI=1S/C55H75N17O13.C2H4O2/c1-29(2)19-38(49(80)67-37(9-5-17-60-55(57)58)54(85)72-18-6-10-43(72)53(84)62-25-44(56)75)66-46(77)26-63-47(78)39(20-30-11-13-33(74)14-12-30)68-52(83)42(27-73)71-50(81)40(21-31-23-61-35-8-4-3-7-34(31)35)69-51(82)41(22-32-24-59-28-64-32)70-48(79)36-15-16-45(76)65-36;1-2(3)4/h3-4,7-8,11-14,23-24,28-29,36-43,61,73-74H,5-6,9-10,15-22,25-27H2,1-2H3,(H2,56,75)(H,59,64)(H,62,84)(H,63,78)(H,65,76)(H,66,77)(H,67,80)(H,68,83)(H,69,82)(H,70,79)(H,71,81)(H4,57,58,60);1H3,(H,3,4)/t36-,37-,38-,39-,40-,41-,42-,43-;/m0./s1	Gonadotropin-releasing hormone receptor agonist	AGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL1252	ABARELIX	CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N(C)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O	AIWRTTMUVOZGPW-HSPKUQOVSA-N	InChI=1S/C72H95ClN14O14/c1-41(2)32-54(64(93)80-53(17-10-11-30-77-42(3)4)72(101)87-31-13-18-60(87)69(98)78-43(5)63(75)92)81-68(97)58(38-62(74)91)84-70(99)61(37-46-22-27-52(90)28-23-46)86(7)71(100)59(40-88)85-67(96)57(36-48-14-12-29-76-39-48)83-66(95)56(34-45-20-25-51(73)26-21-45)82-65(94)55(79-44(6)89)35-47-19-24-49-15-8-9-16-50(49)33-47/h8-9,12,14-16,19-29,33,39,41-43,53-61,77,88,90H,10-11,13,17-18,30-32,34-38,40H2,1-7H3,(H2,74,91)(H2,75,92)(H,78,98)(H,79,89)(H,80,93)(H,81,97)(H,82,94)(H,83,95)(H,84,99)(H,85,96)/t43-,53+,54+,55-,56-,57-,58-,59+,60+,61+/m1/s1	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL2028987	DEGARELIX ACETATE	CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(NC(=O)[C@@H]2CC(=O)NC(=O)N2)cc1)C(=O)N[C@H](Cc1ccc(NC(N)=O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O.CC(=O)O	AUTFSFUMNFDPLH-KYMMNHPFSA-N	InChI=1S/C82H103ClN18O16.C2H4O2/c1-45(2)35-60(72(107)92-59(16-9-10-33-87-46(3)4)80(115)101-34-12-17-68(101)79(114)88-47(5)70(84)105)93-74(109)63(38-51-23-30-58(31-24-51)91-81(85)116)95-76(111)64(39-50-21-28-57(29-22-50)90-71(106)66-42-69(104)100-82(117)99-66)97-78(113)67(44-102)98-77(112)65(41-53-13-11-32-86-43-53)96-75(110)62(37-49-19-26-56(83)27-20-49)94-73(108)61(89-48(6)103)40-52-18-25-54-14-7-8-15-55(54)36-52;1-2(3)4/h7-8,11,13-15,18-32,36,43,45-47,59-68,87,102H,9-10,12,16-17,33-35,37-42,44H2,1-6H3,(H2,84,105)(H,88,114)(H,89,103)(H,90,106)(H,92,107)(H,93,109)(H,94,108)(H,95,111)(H,96,110)(H,97,113)(H,98,112)(H3,85,91,116)(H2,99,100,104,117);1H3,(H,3,4)/t47-,59+,60+,61-,62-,63-,64+,65-,66+,67+,68+;/m1./s1	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL1200501	GOSERELIN ACETATE	CC(=O)O.CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O	IKDXDQDKCZPQSZ-JHYYTBFNSA-N	InChI=1S/C59H84N18O14.C2H4O2/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38;1-2(3)4/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90);1H3,(H,3,4)/t38-,39-,40-,41-,42-,43-,44-,45+,46-;/m0./s1	Gonadotropin-releasing hormone receptor agonist	AGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL1200509	HISTRELIN ACETATE	CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1cn(Cc2ccccc2)cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1	OWAUGAMNPZHEOJ-YKZVIGSYSA-N	InChI=1S/C66H86N18O12.C2H4O2/c1-4-70-64(95)55-17-11-25-84(55)65(96)48(16-10-24-71-66(67)68)76-58(89)49(26-38(2)3)77-62(93)53(30-43-34-83(37-74-43)33-40-12-6-5-7-13-40)81-59(90)50(27-39-18-20-44(86)21-19-39)78-63(94)54(35-85)82-60(91)51(28-41-31-72-46-15-9-8-14-45(41)46)79-61(92)52(29-42-32-69-36-73-42)80-57(88)47-22-23-56(87)75-47;1-2(3)4/h5-9,12-15,18-21,31-32,34,36-38,47-55,72,85-86H,4,10-11,16-17,22-30,33,35H2,1-3H3,(H,69,73)(H,70,95)(H,75,87)(H,76,89)(H,77,93)(H,78,94)(H,79,92)(H,80,88)(H,81,90)(H,82,91)(H4,67,68,71);1H3,(H,3,4)/t47-,48-,49-,50-,51-,52-,53+,54-,55-;/m0./s1	Gonadotropin-releasing hormone receptor agonist	AGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL1200516	GONADORELIN HYDROCHLORIDE	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O.Cl	UPRWQSQENCASAD-HBBGHHHDSA-N	InChI=1S/C55H75N17O13.ClH/c1-29(2)19-38(49(80)67-37(9-5-17-60-55(57)58)54(85)72-18-6-10-43(72)53(84)62-25-44(56)75)66-46(77)26-63-47(78)39(20-30-11-13-33(74)14-12-30)68-52(83)42(27-73)71-50(81)40(21-31-23-61-35-8-4-3-7-34(31)35)69-51(82)41(22-32-24-59-28-64-32)70-48(79)36-15-16-45(76)65-36;/h3-4,7-8,11-14,23-24,28-29,36-43,61,73-74H,5-6,9-10,15-22,25-27H2,1-2H3,(H2,56,75)(H,59,64)(H,62,84)(H,63,78)(H,65,76)(H,66,77)(H,67,80)(H,68,83)(H,69,82)(H,70,79)(H,71,81)(H4,57,58,60);1H/t36-,37-,38-,39-,40-,41-,42-,43-;/m0./s1	Gonadotropin-releasing hormone receptor agonist	AGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL1200554	TRIPTORELIN PAMOATE	CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O	ZBVJFYPGLGEMIN-OYLNGHKZSA-N	InChI=1S/C64H82N18O13.C23H16O6/c1-34(2)23-46(56(88)75-45(13-7-21-69-64(66)67)63(95)82-22-8-14-52(82)62(94)72-31-53(65)85)76-58(90)48(25-36-28-70-42-11-5-3-9-40(36)42)78-57(89)47(24-35-15-17-39(84)18-16-35)77-61(93)51(32-83)81-59(91)49(26-37-29-71-43-12-6-4-10-41(37)43)79-60(92)50(27-38-30-68-33-73-38)80-55(87)44-19-20-54(86)74-44;24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29/h3-6,9-12,15-18,28-30,33-34,44-52,70-71,83-84H,7-8,13-14,19-27,31-32H2,1-2H3,(H2,65,85)(H,68,73)(H,72,94)(H,74,86)(H,75,88)(H,76,90)(H,77,93)(H,78,89)(H,79,92)(H,80,87)(H,81,91)(H4,66,67,69);1-10,24-25H,11H2,(H,26,27)(H,28,29)/t44-,45-,46-,47-,48+,49-,50-,51-,52-;/m0./s1	Gonadotropin-releasing hormone receptor agonist	AGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL1251	GANIRELIX ACETATE	CC/N=C(\NCC)NCCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCN/C(=N/CC)NCC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O	GJNXBNATEDXMAK-PFLSVRRQSA-N	InChI=1S/C80H113ClN18O13/c1-9-84-79(85-10-2)88-38-17-15-24-60(70(104)94-62(41-49(5)6)71(105)93-61(25-16-18-39-89-80(86-11-3)87-12-4)78(112)99-40-20-26-68(99)77(111)90-50(7)69(82)103)92-73(107)64(44-53-30-35-59(102)36-31-53)97-76(110)67(48-100)98-75(109)66(46-55-21-19-37-83-47-55)96-74(108)65(43-52-28-33-58(81)34-29-52)95-72(106)63(91-51(8)101)45-54-27-32-56-22-13-14-23-57(56)42-54/h13-14,19,21-23,27-37,42,47,49-50,60-68,100,102H,9-12,15-18,20,24-26,38-41,43-46,48H2,1-8H3,(H2,82,103)(H,90,111)(H,91,101)(H,92,107)(H,93,105)(H,94,104)(H,95,106)(H,96,108)(H,97,110)(H,98,109)(H2,84,85,88)(H2,86,87,89)/t50-,60-,61+,62+,63-,64+,65-,66-,67+,68+/m1/s1	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL1200775	LEUPROLIDE ACETATE	CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1	RGLRXNKKBLIBQS-XNHQSDQCSA-N	InChI=1S/C59H84N16O12.C2H4O2/c1-6-63-57(86)48-14-10-22-75(48)58(87)41(13-9-21-64-59(60)61)68-51(80)42(23-32(2)3)69-52(81)43(24-33(4)5)70-53(82)44(25-34-15-17-37(77)18-16-34)71-56(85)47(30-76)74-54(83)45(26-35-28-65-39-12-8-7-11-38(35)39)72-55(84)46(27-36-29-62-31-66-36)73-50(79)40-19-20-49(78)67-40;1-2(3)4/h7-8,11-12,15-18,28-29,31-33,40-48,65,76-77H,6,9-10,13-14,19-27,30H2,1-5H3,(H,62,66)(H,63,86)(H,67,78)(H,68,80)(H,69,81)(H,70,82)(H,71,85)(H,72,84)(H,73,79)(H,74,83)(H4,60,61,64);1H3,(H,3,4)/t40-,41-,42-,43+,44-,45-,46-,47-,48-;/m0./s1	Gonadotropin-releasing hormone receptor agonist	AGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL710	FINASTERIDE	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C	DBEPLOCGEIEOCV-WSBQPABSSA-N	InChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1	Steroid 5-alpha-reductase 2 inhibitor	INHIBITOR	CHEMBL1856	Steroid 5-alpha-reductase 2	Homo sapiens
CHEMBL93	ZILEUTON	CC(c1cc2ccccc2s1)N(O)C(N)=O	MWLSOWXNZPKENC-UHFFFAOYSA-N	InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)	Arachidonate 5-lipoxygenase inhibitor	INHIBITOR	CHEMBL215	Arachidonate 5-lipoxygenase	Homo sapiens
CHEMBL1200760	BALSALAZIDE DISODIUM	O=C([O-])CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)[O-])c2)cc1.[Na+].[Na+]	CKMOQBVBEGCJGW-LLIZZRELSA-L	InChI=1S/C17H15N3O6.2Na/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23;;/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26);;/q;2*+1/p-2/b20-19+;;	Arachidonate 5-lipoxygenase inhibitor	INHIBITOR	CHEMBL215	Arachidonate 5-lipoxygenase	Homo sapiens
CHEMBL1562610	MECLOFENAMATE SODIUM	Cc1ccc(Cl)c(Nc2ccccc2C(=O)[O-])c1Cl.O.[Na+]	QHJLLDJTVQAFAN-UHFFFAOYSA-M	InChI=1S/C14H11Cl2NO2.Na.H2O/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19;;/h2-7,17H,1H3,(H,18,19);;1H2/q;+1;/p-1	Arachidonate 5-lipoxygenase inhibitor	INHIBITOR	CHEMBL215	Arachidonate 5-lipoxygenase	Homo sapiens
CHEMBL704	MESALAMINE	Nc1ccc(O)c(C(=O)O)c1	KBOPZPXVLCULAV-UHFFFAOYSA-N	InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)	Arachidonate 5-lipoxygenase inhibitor	INHIBITOR	CHEMBL215	Arachidonate 5-lipoxygenase	Homo sapiens
CHEMBL1201013	OLSALAZINE SODIUM	O=C([O-])c1cc(/N=N/c2ccc(O)c(C(=O)[O-])c2)ccc1O.[Na+].[Na+]	ZJEFYLVGGFISGT-VRZXRVJBSA-L	InChI=1S/C14H10N2O6.2Na/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22;;/h1-6,17-18H,(H,19,20)(H,21,22);;/q;2*+1/p-2/b16-15+;;	Arachidonate 5-lipoxygenase inhibitor	INHIBITOR	CHEMBL215	Arachidonate 5-lipoxygenase	Homo sapiens
CHEMBL421	SULFASALAZINE	O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O	NCEXYHBECQHGNR-QZQOTICOSA-N	InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+	Arachidonate 5-lipoxygenase inhibitor	INHIBITOR	CHEMBL215	Arachidonate 5-lipoxygenase	Homo sapiens
CHEMBL1200906	OXYPHENONIUM BROMIDE	CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1.[Br-]	UKLQXHUGTKWPSR-UHFFFAOYSA-M	InChI=1S/C21H34NO3.BrH/c1-4-22(3,5-2)16-17-25-20(23)21(24,18-12-8-6-9-13-18)19-14-10-7-11-15-19;/h6,8-9,12-13,19,24H,4-5,7,10-11,14-17H2,1-3H3;1H/q+1;/p-1	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1200880	DIPHEMANIL METHYLSULFATE	COS(=O)(=O)[O-].C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1	BREMLQBSKCSNNH-UHFFFAOYSA-M	InChI=1S/C20H24N.CH4O4S/c1-21(2)15-13-19(14-16-21)20(17-9-5-3-6-10-17)18-11-7-4-8-12-18;1-5-6(2,3)4/h3-12H,13-16H2,1-2H3;1H3,(H,2,3,4)/q+1;/p-1	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1240	PROPANTHELINE BROMIDE	CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C.[Br-]	XLBIBBZXLMYSFF-UHFFFAOYSA-M	InChI=1S/C23H30NO3.BrH/c1-16(2)24(5,17(3)4)14-15-26-23(25)22-18-10-6-8-12-20(18)27-21-13-9-7-11-19(21)22;/h6-13,16-17,22H,14-15H2,1-5H3;1H/q+1;/p-1	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1724	MEPENZOLATE BROMIDE	C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1.[Br-]	JRRNZNSGDSFFIR-UHFFFAOYSA-M	InChI=1S/C21H26NO3.BrH/c1-22(2)15-9-14-19(16-22)25-20(23)21(24,17-10-5-3-6-11-17)18-12-7-4-8-13-18;/h3-8,10-13,19,24H,9,14-16H2,1-2H3;1H/q+1;/p-1	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1578	ANISOTROPINE METHYLBROMIDE	CCCC(CCC)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]2(C)C.[Br-]	QSFKGMJOKUZAJM-CNKDKAJDSA-M	InChI=1S/C17H32NO2.BrH/c1-5-7-13(8-6-2)17(19)20-16-11-14-9-10-15(12-16)18(14,3)4;/h13-16H,5-12H2,1-4H3;1H/q+1;/p-1/t14-,15+,16+;	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1092	TRIHEXYPHENIDYL HYDROCHLORIDE	Cl.OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1	QDWJJTJNXAKQKD-UHFFFAOYSA-N	InChI=1S/C20H31NO.ClH/c22-20(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21;/h1,4-5,10-11,19,22H,2-3,6-9,12-17H2;1H	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1200828	CYCRIMINE HYDROCHLORIDE	Cl.OC(CCN1CCCCC1)(c1ccccc1)C1CCCC1	WBCWFMFZMRFRLT-UHFFFAOYSA-N	InChI=1S/C19H29NO.ClH/c21-19(18-11-5-6-12-18,17-9-3-1-4-10-17)13-16-20-14-7-2-8-15-20;/h1,3-4,9-10,18,21H,2,5-8,11-16H2;1H	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1201035	BIPERIDEN HYDROCHLORIDE	Cl.OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2	RDNLAULGBSQZMP-UHFFFAOYSA-N	InChI=1S/C21H29NO.ClH/c23-21(19-7-3-1-4-8-19,11-14-22-12-5-2-6-13-22)20-16-17-9-10-18(20)15-17;/h1,3-4,7-10,17-18,20,23H,2,5-6,11-16H2;1H	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1626570	HEXOCYCLIUM METHYLSULFATE	COS(=O)(=O)[O-].C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1	NSILVESQCSUIAJ-UHFFFAOYSA-M	InChI=1S/C20H33N2O.CH4O4S/c1-22(2)15-13-21(14-16-22)17-20(23,18-9-5-3-6-10-18)19-11-7-4-8-12-19;1-5-6(2,3)4/h3,5-6,9-10,19,23H,4,7-8,11-17H2,1-2H3;1H3,(H,2,3,4)/q+1;/p-1	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1201067	BIPERIDEN LACTATE	CC(O)C(=O)O.OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2	GLPUBCPQWZZFNJ-UHFFFAOYSA-N	InChI=1S/C21H29NO.C3H6O3/c23-21(19-7-3-1-4-8-19,11-14-22-12-5-2-6-13-22)20-16-17-9-10-18(20)15-17;1-2(4)3(5)6/h1,3-4,7-10,17-18,20,23H,2,5-6,11-16H2;2,4H,1H3,(H,5,6)	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1200479	DICYCLOMINE HYDROCHLORIDE	CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1.Cl	GUBNMFJOJGDCEL-UHFFFAOYSA-N	InChI=1S/C19H35NO2.ClH/c1-3-20(4-2)15-16-22-18(21)19(13-9-6-10-14-19)17-11-7-5-8-12-17;/h17H,3-16H2,1-2H3;1H	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1200771	TRIDIHEXETHYL CHLORIDE	CC[N+](CC)(CC)CCC(O)(c1ccccc1)C1CCCCC1.[Cl-]	XJGONMZLEDGBRM-UHFFFAOYSA-M	InChI=1S/C21H36NO.ClH/c1-4-22(5-2,6-3)18-17-21(23,19-13-9-7-10-14-19)20-15-11-8-12-16-20;/h7,9-10,13-14,20,23H,4-6,8,11-12,15-18H2,1-3H3;1H/q+1;/p-1	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL2146146	ATROPINE SULFATE	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2.O=S(=O)(O)O	VJFQPODMEGSXHC-RIMUKSHESA-N	InChI=1S/C17H23NO3.H2O4S/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12;1-5(2,3)4/h2-6,13-16,19H,7-11H2,1H3;(H2,1,2,3,4)/t13-,14+,15+,16?;	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1761	PROCYCLIDINE HYDROCHLORIDE	Cl.OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1	ZFSPFXJSEHCTTR-UHFFFAOYSA-N	InChI=1S/C19H29NO.ClH/c21-19(17-9-3-1-4-10-17,18-11-5-2-6-12-18)13-16-20-14-7-8-15-20;/h1,3-4,9-10,18,21H,2,5-8,11-16H2;1H	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL517712	ATROPINE	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2	RKUNBYITZUJHSG-SPUOUPEWSA-N	InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15+,16?	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1529	DIPHENIDOL HYDROCHLORIDE	Cl.OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1	AVZIYZHXZAYGJS-UHFFFAOYSA-N	InChI=1S/C21H27NO.ClH/c23-21(19-11-4-1-5-12-19,20-13-6-2-7-14-20)15-10-18-22-16-8-3-9-17-22;/h1-2,4-7,11-14,23H,3,8-10,15-18H2;1H	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL569713	SCOPOLAMINE	CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21	STECJAGHUSJQJN-FWXGHANASA-N	InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11-,12-,13-,14+,15-,16+/m1/s1	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1200426	METHIXENE HYDROCHLORIDE	CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1.Cl.O	RAOHHYUBMJLHNC-UHFFFAOYSA-N	InChI=1S/C20H23NS.ClH.H2O/c1-21-12-6-7-15(14-21)13-18-16-8-2-4-10-19(16)22-20-11-5-3-9-17(18)20;;/h2-5,8-11,15,18H,6-7,12-14H2,1H3;1H;1H2	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1200970	ETHOPROPAZINE HYDROCHLORIDE	CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21.Cl	VXPCQISYVPFYRK-UHFFFAOYSA-N	InChI=1S/C19H24N2S.ClH/c1-4-20(5-2)15(3)14-21-16-10-6-8-12-18(16)22-19-13-9-7-11-17(19)21;/h6-13,15H,4-5,14H2,1-3H3;1H	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1200383	BENZTROPINE MESYLATE	CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2.CS(=O)(=O)O	CPFJLLXFNPCTDW-BWSPSPBFSA-N	InChI=1S/C21H25NO.CH4O3S/c1-22-18-12-13-19(22)15-20(14-18)23-21(16-8-4-2-5-9-16)17-10-6-3-7-11-17;1-5(2,3)4/h2-11,18-21H,12-15H2,1H3;1H3,(H,2,3,4)/t18-,19+,20+;	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1200891	OXYPHENCYCLIMINE HYDROCHLORIDE	CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1.Cl	WXAYTPABEADAAB-UHFFFAOYSA-N	InChI=1S/C20H28N2O3.ClH/c1-22-14-8-13-21-18(22)15-25-19(23)20(24,16-9-4-2-5-10-16)17-11-6-3-7-12-17;/h2,4-5,9-10,17,24H,3,6-8,11-15H2,1H3;1H	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1201740	NILOTINIB HYDROCHLORIDE MONOHYDRATE	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1.Cl.O	YCBPQSYLYYBPDW-UHFFFAOYSA-N	InChI=1S/C28H22F3N7O.ClH.H2O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38;;/h3-16H,1-2H3,(H,35,39)(H,33,36,37);1H;1H2	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	CHEMBL1862	Tyrosine-protein kinase ABL	Homo sapiens
CHEMBL1421	DASATINIB	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1	ZBNZXTGUTAYRHI-UHFFFAOYSA-N	InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	CHEMBL1862	Tyrosine-protein kinase ABL	Homo sapiens
CHEMBL288441	BOSUTINIB	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl	UBPYILGKFZZVDX-UHFFFAOYSA-N	InChI=1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31)	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	CHEMBL1862	Tyrosine-protein kinase ABL	Homo sapiens
CHEMBL1946170	REGORAFENIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1	FNHKPVJBJVTLMP-UHFFFAOYSA-N	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	CHEMBL1862	Tyrosine-protein kinase ABL	Homo sapiens
CHEMBL1642	IMATINIB MESYLATE	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1	YLMAHDNUQAMNNX-UHFFFAOYSA-N	InChI=1S/C29H31N7O.CH4O3S/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36;1-5(2,3)4/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34);1H3,(H,2,3,4)	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	CHEMBL1862	Tyrosine-protein kinase ABL	Homo sapiens
CHEMBL3989691	ELTROMBOPAG OLAMINE	CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\Nc1cccc(-c2cccc(C(=O)O)c2)c1O.NCCO.NCCO	PLILLUUXAVKBPY-SBIAVEDLSA-N	InChI=1S/C25H22N4O4.2C2H7NO/c1-14-10-11-19(12-15(14)2)29-24(31)22(16(3)28-29)27-26-21-9-5-8-20(23(21)30)17-6-4-7-18(13-17)25(32)33;2*3-1-2-4/h4-13,26,30H,1-3H3,(H,32,33);2*4H,1-3H2/b27-22-;;	Thrombopoietin receptor agonist	AGONIST	CHEMBL1864	Thrombopoietin receptor	Homo sapiens
CHEMBL98	VORINOSTAT	O=C(CCCCCCC(=O)Nc1ccccc1)NO	WAEXFXRVDQXREF-UHFFFAOYSA-N	InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)	Histone deacetylase 6 inhibitor	INHIBITOR	CHEMBL1865	Histone deacetylase 6	Homo sapiens
CHEMBL24	ATENOLOL	CC(C)NCC(O)COc1ccc(CC(N)=O)cc1	METKIMKYRPQLGS-UHFFFAOYSA-N	InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL1200837	LEVOBETAXOLOL HYDROCHLORIDE	CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1.Cl	CHDPSNLJFOQTRK-LMOVPXPDSA-N	InChI=1S/C18H29NO3.ClH/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16;/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3;1H/t17-;/m0./s1	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL1200813	ACEBUTOLOL HYDROCHLORIDE	CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1.Cl	KTUFKADDDORSSI-UHFFFAOYSA-N	InChI=1S/C18H28N2O4.ClH/c1-5-6-18(23)20-14-7-8-17(16(9-14)13(4)21)24-11-15(22)10-19-12(2)3;/h7-9,12,15,19,22H,5-6,10-11H2,1-4H3,(H,20,23);1H	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL1201115	ESMOLOL HYDROCHLORIDE	COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1.Cl	GEKNCWBANDDJJL-UHFFFAOYSA-N	InChI=1S/C16H25NO4.ClH/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3;/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3;1H	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL1200745	OXPRENOLOL HYDROCHLORIDE	C=CCOc1ccccc1OCC(O)CNC(C)C.Cl	COAJXCLTPGGDAJ-UHFFFAOYSA-N	InChI=1S/C15H23NO3.ClH/c1-4-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3;/h4-8,12-13,16-17H,1,9-11H2,2-3H3;1H	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL1472989	BISOPROLOL FUMARATE	CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.O=C(O)/C=C/C(=O)O	VMDFASMUILANOL-WXXKFALUSA-N	InChI=1S/2C18H31NO4.C4H4O4/c2*1-14(2)19-11-17(20)13-23-18-7-5-16(6-8-18)12-21-9-10-22-15(3)4;5-3(6)1-2-4(7)8/h2*5-8,14-15,17,19-20H,9-13H2,1-4H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL1201177	LEVOBUNOLOL HYDROCHLORIDE	CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O.Cl	DNTDOBSIBZKFCP-YDALLXLXSA-N	InChI=1S/C17H25NO3.ClH/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20;/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3;1H/t12-;/m0./s1	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL500	PINDOLOL	CC(C)NCC(O)COc1cccc2[nH]ccc12	JZQKKSLKJUAGIC-UHFFFAOYSA-N	InChI=1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3	Beta-1 adrenergic receptor partial agonist	PARTIAL AGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL1200947	METIPRANOLOL HYDROCHLORIDE	CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C.Cl	BLWNYSZZZWQCKO-UHFFFAOYSA-N	InChI=1S/C17H27NO4.ClH/c1-10(2)18-8-15(20)9-21-16-7-11(3)17(22-14(6)19)13(5)12(16)4;/h7,10,15,18,20H,8-9H2,1-6H3;1H	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL1200418	DOBUTAMINE HYDROCHLORIDE	CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1.Cl	BQKADKWNRWCIJL-UHFFFAOYSA-N	InChI=1S/C18H23NO3.ClH/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15;/h4-9,12-13,19-22H,2-3,10-11H2,1H3;1H	Beta-1 adrenergic receptor agonist	AGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL1557	DOPAMINE HYDROCHLORIDE	Cl.NCCc1ccc(O)c(O)c1	CTENFNNZBMHDDG-UHFFFAOYSA-N	InChI=1S/C8H11NO2.ClH/c9-4-3-6-1-2-7(10)8(11)5-6;/h1-2,5,10-11H,3-4,9H2;1H	Beta-1 adrenergic receptor agonist	AGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL649	NADOLOL	CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2	VWPOSFSPZNDTMJ-UCWKZMIHSA-N	InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL1671	PROPRANOLOL HYDROCHLORIDE	CC(C)NCC(O)COc1cccc2ccccc12.Cl	ZMRUPTIKESYGQW-UHFFFAOYSA-N	InChI=1S/C16H21NO2.ClH/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16;/h3-9,12,14,17-18H,10-11H2,1-2H3;1H	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL2361370	PENBUTOLOL SULFATE	CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1.CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1.O=S(=O)(O)O	FEDSNBHHWZEYTP-ZFQYHYQMSA-N	InChI=1S/2C18H29NO2.H2O4S/c2*1-18(2,3)19-12-15(20)13-21-17-11-7-6-10-16(17)14-8-4-5-9-14;1-5(2,3)4/h2*6-7,10-11,14-15,19-20H,4-5,8-9,12-13H2,1-3H3;(H2,1,2,3,4)/t2*15-;/m00./s1	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL1700	SOTALOL HYDROCHLORIDE	CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1.Cl	VIDRYROWYFWGSY-UHFFFAOYSA-N	InChI=1S/C12H20N2O3S.ClH/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17;/h4-7,9,12-15H,8H2,1-3H3;1H	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL3989566	METOPROLOL FUMARATE	COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)/C=C/C(=O)O	BRIPGNJWPCKDQZ-WXXKFALUSA-N	InChI=1S/2C15H25NO3.C4H4O4/c2*1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3;5-3(6)1-2-4(7)8/h2*4-7,12,14,16-17H,8-11H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL1691	BETAXOLOL HYDROCHLORIDE	CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1.Cl	CHDPSNLJFOQTRK-UHFFFAOYSA-N	InChI=1S/C18H29NO3.ClH/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16;/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3;1H	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL1200870	TIMOLOL MALEATE	CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1.O=C(O)/C=C\C(=O)O	WLRMANUAADYWEA-NWASOUNVSA-N	InChI=1S/C13H24N4O3S.C4H4O4/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17;5-3(6)1-2-4(7)8/h10,14,18H,4-9H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t10-;/m0./s1	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL2356097	METOPROLOL SUCCINATE	COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)CCC(=O)O	RGHAZVBIOOEVQX-UHFFFAOYSA-N	InChI=1S/2C15H25NO3.C4H6O4/c2*1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3;5-3(6)1-2-4(7)8/h2*4-7,12,14,16-17H,8-11H2,1-3H3;1-2H2,(H,5,6)(H,7,8)	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL2062335	METOPROLOL TARTRATE	COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)C(O)C(O)C(=O)O	YGULWPYYGQCFMP-UHFFFAOYSA-N	InChI=1S/2C15H25NO3.C4H6O6/c2*1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3;5-1(3(7)8)2(6)4(9)10/h2*4-7,12,14,16-17H,8-11H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL1201731	NEBIVOLOL HYDROCHLORIDE	Cl.OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1	JWEXHQAEWHKGCW-UHFFFAOYSA-N	InChI=1S/C22H25F2NO4.ClH/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22;/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2;1H	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL1201063	PROPAFENONE HYDROCHLORIDE	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1.Cl	XWIHRGFIPXWGEF-UHFFFAOYSA-N	InChI=1S/C21H27NO3.ClH/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17;/h3-11,18,22-23H,2,12-16H2,1H3;1H	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL499	TIMOLOL	CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1	BLJRIMJGRPQVNF-JTQLQIEISA-N	InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL3989509	PENTAZOCINE LACTATE	CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C.CC(O)C(=O)O	QNLDTXPVZPRSAM-UHFFFAOYSA-N	InChI=1S/C19H27NO.C3H6O3/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19;1-2(4)3(5)6/h5-7,12,14,18,21H,8-11H2,1-4H3;2,4H,1H3,(H,5,6)	Sigma opioid receptor modulator	MODULATOR	CHEMBL287	Sigma opioid receptor	Homo sapiens
CHEMBL3989510	PENTAZOCINE HYDROCHLORIDE	CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C.Cl	OQGYMIIFOSJQSF-UHFFFAOYSA-N	InChI=1S/C19H27NO.ClH/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19;/h5-7,12,14,18,21H,8-11H2,1-4H3;1H	Sigma opioid receptor modulator	MODULATOR	CHEMBL287	Sigma opioid receptor	Homo sapiens
CHEMBL1256818	DEXTROMETHORPHAN HYDROBROMIDE	Br.COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3.O	STTADZBLEUMJRG-IKNOHUQMSA-N	InChI=1S/C18H25NO.BrH.H2O/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18;;/h6-7,12,15,17H,3-5,8-11H2,1-2H3;1H;1H2/t15-,17+,18+;;/m1../s1	Sigma opioid receptor agonist	AGONIST	CHEMBL287	Sigma opioid receptor	Homo sapiens
CHEMBL1046	AMINOCAPROIC ACID	NCCCCCC(=O)O	SLXKOJJOQWFEFD-UHFFFAOYSA-N	InChI=1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9)	Tissue-type plasminogen activator inhibitor	INHIBITOR	CHEMBL1873	Tissue-type plasminogen activator	Homo sapiens
CHEMBL1072	BUMETANIDE	CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1	MAEIEVLCKWDQJH-UHFFFAOYSA-N	InChI=1S/C17H20N2O5S/c1-2-3-9-19-14-10-12(17(20)21)11-15(25(18,22)23)16(14)24-13-7-5-4-6-8-13/h4-8,10-11,19H,2-3,9H2,1H3,(H,20,21)(H2,18,22,23)	Sodium-(potassium)-chloride cotransporter 2 inhibitor	INHIBITOR	CHEMBL1874	Sodium-(potassium)-chloride cotransporter 2	Homo sapiens
CHEMBL456	ETHACRYNIC ACID	C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl	AVOLMBLBETYQHX-UHFFFAOYSA-N	InChI=1S/C13H12Cl2O4/c1-3-7(2)13(18)8-4-5-9(12(15)11(8)14)19-6-10(16)17/h4-5H,2-3,6H2,1H3,(H,16,17)	Sodium-(potassium)-chloride cotransporter 2 inhibitor	INHIBITOR	CHEMBL1874	Sodium-(potassium)-chloride cotransporter 2	Homo sapiens
CHEMBL1148	TORSEMIDE	Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1	NGBFQHCMQULJNZ-UHFFFAOYSA-N	InChI=1S/C16H20N4O3S/c1-11(2)18-16(21)20-24(22,23)15-10-17-8-7-14(15)19-13-6-4-5-12(3)9-13/h4-11H,1-3H3,(H,17,19)(H2,18,20,21)	Sodium-(potassium)-chloride cotransporter 2 inhibitor	INHIBITOR	CHEMBL1874	Sodium-(potassium)-chloride cotransporter 2	Homo sapiens
CHEMBL35	FUROSEMIDE	NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl	ZZUFCTLCJUWOSV-UHFFFAOYSA-N	InChI=1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)8(12(16)17)4-11(9)21(14,18)19/h1-5,15H,6H2,(H,16,17)(H2,14,18,19)	Sodium-(potassium)-chloride cotransporter 2 inhibitor	INHIBITOR	CHEMBL1874	Sodium-(potassium)-chloride cotransporter 2	Homo sapiens
CHEMBL1200487	ETHACRYNATE SODIUM	C=C(CC)C(=O)c1ccc(OCC(=O)[O-])c(Cl)c1Cl.[Na+]	CWCSCNSKBSCYCS-UHFFFAOYSA-M	InChI=1S/C13H12Cl2O4.Na/c1-3-7(2)13(18)8-4-5-9(12(15)11(8)14)19-6-10(16)17;/h4-5H,2-3,6H2,1H3,(H,16,17);/q;+1/p-1	Sodium-(potassium)-chloride cotransporter 2 inhibitor	INHIBITOR	CHEMBL1874	Sodium-(potassium)-chloride cotransporter 2	Homo sapiens
CHEMBL406	INDAPAMIDE	CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1	NDDAHWYSQHTHNT-UHFFFAOYSA-N	InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	CHEMBL1876	Thiazide-sensitive sodium-chloride cotransporter	Homo sapiens
CHEMBL878	METOLAZONE	Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C	AQCHWTWZEMGIFD-UHFFFAOYSA-N	InChI=1S/C16H16ClN3O3S/c1-9-5-3-4-6-14(9)20-10(2)19-13-8-12(17)15(24(18,22)23)7-11(13)16(20)21/h3-8,10,19H,1-2H3,(H2,18,22,23)	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	CHEMBL1876	Thiazide-sensitive sodium-chloride cotransporter	Homo sapiens
CHEMBL61593	CYCLOTHIAZIDE	NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O	BOCUKUHCLICSIY-UHFFFAOYSA-N	InChI=1S/C14H16ClN3O4S2/c15-10-5-11-13(6-12(10)23(16,19)20)24(21,22)18-14(17-11)9-4-7-1-2-8(9)3-7/h1-2,5-9,14,17-18H,3-4H2,(H2,16,19,20)	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	CHEMBL1876	Thiazide-sensitive sodium-chloride cotransporter	Homo sapiens
CHEMBL1201039	BENZTHIAZIDE	NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O	NDTSRXAMMQDVSW-UHFFFAOYSA-N	InChI=1S/C15H14ClN3O4S3/c16-11-6-12-14(7-13(11)25(17,20)21)26(22,23)19-15(18-12)9-24-8-10-4-2-1-3-5-10/h1-7H,8-9H2,(H,18,19)(H2,17,20,21)	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	CHEMBL1876	Thiazide-sensitive sodium-chloride cotransporter	Homo sapiens
CHEMBL842	CHLOROTHIAZIDE	NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O	JBMKAUGHUNFTOL-UHFFFAOYSA-N	InChI=1S/C7H6ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-3H,(H,10,11)(H2,9,12,13)	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	CHEMBL1876	Thiazide-sensitive sodium-chloride cotransporter	Homo sapiens
CHEMBL1200616	CHLOROTHIAZIDE SODIUM	NS(=O)(=O)c1cc2c(cc1Cl)N=C[N-]S2(=O)=O.[Na+]	CPIWHAFLBZQYLQ-UHFFFAOYSA-N	InChI=1S/C7H5ClN3O4S2.Na/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5;/h1-3H,(H2-,9,10,11,12,13);/q-1;+1	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	CHEMBL1876	Thiazide-sensitive sodium-chloride cotransporter	Homo sapiens
CHEMBL1532	QUINETHAZONE	CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1	AGMMTXLNIQSRCG-UHFFFAOYSA-N	InChI=1S/C10H12ClN3O3S/c1-2-9-13-7-4-6(11)8(18(12,16)17)3-5(7)10(15)14-9/h3-4,9,13H,2H2,1H3,(H,14,15)(H2,12,16,17)	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	CHEMBL1876	Thiazide-sensitive sodium-chloride cotransporter	Homo sapiens
CHEMBL1577	METHYCLOTHIAZIDE	CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O	CESYKOGBSMNBPD-UHFFFAOYSA-N	InChI=1S/C9H11Cl2N3O4S2/c1-14-9(4-10)13-6-2-5(11)7(19(12,15)16)3-8(6)20(14,17)18/h2-3,9,13H,4H2,1H3,(H2,12,15,16)	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	CHEMBL1876	Thiazide-sensitive sodium-chloride cotransporter	Homo sapiens
CHEMBL435	HYDROCHLOROTHIAZIDE	NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O	JZUFKLXOESDKRF-UHFFFAOYSA-N	InChI=1S/C7H8ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-2,10-11H,3H2,(H2,9,12,13)	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	CHEMBL1876	Thiazide-sensitive sodium-chloride cotransporter	Homo sapiens
CHEMBL1684	BENDROFLUMETHIAZIDE	NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O	HDWIHXWEUNVBIY-UHFFFAOYSA-N	InChI=1S/C15H14F3N3O4S2/c16-15(17,18)10-7-11-13(8-12(10)26(19,22)23)27(24,25)21-14(20-11)6-9-4-2-1-3-5-9/h1-5,7-8,14,20-21H,6H2,(H2,19,22,23)	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	CHEMBL1876	Thiazide-sensitive sodium-chloride cotransporter	Homo sapiens
CHEMBL1763	HYDROFLUMETHIAZIDE	NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O	DMDGGSIALPNSEE-UHFFFAOYSA-N	InChI=1S/C8H8F3N3O4S2/c9-8(10,11)4-1-5-7(2-6(4)19(12,15)16)20(17,18)14-3-13-5/h1-2,13-14H,3H2,(H2,12,15,16)	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	CHEMBL1876	Thiazide-sensitive sodium-chloride cotransporter	Homo sapiens
CHEMBL1054	TRICHLORMETHIAZIDE	NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O	LMJSLTNSBFUCMU-UHFFFAOYSA-N	InChI=1S/C8H8Cl3N3O4S2/c9-3-1-4-6(2-5(3)19(12,15)16)20(17,18)14-8(13-4)7(10)11/h1-2,7-8,13-14H,(H2,12,15,16)	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	CHEMBL1876	Thiazide-sensitive sodium-chloride cotransporter	Homo sapiens
CHEMBL1055	CHLORTHALIDONE	NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl	JIVPVXMEBJLZRO-UHFFFAOYSA-N	InChI=1S/C14H11ClN2O4S/c15-11-6-5-8(7-12(11)22(16,20)21)14(19)10-4-2-1-3-9(10)13(18)17-14/h1-7,19H,(H,17,18)(H2,16,20,21)	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	CHEMBL1876	Thiazide-sensitive sodium-chloride cotransporter	Homo sapiens
CHEMBL1587	POLYTHIAZIDE	CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O	CYLWJCABXYDINA-UHFFFAOYSA-N	InChI=1S/C11H13ClF3N3O4S3/c1-18-10(4-23-5-11(13,14)15)17-7-2-6(12)8(24(16,19)20)3-9(7)25(18,21)22/h2-3,10,17H,4-5H2,1H3,(H2,16,19,20)	Thiazide-sensitive sodium-chloride cotransporter inhibitor	INHIBITOR	CHEMBL1876	Thiazide-sensitive sodium-chloride cotransporter	Homo sapiens
CHEMBL3140361	ETHAMBUTOL HYDROCHLORIDE	CC[C@@H](CO)NCCN[C@@H](CC)CO.Cl.Cl	AUAHHJJRFHRVPV-BZDVOYDHSA-N	InChI=1S/C10H24N2O2.2ClH/c1-3-9(7-13)11-5-6-12-10(4-2)8-14;;/h9-14H,3-8H2,1-2H3;2*1H/t9-,10-;;/m0../s1	Arabinosyltransferase A inhibitor	INHIBITOR	CHEMBL1877	Arabinosyltransferase A	Mycobacterium tuberculosis
CHEMBL1200776	CINACALCET HYDROCHLORIDE	C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12.Cl	QANQWUQOEJZMLL-PKLMIRHRSA-N	InChI=1S/C22H22F3N.ClH/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25;/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3;1H/t16-;/m1./s1	Calcium sensing receptor positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL1878	Calcium sensing receptor	Homo sapiens
CHEMBL495	ALPROSTADIL	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O	GMVPRGQOIOIIMI-DWKJAMRDSA-N	InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,19+/m0/s1	Prostanoid EP2 receptor agonist	AGONIST	CHEMBL1881	Prostanoid EP2 receptor	Homo sapiens
CHEMBL1770	LEVAMISOLE HYDROCHLORIDE	Cl.c1ccc([C@H]2CN3CCSC3=N2)cc1	LAZPBGZRMVRFKY-HNCPQSOCSA-N	InChI=1S/C11H12N2S.ClH/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10;/h1-5,10H,6-8H2;1H/t10-;/m1./s1	Nicotinic acetylcholine receptor alpha subunit agonist	AGONIST	CHEMBL1884	Nicotinic acetylcholine receptor alpha subunit	Ascaris suum
CHEMBL181	DIAZOXIDE	CC1=NS(=O)(=O)c2cc(Cl)ccc2N1	GDLBFKVLRPITMI-UHFFFAOYSA-N	InChI=1S/C8H7ClN2O2S/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5/h2-4H,1H3,(H,10,11)	Potassium channel, inwardly rectifying, subfamily J, member 11 opener	OPENER	CHEMBL1886	Potassium channel, inwardly rectifying, subfamily J, member 11	Homo sapiens
CHEMBL1201108	CONIVAPTAN HYDROCHLORIDE	Cc1nc2c([nH]1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2.Cl	BTYHAFSDANBVMJ-UHFFFAOYSA-N	InChI=1S/C32H26N4O2.ClH/c1-21-33-28-19-20-36(29-14-8-7-13-27(29)30(28)34-21)32(38)23-15-17-24(18-16-23)35-31(37)26-12-6-5-11-25(26)22-9-3-2-4-10-22;/h2-18H,19-20H2,1H3,(H,33,34)(H,35,37);1H	Vasopressin V1a receptor antagonist	ANTAGONIST	CHEMBL1889	Vasopressin V1a receptor	Homo sapiens
CHEMBL1185	ZOLMITRIPTAN	CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12	ULSDMUVEXKOYBU-ZDUSSCGKSA-N	InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	CHEMBL1898	Serotonin 1b (5-HT1b) receptor	Homo sapiens
CHEMBL1201003	ELETRIPTAN HYDROBROMIDE	Br.CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12	UTINOWOSWSPFLJ-FSRHSHDFSA-N	InChI=1S/C22H26N2O2S.BrH/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20;/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3;1H/t19-;/m1./s1	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	CHEMBL1898	Serotonin 1b (5-HT1b) receptor	Homo sapiens
CHEMBL2138684	FROVATRIPTAN SUCCINATE	CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1.O.O=C(O)CCC(=O)O	CUETXFMONOSVJA-KLQYNRQASA-N	InChI=1S/C14H17N3O.C4H6O4.H2O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13;5-3(6)1-2-4(7)8;/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18);1-2H2,(H,5,6)(H,7,8);1H2/t9-;;/m1../s1	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	CHEMBL1898	Serotonin 1b (5-HT1b) receptor	Homo sapiens
CHEMBL1200521	ALMOTRIPTAN MALATE	CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12.O=C(O)CC(O)C(=O)O	QHATUKWEVNMHRY-UHFFFAOYSA-N	InChI=1S/C17H25N3O2S.C4H6O5/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20;5-2(4(8)9)1-3(6)7/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3;2,5H,1H2,(H,6,7)(H,8,9)	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	CHEMBL1898	Serotonin 1b (5-HT1b) receptor	Homo sapiens
CHEMBL1200601	NARATRIPTAN HYDROCHLORIDE	CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1.Cl	AWEZYKMQFAUBTD-UHFFFAOYSA-N	InChI=1S/C17H25N3O2S.ClH/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14;/h3-4,11-12,14,18-19H,5-10H2,1-2H3;1H	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	CHEMBL1898	Serotonin 1b (5-HT1b) receptor	Homo sapiens
CHEMBL1201032	RIZATRIPTAN BENZOATE	CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12.O=C(O)c1ccccc1	JPRXYLQNJJVCMZ-UHFFFAOYSA-N	InChI=1S/C15H19N5.C7H6O2/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20;8-7(9)6-4-2-1-3-5-6/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3;1-5H,(H,8,9)	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	CHEMBL1898	Serotonin 1b (5-HT1b) receptor	Homo sapiens
CHEMBL128	SUMATRIPTAN	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1	KQKPFRSPSRPDEB-UHFFFAOYSA-N	InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	CHEMBL1898	Serotonin 1b (5-HT1b) receptor	Homo sapiens
CHEMBL1201150	SUMATRIPTAN SUCCINATE	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1.O=C(O)CCC(=O)O	PORMUFZNYQJOEI-UHFFFAOYSA-N	InChI=1S/C14H21N3O2S.C4H6O4/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3;5-3(6)1-2-4(7)8/h4-5,8-9,15-16H,6-7,10H2,1-3H3;1-2H2,(H,5,6)(H,7,8)	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	CHEMBL1898	Serotonin 1b (5-HT1b) receptor	Homo sapiens
CHEMBL46	ONDANSETRON	Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O	FELGMEQIXOGIFQ-UHFFFAOYSA-N	InChI=1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3	Serotonin 3a (5-HT3a) receptor antagonist	ANTAGONIST	CHEMBL1899	Serotonin 3a (5-HT3a) receptor	Homo sapiens
CHEMBL1237080	GRANISETRON HYDROCHLORIDE	CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2.Cl	QYZRTBKYBJRGJB-UHFFFAOYSA-N	InChI=1S/C18H24N4O.ClH/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17;/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23);1H	Serotonin 3a (5-HT3a) receptor antagonist	ANTAGONIST	CHEMBL1899	Serotonin 3a (5-HT3a) receptor	Homo sapiens
CHEMBL289469	GRANISETRON	CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2	MFWNKCLOYSRHCJ-UHFFFAOYSA-N	InChI=1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)	Serotonin 3a (5-HT3a) receptor antagonist	ANTAGONIST	CHEMBL1899	Serotonin 3a (5-HT3a) receptor	Homo sapiens
CHEMBL1720	PALONOSETRON HYDROCHLORIDE	Cl.O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2	OLDRWYVIKMSFFB-SSPJITILSA-N	InChI=1S/C19H24N2O.ClH/c22-19-16-6-2-4-14-3-1-5-15(18(14)16)11-21(19)17-12-20-9-7-13(17)8-10-20;/h2,4,6,13,15,17H,1,3,5,7-12H2;1H/t15-,17-;/m1./s1	Serotonin 3a (5-HT3a) receptor antagonist	ANTAGONIST	CHEMBL1899	Serotonin 3a (5-HT3a) receptor	Homo sapiens
CHEMBL3186492	ONDANSETRON HYDROCHLORIDE	Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O.Cl.O.O	VRSLTNZJOUZKLX-UHFFFAOYSA-N	InChI=1S/C18H19N3O.ClH.2H2O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2;;;/h3-6,9-10,13H,7-8,11H2,1-2H3;1H;2*1H2	Serotonin 3a (5-HT3a) receptor antagonist	ANTAGONIST	CHEMBL1899	Serotonin 3a (5-HT3a) receptor	Homo sapiens
CHEMBL1200885	ALOSETRON HYDROCHLORIDE	Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O.Cl	FNYQZOVOVDSGJH-UHFFFAOYSA-N	InChI=1S/C17H18N4O.ClH/c1-11-13(19-10-18-11)9-21-8-7-15-16(17(21)22)12-5-3-4-6-14(12)20(15)2;/h3-6,10H,7-9H2,1-2H3,(H,18,19);1H	Serotonin 3a (5-HT3a) receptor antagonist	ANTAGONIST	CHEMBL1899	Serotonin 3a (5-HT3a) receptor	Homo sapiens
CHEMBL1200940	METOCLOPRAMIDE HYDROCHLORIDE	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC.Cl.O	KJBLQGHJOCAOJP-UHFFFAOYSA-N	InChI=1S/C14H22ClN3O2.ClH.H2O/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3;;/h8-9H,4-7,16H2,1-3H3,(H,17,19);1H;1H2	Serotonin 3a (5-HT3a) receptor antagonist	ANTAGONIST	CHEMBL1899	Serotonin 3a (5-HT3a) receptor	Homo sapiens
CHEMBL1200755	CERULETIDE DIETHYLAMINE	CCNCC.CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O	FHDKSYKZXIFRKJ-CBCFNHQSSA-N	InChI=1S/C58H73N13O21S2.C4H11N/c1-29(72)49(71-57(87)40(23-31-12-14-33(15-13-31)92-94(89,90)91)68-56(86)43(26-48(78)79)69-52(82)37(16-18-44(59)73)65-51(81)36-17-19-45(74)63-36)58(88)62-28-46(75)64-41(24-32-27-61-35-11-7-6-10-34(32)35)54(84)66-38(20-21-93-2)53(83)70-42(25-47(76)77)55(85)67-39(50(60)80)22-30-8-4-3-5-9-30;1-3-5-4-2/h3-15,27,29,36-43,49,61,72H,16-26,28H2,1-2H3,(H2,59,73)(H2,60,80)(H,62,88)(H,63,74)(H,64,75)(H,65,81)(H,66,84)(H,67,85)(H,68,86)(H,69,82)(H,70,83)(H,71,87)(H,76,77)(H,78,79)(H,89,90,91);5H,3-4H2,1-2H3/t29-,36+,37+,38+,39+,40+,41+,42+,43+,49+;/m1./s1	Cholecystokinin A receptor agonist	AGONIST	CHEMBL1901	Cholecystokinin A receptor	Homo sapiens
CHEMBL1201182	TEMSIROLIMUS	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C	CBPNZQVSJQDFBE-FUXHJELOSA-N	InChI=1S/C56H87NO16/c1-33-17-13-12-14-18-34(2)45(68-9)29-41-22-20-39(7)56(67,73-41)51(63)52(64)57-24-16-15-19-42(57)53(65)71-46(30-43(60)35(3)26-38(6)49(62)50(70-11)48(61)37(5)25-33)36(4)27-40-21-23-44(47(28-40)69-10)72-54(66)55(8,31-58)32-59/h12-14,17-18,26,33,35-37,39-42,44-47,49-50,58-59,62,67H,15-16,19-25,27-32H2,1-11H3/b14-12+,17-13+,34-18+,38-26+/t33-,35-,36-,37-,39-,40+,41+,42+,44-,45+,46+,47-,49-,50+,56-/m1/s1	FK506-binding protein 1A inhibitor	INHIBITOR	CHEMBL1902	FK506-binding protein 1A	Homo sapiens
CHEMBL413	SIROLIMUS	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C	QFJCIRLUMZQUOT-HPLJOQBZSA-N	InChI=1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1	FK506-binding protein 1A inhibitor	INHIBITOR	CHEMBL1902	FK506-binding protein 1A	Homo sapiens
CHEMBL1908360	EVEROLIMUS	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C	HKVAMNSJSFKALM-GKUWKFKPSA-N	InChI=1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1	FK506-binding protein 1A inhibitor	INHIBITOR	CHEMBL1902	FK506-binding protein 1A	Homo sapiens
CHEMBL1200686	PIMECROLIMUS	CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@H](Cl)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC	KASDHRXLYQOAKZ-XDSKOBMDSA-N	InChI=1S/C43H68ClNO11/c1-10-30-18-24(2)17-25(3)19-36(53-8)39-37(54-9)21-27(5)43(51,56-39)40(48)41(49)45-16-12-11-13-32(45)42(50)55-38(28(6)33(46)23-34(30)47)26(4)20-29-14-15-31(44)35(22-29)52-7/h18,20,25,27-33,35-39,46,51H,10-17,19,21-23H2,1-9H3/b24-18+,26-20+/t25-,27+,28+,29-,30+,31-,32-,33-,35+,36-,37-,38+,39+,43+/m0/s1	FK506-binding protein 1A inhibitor	INHIBITOR	CHEMBL1902	FK506-binding protein 1A	Homo sapiens
CHEMBL3989887	TACROLIMUS	C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC.O	NWJQLQGQZSIBAF-MLAUYUEBSA-N	InChI=1S/C44H69NO12.H2O/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7;/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3;1H2/b25-19+,27-21+;/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+;/m0./s1	FK506-binding protein 1A inhibitor	INHIBITOR	CHEMBL1902	FK506-binding protein 1A	Homo sapiens
CHEMBL1946170	REGORAFENIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1	FNHKPVJBJVTLMP-UHFFFAOYSA-N	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	Serine/threonine-protein kinase RAF inhibitor	INHIBITOR	CHEMBL1906	Serine/threonine-protein kinase RAF	Homo sapiens
CHEMBL1200485	SORAFENIB TOSYLATE	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1	IVDHYUQIDRJSTI-UHFFFAOYSA-N	InChI=1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)	Serine/threonine-protein kinase RAF inhibitor	INHIBITOR	CHEMBL1906	Serine/threonine-protein kinase RAF	Homo sapiens
CHEMBL1580	PENTOSTATIN	OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)C[C@@H]1O	FPVKHBSQESCIEP-JQCXWYLXSA-N	InChI=1S/C11H16N4O4/c16-3-8-6(17)1-9(19-8)15-5-14-10-7(18)2-12-4-13-11(10)15/h4-9,16-18H,1-3H2,(H,12,13)/t6-,7+,8+,9+/m0/s1	Adenosine deaminase inhibitor	INHIBITOR	CHEMBL1910	Adenosine deaminase	Homo sapiens
CHEMBL2105613	DIVALPROEX SODIUM	CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+]	MSRILKIQRXUYCT-UHFFFAOYSA-M	InChI=1S/2C8H16O2.Na/c2*1-3-5-7(6-4-2)8(9)10;/h2*7H,3-6H2,1-2H3,(H,9,10);/q;;+1/p-1	Succinate semialdehyde dehydrogenase inhibitor	INHIBITOR	CHEMBL1911	Succinate semialdehyde dehydrogenase	Homo sapiens
CHEMBL433	VALPROATE SODIUM	CCCC(CCC)C(=O)[O-].[Na+]	AEQFSUDEHCCHBT-UHFFFAOYSA-M	InChI=1S/C8H16O2.Na/c1-3-5-7(6-4-2)8(9)10;/h7H,3-6H2,1-2H3,(H,9,10);/q;+1/p-1	Succinate semialdehyde dehydrogenase inhibitor	INHIBITOR	CHEMBL1911	Succinate semialdehyde dehydrogenase	Homo sapiens
CHEMBL109	VALPROIC ACID	CCCC(CCC)C(=O)O	NIJJYAXOARWZEE-UHFFFAOYSA-N	InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)	Succinate semialdehyde dehydrogenase inhibitor	INHIBITOR	CHEMBL1911	Succinate semialdehyde dehydrogenase	Homo sapiens
CHEMBL1118	DESVENLAFAXINE	CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1	KYYIDSXMWOZKMP-UHFFFAOYSA-N	InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1708	PAROXETINE HYDROCHLORIDE	Cl.Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1	GELRVIPPMNMYGS-RVXRQPKJSA-N	InChI=1S/C19H20FNO3.ClH/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18;/h1-6,9,14,17,21H,7-8,10-12H2;1H/t14-,17-;/m0./s1	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1200322	ESCITALOPRAM OXALATE	CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21.O=C(O)C(=O)O	KTGRHKOEFSJQNS-BDQAORGHSA-N	InChI=1S/C20H21FN2O.C2H2O4/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20;3-1(4)2(5)6/h4-9,12H,3,10-11,14H2,1-2H3;(H,3,4)(H,5,6)/t20-;/m0./s1	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1200710	CLOMIPRAMINE HYDROCHLORIDE	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21.Cl	WIMWMKZEIBHDTH-UHFFFAOYSA-N	InChI=1S/C19H23ClN2.ClH/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22;/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3;1H	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1200781	CITALOPRAM HYDROBROMIDE	Br.CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21	WIHMBLDNRMIGDW-UHFFFAOYSA-N	InChI=1S/C20H21FN2O.BrH/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20;/h4-9,12H,3,10-11,14H2,1-2H3;1H	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1409	FLUVOXAMINE MALEATE	COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1.O=C(O)/C=C\C(=O)O	LFMYNZPAVPMEGP-PIDGMYBPSA-N	InChI=1S/C15H21F3N2O2.C4H4O4/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18;5-3(6)1-2-4(7)8/h5-8H,2-4,9-11,19H2,1H3;1-2H,(H,5,6)(H,7,8)/b20-14+;2-1-	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1709	SERTRALINE HYDROCHLORIDE	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21.Cl	BLFQGGGGFNSJKA-XHXSRVRCSA-N	InChI=1S/C17H17Cl2N.ClH/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11;/h2-6,8,10,12,17,20H,7,9H2,1H3;1H/t12-,17-;/m0./s1	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1200609	PAROXETINE MESYLATE	CS(=O)(=O)O.Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1	SHIJTGJXUHTGGZ-RVXRQPKJSA-N	InChI=1S/C19H20FNO3.CH4O3S/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18;1-5(2,3)4/h1-6,9,14,17,21H,7-8,10-12H2;1H3,(H,2,3,4)/t14-,17-;/m0./s1	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1201082	FLUOXETINE HYDROCHLORIDE	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1.Cl	GIYXAJPCNFJEHY-UHFFFAOYSA-N	InChI=1S/C17H18F3NO.ClH/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20;/h2-10,16,21H,11-12H2,1H3;1H	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1200595	CHLORPHENTERMINE HYDROCHLORIDE	CC(C)(N)Cc1ccc(Cl)cc1.Cl	WEJDYJKJPUPMLH-UHFFFAOYSA-N	InChI=1S/C10H14ClN.ClH/c1-10(2,12)7-8-3-5-9(11)6-4-8;/h3-6H,7,12H2,1-2H3;1H	Serotonin transporter substrate	SUBSTRATE	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1615374	VILAZODONE HYDROCHLORIDE	Cl.N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1	RPZBRGFNBNQSOP-UHFFFAOYSA-N	InChI=1S/C26H27N5O2.ClH/c27-16-18-4-6-23-22(13-18)19(17-29-23)3-1-2-8-30-9-11-31(12-10-30)21-5-7-24-20(14-21)15-25(33-24)26(28)32;/h4-7,13-15,17,29H,1-3,8-12H2,(H2,28,32);1H	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1200798	TRAZODONE HYDROCHLORIDE	Cl.O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	OHHDIOKRWWOXMT-UHFFFAOYSA-N	InChI=1S/C19H22ClN5O.ClH/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25;/h1-3,5-7,9,15H,4,8,10-14H2;1H	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1201066	VENLAFAXINE HYDROCHLORIDE	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1.Cl	QYRYFNHXARDNFZ-UHFFFAOYSA-N	InChI=1S/C17H27NO2.ClH/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14;/h7-10,16,19H,4-6,11-13H2,1-3H3;1H	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1200964	AMITRIPTYLINE HYDROCHLORIDE	CN(C)CCC=C1c2ccccc2CCc2ccccc21.Cl	KFYRPLNVJVHZGT-UHFFFAOYSA-N	InChI=1S/C20H23N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-12H,7,13-15H2,1-2H3;1H	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1113	AMOXAPINE	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	QWGDMFLQWFTERH-UHFFFAOYSA-N	InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1201728	DESVENLAFAXINE SUCCINATE	CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1.O=C(O)CCC(=O)O	ORUUBRMVQCKYHB-UHFFFAOYSA-N	InChI=1S/C16H25NO2.C4H6O4/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16;5-3(6)1-2-4(7)8/h6-9,15,18-19H,3-5,10-12H2,1-2H3;1-2H2,(H,5,6)(H,7,8)	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1200328	DULOXETINE HYDROCHLORIDE	CNCC[C@H](Oc1cccc2ccccc12)c1cccs1.Cl	BFFSMCNJSOPUAY-LMOVPXPDSA-N	InChI=1S/C18H19NOS.ClH/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16;/h2-10,13,17,19H,11-12H2,1H3;1H/t17-;/m0./s1	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1692	IMIPRAMINE HYDROCHLORIDE	CN(C)CCCN1c2ccccc2CCc2ccccc21.Cl	XZZXIYZZBJDEEP-UHFFFAOYSA-N	InChI=1S/C19H24N2.ClH/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21;/h3-6,8-11H,7,12-15H2,1-2H3;1H	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL3989845	IMIPRAMINE PAMOATE	CN(C)CCCN1c2ccccc2CCc2ccccc21.CN(C)CCCN1c2ccccc2CCc2ccccc21.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O	BPQZYOJIXDMZSX-UHFFFAOYSA-N	InChI=1S/C23H16O6.2C19H24N2/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;2*1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h1-10,24-25H,11H2,(H,26,27)(H,28,29);2*3-6,8-11H,7,12-15H2,1-2H3	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL4297064	MILNACIPRAN HYDROCHLORIDE	CCN(CC)C(=O)C1(c2ccccc2)CC1CN.Cl	XNCDYJFPRPDERF-UHFFFAOYSA-N	InChI=1S/C15H22N2O.ClH/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12;/h5-9,13H,3-4,10-11,16H2,1-2H3;1H	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1200492	NEFAZODONE HYDROCHLORIDE	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl	DYCKFEBIOUQECE-UHFFFAOYSA-N	InChI=1S/C25H32ClN5O2.ClH/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22;/h3-6,8-11,20H,2,7,12-19H2,1H3;1H	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1201156	NORTRIPTYLINE HYDROCHLORIDE	CNCCC=C1c2ccccc2CCc2ccccc21.Cl	SHAYBENGXDALFF-UHFFFAOYSA-N	InChI=1S/C19H21N.ClH/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19;/h2-5,7-11,20H,6,12-14H2,1H3;1H	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1200332	PROTRIPTYLINE HYDROCHLORIDE	CNCCCC1c2ccccc2C=Cc2ccccc21.Cl	OGQDIIKRQRZXJH-UHFFFAOYSA-N	InChI=1S/C19H21N.ClH/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19;/h2-5,7-10,12-13,19-20H,6,11,14H2,1H3;1H	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1421	DASATINIB	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1	ZBNZXTGUTAYRHI-UHFFFAOYSA-N	InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)	Platelet-derived growth factor receptor beta inhibitor	INHIBITOR	CHEMBL1913	Platelet-derived growth factor receptor beta	Homo sapiens
CHEMBL1200485	SORAFENIB TOSYLATE	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1	IVDHYUQIDRJSTI-UHFFFAOYSA-N	InChI=1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)	Platelet-derived growth factor receptor beta inhibitor	INHIBITOR	CHEMBL1913	Platelet-derived growth factor receptor beta	Homo sapiens
CHEMBL1642	IMATINIB MESYLATE	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1	YLMAHDNUQAMNNX-UHFFFAOYSA-N	InChI=1S/C29H31N7O.CH4O3S/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36;1-5(2,3)4/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34);1H3,(H,2,3,4)	Platelet-derived growth factor receptor beta inhibitor	INHIBITOR	CHEMBL1913	Platelet-derived growth factor receptor beta	Homo sapiens
CHEMBL3039588	PASIREOTIDE DIASPARTATE	NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O.N[C@@H](CC(=O)O)C(=O)O.N[C@@H](CC(=O)O)C(=O)O	NEEFMPSSNFRRNC-PPCPDXGKSA-N	InChI=1S/C58H66N10O9.2C4H7NO4/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45;2*5-2(4(8)9)1-3(6)7/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72);2*2H,1,5H2,(H,6,7)(H,8,9)/t43-,46-,47-,48+,49-,50-,51-;2*2-/m000/s1	Somatostatin receptor 1 agonist	AGONIST	CHEMBL1917	Somatostatin receptor 1	Homo sapiens
CHEMBL1715	PIOGLITAZONE HYDROCHLORIDE	CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1.Cl	GHUUBYQTCDQWRA-UHFFFAOYSA-N	InChI=1S/C19H20N2O3S.ClH/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17;/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23);1H	Peroxisome proliferator-activated receptor gamma agonist	AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL843	ROSIGLITAZONE MALEATE	CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O	SUFUKZSWUHZXAV-BTJKTKAUSA-N	InChI=1S/C18H19N3O3S.C4H4O4/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15;5-3(6)1-2-4(7)8/h2-9,15H,10-12H2,1H3,(H,20,22,23);1-2H,(H,5,6)(H,7,8)/b;2-1-	Peroxisome proliferator-activated receptor gamma agonist	AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL408	TROGLITAZONE	Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2	GXPHKUHSUJUWKP-UHFFFAOYSA-N	InChI=1S/C24H27NO5S/c1-13-14(2)21-18(15(3)20(13)26)9-10-24(4,30-21)12-29-17-7-5-16(6-8-17)11-19-22(27)25-23(28)31-19/h5-8,19,26H,9-12H2,1-4H3,(H,25,27,28)	Peroxisome proliferator-activated receptor gamma agonist	AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL1200760	BALSALAZIDE DISODIUM	O=C([O-])CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)[O-])c2)cc1.[Na+].[Na+]	CKMOQBVBEGCJGW-LLIZZRELSA-L	InChI=1S/C17H15N3O6.2Na/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23;;/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26);;/q;2*+1/p-2/b20-19+;;	Peroxisome proliferator-activated receptor gamma agonist	AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL704	MESALAMINE	Nc1ccc(O)c(C(=O)O)c1	KBOPZPXVLCULAV-UHFFFAOYSA-N	InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)	Peroxisome proliferator-activated receptor gamma agonist	AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL1201013	OLSALAZINE SODIUM	O=C([O-])c1cc(/N=N/c2ccc(O)c(C(=O)[O-])c2)ccc1O.[Na+].[Na+]	ZJEFYLVGGFISGT-VRZXRVJBSA-L	InChI=1S/C14H10N2O6.2Na/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22;;/h1-6,17-18H,(H,19,20)(H,21,22);;/q;2*+1/p-2/b16-15+;;	Peroxisome proliferator-activated receptor gamma agonist	AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL3039582	SECRETIN	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(N)=O)C(C)C	OWMZNFCDEHGFEP-NFBCVYDUSA-N	InChI=1S/C130H220N44O40/c1-60(2)43-81(120(208)173-100(66(13)14)103(134)191)153-95(183)54-149-106(194)77(31-35-92(132)180)159-116(204)84(46-63(7)8)166-118(206)85(47-64(9)10)164-111(199)75(29-23-41-146-129(139)140)155-113(201)79(32-36-93(133)181)160-117(205)83(45-62(5)6)162-110(198)73(27-21-39-144-127(135)136)154-104(192)67(15)152-94(182)53-148-107(195)78(33-37-97(185)186)158-109(197)74(28-22-40-145-128(137)138)156-115(203)82(44-61(3)4)163-112(200)76(30-24-42-147-130(141)142)157-122(210)90(57-176)170-119(207)86(48-65(11)12)165-114(202)80(34-38-98(187)188)161-123(211)91(58-177)171-126(214)102(69(17)179)174-121(209)87(49-70-25-19-18-20-26-70)168-125(213)101(68(16)178)172-96(184)55-150-108(196)88(51-99(189)190)167-124(212)89(56-175)169-105(193)72(131)50-71-52-143-59-151-71/h18-20,25-26,52,59-69,72-91,100-102,175-179H,21-24,27-51,53-58,131H2,1-17H3,(H2,132,180)(H2,133,181)(H2,134,191)(H,143,151)(H,148,195)(H,149,194)(H,150,196)(H,152,182)(H,153,183)(H,154,192)(H,155,201)(H,156,203)(H,157,210)(H,158,197)(H,159,204)(H,160,205)(H,161,211)(H,162,198)(H,163,200)(H,164,199)(H,165,202)(H,166,206)(H,167,212)(H,168,213)(H,169,193)(H,170,207)(H,171,214)(H,172,184)(H,173,208)(H,174,209)(H,185,186)(H,187,188)(H,189,190)(H4,135,136,144)(H4,137,138,145)(H4,139,140,146)(H4,141,142,147)/t67-,68+,69+,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,100-,101-,102-/m0/s1	Secretin receptor agonist	AGONIST	CHEMBL1925	Secretin receptor	Homo sapiens
CHEMBL1201745	CHOLINE FENOFIBRATE	CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)[O-].C[N+](C)(C)CCO	JWAZHODZSADEHB-UHFFFAOYSA-M	InChI=1S/C17H15ClO4.C5H14NO/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11;1-6(2,3)4-5-7/h3-10H,1-2H3,(H,20,21);7H,4-5H2,1-3H3/q;+1/p-1	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	CHEMBL239	Peroxisome proliferator-activated receptor alpha	Homo sapiens
CHEMBL457	GEMFIBROZIL	Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1	HEMJJKBWTPKOJG-UHFFFAOYSA-N	InChI=1S/C15H22O3/c1-11-6-7-12(2)13(10-11)18-9-5-8-15(3,4)14(16)17/h6-7,10H,5,8-9H2,1-4H3,(H,16,17)	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	CHEMBL239	Peroxisome proliferator-activated receptor alpha	Homo sapiens
CHEMBL672	FENOFIBRATE	CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1	YMTINGFKWWXKFG-UHFFFAOYSA-N	InChI=1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	CHEMBL239	Peroxisome proliferator-activated receptor alpha	Homo sapiens
CHEMBL565	CLOFIBRATE	CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1	KNHUKKLJHYUCFP-UHFFFAOYSA-N	InChI=1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	CHEMBL239	Peroxisome proliferator-activated receptor alpha	Homo sapiens
CHEMBL981	FENOFIBRIC ACID	CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)O	MQOBSOSZFYZQOK-UHFFFAOYSA-N	InChI=1S/C17H15ClO4/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11/h3-10H,1-2H3,(H,20,21)	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	CHEMBL239	Peroxisome proliferator-activated receptor alpha	Homo sapiens
CHEMBL2362016	ARSENIC TRIOXIDE	O1[As]2O[As]3O[As]1O[As](O2)O3	KTTMEOWBIWLMSE-UHFFFAOYSA-N	InChI=1S/As4O6/c5-1-6-3-8-2(5)9-4(7-1)10-3	Thioredoxin reductase 1 inhibitor	INHIBITOR	CHEMBL1927	Thioredoxin reductase 1	Homo sapiens
CHEMBL1200477	ALLOPURINOL SODIUM	O=c1[n-]cnc2[nH]ncc12.[Na+]	PTJRZVJXXNYNLN-UHFFFAOYSA-M	InChI=1S/C5H4N4O.Na/c10-5-3-1-8-9-4(3)6-2-7-5;/h1-2H,(H2,6,7,8,9,10);/q;+1/p-1	Xanthine dehydrogenase inhibitor	INHIBITOR	CHEMBL1929	Xanthine dehydrogenase	Homo sapiens
CHEMBL1164729	FEBUXOSTAT	Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O	BQSJTQLCZDPROO-UHFFFAOYSA-N	InChI=1S/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20)	Xanthine dehydrogenase inhibitor	INHIBITOR	CHEMBL1929	Xanthine dehydrogenase	Homo sapiens
CHEMBL1467	ALLOPURINOL	O=c1ncnc2[nH][nH]cc1-2	OFCNXPDARWKPPY-UHFFFAOYSA-N	InChI=1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)	Xanthine dehydrogenase inhibitor	INHIBITOR	CHEMBL1929	Xanthine dehydrogenase	Homo sapiens
CHEMBL1465	PHENPROCOUMON	CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O	DQDAYGNAKTZFIW-UHFFFAOYSA-N	InChI=1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3	Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor	INHIBITOR	CHEMBL1930	Vitamin k epoxide reductase complex subunit 1 isoform 1	Homo sapiens
CHEMBL711	PHENINDIONE	O=C1c2ccccc2C(=O)C1c1ccccc1	NFBAXHOPROOJAW-UHFFFAOYSA-N	InChI=1S/C15H10O2/c16-14-11-8-4-5-9-12(11)15(17)13(14)10-6-2-1-3-7-10/h1-9,13H	Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor	INHIBITOR	CHEMBL1930	Vitamin k epoxide reductase complex subunit 1 isoform 1	Homo sapiens
CHEMBL1466	DICUMAROL	O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O	DOBMPNYZJYQDGZ-UHFFFAOYSA-N	InChI=1S/C19H12O6/c20-16-10-5-1-3-7-14(10)24-18(22)12(16)9-13-17(21)11-6-2-4-8-15(11)25-19(13)23/h1-8,20-21H,9H2	Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor	INHIBITOR	CHEMBL1930	Vitamin k epoxide reductase complex subunit 1 isoform 1	Homo sapiens
CHEMBL1200772	WARFARIN POTASSIUM	CC(=O)CC(c1ccccc1)c1c([O-])c2ccccc2oc1=O.[K+]	WSHYKIAQCMIPTB-UHFFFAOYSA-M	InChI=1S/C19H16O4.K/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22;/h2-10,15,21H,11H2,1H3;/q;+1/p-1	Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor	INHIBITOR	CHEMBL1930	Vitamin k epoxide reductase complex subunit 1 isoform 1	Homo sapiens
CHEMBL1200879	WARFARIN SODIUM	CC(=O)CC(c1ccccc1)c1c([O-])c2ccccc2oc1=O.[Na+]	KYITYFHKDODNCQ-UHFFFAOYSA-M	InChI=1S/C19H16O4.Na/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22;/h2-10,15,21H,11H2,1H3;/q;+1/p-1	Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor	INHIBITOR	CHEMBL1930	Vitamin k epoxide reductase complex subunit 1 isoform 1	Homo sapiens
CHEMBL964	DISULFIRAM	CCN(CC)C(=S)SSC(=S)N(CC)CC	AUZONCFQVSMFAP-UHFFFAOYSA-N	InChI=1S/C10H20N2S4/c1-5-11(6-2)9(13)15-16-10(14)12(7-3)8-4/h5-8H2,1-4H3	Aldehyde dehydrogenase inhibitor	INHIBITOR	CHEMBL1935	Aldehyde dehydrogenase	Homo sapiens
CHEMBL1421	DASATINIB	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1	ZBNZXTGUTAYRHI-UHFFFAOYSA-N	InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL1201733	PAZOPANIB HYDROCHLORIDE	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O.Cl	MQHIQUBXFFAOMK-UHFFFAOYSA-N	InChI=1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL1946170	REGORAFENIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1	FNHKPVJBJVTLMP-UHFFFAOYSA-N	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL1200485	SORAFENIB TOSYLATE	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1	IVDHYUQIDRJSTI-UHFFFAOYSA-N	InChI=1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL1567	SUNITINIB MALATE	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O	LBWFXVZLPYTWQI-IPOVEDGCSA-N	InChI=1S/C22H27FN4O2.C4H6O5/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28;5-2(4(8)9)1-3(6)7/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28);2,5H,1H2,(H,6,7)(H,8,9)/b17-12-;/t;2-/m.0/s1	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL1642	IMATINIB MESYLATE	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1	YLMAHDNUQAMNNX-UHFFFAOYSA-N	InChI=1S/C29H31N7O.CH4O3S/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36;1-5(2,3)4/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34);1H3,(H,2,3,4)	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL1201187	MARAVIROC	Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1	GSNHKUDZZFZSJB-QYOOZWMWSA-N	InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25-,26-/m0/s1	C-C chemokine receptor type 5 antagonist	ANTAGONIST	CHEMBL274	C-C chemokine receptor type 5	Homo sapiens
CHEMBL36	PYRIMETHAMINE	CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1	WKSAUQYGYAYLPV-UHFFFAOYSA-N	InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7/h3-6H,2H2,1H3,(H4,14,15,16,17)	Dihydrofolate reductase inhibitor	INHIBITOR	CHEMBL1939	Dihydrofolate reductase	Plasmodium falciparum K1
CHEMBL3989825	CYCLOGUANIL PAMOATE	CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1.CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O	LUNRMKZYOGNOTR-UHFFFAOYSA-N	InChI=1S/C23H16O6.2C11H14ClN5/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;2*1-11(2)16-9(13)15-10(14)17(11)8-5-3-7(12)4-6-8/h1-10,24-25H,11H2,(H,26,27)(H,28,29);2*3-6H,1-2H3,(H4,13,14,15,16)	Dihydrofolate reductase inhibitor	INHIBITOR	CHEMBL1939	Dihydrofolate reductase	Plasmodium falciparum K1
CHEMBL1201059	CHLOROGUANIDE HYDROCHLORIDE	CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1.Cl	SARMGXPVOFNNNG-UHFFFAOYSA-N	InChI=1S/C11H16ClN5.ClH/c1-7(2)15-10(13)17-11(14)16-9-5-3-8(12)4-6-9;/h3-7H,1-2H3,(H5,13,14,15,16,17);1H	Dihydrofolate reductase inhibitor	INHIBITOR	CHEMBL1939	Dihydrofolate reductase	Plasmodium falciparum K1
CHEMBL902	FAMOTIDINE	NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1	XUFQPHANEAPEMJ-UHFFFAOYSA-N	InChI=1S/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14)	Histamine H2 receptor antagonist	ANTAGONIST	CHEMBL1941	Histamine H2 receptor	Homo sapiens
CHEMBL1201051	CIMETIDINE HYDROCHLORIDE	CN/C(=N\CCSCc1nc[nH]c1C)NC#N.Cl	QJHCNBWLPSXHBL-UHFFFAOYSA-N	InChI=1S/C10H16N6S.ClH/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11;/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14);1H	Histamine H2 receptor antagonist	ANTAGONIST	CHEMBL1941	Histamine H2 receptor	Homo sapiens
CHEMBL1200949	BETAZOLE HYDROCHLORIDE	Cl.NCCc1cc[nH]n1	HLJRAERMLKNULP-UHFFFAOYSA-N	InChI=1S/C5H9N3.ClH/c6-3-1-5-2-4-7-8-5;/h2,4H,1,3,6H2,(H,7,8);1H	Histamine H2 receptor agonist	AGONIST	CHEMBL1941	Histamine H2 receptor	Homo sapiens
CHEMBL3183075	NIZATIDINE	CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1	SGXXNSQHWDMGGP-UHFFFAOYSA-N	InChI=1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3	Histamine H2 receptor antagonist	ANTAGONIST	CHEMBL1941	Histamine H2 receptor	Homo sapiens
CHEMBL2110372	RANITIDINE HYDROCHLORIDE	CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1.Cl	GGWBHVILAJZWKJ-UHFFFAOYSA-N	InChI=1S/C13H22N4O3S.ClH/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;/h4-5,9,14-15H,6-8,10H2,1-3H3;1H	Histamine H2 receptor antagonist	ANTAGONIST	CHEMBL1941	Histamine H2 receptor	Homo sapiens
CHEMBL30	CIMETIDINE	CN/C(=N/CCSCc1nc[nH]c1C)NC#N	AQIXAKUUQRKLND-UHFFFAOYSA-N	InChI=1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)	Histamine H2 receptor antagonist	ANTAGONIST	CHEMBL1941	Histamine H2 receptor	Homo sapiens
CHEMBL2111286	RANITIDINE BISMUTH CITRATE	CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Bi+3]	XAUTYMZTJWXZHZ-UHFFFAOYSA-K	InChI=1S/C13H22N4O3S.C6H8O7.Bi/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;7-3(8)1-6(13,5(11)12)2-4(9)10;/h4-5,9,14-15H,6-8,10H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;;+3/p-3	Histamine H2 receptor antagonist	ANTAGONIST	CHEMBL1941	Histamine H2 receptor	Homo sapiens
CHEMBL1200988	METHANTHELINE BROMIDE	CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21.[Br-]	PQMWYJDJHJQZDE-UHFFFAOYSA-M	InChI=1S/C21H26NO3.BrH/c1-4-22(3,5-2)14-15-24-21(23)20-16-10-6-8-12-18(16)25-19-13-9-7-11-17(19)20;/h6-13,20H,4-5,14-15H2,1-3H3;1H/q+1;/p-1	Histamine H2 receptor antagonist	ANTAGONIST	CHEMBL1941	Histamine H2 receptor	Homo sapiens
CHEMBL1689	TOLAZOLINE HYDROCHLORIDE	Cl.c1ccc(CC2=NCCN2)cc1	RHTNTTODYGNRSP-UHFFFAOYSA-N	InChI=1S/C10H12N2.ClH/c1-2-4-9(5-3-1)8-10-11-6-7-12-10;/h1-5H,6-8H2,(H,11,12);1H	Histamine H2 receptor agonist	AGONIST	CHEMBL1941	Histamine H2 receptor	Homo sapiens
CHEMBL227529	ALOGLIPTIN BENZOATE	Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O.O=C(O)c1ccccc1	KEJICOXJTRHYAK-XFULWGLBSA-N	InChI=1S/C18H21N5O2.C7H6O2/c1-21-17(24)9-16(22-8-4-7-15(20)12-22)23(18(21)25)11-14-6-3-2-5-13(14)10-19;8-7(9)6-4-2-1-3-5-6/h2-3,5-6,9,15H,4,7-8,11-12,20H2,1H3;1-5H,(H,8,9)/t15-;/m1./s1	Dipeptidyl peptidase IV inhibitor	INHIBITOR	CHEMBL284	Dipeptidyl peptidase IV	Homo sapiens
CHEMBL1201174	SITAGLIPTIN PHOSPHATE	N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F.O.O=P(O)(O)O	GQPYTJVDPQTBQC-KLQYNRQASA-N	InChI=1S/C16H15F6N5O.H3O4P.H2O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22;1-5(2,3)4;/h4,6,9H,1-3,5,7,23H2;(H3,1,2,3,4);1H2/t9-;;/m1../s1	Dipeptidyl peptidase IV inhibitor	INHIBITOR	CHEMBL284	Dipeptidyl peptidase IV	Homo sapiens
CHEMBL237500	LINAGLIPTIN	CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C	LTXREWYXXSTFRX-QGZVFWFLSA-N	InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1	Dipeptidyl peptidase IV inhibitor	INHIBITOR	CHEMBL284	Dipeptidyl peptidase IV	Homo sapiens
CHEMBL1201743	SAXAGLIPTIN HYDROCHLORIDE	Cl.N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2	TUAZNHHHYVBVBR-NHKADLRUSA-N	InChI=1S/C18H25N3O2.ClH/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17;/h10-15,23H,1-7,9,20H2;1H/t10?,11?,12-,13+,14+,15-,17?,18?;/m1./s1	Dipeptidyl peptidase IV inhibitor	INHIBITOR	CHEMBL284	Dipeptidyl peptidase IV	Homo sapiens
CHEMBL1200399	BUSPIRONE HYDROCHLORIDE	Cl.O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1	RICLFGYGYQXUFH-UHFFFAOYSA-N	InChI=1S/C21H31N5O2.ClH/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20;/h5,8-9H,1-4,6-7,10-17H2;1H	Serotonin 1a (5-HT1a) receptor partial agonist	PARTIAL AGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL3989558	METHYSERGIDE MALEATE	CCC(CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1.O=C(O)/C=C\C(=O)O	LWYXFDXUMVEZKS-TZTNOGQLSA-N	InChI=1S/C21H27N3O2.C4H4O4/c1-4-15(12-25)22-21(26)14-8-17-16-6-5-7-18-20(16)13(10-23(18)2)9-19(17)24(3)11-14;5-3(6)1-2-4(7)8/h5-8,10,14-15,19,25H,4,9,11-12H2,1-3H3,(H,22,26);1-2H,(H,5,6)(H,7,8)/b;2-1-/t14-,15?,19-;/m1./s1	Serotonin 1a (5-HT1a) receptor partial agonist	PARTIAL AGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL1112	ARIPIPRAZOLE	O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1	CEUORZQYGODEFX-UHFFFAOYSA-N	InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)	Serotonin 1a (5-HT1a) receptor partial agonist	PARTIAL AGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL1615374	VILAZODONE HYDROCHLORIDE	Cl.N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1	RPZBRGFNBNQSOP-UHFFFAOYSA-N	InChI=1S/C26H27N5O2.ClH/c27-16-18-4-6-23-22(13-18)19(17-29-23)3-1-2-8-30-9-11-31(12-10-30)21-5-7-24-20(14-21)15-25(33-24)26(28)32;/h4-7,13-15,17,29H,1-3,8-12H2,(H2,28,32);1H	Serotonin 1a (5-HT1a) receptor partial agonist	PARTIAL AGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL160	CYCLOSPORINE	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C	PMATZTZNYRCHOR-CGLBZJNRSA-N	InChI=1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42-,43+,44+,45+,46+,47+,49+,50+,51+,52-/m1/s1	Cyclophilin A modulator	MODULATOR	CHEMBL1949	Cyclophilin A	Homo sapiens
CHEMBL1200644	FONDAPARINUX SODIUM	CO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]2O[C@@H](C(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]4O[C@H](C(=O)[O-])[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)[O-])[C@H](O)[C@H]4O)[C@H](OS(=O)(=O)[O-])[C@H]3NS(=O)(=O)[O-])[C@H](O)[C@H]2OS(=O)(=O)[O-])[C@H](O)[C@H]1NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]	XEKSTYNIJLDDAZ-JASSWCPGSA-D	InChI=1S/C31H53N3O49S8.10Na/c1-69-27-9(33-85(48,49)50)13(37)17(6(74-27)3-71-88(57,58)59)76-31-22(83-91(66,67)68)16(40)21(24(81-31)26(43)44)79-29-10(34-86(51,52)53)19(82-90(63,64)65)18(7(75-29)4-72-89(60,61)62)77-30-15(39)14(38)20(23(80-30)25(41)42)78-28-8(32-84(45,46)47)12(36)11(35)5(73-28)2-70-87(54,55)56;;;;;;;;;;/h5-24,27-40H,2-4H2,1H3,(H,41,42)(H,43,44)(H,45,46,47)(H,48,49,50)(H,51,52,53)(H,54,55,56)(H,57,58,59)(H,60,61,62)(H,63,64,65)(H,66,67,68);;;;;;;;;;/q;10*+1/p-10/t5-,6-,7-,8-,9-,10-,11-,12-,13-,14-,15-,16+,17-,18-,19-,20+,21+,22-,23+,24-,27+,28-,29-,30-,31-;;;;;;;;;;/m1........../s1	Antithrombin-III activator	ACTIVATOR	CHEMBL1950	Antithrombin-III	Homo sapiens
CHEMBL917	FLOXURIDINE	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F	ODKNJVUHOIMIIZ-RRKCRQDMSA-N	InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1	Thymidylate synthase inhibitor	INHIBITOR	CHEMBL1952	Thymidylate synthase	Homo sapiens
CHEMBL2360464	PEMETREXED DISODIUM	Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc3)c2c(=O)[nH]1.[Na+].[Na+]	NYDXNILOWQXUOF-GXKRWWSZSA-L	InChI=1S/C20H21N5O6.2Na/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27;;/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29);;/q;2*+1/p-2/t13-;;/m0../s1	Thymidylate synthase inhibitor	INHIBITOR	CHEMBL1952	Thymidylate synthase	Homo sapiens
CHEMBL1773	CAPECITABINE	CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F	GAGWJHPBXLXJQN-UORFTKCHSA-N	InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1	Thymidylate synthase inhibitor	INHIBITOR	CHEMBL1952	Thymidylate synthase	Homo sapiens
CHEMBL185	FLUOROURACIL	O=c1[nH]cc(F)c(=O)[nH]1	GHASVSINZRGABV-UHFFFAOYSA-N	InChI=1S/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)	Thymidylate synthase inhibitor	INHIBITOR	CHEMBL1952	Thymidylate synthase	Homo sapiens
CHEMBL2103784	COSYNTROPIN	CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C)C(C)C	ZOEFCCMDUURGSE-SQKVDDBVSA-N	InChI=1S/C136H210N40O31S/c1-75(2)109(127(200)154-71-106(181)156-88(31-13-17-52-137)114(187)158-89(32-14-18-53-138)115(188)159-91(35-21-56-149-134(142)143)116(189)164-96(37-23-58-151-136(146)147)131(204)175-60-25-39-104(175)126(199)173-111(77(5)6)128(201)163-90(33-15-19-54-139)120(193)171-110(76(3)4)129(202)169-101(65-80-43-47-84(180)48-44-80)132(205)176-61-26-40-105(176)133(206)207)172-125(198)103-38-24-59-174(103)130(203)95(34-16-20-55-140)157-107(182)70-153-113(186)99(66-81-68-152-87-30-12-11-29-85(81)87)167-117(190)92(36-22-57-150-135(144)145)160-121(194)98(63-78-27-9-8-10-28-78)166-123(196)100(67-82-69-148-74-155-82)168-118(191)93(49-50-108(183)184)161-119(192)94(51-62-208-7)162-124(197)102(73-178)170-122(195)97(165-112(185)86(141)72-177)64-79-41-45-83(179)46-42-79/h8-12,27-30,41-48,68-69,74-77,86,88-105,109-111,152,177-180H,13-26,31-40,49-67,70-73,137-141H2,1-7H3,(H,148,155)(H,153,186)(H,154,200)(H,156,181)(H,157,182)(H,158,187)(H,159,188)(H,160,194)(H,161,192)(H,162,197)(H,163,201)(H,164,189)(H,165,185)(H,166,196)(H,167,190)(H,168,191)(H,169,202)(H,170,195)(H,171,193)(H,172,198)(H,173,199)(H,183,184)(H,206,207)(H4,142,143,149)(H4,144,145,150)(H4,146,147,151)/t86-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,109-,110-,111-/m0/s1	Melanocortin receptor 2 agonist	AGONIST	CHEMBL1965	Melanocortin receptor 2	Homo sapiens
CHEMBL960	LEFLUNOMIDE	Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1	VHOGYURTWQBHIL-UHFFFAOYSA-N	InChI=1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18)	Dihydroorotate dehydrogenase inhibitor	INHIBITOR	CHEMBL1966	Dihydroorotate dehydrogenase	Homo sapiens
CHEMBL973	TERIFLUNOMIDE	C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1	UTNUDOFZCWSZMS-YFHOEESVSA-N	InChI=1S/C12H9F3N2O2/c1-7(18)10(6-16)11(19)17-9-4-2-8(3-5-9)12(13,14)15/h2-5,18H,1H3,(H,17,19)/b10-7-	Dihydroorotate dehydrogenase inhibitor	INHIBITOR	CHEMBL1966	Dihydroorotate dehydrogenase	Homo sapiens
CHEMBL1200862	METYROSINE	C[C@](N)(Cc1ccc(O)cc1)C(=O)O	NHTGHBARYWONDQ-JTQLQIEISA-N	InChI=1S/C10H13NO3/c1-10(11,9(13)14)6-7-2-4-8(12)5-3-7/h2-5,12H,6,11H2,1H3,(H,13,14)/t10-/m0/s1	Tyrosine 3-hydroxylase inhibitor	INHIBITOR	CHEMBL1969	Tyrosine 3-hydroxylase	Homo sapiens
CHEMBL473	DOFETILIDE	CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1	IXTMWRCNAAVVAI-UHFFFAOYSA-N	InChI=1S/C19H27N3O5S2/c1-22(13-12-16-4-6-17(7-5-16)20-28(2,23)24)14-15-27-19-10-8-18(9-11-19)21-29(3,25)26/h4-11,20-21H,12-15H2,1-3H3	HERG blocker	BLOCKER	CHEMBL240	HERG	Homo sapiens
CHEMBL2355456	IBUTILIDE FUMARATE	CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1.CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1.O=C(O)/C=C/C(=O)O	PCIOHQNIRPWFMV-WXXKFALUSA-N	InChI=1S/2C20H36N2O3S.C4H4O4/c2*1-4-6-7-8-9-16-22(5-2)17-10-11-20(23)18-12-14-19(15-13-18)21-26(3,24)25;5-3(6)1-2-4(7)8/h2*12-15,20-21,23H,4-11,16-17H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+	HERG blocker	BLOCKER	CHEMBL240	HERG	Homo sapiens
CHEMBL1083993	AMIODARONE HYDROCHLORIDE	CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1.Cl	ITPDYQOUSLNIHG-UHFFFAOYSA-N	InChI=1S/C25H29I2NO3.ClH/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3;/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3;1H	HERG blocker	BLOCKER	CHEMBL240	HERG	Homo sapiens
CHEMBL1700	SOTALOL HYDROCHLORIDE	CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1.Cl	VIDRYROWYFWGSY-UHFFFAOYSA-N	InChI=1S/C12H20N2O3S.ClH/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17;/h4-7,9,12-15H,8H2,1-3H3;1H	HERG blocker	BLOCKER	CHEMBL240	HERG	Homo sapiens
CHEMBL1256818	DEXTROMETHORPHAN HYDROBROMIDE	Br.COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3.O	STTADZBLEUMJRG-IKNOHUQMSA-N	InChI=1S/C18H25NO.BrH.H2O/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18;;/h6-7,12,15,17H,3-5,8-11H2,1-2H3;1H;1H2/t15-,17+,18+;;/m1../s1	Glutamate [NMDA] receptor subunit epsilon 1 antagonist	ANTAGONIST	CHEMBL1972	Glutamate [NMDA] receptor subunit epsilon 1	Homo sapiens
CHEMBL1388	MONOBENZONE	Oc1ccc(OCc2ccccc2)cc1	VYQNWZOUAUKGHI-UHFFFAOYSA-N	InChI=1S/C13H12O2/c14-12-6-8-13(9-7-12)15-10-11-4-2-1-3-5-11/h1-9,14H,10H2	Tyrosinase inhibitor	INHIBITOR	CHEMBL1973	Tyrosinase	Homo sapiens
CHEMBL544	MEQUINOL	COc1ccc(O)cc1	NWVVVBRKAWDGAB-UHFFFAOYSA-N	InChI=1S/C7H8O2/c1-9-7-4-2-6(8)3-5-7/h2-5,8H,1H3	Tyrosinase inhibitor	INHIBITOR	CHEMBL1973	Tyrosinase	Homo sapiens
CHEMBL1200485	SORAFENIB TOSYLATE	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1	IVDHYUQIDRJSTI-UHFFFAOYSA-N	InChI=1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL1567	SUNITINIB MALATE	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O	LBWFXVZLPYTWQI-IPOVEDGCSA-N	InChI=1S/C22H27FN4O2.C4H6O5/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28;5-2(4(8)9)1-3(6)7/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28);2,5H,1H2,(H,6,7)(H,8,9)/b17-12-;/t;2-/m.0/s1	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL1042	CHOLECALCIFEROL	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C	QYSXJUFSXHHAJI-YRZJJWOYSA-N	InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL1536	ERGOCALCIFEROL	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C	MECHNRXZTMCUDQ-RKHKHRCZSA-N	InChI=1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL1200666	CALCIPOTRIENE	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@@H](O)C2CC2)C[C@@H](O)C[C@@H]1O	LWQQLNNNIPYSNX-UROSTWAQSA-N	InChI=1S/C27H40O3/c1-17(6-13-25(29)20-8-9-20)23-11-12-24-19(5-4-14-27(23,24)3)7-10-21-15-22(28)16-26(30)18(21)2/h6-7,10,13,17,20,22-26,28-30H,2,4-5,8-9,11-12,14-16H2,1,3H3/b13-6+,19-7+,21-10-/t17-,22-,23-,24+,25-,26+,27-/m1/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL1200622	PARICALCITOL	C[C@@H](/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C)C(C)(C)O	BPKAHTKRCLCHEA-UBFJEZKGSA-N	InChI=1S/C27H44O3/c1-18(8-9-19(2)26(3,4)30)24-12-13-25-21(7-6-14-27(24,25)5)11-10-20-15-22(28)17-23(29)16-20/h8-11,18-19,22-25,28-30H,6-7,12-17H2,1-5H3/b9-8+,21-11+/t18-,19+,22-,23-,24-,25+,27-/m1/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL846	CALCITRIOL	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O	GMRQFYUYWCNGIN-NKMMMXOESA-N	InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL3544909	CALCIFEDIOL	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)(C)O.O	WRLFSJXJGJBFJQ-WPUCQFJDSA-N	InChI=1S/C27H44O2.H2O/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29;/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3;1H2/b21-11+,22-12-;/t20-,23+,24-,25+,27-;/m1./s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL1200810	DOXERCALCIFEROL	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@H](C)C(C)C)C[C@@H](O)C[C@@H]1O	HKXBNHCUPKIYDM-CGMHZMFXSA-N	InChI=1S/C28H44O2/c1-18(2)19(3)9-10-20(4)25-13-14-26-22(8-7-15-28(25,26)6)11-12-23-16-24(29)17-27(30)21(23)5/h9-12,18-20,24-27,29-30H,5,7-8,13-17H2,1-4,6H3/b10-9+,22-11+,23-12-/t19-,20+,24+,25+,26-,27-,28+/m0/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL1571	TESTOLACTONE	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CCC(=O)O2	BPEWUONYVDABNZ-DZBHQSCQSA-N	InChI=1S/C19H24O3/c1-18-9-7-13(20)11-12(18)3-4-14-15(18)8-10-19(2)16(14)5-6-17(21)22-19/h7,9,11,14-16H,3-6,8,10H2,1-2H3/t14-,15+,16+,18+,19+/m1/s1	Cytochrome P450 19A1 inhibitor	INHIBITOR	CHEMBL1978	Cytochrome P450 19A1	Homo sapiens
CHEMBL1399	ANASTROZOLE	CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1	YBBLVLTVTVSKRW-UHFFFAOYSA-N	InChI=1S/C17H19N5/c1-16(2,9-18)14-5-13(8-22-12-20-11-21-22)6-15(7-14)17(3,4)10-19/h5-7,11-12H,8H2,1-4H3	Cytochrome P450 19A1 inhibitor	INHIBITOR	CHEMBL1978	Cytochrome P450 19A1	Homo sapiens
CHEMBL1444	LETROZOLE	N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1	HPJKCIUCZWXJDR-UHFFFAOYSA-N	InChI=1S/C17H11N5/c18-9-13-1-5-15(6-2-13)17(22-12-20-11-21-22)16-7-3-14(10-19)4-8-16/h1-8,11-12,17H	Cytochrome P450 19A1 inhibitor	INHIBITOR	CHEMBL1978	Cytochrome P450 19A1	Homo sapiens
CHEMBL1200374	EXEMESTANE	C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12	BFYIZQONLCFLEV-DAELLWKTSA-N	InChI=1S/C20H24O2/c1-12-10-14-15-4-5-18(22)20(15,3)9-7-16(14)19(2)8-6-13(21)11-17(12)19/h6,8,11,14-16H,1,4-5,7,9-10H2,2-3H3/t14-,15-,16-,19+,20-/m0/s1	Cytochrome P450 19A1 inhibitor	INHIBITOR	CHEMBL1978	Cytochrome P450 19A1	Homo sapiens
CHEMBL488	AMINOGLUTETHIMIDE	CCC1(c2ccc(N)cc2)CCC(=O)NC1=O	ROBVIMPUHSLWNV-UHFFFAOYSA-N	InChI=1S/C13H16N2O2/c1-2-13(8-7-11(16)15-12(13)17)9-3-5-10(14)6-4-9/h3-6H,2,7-8,14H2,1H3,(H,15,16,17)	Cytochrome P450 19A1 inhibitor	INHIBITOR	CHEMBL1978	Cytochrome P450 19A1	Homo sapiens
CHEMBL1200822	FLECAINIDE ACETATE	CC(=O)O.O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F	RKXNZRPQSOPPRN-UHFFFAOYSA-N	InChI=1S/C17H20F6N2O3.C2H4O2/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11;1-2(3)4/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26);1H3,(H,3,4)	Sodium channel protein type V alpha subunit blocker	BLOCKER	CHEMBL1980	Sodium channel protein type V alpha subunit	Homo sapiens
CHEMBL1200612	DIBUCAINE HYDROCHLORIDE	CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1.Cl	IVHBBMHQKZBJEU-UHFFFAOYSA-N	InChI=1S/C20H29N3O2.ClH/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3;/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24);1H	Sodium channel protein type V alpha subunit blocker	BLOCKER	CHEMBL1980	Sodium channel protein type V alpha subunit	Homo sapiens
CHEMBL719	MUPIROCIN	C/C(=C\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O	MINDHVHHQZYEEK-HBBNESRFSA-N	InChI=1S/C26H44O9/c1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27/h13,17-21,24-27,31-32H,4-12,14-15H2,1-3H3,(H,28,29)/b16-13+/t17-,18-,19-,20-,21-,24+,25-,26-/m0/s1	Isoleucyl-tRNA synthetase inhibitor	INHIBITOR	CHEMBL1982	Isoleucyl-tRNA synthetase	Staphylococcus aureus
CHEMBL3989715	MUPIROCIN CALCIUM	C/C(=C\C(=O)OCCCCCCCCC(=O)[O-])C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O.C/C(=C\C(=O)OCCCCCCCCC(=O)[O-])C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O.O.O.[Ca+2]	DDHVILIIHBIMQU-YJGQQKNPSA-L	InChI=1S/2C26H44O9.Ca.2H2O/c2*1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27;;;/h2*13,17-21,24-27,31-32H,4-12,14-15H2,1-3H3,(H,28,29);;2*1H2/q;;+2;;/p-2/b2*16-13+;;;/t2*17-,18-,19-,20-,21-,24+,25-,26-;;;/m00.../s1	Isoleucyl-tRNA synthetase inhibitor	INHIBITOR	CHEMBL1982	Isoleucyl-tRNA synthetase	Staphylococcus aureus
CHEMBL1200517	DIHYDROERGOTAMINE MESYLATE	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.CS(=O)(=O)O	ADYPXRFPBQGGAH-UMYZUSPBSA-N	InChI=1S/C33H37N5O5.CH4O3S/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32;1-5(2,3)4/h3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39);1H3,(H,2,3,4)/t21-,23-,25-,26+,27+,32-,33+;/m1./s1	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	CHEMBL1983	Serotonin 1d (5-HT1d) receptor	Homo sapiens
CHEMBL2448612	ERGOTAMINE TARTRATE	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.O=C(O)C(O)C(O)C(=O)O	CJMJLDQKTOJACI-SEUSHGJOSA-N	InChI=1S/2C33H35N5O5.C4H6O6/c2*1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32;5-1(3(7)8)2(6)4(9)10/h2*3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39);1-2,5-6H,(H,7,8)(H,9,10)/t2*21-,25-,26+,27+,32-,33+;/m11./s1	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	CHEMBL1983	Serotonin 1d (5-HT1d) receptor	Homo sapiens
CHEMBL1201003	ELETRIPTAN HYDROBROMIDE	Br.CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12	UTINOWOSWSPFLJ-FSRHSHDFSA-N	InChI=1S/C22H26N2O2S.BrH/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20;/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3;1H/t19-;/m1./s1	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	CHEMBL1983	Serotonin 1d (5-HT1d) receptor	Homo sapiens
CHEMBL1200601	NARATRIPTAN HYDROCHLORIDE	CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1.Cl	AWEZYKMQFAUBTD-UHFFFAOYSA-N	InChI=1S/C17H25N3O2S.ClH/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14;/h3-4,11-12,14,18-19H,5-10H2,1-2H3;1H	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	CHEMBL1983	Serotonin 1d (5-HT1d) receptor	Homo sapiens
CHEMBL1185	ZOLMITRIPTAN	CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12	ULSDMUVEXKOYBU-ZDUSSCGKSA-N	InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	CHEMBL1983	Serotonin 1d (5-HT1d) receptor	Homo sapiens
CHEMBL1200521	ALMOTRIPTAN MALATE	CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12.O=C(O)CC(O)C(=O)O	QHATUKWEVNMHRY-UHFFFAOYSA-N	InChI=1S/C17H25N3O2S.C4H6O5/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20;5-2(4(8)9)1-3(6)7/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3;2,5H,1H2,(H,6,7)(H,8,9)	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	CHEMBL1983	Serotonin 1d (5-HT1d) receptor	Homo sapiens
CHEMBL2138684	FROVATRIPTAN SUCCINATE	CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1.O.O=C(O)CCC(=O)O	CUETXFMONOSVJA-KLQYNRQASA-N	InChI=1S/C14H17N3O.C4H6O4.H2O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13;5-3(6)1-2-4(7)8;/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18);1-2H2,(H,5,6)(H,7,8);1H2/t9-;;/m1../s1	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	CHEMBL1983	Serotonin 1d (5-HT1d) receptor	Homo sapiens
CHEMBL1201032	RIZATRIPTAN BENZOATE	CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12.O=C(O)c1ccccc1	JPRXYLQNJJVCMZ-UHFFFAOYSA-N	InChI=1S/C15H19N5.C7H6O2/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20;8-7(9)6-4-2-1-3-5-6/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3;1-5H,(H,8,9)	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	CHEMBL1983	Serotonin 1d (5-HT1d) receptor	Homo sapiens
CHEMBL1201150	SUMATRIPTAN SUCCINATE	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1.O=C(O)CCC(=O)O	PORMUFZNYQJOEI-UHFFFAOYSA-N	InChI=1S/C14H21N3O2S.C4H6O4/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3;5-3(6)1-2-4(7)8/h4-5,8-9,15-16H,6-7,10H2,1-3H3;1-2H2,(H,5,6)(H,7,8)	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	CHEMBL1983	Serotonin 1d (5-HT1d) receptor	Homo sapiens
CHEMBL128	SUMATRIPTAN	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1	KQKPFRSPSRPDEB-UHFFFAOYSA-N	InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	CHEMBL1983	Serotonin 1d (5-HT1d) receptor	Homo sapiens
CHEMBL831	LOXAPINE	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1	XJGVXQDUIWGIRW-UHFFFAOYSA-N	InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL908	CHLORPROTHIXENE	CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21	WSPOMRSOLSGNFJ-AUWJEWJLSA-N	InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7-	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1713	CHLORPROMAZINE HYDROCHLORIDE	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21.Cl	FBSMERQALIEGJT-UHFFFAOYSA-N	InChI=1S/C17H19ClN2S.ClH/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20;/h3-4,6-9,12H,5,10-11H2,1-2H3;1H	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL42	CLOZAPINE	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1	QZUDBNBUXVUHMW-UHFFFAOYSA-N	InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1200636	CYCLOBENZAPRINE HYDROCHLORIDE	CN(C)CCC=C1c2ccccc2C=Cc2ccccc21.Cl	VXEAYBOGHINOKW-UHFFFAOYSA-N	InChI=1S/C20H21N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-14H,7,15H2,1-2H3;1H	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL71	CHLORPROMAZINE	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21	ZPEIMTDSQAKGNT-UHFFFAOYSA-N	InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1200798	TRAZODONE HYDROCHLORIDE	Cl.O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	OHHDIOKRWWOXMT-UHFFFAOYSA-N	InChI=1S/C19H22ClN5O.ClH/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25;/h1-3,5-7,9,15H,4,8,10-14H2;1H	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL2358147	CARPHENAZINE MALEATE	CCC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O	TVPJGGZLZLUPOB-SPIKMXEPSA-N	InChI=1S/C24H31N3O2S.2C4H4O4/c1-2-22(29)19-8-9-24-21(18-19)27(20-6-3-4-7-23(20)30-24)11-5-10-25-12-14-26(15-13-25)16-17-28;2*5-3(6)1-2-4(7)8/h3-4,6-9,18,28H,2,5,10-17H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1108	DROPERIDOL	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1	RMEDXOLNCUSCGS-UHFFFAOYSA-N	InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1112	ARIPIPRAZOLE	O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1	CEUORZQYGODEFX-UHFFFAOYSA-N	InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL3544974	ASENAPINE MALEATE	CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1.O=C(O)/C=C\C(=O)O	GMDCDXMAFMEDAG-BTJKTKAUSA-N	InChI=1S/C17H16ClNO.C4H4O4/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19;5-3(6)1-2-4(7)8/h2-8,14-15H,9-10H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1201060	LOXAPINE HYDROCHLORIDE	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.Cl	JSXBVMKACNEMKY-UHFFFAOYSA-N	InChI=1S/C18H18ClN3O.ClH/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;/h2-7,12H,8-11H2,1H3;1H	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1201155	LOXAPINE SUCCINATE	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.O=C(O)CCC(=O)O	YQZBAXDVDZTKEQ-UHFFFAOYSA-N	InChI=1S/C18H18ClN3O.C4H6O4/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;5-3(6)1-2-4(7)8/h2-7,12H,8-11H2,1H3;1-2H2,(H,5,6)(H,7,8)	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1615372	LURASIDONE HYDROCHLORIDE	Cl.O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1	NEKCRUIRPWNMLK-SCIYSFAVSA-N	InChI=1S/C28H36N4O2S.ClH/c33-27-24-18-9-10-19(15-18)25(24)28(34)32(27)17-21-6-2-1-5-20(21)16-30-11-13-31(14-12-30)26-22-7-3-4-8-23(22)35-29-26;/h3-4,7-8,18-21,24-25H,1-2,5-6,9-17H2;1H/t18-,19+,20-,21-,24+,25-;/m0./s1	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1201052	MESORIDAZINE BESYLATE	CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21.O=S(=O)(O)c1ccccc1	CRJHBCPQHRVYBS-UHFFFAOYSA-N	InChI=1S/C21H26N2OS2.C6H6O3S/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(26(2)24)15-19(21)23;7-10(8,9)6-4-2-1-3-5-6/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1-5H,(H,7,8,9)	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL654	MIRTAZAPINE	CN1CCN2c3ncccc3Cc3ccccc3C2C1	RONZAEMNMFQXRA-UHFFFAOYSA-N	InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1200419	MOLINDONE HYDROCHLORIDE	CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2.Cl	GQWNECFJGBQMBO-UHFFFAOYSA-N	InChI=1S/C16H24N2O2.ClH/c1-3-13-11(2)17-14-5-4-12(16(19)15(13)14)10-18-6-8-20-9-7-18;/h12,17H,3-10H2,1-2H3;1H	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1200492	NEFAZODONE HYDROCHLORIDE	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl	DYCKFEBIOUQECE-UHFFFAOYSA-N	InChI=1S/C25H32ClN5O2.ClH/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22;/h3-6,8-11,20H,2,7,12-19H2,1H3;1H	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL715	OLANZAPINE	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1	KVWDHTXUZHCGIO-UHFFFAOYSA-N	InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL3989694	OLANZAPINE PAMOATE	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1.O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O	ZIMCQJVMPKQQPB-UHFFFAOYSA-N	InChI=1S/C23H16O6.C17H20N4S.H2O/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12;/h1-10,24-25H,11H2,(H,26,27)(H,28,29);3-6,11,19H,7-10H2,1-2H3;1H2	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1621	PALIPERIDONE	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O	PMXMIIMHBWHSKN-UHFFFAOYSA-N	InChI=1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL2107360	PALIPERIDONE PALMITATE	CCCCCCCCCCCCCCCC(=O)OC1CCCn2c1nc(C)c(CCN1CCC(c3noc4cc(F)ccc34)CC1)c2=O	VOMKSBFLAZZBOW-UHFFFAOYSA-N	InChI=1S/C39H57FN4O4/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-18-36(45)47-34-17-16-24-44-38(34)41-29(2)32(39(44)46)23-27-43-25-21-30(22-26-43)37-33-20-19-31(40)28-35(33)48-42-37/h19-20,28,30,34H,3-18,21-27H2,1-2H3	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1200469	PROMAZINE HYDROCHLORIDE	CN(C)CCCN1c2ccccc2Sc2ccccc21.Cl	JIVSXRLRGOICGA-UHFFFAOYSA-N	InChI=1S/C17H20N2S.ClH/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19;/h3-6,8-11H,7,12-13H2,1-2H3;1H	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL3188993	QUETIAPINE FUMARATE	O=C(O)/C=C/C(=O)O.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1	ZTHJULTYCAQOIJ-WXXKFALUSA-N	InChI=1S/2C21H25N3O2S.C4H4O4/c2*25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21;5-3(6)1-2-4(7)8/h2*1-8,25H,9-16H2;1-2H,(H,5,6)(H,7,8)/b;;2-1+	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1423	PIMOZIDE	O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	YVUQSNJEYSNKRX-UHFFFAOYSA-N	InChI=1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34)	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL85	RISPERIDONE	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2	RAPZEAPATHNIPO-UHFFFAOYSA-N	InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL54	HALOPERIDOL	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1	LNEPOXFFQSENCJ-UHFFFAOYSA-N	InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1200986	HALOPERIDOL DECANOATE	CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1	GUTXTARXLVFHDK-UHFFFAOYSA-N	InChI=1S/C31H41ClFNO3/c1-2-3-4-5-6-7-8-11-30(36)37-31(26-14-16-27(32)17-15-26)20-23-34(24-21-31)22-9-10-29(35)25-12-18-28(33)19-13-25/h12-19H,2-11,20-24H2,1H3	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL4297147	HALOPERIDOL LACTATE	CC(O)C(=O)O.O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1	BVUSNQJCSYDJJG-UHFFFAOYSA-N	InChI=1S/C21H23ClFNO2.C3H6O3/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16;1-2(4)3(5)6/h3-10,26H,1-2,11-15H2;2,4H,1H3,(H,5,6)	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL14376	ILOPERIDONE	COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1	XMXHEBAFVSFQEX-UHFFFAOYSA-N	InChI=1S/C24H27FN2O4/c1-16(28)18-4-7-21(23(14-18)29-2)30-13-3-10-27-11-8-17(9-12-27)24-20-6-5-19(25)15-22(20)31-26-24/h4-7,14-15,17H,3,8-13H2,1-2H3	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL479	THIORIDAZINE	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2	KLBQZWRITKRQQV-UHFFFAOYSA-N	InChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1200916	THIORIDAZINE HYDROCHLORIDE	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2.Cl	NZFNXWQNBYZDAQ-UHFFFAOYSA-N	InChI=1S/C21H26N2S2.ClH/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23;/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1H	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1201	THIOTHIXENE	CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1	GFBKORZTTCHDGY-UWVJOHFNSA-N	InChI=1S/C23H29N3O2S2/c1-24(2)30(27,28)18-10-11-23-21(17-18)19(20-7-4-5-9-22(20)29-23)8-6-12-26-15-13-25(3)14-16-26/h4-5,7-11,17H,6,12-16H2,1-3H3/b19-8-	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL3989824	THIOTHIXENE HYDROCHLORIDE	CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1.Cl.Cl.O.O	MEUAAEMCZUPORO-LRSHZYOCSA-N	InChI=1S/C23H29N3O2S2.2ClH.2H2O/c1-24(2)30(27,28)18-10-11-23-21(17-18)19(20-7-4-5-9-22(20)29-23)8-6-12-26-15-13-25(3)14-16-26;;;;/h4-5,7-11,17H,6,12-16H2,1-3H3;2*1H;2*1H2/b19-8-;;;;	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1257040	TRIFLUOPERAZINE HYDROCHLORIDE	CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1.Cl.Cl	BXDAOUXDMHXPDI-UHFFFAOYSA-N	InChI=1S/C21H24F3N3S.2ClH/c1-25-11-13-26(14-12-25)9-4-10-27-17-5-2-3-6-19(17)28-20-8-7-16(15-18(20)27)21(22,23)24;;/h2-3,5-8,15H,4,9-14H2,1H3;2*1H	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1200948	TRIMIPRAMINE MALEATE	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21.O=C(O)/C=C\C(=O)O	YDGHCKHAXOUQOS-BTJKTKAUSA-N	InChI=1S/C20H26N2.C4H4O4/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22;5-3(6)1-2-4(7)8/h4-11,16H,12-15H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1375743	ZIPRASIDONE HYDROCHLORIDE	Cl.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1	ZCBZSCBNOOIHFP-UHFFFAOYSA-N	InChI=1S/C21H21ClN4OS.ClH.H2O/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;;/h1-4,11,13H,5-10,12H2,(H,23,27);1H;1H2	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL3989833	ZIPRASIDONE MESYLATE	CS(=O)(=O)O.O.O.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1	WLQZEFFFIUHSJB-UHFFFAOYSA-N	InChI=1S/C21H21ClN4OS.CH4O3S.3H2O/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;1-5(2,3)4;;;/h1-4,11,13H,5-10,12H2,(H,23,27);1H3,(H,2,3,4);3*1H2	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL831	LOXAPINE	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1	XJGVXQDUIWGIRW-UHFFFAOYSA-N	InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL2095211	LORCASERIN HYDROCHLORIDE	C[C@H]1CNCCc2ccc(Cl)cc21.Cl	ITIHHRMYZPNGRC-QRPNPIFTSA-N	InChI=1S/C11H14ClN.ClH/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9;/h2-3,6,8,13H,4-5,7H2,1H3;1H/t8-;/m0./s1	Serotonin 2c (5-HT2c) receptor agonist	AGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL1200426	METHIXENE HYDROCHLORIDE	CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1.Cl.O	RAOHHYUBMJLHNC-UHFFFAOYSA-N	InChI=1S/C20H23NS.ClH.H2O/c1-21-12-6-7-15(14-21)13-18-16-8-2-4-10-19(16)22-20-11-5-3-9-17(18)20;;/h2-5,8-11,15,18H,6-7,12-14H2,1H3;1H;1H2	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL3989558	METHYSERGIDE MALEATE	CCC(CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1.O=C(O)/C=C\C(=O)O	LWYXFDXUMVEZKS-TZTNOGQLSA-N	InChI=1S/C21H27N3O2.C4H4O4/c1-4-15(12-25)22-21(26)14-8-17-16-6-5-7-18-20(16)13(10-23(18)2)9-19(17)24(3)11-14;5-3(6)1-2-4(7)8/h5-8,10,14-15,19,25H,4,9,11-12H2,1-3H3,(H,22,26);1-2H,(H,5,6)(H,7,8)/b;2-1-/t14-,15?,19-;/m1./s1	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL654	MIRTAZAPINE	CN1CCN2c3ncccc3Cc3ccccc3C2C1	RONZAEMNMFQXRA-UHFFFAOYSA-N	InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL1200492	NEFAZODONE HYDROCHLORIDE	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl	DYCKFEBIOUQECE-UHFFFAOYSA-N	InChI=1S/C25H32ClN5O2.ClH/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22;/h3-6,8-11,20H,2,7,12-19H2,1H3;1H	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL715	OLANZAPINE	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1	KVWDHTXUZHCGIO-UHFFFAOYSA-N	InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL3989694	OLANZAPINE PAMOATE	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1.O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O	ZIMCQJVMPKQQPB-UHFFFAOYSA-N	InChI=1S/C23H16O6.C17H20N4S.H2O/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12;/h1-10,24-25H,11H2,(H,26,27)(H,28,29);3-6,11,19H,7-10H2,1-2H3;1H2	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL3188993	QUETIAPINE FUMARATE	O=C(O)/C=C/C(=O)O.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1	ZTHJULTYCAQOIJ-WXXKFALUSA-N	InChI=1S/2C21H25N3O2S.C4H4O4/c2*25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21;5-3(6)1-2-4(7)8/h2*1-8,25H,9-16H2;1-2H,(H,5,6)(H,7,8)/b;;2-1+	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL85	RISPERIDONE	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2	RAPZEAPATHNIPO-UHFFFAOYSA-N	InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL479	THIORIDAZINE	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2	KLBQZWRITKRQQV-UHFFFAOYSA-N	InChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL1200916	THIORIDAZINE HYDROCHLORIDE	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2.Cl	NZFNXWQNBYZDAQ-UHFFFAOYSA-N	InChI=1S/C21H26N2S2.ClH/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23;/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1H	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL1200798	TRAZODONE HYDROCHLORIDE	Cl.O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12	OHHDIOKRWWOXMT-UHFFFAOYSA-N	InChI=1S/C19H22ClN5O.ClH/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25;/h1-3,5-7,9,15H,4,8,10-14H2;1H	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL1257040	TRIFLUOPERAZINE HYDROCHLORIDE	CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1.Cl.Cl	BXDAOUXDMHXPDI-UHFFFAOYSA-N	InChI=1S/C21H24F3N3S.2ClH/c1-25-11-13-26(14-12-25)9-4-10-27-17-5-2-3-6-19(17)28-20-8-7-16(15-18(20)27)21(22,23)24;;/h2-3,5-8,15H,4,9-14H2,1H3;2*1H	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL1200948	TRIMIPRAMINE MALEATE	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21.O=C(O)/C=C\C(=O)O	YDGHCKHAXOUQOS-BTJKTKAUSA-N	InChI=1S/C20H26N2.C4H4O4/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22;5-3(6)1-2-4(7)8/h4-11,16H,12-15H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL1375743	ZIPRASIDONE HYDROCHLORIDE	Cl.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1	ZCBZSCBNOOIHFP-UHFFFAOYSA-N	InChI=1S/C21H21ClN4OS.ClH.H2O/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;;/h1-4,11,13H,5-10,12H2,(H,23,27);1H;1H2	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL3989833	ZIPRASIDONE MESYLATE	CS(=O)(=O)O.O.O.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1	WLQZEFFFIUHSJB-UHFFFAOYSA-N	InChI=1S/C21H21ClN4OS.CH4O3S.3H2O/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;1-5(2,3)4;;;/h1-4,11,13H,5-10,12H2,(H,23,27);1H3,(H,2,3,4);3*1H2	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL2358147	CARPHENAZINE MALEATE	CCC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O	TVPJGGZLZLUPOB-SPIKMXEPSA-N	InChI=1S/C24H31N3O2S.2C4H4O4/c1-2-22(29)19-8-9-24-21(18-19)27(20-6-3-4-7-23(20)30-24)11-5-10-25-12-14-26(15-13-25)16-17-28;2*5-3(6)1-2-4(7)8/h3-4,6-9,18,28H,2,5,10-17H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL908	CHLORPROTHIXENE	CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21	WSPOMRSOLSGNFJ-AUWJEWJLSA-N	InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7-	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL1200636	CYCLOBENZAPRINE HYDROCHLORIDE	CN(C)CCC=C1c2ccccc2C=Cc2ccccc21.Cl	VXEAYBOGHINOKW-UHFFFAOYSA-N	InChI=1S/C20H21N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-14H,7,15H2,1-2H3;1H	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL1201155	LOXAPINE SUCCINATE	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.O=C(O)CCC(=O)O	YQZBAXDVDZTKEQ-UHFFFAOYSA-N	InChI=1S/C18H18ClN3O.C4H6O4/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;5-3(6)1-2-4(7)8/h2-7,12H,8-11H2,1H3;1-2H2,(H,5,6)(H,7,8)	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL1201060	LOXAPINE HYDROCHLORIDE	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.Cl	JSXBVMKACNEMKY-UHFFFAOYSA-N	InChI=1S/C18H18ClN3O.ClH/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;/h2-7,12H,8-11H2,1H3;1H	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL1200331	FOSFOMYCIN TROMETHAMINE	C[C@@H]1O[C@@H]1P(=O)(O)O.NC(CO)(CO)CO	QZJIMDIBFFHQDW-LMLSDSMGSA-N	InChI=1S/C4H11NO3.C3H7O4P/c5-4(1-6,2-7)3-8;1-2-3(7-2)8(4,5)6/h6-8H,1-3,5H2;2-3H,1H3,(H2,4,5,6)/t;2-,3+/m.0/s1	UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor	INHIBITOR	CHEMBL1984	UDP-N-acetylglucosamine 1-carboxyvinyltransferase	Escherichia coli K-12
CHEMBL266481	GLUCAGON	CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)O	MASNOZXLGMXCHN-ZLPAWPGGSA-N	InChI=1S/C153H225N43O49S/c1-72(2)52-97(133(226)176-96(47-51-246-11)132(225)184-104(60-115(159)209)143(236)196-123(78(10)203)151(244)245)179-137(230)103(58-83-64-167-89-29-19-18-28-87(83)89)183-131(224)95(43-46-114(158)208)177-148(241)120(74(5)6)194-141(234)101(54-79-24-14-12-15-25-79)182-138(231)105(61-117(211)212)185-130(223)94(42-45-113(157)207)171-124(217)75(7)170-127(220)91(31-22-49-165-152(160)161)172-128(221)92(32-23-50-166-153(162)163)174-146(239)110(69-199)191-140(233)107(63-119(215)216)186-134(227)98(53-73(3)4)178-135(228)99(56-81-33-37-85(204)38-34-81)180-129(222)90(30-20-21-48-154)173-145(238)109(68-198)190-136(229)100(57-82-35-39-86(205)40-36-82)181-139(232)106(62-118(213)214)187-147(240)111(70-200)192-150(243)122(77(9)202)195-142(235)102(55-80-26-16-13-17-27-80)188-149(242)121(76(8)201)193-116(210)66-168-126(219)93(41-44-112(156)206)175-144(237)108(67-197)189-125(218)88(155)59-84-65-164-71-169-84/h12-19,24-29,33-40,64-65,71-78,88,90-111,120-123,167,197-205H,20-23,30-32,41-63,66-70,154-155H2,1-11H3,(H2,156,206)(H2,157,207)(H2,158,208)(H2,159,209)(H,164,169)(H,168,219)(H,170,220)(H,171,217)(H,172,221)(H,173,238)(H,174,239)(H,175,237)(H,176,226)(H,177,241)(H,178,228)(H,179,230)(H,180,222)(H,181,232)(H,182,231)(H,183,224)(H,184,225)(H,185,223)(H,186,227)(H,187,240)(H,188,242)(H,189,218)(H,190,229)(H,191,233)(H,192,243)(H,193,210)(H,194,234)(H,195,235)(H,196,236)(H,211,212)(H,213,214)(H,215,216)(H,244,245)(H4,160,161,165)(H4,162,163,166)/t75-,76+,77+,78+,88-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,120-,121-,122-,123-/m0/s1	Glucagon receptor agonist	AGONIST	CHEMBL1985	Glucagon receptor	Homo sapiens
CHEMBL3545059	ALISKIREN FUMARATE	COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC.COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC.O=C(O)/C=C/C(=O)O	KLRSDBSKUSSCGU-KRQUFFFQSA-N	InChI=1S/2C30H53N3O6.C4H4O4/c2*1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36;5-3(6)1-2-4(7)8/h2*10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35);1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*22-,23-,24-,25-;/m00./s1	Renin inhibitor	INHIBITOR	CHEMBL286	Renin	Homo sapiens
CHEMBL1963683	TAFLUPROST	CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/C(F)(F)COc1ccccc1	WSNODXPBBALQOF-VEJSHDCNSA-N	InChI=1S/C25H34F2O5/c1-18(2)32-24(30)13-9-4-3-8-12-20-21(23(29)16-22(20)28)14-15-25(26,27)17-31-19-10-6-5-7-11-19/h3,5-8,10-11,14-15,18,20-23,28-29H,4,9,12-13,16-17H2,1-2H3/b8-3-,15-14+/t20-,21-,22+,23-/m1/s1	Prostanoid FP receptor agonist	AGONIST	CHEMBL1987	Prostanoid FP receptor	Homo sapiens
CHEMBL1051	LATANOPROST	CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1	GGXICVAJURFBLW-CEYXHVGTSA-N	InChI=1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1	Prostanoid FP receptor agonist	AGONIST	CHEMBL1987	Prostanoid FP receptor	Homo sapiens
CHEMBL1200799	TRAVOPROST	CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1cccc(C(F)(F)F)c1	MKPLKVHSHYCHOC-AHTXBMBWSA-N	InChI=1S/C26H35F3O6/c1-17(2)35-25(33)11-6-4-3-5-10-21-22(24(32)15-23(21)31)13-12-19(30)16-34-20-9-7-8-18(14-20)26(27,28)29/h3,5,7-9,12-14,17,19,21-24,30-32H,4,6,10-11,15-16H2,1-2H3/b5-3-,13-12+/t19-,21-,22-,23+,24-/m1/s1	Prostanoid FP receptor agonist	AGONIST	CHEMBL1987	Prostanoid FP receptor	Homo sapiens
CHEMBL1200896	DINOPROST TROMETHAMINE	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O.NC(CO)(CO)CO	IYGXEHDCSOYNKY-RZHHZEQLSA-N	InChI=1S/C20H34O5.C4H11NO3/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25;5-4(1-6,2-7)3-8/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25);6-8H,1-3,5H2/b7-4-,13-12+;/t15-,16+,17+,18-,19+;/m0./s1	Prostanoid FP receptor agonist	AGONIST	CHEMBL1987	Prostanoid FP receptor	Homo sapiens
CHEMBL1200963	BIMATOPROST	CCNC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc1ccccc1	AQOKCDNYWBIDND-FTOWTWDKSA-N	InChI=1S/C25H37NO4/c1-2-26-25(30)13-9-4-3-8-12-21-22(24(29)18-23(21)28)17-16-20(27)15-14-19-10-6-5-7-11-19/h3,5-8,10-11,16-17,20-24,27-29H,2,4,9,12-15,18H2,1H3,(H,26,30)/b8-3-,17-16+/t20-,21+,22+,23-,24+/m0/s1	Prostanoid FP receptor agonist	AGONIST	CHEMBL1987	Prostanoid FP receptor	Homo sapiens
CHEMBL1237105	CARBOPROST TROMETHAMINE	CCCCC[C@](C)(O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O.NC(CO)(CO)CO	UMMADZJLZAPZAW-XOWPVRJPSA-N	InChI=1S/C21H36O5.C4H11NO3/c1-3-4-9-13-21(2,26)14-12-17-16(18(22)15-19(17)23)10-7-5-6-8-11-20(24)25;5-4(1-6,2-7)3-8/h5,7,12,14,16-19,22-23,26H,3-4,6,8-11,13,15H2,1-2H3,(H,24,25);6-8H,1-3,5H2/b7-5-,14-12+;/t16-,17-,18+,19-,21+;/m1./s1	Prostanoid FP receptor agonist	AGONIST	CHEMBL1987	Prostanoid FP receptor	Homo sapiens
CHEMBL1200721	ESTRAMUSTINE PHOSPHATE SODIUM	C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2OP(=O)([O-])[O-].[Na+].[Na+]	IIUMCNJTGSMNRO-VVSKJQCTSA-L	InChI=1S/C23H32Cl2NO6P.2Na/c1-23-9-8-18-17-5-3-16(31-22(27)26(12-10-24)13-11-25)14-15(17)2-4-19(18)20(23)6-7-21(23)32-33(28,29)30;;/h3,5,14,18-21H,2,4,6-13H2,1H3,(H2,28,29,30);;/q;2*+1/p-2/t18-,19-,20+,21+,23+;;/m1../s1	Estrogen receptor beta modulator	MODULATOR	CHEMBL242	Estrogen receptor beta	Homo sapiens
CHEMBL1200761	CHLOROTRIANISENE	COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1	BFPSDSIWYFKGBC-UHFFFAOYSA-N	InChI=1S/C23H21ClO3/c1-25-19-10-4-16(5-11-19)22(17-6-12-20(26-2)13-7-17)23(24)18-8-14-21(27-3)15-9-18/h4-15H,1-3H3	Estrogen receptor beta modulator	MODULATOR	CHEMBL242	Estrogen receptor beta	Homo sapiens
CHEMBL1116	RALOXIFENE HYDROCHLORIDE	Cl.O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12	BKXVVCILCIUCLG-UHFFFAOYSA-N	InChI=1S/C28H27NO4S.ClH/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29;/h4-13,18,30-31H,1-3,14-17H2;1H	Estrogen receptor beta modulator	MODULATOR	CHEMBL242	Estrogen receptor beta	Homo sapiens
CHEMBL1201057	CILASTATIN SODIUM	CC1(C)C[C@@H]1C(=O)N/C(=C\CCCCSC[C@H](N)C(=O)O)C(=O)[O-].[Na+]	QXPBTTUOVWMPJN-QBNHLFMHSA-M	InChI=1S/C16H26N2O5S.Na/c1-16(2)8-10(16)13(19)18-12(15(22)23)6-4-3-5-7-24-9-11(17)14(20)21;/h6,10-11H,3-5,7-9,17H2,1-2H3,(H,18,19)(H,20,21)(H,22,23);/q;+1/p-1/b12-6-;/t10-,11+;/m1./s1	Renal dipeptidase inhibitor	INHIBITOR	CHEMBL1989	Renal dipeptidase	Homo sapiens
CHEMBL1489	AZACITIDINE	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1	NMUSYJAQQFHJEW-KVTDHHQDSA-N	InChI=1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1	DNA (cytosine-5)-methyltransferase 3A inhibitor	INHIBITOR	CHEMBL1992	DNA (cytosine-5)-methyltransferase 3A	Homo sapiens
CHEMBL1201129	DECITABINE	Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1	XAUDJQYHKZQPEU-KVQBGUIXSA-N	InChI=1S/C8H12N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h3-6,13-14H,1-2H2,(H2,9,11,15)/t4-,5+,6+/m0/s1	DNA (cytosine-5)-methyltransferase 3A inhibitor	INHIBITOR	CHEMBL1992	DNA (cytosine-5)-methyltransferase 3A	Homo sapiens
CHEMBL1489	AZACITIDINE	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1	NMUSYJAQQFHJEW-KVTDHHQDSA-N	InChI=1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1	DNA (cytosine-5)-methyltransferase 1 inhibitor	INHIBITOR	CHEMBL1993	DNA (cytosine-5)-methyltransferase 1	Homo sapiens
CHEMBL1201129	DECITABINE	Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1	XAUDJQYHKZQPEU-KVQBGUIXSA-N	InChI=1S/C8H12N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h3-6,13-14H,1-2H2,(H2,9,11,15)/t4-,5+,6+/m0/s1	DNA (cytosine-5)-methyltransferase 1 inhibitor	INHIBITOR	CHEMBL1993	DNA (cytosine-5)-methyltransferase 1	Homo sapiens
CHEMBL1095097	EPLERENONE	COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@H]13	JUKPWJGBANNWMW-VWBFHTRKSA-N	InChI=1S/C24H30O6/c1-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,22+,23-,24-/m1/s1	Mineralocorticoid receptor antagonist	ANTAGONIST	CHEMBL1994	Mineralocorticoid receptor	Homo sapiens
CHEMBL1200542	DESOXYCORTICOSTERONE ACETATE	CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	VPGRYOFKCNULNK-ACXQXYJUSA-N	InChI=1S/C23H32O4/c1-14(24)27-13-21(26)20-7-6-18-17-5-4-15-12-16(25)8-10-22(15,2)19(17)9-11-23(18,20)3/h12,17-20H,4-11,13H2,1-3H3/t17-,18-,19-,20+,22-,23-/m0/s1	Mineralocorticoid receptor agonist	AGONIST	CHEMBL1994	Mineralocorticoid receptor	Homo sapiens
CHEMBL1201010	FLUDROCORTISONE ACETATE	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	SYWHXTATXSMDSB-GSLJADNHSA-N	InChI=1S/C23H31FO6/c1-13(25)30-12-19(28)22(29)9-7-16-17-5-4-14-10-15(26)6-8-20(14,2)23(17,24)18(27)11-21(16,22)3/h10,16-18,27,29H,4-9,11-12H2,1-3H3/t16-,17-,18-,20-,21-,22-,23-/m0/s1	Mineralocorticoid receptor agonist	AGONIST	CHEMBL1994	Mineralocorticoid receptor	Homo sapiens
CHEMBL1393	SPIRONOLACTONE	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21	LXMSZDCAJNLERA-ZHYRCANASA-N	InChI=1S/C24H32O4S/c1-14(25)29-19-13-15-12-16(26)4-8-22(15,2)17-5-9-23(3)18(21(17)19)6-10-24(23)11-7-20(27)28-24/h12,17-19,21H,4-11,13H2,1-3H3/t17-,18-,19+,21+,22-,23-,24+/m0/s1	Mineralocorticoid receptor antagonist	ANTAGONIST	CHEMBL1994	Mineralocorticoid receptor	Homo sapiens
CHEMBL1200592	DESOXYCORTICOSTERONE PIVALATE	CC(C)(C)C(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	VVOIQBFMTVCINR-WWMZEODYSA-N	InChI=1S/C26H38O4/c1-24(2,3)23(29)30-15-22(28)21-9-8-19-18-7-6-16-14-17(27)10-12-25(16,4)20(18)11-13-26(19,21)5/h14,18-21H,6-13,15H2,1-5H3/t18-,19-,20-,21+,25-,26-/m0/s1	Mineralocorticoid receptor agonist	AGONIST	CHEMBL1994	Mineralocorticoid receptor	Homo sapiens
CHEMBL1509	DROSPIRENONE	C[C@]12CC[C@H]3[C@H]([C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1)[C@H]1C[C@H]1C1=CC(=O)CC[C@@]13C	METQSPRSQINEEU-HXCATZOESA-N	InChI=1S/C24H30O3/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23)8-5-19(26)27-24/h9,13-16,18,20-21H,3-8,10-11H2,1-2H3/t13-,14+,15-,16+,18+,20-,21+,22-,23+,24+/m1/s1	Mineralocorticoid receptor antagonist	ANTAGONIST	CHEMBL1994	Mineralocorticoid receptor	Homo sapiens
CHEMBL1428	NIMODIPINE	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1	UIAGMCDKSXEBJQ-UHFFFAOYSA-N	InChI=1S/C21H26N2O7/c1-12(2)30-21(25)18-14(4)22-13(3)17(20(24)29-10-9-28-5)19(18)15-7-6-8-16(11-15)23(26)27/h6-8,11-12,19,22H,9-10H2,1-5H3	Mineralocorticoid receptor antagonist	ANTAGONIST	CHEMBL1994	Mineralocorticoid receptor	Homo sapiens
CHEMBL1480	FELODIPINE	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl	RZTAMFZIAATZDJ-UHFFFAOYSA-N	InChI=1S/C18H19Cl2NO4/c1-5-25-18(23)14-10(3)21-9(2)13(17(22)24-4)15(14)11-7-6-8-12(19)16(11)20/h6-8,15,21H,5H2,1-4H3	Mineralocorticoid receptor antagonist	ANTAGONIST	CHEMBL1994	Mineralocorticoid receptor	Homo sapiens
CHEMBL1237119	TREPROSTINIL	CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O	PAJMKGZZBBTTOY-ZFORQUDYSA-N	InChI=1S/C23H34O5/c1-2-3-4-7-17(24)9-10-18-19-11-15-6-5-8-22(28-14-23(26)27)20(15)12-16(19)13-21(18)25/h5-6,8,16-19,21,24-25H,2-4,7,9-14H2,1H3,(H,26,27)/t16-,17-,18+,19-,21+/m0/s1	Prostanoid IP receptor agonist	AGONIST	CHEMBL1995	Prostanoid IP receptor	Homo sapiens
CHEMBL494	ILOPROST	CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O	HIFJCPQKFCZDDL-ACWOEMLNSA-N	InChI=1S/C22H32O4/c1-3-4-7-15(2)20(23)11-10-18-19-13-16(8-5-6-9-22(25)26)12-17(19)14-21(18)24/h8,10-11,15,17-21,23-24H,5-7,9,12-14H2,1-2H3,(H,25,26)/b11-10+,16-8+/t15?,17-,18+,19-,20+,21+/m0/s1	Prostanoid IP receptor agonist	AGONIST	CHEMBL1995	Prostanoid IP receptor	Homo sapiens
CHEMBL962	EPOPROSTENOL SODIUM	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2O/C(=C\CCCC(=O)[O-])C[C@@H]21.[Na+]	LMHIPJMTZHDKEW-XQYLJSSYSA-M	InChI=1S/C20H32O5.Na/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22;/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24);/q;+1/p-1/b11-10+,15-8-;/t14-,16+,17+,18+,19-;/m0./s1	Prostanoid IP receptor agonist	AGONIST	CHEMBL1995	Prostanoid IP receptor	Homo sapiens
CHEMBL3989695	REGADENOSON	CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1.O	CDQVVPUXSPZONN-WPPLYIOHSA-N	InChI=1S/C15H18N8O5.H2O/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14;/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21);1H2/t7-,9-,10-,14-;/m1./s1	Adenosine A2a receptor agonist	AGONIST	CHEMBL251	Adenosine A2a receptor	Homo sapiens
CHEMBL932	DIPYRIDAMOLE	OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1	IZEKFCXSFNUWAM-UHFFFAOYSA-N	InChI=1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2	Equilibrative nucleoside transporter 1 inhibitor	INHIBITOR	CHEMBL1997	Equilibrative nucleoside transporter 1	Homo sapiens
CHEMBL1286	LEVETIRACETAM	CC[C@@H](C(N)=O)N1CCCC1=O	HPHUVLMMVZITSG-LURJTMIESA-N	InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1	Synaptic vesicle glycoprotein 2A modulator	MODULATOR	CHEMBL1998	Synaptic vesicle glycoprotein 2A	Homo sapiens
CHEMBL1265	ADAPALENE	COc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C12CC3CC(CC(C3)C1)C2	LZCDAPDGXCYOEH-UHFFFAOYSA-N	InChI=1S/C28H28O3/c1-31-26-7-6-23(21-2-3-22-12-24(27(29)30)5-4-20(22)11-21)13-25(26)28-14-17-8-18(15-28)10-19(9-17)16-28/h2-7,11-13,17-19H,8-10,14-16H2,1H3,(H,29,30)	Retinoic acid receptor agonist	AGONIST	CHEMBL2363069	Retinoic acid receptor	Homo sapiens
CHEMBL614	PYRAZINAMIDE	NC(=O)c1cnccn1	IPEHBUMCGVEMRF-UHFFFAOYSA-N	InChI=1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9)	Fatty acid synthase inhibitor	INHIBITOR	CHEMBL2011	Fatty acid synthase	Mycobacterium tuberculosis
CHEMBL712	ANISINDIONE	COc1ccc(C2C(=O)c3ccccc3C2=O)cc1	XRCFXMGQEVUZFC-UHFFFAOYSA-N	InChI=1S/C16H12O3/c1-19-11-8-6-10(7-9-11)14-15(17)12-4-2-3-5-13(12)16(14)18/h2-9,14H,1H3	Vitamin K-dependent gamma-carboxylase inhibitor	INHIBITOR	CHEMBL2012	Vitamin K-dependent gamma-carboxylase	Homo sapiens
CHEMBL1539	SULFADOXINE	COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC	PJSFRIWCGOHTNF-UHFFFAOYSA-N	InChI=1S/C12H14N4O4S/c1-19-10-11(14-7-15-12(10)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)	Dihydropteroate synthetase inhibitor	INHIBITOR	CHEMBL2013	Dihydropteroate synthetase	Plasmodium falciparum
CHEMBL1201056	SULFACYTINE	CCn1ccc(NS(=O)(=O)c2ccc(N)cc2)nc1=O	SIBQAECNSSQUOD-UHFFFAOYSA-N	InChI=1S/C12H14N4O3S/c1-2-16-8-7-11(14-12(16)17)15-20(18,19)10-5-3-9(13)4-6-10/h3-8H,2,13H2,1H3,(H,14,15,17)	Dihydropteroate synthetase inhibitor	INHIBITOR	CHEMBL2013	Dihydropteroate synthetase	Plasmodium falciparum
CHEMBL288441	BOSUTINIB	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl	UBPYILGKFZZVDX-UHFFFAOYSA-N	InChI=1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31)	Tyrosine-protein kinase SRC inhibitor	INHIBITOR	CHEMBL267	Tyrosine-protein kinase SRC	Homo sapiens
CHEMBL24828	VANDETANIB	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1	UHTHHESEBZOYNR-UHFFFAOYSA-N	InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)	Tyrosine-protein kinase SRC inhibitor	INHIBITOR	CHEMBL267	Tyrosine-protein kinase SRC	Homo sapiens
CHEMBL1373	MODAFINIL	NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1	YFGHCGITMMYXAQ-UHFFFAOYSA-N	InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)	Dopamine transporter inhibitor	INHIBITOR	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL1201192	ARMODAFINIL	NC(=O)C[S@@+]([O-])C(c1ccccc1)c1ccccc1	YFGHCGITMMYXAQ-LJQANCHMSA-N	InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)/t19-/m1/s1	Dopamine transporter inhibitor	INHIBITOR	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL1200377	AMPHETAMINE ASPARTATE	CC(N)Cc1ccccc1.NC(CC(=O)O)C(=O)O	DYOBNLAYPQSBLB-UHFFFAOYSA-N	InChI=1S/C9H13N.C4H7NO4/c1-8(10)7-9-5-3-2-4-6-9;5-2(4(8)9)1-3(6)7/h2-6,8H,7,10H2,1H3;2H,1,5H2,(H,6,7)(H,8,9)	Dopamine transporter releasing agent	RELEASING AGENT	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL405	AMPHETAMINE	CC(N)Cc1ccccc1	KWTSXDURSIMDCE-UHFFFAOYSA-N	InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3	Dopamine transporter releasing agent	RELEASING AGENT	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL501	AMPHETAMINE SULFATE	CC(N)Cc1ccccc1.O=S(=O)(O)O	SOFQDLYSFOWTJX-UHFFFAOYSA-N	InChI=1S/C9H13N.H2O4S/c1-8(10)7-9-5-3-2-4-6-9;1-5(2,3)4/h2-6,8H,7,10H2,1H3;(H2,1,2,3,4)	Dopamine transporter releasing agent	RELEASING AGENT	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL1201735	BUPROPION HYDROBROMIDE	Br.CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	WSTCENNATOVXKQ-UHFFFAOYSA-N	InChI=1S/C13H18ClNO.BrH/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10;/h5-9,15H,1-4H3;1H	Dopamine transporter inhibitor	INHIBITOR	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL1698	BUPROPION HYDROCHLORIDE	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1.Cl	HEYVINCGKDONRU-UHFFFAOYSA-N	InChI=1S/C13H18ClNO.ClH/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10;/h5-9,15H,1-4H3;1H	Dopamine transporter inhibitor	INHIBITOR	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL904	DEXMETHYLPHENIDATE HYDROCHLORIDE	COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1.Cl	JUMYIBMBTDDLNG-OJERSXHUSA-N	InChI=1S/C14H19NO2.ClH/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12;/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3;1H/t12-,13-;/m1./s1	Dopamine transporter inhibitor	INHIBITOR	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL1200387	AMPHETAMINE ADIPATE	CC(N)Cc1ccccc1.O=C(O)CCCCC(=O)O	OFCJKOOVFDGTLY-UHFFFAOYSA-N	InChI=1S/C9H13N.C6H10O4/c1-8(10)7-9-5-3-2-4-6-9;7-5(8)3-1-2-4-6(9)10/h2-6,8H,7,10H2,1H3;1-4H2,(H,7,8)(H,9,10)	Dopamine transporter releasing agent	RELEASING AGENT	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL612	DEXTROAMPHETAMINE	C[C@H](N)Cc1ccccc1	KWTSXDURSIMDCE-QMMMGPOBSA-N	InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1	Dopamine transporter releasing agent	RELEASING AGENT	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL1200782	DEXTROAMPHETAMINE ADIPATE	C[C@H](N)Cc1ccccc1.O=C(O)CCCCC(=O)O	OFCJKOOVFDGTLY-QRPNPIFTSA-N	InChI=1S/C9H13N.C6H10O4/c1-8(10)7-9-5-3-2-4-6-9;7-5(8)3-1-2-4-6(9)10/h2-6,8H,7,10H2,1H3;1-4H2,(H,7,8)(H,9,10)/t8-;/m0./s1	Dopamine transporter releasing agent	RELEASING AGENT	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL3544971	DEXTROAMPHETAMINE SULFATE	C[C@H](N)Cc1ccccc1.C[C@H](N)Cc1ccccc1.O=S(=O)(O)O	PYHRZPFZZDCOPH-QXGOIDDHSA-N	InChI=1S/2C9H13N.H2O4S/c2*1-8(10)7-9-5-3-2-4-6-9;1-5(2,3)4/h2*2-6,8H,7,10H2,1H3;(H2,1,2,3,4)/t2*8-;/m00./s1	Dopamine transporter releasing agent	RELEASING AGENT	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL3989844	DEXTROAMPHETAMINE SACCHARATE	C[C@H](N)Cc1ccccc1.O=C(O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O	VHKVKWTWHZUFIA-DGOKBZBKSA-N	InChI=1S/C9H13N.C6H10O8/c1-8(10)7-9-5-3-2-4-6-9;7-1(3(9)5(11)12)2(8)4(10)6(13)14/h2-6,8H,7,10H2,1H3;1-4,7-10H,(H,11,12)(H,13,14)/t8-;1-,2-,3-,4+/m00/s1	Dopamine transporter releasing agent	RELEASING AGENT	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL1693	DIETHYLPROPION HYDROCHLORIDE	CCN(CC)C(C)C(=O)c1ccccc1.Cl	ICFXZZFWRWNZMA-UHFFFAOYSA-N	InChI=1S/C13H19NO.ClH/c1-4-14(5-2)11(3)13(15)12-9-7-6-8-10-12;/h6-11H,4-5H2,1-3H3;1H	Dopamine transporter inhibitor	INHIBITOR	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL1201178	LISDEXAMFETAMINE DIMESYLATE	CS(=O)(=O)O.CS(=O)(=O)O.C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN	CETWSOHVEGTIBR-FORAGAHYSA-N	InChI=1S/C15H25N3O.2CH4O3S/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16;2*1-5(2,3)4/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19);2*1H3,(H,2,3,4)/t12-,14-;;/m0../s1	Dopamine transporter releasing agent	RELEASING AGENT	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL1722	METHYLPHENIDATE HYDROCHLORIDE	COC(=O)C(c1ccccc1)C1CCCCN1.Cl	JUMYIBMBTDDLNG-UHFFFAOYSA-N	InChI=1S/C14H19NO2.ClH/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12;/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3;1H	Dopamine transporter inhibitor	INHIBITOR	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL796	METHYLPHENIDATE	COC(=O)C(c1ccccc1)C1CCCCN1	DUGOZIWVEXMGBE-UHFFFAOYSA-N	InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3	Dopamine transporter inhibitor	INHIBITOR	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL2062163	PHENDIMETRAZINE TARTRATE	C[C@H]1[C@H](c2ccccc2)OCCN1C.O=C(O)C(O)C(O)C(=O)O	VEPOHXYIFQMVHW-XOZOLZJESA-N	InChI=1S/C12H17NO.C4H6O6/c1-10-12(14-9-8-13(10)2)11-6-4-3-5-7-11;5-1(3(7)8)2(6)4(9)10/h3-7,10,12H,8-9H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10)/t10-,12+;/m0./s1	Dopamine transporter inhibitor	INHIBITOR	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL1200483	PHENMETRAZINE HYDROCHLORIDE	CC1NCCOC1c1ccccc1.Cl	VJNXVAVKCZJOFQ-UHFFFAOYSA-N	InChI=1S/C11H15NO.ClH/c1-9-11(13-8-7-12-9)10-5-3-2-4-6-10;/h2-6,9,11-12H,7-8H2,1H3;1H	Dopamine transporter inhibitor	INHIBITOR	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL1237055	HYDROMORPHONE HYDROCHLORIDE	CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5.Cl	XHILEZUETWRSHC-NRGUFEMZSA-N	InChI=1S/C17H19NO3.ClH/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18;/h2,4,10-11,16,19H,3,5-8H2,1H3;1H/t10-,11+,16-,17-;/m0./s1	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL3989826	OXYCODONE TEREPHTHALATE	COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.O=C(O)c1ccc(C(=O)O)cc1	BTEYIHUKHHAVAN-KDKWOIFOSA-N	InChI=1S/2C18H21NO4.C8H6O4/c2*1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10;9-7(10)5-1-2-6(4-3-5)8(11)12/h2*3-4,13,16,21H,5-9H2,1-2H3;1-4H,(H,9,10)(H,11,12)/t2*13-,16+,17+,18-;/m11./s1	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1707	LOPERAMIDE HYDROCHLORIDE	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1.Cl	PGYPOBZJRVSMDS-UHFFFAOYSA-N	InChI=1S/C29H33ClN2O2.ClH/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23;/h3-16,34H,17-22H2,1-2H3;1H	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1237065	TRAMADOL HYDROCHLORIDE	COc1cccc(C2(O)CCCCC2CN(C)C)c1.Cl	PPKXEPBICJTCRU-UHFFFAOYSA-N	InChI=1S/C16H25NO2.ClH/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3;/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3;1H	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1200531	ALFENTANIL HYDROCHLORIDE	CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1.Cl	AQORHZJDCHLLJN-UHFFFAOYSA-N	InChI=1S/C21H32N6O3.ClH/c1-4-19(28)27(18-9-7-6-8-10-18)21(17-30-3)11-13-24(14-12-21)15-16-26-20(29)25(5-2)22-23-26;/h6-10H,4-5,11-17H2,1-3H3;1H	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1200599	DIFENOXIN HYDROCHLORIDE	Cl.N#CC(CCN1CCC(C(=O)O)(c2ccccc2)CC1)(c1ccccc1)c1ccccc1	VMIZTXDGZPTKIK-UHFFFAOYSA-N	InChI=1S/C28H28N2O2.ClH/c29-22-28(24-12-6-2-7-13-24,25-14-8-3-9-15-25)18-21-30-19-16-27(17-20-30,26(31)32)23-10-4-1-5-11-23;/h1-15H,16-21H2,(H,31,32);1H	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1200665	DIPHENOXYLATE HYDROCHLORIDE	CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1.Cl	SHTAFWKOISOCBI-UHFFFAOYSA-N	InChI=1S/C30H32N2O2.ClH/c1-2-34-28(33)29(25-12-6-3-7-13-25)18-21-32(22-19-29)23-20-30(24-31,26-14-8-4-9-15-26)27-16-10-5-11-17-27;/h3-17H,2,18-23H2,1H3;1H	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1201159	FENTANYL HYDROCHLORIDE	CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl	LHCBOXPPRUIAQT-UHFFFAOYSA-N	InChI=1S/C22H28N2O.ClH/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19;/h3-12,21H,2,13-18H2,1H3;1H	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL688	FENTANYL CITRATE	CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O	IVLVTNPOHDFFCJ-UHFFFAOYSA-N	InChI=1S/C22H28N2O.C6H8O7/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-12,21H,2,13-18H2,1H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1200890	OXYCODONE HYDROCHLORIDE	COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.Cl	MUZQPDBAOYKNLO-RKXJKUSZSA-N	InChI=1S/C18H21NO4.ClH/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10;/h3-4,13,16,21H,5-9H2,1-2H3;1H/t13-,16+,17+,18-;/m1./s1	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL2103744	MORPHINE SULFATE	CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.O.O.O.O.O.O=S(=O)(O)O	GRVOTVYEFDAHCL-RTSZDRIGSA-N	InChI=1S/2C17H19NO3.H2O4S.5H2O/c2*1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18;1-5(2,3)4;;;;;/h2*2-5,10-11,13,16,19-20H,6-8H2,1H3;(H2,1,2,3,4);5*1H2/t2*10-,11+,13-,16-,17-;;;;;;/m00....../s1	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL3989716	PROPOXYPHENE NAPSYLATE	CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C.O.O=S(=O)(O)c1ccc2ccccc2c1	GBKONKCASNNUQD-VGHSCWAPSA-N	InChI=1S/C22H29NO2.C10H8O3S.H2O/c1-5-21(24)25-22(18(2)17-23(3)4,20-14-10-7-11-15-20)16-19-12-8-6-9-13-19;11-14(12,13)10-6-5-8-3-1-2-4-9(8)7-10;/h6-15,18H,5,16-17H2,1-4H3;1-7H,(H,11,12,13);1H2/t18-,22+;;/m1../s1	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL270190	ALVIMOPAN	C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c1cccc(O)c1	UPNUIXSCZBYVBB-JVFUWBCBSA-N	InChI=1S/C25H32N2O4/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30)/t18-,20-,25+/m0/s1	Mu opioid receptor antagonist	ANTAGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1701	MEPERIDINE HYDROCHLORIDE	CCOC(=O)C1(c2ccccc2)CCN(C)CC1.Cl	WCNLCIJMFAJCPX-UHFFFAOYSA-N	InChI=1S/C15H21NO2.ClH/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13;/h4-8H,3,9-12H2,1-2H3;1H	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1200825	METHADONE HYDROCHLORIDE	CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1.Cl	FJQXCDYVZAHXNS-UHFFFAOYSA-N	InChI=1S/C21H27NO.ClH/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19;/h6-15,17H,5,16H2,1-4H3;1H	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1237104	PROPOXYPHENE HYDROCHLORIDE	CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C.Cl	QMQBBUPJKANITL-MYXGOWFTSA-N	InChI=1S/C22H29NO2.ClH/c1-5-21(24)25-22(18(2)17-23(3)4,20-14-10-7-11-15-20)16-19-12-8-6-9-13-19;/h6-15,18H,5,16-17H2,1-4H3;1H/t18-,22+;/m1./s1	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL3989768	LEVORPHANOL TARTRATE	CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13.O.O.O=C(O)C(O)C(O)C(=O)O	UMZNDVASJKIQCB-SODJFYQGSA-N	InChI=1S/C17H23NO.C4H6O6.2H2O/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17;5-1(3(7)8)2(6)4(9)10;;/h5-6,11,14,16,19H,2-4,7-10H2,1H3;1-2,5-6H,(H,7,8)(H,9,10);2*1H2/t14-,16+,17+;;;/m0.../s1	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL2062266	DIHYDROCODEINE BITARTRATE	COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314.O=C(O)C(O)C(O)C(=O)O	ZGSZBVAEVPSPFM-FFHNEAJVSA-N	InChI=1S/C18H23NO3.C4H6O6/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19;5-1(3(7)8)2(6)4(9)10/h3,6,11-13,17,20H,4-5,7-9H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-,12+,13-,17-,18-;/m0./s1	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1201120	REMIFENTANIL HYDROCHLORIDE	CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1.Cl	WFBMIPUMYUHANP-UHFFFAOYSA-N	InChI=1S/C20H28N2O5.ClH/c1-4-17(23)22(16-8-6-5-7-9-16)20(19(25)27-3)11-14-21(15-12-20)13-10-18(24)26-2;/h5-9H,4,10-15H2,1-3H3;1H	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1201770	METHYLNALTREXONE BROMIDE	C[N+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.[Br-]	IFGIYSGOEZJNBE-KNLJMPJLSA-N	InChI=1S/C21H25NO4.BrH/c1-22(11-12-2-3-12)9-8-20-17-13-4-5-14(23)18(17)26-19(20)15(24)6-7-21(20,25)16(22)10-13;/h4-5,12,16,19,25H,2-3,6-11H2,1H3;1H/t16-,19+,20+,21-,22?;/m1./s1	Mu opioid receptor antagonist	ANTAGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1201163	SUFENTANIL CITRATE	CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O	OJCZPLDERGDQRJ-UHFFFAOYSA-N	InChI=1S/C22H30N2O2S.C6H8O7/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-10,17H,3,11-16,18H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL596	FENTANYL	CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1	PJMPHNIQZUBGLI-UHFFFAOYSA-N	InChI=1S/C22H28N2O/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19/h3-12,21H,2,13-18H2,1H3	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1200817	LEVOMETHADYL ACETATE HYDROCHLORIDE	CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1.Cl	UXBPQRGCVJOTNT-COBSGTNCSA-N	InChI=1S/C23H31NO2.ClH/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21;/h7-16,18,22H,6,17H2,1-5H3;1H/t18-,22-;/m0./s1	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1201047	ANILERIDINE HYDROCHLORIDE	CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1.Cl	UDUQHZSAAWGSPJ-UHFFFAOYSA-N	InChI=1S/C22H28N2O2.ClH/c1-2-26-21(25)22(19-6-4-3-5-7-19)13-16-24(17-14-22)15-12-18-8-10-20(23)11-9-18;/h3-11H,2,12-17,23H2,1H3;1H	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1685	DEZOCINE	C[C@@]12CCCCC[C@@H](Cc3ccc(O)cc31)[C@@H]2N	VTMVHDZWSFQSQP-VBNZEHGJSA-N	InChI=1S/C16H23NO/c1-16-8-4-2-3-5-12(15(16)17)9-11-6-7-13(18)10-14(11)16/h6-7,10,12,15,18H,2-5,8-9,17H2,1H3/t12-,15-,16+/m0/s1	Mu opioid receptor partial agonist	PARTIAL AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1200543	ANILERIDINE PHOSPHATE	CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1.O=P(O)(O)O	FLQCEKVTYABVSH-UHFFFAOYSA-N	InChI=1S/C22H28N2O2.H3O4P/c1-2-26-21(25)22(19-6-4-3-5-7-19)13-16-24(17-14-22)15-12-18-8-10-20(23)11-9-18;1-5(2,3)4/h3-11H,2,12-17,23H2,1H3;(H3,1,2,3,4)	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1201777	TAPENTADOL HYDROCHLORIDE	CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C.Cl	ZELFLGGRLLOERW-YECZQDJWSA-N	InChI=1S/C14H23NO.ClH/c1-5-14(11(2)10-15(3)4)12-7-6-8-13(16)9-12;/h6-9,11,14,16H,5,10H2,1-4H3;1H/t11-,14+;/m0./s1	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL299400	BUTORPHANOL TARTRATE	O=C(O)C(O)C(O)C(=O)O.Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3	GMTYREVWZXJPLF-SXWPHCFWSA-N	InChI=1S/C21H29NO2.C4H6O6/c23-17-7-6-16-12-19-21(24)9-2-1-8-20(21,18(16)13-17)10-11-22(19)14-15-4-3-5-15;5-1(3(7)8)2(6)4(9)10/h6-7,13,15,19,23-24H,1-5,8-12,14H2;1-2,5-6H,(H,7,8)(H,9,10)/t19-,20+,21-;/m1./s1	Mu opioid receptor partial agonist	PARTIAL AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL2062276	LEVALLORPHAN TARTRATE	C=CCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13.O=C(O)C(O)C(O)C(=O)O	FWMLYVACGDQRFU-MBHUSPCXSA-N	InChI=1S/C19H25NO.C4H6O6/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19;5-1(3(7)8)2(6)4(9)10/h2,6-7,13,16,18,21H,1,3-5,8-12H2;1-2,5-6H,(H,7,8)(H,9,10)/t16-,18+,19+;/m0./s1	Mu opioid receptor antagonist	ANTAGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL1324	TOLCAPONE	Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1	MIQPIUSUKVNLNT-UHFFFAOYSA-N	InChI=1S/C14H11NO5/c1-8-2-4-9(5-3-8)13(17)10-6-11(15(19)20)14(18)12(16)7-10/h2-7,16,18H,1H3	Catechol O-methyltransferase inhibitor	INHIBITOR	CHEMBL2023	Catechol O-methyltransferase	Homo sapiens
CHEMBL953	ENTACAPONE	CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1	JRURYQJSLYLRLN-BJMVGYQFSA-N	InChI=1S/C14H15N3O5/c1-3-16(4-2)14(20)10(8-15)5-9-6-11(17(21)22)13(19)12(18)7-9/h5-7,18-19H,3-4H2,1-2H3/b10-5+	Catechol O-methyltransferase inhibitor	INHIBITOR	CHEMBL2023	Catechol O-methyltransferase	Homo sapiens
CHEMBL211471	NEOSTIGMINE METHYLSULFATE	CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.COS(=O)(=O)[O-]	OSZNNLWOYWAHSS-UHFFFAOYSA-M	InChI=1S/C12H19N2O2.CH4O4S/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;1-5-6(2,3)4/h6-9H,1-5H3;1H3,(H,2,3,4)/q+1;/p-1	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL220	Acetylcholinesterase	Homo sapiens
CHEMBL1678	DONEPEZIL HYDROCHLORIDE	COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2.Cl	XWAIAVWHZJNZQQ-UHFFFAOYSA-N	InChI=1S/C24H29NO3.ClH/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18;/h3-7,14-15,17,20H,8-13,16H2,1-2H3;1H	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL220	Acetylcholinesterase	Homo sapiens
CHEMBL1200933	HEXAFLUORENIUM BROMIDE	C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21.[Br-].[Br-]	WDEFPRUEZRUYNW-UHFFFAOYSA-L	InChI=1S/C36H42N2.2BrH/c1-37(2,35-31-21-11-7-17-27(31)28-18-8-12-22-32(28)35)25-15-5-6-16-26-38(3,4)36-33-23-13-9-19-29(33)30-20-10-14-24-34(30)36;;/h7-14,17-24,35-36H,5-6,15-16,25-26H2,1-4H3;2*1H/q+2;;/p-2	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL220	Acetylcholinesterase	Homo sapiens
CHEMBL812	PYRIDOSTIGMINE BROMIDE	CN(C)C(=O)Oc1ccc[n+](C)c1.[Br-]	VNYBTNPBYXSMOO-UHFFFAOYSA-M	InChI=1S/C9H13N2O2.BrH/c1-10(2)9(12)13-8-5-4-6-11(3)7-8;/h4-7H,1-3H3;1H/q+1;/p-1	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL220	Acetylcholinesterase	Homo sapiens
CHEMBL1555	GALANTAMINE HYDROBROMIDE	Br.COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2	QORVDGQLPPAFRS-XPSHAMGMSA-N	InChI=1S/C17H21NO3.BrH/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17;/h3-6,12,14,19H,7-10H2,1-2H3;1H/t12-,14-,17-;/m0./s1	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL220	Acetylcholinesterase	Homo sapiens
CHEMBL1025	ISOFLUROPHATE	CC(C)OP(=O)(F)OC(C)C	MUCZHBLJLSDCSD-UHFFFAOYSA-N	InChI=1S/C6H14FO3P/c1-5(2)9-11(7,8)10-6(3)4/h5-6H,1-4H3	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL220	Acetylcholinesterase	Homo sapiens
CHEMBL1128	EDROPHONIUM CHLORIDE	CC[N+](C)(C)c1cccc(O)c1.[Cl-]	BXKDSDJJOVIHMX-UHFFFAOYSA-N	InChI=1S/C10H15NO.ClH/c1-4-11(2,3)9-6-5-7-10(12)8-9;/h5-8H,4H2,1-3H3;1H	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL220	Acetylcholinesterase	Homo sapiens
CHEMBL1200367	ECHOTHIOPHATE IODIDE	CCOP(=O)(OCC)SCC[N+](C)(C)C.[I-]	OVXQHPWHMXOFRD-UHFFFAOYSA-M	InChI=1S/C9H23NO3PS.HI/c1-6-12-14(11,13-7-2)15-9-8-10(3,4)5;/h6-9H2,1-5H3;1H/q+1;/p-1	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL220	Acetylcholinesterase	Homo sapiens
CHEMBL1200514	DEMECARIUM BROMIDE	CN(CCCCCCCCCCN(C)C(=O)Oc1cccc([N+](C)(C)C)c1)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-].[Br-]	YHKBUDZECQDYBR-UHFFFAOYSA-L	InChI=1S/C32H52N4O4.2BrH/c1-33(31(37)39-29-21-17-19-27(25-29)35(3,4)5)23-15-13-11-9-10-12-14-16-24-34(2)32(38)40-30-22-18-20-28(26-30)36(6,7)8;;/h17-22,25-26H,9-16,23-24H2,1-8H3;2*1H/q+2;;/p-2	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL220	Acetylcholinesterase	Homo sapiens
CHEMBL1200541	AMBENONIUM CHLORIDE	CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl.[Cl-].[Cl-]	DXUUXWKFVDVHIK-UHFFFAOYSA-N	InChI=1S/C28H40Cl2N4O2.2ClH/c1-5-33(6-2,21-23-13-9-11-15-25(23)29)19-17-31-27(35)28(36)32-18-20-34(7-3,8-4)22-24-14-10-12-16-26(24)30;;/h9-16H,5-8,17-22H2,1-4H3;2*1H	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL220	Acetylcholinesterase	Homo sapiens
CHEMBL748	PRALIDOXIME CHLORIDE	C[n+]1ccccc1/C=N/O.[Cl-]	HIGSLXSBYYMVKI-UHFFFAOYSA-N	InChI=1S/C7H8N2O.ClH/c1-9-5-3-2-4-7(9)6-8-10;/h2-6H,1H3;1H	Acetylcholinesterase activator	ACTIVATOR	CHEMBL220	Acetylcholinesterase	Homo sapiens
CHEMBL2103868	CABOZANTINIB S-MALATE	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC.O=C(O)C[C@H](O)C(=O)O	HFCFMRYTXDINDK-WNQIDUERSA-N	InChI=1S/C28H24FN3O5.C4H6O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18;5-2(4(8)9)1-3(6)7/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34);2,5H,1H2,(H,6,7)(H,8,9)/t;2-/m.0/s1	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL3039588	PASIREOTIDE DIASPARTATE	NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O.N[C@@H](CC(=O)O)C(=O)O.N[C@@H](CC(=O)O)C(=O)O	NEEFMPSSNFRRNC-PPCPDXGKSA-N	InChI=1S/C58H66N10O9.2C4H7NO4/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45;2*5-2(4(8)9)1-3(6)7/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72);2*2H,1,5H2,(H,6,7)(H,8,9)/t43-,46-,47-,48+,49-,50-,51-;2*2-/m000/s1	Somatostatin receptor 3 agonist	AGONIST	CHEMBL2028	Somatostatin receptor 3	Homo sapiens
CHEMBL771	CYCLOSERINE	N[C@@H]1CONC1=O	DYDCUQKUCUHJBH-UWTATZPHSA-N	InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m1/s1	D-alanylalanine synthetase inhibitor	INHIBITOR	CHEMBL2030	D-alanylalanine synthetase	Mycobacterium tuberculosis
CHEMBL488	AMINOGLUTETHIMIDE	CCC1(c2ccc(N)cc2)CCC(=O)NC1=O	ROBVIMPUHSLWNV-UHFFFAOYSA-N	InChI=1S/C13H16N2O2/c1-2-13(8-7-11(16)15-12(13)17)9-3-5-10(14)6-4-9/h3-6H,2,7-8,14H2,1H3,(H,15,16,17)	Cytochrome P450 11A1 inhibitor	INHIBITOR	CHEMBL2033	Cytochrome P450 11A1	Homo sapiens
CHEMBL1670	MITOTANE	Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1	JWBOIMRXGHLCPP-UHFFFAOYSA-N	InChI=1S/C14H10Cl4/c15-10-7-5-9(6-8-10)13(14(17)18)11-3-1-2-4-12(11)16/h1-8,13-14H	Cytochrome P450 11A1 inhibitor	INHIBITOR	CHEMBL2033	Cytochrome P450 11A1	Homo sapiens
CHEMBL635	PREDNISONE	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO	XOFYZVNMUHMLCC-ZPOLXVRWSA-N	InChI=1S/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200845	HALCINONIDE	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1	MUQNGPZZQDCDFT-JNQJZLCISA-N	InChI=1S/C24H32ClFO5/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,26)17(28)11-22(16,4)24(19,31-20)18(29)12-25/h9,15-17,19,28H,5-8,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1201173	MEDRYSONE	CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C	GZENKSODFLBBHQ-ILSZZQPISA-N	InChI=1S/C22H32O3/c1-12-9-15-17-6-5-16(13(2)23)22(17,4)11-19(25)20(15)21(3)8-7-14(24)10-18(12)21/h10,12,15-17,19-20,25H,5-9,11H2,1-4H3/t12-,15-,16+,17-,19-,20+,21-,22+/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1201749	DIFLUPREDNATE	CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	WYQPLTPSGFELIB-JTQPXKBDSA-N	InChI=1S/C27H34F2O7/c1-5-6-23(34)36-26(22(33)14-35-15(2)30)10-8-17-18-12-20(28)19-11-16(31)7-9-24(19,3)27(18,29)21(32)13-25(17,26)4/h7,9,11,17-18,20-21,32H,5-6,8,10,12-14H2,1-4H3/t17-,18-,20-,21-,24-,25-,26-,27-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL632	BETAMETHASONE	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	UREBDLICKHMUKA-DVTGEIKXSA-N	InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL389621	HYDROCORTISONE	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO	JYGXADMDTFJGBT-VWUMJDOOSA-N	InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1504	TRIAMCINOLONE ACETONIDE	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	YNDXUCZADRHECN-JNQJZLCISA-N	InChI=1S/C24H31FO6/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,25)17(28)11-22(16,4)24(19,31-20)18(29)12-26/h7-9,15-17,19,26,28H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1549	HYDROCORTISONE CYPIONATE	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC1CCCC1	DLVOSEUFIRPIRM-KAQKJVHQSA-N	InChI=1S/C29H42O6/c1-27-13-11-20(30)15-19(27)8-9-21-22-12-14-29(34,28(22,2)16-23(31)26(21)27)24(32)17-35-25(33)10-7-18-5-3-4-6-18/h15,18,21-23,26,31,34H,3-14,16-17H2,1-2H3/t21-,22-,23-,26+,27-,28-,29-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1159650	CLOBETASOL PROPIONATE	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	CBGUOGMQLZIXBE-XGQKBEPLSA-N	InChI=1S/C25H32ClFO5/c1-5-21(31)32-25(20(30)13-26)14(2)10-18-17-7-6-15-11-16(28)8-9-22(15,3)24(17,27)19(29)12-23(18,25)4/h8-9,11,14,17-19,29H,5-7,10,12-13H2,1-4H3/t14-,17-,18-,19-,22-,23-,24-,25-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200495	HYDROCORTISONE SODIUM SUCCINATE	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)[O-].[Na+]	HHZQLQREDATOBM-CODXZCKSSA-M	InChI=1S/C25H34O8.Na/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30;/h11,16-18,22,27,32H,3-10,12-13H2,1-2H3,(H,29,30);/q;+1/p-1/t16-,17-,18-,22+,23-,24-,25-;/m0./s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200600	FLUOROMETHOLONE	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	FAOZLTXFLGPHNG-KNAQIMQKSA-N	InChI=1S/C22H29FO4/c1-12-9-17-15-6-8-21(27,13(2)24)20(15,4)11-18(26)22(17,23)19(3)7-5-14(25)10-16(12)19/h5,7,10,12,15,17-18,26-27H,6,8-9,11H2,1-4H3/t12-,15-,17-,18-,19-,20-,21-,22-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200635	HYDROCORTAMATE HYDROCHLORIDE	CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C.Cl	AKQNAIYKSALPKV-OYHXESGYSA-N	InChI=1S/C27H41NO6.ClH/c1-5-28(6-2)15-23(32)34-16-22(31)27(33)12-10-20-19-8-7-17-13-18(29)9-11-25(17,3)24(19)21(30)14-26(20,27)4;/h13,19-21,24,30,33H,5-12,14-16H2,1-4H3;1H/t19-,20-,21-,24+,25-,26-,27-;/m0./s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200762	BETAMETHASONE SODIUM PHOSPHATE	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]	PLCQGRYPOISRTQ-LWCNAHDDSA-L	InChI=1S/C22H30FO8P.2Na/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30;;/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30);;/q;2*+1/p-2/t12-,15-,16-,17-,19-,20-,21-,22-;;/m0../s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200865	LOTEPREDNOL ETABONATE	CCOC(=O)O[C@]1(C(=O)OCCl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	DMKSVUSAATWOCU-HROMYWEYSA-N	InChI=1S/C24H31ClO7/c1-4-30-21(29)32-24(20(28)31-13-25)10-8-17-16-6-5-14-11-15(26)7-9-22(14,2)19(16)18(27)12-23(17,24)3/h7,9,11,16-19,27H,4-6,8,10,12-13H2,1-3H3/t16-,17-,18-,19+,22-,23-,24-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200909	PREDNISOLONE TEBUTATE	CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	HUMXXHTVHHLNRO-KAJVQRHHSA-N	InChI=1S/C27H38O6/c1-24(2,3)14-22(31)33-15-21(30)27(32)11-9-19-18-7-6-16-12-17(28)8-10-25(16,4)23(18)20(29)13-26(19,27)5/h8,10,12,18-20,23,29,32H,6-7,9,11,13-15H2,1-5H3/t18-,19-,20-,23+,25-,26-,27-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL131	PREDNISOLONE	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO	OIGNJSKKLXVSLS-VWUMJDOOSA-N	InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1512	FLUNISOLIDE	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	XSFJVAJPIHIPKU-XWCQMRHXSA-N	InChI=1S/C24H31FO6/c1-21(2)30-19-9-14-13-8-16(25)15-7-12(27)5-6-22(15,3)20(13)17(28)10-23(14,4)24(19,31-21)18(29)11-26/h5-7,13-14,16-17,19-20,26,28H,8-11H2,1-4H3/t13-,14-,16-,17-,19+,20+,22-,23-,24+/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200342	PARAMETHASONE ACETATE	CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	HYRKAAMZBDSJFJ-LFDBJOOHSA-N	InChI=1S/C24H31FO6/c1-12-7-16-15-9-18(25)17-8-14(27)5-6-22(17,3)21(15)19(28)10-23(16,4)24(12,30)20(29)11-31-13(2)26/h5-6,8,12,15-16,18-19,21,28,30H,7,9-11H2,1-4H3/t12-,15+,16+,18+,19+,21-,22+,23+,24+/m1/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200384	BETAMETHASONE DIPROPIONATE	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	CIWBQSYVNNPZIQ-XYWKZLDCSA-N	InChI=1S/C28H37FO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200538	BETAMETHASONE ACETATE	CC(=O)OCC(=O)[C@@]1(O)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	AKUJBENLRBOFTD-QZIXMDIESA-N	InChI=1S/C24H31FO6/c1-13-9-18-17-6-5-15-10-16(27)7-8-21(15,3)23(17,25)19(28)11-22(18,4)24(13,30)20(29)12-31-14(2)26/h7-8,10,13,17-19,28,30H,5-6,9,11-12H2,1-4H3/t13-,17-,18-,19-,21-,22-,23-,24-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL2021430	DEXAMETHASONE SODIUM PHOSPHATE	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]	PLCQGRYPOISRTQ-FCJDYXGNSA-L	InChI=1S/C22H30FO8P.2Na/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30;;/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30);;/q;2*+1/p-2/t12-,15+,16+,17+,19+,20+,21+,22+;;/m1../s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1201081	METHYLPREDNISOLONE SODIUM SUCCINATE	C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)COC(=O)CCC(=O)[O-])[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12.[Na+]	FQISKWAFAHGMGT-SGJOWKDISA-M	InChI=1S/C26H34O8.Na/c1-14-10-16-17-7-9-26(33,20(29)13-34-22(32)5-4-21(30)31)25(17,3)12-19(28)23(16)24(2)8-6-15(27)11-18(14)24;/h6,8,11,14,16-17,19,23,28,33H,4-5,7,9-10,12-13H2,1-3H3,(H,30,31);/q;+1/p-1/t14-,16-,17-,19-,23+,24-,25-,26-;/m0./s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1201109	DESONIDE	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	WBGKWQHBNHJJPZ-LECWWXJVSA-N	InChI=1S/C24H32O6/c1-21(2)29-19-10-16-15-6-5-13-9-14(26)7-8-22(13,3)20(15)17(27)11-23(16,4)24(19,30-21)18(28)12-25/h7-9,15-17,19-20,25,27H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,20+,22-,23-,24+/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200386	PREDNICARBATE	CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	FNPXMHRZILFCKX-KAJVQRHHSA-N	InChI=1S/C27H36O8/c1-5-22(31)34-15-21(30)27(35-24(32)33-6-2)12-10-19-18-8-7-16-13-17(28)9-11-25(16,3)23(18)20(29)14-26(19,27)4/h9,11,13,18-20,23,29H,5-8,10,12,14-15H2,1-4H3/t18-,19-,20-,23+,25-,26-,27-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200500	BECLOMETHASONE DIPROPIONATE	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C	KUVIULQEHSCUHY-XYWKZLDCSA-N	InChI=1S/C28H37ClO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200545	DIFLORASONE DIACETATE	CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	BOBLHFUVNSFZPJ-JOYXJVLSSA-N	InChI=1S/C26H32F2O7/c1-13-8-17-18-10-20(27)19-9-16(31)6-7-23(19,4)25(18,28)21(32)11-24(17,5)26(13,35-15(3)30)22(33)12-34-14(2)29/h6-7,9,13,17-18,20-21,32H,8,10-12H2,1-5H3/t13-,17-,18-,20-,21-,23-,24-,25-,26-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200877	FLUMETHASONE PIVALATE	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C	JWRMHDSINXPDHB-OJAGFMMFSA-N	InChI=1S/C27H36F2O6/c1-14-9-16-17-11-19(28)18-10-15(30)7-8-24(18,5)26(17,29)20(31)12-25(16,6)27(14,34)21(32)13-35-22(33)23(2,3)4/h7-8,10,14,16-17,19-20,31,34H,9,11-13H2,1-6H3/t14-,16+,17+,19+,20+,24+,25+,26+,27+/m1/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200908	HALOBETASOL PROPIONATE	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	BDSYKGHYMJNPAB-LICBFIPMSA-N	InChI=1S/C25H31ClF2O5/c1-5-21(32)33-25(20(31)12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15-,16-,18-,19-,22-,23-,24-,25-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200968	HYDROCORTISONE SODIUM PHOSPHATE	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]	RYJIRNNXCHOUTQ-OJJGEMKLSA-L	InChI=1S/C21H31O8P.2Na/c1-19-7-5-13(22)9-12(19)3-4-14-15-6-8-21(25,17(24)11-29-30(26,27)28)20(15,2)10-16(23)18(14)19;;/h9,14-16,18,23,25H,3-8,10-11H2,1-2H3,(H2,26,27,28);;/q;2*+1/p-2/t14-,15-,16-,18+,19-,20-,21-;;/m0../s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1201064	FLUOROMETHOLONE ACETATE	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	YRFXGQHBPBMFHW-SBTZIJSASA-N	InChI=1S/C24H31FO5/c1-13-10-19-17-7-9-23(14(2)26,30-15(3)27)22(17,5)12-20(29)24(19,25)21(4)8-6-16(28)11-18(13)21/h6,8,11,13,17,19-20,29H,7,9-10,12H2,1-5H3/t13-,17-,19-,20-,21-,22-,23-,24-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL650	METHYLPREDNISOLONE	C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12	VHRSUDSXCMQTMA-PJHHCJLFSA-N	InChI=1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1451	TRIAMCINOLONE	C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO	GFNANZIMVAIWHM-OBYCQNJPSA-N	InChI=1S/C21H27FO6/c1-18-6-5-12(24)7-11(18)3-4-13-14-8-15(25)21(28,17(27)10-23)19(14,2)9-16(26)20(13,18)22/h5-7,13-16,23,25-26,28H,3-4,8-10H2,1-2H3/t13-,14-,15+,16-,18-,19-,20-,21-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1501	FLUOCINONIDE	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C	WJOHZNCJWYWUJD-IUGZLZTKSA-N	InChI=1S/C26H32F2O7/c1-13(29)33-12-20(32)26-21(34-22(2,3)35-26)10-15-16-9-18(27)17-8-14(30)6-7-23(17,4)25(16,28)19(31)11-24(15,26)5/h6-8,15-16,18-19,21,31H,9-12H2,1-5H3/t15-,16-,18-,19-,21+,23-,24-,25-,26+/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1676	FLUTICASONE FUROATE	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF	XTULMSXFIHGYFS-VLSRWLAYSA-N	InChI=1S/C27H29F3O6S/c1-14-9-16-17-11-19(29)18-10-15(31)6-7-24(18,2)26(17,30)21(32)12-25(16,3)27(14,23(34)37-13-28)36-22(33)20-5-4-8-35-20/h4-8,10,14,16-17,19,21,32H,9,11-13H2,1-3H3/t14-,16+,17+,19+,21+,24+,25+,26+,27+/m1/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1766	DESOXIMETASONE	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO	VWVSBHGCDBMOOT-IIEHVVJPSA-N	InChI=1S/C22H29FO4/c1-12-8-16-15-5-4-13-9-14(25)6-7-21(13,3)22(15,23)18(27)10-20(16,2)19(12)17(26)11-24/h6-7,9,12,15-16,18-19,24,27H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,18+,19-,20+,21+,22+/m1/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200376	BETAMETHASONE BENZOATE	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccccc1)C(=O)CO	SOQJPQZCPBDOMF-YCUXZELOSA-N	InChI=1S/C29H33FO6/c1-17-13-22-21-10-9-19-14-20(32)11-12-26(19,2)28(21,30)23(33)15-27(22,3)29(17,24(34)16-31)36-25(35)18-7-5-4-6-8-18/h4-8,11-12,14,17,21-23,31,33H,9-10,13,15-16H2,1-3H3/t17-,21-,22-,23-,26-,27-,28-,29-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200449	TRIAMCINOLONE DIACETATE	CC(=O)OCC(=O)[C@@]1(O)[C@H](OC(C)=O)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	XGMPVBXKDAHORN-RBWIMXSLSA-N	InChI=1S/C25H31FO8/c1-13(27)33-12-20(31)25(32)21(34-14(2)28)10-18-17-6-5-15-9-16(29)7-8-22(15,3)24(17,26)19(30)11-23(18,25)4/h7-9,17-19,21,30,32H,5-6,10-12H2,1-4H3/t17-,18-,19-,21+,22-,23-,24-,25+/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200562	HYDROCORTISONE VALERATE	CCCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	FZCHYNWYXKICIO-FZNHGJLXSA-N	InChI=1S/C26H38O6/c1-4-5-6-22(31)32-26(21(30)15-27)12-10-19-18-8-7-16-13-17(28)9-11-24(16,2)23(18)20(29)14-25(19,26)3/h13,18-20,23,27,29H,4-12,14-15H2,1-3H3/t18-,19-,20-,23+,24-,25-,26-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200732	AMCINONIDE	CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C	ILKJAFIWWBXGDU-MOGDOJJUSA-N	InChI=1S/C28H35FO7/c1-16(30)34-15-22(33)28-23(35-26(36-28)9-4-5-10-26)13-20-19-7-6-17-12-18(31)8-11-24(17,2)27(19,29)21(32)14-25(20,28)3/h8,11-12,19-21,23,32H,4-7,9-10,13-15H2,1-3H3/t19-,20-,21-,23+,24-,25-,27-,28+/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200989	ALCLOMETASONE DIPROPIONATE	CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@H]3[C@H]([C@@H](O)C[C@@]21C)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl	DJHCCTTVDRAMEH-DUUJBDRPSA-N	InChI=1S/C28H37ClO7/c1-6-22(33)35-14-21(32)28(36-23(34)7-2)15(3)10-18-24-19(29)12-16-11-17(30)8-9-26(16,4)25(24)20(31)13-27(18,28)5/h8-9,11,15,18-20,24-25,31H,6-7,10,12-14H2,1-5H3/t15-,18+,19-,20+,24-,25+,26+,27+,28+/m1/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1201014	PREDNISOLONE SODIUM PHOSPHATE	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]	VJZLQIPZNBPASX-OJJGEMKLSA-L	InChI=1S/C21H29O8P.2Na/c1-19-7-5-13(22)9-12(19)3-4-14-15-6-8-21(25,17(24)11-29-30(26,27)28)20(15,2)10-16(23)18(14)19;;/h5,7,9,14-16,18,23,25H,3-4,6,8,10-11H2,1-2H3,(H2,26,27,28);;/q;2*+1/p-2/t14-,15-,16-,18+,19-,20-,21-;;/m0../s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1091	HYDROCORTISONE ACETATE	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	ALEXXDVDDISNDU-JZYPGELDSA-N	InChI=1S/C23H32O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h10,16-18,20,26,28H,4-9,11-12H2,1-3H3/t16-,17-,18-,20+,21-,22-,23-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1161	MOMETASONE FUROATE	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl	WOFMFGQZHJDGCX-ZULDAHANSA-N	InChI=1S/C27H30Cl2O6/c1-15-11-19-18-7-6-16-12-17(30)8-9-24(16,2)26(18,29)21(31)13-25(19,3)27(15,22(32)14-28)35-23(33)20-5-4-10-34-20/h4-5,8-10,12,15,18-19,21,31H,6-7,11,13-14H2,1-3H3/t15-,18+,19+,21+,24+,25+,26+,27+/m1/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1530428	DEXAMETHASONE ACETATE	CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	AKUJBENLRBOFTD-RPRRAYFGSA-N	InChI=1S/C24H31FO6/c1-13-9-18-17-6-5-15-10-16(27)7-8-21(15,3)23(17,25)19(28)11-22(18,4)24(13,30)20(29)12-31-14(2)26/h7-8,10,13,17-19,28,30H,5-6,9,11-12H2,1-4H3/t13-,17+,18+,19+,21+,22+,23+,24+/m1/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1683	HYDROCORTISONE BUTYRATE	CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	BMCQMVFGOVHVNG-TUFAYURCSA-N	InChI=1S/C25H36O6/c1-4-5-21(30)31-25(20(29)14-26)11-9-18-17-7-6-15-12-16(27)8-10-23(15,2)22(17)19(28)13-24(18,25)3/h12,17-19,22,26,28H,4-11,13-14H2,1-3H3/t17-,18-,19-,22+,23-,24-,25-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200774	FLUPREDNISOLONE	C[C@]12C[C@H](O)[C@H]3[C@@H](C[C@H](F)C4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO	MYYIMZRZXIQBGI-HVIRSNARSA-N	InChI=1S/C21H27FO5/c1-19-5-3-11(24)7-14(19)15(22)8-12-13-4-6-21(27,17(26)10-23)20(13,2)9-16(25)18(12)19/h3,5,7,12-13,15-16,18,23,25,27H,4,6,8-10H2,1-2H3/t12-,13-,15-,16-,18+,19-,20-,21-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200878	TRIAMCINOLONE HEXACETONIDE	CC(C)(C)CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C	TZIZWYVVGLXXFV-FLRHRWPCSA-N	InChI=1S/C30H41FO7/c1-25(2,3)15-24(35)36-16-22(34)30-23(37-26(4,5)38-30)13-20-19-9-8-17-12-18(32)10-11-27(17,6)29(19,31)21(33)14-28(20,30)7/h10-12,19-21,23,33H,8-9,13-16H2,1-7H3/t19-,20-,21-,23+,27-,28-,29-,30+/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200975	CLOCORTOLONE PIVALATE	C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C	SXYZQZLHAIHKKY-GSTUPEFVSA-N	InChI=1S/C27H36ClFO5/c1-14-9-16-17-11-19(29)18-10-15(30)7-8-26(18,6)27(17,28)21(32)12-25(16,5)22(14)20(31)13-34-23(33)24(2,3)4/h7-8,10,14,16-17,19,21-22,32H,9,11-13H2,1-6H3/t14-,16+,17+,19+,21+,22-,25+,26+,27+/m1/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1201148	MEPREDNISONE	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO	PIDANAQULIKBQS-RNUIGHNZSA-N	InChI=1S/C22H28O5/c1-12-8-16-15-5-4-13-9-14(24)6-7-20(13,2)19(15)17(25)10-21(16,3)22(12,27)18(26)11-23/h6-7,9,12,15-16,19,23,27H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,19+,20-,21-,22-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL2040682	CICLESONIDE	CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C	LUKZNWIVRBCLON-GXOBDPJESA-N	InChI=1S/C32H44O7/c1-18(2)28(36)37-17-25(35)32-26(38-29(39-32)19-8-6-5-7-9-19)15-23-22-11-10-20-14-21(33)12-13-30(20,3)27(22)24(34)16-31(23,32)4/h12-14,18-19,22-24,26-27,29,34H,5-11,15-17H2,1-4H3/t22-,23-,24-,26+,27+,29+,30-,31-,32+/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL989	FLUOCINOLONE ACETONIDE	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	FEBLZLNTKCEFIT-VSXGLTOVSA-N	InChI=1S/C24H30F2O6/c1-20(2)31-19-9-13-14-8-16(25)15-7-12(28)5-6-21(15,3)23(14,26)17(29)10-22(13,4)24(19,32-20)18(30)11-27/h5-7,13-14,16-17,19,27,29H,8-11H2,1-4H3/t13-,14-,16-,17-,19+,21-,22-,23-,24+/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1152	PREDNISOLONE ACETATE	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	LRJOMUJRLNCICJ-JZYPGELDSA-N	InChI=1S/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h6,8,10,16-18,20,26,28H,4-5,7,9,11-12H2,1-3H3/t16-,17-,18-,20+,21-,22-,23-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1370	BUDESONIDE	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	VOVIALXJUBGFJZ-KWVAZRHASA-N	InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL384467	DEXAMETHASONE	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO	UREBDLICKHMUKA-CXSFZGCWSA-N	InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1497	BETAMETHASONE VALERATE	CCCCC(=O)O[C@]1(C(=O)CO)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	SNHRLVCMMWUAJD-SUYDQAKGSA-N	InChI=1S/C27H37FO6/c1-5-6-7-23(33)34-27(22(32)15-29)16(2)12-20-19-9-8-17-13-18(30)10-11-24(17,3)26(19,28)21(31)14-25(20,27)4/h10-11,13,16,19-21,29,31H,5-9,12,14-15H2,1-4H3/t16-,19-,20-,21-,24-,25-,26-,27-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1650	CORTISONE ACETATE	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C	ITRJWOMZKQRYTA-RFZYENFJSA-N	InChI=1S/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h10,16-17,20,28H,4-9,11-12H2,1-3H3/t16-,17-,20+,21-,22-,23-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200617	RIMEXOLONE	CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	QTTRZHGPGKRAFB-OOKHYKNYSA-N	InChI=1S/C24H34O3/c1-6-20(27)24(5)14(2)11-18-17-8-7-15-12-16(25)9-10-22(15,3)21(17)19(26)13-23(18,24)4/h9-10,12,14,17-19,21,26H,6-8,11,13H2,1-5H3/t14-,17+,18+,19+,21-,22+,23+,24-/m1/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1364144	METHYLPREDNISOLONE ACETATE	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	PLBHSZGDDKCEHR-LFYFAGGJSA-N	InChI=1S/C24H32O6/c1-13-9-16-17-6-8-24(29,20(28)12-30-14(2)25)23(17,4)11-19(27)21(16)22(3)7-5-15(26)10-18(13)22/h5,7,10,13,16-17,19,21,27,29H,6,8-9,11-12H2,1-4H3/t13-,16-,17-,19-,21+,22-,23-,24-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1200953	HYDROCORTISONE PROBUTATE	CCCC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	FOGXJPFPZOHSQS-AYVLZSQQSA-N	InChI=1S/C28H40O7/c1-5-7-24(33)35-28(22(31)16-34-23(32)6-2)13-11-20-19-9-8-17-14-18(29)10-12-26(17,3)25(19)21(30)15-27(20,28)4/h14,19-21,25,30H,5-13,15-16H2,1-4H3/t19-,20-,21-,25+,26-,27-,28-/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1201012	FLURANDRENOLIDE	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1	POPFMWWJOGLOIF-XWCQMRHXSA-N	InChI=1S/C24H33FO6/c1-21(2)30-19-9-14-13-8-16(25)15-7-12(27)5-6-22(15,3)20(13)17(28)10-23(14,4)24(19,31-21)18(29)11-26/h7,13-14,16-17,19-20,26,28H,5-6,8-11H2,1-4H3/t13-,14-,16-,17-,19+,20+,22-,23-,24+/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1473	FLUTICASONE PROPIONATE	CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	WMWTYOKRWGGJOA-CENSZEJFSA-N	InChI=1S/C25H31F3O5S/c1-5-20(31)33-25(21(32)34-12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL1276308	MIFEPRISTONE	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C	VKHAHZOOUSRJNA-GCNJZUOMSA-N	InChI=1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1	Glucocorticoid receptor antagonist	ANTAGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL853	ZALCITABINE	Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1	WREGKURFCTUGRC-POYBYMJQSA-N	InChI=1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8+/m0/s1	Human immunodeficiency virus type 1 reverse transcriptase inhibitor	INHIBITOR	CHEMBL247	Human immunodeficiency virus type 1 reverse transcriptase	Human immunodeficiency virus 1
CHEMBL929	DELAVIRDINE MESYLATE	CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1.CS(=O)(=O)O	MEPNHSOMXMALDZ-UHFFFAOYSA-N	InChI=1S/C22H28N6O3S.CH4O3S/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20;1-5(2,3)4/h4-8,13-15,24-26H,9-12H2,1-3H3;1H3,(H,2,3,4)	Human immunodeficiency virus type 1 reverse transcriptase inhibitor	INHIBITOR	CHEMBL247	Human immunodeficiency virus type 1 reverse transcriptase	Human immunodeficiency virus 1
CHEMBL1460	DIDANOSINE	O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1	BXZVVICBKDXVGW-NKWVEPMBSA-N	InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1	Human immunodeficiency virus type 1 reverse transcriptase inhibitor	INHIBITOR	CHEMBL247	Human immunodeficiency virus type 1 reverse transcriptase	Human immunodeficiency virus 1
CHEMBL1486	TENOFOVIR DISOPROXIL FUMARATE	CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C.O=C(O)/C=C/C(=O)O	VCMJCVGFSROFHV-WZGZYPNHSA-N	InChI=1S/C19H30N5O10P.C4H4O4/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24;5-3(6)1-2-4(7)8/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22);1-2H,(H,5,6)(H,7,8)/b;2-1+/t14-;/m1./s1	Human immunodeficiency virus type 1 reverse transcriptase inhibitor	INHIBITOR	CHEMBL247	Human immunodeficiency virus type 1 reverse transcriptase	Human immunodeficiency virus 1
CHEMBL885	EMTRICITABINE	Nc1nc(=O)n([C@@H]2CS[C@H](CO)O2)cc1F	XQSPYNMVSIKCOC-NTSWFWBYSA-N	InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m0/s1	Human immunodeficiency virus type 1 reverse transcriptase inhibitor	INHIBITOR	CHEMBL247	Human immunodeficiency virus type 1 reverse transcriptase	Human immunodeficiency virus 1
CHEMBL223228	EFAVIRENZ	O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1	XPOQHMRABVBWPR-ZDUSSCGKSA-N	InChI=1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)/t13-/m0/s1	Human immunodeficiency virus type 1 reverse transcriptase inhibitor	INHIBITOR	CHEMBL247	Human immunodeficiency virus type 1 reverse transcriptase	Human immunodeficiency virus 1
CHEMBL129	ZIDOVUDINE	Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O	HBOMLICNUCNMMY-XLPZGREQSA-N	InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1	Human immunodeficiency virus type 1 reverse transcriptase inhibitor	INHIBITOR	CHEMBL247	Human immunodeficiency virus type 1 reverse transcriptase	Human immunodeficiency virus 1
CHEMBL1200619	ABACAVIR SULFATE	Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1.O=S(=O)(O)O	MBFKCGGQTYQTLR-SCYNACPDSA-N	InChI=1S/C14H18N6O.H2O4S/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21;1-5(2,3)4/h1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19);(H2,1,2,3,4)/t8-,10+;/m1./s1	Human immunodeficiency virus type 1 reverse transcriptase inhibitor	INHIBITOR	CHEMBL247	Human immunodeficiency virus type 1 reverse transcriptase	Human immunodeficiency virus 1
CHEMBL57	NEVIRAPINE	Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1	NQDJXKOVJZTUJA-UHFFFAOYSA-N	InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)	Human immunodeficiency virus type 1 reverse transcriptase inhibitor	INHIBITOR	CHEMBL247	Human immunodeficiency virus type 1 reverse transcriptase	Human immunodeficiency virus 1
CHEMBL991	STAVUDINE	Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O	XNKLLVCARDGLGL-JGVFFNPUSA-N	InChI=1S/C10H12N2O4/c1-6-4-12(10(15)11-9(6)14)8-3-2-7(5-13)16-8/h2-4,7-8,13H,5H2,1H3,(H,11,14,15)/t7-,8+/m0/s1	Human immunodeficiency virus type 1 reverse transcriptase inhibitor	INHIBITOR	CHEMBL247	Human immunodeficiency virus type 1 reverse transcriptase	Human immunodeficiency virus 1
CHEMBL1628504	RILPIVIRINE HYDROCHLORIDE	Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1.Cl	KZVVGZKAVZUACK-BJILWQEISA-N	InChI=1S/C22H18N6.ClH/c1-15-12-18(4-3-10-23)13-16(2)21(15)27-20-9-11-25-22(28-20)26-19-7-5-17(14-24)6-8-19;/h3-9,11-13H,1-2H3,(H2,25,26,27,28);1H/b4-3+;	Human immunodeficiency virus type 1 reverse transcriptase inhibitor	INHIBITOR	CHEMBL247	Human immunodeficiency virus type 1 reverse transcriptase	Human immunodeficiency virus 1
CHEMBL308954	ETRAVIRINE	Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br	PYGWGZALEOIKDF-UHFFFAOYSA-N	InChI=1S/C20H15BrN6O/c1-11-7-14(10-23)8-12(2)17(11)28-19-16(21)18(24)26-20(27-19)25-15-5-3-13(9-22)4-6-15/h3-8H,1-2H3,(H3,24,25,26,27)	Human immunodeficiency virus type 1 reverse transcriptase inhibitor	INHIBITOR	CHEMBL247	Human immunodeficiency virus type 1 reverse transcriptase	Human immunodeficiency virus 1
CHEMBL141	LAMIVUDINE	Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1	JTEGQNOMFQHVDC-NKWVEPMBSA-N	InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1	Human immunodeficiency virus type 1 reverse transcriptase inhibitor	INHIBITOR	CHEMBL247	Human immunodeficiency virus type 1 reverse transcriptase	Human immunodeficiency virus 1
CHEMBL1201142	RASAGILINE MESYLATE	C#CCN[C@@H]1CCc2ccccc21.CS(=O)(=O)O	JDBJJCWRXSVHOQ-UTONKHPSSA-N	InChI=1S/C12H13N.CH4O3S/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12;1-5(2,3)4/h1,3-6,12-13H,7-9H2;1H3,(H,2,3,4)/t12-;/m1./s1	Monoamine oxidase B inhibitor	INHIBITOR	CHEMBL2039	Monoamine oxidase B	Homo sapiens
CHEMBL1200904	SELEGILINE HYDROCHLORIDE	C#CCN(C)[C@H](C)Cc1ccccc1.Cl	IYETZZCWLLUHIJ-UTONKHPSSA-N	InChI=1S/C13H17N.ClH/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13;/h1,5-9,12H,10-11H2,2-3H3;1H/t12-;/m1./s1	Monoamine oxidase B inhibitor	INHIBITOR	CHEMBL2039	Monoamine oxidase B	Homo sapiens
CHEMBL972	SELEGILINE	C#CCN(C)[C@H](C)Cc1ccccc1	MEZLKOACVSPNER-GFCCVEGCSA-N	InChI=1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/t12-/m1/s1	Monoamine oxidase B inhibitor	INHIBITOR	CHEMBL2039	Monoamine oxidase B	Homo sapiens
CHEMBL1201733	PAZOPANIB HYDROCHLORIDE	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O.Cl	MQHIQUBXFFAOMK-UHFFFAOYSA-N	InChI=1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H	Tyrosine-protein kinase LCK inhibitor	INHIBITOR	CHEMBL258	Tyrosine-protein kinase LCK	Homo sapiens
CHEMBL1566	ACARBOSE	C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O	XUFXOAAUWZOOIT-SXARVLRPSA-N	InChI=1S/C25H43NO18/c1-6-11(26-8-2-7(3-27)12(30)15(33)13(8)31)14(32)19(37)24(40-6)43-22-10(5-29)42-25(20(38)17(22)35)44-21-9(4-28)41-23(39)18(36)16(21)34/h2,6,8-39H,3-5H2,1H3/t6-,8+,9-,10-,11-,12-,13+,14+,15+,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-/m1/s1	Pancreatic alpha-amylase inhibitor	INHIBITOR	CHEMBL2045	Pancreatic alpha-amylase	Homo sapiens
CHEMBL1551	URSODIOL	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	RUDATBOHQWOJDD-UZVSRGJWSA-N	InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1	Bile acid receptor FXR agonist	AGONIST	CHEMBL2047	Bile acid receptor FXR	Homo sapiens
CHEMBL240597	CHENODIOL	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O	RUDATBOHQWOJDD-BSWAIDMHSA-N	InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20-,22+,23+,24-/m1/s1	Bile acid receptor FXR agonist	AGONIST	CHEMBL2047	Bile acid receptor FXR	Homo sapiens
CHEMBL395429	OXYTOCIN	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O	XNOPRXBHLZRZKH-DSZYJQQASA-N	InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1	Oxytocin receptor agonist	AGONIST	CHEMBL2049	Oxytocin receptor	Homo sapiens
CHEMBL1200340	OSELTAMIVIR PHOSPHATE	CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1.O=P(O)(O)O	PGZUMBJQJWIWGJ-ONAKXNSWSA-N	InChI=1S/C16H28N2O4.H3O4P/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19;1-5(2,3)4/h9,12-15H,5-8,17H2,1-4H3,(H,18,19);(H3,1,2,3,4)/t13-,14+,15+;/m0./s1	Neuraminidase inhibitor	INHIBITOR	CHEMBL2051	Neuraminidase	Influenza A virus (A/Puerto Rico/8/1934(H1N1))
CHEMBL222813	ZANAMIVIR	CC(=O)N[C@@H]1[C@@H](NC(=N)N)C=C(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO	ARAIBEBZBOPLMB-UFGQHTETSA-N	InChI=1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1	Neuraminidase inhibitor	INHIBITOR	CHEMBL2051	Neuraminidase	Influenza A virus (A/Puerto Rico/8/1934(H1N1))
CHEMBL535396	RIMANTADINE HYDROCHLORIDE	CC(N)C12CC3CC(CC(C3)C1)C2.Cl	OZBDFBJXRJWNAV-UHFFFAOYSA-N	InChI=1S/C12H21N.ClH/c1-8(13)12-5-9-2-10(6-12)4-11(3-9)7-12;/h8-11H,2-7,13H2,1H3;1H	Influenza virus A matrix protein M2 inhibitor	INHIBITOR	CHEMBL2052	Influenza virus A matrix protein M2	Influenza A virus (A/Udorn/307/1972(H3N2))
CHEMBL1201746	PRALATREXATE	C#CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1	OGSBUKJUDHAQEA-WMCAAGNKSA-N	InChI=1S/C23H23N7O5/c1-2-3-14(10-15-11-26-20-18(27-15)19(24)29-23(25)30-20)12-4-6-13(7-5-12)21(33)28-16(22(34)35)8-9-17(31)32/h1,4-7,11,14,16H,3,8-10H2,(H,28,33)(H,31,32)(H,34,35)(H4,24,25,26,29,30)/t14?,16-/m0/s1	Dihydrofolate reductase inhibitor	INHIBITOR	CHEMBL202	Dihydrofolate reductase	Homo sapiens
CHEMBL3244648	METHOTREXATE SODIUM	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1.[Na+].[Na+]	DASQOOZCTWOQPA-GXKRWWSZSA-L	InChI=1S/C20H22N8O5.2Na/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30;;/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27);;/q;2*+1/p-2/t13-;;/m0../s1	Dihydrofolate reductase inhibitor	INHIBITOR	CHEMBL202	Dihydrofolate reductase	Homo sapiens
CHEMBL2360464	PEMETREXED DISODIUM	Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc3)c2c(=O)[nH]1.[Na+].[Na+]	NYDXNILOWQXUOF-GXKRWWSZSA-L	InChI=1S/C20H21N5O6.2Na/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27;;/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29);;/q;2*+1/p-2/t13-;;/m0../s1	Dihydrofolate reductase inhibitor	INHIBITOR	CHEMBL202	Dihydrofolate reductase	Homo sapiens
CHEMBL1026	FENOLDOPAM MESYLATE	CS(=O)(=O)O.Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1	CVKUMNRCIJMVAR-UHFFFAOYSA-N	InChI=1S/C16H16ClNO3.CH4O3S/c17-15-11-5-6-18-8-13(9-1-3-10(19)4-2-9)12(11)7-14(20)16(15)21;1-5(2,3)4/h1-4,7,13,18-21H,5-6,8H2;1H3,(H,2,3,4)	Dopamine D1 receptor agonist	AGONIST	CHEMBL2056	Dopamine D1 receptor	Homo sapiens
CHEMBL1200843	METHYLERGONOVINE MALEATE	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1.O=C(O)/C=C\C(=O)O	NOFOWWRHEPHDCY-DAUURJMHSA-N	InChI=1S/C20H25N3O2.C4H4O4/c1-3-14(11-24)22-20(25)13-7-16-15-5-4-6-17-19(15)12(9-21-17)8-18(16)23(2)10-13;5-3(6)1-2-4(7)8/h4-7,9,13-14,18,21,24H,3,8,10-11H2,1-2H3,(H,22,25);1-2H,(H,5,6)(H,7,8)/b;2-1-/t13-,14+,18-;/m1./s1	Dopamine D1 receptor antagonist	ANTAGONIST	CHEMBL2056	Dopamine D1 receptor	Homo sapiens
CHEMBL1029	MIGLUSTAT	CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	UQRORFVVSGFNRO-UTINFBMNSA-N	InChI=1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1	Ceramide glucosyltransferase inhibitor	INHIBITOR	CHEMBL2063	Ceramide glucosyltransferase	Homo sapiens
CHEMBL1421	DASATINIB	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1	ZBNZXTGUTAYRHI-UHFFFAOYSA-N	InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)	Ephrin type-A receptor 2 inhibitor	INHIBITOR	CHEMBL2068	Ephrin type-A receptor 2	Homo sapiens
CHEMBL786	TAMOXIFEN CITRATE	CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O	FQZYTYWMLGAPFJ-OQKDUQJOSA-N	InChI=1S/C26H29NO.C6H8O7/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3;7-3(8)1-6(13,5(11)12)2-4(9)10/h5-18H,4,19-20H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b26-25-;	Estrogen receptor alpha modulator	MODULATOR	CHEMBL206	Estrogen receptor alpha	Homo sapiens
CHEMBL1405	ESTRONE	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O	DNXHEGUUPJUMQT-CBZIJGRNSA-N	InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1	Estrogen receptor alpha agonist	AGONIST	CHEMBL206	Estrogen receptor alpha	Homo sapiens
CHEMBL135	ESTRADIOL	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O	VOXZDWNPVJITMN-ZBRFXRBCSA-N	InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1	Estrogen receptor alpha agonist	AGONIST	CHEMBL206	Estrogen receptor alpha	Homo sapiens
CHEMBL1200430	ESTRADIOL ACETATE	CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12	FHXBMXJMKMWVRG-SLHNCBLASA-N	InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1	Estrogen receptor alpha agonist	AGONIST	CHEMBL206	Estrogen receptor alpha	Homo sapiens
CHEMBL1511	ESTRADIOL VALERATE	CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C	RSEPBGGWRJCQGY-RBRWEJTLSA-N	InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1	Estrogen receptor alpha agonist	AGONIST	CHEMBL206	Estrogen receptor alpha	Homo sapiens
CHEMBL3185958	CLOMIPHENE CITRATE	CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O	PYTMYKVIJXPNBD-UHFFFAOYSA-N	InChI=1S/C26H28ClNO.C6H8O7/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23;7-3(8)1-6(13,5(11)12)2-4(9)10/h5-18H,3-4,19-20H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)	Estrogen receptor alpha modulator	MODULATOR	CHEMBL206	Estrogen receptor alpha	Homo sapiens
CHEMBL691	ETHINYL ESTRADIOL	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C	BFPYWIDHMRZLRN-SLHNCBLASA-N	InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1	Estrogen receptor alpha agonist	AGONIST	CHEMBL206	Estrogen receptor alpha	Homo sapiens
CHEMBL1018	DIENESTROL	C/C=C(C(=C/C)/c1ccc(O)cc1)\c1ccc(O)cc1	NFDFQCUYFHCNBW-SCGPFSFSSA-N	InChI=1S/C18H18O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h3-12,19-20H,1-2H3/b17-3+,18-4+	Estrogen receptor alpha agonist	AGONIST	CHEMBL206	Estrogen receptor alpha	Homo sapiens
CHEMBL1200973	ESTRADIOL CYPIONATE	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1	UOACKFBJUYNSLK-XRKIENNPSA-N	InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1	Estrogen receptor alpha agonist	AGONIST	CHEMBL206	Estrogen receptor alpha	Homo sapiens
CHEMBL1200980	ESTROPIPATE	C1CNCCN1.C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)O)cc4CC[C@H]3[C@@H]1CCC2=O	HZEQBCVBILBTEP-ZFINNJDLSA-N	InChI=1S/C18H22O5S.C4H10N2/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19;1-2-6-4-3-5-1/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22);5-6H,1-4H2/t14-,15-,16+,18+;/m1./s1	Estrogen receptor alpha agonist	AGONIST	CHEMBL206	Estrogen receptor alpha	Homo sapiens
CHEMBL1201151	MESTRANOL	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C	IMSSROKUHAOUJS-MJCUULBUSA-N	InChI=1S/C21H26O2/c1-4-21(22)12-10-19-18-7-5-14-13-15(23-3)6-8-16(14)17(18)9-11-20(19,21)2/h1,6,8,13,17-19,22H,5,7,9-12H2,2-3H3/t17-,18-,19+,20+,21+/m1/s1	Estrogen receptor alpha agonist	AGONIST	CHEMBL206	Estrogen receptor alpha	Homo sapiens
CHEMBL411	DIETHYLSTILBESTROL	CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1	RGLYKWWBQGJZGM-ISLYRVAYSA-N	InChI=1S/C18H20O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h5-12,19-20H,3-4H2,1-2H3/b18-17+	Estrogen receptor alpha agonist	AGONIST	CHEMBL206	Estrogen receptor alpha	Homo sapiens
CHEMBL1200749	LEVOBUPIVACAINE HYDROCHLORIDE	CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C.Cl	SIEYLFHKZGLBNX-NTISSMGPSA-N	InChI=1S/C18H28N2O.ClH/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3;/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21);1H/t16-;/m0./s1	Sodium channel protein type IV alpha subunit blocker	BLOCKER	CHEMBL2072	Sodium channel protein type IV alpha subunit	Homo sapiens
CHEMBL1098	BUPIVACAINE	CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C	LEBVLXFERQHONN-UHFFFAOYSA-N	InChI=1S/C18H28N2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21)	Sodium channel protein type IV alpha subunit blocker	BLOCKER	CHEMBL2072	Sodium channel protein type IV alpha subunit	Homo sapiens
CHEMBL1200396	BUPIVACAINE HYDROCHLORIDE	CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl	SIEYLFHKZGLBNX-UHFFFAOYSA-N	InChI=1S/C18H28N2O.ClH/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3;/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21);1H	Sodium channel protein type IV alpha subunit blocker	BLOCKER	CHEMBL2072	Sodium channel protein type IV alpha subunit	Homo sapiens
CHEMBL1561	MIGLITOL	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	IBAQFPQHRJAVAV-ULAWRXDQSA-N	InChI=1S/C8H17NO5/c10-2-1-9-3-6(12)8(14)7(13)5(9)4-11/h5-8,10-14H,1-4H2/t5-,6+,7-,8-/m1/s1	Maltase-glucoamylase inhibitor	INHIBITOR	CHEMBL2074	Maltase-glucoamylase	Homo sapiens
CHEMBL1566	ACARBOSE	C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O	XUFXOAAUWZOOIT-SXARVLRPSA-N	InChI=1S/C25H43NO18/c1-6-11(26-8-2-7(3-27)12(30)15(33)13(8)31)14(32)19(37)24(40-6)43-22-10(5-29)42-25(20(38)17(22)35)44-21-9(4-28)41-23(39)18(36)16(21)34/h2,6,8-39H,3-5H2,1H3/t6-,8+,9-,10-,11-,12-,13+,14+,15+,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-/m1/s1	Maltase-glucoamylase inhibitor	INHIBITOR	CHEMBL2074	Maltase-glucoamylase	Homo sapiens
CHEMBL2110368	BETHANIDINE SULFATE	C/N=C(\NC)NCc1ccccc1.C/N=C(\NC)NCc1ccccc1.O=S(=O)(O)O	YTIJUXVIZLYQTB-UHFFFAOYSA-N	InChI=1S/2C10H15N3.H2O4S/c2*1-11-10(12-2)13-8-9-6-4-3-5-7-9;1-5(2,3)4/h2*3-7H,8H2,1-2H3,(H2,11,12,13);(H2,1,2,3,4)	Norepinephrine transporter substrate	SUBSTRATE	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1118	DESVENLAFAXINE	CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1	KYYIDSXMWOZKMP-UHFFFAOYSA-N	InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1237135	MAPROTILINE HYDROCHLORIDE	CNCCCC12CCC(c3ccccc31)c1ccccc12.Cl	NZDMFGKECODQRY-UHFFFAOYSA-N	InChI=1S/C20H23N.ClH/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20;/h2-5,7-10,15,21H,6,11-14H2,1H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL3184143	GUANADREL SULFATE	N=C(N)NCC1COC2(CCCCC2)O1.N=C(N)NCC1COC2(CCCCC2)O1.O=S(=O)(O)O	RTEVGQJRTFFMLL-UHFFFAOYSA-N	InChI=1S/2C10H19N3O2.H2O4S/c2*11-9(12)13-6-8-7-14-10(15-8)4-2-1-3-5-10;1-5(2,3)4/h2*8H,1-7H2,(H4,11,12,13);(H2,1,2,3,4)	Norepinephrine transporter substrate	SUBSTRATE	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1574	PHENTERMINE	CC(C)(N)Cc1ccccc1	DHHVAGZRUROJKS-UHFFFAOYSA-N	InChI=1S/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3	Norepinephrine transporter releasing agent	RELEASING AGENT	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1628234	DOXEPIN HYDROCHLORIDE	CN(C)CCC=C1c2ccccc2COc2ccccc21.Cl	MHNSPTUQQIYJOT-UHFFFAOYSA-N	InChI=1S/C19H21NO.ClH/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19;/h3-6,8-12H,7,13-14H2,1-2H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1696	DESIPRAMINE HYDROCHLORIDE	CNCCCN1c2ccccc2CCc2ccccc21.Cl	XAEWZDYWZHIUCT-UHFFFAOYSA-N	InChI=1S/C18H22N2.ClH/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20;/h2-5,7-10,19H,6,11-14H2,1H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1095292	BRETYLIUM TOSYLATE	CC[N+](C)(C)Cc1ccccc1Br.Cc1ccc(S(=O)(=O)[O-])cc1	KVWNWTZZBKCOPM-UHFFFAOYSA-M	InChI=1S/C11H17BrN.C7H8O3S/c1-4-13(2,3)9-10-7-5-6-8-11(10)12;1-6-2-4-7(5-3-6)11(8,9)10/h5-8H,4,9H2,1-3H3;2-5H,1H3,(H,8,9,10)/q+1;/p-1	Norepinephrine transporter substrate	SUBSTRATE	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1345	GUANETHIDINE MONOSULFATE	N=C(N)NCCN1CCCCCCC1.O=S(=O)(O)O	YUFWAVFNITUSHI-UHFFFAOYSA-N	InChI=1S/C10H22N4.H2O4S/c11-10(12)13-6-9-14-7-4-2-1-3-5-8-14;1-5(2,3)4/h1-9H2,(H4,11,12,13);(H2,1,2,3,4)	Norepinephrine transporter substrate	SUBSTRATE	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1702	ATOMOXETINE HYDROCHLORIDE	CNCC[C@@H](Oc1ccccc1C)c1ccccc1.Cl	LUCXVPAZUDVVBT-UNTBIKODSA-N	InChI=1S/C17H21NO.ClH/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15;/h3-11,17-18H,12-13H2,1-2H3;1H/t17-;/m1./s1	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1200912	PHENTERMINE HYDROCHLORIDE	CC(C)(N)Cc1ccccc1.Cl	NCAIGTHBQTXTLR-UHFFFAOYSA-N	InChI=1S/C10H15N.ClH/c1-10(2,11)8-9-6-4-3-5-7-9;/h3-7H,8,11H2,1-2H3;1H	Norepinephrine transporter releasing agent	RELEASING AGENT	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL3544906	BENZPHETAMINE HYDROCHLORIDE	C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1.Cl	ANFSNXAXVLRZCG-RSAXXLAASA-N	InChI=1S/C17H21N.ClH/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17;/h3-12,15H,13-14H2,1-2H3;1H/t15-;/m0./s1	Norepinephrine transporter releasing agent	RELEASING AGENT	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1201735	BUPROPION HYDROBROMIDE	Br.CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1	WSTCENNATOVXKQ-UHFFFAOYSA-N	InChI=1S/C13H18ClNO.BrH/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10;/h5-9,15H,1-4H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1201728	DESVENLAFAXINE SUCCINATE	CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1.O=C(O)CCC(=O)O	ORUUBRMVQCKYHB-UHFFFAOYSA-N	InChI=1S/C16H25NO2.C4H6O4/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16;5-3(6)1-2-4(7)8/h6-9,15,18-19H,3-5,10-12H2,1-2H3;1-2H2,(H,5,6)(H,7,8)	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL904	DEXMETHYLPHENIDATE HYDROCHLORIDE	COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1.Cl	JUMYIBMBTDDLNG-OJERSXHUSA-N	InChI=1S/C14H19NO2.ClH/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12;/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3;1H/t12-,13-;/m1./s1	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL612	DEXTROAMPHETAMINE	C[C@H](N)Cc1ccccc1	KWTSXDURSIMDCE-QMMMGPOBSA-N	InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1	Norepinephrine transporter releasing agent	RELEASING AGENT	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1200782	DEXTROAMPHETAMINE ADIPATE	C[C@H](N)Cc1ccccc1.O=C(O)CCCCC(=O)O	OFCJKOOVFDGTLY-QRPNPIFTSA-N	InChI=1S/C9H13N.C6H10O4/c1-8(10)7-9-5-3-2-4-6-9;7-5(8)3-1-2-4-6(9)10/h2-6,8H,7,10H2,1H3;1-4H2,(H,7,8)(H,9,10)/t8-;/m0./s1	Norepinephrine transporter releasing agent	RELEASING AGENT	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL3544971	DEXTROAMPHETAMINE SULFATE	C[C@H](N)Cc1ccccc1.C[C@H](N)Cc1ccccc1.O=S(=O)(O)O	PYHRZPFZZDCOPH-QXGOIDDHSA-N	InChI=1S/2C9H13N.H2O4S/c2*1-8(10)7-9-5-3-2-4-6-9;1-5(2,3)4/h2*2-6,8H,7,10H2,1H3;(H2,1,2,3,4)/t2*8-;/m00./s1	Norepinephrine transporter releasing agent	RELEASING AGENT	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL3989844	DEXTROAMPHETAMINE SACCHARATE	C[C@H](N)Cc1ccccc1.O=C(O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O	VHKVKWTWHZUFIA-DGOKBZBKSA-N	InChI=1S/C9H13N.C6H10O8/c1-8(10)7-9-5-3-2-4-6-9;7-1(3(9)5(11)12)2(8)4(10)6(13)14/h2-6,8H,7,10H2,1H3;1-4,7-10H,(H,11,12)(H,13,14)/t8-;1-,2-,3-,4+/m00/s1	Norepinephrine transporter releasing agent	RELEASING AGENT	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1693	DIETHYLPROPION HYDROCHLORIDE	CCN(CC)C(C)C(=O)c1ccccc1.Cl	ICFXZZFWRWNZMA-UHFFFAOYSA-N	InChI=1S/C13H19NO.ClH/c1-4-14(5-2)11(3)13(15)12-9-7-6-8-10-12;/h6-11H,4-5H2,1-3H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1200483	PHENMETRAZINE HYDROCHLORIDE	CC1NCCOC1c1ccccc1.Cl	VJNXVAVKCZJOFQ-UHFFFAOYSA-N	InChI=1S/C11H15NO.ClH/c1-9-11(13-8-7-12-9)10-5-3-2-4-6-10;/h2-6,9,11-12H,7-8H2,1H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1200377	AMPHETAMINE ASPARTATE	CC(N)Cc1ccccc1.NC(CC(=O)O)C(=O)O	DYOBNLAYPQSBLB-UHFFFAOYSA-N	InChI=1S/C9H13N.C4H7NO4/c1-8(10)7-9-5-3-2-4-6-9;5-2(4(8)9)1-3(6)7/h2-6,8H,7,10H2,1H3;2H,1,5H2,(H,6,7)(H,8,9)	Norepinephrine transporter releasing agent	RELEASING AGENT	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL3989845	IMIPRAMINE PAMOATE	CN(C)CCCN1c2ccccc2CCc2ccccc21.CN(C)CCCN1c2ccccc2CCc2ccccc21.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O	BPQZYOJIXDMZSX-UHFFFAOYSA-N	InChI=1S/C23H16O6.2C19H24N2/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;2*1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h1-10,24-25H,11H2,(H,26,27)(H,28,29);2*3-6,8-11H,7,12-15H2,1-2H3	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1113	AMOXAPINE	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	QWGDMFLQWFTERH-UHFFFAOYSA-N	InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL501	AMPHETAMINE SULFATE	CC(N)Cc1ccccc1.O=S(=O)(O)O	SOFQDLYSFOWTJX-UHFFFAOYSA-N	InChI=1S/C9H13N.H2O4S/c1-8(10)7-9-5-3-2-4-6-9;1-5(2,3)4/h2-6,8H,7,10H2,1H3;(H2,1,2,3,4)	Norepinephrine transporter releasing agent	RELEASING AGENT	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1200328	DULOXETINE HYDROCHLORIDE	CNCC[C@H](Oc1cccc2ccccc12)c1cccs1.Cl	BFFSMCNJSOPUAY-LMOVPXPDSA-N	InChI=1S/C18H19NOS.ClH/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16;/h2-10,13,17,19H,11-12H2,1H3;1H/t17-;/m0./s1	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL405	AMPHETAMINE	CC(N)Cc1ccccc1	KWTSXDURSIMDCE-UHFFFAOYSA-N	InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3	Norepinephrine transporter releasing agent	RELEASING AGENT	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL3989855	PSEUDOEPHEDRINE SULFATE	CN[C@@H](C)[C@@H](O)c1ccccc1.CN[C@@H](C)[C@@H](O)c1ccccc1.O=S(=O)(O)O	CAVQBDOACNULDN-NRCOEFLKSA-N	InChI=1S/2C10H15NO.H2O4S/c2*1-8(11-2)10(12)9-6-4-3-5-7-9;1-5(2,3)4/h2*3-8,10-12H,1-2H3;(H2,1,2,3,4)/t2*8-,10+;/m00./s1	Norepinephrine transporter releasing agent	RELEASING AGENT	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1200964	AMITRIPTYLINE HYDROCHLORIDE	CN(C)CCC=C1c2ccccc2CCc2ccccc21.Cl	KFYRPLNVJVHZGT-UHFFFAOYSA-N	InChI=1S/C20H23N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-12H,7,13-15H2,1-2H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1200332	PROTRIPTYLINE HYDROCHLORIDE	CNCCCC1c2ccccc2C=Cc2ccccc21.Cl	OGQDIIKRQRZXJH-UHFFFAOYSA-N	InChI=1S/C19H21N.ClH/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19;/h2-5,7-10,12-13,19-20H,6,11,14H2,1H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1200387	AMPHETAMINE ADIPATE	CC(N)Cc1ccccc1.O=C(O)CCCCC(=O)O	OFCJKOOVFDGTLY-UHFFFAOYSA-N	InChI=1S/C9H13N.C6H10O4/c1-8(10)7-9-5-3-2-4-6-9;7-5(8)3-1-2-4-6(9)10/h2-6,8H,7,10H2,1H3;1-4H2,(H,7,8)(H,9,10)	Norepinephrine transporter releasing agent	RELEASING AGENT	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1698	BUPROPION HYDROCHLORIDE	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1.Cl	HEYVINCGKDONRU-UHFFFAOYSA-N	InChI=1S/C13H18ClNO.ClH/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10;/h5-9,15H,1-4H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL4297064	MILNACIPRAN HYDROCHLORIDE	CCN(CC)C(=O)C1(c2ccccc2)CC1CN.Cl	XNCDYJFPRPDERF-UHFFFAOYSA-N	InChI=1S/C15H22N2O.ClH/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12;/h5-9,13H,3-4,10-11,16H2,1-2H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL796	METHYLPHENIDATE	COC(=O)C(c1ccccc1)C1CCCCN1	DUGOZIWVEXMGBE-UHFFFAOYSA-N	InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1722	METHYLPHENIDATE HYDROCHLORIDE	COC(=O)C(c1ccccc1)C1CCCCN1.Cl	JUMYIBMBTDDLNG-UHFFFAOYSA-N	InChI=1S/C14H19NO2.ClH/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12;/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1200492	NEFAZODONE HYDROCHLORIDE	CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl	DYCKFEBIOUQECE-UHFFFAOYSA-N	InChI=1S/C25H32ClN5O2.ClH/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22;/h3-6,8-11,20H,2,7,12-19H2,1H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1201156	NORTRIPTYLINE HYDROCHLORIDE	CNCCC=C1c2ccccc2CCc2ccccc21.Cl	SHAYBENGXDALFF-UHFFFAOYSA-N	InChI=1S/C19H21N.ClH/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19;/h2-5,7-11,20H,6,12-14H2,1H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1201023	ORPHENADRINE HYDROCHLORIDE	Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl	UQZKYYIKWZOKKD-UHFFFAOYSA-N	InChI=1S/C18H23NO.ClH/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;/h4-12,18H,13-14H2,1-3H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1200395	ORPHENADRINE CITRATE	Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O	MMMNTDFSPSQXJP-UHFFFAOYSA-N	InChI=1S/C18H23NO.C6H8O7/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-12,18H,13-14H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1200724	PSEUDOEPHEDRINE HYDROCHLORIDE	CN[C@@H](C)[C@@H](O)c1ccccc1.Cl	BALXUFOVQVENIU-KXNXZCPBSA-N	InChI=1S/C10H15NO.ClH/c1-8(11-2)10(12)9-6-4-3-5-7-9;/h3-8,10-12H,1-2H3;1H/t8-,10+;/m0./s1	Norepinephrine transporter releasing agent	RELEASING AGENT	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL2062163	PHENDIMETRAZINE TARTRATE	C[C@H]1[C@H](c2ccccc2)OCCN1C.O=C(O)C(O)C(O)C(=O)O	VEPOHXYIFQMVHW-XOZOLZJESA-N	InChI=1S/C12H17NO.C4H6O6/c1-10-12(14-9-8-13(10)2)11-6-4-3-5-7-11;5-1(3(7)8)2(6)4(9)10/h3-7,10,12H,8-9H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10)/t10-,12+;/m0./s1	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1200695	PHENYLPROPANOLAMINE HYDROCHLORIDE	CC(N)C(O)c1ccccc1.Cl	DYWNLSQWJMTVGJ-UHFFFAOYSA-N	InChI=1S/C9H13NO.ClH/c1-7(10)9(11)8-5-3-2-4-6-8;/h2-7,9,11H,10H2,1H3;1H	Norepinephrine transporter releasing agent	RELEASING AGENT	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1201777	TAPENTADOL HYDROCHLORIDE	CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C.Cl	ZELFLGGRLLOERW-YECZQDJWSA-N	InChI=1S/C14H23NO.ClH/c1-5-14(11(2)10-15(3)4)12-7-6-8-13(16)9-12;/h6-9,11,14,16H,5,10H2,1-4H3;1H/t11-,14+;/m0./s1	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1692	IMIPRAMINE HYDROCHLORIDE	CN(C)CCCN1c2ccccc2CCc2ccccc21.Cl	XZZXIYZZBJDEEP-UHFFFAOYSA-N	InChI=1S/C19H24N2.ClH/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21;/h3-6,8-11H,7,12-15H2,1-2H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1201178	LISDEXAMFETAMINE DIMESYLATE	CS(=O)(=O)O.CS(=O)(=O)O.C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN	CETWSOHVEGTIBR-FORAGAHYSA-N	InChI=1S/C15H25N3O.2CH4O3S/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16;2*1-5(2,3)4/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19);2*1H3,(H,2,3,4)/t12-,14-;;/m0../s1	Norepinephrine transporter releasing agent	RELEASING AGENT	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1200948	TRIMIPRAMINE MALEATE	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21.O=C(O)/C=C\C(=O)O	YDGHCKHAXOUQOS-BTJKTKAUSA-N	InChI=1S/C20H26N2.C4H4O4/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22;5-3(6)1-2-4(7)8/h4-11,16H,12-15H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL1201066	VENLAFAXINE HYDROCHLORIDE	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1.Cl	QYRYFNHXARDNFZ-UHFFFAOYSA-N	InChI=1S/C17H27NO2.ClH/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14;/h7-10,16,19H,4-6,11-13H2,1-3H3;1H	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL18442	PLERIXAFOR	c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1	YIQPUIGJQJDJOS-UHFFFAOYSA-N	InChI=1S/C28H54N8/c1-9-29-15-17-31-13-3-21-35(23-19-33-11-1)25-27-5-7-28(8-6-27)26-36-22-4-14-32-18-16-30-10-2-12-34-20-24-36/h5-8,29-34H,1-4,9-26H2	C-X-C chemokine receptor type 4 partial agonist	PARTIAL AGONIST	CHEMBL2107	C-X-C chemokine receptor type 4	Homo sapiens
CHEMBL2028852	ICATIBANT ACETATE	CC(=O)O.N=C(N)NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)O	HKMZRZUEADSZDQ-DZJWSCHMSA-N	InChI=1S/C59H89N19O13S.C2H4O2/c60-37(14-5-19-67-57(61)62)48(82)72-38(15-6-20-68-58(63)64)52(86)75-22-8-18-43(75)54(88)77-30-35(80)26-44(77)50(84)70-28-47(81)71-40(27-36-13-9-23-92-36)49(83)74-41(31-79)53(87)76-29-34-12-2-1-10-32(34)24-46(76)55(89)78-42-17-4-3-11-33(42)25-45(78)51(85)73-39(56(90)91)16-7-21-69-59(65)66;1-2(3)4/h1-2,9-10,12-13,23,33,35,37-46,79-80H,3-8,11,14-22,24-31,60H2,(H,70,84)(H,71,81)(H,72,82)(H,73,85)(H,74,83)(H,90,91)(H4,61,62,67)(H4,63,64,68)(H4,65,66,69);1H3,(H,3,4)/t33-,35+,37+,38-,39-,40-,41-,42-,43-,44-,45-,46+;/m0./s1	Bradykinin B2 receptor antagonist	ANTAGONIST	CHEMBL3157	Bradykinin B2 receptor	Homo sapiens
CHEMBL288441	BOSUTINIB	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl	UBPYILGKFZZVDX-UHFFFAOYSA-N	InChI=1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31)	Tyrosine-protein kinase HCK inhibitor	INHIBITOR	CHEMBL3234	Tyrosine-protein kinase HCK	Homo sapiens
CHEMBL17	DICHLORPHENAMIDE	NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1	GJQPMPFPNINLKP-UHFFFAOYSA-N	InChI=1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14)	Carbonic anhydrase XII inhibitor	INHIBITOR	CHEMBL3242	Carbonic anhydrase XII	Homo sapiens
CHEMBL20	ACETAZOLAMIDE	CC(=O)Nc1nnc(S(N)(=O)=O)s1	BZKPWHYZMXOIDC-UHFFFAOYSA-N	InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)	Carbonic anhydrase XII inhibitor	INHIBITOR	CHEMBL3242	Carbonic anhydrase XII	Homo sapiens
CHEMBL1200814	ACETAZOLAMIDE SODIUM	CC(=O)Nc1nnc(S([NH-])(=O)=O)s1.[Na+]	MRSXAJAOWWFZJJ-UHFFFAOYSA-M	InChI=1S/C4H6N4O3S2.Na/c1-2(9)6-3-7-8-4(12-3)13(5,10)11;/h1H3,(H3,5,6,7,9,10,11);/q;+1/p-1	Carbonic anhydrase XII inhibitor	INHIBITOR	CHEMBL3242	Carbonic anhydrase XII	Homo sapiens
CHEMBL1561	MIGLITOL	OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO	IBAQFPQHRJAVAV-ULAWRXDQSA-N	InChI=1S/C8H17NO5/c10-2-1-9-3-6(12)8(14)7(13)5(9)4-11/h5-8,10-14H,1-4H2/t5-,6+,7-,8-/m1/s1	Lysosomal alpha-glucosidase inhibitor	INHIBITOR	CHEMBL2608	Lysosomal alpha-glucosidase	Homo sapiens
CHEMBL1201733	PAZOPANIB HYDROCHLORIDE	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O.Cl	MQHIQUBXFFAOMK-UHFFFAOYSA-N	InChI=1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H	Fibroblast growth factor receptor 3 inhibitor	INHIBITOR	CHEMBL2742	Fibroblast growth factor receptor 3	Homo sapiens
CHEMBL1372	OXIGLUTATIONE	N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O	YPZRWBKMTBYPTK-BJDJZHNGSA-N	InChI=1S/C20H32N6O12S2/c21-9(19(35)36)1-3-13(27)25-11(17(33)23-5-15(29)30)7-39-40-8-12(18(34)24-6-16(31)32)26-14(28)4-2-10(22)20(37)38/h9-12H,1-8,21-22H2,(H,23,33)(H,24,34)(H,25,27)(H,26,28)(H,29,30)(H,31,32)(H,35,36)(H,37,38)/t9-,10-,11-,12-/m0/s1	Glutathione reductase 	OTHER	CHEMBL2755	Glutathione reductase	Homo sapiens
CHEMBL513	CARMUSTINE	O=NN(CCCl)C(=O)NCCCl	DLGOEMSEDOSKAD-UHFFFAOYSA-N	InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11)	Glutathione reductase inhibitor	INHIBITOR	CHEMBL2755	Glutathione reductase	Homo sapiens
CHEMBL1795071	RUXOLITINIB PHOSPHATE	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1.O=P(O)(O)O	JFMWPOCYMYGEDM-XFULWGLBSA-N	InChI=1S/C17H18N6.H3O4P/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16;1-5(2,3)4/h6,8-12,15H,1-5H2,(H,19,20,21);(H3,1,2,3,4)/t15-;/m1./s1	Tyrosine-protein kinase JAK1 inhibitor	INHIBITOR	CHEMBL2835	Tyrosine-protein kinase JAK1	Homo sapiens
CHEMBL2105741	TRAMETINIB DIMETHYL SULFOXIDE	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1.C[S+](C)[O-]	OQUFJVRYDFIQBW-UHFFFAOYSA-N	InChI=1S/C26H23FIN5O4.C2H6OS/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34;1-4(2)3/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34);1-2H3	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	CHEMBL2964	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens
CHEMBL1795071	RUXOLITINIB PHOSPHATE	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1.O=P(O)(O)O	JFMWPOCYMYGEDM-XFULWGLBSA-N	InChI=1S/C17H18N6.H3O4P/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16;1-5(2,3)4/h6,8-12,15H,1-5H2,(H,19,20,21);(H3,1,2,3,4)/t15-;/m1./s1	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	CHEMBL2971	Tyrosine-protein kinase JAK2	Homo sapiens
CHEMBL1201775	SAPROPTERIN DIHYDROCHLORIDE	C[C@H](O)[C@H](O)[C@H]1CNc2[nH]c(N)nc(=O)c2N1.Cl.Cl	RKSUYBCOVNCALL-NTVURLEBSA-N	InChI=1S/C9H15N5O3.2ClH/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7;;/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17);2*1H/t3-,4+,6-;;/m0../s1	Phenylalanine-4-hydroxylase activator	ACTIVATOR	CHEMBL3076	Phenylalanine-4-hydroxylase	Homo sapiens
CHEMBL2103841	CANAGLIFLOZIN	Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1.Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1.O	VHOFTEAWFCUTOS-TUGBYPPCSA-N	InChI=1S/2C24H25FO5S.H2O/c2*1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14;/h2*2-10,19,21-24,26-29H,11-12H2,1H3;1H2/t2*19-,21-,22+,23-,24+;/m11./s1	Sodium/glucose cotransporter 2 inhibitor	INHIBITOR	CHEMBL3884	Sodium/glucose cotransporter 2	Homo sapiens
CHEMBL288441	BOSUTINIB	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl	UBPYILGKFZZVDX-UHFFFAOYSA-N	InChI=1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31)	Tyrosine-protein kinase Lyn inhibitor	INHIBITOR	CHEMBL3905	Tyrosine-protein kinase Lyn	Homo sapiens
CHEMBL3989780	SUCRALFATE	O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O=S(=O)(OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O)O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O	WXOMTJVVIMOXJL-BOBFKVMVSA-A	InChI=1S/C11H20O35S8.16Al.62H2O/c12-47(13,14)36-1-3-4(41-49(18,19)20)5(42-50(21,22)23)6(43-51(24,25)26)9(38-3)39-11(2-37-48(15,16)17)8(45-53(30,31)32)7(44-52(27,28)29)10(40-11)46-54(33,34)35;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/h3-10H,1-2H2,(H,12,13,14)(H,15,16,17)(H,18,19,20)(H,21,22,23)(H,24,25,26)(H,27,28,29)(H,30,31,32)(H,33,34,35);;;;;;;;;;;;;;;;;62*1H2/q;16*+3;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/p-48/t3-,4-,5+,6-,7+,8+,9+,10-,11-;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/m1............................................................................../s1	Pepsin A inhibitor	INHIBITOR	CHEMBL3295	Pepsin A	Homo sapiens
CHEMBL256087	MENTHOL	CC1CCC(C(C)C)C(O)C1	NOOLISFMXDJSKH-UHFFFAOYSA-N	InChI=1S/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3	Transient receptor potential cation channel subfamily M member 8 opener	OPENER	CHEMBL1075319	Transient receptor potential cation channel subfamily M member 8	Homo sapiens
CHEMBL222813	ZANAMIVIR	CC(=O)N[C@@H]1[C@@H](NC(=N)N)C=C(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO	ARAIBEBZBOPLMB-UFGQHTETSA-N	InChI=1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1	Neuraminidase inhibitor	INHIBITOR	CHEMBL3377	Neuraminidase	Influenza B virus (strain B/Lee/1940)
CHEMBL1200340	OSELTAMIVIR PHOSPHATE	CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1.O=P(O)(O)O	PGZUMBJQJWIWGJ-ONAKXNSWSA-N	InChI=1S/C16H28N2O4.H3O4P/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19;1-5(2,3)4/h9,12-15H,5-8,17H2,1-4H3,(H,18,19);(H3,1,2,3,4)/t13-,14+,15+;/m0./s1	Neuraminidase inhibitor	INHIBITOR	CHEMBL3377	Neuraminidase	Influenza B virus (strain B/Lee/1940)
CHEMBL204656	ELVITEGRAVIR	COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C	JUZYLCPPVHEVSV-LJQANCHMSA-N	InChI=1S/C23H23ClFNO5/c1-12(2)19(11-27)26-10-16(23(29)30)22(28)15-8-14(20(31-3)9-18(15)26)7-13-5-4-6-17(24)21(13)25/h4-6,8-10,12,19,27H,7,11H2,1-3H3,(H,29,30)/t19-/m1/s1	Human immunodeficiency virus type 1 integrase inhibitor	INHIBITOR	CHEMBL3471	Human immunodeficiency virus type 1 integrase	Human immunodeficiency virus 1
CHEMBL518520	RALTEGRAVIR POTASSIUM	Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c([O-])c(=O)n2C)o1.[K+]	IFUKBHBISRAZTF-UHFFFAOYSA-M	InChI=1S/C20H21FN6O5.K/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11;/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30);/q;+1/p-1	Human immunodeficiency virus type 1 integrase inhibitor	INHIBITOR	CHEMBL3471	Human immunodeficiency virus type 1 integrase	Human immunodeficiency virus 1
CHEMBL271227	ABIRATERONE ACETATE	CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC=C(c5cccnc5)[C@@]4(C)CC[C@@H]32)C1	UVIQSJCZCSLXRZ-UBUQANBQSA-N	InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1	Cytochrome P450 17A1 inhibitor	INHIBITOR	CHEMBL3522	Cytochrome P450 17A1	Homo sapiens
CHEMBL2105741	TRAMETINIB DIMETHYL SULFOXIDE	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1.C[S+](C)[O-]	OQUFJVRYDFIQBW-UHFFFAOYSA-N	InChI=1S/C26H23FIN5O4.C2H6OS/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34;1-4(2)3/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34);1-2H3	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3587	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens
CHEMBL1201733	PAZOPANIB HYDROCHLORIDE	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O.Cl	MQHIQUBXFFAOMK-UHFFFAOYSA-N	InChI=1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H	Fibroblast growth factor receptor 1 inhibitor	INHIBITOR	CHEMBL3650	Fibroblast growth factor receptor 1	Homo sapiens
CHEMBL1946170	REGORAFENIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1	FNHKPVJBJVTLMP-UHFFFAOYSA-N	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	Fibroblast growth factor receptor 1 inhibitor	INHIBITOR	CHEMBL3650	Fibroblast growth factor receptor 1	Homo sapiens
CHEMBL1200907	TRILOSTANE	C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(O)=C(C#N)C[C@]35C)[C@@H]1CC[C@@H]2O	KVJXBPDAXMEYOA-CXANFOAXSA-N	InChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1	3-beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type II inhibitor	INHIBITOR	CHEMBL3670	3-beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type II	Homo sapiens
CHEMBL606	MISOPROSTOL	CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC	OJLOPKGSLYJEMD-URPKTTJQSA-N	InChI=1S/C22H38O5/c1-4-5-14-22(2,26)15-10-12-18-17(19(23)16-20(18)24)11-8-6-7-9-13-21(25)27-3/h10,12,17-18,20,24,26H,4-9,11,13-16H2,1-3H3/b12-10+/t17-,18-,20-,22?/m1/s1	Prostanoid EP3 receptor agonist	AGONIST	CHEMBL3710	Prostanoid EP3 receptor	Homo sapiens
CHEMBL2103868	CABOZANTINIB S-MALATE	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC.O=C(O)C[C@H](O)C(=O)O	HFCFMRYTXDINDK-WNQIDUERSA-N	InChI=1S/C28H24FN3O5.C4H6O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18;5-2(4(8)9)1-3(6)7/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34);2,5H,1H2,(H,6,7)(H,8,9)/t;2-/m.0/s1	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL601719	CRIZOTINIB	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl	KTEIFNKAUNYNJU-GFCCVEGCSA-N	InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL17	DICHLORPHENAMIDE	NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1	GJQPMPFPNINLKP-UHFFFAOYSA-N	InChI=1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14)	Carbonic anhydrase IV inhibitor	INHIBITOR	CHEMBL3729	Carbonic anhydrase IV	Homo sapiens
CHEMBL19	METHAZOLAMIDE	CC(=O)/N=c1/sc(S(N)(=O)=O)nn1C	FLOSMHQXBMRNHR-QPJJXVBHSA-N	InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12)/b7-4+	Carbonic anhydrase IV inhibitor	INHIBITOR	CHEMBL3729	Carbonic anhydrase IV	Homo sapiens
CHEMBL220492	TOPIRAMATE	CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1	KJADKKWYZYXHBB-XBWDGYHZSA-N	InChI=1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1	Carbonic anhydrase IV inhibitor	INHIBITOR	CHEMBL3729	Carbonic anhydrase IV	Homo sapiens
CHEMBL20	ACETAZOLAMIDE	CC(=O)Nc1nnc(S(N)(=O)=O)s1	BZKPWHYZMXOIDC-UHFFFAOYSA-N	InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)	Carbonic anhydrase IV inhibitor	INHIBITOR	CHEMBL3729	Carbonic anhydrase IV	Homo sapiens
CHEMBL1200814	ACETAZOLAMIDE SODIUM	CC(=O)Nc1nnc(S([NH-])(=O)=O)s1.[Na+]	MRSXAJAOWWFZJJ-UHFFFAOYSA-M	InChI=1S/C4H6N4O3S2.Na/c1-2(9)6-3-7-8-4(12-3)13(5,10)11;/h1H3,(H3,5,6,7,9,10,11);/q;+1/p-1	Carbonic anhydrase IV inhibitor	INHIBITOR	CHEMBL3729	Carbonic anhydrase IV	Homo sapiens
CHEMBL2095212	MIRABEGRON	Nc1nc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccccc3)cc2)cs1	PBAPPPCECJKMCM-IBGZPJMESA-N	InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1	Beta-3 adrenergic receptor agonist	AGONIST	CHEMBL246	Beta-3 adrenergic receptor	Homo sapiens
CHEMBL1946170	REGORAFENIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1	FNHKPVJBJVTLMP-UHFFFAOYSA-N	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	MAP kinase p38 beta inhibitor	INHIBITOR	CHEMBL3961	MAP kinase p38 beta	Homo sapiens
CHEMBL2360464	PEMETREXED DISODIUM	Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc3)c2c(=O)[nH]1.[Na+].[Na+]	NYDXNILOWQXUOF-GXKRWWSZSA-L	InChI=1S/C20H21N5O6.2Na/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27;;/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29);;/q;2*+1/p-2/t13-;;/m0../s1	GAR transformylase inhibitor	INHIBITOR	CHEMBL3972	GAR transformylase	Homo sapiens
CHEMBL2010601	IVACAFTOR	CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O	PURKAOJPTOLRMP-UHFFFAOYSA-N	InChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)	Cystic fibrosis transmembrane conductance regulator positive modulator	POSITIVE MODULATOR	CHEMBL4051	Cystic fibrosis transmembrane conductance regulator	Homo sapiens
CHEMBL1200699	DOXYCYCLINE	C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O	XQTWDDCIUJNLTR-CVHRZJFOSA-N	InChI=1S/C22H24N2O8.H2O/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;/h4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);1H2/t7-,10+,14+,15-,17-,22-;/m0./s1	Matrix metalloproteinase 7 inhibitor	INHIBITOR	CHEMBL4073	Matrix metalloproteinase 7	Homo sapiens
CHEMBL2364574	DOXYCYCLINE CALCIUM	C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.[Ca+2]	GJPGCACMCURAKH-YQCFNCLSSA-L	InChI=1S/2C22H24N2O8.Ca/c2*1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;/h2*4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);/q;;+2/p-2/t2*7-,10+,14+,15-,17-,22-;/m00./s1	Matrix metalloproteinase 7 inhibitor	INHIBITOR	CHEMBL4073	Matrix metalloproteinase 7	Homo sapiens
CHEMBL3989740	DOXYCYCLINE HYCLATE	CCO.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl.Cl.O	HALQELOKLVRWRI-VDBOFHIQSA-N	InChI=1S/2C22H24N2O8.C2H6O.2ClH.H2O/c2*1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;1-2-3;;;/h2*4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);3H,2H2,1H3;2*1H;1H2/t2*7-,10+,14+,15-,17-,22-;;;;/m00..../s1	Matrix metalloproteinase 7 inhibitor	INHIBITOR	CHEMBL4073	Matrix metalloproteinase 7	Homo sapiens
CHEMBL1946170	REGORAFENIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1	FNHKPVJBJVTLMP-UHFFFAOYSA-N	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	Fibroblast growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL4142	Fibroblast growth factor receptor 2	Homo sapiens
CHEMBL1946170	REGORAFENIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1	FNHKPVJBJVTLMP-UHFFFAOYSA-N	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	Tyrosine-protein kinase FRK inhibitor	INHIBITOR	CHEMBL4223	Tyrosine-protein kinase FRK	Homo sapiens
CHEMBL601719	CRIZOTINIB	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl	KTEIFNKAUNYNJU-GFCCVEGCSA-N	InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1	ALK tyrosine kinase receptor inhibitor	INHIBITOR	CHEMBL4247	ALK tyrosine kinase receptor	Homo sapiens
CHEMBL1371	CHLORZOXAZONE	O=c1[nH]c2cc(Cl)ccc2o1	TZFWDZFKRBELIQ-UHFFFAOYSA-N	InChI=1S/C7H4ClNO2/c8-4-1-2-6-5(3-4)9-7(10)11-6/h1-3H,(H,9,10)	Intermediate conductance calcium-activated potassium channel protein 4 opener	OPENER	CHEMBL4305	Intermediate conductance calcium-activated potassium channel protein 4	Homo sapiens
CHEMBL1463	FLUCYTOSINE	Nc1[nH]c(=O)ncc1F	XRECTZIEBJDKEO-UHFFFAOYSA-N	InChI=1S/C4H4FN3O/c5-2-1-7-4(9)8-3(2)6/h1H,(H3,6,7,8,9)	Thymidylate synthase inhibitor	INHIBITOR	CHEMBL4665	Thymidylate synthase	Cryptococcus neoformans var. neoformans B-3501A
CHEMBL1200699	DOXYCYCLINE	C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O	XQTWDDCIUJNLTR-CVHRZJFOSA-N	InChI=1S/C22H24N2O8.H2O/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;/h4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);1H2/t7-,10+,14+,15-,17-,22-;/m0./s1	Matrix metalloproteinase 8 inhibitor	INHIBITOR	CHEMBL4588	Matrix metalloproteinase 8	Homo sapiens
CHEMBL2364574	DOXYCYCLINE CALCIUM	C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.[Ca+2]	GJPGCACMCURAKH-YQCFNCLSSA-L	InChI=1S/2C22H24N2O8.Ca/c2*1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;/h2*4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);/q;;+2/p-2/t2*7-,10+,14+,15-,17-,22-;/m00./s1	Matrix metalloproteinase 8 inhibitor	INHIBITOR	CHEMBL4588	Matrix metalloproteinase 8	Homo sapiens
CHEMBL3989740	DOXYCYCLINE HYCLATE	CCO.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl.Cl.O	HALQELOKLVRWRI-VDBOFHIQSA-N	InChI=1S/2C22H24N2O8.C2H6O.2ClH.H2O/c2*1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;1-2-3;;;/h2*4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);3H,2H2,1H3;2*1H;1H2/t2*7-,10+,14+,15-,17-,22-;;;;/m00..../s1	Matrix metalloproteinase 8 inhibitor	INHIBITOR	CHEMBL4588	Matrix metalloproteinase 8	Homo sapiens
CHEMBL1200699	DOXYCYCLINE	C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O	XQTWDDCIUJNLTR-CVHRZJFOSA-N	InChI=1S/C22H24N2O8.H2O/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;/h4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);1H2/t7-,10+,14+,15-,17-,22-;/m0./s1	Matrix metalloproteinase 13 inhibitor	INHIBITOR	CHEMBL280	Matrix metalloproteinase 13	Homo sapiens
CHEMBL2364574	DOXYCYCLINE CALCIUM	C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.[Ca+2]	GJPGCACMCURAKH-YQCFNCLSSA-L	InChI=1S/2C22H24N2O8.Ca/c2*1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;/h2*4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);/q;;+2/p-2/t2*7-,10+,14+,15-,17-,22-;/m00./s1	Matrix metalloproteinase 13 inhibitor	INHIBITOR	CHEMBL280	Matrix metalloproteinase 13	Homo sapiens
CHEMBL3989740	DOXYCYCLINE HYCLATE	CCO.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl.Cl.O	HALQELOKLVRWRI-VDBOFHIQSA-N	InChI=1S/2C22H24N2O8.C2H6O.2ClH.H2O/c2*1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;1-2-3;;;/h2*4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);3H,2H2,1H3;2*1H;1H2/t2*7-,10+,14+,15-,17-,22-;;;;/m00..../s1	Matrix metalloproteinase 13 inhibitor	INHIBITOR	CHEMBL280	Matrix metalloproteinase 13	Homo sapiens
CHEMBL24828	VANDETANIB	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1	UHTHHESEBZOYNR-UHFFFAOYSA-N	InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)	Tyrosine-protein kinase BRK inhibitor	INHIBITOR	CHEMBL4601	Tyrosine-protein kinase BRK	Homo sapiens
CHEMBL181	DIAZOXIDE	CC1=NS(=O)(=O)c2cc(Cl)ccc2N1	GDLBFKVLRPITMI-UHFFFAOYSA-N	InChI=1S/C8H7ClN2O2S/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5/h2-4H,1H3,(H,10,11)	Potassium channel, inwardly rectifying, subfamily J, member 8 opener	OPENER	CHEMBL4770	Potassium channel, inwardly rectifying, subfamily J, member 8	Homo sapiens
CHEMBL294199	CAPSAICIN	COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O	YKPUWZUDDOIDPM-SOFGYWHQSA-N	InChI=1S/C18H27NO3/c1-14(2)8-6-4-5-7-9-18(21)19-13-15-10-11-16(20)17(12-15)22-3/h6,8,10-12,14,20H,4-5,7,9,13H2,1-3H3,(H,19,21)/b8-6+	Vanilloid receptor opener	OPENER	CHEMBL4794	Vanilloid receptor	Homo sapiens
CHEMBL1200699	DOXYCYCLINE	C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O	XQTWDDCIUJNLTR-CVHRZJFOSA-N	InChI=1S/C22H24N2O8.H2O/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;/h4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);1H2/t7-,10+,14+,15-,17-,22-;/m0./s1	Matrix metalloproteinase-1 inhibitor	INHIBITOR	CHEMBL332	Matrix metalloproteinase-1	Homo sapiens
CHEMBL3989740	DOXYCYCLINE HYCLATE	CCO.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl.Cl.O	HALQELOKLVRWRI-VDBOFHIQSA-N	InChI=1S/2C22H24N2O8.C2H6O.2ClH.H2O/c2*1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;1-2-3;;;/h2*4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);3H,2H2,1H3;2*1H;1H2/t2*7-,10+,14+,15-,17-,22-;;;;/m00..../s1	Matrix metalloproteinase-1 inhibitor	INHIBITOR	CHEMBL332	Matrix metalloproteinase-1	Homo sapiens
CHEMBL2364574	DOXYCYCLINE CALCIUM	C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.[Ca+2]	GJPGCACMCURAKH-YQCFNCLSSA-L	InChI=1S/2C22H24N2O8.Ca/c2*1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;/h2*4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);/q;;+2/p-2/t2*7-,10+,14+,15-,17-,22-;/m00./s1	Matrix metalloproteinase-1 inhibitor	INHIBITOR	CHEMBL332	Matrix metalloproteinase-1	Homo sapiens
CHEMBL1286	LEVETIRACETAM	CC[C@@H](C(N)=O)N1CCCC1=O	HPHUVLMMVZITSG-LURJTMIESA-N	InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1	Voltage-gated N-type calcium channel alpha-1B subunit blocker	BLOCKER	CHEMBL4478	Voltage-gated N-type calcium channel alpha-1B subunit	Homo sapiens
CHEMBL1946170	REGORAFENIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1	FNHKPVJBJVTLMP-UHFFFAOYSA-N	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	Discoidin domain-containing receptor 2 inhibitor	INHIBITOR	CHEMBL5122	Discoidin domain-containing receptor 2	Homo sapiens
CHEMBL2105729	DABRAFENIB MESYLATE	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1.CS(=O)(=O)O	YKGMKSIHIVVYKY-UHFFFAOYSA-N	InChI=1S/C23H20F3N5O2S2.CH4O3S/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25;1-5(2,3)4/h4-11,31H,1-3H3,(H2,27,28,29);1H3,(H,2,3,4)	Serine/threonine-protein kinase B-raf inhibitor	INHIBITOR	CHEMBL5145	Serine/threonine-protein kinase B-raf	Homo sapiens
CHEMBL1946170	REGORAFENIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1	FNHKPVJBJVTLMP-UHFFFAOYSA-N	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	Serine/threonine-protein kinase B-raf inhibitor	INHIBITOR	CHEMBL5145	Serine/threonine-protein kinase B-raf	Homo sapiens
CHEMBL1200485	SORAFENIB TOSYLATE	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1	IVDHYUQIDRJSTI-UHFFFAOYSA-N	InChI=1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)	Serine/threonine-protein kinase B-raf inhibitor	INHIBITOR	CHEMBL5145	Serine/threonine-protein kinase B-raf	Homo sapiens
CHEMBL1229517	VEMURAFENIB	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F	GPXBXXGIAQBQNI-UHFFFAOYSA-N	InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)	Serine/threonine-protein kinase B-raf inhibitor	INHIBITOR	CHEMBL5145	Serine/threonine-protein kinase B-raf	Homo sapiens
CHEMBL535650	MEFLOQUINE HYDROCHLORIDE	Cl.OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1	WESWYMRNZNDGBX-UHFFFAOYSA-N	InChI=1S/C17H16F6N2O.ClH/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11;/h3-5,8,12,15,24,26H,1-2,6-7H2;1H	Ferriprotoporphyrin IX inhibitor	INHIBITOR	CHEMBL613897	Ferriprotoporphyrin IX	Plasmodium falciparum
CHEMBL1200901	HALOFANTRINE HYDROCHLORIDE	CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12.Cl	WANGFTDWOFGECH-UHFFFAOYSA-N	InChI=1S/C26H30Cl2F3NO.ClH/c1-3-5-10-32(11-6-4-2)12-9-25(33)23-16-22-21(14-18(27)15-24(22)28)20-13-17(26(29,30)31)7-8-19(20)23;/h7-8,13-16,25,33H,3-6,9-12H2,1-2H3;1H	Ferriprotoporphyrin IX inhibitor	INHIBITOR	CHEMBL613897	Ferriprotoporphyrin IX	Plasmodium falciparum
CHEMBL1357648	AMODIAQUINE HYDROCHLORIDE	CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl.Cl.O.O	YVNAYSHNIILOJS-UHFFFAOYSA-N	InChI=1S/C20H22ClN3O.2ClH.2H2O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19;;;;/h5-12,25H,3-4,13H2,1-2H3,(H,22,23);2*1H;2*1H2	Ferriprotoporphyrin IX inhibitor	INHIBITOR	CHEMBL613897	Ferriprotoporphyrin IX	Plasmodium falciparum
CHEMBL58510	CHLOROQUINE PHOSPHATE	CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=P(O)(O)O.O=P(O)(O)O	QKICWELGRMTQCR-UHFFFAOYSA-N	InChI=1S/C18H26ClN3.2H3O4P/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18;2*1-5(2,3)4/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21);2*(H3,1,2,3,4)	Ferriprotoporphyrin IX inhibitor	INHIBITOR	CHEMBL613897	Ferriprotoporphyrin IX	Plasmodium falciparum
CHEMBL566534	ARTEMETHER	CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3	SXYIRMFQILZOAM-HVNFFKDJSA-N	InChI=1S/C16H26O5/c1-9-5-6-12-10(2)13(17-4)18-14-16(12)11(9)7-8-15(3,19-14)20-21-16/h9-14H,5-8H2,1-4H3/t9-,10-,11+,12+,13+,14-,15-,16-/m1/s1	Ferriprotoporphyrin IX inhibitor	INHIBITOR	CHEMBL613897	Ferriprotoporphyrin IX	Plasmodium falciparum
CHEMBL2359966	QUININE SULFATE	C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.O.O.O=S(=O)(O)O	ZHNFLHYOFXQIOW-LPYZJUEESA-N	InChI=1S/2C20H24N2O2.H2O4S.2H2O/c2*1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18;1-5(2,3)4;;/h2*3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3;(H2,1,2,3,4);2*1H2/t2*13-,14-,19-,20+;;;/m00.../s1	Ferriprotoporphyrin IX inhibitor	INHIBITOR	CHEMBL613897	Ferriprotoporphyrin IX	Plasmodium falciparum
CHEMBL4297165	CHLOROQUINE HYDROCHLORIDE	CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.Cl.Cl	PCFGECQRSMVKCC-UHFFFAOYSA-N	InChI=1S/C18H26ClN3.2ClH/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18;;/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21);2*1H	Ferriprotoporphyrin IX inhibitor	INHIBITOR	CHEMBL613897	Ferriprotoporphyrin IX	Plasmodium falciparum
CHEMBL38827	LUMEFANTRINE	CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1/C2=C/c1ccc(Cl)cc1	DYLGFOYVTXJFJP-MYYYXRDXSA-N	InChI=1S/C30H32Cl3NO/c1-3-5-13-34(14-6-4-2)19-29(35)28-18-23(33)17-27-25(15-20-7-9-21(31)10-8-20)26-16-22(32)11-12-24(26)30(27)28/h7-12,15-18,29,35H,3-6,13-14,19H2,1-2H3/b25-15-	Ferriprotoporphyrin IX inhibitor	INHIBITOR	CHEMBL613897	Ferriprotoporphyrin IX	Plasmodium falciparum
CHEMBL1690	HYDROXYCHLOROQUINE SULFATE	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=S(=O)(O)O	JCBIVZZPXRZKTI-UHFFFAOYSA-N	InChI=1S/C18H26ClN3O.H2O4S/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18;1-5(2,3)4/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21);(H2,1,2,3,4)	Ferriprotoporphyrin IX inhibitor	INHIBITOR	CHEMBL613897	Ferriprotoporphyrin IX	Plasmodium falciparum
CHEMBL1643	RIBAVIRIN	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1	IWUCXVSUMQZMFG-AFCXAGJDSA-N	InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1	Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor	INHIBITOR	CHEMBL5375	Hepatitis C virus NS5B RNA-dependent RNA polymerase	Hepatitis C virus
CHEMBL1200612	DIBUCAINE HYDROCHLORIDE	CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1.Cl	IVHBBMHQKZBJEU-UHFFFAOYSA-N	InChI=1S/C20H29N3O2.ClH/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3;/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24);1H	Sodium channel protein type X alpha subunit blocker	BLOCKER	CHEMBL5451	Sodium channel protein type X alpha subunit	Homo sapiens
CHEMBL2104987	TEDUGLUTIDE	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC	CILIXQOJUNDIDU-ASQIGDHWSA-N	InChI=1S/C164H252N44O55S/c1-21-77(11)126(156(255)187-95(44-46-114(167)214)141(240)206-130(83(17)211)160(259)186-93(42-33-34-49-165)140(239)202-129(80(14)24-4)159(258)208-131(84(18)212)161(260)200-111(163(262)263)66-125(230)231)203-151(250)100(54-76(9)10)189-145(244)103(57-88-67-175-92-41-32-31-40-90(88)92)192-147(246)105(60-116(169)216)199-157(256)127(78(12)22-2)204-152(251)102(56-87-38-29-26-30-39-87)190-149(248)109(64-123(226)227)195-137(236)94(43-35-50-174-164(171)172)183-134(233)82(16)179-133(232)81(15)180-142(241)98(52-74(5)6)188-146(245)104(59-115(168)215)194-150(249)110(65-124(228)229)196-143(242)99(53-75(7)8)198-158(257)128(79(13)23-3)205-162(261)132(85(19)213)207-153(252)106(61-117(170)217)193-139(238)97(48-51-264-20)185-138(237)96(45-47-120(220)221)184-148(247)108(63-122(224)225)197-155(254)113(72-210)201-144(243)101(55-86-36-27-25-28-37-86)191-154(253)112(71-209)182-119(219)70-177-136(235)107(62-121(222)223)181-118(218)69-176-135(234)91(166)58-89-68-173-73-178-89/h25-32,36-41,67-68,73-85,91,93-113,126-132,175,209-213H,21-24,33-35,42-66,69-72,165-166H2,1-20H3,(H2,167,214)(H2,168,215)(H2,169,216)(H2,170,217)(H,173,178)(H,176,234)(H,177,235)(H,179,232)(H,180,241)(H,181,218)(H,182,219)(H,183,233)(H,184,247)(H,185,237)(H,186,259)(H,187,255)(H,188,245)(H,189,244)(H,190,248)(H,191,253)(H,192,246)(H,193,238)(H,194,249)(H,195,236)(H,196,242)(H,197,254)(H,198,257)(H,199,256)(H,200,260)(H,201,243)(H,202,239)(H,203,250)(H,204,251)(H,205,261)(H,206,240)(H,207,252)(H,208,258)(H,220,221)(H,222,223)(H,224,225)(H,226,227)(H,228,229)(H,230,231)(H,262,263)(H4,171,172,174)/t77-,78-,79-,80-,81-,82-,83+,84+,85+,91-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,126-,127-,128-,129-,130-,131-,132-/m0/s1	Glucagon-like peptide 2 receptor agonist	AGONIST	CHEMBL5844	Glucagon-like peptide 2 receptor	Homo sapiens
CHEMBL1201134	LUBIPROSTONE	CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(=O)O)O1	WGFOBBZOWHGYQH-MXHNKVEKSA-N	InChI=1S/C20H32F2O5/c1-2-3-11-19(21,22)20(26)12-10-15-14(16(23)13-17(15)27-20)8-6-4-5-7-9-18(24)25/h14-15,17,26H,2-13H2,1H3,(H,24,25)/t14-,15-,17-,20-/m1/s1	Chloride channel protein 2 opener	OPENER	CHEMBL1628478	Chloride channel protein 2	Homo sapiens
CHEMBL1387	NORETHYNODREL	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C	ICTXHFFSOAJUMG-SLHNCBLASA-N	InChI=1S/C20H26O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,16-18,22H,4-12H2,2H3/t16-,17-,18+,19+,20+/m1/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL1531	ETONOGESTREL	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3C(=C)C[C@@]21CC	GCKFUYQCUCGESZ-BPIQYHPVSA-N	InChI=1S/C22H28O2/c1-4-21-13-14(3)20-17-9-7-16(23)12-15(17)6-8-18(20)19(21)10-11-22(21,24)5-2/h2,12,17-20,24H,3-4,6-11,13H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL1201139	MEGESTROL ACETATE	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	RQZAXGRLVPAYTJ-GQFGMJRRSA-N	InChI=1S/C24H32O4/c1-14-12-18-19(22(4)9-6-17(27)13-21(14)22)7-10-23(5)20(18)8-11-24(23,15(2)25)28-16(3)26/h12-13,18-20H,6-11H2,1-5H3/t18-,19+,20+,22-,23+,24+/m1/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL1201146	NORETHINDRONE ACETATE	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C	IMONTRJLAWHYGT-ZCPXKWAGSA-N	InChI=1S/C22H28O3/c1-4-22(25-14(2)23)12-10-20-19-7-5-15-13-16(24)6-8-17(15)18(19)9-11-21(20,22)3/h1,13,17-20H,5-12H2,2-3H3/t17-,18+,19+,20-,21-,22-/m0/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL717	MEDROXYPROGESTERONE ACETATE	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	PSGAAPLEWMOORI-PEINSRQWSA-N	InChI=1S/C24H34O4/c1-14-12-18-19(22(4)9-6-17(27)13-21(14)22)7-10-23(5)20(18)8-11-24(23,15(2)25)28-16(3)26/h13-14,18-20H,6-12H2,1-5H3/t14-,18+,19-,20-,22+,23-,24-/m0/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL1162	NORETHINDRONE	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C	VIKNJXKGJWUCNN-XGXHKTLJSA-N	InChI=1S/C20H26O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,12,15-18,22H,4-11H2,2H3/t15-,16+,17+,18-,19-,20-/m0/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL1200848	HYDROXYPROGESTERONE CAPROATE	CCCCCC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	DOMWKUIIPQCAJU-LJHIYBGHSA-N	InChI=1S/C27H40O4/c1-5-6-7-8-24(30)31-27(18(2)28)16-13-23-21-10-9-19-17-20(29)11-14-25(19,3)22(21)12-15-26(23,27)4/h17,21-23H,5-16H2,1-4H3/t21-,22+,23+,25+,26+,27+/m1/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL1200853	DYDROGESTERONE	CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C	JGMOKGBVKVMRFX-HQZYFCCVSA-N	InChI=1S/C21H28O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4-5,12,16-19H,6-11H2,1-3H3/t16-,17+,18-,19+,20+,21+/m0/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL103	PROGESTERONE	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	RJKFOVLPORLFTN-LEKSSAKUSA-N	InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL2107797	NORGESTREL	C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC	WWYNJERNGUHSAO-CULCCENASA-N	InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21?/m0/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL1200934	NORGESTIMATE	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC	KIQQMECNKUGGKA-NMYWJIRASA-N	InChI=1S/C23H31NO3/c1-4-22-12-10-19-18-9-7-17(24-26)14-16(18)6-8-20(19)21(22)11-13-23(22,5-2)27-15(3)25/h2,14,18-21,26H,4,6-13H2,1,3H3/b24-17+/t18-,19+,20+,21-,22-,23-/m0/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL1389	LEVONORGESTREL	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC	WWYNJERNGUHSAO-XUDSTZEESA-N	InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL1533	DESOGESTREL	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3C(=C)C[C@@]21CC	RPLCPCMSCLEKRS-BPIQYHPVSA-N	InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL260538	ULIPRISTAL ACETATE	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C	OOLLAFOLCSJHRE-ZHAKMVSLSA-N	InChI=1S/C30H37NO4/c1-18(32)30(35-19(2)33)15-14-27-25-12-8-21-16-23(34)11-13-24(21)28(25)26(17-29(27,30)3)20-6-9-22(10-7-20)31(4)5/h6-7,9-10,16,25-27H,8,11-15,17H2,1-5H3/t25-,26+,27-,29-,30-/m0/s1	Progesterone receptor modulator	MODULATOR	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL1200807	NORELGESTROMIN	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC	ISHXLNHNDMZNMC-VTKCIJPMSA-N	InChI=1S/C21H29NO2/c1-3-20-11-9-17-16-8-6-15(22-24)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23-24H,3,5-12H2,1H3/b22-15+/t16-,17+,18+,19-,20-,21-/m0/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL1200624	ETHYNODIOL DIACETATE	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C	ONKUMRGIYFNPJW-KIEAKMPYSA-N	InChI=1S/C24H32O4/c1-5-24(28-16(3)26)13-11-22-21-8-6-17-14-18(27-15(2)25)7-9-19(17)20(21)10-12-23(22,24)4/h1,14,18-22H,6-13H2,2-4H3/t18-,19-,20+,21+,22-,23-,24-/m0/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL1276308	MIFEPRISTONE	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C	VKHAHZOOUSRJNA-GCNJZUOMSA-N	InChI=1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1	Progesterone receptor antagonist	ANTAGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL1509	DROSPIRENONE	C[C@]12CC[C@H]3[C@H]([C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1)[C@H]1C[C@H]1C1=CC(=O)CC[C@@]13C	METQSPRSQINEEU-HXCATZOESA-N	InChI=1S/C24H30O3/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23)8-5-19(26)27-24/h9,13-16,18,20-21H,3-8,10-11H2,1-2H3/t13-,14+,15-,16+,18+,20-,21+,22-,23+,24+/m1/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL1479	DANAZOL	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C	POZRVZJJTULAOH-LHZXLZLDSA-N	InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL473417	VISMODEGIB	CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1	BPQMGSKTAYIVFO-UHFFFAOYSA-N	InChI=1S/C19H14Cl2N2O3S/c1-27(25,26)13-6-7-14(17(21)11-13)19(24)23-12-5-8-16(20)15(10-12)18-4-2-3-9-22-18/h2-11H,1H3,(H,23,24)	Smoothened homolog inhibitor	INHIBITOR	CHEMBL5971	Smoothened homolog	Homo sapiens
CHEMBL256087	MENTHOL	CC1CCC(C(C)C)C(O)C1	NOOLISFMXDJSKH-UHFFFAOYSA-N	InChI=1S/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3	Transient receptor potential cation channel subfamily A member 1 opener	OPENER	CHEMBL6007	Transient receptor potential cation channel subfamily A member 1	Homo sapiens
CHEMBL832	SULFINPYRAZONE	O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1	MBGGBVCUIVRRBF-UHFFFAOYSA-N	InChI=1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2	Solute carrier family 22 member 12 inhibitor	INHIBITOR	CHEMBL6120	Solute carrier family 22 member 12	Homo sapiens
CHEMBL1946170	REGORAFENIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1	FNHKPVJBJVTLMP-UHFFFAOYSA-N	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	Tyrosine-protein kinase TIE-2 inhibitor	INHIBITOR	CHEMBL4128	Tyrosine-protein kinase TIE-2	Homo sapiens
CHEMBL24828	VANDETANIB	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1	UHTHHESEBZOYNR-UHFFFAOYSA-N	InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)	Tyrosine-protein kinase TIE-2 inhibitor	INHIBITOR	CHEMBL4128	Tyrosine-protein kinase TIE-2	Homo sapiens
CHEMBL897	PROBENECID	CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1	DBABZHXKTCFAPX-UHFFFAOYSA-N	InChI=1S/C13H19NO4S/c1-3-9-14(10-4-2)19(17,18)12-7-5-11(6-8-12)13(15)16/h5-8H,3-4,9-10H2,1-2H3,(H,15,16)	Solute carrier family 22 member 6 inhibitor	INHIBITOR	CHEMBL1641347	Solute carrier family 22 member 6	Homo sapiens
CHEMBL897	PROBENECID	CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1	DBABZHXKTCFAPX-UHFFFAOYSA-N	InChI=1S/C13H19NO4S/c1-3-9-14(10-4-2)19(17,18)12-7-5-11(6-8-12)13(15)16/h5-8H,3-4,9-10H2,1-2H3,(H,15,16)	Solute carrier family 22 member 8 inhibitor	INHIBITOR	CHEMBL1641348	Solute carrier family 22 member 8	Homo sapiens
CHEMBL1214124	PERAMPANEL	N#Cc1ccccc1-c1cc(-c2ccccn2)cn(-c2ccccc2)c1=O	PRMWGUBFXWROHD-UHFFFAOYSA-N	InChI=1S/C23H15N3O/c24-15-17-8-4-5-11-20(17)21-14-18(22-12-6-7-13-25-22)16-26(23(21)27)19-9-2-1-3-10-19/h1-14,16H	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	CHEMBL2096670	Glutamate receptor ionotropic AMPA	Homo sapiens
CHEMBL220492	TOPIRAMATE	CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1	KJADKKWYZYXHBB-XBWDGYHZSA-N	InChI=1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	CHEMBL2096670	Glutamate receptor ionotropic AMPA	Homo sapiens
CHEMBL957	BOSENTAN	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO	GJPICJJJRGTNOD-UHFFFAOYSA-N	InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32)	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	CHEMBL2096678	Endothelin receptor, ET-A/ET-B	Homo sapiens
CHEMBL1111	AMBRISENTAN	COC(c1ccccc1)(c1ccccc1)[C@H](Oc1nc(C)cc(C)n1)C(=O)O	OUJTZYPIHDYQMC-LJQANCHMSA-N	InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	CHEMBL2096678	Endothelin receptor, ET-A/ET-B	Homo sapiens
CHEMBL897	PROBENECID	CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1	DBABZHXKTCFAPX-UHFFFAOYSA-N	InChI=1S/C13H19NO4S/c1-3-9-14(10-4-2)19(17,18)12-7-5-11(6-8-12)13(15)16/h5-8H,3-4,9-10H2,1-2H3,(H,15,16)	Solute carrier family 22 member 11 inhibitor	INHIBITOR	CHEMBL2073677	Solute carrier family 22 member 11	Homo sapiens
CHEMBL3	NICOTINE	CN1CCC[C@H]1c1cccnc1	SNICXCGAKADSCV-JTQLQIEISA-N	InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1	Neuronal acetylcholine receptor; alpha4/beta2 agonist	AGONIST	CHEMBL1907589	Neuronal acetylcholine receptor; alpha4/beta2	Homo sapiens
CHEMBL2062259	VARENICLINE TARTRATE	O=C(O)C(O)C(O)C(=O)O.c1cnc2cc3c(cc2n1)C1CNCC3C1	TWYFGYXQSYOKLK-UHFFFAOYSA-N	InChI=1S/C13H13N3.C4H6O6/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1;5-1(3(7)8)2(6)4(9)10/h1-2,4-5,8-9,14H,3,6-7H2;1-2,5-6H,(H,7,8)(H,9,10)	Neuronal acetylcholine receptor; alpha4/beta2 agonist	AGONIST	CHEMBL1907589	Neuronal acetylcholine receptor; alpha4/beta2	Homo sapiens
CHEMBL3301675	LINACLOTIDE	C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CSSC[C@H](N)C(=O)N[C@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)CSSC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC3=O)C(=O)N2	KXGCNMMJRFDFNR-WDRJZQOASA-N	InChI=1S/C59H79N15O21S6/c1-26-47(82)69-41-25-101-99-22-38-52(87)65-33(13-14-45(80)81)49(84)66-34(16-28-5-9-30(76)10-6-28)50(85)71-40(54(89)72-39(23-97-96-20-32(60)48(83)70-38)53(88)67-35(18-43(61)78)58(93)74-15-3-4-42(74)56(91)63-26)24-100-98-21-37(64-44(79)19-62-57(92)46(27(2)75)73-55(41)90)51(86)68-36(59(94)95)17-29-7-11-31(77)12-8-29/h5-12,26-27,32-42,46,75-77H,3-4,13-25,60H2,1-2H3,(H2,61,78)(H,62,92)(H,63,91)(H,64,79)(H,65,87)(H,66,84)(H,67,88)(H,68,86)(H,69,82)(H,70,83)(H,71,85)(H,72,89)(H,73,90)(H,80,81)(H,94,95)/t26-,27+,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,46-/m0/s1	Heat-stable enterotoxin receptor agonist	AGONIST	CHEMBL1795197	Heat-stable enterotoxin receptor	Homo sapiens
CHEMBL675	ALENDRONATE SODIUM	NCCCC(O)(P(=O)([O-])O)P(=O)(O)O.[Na+]	CAKRAHQRJGUPIG-UHFFFAOYSA-M	InChI=1S/C4H13NO7P2.Na/c5-3-1-2-4(6,13(7,8)9)14(10,11)12;/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12);/q;+1/p-1	Farnesyl diphosphate synthase inhibitor	INHIBITOR	CHEMBL1782	Farnesyl diphosphate synthase	Homo sapiens
CHEMBL1654	RISEDRONATE SODIUM	O=P([O-])(O)C(O)(Cc1cccnc1)P(=O)(O)O.[Na+]	DRFDPXKCEWYIAW-UHFFFAOYSA-M	InChI=1S/C7H11NO7P2.Na/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6;/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15);/q;+1/p-1	Farnesyl diphosphate synthase inhibitor	INHIBITOR	CHEMBL1782	Farnesyl diphosphate synthase	Homo sapiens
CHEMBL924	ZOLEDRONIC ACID	O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O	XRASPMIURGNCCH-UHFFFAOYSA-N	InChI=1S/C5H10N2O7P2/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14)	Farnesyl diphosphate synthase inhibitor	INHIBITOR	CHEMBL1782	Farnesyl diphosphate synthase	Homo sapiens
CHEMBL3989569	IBANDRONATE SODIUM	CCCCCN(C)CCC(O)(P(=O)([O-])O)P(=O)(O)O.O.[Na+]	VBDRTGFACFYFCT-UHFFFAOYSA-M	InChI=1S/C9H23NO7P2.Na.H2O/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17;;/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17);;1H2/q;+1;/p-1	Farnesyl diphosphate synthase inhibitor	INHIBITOR	CHEMBL1782	Farnesyl diphosphate synthase	Homo sapiens
CHEMBL3989401	PAMIDRONATE DISODIUM	NCCC(O)(P(=O)([O-])O)P(=O)([O-])O.O.O.O.O.O.[Na+].[Na+]	CZYWHNTUXNGDGR-UHFFFAOYSA-L	InChI=1S/C3H11NO7P2.2Na.5H2O/c4-2-1-3(5,12(6,7)8)13(9,10)11;;;;;;;/h5H,1-2,4H2,(H2,6,7,8)(H2,9,10,11);;;5*1H2/q;2*+1;;;;;/p-2	Farnesyl diphosphate synthase inhibitor	INHIBITOR	CHEMBL1782	Farnesyl diphosphate synthase	Homo sapiens
CHEMBL503	LOVASTATIN	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21	PCZOHLXUXFIOCF-BXMDZJJMSA-N	InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15-,16-,18+,19+,20-,21-,23-/m0/s1	HMG-CoA reductase inhibitor	INHIBITOR	CHEMBL402	HMG-CoA reductase	Homo sapiens
CHEMBL1200563	CERIVASTATIN SODIUM	COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])c1-c1ccc(F)cc1.[Na+]	GPUADMRJQVPIAS-QCVDVZFFSA-M	InChI=1S/C26H34FNO5.Na/c1-15(2)25-21(11-10-19(29)12-20(30)13-23(31)32)24(17-6-8-18(27)9-7-17)22(14-33-5)26(28-25)16(3)4;/h6-11,15-16,19-20,29-30H,12-14H2,1-5H3,(H,31,32);/q;+1/p-1/b11-10+;/t19-,20-;/m1./s1	HMG-CoA reductase inhibitor	INHIBITOR	CHEMBL402	HMG-CoA reductase	Homo sapiens
CHEMBL1237061	PITAVASTATIN CALCIUM	O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Ca+2]	RHGYHLPFVJEAOC-FFNUKLMVSA-L	InChI=1S/2C25H24FNO4.Ca/c2*26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31;/h2*1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31);/q;;+2/p-2/b2*12-11+;/t2*18-,19-;/m11./s1	HMG-CoA reductase inhibitor	INHIBITOR	CHEMBL402	HMG-CoA reductase	Homo sapiens
CHEMBL2218894	FLUVASTATIN SODIUM	CC(C)n1c(/C=C/C(O)CC(O)CC(=O)[O-])c(-c2ccc(F)cc2)c2ccccc21.[Na+]	ZGGHKIMDNBDHJB-CALJPSDSSA-M	InChI=1S/C24H26FNO4.Na/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30;/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30);/q;+1/p-1/b12-11+;	HMG-CoA reductase inhibitor	INHIBITOR	CHEMBL402	HMG-CoA reductase	Homo sapiens
CHEMBL1744447	ROSUVASTATIN CALCIUM	CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2]	LALFOYNTGMUKGG-BGRFNVSISA-L	InChI=1S/2C22H28FN3O6S.Ca/c2*1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32;/h2*5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30);/q;;+2/p-2/b2*10-9+;/t2*16-,17-;/m11./s1	HMG-CoA reductase inhibitor	INHIBITOR	CHEMBL402	HMG-CoA reductase	Homo sapiens
CHEMBL690	PRAVASTATIN SODIUM	CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@H]21.[Na+]	VWBQYTRBTXKKOG-IYNICTALSA-M	InChI=1S/C23H36O7.Na/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28;/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28);/q;+1/p-1/t13-,14-,16+,17+,18+,19-,20-,22-;/m0./s1	HMG-CoA reductase inhibitor	INHIBITOR	CHEMBL402	HMG-CoA reductase	Homo sapiens
CHEMBL393220	ATORVASTATIN CALCIUM	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2]	FQCKMBLVYCEXJB-MNSAWQCASA-L	InChI=1S/2C33H35FN2O5.Ca/c2*1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40;/h2*3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40);/q;;+2/p-2/t2*26-,27-;/m11./s1	HMG-CoA reductase inhibitor	INHIBITOR	CHEMBL402	HMG-CoA reductase	Homo sapiens
CHEMBL1064	SIMVASTATIN	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21	RYMZZMVNJRMUDD-HGQWONQESA-N	InChI=1S/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1	HMG-CoA reductase inhibitor	INHIBITOR	CHEMBL402	HMG-CoA reductase	Homo sapiens
CHEMBL1096	AMLEXANOX	CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1	SGRYPYWGNKJSDL-UHFFFAOYSA-N	InChI=1S/C16H14N2O4/c1-7(2)8-3-4-12-9(5-8)13(19)10-6-11(16(20)21)14(17)18-15(10)22-12/h3-7H,1-2H3,(H2,17,18)(H,20,21)	Phosphodiesterase 4 inhibitor	INHIBITOR	CHEMBL2093863	Phosphodiesterase 4	Homo sapiens
CHEMBL1752	DYPHYLLINE	Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O	KSCFJBIXMNOVSH-UHFFFAOYSA-N	InChI=1S/C10H14N4O4/c1-12-8-7(9(17)13(2)10(12)18)14(5-11-8)3-6(16)4-15/h5-6,15-16H,3-4H2,1-2H3	Phosphodiesterase 4 inhibitor	INHIBITOR	CHEMBL2093863	Phosphodiesterase 4	Homo sapiens
CHEMBL193240	ROFLUMILAST	O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1	MNDBXUUTURYVHR-UHFFFAOYSA-N	InChI=1S/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24)	Phosphodiesterase 4 inhibitor	INHIBITOR	CHEMBL2093863	Phosphodiesterase 4	Homo sapiens
CHEMBL190	THEOPHYLLINE	Cn1c(=O)c2nc[nH]c2n(C)c1=O	ZFXYFBGIUFBOJW-UHFFFAOYSA-N	InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)	Phosphodiesterase 4 inhibitor	INHIBITOR	CHEMBL2093863	Phosphodiesterase 4	Homo sapiens
CHEMBL1200578	THEOPHYLLINE SODIUM GLYCINATE	Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCC(=O)[O-].[Na+]	AIJQWRAOMFRHTQ-UHFFFAOYSA-M	InChI=1S/C7H8N4O2.C2H5NO2.Na/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;3-1-2(4)5;/h3H,1-2H3,(H,8,9);1,3H2,(H,4,5);/q;;+1/p-1	Phosphodiesterase 4 inhibitor	INHIBITOR	CHEMBL2093863	Phosphodiesterase 4	Homo sapiens
CHEMBL1200875	FLAVOXATE HYDROCHLORIDE	Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O.Cl	XOEVKNFZUQEERE-UHFFFAOYSA-N	InChI=1S/C24H25NO4.ClH/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25;/h2,4-5,8-12H,3,6-7,13-16H2,1H3;1H	Phosphodiesterase 4 inhibitor	INHIBITOR	CHEMBL2093863	Phosphodiesterase 4	Homo sapiens
CHEMBL1370561	AMINOPHYLLINE	Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN	FQPFAHBPWDRTLU-UHFFFAOYSA-N	InChI=1S/2C7H8N4O2.C2H8N2/c2*1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;3-1-2-4/h2*3H,1-2H3,(H,8,9);1-4H2	Phosphodiesterase 4 inhibitor	INHIBITOR	CHEMBL2093863	Phosphodiesterase 4	Homo sapiens
CHEMBL343448	ROMIDEPSIN	C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O	OHRURASPPZQGQM-GCCNXGTGSA-N	InChI=1S/C24H36N4O6S2/c1-6-16-21(30)28-20(14(4)5)24(33)34-15-9-7-8-10-35-36-12-17(22(31)25-16)26-23(32)19(13(2)3)27-18(29)11-15/h6-7,9,13-15,17,19-20H,8,10-12H2,1-5H3,(H,25,31)(H,26,32)(H,27,29)(H,28,30)/b9-7+,16-6-/t15-,17-,19-,20+/m1/s1	Histone deacetylase inhibitor	INHIBITOR	CHEMBL2093865	Histone deacetylase	Homo sapiens
CHEMBL2105395	OSPEMIFENE	OCCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1	LUMKNAVTFCDUIE-VHXPQNKSSA-N	InChI=1S/C24H23ClO2/c25-16-15-23(19-7-3-1-4-8-19)24(20-9-5-2-6-10-20)21-11-13-22(14-12-21)27-18-17-26/h1-14,26H,15-18H2/b24-23-	Estrogen receptor modulator	MODULATOR	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL1200598	DIETHYLSTILBESTROL DIPHOSPHATE	CC/C(=C(/CC)c1ccc(OP(=O)(O)O)cc1)c1ccc(OP(=O)(O)O)cc1	NLORYLAYLIXTID-ISLYRVAYSA-N	InChI=1S/C18H22O8P2/c1-3-17(13-5-9-15(10-6-13)25-27(19,20)21)18(4-2)14-7-11-16(12-8-14)26-28(22,23)24/h5-12H,3-4H2,1-2H3,(H2,19,20,21)(H2,22,23,24)/b18-17+	Estrogen receptor agonist	AGONIST	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL1201165	QUINESTROL	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC5CCCC5)ccc4[C@H]3CC[C@@]21C	PWZUUYSISTUNDW-VAFBSOEGSA-N	InChI=1S/C25H32O2/c1-3-25(26)15-13-23-22-10-8-17-16-19(27-18-6-4-5-7-18)9-11-20(17)21(22)12-14-24(23,25)2/h1,9,11,16,18,21-23,26H,4-8,10,12-15H2,2H3/t21-,22-,23+,24+,25+/m1/s1	Estrogen receptor agonist	AGONIST	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL1358	FULVESTRANT	C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O	VWUXBMIQPBEWFH-WCCTWKNTSA-N	InChI=1S/C32H47F5O3S/c1-30-17-15-26-25-12-11-24(38)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-41(40)19-9-16-31(33,34)32(35,36)37/h11-12,21-22,26-29,38-39H,2-10,13-20H2,1H3/t22-,26-,27+,28+,29-,30+,41?/m1/s1	Estrogen receptor antagonist	ANTAGONIST	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL1200675	TOREMIFENE CITRATE	CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O	IWEQQRMGNVVKQW-OQKDUQJOSA-N	InChI=1S/C26H28ClNO.C6H8O7/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-16H,17-20H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b26-25-;	Estrogen receptor modulator	MODULATOR	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL1174	EPTIFIBATIDE	N=C(N)NCCCC[C@@H]1NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O	CZKPOZZJODAYPZ-LROMGURASA-N	InChI=1S/C35H49N11O9S2/c36-30(51)25-18-57-56-13-10-27(47)42-22(8-3-4-11-39-35(37)38)31(52)41-17-28(48)43-23(15-29(49)50)32(53)44-24(14-19-16-40-21-7-2-1-6-20(19)21)34(55)46-12-5-9-26(46)33(54)45-25/h1-2,6-7,16,22-26,40H,3-5,8-15,17-18H2,(H2,36,51)(H,41,52)(H,42,47)(H,43,48)(H,44,53)(H,45,54)(H,49,50)(H4,37,38,39)/t22-,23-,24-,25-,26-/m0/s1	Integrin alpha-IIb/beta-3 inhibitor	INHIBITOR	CHEMBL2093869	Integrin alpha-IIb/beta-3	Homo sapiens
CHEMBL3189072	TIROFIBAN HYDROCHLORIDE	CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O.Cl.O	HWAAPJPFZPHHBC-FGJQBABTSA-N	InChI=1S/C22H36N2O5S.ClH.H2O/c1-2-3-16-30(27,28)24-21(22(25)26)17-19-7-9-20(10-8-19)29-15-5-4-6-18-11-13-23-14-12-18;;/h7-10,18,21,23-24H,2-6,11-17H2,1H3,(H,25,26);1H;1H2/t21-;;/m0../s1	Integrin alpha-IIb/beta-3 inhibitor	INHIBITOR	CHEMBL2093869	Integrin alpha-IIb/beta-3	Homo sapiens
CHEMBL1503	OMEPRAZOLE	COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1	SUBDBMMJDZJVOS-UHFFFAOYSA-N	InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)	Potassium-transporting ATPase inhibitor	INHIBITOR	CHEMBL2095173	Potassium-transporting ATPase	Homo sapiens
CHEMBL1201863	DEXLANSOPRAZOLE	Cc1c(OCC(F)(F)F)ccnc1C[S@@+]([O-])c1nc2ccccc2[nH]1	MJIHNNLFOKEZEW-RUZDIDTESA-N	InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)/t25-/m1/s1	Potassium-transporting ATPase inhibitor	INHIBITOR	CHEMBL2095173	Potassium-transporting ATPase	Homo sapiens
CHEMBL1567328	OMEPRAZOLE MAGNESIUM	COc1ccc2[n-]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.COc1ccc2[n-]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.[Mg+2]	KWORUUGOSLYAGD-UHFFFAOYSA-N	InChI=1S/2C17H18N3O3S.Mg/c2*1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17;/h2*5-8H,9H2,1-4H3;/q2*-1;+2	Potassium-transporting ATPase inhibitor	INHIBITOR	CHEMBL2095173	Potassium-transporting ATPase	Homo sapiens
CHEMBL1200930	RABEPRAZOLE SODIUM	COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[n-]2)c1C.[Na+]	KRCQSTCYZUOBHN-UHFFFAOYSA-N	InChI=1S/C18H20N3O3S.Na/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18;/h3-4,6-9H,5,10-12H2,1-2H3;/q-1;+1	Potassium-transporting ATPase inhibitor	INHIBITOR	CHEMBL2095173	Potassium-transporting ATPase	Homo sapiens
CHEMBL3989559	PANTOPRAZOLE SODIUM	COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[n-]2)c1OC.O.[Na+]	CGJRLPRCWSHOFU-UHFFFAOYSA-N	InChI=1S/C16H14F2N3O4S.Na.H2O/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16;;/h3-7,15H,8H2,1-2H3;;1H2/q-1;+1;	Potassium-transporting ATPase inhibitor	INHIBITOR	CHEMBL2095173	Potassium-transporting ATPase	Homo sapiens
CHEMBL480	LANSOPRAZOLE	Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1	MJIHNNLFOKEZEW-UHFFFAOYSA-N	InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)	Potassium-transporting ATPase inhibitor	INHIBITOR	CHEMBL2095173	Potassium-transporting ATPase	Homo sapiens
CHEMBL1200470	ESOMEPRAZOLE SODIUM	COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.[Na+]	RYXPMWYHEBGTRV-JIDHJSLPSA-N	InChI=1S/C17H18N3O3S.Na/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17;/h5-8H,9H2,1-4H3;/q-1;+1/t24-;/m0./s1	Potassium-transporting ATPase inhibitor	INHIBITOR	CHEMBL2095173	Potassium-transporting ATPase	Homo sapiens
CHEMBL2146133	ESOMEPRAZOLE MAGNESIUM	COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.[Mg+2]	KWORUUGOSLYAGD-YPPDDXJESA-N	InChI=1S/2C17H18N3O3S.Mg/c2*1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17;/h2*5-8H,9H2,1-4H3;/q2*-1;+2/t2*24-;/m00./s1	Potassium-transporting ATPase inhibitor	INHIBITOR	CHEMBL2095173	Potassium-transporting ATPase	Homo sapiens
CHEMBL18	ETHOXZOLAMIDE	CCOc1ccc2nc(S(N)(=O)=O)sc2c1	OUZWUKMCLIBBOG-UHFFFAOYSA-N	InChI=1S/C9H10N2O3S2/c1-2-14-6-3-4-7-8(5-6)15-9(11-7)16(10,12)13/h3-5H,2H2,1H3,(H2,10,12,13)	Carbonic anhydrase inhibitor	INHIBITOR	CHEMBL2095180	Carbonic anhydrase	Homo sapiens
CHEMBL1200794	OXYMORPHONE HYDROCHLORIDE	CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.Cl	BCGJBQBWUGVESK-KCTCKCTRSA-N	InChI=1S/C17H19NO4.ClH/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9;/h2-3,12,15,19,21H,4-8H2,1H3;1H/t12-,15+,16+,17-;/m1./s1	Opioid receptors; mu/kappa/delta agonist	AGONIST	CHEMBL2095181	Opioid receptors; mu/kappa/delta	Homo sapiens
CHEMBL19019	NALTREXONE	O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5	DQCKKXVULJGBQN-XFWGSAIBSA-N	InChI=1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	CHEMBL2095181	Opioid receptors; mu/kappa/delta	Homo sapiens
CHEMBL1201099	CODEINE PHOSPHATE	COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314.O.O=P(O)(O)O	JPGKFBXFEQWCAI-CCLYOLAMSA-N	InChI=1S/C18H21NO3.H3O4P.H2O/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19;1-5(2,3)4;/h3-6,11-13,17,20H,7-9H2,1-2H3;(H3,1,2,3,4);1H2/t11-,12+,13-,17-,18-;;/m0../s1	Opioid receptors; mu/kappa/delta agonist	AGONIST	CHEMBL2095181	Opioid receptors; mu/kappa/delta	Homo sapiens
CHEMBL4297091	CODEINE SULFATE	COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314.COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314.O.O.O.O=S(=O)(O)O	BOLDZXRCJAJADM-AAXBYHQXSA-N	InChI=1S/2C18H21NO3.H2O4S.3H2O/c2*1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19;1-5(2,3)4;;;/h2*3-6,11-13,17,20H,7-9H2,1-2H3;(H2,1,2,3,4);3*1H2/t2*11-,12+,13-,17-,18-;;;;/m00..../s1	Opioid receptors; mu/kappa/delta agonist	AGONIST	CHEMBL2095181	Opioid receptors; mu/kappa/delta	Homo sapiens
CHEMBL1201149	NALTREXONE HYDROCHLORIDE	Cl.O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5	RHBRMCOKKKZVRY-ITLPAZOVSA-N	InChI=1S/C20H23NO4.ClH/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11;/h3-4,11,15,18,22,24H,1-2,5-10H2;1H/t15-,18+,19+,20-;/m1./s1	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	CHEMBL2095181	Opioid receptors; mu/kappa/delta	Homo sapiens
CHEMBL1201132	NALBUPHINE HYDROCHLORIDE	Cl.Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314	YZLZPSJXMWGIFH-BCXQGASESA-N	InChI=1S/C21H27NO4.ClH/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12;/h4-5,12,15-16,19,23-25H,1-3,6-11H2;1H/t15-,16+,19-,20-,21+;/m0./s1	Opioid receptors; mu/kappa/delta agonist	AGONIST	CHEMBL2095181	Opioid receptors; mu/kappa/delta	Homo sapiens
CHEMBL1201152	NALMEFENE HYDROCHLORIDE	C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5.Cl	GYWMRGWFQPSQLK-OPHZJPRHSA-N	InChI=1S/C21H25NO3.ClH/c1-12-6-7-21(24)16-10-14-4-5-15(23)18-17(14)20(21,19(12)25-18)8-9-22(16)11-13-2-3-13;/h4-5,13,16,19,23-24H,1-3,6-11H2;1H/t16-,19+,20+,21-;/m1./s1	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	CHEMBL2095181	Opioid receptors; mu/kappa/delta	Homo sapiens
CHEMBL1718	NALOXONE HYDROCHLORIDE	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.Cl	RGPDIGOSVORSAK-STHHAXOLSA-N	InChI=1S/C19H21NO4.ClH/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11;/h2-4,14,17,21,23H,1,5-10H2;1H/t14-,17+,18+,19-;/m1./s1	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	CHEMBL2095181	Opioid receptors; mu/kappa/delta	Homo sapiens
CHEMBL3989677	HYDROCODONE BITARTRATE	COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314.O.O.O=C(O)C(O)C(O)C(=O)O	IUAXSWPNEQYKDR-GXTZACRKSA-N	InChI=1S/C18H21NO3.C4H6O6.2H2O/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19;5-1(3(7)8)2(6)4(9)10;;/h3,6,11-12,17H,4-5,7-9H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10);2*1H2/t11-,12+,17-,18-;;;/m0.../s1	Opioid receptors; mu/kappa/delta agonist	AGONIST	CHEMBL2095181	Opioid receptors; mu/kappa/delta	Homo sapiens
CHEMBL428647	PACLITAXEL	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C	RCINICONZNJXQF-MZXODVADSA-N	InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1	Tubulin inhibitor	INHIBITOR	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL3545252	DOCETAXEL	CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C.O.O.O	XCDIRYDKECHIPE-QHEQPUDQSA-N	InChI=1S/C43H53NO14.3H2O/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45;;;/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,52);3*1H2/t26-,27-,28+,30-,31+,32+,33-,35-,41+,42-,43+;;;/m0.../s1	Tubulin inhibitor	INHIBITOR	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL1683544	ERIBULIN MESYLATE	C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@H]3[C@H](C[C@H]4O[C@@H](CC[C@@H]1O2)C[C@@H](C)C4=C)O[C@H](C[C@H](O)CN)[C@@H]3OC.CS(=O)(=O)O	QAMYWGZHLCQOOJ-WRNBYXCMSA-N	InChI=1S/C40H59NO11.CH4O3S/c1-19-11-24-5-7-28-20(2)12-26(45-28)9-10-40-17-33-36(51-40)37-38(50-33)39(52-40)35-29(49-37)8-6-25(47-35)13-22(42)14-27-31(16-30(46-24)21(19)3)48-32(34(27)44-4)15-23(43)18-41;1-5(2,3)4/h19,23-39,43H,2-3,5-18,41H2,1,4H3;1H3,(H,2,3,4)/t19-,23+,24+,25-,26+,27+,28+,29+,30-,31+,32-,33-,34-,35+,36+,37+,38-,39+,40+;/m1./s1	Tubulin inhibitor	INHIBITOR	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL1201748	CABAZITAXEL	CO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C(C)=C([C@@H](OC)C(=O)[C@]12C)C3(C)C	BMQGVNUXMIRLCK-OAGWZNDDSA-N	InChI=1S/C45H57NO14/c1-24-28(57-39(51)33(48)32(26-17-13-11-14-18-26)46-40(52)60-41(3,4)5)22-45(53)37(58-38(50)27-19-15-12-16-20-27)35-43(8,36(49)34(55-10)31(24)42(45,6)7)29(54-9)21-30-44(35,23-56-30)59-25(2)47/h11-20,28-30,32-35,37,48,53H,21-23H2,1-10H3,(H,46,52)/t28-,29-,30+,32-,33+,34+,35-,37-,43+,44-,45+/m0/s1	Tubulin inhibitor	INHIBITOR	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL107	COLCHICINE	COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2	IAKHMKGGTNLKSZ-INIZCTEOSA-N	InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1	Tubulin inhibitor	INHIBITOR	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL1201752	IXABEPILONE	C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1	FABUFPQFXZVHFB-PVYNADRNSA-N	InChI=1S/C27H42N2O5S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)29-23(31)13-21(30)26(5,6)25(33)17(3)24(15)32/h11,14-15,17,20-22,24,30,32H,8-10,12-13H2,1-7H3,(H,29,31)/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1	Tubulin inhibitor	INHIBITOR	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL501867	VINCRISTINE SULFATE	CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O	AQTQHPDCURKLKT-JKDPCDLQSA-N	InChI=1S/C46H56N4O10.H2O4S/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6;1-5(2,3)4/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3;(H2,1,2,3,4)/t28-,37+,38-,39-,42+,43-,44-,45+,46+;/m1./s1	Tubulin inhibitor	INHIBITOR	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL538943	VINORELBINE TARTRATE	CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O	CILBMBUYJCWATM-UDRBCWGGSA-N	InChI=1S/C45H54N4O8.2C4H6O6/c1-8-27-19-28-22-44(40(51)55-6,36-30(25-48(23-27)24-28)29-13-10-11-14-33(29)46-36)32-20-31-34(21-35(32)54-5)47(4)38-43(31)16-18-49-17-12-15-42(9-2,37(43)49)39(57-26(3)50)45(38,53)41(52)56-7;2*5-1(3(7)8)2(6)4(9)10/h10-15,19-21,28,37-39,46,53H,8-9,16-18,22-25H2,1-7H3;2*1-2,5-6H,(H,7,8)(H,9,10)/t28-,37-,38+,39+,42+,43+,44-,45-;;/m0../s1	Tubulin inhibitor	INHIBITOR	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL378544	VINBLASTINE SULFATE	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O	KDQAABAKXDWYSZ-PNYVAJAMSA-N	InChI=1S/C46H58N4O9.H2O4S/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7;1-5(2,3)4/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3;(H2,1,2,3,4)/t28-,37-,38+,39+,42-,43+,44+,45-,46-;/m0./s1	Tubulin inhibitor	INHIBITOR	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL1201733	PAZOPANIB HYDROCHLORIDE	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O.Cl	MQHIQUBXFFAOMK-UHFFFAOYSA-N	InChI=1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL1946170	REGORAFENIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1	FNHKPVJBJVTLMP-UHFFFAOYSA-N	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL1567	SUNITINIB MALATE	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O	LBWFXVZLPYTWQI-IPOVEDGCSA-N	InChI=1S/C22H27FN4O2.C4H6O5/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28;5-2(4(8)9)1-3(6)7/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28);2,5H,1H2,(H,6,7)(H,8,9)/b17-12-;/t;2-/m.0/s1	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL2105708	PONATINIB HYDROCHLORIDE	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12.Cl	BWTNNZPNKQIADY-UHFFFAOYSA-N	InChI=1S/C29H27F3N6O.ClH/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37;/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39);1H	Bcr/Abl fusion protein inhibitor	INHIBITOR	CHEMBL2096618	Bcr/Abl fusion protein	Homo sapiens
CHEMBL723	CARVEDILOL	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12	OGHNVEJMJSYVRP-UHFFFAOYSA-N	InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3	Adrenergic receptor beta antagonist	ANTAGONIST	CHEMBL2094118	Adrenergic receptor beta	Homo sapiens
CHEMBL1201167	CARVEDILOL PHOSPHATE	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.O=P(O)(O)O	XCPXNPBILMXKNX-UHFFFAOYSA-N	InChI=1S/C24H26N2O4.H3O4P/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20;1-5(2,3)4/h2-12,17,25-27H,13-16H2,1H3;(H3,1,2,3,4)	Adrenergic receptor beta antagonist	ANTAGONIST	CHEMBL2094118	Adrenergic receptor beta	Homo sapiens
CHEMBL3989521	ISOPROTERENOL SULFATE	CC(C)NCC(O)c1ccc(O)c(O)c1.CC(C)NCC(O)c1ccc(O)c(O)c1.O.O.O=S(=O)(O)O	CUQPTVCVZLUXJB-UHFFFAOYSA-N	InChI=1S/2C11H17NO3.H2O4S.2H2O/c2*1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8;1-5(2,3)4;;/h2*3-5,7,11-15H,6H2,1-2H3;(H2,1,2,3,4);2*1H2	Adrenergic receptor beta agonist	AGONIST	CHEMBL2094118	Adrenergic receptor beta	Homo sapiens
CHEMBL1201002	CARTEOLOL HYDROCHLORIDE	CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2.Cl	FYBXRCFPOTXTJF-UHFFFAOYSA-N	InChI=1S/C16H24N2O3.ClH/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13;/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20);1H	Adrenergic receptor beta antagonist	ANTAGONIST	CHEMBL2094118	Adrenergic receptor beta	Homo sapiens
CHEMBL1711	ISOPROTERENOL HYDROCHLORIDE	CC(C)NCC(O)c1ccc(O)c(O)c1.Cl	IROWCYIEJAOFOW-UHFFFAOYSA-N	InChI=1S/C11H17NO3.ClH/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8;/h3-5,7,11-15H,6H2,1-2H3;1H	Adrenergic receptor beta agonist	AGONIST	CHEMBL2094118	Adrenergic receptor beta	Homo sapiens
CHEMBL1200395	ORPHENADRINE CITRATE	Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O	MMMNTDFSPSQXJP-UHFFFAOYSA-N	InChI=1S/C18H23NO.C6H8O7/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-12,18H,13-14H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)	Glutamate [NMDA] receptor antagonist	ANTAGONIST	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL2068724	ACAMPROSATE CALCIUM	CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]	BUVGWDNTAWHSKI-UHFFFAOYSA-L	InChI=1S/2C5H11NO4S.Ca/c2*1-5(7)6-3-2-4-11(8,9)10;/h2*2-4H2,1H3,(H,6,7)(H,8,9,10);/q;;+2/p-2	Glutamate [NMDA] receptor antagonist	ANTAGONIST	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL1569	AMANTADINE HYDROCHLORIDE	Cl.NC12CC3CC(CC(C3)C1)C2	WOLHOYHSEKDWQH-UHFFFAOYSA-N	InChI=1S/C10H17N.ClH/c11-10-4-7-1-8(5-10)3-9(2-7)6-10;/h7-9H,1-6,11H2;1H	Glutamate [NMDA] receptor antagonist	ANTAGONIST	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL1699	MEMANTINE HYDROCHLORIDE	CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl	LDDHMLJTFXJGPI-UHFFFAOYSA-N	InChI=1S/C12H21N.ClH/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10;/h9H,3-8,13H2,1-2H3;1H	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL1201023	ORPHENADRINE HYDROCHLORIDE	Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl	UQZKYYIKWZOKKD-UHFFFAOYSA-N	InChI=1S/C18H23NO.ClH/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;/h4-12,18H,13-14H2,1-3H3;1H	Glutamate [NMDA] receptor antagonist	ANTAGONIST	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL1094	FELBAMATE	NC(=O)OCC(COC(N)=O)c1ccccc1	WKGXYQFOCVYPAC-UHFFFAOYSA-N	InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)	Glutamate [NMDA] receptor antagonist	ANTAGONIST	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL1714	KETAMINE HYDROCHLORIDE	CNC1(c2ccccc2Cl)CCCCC1=O.Cl	VCMGMSHEPQENPE-UHFFFAOYSA-N	InChI=1S/C13H16ClNO.ClH/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14;/h2-3,6-7,15H,4-5,8-9H2,1H3;1H	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL1200578	THEOPHYLLINE SODIUM GLYCINATE	Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCC(=O)[O-].[Na+]	AIJQWRAOMFRHTQ-UHFFFAOYSA-M	InChI=1S/C7H8N4O2.C2H5NO2.Na/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;3-1-2(4)5;/h3H,1-2H3,(H,8,9);1,3H2,(H,4,5);/q;;+1/p-1	Phosphodiesterase 3 inhibitor	INHIBITOR	CHEMBL2094125	Phosphodiesterase 3	Homo sapiens
CHEMBL1200759	ANAGRELIDE HYDROCHLORIDE	Cl.O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1	TVWRQCIPWUCNMI-UHFFFAOYSA-N	InChI=1S/C10H7Cl2N3O.ClH/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7;/h1-2H,3-4H2,(H,13,14,16);1H	Phosphodiesterase 3 inhibitor	INHIBITOR	CHEMBL2094125	Phosphodiesterase 3	Homo sapiens
CHEMBL1370561	AMINOPHYLLINE	Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN	FQPFAHBPWDRTLU-UHFFFAOYSA-N	InChI=1S/2C7H8N4O2.C2H8N2/c2*1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;3-1-2-4/h2*3H,1-2H3,(H,8,9);1-4H2	Phosphodiesterase 3 inhibitor	INHIBITOR	CHEMBL2094125	Phosphodiesterase 3	Homo sapiens
CHEMBL190	THEOPHYLLINE	Cn1c(=O)c2nc[nH]c2n(C)c1=O	ZFXYFBGIUFBOJW-UHFFFAOYSA-N	InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)	Phosphodiesterase 3 inhibitor	INHIBITOR	CHEMBL2094125	Phosphodiesterase 3	Homo sapiens
CHEMBL1218	RAMELTEON	CCC(=O)NCC[C@@H]1CCc2ccc3c(c21)CCO3	YLXDSYKOBKBWJQ-LBPRGKRZSA-N	InChI=1S/C16H21NO2/c1-2-15(18)17-9-7-12-4-3-11-5-6-14-13(16(11)12)8-10-19-14/h5-6,12H,2-4,7-10H2,1H3,(H,17,18)/t12-/m0/s1	Melatonin receptor agonist	AGONIST	CHEMBL2094268	Melatonin receptor	Homo sapiens
CHEMBL2062257	BRIMONIDINE TARTRATE	Brc1c(NC2=NCCN2)ccc2nccnc12.O=C(O)C(O)C(O)C(=O)O	QZHBYNSSDLTCRG-UHFFFAOYSA-N	InChI=1S/C11H10BrN5.C4H6O6/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8;5-1(3(7)8)2(6)4(9)10/h1-4H,5-6H2,(H2,15,16,17);1-2,5-6H,(H,7,8)(H,9,10)	Adrenergic receptor alpha-2 agonist	AGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL2106195	DEXMEDETOMIDINE HYDROCHLORIDE	Cc1cccc([C@H](C)c2c[nH]cn2)c1C.Cl	VPNGEIHDPSLNMU-MERQFXBCSA-N	InChI=1S/C13H16N2.ClH/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13;/h4-8,11H,1-3H3,(H,14,15);1H/t11-;/m0./s1	Adrenergic receptor alpha-2 agonist	AGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL1200329	TIZANIDINE HYDROCHLORIDE	Cl.Clc1ccc2nsnc2c1NC1=NCCN1	ZWUKMNZJRDGCTQ-UHFFFAOYSA-N	InChI=1S/C9H8ClN5S.ClH/c10-5-1-2-6-8(15-16-14-6)7(5)13-9-11-3-4-12-9;/h1-2H,3-4H2,(H2,11,12,13);1H	Adrenergic receptor alpha-2 agonist	AGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL654	MIRTAZAPINE	CN1CCN2c3ncccc3Cc3ccccc3C2C1	RONZAEMNMFQXRA-UHFFFAOYSA-N	InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3	Adrenergic receptor alpha-2 antagonist	ANTAGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL1705	CLONIDINE HYDROCHLORIDE	Cl.Clc1cccc(Cl)c1NC1=NCCN1	ZNIFSRGNXRYGHF-UHFFFAOYSA-N	InChI=1S/C9H9Cl2N3.ClH/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9;/h1-3H,4-5H2,(H2,12,13,14);1H	Adrenergic receptor alpha-2 agonist	AGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL1200432	METHYLDOPATE HYDROCHLORIDE	CCOC(=O)[C@@](C)(N)Cc1ccc(O)c(O)c1.Cl	QSRVZCCJDKYRRF-YDALLXLXSA-N	InChI=1S/C12H17NO4.ClH/c1-3-17-11(16)12(2,13)7-8-4-5-9(14)10(15)6-8;/h4-6,14-15H,3,7,13H2,1-2H3;1H/t12-;/m0./s1	Adrenergic receptor alpha-2 agonist	AGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL1200494	GUANFACINE HYDROCHLORIDE	Cl.N=C(N)NC(=O)Cc1c(Cl)cccc1Cl	DGFYECXYGUIODH-UHFFFAOYSA-N	InChI=1S/C9H9Cl2N3O.ClH/c10-6-2-1-3-7(11)5(6)4-8(15)14-9(12)13;/h1-3H,4H2,(H4,12,13,14,15);1H	Adrenergic receptor alpha-2 agonist	AGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL134	CLONIDINE	Clc1cccc(Cl)c1N=C1NCCN1	GJSURZIOUXUGAL-UHFFFAOYSA-N	InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)	Adrenergic receptor alpha-2 agonist	AGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL1200379	APRACLONIDINE HYDROCHLORIDE	Cl.Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1	OTQYGBJVDRBCHC-UHFFFAOYSA-N	InChI=1S/C9H10Cl2N4.ClH/c10-6-3-5(12)4-7(11)8(6)15-9-13-1-2-14-9;/h3-4H,1-2,12H2,(H2,13,14,15);1H	Adrenergic receptor alpha-2 agonist	AGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL459	METHYLDOPA	C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O	CJCSPKMFHVPWAR-JTQLQIEISA-N	InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1	Adrenergic receptor alpha-2 agonist	AGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL1200560	GUANABENZ ACETATE	CC(=O)O.N=C(N)N/N=C/c1c(Cl)cccc1Cl	MCSPBPXATWBACD-GAYQJXMFSA-N	InChI=1S/C8H8Cl2N4.C2H4O2/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12;1-2(3)4/h1-4H,(H4,11,12,14);1H3,(H,3,4)/b13-4+;	Adrenergic receptor alpha-2 agonist	AGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL677	LEVONORDEFRIN	C[C@H](N)[C@H](O)c1ccc(O)c(O)c1	GEFQWZLICWMTKF-CDUCUWFYSA-N	InChI=1S/C9H13NO3/c1-5(10)9(13)6-2-3-7(11)8(12)4-6/h2-5,9,11-13H,10H2,1H3/t5-,9-/m0/s1	Adrenergic receptor alpha-2 agonist	AGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL1275	PERGOLIDE MESYLATE	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.CS(=O)(=O)O	UWCVGPLTGZWHGS-ZORIOUSZSA-N	InChI=1S/C19H26N2S.CH4O3S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21;1-5(2,3)4/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3;1H3,(H,2,3,4)/t13-,16-,18-;/m1./s1	Dopamine receptor agonist	AGONIST	CHEMBL2096905	Dopamine receptor	Homo sapiens
CHEMBL1113	AMOXAPINE	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2	QWGDMFLQWFTERH-UHFFFAOYSA-N	InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2	Dopamine receptor antagonist	ANTAGONIST	CHEMBL2096905	Dopamine receptor	Homo sapiens
CHEMBL1423	PIMOZIDE	O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	YVUQSNJEYSNKRX-UHFFFAOYSA-N	InChI=1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34)	Dopamine receptor antagonist	ANTAGONIST	CHEMBL2096905	Dopamine receptor	Homo sapiens
CHEMBL220492	TOPIRAMATE	CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1	KJADKKWYZYXHBB-XBWDGYHZSA-N	InChI=1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1	Glutamate receptor ionotropic kainate antagonist	ANTAGONIST	CHEMBL2109241	Glutamate receptor ionotropic kainate	Homo sapiens
CHEMBL3833353	PRAMLINTIDE ACETATE	CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O	DTPWZYSUQQHRKD-VIUAGAKSSA-N	InChI=1S/C171H267N51O53S2.C2H4O2/c1-21-81(12)130(163(268)207-110(56-78(6)7)169(274)222-53-33-42-118(222)170(275)221-52-32-41-117(221)160(265)219-135(89(20)230)167(272)206-109(66-125(180)238)151(256)212-128(79(8)9)161(266)186-68-126(239)192-111(70-223)154(259)203-107(64-123(178)236)152(257)218-134(88(19)229)166(271)195-98(136(181)241)57-92-43-45-94(231)46-44-92)214-159(264)116-40-31-51-220(116)127(240)69-187-141(246)101(58-90-34-24-22-25-35-90)199-148(253)105(62-121(176)234)201-149(254)106(63-122(177)235)202-155(260)112(71-224)209-156(261)113(72-225)208-146(251)103(60-93-67-184-75-188-93)205-162(267)129(80(10)11)213-150(255)100(55-77(4)5)198-145(250)102(59-91-36-26-23-27-37-91)200-147(252)104(61-120(175)233)196-137(242)82(13)189-144(249)99(54-76(2)3)197-142(247)96(39-30-50-185-171(182)183)193-143(248)97(47-48-119(174)232)194-165(270)132(86(17)227)215-138(243)83(14)190-157(262)114-73-276-277-74-115(210-140(245)95(173)38-28-29-49-172)158(263)204-108(65-124(179)237)153(258)217-131(85(16)226)164(269)191-84(15)139(244)216-133(87(18)228)168(273)211-114;1-2(3)4/h22-27,34-37,43-46,67,75-89,95-118,128-135,223-231H,21,28-33,38-42,47-66,68-74,172-173H2,1-20H3,(H2,174,232)(H2,175,233)(H2,176,234)(H2,177,235)(H2,178,236)(H2,179,237)(H2,180,238)(H2,181,241)(H,184,188)(H,186,266)(H,187,246)(H,189,249)(H,190,262)(H,191,269)(H,192,239)(H,193,248)(H,194,270)(H,195,271)(H,196,242)(H,197,247)(H,198,250)(H,199,253)(H,200,252)(H,201,254)(H,202,260)(H,203,259)(H,204,263)(H,205,267)(H,206,272)(H,207,268)(H,208,251)(H,209,261)(H,210,245)(H,211,273)(H,212,256)(H,213,255)(H,214,264)(H,215,243)(H,216,244)(H,217,258)(H,218,257)(H,219,265)(H4,182,183,185);1H3,(H,3,4)/t81-,82-,83-,84-,85+,86+,87+,88+,89+,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,128-,129-,130-,131-,132-,133-,134-,135-;/m0./s1	Amylin receptor AMY1, CALCR/RAMP1 agonist	AGONIST	CHEMBL2111189	Amylin receptor AMY1, CALCR/RAMP1	Homo sapiens
CHEMBL3833353	PRAMLINTIDE ACETATE	CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O	DTPWZYSUQQHRKD-VIUAGAKSSA-N	InChI=1S/C171H267N51O53S2.C2H4O2/c1-21-81(12)130(163(268)207-110(56-78(6)7)169(274)222-53-33-42-118(222)170(275)221-52-32-41-117(221)160(265)219-135(89(20)230)167(272)206-109(66-125(180)238)151(256)212-128(79(8)9)161(266)186-68-126(239)192-111(70-223)154(259)203-107(64-123(178)236)152(257)218-134(88(19)229)166(271)195-98(136(181)241)57-92-43-45-94(231)46-44-92)214-159(264)116-40-31-51-220(116)127(240)69-187-141(246)101(58-90-34-24-22-25-35-90)199-148(253)105(62-121(176)234)201-149(254)106(63-122(177)235)202-155(260)112(71-224)209-156(261)113(72-225)208-146(251)103(60-93-67-184-75-188-93)205-162(267)129(80(10)11)213-150(255)100(55-77(4)5)198-145(250)102(59-91-36-26-23-27-37-91)200-147(252)104(61-120(175)233)196-137(242)82(13)189-144(249)99(54-76(2)3)197-142(247)96(39-30-50-185-171(182)183)193-143(248)97(47-48-119(174)232)194-165(270)132(86(17)227)215-138(243)83(14)190-157(262)114-73-276-277-74-115(210-140(245)95(173)38-28-29-49-172)158(263)204-108(65-124(179)237)153(258)217-131(85(16)226)164(269)191-84(15)139(244)216-133(87(18)228)168(273)211-114;1-2(3)4/h22-27,34-37,43-46,67,75-89,95-118,128-135,223-231H,21,28-33,38-42,47-66,68-74,172-173H2,1-20H3,(H2,174,232)(H2,175,233)(H2,176,234)(H2,177,235)(H2,178,236)(H2,179,237)(H2,180,238)(H2,181,241)(H,184,188)(H,186,266)(H,187,246)(H,189,249)(H,190,262)(H,191,269)(H,192,239)(H,193,248)(H,194,270)(H,195,271)(H,196,242)(H,197,247)(H,198,250)(H,199,253)(H,200,252)(H,201,254)(H,202,260)(H,203,259)(H,204,263)(H,205,267)(H,206,272)(H,207,268)(H,208,251)(H,209,261)(H,210,245)(H,211,273)(H,212,256)(H,213,255)(H,214,264)(H,215,243)(H,216,244)(H,217,258)(H,218,257)(H,219,265)(H4,182,183,185);1H3,(H,3,4)/t81-,82-,83-,84-,85+,86+,87+,88+,89+,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,128-,129-,130-,131-,132-,133-,134-,135-;/m0./s1	Amylin receptor AMY3; CALCR/RAMP3 agonist	AGONIST	CHEMBL2111190	Amylin receptor AMY3; CALCR/RAMP3	Homo sapiens
CHEMBL1200948	TRIMIPRAMINE MALEATE	CC(CN(C)C)CN1c2ccccc2CCc2ccccc21.O=C(O)/C=C\C(=O)O	YDGHCKHAXOUQOS-BTJKTKAUSA-N	InChI=1S/C20H26N2.C4H4O4/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22;5-3(6)1-2-4(7)8/h4-11,16H,12-15H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	CHEMBL2094251	Adrenergic receptor alpha-1	Homo sapiens
CHEMBL2062264	PHENYLEPHRINE BITARTRATE	CNC[C@H](O)c1cccc(O)c1.O=C(O)C(O)C(O)C(=O)O	NHKOTKKHHYKARN-FVGYRXGTSA-N	InChI=1S/C9H13NO2.C4H6O6/c1-10-6-9(12)7-3-2-4-8(11)5-7;5-1(3(7)8)2(6)4(9)10/h2-5,9-12H,6H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t9-;/m0./s1	Adrenergic receptor alpha-1 agonist	AGONIST	CHEMBL2094251	Adrenergic receptor alpha-1	Homo sapiens
CHEMBL723	CARVEDILOL	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12	OGHNVEJMJSYVRP-UHFFFAOYSA-N	InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	CHEMBL2094251	Adrenergic receptor alpha-1	Homo sapiens
CHEMBL1723	ALFUZOSIN HYDROCHLORIDE	COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC.Cl	YTNKWDJILNVLGX-UHFFFAOYSA-N	InChI=1S/C19H27N5O4.ClH/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19;/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23);1H	Adrenergic receptor alpha-1 agonist	AGONIST	CHEMBL2094251	Adrenergic receptor alpha-1	Homo sapiens
CHEMBL1200561	DOXAZOSIN MESYLATE	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC.CS(=O)(=O)O	VJECBOKJABCYMF-UHFFFAOYSA-N	InChI=1S/C23H25N5O5.CH4O3S/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20;1-5(2,3)4/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26);1H3,(H,2,3,4)	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	CHEMBL2094251	Adrenergic receptor alpha-1	Homo sapiens
CHEMBL1201103	METHOXAMINE HYDROCHLORIDE	COc1ccc(OC)c(C(O)C(C)N)c1.Cl	YGRFXPCHZBRUKP-UHFFFAOYSA-N	InChI=1S/C11H17NO3.ClH/c1-7(12)11(13)9-6-8(14-2)4-5-10(9)15-3;/h4-7,11,13H,12H2,1-3H3;1H	Adrenergic receptor alpha-1 agonist	AGONIST	CHEMBL2094251	Adrenergic receptor alpha-1	Homo sapiens
CHEMBL2062262	METARAMINOL BITARTRATE	C[C@H](N)[C@H](O)c1cccc(O)c1.O=C(O)C(O)C(O)C(=O)O	VENXSELNXQXCNT-YDYUUSCQSA-N	InChI=1S/C9H13NO2.C4H6O6/c1-6(10)9(12)7-3-2-4-8(11)5-7;5-1(3(7)8)2(6)4(9)10/h2-6,9,11-12H,10H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t6-,9-;/m0./s1	Adrenergic receptor alpha-1 agonist	AGONIST	CHEMBL2094251	Adrenergic receptor alpha-1	Homo sapiens
CHEMBL1201167	CARVEDILOL PHOSPHATE	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.O=P(O)(O)O	XCPXNPBILMXKNX-UHFFFAOYSA-N	InChI=1S/C24H26N2O4.H3O4P/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20;1-5(2,3)4/h2-12,17,25-27H,13-16H2,1H3;(H3,1,2,3,4)	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	CHEMBL2094251	Adrenergic receptor alpha-1	Homo sapiens
CHEMBL1200461	MIDODRINE HYDROCHLORIDE	COc1ccc(OC)c(C(O)CNC(=O)CN)c1.Cl	MGCQZNBCJBRZDT-UHFFFAOYSA-N	InChI=1S/C12H18N2O4.ClH/c1-17-8-3-4-11(18-2)9(5-8)10(15)7-14-12(16)6-13;/h3-5,10,15H,6-7,13H2,1-2H3,(H,14,16);1H	Adrenergic receptor alpha-1 agonist	AGONIST	CHEMBL2094251	Adrenergic receptor alpha-1	Homo sapiens
CHEMBL1200339	PHENYLEPHRINE HYDROCHLORIDE	CNC[C@H](O)c1cccc(O)c1.Cl	OCYSGIYOVXAGKQ-FVGYRXGTSA-N	InChI=1S/C9H13NO2.ClH/c1-10-6-9(12)7-3-2-4-8(11)5-7;/h2-5,9-12H,6H2,1H3;1H/t9-;/m0./s1	Adrenergic receptor alpha-1 agonist	AGONIST	CHEMBL2094251	Adrenergic receptor alpha-1	Homo sapiens
CHEMBL1558	PRAZOSIN HYDROCHLORIDE	COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC.Cl	WFXFYZULCQKPIP-UHFFFAOYSA-N	InChI=1S/C19H21N5O4.ClH/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22);1H	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	CHEMBL2094251	Adrenergic receptor alpha-1	Homo sapiens
CHEMBL1200914	TAMSULOSIN HYDROCHLORIDE	CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1.Cl	ZZIZZTHXZRDOFM-XFULWGLBSA-N	InChI=1S/C20H28N2O5S.ClH/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24;/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24);1H/t15-;/m1./s1	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	CHEMBL2094251	Adrenergic receptor alpha-1	Homo sapiens
CHEMBL3989562	TERAZOSIN HYDROCHLORIDE	COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC.Cl.O.O	NZMOFYDMGFQZLS-UHFFFAOYSA-N	InChI=1S/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	CHEMBL2094251	Adrenergic receptor alpha-1	Homo sapiens
CHEMBL3989408	IBUPROFEN SODIUM	CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.O.O.[Na+]	VTGPMVCGAVZLQI-UHFFFAOYSA-M	InChI=1S/C13H18O2.Na.2H2O/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15;;;/h4-7,9-10H,8H2,1-3H3,(H,14,15);;2*1H2/q;+1;;/p-1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL112	ACETAMINOPHEN	CC(=O)Nc1ccc(O)cc1	RZVAJINKPMORJF-UHFFFAOYSA-N	InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL154	NAPROXEN	COc1ccc2cc([C@H](C)C(=O)O)ccc2c1	CMWTZPSULFXXJA-VIFPVBQESA-N	InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1200806	NAPROXEN SODIUM	COc1ccc2cc([C@H](C)C(=O)[O-])ccc2c1.[Na+]	CDBRNDSHEYLDJV-FVGYRXGTSA-M	InChI=1S/C14H14O3.Na/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10;/h3-9H,1-2H3,(H,15,16);/q;+1/p-1/t9-;/m0./s1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1201180	DICLOFENAC EPOLAMINE	O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl.OCCN1CCCC1	DCERVXIINVUMKU-UHFFFAOYSA-N	InChI=1S/C14H11Cl2NO2.C6H13NO/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;8-6-5-7-3-1-2-4-7/h1-7,17H,8H2,(H,18,19);8H,1-6H2	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1034	DICLOFENAC SODIUM	O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[Na+]	KPHWPUGNDIVLNH-UHFFFAOYSA-M	InChI=1S/C14H11Cl2NO2.Na/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;/h1-7,17H,8H2,(H,18,19);/q;+1/p-1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL2103736	FENOPROFEN CALCIUM	CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.O.O.[Ca+2]	LZPBLUATTGKZBH-UHFFFAOYSA-L	InChI=1S/2C15H14O3.Ca.2H2O/c2*1-11(15(16)17)12-6-5-9-14(10-12)18-13-7-3-2-4-8-13;;;/h2*2-11H,1H3,(H,16,17);;2*1H2/q;;+2;;/p-2	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL898	DIFLUNISAL	O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O	HUPFGZXOMWLGNK-UHFFFAOYSA-N	InChI=1S/C13H8F2O3/c14-8-2-3-9(11(15)6-8)7-1-4-12(16)10(5-7)13(17)18/h1-6,16H,(H,17,18)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL421	SULFASALAZINE	O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O	NCEXYHBECQHGNR-QZQOTICOSA-N	InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL521	IBUPROFEN	CC(C)Cc1ccc(C(C)C(=O)O)cc1	HEFNNWSXXWATRW-UHFFFAOYSA-N	InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1562610	MECLOFENAMATE SODIUM	Cc1ccc(Cl)c(Nc2ccccc2C(=O)[O-])c1Cl.O.[Na+]	QHJLLDJTVQAFAN-UHFFFAOYSA-M	InChI=1S/C14H11Cl2NO2.Na.H2O/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19;;/h2-7,17H,1H3,(H,18,19);;1H2/q;+1;/p-1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1021	NEPAFENAC	NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N	QEFAQIPZVLVERP-UHFFFAOYSA-N	InChI=1S/C15H14N2O2/c16-13(18)9-11-7-4-8-12(14(11)17)15(19)10-5-2-1-3-6-10/h1-8H,9,17H2,(H2,16,18)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL3989676	OXYPHENBUTAZONE	CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O.O	CNDQSXOVEQXJOE-UHFFFAOYSA-N	InChI=1S/C19H20N2O3.H2O/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15;/h4-8,10-13,17,22H,2-3,9H2,1H3;1H2	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL3989754	FLURBIPROFEN SODIUM	CC(C(=O)[O-])c1ccc(-c2ccccc2)c(F)c1.O.O.[Na+]	GNMBMOULKUXEQF-UHFFFAOYSA-M	InChI=1S/C15H13FO2.Na.2H2O/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11;;;/h2-10H,1H3,(H,17,18);;2*1H2/q;+1;;/p-1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL25	ASPIRIN	CC(=O)Oc1ccccc1C(=O)O	BSYNRYMUTXBXSQ-UHFFFAOYSA-N	InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1200613	TOLMETIN SODIUM	Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1.[Na+]	QGUALMNFRILWRA-UHFFFAOYSA-M	InChI=1S/C15H15NO3.Na/c1-10-3-5-11(6-4-10)15(19)13-8-7-12(16(13)2)9-14(17)18;/h3-8H,9H2,1-2H3,(H,17,18);/q;+1/p-1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1200804	DICLOFENAC POTASSIUM	O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[K+]	KXZOIWWTXOCYKR-UHFFFAOYSA-M	InChI=1S/C14H11Cl2NO2.K/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;/h1-7,17H,8H2,(H,18,19);/q;+1/p-1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1200760	BALSALAZIDE DISODIUM	O=C([O-])CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)[O-])c2)cc1.[Na+].[Na+]	CKMOQBVBEGCJGW-LLIZZRELSA-L	InChI=1S/C17H15N3O6.2Na/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23;;/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26);;/q;2*+1/p-2/b20-19+;;	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL6	INDOMETHACIN	COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1	CGIGDMFJXJATDK-UHFFFAOYSA-N	InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL751	BROMFENAC SODIUM	Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.[Na+]	HZFGMQJYAFHESD-UHFFFAOYSA-M	InChI=1S/C15H12BrNO3.Na/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19;/h1-7H,8,17H2,(H,18,19);/q;+1/p-1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL563	FLURBIPROFEN	CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1	SYTBZMRGLBWNTM-UHFFFAOYSA-N	InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1201124	KETOROLAC TROMETHAMINE	NC(CO)(CO)CO.O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O	BWHLPLXXIDYSNW-UHFFFAOYSA-N	InChI=1S/C15H13NO3.C4H11NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13;5-4(1-6,2-7)3-8/h1-7,11H,8-9H2,(H,18,19);6-8H,1-3,5H2	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL15770	SULINDAC	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1	MLKXDPUZXIRXEP-MFOYZWKCSA-N	InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1201013	OLSALAZINE SODIUM	O=C([O-])c1cc(/N=N/c2ccc(O)c(C(=O)[O-])c2)ccc1O.[Na+].[Na+]	ZJEFYLVGGFISGT-VRZXRVJBSA-L	InChI=1S/C14H10N2O6.2Na/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22;;/h1-6,17-18H,(H,19,20)(H,21,22);;/q;2*+1/p-2/b16-15+;;	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL3989410	INDOMETHACIN SODIUM	COc1ccc2c(c1)c(CC(=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1.O.O.O.[Na+]	UHYAQBLOGVNWNT-UHFFFAOYSA-M	InChI=1S/C19H16ClNO4.Na.3H2O/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12;;;;/h3-9H,10H2,1-2H3,(H,22,23);;3*1H2/q;+1;;;/p-1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1200463	OXAPROZIN POTASSIUM	O=C([O-])CCc1nc(-c2ccccc2)c(-c2ccccc2)o1.[K+]	QTAQWNSMRSLSCG-UHFFFAOYSA-M	InChI=1S/C18H15NO3.K/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14;/h1-10H,11-12H2,(H,20,21);/q;+1/p-1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL686	MEFENAMIC ACID	Cc1cccc(Nc2ccccc2C(=O)O)c1C	HYYBABOKPJLUIN-UHFFFAOYSA-N	InChI=1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL704	MESALAMINE	Nc1ccc(O)c(C(=O)O)c1	KBOPZPXVLCULAV-UHFFFAOYSA-N	InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1201141	IBUPROFEN LYSINE	CC(C)Cc1ccc(C(C)C(=O)O)cc1.NCCCC[C@H](N)C(=O)O	IHHXIUAEPKVVII-ZSCHJXSPSA-N	InChI=1S/C13H18O2.C6H14N2O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15;7-4-2-1-3-5(8)6(9)10/h4-7,9-10H,8H2,1-3H3,(H,14,15);5H,1-4,7-8H2,(H,9,10)/t;5-/m.0/s1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1071	OXAPROZIN	O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1	OFPXSFXSNFPTHF-UHFFFAOYSA-N	InChI=1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL101	PHENYLBUTAZONE	CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O	VYMDGNCVAMGZFE-UHFFFAOYSA-N	InChI=1S/C19H20N2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16/h4-13,17H,2-3,14H2,1H3	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL527	PIROXICAM	CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O	QYSPLQLAKJAUJT-UHFFFAOYSA-N	InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL956	SUPROFEN	CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1	MDKGKXOCJGEUJW-UHFFFAOYSA-N	InChI=1S/C14H12O3S/c1-9(14(16)17)10-4-6-11(7-5-10)13(15)12-3-2-8-18-12/h2-9H,1H3,(H,16,17)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL571	KETOPROFEN	CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1	DKYWVDODHFEZIM-UHFFFAOYSA-N	InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL44657	ETOPOSIDE	COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O	VJJPUSNTGOMMGY-MRVIYFEKSA-N	InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1	DNA topoisomerase II inhibitor	INHIBITOR	CHEMBL2094255	DNA topoisomerase II	Homo sapiens
CHEMBL452231	TENIPOSIDE	COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](c6cccs6)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O	NRUKOCRGYNPUPR-QBPJDGROSA-N	InChI=1S/C32H32O13S/c1-37-19-6-13(7-20(38-2)25(19)33)23-14-8-17-18(42-12-41-17)9-15(14)28(16-10-39-30(36)24(16)23)44-32-27(35)26(34)29-21(43-32)11-40-31(45-29)22-4-3-5-46-22/h3-9,16,21,23-24,26-29,31-35H,10-12H2,1-2H3/t16-,21+,23+,24-,26+,27+,28+,29+,31+,32-/m0/s1	DNA topoisomerase II inhibitor	INHIBITOR	CHEMBL2094255	DNA topoisomerase II	Homo sapiens
CHEMBL628	PENTOXIFYLLINE	CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O	BYPFEZZEUUWMEJ-UHFFFAOYSA-N	InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3	Adenosine A2 receptor antagonist	ANTAGONIST	CHEMBL2094257	Adenosine A2 receptor	Homo sapiens
CHEMBL1370561	AMINOPHYLLINE	Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN	FQPFAHBPWDRTLU-UHFFFAOYSA-N	InChI=1S/2C7H8N4O2.C2H8N2/c2*1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;3-1-2-4/h2*3H,1-2H3,(H,8,9);1-4H2	Adenosine receptor antagonist	ANTAGONIST	CHEMBL2111329	Adenosine receptor	Homo sapiens
CHEMBL1200569	CAFFEINE, CITRATED	Cn1c(=O)c2c(ncn2C)n(C)c1=O.O=C(O)CC(O)(CC(=O)O)C(=O)O	RCQXSQPPHJPGOF-UHFFFAOYSA-N	InChI=1S/C8H10N4O2.C6H8O7/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2;7-3(8)1-6(13,5(11)12)2-4(9)10/h4H,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)	Adenosine receptor antagonist	ANTAGONIST	CHEMBL2111329	Adenosine receptor	Homo sapiens
CHEMBL113	CAFFEINE	Cn1c(=O)c2c(ncn2C)n(C)c1=O	RYYVLZVUVIJVGH-UHFFFAOYSA-N	InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3	Adenosine receptor antagonist	ANTAGONIST	CHEMBL2111329	Adenosine receptor	Homo sapiens
CHEMBL477	ADENOSINE	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	OIRDTQYFTABQOQ-KQYNXXCUSA-N	InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1	Adenosine receptor agonist	AGONIST	CHEMBL2111329	Adenosine receptor	Homo sapiens
CHEMBL190	THEOPHYLLINE	Cn1c(=O)c2nc[nH]c2n(C)c1=O	ZFXYFBGIUFBOJW-UHFFFAOYSA-N	InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)	Adenosine receptor antagonist	ANTAGONIST	CHEMBL2111329	Adenosine receptor	Homo sapiens
CHEMBL1200578	THEOPHYLLINE SODIUM GLYCINATE	Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCC(=O)[O-].[Na+]	AIJQWRAOMFRHTQ-UHFFFAOYSA-M	InChI=1S/C7H8N4O2.C2H5NO2.Na/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;3-1-2(4)5;/h3H,1-2H3,(H,8,9);1,3H2,(H,4,5);/q;;+1/p-1	Adenosine receptor antagonist	ANTAGONIST	CHEMBL2111329	Adenosine receptor	Homo sapiens
CHEMBL730	NITROGLYCERIN	O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-]	SNIOPGDIGTZGOP-UHFFFAOYSA-N	InChI=1S/C3H5N3O9/c7-4(8)13-1-3(15-6(11)12)2-14-5(9)10/h3H,1-2H2	Soluble guanylate cyclase activator	ACTIVATOR	CHEMBL2111348	Soluble guanylate cyclase	Homo sapiens
CHEMBL1200689	NITRIC OXIDE	[N]=O	MWUXSHHQAYIFBG-UHFFFAOYSA-N	InChI=1S/NO/c1-2	Soluble guanylate cyclase activator	ACTIVATOR	CHEMBL2111348	Soluble guanylate cyclase	Homo sapiens
CHEMBL1311	ISOSORBIDE MONONITRATE	O=[N+]([O-])O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@H]12	YWXYYJSYQOXTPL-SLPGGIOYSA-N	InChI=1S/C6H9NO6/c8-3-1-11-6-4(13-7(9)10)2-12-5(3)6/h3-6,8H,1-2H2/t3-,4+,5+,6+/m0/s1	Soluble guanylate cyclase activator	ACTIVATOR	CHEMBL2111348	Soluble guanylate cyclase	Homo sapiens
CHEMBL6622	ISOSORBIDE DINITRATE	O=[N+]([O-])O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[N+](=O)[O-]	MOYKHGMNXAOIAT-JGWLITMVSA-N	InChI=1S/C6H8N2O8/c9-7(10)15-3-1-13-6-4(16-8(11)12)2-14-5(3)6/h3-6H,1-2H2/t3-,4+,5-,6-/m1/s1	Soluble guanylate cyclase activator	ACTIVATOR	CHEMBL2111348	Soluble guanylate cyclase	Homo sapiens
CHEMBL1456	MYCOPHENOLATE MOFETIL	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2	RTGDFNSFWBGLEC-SYZQJQIISA-N	InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	CHEMBL2111369	Inosine-5'-monophosphate dehydrogenase (IMPDH)	Homo sapiens
CHEMBL866	MYCOPHENOLIC ACID	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2	HPNSFSBZBAHARI-RUDMXATFSA-N	InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	CHEMBL2111369	Inosine-5'-monophosphate dehydrogenase (IMPDH)	Homo sapiens
CHEMBL1200955	MYCOPHENOLATE MOFETIL HYDROCHLORIDE	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2.Cl	OWLCGJBUTJXNOF-HDNKIUSMSA-N	InChI=1S/C23H31NO7.ClH/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3;/h4,26H,5-14H2,1-3H3;1H/b15-4+;	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	CHEMBL2111369	Inosine-5'-monophosphate dehydrogenase (IMPDH)	Homo sapiens
CHEMBL727	THIOGUANINE	Nc1nc2[nH]cnc2c(=S)[nH]1	WYWHKKSPHMUBEB-UHFFFAOYSA-N	InChI=1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	CHEMBL2111369	Inosine-5'-monophosphate dehydrogenase (IMPDH)	Homo sapiens
CHEMBL1200875	FLAVOXATE HYDROCHLORIDE	Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O.Cl	XOEVKNFZUQEERE-UHFFFAOYSA-N	InChI=1S/C24H25NO4.ClH/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25;/h2,4-5,8-12H,3,6-7,13-16H2,1H3;1H	Phosphodiesterase 7 inhibitor	INHIBITOR	CHEMBL2111411	Phosphodiesterase 7	Homo sapiens
CHEMBL1200480	OCTREOTIDE ACETATE	CC(=O)O.C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O	XQEJFZYLWPSJOV-XJQYZYIXSA-N	InChI=1S/C49H66N10O10S2.C2H4O2/c1-28(61)39(25-60)56-48(68)41-27-71-70-26-40(57-43(63)34(51)21-30-13-5-3-6-14-30)47(67)54-37(22-31-15-7-4-8-16-31)45(65)55-38(23-32-24-52-35-18-10-9-17-33(32)35)46(66)53-36(19-11-12-20-50)44(64)59-42(29(2)62)49(69)58-41;1-2(3)4/h3-10,13-18,24,28-29,34,36-42,52,60-62H,11-12,19-23,25-27,50-51H2,1-2H3,(H,53,66)(H,54,67)(H,55,65)(H,56,68)(H,57,63)(H,58,69)(H,59,64);1H3,(H,3,4)/t28-,29-,34-,36+,37+,38-,39-,40+,41+,42+;/m1./s1	Somatostatin receptor agonist	AGONIST	CHEMBL2111436	Somatostatin receptor	Homo sapiens
CHEMBL802	MINOXIDIL	Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]	ZFMITUMMTDLWHR-UHFFFAOYSA-N	InChI=1S/C9H15N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6H,1-5,10H2,(H2,11,12)	Sulfonylurea receptor 2, Kir6.2 opener	OPENER	CHEMBL2095198	Sulfonylurea receptor 2, Kir6.2	Homo sapiens
CHEMBL1200338	PINACIDIL	CC(N/C(=N\C#N)Nc1ccncc1)C(C)(C)C.O	AFJCNBBHEVLGCZ-UHFFFAOYSA-N	InChI=1S/C13H19N5.H2O/c1-10(13(2,3)4)17-12(16-9-14)18-11-5-7-15-8-6-11;/h5-8,10H,1-4H3,(H2,15,16,17,18);1H2	Sulfonylurea receptor 2, Kir6.2 opener	OPENER	CHEMBL2095198	Sulfonylurea receptor 2, Kir6.2	Homo sapiens
CHEMBL2448612	ERGOTAMINE TARTRATE	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.O=C(O)C(O)C(O)C(=O)O	CJMJLDQKTOJACI-SEUSHGJOSA-N	InChI=1S/2C33H35N5O5.C4H6O6/c2*1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32;5-1(3(7)8)2(6)4(9)10/h2*3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39);1-2,5-6H,(H,7,8)(H,9,10)/t2*21-,25-,26+,27+,32-,33+;/m11./s1	Adrenergic receptor alpha agonist	AGONIST	CHEMBL2095203	Adrenergic receptor alpha	Homo sapiens
CHEMBL1706	NAPHAZOLINE HYDROCHLORIDE	Cl.c1ccc2c(CC3=NCCN3)cccc2c1	DJDFFEBSKJCGHC-UHFFFAOYSA-N	InChI=1S/C14H14N2.ClH/c1-2-7-13-11(4-1)5-3-6-12(13)10-14-15-8-9-16-14;/h1-7H,8-10H2,(H,15,16);1H	Adrenergic receptor alpha agonist	AGONIST	CHEMBL2095203	Adrenergic receptor alpha	Homo sapiens
CHEMBL1200413	TETRAHYDROZOLINE HYDROCHLORIDE	Cl.c1ccc2c(c1)CCCC2C1=NCCN1	BJORNXNYWNIWEY-UHFFFAOYSA-N	InChI=1S/C13H16N2.ClH/c1-2-6-11-10(4-1)5-3-7-12(11)13-14-8-9-15-13;/h1-2,4,6,12H,3,5,7-9H2,(H,14,15);1H	Adrenergic receptor alpha agonist	AGONIST	CHEMBL2095203	Adrenergic receptor alpha	Homo sapiens
CHEMBL1200873	PHENTOLAMINE MESYLATE	CS(=O)(=O)O.Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1	OGIYDFVHFQEFKQ-UHFFFAOYSA-N	InChI=1S/C17H19N3O.CH4O3S/c1-13-5-7-14(8-6-13)20(12-17-18-9-10-19-17)15-3-2-4-16(21)11-15;1-5(2,3)4/h2-8,11,21H,9-10,12H2,1H3,(H,18,19);1H3,(H,2,3,4)	Adrenergic receptor alpha antagonist	ANTAGONIST	CHEMBL2095203	Adrenergic receptor alpha	Homo sapiens
CHEMBL1200791	OXYMETAZOLINE HYDROCHLORIDE	Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1.Cl	BEEDODBODQVSIM-UHFFFAOYSA-N	InChI=1S/C16H24N2O.ClH/c1-10-8-13(16(3,4)5)15(19)11(2)12(10)9-14-17-6-7-18-14;/h8,19H,6-7,9H2,1-5H3,(H,17,18);1H	Adrenergic receptor alpha agonist	AGONIST	CHEMBL2095203	Adrenergic receptor alpha	Homo sapiens
CHEMBL1200787	PHENOXYBENZAMINE HYDROCHLORIDE	CC(COc1ccccc1)N(CCCl)Cc1ccccc1.Cl	VBCPVIWPDJVHAN-UHFFFAOYSA-N	InChI=1S/C18H22ClNO.ClH/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17;/h2-11,16H,12-15H2,1H3;1H	Adrenergic receptor alpha antagonist	ANTAGONIST	CHEMBL2095203	Adrenergic receptor alpha	Homo sapiens
CHEMBL1689	TOLAZOLINE HYDROCHLORIDE	Cl.c1ccc(CC2=NCCN2)cc1	RHTNTTODYGNRSP-UHFFFAOYSA-N	InChI=1S/C10H12N2.ClH/c1-2-4-9(5-3-1)8-10-11-6-7-12-10;/h1-5H,6-8H2,(H,11,12);1H	Adrenergic receptor alpha antagonist	ANTAGONIST	CHEMBL2095203	Adrenergic receptor alpha	Homo sapiens
CHEMBL1200895	PHENELZINE SULFATE	NNCCc1ccccc1.O=S(=O)(O)O	RXBKMJIPNDOHFR-UHFFFAOYSA-N	InChI=1S/C8H12N2.H2O4S/c9-10-7-6-8-4-2-1-3-5-8;1-5(2,3)4/h1-5,10H,6-7,9H2;(H2,1,2,3,4)	Monoamine oxidase inhibitor	INHIBITOR	CHEMBL2095205	Monoamine oxidase	Homo sapiens
CHEMBL1200425	PARGYLINE HYDROCHLORIDE	C#CCN(C)Cc1ccccc1.Cl	BCXCABRDBBWWGY-UHFFFAOYSA-N	InChI=1S/C11H13N.ClH/c1-3-9-12(2)10-11-7-5-4-6-8-11;/h1,4-8H,9-10H2,2H3;1H	Monoamine oxidase inhibitor	INHIBITOR	CHEMBL2095205	Monoamine oxidase	Homo sapiens
CHEMBL1201168	ISOCARBOXAZID	Cc1cc(C(=O)NNCc2ccccc2)no1	XKFPYPQQHFEXRZ-UHFFFAOYSA-N	InChI=1S/C12H13N3O2/c1-9-7-11(15-17-9)12(16)14-13-8-10-5-3-2-4-6-10/h2-7,13H,8H2,1H3,(H,14,16)	Monoamine oxidase inhibitor	INHIBITOR	CHEMBL2095205	Monoamine oxidase	Homo sapiens
CHEMBL3989698	TRANYLCYPROMINE SULFATE	N[C@@H]1C[C@H]1c1ccccc1.N[C@H]1C[C@@H]1c1ccccc1.O=S(=O)(O)O	BKPRVQDIOGQWTG-ICOOEGOYSA-N	InChI=1S/2C9H11N.H2O4S/c2*10-9-6-8(9)7-4-2-1-3-5-7;1-5(2,3)4/h2*1-5,8-9H,6,10H2;(H2,1,2,3,4)/t2*8-,9+;/m10./s1	Monoamine oxidase inhibitor	INHIBITOR	CHEMBL2095205	Monoamine oxidase	Homo sapiens
CHEMBL1481	GLIMEPIRIDE	CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O	WIGIZIANZCJQQY-RUCARUNLSA-N	InChI=1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)/t16-,19-	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	CHEMBL2096972	Sulfonylurea receptor 1, Kir6.2	Homo sapiens
CHEMBL472	GLYBURIDE	COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1	ZNNLBTZKUZBEKO-UHFFFAOYSA-N	InChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	CHEMBL2096972	Sulfonylurea receptor 1, Kir6.2	Homo sapiens
CHEMBL498	CHLORPROPAMIDE	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1	RKWGIWYCVPQPMF-UHFFFAOYSA-N	InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	CHEMBL2096972	Sulfonylurea receptor 1, Kir6.2	Homo sapiens
CHEMBL1200874	TOLBUTAMIDE SODIUM, STERILE	CCCCNC(=O)[N-]S(=O)(=O)c1ccc(C)cc1.[Na+]	QKHDBRQBSNZFAK-UHFFFAOYSA-M	InChI=1S/C12H18N2O3S.Na/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11;/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15);/q;+1/p-1	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	CHEMBL2096972	Sulfonylurea receptor 1, Kir6.2	Homo sapiens
CHEMBL1073	GLIPIZIDE	Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1	ZJJXGWJIGJFDTL-UHFFFAOYSA-N	InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	CHEMBL2096972	Sulfonylurea receptor 1, Kir6.2	Homo sapiens
CHEMBL1589	ACETOHEXAMIDE	CC(=O)c1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1	VGZSUPCWNCWDAN-UHFFFAOYSA-N	InChI=1S/C15H20N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-10,13H,2-6H2,1H3,(H2,16,17,19)	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	CHEMBL2096972	Sulfonylurea receptor 1, Kir6.2	Homo sapiens
CHEMBL817	TOLAZAMIDE	Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1	OUDSBRTVNLOZBN-UHFFFAOYSA-N	InChI=1S/C14H21N3O3S/c1-12-6-8-13(9-7-12)21(19,20)16-14(18)15-17-10-4-2-3-5-11-17/h6-9H,2-5,10-11H2,1H3,(H2,15,16,18)	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	CHEMBL2096972	Sulfonylurea receptor 1, Kir6.2	Homo sapiens
CHEMBL1272	REPAGLINIDE	CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O	FAEKWTJYAYMJKF-QHCPKHFHSA-N	InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	CHEMBL2096972	Sulfonylurea receptor 1, Kir6.2	Homo sapiens
CHEMBL783	NATEGLINIDE	CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1	OELFLUMRDSZNSF-BRWVUGGUSA-N	InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	CHEMBL2096972	Sulfonylurea receptor 1, Kir6.2	Homo sapiens
CHEMBL782	TOLBUTAMIDE	CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1	JLRGJRBPOGGCBT-UHFFFAOYSA-N	InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	CHEMBL2096972	Sulfonylurea receptor 1, Kir6.2	Homo sapiens
CHEMBL585	TRIAMTERENE	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1	FNYLWPVRPXGIIP-UHFFFAOYSA-N	InChI=1S/C12H11N7/c13-9-7(6-4-2-1-3-5-6)16-8-10(14)18-12(15)19-11(8)17-9/h1-5H,(H6,13,14,15,17,18,19)	Amiloride-sensitive sodium channel, ENaC blocker	BLOCKER	CHEMBL2107836	Amiloride-sensitive sodium channel, ENaC	Homo sapiens
CHEMBL1398126	AMILORIDE HYDROCHLORIDE	Cl.N=C(N)NC(=O)c1nc(Cl)c(N)nc1N.O.O	LTKVFMLMEYCWMK-UHFFFAOYSA-N	InChI=1S/C6H8ClN7O.ClH.2H2O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11;;;/h(H4,8,9,13)(H4,10,11,14,15);1H;2*1H2	Amiloride-sensitive sodium channel, ENaC blocker	BLOCKER	CHEMBL2107836	Amiloride-sensitive sodium channel, ENaC	Homo sapiens
CHEMBL467	HYDROXYUREA	NC(=O)NO	VSNHCAURESNICA-UHFFFAOYSA-N	InChI=1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4)	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	CHEMBL2095215	Ribonucleoside-diphosphate reductase RR1	Homo sapiens
CHEMBL1750	CLOFARABINE	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F	WDDPHFBMKLOVOX-AYQXTPAHSA-N	InChI=1S/C10H11ClFN5O3/c11-10-15-7(13)5-8(16-10)17(2-14-5)9-4(12)6(19)3(1-18)20-9/h2-4,6,9,18-19H,1H2,(H2,13,15,16)/t3-,4+,6-,9-/m1/s1	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	CHEMBL2095215	Ribonucleoside-diphosphate reductase RR1	Homo sapiens
CHEMBL1637	GEMCITABINE HYDROCHLORIDE	Cl.Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1	OKKDEIYWILRZIA-OSZBKLCCSA-N	InChI=1S/C9H11F2N3O4.ClH/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17;/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17);1H/t4-,6-,7-;/m1./s1	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	CHEMBL2095215	Ribonucleoside-diphosphate reductase RR1	Homo sapiens
CHEMBL1096882	FLUDARABINE PHOSPHATE	Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]1O	GIUYCYHIANZCFB-FJFJXFQQSA-N	InChI=1S/C10H13FN5O7P/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(18)5(17)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,17-18H,1H2,(H2,12,14,15)(H2,19,20,21)/t3-,5-,6+,9-/m1/s1	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	CHEMBL2095215	Ribonucleoside-diphosphate reductase RR1	Homo sapiens
CHEMBL1567	SUNITINIB MALATE	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O	LBWFXVZLPYTWQI-IPOVEDGCSA-N	InChI=1S/C22H27FN4O2.C4H6O5/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28;5-2(4(8)9)1-3(6)7/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28);2,5H,1H2,(H,6,7)(H,8,9)/b17-12-;/t;2-/m.0/s1	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL1289926	AXITINIB	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1	RITAVMQDGBJQJZ-FMIVXFBMSA-N	InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL24828	VANDETANIB	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1	UHTHHESEBZOYNR-UHFFFAOYSA-N	InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL1200485	SORAFENIB TOSYLATE	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1	IVDHYUQIDRJSTI-UHFFFAOYSA-N	InChI=1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL1201733	PAZOPANIB HYDROCHLORIDE	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O.Cl	MQHIQUBXFFAOMK-UHFFFAOYSA-N	InChI=1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL1946170	REGORAFENIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1	FNHKPVJBJVTLMP-UHFFFAOYSA-N	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL1237132	CLEVIDIPINE	CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl	KPBZROQVTHLCDU-UHFFFAOYSA-N	InChI=1S/C21H23Cl2NO6/c1-5-7-15(25)29-10-30-21(27)17-12(3)24-11(2)16(20(26)28-4)18(17)13-8-6-9-14(22)19(13)23/h6,8-9,18,24H,5,7,10H2,1-4H3	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL1648	ISRADIPINE	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12	HMJIYCCIJYRONP-UHFFFAOYSA-N	InChI=1S/C19H21N3O5/c1-9(2)26-19(24)15-11(4)20-10(3)14(18(23)25-5)16(15)12-7-6-8-13-17(12)22-27-21-13/h6-9,16,20H,1-5H3	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL1697	DILTIAZEM HYDROCHLORIDE	COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1.Cl	HDRXZJPWHTXQRI-BHDTVMLSSA-N	InChI=1S/C22H26N2O4S.ClH/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3;/h5-12,20-21H,13-14H2,1-4H3;1H/t20-,21+;/m1./s1	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL1201729	DRONEDARONE HYDROCHLORIDE	CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1.Cl	DWKVCQXJYURSIQ-UHFFFAOYSA-N	InChI=1S/C31H44N2O5S.ClH/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3;/h13-18,23,32H,5-12,19-22H2,1-4H3;1H	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL1200984	AMLODIPINE MALEATE	CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl.O=C(O)/C=C\C(=O)O	TZNOWAJJWCGILX-BTJKTKAUSA-N	InChI=1S/C20H25ClN2O5.C4H4O4/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21;5-3(6)1-2-4(7)8/h5-8,17,23H,4,9-11,22H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL1280	VERAPAMIL HYDROCHLORIDE	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC.Cl	DOQPXTMNIUCOSY-UHFFFAOYSA-N	InChI=1S/C27H38N2O4.ClH/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6;/h9-12,17-18,20H,8,13-16H2,1-7H3;1H	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL193	NIFEDIPINE	COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]	HYIMSNHJOBLJNT-UHFFFAOYSA-N	InChI=1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-7-5-6-8-12(11)19(22)23/h5-8,15,18H,1-4H3	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL1200805	DILTIAZEM MALATE	COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1.O=C(O)CC(O)C(=O)O	IUSFTUWHKCSCDY-BHDTVMLSSA-N	InChI=1S/C22H26N2O4S.C4H6O5/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3;5-2(4(8)9)1-3(6)7/h5-12,20-21H,13-14H2,1-4H3;2,5H,1H2,(H,6,7)(H,8,9)/t20-,21+;/m1./s1	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL1200402	AMLODIPINE BESYLATE	CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl.O=S(=O)(O)c1ccccc1	ZPBWCRDSRKPIDG-UHFFFAOYSA-N	InChI=1S/C20H25ClN2O5.C6H6O3S/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21;7-10(8,9)6-4-2-1-3-5-6/h5-8,17,23H,4,9-11,22H2,1-3H3;1-5H,(H,7,8,9)	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL1200326	NICARDIPINE HYDROCHLORIDE	COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1.Cl	AIKVCUNQWYTVTO-UHFFFAOYSA-N	InChI=1S/C26H29N3O6.ClH/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19;/h5-12,15,24,27H,13-14,16H2,1-4H3;1H	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL1428	NIMODIPINE	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1	UIAGMCDKSXEBJQ-UHFFFAOYSA-N	InChI=1S/C21H26N2O7/c1-12(2)30-21(25)18-14(4)22-13(3)17(20(24)29-10-9-28-5)19(18)15-7-6-8-16(11-15)23(26)27/h6-8,11-12,19,22H,9-10H2,1-5H3	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL1726	NISOLDIPINE	COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]	VKQFCGNPDRICFG-UHFFFAOYSA-N	InChI=1S/C20H24N2O6/c1-11(2)10-28-20(24)17-13(4)21-12(3)16(19(23)27-5)18(17)14-8-6-7-9-15(14)22(25)26/h6-9,11,18,21H,10H2,1-5H3	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL1480	FELODIPINE	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl	RZTAMFZIAATZDJ-UHFFFAOYSA-N	InChI=1S/C18H19Cl2NO4/c1-5-25-18(23)14-10(3)21-9(2)13(17(22)24-4)15(14)11-7-6-8-12(19)16(11)20/h6-8,15,21H,5H2,1-4H3	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL218394	BOCEPREVIR	CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C	LHHCSNFAOIFYRV-DOVBMPENSA-N	InChI=1S/C27H45N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-18,20H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16?,17-,18-,20+/m0/s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL231813	TELAPREVIR	CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1	BBAWEDCPNXPBQM-GDEBMMAJSA-N	InChI=1S/C36H53N7O6/c1-5-10-25(29(44)34(48)39-23-15-16-23)40-33(47)28-24-14-9-13-22(24)20-43(28)35(49)30(36(2,3)4)42-32(46)27(21-11-7-6-8-12-21)41-31(45)26-19-37-17-18-38-26/h17-19,21-25,27-28,30H,5-16,20H2,1-4H3,(H,39,48)(H,40,47)(H,41,45)(H,42,46)/t22-,24-,25-,27-,28-,30+/m0/s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL215645	RIVASTIGMINE TARTRATE	CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1.O=C(O)C(O)C(O)C(=O)O	GWHQHAUAXRMMOT-MERQFXBCSA-N	InChI=1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;/m0./s1	Cholinesterases; ACHE & BCHE inhibitor	INHIBITOR	CHEMBL2095233	Cholinesterases; ACHE & BCHE	Homo sapiens
CHEMBL636	RIVASTIGMINE	CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1	XSVMFMHYUFZWBK-NSHDSACASA-N	InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1	Cholinesterases; ACHE & BCHE inhibitor	INHIBITOR	CHEMBL2095233	Cholinesterases; ACHE & BCHE	Homo sapiens
CHEMBL1677	TACRINE HYDROCHLORIDE	Cl.Nc1c2c(nc3ccccc13)CCCC2	ZUFVXZVXEJHHBN-UHFFFAOYSA-N	InChI=1S/C13H14N2.ClH/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13;/h1,3,5,7H,2,4,6,8H2,(H2,14,15);1H	Cholinesterases; ACHE & BCHE inhibitor	INHIBITOR	CHEMBL2095233	Cholinesterases; ACHE & BCHE	Homo sapiens
CHEMBL1569	AMANTADINE HYDROCHLORIDE	Cl.NC12CC3CC(CC(C3)C1)C2	WOLHOYHSEKDWQH-UHFFFAOYSA-N	InChI=1S/C10H17N.ClH/c11-10-4-7-1-8(5-10)3-9(2-7)6-10;/h7-9H,1-6,11H2;1H	Matrix protein 2 inhibitor	INHIBITOR	CHEMBL1932894	Matrix protein 2	Influenza A virus (strain A/Puerto Rico/8/1934 H1N1)
CHEMBL1237082	MECAMYLAMINE HYDROCHLORIDE	CNC1(C)C2CCC(C2)C1(C)C.Cl	PKVZBNCYEICAQP-UHFFFAOYSA-N	InChI=1S/C11H21N.ClH/c1-10(2)8-5-6-9(7-8)11(10,3)12-4;/h8-9,12H,5-7H2,1-4H3;1H	Neuronal acetylcholine receptor; alpha3/beta4 negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	CHEMBL1907594	Neuronal acetylcholine receptor; alpha3/beta4	Homo sapiens
CHEMBL1318287	PENTOLINIUM TARTRATE	C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1.O=C([O-])[C@H](O)[C@@H](O)C(=O)O.O=C([O-])[C@H](O)[C@@H](O)C(=O)O	HSMKTIKKPMTUQH-WBPXWQEISA-L	InChI=1S/C15H32N2.2C4H6O6/c1-16(12-6-7-13-16)10-4-3-5-11-17(2)14-8-9-15-17;2*5-1(3(7)8)2(6)4(9)10/h3-15H2,1-2H3;2*1-2,5-6H,(H,7,8)(H,9,10)/q+2;;/p-2/t;2*1-,2-/m.11/s1	Neuronal acetylcholine receptor; alpha3/beta4 antagonist	ANTAGONIST	CHEMBL1907594	Neuronal acetylcholine receptor; alpha3/beta4	Homo sapiens
CHEMBL1245	TRIMETHAPHAN CAMSYLATE	CC1(C)C2CCC1(CS(=O)(=O)[O-])C(=O)C2.O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1	HALWUDBBYKMYPW-UHFFFAOYSA-M	InChI=1S/C22H25N2OS.C10H16O4S/c25-22-23(14-17-8-3-1-4-9-17)19-16-26-13-7-12-20(26)21(19)24(22)15-18-10-5-2-6-11-18;1-9(2)7-3-4-10(9,8(11)5-7)6-15(12,13)14/h1-6,8-11,19-21H,7,12-16H2;7H,3-6H2,1-2H3,(H,12,13,14)/q+1;/p-1	Neuronal acetylcholine receptor; alpha3/beta4 antagonist	ANTAGONIST	CHEMBL1907594	Neuronal acetylcholine receptor; alpha3/beta4	Homo sapiens
CHEMBL2107333	DIMETHYL FUMARATE	COC(=O)/C=C/C(=O)OC	LDCRTTXIJACKKU-ONEGZZNKSA-N	InChI=1S/C6H8O4/c1-9-5(7)3-4-6(8)10-2/h3-4H,1-2H3/b4-3+	Kelch-like ECH-associated protein 1 inhibitor	INHIBITOR	CHEMBL2069156	Kelch-like ECH-associated protein 1	Homo sapiens
CHEMBL928	DANTROLENE SODIUM	O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)[N-]1.[Na+]	KSRLIXGNPXAZHD-HAZZGOGXSA-M	InChI=1S/C14H10N4O5.Na/c19-13-8-17(14(20)16-13)15-7-11-5-6-12(23-11)9-1-3-10(4-2-9)18(21)22;/h1-7H,8H2,(H,16,19,20);/q;+1/p-1/b15-7+;	Ryanodine receptor 3 antagonist	ANTAGONIST	CHEMBL2062	Ryanodine receptor 3	Homo sapiens
CHEMBL3545058	DEXTROTHYROXINE SODIUM	N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)[O-].O.[Na+]	ANMYAHDLKVNJJO-CURYUGHLSA-M	InChI=1S/C15H11I4NO4.Na.H2O/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23;;/h1-2,4-5,12,21H,3,20H2,(H,22,23);;1H2/q;+1;/p-1/t12-;;/m1../s1	Thyroid hormone receptor agonist	AGONIST	CHEMBL2111462	Thyroid hormone receptor	Homo sapiens
CHEMBL1201119	LIOTHYRONINE SODIUM	N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)[O-].[Na+]	SBXXSUDPJJJJLC-YDALLXLXSA-M	InChI=1S/C15H12I3NO4.Na/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22;/h1-4,6,12,20H,5,19H2,(H,21,22);/q;+1/p-1/t12-;/m0./s1	Thyroid hormone receptor agonist	AGONIST	CHEMBL2111462	Thyroid hormone receptor	Homo sapiens
CHEMBL559	DEXTROTHYROXINE	N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O	XUIIKFGFIJCVMT-GFCCVEGCSA-N	InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m1/s1	Thyroid hormone receptor agonist	AGONIST	CHEMBL2111462	Thyroid hormone receptor	Homo sapiens
CHEMBL1544	LIOTHYRONINE	N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O	AUYYCJSJGJYCDS-LBPRGKRZSA-N	InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1	Thyroid hormone receptor agonist	AGONIST	CHEMBL2111462	Thyroid hormone receptor	Homo sapiens
CHEMBL2103741	LEVOTHYROXINE SODIUM	N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)[O-].O.[Na+]	ANMYAHDLKVNJJO-LTCKWSDVSA-M	InChI=1S/C15H11I4NO4.Na.H2O/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23;;/h1-2,4-5,12,21H,3,20H2,(H,22,23);;1H2/q;+1;/p-1/t12-;;/m0../s1	Thyroid hormone receptor agonist	AGONIST	CHEMBL2111462	Thyroid hormone receptor	Homo sapiens
CHEMBL1200682	SODIUM OXYBATE	O=C([O-])CCCO.[Na+]	XYGBKMMCQDZQOZ-UHFFFAOYSA-M	InChI=1S/C4H8O3.Na/c5-3-1-2-4(6)7;/h5H,1-3H2,(H,6,7);/q;+1/p-1	GABA-B receptor agonist	AGONIST	CHEMBL2111463	GABA-B receptor	Homo sapiens
CHEMBL701	BACLOFEN	NCC(CC(=O)O)c1ccc(Cl)cc1	KPYSYYIEGFHWSV-UHFFFAOYSA-N	InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)	GABA-B receptor agonist	AGONIST	CHEMBL2111463	GABA-B receptor	Homo sapiens
CHEMBL1337	NITISINONE	O=C1CCCC(=O)C1C(=O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-]	OUBCNLGXQFSTLU-UHFFFAOYSA-N	InChI=1S/C14H10F3NO5/c15-14(16,17)7-4-5-8(9(6-7)18(22)23)13(21)12-10(19)2-1-3-11(12)20/h4-6,12H,1-3H2	4-hydroxyphenylpyruvate dioxygenase inhibitor	INHIBITOR	CHEMBL1861	4-hydroxyphenylpyruvate dioxygenase	Homo sapiens
CHEMBL1685	DEZOCINE	C[C@@]12CCCCC[C@@H](Cc3ccc(O)cc31)[C@@H]2N	VTMVHDZWSFQSQP-VBNZEHGJSA-N	InChI=1S/C16H23NO/c1-16-8-4-2-3-5-12(15(16)17)9-11-6-7-13(18)10-14(11)16/h6-7,10,12,15,18H,2-5,8-9,17H2,1H3/t12-,15-,16+/m0/s1	Kappa opioid receptor antagonist	ANTAGONIST	CHEMBL237	Kappa opioid receptor	Homo sapiens
CHEMBL1200543	ANILERIDINE PHOSPHATE	CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1.O=P(O)(O)O	FLQCEKVTYABVSH-UHFFFAOYSA-N	InChI=1S/C22H28N2O2.H3O4P/c1-2-26-21(25)22(19-6-4-3-5-7-19)13-16-24(17-14-22)15-12-18-8-10-20(23)11-9-18;1-5(2,3)4/h3-11H,2,12-17,23H2,1H3;(H3,1,2,3,4)	Kappa opioid receptor agonist	AGONIST	CHEMBL237	Kappa opioid receptor	Homo sapiens
CHEMBL1201047	ANILERIDINE HYDROCHLORIDE	CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1.Cl	UDUQHZSAAWGSPJ-UHFFFAOYSA-N	InChI=1S/C22H28N2O2.ClH/c1-2-26-21(25)22(19-6-4-3-5-7-19)13-16-24(17-14-22)15-12-18-8-10-20(23)11-9-18;/h3-11H,2,12-17,23H2,1H3;1H	Kappa opioid receptor agonist	AGONIST	CHEMBL237	Kappa opioid receptor	Homo sapiens
CHEMBL299400	BUTORPHANOL TARTRATE	O=C(O)C(O)C(O)C(=O)O.Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3	GMTYREVWZXJPLF-SXWPHCFWSA-N	InChI=1S/C21H29NO2.C4H6O6/c23-17-7-6-16-12-19-21(24)9-2-1-8-20(21,18(16)13-17)10-11-22(19)14-15-4-3-5-15;5-1(3(7)8)2(6)4(9)10/h6-7,13,15,19,23-24H,1-5,8-12,14H2;1-2,5-6H,(H,7,8)(H,9,10)/t19-,20+,21-;/m1./s1	Kappa opioid receptor partial agonist	PARTIAL AGONIST	CHEMBL237	Kappa opioid receptor	Homo sapiens
CHEMBL2062276	LEVALLORPHAN TARTRATE	C=CCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13.O=C(O)C(O)C(O)C(=O)O	FWMLYVACGDQRFU-MBHUSPCXSA-N	InChI=1S/C19H25NO.C4H6O6/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19;5-1(3(7)8)2(6)4(9)10/h2,6-7,13,16,18,21H,1,3-5,8-12H2;1-2,5-6H,(H,7,8)(H,9,10)/t16-,18+,19+;/m0./s1	Kappa opioid receptor partial agonist	PARTIAL AGONIST	CHEMBL237	Kappa opioid receptor	Homo sapiens
CHEMBL1201037	EFLORNITHINE HYDROCHLORIDE	Cl.NCCCC(N)(C(=O)O)C(F)F.O	FJPAMFNRCFEGSD-UHFFFAOYSA-N	InChI=1S/C6H12F2N2O2.ClH.H2O/c7-4(8)6(10,5(11)12)2-1-3-9;;/h4H,1-3,9-10H2,(H,11,12);1H;1H2	Ornithine decarboxylase inhibitor	INHIBITOR	CHEMBL1869	Ornithine decarboxylase	Homo sapiens
CHEMBL1200585	OXYMETHOLONE	C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O	ICMWWNHDUZJFDW-DHODBPELSA-N	InChI=1S/C21H32O3/c1-19-11-13(12-22)18(23)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,22,24H,4-11H2,1-3H3/b13-12-/t14-,15+,16-,17-,19-,20-,21-/m0/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL806	FLUTAMIDE	CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1	MKXKFYHWDHIYRV-UHFFFAOYSA-N	InChI=1S/C11H11F3N2O3/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14/h3-6H,1-2H3,(H,15,17)	Androgen Receptor antagonist	ANTAGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1274	NILUTAMIDE	CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O	XWXYUMMDTVBTOU-UHFFFAOYSA-N	InChI=1S/C12H10F3N3O4/c1-11(2)9(19)17(10(20)16-11)6-3-4-8(18(21)22)7(5-6)12(13,14)15/h3-5H,1-2H3,(H,16,20)	Androgen Receptor antagonist	ANTAGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1201048	DROMOSTANOLONE PROPIONATE	CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)[C@H](C)C[C@]4(C)[C@H]3CC[C@]12C	NOTIQUSPUUHHEH-UXOVVSIBSA-N	InChI=1S/C23H36O3/c1-5-21(25)26-20-9-8-17-16-7-6-15-12-19(24)14(2)13-23(15,4)18(16)10-11-22(17,20)3/h14-18,20H,5-13H2,1-4H3/t14-,15+,16+,17+,18+,20+,22+,23+/m1/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL409	BICALUTAMIDE	CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	LKJPYSCBVHEWIU-UHFFFAOYSA-N	InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)	Androgen Receptor antagonist	ANTAGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1395	METHYLTESTOSTERONE	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	GCKMFJBGXUYNAG-HLXURNFRSA-N	InChI=1S/C20H30O2/c1-18-9-6-14(21)12-13(18)4-5-15-16(18)7-10-19(2)17(15)8-11-20(19,3)22/h12,15-17,22H,4-11H2,1-3H3/t15-,16+,17+,18+,19+,20+/m1/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1200623	ETHYLESTRENOL	CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C	AOXRBFRFYPMWLR-XGXHKTLJSA-N	InChI=1S/C20H32O/c1-3-20(21)13-11-18-17-9-8-14-6-4-5-7-15(14)16(17)10-12-19(18,20)2/h6,15-18,21H,3-5,7-13H2,1-2H3/t15-,16+,17+,18-,19-,20-/m0/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL2079587	STANOZOLOL	C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O	LKAJKIOFIWVMDJ-IYRCEVNGSA-N	InChI=1S/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1170	TESTOSTERONE PROPIONATE	CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	PDMMFKSKQVNJMI-BLQWBTBKSA-N	InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1200335	TESTOSTERONE ENANTHATE	CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	VOCBWIIFXDYGNZ-IXKNJLPQSA-N	InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1200946	NANDROLONE DECANOATE	CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C	JKWKMORAXJQQSR-MOPIKTETSA-N	InChI=1S/C28H44O3/c1-3-4-5-6-7-8-9-10-27(30)31-26-16-15-25-24-13-11-20-19-21(29)12-14-22(20)23(24)17-18-28(25,26)2/h19,22-26H,3-18H2,1-2H3/t22-,23+,24+,25-,26-,28-/m0/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1200436	OXANDROLONE	C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O	QSLJIVKCVHQPLV-PEMPUTJUSA-N	InChI=1S/C19H30O3/c1-17-11-22-16(20)10-12(17)4-5-13-14(17)6-8-18(2)15(13)7-9-19(18,3)21/h12-15,21H,4-11H2,1-3H3/t12-,13+,14-,15-,17-,18-,19-/m0/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1201101	TESTOSTERONE CYPIONATE	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1	HPFVBGJFAYZEBE-ZLQWOROUSA-N	InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL386630	TESTOSTERONE	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O	MUMGGOZAMZWBJJ-DYKIIFRCSA-N	InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1445	FLUOXYMESTERONE	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C	YLRFCQOZQXIBAB-RBZZARIASA-N	InChI=1S/C20H29FO3/c1-17-8-6-13(22)10-12(17)4-5-15-14-7-9-19(3,24)18(14,2)11-16(23)20(15,17)21/h10,14-16,23-24H,4-9,11H2,1-3H3/t14-,15-,16-,17-,18-,19-,20-/m0/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1082407	ENZALUTAMIDE	CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F	WXCXUHSOUPDCQV-UHFFFAOYSA-N	InChI=1S/C21H16F4N4O2S/c1-20(2)18(31)28(12-5-4-11(10-26)15(8-12)21(23,24)25)19(32)29(20)13-6-7-14(16(22)9-13)17(30)27-3/h4-9H,1-3H3,(H,27,30)	Androgen Receptor antagonist	ANTAGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1200412	NANDROLONE PHENPROPIONATE	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCc1ccccc1	UBWXUGDQUBIEIZ-QNTYDACNSA-N	InChI=1S/C27H34O3/c1-27-16-15-22-21-11-9-20(28)17-19(21)8-10-23(22)24(27)12-13-25(27)30-26(29)14-7-18-5-3-2-4-6-18/h2-6,17,21-25H,7-16H2,1H3/t21-,22+,23+,24-,25-,27-/m0/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1479	DANAZOL	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C	POZRVZJJTULAOH-LHZXLZLDSA-N	InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1516474	TEGASEROD MALEATE	CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12.O=C(O)/C=C\C(=O)O	CPDDZSSEAVLMRY-FEQFWAPWSA-N	InChI=1S/C16H23N5O.C4H4O4/c1-3-4-5-8-18-16(17)21-20-11-12-10-19-15-7-6-13(22-2)9-14(12)15;5-3(6)1-2-4(7)8/h6-7,9-11,19H,3-5,8H2,1-2H3,(H3,17,18,21);1-2H,(H,5,6)(H,7,8)/b20-11+;2-1-	Serotonin 4 (5-HT4) receptor partial agonist	PARTIAL AGONIST	CHEMBL1875	Serotonin 4 (5-HT4) receptor	Homo sapiens
CHEMBL1729	CISAPRIDE	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC	DCSUBABJRXZOMT-UHFFFAOYSA-N	InChI=1S/C23H29ClFN3O4/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(H,27,29)	Serotonin 4 (5-HT4) receptor agonist	AGONIST	CHEMBL1875	Serotonin 4 (5-HT4) receptor	Homo sapiens
CHEMBL1200940	METOCLOPRAMIDE HYDROCHLORIDE	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC.Cl.O	KJBLQGHJOCAOJP-UHFFFAOYSA-N	InChI=1S/C14H22ClN3O2.ClH.H2O/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3;;/h8-9H,4-7,16H2,1-3H3,(H,17,19);1H;1H2	Serotonin 4 (5-HT4) receptor agonist	AGONIST	CHEMBL1875	Serotonin 4 (5-HT4) receptor	Homo sapiens
CHEMBL1084172	VILANTEROL TRIFENATATE	O=C(O)C(c1ccccc1)(c1ccccc1)c1ccccc1.OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O	KLOLZALDXGTNQE-JIDHJSLPSA-N	InChI=1S/C24H33Cl2NO5.C20H16O2/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28;21-19(22)20(16-10-4-1-5-11-16,17-12-6-2-7-13-17)18-14-8-3-9-15-18/h5-9,14,24,27-30H,1-4,10-13,15-17H2;1-15H,(H,21,22)/t24-;/m0./s1	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL714	ALBUTEROL	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1	NDAUXUAQIAJITI-UHFFFAOYSA-N	InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1200444	PIRBUTEROL ACETATE	CC(=O)O.CC(C)(C)NCC(O)c1ccc(O)c(CO)n1	QSXMZJGGEWYVCN-UHFFFAOYSA-N	InChI=1S/C12H20N2O3.C2H4O2/c1-12(2,3)13-6-11(17)8-4-5-10(16)9(7-15)14-8;1-2(3)4/h4-5,11,13,15-17H,6-7H2,1-3H3;1H3,(H,3,4)	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1200893	PROTOKYLOL HYDROCHLORIDE	CC(Cc1ccc2c(c1)OCO2)NCC(O)c1ccc(O)c(O)c1.Cl	LOVXREQUMZKFCM-UHFFFAOYSA-N	InChI=1S/C18H21NO5.ClH/c1-11(6-12-2-5-17-18(7-12)24-10-23-17)19-9-16(22)13-3-4-14(20)15(21)8-13;/h2-5,7-8,11,16,19-22H,6,9-10H2,1H3;1H	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1201061	LEVALBUTEROL HYDROCHLORIDE	CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.Cl	OWNWYCOLFIFTLK-YDALLXLXSA-N	InChI=1S/C13H21NO3.ClH/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;/h4-6,12,14-17H,7-8H2,1-3H3;1H/t12-;/m0./s1	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1951071	ARFORMOTEROL TARTRATE	COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1.O=C(O)C(O)C(O)C(=O)O	FCSXYHUNDAXDRH-QVRIGTRMSA-N	InChI=1S/C19H24N2O4.C4H6O6/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22;5-1(3(7)8)2(6)4(9)10/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22);1-2,5-6H,(H,7,8)(H,9,10)/t13-,19+;/m1./s1	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1200405	BITOLTEROL MESYLATE	CS(=O)(=O)O.Cc1ccc(C(=O)Oc2ccc(C(O)CNC(C)(C)C)cc2OC(=O)c2ccc(C)cc2)cc1	HODFCFXCOMKRCG-UHFFFAOYSA-N	InChI=1S/C28H31NO5.CH4O3S/c1-18-6-10-20(11-7-18)26(31)33-24-15-14-22(23(30)17-29-28(3,4)5)16-25(24)34-27(32)21-12-8-19(2)9-13-21;1-5(2,3)4/h6-16,23,29-30H,17H2,1-5H3;1H3,(H,2,3,4)	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1082607	SALMETEROL XINAFOATE	O=C(O)c1ccc2ccccc2c1O.OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O	XTZNCVSCVHTPAI-UHFFFAOYSA-N	InChI=1S/C25H37NO4.C11H8O3/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21;12-10-8-4-2-1-3-7(8)5-6-9(10)11(13)14/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2;1-6,12H,(H,13,14)	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1367605	RITODRINE HYDROCHLORIDE	CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1.Cl	IDLSITKDRVDKRV-UHFFFAOYSA-N	InChI=1S/C17H21NO3.ClH/c1-12(17(21)14-4-8-16(20)9-5-14)18-11-10-13-2-6-15(19)7-3-13;/h2-9,12,17-21H,10-11H2,1H3;1H	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1789842	INDACATEROL MALEATE	CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2.O=C(O)/C=C\C(=O)O	IREJFXIHXRZFER-PCBAQXHCSA-N	InChI=1S/C24H28N2O3.C4H4O4/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24;5-3(6)1-2-4(7)8/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29);1-2H,(H,5,6)(H,7,8)/b;2-1-/t22-;/m0./s1	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1315867	TERBUTALINE SULFATE	CC(C)(C)NCC(O)c1cc(O)cc(O)c1.CC(C)(C)NCC(O)c1cc(O)cc(O)c1.O=S(=O)(O)O	KFVSLSTULZVNPG-UHFFFAOYSA-N	InChI=1S/2C12H19NO3.H2O4S/c2*1-12(2,3)13-7-11(16)8-4-9(14)6-10(15)5-8;1-5(2,3)4/h2*4-6,11,13-16H,7H2,1-3H3;(H2,1,2,3,4)	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL3989693	LEVALBUTEROL TARTRATE	CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.O=C(O)C(O)C(O)C(=O)O	VNVNZKCCDVFGAP-NMFAMCKASA-N	InChI=1S/2C13H21NO3.C4H6O6/c2*1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;5-1(3(7)8)2(6)4(9)10/h2*4-6,12,14-17H,7-8H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)/t2*12-;/m00./s1	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL3989798	FORMOTEROL FUMARATE	COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1.COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1.O.O.O=C(O)/C=C/C(=O)O	RATSWNOMCHFQGJ-XODSYJLDSA-N	InChI=1S/2C19H24N2O4.C4H4O4.2H2O/c2*1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22;5-3(6)1-2-4(7)8;;/h2*3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22);1-2H,(H,5,6)(H,7,8);2*1H2/b;;2-1+;;	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1568057	METAPROTERENOL SULFATE	CC(C)NCC(O)c1cc(O)cc(O)c1.CC(C)NCC(O)c1cc(O)cc(O)c1.O=S(=O)(O)O	MKFFGUZYVNDHIH-UHFFFAOYSA-N	InChI=1S/2C11H17NO3.H2O4S/c2*1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8;1-5(2,3)4/h2*3-5,7,11-15H,6H2,1-2H3;(H2,1,2,3,4)	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1441059	ALBUTEROL SULFATE	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.O=S(=O)(O)O	BNPSSFBOAGDEEL-UHFFFAOYSA-N	InChI=1S/2C13H21NO3.H2O4S/c2*1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;1-5(2,3)4/h2*4-6,12,14-17H,7-8H2,1-3H3;(H2,1,2,3,4)	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1201153	ISOETHARINE MESYLATE	CCC(NC(C)C)C(O)c1ccc(O)c(O)c1.CS(=O)(=O)O	SOYAGMVKMXZVNZ-UHFFFAOYSA-N	InChI=1S/C13H21NO3.CH4O3S/c1-4-10(14-8(2)3)13(17)9-5-6-11(15)12(16)7-9;1-5(2,3)4/h5-8,10,13-17H,4H2,1-3H3;1H3,(H,2,3,4)	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1200947	METIPRANOLOL HYDROCHLORIDE	CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C.Cl	BLWNYSZZZWQCKO-UHFFFAOYSA-N	InChI=1S/C17H27NO4.ClH/c1-10(2)18-8-15(20)9-21-16-7-11(3)17(22-14(6)19)13(5)12(16)4;/h7,10,15,18,20H,8-9H2,1-6H3;1H	Beta-2 adrenergic receptor antagonist	ANTAGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL649	NADOLOL	CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2	VWPOSFSPZNDTMJ-UCWKZMIHSA-N	InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1	Beta-2 adrenergic receptor antagonist	ANTAGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1201731	NEBIVOLOL HYDROCHLORIDE	Cl.OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1	JWEXHQAEWHKGCW-UHFFFAOYSA-N	InChI=1S/C22H25F2NO4.ClH/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22;/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2;1H	Beta-2 adrenergic receptor antagonist	ANTAGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1200745	OXPRENOLOL HYDROCHLORIDE	C=CCOc1ccccc1OCC(O)CNC(C)C.Cl	COAJXCLTPGGDAJ-UHFFFAOYSA-N	InChI=1S/C15H23NO3.ClH/c1-4-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3;/h4-8,12-13,16-17H,1,9-11H2,2-3H3;1H	Beta-2 adrenergic receptor antagonist	ANTAGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL2361370	PENBUTOLOL SULFATE	CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1.CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1.O=S(=O)(O)O	FEDSNBHHWZEYTP-ZFQYHYQMSA-N	InChI=1S/2C18H29NO2.H2O4S/c2*1-18(2,3)19-12-15(20)13-21-17-11-7-6-10-16(17)14-8-4-5-9-14;1-5(2,3)4/h2*6-7,10-11,14-15,19-20H,4-5,8-9,12-13H2,1-3H3;(H2,1,2,3,4)/t2*15-;/m00./s1	Beta-2 adrenergic receptor antagonist	ANTAGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1201063	PROPAFENONE HYDROCHLORIDE	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1.Cl	XWIHRGFIPXWGEF-UHFFFAOYSA-N	InChI=1S/C21H27NO3.ClH/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17;/h3-11,18,22-23H,2,12-16H2,1H3;1H	Beta-2 adrenergic receptor antagonist	ANTAGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1671	PROPRANOLOL HYDROCHLORIDE	CC(C)NCC(O)COc1cccc2ccccc12.Cl	ZMRUPTIKESYGQW-UHFFFAOYSA-N	InChI=1S/C16H21NO2.ClH/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16;/h3-9,12,14,17-18H,10-11H2,1-2H3;1H	Beta-2 adrenergic receptor antagonist	ANTAGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL500	PINDOLOL	CC(C)NCC(O)COc1cccc2[nH]ccc12	JZQKKSLKJUAGIC-UHFFFAOYSA-N	InChI=1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3	Beta-2 adrenergic receptor partial agonist	PARTIAL AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1700	SOTALOL HYDROCHLORIDE	CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1.Cl	VIDRYROWYFWGSY-UHFFFAOYSA-N	InChI=1S/C12H20N2O3S.ClH/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17;/h4-7,9,12-15H,8H2,1-3H3;1H	Beta-2 adrenergic receptor antagonist	ANTAGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1200920	ISOETHARINE HYDROCHLORIDE	CCC(NC(C)C)C(O)c1ccc(O)c(O)c1.Cl	MUFDLGGSOCHQOC-UHFFFAOYSA-N	InChI=1S/C13H21NO3.ClH/c1-4-10(14-8(2)3)13(17)9-5-6-11(15)12(16)7-9;/h5-8,10,13-17H,4H2,1-3H3;1H	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1201177	LEVOBUNOLOL HYDROCHLORIDE	CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O.Cl	DNTDOBSIBZKFCP-YDALLXLXSA-N	InChI=1S/C17H25NO3.ClH/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20;/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3;1H/t12-;/m0./s1	Beta-2 adrenergic receptor antagonist	ANTAGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1200870	TIMOLOL MALEATE	CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1.O=C(O)/C=C\C(=O)O	WLRMANUAADYWEA-NWASOUNVSA-N	InChI=1S/C13H24N4O3S.C4H4O4/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17;5-3(6)1-2-4(7)8/h10,14,18H,4-9H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t10-;/m0./s1	Beta-2 adrenergic receptor antagonist	ANTAGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL499	TIMOLOL	CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1	BLJRIMJGRPQVNF-JTQLQIEISA-N	InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1	Beta-2 adrenergic receptor antagonist	ANTAGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1200418	DOBUTAMINE HYDROCHLORIDE	CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1.Cl	BQKADKWNRWCIJL-UHFFFAOYSA-N	InChI=1S/C18H23NO3.ClH/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15;/h4-9,12-13,19-22H,2-3,10-11H2,1H3;1H	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1201115	ESMOLOL HYDROCHLORIDE	COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1.Cl	GEKNCWBANDDJJL-UHFFFAOYSA-N	InChI=1S/C16H25NO4.ClH/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3;/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3;1H	Beta-2 adrenergic receptor antagonist	ANTAGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1695	TIAGABINE HYDROCHLORIDE	Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C.Cl	YUKARLAABCGMCN-PKLMIRHRSA-N	InChI=1S/C20H25NO2S2.ClH/c1-14-7-11-24-18(14)17(19-15(2)8-12-25-19)6-4-10-21-9-3-5-16(13-21)20(22)23;/h6-8,11-12,16H,3-5,9-10,13H2,1-2H3,(H,22,23);1H/t16-;/m1./s1	GABA transporter 1 inhibitor	INHIBITOR	CHEMBL1903	GABA transporter 1	Homo sapiens
CHEMBL1670	MITOTANE	Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1	JWBOIMRXGHLCPP-UHFFFAOYSA-N	InChI=1S/C14H10Cl4/c15-10-7-5-9(6-8-10)13(14(17)18)11-3-1-2-4-12(11)16/h1-8,13-14H	Cytochrome P450 11B1 inhibitor	INHIBITOR	CHEMBL1908	Cytochrome P450 11B1	Homo sapiens
CHEMBL1471	APREPITANT	C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	ATALOFNDEOCMKK-OITMNORJSA-N	InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1	Neurokinin 1 receptor antagonist	ANTAGONIST	CHEMBL249	Neurokinin 1 receptor	Homo sapiens
CHEMBL1201782	FOSAPREPITANT DIMEGLUMINE	CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C[C@@H](O[C@H]1OCCN(Cc2nn(P(=O)(O)O)c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	VRQHBYGYXDWZDL-OOZCZQCLSA-N	InChI=1S/C23H22F7N4O6P.2C7H17NO5/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)40-20-19(13-2-4-17(24)5-3-13)33(6-7-39-20)11-18-31-21(35)34(32-18)41(36,37)38;2*1-8-2-4(10)6(12)7(13)5(11)3-9/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H,31,32,35)(H2,36,37,38);2*4-13H,2-3H2,1H3/t12-,19+,20-;2*4-,5+,6+,7+/m100/s1	Neurokinin 1 receptor antagonist	ANTAGONIST	CHEMBL249	Neurokinin 1 receptor	Homo sapiens
CHEMBL231779	APIXABAN	COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1	QNZCBYKSOIHPEH-UHFFFAOYSA-N	InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)	Coagulation factor X inhibitor	INHIBITOR	CHEMBL244	Coagulation factor X	Homo sapiens
CHEMBL198362	RIVAROXABAN	O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1	KGFYHTZWPPHNLQ-AWEZNQCLSA-N	InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1	Coagulation factor X inhibitor	INHIBITOR	CHEMBL244	Coagulation factor X	Homo sapiens
CHEMBL1518	PROPYLTHIOURACIL	CCCc1cc(=O)[nH]c(=S)[nH]1	KNAHARQHSZJURB-UHFFFAOYSA-N	InChI=1S/C7H10N2OS/c1-2-3-5-4-6(10)9-7(11)8-5/h4H,2-3H2,1H3,(H2,8,9,10,11)	Type I iodothyronine deiodinase (Type-I 5'-deiodinase) (DIOI) (Type 1 DI) (5DI) inhibitor	INHIBITOR	CHEMBL2019	Type I iodothyronine deiodinase (Type-I 5'-deiodinase) (DIOI) (Type 1 DI) (5DI)	Homo sapiens
CHEMBL1138	EZETIMIBE	O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1	OLNTVTPDXPETLC-XPWALMASSA-N	InChI=1S/C24H21F2NO3/c25-17-5-1-15(2-6-17)22(29)14-13-21-23(16-3-11-20(28)12-4-16)27(24(21)30)19-9-7-18(26)8-10-19/h1-12,21-23,28-29H,13-14H2/t21-,22+,23-/m1/s1	Niemann-Pick C1-like protein 1 inhibitor	INHIBITOR	CHEMBL2027	Niemann-Pick C1-like protein 1	Homo sapiens
CHEMBL771	CYCLOSERINE	N[C@@H]1CONC1=O	DYDCUQKUCUHJBH-UWTATZPHSA-N	InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m1/s1	Alanine racemase inhibitor	INHIBITOR	CHEMBL2031	Alanine racemase	Mycobacterium tuberculosis
CHEMBL2096642	INAMRINONE LACTATE	CC(O)C(=O)O.Nc1cc(-c2ccncc2)c[nH]c1=O	DOSIONJFGDSKCQ-UHFFFAOYSA-N	InChI=1S/C10H9N3O.C3H6O3/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7;1-2(4)3(5)6/h1-6H,11H2,(H,13,14);2,4H,1H3,(H,5,6)	Phosphodiesterase 3A inhibitor	INHIBITOR	CHEMBL241	Phosphodiesterase 3A	Homo sapiens
CHEMBL799	CILOSTAZOL	O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1	RRGUKTPIGVIEKM-UHFFFAOYSA-N	InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26)	Phosphodiesterase 3A inhibitor	INHIBITOR	CHEMBL241	Phosphodiesterase 3A	Homo sapiens
CHEMBL1200977	MILRINONE LACTATE	CC(O)C(=O)O.Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1	VWUPWEAFIOQCGF-UHFFFAOYSA-N	InChI=1S/C12H9N3O.C3H6O3/c1-8-11(9-2-4-14-5-3-9)6-10(7-13)12(16)15-8;1-2(4)3(5)6/h2-6H,1H3,(H,15,16);2,4H,1H3,(H,5,6)	Phosphodiesterase 3A inhibitor	INHIBITOR	CHEMBL241	Phosphodiesterase 3A	Homo sapiens
CHEMBL1752	DYPHYLLINE	Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O	KSCFJBIXMNOVSH-UHFFFAOYSA-N	InChI=1S/C10H14N4O4/c1-12-8-7(9(17)13(2)10(12)18)14(5-11-8)3-6(16)4-15/h5-6,15-16H,3-4H2,1-2H3	Phosphodiesterase 3A inhibitor	INHIBITOR	CHEMBL241	Phosphodiesterase 3A	Homo sapiens
CHEMBL89598	VIGABATRIN	C=CC(N)CCC(=O)O	PJDFLNIOAUIZSL-UHFFFAOYSA-N	InChI=1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9)	Gamma-amino-N-butyrate transaminase inhibitor	INHIBITOR	CHEMBL2044	Gamma-amino-N-butyrate transaminase	Homo sapiens
CHEMBL374478	RIFAMPIN	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	JQXXHWHPUNPDRT-WLSIYKJHSA-N	InChI=1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1	Bacterial DNA-directed RNA polymerase inhibitor	INHIBITOR	CHEMBL2364672	Bacterial DNA-directed RNA polymerase	Bacteria
CHEMBL444633	RIFABUTIN	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O	ATEBXHFBFRCZMA-VXTBVIBXSA-N	InChI=1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,49,52-54H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14-/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1	Bacterial DNA-directed RNA polymerase inhibitor	INHIBITOR	CHEMBL2364672	Bacterial DNA-directed RNA polymerase	Bacteria
CHEMBL1660	RIFAPENTINE	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	WDZCUPBHRAEYDL-GZAUEHORSA-N	InChI=1S/C47H64N4O12/c1-24-13-12-14-25(2)46(59)49-37-32(23-48-51-20-18-50(19-21-51)31-15-10-11-16-31)41(56)34-35(42(37)57)40(55)29(6)44-36(34)45(58)47(8,63-44)61-22-17-33(60-9)26(3)43(62-30(7)52)28(5)39(54)27(4)38(24)53/h12-14,17,22-24,26-28,31,33,38-39,43,53-57H,10-11,15-16,18-21H2,1-9H3,(H,49,59)/b13-12+,22-17+,25-14-,48-23+/t24-,26+,27+,28+,33-,38-,39+,43+,47-/m0/s1	Bacterial DNA-directed RNA polymerase inhibitor	INHIBITOR	CHEMBL2364672	Bacterial DNA-directed RNA polymerase	Bacteria
CHEMBL1617	RIFAXIMIN	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C	NZCRJKRKKOLAOJ-XRCRFVBUSA-N	InChI=1S/C43H51N3O11/c1-19-14-16-46-28(18-19)44-32-29-30-37(50)25(7)40-31(29)41(52)43(9,57-40)55-17-15-27(54-10)22(4)39(56-26(8)47)24(6)36(49)23(5)35(48)20(2)12-11-13-21(3)42(53)45-33(34(32)46)38(30)51/h11-18,20,22-24,27,35-36,39,48-51H,1-10H3,(H,45,53)/b12-11+,17-15+,21-13-/t20-,22+,23+,24+,27-,35-,36+,39+,43-/m0/s1	Bacterial DNA-directed RNA polymerase inhibitor	INHIBITOR	CHEMBL2364672	Bacterial DNA-directed RNA polymerase	Bacteria
CHEMBL264241	ANIDULAFUNGIN	CCCCCOc1ccc(-c2ccc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)cc5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)cc2)cc1	JHVAMHSQVVQIOT-MFAJLEFUSA-N	InChI=1S/C58H73N7O17/c1-5-6-7-24-82-40-22-18-35(19-23-40)33-10-8-32(9-11-33)34-12-14-37(15-13-34)51(74)59-41-26-43(70)54(77)63-56(79)47-48(71)29(2)27-65(47)58(81)45(31(4)67)61-55(78)46(50(73)49(72)36-16-20-38(68)21-17-36)62-53(76)42-25-39(69)28-64(42)57(80)44(30(3)66)60-52(41)75/h8-23,29-31,39,41-50,54,66-73,77H,5-7,24-28H2,1-4H3,(H,59,74)(H,60,75)(H,61,78)(H,62,76)(H,63,79)/t29-,30+,31+,39+,41-,42-,43+,44-,45-,46-,47-,48-,49-,50-,54+/m0/s1	1,3-beta-glucan synthase inhibitor	INHIBITOR	CHEMBL2364673	1,3-beta-glucan synthase	Candida
CHEMBL4297142	CASPOFUNGIN ACETATE	CC(=O)O.CC(=O)O.CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O	OGUJBRYAAJYXQP-LLXMLGLCSA-N	InChI=1S/C52H88N10O15.2C2H4O2/c1-5-28(2)24-29(3)12-10-8-6-7-9-11-13-39(69)56-34-26-38(68)46(55-22-21-54)60-50(75)43-37(67)19-23-61(43)52(77)41(36(66)18-20-53)58-49(74)42(45(71)44(70)31-14-16-32(64)17-15-31)59-48(73)35-25-33(65)27-62(35)51(76)40(30(4)63)57-47(34)72;2*1-2(3)4/h14-17,28-30,33-38,40-46,55,63-68,70-71H,5-13,18-27,53-54H2,1-4H3,(H,56,69)(H,57,72)(H,58,74)(H,59,73)(H,60,75);2*1H3,(H,3,4)/t28?,29?,30-,33-,34+,35+,36-,37+,38-,40+,41+,42+,43+,44+,45+,46+;;/m1../s1	1,3-beta-glucan synthase inhibitor	INHIBITOR	CHEMBL2364673	1,3-beta-glucan synthase	Candida
CHEMBL1237070	MICAFUNGIN SODIUM	CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)c(OS(=O)(=O)[O-])c5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)no2)cc1.[Na+]	KOOAFHGJVIVFMZ-WZPXRXMFSA-M	InChI=1S/C56H71N9O23S.Na/c1-4-5-6-17-86-32-14-11-28(12-15-32)39-21-33(63-87-39)27-7-9-29(10-8-27)49(75)58-34-20-38(70)52(78)62-54(80)45-46(72)25(2)23-65(45)56(82)43(37(69)22-41(57)71)60-53(79)44(48(74)47(73)30-13-16-36(68)40(18-30)88-89(83,84)85)61-51(77)35-19-31(67)24-64(35)55(81)42(26(3)66)59-50(34)76;/h7-16,18,21,25-26,31,34-35,37-38,42-48,52,66-70,72-74,78H,4-6,17,19-20,22-24H2,1-3H3,(H2,57,71)(H,58,75)(H,59,76)(H,60,79)(H,61,77)(H,62,80)(H,83,84,85);/q;+1/p-1/t25-,26+,31+,34-,35-,37+,38+,42-,43-,44-,45-,46-,47-,48-,52+;/m0./s1	1,3-beta-glucan synthase inhibitor	INHIBITOR	CHEMBL2364673	1,3-beta-glucan synthase	Candida
CHEMBL4297142	CASPOFUNGIN ACETATE	CC(=O)O.CC(=O)O.CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O	OGUJBRYAAJYXQP-LLXMLGLCSA-N	InChI=1S/C52H88N10O15.2C2H4O2/c1-5-28(2)24-29(3)12-10-8-6-7-9-11-13-39(69)56-34-26-38(68)46(55-22-21-54)60-50(75)43-37(67)19-23-61(43)52(77)41(36(66)18-20-53)58-49(74)42(45(71)44(70)31-14-16-32(64)17-15-31)59-48(73)35-25-33(65)27-62(35)51(76)40(30(4)63)57-47(34)72;2*1-2(3)4/h14-17,28-30,33-38,40-46,55,63-68,70-71H,5-13,18-27,53-54H2,1-4H3,(H,56,69)(H,57,72)(H,58,74)(H,59,73)(H,60,75);2*1H3,(H,3,4)/t28?,29?,30-,33-,34+,35+,36-,37+,38-,40+,41+,42+,43+,44+,45+,46+;;/m1../s1	1,3-beta-glucan synthase inhibitor	INHIBITOR	CHEMBL2364674	1,3-beta-glucan synthase	Aspergillus
CHEMBL2095208	COBICISTAT	CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1	ZCIGNRJZKPOIKD-CQXVEOKZSA-N	InChI=1S/C40H53N7O5S2/c1-29(2)38-43-34(27-53-38)25-46(3)39(49)45-36(16-17-47-18-20-51-21-19-47)37(48)42-32(22-30-10-6-4-7-11-30)14-15-33(23-31-12-8-5-9-13-31)44-40(50)52-26-35-24-41-28-54-35/h4-13,24,27-29,32-33,36H,14-23,25-26H2,1-3H3,(H,42,48)(H,44,50)(H,45,49)/t32-,33-,36+/m1/s1	Cytochrome P450 3A inhibitor	INHIBITOR	CHEMBL2364675	Cytochrome P450 3A	Homo sapiens
CHEMBL3989678	PIPERAZINE CITRATE	C1CNCCN1.C1CNCCN1.C1CNCCN1.O.O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C(O)CC(O)(CC(=O)O)C(=O)O	LWMBPKJYEQGDLN-UHFFFAOYSA-N	InChI=1S/2C6H8O7.3C4H10N2.H2O/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;3*1-2-6-4-3-5-1;/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);3*5-6H,1-4H2;1H2	Nematode GABA-A receptor positive modulator	POSITIVE MODULATOR	CHEMBL2364676	Nematode GABA-A receptor	Onchocercidae
CHEMBL937	DIETHYLCARBAMAZINE CITRATE	CCN(CC)C(=O)N1CCN(C)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O	PGNKBEARDDELNB-UHFFFAOYSA-N	InChI=1S/C10H21N3O.C6H8O7/c1-4-12(5-2)10(14)13-8-6-11(3)7-9-13;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-9H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)	Nematode GABA-A receptor positive modulator	POSITIVE MODULATOR	CHEMBL2364676	Nematode GABA-A receptor	Onchocercidae
CHEMBL496	HEXACHLOROPHENE	Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl	ACGUYXCXAPNIKK-UHFFFAOYSA-N	InChI=1S/C13H6Cl6O2/c14-6-2-8(16)12(20)4(10(6)18)1-5-11(19)7(15)3-9(17)13(5)21/h2-3,20-21H,1H2	Bacterial enoyl-[acyl-carrier-protein] reductase inhibitor	INHIBITOR	CHEMBL2364678	Bacterial enoyl-[acyl-carrier-protein] reductase	Bacteria
CHEMBL849	TRICLOSAN	Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl	XEFQLINVKFYRCS-UHFFFAOYSA-N	InChI=1S/C12H7Cl3O2/c13-7-1-3-11(9(15)5-7)17-12-4-2-8(14)6-10(12)16/h1-6,16H	Bacterial enoyl-[acyl-carrier-protein] reductase inhibitor	INHIBITOR	CHEMBL2364678	Bacterial enoyl-[acyl-carrier-protein] reductase	Bacteria
CHEMBL1200397	BUTENAFINE HYDROCHLORIDE	CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12.Cl	LJBSAUIFGPSHCN-UHFFFAOYSA-N	InChI=1S/C23H27N.ClH/c1-23(2,3)21-14-12-18(13-15-21)16-24(4)17-20-10-7-9-19-8-5-6-11-22(19)20;/h5-15H,16-17H2,1-4H3;1H	Squalene monooxygenase inhibitor	INHIBITOR	CHEMBL2364679	Squalene monooxygenase	Trichophyton
CHEMBL1200832	TERBINAFINE HYDROCHLORIDE	CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12.Cl	BWMISRWJRUSYEX-SZKNIZGXSA-N	InChI=1S/C21H25N.ClH/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19;/h5-7,9-14H,16-17H2,1-4H3;1H/b9-5+;	Squalene monooxygenase inhibitor	INHIBITOR	CHEMBL2364679	Squalene monooxygenase	Trichophyton
CHEMBL822	TERBINAFINE	CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12	DOMXUEMWDBAQBQ-WEVVVXLNSA-N	InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+	Squalene monooxygenase inhibitor	INHIBITOR	CHEMBL2364679	Squalene monooxygenase	Trichophyton
CHEMBL1200493	NAFTIFINE HYDROCHLORIDE	CN(C/C=C/c1ccccc1)Cc1cccc2ccccc12.Cl	OLUNPKFOFGZHRT-YGCVIUNWSA-N	InChI=1S/C21H21N.ClH/c1-22(16-8-11-18-9-3-2-4-10-18)17-20-14-7-13-19-12-5-6-15-21(19)20;/h2-15H,16-17H2,1H3;1H/b11-8+;	Squalene monooxygenase inhibitor	INHIBITOR	CHEMBL2364679	Squalene monooxygenase	Trichophyton
CHEMBL1463	FLUCYTOSINE	Nc1[nH]c(=O)ncc1F	XRECTZIEBJDKEO-UHFFFAOYSA-N	InChI=1S/C4H4FN3O/c5-2-1-7-4(9)8-3(2)6/h1H,(H3,6,7,8,9)	Thymidylate synthase inhibitor	INHIBITOR	CHEMBL2364680	Thymidylate synthase	Candida albicans
CHEMBL2105662	LOMITAPIDE MESYLATE	CS(=O)(=O)O.O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1	QKVKOFVWUHNEBX-UHFFFAOYSA-N	InChI=1S/C39H37F6N3O2.CH4O3S/c40-38(41,42)25-46-36(50)37(33-13-5-3-10-30(33)31-11-4-6-14-34(31)37)21-7-8-22-48-23-19-28(20-24-48)47-35(49)32-12-2-1-9-29(32)26-15-17-27(18-16-26)39(43,44)45;1-5(2,3)4/h1-6,9-18,28H,7-8,19-25H2,(H,46,50)(H,47,49);1H3,(H,2,3,4)	Microsomal triglyceride transfer protein inhibitor	INHIBITOR	CHEMBL2364681	Microsomal triglyceride transfer protein	Homo sapiens
CHEMBL1374379	BENZONATATE	CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1	MAFMQEKGGFWBAB-UHFFFAOYSA-N	InChI=1S/C30H53NO11/c1-3-4-9-31-29-7-5-28(6-8-29)30(32)42-27-26-41-25-24-40-23-22-39-21-20-38-19-18-37-17-16-36-15-14-35-13-12-34-11-10-33-2/h5-8,31H,3-4,9-27H2,1-2H3	Slowly adapting pulmonary stretch receptor inhibitor	INHIBITOR	CHEMBL2364682	Slowly adapting pulmonary stretch receptor	Homo sapiens
CHEMBL734	ACETOHYDROXAMIC ACID	CC(=O)NO	RRUDCFGSUDOHDG-UHFFFAOYSA-N	InChI=1S/C2H5NO2/c1-2(4)3-5/h5H,1H3,(H,3,4)	Bacterial urease inhibitor	INHIBITOR	CHEMBL2364683	Bacterial urease	Bacteria
CHEMBL1200453	DOCOSANOL	CCCCCCCCCCCCCCCCCCCCCCO	NOPFSRXAKWQILS-UHFFFAOYSA-N	InChI=1S/C22H46O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23/h23H,2-22H2,1H3	Envelope glycoprotein inhibitor	INHIBITOR	CHEMBL2364696	Envelope glycoprotein	Human herpesvirus 1
CHEMBL1201041	AZLOCILLIN SODIUM	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]	UVOCNBWUHNCKJM-XFAPPKAWSA-M	InChI=1S/C20H23N5O6S.Na/c1-20(2)13(17(28)29)25-15(27)12(16(25)32-20)22-14(26)11(10-6-4-3-5-7-10)23-19(31)24-9-8-21-18(24)30;/h3-7,11-13,16H,8-9H2,1-2H3,(H,21,30)(H,22,26)(H,23,31)(H,28,29);/q;+1/p-1/t11-,12-,13+,16-;/m1./s1	Penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2363020	Penicillin-binding protein	Pseudomonas aeruginosa
CHEMBL1200388	CLOXACILLIN SODIUM	Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.O.[Na+]	KCUWTKOTPIUBRI-VICXVTCVSA-M	InChI=1S/C19H18ClN3O5S.Na.H2O/c1-8-11(12(22-28-8)9-6-4-5-7-10(9)20)15(24)21-13-16(25)23-14(18(26)27)19(2,3)29-17(13)23;;/h4-7,13-14,17H,1-3H3,(H,21,24)(H,26,27);;1H2/q;+1;/p-1/t13-,14+,17-;;/m1../s1	Penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2363021	Penicillin-binding protein	Staphylococcus
CHEMBL3181832	METHICILLIN SODIUM	COc1cccc(OC)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.O.[Na+]	NRZPASQBOYNGHR-HWROMZCQSA-M	InChI=1S/C17H20N2O6S.Na.H2O/c1-17(2)12(16(22)23)19-14(21)11(15(19)26-17)18-13(20)10-8(24-3)6-5-7-9(10)25-4;;/h5-7,11-12,15H,1-4H3,(H,18,20)(H,22,23);;1H2/q;+1;/p-1/t11-,12+,15-;;/m1../s1	Penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2363021	Penicillin-binding protein	Staphylococcus
CHEMBL451887	CARFILZOMIB	CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1	BLMPQMFVWMYDKT-NZTKNTHTSA-N	InChI=1S/C40H57N5O7/c1-27(2)22-32(36(47)40(5)26-52-40)42-39(50)34(24-30-14-10-7-11-15-30)44-38(49)33(23-28(3)4)43-37(48)31(17-16-29-12-8-6-9-13-29)41-35(46)25-45-18-20-51-21-19-45/h6-15,27-28,31-34H,16-26H2,1-5H3,(H,41,46)(H,42,50)(H,43,48)(H,44,49)/t31-,32-,33-,34-,40+/m0/s1	26S proteosome inhibitor	INHIBITOR	CHEMBL2364701	26S proteasome	Homo sapiens
CHEMBL325041	BORTEZOMIB	CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O	GXJABQQUPOEUTA-RDJZCZTQSA-N	InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1	26S proteosome inhibitor	INHIBITOR	CHEMBL2364701	26S proteasome	Homo sapiens
CHEMBL1201131	PIPERONYL BUTOXIDE	CCCCOCCOCCOCc1cc2c(cc1CCC)OCO2	FIPWRIJSWJWJAI-UHFFFAOYSA-N	InChI=1S/C19H30O5/c1-3-5-7-20-8-9-21-10-11-22-14-17-13-19-18(23-15-24-19)12-16(17)6-4-2/h12-13H,3-11,14-15H2,1-2H3	Cytochrome P450 inhibitor	INHIBITOR	CHEMBL2364702	Cytochrome P450	Pediculus humanus capitis
CHEMBL562	GRISEOFULVIN	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O	DDUHZTYCFQRHIY-RBHXEPJQSA-N	InChI=1S/C17H17ClO6/c1-8-5-9(19)6-12(23-4)17(8)16(20)13-10(21-2)7-11(22-3)14(18)15(13)24-17/h6-8H,5H2,1-4H3/t8-,17+/m1/s1	Tubulin inhibitor	INHIBITOR	CHEMBL2364703	Tubulin	Trichophyton
CHEMBL685	MEBENDAZOLE	COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1	OPXLLQIJSORQAM-UHFFFAOYSA-N	InChI=1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,21)	Tubulin inhibitor	INHIBITOR	CHEMBL2364704	Tubulin	Taeniidae
CHEMBL625	THIABENDAZOLE	c1ccc2[nH]c(-c3cscn3)nc2c1	WJCNZQLZVWNLKY-UHFFFAOYSA-N	InChI=1S/C10H7N3S/c1-2-4-8-7(3-1)12-10(13-8)9-5-14-6-11-9/h1-6H,(H,12,13)	Tubulin inhibitor	INHIBITOR	CHEMBL2364704	Tubulin	Taeniidae
CHEMBL1483	ALBENDAZOLE	CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1	HXHWSAZORRCQMX-UHFFFAOYSA-N	InChI=1S/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)	Tubulin inhibitor	INHIBITOR	CHEMBL2364704	Tubulin	Taeniidae
CHEMBL1483	ALBENDAZOLE	CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1	HXHWSAZORRCQMX-UHFFFAOYSA-N	InChI=1S/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)	Tubulin inhibitor	INHIBITOR	CHEMBL2364705	Tubulin	Nematoda
CHEMBL685	MEBENDAZOLE	COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1	OPXLLQIJSORQAM-UHFFFAOYSA-N	InChI=1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,21)	Tubulin inhibitor	INHIBITOR	CHEMBL2364705	Tubulin	Nematoda
CHEMBL625	THIABENDAZOLE	c1ccc2[nH]c(-c3cscn3)nc2c1	WJCNZQLZVWNLKY-UHFFFAOYSA-N	InChI=1S/C10H7N3S/c1-2-4-8-7(3-1)12-10(13-8)9-5-14-6-11-9/h1-6H,(H,12,13)	Tubulin inhibitor	INHIBITOR	CHEMBL2364705	Tubulin	Nematoda
CHEMBL1282	IMIQUIMOD	CC(C)Cn1cnc2c(N)nc3ccccc3c21	DOUYETYNHWVLEO-UHFFFAOYSA-N	InChI=1S/C14H16N4/c1-9(2)7-18-8-16-12-13(18)10-5-3-4-6-11(10)17-14(12)15/h3-6,8-9H,7H2,1-2H3,(H2,15,17)	Toll-like receptor 7 agonist	AGONIST	CHEMBL5936	Toll-like receptor 7	Homo sapiens
CHEMBL1690	HYDROXYCHLOROQUINE SULFATE	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=S(=O)(O)O	JCBIVZZPXRZKTI-UHFFFAOYSA-N	InChI=1S/C18H26ClN3O.H2O4S/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18;1-5(2,3)4/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21);(H2,1,2,3,4)	Toll-like receptor 7 antagonist	ANTAGONIST	CHEMBL5936	Toll-like receptor 7	Homo sapiens
CHEMBL104	CLOTRIMAZOLE	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1	VNFPBHJOKIVQEB-UHFFFAOYSA-N	InChI=1S/C22H17ClN2/c23-21-14-8-7-13-20(21)22(25-16-15-24-17-25,18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-17H	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL1201049	ECONAZOLE NITRATE	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1.O=[N+]([O-])O	DDXORDQKGIZAME-UHFFFAOYSA-N	InChI=1S/C18H15Cl3N2O.HNO3/c19-14-3-1-13(2-4-14)11-24-18(10-23-8-7-22-12-23)16-6-5-15(20)9-17(16)21;2-1(3)4/h1-9,12,18H,10-11H2;(H,2,3,4)	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL638	VORICONAZOLE	C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F	BCEHBSKCWLPMDN-MGPLVRAMSA-N	InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL157101	KETOCONAZOLE	CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1	XMAYWYJOQHXEEK-UHFFFAOYSA-N	InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL91	MICONAZOLE	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1	BYBLEWFAAKGYCD-UHFFFAOYSA-N	InChI=1S/C18H14Cl4N2O/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22/h1-8,11,18H,9-10H2	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL64391	ITRACONAZOLE	CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O	VHVPQPYKVGDNFY-UHFFFAOYSA-N	InChI=1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL1306	TERCONAZOLE	CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1	BLSQLHNBWJLIBQ-OZXSUGGESA-N	InChI=1S/C26H31Cl2N5O3/c1-19(2)31-9-11-32(12-10-31)21-4-6-22(7-5-21)34-14-23-15-35-26(36-23,16-33-18-29-17-30-33)24-8-3-20(27)13-25(24)28/h3-8,13,17-19,23H,9-12,14-16H2,1-2H3/t23-,26-/m0/s1	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL1559	MICONAZOLE NITRATE	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1.O=[N+]([O-])O	MCCACAIVAXEFAL-UHFFFAOYSA-N	InChI=1S/C18H14Cl4N2O.HNO3/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22;2-1(3)4/h1-8,11,18H,9-10H2;(H,2,3,4)	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL106	FLUCONAZOLE	OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F	RFHAOTPXVQNOHP-UHFFFAOYSA-N	InChI=1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL1200348	SULCONAZOLE NITRATE	Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1.O=[N+]([O-])O	CRKGMGQUHDNAPB-UHFFFAOYSA-N	InChI=1S/C18H15Cl3N2S.HNO3/c19-14-3-1-13(2-4-14)11-24-18(10-23-8-7-22-12-23)16-6-5-15(20)9-17(16)21;2-1(3)4/h1-9,12,18H,10-11H2;(H,2,3,4)	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL1200438	TIOCONAZOLE	Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1	QXHHHPZILQDDPS-UHFFFAOYSA-N	InChI=1S/C16H13Cl3N2OS/c17-12-1-2-13(14(18)7-12)15(8-21-5-4-20-10-21)22-9-11-3-6-23-16(11)19/h1-7,10,15H,8-9H2	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL1397	POSACONAZOLE	CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O	RAGOYPUPXAKGKH-XAKZXMRKSA-N	InChI=1S/C37H42F2N8O4/c1-3-35(26(2)48)47-36(49)46(25-42-47)31-7-5-29(6-8-31)43-14-16-44(17-15-43)30-9-11-32(12-10-30)50-20-27-19-37(51-21-27,22-45-24-40-23-41-45)33-13-4-28(38)18-34(33)39/h4-13,18,23-27,35,48H,3,14-17,19-22H2,1-2H3/t26-,27+,35-,37-/m0/s1	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL1200725	SERTACONAZOLE NITRATE	Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1.O=[N+]([O-])O	HAAITRDZHUANGT-UHFFFAOYSA-N	InChI=1S/C20H15Cl3N2OS.HNO3/c21-14-4-5-16(18(23)8-14)19(9-25-7-6-24-12-25)26-10-13-11-27-20-15(13)2-1-3-17(20)22;2-1(3)4/h1-8,11-12,19H,9-10H2;(H,2,3,4)	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL1200398	BUTOCONAZOLE NITRATE	Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1.O=[N+]([O-])O	ZHPWRQIPPNZNML-UHFFFAOYSA-N	InChI=1S/C19H17Cl3N2S.HNO3/c20-15-7-4-14(5-8-15)6-9-16(12-24-11-10-23-13-24)25-19-17(21)2-1-3-18(19)22;2-1(3)4/h1-5,7-8,10-11,13,16H,6,9,12H2;(H,2,3,4)	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL1200836	OXICONAZOLE NITRATE	Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1.O=[N+]([O-])O	WVNOAGNOIPTWPT-NDUABGMUSA-N	InChI=1S/C18H13Cl4N3O.HNO3/c19-13-2-1-12(16(21)7-13)10-26-24-18(9-25-6-5-23-11-25)15-4-3-14(20)8-17(15)22;2-1(3)4/h1-8,11H,9-10H2;(H,2,3,4)/b24-18+;	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL122	ROFECOXIB	CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1	RZJQGNCSTQAWON-UHFFFAOYSA-N	InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3	Cyclooxygenase-2 inhibitor	INHIBITOR	CHEMBL230	Cyclooxygenase-2	Homo sapiens
CHEMBL1316	CARPROFEN	CC(C(=O)O)c1ccc2c(c1)[nH]c1ccc(Cl)cc12	PUXBGTOOZJQSKH-UHFFFAOYSA-N	InChI=1S/C15H12ClNO2/c1-8(15(18)19)9-2-4-11-12-7-10(16)3-5-13(12)17-14(11)6-9/h2-8,17H,1H3,(H,18,19)	Cyclooxygenase-2 inhibitor	INHIBITOR	CHEMBL230	Cyclooxygenase-2	Homo sapiens
CHEMBL599	MELOXICAM	Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1	ZRVUJXDFFKFLMG-UHFFFAOYSA-N	InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)	Cyclooxygenase-2 inhibitor	INHIBITOR	CHEMBL230	Cyclooxygenase-2	Homo sapiens
CHEMBL1070	NABUMETONE	COc1ccc2cc(CCC(C)=O)ccc2c1	BLXXJMDCKKHMKV-UHFFFAOYSA-N	InChI=1S/C15H16O2/c1-11(16)3-4-12-5-6-14-10-15(17-2)8-7-13(14)9-12/h5-10H,3-4H2,1-2H3	Cyclooxygenase-2 inhibitor	INHIBITOR	CHEMBL230	Cyclooxygenase-2	Homo sapiens
CHEMBL865	VALDECOXIB	Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1	LNPDTQAFDNKSHK-UHFFFAOYSA-N	InChI=1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20)	Cyclooxygenase-2 inhibitor	INHIBITOR	CHEMBL230	Cyclooxygenase-2	Homo sapiens
CHEMBL118	CELECOXIB	Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1	RZEKVGVHFLEQIL-UHFFFAOYSA-N	InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)	Cyclooxygenase-2 inhibitor	INHIBITOR	CHEMBL230	Cyclooxygenase-2	Homo sapiens
CHEMBL622	ETODOLAC	CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3	NNYBQONXHNTVIJ-UHFFFAOYSA-N	InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)	Cyclooxygenase-2 inhibitor	INHIBITOR	CHEMBL230	Cyclooxygenase-2	Homo sapiens
CHEMBL2218896	NABILONE	CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21	GECBBEABIDMGGL-UHFFFAOYSA-N	InChI=1S/C24H36O3/c1-6-7-8-9-12-23(2,3)16-13-20(26)22-18-15-17(25)10-11-19(18)24(4,5)27-21(22)14-16/h13-14,18-19,26H,6-12,15H2,1-5H3	Cannabinoid CB1 receptor agonist	AGONIST	CHEMBL218	Cannabinoid CB1 receptor	Homo sapiens
CHEMBL465	DRONABINOL	CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21	CYQFCXCEBYINGO-IAGOWNOFSA-N	InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1	Cannabinoid CB1 receptor agonist	AGONIST	CHEMBL218	Cannabinoid CB1 receptor	Homo sapiens
CHEMBL754	FOSCARNET SODIUM	O=C([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+]	DFHAXXVZCFXGOQ-UHFFFAOYSA-K	InChI=1S/CH3O5P.3Na/c2-1(3)7(4,5)6;;;/h(H,2,3)(H2,4,5,6);;;/q;3*+1/p-3	Human herpesvirus 1 DNA polymerase inhibitor	INHIBITOR	CHEMBL1872	Human herpesvirus 1 DNA polymerase	Herpes simplex virus (type 1 / strain 17)
CHEMBL152	CIDOFOVIR	Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1	VWFCHDSQECPREK-LURJTMIESA-N	InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1	Human herpesvirus 1 DNA polymerase inhibitor	INHIBITOR	CHEMBL1872	Human herpesvirus 1 DNA polymerase	Herpes simplex virus (type 1 / strain 17)
CHEMBL2079793	PENCICLOVIR SODIUM	Nc1nc([O-])c2ncn(CCC(CO)CO)c2n1.[Na+]	NMQFQBOIHUIALG-UHFFFAOYSA-M	InChI=1S/C10H15N5O3.Na/c11-10-13-8-7(9(18)14-10)12-5-15(8)2-1-6(3-16)4-17;/h5-6,16-17H,1-4H2,(H3,11,13,14,18);/q;+1/p-1	Human herpesvirus 1 DNA polymerase inhibitor	INHIBITOR	CHEMBL1872	Human herpesvirus 1 DNA polymerase	Herpes simplex virus (type 1 / strain 17)
CHEMBL1200850	GANCICLOVIR SODIUM	Nc1nc([O-])c2ncn(COC(CO)CO)c2n1.[Na+]	JJICLMJFIKGAAU-UHFFFAOYSA-M	InChI=1S/C9H13N5O4.Na/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16;/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17);/q;+1/p-1	Human herpesvirus 1 DNA polymerase inhibitor	INHIBITOR	CHEMBL1872	Human herpesvirus 1 DNA polymerase	Herpes simplex virus (type 1 / strain 17)
CHEMBL182	GANCICLOVIR	Nc1nc(O)c2ncn(COC(CO)CO)c2n1	IRSCQMHQWWYFCW-UHFFFAOYSA-N	InChI=1S/C9H13N5O4/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17)	Human herpesvirus 1 DNA polymerase inhibitor	INHIBITOR	CHEMBL1872	Human herpesvirus 1 DNA polymerase	Herpes simplex virus (type 1 / strain 17)
CHEMBL184	ACYCLOVIR	Nc1nc(O)c2ncn(COCCO)c2n1	MKUXAQIIEYXACX-UHFFFAOYSA-N	InChI=1S/C8H11N5O3/c9-8-11-6-5(7(15)12-8)10-3-13(6)4-16-2-1-14/h3,14H,1-2,4H2,(H3,9,11,12,15)	Human herpesvirus 1 DNA polymerase inhibitor	INHIBITOR	CHEMBL1872	Human herpesvirus 1 DNA polymerase	Herpes simplex virus (type 1 / strain 17)
CHEMBL1200454	VALGANCICLOVIR HYDROCHLORIDE	CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)nc(N)[nH]c21.Cl	ZORWARFPXPVJLW-MTFPJWTKSA-N	InChI=1S/C14H22N6O5.ClH/c1-7(2)9(15)13(23)24-4-8(3-21)25-6-20-5-17-10-11(20)18-14(16)19-12(10)22;/h5,7-9,21H,3-4,6,15H2,1-2H3,(H3,16,18,19,22);1H/t8?,9-;/m0./s1	Human herpesvirus 1 DNA polymerase inhibitor	INHIBITOR	CHEMBL1872	Human herpesvirus 1 DNA polymerase	Herpes simplex virus (type 1 / strain 17)
CHEMBL1090	VIDARABINE	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	OIRDTQYFTABQOQ-UHTZMRCNSA-N	InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7+,10-/m1/s1	Human herpesvirus 1 DNA polymerase inhibitor	INHIBITOR	CHEMBL1872	Human herpesvirus 1 DNA polymerase	Herpes simplex virus (type 1 / strain 17)
CHEMBL1200380	ACYCLOVIR SODIUM	Nc1nc([O-])c2ncn(COCCO)c2n1.[Na+]	RMLUKZWYIKEASN-UHFFFAOYSA-M	InChI=1S/C8H11N5O3.Na/c9-8-11-6-5(7(15)12-8)10-3-13(6)4-16-2-1-14;/h3,14H,1-2,4H2,(H3,9,11,12,15);/q;+1/p-1	Human herpesvirus 1 DNA polymerase inhibitor	INHIBITOR	CHEMBL1872	Human herpesvirus 1 DNA polymerase	Herpes simplex virus (type 1 / strain 17)
CHEMBL880	FAMCICLOVIR	CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O	GGXKWVWZWMLJEH-UHFFFAOYSA-N	InChI=1S/C14H19N5O4/c1-9(20)22-6-11(7-23-10(2)21)3-4-19-8-17-12-5-16-14(15)18-13(12)19/h5,8,11H,3-4,6-7H2,1-2H3,(H2,15,16,18)	Human herpesvirus 1 DNA polymerase inhibitor	INHIBITOR	CHEMBL1872	Human herpesvirus 1 DNA polymerase	Herpes simplex virus (type 1 / strain 17)
CHEMBL1201110	VALACYCLOVIR HYDROCHLORIDE	CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21.Cl	ZCDDBUOENGJMLV-QRPNPIFTSA-N	InChI=1S/C13H20N6O4.ClH/c1-7(2)8(14)12(21)23-4-3-22-6-19-5-16-9-10(19)17-13(15)18-11(9)20;/h5,7-8H,3-4,6,14H2,1-2H3,(H3,15,17,18,20);1H/t8-;/m0./s1	Human herpesvirus 1 DNA polymerase inhibitor	INHIBITOR	CHEMBL1872	Human herpesvirus 1 DNA polymerase	Herpes simplex virus (type 1 / strain 17)
CHEMBL1668	RESCINNAMINE	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC	SZLZWPPUNLXJEA-QEGASFHISA-N	InChI=1S/C35H42N2O9/c1-40-21-8-9-22-23-11-12-37-18-20-15-29(46-30(38)10-7-19-13-27(41-2)33(43-4)28(14-19)42-3)34(44-5)31(35(39)45-6)24(20)17-26(37)32(23)36-25(22)16-21/h7-10,13-14,16,20,24,26,29,31,34,36H,11-12,15,17-18H2,1-6H3/b10-7+/t20-,24+,26-,29-,31+,34+/m1/s1	Synaptic vesicular amine transporter inhibitor	INHIBITOR	CHEMBL1893	Synaptic vesicular amine transporter	Homo sapiens
CHEMBL772	RESERPINE	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC	QEVHRUUCFGRFIF-MDEJGZGSSA-N	InChI=1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-24(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1	Synaptic vesicular amine transporter inhibitor	INHIBITOR	CHEMBL1893	Synaptic vesicular amine transporter	Homo sapiens
CHEMBL1200515	DESERPIDINE	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5ccccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC	CVBMAZKKCSYWQR-WCGOZPBSSA-N	InChI=1S/C32H38N2O8/c1-37-24-12-17(13-25(38-2)29(24)39-3)31(35)42-26-14-18-16-34-11-10-20-19-8-6-7-9-22(19)33-28(20)23(34)15-21(18)27(30(26)40-4)32(36)41-5/h6-9,12-13,18,21,23,26-27,30,33H,10-11,14-16H2,1-5H3/t18-,21+,23-,26-,27+,30+/m1/s1	Synaptic vesicular amine transporter inhibitor	INHIBITOR	CHEMBL1893	Synaptic vesicular amine transporter	Homo sapiens
CHEMBL117785	TETRABENAZINE	COc1cc2c(cc1OC)C1CC(=O)C(CC(C)C)CN1CC2	MKJIEFSOBYUXJB-UHFFFAOYSA-N	InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3	Synaptic vesicular amine transporter inhibitor	INHIBITOR	CHEMBL1893	Synaptic vesicular amine transporter	Homo sapiens
CHEMBL3989844	DEXTROAMPHETAMINE SACCHARATE	C[C@H](N)Cc1ccccc1.O=C(O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O	VHKVKWTWHZUFIA-DGOKBZBKSA-N	InChI=1S/C9H13N.C6H10O8/c1-8(10)7-9-5-3-2-4-6-9;7-1(3(9)5(11)12)2(8)4(10)6(13)14/h2-6,8H,7,10H2,1H3;1-4,7-10H,(H,11,12)(H,13,14)/t8-;1-,2-,3-,4+/m00/s1	Synaptic vesicular amine transporter inhibitor	INHIBITOR	CHEMBL1893	Synaptic vesicular amine transporter	Homo sapiens
CHEMBL3544971	DEXTROAMPHETAMINE SULFATE	C[C@H](N)Cc1ccccc1.C[C@H](N)Cc1ccccc1.O=S(=O)(O)O	PYHRZPFZZDCOPH-QXGOIDDHSA-N	InChI=1S/2C9H13N.H2O4S/c2*1-8(10)7-9-5-3-2-4-6-9;1-5(2,3)4/h2*2-6,8H,7,10H2,1H3;(H2,1,2,3,4)/t2*8-;/m00./s1	Synaptic vesicular amine transporter inhibitor	INHIBITOR	CHEMBL1893	Synaptic vesicular amine transporter	Homo sapiens
CHEMBL3544906	BENZPHETAMINE HYDROCHLORIDE	C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1.Cl	ANFSNXAXVLRZCG-RSAXXLAASA-N	InChI=1S/C17H21N.ClH/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17;/h3-12,15H,13-14H2,1-2H3;1H/t15-;/m0./s1	Synaptic vesicular amine transporter inhibitor	INHIBITOR	CHEMBL1893	Synaptic vesicular amine transporter	Homo sapiens
CHEMBL1200782	DEXTROAMPHETAMINE ADIPATE	C[C@H](N)Cc1ccccc1.O=C(O)CCCCC(=O)O	OFCJKOOVFDGTLY-QRPNPIFTSA-N	InChI=1S/C9H13N.C6H10O4/c1-8(10)7-9-5-3-2-4-6-9;7-5(8)3-1-2-4-6(9)10/h2-6,8H,7,10H2,1H3;1-4H2,(H,7,8)(H,9,10)/t8-;/m0./s1	Synaptic vesicular amine transporter inhibitor	INHIBITOR	CHEMBL1893	Synaptic vesicular amine transporter	Homo sapiens
CHEMBL612	DEXTROAMPHETAMINE	C[C@H](N)Cc1ccccc1	KWTSXDURSIMDCE-QMMMGPOBSA-N	InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1	Synaptic vesicular amine transporter inhibitor	INHIBITOR	CHEMBL1893	Synaptic vesicular amine transporter	Homo sapiens
CHEMBL1201178	LISDEXAMFETAMINE DIMESYLATE	CS(=O)(=O)O.CS(=O)(=O)O.C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN	CETWSOHVEGTIBR-FORAGAHYSA-N	InChI=1S/C15H25N3O.2CH4O3S/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16;2*1-5(2,3)4/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19);2*1H3,(H,2,3,4)/t12-,14-;;/m0../s1	Synaptic vesicular amine transporter inhibitor	INHIBITOR	CHEMBL1893	Synaptic vesicular amine transporter	Homo sapiens
CHEMBL2218878	TRIMETREXATE GLUCURONATE	COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC.O=C(O)[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O	DQOGWKZQQBYYMW-LQGIGNHCSA-N	InChI=1S/C19H23N5O3.C6H10O7/c1-10-11(5-6-13-16(10)18(20)24-19(21)23-13)9-22-12-7-14(25-2)17(27-4)15(8-12)26-3;7-1-2(8)4(5(10)11)13-6(12)3(1)9/h5-8,22H,9H2,1-4H3,(H4,20,21,23,24);1-4,6-9,12H,(H,10,11)/t;1-,2-,3+,4-,6-/m.0/s1	Dihydrofolate reductase inhibitor	INHIBITOR	CHEMBL1926	Dihydrofolate reductase	Pneumocystis carinii
CHEMBL98	VORINOSTAT	O=C(CCCCCCC(=O)Nc1ccccc1)NO	WAEXFXRVDQXREF-UHFFFAOYSA-N	InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)	Histone deacetylase 2 inhibitor	INHIBITOR	CHEMBL1937	Histone deacetylase 2	Homo sapiens
CHEMBL282042	SAQUINAVIR MESYLATE	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1.CS(=O)(=O)O	IRHXGOXEBNJUSN-YOXDLBRISA-N	InChI=1S/C38H50N6O5.CH4O3S/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29;1-5(2,3)4/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49);1H3,(H,2,3,4)/t26-,27+,30-,31-,32-,33+;/m0./s1	Human immunodeficiency virus type 1 protease inhibitor	INHIBITOR	CHEMBL243	Human immunodeficiency virus type 1 protease	Human immunodeficiency virus 1
CHEMBL163	RITONAVIR	CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1	NCDNCNXCDXHOMX-XGKFQTDJSA-N	InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1	Human immunodeficiency virus type 1 protease inhibitor	INHIBITOR	CHEMBL243	Human immunodeficiency virus type 1 protease	Human immunodeficiency virus 1
CHEMBL1205	NELFINAVIR MESYLATE	CS(=O)(=O)O.Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C	NQHXCOAXSHGTIA-SKXNDZRYSA-N	InChI=1S/C32H45N3O4S.CH4O3S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4;1-5(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39);1H3,(H,2,3,4)/t22-,23+,26-,27-,29+;/m0./s1	Human immunodeficiency virus type 1 protease inhibitor	INHIBITOR	CHEMBL243	Human immunodeficiency virus type 1 protease	Human immunodeficiency virus 1
CHEMBL116	AMPRENAVIR	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1	YMARZQAQMVYCKC-OEMFJLHTSA-N	InChI=1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1	Human immunodeficiency virus type 1 protease inhibitor	INHIBITOR	CHEMBL243	Human immunodeficiency virus type 1 protease	Human immunodeficiency virus 1
CHEMBL1200734	FOSAMPRENAVIR CALCIUM	CC(C)CN(C[C@@H](OP(=O)([O-])[O-])[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1.[Ca+2]	PMDQGYMGQKTCSX-HQROKSDRSA-L	InChI=1S/C25H36N3O9PS.Ca/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21;/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32);/q;+2/p-2/t21-,23-,24+;/m0./s1	Human immunodeficiency virus type 1 protease inhibitor	INHIBITOR	CHEMBL243	Human immunodeficiency virus type 1 protease	Human immunodeficiency virus 1
CHEMBL114	SAQUINAVIR	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1	QWAXKHKRTORLEM-UGJKXSETSA-N	InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1	Human immunodeficiency virus type 1 protease inhibitor	INHIBITOR	CHEMBL243	Human immunodeficiency virus type 1 protease	Human immunodeficiency virus 1
CHEMBL729	LOPINAVIR	Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O	KJHKTHWMRKYKJE-SUGCFTRWSA-N	InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1	Human immunodeficiency virus type 1 protease inhibitor	INHIBITOR	CHEMBL243	Human immunodeficiency virus type 1 protease	Human immunodeficiency virus 1
CHEMBL222559	TIPRANAVIR	CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1	SUJUHGSWHZTSEU-FYBSXPHGSA-N	InChI=1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,36-37H,3-4,15-17,19H2,1-2H3/t25-,30-/m1/s1	Human immunodeficiency virus type 1 protease inhibitor	INHIBITOR	CHEMBL243	Human immunodeficiency virus type 1 protease	Human immunodeficiency virus 1
CHEMBL1201127	DARUNAVIR ETHANOLATE	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1.CCO	QWSHKNICRJHQCY-VBTXLZOXSA-N	InChI=1S/C27H37N3O7S.C2H6O/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26;1-2-3/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32);3H,2H2,1H3/t22-,23-,24+,25-,26+;/m0./s1	Human immunodeficiency virus type 1 protease inhibitor	INHIBITOR	CHEMBL243	Human immunodeficiency virus type 1 protease	Human immunodeficiency virus 1
CHEMBL1735	INDINAVIR SULFATE	CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O.O=S(=O)(O)O	NUBQKPWHXMGDLP-BDEHJDMKSA-N	InChI=1S/C36H47N5O4.H2O4S/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43;1-5(2,3)4/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45);(H2,1,2,3,4)/t28-,29+,31+,32-,33+;/m1./s1	Human immunodeficiency virus type 1 protease inhibitor	INHIBITOR	CHEMBL243	Human immunodeficiency virus type 1 protease	Human immunodeficiency virus 1
CHEMBL1200678	ATAZANAVIR SULFATE	COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C.O=S(=O)(O)O	DQSGVVGOPRWTKI-QVFAWCHISA-N	InChI=1S/C38H52N6O7.H2O4S/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28;1-5(2,3)4/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47);(H2,1,2,3,4)/t29-,30-,31+,32+;/m0./s1	Human immunodeficiency virus type 1 protease inhibitor	INHIBITOR	CHEMBL243	Human immunodeficiency virus type 1 protease	Human immunodeficiency virus 1
CHEMBL1083385	CLOPIDOGREL BISULFATE	COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1.O=S(=O)(O)O	FDEODCTUSIWGLK-RSAXXLAASA-N	InChI=1S/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4)/t15-;/m0./s1	Purinergic receptor P2Y12 antagonist	ANTAGONIST	CHEMBL2001	Purinergic receptor P2Y12	Homo sapiens
CHEMBL1717	TICLOPIDINE HYDROCHLORIDE	Cl.Clc1ccccc1CN1CCc2sccc2C1	MTKNGOHFNXIVOS-UHFFFAOYSA-N	InChI=1S/C14H14ClNS.ClH/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14;/h1-4,6,8H,5,7,9-10H2;1H	Purinergic receptor P2Y12 antagonist	ANTAGONIST	CHEMBL2001	Purinergic receptor P2Y12	Homo sapiens
CHEMBL398435	TICAGRELOR	CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1	OEKWJQXRCDYSHL-FNOIDJSQSA-N	InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1	Purinergic receptor P2Y12 negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	CHEMBL2001	Purinergic receptor P2Y12	Homo sapiens
CHEMBL1201773	PRASUGREL HYDROCHLORIDE	CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2.Cl	JALHGCPDPSNJNY-UHFFFAOYSA-N	InChI=1S/C20H20FNO3S.ClH/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21;/h2-5,10,13,19H,6-9,11H2,1H3;1H	Purinergic receptor P2Y12 antagonist	ANTAGONIST	CHEMBL2001	Purinergic receptor P2Y12	Homo sapiens
CHEMBL1200803	SOLIFENACIN SUCCINATE	O=C(O)CCC(=O)O.O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1	RXZMMZZRUPYENV-VROPFNGYSA-N	InChI=1S/C23H26N2O2.C4H6O4/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19;5-3(6)1-2-4(7)8/h1-9,18,21-22H,10-16H2;1-2H2,(H,5,6)(H,7,8)/t21-,22-;/m0./s1	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	CHEMBL211	Muscarinic acetylcholine receptor M2	Homo sapiens
CHEMBL1240	PROPANTHELINE BROMIDE	CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C.[Br-]	XLBIBBZXLMYSFF-UHFFFAOYSA-M	InChI=1S/C23H30NO3.BrH/c1-16(2)24(5,17(3)4)14-15-26-23(25)22-18-10-6-8-12-20(18)27-21-13-9-7-11-19(21)22;/h6-13,16-17,22H,14-15H2,1-5H3;1H/q+1;/p-1	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	CHEMBL211	Muscarinic acetylcholine receptor M2	Homo sapiens
CHEMBL1768	BETHANECHOL CHLORIDE	CC(C[N+](C)(C)C)OC(N)=O.[Cl-]	XXRMYXBSBOVVBH-UHFFFAOYSA-N	InChI=1S/C7H16N2O2.ClH/c1-6(11-7(8)10)5-9(2,3)4;/h6H,5H2,1-4H3,(H-,8,10);1H	Muscarinic acetylcholine receptor M2 agonist	AGONIST	CHEMBL211	Muscarinic acetylcholine receptor M2	Homo sapiens
CHEMBL1201765	FESOTERODINE FUMARATE	CC(C)C(=O)Oc1ccc(CO)cc1[C@H](CCN(C(C)C)C(C)C)c1ccccc1.O=C(O)/C=C/C(=O)O	MWHXMIASLKXGBU-RNCYCKTQSA-N	InChI=1S/C26H37NO3.C4H4O4/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6;5-3(6)1-2-4(7)8/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t23-;/m1./s1	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	CHEMBL211	Muscarinic acetylcholine receptor M2	Homo sapiens
CHEMBL1200935	DARIFENACIN HYDROBROMIDE	Br.NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1	UQAVIASOPREUIT-VQIWEWKSSA-N	InChI=1S/C28H30N2O2.BrH/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26;/h1-12,19,25H,13-18,20H2,(H2,29,31);1H/t25-;/m1./s1	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	CHEMBL211	Muscarinic acetylcholine receptor M2	Homo sapiens
CHEMBL517712	ATROPINE	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2	RKUNBYITZUJHSG-SPUOUPEWSA-N	InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15+,16?	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	CHEMBL211	Muscarinic acetylcholine receptor M2	Homo sapiens
CHEMBL2146146	ATROPINE SULFATE	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2.O=S(=O)(O)O	VJFQPODMEGSXHC-RIMUKSHESA-N	InChI=1S/C17H23NO3.H2O4S/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12;1-5(2,3)4/h2-6,13-16,19H,7-11H2,1H3;(H2,1,2,3,4)/t13-,14+,15+,16?;	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	CHEMBL211	Muscarinic acetylcholine receptor M2	Homo sapiens
CHEMBL1231	OXYBUTYNIN	CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1	XIQVNETUBQGFHX-UHFFFAOYSA-N	InChI=1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	CHEMBL211	Muscarinic acetylcholine receptor M2	Homo sapiens
CHEMBL1722209	TOLTERODINE TARTRATE	Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1.O=C(O)C(O)C(O)C(=O)O	TWHNMSJGYKMTRB-VEIFNGETSA-N	InChI=1S/C22H31NO.C4H6O6/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24;5-1(3(7)8)2(6)4(9)10/h6-12,15-17,20,24H,13-14H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t20-;/m1./s1	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	CHEMBL211	Muscarinic acetylcholine receptor M2	Homo sapiens
CHEMBL1946170	REGORAFENIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1	FNHKPVJBJVTLMP-UHFFFAOYSA-N	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	CHEMBL2041	Tyrosine-protein kinase receptor RET	Homo sapiens
CHEMBL1200485	SORAFENIB TOSYLATE	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1	IVDHYUQIDRJSTI-UHFFFAOYSA-N	InChI=1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	CHEMBL2041	Tyrosine-protein kinase receptor RET	Homo sapiens
CHEMBL1567	SUNITINIB MALATE	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O	LBWFXVZLPYTWQI-IPOVEDGCSA-N	InChI=1S/C22H27FN4O2.C4H6O5/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28;5-2(4(8)9)1-3(6)7/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28);2,5H,1H2,(H,6,7)(H,8,9)/b17-12-;/t;2-/m.0/s1	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	CHEMBL2041	Tyrosine-protein kinase receptor RET	Homo sapiens
CHEMBL24828	VANDETANIB	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1	UHTHHESEBZOYNR-UHFFFAOYSA-N	InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	CHEMBL2041	Tyrosine-protein kinase receptor RET	Homo sapiens
CHEMBL1201733	PAZOPANIB HYDROCHLORIDE	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O.Cl	MQHIQUBXFFAOMK-UHFFFAOYSA-N	InChI=1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H	Tyrosine-protein kinase ITK/TSK inhibitor	INHIBITOR	CHEMBL2959	Tyrosine-protein kinase ITK/TSK	Homo sapiens
CHEMBL1201121	HETACILLIN POTASSIUM	CC1(C)S[C@@H]2[C@H](N3C(=O)[C@@H](c4ccccc4)NC3(C)C)C(=O)N2[C@H]1C(=O)[O-].[K+]	QRSPJBLLJXVPDD-XFAPPKAWSA-M	InChI=1S/C19H23N3O4S.K/c1-18(2)13(17(25)26)21-15(24)12(16(21)27-18)22-14(23)11(20-19(22,3)4)10-8-6-5-7-9-10;/h5-9,11-13,16,20H,1-4H3,(H,25,26);/q;+1/p-1/t11-,12-,13+,16-;/m1./s1	Penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2362973	Penicillin-binding protein	Streptococcus pneumoniae
CHEMBL1201116	HETACILLIN	CC1(C)S[C@@H]2[C@H](N3C(=O)[C@@H](c4ccccc4)NC3(C)C)C(=O)N2[C@H]1C(=O)O	DXVUYOAEDJXBPY-NFFDBFGFSA-N	InChI=1S/C19H23N3O4S/c1-18(2)13(17(25)26)21-15(24)12(16(21)27-18)22-14(23)11(20-19(22,3)4)10-8-6-5-7-9-10/h5-9,11-13,16,20H,1-4H3,(H,25,26)/t11-,12-,13+,16-/m1/s1	Penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2362973	Penicillin-binding protein	Streptococcus pneumoniae
CHEMBL1134	DECAMETHONIUM BROMIDE	C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C.[Br-].[Br-]	HLXQFVXURMXRPU-UHFFFAOYSA-L	InChI=1S/C16H38N2.2BrH/c1-17(2,3)15-13-11-9-7-8-10-12-14-16-18(4,5)6;;/h7-16H2,1-6H3;2*1H/q+2;;/p-2	Muscle-type nicotinic acetylcholine receptor partial agonist	PARTIAL AGONIST	CHEMBL2362997	Muscle-type nicotinic acetylcholine receptor	Homo sapiens
CHEMBL1200757	PANCURONIUM BROMIDE	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1[N+]1(C)CCCCC1.[Br-].[Br-]	NPIJXCQZLFKBMV-YTGGZNJNSA-L	InChI=1S/C35H60N2O4.2BrH/c1-24(38)40-32-21-26-13-14-27-28(35(26,4)23-31(32)37(6)19-11-8-12-20-37)15-16-34(3)29(27)22-30(33(34)41-25(2)39)36(5)17-9-7-10-18-36;;/h26-33H,7-23H2,1-6H3;2*1H/q+2;;/p-2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-;;/m0../s1	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	CHEMBL2362997	Muscle-type nicotinic acetylcholine receptor	Homo sapiens
CHEMBL1200641	CISATRACURIUM BESYLATE	COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1	XXZSQOVSEBAPGS-DONVQRBFSA-L	InChI=1S/C53H72N2O12.2C6H6O3S/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6;2*7-10(8,9)6-4-2-1-3-5-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3;2*1-5H,(H,7,8,9)/q+2;;/p-2/t42-,43-,54-,55-;;/m1../s1	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	CHEMBL2362997	Muscle-type nicotinic acetylcholine receptor	Homo sapiens
CHEMBL1200993	GALLAMINE TRIETHIODIDE	CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]	REEUVFCVXKWOFE-UHFFFAOYSA-K	InChI=1S/C30H60N3O3.3HI/c1-10-31(11-2,12-3)22-25-34-28-20-19-21-29(35-26-23-32(13-4,14-5)15-6)30(28)36-27-24-33(16-7,17-8)18-9;;;/h19-21H,10-18,22-27H2,1-9H3;3*1H/q+3;;;/p-3	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	CHEMBL2362997	Muscle-type nicotinic acetylcholine receptor	Homo sapiens
CHEMBL1237099	DOXACURIUM CHLORIDE	COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC.[Cl-].[Cl-]	APADFLLAXHIMFU-UHFFFAOYSA-L	InChI=1S/C56H78N2O16.2ClH/c1-57(23-19-37-33-45(65-7)53(69-11)55(71-13)49(37)39(57)27-35-29-41(61-3)51(67-9)42(30-35)62-4)21-15-25-73-47(59)17-18-48(60)74-26-16-22-58(2)24-20-38-34-46(66-8)54(70-12)56(72-14)50(38)40(58)28-36-31-43(63-5)52(68-10)44(32-36)64-6;;/h29-34,39-40H,15-28H2,1-14H3;2*1H/q+2;;/p-2	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	CHEMBL2362997	Muscle-type nicotinic acetylcholine receptor	Homo sapiens
CHEMBL1200549	RAPACURONIUM BROMIDE	C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](OC(C)=O)[C@@H](N6CCCCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(=O)CC)CCCCC1.[Br-]	LVQTUXZKLGXYIU-GWSNJHLMSA-M	InChI=1S/C37H61N2O4.BrH/c1-6-20-39(21-12-9-13-22-39)32-24-30-28-15-14-27-23-33(42-26(3)40)31(38-18-10-8-11-19-38)25-37(27,5)29(28)16-17-36(30,4)35(32)43-34(41)7-2;/h6,27-33,35H,1,7-25H2,2-5H3;1H/q+1;/p-1/t27-,28+,29-,30-,31-,32-,33-,35-,36-,37-;/m0./s1	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	CHEMBL2362997	Muscle-type nicotinic acetylcholine receptor	Homo sapiens
CHEMBL1200722	PIPECURONIUM BROMIDE	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H](N3CC[N+](C)(C)CC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CC[N+](C)(C)CC1.[Br-].[Br-]	TXWBOBJCRVVBJF-YTGGZNJNSA-L	InChI=1S/C35H62N4O4.2BrH/c1-24(40)42-32-21-26-9-10-27-28(35(26,4)23-31(32)37-15-19-39(7,8)20-16-37)11-12-34(3)29(27)22-30(33(34)43-25(2)41)36-13-17-38(5,6)18-14-36;;/h26-33H,9-23H2,1-8H3;2*1H/q+2;;/p-2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-;;/m0../s1	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	CHEMBL2362997	Muscle-type nicotinic acetylcholine receptor	Homo sapiens
CHEMBL1200527	ATRACURIUM BESYLATE	COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1	XXZSQOVSEBAPGS-UHFFFAOYSA-L	InChI=1S/C53H72N2O12.2C6H6O3S/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6;2*7-10(8,9)6-4-2-1-3-5-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3;2*1-5H,(H,7,8,9)/q+2;;/p-2	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	CHEMBL2362997	Muscle-type nicotinic acetylcholine receptor	Homo sapiens
CHEMBL1739	METOCURINE IODIDE	COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)[C@H]3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1[C@@H](C2)[N+](C)(C)CC3.[I-].[I-]	DIGFQJFCDPKEPF-OIUSMDOTSA-L	InChI=1S/C40H48N2O6.2HI/c1-41(2)17-15-27-22-34(44-6)36-24-30(27)31(41)19-25-9-12-29(13-10-25)47-40-38-28(23-37(45-7)39(40)46-8)16-18-42(3,4)32(38)20-26-11-14-33(43-5)35(21-26)48-36;;/h9-14,21-24,31-32H,15-20H2,1-8H3;2*1H/q+2;;/p-2/t31-,32+;;/m0../s1	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	CHEMBL2362997	Muscle-type nicotinic acetylcholine receptor	Homo sapiens
CHEMBL984	MIVACURIUM CHLORIDE	COc1cc2c(cc1OC)[C@@H](Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3[C@H]1Cc1cc(OC)c(OC)c(OC)c1)CC2.[Cl-].[Cl-]	WMSYWJSZGVOIJW-ONUALHDOSA-L	InChI=1S/C58H80N2O14.2ClH/c1-59(25-21-41-35-47(63-3)49(65-5)37-43(41)45(59)29-39-31-51(67-7)57(71-11)52(32-39)68-8)23-17-27-73-55(61)19-15-13-14-16-20-56(62)74-28-18-24-60(2)26-22-42-36-48(64-4)50(66-6)38-44(42)46(60)30-40-33-53(69-9)58(72-12)54(34-40)70-10;;/h13-14,31-38,45-46H,15-30H2,1-12H3;2*1H/q+2;;/p-2/b14-13+;;/t45-,46-,59?,60?;;/m1../s1	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	CHEMBL2362997	Muscle-type nicotinic acetylcholine receptor	Homo sapiens
CHEMBL1200648	ROCURONIUM BROMIDE	C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1.[Br-]	OYTJKRAYGYRUJK-FMCCZJBLSA-M	InChI=1S/C32H53N2O4.BrH/c1-5-14-34(15-6-7-16-34)28-20-26-24-9-8-23-19-29(36)27(33-12-17-37-18-13-33)21-32(23,4)25(24)10-11-31(26,3)30(28)38-22(2)35;/h5,23-30,36H,1,6-21H2,2-4H3;1H/q+1;/p-1/t23-,24+,25-,26-,27-,28-,29-,30-,31-,32-;/m0./s1	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	CHEMBL2362997	Muscle-type nicotinic acetylcholine receptor	Homo sapiens
CHEMBL983	SUCCINYLCHOLINE CHLORIDE	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]	YOEWQQVKRJEPAE-UHFFFAOYSA-L	InChI=1S/C14H30N2O4.2ClH/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6;;/h7-12H2,1-6H3;2*1H/q+2;;/p-2	Muscle-type nicotinic acetylcholine receptor agonist	AGONIST	CHEMBL2362997	Muscle-type nicotinic acetylcholine receptor	Homo sapiens
CHEMBL3989821	TUBOCURARINE CHLORIDE	COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.Cl.O.O.O.O.O.[Cl-]	WMIZITXEJNQAQK-GGDSLZADSA-N	InChI=1S/C37H40N2O6.2ClH.5H2O/c1-38-14-12-24-19-32(42-4)33-21-27(24)28(38)16-22-6-9-26(10-7-22)44-37-35-25(20-34(43-5)36(37)41)13-15-39(2,3)29(35)17-23-8-11-30(40)31(18-23)45-33;;;;;;;/h6-11,18-21,28-29H,12-17H2,1-5H3,(H-,40,41);2*1H;5*1H2/t28-,29+;;;;;;;/m0......./s1	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	CHEMBL2362997	Muscle-type nicotinic acetylcholine receptor	Homo sapiens
CHEMBL1200629	VECURONIUM BROMIDE	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]	VEPSYABRBFXYIB-PWXDFCLTSA-M	InChI=1S/C34H57N2O4.BrH/c1-23(37)39-31-20-25-12-13-26-27(34(25,4)22-29(31)35-16-8-6-9-17-35)14-15-33(3)28(26)21-30(32(33)40-24(2)38)36(5)18-10-7-11-19-36;/h25-32H,6-22H2,1-5H3;1H/q+1;/p-1/t25-,26+,27-,28-,29-,30-,31-,32-,33-,34-;/m0./s1	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	CHEMBL2362997	Muscle-type nicotinic acetylcholine receptor	Homo sapiens
CHEMBL24828	VANDETANIB	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1	UHTHHESEBZOYNR-UHFFFAOYSA-N	InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)	Ephrin receptor inhibitor	INHIBITOR	CHEMBL2363043	Ephrin receptor	Homo sapiens
CHEMBL1308	FOMEPIZOLE	Cc1cn[nH]c1	RIKMMFOAQPJVMX-UHFFFAOYSA-N	InChI=1S/C4H6N2/c1-4-2-5-6-3-4/h2-3H,1H3,(H,5,6)	Alcohol dehydrogenase class I inhibitor	INHIBITOR	CHEMBL2363044	Alcohol dehydrogenase class I	Homo sapiens
CHEMBL141	LAMIVUDINE	Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1	JTEGQNOMFQHVDC-NKWVEPMBSA-N	InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1	DNA inhibitor	INHIBITOR	CHEMBL2363048	DNA	Hepatitis B virus
CHEMBL141	LAMIVUDINE	Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1	JTEGQNOMFQHVDC-NKWVEPMBSA-N	InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1	DNA inhibitor	INHIBITOR	CHEMBL2363046	DNA	Human immunodeficiency virus 1
CHEMBL141	LAMIVUDINE	Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1	JTEGQNOMFQHVDC-NKWVEPMBSA-N	InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1	DNA inhibitor	INHIBITOR	CHEMBL2363047	DNA	Human immunodeficiency virus 2
CHEMBL24828	VANDETANIB	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1	UHTHHESEBZOYNR-UHFFFAOYSA-N	InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)	Epidermal growth factor receptor inhibitor	INHIBITOR	CHEMBL2363049	Epidermal growth factor receptor	Homo sapiens
CHEMBL1200633	IVERMECTIN	CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O	SPBDXSGPUHCETR-JFUDTMANSA-N	InChI=1S/C48H74O14.C47H72O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38;1-24(2)41-27(5)16-17-46(61-41)22-33-19-32(60-46)15-14-26(4)42(25(3)12-11-13-31-23-54-44-39(48)28(6)18-34(45(50)57-33)47(31,44)51)58-38-21-36(53-10)43(30(8)56-38)59-37-20-35(52-9)40(49)29(7)55-37/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3;11-14,18,24-25,27,29-30,32-44,48-49,51H,15-17,19-23H2,1-10H3/b13-12+,27-15+,32-14+;12-11+,26-14+,31-13+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+;25-,27-,29-,30-,32+,33-,34-,35-,36-,37-,38-,39+,40-,41+,42-,43-,44+,46+,47+/m00/s1	Glutamate-gated chloride channel modulator	MODULATOR	CHEMBL2363050	Glutamate-gated chloride channel	Strongyloides stercoralis
CHEMBL1200633	IVERMECTIN	CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O	SPBDXSGPUHCETR-JFUDTMANSA-N	InChI=1S/C48H74O14.C47H72O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38;1-24(2)41-27(5)16-17-46(61-41)22-33-19-32(60-46)15-14-26(4)42(25(3)12-11-13-31-23-54-44-39(48)28(6)18-34(45(50)57-33)47(31,44)51)58-38-21-36(53-10)43(30(8)56-38)59-37-20-35(52-9)40(49)29(7)55-37/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3;11-14,18,24-25,27,29-30,32-44,48-49,51H,15-17,19-23H2,1-10H3/b13-12+,27-15+,32-14+;12-11+,26-14+,31-13+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+;25-,27-,29-,30-,32+,33-,34-,35-,36-,37-,38-,39+,40-,41+,42-,43-,44+,46+,47+/m00/s1	Glutamate-gated chloride channel modulator	MODULATOR	CHEMBL2363051	Glutamate-gated chloride channel	Onchocerca volvulus
CHEMBL1341	METHOXYFLURANE	COC(F)(F)C(Cl)Cl	RFKMCNOHBTXSMU-UHFFFAOYSA-N	InChI=1S/C3H4Cl2F2O/c1-8-3(6,7)2(4)5/h2H,1H3	Glycine receptor (alpha-1/beta) agonist	AGONIST	CHEMBL2363052	Glycine receptor (alpha-1/beta)	Homo sapiens
CHEMBL1200733	DESFLURANE	FC(F)OC(F)C(F)(F)F	DPYMFVXJLLWWEU-UHFFFAOYSA-N	InChI=1S/C3H2F6O/c4-1(3(7,8)9)10-2(5)6/h1-2H	Glycine receptor (alpha-1/beta) positive modulator	POSITIVE MODULATOR	CHEMBL2363052	Glycine receptor (alpha-1/beta)	Homo sapiens
CHEMBL1257	ENFLURANE	FC(F)OC(F)(F)C(F)Cl	JPGQOUSTVILISH-UHFFFAOYSA-N	InChI=1S/C3H2ClF5O/c4-1(5)3(8,9)10-2(6)7/h1-2H	Glycine receptor (alpha-1/beta) positive modulator	POSITIVE MODULATOR	CHEMBL2363052	Glycine receptor (alpha-1/beta)	Homo sapiens
CHEMBL1200694	SEVOFLURANE	FCOC(C(F)(F)F)C(F)(F)F	DFEYYRMXOJXZRJ-UHFFFAOYSA-N	InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2	Glycine receptor (alpha-1/beta) positive modulator	POSITIVE MODULATOR	CHEMBL2363052	Glycine receptor (alpha-1/beta)	Homo sapiens
CHEMBL931	HALOTHANE	FC(F)(F)C(Cl)Br	BCQZXOMGPXTTIC-UHFFFAOYSA-N	InChI=1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H	Glycine receptor (alpha-1/beta) positive modulator	POSITIVE MODULATOR	CHEMBL2363052	Glycine receptor (alpha-1/beta)	Homo sapiens
CHEMBL1256	ISOFLURANE	FC(F)OC(Cl)C(F)(F)F	PIWKPBJCKXDKJR-UHFFFAOYSA-N	InChI=1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2H	Glycine receptor (alpha-1/beta) positive modulator	POSITIVE MODULATOR	CHEMBL2363052	Glycine receptor (alpha-1/beta)	Homo sapiens
CHEMBL1597	DIMERCAPROL	OCC(S)CS	WQABCVAJNWAXTE-UHFFFAOYSA-N	InChI=1S/C3H8OS2/c4-1-3(6)2-5/h3-6H,1-2H2	Heavy metals chelating agent	CHELATING AGENT	CHEMBL2363053	Heavy metals	
CHEMBL3989780	SUCRALFATE	O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O=S(=O)(OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O)O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O	WXOMTJVVIMOXJL-BOBFKVMVSA-A	InChI=1S/C11H20O35S8.16Al.62H2O/c12-47(13,14)36-1-3-4(41-49(18,19)20)5(42-50(21,22)23)6(43-51(24,25)26)9(38-3)39-11(2-37-48(15,16)17)8(45-53(30,31)32)7(44-52(27,28)29)10(40-11)46-54(33,34)35;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/h3-10H,1-2H2,(H,12,13,14)(H,15,16,17)(H,18,19,20)(H,21,22,23)(H,24,25,26)(H,27,28,29)(H,30,31,32)(H,33,34,35);;;;;;;;;;;;;;;;;62*1H2/q;16*+3;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/p-48/t3-,4-,5+,6-,7+,8+,9+,10-,11-;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/m1............................................................................../s1	Glycoproteins cross-linking agent	CROSS-LINKING AGENT	CHEMBL2363054	Glycoproteins	Homo sapiens
CHEMBL497	CLIOQUINOL	Oc1c(I)cc(Cl)c2cccnc12	QCDFBFJGMNKBDO-UHFFFAOYSA-N	InChI=1S/C9H5ClINO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H	Zinc chelating agent	CHELATING AGENT	CHEMBL2363056	Zinc	
CHEMBL1430	PENICILLAMINE	CC(C)(S)[C@@H](N)C(=O)O	VVNCNSJFMMFHPL-VKHMYHEASA-N	InChI=1S/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8)/t3-/m0/s1	Copper chelating agent	CHELATING AGENT	CHEMBL2363057	Copper	
CHEMBL3989777	TRIENTINE HYDROCHLORIDE	Cl.Cl.NCCNCCNCCN	WYHIICXRPHEJKI-UHFFFAOYSA-N	InChI=1S/C6H18N4.2ClH/c7-1-3-9-5-6-10-4-2-8;;/h9-10H,1-8H2;2*1H	Copper chelating agent	CHELATING AGENT	CHEMBL2363057	Copper	
CHEMBL497	CLIOQUINOL	Oc1c(I)cc(Cl)c2cccnc12	QCDFBFJGMNKBDO-UHFFFAOYSA-N	InChI=1S/C9H5ClINO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H	Copper chelating agent	CHELATING AGENT	CHEMBL2363057	Copper	
CHEMBL550348	DEFERASIROX	O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1	BOFQWVMAQOTZIW-UHFFFAOYSA-N	InChI=1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,25-26H,(H,27,28)	Iron chelating agent	CHELATING AGENT	CHEMBL2363058	Iron	
CHEMBL1234	DEFEROXAMINE MESYLATE	CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN.CS(=O)(=O)O	IDDIJAWJANBQLJ-UHFFFAOYSA-N	InChI=1S/C25H48N6O8.CH4O3S/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;1-5(2,3)4/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);1H3,(H,2,3,4)	Iron chelating agent	CHELATING AGENT	CHEMBL2363058	Iron	
CHEMBL497	CLIOQUINOL	Oc1c(I)cc(Cl)c2cccnc12	QCDFBFJGMNKBDO-UHFFFAOYSA-N	InChI=1S/C9H5ClINO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H	Iron chelating agent	CHELATING AGENT	CHEMBL2363058	Iron	
CHEMBL2103743	TOFACITINIB CITRATE	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O	SYIKUFDOYJFGBQ-YLAFAASESA-N	InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1	Janus Kinase (JAK) inhibitor	INHIBITOR	CHEMBL2363062	Janus Kinase (JAK)	Homo sapiens
CHEMBL41355	EZOGABINE	CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N	PCOBBVZJEWWZFR-UHFFFAOYSA-N	InChI=1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21)	KCNQ (Kv7) potassium channel blocker	BLOCKER	CHEMBL2363063	KCNQ (Kv7) potassium channel	Homo sapiens
CHEMBL1200952	METHAMPHETAMINE HYDROCHLORIDE	CN[C@@H](C)Cc1ccccc1.Cl	TWXDDNPPQUTEOV-FVGYRXGTSA-N	InChI=1S/C10H15N.ClH/c1-9(11-2)8-10-6-4-3-5-7-10;/h3-7,9,11H,8H2,1-2H3;1H/t9-;/m0./s1	Monoamine transporter inhibitor	INHIBITOR	CHEMBL2363064	Monoamine transporter	Homo sapiens
CHEMBL781	MAZINDOL	OC1(c2ccc(Cl)cc2)c2ccccc2C2=NCCN21	ZPXSCAKFGYXMGA-UHFFFAOYSA-N	InChI=1S/C16H13ClN2O/c17-12-7-5-11(6-8-12)16(20)14-4-2-1-3-13(14)15-18-9-10-19(15)16/h1-8,20H,9-10H2	Monoamine transporter inhibitor	INHIBITOR	CHEMBL2363064	Monoamine transporter	Homo sapiens
CHEMBL3989830	SIBUTRAMINE HYDROCHLORIDE	CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1.Cl.O	KFNNPQDSPLWLCX-UHFFFAOYSA-N	InChI=1S/C17H26ClN.ClH.H2O/c1-13(2)12-16(19(3)4)17(10-5-11-17)14-6-8-15(18)9-7-14;;/h6-9,13,16H,5,10-12H2,1-4H3;1H;1H2	Monoamine transporter inhibitor	INHIBITOR	CHEMBL2363064	Monoamine transporter	Homo sapiens
CHEMBL1703	METFORMIN HYDROCHLORIDE	CN(C)C(=N)N=C(N)N.Cl	OETHQSJEHLVLGH-UHFFFAOYSA-N	InChI=1S/C4H11N5.ClH/c1-9(2)4(7)8-3(5)6;/h1-2H3,(H5,5,6,7,8);1H	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	CHEMBL2363065	Mitochondrial complex I (NADH dehydrogenase)	Homo sapiens
CHEMBL628	PENTOXIFYLLINE	CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O	BYPFEZZEUUWMEJ-UHFFFAOYSA-N	InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	CHEMBL2363066	3',5'-cyclic phosphodiesterase	Homo sapiens
CHEMBL1200875	FLAVOXATE HYDROCHLORIDE	Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O.Cl	XOEVKNFZUQEERE-UHFFFAOYSA-N	InChI=1S/C24H25NO4.ClH/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25;/h2,4-5,8-12H,3,6-7,13-16H2,1H3;1H	Phosphodiesterase 8 inhibitor	INHIBITOR	CHEMBL2363067	Phosphodiesterase 8	Homo sapiens
CHEMBL548	DINOPROSTONE	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O	XEYBRNLFEZDVAW-ARSRFYASSA-N	InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1	Prostaglandin E2 receptor agonist	AGONIST	CHEMBL2363068	Prostaglandin E2 receptor	Homo sapiens
CHEMBL1657	TAZAROTENE	CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1	OGQICQVSFDPSEI-UHFFFAOYSA-N	InChI=1S/C21H21NO2S/c1-4-24-20(23)16-7-9-17(22-14-16)8-5-15-6-10-19-18(13-15)21(2,3)11-12-25-19/h6-7,9-10,13-14H,4,11-12H2,1-3H3	Retinoic acid receptor agonist	AGONIST	CHEMBL2363069	Retinoic acid receptor	Homo sapiens
CHEMBL38	TRETINOIN	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1	SHGAZHPCJJPHSC-YCNIQYBTSA-N	InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+	Retinoic acid receptor agonist	AGONIST	CHEMBL2363069	Retinoic acid receptor	Homo sapiens
CHEMBL1023	BEXAROTENE	C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C	NAVMQTYZDKMPEU-UHFFFAOYSA-N	InChI=1S/C24H28O2/c1-15-13-20-21(24(5,6)12-11-23(20,3)4)14-19(15)16(2)17-7-9-18(10-8-17)22(25)26/h7-10,13-14H,2,11-12H2,1,3-6H3,(H,25,26)	Retinoid X receptor agonist	AGONIST	CHEMBL2363070	Retinoid X receptor	Homo sapiens
CHEMBL705	ALITRETINOIN	CC1=C(/C=C/C(C)=C\C=C\C(C)=C\C(=O)O)C(C)(C)CCC1	SHGAZHPCJJPHSC-ZVCIMWCZSA-N	InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8-,16-14+	Retinoid receptor agonist	AGONIST	CHEMBL2363071	Retinoid receptor	Homo sapiens
CHEMBL1131	ACITRETIN	COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C	IHUNBGSDBOWDMA-AQFIFDHZSA-N	InChI=1S/C21H26O3/c1-14(8-7-9-15(2)12-21(22)23)10-11-19-16(3)13-20(24-6)18(5)17(19)4/h7-13H,1-6H3,(H,22,23)/b9-7+,11-10+,14-8+,15-12+	Retinoid receptor agonist	AGONIST	CHEMBL2363071	Retinoid receptor	Homo sapiens
CHEMBL464	ETRETINATE	CCOC(=O)/C=C(C)/C=C/C=C(C)/C=C/c1c(C)cc(OC)c(C)c1C	HQMNCQVAMBCHCO-DJRRULDNSA-N	InChI=1S/C23H30O3/c1-8-26-23(24)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(25-7)20(6)19(21)5/h9-15H,8H2,1-7H3/b11-9+,13-12+,16-10+,17-14+	Retinoid receptor agonist	AGONIST	CHEMBL2363071	Retinoid receptor	Homo sapiens
CHEMBL1643	RIBAVIRIN	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1	IWUCXVSUMQZMFG-AFCXAGJDSA-N	InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1	RNA inhibitor	INHIBITOR	CHEMBL2363073	RNA	Hepatitis C virus
CHEMBL4297065	SPINOSAD	CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)C2CC(=O)O1.CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@H]3[C@@H]4C[C@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@H]4C(C)=C[C@H]3[C@@H]2CC(=O)O1	JFLRKDZMHNBDQS-UCQUSYKYSA-N	InChI=1S/C42H67NO10.C41H65NO10/c1-11-26-13-12-14-35(53-37-16-15-34(43(6)7)24(4)49-37)23(3)38(45)33-20-31-29(32(33)21-36(44)51-26)17-22(2)28-18-27(19-30(28)31)52-42-41(48-10)40(47-9)39(46-8)25(5)50-42;1-10-26-12-11-13-34(52-36-17-16-33(42(5)6)23(3)48-36)22(2)37(44)32-20-30-28(31(32)21-35(43)50-26)15-14-25-18-27(19-29(25)30)51-41-40(47-9)39(46-8)38(45-7)24(4)49-41/h17,20,23-32,34-35,37,39-42H,11-16,18-19,21H2,1-10H3;14-15,20,22-31,33-34,36,38-41H,10-13,16-19,21H2,1-9H3/t23-,24-,25+,26+,27-,28+,29-,30-,31-,32+,34+,35+,37+,39+,40-,41-,42+;22-,23-,24+,25-,26+,27-,28-,29-,30-,31?,33+,34+,36+,38+,39-,40-,41+/m11/s1	Nicotinic acetylcholine receptor agonist	AGONIST	CHEMBL2364023	Nicotinic acetylcholine receptor	Pediculus humanus capitis
CHEMBL1690	HYDROXYCHLOROQUINE SULFATE	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=S(=O)(O)O	JCBIVZZPXRZKTI-UHFFFAOYSA-N	InChI=1S/C18H26ClN3O.H2O4S/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18;1-5(2,3)4/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21);(H2,1,2,3,4)	Toll-like receptor 9 antagonist	ANTAGONIST	CHEMBL5804	Toll-like receptor 9	Homo sapiens
CHEMBL1614	DESLANOSIDE	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@]4(C)[C@H]5C[C@@H](O)[C@]6(C)[C@@H](C7=CC(=O)OC7)CC[C@]6(O)[C@@H]5CC[C@@H]4C3)O[C@@H]2C)C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](C)O1	OBATZBGFDSVCJD-LALPQLPRSA-N	InChI=1S/C47H74O19/c1-20-41(64-36-16-30(50)42(21(2)60-36)65-37-17-31(51)43(22(3)61-37)66-44-40(56)39(55)38(54)32(18-48)63-44)29(49)15-35(59-20)62-25-8-10-45(4)24(13-25)6-7-27-28(45)14-33(52)46(5)26(9-11-47(27,46)57)23-12-34(53)58-19-23/h12,20-22,24-33,35-44,48-52,54-57H,6-11,13-19H2,1-5H3/t20-,21-,22-,24-,25+,26-,27-,28+,29+,30+,31+,32-,33-,35+,36+,37+,38-,39+,40-,41-,42-,43-,44+,45+,46+,47+/m1/s1	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	CHEMBL2095186	Sodium/potassium-transporting ATPase	Homo sapiens
CHEMBL254219	DIGITOXIN	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O	WDJUZGPOPHTGOT-XUDUSOBPSA-N	InChI=1S/C41H64O13/c1-20-36(46)29(42)16-34(49-20)53-38-22(3)51-35(18-31(38)44)54-37-21(2)50-33(17-30(37)43)52-25-8-11-39(4)24(15-25)6-7-28-27(39)9-12-40(5)26(10-13-41(28,40)47)23-14-32(45)48-19-23/h14,20-22,24-31,33-38,42-44,46-47H,6-13,15-19H2,1-5H3/t20-,21-,22-,24-,25+,26-,27+,28-,29+,30+,31+,33+,34+,35+,36-,37-,38-,39+,40-,41+/m1/s1	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	CHEMBL2095186	Sodium/potassium-transporting ATPase	Homo sapiens
CHEMBL1751	DIGOXIN	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O	LTMHDMANZUZIPE-PUGKRICDSA-N	InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24+,25-,26-,27+,28+,29+,30+,31-,33+,34+,35+,36-,37-,38-,39+,40+,41+/m1/s1	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	CHEMBL2095186	Sodium/potassium-transporting ATPase	Homo sapiens
CHEMBL3545057	ACETYLDIGITOXIN	CC(=O)O[C@H]1C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)O[C@H](C)[C@H]1O	HPMZBILYSWLILX-UMDUKNJSSA-N	InChI=1S/C43H66O14/c1-21-38(48)33(54-24(4)44)19-37(51-21)57-40-23(3)53-36(18-32(40)46)56-39-22(2)52-35(17-31(39)45)55-27-9-12-41(5)26(16-27)7-8-30-29(41)10-13-42(6)28(11-14-43(30,42)49)25-15-34(47)50-20-25/h15,21-23,26-33,35-40,45-46,48-49H,7-14,16-20H2,1-6H3/t21-,22-,23-,26-,27+,28-,29+,30-,31+,32+,33+,35+,36+,37+,38-,39-,40-,41+,42-,43+/m1/s1	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	CHEMBL2095186	Sodium/potassium-transporting ATPase	Homo sapiens
CHEMBL1341	METHOXYFLURANE	COC(F)(F)C(Cl)Cl	RFKMCNOHBTXSMU-UHFFFAOYSA-N	InChI=1S/C3H4Cl2F2O/c1-8-3(6,7)2(4)5/h2H,1H3	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL407	FLUMAZENIL	CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2	OFBIFZUFASYYRE-UHFFFAOYSA-N	InChI=1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL2096631	CLORAZEPATE DIPOTASSIUM	O=C([O-])C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O.[K+].[K+].[OH-]	QCHSEDTUUKDTIG-UHFFFAOYSA-L	InChI=1S/C16H11ClN2O3.2K.H2O/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12;;;/h1-8,14H,(H,18,20)(H,21,22);;;1H2/q;2*+1;/p-2	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL451	CHLORDIAZEPOXIDE	CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1	ANTSCNMPPGJYLG-UHFFFAOYSA-N	InChI=1S/C16H14ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-9H,10H2,1H3,(H,18,19)	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1200703	CHLORDIAZEPOXIDE HYDROCHLORIDE	CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1.Cl	DMLFJMQTNDSRFU-UHFFFAOYSA-N	InChI=1S/C16H14ClN3O.ClH/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15;/h2-9H,10H2,1H3,(H,18,19);1H	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL12	DIAZEPAM	CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21	AAOVKJBEBIDNHE-UHFFFAOYSA-N	InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1522	ESZOPICLONE	CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1	GBBSUAFBMRNDJC-INIZCTEOSA-N	InChI=1S/C17H17ClN6O3/c1-22-6-8-23(9-7-22)17(26)27-16-14-13(19-4-5-20-14)15(25)24(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3/t16-/m0/s1	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL568	OXAZEPAM	O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O	ADIMAYPTOBDMTL-UHFFFAOYSA-N	InChI=1S/C15H11ClN2O2/c16-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)18-15(20)14(19)17-12/h1-8,15,20H,(H,17,19)	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL979	MEPROBAMATE	CCCC(C)(COC(N)=O)COC(N)=O	NPPQSCRMBWNHMW-UHFFFAOYSA-N	InChI=1S/C9H18N2O4/c1-3-4-9(2,5-14-7(10)12)6-15-8(11)13/h3-6H2,1-2H3,(H2,10,12)(H2,11,13)	GABA-A receptor; anion channel agonist	AGONIST	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL70418	CLOBAZAM	CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21	CXOXHMZGEKVPMT-UHFFFAOYSA-N	InChI=1S/C16H13ClN2O2/c1-18-13-8-7-11(17)9-14(13)19(16(21)10-15(18)20)12-5-3-2-4-6-12/h2-9H,10H2,1H3	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL661	ALPRAZOLAM	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2	VREFGVBLTWBCJP-UHFFFAOYSA-N	InChI=1S/C17H13ClN4/c1-11-20-21-16-10-19-17(12-5-3-2-4-6-12)14-9-13(18)7-8-15(14)22(11)16/h2-9H,10H2,1H3	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL646	TRIAZOLAM	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2	JOFWLTCLBGQGBO-UHFFFAOYSA-N	InChI=1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL454	BUTALBITAL	C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O	UZVHFVZFNXBMQJ-UHFFFAOYSA-N	InChI=1S/C11H16N2O3/c1-4-5-11(6-7(2)3)8(14)12-10(16)13-9(11)15/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16)	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL452	CLONAZEPAM	O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1	DGBIGWXXNGSACT-UHFFFAOYSA-N	InChI=1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20)	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1200733	DESFLURANE	FC(F)OC(F)C(F)(F)F	DPYMFVXJLLWWEU-UHFFFAOYSA-N	InChI=1S/C3H2F6O/c4-1(3(7,8)9)10-2(5)6/h1-2H	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL285674	ESTAZOLAM	Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2	CDCHDCWJMGXXRH-UHFFFAOYSA-N	InChI=1S/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1200802	TALBUTAL	C=CCC1(C(C)CC)C(=O)NC(=O)NC1=O	BJVVMKUXKQHWJK-UHFFFAOYSA-N	InChI=1S/C11H16N2O3/c1-4-6-11(7(3)5-2)8(14)12-10(16)13-9(11)15/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16)	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1200982	BUTABARBITAL SODIUM	CCC(C)C1(CC)C(=O)[N-]C(=O)NC1=O.[Na+]	QORQZMBCPRBCAB-UHFFFAOYSA-M	InChI=1S/C10H16N2O3.Na/c1-4-6(3)10(5-2)7(13)11-9(15)12-8(10)14;/h6H,4-5H2,1-3H3,(H2,11,12,13,14,15);/q;+1/p-1	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1102	GLUTETHIMIDE	CCC1(c2ccccc2)CCC(=O)NC1=O	JMBQKKAJIKAWKF-UHFFFAOYSA-N	InChI=1S/C13H15NO2/c1-2-13(10-6-4-3-5-7-10)9-8-11(15)14-12(13)16/h3-7H,2,8-9H2,1H3,(H,14,15,16)	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL2068724	ACAMPROSATE CALCIUM	CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]	BUVGWDNTAWHSKI-UHFFFAOYSA-L	InChI=1S/2C5H11NO4S.Ca/c2*1-5(7)6-3-2-4-11(8,9)10;/h2*2-4H2,1H3,(H,6,7)(H,8,9,10);/q;;+2/p-2	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL580	LORAZEPAM	O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O	DIWRORZWFLOCLC-UHFFFAOYSA-N	InChI=1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1257	ENFLURANE	FC(F)OC(F)(F)C(F)Cl	JPGQOUSTVILISH-UHFFFAOYSA-N	InChI=1S/C3H2ClF5O/c4-1(5)3(8,9)10-2(6)7/h1-2H	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL591	ETHCHLORVYNOL	C#CC(O)(/C=C/Cl)CC	ZEHYJZXQEQOSON-AATRIKPKSA-N	InChI=1S/C7H9ClO/c1-3-7(9,4-2)5-6-8/h1,5-6,9H,4H2,2H3/b6-5+	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL450	METHARBITAL	CCC1(CC)C(=O)NC(=O)N(C)C1=O	FWJKNZONDWOGMI-UHFFFAOYSA-N	InChI=1S/C9H14N2O3/c1-4-9(5-2)6(12)10-8(14)11(3)7(9)13/h4-5H2,1-3H3,(H,10,12,14)	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL30219	METHOHEXITAL SODIUM	C=CCC1(C(C)C#CCC)C(=O)[N-]C(=O)N(C)C1=O.[Na+]	KDXZREBVGAGZHS-UHFFFAOYSA-M	InChI=1S/C14H18N2O3.Na/c1-5-7-8-10(3)14(9-6-2)11(17)15-13(19)16(4)12(14)18;/h6,10H,2,5,9H2,1,3-4H3,(H,15,17,19);/q;+1/p-1	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1200790	METHYPRYLON	CCC1(CC)C(=O)NCC(C)C1=O	SIDLZWOQUZRBRU-UHFFFAOYSA-N	InChI=1S/C10H17NO2/c1-4-10(5-2)8(12)7(3)6-11-9(10)13/h7H,4-6H2,1-3H3,(H,11,13)	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1200420	MIDAZOLAM HYDROCHLORIDE	Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2.Cl	PLYSCVSCYOQVRP-UHFFFAOYSA-N	InChI=1S/C18H13ClFN3.ClH/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13;/h2-9H,10H2,1H3;1H	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL969	PRAZEPAM	O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1	MWQCHHACWWAQLJ-UHFFFAOYSA-N	InChI=1S/C19H17ClN2O/c20-15-8-9-17-16(10-15)19(14-4-2-1-3-5-14)21-11-18(23)22(17)12-13-6-7-13/h1-5,8-10,13H,6-7,11-12H2	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL856	PRIMIDONE	CCC1(c2ccccc2)C(=O)NCNC1=O	DQMZLTXERSFNPB-UHFFFAOYSA-N	InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL526	PROPOFOL	CC(C)c1cccc(C(C)C)c1O	OLBCVFGFOZPWHH-UHFFFAOYSA-N	InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1200472	QUAZEPAM	Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21	IKMPWMZBZSAONZ-UHFFFAOYSA-N	InChI=1S/C17H11ClF4N2S/c18-10-5-6-14-12(7-10)16(11-3-1-2-4-13(11)19)23-8-15(25)24(14)9-17(20,21)22/h1-7H,8-9H2	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL448	PENTOBARBITAL	CCCC(C)C1(CC)C(=O)NC(=O)NC1=O	WEXRUCMBJFQVBZ-UHFFFAOYSA-N	InChI=1S/C11H18N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL971	PENTOBARBITAL SODIUM	CCCC(C)C1(CC)C(=O)[N-]C(=O)NC1=O.[Na+]	QGMRQYFBGABWDR-UHFFFAOYSA-M	InChI=1S/C11H18N2O3.Na/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15;/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16);/q;+1/p-1	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1200903	SECOBARBITAL SODIUM	C=CCC1(C(C)CCC)C(=O)[N-]C(=O)NC1=O.[Na+]	AXXJTNXVUHVOJW-UHFFFAOYSA-M	InChI=1S/C12H18N2O3.Na/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16;/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17);/q;+1/p-1	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1200694	SEVOFLURANE	FCOC(C(F)(F)F)C(F)(F)F	DFEYYRMXOJXZRJ-UHFFFAOYSA-N	InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL967	TEMAZEPAM	CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21	SEQDDYPDSLOBDC-UHFFFAOYSA-N	InChI=1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1201065	THIAMYLAL SODIUM	C=CCC1(C(C)CCC)C(=O)N=C([S-])NC1=O.[Na+]	LYZGJWXNOGIVQA-UHFFFAOYSA-M	InChI=1S/C12H18N2O2S.Na/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16;/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17);/q;+1/p-1	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL738	THIOPENTAL SODIUM	CCCC(C)C1(CC)C(=O)N=C([S-])NC1=O.[Na+]	AWLILQARPMWUHA-UHFFFAOYSA-M	InChI=1S/C11H18N2O2S.Na/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15;/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16);/q;+1/p-1	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL681	ETOMIDATE	CCOC(=O)c1cncn1[C@H](C)c1ccccc1	NPUKDXXFDDZOKR-LLVKDONJSA-N	InChI=1S/C14H16N2O2/c1-3-18-14(17)13-9-15-10-16(13)11(2)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3/t11-/m1/s1	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL3989724	FLURAZEPAM HYDROCHLORIDE	CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21.Cl.Cl	ZIIJJOPLRSCQNX-UHFFFAOYSA-N	InChI=1S/C21H23ClFN3O.2ClH/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23;;/h5-10,13H,3-4,11-12,14H2,1-2H3;2*1H	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL970	HALAZEPAM	O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F	WYCLKVQLVUQKNZ-UHFFFAOYSA-N	InChI=1S/C17H12ClF3N2O/c18-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)22-9-15(24)23(14)10-17(19,20)21/h1-8H,9-10H2	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL931	HALOTHANE	FC(F)(F)C(Cl)Br	BCQZXOMGPXTTIC-UHFFFAOYSA-N	InChI=1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1256	ISOFLURANE	FC(F)OC(Cl)C(F)(F)F	PIWKPBJCKXDKJR-UHFFFAOYSA-N	InChI=1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2H	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL220492	TOPIRAMATE	CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1	KJADKKWYZYXHBB-XBWDGYHZSA-N	InChI=1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1200789	TRICLOFOS SODIUM	O=P([O-])(O)OCC(Cl)(Cl)Cl.[Na+]	WFKJEZKHPGDCRK-UHFFFAOYSA-M	InChI=1S/C2H4Cl3O4P.Na/c3-2(4,5)1-9-10(6,7)8;/h1H2,(H2,6,7,8);/q;+1/p-1	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL3989820	ZOLPIDEM TARTRATE	Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1.Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1.O=C(O)C(O)C(O)C(=O)O	VXRDAMSNTXUHFX-UHFFFAOYSA-N	InChI=1S/2C19H21N3O.C4H6O6/c2*1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19;5-1(3(7)8)2(6)4(9)10/h2*5-10,12H,11H2,1-4H3;1-2,5-6H,(H,7,8)(H,9,10)	GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2111392	GABA A receptor alpha-1/beta-1/gamma-2	Homo sapiens
CHEMBL1521	ZALEPLON	CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1	HUNXMJYCHXQEGX-UHFFFAOYSA-N	InChI=1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3	GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2111392	GABA A receptor alpha-1/beta-1/gamma-2	Homo sapiens
CHEMBL1421	DASATINIB	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1	ZBNZXTGUTAYRHI-UHFFFAOYSA-N	InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)	SRC inhibitor	INHIBITOR	CHEMBL2363074	SRC	Homo sapiens
CHEMBL1200969	DUTASTERIDE	C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)Nc1cc(C(F)(F)F)ccc1C(F)(F)F	JWJOTENAMICLJG-QWBYCMEYSA-N	InChI=1S/C27H30F6N2O2/c1-24-11-9-17-15(4-8-21-25(17,2)12-10-22(36)35-21)16(24)6-7-19(24)23(37)34-20-13-14(26(28,29)30)3-5-18(20)27(31,32)33/h3,5,10,12-13,15-17,19,21H,4,6-9,11H2,1-2H3,(H,34,37)(H,35,36)/t15-,16-,17-,19+,21+,24-,25+/m0/s1	Steroid 5-alpha-reductase inhibitor	INHIBITOR	CHEMBL2363075	Steroid 5-alpha-reductase	Homo sapiens
CHEMBL1201761	BESIFLOXACIN HYDROCHLORIDE	Cl.N[C@@H]1CCCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1	PMQBICKXAAKXAY-HNCPQSOCSA-N	InChI=1S/C19H21ClFN3O3.ClH/c20-15-16-12(18(25)13(19(26)27)9-24(16)11-4-5-11)7-14(21)17(15)23-6-2-1-3-10(22)8-23;/h7,9-11H,1-6,8,22H2,(H,26,27);1H/t10-;/m1./s1	Topoisomerase IV inhibitor	INHIBITOR	CHEMBL2363076	Topoisomerase IV	Bacteria
CHEMBL1200498	ALATROFLOXACIN MESYLATE	CS(=O)(=O)O.C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]21	CYETUYYEVKNSHZ-LGOOQLFJSA-N	InChI=1S/C26H25F3N6O5.CH4O3S/c1-10(30)24(37)31-11(2)25(38)32-20-14-7-34(8-15(14)20)23-18(29)6-13-21(36)16(26(39)40)9-35(22(13)33-23)19-4-3-12(27)5-17(19)28;1-5(2,3)4/h3-6,9-11,14-15,20H,7-8,30H2,1-2H3,(H,31,37)(H,32,38)(H,39,40);1H3,(H,2,3,4)/t10-,11-,14-,15+,20+;/m0./s1	Topoisomerase IV inhibitor	INHIBITOR	CHEMBL2363076	Topoisomerase IV	Bacteria
CHEMBL1200735	MOXIFLOXACIN HYDROCHLORIDE	COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12.Cl	IDIIJJHBXUESQI-DFIJPDEKSA-N	InChI=1S/C21H24FN3O4.ClH/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H/t11-,16+;/m0./s1	Topoisomerase IV inhibitor	INHIBITOR	CHEMBL2363076	Topoisomerase IV	Bacteria
CHEMBL9	NORFLOXACIN	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21	OGJPXUAPXNRGGI-UHFFFAOYSA-N	InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23)	Topoisomerase IV inhibitor	INHIBITOR	CHEMBL2363076	Topoisomerase IV	Bacteria
CHEMBL850	SPARFLOXACIN	C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1	DZZWHBIBMUVIIW-DTORHVGOSA-N	InChI=1S/C19H22F2N4O3/c1-8-5-24(6-9(2)23-8)17-13(20)15(22)12-16(14(17)21)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6,22H2,1-2H3,(H,27,28)/t8-,9+	Topoisomerase IV inhibitor	INHIBITOR	CHEMBL2363076	Topoisomerase IV	Bacteria
CHEMBL1200779	TROVAFLOXACIN MESYLATE	CS(=O)(=O)O.N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12	DYNZICQDCVYXFW-AHZSKCOESA-N	InChI=1S/C20H15F3N4O3.CH4O3S/c21-8-1-2-15(13(22)3-8)27-7-12(20(29)30)17(28)9-4-14(23)19(25-18(9)27)26-5-10-11(6-26)16(10)24;1-5(2,3)4/h1-4,7,10-11,16H,5-6,24H2,(H,29,30);1H3,(H,2,3,4)/t10-,11+,16+;	Topoisomerase IV inhibitor	INHIBITOR	CHEMBL2363076	Topoisomerase IV	Bacteria
CHEMBL826	ENOXACIN	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21	IDYZIJYBMGIQMJ-UHFFFAOYSA-N	InChI=1S/C15H17FN4O3/c1-2-19-8-10(15(22)23)12(21)9-7-11(16)14(18-13(9)19)20-5-3-17-4-6-20/h7-8,17H,2-6H2,1H3,(H,22,23)	Topoisomerase IV inhibitor	INHIBITOR	CHEMBL2363077	Topoisomerase IV	Neisseria gonorrhoeae
CHEMBL1200556	DESMOPRESSIN ACETATE	CC(=O)O.N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O	MLSVJHOYXJGGTR-IFHOVBQLSA-N	InChI=1S/C46H64N14O12S2.C2H4O2/c47-35(62)15-14-29-40(67)58-32(22-36(48)63)43(70)59-33(45(72)60-18-5-9-34(60)44(71)56-28(8-4-17-52-46(50)51)39(66)53-23-37(49)64)24-74-73-19-16-38(65)54-30(21-26-10-12-27(61)13-11-26)41(68)57-31(42(69)55-29)20-25-6-2-1-3-7-25;1-2(3)4/h1-3,6-7,10-13,28-34,61H,4-5,8-9,14-24H2,(H2,47,62)(H2,48,63)(H2,49,64)(H,53,66)(H,54,65)(H,55,69)(H,56,71)(H,57,68)(H,58,67)(H,59,70)(H4,50,51,52);1H3,(H,3,4)/t28-,29+,30+,31+,32+,33+,34+;/m1./s1	Vasopressin receptor agonist	AGONIST	CHEMBL2363078	Vasopressin receptor	Homo sapiens
CHEMBL1200690	LYPRESSIN	NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O	BJFIDCADFRDPIO-DZCXQCEKSA-N	InChI=1S/C46H65N13O12S2/c47-17-5-4-9-29(40(65)52-22-38(51)63)54-45(70)35-10-6-18-59(35)46(71)34-24-73-72-23-28(48)39(64)55-31(20-26-11-13-27(60)14-12-26)43(68)56-32(19-25-7-2-1-3-8-25)42(67)53-30(15-16-36(49)61)41(66)57-33(21-37(50)62)44(69)58-34/h1-3,7-8,11-14,28-35,60H,4-6,9-10,15-24,47-48H2,(H2,49,61)(H2,50,62)(H2,51,63)(H,52,65)(H,53,67)(H,54,70)(H,55,64)(H,56,68)(H,57,66)(H,58,69)/t28-,29-,30-,31-,32-,33-,34-,35-/m0/s1	Vasopressin receptor agonist	AGONIST	CHEMBL2363078	Vasopressin receptor	Homo sapiens
CHEMBL437	SULFATHIAZOLE	Nc1ccc(S(=O)(=O)Nc2nccs2)cc1	JNMRHUJNCSQMMB-UHFFFAOYSA-N	InChI=1S/C9H9N3O2S2/c10-7-1-3-8(4-2-7)16(13,14)12-9-11-5-6-15-9/h1-6H,10H2,(H,11,12)	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL1382627	SULFADIAZINE, SILVER	Nc1ccc(S(=O)(=O)[N-]c2ncccn2)cc1.[Ag+]	UEJSSZHHYBHCEL-UHFFFAOYSA-N	InChI=1S/C10H9N4O2S.Ag/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL446	SULFAMETHAZINE	Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1	ASWVTGNCAZCNNR-UHFFFAOYSA-N	InChI=1S/C12H14N4O2S/c1-8-7-9(2)15-12(14-8)16-19(17,18)11-5-3-10(13)4-6-11/h3-7H,13H2,1-2H3,(H,14,15,16)	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL21	SULFANILAMIDE	Nc1ccc(S(N)(=O)=O)cc1	FDDDEECHVMSUSB-UHFFFAOYSA-N	InChI=1S/C6H8N2O2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,7H2,(H2,8,9,10)	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL1525826	SULFALENE	COc1nccnc1NS(=O)(=O)c1ccc(N)cc1	KXRZBTAEDBELFD-UHFFFAOYSA-N	InChI=1S/C11H12N4O3S/c1-18-11-10(13-6-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15)	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL1201161	MAFENIDE ACETATE	CC(=O)O.NCc1ccc(S(N)(=O)=O)cc1	UILOTUUZKGTYFQ-UHFFFAOYSA-N	InChI=1S/C7H10N2O2S.C2H4O2/c8-5-6-1-3-7(4-2-6)12(9,10)11;1-2(3)4/h1-4H,5,8H2,(H2,9,10,11);1H3,(H,3,4)	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL1200910	SULFISOXAZOLE ACETYL	CC(=O)N(c1onc(C)c1C)S(=O)(=O)c1ccc(N)cc1	JFNWFXVFBDDWCX-UHFFFAOYSA-N	InChI=1S/C13H15N3O4S/c1-8-9(2)15-20-13(8)16(10(3)17)21(18,19)12-6-4-11(14)5-7-12/h4-7H,14H2,1-3H3	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL1723241	SULFACETAMIDE SODIUM	CC(=O)[N-]S(=O)(=O)c1ccc(N)cc1.O.[Na+]	IHCDKJZZFOUARO-UHFFFAOYSA-M	InChI=1S/C8H10N2O3S.Na.H2O/c1-6(11)10-14(12,13)8-4-2-7(9)3-5-8;;/h2-5H,9H2,1H3,(H,10,11);;1H2/q;+1;/p-1	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL443	SULFAMETHOXAZOLE	Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1	JLKIGFTWXXRPMT-UHFFFAOYSA-N	InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL1200321	SULFISOXAZOLE DIOLAMINE	Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C.OCCNCCO	FEPTXVIRMZIGFY-UHFFFAOYSA-N	InChI=1S/C11H13N3O3S.C4H11NO2/c1-7-8(2)13-17-11(7)14-18(15,16)10-5-3-9(12)4-6-10;6-3-1-5-2-4-7/h3-6,14H,12H2,1-2H3;5-7H,1-4H2	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL1109	SULFAPHENAZOLE	Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1	QWCJHSGMANYXCW-UHFFFAOYSA-N	InChI=1S/C15H14N4O2S/c16-12-6-8-14(9-7-12)22(20,21)18-15-10-11-17-19(15)13-4-2-1-3-5-13/h1-11,18H,16H2	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL1200351	SULFADIAZINE SODIUM	Nc1ccc(S(=O)(=O)[N-]c2ncccn2)cc1.[Na+]	JLDCNMJPBBKAHH-UHFFFAOYSA-N	InChI=1S/C10H9N4O2S.Na/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL438	SULFAMERAZINE	Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1	QPPBRPIAZZHUNT-UHFFFAOYSA-N	InChI=1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL453	SULFISOXAZOLE	Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C	NHUHCSRWZMLRLA-UHFFFAOYSA-N	InChI=1S/C11H13N3O3S/c1-7-8(2)13-17-11(7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6,14H,12H2,1-2H3	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL700	SULFAPYRIDINE	Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1	GECHUMIMRBOMGK-UHFFFAOYSA-N	InChI=1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14)	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL439	SULFADIAZINE	Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1	SEEPANYCNGTZFQ-UHFFFAOYSA-N	InChI=1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14)	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL1200359	SULFAMETER	COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1	GPTONYMQFTZPKC-UHFFFAOYSA-N	InChI=1S/C11H12N4O3S/c1-18-9-6-13-11(14-7-9)15-19(16,17)10-4-2-8(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL455	SULFACETAMIDE	CC(=O)NS(=O)(=O)c1ccc(N)cc1	SKIVFJLNDNKQPD-UHFFFAOYSA-N	InChI=1S/C8H10N2O3S/c1-6(11)10-14(12,13)8-4-2-7(9)3-5-8/h2-5H,9H2,1H3,(H,10,11)	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL1191	SULFAMETHIZOLE	Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1	VACCAVUAMIDAGB-UHFFFAOYSA-N	InChI=1S/C9H10N4O2S2/c1-6-11-12-9(16-6)13-17(14,15)8-4-2-7(10)3-5-8/h2-5H,10H2,1H3,(H,12,13)	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL22	TRIMETHOPRIM	COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC	IEDVJHCEMCRBQM-UHFFFAOYSA-N	InChI=1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18)	Bacterial dihydrofolate reductase inhibitor	INHIBITOR	CHEMBL2364669	Bacterial dihydrofolate reductase	Bacteria
CHEMBL2110367	TRIMETHOPRIM SULFATE	COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.O=S(=O)(O)O	UILMMYFRNCCPLK-UHFFFAOYSA-N	InChI=1S/2C14H18N4O3.H2O4S/c2*1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15;1-5(2,3)4/h2*5-7H,4H2,1-3H3,(H4,15,16,17,18);(H2,1,2,3,4)	Bacterial dihydrofolate reductase inhibitor	INHIBITOR	CHEMBL2364669	Bacterial dihydrofolate reductase	Bacteria
CHEMBL1201080	TRIMETHOPRIM HYDROCHLORIDE	COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.Cl	YLCCEQZHUHUYPA-UHFFFAOYSA-N	InChI=1S/C14H18N4O3.ClH/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15;/h5-7H,4H2,1-3H3,(H4,15,16,17,18);1H	Bacterial dihydrofolate reductase inhibitor	INHIBITOR	CHEMBL2364669	Bacterial dihydrofolate reductase	Bacteria
CHEMBL1003	CLAVULANATE POTASSIUM	O=C([O-])[C@H]1/C(=C/CO)O[C@@H]2CC(=O)N21.[K+]	ABVRVIZBZKUTMK-JSYANWSFSA-M	InChI=1S/C8H9NO5.K/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4;/h1,6-7,10H,2-3H2,(H,12,13);/q;+1/p-1/b4-1-;/t6-,7-;/m1./s1	Bacterial beta-lactamase TEM inhibitor	INHIBITOR	CHEMBL2364670	Bacterial beta-lactamase TEM	Bacteria
CHEMBL1439	TAZOBACTAM SODIUM	C[C@]1(Cn2ccnn2)[C@H](C(=O)[O-])N2C(=O)C[C@H]2S1(=O)=O.[Na+]	RFMIKMMOLPNEDG-QVUDESDKSA-M	InChI=1S/C10H12N4O5S.Na/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19;/h2-3,7-8H,4-5H2,1H3,(H,16,17);/q;+1/p-1/t7-,8+,10+;/m1./s1	Bacterial beta-lactamase TEM inhibitor	INHIBITOR	CHEMBL2364670	Bacterial beta-lactamase TEM	Bacteria
CHEMBL1200944	SULBACTAM SODIUM	CC1(C)[C@H](C(=O)[O-])N2C(=O)C[C@H]2S1(=O)=O.[Na+]	NKZMPZCWBSWAOX-IBTYICNHSA-M	InChI=1S/C8H11NO5S.Na/c1-8(2)6(7(11)12)9-4(10)3-5(9)15(8,13)14;/h5-6H,3H2,1-2H3,(H,11,12);/q;+1/p-1/t5-,6+;/m1./s1	Bacterial beta-lactamase TEM inhibitor	INHIBITOR	CHEMBL2364670	Bacterial beta-lactamase TEM	Bacteria
CHEMBL3989715	MUPIROCIN CALCIUM	C/C(=C\C(=O)OCCCCCCCCC(=O)[O-])C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O.C/C(=C\C(=O)OCCCCCCCCC(=O)[O-])C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O.O.O.[Ca+2]	DDHVILIIHBIMQU-YJGQQKNPSA-L	InChI=1S/2C26H44O9.Ca.2H2O/c2*1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27;;;/h2*13,17-21,24-27,31-32H,4-12,14-15H2,1-3H3,(H,28,29);;2*1H2/q;;+2;;/p-2/b2*16-13+;;;/t2*17-,18-,19-,20-,21-,24+,25-,26-;;;/m00.../s1	Isoleucyl-tRNA synthetase inhibitor	INHIBITOR	CHEMBL2364671	Isoleucyl-tRNA synthetase	Streptococcus pyogenes
CHEMBL719	MUPIROCIN	C/C(=C\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O	MINDHVHHQZYEEK-HBBNESRFSA-N	InChI=1S/C26H44O9/c1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27/h13,17-21,24-27,31-32H,4-12,14-15H2,1-3H3,(H,28,29)/b16-13+/t17-,18-,19-,20-,21-,24+,25-,26-/m0/s1	Isoleucyl-tRNA synthetase inhibitor	INHIBITOR	CHEMBL2364671	Isoleucyl-tRNA synthetase	Streptococcus pyogenes
CHEMBL1200424	PENTETATE ZINC TRISODIUM	O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CCN(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Zn+2]	HVASDHJNLYRZEA-UHFFFAOYSA-I	InChI=1S/C14H23N3O10.3Na.Zn/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;;;;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);;;;/q;3*+1;+2/p-5	Radioactive metals chelating agent	CHELATING AGENT	CHEMBL2366037	Radioactive metals	
CHEMBL1200945	PENTETATE CALCIUM TRISODIUM	O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CCN(CC(=O)[O-])CC(=O)[O-].[Ca+2].[Na+].[Na+].[Na+]	AYFCVLSUPGCQKD-UHFFFAOYSA-I	InChI=1S/C14H23N3O10.Ca.3Na/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;;;;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);;;;/q;+2;3*+1/p-5	Radioactive metals chelating agent	CHELATING AGENT	CHEMBL2366037	Radioactive metals	
CHEMBL2105745	GLYCEROL PHENYLBUTYRATE	O=C(CCCc1ccccc1)OCC(COC(=O)CCCc1ccccc1)OC(=O)CCCc1ccccc1	ZSDBFLMJVAGKOU-UHFFFAOYSA-N	InChI=1S/C33H38O6/c34-31(22-10-19-27-13-4-1-5-14-27)37-25-30(39-33(36)24-12-21-29-17-8-3-9-18-29)26-38-32(35)23-11-20-28-15-6-2-7-16-28/h1-9,13-18,30H,10-12,19-26H2	Glutamine sequestering agent	SEQUESTERING AGENT	CHEMBL2366039	Glutamine	Homo sapiens
CHEMBL1201043	CEPHAPIRIN SODIUM	CC(=O)OCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)CSc3ccncc3)[C@H]2SC1.[Na+]	VGEOUKPOQQEQSX-OALZAMAHSA-M	InChI=1S/C17H17N3O6S2.Na/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11;/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25);/q;+1/p-1/t13-,16-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200991	CARBENICILLIN INDANYL SODIUM	CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)Oc3ccc4c(c3)CCC4)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]	QFWPXOXWAUAYAB-XZVIDJSISA-M	InChI=1S/C26H26N2O6S.Na/c1-26(2)20(24(31)32)28-22(30)19(23(28)35-26)27-21(29)18(15-7-4-3-5-8-15)25(33)34-17-12-11-14-9-6-10-16(14)13-17;/h3-5,7-8,11-13,18-20,23H,6,9-10H2,1-2H3,(H,27,29)(H,31,32);/q;+1/p-1/t18?,19-,20+,23-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1618	CEFAMANDOLE NAFATE	Cn1nnnc1SCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)[C@H](OC=O)c3ccccc3)[C@H]2SC1.[Na+]	ICZOIXFFVKYXOM-YCLOEFEOSA-M	InChI=1S/C19H18N6O6S2.Na/c1-24-19(21-22-23-24)33-8-11-7-32-17-12(16(28)25(17)13(11)18(29)30)20-15(27)14(31-9-26)10-5-3-2-4-6-10;/h2-6,9,12,14,17H,7-8H2,1H3,(H,20,27)(H,29,30);/q;+1/p-1/t12-,14-,17-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1201018	CEFACLOR	N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CS[C@H]12)c1ccccc1.O	WKJGTOYAEQDNIA-IOOZKYRYSA-N	InChI=1S/C15H14ClN3O4S.H2O/c16-8-6-24-14-10(13(21)19(14)11(8)15(22)23)18-12(20)9(17)7-4-2-1-3-5-7;/h1-5,9-10,14H,6,17H2,(H,18,20)(H,22,23);1H2/t9-,10-,14-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1604	CEPHRADINE	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)C3=CCC=CC3)[C@H]2SC1	RDLPVSKMFDYCOR-UEKVPHQBSA-N	InChI=1S/C16H19N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-3,6,10-11,15H,4-5,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200855	TICARCILLIN DISODIUM	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(=O)[O-])c3ccsc3)C(=O)N2[C@H]1C(=O)[O-].[Na+].[Na+]	ZBBCUBMBMZNEME-QBGWIPKPSA-L	InChI=1S/C15H16N2O6S2.2Na/c1-15(2)9(14(22)23)17-11(19)8(12(17)25-15)16-10(18)7(13(20)21)6-3-4-24-5-6;;/h3-5,7-9,12H,1-2H3,(H,16,18)(H,20,21)(H,22,23);;/q;2*+1/p-2/t7-,8-,9+,12-;;/m1../s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL2146124	CEFUROXIME SODIUM	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(COC(N)=O)CS[C@H]12)c1ccco1.[Na+]	URDOHUPGIOGTKV-JTBFTWTJSA-M	InChI=1S/C16H16N4O8S.Na/c1-26-19-9(8-3-2-4-27-8)12(21)18-10-13(22)20-11(15(23)24)7(5-28-16(17)25)6-29-14(10)20;/h2-4,10,14H,5-6H2,1H3,(H2,17,25)(H,18,21)(H,23,24);/q;+1/p-1/b19-9-;/t10-,14-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL615	PENICILLIN V	CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O	BPLBGHOLXOTWMN-MBNYWOFBSA-N	InChI=1S/C16H18N2O5S/c1-16(2)12(15(21)22)18-13(20)11(14(18)24-16)17-10(19)8-23-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200852	PENICILLIN V POTASSIUM	CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[K+]	HCTVWSOKIJULET-LQDWTQKMSA-M	InChI=1S/C16H18N2O5S.K/c1-16(2)12(15(21)22)18-13(20)11(14(18)24-16)17-10(19)8-23-9-6-4-3-5-7-9;/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22);/q;+1/p-1/t11-,12+,14-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL158	AZTREONAM	C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O	WZPBZJONDBGPKJ-VEHQQRBSSA-N	InChI=1S/C13H17N5O8S2/c1-5-7(10(20)18(5)28(23,24)25)16-9(19)8(6-4-27-12(14)15-6)17-26-13(2,3)11(21)22/h4-5,7H,1-3H3,(H2,14,15)(H,16,19)(H,21,22)(H,23,24,25)/b17-8-/t5-,7-/m0/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1632	CEPHALOTHIN SODIUM	CC(=O)OCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)Cc3cccs3)[C@H]2SC1.[Na+]	VUFGUVLLDPOSBC-XRZFDKQNSA-M	InChI=1S/C16H16N2O6S2.Na/c1-8(19)24-6-9-7-26-15-12(14(21)18(15)13(9)16(22)23)17-11(20)5-10-3-2-4-25-10;/h2-4,12,15H,5-7H2,1H3,(H,17,20)(H,22,23);/q;+1/p-1/t12-,15-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1095930	CEFUROXIME AXETIL	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)OC(C)OC(C)=O)=C(COC(N)=O)CS[C@H]12)c1ccco1	KEJCWVGMRLCZQQ-YJBYXUATSA-N	InChI=1S/C20H22N4O10S/c1-9(25)33-10(2)34-19(28)15-11(7-32-20(21)29)8-35-18-14(17(27)24(15)18)22-16(26)13(23-30-3)12-5-4-6-31-12/h4-6,10,14,18H,7-8H2,1-3H3,(H2,21,29)(H,22,26)/b23-13-/t10?,14-,18-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200357	MOXALACTAM DISODIUM	CO[C@@]1(NC(=O)C(C(=O)[O-])c2ccc(O)cc2)C(=O)N2C(C(=O)[O-])=C(CSc3nnnn3C)CO[C@@H]21.[Na+].[Na+]	GRIXGZQULWMCLU-HUTAOCTPSA-L	InChI=1S/C20H20N6O9S.2Na/c1-25-19(22-23-24-25)36-8-10-7-35-18-20(34-2,17(33)26(18)13(10)16(31)32)21-14(28)12(15(29)30)9-3-5-11(27)6-4-9;;/h3-6,12,18,27H,7-8H2,1-2H3,(H,21,28)(H,29,30)(H,31,32);;/q;2*+1/p-2/t12?,18-,20+;;/m1../s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200971	CEPHALOGLYCIN	CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1	FUBBGQLTSCSAON-PBFPGSCMSA-N	InChI=1S/C18H19N3O6S/c1-9(22)27-7-11-8-28-17-13(16(24)21(17)14(11)18(25)26)20-15(23)12(19)10-5-3-2-4-6-10/h2-6,12-13,17H,7-8,19H2,1H3,(H,20,23)(H,25,26)/t12-,13-,17-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200965	BACAMPICILLIN HYDROCHLORIDE	CCOC(=O)OC(C)OC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C.Cl	IWVTXAGTHUECPN-ANBBSHPLSA-N	InChI=1S/C21H27N3O7S.ClH/c1-5-29-20(28)31-11(2)30-19(27)15-21(3,4)32-18-14(17(26)24(15)18)23-16(25)13(22)12-9-7-6-8-10-12;/h6-11,13-15,18H,5,22H2,1-4H3,(H,23,25);1H/t11?,13-,14-,15+,18-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1201118	CEFMETAZOLE SODIUM	CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)[O-])=C(CSc3nnnn3C)CS[C@@H]21.[Na+]	BITQGIOJQWZUPL-PBCQUBLHSA-M	InChI=1S/C15H17N7O5S3.Na/c1-21-14(18-19-20-21)30-6-8-5-29-13-15(27-2,17-9(23)7-28-4-3-16)12(26)22(13)10(8)11(24)25;/h13H,4-7H2,1-2H3,(H,17,23)(H,24,25);/q;+1/p-1/t13-,15+;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1201046	CEFORANIDE	NCc1ccccc1CC(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3CC(=O)O)CS[C@H]12	SLAYUXIURFNXPG-CRAIPNDOSA-N	InChI=1S/C20H21N7O6S2/c21-6-11-4-2-1-3-10(11)5-13(28)22-15-17(31)27-16(19(32)33)12(8-34-18(15)27)9-35-20-23-24-25-26(20)7-14(29)30/h1-4,15,18H,5-9,21H2,(H,22,28)(H,29,30)(H,32,33)/t15-,18-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200589	CEFOTIAM HYDROCHLORIDE	CN(C)CCn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3csc(N)n3)[C@H]2SC1.Cl	SVSFIELZISOJDT-XRZFDKQNSA-N	InChI=1S/C18H23N9O4S3.ClH/c1-25(2)3-4-26-18(22-23-24-26)34-7-9-6-32-15-12(14(29)27(15)13(9)16(30)31)21-11(28)5-10-8-33-17(19)20-10;/h8,12,15H,3-7H2,1-2H3,(H2,19,20)(H,21,28)(H,30,31);1H/t12-,15-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200530	CEFOXITIN SODIUM	CO[C@@]1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)[O-])=C(COC(N)=O)CS[C@@H]21.[Na+]	GNWUOVJNSFPWDD-XMZRARIVSA-M	InChI=1S/C16H17N3O7S2.Na/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19;/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22);/q;+1/p-1/t14-,16+;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL3184906	CEFPROZIL	CC=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1.O	ALYUMNAHLSSTOU-PFBPGKLMSA-N	InChI=1S/C18H19N3O5S.H2O/c1-2-3-10-8-27-17-13(16(24)21(17)14(10)18(25)26)20-15(23)12(19)9-4-6-11(22)7-5-9;/h2-7,12-13,17,22H,8,19H2,1H3,(H,20,23)(H,25,26);1H2/t12-,13-,17-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1201019	CEFTIZOXIME SODIUM	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=CCS[C@H]12)c1csc(N)n1.[Na+]	ADLFUPFRVXCDMO-LIGXYSTNSA-M	InChI=1S/C13H13N5O5S2.Na/c1-23-17-7(5-4-25-13(14)15-5)9(19)16-8-10(20)18-6(12(21)22)2-3-24-11(8)18;/h2,4,8,11H,3H2,1H3,(H2,14,15)(H,16,19)(H,21,22);/q;+1/p-1/b17-7-;/t8-,11-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200544	CEPHALEXIN	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1.O	AVGYWQBCYZHHPN-CYJZLJNKSA-N	InChI=1S/C16H17N3O4S.H2O/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9;/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23);1H2/t10-,11-,15-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200523	CEFAZOLIN SODIUM	Cc1nnc(SCC2=C(C(=O)[O-])N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1.[Na+]	FLKYBGKDCCEQQM-WYUVZMMLSA-M	InChI=1S/C14H14N8O4S3.Na/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21;/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26);/q;+1/p-1/t9-,12-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL927	CEFDINIR	C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\O)c3csc(N)n3)[C@H]2SC1	RTXOFQZKPXMALH-GHXIOONMSA-N	InChI=1S/C14H13N5O5S2/c1-2-5-3-25-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-26-14(15)16-6/h2,4,8,12,24H,1,3H2,(H2,15,16)(H,17,20)(H,22,23)/b18-7-/t8-,12-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL3183193	CEFMENOXIME HYDROCHLORIDE	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@H]12)c1csc(N)n1.CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@H]12)c1csc(N)n1.Cl	MPTNDTIREFCQLK-UNVJPQNDSA-N	InChI=1S/2C16H17N9O5S3.ClH/c2*1-24-16(20-22-23-24)33-4-6-3-31-13-9(12(27)25(13)10(6)14(28)29)19-11(26)8(21-30-2)7-5-32-15(17)18-7;/h2*5,9,13H,3-4H2,1-2H3,(H2,17,18)(H,19,26)(H,28,29);1H/b2*21-8-;/t2*9-,13-;/m11./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200482	CEFOPERAZONE SODIUM	CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)[O-])=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O.[Na+]	NCFTXMQPRQZFMZ-WERGMSTESA-M	InChI=1S/C25H27N9O8S2.Na/c1-3-32-8-9-33(21(39)20(32)38)24(42)27-15(12-4-6-14(35)7-5-12)18(36)26-16-19(37)34-17(23(40)41)13(10-43-22(16)34)11-44-25-28-29-30-31(25)2;/h4-7,15-16,22,35H,3,8-11H2,1-2H3,(H,26,36)(H,27,42)(H,40,41);/q;+1/p-1/t15-,16-,22-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200672	CEFPIRAMIDE SODIUM	Cc1cc(O)c(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)[O-])=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)cn1.[Na+]	RIWWMGQFMUUYIY-ALLHVENQSA-M	InChI=1S/C25H24N8O7S2.Na/c1-11-7-16(35)15(8-26-11)20(36)27-17(12-3-5-14(34)6-4-12)21(37)28-18-22(38)33-19(24(39)40)13(9-41-23(18)33)10-42-25-29-30-31-32(25)2;/h3-8,17-18,23,34H,9-10H2,1-2H3,(H,26,35)(H,27,36)(H,28,37)(H,39,40);/q;+1/p-1/t17-,18-,23-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL3544973	CEFTAROLINE FOSAMIL ACETATE	CC(=O)O.CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1.O	KRWPPVCZNGQQHZ-IINIBMQSSA-N	InChI=1S/C22H21N8O8PS4.C2H4O2.H2O/c1-3-38-26-13(16-25-21(43-28-16)27-39(35,36)37)17(31)24-14-18(32)30-15(20(33)34)12(9-40-19(14)30)42-22-23-11(8-41-22)10-4-6-29(2)7-5-10;1-2(3)4;/h4-8,14,19H,3,9H2,1-2H3,(H4-,24,25,27,28,31,33,34,35,36,37);1H3,(H,3,4);1H2/b26-13-;;/t14-,19-;;/m1../s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1644	CEFADROXIL	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1	BOEGTKLJZSQCCD-UEKVPHQBSA-N	InChI=1S/C16H17N3O5S/c1-7-6-25-15-11(14(22)19(15)12(7)16(23)24)18-13(21)10(17)8-2-4-9(20)5-3-8/h2-5,10-11,15,20H,6,17H2,1H3,(H,18,21)(H,23,24)/t10-,11-,15-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1232	ERTAPENEM SODIUM	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)Nc4cccc(C(=O)[O-])c4)C3)[C@H](C)[C@H]12.[Na+]	ZXNAQFZBWUNWJM-HRXMHBOMSA-M	InChI=1S/C22H25N3O7S.Na/c1-9-16-15(10(2)26)20(28)25(16)17(22(31)32)18(9)33-13-7-14(23-8-13)19(27)24-12-5-3-4-11(6-12)21(29)30;/h3-6,9-10,13-16,23,26H,7-8H2,1-2H3,(H,24,27)(H,29,30)(H,31,32);/q;+1/p-1/t9-,10-,13+,14+,15-,16-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200768	CEFTAZIDIME SODIUM	CC(C)(O/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12)c1csc(N)n1)C(=O)[O-].[Na+]	JEEWDSDYUSEQML-ROMZVAKDSA-M	InChI=1S/C22H22N6O7S2.Na/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27;/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34);/q;+1/p-1/b26-13-;/t14-,18-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL3183968	CEFTRIAXONE SODIUM	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(CSc3nc(=O)c([O-])nn3C)CS[C@H]12)c1csc(N)n1.O.O.O.[Na+].[Na+]	XMCDZRXQAGFWAK-PMCOHIMVSA-L	InChI=1S/C18H18N8O7S3.2Na.3H2O/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7;;;;;/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32);;;3*1H2/q;2*+1;;;/p-2/b24-8-;;;;;/t9-,15-;;;;;/m1...../s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1605	CEFTIBUTEN	Nc1nc(/C(=C/CC(=O)O)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=CCS[C@H]23)cs1	UNJFKXSSGBWRBZ-BJCIPQKHSA-N	InChI=1S/C15H14N4O6S2/c16-15-17-7(5-27-15)6(1-2-9(20)21)11(22)18-10-12(23)19-8(14(24)25)3-4-26-13(10)19/h1,3,5,10,13H,2,4H2,(H2,16,17)(H,18,22)(H,20,21)(H,24,25)/b6-1-/t10-,13-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1082	AMOXICILLIN	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O	LSQZJLSUYDQPKJ-NJBDSQKTSA-N	InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL174	AMPICILLIN	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O	AVKUERGKIZMTKX-NJBDSQKTSA-N	InChI=1S/C16H19N3O4S/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23)/t9-,10-,11+,14-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1201098	CEFOTETAN DISODIUM	CO[C@@]1(NC(=O)C2SC(=C(C(N)=O)C(=O)[O-])S2)C(=O)N2C(C(=O)[O-])=C(CSc3nnnn3C)CS[C@@H]21.[Na+].[Na+]	ZQQALMSFFARWPK-GLHLDKNHSA-L	InChI=1S/C17H17N7O8S4.2Na/c1-23-16(20-21-22-23)34-4-5-3-33-15-17(32-2,14(31)24(15)7(5)11(29)30)19-9(26)13-35-12(36-13)6(8(18)25)10(27)28;;/h13,15H,3-4H2,1-2H3,(H2,18,25)(H,19,26)(H,27,28)(H,29,30);;/q;2*+1/p-2/b12-6-;;/t13?,15-,17+;;/m1../s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1541	CEFIXIME	C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OCC(=O)O)c3csc(N)n3)[C@H]2SC1	OKBVVJOGVLARMR-QSWIMTSFSA-N	InChI=1S/C16H15N5O7S2/c1-2-6-4-29-14-10(13(25)21(14)11(6)15(26)27)19-12(24)9(20-28-3-8(22)23)7-5-30-16(17)18-7/h2,5,10,14H,1,3-4H2,(H2,17,18)(H,19,24)(H,22,23)(H,26,27)/b20-9-/t10-,14-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL606260	CARBENICILLIN DISODIUM	CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)[O-])c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+].[Na+]	RTYJTGSCYUUYAL-YCAHSCEMSA-L	InChI=1S/C17H18N2O6S.2Na/c1-17(2)11(16(24)25)19-13(21)10(14(19)26-17)18-12(20)9(15(22)23)8-6-4-3-5-7-8;;/h3-7,9-11,14H,1-2H3,(H,18,20)(H,22,23)(H,24,25);;/q;2*+1/p-2/t9?,10-,11+,14-;;/m1../s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200356	CYCLACILLIN	CC1(C)S[C@@H]2[C@H](NC(=O)C3(N)CCCCC3)C(=O)N2[C@H]1C(=O)O	HGBLNBBNRORJKI-WCABBAIRSA-N	InChI=1S/C15H23N3O4S/c1-14(2)9(12(20)21)18-10(19)8(11(18)23-14)17-13(22)15(16)6-4-3-5-7-15/h8-9,11H,3-7,16H2,1-2H3,(H,17,22)(H,20,21)/t8-,9+,11-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL491571	DORIPENEM	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)[C@H](C)[C@H]12	AVAACINZEOAHHE-VFZPANTDSA-N	InChI=1S/C15H24N4O6S2/c1-6-11-10(7(2)20)14(21)19(11)12(15(22)23)13(6)26-9-3-8(17-5-9)4-18-27(16,24)25/h6-11,17-18,20H,3-5H2,1-2H3,(H,22,23)(H2,16,24,25)/t6-,7-,8+,9+,10-,11-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200366	CEPHALEXIN HYDROCHLORIDE	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1.Cl.O	YHJDZIQOCSDIQU-OEDJVVDHSA-N	InChI=1S/C16H17N3O4S.ClH.H2O/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9;;/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23);1H;1H2/t10-,11-,15-;;/m1../s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1201005	CEFONICID SODIUM	O=C([O-])C1=C(CSc2nnnn2CS(=O)(=O)[O-])CS[C@@H]2[C@H](NC(=O)[C@H](O)c3ccccc3)C(=O)N12.[Na+].[Na+]	NAXFZVGOZUWLEP-RFXDPDBWSA-L	InChI=1S/C18H18N6O8S3.2Na/c25-13(9-4-2-1-3-5-9)14(26)19-11-15(27)24-12(17(28)29)10(6-33-16(11)24)7-34-18-20-21-22-23(18)8-35(30,31)32;;/h1-5,11,13,16,25H,6-8H2,(H,19,26)(H,28,29)(H,30,31,32);;/q;2*+1/p-2/t11-,13-,16-;;/m1../s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200758	AMPICILLIN SODIUM	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]	KLOHDWPABZXLGI-YWUHCJSESA-M	InChI=1S/C16H19N3O4S.Na/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8;/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23);/q;+1/p-1/t9-,10-,11+,14-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200962	CEFEPIME HYDROCHLORIDE	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1.Cl.O.[Cl-]	LRAJHPGSGBRUJN-OMIVUECESA-N	InChI=1S/C19H24N6O5S2.2ClH.H2O/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11;;;/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29);2*1H;1H2/b23-12-;;;/t13-,17-;;;/m1.../s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL44354	CEFTAZIDIME	CC(C)(O/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12)c1csc(N)n1)C(=O)O	ORFOPKXBNMVMKC-DWVKKRMSSA-N	InChI=1S/C22H22N6O7S2/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34)/b26-13-/t14-,18-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1010	CEFOTAXIME SODIUM	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(COC(C)=O)CS[C@H]12)c1csc(N)n1.[Na+]	AZZMGZXNTDTSME-JUZDKLSSSA-M	InChI=1S/C16H17N5O7S2.Na/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8;/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26);/q;+1/p-1/b20-9-;/t10-,14-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1201016	CEFPODOXIME PROXETIL	COCC1=C(C(=O)OC(C)OC(=O)OC(C)C)N2C(=O)[C@@H](NC(=O)/C(=N\OC)c3csc(N)n3)[C@H]2SC1	LTINZAODLRIQIX-FBXRGJNPSA-N	InChI=1S/C21H27N5O9S2/c1-9(2)33-21(30)35-10(3)34-19(29)15-11(6-31-4)7-36-18-14(17(28)26(15)18)24-16(27)13(25-32-5)12-8-37-20(22)23-12/h8-10,14,18H,6-7H2,1-5H3,(H2,22,23)(H,24,27)/b25-13-/t10?,14-,18-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL454446	CEFDITOREN PIVOXIL	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(/C=C\c3scnc3C)CS[C@H]12)c1csc(N)n1	AFZFFLVORLEPPO-UVYJNCLZSA-N	InChI=1S/C25H28N6O7S3/c1-12-15(41-10-27-12)7-6-13-8-39-21-17(29-19(32)16(30-36-5)14-9-40-24(26)28-14)20(33)31(21)18(13)22(34)37-11-38-23(35)25(2,3)4/h6-7,9-10,17,21H,8,11H2,1-5H3,(H2,26,28)(H,29,32)/b7-6-,30-16-/t17-,21-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200610	LORACARBEF	N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CC[C@H]12)c1ccccc1.O	GPYKKBAAPVOCIW-HSASPSRMSA-N	InChI=1S/C16H16ClN3O4.H2O/c17-9-6-7-10-12(15(22)20(10)13(9)16(23)24)19-14(21)11(18)8-4-2-1-3-5-8;/h1-5,10-12H,6-7,18H2,(H,19,21)(H,23,24);1H2/t10-,11-,12+;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL127	MEROPENEM	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12	DMJNNHOOLUXYBV-PQTSNVLCSA-N	InChI=1S/C17H25N3O5S/c1-7-12-11(8(2)21)16(23)20(12)13(17(24)25)14(7)26-9-5-10(18-6-9)15(22)19(3)4/h7-12,18,21H,5-6H2,1-4H3,(H,24,25)/t7-,8-,9+,10+,11-,12-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1697708	MEZLOCILLIN SODIUM	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCN(S(C)(=O)=O)C3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]	GTGQRSIMEUWHPA-ZBJAFUORSA-M	InChI=1S/C21H25N5O8S2.Na/c1-21(2)14(18(29)30)26-16(28)13(17(26)35-21)22-15(27)12(11-7-5-4-6-8-11)23-19(31)24-9-10-25(20(24)32)36(3,33)34;/h4-8,12-14,17H,9-10H2,1-3H3,(H,22,27)(H,23,31)(H,29,30);/q;+1/p-1/t12-,13-,14+,17-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL3989515	PENICILLIN G BENZATHINE	CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.O.O.O.O.c1ccc(CNCCNCc2ccccc2)cc1	WIDKTXGNSOORHA-CJHXQPGBSA-N	InChI=1S/2C16H18N2O4S.C16H20N2.4H2O/c2*1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9;1-3-7-15(8-4-1)13-17-11-12-18-14-16-9-5-2-6-10-16;;;;/h2*3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22);1-10,17-18H,11-14H2;4*1H2/t2*11-,12+,14-;;;;;/m11...../s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1223	PENICILLIN G POTASSIUM	CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[K+]	IYNDLOXRXUOGIU-LQDWTQKMSA-M	InChI=1S/C16H18N2O4S.K/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9;/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22);/q;+1/p-1/t11-,12+,14-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1126	PENICILLIN G SODIUM	CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]	FCPVYOBCFFNJFS-LQDWTQKMSA-M	InChI=1S/C16H18N2O4S.Na/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9;/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22);/q;+1/p-1/t11-,12+,14-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200820	PIPERACILLIN SODIUM	CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)[O-])C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O.[Na+]	WCMIIGXFCMNQDS-IDYPWDAWSA-M	InChI=1S/C23H27N5O7S.Na/c1-4-26-10-11-27(19(32)18(26)31)22(35)25-13(12-8-6-5-7-9-12)16(29)24-14-17(30)28-15(21(33)34)23(2,3)36-20(14)28;/h5-9,13-15,20H,4,10-11H2,1-3H3,(H,24,29)(H,25,35)(H,33,34);/q;+1/p-1/t13-,14-,15+,20-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL43708	IMIPENEM	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCCNC=N)C[C@H]12.O	GSOSVVULSKVSLQ-JJVRHELESA-N	InChI=1S/C12H17N3O4S.H2O/c1-6(16)9-7-4-8(20-3-2-14-5-13)10(12(18)19)15(7)11(9)17;/h5-7,9,16H,2-4H2,1H3,(H2,13,14)(H,18,19);1H2/t6-,7-,9-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL530	AMDINOCILLIN	CC1(C)S[C@@H]2[C@H](/N=C/N3CCCCCC3)C(=O)N2[C@H]1C(=O)O	BWWVAEOLVKTZFQ-ISVUSNJMSA-N	InChI=1S/C15H23N3O3S/c1-15(2)11(14(20)21)18-12(19)10(13(18)22-15)16-9-17-7-5-3-4-6-8-17/h9-11,13H,3-8H2,1-2H3,(H,20,21)/b16-9+/t10-,11+,13-/m1/s1	Bacterial penicillin-binding protein 2 inhibitor	INHIBITOR	CHEMBL2354313	Bacterial penicillin-binding protein 2	Bacteria
CHEMBL1200701	DICLOXACILLIN SODIUM	Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.O.[Na+]	SIGZQNJITOWQEF-VICXVTCVSA-M	InChI=1S/C19H17Cl2N3O5S.Na.H2O/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24;;/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28);;1H2/q;+1;/p-1/t13-,14+,17-;;/m1../s1	Penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2362972	Penicillin-binding protein	Staphylococcus aureus
CHEMBL1568276	NAFCILLIN SODIUM	CCOc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.O.[Na+]	OCXSDHJRMYFTMA-KMFBOIRUSA-M	InChI=1S/C21H22N2O5S.Na.H2O/c1-4-28-13-10-9-11-7-5-6-8-12(11)14(13)17(24)22-15-18(25)23-16(20(26)27)21(2,3)29-19(15)23;;/h5-10,15-16,19H,4H2,1-3H3,(H,22,24)(H,26,27);;1H2/q;+1;/p-1/t15-,16+,19-;;/m1../s1	Penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2362972	Penicillin-binding protein	Staphylococcus aureus
CHEMBL3989567	OXACILLIN SODIUM	Cc1onc(-c2ccccc2)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.O.[Na+]	ZVIYWUUZWWBNMB-VICXVTCVSA-M	InChI=1S/C19H19N3O5S.Na.H2O/c1-9-11(12(21-27-9)10-7-5-4-6-8-10)15(23)20-13-16(24)22-14(18(25)26)19(2,3)28-17(13)22;;/h4-8,13-14,17H,1-3H3,(H,20,23)(H,25,26);;1H2/q;+1;/p-1/t13-,14+,17-;;/m1../s1	Penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2362972	Penicillin-binding protein	Staphylococcus aureus
CHEMBL2096637	PYRETHRINS	C=C/C=C\CC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](/C=C(\C)C(=O)OC)C2(C)C)CC1=O.C=C/C=C\CC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](C=C(C)C)C2(C)C)CC1=O	VXSIXFKKSNGRRO-MXOVTSAMSA-N	InChI=1S/C22H28O5.C21H28O3/c1-7-8-9-10-15-14(3)18(12-17(15)23)27-21(25)19-16(22(19,4)5)11-13(2)20(24)26-6;1-7-8-9-10-15-14(4)18(12-17(15)22)24-20(23)19-16(11-13(2)3)21(19,5)6/h7-9,11,16,18-19H,1,10,12H2,2-6H3;7-9,11,16,18-19H,1,10,12H2,2-6H3/b9-8-,13-11+;9-8-/t2*16-,18+,19+/m11/s1	Voltage-sensitive sodium channel alpha-subunit blocker	BLOCKER	CHEMBL2362984	Voltage-sensitive sodium channel alpha-subunit	Pediculus humanus
CHEMBL1525	PERMETHRIN	CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1	RLLPVAHGXHCWKJ-UHFFFAOYSA-N	InChI=1S/C21H20Cl2O3/c1-21(2)17(12-18(22)23)19(21)20(24)25-13-14-7-6-10-16(11-14)26-15-8-4-3-5-9-15/h3-12,17,19H,13H2,1-2H3	Voltage-sensitive sodium channel blocker	BLOCKER	CHEMBL2362985	Voltage-sensitive sodium channel	Sarcoptes scabiei type hominis
CHEMBL608	PROBUCOL	CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1	FYPMFJGVHOHGLL-UHFFFAOYSA-N	InChI=1S/C31H48O2S2/c1-27(2,3)21-15-19(16-22(25(21)32)28(4,5)6)34-31(13,14)35-20-17-23(29(7,8)9)26(33)24(18-20)30(10,11)12/h15-18,32-33H,1-14H3	ATP-binding cassette sub-family A member 1 inhibitor	INHIBITOR	CHEMBL2362986	ATP-binding cassette sub-family A member 1	Homo sapiens
CHEMBL525076	ENFUVIRTIDE	CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(N)=O	PEASPLKKXBYDKL-FXEVSJAOSA-N	InChI=1S/C204H301N51O64/c1-20-102(15)166(253-195(310)137(75-100(11)12)239-200(315)150(93-258)251-190(305)143(82-112-90-215-95-219-112)248-203(318)167(103(16)21-2)254-196(311)138(76-101(13)14)240-201(316)151(94-259)252-204(319)168(105(18)260)255-197(312)139(221-106(19)261)78-108-45-47-113(262)48-46-108)202(317)233-131(58-68-164(280)281)178(293)228-130(57-67-163(278)279)182(297)250-149(92-257)198(313)232-125(52-62-155(210)266)179(294)245-145(84-157(212)268)191(306)229-124(51-61-154(209)265)175(290)224-122(49-59-152(207)263)173(288)226-126(53-63-159(270)271)176(291)222-120(43-31-33-69-205)172(287)244-144(83-156(211)267)192(307)231-127(54-64-160(272)273)177(292)225-123(50-60-153(208)264)174(289)227-128(55-65-161(274)275)180(295)235-134(72-97(5)6)185(300)237-133(71-96(3)4)184(299)230-129(56-66-162(276)277)181(296)236-135(73-98(7)8)187(302)247-147(86-165(282)283)194(309)223-121(44-32-34-70-206)171(286)241-140(79-109-87-216-117-40-28-25-37-114(109)117)183(298)220-104(17)170(285)249-148(91-256)199(314)238-136(74-99(9)10)186(301)242-142(81-111-89-218-119-42-30-27-39-116(111)119)189(304)246-146(85-158(213)269)193(308)243-141(80-110-88-217-118-41-29-26-38-115(110)118)188(303)234-132(169(214)284)77-107-35-23-22-24-36-107/h22-30,35-42,45-48,87-90,95-105,120-151,166-168,216-218,256-260,262H,20-21,31-34,43-44,49-86,91-94,205-206H2,1-19H3,(H2,207,263)(H2,208,264)(H2,209,265)(H2,210,266)(H2,211,267)(H2,212,268)(H2,213,269)(H2,214,284)(H,215,219)(H,220,298)(H,221,261)(H,222,291)(H,223,309)(H,224,290)(H,225,292)(H,226,288)(H,227,289)(H,228,293)(H,229,306)(H,230,299)(H,231,307)(H,232,313)(H,233,317)(H,234,303)(H,235,295)(H,236,296)(H,237,300)(H,238,314)(H,239,315)(H,240,316)(H,241,286)(H,242,301)(H,243,308)(H,244,287)(H,245,294)(H,246,304)(H,247,302)(H,248,318)(H,249,285)(H,250,297)(H,251,305)(H,252,319)(H,253,310)(H,254,311)(H,255,312)(H,270,271)(H,272,273)(H,274,275)(H,276,277)(H,278,279)(H,280,281)(H,282,283)/t102-,103-,104-,105+,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,166-,167-,168-/m0/s1	Transmembrane glycoprotein gp41 inhibitor	INHIBITOR	CHEMBL2362987	Transmembrane glycoprotein gp41	Human immunodeficiency virus
CHEMBL1200468	MALATHION	CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC	JXSJBGJIGXNWCI-UHFFFAOYSA-N	InChI=1S/C10H19O6PS2/c1-5-15-9(11)7-8(10(12)16-6-2)19-17(18,13-3)14-4/h8H,5-7H2,1-4H3	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL2362988	Acetylcholinesterase	Pediculus humanus capitis
CHEMBL1607	TOPOTECAN HYDROCHLORIDE	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1.Cl	DGHHQBMTXTWTJV-BQAIUKQQSA-N	InChI=1S/C23H23N3O5.ClH/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20;/h5-8,27,30H,4,9-11H2,1-3H3;1H/t23-;/m0./s1	DNA topoisomerase I, mitochondrial inhibitor	INHIBITOR	CHEMBL2362989	DNA topoisomerase I, mitochondrial	Homo sapiens
CHEMBL1201780	CARGLUMIC ACID	NC(=O)N[C@@H](CCC(=O)O)C(=O)O	LCQLHJZYVOQKHU-VKHMYHEASA-N	InChI=1S/C6H10N2O5/c7-6(13)8-3(5(11)12)1-2-4(9)10/h3H,1-2H2,(H,9,10)(H,11,12)(H3,7,8,13)/t3-/m0/s1	Carbamoyl-phosphate synthase [ammonia], mitochondrial positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2362990	Carbamoyl-phosphate synthase [ammonia], mitochondrial	Homo sapiens
CHEMBL1542	AZATHIOPRINE	Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12	LMEKQMALGUDUQG-UHFFFAOYSA-N	InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)	Amidophosphoribosyltransferase inhibitor	INHIBITOR	CHEMBL2362992	Amidophosphoribosyltransferase	Homo sapiens
CHEMBL1200751	MERCAPTOPURINE	O.Sc1ncnc2nc[nH]c12	WFFQYWAAEWLHJC-UHFFFAOYSA-N	InChI=1S/C5H4N4S.H2O/c10-5-3-4(7-1-6-3)8-2-9-5;/h1-2H,(H2,6,7,8,9,10);1H2	Amidophosphoribosyltransferase inhibitor	INHIBITOR	CHEMBL2362992	Amidophosphoribosyltransferase	Homo sapiens
CHEMBL1200400	AZATHIOPRINE SODIUM	Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[n-]c12.[Na+]	WISNYKIQFMKSDQ-UHFFFAOYSA-N	InChI=1S/C9H6N7O2S.Na/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8;/h2-4H,1H3;/q-1;+1	Amidophosphoribosyltransferase inhibitor	INHIBITOR	CHEMBL2362992	Amidophosphoribosyltransferase	Homo sapiens
CHEMBL1043	DAPSONE	Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1	MQJKPEGWNLWLTK-UHFFFAOYSA-N	InChI=1S/C12H12N2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H,13-14H2	Dihydropteroate synthase 1 inhibitor	INHIBITOR	CHEMBL2362993	Dihydropteroate synthase 1	Mycobacterium leprae (strain TN)
CHEMBL1200580	SULFOXONE SODIUM	O=S([O-])CNc1ccc(S(=O)(=O)c2ccc(NCS(=O)[O-])cc2)cc1.[Na+].[Na+]	AZBNFLZFSZDPQF-UHFFFAOYSA-L	InChI=1S/C14H16N2O6S3.2Na/c17-23(18)9-15-11-1-5-13(6-2-11)25(21,22)14-7-3-12(4-8-14)16-10-24(19)20;;/h1-8,15-16H,9-10H2,(H,17,18)(H,19,20);;/q;2*+1/p-2	Dihydropteroate synthase 1 inhibitor	INHIBITOR	CHEMBL2362993	Dihydropteroate synthase 1	Mycobacterium leprae (strain TN)
CHEMBL976	PRAZIQUANTEL	O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1	FSVJFNAIGNNGKK-UHFFFAOYSA-N	InChI=1S/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H2	Voltage-activated calcium channel beta 1 subunit blocker	BLOCKER	CHEMBL2363079	Voltage-activated calcium channel beta 1 subunit	Schistosoma mansoni
CHEMBL976	PRAZIQUANTEL	O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1	FSVJFNAIGNNGKK-UHFFFAOYSA-N	InChI=1S/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H2	Voltage-activated calcium channel beta 2 subunit blocker	BLOCKER	CHEMBL2363080	Voltage-activated calcium channel beta 2 subunit	Schistosoma mansoni
CHEMBL130	CHLORAMPHENICOL	O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl	WIIZWVCIJKGZOK-RKDXNWHRSA-N	InChI=1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m1/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL4208954	AMIKACIN SULFATE	NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O	FXKSEJFHKVNEFI-GCZBSULCSA-N	InChI=1S/C22H43N5O13.2H2O4S/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21;2*1-5(2,3)4/h6-19,21-22,28-35H,1-5,23-26H2,(H,27,36);2*(H2,1,2,3,4)/t6-,7+,8-,9+,10+,11-,12+,13+,14+,15-,16+,17-,18+,19-,21+,22+;;/m0../s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1517	OXYTETRACYCLINE	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12	IWVCMVBTMGNXQD-PXOLEDIWSA-N	InChI=1S/C22H24N2O9/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29/h4-6,12-14,17,25,27-29,32-33H,1-3H3,(H2,23,31)/t12-,13-,14+,17+,21-,22+/m1/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL3989568	OXYTETRACYCLINE CALCIUM	CN(C)[C@@H]1C([O-])=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12.CN(C)[C@@H]1C([O-])=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12.[Ca+2]	KIPLYOUQVMMOHB-MXWBXKMOSA-L	InChI=1S/2C22H24N2O9.Ca/c2*1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29;/h2*4-6,12-14,17,25,27-29,32-33H,1-3H3,(H2,23,31);/q;;+2/p-2/t2*12-,13-,14+,17+,21-,22+;/m11./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL2146123	METHACYCLINE HYDROCHLORIDE	C=C1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12.Cl	VZQARNDJLLWXGL-CCHMMTNSSA-N	InChI=1S/C22H22N2O8.ClH/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;/h4-6,10,14-15,17,25,27-29,32H,1H2,2-3H3,(H2,23,31);1H/t10-,14-,15+,17+,22+;/m1./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL3184512	CLINDAMYCIN PHOSPHATE	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](OP(=O)(O)O)[C@@H](O)[C@H]2O)N(C)C1	UFUVLHLTWXBHGZ-MGZQPHGTSA-N	InChI=1S/C18H34ClN2O8PS/c1-5-6-10-7-11(21(3)8-10)17(24)20-12(9(2)19)15-13(22)14(23)16(18(28-15)31-4)29-30(25,26)27/h9-16,18,22-23H,5-8H2,1-4H3,(H,20,24)(H2,25,26,27)/t9-,10+,11-,12+,13+,14-,15+,16+,18+/m0/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1200729	CHLORAMPHENICOL SODIUM SUCCINATE	O=C([O-])CCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1.[Na+]	RPLOPBHEZLFENN-HTMVYDOJSA-M	InChI=1S/C15H16Cl2N2O8.Na/c16-14(17)15(24)18-10(7-27-12(22)6-5-11(20)21)13(23)8-1-3-9(4-2-8)19(25)26;/h1-4,10,13-14,23H,5-7H2,(H,18,24)(H,20,21);/q;+1/p-1/t10-,13-;/m1./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1200510	ERYTHROMYCIN STEARATE	CCCCCCCCCCCCCCCCCC(=O)O.CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	YAVZHCFFUATPRK-YZPBMOCRSA-N	InChI=1S/C37H67NO13.C18H36O2/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26;1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3;2-17H2,1H3,(H,19,20)/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-;/m1./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL3039471	DIRITHROMYCIN	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O	WLOHNSSYAXHWNR-GDLCQVGZSA-N	InChI=1S/C42H78N2O14/c1-15-29-42(10,49)37-24(4)32(43-30(56-37)21-52-17-16-50-13)22(2)19-40(8,48)36(58-39-33(45)28(44(11)12)18-23(3)53-39)25(5)34(26(6)38(47)55-29)57-31-20-41(9,51-14)35(46)27(7)54-31/h22-37,39,43,45-46,48-49H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29?,30-,31+,32+,33-,34+,35+,36-,37-,39+,40-,41-,42-/m1/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL3545060	ERYTHROMYCIN GLUCEPTATE	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O.O=C(O)[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO	ZXBDZLHAHGPXIG-VTXLJDRKSA-N	InChI=1S/C37H67NO13.C7H14O8/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26;8-1-2(9)3(10)4(11)5(12)6(13)7(14)15/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3;2-6,8-13H,1H2,(H,14,15)/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-;2-,3-,4+,5-,6-/m11/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1200937	DALFOPRISTIN	CCN(CC)CCS(=O)(=O)[C@@H]1CCN2C(=O)c3coc(n3)CC(=O)C[C@H](O)/C=C(C)/C=C/CNC(=O)/C=C/[C@@H](C)[C@@H](C(C)C)OC(=O)[C@@H]12	SUYRLXYYZQTJHF-VMBLUXKRSA-N	InChI=1S/C34H50N4O9S/c1-7-37(8-2)16-17-48(44,45)28-13-15-38-31(28)34(43)47-32(22(3)4)24(6)11-12-29(41)35-14-9-10-23(5)18-25(39)19-26(40)20-30-36-27(21-46-30)33(38)42/h9-12,18,21-22,24-25,28,31-32,39H,7-8,13-17,19-20H2,1-6H3,(H,35,41)/b10-9+,12-11+,23-18+/t24-,25-,28-,31-,32-/m1/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1446	KANAMYCIN SULFATE	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O.O=S(=O)(O)O	OOYGSFOGFJDDHP-KMCOLRRFSA-N	InChI=1S/C18H36N4O11.H2O4S/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17;1-5(2,3)4/h4-18,23-29H,1-3,19-22H2;(H2,1,2,3,4)/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-;/m1./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1200588	CLINDAMYCIN HYDROCHLORIDE	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1.Cl	AUODDLQVRAJAJM-XJQDNNTCSA-N	InChI=1S/C18H33ClN2O5S.ClH/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4;/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25);1H/t9-,10+,11-,12+,13-,14+,15+,16+,18+;/m0./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL376140	TIGECYCLINE	CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O	FPZLLRFZJZRHSY-HJYUBDRYSA-N	InChI=1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h10,12,14,21,31,36,38-39,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/t12-,14-,21-,29-/m0/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1200474	DEMECLOCYCLINE HYDROCHLORIDE	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@H](O)[C@H]3C[C@@H]12.Cl	GVSJQNRGSCOSNJ-KBHRXELFSA-N	InChI=1S/C21H21ClN2O8.ClH/c1-24(2)14-7-5-6-10(16(27)12-9(25)4-3-8(22)11(12)15(6)26)18(29)21(7,32)19(30)13(17(14)28)20(23)31;/h3-4,6-7,14-15,25-26,28-29,32H,5H2,1-2H3,(H2,23,31);1H/t6-,7-,14-,15-,21-;/m0./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1136	TELITHROMYCIN	CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C	LJVAJPDWBABPEJ-PNUFFHFMSA-N	InChI=1S/C43H65N5O10/c1-12-33-43(8)37(48(41(53)58-43)19-14-13-18-47-23-31(45-24-47)30-16-15-17-44-22-30)27(4)34(49)25(2)21-42(7,54-11)38(28(5)35(50)29(6)39(52)56-33)57-40-36(51)32(46(9)10)20-26(3)55-40/h15-17,22-29,32-33,36-38,40,51H,12-14,18-21H2,1-11H3/t25-,26-,27+,28+,29-,32+,33-,36-,37-,38-,40+,42-,43-/m1/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL3184791	STREPTOMYCIN SULFATE	CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O.CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O	QTENRWWVYAAPBI-YCRXJPFRSA-N	InChI=1S/2C21H39N7O12.3H2O4S/c2*1-5-21(36,4-30)16(40-17-9(26-2)13(34)10(31)6(3-29)38-17)18(37-5)39-15-8(28-20(24)25)11(32)7(27-19(22)23)12(33)14(15)35;3*1-5(2,3)4/h2*4-18,26,29,31-36H,3H2,1-2H3,(H4,22,23,27)(H4,24,25,28);3*(H2,1,2,3,4)/t2*5-,6-,7+,8-,9-,10-,11+,12-,13-,14+,15+,16-,17-,18-,21+;;;/m00.../s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL454950	TETRACYCLINE HYDROCHLORIDE	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12.Cl	XMEVHPAGJVLHIG-FMZCEJRJSA-N	InChI=1S/C22H24N2O8.ClH/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28;/h4-6,9-10,15,25,27-28,31-32H,7H2,1-3H3,(H2,23,30);1H/t9-,10-,15-,21+,22-;/m0./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1200632	CLINDAMYCIN PALMITATE HYDROCHLORIDE	CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@@H]([C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl)O[C@@H]1SC.Cl	GTNDZRUWKHDICY-DJHAJVGHSA-N	InChI=1S/C34H63ClN2O6S.ClH/c1-6-8-9-10-11-12-13-14-15-16-17-18-19-21-27(38)42-32-30(40)29(39)31(43-34(32)44-5)28(24(3)35)36-33(41)26-22-25(20-7-2)23-37(26)4;/h24-26,28-32,34,39-40H,6-23H2,1-5H3,(H,36,41);1H/t24-,25+,26-,28+,29+,30-,31+,32+,34+;/m0./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1200506	ERYTHROMYCIN LACTOBIONATE	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O.O=C(O)[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO	NNRXCKZMQLFUPL-WBMZRJHASA-N	InChI=1S/C37H67NO13.C12H22O12/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26;13-1-3(15)10(7(18)8(19)11(21)22)24-12-9(20)6(17)5(16)4(2-14)23-12/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3;3-10,12-20H,1-2H2,(H,21,22)/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-;3-,4-,5+,6+,7-,8-,9-,10-,12+/m11/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1440	TETRACYCLINE	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12	OFVLGDICTFRJMM-WESIUVDSSA-N	InChI=1S/C22H24N2O8/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28/h4-6,9-10,15,25,27-28,31-32H,7H2,1-3H3,(H2,23,30)/t9-,10-,15-,21+,22-/m0/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL3989829	NETILMICIN SULFATE	CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O.CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O	AGFWIZQEWFGATK-UNZHCMSXSA-N	InChI=1S/2C21H41N5O7.5H2O4S/c2*1-4-26-13-7-12(24)16(32-19-11(23)6-5-10(8-22)31-19)14(27)17(13)33-20-15(28)18(25-3)21(2,29)9-30-20;5*1-5(2,3)4/h2*5,11-20,25-29H,4,6-9,22-24H2,1-3H3;5*(H2,1,2,3,4)/t2*11-,12+,13-,14+,15-,16-,17+,18-,19-,20-,21+;;;;;/m11...../s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL2146063	CHLORTETRACYCLINE HYDROCHLORIDE	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12.Cl	CBHYYLPALVVVEY-MRFRVZCGSA-N	InChI=1S/C22H23ClN2O8.ClH/c1-21(32)7-6-8-15(25(2)3)17(28)13(20(24)31)19(30)22(8,33)18(29)11(7)16(27)12-10(26)5-4-9(23)14(12)21;/h4-5,7-8,15,26,28-29,32-33H,6H2,1-3H3,(H2,24,31);1H/t7-,8-,15-,21-,22-;/m0./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1201071	TETRACYCLINE PHOSPHATE COMPLEX	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12.O=P(O)(O)O	WXDJNRXQVCECPF-FMZCEJRJSA-N	InChI=1S/C22H24N2O8.H3O4P/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28;1-5(2,3)4/h4-6,9-10,15,25,27-28,31-32H,7H2,1-3H3,(H2,23,30);(H3,1,2,3,4)/t9-,10-,15-,21+,22-;/m0./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL261772	MECLOCYCLINE SULFOSALICYLATE	C=C1c2c(Cl)ccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12.O=C(O)c1cc(S(=O)(=O)O)ccc1O	FYSVKUUNXYGFLA-CCHMMTNSSA-N	InChI=1S/C22H21ClN2O8.C7H6O6S/c1-6-9-7(23)4-5-8(26)11(9)16(27)12-10(6)17(28)14-15(25(2)3)18(29)13(21(24)32)20(31)22(14,33)19(12)30;8-6-2-1-4(14(11,12)13)3-5(6)7(9)10/h4-5,10,14-15,17,26,28-30,33H,1H2,2-3H3,(H2,24,32);1-3,8H,(H,9,10)(H,11,12,13)/t10-,14-,15+,17+,22+;/m1./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1200649	QUINUPRISTIN	CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)[C@H](CS[C@@H]3CN4CCC3CC4)CN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O	WTHRRGMBUAHGNI-LCYNINFDSA-N	InChI=1S/C53H67N9O10S/c1-6-37-50(68)61-23-11-14-38(61)51(69)59(5)40(26-32-16-18-36(19-17-32)58(3)4)52(70)62-28-35(30-73-43-29-60-24-20-33(43)21-25-60)42(64)27-39(62)47(65)57-45(34-12-8-7-9-13-34)53(71)72-31(2)44(48(66)55-37)56-49(67)46-41(63)15-10-22-54-46/h7-10,12-13,15-19,22,31,33,35,37-40,43-45,63H,6,11,14,20-21,23-30H2,1-5H3,(H,55,66)(H,56,67)(H,57,65)/t31-,35+,37-,38+,39+,40+,43-,44+,45+/m1/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1607480	OXYTETRACYCLINE HYDROCHLORIDE	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12.Cl	UBDNTYUBJLXUNN-IFLJXUKPSA-N	InChI=1S/C22H24N2O9.ClH/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29;/h4-6,12-14,17,25,27-29,32-33H,1-3H3,(H2,23,31);1H/t12-,13-,14+,17+,21-,22+;/m1./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL2206196	PAROMOMYCIN SULFATE	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O.O=S(=O)(O)O	LJRDOKAZOAKLDU-UDXJMMFXSA-N	InChI=1S/C23H45N5O14.H2O4S/c24-2-7-13(32)15(34)10(27)21(37-7)41-19-9(4-30)39-23(17(19)36)42-20-12(31)5(25)1-6(26)18(20)40-22-11(28)16(35)14(33)8(3-29)38-22;1-5(2,3)4/h5-23,29-36H,1-4,24-28H2;(H2,1,2,3,4)/t5-,6+,7+,8-,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+;/m1./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1200881	MINOCYCLINE HYDROCHLORIDE	CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O.Cl	GLMUAFMGXXHGLU-VQAITOIOSA-N	InChI=1S/C23H27N3O7.ClH/c1-25(2)12-5-6-13(27)15-10(12)7-9-8-11-17(26(3)4)19(29)16(22(24)32)21(31)23(11,33)20(30)14(9)18(15)28;/h5-6,9,11,17,27,29-30,33H,7-8H2,1-4H3,(H2,24,32);1H/t9-,11-,17-,23-;/m0./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL3039594	GENTAMICIN SULFATE	CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.O=S(=O)(O)O	RDEIXVOBVLKYNT-VQBXQJRRSA-N	InChI=1S/C21H43N5O7.C20H41N5O7.C19H39N5O7.H2O4S/c1-9(25-3)13-6-5-10(22)19(31-13)32-16-11(23)7-12(24)17(14(16)27)33-20-15(28)18(26-4)21(2,29)8-30-20;1-8(21)12-5-4-9(22)18(30-12)31-15-10(23)6-11(24)16(13(15)26)32-19-14(27)17(25-3)20(2,28)7-29-19;1-19(27)7-28-18(13(26)16(19)24-2)31-15-11(23)5-10(22)14(12(15)25)30-17-9(21)4-3-8(6-20)29-17;1-5(2,3)4/h9-20,25-29H,5-8,22-24H2,1-4H3;8-19,25-28H,4-7,21-24H2,1-3H3;8-18,24-27H,3-7,20-23H2,1-2H3;(H2,1,2,3,4)/t9?,10-,11+,12-,13+,14+,15-,16-,17+,18-,19-,20-,21+;8?,9-,10+,11-,12+,13+,14-,15-,16+,17-,18-,19-,20+;8-,9+,10-,11+,12-,13+,14+,15-,16+,17+,18+,19-;/m110./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL2218877	ERYTHROMYCIN ESTOLATE	CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C.CCCCCCCCCCCCOS(=O)(=O)O	AWMFUEJKWXESNL-JZBHMOKNSA-N	InChI=1S/C40H71NO14.C12H26O4S/c1-15-27-40(11,48)33(44)22(5)30(43)20(3)18-38(9,47)35(55-37-32(53-28(42)16-2)26(41(12)13)17-21(4)50-37)23(6)31(24(7)36(46)52-27)54-29-19-39(10,49-14)34(45)25(8)51-29;1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15/h20-27,29,31-35,37,44-45,47-48H,15-19H2,1-14H3;2-12H2,1H3,(H,13,14,15)/t20-,21-,22+,23+,24-,25+,26+,27-,29+,31+,32-,33-,34+,35-,37+,38-,39-,40-;/m1./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1506	CHLORAMPHENICOL PALMITATE	CCCCCCCCCCCCCCCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1	PXKHGMGELZGJQE-ILBGXUMGSA-N	InChI=1S/C27H42Cl2N2O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-24(32)37-20-23(30-27(34)26(28)29)25(33)21-16-18-22(19-17-21)31(35)36/h16-19,23,25-26,33H,2-15,20H2,1H3,(H,30,34)/t23-,25-/m1/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL532	ERYTHROMYCIN	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	ULGZDMOVFRHVEP-RWJQBGPGSA-N	InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL3989571	SPECTINOMYCIN HYDROCHLORIDE	CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12.Cl.Cl.O.O.O.O.O	DCHJOVNPPSBWHK-UXXUFHFZSA-N	InChI=1S/C14H24N2O7.2ClH.5H2O/c1-5-4-6(17)14(20)13(21-5)22-12-10(19)7(15-2)9(18)8(16-3)11(12)23-14;;;;;;;/h5,7-13,15-16,18-20H,4H2,1-3H3;2*1H;5*1H2/t5-,7-,8+,9+,10+,11-,12-,13+,14+;;;;;;;/m1......./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1200688	ERYTHROMYCIN ETHYLSUCCINATE	CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C	NSYZCCDSJNWWJL-YXOIYICCSA-N	InChI=1S/C43H75NO16/c1-15-29-43(11,52)36(48)24(5)33(47)22(3)20-41(9,51)38(25(6)34(26(7)39(50)57-29)59-32-21-42(10,53-14)37(49)27(8)56-32)60-40-35(28(44(12)13)19-23(4)55-40)58-31(46)18-17-30(45)54-16-2/h22-29,32,34-38,40,48-49,51-52H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,32+,34+,35-,36-,37+,38-,40+,41-,42-,43-/m1/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1741	CLARITHROMYCIN	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O	AGOYDEPGAOXOCK-KCBOHYOISA-N	InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL529	AZITHROMYCIN	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O	MQTOSJVFKKJCRP-BICOPXKESA-N	InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL267345	AMPHOTERICIN B	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2	APKFDSVGJQXUKY-INPOYWNPSA-N	InChI=1S/C47H73NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-33(51)22-36(53)35(52)20-19-31(49)21-32(50)23-39(55)62-29(3)28(2)42(27)56/h5-18,27-38,40-44,46,49-54,56-58,61H,19-26,48H2,1-4H3,(H,59,60)/b6-5+,9-7+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31+,32+,33-,34-,35+,36+,37-,38-,40+,41-,42+,43+,44-,46-,47+/m0/s1	Ergosterol sequestering agent	SEQUESTERING AGENT	CHEMBL2364028	Ergosterol	Candida albicans
CHEMBL450895	NYSTATIN	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2	VQOXZBDYSJBXMA-NQTDYLQESA-N	InChI=1S/C47H75NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-36(53)35(52)20-19-31(49)21-32(50)22-33(51)23-39(55)62-29(3)28(2)42(27)56/h5-6,8,10-18,27-38,40-44,46,49-54,56-58,61H,7,9,19-26,48H2,1-4H3,(H,59,60)/b6-5+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31+,32+,33+,34-,35+,36+,37-,38-,40+,41-,42+,43+,44-,46-,47+/m0/s1	Ergosterol sequestering agent	SEQUESTERING AGENT	CHEMBL2364028	Ergosterol	Candida albicans
CHEMBL1200656	NATAMYCIN	C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O	NCXMLFZGDNKEPB-FFPOYIOWSA-N	InChI=1S/C33H47NO13/c1-18-10-8-6-4-3-5-7-9-11-21(45-32-30(39)28(34)29(38)19(2)44-32)15-25-27(31(40)41)22(36)17-33(42,47-25)16-20(35)14-24-23(46-24)12-13-26(37)43-18/h3-9,11-13,18-25,27-30,32,35-36,38-39,42H,10,14-17,34H2,1-2H3,(H,40,41)/b4-3+,7-5+,8-6+,11-9+,13-12+/t18-,19-,20+,21+,22+,23-,24-,25+,27-,28+,29-,30+,32+,33-/m1/s1	Ergosterol sequestering agent	SEQUESTERING AGENT	CHEMBL2364028	Ergosterol	Candida albicans
CHEMBL1201073	SUCCIMER	O=C(O)[C@H](S)[C@H](S)C(=O)O	ACTRVOBWPAIOHC-XIXRPRMCSA-N	InChI=1S/C4H6O4S2/c5-3(6)1(9)2(10)4(7)8/h1-2,9-10H,(H,5,6)(H,7,8)/t1-,2+	Lead chelating agent	CHELATING AGENT	CHEMBL2364029	Lead	null
CHEMBL3989529	ETHANOLAMINE OLEATE	CCCCCCCC/C=C\CCCCCCCC(=O)O.NCCO	KGWDUNBJIMUFAP-KVVVOXFISA-N	InChI=1S/C18H34O2.C2H7NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;3-1-2-4/h9-10H,2-8,11-17H2,1H3,(H,19,20);4H,1-3H2/b10-9-;	Calcium chelating agent	CHELATING AGENT	CHEMBL2364030	Calcium	null
CHEMBL387675	DAPTOMYCIN	CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C	DOAKLVKFURWEDJ-RWDRXURGSA-N	InChI=1S/C72H101N17O26/c1-5-6-7-8-9-10-11-22-53(93)81-44(25-38-31-76-42-20-15-13-17-39(38)42)66(108)84-45(27-52(75)92)67(109)86-48(30-59(102)103)68(110)89-61-37(4)115-72(114)49(26-51(91)40-18-12-14-19-41(40)74)87-71(113)60(35(2)24-56(96)97)88-69(111)50(34-90)82-55(95)32-77-63(105)46(28-57(98)99)83-62(104)36(3)79-65(107)47(29-58(100)101)85-64(106)43(21-16-23-73)80-54(94)33-78-70(61)112/h12-15,17-20,31,35-37,43-50,60-61,76,90H,5-11,16,21-30,32-34,73-74H2,1-4H3,(H2,75,92)(H,77,105)(H,78,112)(H,79,107)(H,80,94)(H,81,93)(H,82,95)(H,83,104)(H,84,108)(H,85,106)(H,86,109)(H,87,113)(H,88,111)(H,89,110)(H,96,97)(H,98,99)(H,100,101)(H,102,103)/t35-,36-,37-,43+,44+,45+,46+,47+,48+,49+,50-,60+,61+/m1/s1	Cell membrane inhibitor	INHIBITOR	CHEMBL2364031	Cell membrane	Bacteria
CHEMBL4297088	CHLORHEXIDINE GLUCONATE	N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1.O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO	YZIYKJHYYHPJIB-UUPCJSQJSA-N	InChI=1S/C22H30Cl2N10.2C6H12O7/c23-15-5-9-17(10-6-15)31-21(27)33-19(25)29-13-3-1-2-4-14-30-20(26)34-22(28)32-18-11-7-16(24)8-12-18;2*7-1-2(8)3(9)4(10)5(11)6(12)13/h5-12H,1-4,13-14H2,(H5,25,27,29,31,33)(H5,26,28,30,32,34);2*2-5,7-11H,1H2,(H,12,13)/t;2*2-,3-,4+,5-/m.11/s1	Cell membrane inhibitor	INHIBITOR	CHEMBL2364031	Cell membrane	Bacteria
CHEMBL3301680	TELAVANCIN HYDROCHLORIDE	CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O.Cl	GSSIWSIRBWAZHG-ACOPVEIWSA-N	InChI=1S/C80H106Cl2N11O27P.ClH/c1-7-8-9-10-11-12-13-14-21-85-22-23-87-80(5)32-57(115-37(4)71(80)103)119-70-68(102)67(101)55(34-94)118-79(70)120-69-53-28-41-29-54(69)117-52-20-17-40(27-46(52)82)65(99)63-77(109)91-61(78(110)111)43-30-50(96)44(33-86-35-121(112,113)114)66(100)58(43)42-25-38(15-18-49(42)95)59(74(106)93-63)90-75(107)60(41)89-73(105)48(31-56(83)97)88-76(108)62(92-72(104)47(84-6)24-36(2)3)64(98)39-16-19-51(116-53)45(81)26-39;/h15-20,25-30,36-37,47-48,55,57,59-65,67-68,70-71,79,84-87,94-96,98-103H,7-14,21-24,31-35H2,1-6H3,(H2,83,97)(H,88,108)(H,89,105)(H,90,107)(H,91,109)(H,92,104)(H,93,106)(H,110,111)(H2,112,113,114);1H/t37-,47+,48-,55+,57-,59+,60+,61-,62+,63-,64+,65+,67+,68-,70+,71+,79-,80-;/m0./s1	Cell outer membrane inhibitor	INHIBITOR	CHEMBL2364032	Cell outer membrane	Bacteria
CHEMBL2218908	COLISTIN SULFATE	CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.O=S(=O)(O)O.O=S(=O)(O)O	ZESIAEVDVPWEKB-ORCFLVBFSA-N	InChI=1S/C53H102N16O12.C52H100N16O12.2H2O4S/c1-9-31(6)12-10-11-13-43(72)61-35(15-21-55)46(74)68-42(32(7)70)28-60-34(14-20-54)45(73)65-39-19-25-59-53(81)44(33(8)71)69-50(78)38(18-24-58)63-47(75)36(16-22-56)64-51(79)40(26-29(2)3)67-52(80)41(27-30(4)5)66-48(76)37(17-23-57)62-49(39)77;1-28(2)11-9-10-12-42(71)60-34(14-20-54)45(73)67-41(31(7)69)27-59-33(13-19-53)44(72)64-38-18-24-58-52(80)43(32(8)70)68-49(77)37(17-23-57)62-46(74)35(15-21-55)63-50(78)39(25-29(3)4)66-51(79)40(26-30(5)6)65-47(75)36(16-22-56)61-48(38)76;2*1-5(2,3)4/h29-42,44,60,70-71H,9-28,54-58H2,1-8H3,(H,59,81)(H,61,72)(H,62,77)(H,63,75)(H,64,79)(H,65,73)(H,66,76)(H,67,80)(H,68,74)(H,69,78);28-41,43,59,69-70H,9-27,53-57H2,1-8H3,(H,58,80)(H,60,71)(H,61,76)(H,62,74)(H,63,78)(H,64,72)(H,65,75)(H,66,79)(H,67,73)(H,68,77);2*(H2,1,2,3,4)/t31?,32-,33-,34+,35+,36+,37+,38+,39+,40+,41-,42+,44+;31-,32-,33+,34+,35+,36+,37+,38+,39+,40-,41+,43+;;/m11../s1	Cell outer membrane inhibitor	INHIBITOR	CHEMBL2364032	Cell outer membrane	Bacteria
CHEMBL3989714	POLYMYXIN B SULFATE	CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.O=S(=O)(O)O	SBKRTALNRRAOJP-BWSIXKJUSA-N	InChI=1S/C56H98N16O13.C55H96N16O13.H2O4S/c1-7-32(4)13-11-12-16-44(75)63-36(17-23-57)51(80)72-46(34(6)74)56(85)68-39(20-26-60)48(77)67-41-22-28-62-55(84)45(33(5)73)71-52(81)40(21-27-61)65-47(76)37(18-24-58)66-53(82)42(29-31(2)3)69-54(83)43(30-35-14-9-8-10-15-35)70-49(78)38(19-25-59)64-50(41)79;1-30(2)12-10-11-15-43(74)62-35(16-22-56)50(79)71-45(33(6)73)55(84)67-38(19-25-59)47(76)66-40-21-27-61-54(83)44(32(5)72)70-51(80)39(20-26-60)64-46(75)36(17-23-57)65-52(81)41(28-31(3)4)68-53(82)42(29-34-13-8-7-9-14-34)69-48(77)37(18-24-58)63-49(40)78;1-5(2,3)4/h8-10,14-15,31-34,36-43,45-46,73-74H,7,11-13,16-30,57-61H2,1-6H3,(H,62,84)(H,63,75)(H,64,79)(H,65,76)(H,66,82)(H,67,77)(H,68,85)(H,69,83)(H,70,78)(H,71,81)(H,72,80);7-9,13-14,30-33,35-42,44-45,72-73H,10-12,15-29,56-60H2,1-6H3,(H,61,83)(H,62,74)(H,63,78)(H,64,75)(H,65,81)(H,66,76)(H,67,84)(H,68,82)(H,69,77)(H,70,80)(H,71,79);(H2,1,2,3,4)/t32-,33+,34+,36-,37-,38+,39-,40-,41-,42-,43+,45-,46-;32-,33-,35+,36+,37-,38+,39+,40+,41+,42-,44+,45+;/m01./s1	Cell outer membrane inhibitor	INHIBITOR	CHEMBL2364032	Cell outer membrane	Bacteria
CHEMBL1289	HALOPROGIN	Clc1cc(Cl)c(OCC#CI)cc1Cl	CTETYYAZBPJBHE-UHFFFAOYSA-N	InChI=1S/C9H4Cl3IO/c10-6-4-8(12)9(5-7(6)11)14-3-1-2-13/h4-5H,3H2	Cell membrane inhibitor	INHIBITOR	CHEMBL2364033	Cell membrane	Trichophyton
CHEMBL1200647	CANDICIDIN	CC1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C(OC2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)CC(O)C(C(=O)O)C(O)CC(=O)CC(O)CC(O)CC(O)CC(=O)CCCC(=O)CC(=O)OC1C(C)CC(C)C(O)CC(=O)c1ccc(N)cc1	OPGSFDUODIJJGF-JBUZINEHSA-N	InChI=1S/C59H84N2O18/c1-35-18-15-13-11-9-7-5-6-8-10-12-14-16-21-47(78-59-56(74)54(61)55(73)38(4)77-59)33-51(71)53(58(75)76)50(70)31-46(67)30-45(66)29-44(65)28-43(64)27-41(62)19-17-20-42(63)32-52(72)79-57(35)37(3)26-36(2)48(68)34-49(69)39-22-24-40(60)25-23-39/h5-16,18,21-25,35-38,43-45,47-48,50-51,53-57,59,64-66,68,70-71,73-74H,17,19-20,26-34,60-61H2,1-4H3,(H,75,76)/b6-5+,9-7+,10-8+,13-11+,14-12+,18-15+,21-16+/t35?,36?,37?,38-,43?,44?,45?,47?,48?,50?,51?,53?,54+,55-,56+,57?,59?/m1/s1	Cell membrane inhibitor	INHIBITOR	CHEMBL2364035	Cell membrane	Candida albicans
CHEMBL1200558	BACITRACIN	CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1	CLKOFPXJLQSYAH-ABRJDSQDSA-N	InChI=1S/C66H103N17O16S/c1-9-35(6)52(69)66-81-48(32-100-66)63(97)76-43(26-34(4)5)59(93)74-42(22-23-50(85)86)58(92)83-53(36(7)10-2)64(98)75-40-20-15-16-25-71-55(89)46(29-49(68)84)78-62(96)47(30-51(87)88)79-61(95)45(28-39-31-70-33-72-39)77-60(94)44(27-38-18-13-12-14-19-38)80-65(99)54(37(8)11-3)82-57(91)41(21-17-24-67)73-56(40)90/h12-14,18-19,31,33-37,40-48,52-54H,9-11,15-17,20-30,32,67,69H2,1-8H3,(H2,68,84)(H,70,72)(H,71,89)(H,73,90)(H,74,93)(H,75,98)(H,76,97)(H,77,94)(H,78,96)(H,79,95)(H,80,99)(H,82,91)(H,83,92)(H,85,86)(H,87,88)/t35-,36-,37-,40-,41+,42+,43-,44+,45-,46-,47+,48-,52-,53-,54-/m0/s1	C55-isoprenyl pyrophosphate inhibitor	INHIBITOR	CHEMBL2364036	C55-isoprenyl pyrophosphate	Bacteria
CHEMBL2096639	BACITRACIN ZINC	CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)[O-])C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)[O-])NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1.[Zn+2]	UCRLQOPRDMGYOA-DFTDUNEMSA-L	InChI=1S/C66H103N17O16S.Zn/c1-9-35(6)52(69)66-81-48(32-100-66)63(97)76-43(26-34(4)5)59(93)74-42(22-23-50(85)86)58(92)83-53(36(7)10-2)64(98)75-40-20-15-16-25-71-55(89)46(29-49(68)84)78-62(96)47(30-51(87)88)79-61(95)45(28-39-31-70-33-72-39)77-60(94)44(27-38-18-13-12-14-19-38)80-65(99)54(37(8)11-3)82-57(91)41(21-17-24-67)73-56(40)90;/h12-14,18-19,31,33-37,40-48,52-54H,9-11,15-17,20-30,32,67,69H2,1-8H3,(H2,68,84)(H,70,72)(H,71,89)(H,73,90)(H,74,93)(H,75,98)(H,76,97)(H,77,94)(H,78,96)(H,79,95)(H,80,99)(H,82,91)(H,83,92)(H,85,86)(H,87,88);/q;+2/p-2/t35-,36-,37-,40-,41+,42+,43-,44+,45-,46-,47+,48-,52-,53-,54-;/m0./s1	C55-isoprenyl pyrophosphate inhibitor	INHIBITOR	CHEMBL2364036	C55-isoprenyl pyrophosphate	Bacteria
CHEMBL2062263	CYSTEAMINE BITARTRATE	NCCS.O=C(O)C(O)C(O)C(=O)O	NSKJTUFFDRENDM-UHFFFAOYSA-N	InChI=1S/C4H6O6.C2H7NS/c5-1(3(7)8)2(6)4(9)10;3-1-2-4/h1-2,5-6H,(H,7,8)(H,9,10);4H,1-3H2	Cystine reducing agent	REDUCING AGENT	CHEMBL2364039	Cystine	Homo sapiens
CHEMBL1256137	CYSTEAMINE HYDROCHLORIDE	Cl.NCCS	OGMADIBCHLQMIP-UHFFFAOYSA-N	InChI=1S/C2H7NS.ClH/c3-1-2-4;/h4H,1-3H2;1H	Cystine reducing agent	REDUCING AGENT	CHEMBL2364039	Cystine	Homo sapiens
CHEMBL137	METRONIDAZOLE	Cc1ncc([N+](=O)[O-])n1CCO	VAOCPAMSLUNLGC-UHFFFAOYSA-N	InChI=1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3	DNA inhibitor	INHIBITOR	CHEMBL2364041	DNA	Bacteria
CHEMBL64894	GENTIAN VIOLET	CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]	ZXJXZNDDNMQXFV-UHFFFAOYSA-M	InChI=1S/C25H30N3.ClH/c1-26(2)22-13-7-19(8-14-22)25(20-9-15-23(16-10-20)27(3)4)21-11-17-24(18-12-21)28(5)6;/h7-18H,1-6H3;1H/q+1;/p-1	DNA inhibitor	INHIBITOR	CHEMBL2364041	DNA	Bacteria
CHEMBL1200869	METRONIDAZOLE HYDROCHLORIDE	Cc1ncc([N+](=O)[O-])n1CCO.Cl	FPTPAIQTXYFGJC-UHFFFAOYSA-N	InChI=1S/C6H9N3O3.ClH/c1-5-7-4-6(9(11)12)8(5)2-3-10;/h4,10H,2-3H2,1H3;1H	DNA inhibitor	INHIBITOR	CHEMBL2364041	DNA	Bacteria
CHEMBL1201104	METHENAMINE HIPPURATE	C1N2CN3CN1CN(C2)C3.O=C(O)CNC(=O)c1ccccc1	ROAIXOJGRFKICW-UHFFFAOYSA-N	InChI=1S/C9H9NO3.C6H12N4/c11-8(12)6-10-9(13)7-4-2-1-3-5-7;1-7-2-9-4-8(1)5-10(3-7)6-9/h1-5H,6H2,(H,10,13)(H,11,12);1-6H2	DNA inhibitor	INHIBITOR	CHEMBL2364041	DNA	Bacteria
CHEMBL869	NITROFURAZONE	NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1	IAIWVQXQOWNYOU-FPYGCLRLSA-N	InChI=1S/C6H6N4O4/c7-6(11)9-8-3-4-1-2-5(14-4)10(12)13/h1-3H,(H3,7,9,11)/b8-3+	DNA inhibitor	INHIBITOR	CHEMBL2364041	DNA	Bacteria
CHEMBL1103	FURAZOLIDONE	O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1	PLHJDBGFXBMTGZ-WEVVVXLNSA-N	InChI=1S/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2/b9-5+	DNA inhibitor	INHIBITOR	CHEMBL2364041	DNA	Bacteria
CHEMBL1200596	CHLOROXINE	Oc1c(Cl)cc(Cl)c2cccnc12	WDFKMLRRRCGAKS-UHFFFAOYSA-N	InChI=1S/C9H5Cl2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H	DNA inhibitor	INHIBITOR	CHEMBL2364041	DNA	Bacteria
CHEMBL1201000	NITROFURANTOIN SODIUM	O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)[N-]1.[Na+]	AFDJQFFKYDCYIG-JSGFVSQVSA-M	InChI=1S/C8H6N4O5.Na/c13-6-4-11(8(14)10-6)9-3-5-1-2-7(17-5)12(15)16;/h1-3H,4H2,(H,10,13,14);/q;+1/p-1/b9-3+;	DNA inhibitor	INHIBITOR	CHEMBL2364041	DNA	Bacteria
CHEMBL572	NITROFURANTOIN	O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1	NXFQHRVNIOXGAQ-YCRREMRBSA-N	InChI=1S/C8H6N4O5/c13-6-4-11(8(14)10-6)9-3-5-1-2-7(17-5)12(15)16/h1-3H,4H2,(H,10,13,14)/b9-3+	DNA inhibitor	INHIBITOR	CHEMBL2364041	DNA	Bacteria
CHEMBL1658	RETAPAMULIN	C=C[C@]1(C)C[C@@H](OC(=O)CS[C@H]2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O	STZYTFJPGGDRJD-NHUWBDDWSA-N	InChI=1S/C30H47NO4S/c1-7-28(4)16-24(35-25(33)17-36-22-14-20-8-9-21(15-22)31(20)6)29(5)18(2)10-12-30(19(3)27(28)34)13-11-23(32)26(29)30/h7,18-22,24,26-27,34H,1,8-17H2,2-6H3/t18-,19+,20-,21+,22-,24-,26+,27+,28-,29+,30+/m1/s1	70S ribosome inhibitor	INHIBITOR	CHEMBL2364096	70S ribosome	Staphylococcus aureus
CHEMBL1658	RETAPAMULIN	C=C[C@]1(C)C[C@@H](OC(=O)CS[C@H]2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O	STZYTFJPGGDRJD-NHUWBDDWSA-N	InChI=1S/C30H47NO4S/c1-7-28(4)16-24(35-25(33)17-36-22-14-20-8-9-21(15-22)31(20)6)29(5)18(2)10-12-30(19(3)27(28)34)13-11-23(32)26(29)30/h7,18-22,24,26-27,34H,1,8-17H2,2-6H3/t18-,19+,20-,21+,22-,24-,26+,27+,28-,29+,30+/m1/s1	70S ribosome inhibitor	INHIBITOR	CHEMBL2364103	70S ribosome	Streptococcus pyogenes
CHEMBL2105700	BEDAQUILINE FUMARATE	COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12.O=C(O)/C=C/C(=O)O	ZLVSPMRFRHMMOY-WWCCMVHESA-N	InChI=1S/C32H31BrN2O2.C4H4O4/c1-35(2)19-18-32(36,28-15-9-13-22-10-7-8-14-26(22)28)30(23-11-5-4-6-12-23)27-21-24-20-25(33)16-17-29(24)34-31(27)37-3;5-3(6)1-2-4(7)8/h4-17,20-21,30,36H,18-19H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t30-,32-;/m1./s1	ATP synthase inhibitor	INHIBITOR	CHEMBL2364166	ATP synthase	Mycobacterium tuberculosis
CHEMBL1201734	BENDAMUSTINE HYDROCHLORIDE	Cl.Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21	ZHSKUOZOLHMKEA-UHFFFAOYSA-N	InChI=1S/C16H21Cl2N3O2.ClH/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23;/h5-6,11H,2-4,7-10H2,1H3,(H,22,23);1H	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1554	DACTINOMYCIN	Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O	RJURFGZVJUQBHK-IIXSONLDSA-N	InChI=1S/C62H86N12O16/c1-27(2)42-59(84)73-23-17-19-36(73)57(82)69(13)25-38(75)71(15)48(29(5)6)61(86)88-33(11)44(55(80)65-42)67-53(78)35-22-21-31(9)51-46(35)64-47-40(41(63)50(77)32(10)52(47)90-51)54(79)68-45-34(12)89-62(87)49(30(7)8)72(16)39(76)26-70(14)58(83)37-20-18-24-74(37)60(85)43(28(3)4)66-56(45)81/h21-22,27-30,33-34,36-37,42-45,48-49H,17-20,23-26,63H2,1-16H3,(H,65,80)(H,66,81)(H,67,78)(H,68,79)/t33-,34-,36+,37+,42-,43-,44+,45+,48+,49+/m1/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1200796	CYCLOPHOSPHAMIDE	O.O=P1(N(CCCl)CCCl)NCCCO1	PWOQRKCAHTVFLB-UHFFFAOYSA-N	InChI=1S/C7H15Cl2N2O2P.H2O/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14;/h1-7H2,(H,10,12);1H2	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1201001	MECHLORETHAMINE HYDROCHLORIDE	CN(CCCl)CCCl.Cl	QZIQJVCYUQZDIR-UHFFFAOYSA-N	InChI=1S/C5H11Cl2N.ClH/c1-8(4-2-6)5-3-7;/h2-5H2,1H3;1H	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1651906	STREPTOZOCIN	CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O	ZSJLQEPLLKMAKR-YDEIVXIUSA-N	InChI=1S/C8H15N3O7/c1-11(10-17)8(16)9-4-6(14)5(13)3(2-12)18-7(4)15/h3-7,12-15H,2H2,1H3,(H,9,16)/t3-,4-,5-,6-,7?/m1/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1201112	NELARABINE	COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O	IXOXBSCIXZEQEQ-UHTZMRCNSA-N	InChI=1S/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7+,10-/m1/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1200981	EPIRUBICIN HYDROCHLORIDE	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1.Cl	MWWSFMDVAYGXBV-FGBSZODSSA-N	InChI=1S/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,17-,22-,27-;/m0./s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL820	BUSULFAN	CS(=O)(=O)OCCCCOS(C)(=O)=O	COVZYZSDYWQREU-UHFFFAOYSA-N	InChI=1S/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL514	LOMUSTINE	O=NN(CCCl)C(=O)NC1CCCCC1	GQYIWUVLTXOXAJ-UHFFFAOYSA-N	InChI=1S/C9H16ClN3O2/c10-6-7-13(12-15)9(14)11-8-4-2-1-3-5-8/h8H,1-7H2,(H,11,14)	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1237054	PLICAMYCIN	CO[C@H](C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@@H]2C[C@@H](O)[C@@H](O[C@@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@H](O)[C@@H](C)O1	XDKMHMINQXATOR-RCFLUEAHSA-N	InChI=1S/C52H76O24/c1-18-30(72-35-15-31(43(59)21(4)68-35)73-33-13-28(54)42(58)20(3)67-33)12-26-10-25-11-27(49(66-9)47(63)41(57)19(2)53)50(46(62)39(25)45(61)38(26)40(18)56)75-36-16-32(44(60)22(5)69-36)74-34-14-29(55)48(23(6)70-34)76-37-17-52(8,65)51(64)24(7)71-37/h10,12,19-24,27-29,31-37,41-44,48-51,53-61,64-65H,11,13-17H2,1-9H3/t19-,20-,21-,22-,23-,24-,27+,28-,29-,31-,32-,33-,34-,35+,36+,37-,41+,42-,43-,44-,48+,49+,50+,51-,52+/m1/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1488	URACIL MUSTARD	O=c1[nH]cc(N(CCCl)CCCl)c(=O)[nH]1	IDPUKCWIGUEADI-UHFFFAOYSA-N	InChI=1S/C8H11Cl2N3O2/c9-1-3-13(4-2-10)6-5-11-8(15)12-7(6)14/h5H,1-4H2,(H2,11,12,14,15)	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1455	ALTRETAMINE	CN(C)c1nc(N(C)C)nc(N(C)C)n1	UUVWYPNAQBNQJQ-UHFFFAOYSA-N	InChI=1S/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H3	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL852	MELPHALAN	N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O	SGDBTWWWUNNDEQ-LBPRGKRZSA-N	InChI=1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)/t12-/m0/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL515	CHLORAMBUCIL	O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1	JCKYGMPEJWAADB-UHFFFAOYSA-N	InChI=1S/C14H19Cl2NO2/c15-8-10-17(11-9-16)13-6-4-12(5-7-13)2-1-3-14(18)19/h4-7H,1-3,8-11H2,(H,18,19)	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL3085504	BLEOMYCIN SULFATE	Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.O=S(=O)(O)O	WUIABRMSWOKTOF-OYALTWQYSA-O	InChI=1S/C55H83N17O21S3.H2O4S/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6;1-5(2,3)4/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81H,7-13,15-16,56H2,1-6H3,(H13-,57,58,59,60,61,62,63,65,66,69,70,71,72,76,82,83,84,85,86,87,88);(H2,1,2,3,4)/p+1/t21-,22+,23+,24-,25-,29-,30+,34-,35-,36-,37+,38+,39-,40-,41-,42-,43-,53+,54-;/m0./s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL671	THIOTEPA	S=P(N1CC1)(N1CC1)N1CC1	FOCVUCIESVLUNU-UHFFFAOYSA-N	InChI=1S/C6H12N3PS/c11-10(7-1-2-7,8-3-4-8)9-5-6-9/h1-6H2	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL416	METHOXSALEN	COc1c2occc2cc2ccc(=O)oc12	QXKHYNVANLEOEG-UHFFFAOYSA-N	InChI=1S/C12H8O4/c1-14-12-10-8(4-5-15-10)6-7-2-3-9(13)16-11(7)12/h2-6H,1H3	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1585	PIPOBROMAN	O=C(CCBr)N1CCN(C(=O)CCBr)CC1	NJBFOOCLYDNZJN-UHFFFAOYSA-N	InChI=1S/C10H16Br2N2O2/c11-3-1-9(15)13-5-7-14(8-6-13)10(16)2-4-12/h1-8H2	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL105	MITOMYCIN	CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12	NWIBSHFKIJFRCO-WUDYKRTCSA-N	InChI=1S/C15H18N4O5/c1-5-9(16)12(21)8-6(4-24-14(17)22)15(23-2)13-7(18-13)3-19(15)10(8)11(5)20/h6-7,13,18H,3-4,16H2,1-2H3,(H2,17,22)/t6-,7+,13+,15-/m1/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL810	TEMOZOLOMIDE	Cn1nnc2c(C(N)=O)ncn2c1=O	BPEGJWRSRHCHSN-UHFFFAOYSA-N	InChI=1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1200863	MELPHALAN HYDROCHLORIDE	Cl.N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O	OUUYBRCCFUEMLH-YDALLXLXSA-N	InChI=1S/C13H18Cl2N2O2.ClH/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19;/h1-4,12H,5-9,16H2,(H,18,19);1H/t12-;/m0./s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1619	CLADRIBINE	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1	PTOAARAWEBMLNO-KVQBGUIXSA-N	InChI=1S/C10H12ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,6+/m0/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL476	DACARBAZINE	CN(C)/N=N/c1[nH]cnc1C(N)=O	FDKXTQMXEQVLRF-ZHACJKMWSA-N	InChI=1S/C6H10N6O/c1-12(2)11-10-6-4(5(7)13)8-3-9-6/h3H,1-2H3,(H2,7,13)(H,8,9)/b11-10+	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1024	IFOSFAMIDE	O=P1(NCCCl)OCCCN1CCCl	HOMGKSMUEGBAAB-UHFFFAOYSA-N	InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1200410	PROCARBAZINE HYDROCHLORIDE	CNNCc1ccc(C(=O)NC(C)C)cc1.Cl	DERJYEZSLHIUKF-UHFFFAOYSA-N	InChI=1S/C12H19N3O.ClH/c1-9(2)15-12(16)11-6-4-10(5-7-11)8-14-13-3;/h4-7,9,13-14H,8H2,1-3H3,(H,15,16);1H	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1475	TRIOXSALEN	Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1	FMHHVULEAZTJMA-UHFFFAOYSA-N	InChI=1S/C14H12O3/c1-7-4-12(15)17-14-9(3)13-10(6-11(7)14)5-8(2)16-13/h4-6H,1-3H3	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1489	AZACITIDINE	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1	NMUSYJAQQFHJEW-KVTDHHQDSA-N	InChI=1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1542	AZATHIOPRINE	Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12	LMEKQMALGUDUQG-UHFFFAOYSA-N	InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1200400	AZATHIOPRINE SODIUM	Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[n-]c12.[Na+]	WISNYKIQFMKSDQ-UHFFFAOYSA-N	InChI=1S/C9H6N7O2S.Na/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8;/h2-4H,1H3;/q-1;+1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1200475	DAUNORUBICIN CITRATE	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.O=C(O)CC(O)(CC(=O)O)C(=O)O	VNTHYLVDGVBPOU-QQYBVWGSSA-N	InChI=1S/C27H29NO10.C6H8O7/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t10-,14-,16-,17-,22+,27-;/m0./s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1563	DAUNORUBICIN HYDROCHLORIDE	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl	GUGHGUXZJWAIAS-QQYBVWGSSA-N	InChI=1S/C27H29NO10.ClH/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33;/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3;1H/t10-,14-,16-,17-,22+,27-;/m0./s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL359744	DOXORUBICIN HYDROCHLORIDE	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl	MWWSFMDVAYGXBV-RUELKSSGSA-N	InChI=1S/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,17-,22+,27-;/m0./s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1750	CLOFARABINE	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F	WDDPHFBMKLOVOX-AYQXTPAHSA-N	InChI=1S/C10H11ClFN5O3/c11-10-15-7(13)5-8(16-10)17(2-14-5)9-4(12)6(19)3(1-18)20-9/h2-4,6,9,18-19H,1H2,(H2,13,15,16)/t3-,4+,6-,9-/m1/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1201129	DECITABINE	Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1	XAUDJQYHKZQPEU-KVQBGUIXSA-N	InChI=1S/C8H12N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h3-6,13-14H,1-2H2,(H2,9,11,15)/t4-,5+,6+/m0/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1773	CAPECITABINE	CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F	GAGWJHPBXLXJQN-UORFTKCHSA-N	InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL513	CARMUSTINE	O=NN(CCCl)C(=O)NCCCl	DLGOEMSEDOSKAD-UHFFFAOYSA-N	InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11)	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL803	CYTARABINE	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1	UHDGCWIWMRVCDJ-CCXZUQQUSA-N	InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL2023895	HYDROXYSTILBAMIDINE ISETHIONATE	N=C(N)c1ccc(/C=C/c2ccc(C(=N)N)cc2O)cc1.O=S(=O)(O)CCO.O=S(=O)(O)CCO	XVTQTNAKZYLTNZ-HFPMQDOPSA-N	InChI=1S/C16H16N4O.2C2H6O4S/c17-15(18)12-5-2-10(3-6-12)1-4-11-7-8-13(16(19)20)9-14(11)21;2*3-1-2-7(4,5)6/h1-9,21H,(H3,17,18)(H3,19,20);2*3H,1-2H2,(H,4,5,6)/b4-1+;;	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1200751	MERCAPTOPURINE	O.Sc1ncnc2nc[nH]c12	WFFQYWAAEWLHJC-UHFFFAOYSA-N	InChI=1S/C5H4N4S.H2O/c10-5-3-4(7-1-6-3)8-2-9-5;/h1-2H,(H2,6,7,8,9,10);1H2	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1417019	MITOXANTRONE HYDROCHLORIDE	Cl.Cl.O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21	ZAHQPTJLOCWVPG-UHFFFAOYSA-N	InChI=1S/C22H28N4O6.2ClH/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32;;/h1-4,23-30H,5-12H2;2*1H	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL727	THIOGUANINE	Nc1nc2[nH]cnc2c(=S)[nH]1	WYWHKKSPHMUBEB-UHFFFAOYSA-N	InChI=1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL185	FLUOROURACIL	O=c1[nH]cc(F)c(=O)[nH]1	GHASVSINZRGABV-UHFFFAOYSA-N	InChI=1S/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1200976	IDARUBICIN HYDROCHLORIDE	CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O.Cl	JVHPTYWUBOQMBP-RVFAQHLVSA-N	InChI=1S/C26H27NO9.ClH/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31;/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3;1H/t10-,15-,16-,17-,21+,26-;/m0./s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1096885	VALRUBICIN	CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O	ZOCKGBMQLCSHFP-KQRAQHLDSA-N	InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22-,27+,33-/m0/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1773	CAPECITABINE	CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F	GAGWJHPBXLXJQN-UORFTKCHSA-N	InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1	RNA inhibitor	INHIBITOR	CHEMBL2311222	RNA	Homo sapiens
CHEMBL513	CARMUSTINE	O=NN(CCCl)C(=O)NCCCl	DLGOEMSEDOSKAD-UHFFFAOYSA-N	InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11)	RNA inhibitor	INHIBITOR	CHEMBL2311222	RNA	Homo sapiens
CHEMBL803	CYTARABINE	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1	UHDGCWIWMRVCDJ-CCXZUQQUSA-N	InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1	RNA inhibitor	INHIBITOR	CHEMBL2311222	RNA	Homo sapiens
CHEMBL1489	AZACITIDINE	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1	NMUSYJAQQFHJEW-KVTDHHQDSA-N	InChI=1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1	RNA inhibitor	INHIBITOR	CHEMBL2311222	RNA	Homo sapiens
CHEMBL185	FLUOROURACIL	O=c1[nH]cc(F)c(=O)[nH]1	GHASVSINZRGABV-UHFFFAOYSA-N	InChI=1S/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)	RNA inhibitor	INHIBITOR	CHEMBL2311222	RNA	Homo sapiens
CHEMBL2023895	HYDROXYSTILBAMIDINE ISETHIONATE	N=C(N)c1ccc(/C=C/c2ccc(C(=N)N)cc2O)cc1.O=S(=O)(O)CCO.O=S(=O)(O)CCO	XVTQTNAKZYLTNZ-HFPMQDOPSA-N	InChI=1S/C16H16N4O.2C2H6O4S/c17-15(18)12-5-2-10(3-6-12)1-4-11-7-8-13(16(19)20)9-14(11)21;2*3-1-2-7(4,5)6/h1-9,21H,(H3,17,18)(H3,19,20);2*3H,1-2H2,(H,4,5,6)/b4-1+;;	RNA inhibitor	INHIBITOR	CHEMBL2311222	RNA	Homo sapiens
CHEMBL1201761	BESIFLOXACIN HYDROCHLORIDE	Cl.N[C@@H]1CCCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1	PMQBICKXAAKXAY-HNCPQSOCSA-N	InChI=1S/C19H21ClFN3O3.ClH/c20-15-16-12(18(25)13(19(26)27)9-24(16)11-4-5-11)7-14(21)17(15)23-6-2-1-3-10(22)8-23;/h7,9-11H,1-6,8,22H2,(H,26,27);1H/t10-;/m1./s1	Bacterial DNA gyrase inhibitor	INHIBITOR	CHEMBL2311224	Bacterial DNA gyrase	Bacteria
CHEMBL1200498	ALATROFLOXACIN MESYLATE	CS(=O)(=O)O.C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]21	CYETUYYEVKNSHZ-LGOOQLFJSA-N	InChI=1S/C26H25F3N6O5.CH4O3S/c1-10(30)24(37)31-11(2)25(38)32-20-14-7-34(8-15(14)20)23-18(29)6-13-21(36)16(26(39)40)9-35(22(13)33-23)19-4-3-12(27)5-17(19)28;1-5(2,3)4/h3-6,9-11,14-15,20H,7-8,30H2,1-2H3,(H,31,37)(H,32,38)(H,39,40);1H3,(H,2,3,4)/t10-,11-,14-,15+,20+;/m0./s1	Bacterial DNA gyrase inhibitor	INHIBITOR	CHEMBL2311224	Bacterial DNA gyrase	Bacteria
CHEMBL4	OFLOXACIN	CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23	GSDSWSVVBLHKDQ-UHFFFAOYSA-N	InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)	Bacterial DNA gyrase inhibitor	INHIBITOR	CHEMBL2311224	Bacterial DNA gyrase	Bacteria
CHEMBL1208	CINOXACIN	CCn1nc(C(=O)O)c(=O)c2cc3c(cc21)OCO3	VDUWPHTZYNWKRN-UHFFFAOYSA-N	InChI=1S/C12H10N2O5/c1-2-14-7-4-9-8(18-5-19-9)3-6(7)11(15)10(13-14)12(16)17/h3-4H,2,5H2,1H3,(H,16,17)	Bacterial DNA gyrase inhibitor	INHIBITOR	CHEMBL2311224	Bacterial DNA gyrase	Bacteria
CHEMBL8	CIPROFLOXACIN	O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O	MYSWGUAQZAJSOK-UHFFFAOYSA-N	InChI=1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)	Bacterial DNA gyrase inhibitor	INHIBITOR	CHEMBL2311224	Bacterial DNA gyrase	Bacteria
CHEMBL1202	CIPROFLOXACIN HYDROCHLORIDE	Cl.O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O	DIOIOSKKIYDRIQ-UHFFFAOYSA-N	InChI=1S/C17H18FN3O3.ClH/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24;/h7-10,19H,1-6H2,(H,23,24);1H	Bacterial DNA gyrase inhibitor	INHIBITOR	CHEMBL2311224	Bacterial DNA gyrase	Bacteria
CHEMBL1200779	TROVAFLOXACIN MESYLATE	CS(=O)(=O)O.N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12	DYNZICQDCVYXFW-AHZSKCOESA-N	InChI=1S/C20H15F3N4O3.CH4O3S/c21-8-1-2-15(13(22)3-8)27-7-12(20(29)30)17(28)9-4-14(23)19(25-18(9)27)26-5-10-11(6-26)16(10)24;1-5(2,3)4/h1-4,7,10-11,16H,5-6,24H2,(H,29,30);1H3,(H,2,3,4)/t10-,11+,16+;	Bacterial DNA gyrase inhibitor	INHIBITOR	CHEMBL2311224	Bacterial DNA gyrase	Bacteria
CHEMBL9	NORFLOXACIN	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21	OGJPXUAPXNRGGI-UHFFFAOYSA-N	InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23)	Bacterial DNA gyrase inhibitor	INHIBITOR	CHEMBL2311224	Bacterial DNA gyrase	Bacteria
CHEMBL5	NALIDIXIC ACID	CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21	MHWLWQUZZRMNGJ-UHFFFAOYSA-N	InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)	Bacterial DNA gyrase inhibitor	INHIBITOR	CHEMBL2311224	Bacterial DNA gyrase	Bacteria
CHEMBL1200735	MOXIFLOXACIN HYDROCHLORIDE	COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12.Cl	IDIIJJHBXUESQI-DFIJPDEKSA-N	InChI=1S/C21H24FN3O4.ClH/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H/t11-,16+;/m0./s1	Bacterial DNA gyrase inhibitor	INHIBITOR	CHEMBL2311224	Bacterial DNA gyrase	Bacteria
CHEMBL850	SPARFLOXACIN	C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1	DZZWHBIBMUVIIW-DTORHVGOSA-N	InChI=1S/C19H22F2N4O3/c1-8-5-24(6-9(2)23-8)17-13(20)15(22)12-16(14(17)21)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6,22H2,1-2H3,(H,27,28)/t8-,9+	Bacterial DNA gyrase inhibitor	INHIBITOR	CHEMBL2311224	Bacterial DNA gyrase	Bacteria
CHEMBL1728	LOMEFLOXACIN HYDROCHLORIDE	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21.Cl	KXEBLAPZMOQCKO-UHFFFAOYSA-N	InChI=1S/C17H19F2N3O3.ClH/c1-3-21-8-11(17(24)25)16(23)10-6-12(18)15(13(19)14(10)21)22-5-4-20-9(2)7-22;/h6,8-9,20H,3-5,7H2,1-2H3,(H,24,25);1H	Bacterial DNA gyrase inhibitor	INHIBITOR	CHEMBL2311224	Bacterial DNA gyrase	Bacteria
CHEMBL33	LEVOFLOXACIN	C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23	GSDSWSVVBLHKDQ-JTQLQIEISA-N	InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1	DNA gyrase inhibitor	INHIBITOR	CHEMBL2311225	DNA gyrase	Streptococcus pneumoniae
CHEMBL1200393	GREPAFLOXACIN HYDROCHLORIDE	Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1.Cl	IEPMBYOIQGCVHO-UHFFFAOYSA-N	InChI=1S/C19H22FN3O3.ClH/c1-10-8-22(6-5-21-10)15-7-14-16(11(2)17(15)20)18(24)13(19(25)26)9-23(14)12-3-4-12;/h7,9-10,12,21H,3-6,8H2,1-2H3,(H,25,26);1H	DNA gyrase inhibitor	INHIBITOR	CHEMBL2311225	DNA gyrase	Streptococcus pneumoniae
CHEMBL31	GATIFLOXACIN	COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12	XUBOMFCQGDBHNK-UHFFFAOYSA-N	InChI=1S/C19H22FN3O4/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26)	DNA gyrase inhibitor	INHIBITOR	CHEMBL2311225	DNA gyrase	Streptococcus pneumoniae
CHEMBL1200621	GEMIFLOXACIN MESYLATE	CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN.CS(=O)(=O)O	JIYMVSQRGZEYAX-CWUUNJJBSA-N	InChI=1S/C18H20FN5O4.CH4O3S/c1-28-22-14-8-23(6-9(14)5-20)17-13(19)4-11-15(25)12(18(26)27)7-24(10-2-3-10)16(11)21-17;1-5(2,3)4/h4,7,9-10H,2-3,5-6,8,20H2,1H3,(H,26,27);1H3,(H,2,3,4)/b22-14+;	DNA gyrase inhibitor	INHIBITOR	CHEMBL2311225	DNA gyrase	Streptococcus pneumoniae
CHEMBL826	ENOXACIN	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21	IDYZIJYBMGIQMJ-UHFFFAOYSA-N	InChI=1S/C15H17FN4O3/c1-2-19-8-10(15(22)23)12(21)9-7-11(16)14(18-13(9)19)20-5-3-17-4-6-20/h7-8,17H,2-6H2,1H3,(H,22,23)	DNA gyrase inhibitor	INHIBITOR	CHEMBL2311244	DNA gyrase	Neisseria gonorrhoeae
CHEMBL544665	FINGOLIMOD HYDROCHLORIDE	CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1.Cl	SWZTYAVBMYWFGS-UHFFFAOYSA-N	InChI=1S/C19H33NO2.ClH/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22;/h9-12,21-22H,2-8,13-16,20H2,1H3;1H	Sphingosine 1-phosphate receptor agonist	AGONIST	CHEMBL2363041	Sphingosine 1-phosphate receptor	Homo sapiens
CHEMBL1750	CLOFARABINE	Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F	WDDPHFBMKLOVOX-AYQXTPAHSA-N	InChI=1S/C10H11ClFN5O3/c11-10-15-7(13)5-8(16-10)17(2-14-5)9-4(12)6(19)3(1-18)20-9/h2-4,6,9,18-19H,1H2,(H2,13,15,16)/t3-,4+,6-,9-/m1/s1	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	CHEMBL2363042	DNA polymerase (alpha/delta/epsilon)	Homo sapiens
CHEMBL803	CYTARABINE	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1	UHDGCWIWMRVCDJ-CCXZUQQUSA-N	InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	CHEMBL2363042	DNA polymerase (alpha/delta/epsilon)	Homo sapiens
CHEMBL1096882	FLUDARABINE PHOSPHATE	Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]1O	GIUYCYHIANZCFB-FJFJXFQQSA-N	InChI=1S/C10H13FN5O7P/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(18)5(17)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,17-18H,1H2,(H2,12,14,15)(H2,19,20,21)/t3-,5-,6+,9-/m1/s1	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	CHEMBL2363042	DNA polymerase (alpha/delta/epsilon)	Homo sapiens
CHEMBL1637	GEMCITABINE HYDROCHLORIDE	Cl.Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1	OKKDEIYWILRZIA-OSZBKLCCSA-N	InChI=1S/C9H11F2N3O4.ClH/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17;/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17);1H/t4-,6-,7-;/m1./s1	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	CHEMBL2363042	DNA polymerase (alpha/delta/epsilon)	Homo sapiens
CHEMBL1200382	BEPRIDIL HYDROCHLORIDE	CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1.Cl.O	UEECHQPWQHYEDE-UHFFFAOYSA-N	InChI=1S/C24H34N2O.ClH.H2O/c1-21(2)19-27-20-24(25-15-9-10-16-25)18-26(23-13-7-4-8-14-23)17-22-11-5-3-6-12-22;;/h3-8,11-14,21,24H,9-10,15-20H2,1-2H3;1H;1H2	Voltage-gated calcium channel blocker	BLOCKER	CHEMBL2363032	Voltage-gated calcium channel	Homo sapiens
CHEMBL1059	PREGABALIN	CC(C)C[C@H](CN)CC(=O)O	AYXYPKUFHZROOJ-ZETCQYMHSA-N	InChI=1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)/t7-/m0/s1	Voltage-gated calcium channel modulator	MODULATOR	CHEMBL2363032	Voltage-gated calcium channel	Homo sapiens
CHEMBL940	GABAPENTIN	NCC1(CC(=O)O)CCCCC1	UGJMXCAKCUNAIE-UHFFFAOYSA-N	InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)	Voltage-gated calcium channel modulator	MODULATOR	CHEMBL2363032	Voltage-gated calcium channel	Homo sapiens
CHEMBL1628502	GABAPENTIN ENACARBIL	CC(OC(=O)NCC1(CC(=O)O)CCCCC1)OC(=O)C(C)C	TZDUHAJSIBHXDL-UHFFFAOYSA-N	InChI=1S/C16H27NO6/c1-11(2)14(20)22-12(3)23-15(21)17-10-16(9-13(18)19)7-5-4-6-8-16/h11-12H,4-10H2,1-3H3,(H,17,21)(H,18,19)	Voltage-gated calcium channel modulator	MODULATOR	CHEMBL2363032	Voltage-gated calcium channel	Homo sapiens
CHEMBL713	ENTECAVIR	C=C1[C@@H](n2cnc3c(=O)[nH]c(N)nc32)C[C@H](O)[C@H]1CO	QDGZDCVAUDNJFG-FXQIFTODSA-N	InChI=1S/C12H15N5O3/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20)/t6-,7-,8-/m0/s1	DNA polymerase/reverse transcriptase inhibitor	INHIBITOR	CHEMBL2362994	DNA polymerase/reverse transcriptase	Hepatitis B virus
CHEMBL922	ADEFOVIR DIPIVOXIL	CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C	WOZSCQDILHKSGG-UHFFFAOYSA-N	InChI=1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23)	DNA polymerase/reverse transcriptase inhibitor	INHIBITOR	CHEMBL2362994	DNA polymerase/reverse transcriptase	Hepatitis B virus
CHEMBL374731	TELBIVUDINE	Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O	IQFYYKKMVGJFEH-CSMHCCOUSA-N	InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m1/s1	DNA polymerase/reverse transcriptase inhibitor	INHIBITOR	CHEMBL2362994	DNA polymerase/reverse transcriptase	Hepatitis B virus
CHEMBL141	LAMIVUDINE	Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1	JTEGQNOMFQHVDC-NKWVEPMBSA-N	InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1	DNA polymerase/reverse transcriptase inhibitor	INHIBITOR	CHEMBL2362994	DNA polymerase/reverse transcriptase	Hepatitis B virus
CHEMBL1292	CLOFAZIMINE	CC(C)/N=c1\cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1	WDQPAMHFFCXSNU-BGABXYSRSA-N	InChI=1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3/b30-24+	DNA inhibitor	INHIBITOR	CHEMBL2366041	DNA	Mycobacterium leprae
CHEMBL788	IDOXURIDINE	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I	XQFRJNBWHJMXHO-RRKCRQDMSA-N	InChI=1S/C9H11IN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1	DNA inhibitor	INHIBITOR	CHEMBL2366042	DNA	Human herpesvirus 1
CHEMBL1129	TRIFLURIDINE	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F	VSQQQLOSPVPRAZ-RRKCRQDMSA-N	InChI=1S/C10H11F3N2O5/c11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7/h2,5-7,16-17H,1,3H2,(H,14,18,19)/t5-,6+,7+/m0/s1	DNA inhibitor	INHIBITOR	CHEMBL2366042	DNA	Human herpesvirus 1
CHEMBL1448	NICLOSAMIDE	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O	RJMUSRYZPJIFPJ-UHFFFAOYSA-N	InChI=1S/C13H8Cl2N2O4/c14-7-1-4-12(18)9(5-7)13(19)16-11-3-2-8(17(20)21)6-10(11)15/h1-6,18H,(H,16,19)	DNA inhibitor	INHIBITOR	CHEMBL2366043	DNA	Schistosoma mansoni
CHEMBL847	OXAMNIQUINE	CC(C)NCC1CCc2cc(CO)c([N+](=O)[O-])cc2N1	XCGYUJZMCCFSRP-UHFFFAOYSA-N	InChI=1S/C14H21N3O3/c1-9(2)15-7-12-4-3-10-5-11(8-18)14(17(19)20)6-13(10)16-12/h5-6,9,12,15-16,18H,3-4,7-8H2,1-2H3	DNA inhibitor	INHIBITOR	CHEMBL2366043	DNA	Schistosoma mansoni
CHEMBL1448	NICLOSAMIDE	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O	RJMUSRYZPJIFPJ-UHFFFAOYSA-N	InChI=1S/C13H8Cl2N2O4/c14-7-1-4-12(18)9(5-7)13(19)16-11-3-2-8(17(20)21)6-10(11)15/h1-6,18H,(H,16,19)	DNA inhibitor	INHIBITOR	CHEMBL2366044	DNA	Taenia
CHEMBL1220	TINIDAZOLE	CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C	HJLSLZFTEKNLFI-UHFFFAOYSA-N	InChI=1S/C8H13N3O4S/c1-3-16(14,15)5-4-10-7(2)9-6-8(10)11(12)13/h6H,3-5H2,1-2H3	DNA inhibitor	INHIBITOR	CHEMBL2366045	DNA	Trichomonas
CHEMBL361506	PENTAMIDINE ISETHIONATE	N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1.O=S(=O)(O)CCO.O=S(=O)(O)CCO	YBVNFKZSMZGRAD-UHFFFAOYSA-N	InChI=1S/C19H24N4O2.2C2H6O4S/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23;2*3-1-2-7(4,5)6/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,23);2*3H,1-2H2,(H,4,5,6)	DNA inhibitor	INHIBITOR	CHEMBL2366046	DNA	Pneumocystis jirovecii
CHEMBL361506	PENTAMIDINE ISETHIONATE	N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1.O=S(=O)(O)CCO.O=S(=O)(O)CCO	YBVNFKZSMZGRAD-UHFFFAOYSA-N	InChI=1S/C19H24N4O2.2C2H6O4S/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23;2*3-1-2-7(4,5)6/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,23);2*3H,1-2H2,(H,4,5,6)	Kinetoplast DNA inhibitor	INHIBITOR	CHEMBL2366047	Kinetoplast DNA	Trypanosoma brucei
CHEMBL1200448	TILUDRONATE DISODIUM	O=P([O-])(O)C(Sc1ccc(Cl)cc1)P(=O)([O-])O.[Na+].[Na+]	SKUHWSDHMJMHIW-UHFFFAOYSA-L	InChI=1S/C7H9ClO6P2S.2Na/c8-5-1-3-6(4-2-5)17-7(15(9,10)11)16(12,13)14;;/h1-4,7H,(H2,9,10,11)(H2,12,13,14);;/q;2*+1/p-2	ATP inhibitor	INHIBITOR	CHEMBL2366048	ATP	Homo sapiens
CHEMBL1201042	ETIDRONATE DISODIUM	CC(O)(P(=O)([O-])O)P(=O)([O-])O.[Na+].[Na+]	GWBBVOVXJZATQQ-UHFFFAOYSA-L	InChI=1S/C2H8O7P2.2Na/c1-2(3,10(4,5)6)11(7,8)9;;/h3H,1H3,(H2,4,5,6)(H2,7,8,9);;/q;2*+1/p-2	ATP inhibitor	INHIBITOR	CHEMBL2366048	ATP	Homo sapiens
CHEMBL3183453	NOVOBIOCIN SODIUM	CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c([O-])c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C.[Na+]	WWPRGAYLRGSOSU-RNROJPEYSA-M	InChI=1S/C31H36N2O11.Na/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29;/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37);/q;+1/p-1/t23-,25+,26-,29-;/m1./s1	DNA gyrase inhibitor	INHIBITOR	CHEMBL2331040	DNA gyrase	Staphylococcus epidermidis
CHEMBL1200733	DESFLURANE	FC(F)OC(F)C(F)(F)F	DPYMFVXJLLWWEU-UHFFFAOYSA-N	InChI=1S/C3H2F6O/c4-1(3(7,8)9)10-2(5)6/h1-2H	Potassium channel subfamily K member 10 opener	OPENER	CHEMBL2331041	Potassium channel subfamily K member 10	Homo sapiens
CHEMBL1200694	SEVOFLURANE	FCOC(C(F)(F)F)C(F)(F)F	DFEYYRMXOJXZRJ-UHFFFAOYSA-N	InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2	Potassium channel subfamily K member 10 opener	OPENER	CHEMBL2331041	Potassium channel subfamily K member 10	Homo sapiens
CHEMBL931	HALOTHANE	FC(F)(F)C(Cl)Br	BCQZXOMGPXTTIC-UHFFFAOYSA-N	InChI=1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H	Potassium channel subfamily K member 10 opener	OPENER	CHEMBL2331041	Potassium channel subfamily K member 10	Homo sapiens
CHEMBL1256	ISOFLURANE	FC(F)OC(Cl)C(F)(F)F	PIWKPBJCKXDKJR-UHFFFAOYSA-N	InChI=1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2H	Potassium channel subfamily K member 10 opener	OPENER	CHEMBL2331041	Potassium channel subfamily K member 10	Homo sapiens
CHEMBL1257	ENFLURANE	FC(F)OC(F)(F)C(F)Cl	JPGQOUSTVILISH-UHFFFAOYSA-N	InChI=1S/C3H2ClF5O/c4-1(5)3(8,9)10-2(6)7/h1-2H	Potassium channel subfamily K member 10 opener	OPENER	CHEMBL2331041	Potassium channel subfamily K member 10	Homo sapiens
CHEMBL1200733	DESFLURANE	FC(F)OC(F)C(F)(F)F	DPYMFVXJLLWWEU-UHFFFAOYSA-N	InChI=1S/C3H2F6O/c4-1(3(7,8)9)10-2(5)6/h1-2H	Potassium channel subfamily K member 18 opener	OPENER	CHEMBL2331042	Potassium channel subfamily K member 18	Homo sapiens
CHEMBL1200694	SEVOFLURANE	FCOC(C(F)(F)F)C(F)(F)F	DFEYYRMXOJXZRJ-UHFFFAOYSA-N	InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2	Potassium channel subfamily K member 18 opener	OPENER	CHEMBL2331042	Potassium channel subfamily K member 18	Homo sapiens
CHEMBL931	HALOTHANE	FC(F)(F)C(Cl)Br	BCQZXOMGPXTTIC-UHFFFAOYSA-N	InChI=1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H	Potassium channel subfamily K member 18 opener	OPENER	CHEMBL2331042	Potassium channel subfamily K member 18	Homo sapiens
CHEMBL1256	ISOFLURANE	FC(F)OC(Cl)C(F)(F)F	PIWKPBJCKXDKJR-UHFFFAOYSA-N	InChI=1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2H	Potassium channel subfamily K member 18 opener	OPENER	CHEMBL2331042	Potassium channel subfamily K member 18	Homo sapiens
CHEMBL1257	ENFLURANE	FC(F)OC(F)(F)C(F)Cl	JPGQOUSTVILISH-UHFFFAOYSA-N	InChI=1S/C3H2ClF5O/c4-1(5)3(8,9)10-2(6)7/h1-2H	Potassium channel subfamily K member 18 opener	OPENER	CHEMBL2331042	Potassium channel subfamily K member 18	Homo sapiens
CHEMBL1889140	ROPIVACAINE HYDROCHLORIDE	CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C.Cl	NDNSIBYYUOEUSV-RSAXXLAASA-N	InChI=1S/C17H26N2O.ClH/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3;/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20);1H/t15-;/m0./s1	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL918	PHENACEMIDE	NC(=O)NC(=O)Cc1ccccc1	XPFRXWCVYUEORT-UHFFFAOYSA-N	InChI=1S/C9H10N2O2/c10-9(13)11-8(12)6-7-4-2-1-3-5-7/h1-5H,6H2,(H3,10,11,12,13)	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200654	BENOXINATE HYDROCHLORIDE	CCCCOc1cc(C(=O)OCCN(CC)CC)ccc1N.Cl	PRGUDWLMFLCODA-UHFFFAOYSA-N	InChI=1S/C17H28N2O3.ClH/c1-4-7-11-21-16-13-14(8-9-15(16)18)17(20)22-12-10-19(5-2)6-3;/h8-9,13H,4-7,10-12,18H2,1-3H3;1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL944	CHLOROPROCAINE HYDROCHLORIDE	CCN(CC)CCOC(=O)c1ccc(N)cc1Cl.Cl	SZKQYDBPUCZLRX-UHFFFAOYSA-N	InChI=1S/C13H19ClN2O2.ClH/c1-3-16(4-2)7-8-18-13(17)11-6-5-10(15)9-12(11)14;/h5-6,9H,3-4,7-8,15H2,1-2H3;1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200606	MEXILETINE HYDROCHLORIDE	Cc1cccc(C)c1OCC(C)N.Cl	NFEIBWMZVIVJLQ-UHFFFAOYSA-N	InChI=1S/C11H17NO.ClH/c1-8-5-4-6-9(2)11(8)13-7-10(3)12;/h4-6,10H,7,12H2,1-3H3;1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL744	RILUZOLE	Nc1nc2ccc(OC(F)(F)F)cc2s1	FTALBRSUTCGOEG-UHFFFAOYSA-N	InChI=1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13)	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200715	HEXYLCAINE HYDROCHLORIDE	CC(CNC1CCCCC1)OC(=O)c1ccccc1.Cl	MTFCPNHRBINLRQ-UHFFFAOYSA-N	InChI=1S/C16H23NO2.ClH/c1-13(12-17-15-10-6-3-7-11-15)19-16(18)14-8-4-2-5-9-14;/h2,4-5,8-9,13,15,17H,3,6-7,10-12H2,1H3;1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1201022	PHENAZOPYRIDINE HYDROCHLORIDE	Cl.Nc1ccc(/N=N/c2ccccc2)c(N)n1	QQBPIHBUCMDKFG-GEEYTBSJSA-N	InChI=1S/C11H11N5.ClH/c12-10-7-6-9(11(13)14-10)16-15-8-4-2-1-3-5-8;/h1-7H,(H4,12,13,14);1H/b16-15+;	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200437	QUINIDINE GLUCONATE	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12.O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO	XHKUDCCTVQUHJQ-LCYSNFERSA-N	InChI=1S/C20H24N2O2.C6H12O7/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18;7-1-2(8)3(9)4(10)5(11)6(12)13/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3;2-5,7-11H,1H2,(H,12,13)/t13-,14-,19+,20-;2-,3-,4+,5-/m01/s1	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL856	PRIMIDONE	CCC1(c2ccccc2)C(=O)NCNC1=O	DQMZLTXERSFNPB-UHFFFAOYSA-N	InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1095	ETHOTOIN	CCN1C(=O)NC(c2ccccc2)C1=O	SZQIFWWUIBRPBZ-UHFFFAOYSA-N	InChI=1S/C11H12N2O2/c1-2-13-10(14)9(12-11(13)15)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H,12,15)	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1201020	DISOPYRAMIDE PHOSPHATE	CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C.O=P(O)(O)O	CGDDQFMPGMYYQP-UHFFFAOYSA-N	InChI=1S/C21H29N3O.H3O4P/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19;1-5(2,3)4/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25);(H3,1,2,3,4)	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1201729	DRONEDARONE HYDROCHLORIDE	CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1.Cl	DWKVCQXJYURSIQ-UHFFFAOYSA-N	InChI=1S/C31H44N2O5S.ClH/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3;/h13-18,23,32H,5-12,19-22H2,1-4H3;1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200478	DYCLONINE HYDROCHLORIDE	CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1.Cl	KNZADIMHVBBPOA-UHFFFAOYSA-N	InChI=1S/C18H27NO2.ClH/c1-2-3-15-21-17-9-7-16(8-10-17)18(20)11-14-19-12-5-4-6-13-19;/h7-10H,2-6,11-15H2,1H3;1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL3707183	QUINIDINE SULFATE	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12.C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12.O.O.O=S(=O)(O)O	ZHNFLHYOFXQIOW-AHSOWCEXSA-N	InChI=1S/2C20H24N2O2.H2O4S.2H2O/c2*1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18;1-5(2,3)4;;/h2*3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3;(H2,1,2,3,4);2*1H2/t2*13-,14-,19+,20-;;;/m00.../s1	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1194	PRILOCAINE	CCCNC(C)C(=O)Nc1ccccc1C	MVFGUOIZUNYYSO-UHFFFAOYSA-N	InChI=1S/C13H20N2O/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2/h5-8,11,14H,4,9H2,1-3H3,(H,15,16)	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1611	PHENYTOIN SODIUM	O=C1N=C([O-])NC1(c1ccccc1)c1ccccc1.[Na+]	FJPYVLNWWICYDW-UHFFFAOYSA-M	InChI=1S/C15H12N2O2.Na/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12;/h1-10H,(H2,16,17,18,19);/q;+1/p-1	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL220492	TOPIRAMATE	CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1	KJADKKWYZYXHBB-XBWDGYHZSA-N	InChI=1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200841	PROCAINE HYDROCHLORIDE	CCN(CC)CCOC(=O)c1ccc(N)cc1.Cl	HCBIBCJNVBAKAB-UHFFFAOYSA-N	InChI=1S/C13H20N2O2.ClH/c1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11;/h5-8H,3-4,9-10,14H2,1-2H3;1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL861	MEPHENYTOIN	CCC1(c2ccccc2)NC(=O)N(C)C1=O	GMHKMTDVRCWUDX-UHFFFAOYSA-N	InChI=1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL108	CARBAMAZEPINE	NC(=O)N1c2ccccc2C=Cc2ccccc21	FFGPTBGBLSHEPO-UHFFFAOYSA-N	InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200819	ARTICAINE HYDROCHLORIDE	CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC.Cl	GDWDBGSWGNEMGJ-UHFFFAOYSA-N	InChI=1S/C13H20N2O3S.ClH/c1-5-6-14-9(3)12(16)15-10-8(2)7-19-11(10)13(17)18-4;/h7,9,14H,5-6H2,1-4H3,(H,15,16);1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL698	TETRACAINE	CCCCNc1ccc(C(=O)OCCN(C)C)cc1	GKCBAIGFKIBETG-UHFFFAOYSA-N	InChI=1S/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H3	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL58323	ERLOSAMIDE	COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1	VPPJLAIAVCUEMN-GFCCVEGCSA-N	InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200440	MEPIVACAINE HYDROCHLORIDE	Cc1cccc(C)c1NC(=O)C1CCCCN1C.Cl	RETIMRUQNCDCQB-UHFFFAOYSA-N	InChI=1S/C15H22N2O.ClH/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3;/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18);1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200334	MORICIZINE HYDROCHLORIDE	CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2.Cl	GAQAKFHSULJNAK-UHFFFAOYSA-N	InChI=1S/C22H25N3O4S.ClH/c1-2-29-22(27)23-16-7-8-20-18(15-16)25(17-5-3-4-6-19(17)30-20)21(26)9-10-24-11-13-28-14-12-24;/h3-8,15H,2,9-14H2,1H3,(H,23,27);1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200597	ETIDOCAINE HYDROCHLORIDE	CCCN(CC)C(CC)C(=O)Nc1c(C)cccc1C.Cl	LMWQQUMMGGIGJQ-UHFFFAOYSA-N	InChI=1S/C17H28N2O.ClH/c1-6-12-19(8-3)15(7-2)17(20)18-16-13(4)10-9-11-14(16)5;/h9-11,15H,6-8,12H2,1-5H3,(H,18,20);1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1201023	ORPHENADRINE HYDROCHLORIDE	Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl	UQZKYYIKWZOKKD-UHFFFAOYSA-N	InChI=1S/C18H23NO.ClH/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;/h4-12,18H,13-14H2,1-3H3;1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200395	ORPHENADRINE CITRATE	Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O	MMMNTDFSPSQXJP-UHFFFAOYSA-N	InChI=1S/C18H23NO.C6H8O7/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-12,18H,13-14H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL605	PROCAINAMIDE HYDROCHLORIDE	CCN(CC)CCNC(=O)c1ccc(N)cc1.Cl	ABTXGJFUQRCPNH-UHFFFAOYSA-N	InChI=1S/C13H21N3O.ClH/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11;/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17);1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1201063	PROPAFENONE HYDROCHLORIDE	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1.Cl	XWIHRGFIPXWGEF-UHFFFAOYSA-N	InChI=1S/C21H27NO3.ClH/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17;/h3-11,18,22-23H,2,12-16H2,1H3;1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200464	PROPARACAINE HYDROCHLORIDE	CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N.Cl	BFUUJUGQJUTPAF-UHFFFAOYSA-N	InChI=1S/C16H26N2O3.ClH/c1-4-10-20-15-8-7-13(12-14(15)17)16(19)21-11-9-18(5-2)6-3;/h7-8,12H,4-6,9-11,17H2,1-3H3;1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1769	PROPOXYCAINE HYDROCHLORIDE	CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC.Cl	GITPCGSPKUQZTE-UHFFFAOYSA-N	InChI=1S/C16H26N2O3.ClH/c1-4-10-20-15-12-13(17)7-8-14(15)16(19)21-11-9-18(5-2)6-3;/h7-8,12H,4-6,9-11,17H2,1-3H3;1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1201754	RUFINAMIDE	NC(=O)c1cn(Cc2c(F)cccc2F)nn1	POGQSBRIGCQNEG-UHFFFAOYSA-N	InChI=1S/C10H8F2N4O/c11-7-2-1-3-8(12)6(7)4-16-5-9(10(13)17)14-15-16/h1-3,5H,4H2,(H2,13,17)	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1068	OXCARBAZEPINE	NC(=O)N1c2ccccc2CC(=O)c2ccccc21	CTRLABGOLIVAIY-UHFFFAOYSA-N	InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19)	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL16	PHENYTOIN	O=C1N=C(O)NC1(c1ccccc1)c1ccccc1	CXOFVDLJLONNDW-UHFFFAOYSA-N	InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200586	PRILOCAINE HYDROCHLORIDE	CCCNC(C)C(=O)Nc1ccccc1C.Cl	BJPJNTKRKALCPP-UHFFFAOYSA-N	InChI=1S/C13H20N2O.ClH/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2;/h5-8,11,14H,4,9H2,1-3H3,(H,15,16);1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL919	FOSPHENYTOIN SODIUM	O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)([O-])[O-].[Na+].[Na+]	GQPXYJNXTAFDLT-UHFFFAOYSA-L	InChI=1S/C16H15N2O6P.2Na/c19-14-16(12-7-3-1-4-8-12,13-9-5-2-6-10-13)17-15(20)18(14)11-24-25(21,22)23;;/h1-10H,11H2,(H,17,20)(H2,21,22,23);;/q;2*+1/p-2	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200341	INDECAINIDE HYDROCHLORIDE	CC(C)NCCCC1(C(N)=O)c2ccccc2-c2ccccc21.Cl	NXNSCUZKMVYAJQ-UHFFFAOYSA-N	InChI=1S/C20H24N2O.ClH/c1-14(2)22-13-7-12-20(19(21)23)17-10-5-3-8-15(17)16-9-4-6-11-18(16)20;/h3-6,8-11,14,22H,7,12-13H2,1-2H3,(H2,21,23);1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL741	LAMOTRIGINE	Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1	PYZRQGJRPPTADH-UHFFFAOYSA-N	InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL79	LIDOCAINE	CCN(CC)CC(=O)Nc1c(C)cccc1C	NNJVILVZKWQKPM-UHFFFAOYSA-N	InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200409	LIDOCAINE HYDROCHLORIDE	CCN(CC)CC(=O)Nc1c(C)cccc1C.Cl.O	YECIFGHRMFEPJK-UHFFFAOYSA-N	InChI=1S/C14H22N2O.ClH.H2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4;;/h7-9H,5-6,10H2,1-4H3,(H,15,17);1H;1H2	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200773	TOCAINIDE HYDROCHLORIDE	Cc1cccc(C)c1NC(=O)C(C)N.Cl	AMZACPWEJDQXGW-UHFFFAOYSA-N	InChI=1S/C11H16N2O.ClH/c1-7-5-4-6-8(2)10(7)13-11(14)9(3)12;/h4-6,9H,12H2,1-3H3,(H,13,14);1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL750	ZONISAMIDE	N=S(=O)(O)Cc1noc2ccccc12	UBQNRHZMVUUOMG-UHFFFAOYSA-N	InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1200323	LABETALOL HYDROCHLORIDE	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1.Cl	WQVZLXWQESQGIF-UHFFFAOYSA-N	InChI=1S/C19H24N2O3.ClH/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24;/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24);1H	Adrenergic receptor antagonist	ANTAGONIST	CHEMBL2331074	Adrenergic receptor	Homo sapiens
CHEMBL1200833	DIPIVEFRIN HYDROCHLORIDE	CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1.Cl	VKFAUCPBMAGVRG-UHFFFAOYSA-N	InChI=1S/C19H29NO5.ClH/c1-18(2,3)16(22)24-14-9-8-12(13(21)11-20-7)10-15(14)25-17(23)19(4,5)6;/h8-10,13,20-21H,11H2,1-7H3;1H	Adrenergic receptor agonist	AGONIST	CHEMBL2331074	Adrenergic receptor	Homo sapiens
CHEMBL1256958	EPINEPHRINE BITARTRATE	CNC[C@H](O)c1ccc(O)c(O)c1.O=C(O)C(O)C(O)C(=O)O	YLXIPWWIOISBDD-FVGYRXGTSA-N	InChI=1S/C9H13NO3.C4H6O6/c1-10-5-9(13)6-2-3-7(11)8(12)4-6;5-1(3(7)8)2(6)4(9)10/h2-4,9-13H,5H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t9-;/m0./s1	Adrenergic receptor agonist	AGONIST	CHEMBL2331074	Adrenergic receptor	Homo sapiens
CHEMBL679	EPINEPHRINE	CNC[C@H](O)c1ccc(O)c(O)c1	UCTWMZQNUQWSLP-VIFPVBQESA-N	InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1	Adrenergic receptor agonist	AGONIST	CHEMBL2331074	Adrenergic receptor	Homo sapiens
CHEMBL3184799	MEPHENTERMINE SULFATE	CNC(C)(C)Cc1ccccc1.CNC(C)(C)Cc1ccccc1.O=S(=O)(O)O	DNKCFBJMFIUNRS-UHFFFAOYSA-N	InChI=1S/2C11H17N.H2O4S/c2*1-11(2,12-3)9-10-7-5-4-6-8-10;1-5(2,3)4/h2*4-8,12H,9H2,1-3H3;(H2,1,2,3,4)	Adrenergic receptor agonist	AGONIST	CHEMBL2331074	Adrenergic receptor	Homo sapiens
CHEMBL1434513	NOREPINEPHRINE BITARTRATE	NC[C@H](O)c1ccc(O)c(O)c1.O.O=C(O)C(O)C(O)C(=O)O	LNBCGLZYLJMGKP-JZGIKJSDSA-N	InChI=1S/C8H11NO3.C4H6O6.H2O/c9-4-8(12)5-1-2-6(10)7(11)3-5;5-1(3(7)8)2(6)4(9)10;/h1-3,8,10-12H,4,9H2;1-2,5-6H,(H,7,8)(H,9,10);1H2/t8-;;/m0../s1	Adrenergic receptor agonist	AGONIST	CHEMBL2331074	Adrenergic receptor	Homo sapiens
CHEMBL1200705	HYDROXYAMPHETAMINE HYDROBROMIDE	Br.CC(N)Cc1ccc(O)cc1	RZCJLMTXBMNRAD-UHFFFAOYSA-N	InChI=1S/C9H13NO.BrH/c1-7(10)6-8-2-4-9(11)5-3-8;/h2-5,7,11H,6,10H2,1H3;1H	Adrenergic receptor agonist	AGONIST	CHEMBL2331074	Adrenergic receptor	Homo sapiens
CHEMBL831	LOXAPINE	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1	XJGVXQDUIWGIRW-UHFFFAOYSA-N	InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3	D2-like dopamine receptor antagonist	ANTAGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL1200503	BROMOCRIPTINE MESYLATE	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O	NOJMTMIRQRDZMT-GSPXQYRGSA-N	InChI=1S/C32H40BrN5O5.CH4O3S/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18;1-5(2,3)4/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39);1H3,(H,2,3,4)/t18-,23-,24+,25+,31-,32+;/m1./s1	D2-like dopamine receptor agonist	AGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL71	CHLORPROMAZINE	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21	ZPEIMTDSQAKGNT-UHFFFAOYSA-N	InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3	D2-like dopamine receptor antagonist	ANTAGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL1713	CHLORPROMAZINE HYDROCHLORIDE	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21.Cl	FBSMERQALIEGJT-UHFFFAOYSA-N	InChI=1S/C17H19ClN2S.ClH/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20;/h3-4,6-9,12H,5,10-11H2,1-2H3;1H	D2-like dopamine receptor antagonist	ANTAGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL42	CLOZAPINE	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1	QZUDBNBUXVUHMW-UHFFFAOYSA-N	InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL3989694	OLANZAPINE PAMOATE	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1.O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O	ZIMCQJVMPKQQPB-UHFFFAOYSA-N	InChI=1S/C23H16O6.C17H20N4S.H2O/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12;/h1-10,24-25H,11H2,(H,26,27)(H,28,29);3-6,11,19H,7-10H2,1-2H3;1H2	D2-like dopamine receptor antagonist	ANTAGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL3182733	PRAMIPEXOLE DIHYDROCHLORIDE	CCCN[C@H]1CCc2nc(N)sc2C1.Cl.Cl.O	APVQOOKHDZVJEX-QTPLPEIMSA-N	InChI=1S/C10H17N3S.2ClH.H2O/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8;;;/h7,12H,2-6H2,1H3,(H2,11,13);2*1H;1H2/t7-;;;/m0.../s1	D2-like dopamine receptor agonist	AGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL2358147	CARPHENAZINE MALEATE	CCC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O	TVPJGGZLZLUPOB-SPIKMXEPSA-N	InChI=1S/C24H31N3O2S.2C4H4O4/c1-2-22(29)19-8-9-24-21(18-19)27(20-6-3-4-7-23(20)30-24)11-5-10-25-12-14-26(15-13-25)16-17-28;2*5-3(6)1-2-4(7)8/h3-4,6-9,18,28H,2,5,10-17H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1108	DROPERIDOL	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1	RMEDXOLNCUSCGS-UHFFFAOYSA-N	InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)	D2-like dopamine receptor antagonist	ANTAGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL85	RISPERIDONE	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2	RAPZEAPATHNIPO-UHFFFAOYSA-N	InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1201155	LOXAPINE SUCCINATE	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.O=C(O)CCC(=O)O	YQZBAXDVDZTKEQ-UHFFFAOYSA-N	InChI=1S/C18H18ClN3O.C4H6O4/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;5-3(6)1-2-4(7)8/h2-7,12H,8-11H2,1H3;1-2H2,(H,5,6)(H,7,8)	D2-like dopamine receptor antagonist	ANTAGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL1200469	PROMAZINE HYDROCHLORIDE	CN(C)CCCN1c2ccccc2Sc2ccccc21.Cl	JIVSXRLRGOICGA-UHFFFAOYSA-N	InChI=1S/C17H20N2S.ClH/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19;/h3-6,8-11H,7,12-13H2,1-2H3;1H	D2-like dopamine receptor antagonist	ANTAGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL1200411	ROPINIROLE HYDROCHLORIDE	CCCN(CCC)CCc1cccc2c1CC(=O)N2.Cl	XDXHAEQXIBQUEZ-UHFFFAOYSA-N	InChI=1S/C16H24N2O.ClH/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15;/h5-7H,3-4,8-12H2,1-2H3,(H,17,19);1H	D2-like dopamine receptor agonist	AGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL1764	LEVOMEPROMAZINE	COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2	VRQVVMDWGGWHTJ-CQSZACIVSA-N	InChI=1S/C19H24N2OS/c1-14(12-20(2)3)13-21-16-7-5-6-8-18(16)23-19-10-9-15(22-4)11-17(19)21/h5-11,14H,12-13H2,1-4H3/t14-/m1/s1	D2-like dopamine receptor antagonist	ANTAGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL1200986	HALOPERIDOL DECANOATE	CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1	GUTXTARXLVFHDK-UHFFFAOYSA-N	InChI=1S/C31H41ClFNO3/c1-2-3-4-5-6-7-8-11-30(36)37-31(26-14-16-27(32)17-15-26)20-23-34(24-21-31)22-9-10-29(35)25-12-18-28(33)19-13-25/h12-19H,2-11,20-24H2,1H3	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL1200916	THIORIDAZINE HYDROCHLORIDE	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2.Cl	NZFNXWQNBYZDAQ-UHFFFAOYSA-N	InChI=1S/C21H26N2S2.ClH/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23;/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1H	D2-like dopamine receptor antagonist	ANTAGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL479	THIORIDAZINE	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2	KLBQZWRITKRQQV-UHFFFAOYSA-N	InChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3	D2-like dopamine receptor antagonist	ANTAGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL1616	APOMORPHINE HYDROCHLORIDE	CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl	SKYZYDSNJIOXRL-BTQNPOSSSA-N	InChI=1S/C17H17NO2.ClH/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12;/h2-6,13,19-20H,7-9H2,1H3;1H/t13-;/m1./s1	D2-like dopamine receptor agonist	AGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL1201060	LOXAPINE HYDROCHLORIDE	CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.Cl	JSXBVMKACNEMKY-UHFFFAOYSA-N	InChI=1S/C18H18ClN3O.ClH/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;/h2-7,12H,8-11H2,1H3;1H	D2-like dopamine receptor antagonist	ANTAGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL1615372	LURASIDONE HYDROCHLORIDE	Cl.O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1	NEKCRUIRPWNMLK-SCIYSFAVSA-N	InChI=1S/C28H36N4O2S.ClH/c33-27-24-18-9-10-19(15-18)25(24)28(34)32(27)17-21-6-2-1-5-20(21)16-30-11-13-31(14-12-30)26-22-7-3-4-8-23(22)35-29-26;/h3-4,7-8,18-21,24-25H,1-2,5-6,9-17H2;1H/t18-,19+,20-,21-,24+,25-;/m0./s1	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL715	OLANZAPINE	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1	KVWDHTXUZHCGIO-UHFFFAOYSA-N	InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3	D2-like dopamine receptor antagonist	ANTAGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL3188993	QUETIAPINE FUMARATE	O=C(O)/C=C/C(=O)O.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1	ZTHJULTYCAQOIJ-WXXKFALUSA-N	InChI=1S/2C21H25N3O2S.C4H4O4/c2*25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21;5-3(6)1-2-4(7)8/h2*1-8,25H,9-16H2;1-2H,(H,5,6)(H,7,8)/b;;2-1+	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1303	ROTIGOTINE	CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1	KFQYTPMOWPVWEJ-INIZCTEOSA-N	InChI=1S/C19H25NOS/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21/h3-7,13,16,21H,2,8-12,14H2,1H3/t16-/m0/s1	D2-like dopamine receptor agonist	AGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL54	HALOPERIDOL	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1	LNEPOXFFQSENCJ-UHFFFAOYSA-N	InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL4297147	HALOPERIDOL LACTATE	CC(O)C(=O)O.O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1	BVUSNQJCSYDJJG-UHFFFAOYSA-N	InChI=1S/C21H23ClFNO2.C3H6O3/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16;1-2(4)3(5)6/h3-10,26H,1-2,11-15H2;2,4H,1H3,(H,5,6)	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL1257040	TRIFLUOPERAZINE HYDROCHLORIDE	CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1.Cl.Cl	BXDAOUXDMHXPDI-UHFFFAOYSA-N	InChI=1S/C21H24F3N3S.2ClH/c1-25-11-13-26(14-12-25)9-4-10-27-17-5-2-3-6-19(17)28-20-8-7-16(15-18(20)27)21(22,23)24;;/h2-3,5-8,15H,4,9-14H2,1H3;2*1H	D2-like dopamine receptor antagonist	ANTAGONIST	CHEMBL2331075	D2-like dopamine receptor	Homo sapiens
CHEMBL1375743	ZIPRASIDONE HYDROCHLORIDE	Cl.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1	ZCBZSCBNOOIHFP-UHFFFAOYSA-N	InChI=1S/C21H21ClN4OS.ClH.H2O/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;;/h1-4,11,13H,5-10,12H2,(H,23,27);1H;1H2	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL3989833	ZIPRASIDONE MESYLATE	CS(=O)(=O)O.O.O.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1	WLQZEFFFIUHSJB-UHFFFAOYSA-N	InChI=1S/C21H21ClN4OS.CH4O3S.3H2O/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;1-5(2,3)4;;;/h1-4,11,13H,5-10,12H2,(H,23,27);1H3,(H,2,3,4);3*1H2	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL15891	LINDANE	Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl	JLYXXMFPNIAWKQ-GNIYUCBRSA-N	InChI=1S/C6H6Cl6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-6H/t1-,2-,3-,4+,5+,6+	GABA-A receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	CHEMBL2364024	GABA-A receptor	Sarcoptes scabiei
CHEMBL15891	LINDANE	Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl	JLYXXMFPNIAWKQ-GNIYUCBRSA-N	InChI=1S/C6H6Cl6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-6H/t1-,2-,3-,4+,5+,6+	GABA-A receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	CHEMBL2364025	GABA-A receptor	Pediculus humanus
CHEMBL1401	NITAZOXANIDE	CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1	YQNQNVDNTFHQSW-UHFFFAOYSA-N	InChI=1S/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17)	Pyruvate:ferredoxin oxidoreductase inhibitor	INHIBITOR	CHEMBL2364026	Pyruvate:ferredoxin oxidoreductase	Cryptosporidium parvum
CHEMBL1401	NITAZOXANIDE	CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1	YQNQNVDNTFHQSW-UHFFFAOYSA-N	InChI=1S/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17)	Pyruvate:ferredoxin oxidoreductase inhibitor	INHIBITOR	CHEMBL2364027	Pyruvate:ferredoxin oxidoreductase	Giardia intestinalis
CHEMBL3833353	PRAMLINTIDE ACETATE	CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O	DTPWZYSUQQHRKD-VIUAGAKSSA-N	InChI=1S/C171H267N51O53S2.C2H4O2/c1-21-81(12)130(163(268)207-110(56-78(6)7)169(274)222-53-33-42-118(222)170(275)221-52-32-41-117(221)160(265)219-135(89(20)230)167(272)206-109(66-125(180)238)151(256)212-128(79(8)9)161(266)186-68-126(239)192-111(70-223)154(259)203-107(64-123(178)236)152(257)218-134(88(19)229)166(271)195-98(136(181)241)57-92-43-45-94(231)46-44-92)214-159(264)116-40-31-51-220(116)127(240)69-187-141(246)101(58-90-34-24-22-25-35-90)199-148(253)105(62-121(176)234)201-149(254)106(63-122(177)235)202-155(260)112(71-224)209-156(261)113(72-225)208-146(251)103(60-93-67-184-75-188-93)205-162(267)129(80(10)11)213-150(255)100(55-77(4)5)198-145(250)102(59-91-36-26-23-27-37-91)200-147(252)104(61-120(175)233)196-137(242)82(13)189-144(249)99(54-76(2)3)197-142(247)96(39-30-50-185-171(182)183)193-143(248)97(47-48-119(174)232)194-165(270)132(86(17)227)215-138(243)83(14)190-157(262)114-73-276-277-74-115(210-140(245)95(173)38-28-29-49-172)158(263)204-108(65-124(179)237)153(258)217-131(85(16)226)164(269)191-84(15)139(244)216-133(87(18)228)168(273)211-114;1-2(3)4/h22-27,34-37,43-46,67,75-89,95-118,128-135,223-231H,21,28-33,38-42,47-66,68-74,172-173H2,1-20H3,(H2,174,232)(H2,175,233)(H2,176,234)(H2,177,235)(H2,178,236)(H2,179,237)(H2,180,238)(H2,181,241)(H,184,188)(H,186,266)(H,187,246)(H,189,249)(H,190,262)(H,191,269)(H,192,239)(H,193,248)(H,194,270)(H,195,271)(H,196,242)(H,197,247)(H,198,250)(H,199,253)(H,200,252)(H,201,254)(H,202,260)(H,203,259)(H,204,263)(H,205,267)(H,206,272)(H,207,268)(H,208,251)(H,209,261)(H,210,245)(H,211,273)(H,212,256)(H,213,255)(H,214,264)(H,215,243)(H,216,244)(H,217,258)(H,218,257)(H,219,265)(H4,182,183,185);1H3,(H,3,4)/t81-,82-,83-,84-,85+,86+,87+,88+,89+,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,128-,129-,130-,131-,132-,133-,134-,135-;/m0./s1	Amylin receptor AMY2; CALCR/RAMP2 agonist	AGONIST	CHEMBL2364173	Amylin receptor AMY2; CALCR/RAMP2	Homo sapiens
CHEMBL1200621	GEMIFLOXACIN MESYLATE	CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN.CS(=O)(=O)O	JIYMVSQRGZEYAX-CWUUNJJBSA-N	InChI=1S/C18H20FN5O4.CH4O3S/c1-28-22-14-8-23(6-9(14)5-20)17-13(19)4-11-15(25)12(18(26)27)7-24(10-2-3-10)16(11)21-17;1-5(2,3)4/h4,7,9-10H,2-3,5-6,8,20H2,1H3,(H,26,27);1H3,(H,2,3,4)/b22-14+;	Topoisomerase IV inhibitor	INHIBITOR	CHEMBL2363033	Topoisomerase IV	Streptococcus pneumoniae
CHEMBL31	GATIFLOXACIN	COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12	XUBOMFCQGDBHNK-UHFFFAOYSA-N	InChI=1S/C19H22FN3O4/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26)	Topoisomerase IV inhibitor	INHIBITOR	CHEMBL2363033	Topoisomerase IV	Streptococcus pneumoniae
CHEMBL1200393	GREPAFLOXACIN HYDROCHLORIDE	Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1.Cl	IEPMBYOIQGCVHO-UHFFFAOYSA-N	InChI=1S/C19H22FN3O3.ClH/c1-10-8-22(6-5-21-10)15-7-14-16(11(2)17(15)20)18(24)13(19(25)26)9-23(14)12-3-4-12;/h7,9-10,12,21H,3-6,8H2,1-2H3,(H,25,26);1H	Topoisomerase IV inhibitor	INHIBITOR	CHEMBL2363033	Topoisomerase IV	Streptococcus pneumoniae
CHEMBL33	LEVOFLOXACIN	C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23	GSDSWSVVBLHKDQ-JTQLQIEISA-N	InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1	Topoisomerase IV inhibitor	INHIBITOR	CHEMBL2363033	Topoisomerase IV	Streptococcus pneumoniae
CHEMBL1200733	DESFLURANE	FC(F)OC(F)C(F)(F)F	DPYMFVXJLLWWEU-UHFFFAOYSA-N	InChI=1S/C3H2F6O/c4-1(3(7,8)9)10-2(5)6/h1-2H	Potassium channel subfamily K member 3 opener	OPENER	CHEMBL2321613	Potassium channel subfamily K member 3	Homo sapiens
CHEMBL3989519	DOXAPRAM HYDROCHLORIDE	CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O.Cl.O	ZOMBFZRWMLIDPX-UHFFFAOYSA-N	InChI=1S/C24H30N2O2.ClH.H2O/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21;;/h3-12,22H,2,13-19H2,1H3;1H;1H2	Potassium channel subfamily K member 3 blocker	BLOCKER	CHEMBL2321613	Potassium channel subfamily K member 3	Homo sapiens
CHEMBL1200694	SEVOFLURANE	FCOC(C(F)(F)F)C(F)(F)F	DFEYYRMXOJXZRJ-UHFFFAOYSA-N	InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2	Potassium channel subfamily K member 3 opener	OPENER	CHEMBL2321613	Potassium channel subfamily K member 3	Homo sapiens
CHEMBL931	HALOTHANE	FC(F)(F)C(Cl)Br	BCQZXOMGPXTTIC-UHFFFAOYSA-N	InChI=1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H	Potassium channel subfamily K member 3 opener	OPENER	CHEMBL2321613	Potassium channel subfamily K member 3	Homo sapiens
CHEMBL1256	ISOFLURANE	FC(F)OC(Cl)C(F)(F)F	PIWKPBJCKXDKJR-UHFFFAOYSA-N	InChI=1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2H	Potassium channel subfamily K member 3 opener	OPENER	CHEMBL2321613	Potassium channel subfamily K member 3	Homo sapiens
CHEMBL1257	ENFLURANE	FC(F)OC(F)(F)C(F)Cl	JPGQOUSTVILISH-UHFFFAOYSA-N	InChI=1S/C3H2ClF5O/c4-1(5)3(8,9)10-2(6)7/h1-2H	Potassium channel subfamily K member 3 opener	OPENER	CHEMBL2321613	Potassium channel subfamily K member 3	Homo sapiens
CHEMBL1200733	DESFLURANE	FC(F)OC(F)C(F)(F)F	DPYMFVXJLLWWEU-UHFFFAOYSA-N	InChI=1S/C3H2F6O/c4-1(3(7,8)9)10-2(5)6/h1-2H	Potassium channel subfamily K member 9 opener	OPENER	CHEMBL2321614	Potassium channel subfamily K member 9	Homo sapiens
CHEMBL3989519	DOXAPRAM HYDROCHLORIDE	CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O.Cl.O	ZOMBFZRWMLIDPX-UHFFFAOYSA-N	InChI=1S/C24H30N2O2.ClH.H2O/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21;;/h3-12,22H,2,13-19H2,1H3;1H;1H2	Potassium channel subfamily K member 9 blocker	BLOCKER	CHEMBL2321614	Potassium channel subfamily K member 9	Homo sapiens
CHEMBL1200694	SEVOFLURANE	FCOC(C(F)(F)F)C(F)(F)F	DFEYYRMXOJXZRJ-UHFFFAOYSA-N	InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2	Potassium channel subfamily K member 9 opener	OPENER	CHEMBL2321614	Potassium channel subfamily K member 9	Homo sapiens
CHEMBL931	HALOTHANE	FC(F)(F)C(Cl)Br	BCQZXOMGPXTTIC-UHFFFAOYSA-N	InChI=1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H	Potassium channel subfamily K member 9 opener	OPENER	CHEMBL2321614	Potassium channel subfamily K member 9	Homo sapiens
CHEMBL1256	ISOFLURANE	FC(F)OC(Cl)C(F)(F)F	PIWKPBJCKXDKJR-UHFFFAOYSA-N	InChI=1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2H	Potassium channel subfamily K member 9 opener	OPENER	CHEMBL2321614	Potassium channel subfamily K member 9	Homo sapiens
CHEMBL1257	ENFLURANE	FC(F)OC(F)(F)C(F)Cl	JPGQOUSTVILISH-UHFFFAOYSA-N	InChI=1S/C3H2ClF5O/c4-1(5)3(8,9)10-2(6)7/h1-2H	Potassium channel subfamily K member 9 opener	OPENER	CHEMBL2321614	Potassium channel subfamily K member 9	Homo sapiens
CHEMBL1200733	DESFLURANE	FC(F)OC(F)C(F)(F)F	DPYMFVXJLLWWEU-UHFFFAOYSA-N	InChI=1S/C3H2F6O/c4-1(3(7,8)9)10-2(5)6/h1-2H	Potassium channel subfamily K member 2 opener	OPENER	CHEMBL2321615	Potassium channel subfamily K member 2	Homo sapiens
CHEMBL1257	ENFLURANE	FC(F)OC(F)(F)C(F)Cl	JPGQOUSTVILISH-UHFFFAOYSA-N	InChI=1S/C3H2ClF5O/c4-1(5)3(8,9)10-2(6)7/h1-2H	Potassium channel subfamily K member 2 opener	OPENER	CHEMBL2321615	Potassium channel subfamily K member 2	Homo sapiens
CHEMBL1200694	SEVOFLURANE	FCOC(C(F)(F)F)C(F)(F)F	DFEYYRMXOJXZRJ-UHFFFAOYSA-N	InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2	Potassium channel subfamily K member 2 opener	OPENER	CHEMBL2321615	Potassium channel subfamily K member 2	Homo sapiens
CHEMBL931	HALOTHANE	FC(F)(F)C(Cl)Br	BCQZXOMGPXTTIC-UHFFFAOYSA-N	InChI=1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H	Potassium channel subfamily K member 2 opener	OPENER	CHEMBL2321615	Potassium channel subfamily K member 2	Homo sapiens
CHEMBL1256	ISOFLURANE	FC(F)OC(Cl)C(F)(F)F	PIWKPBJCKXDKJR-UHFFFAOYSA-N	InChI=1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2H	Potassium channel subfamily K member 2 opener	OPENER	CHEMBL2321615	Potassium channel subfamily K member 2	Homo sapiens
CHEMBL1255800	FIDAXOMICIN	CCc1c(Cl)c(O)c(Cl)c(O)c1C(=O)O[C@H]1[C@H](O)[C@H](OC)[C@H](OC/C2=C\C=C\C[C@H](O)/C(C)=C/[C@H](CC)[C@@H](O[C@@H]3OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]3O)/C(C)=C/C(C)=C/C[C@@H]([C@@H](C)O)OC2=O)O[C@@H]1C	ZVGNESXIJDCBKN-UUEYKCAUSA-N	InChI=1S/C52H74Cl2O18/c1-13-30-22-26(6)33(56)18-16-15-17-31(23-66-51-45(65-12)42(61)44(29(9)67-51)69-49(64)35-32(14-2)36(53)39(58)37(54)38(35)57)48(63)68-34(28(8)55)20-19-25(5)21-27(7)43(30)70-50-41(60)40(59)46(52(10,11)72-50)71-47(62)24(3)4/h15-17,19,21-22,24,28-30,33-34,40-46,50-51,55-61H,13-14,18,20,23H2,1-12H3/b16-15+,25-19+,26-22+,27-21+,31-17+/t28-,29-,30+,33+,34+,40-,41+,42+,43+,44-,45+,46+,50-,51-/m1/s1	DNA-directed RNA polymerase inhibitor	INHIBITOR	CHEMBL2363852	DNA-directed RNA polymerase	Clostridium difficile
CHEMBL3989551	LINCOMYCIN HYDROCHLORIDE	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1.Cl.O	LFZGYTBWUHCAKF-DCNJEFSFSA-N	InChI=1S/C18H34N2O6S.ClH.H2O/c1-5-6-10-7-11(20(3)8-10)17(25)19-12(9(2)21)16-14(23)13(22)15(24)18(26-16)27-4;;/h9-16,18,21-24H,5-8H2,1-4H3,(H,19,25);1H;1H2/t9-,10-,11+,12-,13+,14-,15-,16-,18-;;/m1../s1	70S ribosome inhibitor	INHIBITOR	CHEMBL2363853	70S ribosome	Streptococcus pneumoniae
CHEMBL126	LINEZOLID	CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1	TYZROVQLWOKYKF-ZDUSSCGKSA-N	InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL564085	TROLEANDOMYCIN	CO[C@H]1C[C@H](O[C@@H]2[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](OC(C)=O)[C@@H](C)C(=O)[C@]3(CO3)C[C@H](C)[C@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@H]2C)O[C@@H](C)[C@@H]1OC(C)=O	LQCLVBQBTUVCEQ-QTFUVMRISA-N	InChI=1S/C41H67NO15/c1-19-17-41(18-49-41)38(46)23(5)34(53-27(9)43)21(3)25(7)52-39(47)24(6)35(56-32-16-31(48-14)36(26(8)51-32)54-28(10)44)22(4)33(19)57-40-37(55-29(11)45)30(42(12)13)15-20(2)50-40/h19-26,30-37,40H,15-18H2,1-14H3/t19-,20+,21-,22+,23+,24+,25+,26-,30-,31-,32-,33-,34-,35-,36-,37+,40-,41+/m0/s1	70S ribosome inhibitor	INHIBITOR	CHEMBL2363853	70S ribosome	Streptococcus pneumoniae
CHEMBL3989823	VIOMYCIN SULFATE	NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@H]([C@H]2C[C@H](O)NC(N)=N2)NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O.O=S(=O)(O)O	AQONYROJHRNYQQ-QMAPKBLTSA-N	InChI=1S/C25H43N13O10.H2O4S/c26-3-1-2-10(27)4-16(41)32-12-6-30-23(47)18(11-5-17(42)37-24(28)36-11)38-20(44)13(7-31-25(29)48)33-21(45)14(8-39)35-22(46)15(9-40)34-19(12)43;1-5(2,3)4/h7,10-12,14-15,17-18,39-40,42H,1-6,8-9,26-27H2,(H,30,47)(H,32,41)(H,33,45)(H,34,43)(H,35,46)(H,38,44)(H3,28,36,37)(H3,29,31,48);(H2,1,2,3,4)/b13-7-;/t10-,11+,12-,14-,15-,17-,18-;/m0./s1	70S ribosome inhibitor	INHIBITOR	CHEMBL2363965	70S ribosome	Mycobacterium tuberculosis
CHEMBL2218913	CAPREOMYCIN SULFATE	C[C@@H]1NC(=O)[C@@H](N)CNC(=O)[C@H](C2CCNC(=N)N2)NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC1=O.N=C1NCCC([C@@H]2NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC2=O)N1.O=S(=O)(O)O.O=S(=O)(O)O	TUATYNXRYJTQTQ-BVRBKCERSA-N	InChI=1S/C25H44N14O8.C25H44N14O7.2H2O4S/c26-4-1-2-11(27)6-17(41)32-8-14-20(43)35-15(9-34-25(30)47)21(44)39-18(13-3-5-31-24(29)38-13)23(46)33-7-12(28)19(42)37-16(10-40)22(45)36-14;1-11-19(41)36-15(9-32-17(40)7-12(27)3-2-5-26)21(43)37-16(10-34-25(30)46)22(44)39-18(14-4-6-31-24(29)38-14)23(45)33-8-13(28)20(42)35-11;2*1-5(2,3)4/h9,11-14,16,18,40H,1-8,10,26-28H2,(H,32,41)(H,33,46)(H,35,43)(H,36,45)(H,37,42)(H,39,44)(H3,29,31,38)(H3,30,34,47);10-15,18H,2-9,26-28H2,1H3,(H,32,40)(H,33,45)(H,35,42)(H,36,41)(H,37,43)(H,39,44)(H3,29,31,38)(H3,30,34,46);2*(H2,1,2,3,4)/b15-9-;16-10-;;/t11?,12-,13?,14-,16-,18-;11-,12?,13-,14?,15-,18-;;/m00../s1	70S ribosome inhibitor	INHIBITOR	CHEMBL2363965	70S ribosome	Mycobacterium tuberculosis
CHEMBL614	PYRAZINAMIDE	NC(=O)c1cnccn1	IPEHBUMCGVEMRF-UHFFFAOYSA-N	InChI=1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9)	70S ribosome inhibitor	INHIBITOR	CHEMBL2363965	70S ribosome	Mycobacterium tuberculosis
CHEMBL3989564	TOBRAMYCIN SULFATE	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O.NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O	NZKFUBQRAWPZJP-BXKLGIMVSA-N	InChI=1S/2C18H37N5O9.5H2O4S/c2*19-3-9-8(25)2-7(22)17(29-9)31-15-5(20)1-6(21)16(14(15)28)32-18-13(27)11(23)12(26)10(4-24)30-18;5*1-5(2,3)4/h2*5-18,24-28H,1-4,19-23H2;5*(H2,1,2,3,4)/t2*5-,6+,7+,8-,9+,10+,11-,12+,13+,14-,15+,16-,17+,18+;;;;;/m00...../s1	70S ribosome inhibitor	INHIBITOR	CHEMBL2364022	70S ribosome	Pseudomonas aeruginosa
CHEMBL1747	TOBRAMYCIN	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O	NLVFBUXFDBBNBW-PBSUHMDJSA-N	InChI=1S/C18H37N5O9/c19-3-9-8(25)2-7(22)17(29-9)31-15-5(20)1-6(21)16(14(15)28)32-18-13(27)11(23)12(26)10(4-24)30-18/h5-18,24-28H,1-4,19-23H2/t5-,6+,7+,8-,9+,10+,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1	70S ribosome inhibitor	INHIBITOR	CHEMBL2364022	70S ribosome	Pseudomonas aeruginosa
CHEMBL502097	MIPOMERSEN SODIUM	COCCO[C@H]1[C@@H](O)[C@H](COP(=O)([O-])S[C@H]2[C@H](COP(=O)([O-])S[C@H]3[C@H](COP(=O)([O-])S[C@H]4[C@H](COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cnc7c(N)ncnc76)O[C@@H]5COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5CO)O[C@H](n5cc(C)c(N)nc5=O)[C@H]4OCCOC)O[C@H](n4cnc5c(N)ncnc54)[C@H]3OCCOC)O[C@H](n3cc(C)c(N)nc3=O)[C@H]2OCCOC)O[C@@H]1n1cc(C)c(N)nc1=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]	OSGPYAHSKOGBFY-KMHHXCEHSA-A	InChI=1S/C230H324N67O122P19S19.19Na/c1-97-55-278(217(309)256-177(97)231)141-45-131(112(400-141)70-381-422(327,328)442-136-50-146(283-66-108(12)196(302)275-228(283)320)406-118(136)76-387-427(337,338)448-140-54-150(294-93-253-154-191(294)266-214(243)270-200(154)306)409-120(140)78-389-428(339,340)446-138-52-148(292-91-250-151-186(240)246-89-248-188(151)292)407-121(138)79-390-430(343,344)450-169-124(413-204(160(169)373-37-27-363-17)286-59-101(5)181(235)260-221(286)313)83-394-435(353,354)455-174-128(417-209(165(174)378-42-32-368-22)291-68-110(14)198(304)277-230(291)322)87-396-434(351,352)453-172-126(415-207(163(172)376-40-30-366-20)289-62-104(8)184(238)263-224(289)316)85-395-433(349,350)452-171-123(412-206(162(171)375-39-29-365-19)288-61-103(7)183(237)262-223(288)315)82-393-432(347,348)449-168-111(69-298)410-211(159(168)372-36-26-362-16)296-95-254-155-192(296)267-215(244)271-201(155)307)439-420(323,324)384-74-117-137(51-147(405-117)284-67-109(13)197(303)276-229(284)321)444-425(333,334)388-77-119-139(53-149(408-119)293-92-252-153-190(293)265-213(242)269-199(153)305)447-426(335,336)386-71-113-132(46-142(401-113)279-56-98(2)178(232)257-218(279)310)440-421(325,326)383-73-115-135(49-145(403-115)282-65-107(11)195(301)274-227(282)319)443-424(331,332)385-75-116-134(48-144(404-116)281-64-106(10)194(300)273-226(281)318)441-423(329,330)382-72-114-133(47-143(402-114)280-57-99(3)179(233)258-219(280)311)445-429(341,342)392-81-129-176(167(380-44-34-370-24)212(419-129)297-96-255-156-193(297)268-216(245)272-202(156)308)457-438(359,360)398-86-127-173(164(377-41-31-367-21)208(416-127)290-63-105(9)185(239)264-225(290)317)454-436(355,356)399-88-130-175(166(379-43-33-369-23)210(418-130)295-94-251-152-187(241)247-90-249-189(152)295)456-437(357,358)397-84-125-170(161(374-38-28-364-18)205(414-125)287-60-102(6)182(236)261-222(287)314)451-431(345,346)391-80-122-157(299)158(371-35-25-361-15)203(411-122)285-58-100(4)180(234)259-220(285)312;;;;;;;;;;;;;;;;;;;/h55-68,89-96,111-150,157-176,203-212,298-299H,25-54,69-88H2,1-24H3,(H,323,324)(H,325,326)(H,327,328)(H,329,330)(H,331,332)(H,333,334)(H,335,336)(H,337,338)(H,339,340)(H,341,342)(H,343,344)(H,345,346)(H,347,348)(H,349,350)(H,351,352)(H,353,354)(H,355,356)(H,357,358)(H,359,360)(H2,231,256,309)(H2,232,257,310)(H2,233,258,311)(H2,234,259,312)(H2,235,260,313)(H2,236,261,314)(H2,237,262,315)(H2,238,263,316)(H2,239,264,317)(H2,240,246,248)(H2,241,247,249)(H,273,300,318)(H,274,301,319)(H,275,302,320)(H,276,303,321)(H,277,304,322)(H3,242,265,269,305)(H3,243,266,270,306)(H3,244,267,271,307)(H3,245,268,272,308);;;;;;;;;;;;;;;;;;;/q;19*+1/p-19/t111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122+,123-,124-,125+,126-,127+,128-,129-,130+,131+,132+,133+,134+,135+,136+,137+,138+,139+,140+,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,157+,158+,159-,160-,161+,162-,163-,164+,165-,166+,167-,168-,169-,170+,171-,172-,173+,174-,175+,176-,203+,204-,205+,206-,207-,208+,209-,210+,211-,212-;;;;;;;;;;;;;;;;;;;/m1.................../s1	Apo-B 100 mRNA antisense inhibitor	ANTISENSE INHIBITOR	CHEMBL2364185	Apo-B 100 mRNA	Homo sapiens
CHEMBL797	PHENSUXIMIDE	CN1C(=O)CC(c2ccccc2)C1=O	WLWFNJKHKGIJNW-UHFFFAOYSA-N	InChI=1S/C11H11NO2/c1-12-10(13)7-9(11(12)14)8-5-3-2-4-6-8/h2-6,9H,7H2,1H3	Voltage-gated T-type calcium channel blocker	BLOCKER	CHEMBL2362995	Voltage-gated T-type calcium channel	Homo sapiens
CHEMBL1100	PARAMETHADIONE	CCC1(C)OC(=O)N(C)C1=O	VQASKUSHBVDKGU-UHFFFAOYSA-N	InChI=1S/C7H11NO3/c1-4-7(2)5(9)8(3)6(10)11-7/h4H2,1-3H3	Voltage-gated T-type calcium channel blocker	BLOCKER	CHEMBL2362995	Voltage-gated T-type calcium channel	Homo sapiens
CHEMBL697	METHSUXIMIDE	CN1C(=O)CC(C)(c2ccccc2)C1=O	AJXPJJZHWIXJCJ-UHFFFAOYSA-N	InChI=1S/C12H13NO2/c1-12(9-6-4-3-5-7-9)8-10(14)13(2)11(12)15/h3-7H,8H2,1-2H3	Voltage-gated T-type calcium channel blocker	BLOCKER	CHEMBL2362995	Voltage-gated T-type calcium channel	Homo sapiens
CHEMBL696	ETHOSUXIMIDE	CCC1(C)CC(=O)NC1=O	HAPOVYFOVVWLRS-UHFFFAOYSA-N	InChI=1S/C7H11NO2/c1-3-7(2)4-5(9)8-6(7)10/h3-4H2,1-2H3,(H,8,9,10)	Voltage-gated T-type calcium channel blocker	BLOCKER	CHEMBL2362995	Voltage-gated T-type calcium channel	Homo sapiens
CHEMBL695	TRIMETHADIONE	CN1C(=O)OC(C)(C)C1=O	IRYJRGCIQBGHIV-UHFFFAOYSA-N	InChI=1S/C6H9NO3/c1-6(2)4(8)7(3)5(9)10-6/h1-3H3	Voltage-gated T-type calcium channel blocker	BLOCKER	CHEMBL2362995	Voltage-gated T-type calcium channel	Homo sapiens
CHEMBL284348	DALFAMPRIDINE	Nc1ccncc1	NUKYPUAOHBNCPY-UHFFFAOYSA-N	InChI=1S/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7)	Voltage-gated potassium channel blocker	BLOCKER	CHEMBL2362996	Voltage-gated potassium channel	Homo sapiens
CHEMBL1200728	GUANIDINE HYDROCHLORIDE	Cl.N=C(N)N	PJJJBBJSCAKJQF-UHFFFAOYSA-N	InChI=1S/CH5N3.ClH/c2-1(3)4;/h(H5,2,3,4);1H	Voltage-gated potassium channel blocker	BLOCKER	CHEMBL2362996	Voltage-gated potassium channel	Homo sapiens
CHEMBL1200582	AMINOLEVULINIC ACID HYDROCHLORIDE	Cl.NCC(=O)CCC(=O)O	ZLHFONARZHCSET-UHFFFAOYSA-N	InChI=1S/C5H9NO3.ClH/c6-3-4(7)1-2-5(8)9;/h1-3,6H2,(H,8,9);1H	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL2218885	VERTEPORFIN	C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)O)c(CCC(=O)OC)c4C)C1(C)C3=CC=C(C(=O)OC)C1C(=O)OC.C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)OC)c(CCC(=O)O)c4C)C1(C)C3=CC=C(C(=O)OC)C1C(=O)OC	NJLRKAMQPVVOIU-IXZGEAKMSA-N	InChI=1S/2C41H42N4O8/c1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)24(11-14-36(46)47)32(44-30)18-33-25(12-15-37(48)51-6)21(3)28(43-33)16-31(23)42-29;1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)25(12-15-37(48)51-6)33(44-30)18-32-24(11-14-36(46)47)21(3)28(43-32)16-31(23)42-29/h2*9-10,13,16-19,38,42,44H,1,11-12,14-15H2,2-8H3,(H,46,47)/b2*28-16-,29-17-,30-19-,31-16-,32-18-,33-18-,34-17-,35-19-	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1746	SODIUM PHENYLBUTYRATE	O=C([O-])CCCc1ccccc1.[Na+]	VPZRWNZGLKXFOE-UHFFFAOYSA-M	InChI=1S/C10H12O2.Na/c11-10(12)8-4-7-9-5-2-1-3-6-9;/h1-3,5-6H,4,7-8H2,(H,11,12);/q;+1/p-1	Glutamine sequestering agent	SEQUESTERING AGENT	CHEMBL2366039	Glutamine	Homo sapiens
CHEMBL3989507	EDETATE DISODIUM	O.O.O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)O)CC(=O)O.[Na+].[Na+]	OVBJJZOQPCKUOR-UHFFFAOYSA-L	InChI=1S/C10H16N2O8.2Na.2H2O/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20;;;;/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20);;;2*1H2/q;2*+1;;/p-2	Calcium chelating agent	CHELATING AGENT	CHEMBL2364030	Calcium	null
CHEMBL1201154	PROCHLORPERAZINE EDISYLATE	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1.O=S(=O)(O)CCS(=O)(=O)O	SWOUGRBFXFILIB-UHFFFAOYSA-N	InChI=1S/C20H24ClN3S.C2H6O6S2/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24;3-9(4,5)1-2-10(6,7)8/h2-3,5-8,15H,4,9-14H2,1H3;1-2H2,(H,3,4,5)(H,6,7,8)	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1200358	SODIUM PHENYLACETATE	O=C([O-])Cc1ccccc1.[Na+]	HZOREEUASZHZBI-UHFFFAOYSA-M	InChI=1S/C8H8O2.Na/c9-8(10)6-7-4-2-1-3-5-7;/h1-5H,6H2,(H,9,10);/q;+1/p-1	Glutamine sequestering agent	SEQUESTERING AGENT	CHEMBL2366039	Glutamine	Homo sapiens
CHEMBL1413	CICLOPIROX	Cc1cc(C2CCCCC2)n(O)c(=O)c1	SCKYRAXSEDYPSA-UHFFFAOYSA-N	InChI=1S/C12H17NO2/c1-9-7-11(13(15)12(14)8-9)10-5-3-2-4-6-10/h7-8,10,15H,2-6H2,1H3	Iron chelating agent	CHELATING AGENT	CHEMBL2363058	Iron	
CHEMBL1201093	METHYL AMINOLEVULINATE HYDROCHLORIDE	COC(=O)CCC(=O)CN.Cl	UJYSYPVQHFNBML-UHFFFAOYSA-N	InChI=1S/C6H11NO3.ClH/c1-10-6(9)3-2-5(8)4-7;/h2-4,7H2,1H3;1H	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1413	CICLOPIROX	Cc1cc(C2CCCCC2)n(O)c(=O)c1	SCKYRAXSEDYPSA-UHFFFAOYSA-N	InChI=1S/C12H17NO2/c1-9-7-11(13(15)12(14)8-9)10-5-3-2-4-6-10/h7-8,10,15H,2-6H2,1H3	Aluminium chelating agent	CHELATING AGENT	CHEMBL2366381	Aluminium	
CHEMBL1200721	ESTRAMUSTINE PHOSPHATE SODIUM	C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2OP(=O)([O-])[O-].[Na+].[Na+]	IIUMCNJTGSMNRO-VVSKJQCTSA-L	InChI=1S/C23H32Cl2NO6P.2Na/c1-23-9-8-18-17-5-3-16(31-22(27)26(12-10-24)13-11-25)14-15(17)2-4-19(18)20(23)6-7-21(23)32-33(28,29)30;;/h3,5,14,18-21H,2,4,6-13H2,1H3,(H2,28,29,30);;/q;2*+1/p-2/t18-,19-,20+,21+,23+;;/m1../s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL112	ACETAMINOPHEN	CC(=O)Nc1ccc(O)cc1	RZVAJINKPMORJF-UHFFFAOYSA-N	InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)	Anandamide amidohydrolase inhibitor	INHIBITOR	CHEMBL2243	Anandamide amidohydrolase	Homo sapiens
CHEMBL112	ACETAMINOPHEN	CC(=O)Nc1ccc(O)cc1	RZVAJINKPMORJF-UHFFFAOYSA-N	InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)	Vanilloid receptor opener	OPENER	CHEMBL4794	Vanilloid receptor	Homo sapiens
CHEMBL2105712	AFATINIB DIMALEATE	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O	USNRYVNRPYXCSP-JUGPPOIOSA-N	InChI=1S/C24H25ClFN5O3.2C4H4O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;2*5-3(6)1-2-4(7)8/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);2*1-2H,(H,5,6)(H,7,8)/b4-3+;2*2-1-/t16-;;/m0../s1	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL1213165	DOLUTEGRAVIR SODIUM	C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c([O-])c3C(=O)N21.[Na+]	UGWJRRXTMKRYNK-VSLILLSYSA-M	InChI=1S/C20H19F2N3O5.Na/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22;/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28);/q;+1/p-1/t10-,15+;/m1./s1	Human immunodeficiency virus type 1 integrase inhibitor	INHIBITOR	CHEMBL3471	Human immunodeficiency virus type 1 integrase	Human immunodeficiency virus 1
CHEMBL2107387	VORTIOXETINE HYDROBROMIDE	Br.Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1	VNGRUFUIHGGOOM-UHFFFAOYSA-N	InChI=1S/C18H22N2S.BrH/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20;/h3-8,13,19H,9-12H2,1-2H3;1H	Serotonin 1a (5-HT1a) receptor agonist	AGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL2107387	VORTIOXETINE HYDROBROMIDE	Br.Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1	VNGRUFUIHGGOOM-UHFFFAOYSA-N	InChI=1S/C18H22N2S.BrH/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20;/h3-8,13,19H,9-12H2,1-2H3;1H	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL2107387	VORTIOXETINE HYDROBROMIDE	Br.Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1	VNGRUFUIHGGOOM-UHFFFAOYSA-N	InChI=1S/C18H22N2S.BrH/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20;/h3-8,13,19H,9-12H2,1-2H3;1H	Serotonin 3a (5-HT3a) receptor antagonist	ANTAGONIST	CHEMBL1899	Serotonin 3a (5-HT3a) receptor	Homo sapiens
CHEMBL2107834	RIOCIGUAT	COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N	WXXSNCNJFUAIDG-UHFFFAOYSA-N	InChI=1S/C20H19FN8O2/c1-28(20(30)31-2)15-16(22)25-18(26-17(15)23)14-12-7-5-9-24-19(12)29(27-14)10-11-6-3-4-8-13(11)21/h3-9H,10H2,1-2H3,(H4,22,23,25,26)	Soluble guanylate cyclase positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2111348	Soluble guanylate cyclase	Homo sapiens
CHEMBL2103873	MACITENTAN	CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1	JGCMEBMXRHSZKX-UHFFFAOYSA-N	InChI=1S/C19H20Br2N6O4S/c1-2-7-26-32(28,29)27-17-16(13-3-5-14(20)6-4-13)18(25-12-24-17)30-8-9-31-19-22-10-15(21)11-23-19/h3-6,10-12,26H,2,7-9H2,1H3,(H,24,25,27)	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	CHEMBL2096678	Endothelin receptor, ET-A/ET-B	Homo sapiens
CHEMBL1873475	IBRUTINIB	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	XYFPWWZEPKGCCK-GOSISDBHSA-N	InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1	Tyrosine-protein kinase BTK inhibitor	INHIBITOR	CHEMBL5251	Tyrosine-protein kinase BTK	Homo sapiens
CHEMBL3137358	SIMEPREVIR SODIUM	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)[N-]S(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)cc(-c3nc(C(C)C)cs3)nc2c1C.[Na+]	LLXQGDWGCCKOQP-MVZLLIIPSA-M	InChI=1S/C38H47N5O7S2.Na/c1-21(2)30-20-51-35(40-30)29-18-32(26-13-14-31(49-5)22(3)33(26)39-29)50-24-16-27-28(17-24)36(45)43(4)15-9-7-6-8-10-23-19-38(23,41-34(27)44)37(46)42-52(47,48)25-11-12-25;/h8,10,13-14,18,20-21,23-25,27-28H,6-7,9,11-12,15-17,19H2,1-5H3,(H2,41,42,44,46);/q;+1/p-1/b10-8-;/t23-,24-,27-,28-,38-;/m1./s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL87992	ESLICARBAZEPINE ACETATE	CC(=O)O[C@H]1Cc2ccccc2N(C(N)=O)c2ccccc21	QIALRBLEEWJACW-INIZCTEOSA-N	InChI=1S/C17H16N2O3/c1-11(20)22-16-10-12-6-2-4-8-14(12)19(17(18)21)15-9-5-3-7-13(15)16/h2-9,16H,10H2,1H3,(H2,18,21)/t16-/m0/s1	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL2105689	LULICONAZOLE	N#C/C(=C1/SC[C@@H](c2ccc(Cl)cc2Cl)S1)n1ccnc1	YTAOBBFIOAEMLL-REQDGWNSSA-N	InChI=1S/C14H9Cl2N3S2/c15-9-1-2-10(11(16)5-9)13-7-20-14(21-13)12(6-17)19-4-3-18-8-19/h1-5,8,13H,7H2/b14-12+/t13-/m0/s1	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL523299	UMECLIDINIUM BROMIDE	OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2.[Br-]	PEJHHXHHNGORMP-UHFFFAOYSA-M	InChI=1S/C29H34NO2.BrH/c31-29(26-12-6-2-7-13-26,27-14-8-3-9-15-27)28-16-19-30(20-17-28,21-18-28)22-23-32-24-25-10-4-1-5-11-25;/h1-15,31H,16-24H2;1H/q+1;/p-1	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL1259059	SOFOSBUVIR	CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1	TTZHDVOVKQGIBA-IQWMDFIBSA-N	InChI=1S/C22H29FN3O9P/c1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t14-,16+,18+,20+,22+,36-/m0/s1	Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor	INHIBITOR	CHEMBL5375	Hepatitis C virus NS5B RNA-dependent RNA polymerase	Hepatitis C virus
CHEMBL2106615	BAZEDOXIFENE ACETATE	CC(=O)O.Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12	OMZAMQFQZMUNTP-UHFFFAOYSA-N	InChI=1S/C30H34N2O3.C2H4O2/c1-22-28-20-26(34)12-15-29(28)32(30(22)24-8-10-25(33)11-9-24)21-23-6-13-27(14-7-23)35-19-18-31-16-4-2-3-5-17-31;1-2(3)4/h6-15,20,33-34H,2-5,16-19,21H2,1H3;1H3,(H,3,4)	Estrogen receptor modulator	MODULATOR	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL3989861	DESVENLAFAXINE FUMARATE	CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1.O.O=C(O)/C=C/C(=O)O	YETWCSLOYUZBLK-JITBQSAISA-N	InChI=1S/C16H25NO2.C4H4O4.H2O/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16;5-3(6)1-2-4(7)8;/h6-9,15,18-19H,3-5,10-12H2,1-2H3;1-2H,(H,5,6)(H,7,8);1H2/b;2-1+;	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL3989861	DESVENLAFAXINE FUMARATE	CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1.O.O=C(O)/C=C/C(=O)O	YETWCSLOYUZBLK-JITBQSAISA-N	InChI=1S/C16H25NO2.C4H4O4.H2O/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16;5-3(6)1-2-4(7)8;/h6-9,15,18-19H,3-5,10-12H2,1-2H3;1-2H,(H,5,6)(H,7,8);1H2/b;2-1+;	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL2146140	ESOMEPRAZOLE STRONTIUM	COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.O.O.O.O.[Sr+2]	NCGHIAKEJNQSMS-QLGOZJDFSA-N	InChI=1S/2C17H18N3O3S.4H2O.Sr/c2*1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17;;;;;/h2*5-8H,9H2,1-4H3;4*1H2;/q2*-1;;;;;+2/t2*24-;;;;;/m00...../s1	Potassium-transporting ATPase inhibitor	INHIBITOR	CHEMBL2095173	Potassium-transporting ATPase	Homo sapiens
CHEMBL2105732	LEVOMILNACIPRAN HYDROCHLORIDE	CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN.Cl	XNCDYJFPRPDERF-NQQJLSKUSA-N	InChI=1S/C15H22N2O.ClH/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12;/h5-9,13H,3-4,10-11,16H2,1-2H3;1H/t13-,15+;/m0./s1	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL2105732	LEVOMILNACIPRAN HYDROCHLORIDE	CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN.Cl	XNCDYJFPRPDERF-NQQJLSKUSA-N	InChI=1S/C15H22N2O.ClH/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12;/h5-9,13H,3-4,10-11,16H2,1-2H3;1H/t13-,15+;/m0./s1	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL139	DICLOFENAC	O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl	DCOPUUMXTXDBNB-UHFFFAOYSA-N	InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL34259	METHOTREXATE	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1	FBOZXECLQNJBKD-ZDUSSCGKSA-N	InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1	Dihydrofolate reductase inhibitor	INHIBITOR	CHEMBL202	Dihydrofolate reductase	Homo sapiens
CHEMBL2105712	AFATINIB DIMALEATE	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O	USNRYVNRPYXCSP-JUGPPOIOSA-N	InChI=1S/C24H25ClFN5O3.2C4H4O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;2*5-3(6)1-2-4(7)8/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);2*1-2H,(H,5,6)(H,7,8)/b4-3+;2*2-1-/t16-;;/m0../s1	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL2105712	AFATINIB DIMALEATE	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O	USNRYVNRPYXCSP-JUGPPOIOSA-N	InChI=1S/C24H25ClFN5O3.2C4H4O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;2*5-3(6)1-2-4(7)8/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);2*1-2H,(H,5,6)(H,7,8)/b4-3+;2*2-1-/t16-;;/m0../s1	Receptor protein-tyrosine kinase erbB-4 inhibitor	INHIBITOR	CHEMBL3009	Receptor protein-tyrosine kinase erbB-4	Homo sapiens
CHEMBL932	DIPYRIDAMOLE	OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1	IZEKFCXSFNUWAM-UHFFFAOYSA-N	InChI=1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	CHEMBL2363066	3',5'-cyclic phosphodiesterase	Homo sapiens
CHEMBL1200628	VANCOMYCIN HYDROCHLORIDE	CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O.Cl	LCTORFDMHNKUSG-XTTLPDOESA-N	InChI=1S/C66H75Cl2N9O24.ClH/c1-23(2)12-34(71-5)58(88)76-49-51(83)26-7-10-38(32(67)14-26)97-40-16-28-17-41(55(40)101-65-56(54(86)53(85)42(22-78)99-65)100-44-21-66(4,70)57(87)24(3)96-44)98-39-11-8-27(15-33(39)68)52(84)50-63(93)75-48(64(94)95)31-18-29(79)19-37(81)45(31)30-13-25(6-9-36(30)80)46(60(90)77-50)74-61(91)47(28)73-59(89)35(20-43(69)82)72-62(49)92;/h6-11,13-19,23-24,34-35,42,44,46-54,56-57,65,71,78-81,83-87H,12,20-22,70H2,1-5H3,(H2,69,82)(H,72,92)(H,73,89)(H,74,91)(H,75,93)(H,76,88)(H,77,90)(H,94,95);1H/t24-,34+,35-,42+,44-,46+,47+,48-,49+,50-,51+,52+,53+,54-,56+,57+,65-,66-;/m0./s1	Peptidoglycan inhibitor	INHIBITOR	CHEMBL3041361	Peptidoglycan	Bacteria
CHEMBL514800	APREMILAST	CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC	IMOZEMNVLZVGJZ-QGZVFWFLSA-N	InChI=1S/C22H24N2O7S/c1-5-31-19-11-14(9-10-18(19)30-3)17(12-32(4,28)29)24-21(26)15-7-6-8-16(23-13(2)25)20(15)22(24)27/h6-11,17H,5,12H2,1-4H3,(H,23,25)/t17-/m1/s1	Phosphodiesterase 4 inhibitor	INHIBITOR	CHEMBL2093863	Phosphodiesterase 4	Homo sapiens
CHEMBL2103827	DROXIDOPA	N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1	QXWYKJLNLSIPIN-JGVFFNPUSA-N	InChI=1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/t7-,8+/m0/s1	Adrenergic receptor agonist	AGONIST	CHEMBL2331074	Adrenergic receptor	Homo sapiens
CHEMBL2103822	TASIMELTEON	CCC(=O)NC[C@@H]1C[C@H]1c1cccc2c1CCO2	PTOIAAWZLUQTIO-GXFFZTMASA-N	InChI=1S/C15H19NO2/c1-2-15(17)16-9-10-8-13(10)11-4-3-5-14-12(11)6-7-18-14/h3-5,10,13H,2,6-9H2,1H3,(H,16,17)/t10-,13+/m0/s1	Melatonin receptor agonist	AGONIST	CHEMBL2094268	Melatonin receptor	Homo sapiens
CHEMBL2107067	TESTOSTERONE UNDECANOATE	CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	UDSFVOAUHKGBEK-CNQKSJKFSA-N	InChI=1S/C30H48O3/c1-4-5-6-7-8-9-10-11-12-28(32)33-27-16-15-25-24-14-13-22-21-23(31)17-19-29(22,2)26(24)18-20-30(25,27)3/h21,24-27H,4-20H2,1-3H3/t24-,25-,26-,27-,29-,30-/m0/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL408513	BELINOSTAT	O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO	NCNRHFGMJRPRSK-MDZDMXLPSA-N	InChI=1S/C15H14N2O4S/c18-15(16-19)10-9-12-5-4-8-14(11-12)22(20,21)17-13-6-2-1-3-7-13/h1-11,17,19H,(H,16,18)/b10-9+	Histone deacetylase inhibitor	INHIBITOR	CHEMBL2093865	Histone deacetylase	Homo sapiens
CHEMBL3989766	ORITAVANCIN DIPHOSPHATE	CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O[C@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(NCc3ccc(-c4ccc(Cl)cc4)cc3)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O.O=P(O)(O)O.O=P(O)(O)O	PWTROOMOPLCZHB-BHYQHFGMSA-N	InChI=1S/C86H97Cl3N10O26.2H3O4P/c1-35(2)22-51(92-7)77(110)98-67-69(105)42-15-20-55(49(88)24-42)120-57-26-44-27-58(73(57)125-84-74(71(107)70(106)59(34-100)122-84)124-62-32-86(6,76(109)37(4)119-62)93-33-38-8-10-39(11-9-38)40-12-17-45(87)18-13-40)121-56-21-16-43(25-50(56)89)72(123-61-31-85(5,91)75(108)36(3)118-61)68-82(115)97-66(83(116)117)48-28-46(101)29-54(103)63(48)47-23-41(14-19-53(47)102)64(79(112)99-68)96-80(113)65(44)95-78(111)52(30-60(90)104)94-81(67)114;2*1-5(2,3)4/h8-21,23-29,35-37,51-52,59,61-62,64-72,74-76,84,92-93,100-103,105-109H,22,30-34,91H2,1-7H3,(H2,90,104)(H,94,114)(H,95,111)(H,96,113)(H,97,115)(H,98,110)(H,99,112)(H,116,117);2*(H3,1,2,3,4)/t36-,37-,51+,52-,59+,61-,62-,64+,65+,66-,67+,68-,69+,70+,71-,72+,74+,75-,76-,84-,85-,86-;;/m0../s1	Peptidoglycan inhibitor	INHIBITOR	CHEMBL3041361	Peptidoglycan	Bacteria
CHEMBL2105743	OLODATEROL HYDROCHLORIDE	COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1.Cl	KCEHVJZZIGJAAW-FERBBOLQSA-N	InChI=1S/C21H26N2O5.ClH/c1-21(2,10-13-4-6-15(27-3)7-5-13)22-11-18(25)16-8-14(24)9-17-20(16)28-12-19(26)23-17;/h4-9,18,22,24-25H,10-12H2,1-3H3,(H,23,26);1H/t18-;/m0./s1	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL2105669	TEDIZOLID PHOSPHATE	Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](COP(=O)(O)O)OC4=O)cc3F)cn2)n1	QCGUSIANLFXSGE-GFCCVEGCSA-N	InChI=1S/C17H16FN6O6P/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(30-17(24)25)9-29-31(26,27)28/h2-7,12H,8-9H2,1H3,(H2,26,27,28)/t12-/m1/s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL2103877	EFINACONAZOLE	C=C1CCN([C@H](C)[C@](O)(Cn2cncn2)c2ccc(F)cc2F)CC1	NFEZZTICAUWDHU-RDTXWAMCSA-N	InChI=1S/C18H22F2N4O/c1-13-5-7-23(8-6-13)14(2)18(25,10-24-12-21-11-22-24)16-4-3-15(19)9-17(16)20/h3-4,9,11-12,14,25H,1,5-8,10H2,2H3/t14-,18-/m1/s1	Lanosterol 14-alpha demethylase inhibitor	INHIBITOR	CHEMBL3307221	Lanosterol 14-alpha demethylase	Trichophyton rubrum (strain ATCC MYA-4607 / CBS 118892) (Athlete'sfoot fungus)
CHEMBL1083659	SUVOREXANT	Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1	JYTNQNCOQXFQPK-MRXNPFEDSA-N	InChI=1S/C23H23ClN6O2/c1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/h3-6,8-9,13-14,16H,7,10-12H2,1-2H3/t16-/m1/s1	Orexin receptor antagonist	ANTAGONIST	CHEMBL3307226	Orexin receptor	Homo sapiens
CHEMBL3301650	DALBAVANCIN HYDROCHLORIDE	CN[C@H]1C(=O)N[C@@H]2Cc3ccc(cc3)Oc3cc4cc(c3O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(cc(O)c2Cl)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc(O)cc1[C@@H](C(=O)NCCCN(C)C)NC3=O.Cl	PEXPCJWLNBNBNT-AXKGEONOSA-N	InChI=1S/C88H100Cl2N10O28.ClH/c1-38(2)13-10-8-6-7-9-11-14-61(106)94-70-73(109)75(111)78(86(120)121)128-87(70)127-77-58-31-43-32-59(77)124-55-24-19-42(29-50(55)89)71(107)69-85(119)98-67(80(114)92-25-12-26-100(4)5)48-33-44(102)34-57(125-88-76(112)74(110)72(108)60(37-101)126-88)62(48)47-28-40(17-22-52(47)103)65(82(116)99-69)95-83(117)66(43)96-84(118)68-49-35-46(36-54(105)63(49)90)123-56-30-41(18-23-53(56)104)64(91-3)81(115)93-51(79(113)97-68)27-39-15-20-45(122-58)21-16-39;/h15-24,28-36,38,51,60,64-76,78,87-88,91,101-105,107-112H,6-14,25-27,37H2,1-5H3,(H,92,114)(H,93,115)(H,94,106)(H,95,117)(H,96,118)(H,97,113)(H,98,119)(H,99,116)(H,120,121);1H/t51-,60-,64-,65-,66-,67+,68+,69+,70-,71-,72-,73-,74+,75+,76+,78+,87-,88+;/m1./s1	Peptidoglycan inhibitor	INHIBITOR	CHEMBL3041361	Peptidoglycan	Bacteria
CHEMBL2107386	VORAPAXAR SULFATE	CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=C/c1ccc(-c2cccc(F)c2)cn1.O=S(=O)(O)O	NQRYCIGCIAWEIC-CKLVGUEFSA-N	InChI=1S/C29H33FN2O4.H2O4S/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18;1-5(2,3)4/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34);(H2,1,2,3,4)/b12-9+;/t17-,20+,23-,24-,25+,26-,27+;/m1./s1	Proteinase-activated receptor 1 antagonist	ANTAGONIST	CHEMBL3974	Proteinase-activated receptor 1	Homo sapiens
CHEMBL2107830	EMPAGLIFLOZIN	OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O	OBWASQILIWPZMG-QZMOQZSNSA-N	InChI=1S/C23H27ClO7/c24-18-6-3-14(23-22(28)21(27)20(26)19(11-25)31-23)10-15(18)9-13-1-4-16(5-2-13)30-17-7-8-29-12-17/h1-6,10,17,19-23,25-28H,7-9,11-12H2/t17-,19+,20+,21-,22+,23-/m0/s1	Sodium/glucose cotransporter 2 inhibitor	INHIBITOR	CHEMBL3884	Sodium/glucose cotransporter 2	Homo sapiens
CHEMBL443052	TAVABOROLE	OB1OCc2cc(F)ccc21	LFQDNHWZDQTITF-UHFFFAOYSA-N	InChI=1S/C7H6BFO2/c9-6-1-2-7-5(3-6)4-11-8(7)10/h1-3,10H,4H2	Leucine-tRNA ligase inhibitor	INHIBITOR	CHEMBL3307222	Leucine-tRNA ligase	Trichophyton rubrum (strain ATCC MYA-4607 / CBS 118892) (Athlete'sfoot fungus)
CHEMBL2403108	CERITINIB	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1	VERWOWGGCGHDQE-UHFFFAOYSA-N	InChI=1S/C28H36ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3,(H2,31,32,33,34)	ALK tyrosine kinase receptor inhibitor	INHIBITOR	CHEMBL4247	ALK tyrosine kinase receptor	Homo sapiens
CHEMBL2107815	TREPROSTINIL DIOLAMINE	CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O.OCCNCCO	RHWRWEUCEXUUAV-ZSESPEEFSA-N	InChI=1S/C23H34O5.C4H11NO2/c1-2-3-4-7-17(24)9-10-18-19-11-15-6-5-8-22(28-14-23(26)27)20(15)12-16(19)13-21(18)25;6-3-1-5-2-4-7/h5-6,8,16-19,21,24-25H,2-4,7,9-14H2,1H3,(H,26,27);5-7H,1-4H2/t16-,17-,18+,19-,21+;/m0./s1	Prostanoid IP receptor agonist	AGONIST	CHEMBL1995	Prostanoid IP receptor	Homo sapiens
CHEMBL373742	VASOPRESSIN	N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O	KBZOIRJILGZLEJ-LGYYRGKSSA-N	InChI=1S/C46H65N15O12S2/c47-27-22-74-75-23-33(45(73)61-17-5-9-34(61)44(72)56-28(8-4-16-53-46(51)52)39(67)54-21-37(50)65)60-43(71)32(20-36(49)64)59-40(68)29(14-15-35(48)63)55-41(69)31(18-24-6-2-1-3-7-24)58-42(70)30(57-38(27)66)19-25-10-12-26(62)13-11-25/h1-3,6-7,10-13,27-34,62H,4-5,8-9,14-23,47H2,(H2,48,63)(H2,49,64)(H2,50,65)(H,54,67)(H,55,69)(H,56,72)(H,57,66)(H,58,70)(H,59,68)(H,60,71)(H4,51,52,53)/t27-,28-,29-,30-,31-,32-,33-,34-/m0/s1	Vasopressin receptor agonist	AGONIST	CHEMBL2363078	Vasopressin receptor	Homo sapiens
CHEMBL2216870	IDELALISIB	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1	IFSDAJWBUCMOAH-HNNXBMFYSA-N	InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m0/s1	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	CHEMBL3130	PI3-kinase p110-delta subunit	Homo sapiens
CHEMBL4297066	ELIGLUSTAT TARTRATE	CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2.CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2.O=C(O)C(O)C(O)C(=O)O	KUBARPMUNHKBIQ-ZBPSDVLKSA-N	InChI=1S/2C23H36N2O4.C4H6O6/c2*1-2-3-4-5-6-9-22(26)24-19(17-25-12-7-8-13-25)23(27)18-10-11-20-21(16-18)29-15-14-28-20;5-1(3(7)8)2(6)4(9)10/h2*10-11,16,19,23,27H,2-9,12-15,17H2,1H3,(H,24,26);1-2,5-6H,(H,7,8)(H,9,10)/t2*19-,23-;/m11./s1	Ceramide glucosyltransferase inhibitor	INHIBITOR	CHEMBL2063	Ceramide glucosyltransferase	Homo sapiens
CHEMBL3039504	NINTEDANIB ESYLATE	CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1	MMMVNAGRWOJNMW-FJBFXRHMSA-N	InChI=1S/C31H33N5O4.C2H6O3S/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38;1-2-6(3,4)5/h4-14,19,32H,15-18,20H2,1-3H3,(H,33,38);2H2,1H3,(H,3,4,5)/b29-28-;	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL3039504	NINTEDANIB ESYLATE	CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1	MMMVNAGRWOJNMW-FJBFXRHMSA-N	InChI=1S/C31H33N5O4.C2H6O3S/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38;1-2-6(3,4)5/h4-14,19,32H,15-18,20H2,1-3H3,(H,33,38);2H2,1H3,(H,3,4,5)/b29-28-;	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL3039504	NINTEDANIB ESYLATE	CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1	MMMVNAGRWOJNMW-FJBFXRHMSA-N	InChI=1S/C31H33N5O4.C2H6O3S/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38;1-2-6(3,4)5/h4-14,19,32H,15-18,20H2,1-3H3,(H,33,38);2H2,1H3,(H,3,4,5)/b29-28-;	Fibroblast growth factor receptor inhibitor	INHIBITOR	CHEMBL2095217	Fibroblast growth factor receptor	Homo sapiens
CHEMBL2219416	NALOXEGOL OXALATE	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](OCCOCCOCCOCCOCCOCCOCCOC)CC[C@@]3(O)[C@H]1C5.O=C(O)C(=O)O	MNYIRXLCPODKLG-VUTNLTPYSA-N	InChI=1S/C34H53NO11.C2H2O4/c1-3-9-35-10-8-33-30-26-4-5-27(36)31(30)46-32(33)28(6-7-34(33,37)29(35)25-26)45-24-23-44-22-21-43-20-19-42-18-17-41-16-15-40-14-13-39-12-11-38-2;3-1(4)2(5)6/h3-5,28-29,32,36-37H,1,6-25H2,2H3;(H,3,4)(H,5,6)/t28-,29+,32-,33-,34+;/m0./s1	Mu opioid receptor antagonist	ANTAGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL2374220	LEDIPASVIR	COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1nc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5[nH]c([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5c4)ccc2-3)c[nH]1)C(C)C	VRTWBAAJJOHBQU-KMWAZVGDSA-N	InChI=1S/C49H54F2N8O6/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63)/t29-,30+,38-,39-,40-,41-/m0/s1	Nonstructural protein 5A inhibitor	INHIBITOR	CHEMBL3307224	Nonstructural protein 5A	Hepatitis C virus
CHEMBL206253	NETUPITANT	Cc1ccccc1-c1cc(N2CCN(C)CC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	WAXQNWCZJDTGBU-UHFFFAOYSA-N	InChI=1S/C30H32F6N4O/c1-19-8-6-7-9-23(19)24-17-26(40-12-10-38(4)11-13-40)37-18-25(24)39(5)27(41)28(2,3)20-14-21(29(31,32)33)16-22(15-20)30(34,35)36/h6-9,14-18H,10-13H2,1-5H3	Neurokinin 1 receptor antagonist	ANTAGONIST	CHEMBL249	Neurokinin 1 receptor	Homo sapiens
CHEMBL2145077	IVABRADINE HYDROCHLORIDE	COc1cc2c(cc1OC)CC(=O)N(CCCN(C)C[C@H]1Cc3cc(OC)c(OC)cc31)CC2.Cl	HLUKNZUABFFNQS-ZMBIFBSDSA-N	InChI=1S/C27H36N2O5.ClH/c1-28(17-21-11-20-14-25(33-4)26(34-5)16-22(20)21)8-6-9-29-10-7-18-12-23(31-2)24(32-3)13-19(18)15-27(29)30;/h12-14,16,21H,6-11,15,17H2,1-5H3;1H/t21-;/m1./s1	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker	BLOCKER	CHEMBL1250417	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	Homo sapiens
CHEMBL2105704	LENVATINIB MESYLATE	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O.CS(=O)(=O)O	HWLFIUUAYLEFCT-UHFFFAOYSA-N	InChI=1S/C21H19ClN4O4.CH4O3S/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11;1-5(2,3)4/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28);1H3,(H,2,3,4)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL2159122	ELUXADOLINE	COc1ccc(CN(C(=O)[C@@H](N)Cc2c(C)cc(C(N)=O)cc2C)[C@@H](C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O	QFNHIDANIVGXPE-FNZWTVRRSA-N	InChI=1S/C32H35N5O5/c1-18-12-23(29(34)38)13-19(2)24(18)15-26(33)31(39)37(17-21-10-11-28(42-4)25(14-21)32(40)41)20(3)30-35-16-27(36-30)22-8-6-5-7-9-22/h5-14,16,20,26H,15,17,33H2,1-4H3,(H2,34,38)(H,35,36)(H,40,41)/t20-,26-/m0/s1	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL189963	PALBOCICLIB	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O	AHJRHEGDXFFMBM-UHFFFAOYSA-N	InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)	CDK6/cyclin D1 inhibitor	INHIBITOR	CHEMBL2111455	CDK6/cyclin D1	Homo sapiens
CHEMBL189963	PALBOCICLIB	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O	AHJRHEGDXFFMBM-UHFFFAOYSA-N	InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)	Cyclin-dependent kinase 4/cyclin D1 inhibitor	INHIBITOR	CHEMBL1907601	Cyclin-dependent kinase 4/cyclin D1	Homo sapiens
CHEMBL2105682	EDOXABAN TOSYLATE	CN1CCc2nc(C(=O)N[C@@H]3C[C@@H](C(=O)N(C)C)CC[C@@H]3NC(=O)C(=O)Nc3ccc(Cl)cn3)sc2C1.Cc1ccc(S(=O)(=O)O)cc1	ZLFZITWZOYXXAW-QXXZOGQOSA-N	InChI=1S/C24H30ClN7O4S.C7H8O3S/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23;1-6-2-4-7(5-3-6)11(8,9)10/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34);2-5H,1H3,(H,8,9,10)/t13-,15-,17+;/m0./s1	Coagulation factor X inhibitor	INHIBITOR	CHEMBL244	Coagulation factor X	Homo sapiens
CHEMBL521686	OLAPARIB	O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1	FDLYAMZZIXQODN-UHFFFAOYSA-N	InChI=1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30)	PARP 1, 2 and 3 inhibitor	INHIBITOR	CHEMBL3390820	PARP 1, 2 and 3	Homo sapiens
CHEMBL2107817	AVIBACTAM SODIUM	NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)[O-].[Na+]	RTCIKUMODPANKX-JBUOLDKXSA-M	InChI=1S/C7H11N3O6S.Na/c8-6(11)5-2-1-4-3-9(5)7(12)10(4)16-17(13,14)15;/h4-5H,1-3H2,(H2,8,11)(H,13,14,15);/q;+1/p-1/t4-,5+;/m1./s1	Bacterial beta-lactamase TEM inhibitor	INHIBITOR	CHEMBL2364670	Bacterial beta-lactamase TEM	Bacteria
CHEMBL3127326	OMBITASVIR	COC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc([C@@H]2CC[C@@H](c3ccc(NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)OC)C(C)C)cc3)N2c2ccc(C(C)(C)C)cc2)cc1)C(C)C	PIDFDZJZLOTZTM-KHVQSSSXSA-N	InChI=1S/C50H67N7O8/c1-30(2)42(53-48(62)64-8)46(60)55-28-10-12-40(55)44(58)51-35-20-14-32(15-21-35)38-26-27-39(57(38)37-24-18-34(19-25-37)50(5,6)7)33-16-22-36(23-17-33)52-45(59)41-13-11-29-56(41)47(61)43(31(3)4)54-49(63)65-9/h14-25,30-31,38-43H,10-13,26-29H2,1-9H3,(H,51,58)(H,52,59)(H,53,62)(H,54,63)/t38-,39-,40-,41-,42-,43-/m0/s1	Nonstructural protein 5A inhibitor	INHIBITOR	CHEMBL3307224	Nonstructural protein 5A	Hepatitis C virus
CHEMBL3137333	ISAVUCONAZONIUM SULFATE	CNCC(=O)OCc1cccnc1N(C)C(=O)OC(C)[n+]1cnn(C[C@](O)(c2cc(F)ccc2F)[C@@H](C)c2nc(-c3ccc(C#N)cc3)cs2)c1.O=S(=O)([O-])O	LWXUIUUOMSMZKJ-KLFWAVJMSA-M	InChI=1S/C35H35F2N8O5S.H2O4S/c1-22(33-42-30(18-51-33)25-9-7-24(15-38)8-10-25)35(48,28-14-27(36)11-12-29(28)37)19-45-21-44(20-41-45)23(2)50-34(47)43(4)32-26(6-5-13-40-32)17-49-31(46)16-39-3;1-5(2,3)4/h5-14,18,20-23,39,48H,16-17,19H2,1-4H3;(H2,1,2,3,4)/q+1;/p-1/t22-,23?,35+;/m0./s1	Lanosterol 14-alpha demethylase inhibitor	INHIBITOR	CHEMBL3390824	Lanosterol 14-alpha demethylase	Aspergillus
CHEMBL3137333	ISAVUCONAZONIUM SULFATE	CNCC(=O)OCc1cccnc1N(C)C(=O)OC(C)[n+]1cnn(C[C@](O)(c2cc(F)ccc2F)[C@@H](C)c2nc(-c3ccc(C#N)cc3)cs2)c1.O=S(=O)([O-])O	LWXUIUUOMSMZKJ-KLFWAVJMSA-M	InChI=1S/C35H35F2N8O5S.H2O4S/c1-22(33-42-30(18-51-33)25-9-7-24(15-38)8-10-25)35(48,28-14-27(36)11-12-29(28)37)19-45-21-44(20-41-45)23(2)50-34(47)43(4)32-26(6-5-13-40-32)17-49-31(46)16-39-3;1-5(2,3)4/h5-14,18,20-23,39,48H,16-17,19H2,1-4H3;(H2,1,2,3,4)/q+1;/p-1/t22-,23?,35+;/m0./s1	Lanosterol 14-alpha demethylase inhibitor	INHIBITOR	CHEMBL3390825	Lanosterol 14-alpha demethylase	Mucorales
CHEMBL3989402	PERAMIVIR	CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(=O)O)C[C@H]1NC(=N)N.O.O.O	RFUCJKFZFXNIGB-ZBBHRWOZSA-N	InChI=1S/C15H28N4O4.3H2O/c1-4-8(5-2)12(18-7(3)20)11-10(19-15(16)17)6-9(13(11)21)14(22)23;;;/h8-13,21H,4-6H2,1-3H3,(H,18,20)(H,22,23)(H4,16,17,19);3*1H2/t9-,10+,11+,12-,13+;;;/m0.../s1	Neuraminidase inhibitor	INHIBITOR	CHEMBL3377	Neuraminidase	Influenza B virus (strain B/Lee/1940)
CHEMBL3989402	PERAMIVIR	CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(=O)O)C[C@H]1NC(=N)N.O.O.O	RFUCJKFZFXNIGB-ZBBHRWOZSA-N	InChI=1S/C15H28N4O4.3H2O/c1-4-8(5-2)12(18-7(3)20)11-10(19-15(16)17)6-9(13(11)21)14(22)23;;;/h8-13,21H,4-6H2,1-3H3,(H,18,20)(H,22,23)(H4,16,17,19);3*1H2/t9-,10+,11+,12-,13+;;;/m0.../s1	Neuraminidase inhibitor	INHIBITOR	CHEMBL2051	Neuraminidase	Influenza A virus (A/Puerto Rico/8/1934(H1N1))
CHEMBL1908370	FINAFLOXACIN	N#Cc1c(N2C[C@@H]3NCCO[C@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12	FYMHQCNFKNMJAV-HOTGVXAUSA-N	InChI=1S/C20H19FN4O4/c21-14-5-11-17(25(10-1-2-10)7-13(19(11)26)20(27)28)12(6-22)18(14)24-8-15-16(9-24)29-4-3-23-15/h5,7,10,15-16,23H,1-4,8-9H2,(H,27,28)/t15-,16-/m0/s1	Topoisomerase IV inhibitor	INHIBITOR	CHEMBL3038508	Topoisomerase IV	Staphylococcus aureus
CHEMBL1908370	FINAFLOXACIN	N#Cc1c(N2C[C@@H]3NCCO[C@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12	FYMHQCNFKNMJAV-HOTGVXAUSA-N	InChI=1S/C20H19FN4O4/c21-14-5-11-17(25(10-1-2-10)7-13(19(11)26)20(27)28)12(6-22)18(14)24-8-15-16(9-24)29-4-3-23-15/h5,7,10,15-16,23H,1-4,8-9H2,(H,27,28)/t15-,16-/m0/s1	Topoisomerase IV inhibitor	INHIBITOR	CHEMBL3390827	Topoisomerase IV	Pseudomonas aeruginosa
CHEMBL1908370	FINAFLOXACIN	N#Cc1c(N2C[C@@H]3NCCO[C@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12	FYMHQCNFKNMJAV-HOTGVXAUSA-N	InChI=1S/C20H19FN4O4/c21-14-5-11-17(25(10-1-2-10)7-13(19(11)26)20(27)28)12(6-22)18(14)24-8-15-16(9-24)29-4-3-23-15/h5,7,10,15-16,23H,1-4,8-9H2,(H,27,28)/t15-,16-/m0/s1	DNA gyrase inhibitor	INHIBITOR	CHEMBL3038482	DNA gyrase	Staphylococcus aureus
CHEMBL1908370	FINAFLOXACIN	N#Cc1c(N2C[C@@H]3NCCO[C@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12	FYMHQCNFKNMJAV-HOTGVXAUSA-N	InChI=1S/C20H19FN4O4/c21-14-5-11-17(25(10-1-2-10)7-13(19(11)26)20(27)28)12(6-22)18(14)24-8-15-16(9-24)29-4-3-23-15/h5,7,10,15-16,23H,1-4,8-9H2,(H,27,28)/t15-,16-/m0/s1	DNA gyrase inhibitor	INHIBITOR	CHEMBL3390828	DNA gyrase	Pseudomonas aeruginosa
CHEMBL3545368	PANOBINOSTAT LACTATE	CC(O)C(=O)O.Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1	XVDWNSFFSMWXJJ-ASTDGNLGSA-N	InChI=1S/C21H23N3O2.C3H6O3/c1-15-18(19-4-2-3-5-20(19)23-15)12-13-22-14-17-8-6-16(7-9-17)10-11-21(25)24-26;1-2(4)3(5)6/h2-11,22-23,26H,12-14H2,1H3,(H,24,25);2,4H,1H3,(H,5,6)/b11-10+;	Histone deacetylase inhibitor	INHIBITOR	CHEMBL2093865	Histone deacetylase	Homo sapiens
CHEMBL3544985	DASABUVIR SODIUM	COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[n-]c2=O)cc1C(C)(C)C.O.[Na+]	SJHKKWUESHNTBB-UHFFFAOYSA-M	InChI=1S/C26H27N3O5S.Na.H2O/c1-26(2,3)22-15-20(29-11-10-23(30)27-25(29)31)14-21(24(22)34-4)18-7-6-17-13-19(28-35(5,32)33)9-8-16(17)12-18;;/h6-15,28H,1-5H3,(H,27,30,31);;1H2/q;+1;/p-1	Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor	INHIBITOR	CHEMBL5375	Hepatitis C virus NS5B RNA-dependent RNA polymerase	Hepatitis C virus
CHEMBL1097279	CANGRELOR TETRASODIUM	CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])C(Cl)(Cl)P(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+]	COWWROCHWNGJHQ-OPKBHZIBSA-J	InChI=1S/C17H25Cl2F3N5O12P3S2.4Na/c1-43-5-3-23-12-9-13(26-15(25-12)44-4-2-16(20,21)22)27(7-24-9)14-11(29)10(28)8(38-14)6-37-42(35,36)39-41(33,34)17(18,19)40(30,31)32;;;;/h7-8,10-11,14,28-29H,2-6H2,1H3,(H,33,34)(H,35,36)(H,23,25,26)(H2,30,31,32);;;;/q;4*+1/p-4/t8-,10-,11-,14-;;;;/m1..../s1	Purinergic receptor P2Y12 antagonist	ANTAGONIST	CHEMBL2001	Purinergic receptor P2Y12	Homo sapiens
CHEMBL2103870	LUMACAFTOR	Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1	UFSKUSARDNFIRC-UHFFFAOYSA-N	InChI=1S/C24H18F2N2O5/c1-13-5-8-19(27-20(13)14-3-2-4-15(11-14)21(29)30)28-22(31)23(9-10-23)16-6-7-17-18(12-16)33-24(25,26)32-17/h2-8,11-12H,9-10H2,1H3,(H,29,30)(H,27,28,31)	Cystic fibrosis transmembrane conductance regulator stabiliser	STABILISER	CHEMBL4051	Cystic fibrosis transmembrane conductance regulator	Homo sapiens
CHEMBL3137301	SACUBITRIL	CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O	PYNXFZCZUAOOQC-UTKZUKDTSA-N	InChI=1S/C24H29NO5/c1-3-30-24(29)17(2)15-21(25-22(26)13-14-23(27)28)16-18-9-11-20(12-10-18)19-7-5-4-6-8-19/h4-12,17,21H,3,13-16H2,1-2H3,(H,25,26)(H,27,28)/t17-,21+/m1/s1	Neprilysin inhibitor	INHIBITOR	CHEMBL1944	Neprilysin	Homo sapiens
CHEMBL2105760	BREXPIPRAZOLE	O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1	ZKIAIYBUSXZPLP-UHFFFAOYSA-N	InChI=1S/C25H27N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10,17-18H,1-2,11-16H2,(H,26,29)	Dopamine D2 receptor partial agonist	PARTIAL AGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL2105760	BREXPIPRAZOLE	O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1	ZKIAIYBUSXZPLP-UHFFFAOYSA-N	InChI=1S/C25H27N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10,17-18H,1-2,11-16H2,(H,26,29)	Serotonin 1a (5-HT1a) receptor partial agonist	PARTIAL AGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL2105760	BREXPIPRAZOLE	O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1	ZKIAIYBUSXZPLP-UHFFFAOYSA-N	InChI=1S/C25H27N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10,17-18H,1-2,11-16H2,(H,26,29)	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL406393	DEOXYCHOLIC ACID	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@@]21C	KXGVEGMKQFWNSR-LLQZFEROSA-N	InChI=1S/C24H40O4/c1-14(4-9-22(27)28)18-7-8-19-17-6-5-15-12-16(25)10-11-23(15,2)20(17)13-21(26)24(18,19)3/h14-21,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15-,16-,17+,18-,19+,20+,21+,23+,24-/m1/s1	Cell membrane disrupting agent	DISRUPTING AGENT	CHEMBL3390826	Cell membrane	Homo sapiens
CHEMBL1213250	CEFTOLOZANE SULFATE	Cn1c(N)c(NC(=O)NCCN)c[n+]1CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OC(C)(C)C(=O)[O-])c3nsc(N)n3)[C@H]2SC1.O=S(=O)(O)O	UJDQGRLTPBVSFN-TVNHLQOTSA-N	InChI=1S/C23H30N12O8S2.H2O4S/c1-23(2,20(40)41)43-31-11(15-30-21(26)45-32-15)16(36)29-12-17(37)35-13(19(38)39)9(8-44-18(12)35)6-34-7-10(14(25)33(34)3)28-22(42)27-5-4-24;1-5(2,3)4/h7,12,18,25H,4-6,8,24H2,1-3H3,(H7,26,27,28,29,30,32,36,38,39,40,41,42);(H2,1,2,3,4)/b31-11-;/t12-,18-;/m1./s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL1200800	CALCIUM ACETATE	CC(=O)[O-].CC(=O)[O-].[Ca+2]	VSGNNIFQASZAOI-UHFFFAOYSA-L	InChI=1S/2C2H4O2.Ca/c2*1-2(3)4;/h2*1H3,(H,3,4);/q;;+2/p-2	Phosphate sequestering agent	SEQUESTERING AGENT	CHEMBL2364184	Phosphate	Homo sapiens
CHEMBL1201130	BETAINE HYDROCHLORIDE	C[N+](C)(C)CC(=O)O.[Cl-]	HOPSCVCBEOCPJZ-UHFFFAOYSA-N	InChI=1S/C5H11NO2.ClH/c1-6(2,3)4-5(7)8;/h4H2,1-3H3;1H	Betaine-homocysteine S-methyltransferase substrate	SUBSTRATE	CHEMBL3391661	Betaine-homocysteine S-methyltransferase	Homo sapiens
CHEMBL296419	ASTEMIZOLE	COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1	GXDALQBWZGODGZ-UHFFFAOYSA-N	InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1534525	MIBEFRADIL DIHYDROCHLORIDE	COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C.Cl.Cl	MTJLQTFHJIHXIX-GDUXWEAWSA-N	InChI=1S/C29H38FN3O3.2ClH/c1-20(2)28-23-12-11-22(30)18-21(23)13-14-29(28,36-27(34)19-35-4)15-17-33(3)16-7-10-26-31-24-8-5-6-9-25(24)32-26;;/h5-6,8-9,11-12,18,20,28H,7,10,13-17,19H2,1-4H3,(H,31,32);2*1H/t28-,29-;;/m0../s1	Voltage-gated T-type calcium channel blocker	BLOCKER	CHEMBL2362995	Voltage-gated T-type calcium channel	Homo sapiens
CHEMBL3391662	PARITAPREVIR	Cc1cnc(C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@@]3(C(=O)NS(=O)(=O)C3CC3)NC(=O)[C@@H]3C[C@@H](Oc4nc5ccccc5c5ccccc45)CN3C2=O)cn1	UAUIUKWPKRJZJV-QPLHLKROSA-N	InChI=1S/C40H43N7O7S/c1-24-21-42-33(22-41-24)35(48)43-32-16-6-4-2-3-5-11-25-20-40(25,39(51)46-55(52,53)27-17-18-27)45-36(49)34-19-26(23-47(34)38(32)50)54-37-30-14-8-7-12-28(30)29-13-9-10-15-31(29)44-37/h5,7-15,21-22,25-27,32,34H,2-4,6,16-20,23H2,1H3,(H,43,48)(H,45,49)(H,46,51)/b11-5-/t25-,26-,32+,34+,40-/m1/s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL547	ISOTRETINOIN	CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1	SHGAZHPCJJPHSC-XFYACQKRSA-N	InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14-	Retinoic acid receptor agonist	AGONIST	CHEMBL2363069	Retinoic acid receptor	Homo sapiens
CHEMBL1201729	DRONEDARONE HYDROCHLORIDE	CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1.Cl	DWKVCQXJYURSIQ-UHFFFAOYSA-N	InChI=1S/C31H44N2O5S.ClH/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3;/h13-18,23,32H,5-12,19-22H2,1-4H3;1H	Inward rectifier potassium channel 2 blocker	BLOCKER	CHEMBL1914276	Inward rectifier potassium channel 2	Homo sapiens
CHEMBL1201729	DRONEDARONE HYDROCHLORIDE	CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1.Cl	DWKVCQXJYURSIQ-UHFFFAOYSA-N	InChI=1S/C31H44N2O5S.ClH/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3;/h13-18,23,32H,5-12,19-22H2,1-4H3;1H	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker	BLOCKER	CHEMBL1250417	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	Homo sapiens
CHEMBL1200330	PILOCARPINE HYDROCHLORIDE	CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C.Cl	RNAICSBVACLLGM-GNAZCLTHSA-N	InChI=1S/C11H16N2O2.ClH/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2;/h5,7-8,10H,3-4,6H2,1-2H3;1H/t8-,10-;/m0./s1	Muscarinic acetylcholine receptor M1 agonist	AGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL550	PILOCARPINE	CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C	QCHFTSOMWOSFHM-WPRPVWTQSA-N	InChI=1S/C11H16N2O2/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2/h5,7-8,10H,3-4,6H2,1-2H3/t8-,10-/m0/s1	Muscarinic acetylcholine receptor M1 agonist	AGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1703	METFORMIN HYDROCHLORIDE	CN(C)C(=N)N=C(N)N.Cl	OETHQSJEHLVLGH-UHFFFAOYSA-N	InChI=1S/C4H11N5.ClH/c1-9(2)4(7)8-3(5)6;/h1-2H3,(H5,5,6,7,8);1H	Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor	INHIBITOR	CHEMBL3391681	Mitochondrial glycerol-3-phosphate dehydrogenase	Homo sapiens
CHEMBL1200467	HYDROXYZINE PAMOATE	O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O.OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	ASDOKGIIKXGMNB-UHFFFAOYSA-N	InChI=1S/C23H16O6.C21H27ClN2O2/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-10,24-25H,11H2,(H,26,27)(H,28,29);1-9,21,25H,10-17H2	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1200434	OXTRIPHYLLINE	C[N+](C)(C)CCO.Cn1c(=O)c2[n-]cnc2n(C)c1=O	RLANKEDHRWMNRO-UHFFFAOYSA-M	InChI=1S/C7H8N4O2.C5H14NO/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;1-6(2,3)4-5-7/h3H,1-2H3,(H,8,9,12);7H,4-5H2,1-3H3/q;+1/p-1	Phosphodiesterase 4 inhibitor	INHIBITOR	CHEMBL2093863	Phosphodiesterase 4	Homo sapiens
CHEMBL1200434	OXTRIPHYLLINE	C[N+](C)(C)CCO.Cn1c(=O)c2[n-]cnc2n(C)c1=O	RLANKEDHRWMNRO-UHFFFAOYSA-M	InChI=1S/C7H8N4O2.C5H14NO/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;1-6(2,3)4-5-7/h3H,1-2H3,(H,8,9,12);7H,4-5H2,1-3H3/q;+1/p-1	Phosphodiesterase 3 inhibitor	INHIBITOR	CHEMBL2094125	Phosphodiesterase 3	Homo sapiens
CHEMBL1200434	OXTRIPHYLLINE	C[N+](C)(C)CCO.Cn1c(=O)c2[n-]cnc2n(C)c1=O	RLANKEDHRWMNRO-UHFFFAOYSA-M	InChI=1S/C7H8N4O2.C5H14NO/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;1-6(2,3)4-5-7/h3H,1-2H3,(H,8,9,12);7H,4-5H2,1-3H3/q;+1/p-1	Adenosine receptor antagonist	ANTAGONIST	CHEMBL2111329	Adenosine receptor	Homo sapiens
CHEMBL2303621	DACLATASVIR DIHYDROCHLORIDE	COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C.Cl.Cl	BVZLLUDATICXCI-JMSCDMLISA-N	InChI=1S/C40H50N8O6.2ClH/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6;;/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52);2*1H/t31-,32-,33-,34-;;/m0../s1	Nonstructural protein 5A inhibitor	INHIBITOR	CHEMBL3307224	Nonstructural protein 5A	Hepatitis C virus
CHEMBL2103802	DAPAGLIFLOZIN PROPYLENE GLYCOL	CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1.C[C@H](O)CO.O	GOADIQFWSVMMRJ-UPGAGZFNSA-N	InChI=1S/C21H25ClO6.C3H8O2.H2O/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21;1-3(5)2-4;/h3-8,10,17-21,23-26H,2,9,11H2,1H3;3-5H,2H2,1H3;1H2/t17-,18-,19+,20-,21+;3-;/m10./s1	Sodium/glucose cotransporter 2 inhibitor	INHIBITOR	CHEMBL3884	Sodium/glucose cotransporter 2	Homo sapiens
CHEMBL3545188	PASIREOTIDE PAMOATE	NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O	HSXBEUMRBMAVDP-NEOZNVFSSA-N	InChI=1S/C58H66N10O9.C23H16O6/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45;24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72);1-10,24-25H,11H2,(H,26,27)(H,28,29)/t43-,46-,47-,48+,49-,50-,51-;/m0./s1	Somatostatin receptor 3 agonist	AGONIST	CHEMBL2028	Somatostatin receptor 3	Homo sapiens
CHEMBL3545188	PASIREOTIDE PAMOATE	NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O	HSXBEUMRBMAVDP-NEOZNVFSSA-N	InChI=1S/C58H66N10O9.C23H16O6/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45;24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72);1-10,24-25H,11H2,(H,26,27)(H,28,29)/t43-,46-,47-,48+,49-,50-,51-;/m0./s1	Somatostatin receptor 5 agonist	AGONIST	CHEMBL1792	Somatostatin receptor 5	Homo sapiens
CHEMBL3545188	PASIREOTIDE PAMOATE	NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O	HSXBEUMRBMAVDP-NEOZNVFSSA-N	InChI=1S/C58H66N10O9.C23H16O6/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45;24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72);1-10,24-25H,11H2,(H,26,27)(H,28,29)/t43-,46-,47-,48+,49-,50-,51-;/m0./s1	Somatostatin receptor 2 agonist	AGONIST	CHEMBL1804	Somatostatin receptor 2	Homo sapiens
CHEMBL3545188	PASIREOTIDE PAMOATE	NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O	HSXBEUMRBMAVDP-NEOZNVFSSA-N	InChI=1S/C58H66N10O9.C23H16O6/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45;24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72);1-10,24-25H,11H2,(H,26,27)(H,28,29)/t43-,46-,47-,48+,49-,50-,51-;/m0./s1	Somatostatin receptor 1 agonist	AGONIST	CHEMBL1917	Somatostatin receptor 1	Homo sapiens
CHEMBL3544986	PERINDOPRIL ARGININE	CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC.N=C(N)NCCC[C@H](N)C(=O)O	RYCSJJXKEWBUTI-YDYAIEMNSA-N	InChI=1S/C19H32N2O5.C6H14N4O2/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24;7-4(5(11)12)2-1-3-10-6(8)9/h12-16,20H,4-11H2,1-3H3,(H,23,24);4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t12-,13-,14-,15-,16-;4-/m00/s1	Angiotensin-converting enzyme inhibitor	INHIBITOR	CHEMBL1808	Angiotensin-converting enzyme	Homo sapiens
CHEMBL3137317	SONIDEGIB PHOSPHATE	Cc1c(C(=O)Nc2ccc(N3C[C@H](C)O[C@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1.O=P(O)(O)O.O=P(O)(O)O	RWIVSVMMGFFZIJ-VWDRLOGHSA-N	InChI=1S/C26H26F3N3O3.2H3O4P/c1-16-14-32(15-17(2)34-16)24-12-9-20(13-30-24)31-25(33)23-6-4-5-22(18(23)3)19-7-10-21(11-8-19)35-26(27,28)29;2*1-5(2,3)4/h4-13,16-17H,14-15H2,1-3H3,(H,31,33);2*(H3,1,2,3,4)/t16-,17+;;	Smoothened homolog inhibitor	INHIBITOR	CHEMBL5971	Smoothened homolog	Homo sapiens
CHEMBL2024517	CARIPRAZINE HYDROCHLORIDE	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1.Cl	GPPJWWMREQHLQT-BHQIMSFRSA-N	InChI=1S/C21H32Cl2N4O.ClH/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23;/h3-5,16-17H,6-15H2,1-2H3,(H,24,28);1H/t16-,17-;	Dopamine D3 receptor modulator	MODULATOR	CHEMBL234	Dopamine D3 receptor	Homo sapiens
CHEMBL2024517	CARIPRAZINE HYDROCHLORIDE	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1.Cl	GPPJWWMREQHLQT-BHQIMSFRSA-N	InChI=1S/C21H32Cl2N4O.ClH/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23;/h3-5,16-17H,6-15H2,1-2H3,(H,24,28);1H/t16-,17-;	Dopamine D2 receptor modulator	MODULATOR	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL3707330	ROLAPITANT HYDROCHLORIDE	C[C@@H](OC[C@@]1(c2ccccc2)CC[C@]2(CCC(=O)N2)CN1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1.Cl.O	GZQWMYVDLCUBQX-WVZIYJGPSA-N	InChI=1S/C25H26F6N2O2.ClH.H2O/c1-16(17-11-19(24(26,27)28)13-20(12-17)25(29,30)31)35-15-23(18-5-3-2-4-6-18)10-9-22(14-32-23)8-7-21(34)33-22;;/h2-6,11-13,16,32H,7-10,14-15H2,1H3,(H,33,34);1H;1H2/t16-,22-,23-;;/m1../s1	Neurokinin 1 receptor antagonist	ANTAGONIST	CHEMBL249	Neurokinin 1 receptor	Homo sapiens
CHEMBL65375	TIPIRACIL HYDROCHLORIDE	Cl.N=C1CCCN1Cc1[nH]c(=O)[nH]c(=O)c1Cl	KGHYQYACJRXCAT-UHFFFAOYSA-N	InChI=1S/C9H11ClN4O2.ClH/c10-7-5(12-9(16)13-8(7)15)4-14-3-1-2-6(14)11;/h11H,1-4H2,(H2,12,13,15,16);1H	Thymidine phosphorylase inhibitor	INHIBITOR	CHEMBL3106	Thymidine phosphorylase	Homo sapiens
CHEMBL2219425	ARIPIPRAZOLE LAUROXIL	CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21	DDINXHAORAAYAD-UHFFFAOYSA-N	InChI=1S/C36H51Cl2N3O4/c1-2-3-4-5-6-7-8-9-10-16-35(43)45-28-41-33-27-30(19-17-29(33)18-20-34(41)42)44-26-12-11-21-39-22-24-40(25-23-39)32-15-13-14-31(37)36(32)38/h13-15,17,19,27H,2-12,16,18,20-26,28H2,1H3	Dopamine D2 receptor partial agonist	PARTIAL AGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL2219425	ARIPIPRAZOLE LAUROXIL	CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21	DDINXHAORAAYAD-UHFFFAOYSA-N	InChI=1S/C36H51Cl2N3O4/c1-2-3-4-5-6-7-8-9-10-16-35(43)45-28-41-33-27-30(19-17-29(33)18-20-34(41)42)44-26-12-11-21-39-22-24-40(25-23-39)32-15-13-14-31(37)36(32)38/h13-15,17,19,27H,2-12,16,18,20-26,28H2,1H3	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL2219425	ARIPIPRAZOLE LAUROXIL	CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21	DDINXHAORAAYAD-UHFFFAOYSA-N	InChI=1S/C36H51Cl2N3O4/c1-2-3-4-5-6-7-8-9-10-16-35(43)45-28-41-33-27-30(19-17-29(33)18-20-34(41)42)44-26-12-11-21-39-22-24-40(25-23-39)32-15-13-14-31(37)36(32)38/h13-15,17,19,27H,2-12,16,18,20-26,28H2,1H3	Serotonin 1a (5-HT1a) receptor partial agonist	PARTIAL AGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL450449	TRABECTEDIN	COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H](O)[C@@H]3Cc5cc(C)c(OC)c(O)c5[C@H]([C@H]21)N3C)OCO4	PKVRCIRHQMSYJX-AIFWHQITSA-N	InChI=1S/C39H43N3O11S/c1-16-9-20-10-22-37(46)42-23-13-50-38(47)39(21-12-25(48-5)24(44)11-19(21)7-8-40-39)14-54-36(30(42)29(41(22)4)26(20)31(45)32(16)49-6)28-27(23)35-34(51-15-52-35)17(2)33(28)53-18(3)43/h9,11-12,22-23,29-30,36-37,40,44-46H,7-8,10,13-15H2,1-6H3/t22-,23-,29+,30+,36+,37-,39+/m0/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL2364637	TENOFOVIR ALAFENAMIDE FUMARATE	CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1.CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1.O=C(O)/C=C/C(=O)O	SVUJNSGGPUCLQZ-FQQAACOVSA-N	InChI=1S/2C21H29N6O5P.C4H4O4/c2*1-14(2)31-21(28)16(4)26-33(29,32-17-8-6-5-7-9-17)13-30-15(3)10-27-12-25-18-19(22)23-11-24-20(18)27;5-3(6)1-2-4(7)8/h2*5-9,11-12,14-16H,10,13H2,1-4H3,(H,26,29)(H2,22,23,24);1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*15-,16+,33+;/m11./s1	Human immunodeficiency virus type 1 reverse transcriptase inhibitor	INHIBITOR	CHEMBL247	Human immunodeficiency virus type 1 reverse transcriptase	Human immunodeficiency virus 1
CHEMBL2364607	COBIMETINIB FUMARATE	O=C(O)/C=C/C(=O)O.O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1.O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1	RESIMIUSNACMNW-BXRWSSRYSA-N	InChI=1S/2C21H21F3IN3O2.C4H4O4/c2*22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17;5-3(6)1-2-4(7)8/h2*4-7,9,17,26-27,30H,1-3,8,10-11H2;1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*17-;/m00./s1	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3587	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens
CHEMBL2364607	COBIMETINIB FUMARATE	O=C(O)/C=C/C(=O)O.O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1.O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1	RESIMIUSNACMNW-BXRWSSRYSA-N	InChI=1S/2C21H21F3IN3O2.C4H4O4/c2*22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17;5-3(6)1-2-4(7)8/h2*4-7,9,17,26-27,30H,1-3,8,10-11H2;1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*17-;/m00./s1	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	CHEMBL2964	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens
CHEMBL3545063	OSIMERTINIB MESYLATE	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C.CS(=O)(=O)O	FUKSNUHSJBTCFJ-UHFFFAOYSA-N	InChI=1S/C28H33N7O2.CH4O3S/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24;1-5(2,3)4/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32);1H3,(H,2,3,4)	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL3545432	IXAZOMIB CITRATE	CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)C(CC(=O)O)(CC(=O)O)O1	MBOMYENWWXQSNW-AWEZNQCLSA-N	InChI=1S/C20H23BCl2N2O9/c1-10(2)5-14(21-33-19(32)20(34-21,7-16(27)28)8-17(29)30)25-15(26)9-24-18(31)12-6-11(22)3-4-13(12)23/h3-4,6,10,14H,5,7-9H2,1-2H3,(H,24,31)(H,25,26)(H,27,28)(H,29,30)/t14-/m0/s1	26S proteosome inhibitor	INHIBITOR	CHEMBL2364701	26S proteasome	Homo sapiens
CHEMBL3707320	ALECTINIB HYDROCHLORIDE	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O.Cl	GYABBVHSRIHYJR-UHFFFAOYSA-N	InChI=1S/C30H34N4O2.ClH/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29;/h5-6,15-17,21,32H,4,7-14H2,1-3H3;1H	ALK tyrosine kinase receptor inhibitor	INHIBITOR	CHEMBL4247	ALK tyrosine kinase receptor	Homo sapiens
CHEMBL3707320	ALECTINIB HYDROCHLORIDE	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O.Cl	GYABBVHSRIHYJR-UHFFFAOYSA-N	InChI=1S/C30H34N4O2.ClH/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29;/h5-6,15-17,21,32H,4,7-14H2,1-3H3;1H	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	CHEMBL2041	Tyrosine-protein kinase receptor RET	Homo sapiens
CHEMBL2107374	SUGAMMADEX SODIUM	O=C([O-])CCSC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]4[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]5[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]6[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]7[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]8[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]9[C@@H](CSCCC(=O)[O-])O[C@H](O[C@H]1[C@H](O)C2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]	KMGKABOMYQLLDJ-WXBCEIQXSA-F	InChI=1S/C72H112O48S8.8Na/c73-33(74)1-9-121-17-25-57-41(89)49(97)65(105-25)114-58-26(18-122-10-2-34(75)76)107-67(51(99)43(58)91)116-60-28(20-124-12-4-36(79)80)109-69(53(101)45(60)93)118-62-30(22-126-14-6-38(83)84)111-71(55(103)47(62)95)120-64-32(24-128-16-8-40(87)88)112-72(56(104)48(64)96)119-63-31(23-127-15-7-39(85)86)110-70(54(102)46(63)94)117-61-29(21-125-13-5-37(81)82)108-68(52(100)44(61)92)115-59-27(19-123-11-3-35(77)78)106-66(113-57)50(98)42(59)90;;;;;;;;/h25-32,41-72,89-104H,1-24H2,(H,73,74)(H,75,76)(H,77,78)(H,79,80)(H,81,82)(H,83,84)(H,85,86)(H,87,88);;;;;;;;/q;8*+1/p-8/t25-,26-,27-,28-,29-,30-,31-,32-,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56?,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-;;;;;;;;/m1......../s1	Rocuronium sequestering agent	SEQUESTERING AGENT	CHEMBL3559390	Rocuronium	
CHEMBL2107374	SUGAMMADEX SODIUM	O=C([O-])CCSC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]4[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]5[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]6[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]7[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]8[C@@H](CSCCC(=O)[O-])O[C@H](O[C@@H]9[C@@H](CSCCC(=O)[O-])O[C@H](O[C@H]1[C@H](O)C2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]	KMGKABOMYQLLDJ-WXBCEIQXSA-F	InChI=1S/C72H112O48S8.8Na/c73-33(74)1-9-121-17-25-57-41(89)49(97)65(105-25)114-58-26(18-122-10-2-34(75)76)107-67(51(99)43(58)91)116-60-28(20-124-12-4-36(79)80)109-69(53(101)45(60)93)118-62-30(22-126-14-6-38(83)84)111-71(55(103)47(62)95)120-64-32(24-128-16-8-40(87)88)112-72(56(104)48(64)96)119-63-31(23-127-15-7-39(85)86)110-70(54(102)46(63)94)117-61-29(21-125-13-5-37(81)82)108-68(52(100)44(61)92)115-59-27(19-123-11-3-35(77)78)106-66(113-57)50(98)42(59)90;;;;;;;;/h25-32,41-72,89-104H,1-24H2,(H,73,74)(H,75,76)(H,77,78)(H,79,80)(H,81,82)(H,83,84)(H,85,86)(H,87,88);;;;;;;;/q;8*+1/p-8/t25-,26-,27-,28-,29-,30-,31-,32-,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56?,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-;;;;;;;;/m1......../s1	Vecuronium sequestering agent	SEQUESTERING AGENT	CHEMBL3559391	Vecuronium	
CHEMBL238804	SELEXIPAG	CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1	QXWZQTURMXZVHJ-UHFFFAOYSA-N	InChI=1S/C26H32N4O4S/c1-20(2)30(16-10-11-17-34-19-24(31)29-35(3,32)33)23-18-27-25(21-12-6-4-7-13-21)26(28-23)22-14-8-5-9-15-22/h4-9,12-15,18,20H,10-11,16-17,19H2,1-3H3,(H,29,31)	Prostanoid IP receptor agonist	AGONIST	CHEMBL1995	Prostanoid IP receptor	Homo sapiens
CHEMBL2105720	LESINURAD	O=C(O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12	FGQFOYHRJSUHMR-UHFFFAOYSA-N	InChI=1S/C17H14BrN3O2S/c18-16-19-20-17(24-9-15(22)23)21(16)14-8-7-11(10-5-6-10)12-3-1-2-4-13(12)14/h1-4,7-8,10H,5-6,9H2,(H,22,23)	Solute carrier family 22 member 12 inhibitor	INHIBITOR	CHEMBL6120	Solute carrier family 22 member 12	Homo sapiens
CHEMBL52885	ENMD-981693	Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21	OVSKGTONMLKNPZ-UHFFFAOYSA-N	InChI=1S/C22H16N4O4/c1-24-10-15(13-5-3-4-6-17(13)24)19-20(22(28)23-21(19)27)16-11-25(2)18-9-12(26(29)30)7-8-14(16)18/h3-11H,1-2H3,(H,23,27,28)	Serine/threonine-protein kinase Aurora-A inhibitor	INHIBITOR	CHEMBL4722	Serine/threonine-protein kinase Aurora-A	Homo sapiens
CHEMBL52885	ENMD-981693	Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21	OVSKGTONMLKNPZ-UHFFFAOYSA-N	InChI=1S/C22H16N4O4/c1-24-10-15(13-5-3-4-6-17(13)24)19-20(22(28)23-21(19)27)16-11-25(2)18-9-12(26(29)30)7-8-14(16)18/h3-11H,1-2H3,(H,23,27,28)	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL52885	ENMD-981693	Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21	OVSKGTONMLKNPZ-UHFFFAOYSA-N	InChI=1S/C22H16N4O4/c1-24-10-15(13-5-3-4-6-17(13)24)19-20(22(28)23-21(19)27)16-11-25(2)18-9-12(26(29)30)7-8-14(16)18/h3-11H,1-2H3,(H,23,27,28)	SRC inhibitor	INHIBITOR	CHEMBL2363074	SRC	Homo sapiens
CHEMBL52885	ENMD-981693	Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21	OVSKGTONMLKNPZ-UHFFFAOYSA-N	InChI=1S/C22H16N4O4/c1-24-10-15(13-5-3-4-6-17(13)24)19-20(22(28)23-21(19)27)16-11-25(2)18-9-12(26(29)30)7-8-14(16)18/h3-11H,1-2H3,(H,23,27,28)	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL52885	ENMD-981693	Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21	OVSKGTONMLKNPZ-UHFFFAOYSA-N	InChI=1S/C22H16N4O4/c1-24-10-15(13-5-3-4-6-17(13)24)19-20(22(28)23-21(19)27)16-11-25(2)18-9-12(26(29)30)7-8-14(16)18/h3-11H,1-2H3,(H,23,27,28)	Fibroblast growth factor receptor inhibitor	INHIBITOR	CHEMBL2095217	Fibroblast growth factor receptor	Homo sapiens
CHEMBL52885	ENMD-981693	Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21	OVSKGTONMLKNPZ-UHFFFAOYSA-N	InChI=1S/C22H16N4O4/c1-24-10-15(13-5-3-4-6-17(13)24)19-20(22(28)23-21(19)27)16-11-25(2)18-9-12(26(29)30)7-8-14(16)18/h3-11H,1-2H3,(H,23,27,28)	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL3545237	HE3235	C#C[C@]1(O)CCC2C3CCC4CC(O)CC[C@]4(C)C3CC[C@@]21C	CKAXZOYFIHQCBN-UQOAMHMYSA-N	InChI=1S/C21H32O2/c1-4-21(23)12-9-18-16-6-5-14-13-15(22)7-10-19(14,2)17(16)8-11-20(18,21)3/h1,14-18,22-23H,5-13H2,2-3H3/t14?,15?,16?,17?,18?,19-,20-,21-/m0/s1	Androgen Receptor modulator	MODULATOR	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1721885	SU-014813	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1	CTNPALGJUAXMMC-PMFHANACSA-N	InChI=1S/C23H27FN4O4/c1-13-20(10-18-17-9-15(24)3-4-19(17)27-22(18)30)26-14(2)21(13)23(31)25-11-16(29)12-28-5-7-32-8-6-28/h3-4,9-10,16,26,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,30)/b18-10-/t16-/m0/s1	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL1721885	SU-014813	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1	CTNPALGJUAXMMC-PMFHANACSA-N	InChI=1S/C23H27FN4O4/c1-13-20(10-18-17-9-15(24)3-4-19(17)27-22(18)30)26-14(2)21(13)23(31)25-11-16(29)12-28-5-7-32-8-6-28/h3-4,9-10,16,26,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,30)/b18-10-/t16-/m0/s1	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL1721885	SU-014813	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1	CTNPALGJUAXMMC-PMFHANACSA-N	InChI=1S/C23H27FN4O4/c1-13-20(10-18-17-9-15(24)3-4-19(17)27-22(18)30)26-14(2)21(13)23(31)25-11-16(29)12-28-5-7-32-8-6-28/h3-4,9-10,16,26,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,30)/b18-10-/t16-/m0/s1	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL1721885	SU-014813	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1	CTNPALGJUAXMMC-PMFHANACSA-N	InChI=1S/C23H27FN4O4/c1-13-20(10-18-17-9-15(24)3-4-19(17)27-22(18)30)26-14(2)21(13)23(31)25-11-16(29)12-28-5-7-32-8-6-28/h3-4,9-10,16,26,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,30)/b18-10-/t16-/m0/s1	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL216981	NAVARIXIN	CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1	RXIUEIPPLAFSDF-CYBMUJFWSA-N	InChI=1S/C21H23N3O5/c1-5-13(15-10-9-11(2)29-15)22-16-17(20(27)19(16)26)23-14-8-6-7-12(18(14)25)21(28)24(3)4/h6-10,13,22-23,25H,5H2,1-4H3/t13-/m1/s1	Interleukin-8 receptor B antagonist	ANTAGONIST	CHEMBL2434	Interleukin-8 receptor B	Homo sapiens
CHEMBL3545097	SAPANISERTIB	CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21	GYLDXIAOMVERTK-UHFFFAOYSA-N	InChI=1S/C15H15N7O/c1-7(2)22-14-11(13(16)18-6-19-14)12(21-22)8-3-4-10-9(5-8)20-15(17)23-10/h3-7H,1-2H3,(H2,17,20)(H2,16,18,19)	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL146506	MOFAROTENE	C/C(=C\c1ccc(OCCN2CCOCC2)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C	OUQPTBCOEKUHBH-LSDHQDQOSA-N	InChI=1S/C29H39NO2/c1-22(24-8-11-26-27(21-24)29(4,5)13-12-28(26,2)3)20-23-6-9-25(10-7-23)32-19-16-30-14-17-31-18-15-30/h6-11,20-21H,12-19H2,1-5H3/b22-20+	Retinoid receptor modulator	MODULATOR	CHEMBL2363071	Retinoid receptor	Homo sapiens
CHEMBL3545355	CHF4227	COc1ccc(C2=C(Cc3ccc(OCCN4CCCCC4)cc3)c3ccc(O)cc3OC2)cc1	ZUDXUNPSRMREOJ-UHFFFAOYSA-N	InChI=1S/C30H33NO4/c1-33-25-12-7-23(8-13-25)29-21-35-30-20-24(32)9-14-27(30)28(29)19-22-5-10-26(11-6-22)34-18-17-31-15-3-2-4-16-31/h5-14,20,32H,2-4,15-19,21H2,1H3	Estrogen receptor modulator	MODULATOR	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL37676	APC-100	Cc1c(C)c2c(c(C)c1O)CCC(C)(C)O2	SEBPXHSZHLFWRL-UHFFFAOYSA-N	InChI=1S/C14H20O2/c1-8-9(2)13-11(10(3)12(8)15)6-7-14(4,5)16-13/h15H,6-7H2,1-5H3	Androgen Receptor antagonist	ANTAGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL2346976	AZD3514	CC(=O)N1CCN(CCOc2ccc(C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3)cc2)CC1	JMEYDSHPKCSIJC-UHFFFAOYSA-N	InChI=1S/C25H32F3N7O2/c1-18(36)33-14-12-32(13-15-33)16-17-37-21-4-2-19(3-5-21)20-8-10-34(11-9-20)23-7-6-22-29-30-24(25(26,27)28)35(22)31-23/h2-5,20H,6-17H2,1H3	Androgen Receptor modulator	MODULATOR	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL467888	LGD-2941	C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1	HWLLYFXDDGGHOE-BCSUUIJWSA-N	InChI=1S/C17H16F6N2O2/c1-8-2-5-13(15(27)17(21,22)23)25(8)9-3-4-12-10(6-9)11(16(18,19)20)7-14(26)24-12/h3-4,6-8,13,15,27H,2,5H2,1H3,(H,24,26)/t8-,13-,15-/m1/s1	Androgen Receptor modulator	MODULATOR	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL456237	LXR-623	Fc1ccc(-c2c3cccc(C(F)(F)F)c3nn2Cc2ccc(F)cc2Cl)cc1	KYWWJENKIMRJBI-UHFFFAOYSA-N	InChI=1S/C21H12ClF5N2/c22-18-10-15(24)9-6-13(18)11-29-20(12-4-7-14(23)8-5-12)16-2-1-3-17(19(16)28-29)21(25,26)27/h1-10H,11H2	LXR-beta agonist	AGONIST	CHEMBL4093	LXR-beta	Homo sapiens
CHEMBL456237	LXR-623	Fc1ccc(-c2c3cccc(C(F)(F)F)c3nn2Cc2ccc(F)cc2Cl)cc1	KYWWJENKIMRJBI-UHFFFAOYSA-N	InChI=1S/C21H12ClF5N2/c22-18-10-15(24)9-6-13(18)11-29-20(12-4-7-14(23)8-5-12)16-2-1-3-17(19(16)28-29)21(25,26)27/h1-10H,11H2	LXR-alpha agonist	AGONIST	CHEMBL2808	LXR-alpha	Homo sapiens
CHEMBL272621	HYODEOXYCHOLIC_ACID	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	DGABKXLVXPYZII-SIBKNCMHSA-N	InChI=1S/C24H40O4/c1-14(4-7-22(27)28)17-5-6-18-16-13-21(26)20-12-15(25)8-10-24(20,3)19(16)9-11-23(17,18)2/h14-21,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15-,16+,17-,18+,19+,20+,21+,23-,24-/m1/s1	LXR-beta agonist	AGONIST	CHEMBL4093	LXR-beta	Homo sapiens
CHEMBL272621	HYODEOXYCHOLIC_ACID	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C	DGABKXLVXPYZII-SIBKNCMHSA-N	InChI=1S/C24H40O4/c1-14(4-7-22(27)28)17-5-6-18-16-13-21(26)20-12-15(25)8-10-24(20,3)19(16)9-11-23(17,18)2/h14-21,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15-,16+,17-,18+,19+,20+,21+,23-,24-/m1/s1	LXR-alpha agonist	AGONIST	CHEMBL2808	LXR-alpha	Homo sapiens
CHEMBL454138	TUROFEXORATE ISOPROPYL	CC(C)OC(=O)C1=CN(C(=O)c2ccc(F)c(F)c2)CC(C)(C)c2c1[nH]c1ccccc21	INASOKQDNHHMRE-UHFFFAOYSA-N	InChI=1S/C25H24F2N2O3/c1-14(2)32-24(31)17-12-29(23(30)15-9-10-18(26)19(27)11-15)13-25(3,4)21-16-7-5-6-8-20(16)28-22(17)21/h5-12,14,28H,13H2,1-4H3	Bile acid receptor FXR agonist	AGONIST	CHEMBL2047	Bile acid receptor FXR	Homo sapiens
CHEMBL271220	CORT 108297	CCOC[C@]12Cc3cnn(-c4ccc(F)cc4)c3C=C1CCN(S(=O)(=O)c1ccc(C(F)(F)F)cc1)C2	SLKURXRZHJOZOD-RUZDIDTESA-N	InChI=1S/C26H25F4N3O3S/c1-2-36-17-25-14-18-15-31-33(22-7-5-21(27)6-8-22)24(18)13-20(25)11-12-32(16-25)37(34,35)23-9-3-19(4-10-23)26(28,29)30/h3-10,13,15H,2,11-12,14,16-17H2,1H3/t25-/m1/s1	Glucocorticoid receptor antagonist	ANTAGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL3261331	RESMETIROM	CC(C)c1cc(Oc2c(Cl)cc(-n3nc(C#N)c(=O)[nH]c3=O)cc2Cl)n[nH]c1=O	FDBYIYFVSAHJLY-UHFFFAOYSA-N	InChI=1S/C17H12Cl2N6O4/c1-7(2)9-5-13(22-23-15(9)26)29-14-10(18)3-8(4-11(14)19)25-17(28)21-16(27)12(6-20)24-25/h3-5,7H,1-2H3,(H,23,26)(H,21,27,28)	Thyroid hormone receptor beta-1 agonist	AGONIST	CHEMBL1947	Thyroid hormone receptor beta-1	Homo sapiens
CHEMBL284121	ILX23-7553	C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@H](C)CC#CC(C)(C)O)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O	JKFZMIQMKFWJAY-RQJQXFIZSA-N	InChI=1S/C27H38O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-12,18,22,24-25,28-30H,2,7-9,13,15-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,24+,25+,27-/m1/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL3542265	LY2452473	CC(C)OC(=O)N[C@H]1Cc2c(n(Cc3ccccn3)c3ccc(C#N)cc23)C1	IHIWYQYVBNODSV-KRWDZBQOSA-N	InChI=1S/C22H22N4O2/c1-14(2)28-22(27)25-17-10-19-18-9-15(12-23)6-7-20(18)26(21(19)11-17)13-16-5-3-4-8-24-16/h3-9,14,17H,10-11,13H2,1-2H3,(H,25,27)/t17-/m0/s1	Androgen Receptor modulator	MODULATOR	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL4208229	ASCIMINIB	O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1	VOVZXURTCKPRDQ-CQSZACIVSA-N	InChI=1S/C20H18ClF2N5O3/c21-20(22,23)31-15-3-1-13(2-4-15)26-19(30)12-9-16(17-5-7-25-27-17)18(24-10-12)28-8-6-14(29)11-28/h1-5,7,9-10,14,29H,6,8,11H2,(H,25,27)(H,26,30)/t14-/m1/s1	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	CHEMBL1862	Tyrosine-protein kinase ABL	Homo sapiens
CHEMBL1980297	ILORASERTIB	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12	WPHKIQPVPYJNAX-UHFFFAOYSA-N	InChI=1S/C25H21FN6O2S/c26-17-2-1-3-19(10-17)31-25(34)30-18-6-4-15(5-7-18)21-14-35-23-20(12-28-24(27)22(21)23)16-11-29-32(13-16)8-9-33/h1-7,10-14,33H,8-9H2,(H2,27,28)(H2,30,31,34)	Serine/threonine-protein kinase Aurora inhibitor	INHIBITOR	CHEMBL3430911	Serine/threonine-protein kinase Aurora	Homo sapiens
CHEMBL1980297	ILORASERTIB	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12	WPHKIQPVPYJNAX-UHFFFAOYSA-N	InChI=1S/C25H21FN6O2S/c26-17-2-1-3-19(10-17)31-25(34)30-18-6-4-15(5-7-18)21-14-35-23-20(12-28-24(27)22(21)23)16-11-29-32(13-16)8-9-33/h1-7,10-14,33H,8-9H2,(H2,27,28)(H2,30,31,34)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL1980297	ILORASERTIB	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12	WPHKIQPVPYJNAX-UHFFFAOYSA-N	InChI=1S/C25H21FN6O2S/c26-17-2-1-3-19(10-17)31-25(34)30-18-6-4-15(5-7-18)21-14-35-23-20(12-28-24(27)22(21)23)16-11-29-32(13-16)8-9-33/h1-7,10-14,33H,8-9H2,(H2,27,28)(H2,30,31,34)	SRC inhibitor	INHIBITOR	CHEMBL2363074	SRC	Homo sapiens
CHEMBL1980297	ILORASERTIB	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12	WPHKIQPVPYJNAX-UHFFFAOYSA-N	InChI=1S/C25H21FN6O2S/c26-17-2-1-3-19(10-17)31-25(34)30-18-6-4-15(5-7-18)21-14-35-23-20(12-28-24(27)22(21)23)16-11-29-32(13-16)8-9-33/h1-7,10-14,33H,8-9H2,(H2,27,28)(H2,30,31,34)	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL3545241	AC-430	Cc1cc(Nc2nc(C(O)c3ccc(F)cc3)nc3ccccc23)n[nH]1	DCRWIATZWHLIPN-UHFFFAOYSA-N	InChI=1S/C19H16FN5O/c1-11-10-16(25-24-11)22-18-14-4-2-3-5-15(14)21-19(23-18)17(26)12-6-8-13(20)9-7-12/h2-10,17,26H,1H3,(H2,21,22,23,24,25)	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	CHEMBL2971	Tyrosine-protein kinase JAK2	Homo sapiens
CHEMBL1645462	AC-480	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12	LUJZZYWHBDHDQX-QFIPXVFZSA-N	InChI=1S/C27H27FN8O3/c1-17-23(34-27(37)39-15-22-14-38-8-7-29-22)13-36-25(17)26(30-16-32-36)33-21-5-6-24-19(10-21)11-31-35(24)12-18-3-2-4-20(28)9-18/h2-6,9-11,13,16,22,29H,7-8,12,14-15H2,1H3,(H,34,37)(H,30,32,33)/t22-/m0/s1	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL1645462	AC-480	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12	LUJZZYWHBDHDQX-QFIPXVFZSA-N	InChI=1S/C27H27FN8O3/c1-17-23(34-27(37)39-15-22-14-38-8-7-29-22)13-36-25(17)26(30-16-32-36)33-21-5-6-24-19(10-21)11-31-35(24)12-18-3-2-4-20(28)9-18/h2-6,9-11,13,16,22,29H,7-8,12,14-15H2,1H3,(H,34,37)(H,30,32,33)/t22-/m0/s1	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL1645462	AC-480	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12	LUJZZYWHBDHDQX-QFIPXVFZSA-N	InChI=1S/C27H27FN8O3/c1-17-23(34-27(37)39-15-22-14-38-8-7-29-22)13-36-25(17)26(30-16-32-36)33-21-5-6-24-19(10-21)11-31-35(24)12-18-3-2-4-20(28)9-18/h2-6,9-11,13,16,22,29H,7-8,12,14-15H2,1H3,(H,34,37)(H,30,32,33)/t22-/m0/s1	Receptor protein-tyrosine kinase erbB-4 inhibitor	INHIBITOR	CHEMBL3009	Receptor protein-tyrosine kinase erbB-4	Homo sapiens
CHEMBL551064	AEW-541	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1	USVCWSAJUAARAL-MEMLXQNLSA-N	InChI=1S/C26H27N5O/c27-25-24-23(19-8-4-9-22(12-19)32-16-18-6-2-1-3-7-18)15-31(26(24)29-17-28-25)21-13-20(14-21)30-10-5-11-30/h1-4,6-9,12,15,17,20-21H,5,10-11,13-14,16H2,(H2,27,28,29)/t20-,21-	Insulin-like growth factor I receptor inhibitor	INHIBITOR	CHEMBL1957	Insulin-like growth factor I receptor	Homo sapiens
CHEMBL3545420	AG-24322	CCNCc1cncc(-c2ccc3c(c2)/C(=C2/N=c4cc(F)cc(F)c4=N2)NN3)c1C	RBOKLZGCVRXGEP-XTQSDGFTSA-N	InChI=1S/C23H20F2N6/c1-3-26-9-14-10-27-11-17(12(14)2)13-4-5-19-16(6-13)21(31-30-19)23-28-20-8-15(24)7-18(25)22(20)29-23/h4-8,10-11,26,30-31H,3,9H2,1-2H3/b23-21+	Cyclin-dependent kinase 1 inhibitor	INHIBITOR	CHEMBL308	Cyclin-dependent kinase 1	Homo sapiens
CHEMBL3545420	AG-24322	CCNCc1cncc(-c2ccc3c(c2)/C(=C2/N=c4cc(F)cc(F)c4=N2)NN3)c1C	RBOKLZGCVRXGEP-XTQSDGFTSA-N	InChI=1S/C23H20F2N6/c1-3-26-9-14-10-27-11-17(12(14)2)13-4-5-19-16(6-13)21(31-30-19)23-28-20-8-15(24)7-18(25)22(20)29-23/h4-8,10-11,26,30-31H,3,9H2,1-2H3/b23-21+	Cyclin-dependent kinase 2 inhibitor	INHIBITOR	CHEMBL301	Cyclin-dependent kinase 2	Homo sapiens
CHEMBL3545420	AG-24322	CCNCc1cncc(-c2ccc3c(c2)/C(=C2/N=c4cc(F)cc(F)c4=N2)NN3)c1C	RBOKLZGCVRXGEP-XTQSDGFTSA-N	InChI=1S/C23H20F2N6/c1-3-26-9-14-10-27-11-17(12(14)2)13-4-5-19-16(6-13)21(31-30-19)23-28-20-8-15(24)7-18(25)22(20)29-23/h4-8,10-11,26,30-31H,3,9H2,1-2H3/b23-21+	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	CHEMBL331	Cyclin-dependent kinase 4	Homo sapiens
CHEMBL496102	AMG-208	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1	HEAIZQNMNCHNFD-UHFFFAOYSA-N	InChI=1S/C22H17N5O2/c1-28-16-7-8-17-19(13-16)23-12-11-20(17)29-14-22-25-24-21-10-9-18(26-27(21)22)15-5-3-2-4-6-15/h2-13H,14H2,1H3	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL585902	AMG-548	Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O	RQVKVJIRFKVPBF-VWLOTQADSA-N	InChI=1S/C29H27N5O/c1-34-28(35)26(24-12-11-21-9-5-6-10-23(21)18-24)27(22-13-15-31-16-14-22)33-29(34)32-19-25(30)17-20-7-3-2-4-8-20/h2-16,18,25H,17,19,30H2,1H3,(H,32,33)/t25-/m0/s1	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL2140408	AMG-900	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1	IVUGFMLRJOCGAS-UHFFFAOYSA-N	InChI=1S/C28H21N7OS/c1-17-15-24(37-16-17)25-20-5-2-3-6-21(20)26(35-34-25)32-18-8-10-19(11-9-18)36-27-22(7-4-13-30-27)23-12-14-31-28(29)33-23/h2-16H,1H3,(H,32,35)(H2,29,31,33)	Serine/threonine-protein kinase Aurora inhibitor	INHIBITOR	CHEMBL3430911	Serine/threonine-protein kinase Aurora	Homo sapiens
CHEMBL1650595	AR-12	NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1	YULUCECVQOCQFQ-UHFFFAOYSA-N	InChI=1S/C26H19F3N4O/c27-26(28,29)24-14-23(33(32-24)20-10-8-19(9-11-20)31-25(34)15-30)18-7-12-22-17(13-18)6-5-16-3-1-2-4-21(16)22/h1-14H,15,30H2,(H,31,34)	3-phosphoinositide dependent protein kinase-1 inhibitor	INHIBITOR	CHEMBL2534	3-phosphoinositide dependent protein kinase-1	Homo sapiens
CHEMBL4297187	DERAZANTINIB	COCCNCCc1cccc(Nc2ncc3c(n2)-c2ccccc2[C@H](c2ccccc2F)C3)c1	KPJDVVCDVBFRMU-AREMUKBSSA-N	InChI=1S/C29H29FN4O/c1-35-16-15-31-14-13-20-7-6-8-22(17-20)33-29-32-19-21-18-26(24-10-4-5-12-27(24)30)23-9-2-3-11-25(23)28(21)34-29/h2-12,17,19,26,31H,13-16,18H2,1H3,(H,32,33,34)/t26-/m1/s1	Fibroblast growth factor receptor inhibitor	INHIBITOR	CHEMBL2095217	Fibroblast growth factor receptor	Homo sapiens
CHEMBL4297188	MIRANSERTIB	Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1	HNFMVVHMKGFCMB-UHFFFAOYSA-N	InChI=1S/C27H24N6/c28-24-21(8-4-17-30-24)25-32-23-14-13-22(18-6-2-1-3-7-18)31-26(23)33(25)20-11-9-19(10-12-20)27(29)15-5-16-27/h1-4,6-14,17H,5,15-16,29H2,(H2,28,30)	Serine/threonine-protein kinase AKT inhibitor	INHIBITOR	CHEMBL2111353	Serine/threonine-protein kinase AKT	Homo sapiens
CHEMBL129857	AS-602868	COc1cccc2nc(-c3cccs3)nc(NN3C(=O)C=C(C)C3=O)c12	GZGLPBNOIFLLRE-UHFFFAOYSA-N	InChI=1S/C18H14N4O3S/c1-10-9-14(23)22(18(10)24)21-17-15-11(5-3-6-12(15)25-2)19-16(20-17)13-7-4-8-26-13/h3-9H,1-2H3,(H,19,20,21)	Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor	INHIBITOR	CHEMBL1991	Inhibitor of nuclear factor kappa B kinase beta subunit	Homo sapiens
CHEMBL129857	AS-602868	COc1cccc2nc(-c3cccs3)nc(NN3C(=O)C=C(C)C3=O)c12	GZGLPBNOIFLLRE-UHFFFAOYSA-N	InChI=1S/C18H14N4O3S/c1-10-9-14(23)22(18(10)24)21-17-15-11(5-3-6-12(15)25-2)19-16(20-17)13-7-4-8-26-13/h3-9H,1-2H3,(H,19,20,21)	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL1967878	CENISERTIB	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1	KSOVGRCOLZZTPF-UHFFFAOYSA-N	InChI=1S/C24H30FN7O/c1-14-11-17(5-6-19(14)32-9-7-31(2)8-10-32)28-24-27-13-18(25)23(30-24)29-21-16-4-3-15(12-16)20(21)22(26)33/h3-6,11,13,15-16,20-21H,7-10,12H2,1-2H3,(H2,26,33)(H2,27,28,29,30)	Serine/threonine-protein kinase Aurora inhibitor	INHIBITOR	CHEMBL3430911	Serine/threonine-protein kinase Aurora	Homo sapiens
CHEMBL3545360	ASP-3026	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1	MGGBYMDAPCCKCT-UHFFFAOYSA-N	InChI=1S/C29H40N8O3S/c1-21(2)41(38,39)27-8-6-5-7-25(27)33-29-31-20-30-28(34-29)32-24-10-9-23(19-26(24)40-4)36-13-11-22(12-14-36)37-17-15-35(3)16-18-37/h5-10,19-22H,11-18H2,1-4H3,(H2,30,31,32,33,34)	ALK tyrosine kinase receptor inhibitor	INHIBITOR	CHEMBL4247	ALK tyrosine kinase receptor	Homo sapiens
CHEMBL574738	AST-487	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1	ODPGGGTTYSGTGO-UHFFFAOYSA-N	InChI=1S/C26H30F3N7O2/c1-3-35-10-12-36(13-11-35)16-18-4-5-20(14-22(18)26(27,28)29)34-25(37)33-19-6-8-21(9-7-19)38-24-15-23(30-2)31-17-32-24/h4-9,14-15,17H,3,10-13,16H2,1-2H3,(H,30,31,32)(H2,33,34,37)	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL574738	AST-487	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1	ODPGGGTTYSGTGO-UHFFFAOYSA-N	InChI=1S/C26H30F3N7O2/c1-3-35-10-12-36(13-11-35)16-18-4-5-20(14-22(18)26(27,28)29)34-25(37)33-19-6-8-21(9-7-19)38-24-15-23(30-2)31-17-32-24/h4-9,14-15,17H,3,10-13,16H2,1-2H3,(H,30,31,32)(H2,33,34,37)	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	CHEMBL2041	Tyrosine-protein kinase receptor RET	Homo sapiens
CHEMBL3544960	AT-13148	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1	IIRWNGPLJQXWFJ-KRWDZBQOSA-N	InChI=1S/C17H16ClN3O/c18-16-7-5-15(6-8-16)17(22,11-19)14-3-1-12(2-4-14)13-9-20-21-10-13/h1-10,22H,11,19H2,(H,20,21)/t17-/m0/s1	Rho-associated protein kinase inhibitor	INHIBITOR	CHEMBL2111459	Rho-associated protein kinase	Homo sapiens
CHEMBL3544960	AT-13148	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1	IIRWNGPLJQXWFJ-KRWDZBQOSA-N	InChI=1S/C17H16ClN3O/c18-16-7-5-15(6-8-16)17(22,11-19)14-3-1-12(2-4-14)13-9-20-21-10-13/h1-10,22H,11,19H2,(H,20,21)/t17-/m0/s1	MAP kinase-activated protein kinase 2 inhibitor	INHIBITOR	CHEMBL2208	MAP kinase-activated protein kinase 2	Homo sapiens
CHEMBL1969664	AZD-1080	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1	BLTVBQXJFVRPFK-UHFFFAOYSA-N	InChI=1S/C19H18N4O2/c20-10-13-1-3-16-15(9-13)18(19(24)22-16)17-4-2-14(11-21-17)12-23-5-7-25-8-6-23/h1-4,9,11,22,24H,5-8,12H2	Glycogen synthase kinase-3 inhibitor	INHIBITOR	CHEMBL2095188	Glycogen synthase kinase-3	Homo sapiens
CHEMBL3545423	AZD-1208	NC1CCCN(c2c(/C=C3/SC(=O)NC3=O)cccc2-c2ccccc2)C1	MCUJKPPARUPFJM-LDADJPATSA-N	InChI=1S/C21H21N3O2S/c22-16-9-5-11-24(13-16)19-15(12-18-20(25)23-21(26)27-18)8-4-10-17(19)14-6-2-1-3-7-14/h1-4,6-8,10,12,16H,5,9,11,13,22H2,(H,23,25,26)/b18-12+	Serine/threonine-protein kinase PIM inhibitor	INHIBITOR	CHEMBL3559682	Serine/threonine-protein kinase PIM	Homo sapiens
CHEMBL422872	AZD-4769	O=C(O)CSC(CCCc1ccccc1)c1ccc(OCc2ccc3ccccc3n2)cc1	JOIXGLLMSDPZDN-UHFFFAOYSA-N	InChI=1S/C28H27NO3S/c30-28(31)20-33-27(12-6-9-21-7-2-1-3-8-21)23-14-17-25(18-15-23)32-19-24-16-13-22-10-4-5-11-26(22)29-24/h1-5,7-8,10-11,13-18,27H,6,9,12,19-20H2,(H,30,31)	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL488436	AZD-5438	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C	WJRRGYBTGDJBFX-UHFFFAOYSA-N	InChI=1S/C18H21N5O2S/c1-12(2)23-13(3)20-11-17(23)16-9-10-19-18(22-16)21-14-5-7-15(8-6-14)26(4,24)25/h5-12H,1-4H3,(H,19,21,22)	Cyclin-dependent kinase inhibitor	INHIBITOR	CHEMBL3559691	Cyclin-dependent kinase	Homo sapiens
CHEMBL2165191	AZD-6482	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1	IRTDIKMSKMREGO-OAHLLOKOSA-N	InChI=1S/C22H24N4O4/c1-14-11-17(15(2)23-18-6-4-3-5-16(18)22(28)29)21-24-19(12-20(27)26(21)13-14)25-7-9-30-10-8-25/h3-6,11-13,15,23H,7-10H2,1-2H3,(H,28,29)/t15-/m1/s1	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL2031465	AZD-6703	Cc1ccc(C(=O)NC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O	ZMAZXHICVRYLQN-UHFFFAOYSA-N	InChI=1S/C24H27N5O2/c1-16-3-4-17(23(30)26-18-5-6-18)13-22(16)29-15-25-21-8-7-19(14-20(21)24(29)31)28-11-9-27(2)10-12-28/h3-4,7-8,13-15,18H,5-6,9-12H2,1-2H3,(H,26,30)	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL4297189	CERALASERTIB	C[C@@H]1COCCN1c1cc(C2([S@](C)(=N)=O)CC2)nc(-c2cncc3[nH]ccc23)n1	DTTJKLNXNZAVSM-JYCIKRDWSA-N	InChI=1S/C20H24N6O2S/c1-13-12-28-8-7-26(13)18-9-17(20(4-5-20)29(2,21)27)24-19(25-18)15-10-22-11-16-14(15)3-6-23-16/h3,6,9-11,13,21,23H,4-5,7-8,12H2,1-2H3/t13-,29-/m1/s1	Serine-protein kinase ATR inhibitor	INHIBITOR	CHEMBL5024	Serine-protein kinase ATR	Homo sapiens
CHEMBL9960	AZD-7624	CC[C@H](NC(=O)c1cc(-c2ccccc2)nc2ccccc12)c1ccccc1	MXNGYQJJYRVGGJ-QFIPXVFZSA-N	InChI=1S/C25H22N2O/c1-2-22(18-11-5-3-6-12-18)27-25(28)21-17-24(19-13-7-4-8-14-19)26-23-16-10-9-15-20(21)23/h3-17,22H,2H2,1H3,(H,27,28)/t22-/m0/s1	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL2041933	AZD-7762	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1	IAYGCINLNONXHY-LBPRGKRZSA-N	InChI=1S/C17H19FN4O2S/c18-11-4-1-3-10(7-11)14-8-13(22-17(19)24)15(25-14)16(23)21-12-5-2-6-20-9-12/h1,3-4,7-8,12,20H,2,5-6,9H2,(H,21,23)(H3,19,22,24)/t12-/m0/s1	Serine/threonine-protein kinase Chk1 inhibitor	INHIBITOR	CHEMBL4630	Serine/threonine-protein kinase Chk1	Homo sapiens
CHEMBL1801204	AZD-8055	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO	KVLFRAWTRWDEDF-IRXDYDNUSA-N	InChI=1S/C25H31N5O4/c1-16-14-33-10-8-29(16)24-20-5-6-21(18-4-7-22(32-3)19(12-18)13-31)26-23(20)27-25(28-24)30-9-11-34-15-17(30)2/h4-7,12,16-17,31H,8-11,13-15H2,1-3H3/t16-,17-/m0/s1	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL3182621	AZD-8330	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O	RWEVIPRMPFNTLO-UHFFFAOYSA-N	InChI=1S/C16H17FIN3O4/c1-9-7-11(15(23)20-25-6-5-22)14(21(2)16(9)24)19-13-4-3-10(18)8-12(13)17/h3-4,7-8,19,22H,5-6H2,1-2H3,(H,20,23)	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3587	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens
CHEMBL3182621	AZD-8330	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O	RWEVIPRMPFNTLO-UHFFFAOYSA-N	InChI=1S/C16H17FIN3O4/c1-9-7-11(15(23)20-25-6-5-22)14(21(2)16(9)24)19-13-4-3-10(18)8-12(13)17/h3-4,7-8,19,22H,5-6H2,1-2H3,(H,20,23)	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	CHEMBL2964	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens
CHEMBL3963485	ROGARATINIB	COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1	HNLRRJSKGXOYNO-UHFFFAOYSA-N	InChI=1S/C23H26N6O3S/c1-13-6-14-8-18(33-22(14)17(7-13)32-3)20-15(11-31-2)16(9-28-5-4-25-19(30)10-28)29-21(20)23(24)26-12-27-29/h6-8,12H,4-5,9-11H2,1-3H3,(H,25,30)(H2,24,26,27)	Fibroblast growth factor receptor inhibitor	INHIBITOR	CHEMBL2095217	Fibroblast growth factor receptor	Homo sapiens
CHEMBL4209157	LIFIRAFENIB	O=C1CCc2c(Oc3ccc4c(c3)[C@@H]3[C@H](O4)[C@H]3c3nc4cc(C(F)(F)F)ccc4[nH]3)ccnc2N1	NGFFVZQXSRKHBM-FKBYEOEOSA-N	InChI=1S/C25H17F3N4O3/c26-25(27,28)11-1-4-15-16(9-11)31-24(30-15)21-20-14-10-12(2-5-17(14)35-22(20)21)34-18-7-8-29-23-13(18)3-6-19(33)32-23/h1-2,4-5,7-10,20-22H,3,6H2,(H,30,31)(H,29,32,33)/t20-,21-,22-/m0/s1	Serine/threonine-protein kinase B-raf inhibitor	INHIBITOR	CHEMBL5145	Serine/threonine-protein kinase B-raf	Homo sapiens
CHEMBL258940	FALNIDAMOL	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1	FTFRZXFNZVCRSK-UHFFFAOYSA-N	InChI=1S/C18H19ClFN7/c1-27-6-4-11(5-7-27)25-18-21-9-15-16(26-18)17(23-10-22-15)24-12-2-3-14(20)13(19)8-12/h2-3,8-11H,4-7H2,1H3,(H,21,25,26)(H,22,23,24)	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL103667	DORAMAPIMOD	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1	MVCOAUNKQVWQHZ-UHFFFAOYSA-N	InChI=1S/C31H37N5O3/c1-22-9-11-23(12-10-22)36-29(21-28(34-36)31(2,3)4)33-30(37)32-26-13-14-27(25-8-6-5-7-24(25)26)39-20-17-35-15-18-38-19-16-35/h5-14,21H,15-20H2,1-4H3,(H2,32,33,37)	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL296468	BMS-387032	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1	OUSFTKFNBAZUKL-UHFFFAOYSA-N	InChI=1S/C17H24N4O2S2/c1-17(2,3)12-8-19-13(23-12)10-24-14-9-20-16(25-14)21-15(22)11-4-6-18-7-5-11/h8-9,11,18H,4-7,10H2,1-3H3,(H,20,21,22)	Cyclin-dependent kinase 2 inhibitor	INHIBITOR	CHEMBL301	Cyclin-dependent kinase 2	Homo sapiens
CHEMBL296468	BMS-387032	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1	OUSFTKFNBAZUKL-UHFFFAOYSA-N	InChI=1S/C17H24N4O2S2/c1-17(2,3)12-8-19-13(23-12)10-24-14-9-20-16(25-14)21-15(22)11-4-6-18-7-5-11/h8-9,11,18H,4-7,10H2,1-3H3,(H,20,21,22)	Cyclin-dependent kinase 7 inhibitor	INHIBITOR	CHEMBL3055	Cyclin-dependent kinase 7	Homo sapiens
CHEMBL296468	BMS-387032	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1	OUSFTKFNBAZUKL-UHFFFAOYSA-N	InChI=1S/C17H24N4O2S2/c1-17(2,3)12-8-19-13(23-12)10-24-14-9-20-16(25-14)21-15(22)11-4-6-18-7-5-11/h8-9,11,18H,4-7,10H2,1-3H3,(H,20,21,22)	Cyclin-dependent kinase 9 inhibitor	INHIBITOR	CHEMBL3116	Cyclin-dependent kinase 9	Homo sapiens
CHEMBL3301600	SPEBRUTINIB BESYLATE	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1.O=S(=O)(O)c1ccccc1	ABSXPNGWJFAPRT-UHFFFAOYSA-N	InChI=1S/C22H22FN5O3.C6H6O3S/c1-3-20(29)25-16-5-4-6-17(13-16)26-21-19(23)14-24-22(28-21)27-15-7-9-18(10-8-15)31-12-11-30-2;7-10(8,9)6-4-2-1-3-5-6/h3-10,13-14H,1,11-12H2,2H3,(H,25,29)(H2,24,26,27,28);1-5H,(H,7,8,9)	Tyrosine-protein kinase BTK inhibitor	INHIBITOR	CHEMBL5251	Tyrosine-protein kinase BTK	Homo sapiens
CHEMBL2010872	CEP-11981	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3	AEULIVPVIDOLIN-UHFFFAOYSA-N	InChI=1S/C28H27N7O/c1-15(2)13-35-22-8-5-16(32-28-29-9-4-10-30-28)11-18(22)24-19-12-31-27(36)25(19)23-17(26(24)35)6-7-21-20(23)14-34(3)33-21/h4-5,8-11,14-15H,6-7,12-13H2,1-3H3,(H,31,36)(H,29,30,32)	Tyrosine-protein kinase TIE-2 inhibitor	INHIBITOR	CHEMBL4128	Tyrosine-protein kinase TIE-2	Homo sapiens
CHEMBL2010872	CEP-11981	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3	AEULIVPVIDOLIN-UHFFFAOYSA-N	InChI=1S/C28H27N7O/c1-15(2)13-35-22-8-5-16(32-28-29-9-4-10-30-28)11-18(22)24-19-12-31-27(36)25(19)23-17(26(24)35)6-7-21-20(23)14-34(3)33-21/h4-5,8-11,14-15H,6-7,12-13H2,1-3H3,(H,31,36)(H,29,30,32)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL2029988	CEP-32496	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC	DKNUPRMJNUQNHR-UHFFFAOYSA-N	InChI=1S/C24H22F3N5O5/c1-23(2,24(25,26)27)19-11-20(32-37-19)31-22(33)30-13-6-5-7-14(8-13)36-21-15-9-17(34-3)18(35-4)10-16(15)28-12-29-21/h5-12H,1-4H3,(H2,30,31,32,33)	Serine/threonine-protein kinase B-raf inhibitor	INHIBITOR	CHEMBL5145	Serine/threonine-protein kinase B-raf	Homo sapiens
CHEMBL2029988	CEP-32496	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC	DKNUPRMJNUQNHR-UHFFFAOYSA-N	InChI=1S/C24H22F3N5O5/c1-23(2,24(25,26)27)19-11-20(32-37-19)31-22(33)30-13-6-5-7-14(8-13)36-21-15-9-17(34-3)18(35-4)10-16(15)28-12-29-21/h5-12H,1-4H3,(H2,30,31,32,33)	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL2029988	CEP-32496	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC	DKNUPRMJNUQNHR-UHFFFAOYSA-N	InChI=1S/C24H22F3N5O5/c1-23(2,24(25,26)27)19-11-20(32-37-19)31-22(33)30-13-6-5-7-14(8-13)36-21-15-9-17(34-3)18(35-4)10-16(15)28-12-29-21/h5-12H,1-4H3,(H2,30,31,32,33)	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	CHEMBL2041	Tyrosine-protein kinase receptor RET	Homo sapiens
CHEMBL150894	CEP-5214	CC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3	MLIFNJABMANKEU-UHFFFAOYSA-N	InChI=1S/C28H28N2O3/c1-16(2)33-15-17-8-9-23-20(12-17)25-22-14-29-28(32)26(22)24-19-7-4-3-6-18(19)13-21(24)27(25)30(23)10-5-11-31/h3-4,6-9,12,16,31H,5,10-11,13-15H2,1-2H3,(H,29,32)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL346631	CEP-7055	CC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCOC(=O)CN(C)C)Cc1ccccc1-4)C(=O)NC3	UHEBDUAFKQHUBV-UHFFFAOYSA-N	InChI=1S/C32H35N3O4/c1-19(2)39-18-20-10-11-26-23(14-20)29-25-16-33-32(37)30(25)28-22-9-6-5-8-21(22)15-24(28)31(29)35(26)12-7-13-38-27(36)17-34(3)4/h5-6,8-11,14,19H,7,12-13,15-18H2,1-4H3,(H,33,37)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL483321	CP-724714	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1	LLVZBTWPGQVVLW-SNAWJCMRSA-N	InChI=1S/C27H27N5O3/c1-18-13-21(8-11-25(18)35-22-9-6-19(2)29-15-22)32-27-23-14-20(7-10-24(23)30-17-31-27)5-4-12-28-26(33)16-34-3/h4-11,13-15,17H,12,16H2,1-3H3,(H,28,33)(H,30,31,32)/b5-4+	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL598797	CUDC-101	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1	PLIVFNIUGLLCEK-UHFFFAOYSA-N	InChI=1S/C24H26N4O4/c1-3-17-9-8-10-18(13-17)27-24-19-14-22(21(31-2)15-20(19)25-16-26-24)32-12-7-5-4-6-11-23(29)28-30/h1,8-10,13-16,30H,4-7,11-12H2,2H3,(H,28,29)(H,25,26,27)	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL598797	CUDC-101	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1	PLIVFNIUGLLCEK-UHFFFAOYSA-N	InChI=1S/C24H26N4O4/c1-3-17-9-8-10-18(13-17)27-24-19-14-22(21(31-2)15-20(19)25-16-26-24)32-12-7-5-4-6-11-23(29)28-30/h1,8-10,13-16,30H,4-7,11-12H2,2H3,(H,28,29)(H,25,26,27)	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL598797	CUDC-101	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1	PLIVFNIUGLLCEK-UHFFFAOYSA-N	InChI=1S/C24H26N4O4/c1-3-17-9-8-10-18(13-17)27-24-19-14-22(21(31-2)15-20(19)25-16-26-24)32-12-7-5-4-6-11-23(29)28-30/h1,8-10,13-16,30H,4-7,11-12H2,2H3,(H,28,29)(H,25,26,27)	Histone deacetylase inhibitor	INHIBITOR	CHEMBL2093865	Histone deacetylase	Homo sapiens
CHEMBL3622533	FIMEPINOSTAT	COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1	JOWXJLIFIIOYMS-UHFFFAOYSA-N	InChI=1S/C23H24N8O4S/c1-30(23-25-11-15(12-26-23)22(32)29-33)13-16-9-17-19(36-16)21(31-5-7-35-8-6-31)28-20(27-17)14-3-4-18(34-2)24-10-14/h3-4,9-12,33H,5-8,13H2,1-2H3,(H,29,32)	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	CHEMBL3130	PI3-kinase p110-delta subunit	Homo sapiens
CHEMBL3622533	FIMEPINOSTAT	COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1	JOWXJLIFIIOYMS-UHFFFAOYSA-N	InChI=1S/C23H24N8O4S/c1-30(23-25-11-15(12-26-23)22(32)29-33)13-16-9-17-19(36-16)21(31-5-7-35-8-6-31)28-20(27-17)14-3-4-18(34-2)24-10-14/h3-4,9-12,33H,5-8,13H2,1-2H3,(H,29,32)	PI3-kinase p110-beta subunit inhibitor	INHIBITOR	CHEMBL3145	PI3-kinase p110-beta subunit	Homo sapiens
CHEMBL3622533	FIMEPINOSTAT	COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1	JOWXJLIFIIOYMS-UHFFFAOYSA-N	InChI=1S/C23H24N8O4S/c1-30(23-25-11-15(12-26-23)22(32)29-33)13-16-9-17-19(36-16)21(31-5-7-35-8-6-31)28-20(27-17)14-3-4-18(34-2)24-10-14/h3-4,9-12,33H,5-8,13H2,1-2H3,(H,29,32)	PI3-kinase p110-alpha subunit inhibitor	INHIBITOR	CHEMBL4005	PI3-kinase p110-alpha subunit	Homo sapiens
CHEMBL3622533	FIMEPINOSTAT	COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1	JOWXJLIFIIOYMS-UHFFFAOYSA-N	InChI=1S/C23H24N8O4S/c1-30(23-25-11-15(12-26-23)22(32)29-33)13-16-9-17-19(36-16)21(31-5-7-35-8-6-31)28-20(27-17)14-3-4-18(34-2)24-10-14/h3-4,9-12,33H,5-8,13H2,1-2H3,(H,29,32)	Histone deacetylase inhibitor	INHIBITOR	CHEMBL2093865	Histone deacetylase	Homo sapiens
CHEMBL482967	CYC-116	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1	GPSZYOIFQZPWEJ-UHFFFAOYSA-N	InChI=1S/C18H20N6OS/c1-12-16(26-17(19)21-12)15-6-7-20-18(23-15)22-13-2-4-14(5-3-13)24-8-10-25-11-9-24/h2-7H,8-11H2,1H3,(H2,19,21)(H,20,22,23)	Serine/threonine-protein kinase Aurora inhibitor	INHIBITOR	CHEMBL3430911	Serine/threonine-protein kinase Aurora	Homo sapiens
CHEMBL482967	CYC-116	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1	GPSZYOIFQZPWEJ-UHFFFAOYSA-N	InChI=1S/C18H20N6OS/c1-12-16(26-17(19)21-12)15-6-7-20-18(23-15)22-13-2-4-14(5-3-13)24-8-10-25-11-9-24/h2-7H,8-11H2,1H3,(H2,19,21)(H,20,22,23)	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL3545365	ALTIRATINIB	O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1	GNNDEPIMDAZHRQ-UHFFFAOYSA-N	InChI=1S/C26H21F3N4O4/c27-15-3-5-16(6-4-15)31-24(35)26(8-9-26)25(36)32-20-12-19(29)21(13-18(20)28)37-17-7-10-30-22(11-17)33-23(34)14-1-2-14/h3-7,10-14H,1-2,8-9H2,(H,31,35)(H,32,36)(H,30,33,34)	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL3545365	ALTIRATINIB	O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1	GNNDEPIMDAZHRQ-UHFFFAOYSA-N	InChI=1S/C26H21F3N4O4/c27-15-3-5-16(6-4-15)31-24(35)26(8-9-26)25(36)32-20-12-19(29)21(13-18(20)28)37-17-7-10-30-22(11-17)33-23(34)14-1-2-14/h3-7,10-14H,1-2,8-9H2,(H,31,35)(H,32,36)(H,30,33,34)	Tyrosine-protein kinase TIE-2 inhibitor	INHIBITOR	CHEMBL4128	Tyrosine-protein kinase TIE-2	Homo sapiens
CHEMBL3545365	ALTIRATINIB	O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1	GNNDEPIMDAZHRQ-UHFFFAOYSA-N	InChI=1S/C26H21F3N4O4/c27-15-3-5-16(6-4-15)31-24(35)26(8-9-26)25(36)32-20-12-19(29)21(13-18(20)28)37-17-7-10-30-22(11-17)33-23(34)14-1-2-14/h3-7,10-14H,1-2,8-9H2,(H,31,35)(H,32,36)(H,30,33,34)	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL3545365	ALTIRATINIB	O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1	GNNDEPIMDAZHRQ-UHFFFAOYSA-N	InChI=1S/C26H21F3N4O4/c27-15-3-5-16(6-4-15)31-24(35)26(8-9-26)25(36)32-20-12-19(29)21(13-18(20)28)37-17-7-10-30-22(11-17)33-23(34)14-1-2-14/h3-7,10-14H,1-2,8-9H2,(H,31,35)(H,32,36)(H,30,33,34)	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	CHEMBL3559684	Neurotrophic tyrosine kinase receptor	Homo sapiens
CHEMBL3544964	RAVOXERTINIB	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1	RZUOCXOYPYGSKL-GOSISDBHSA-N	InChI=1S/C21H18ClFN6O2/c1-28-19(5-8-25-28)27-21-24-7-4-17(26-21)13-6-9-29(20(31)11-13)18(12-30)14-2-3-15(22)16(23)10-14/h2-11,18,30H,12H2,1H3,(H,24,26,27)/t18-/m1/s1	MAP kinase ERK1 inhibitor	INHIBITOR	CHEMBL3385	MAP kinase ERK1	Homo sapiens
CHEMBL3544964	RAVOXERTINIB	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1	RZUOCXOYPYGSKL-GOSISDBHSA-N	InChI=1S/C21H18ClFN6O2/c1-28-19(5-8-25-28)27-21-24-7-4-17(26-21)13-6-9-29(20(31)11-13)18(12-30)14-2-3-15(22)16(23)10-14/h2-11,18,30H,12H2,1H3,(H,24,26,27)/t18-/m1/s1	MAP kinase ERK2 inhibitor	INHIBITOR	CHEMBL4040	MAP kinase ERK2	Homo sapiens
CHEMBL3916717	SELONSERTIB	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1	YIDDLAAKOYYGJG-UHFFFAOYSA-N	InChI=1S/C24H24FN7O/c1-14(2)32-13-27-30-23(32)19-5-4-6-22(28-19)29-24(33)17-10-21(15(3)9-18(17)25)31-11-20(26-12-31)16-7-8-16/h4-6,9-14,16H,7-8H2,1-3H3,(H,28,29,33)	Mitogen-activated protein kinase kinase kinase 5 inhibitor	INHIBITOR	CHEMBL5285	Mitogen-activated protein kinase kinase kinase 5	Homo sapiens
CHEMBL3544966	GSK-1059615	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1	QDITZBLZQQZVEE-YBEGLDIGSA-N	InChI=1S/C18H11N3O2S/c22-17-16(24-18(23)21-17)10-11-1-2-15-14(9-11)13(5-8-20-15)12-3-6-19-7-4-12/h1-10H,(H,21,22,23)/b16-10-	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL1090479	GSK-1070916	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1	QTBWCSQGBMPECM-UHFFFAOYSA-N	InChI=1S/C30H33N7O/c1-6-37-19-26(28(34-37)21-10-12-23(13-11-21)32-30(38)36(4)5)24-14-15-31-29-25(24)17-27(33-29)22-9-7-8-20(16-22)18-35(2)3/h7-17,19H,6,18H2,1-5H3,(H,31,33)(H,32,38)	Serine/threonine-protein kinase Aurora-B inhibitor	INHIBITOR	CHEMBL2185	Serine/threonine-protein kinase Aurora-B	Homo sapiens
CHEMBL1090479	GSK-1070916	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1	QTBWCSQGBMPECM-UHFFFAOYSA-N	InChI=1S/C30H33N7O/c1-6-37-19-26(28(34-37)21-10-12-23(13-11-21)32-30(38)36(4)5)24-14-15-31-29-25(24)17-27(33-29)22-9-7-8-20(16-22)18-35(2)3/h7-17,19H,6,18H2,1-5H3,(H,31,33)(H,32,38)	Serine/threonine-protein kinase Aurora-C inhibitor	INHIBITOR	CHEMBL3935	Serine/threonine-protein kinase Aurora-C	Homo sapiens
CHEMBL1236962	OMIPALISIB	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F	CGBJSGAELGCMKE-UHFFFAOYSA-N	InChI=1S/C25H17F2N5O3S/c1-35-25-23(32-36(33,34)24-5-3-18(26)12-21(24)27)11-17(13-29-25)15-2-4-22-20(10-15)19(7-8-28-22)16-6-9-30-31-14-16/h2-14,32H,1H3	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL1236962	OMIPALISIB	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F	CGBJSGAELGCMKE-UHFFFAOYSA-N	InChI=1S/C25H17F2N5O3S/c1-35-25-23(32-36(33,34)24-5-3-18(26)12-21(24)27)11-17(13-29-25)15-2-4-22-20(10-15)19(7-8-28-22)16-6-9-30-31-14-16/h2-14,32H,1H3	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL3188551	GSK-2636771	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F	XTKLTGBKIDQGQL-UHFFFAOYSA-N	InChI=1S/C22H22F3N3O3/c1-13-15(4-3-5-18(13)22(23,24)25)12-28-14(2)26-20-17(21(29)30)10-16(11-19(20)28)27-6-8-31-9-7-27/h3-5,10-11H,6-9,12H2,1-2H3,(H,29,30)	PI3-kinase p110-beta subunit inhibitor	INHIBITOR	CHEMBL3145	PI3-kinase p110-beta subunit	Homo sapiens
CHEMBL1908394	GSK-461364	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F	ZHJGWYRLJUCMRT-QGZVFWFLSA-N	InChI=1S/C27H28F3N5O2S/c1-17(19-5-3-4-6-20(19)27(28,29)30)37-23-14-24(38-25(23)26(31)36)35-16-32-21-8-7-18(13-22(21)35)15-34-11-9-33(2)10-12-34/h3-8,13-14,16-17H,9-12,15H2,1-2H3,(H2,31,36)/t17-/m1/s1	Serine/threonine-protein kinase PLK1 inhibitor	INHIBITOR	CHEMBL3024	Serine/threonine-protein kinase PLK1	Homo sapiens
CHEMBL494089	GSK-690693	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21	KGPGFQWBCSZGEL-ZDUSSCGKSA-N	InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-5-9-23-10-13)11-24-14(7-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4-6,9-10,12H2,1-3H3,(H2,22,27)/t13-/m0/s1	Serine/threonine-protein kinase AKT inhibitor	INHIBITOR	CHEMBL2111353	Serine/threonine-protein kinase AKT	Homo sapiens
CHEMBL494089	GSK-690693	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21	KGPGFQWBCSZGEL-ZDUSSCGKSA-N	InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-5-9-23-10-13)11-24-14(7-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4-6,9-10,12H2,1-3H3,(H2,22,27)/t13-/m0/s1	cAMP-dependent protein kinase (PKA) inhibitor	INHIBITOR	CHEMBL2094138	cAMP-dependent protein kinase (PKA)	Homo sapiens
CHEMBL494089	GSK-690693	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21	KGPGFQWBCSZGEL-ZDUSSCGKSA-N	InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-5-9-23-10-13)11-24-14(7-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4-6,9-10,12H2,1-3H3,(H2,22,27)/t13-/m0/s1	Protein kinase C (PKC) inhibitor	INHIBITOR	CHEMBL2093867	Protein kinase C (PKC)	Homo sapiens
CHEMBL3786343	OLMUTINIB	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1	FDMQDKQUTRLUBU-UHFFFAOYSA-N	InChI=1S/C26H26N6O2S/c1-3-23(33)27-19-5-4-6-21(17-19)34-25-24-22(11-16-35-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30)	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL4297190	SURUFATINIB	Cc1cc2cc(Oc3ccnc(Nc4cccc(CS(=O)(=O)NCCN(C)C)c4)n3)ccc2[nH]1	TTZSNFLLYPYKIL-UHFFFAOYSA-N	InChI=1S/C24H28N6O3S/c1-17-13-19-15-21(7-8-22(19)27-17)33-23-9-10-25-24(29-23)28-20-6-4-5-18(14-20)16-34(31,32)26-11-12-30(2)3/h4-10,13-15,26-27H,11-12,16H2,1-3H3,(H,25,28,29)	Fibroblast growth factor receptor 1 inhibitor	INHIBITOR	CHEMBL3650	Fibroblast growth factor receptor 1	Homo sapiens
CHEMBL4297190	SURUFATINIB	Cc1cc2cc(Oc3ccnc(Nc4cccc(CS(=O)(=O)NCCN(C)C)c4)n3)ccc2[nH]1	TTZSNFLLYPYKIL-UHFFFAOYSA-N	InChI=1S/C24H28N6O3S/c1-17-13-19-15-21(7-8-22(19)27-17)33-23-9-10-25-24(29-23)28-20-6-4-5-18(14-20)16-34(31,32)26-11-12-30(2)3/h4-10,13-15,26-27H,11-12,16H2,1-3H3,(H,25,28,29)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL2133806	JNJ-38877605	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1	JRWCBEOAFGHNNU-UHFFFAOYSA-N	InChI=1S/C19H13F2N7/c1-27-11-13(10-23-27)16-6-7-17-24-25-18(28(17)26-16)19(20,21)14-4-5-15-12(9-14)3-2-8-22-15/h2-11H,1H3	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL3674570	EDICOTINIB	CC1(C)CC=C(c2nc(C3CC(C)(C)OC(C)(C)C3)ccc2NC(=O)c2nc(C#N)c[nH]2)CC1	BNVPFDRNGHMRJS-UHFFFAOYSA-N	InChI=1S/C27H35N5O2/c1-25(2)11-9-17(10-12-25)22-21(32-24(33)23-29-16-19(15-28)30-23)8-7-20(31-22)18-13-26(3,4)34-27(5,6)14-18/h7-9,16,18H,10-14H2,1-6H3,(H,29,30)(H,32,33)	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	CHEMBL1844	Macrophage colony stimulating factor receptor	Homo sapiens
CHEMBL406381	KRN-633	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl	VPBYZLCHOKSGRX-UHFFFAOYSA-N	InChI=1S/C20H21ClN4O4/c1-4-7-22-20(26)25-15-6-5-12(8-14(15)21)29-19-13-9-17(27-2)18(28-3)10-16(13)23-11-24-19/h5-6,8-11H,4,7H2,1-3H3,(H2,22,25,26)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL1908397	KW-2449	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1	YYLKKYCXAOBSRM-JXMROGBWSA-N	InChI=1S/C20H20N4O/c25-20(24-13-11-21-12-14-24)16-8-5-15(6-9-16)7-10-19-17-3-1-2-4-18(17)22-23-19/h1-10,21H,11-14H2,(H,22,23)/b10-7+	Serine/threonine-protein kinase Aurora-A inhibitor	INHIBITOR	CHEMBL4722	Serine/threonine-protein kinase Aurora-A	Homo sapiens
CHEMBL1908397	KW-2449	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1	YYLKKYCXAOBSRM-JXMROGBWSA-N	InChI=1S/C20H20N4O/c25-20(24-13-11-21-12-14-24)16-8-5-15(6-9-16)7-10-19-17-3-1-2-4-18(17)22-23-19/h1-10,21H,11-14H2,(H,22,23)/b10-7+	Serine/threonine-protein kinase Aurora-B inhibitor	INHIBITOR	CHEMBL2185	Serine/threonine-protein kinase Aurora-B	Homo sapiens
CHEMBL1908397	KW-2449	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1	YYLKKYCXAOBSRM-JXMROGBWSA-N	InChI=1S/C20H20N4O/c25-20(24-13-11-21-12-14-24)16-8-5-15(6-9-16)7-10-19-17-3-1-2-4-18(17)22-23-19/h1-10,21H,11-14H2,(H,22,23)/b10-7+	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL1908397	KW-2449	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1	YYLKKYCXAOBSRM-JXMROGBWSA-N	InChI=1S/C20H20N4O/c25-20(24-13-11-21-12-14-24)16-8-5-15(6-9-16)7-10-19-17-3-1-2-4-18(17)22-23-19/h1-10,21H,11-14H2,(H,22,23)/b10-7+	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	CHEMBL1862	Tyrosine-protein kinase ABL	Homo sapiens
CHEMBL3889654	LAROTRECTINIB	O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1	NYNZQNWKBKUAII-KBXCAEBGSA-N	InChI=1S/C21H22F2N6O2/c22-13-3-4-16(23)15(10-13)18-2-1-7-28(18)19-6-9-29-20(26-19)17(11-24-29)25-21(31)27-8-5-14(30)12-27/h3-4,6,9-11,14,18,30H,1-2,5,7-8,12H2,(H,25,31)/t14-,18+/m0/s1	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	CHEMBL3559684	Neurotrophic tyrosine kinase receptor	Homo sapiens
CHEMBL3545076	LY-2584702	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1	FYXRSVDHGLUMHB-UHFFFAOYSA-N	InChI=1S/C21H19F4N7/c1-31-10-17(13-2-3-16(22)15(8-13)21(23,24)25)29-19(31)12-4-6-32(7-5-12)20-14-9-28-30-18(14)26-11-27-20/h2-3,8-12H,4-7H2,1H3,(H,26,27,28,30)	Ribosomal protein S6 kinase 1 inhibitor	INHIBITOR	CHEMBL4501	Ribosomal protein S6 kinase 1	Homo sapiens
CHEMBL3545307	MERESTINIB	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1	QHADVLVFMKEIIP-UHFFFAOYSA-N	InChI=1S/C30H22F2N6O3/c1-17-3-9-23(30(40)38(17)22-7-4-20(31)5-8-22)29(39)36-21-6-10-27(25(32)12-21)41-28-11-18-16-35-37(2)26(18)13-24(28)19-14-33-34-15-19/h3-16H,1-2H3,(H,33,34)(H,36,39)	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL3545264	LY-2874455	CC(Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl	GKJCVYLDJWTWQU-DUXPYHPUSA-N	InChI=1S/C21H19Cl2N5O2/c1-13(21-17(22)10-24-11-18(21)23)30-15-3-5-20-16(8-15)19(26-27-20)4-2-14-9-25-28(12-14)6-7-29/h2-5,8-13,29H,6-7H2,1H3,(H,26,27)/b4-2+	Fibroblast growth factor receptor inhibitor	INHIBITOR	CHEMBL2095217	Fibroblast growth factor receptor	Homo sapiens
CHEMBL3182444	MK-5108	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1	LCVIRAZGMYMNNT-UHFFFAOYSA-N	InChI=1S/C22H21ClFN3O3S/c23-16-4-2-5-17(19(16)24)30-15-7-9-22(10-8-15,20(28)29)13-14-3-1-6-18(26-14)27-21-25-11-12-31-21/h1-6,11-12,15H,7-10,13H2,(H,28,29)(H,25,26,27)	Serine/threonine-protein kinase Aurora-A inhibitor	INHIBITOR	CHEMBL4722	Serine/threonine-protein kinase Aurora-A	Homo sapiens
CHEMBL3545378	MK-6592	Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(O[C@H]3CCN(C(=O)c4cc(Cl)ccc4F)C3)n2)n[nH]1	SLUHYAXFRJQTGB-KRWDZBQOSA-N	InChI=1S/C25H26ClF2N7O2/c1-14-8-21(33-32-14)29-20-10-22(35-12-25(28,13-35)15-2-3-15)31-24(30-20)37-17-6-7-34(11-17)23(36)18-9-16(26)4-5-19(18)27/h4-5,8-10,15,17H,2-3,6-7,11-13H2,1H3,(H2,29,30,31,32,33)/t17-/m0/s1	Serine/threonine-protein kinase Aurora inhibitor	INHIBITOR	CHEMBL3430911	Serine/threonine-protein kinase Aurora	Homo sapiens
CHEMBL2323775	MK-8033	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1	VMJFTOSOFDEKTM-UHFFFAOYSA-N	InChI=1S/C25H21N5O3S/c1-30-15-20(13-28-30)19-11-23-24(27-12-19)8-7-18-6-5-17(10-22(18)25(23)31)16-34(32,33)29-14-21-4-2-3-9-26-21/h2-13,15,29H,14,16H2,1H3	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL2323775	MK-8033	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1	VMJFTOSOFDEKTM-UHFFFAOYSA-N	InChI=1S/C25H21N5O3S/c1-30-15-20(13-28-30)19-11-23-24(27-12-19)8-7-18-6-5-17(10-22(18)25(23)31)16-34(32,33)29-14-21-4-2-3-9-26-21/h2-13,15,29H,14,16H2,1H3	Macrophage-stimulating protein receptor inhibitor	INHIBITOR	CHEMBL2689	Macrophage-stimulating protein receptor	Homo sapiens
CHEMBL2104954	BALAMAPIMOD	COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2cc1N1CCC(N2CCCC2)CC1	CVAKNHIXTWLGJO-UHFFFAOYSA-N	InChI=1S/C30H32ClN7OS/c1-36-14-9-33-30(36)40-28-6-5-21(15-24(28)31)35-29-20(18-32)19-34-25-17-26(27(39-2)16-23(25)29)38-12-7-22(8-13-38)37-10-3-4-11-37/h5-6,9,14-17,19,22H,3-4,7-8,10-13H2,1-2H3,(H,34,35)	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3587	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens
CHEMBL2104954	BALAMAPIMOD	COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2cc1N1CCC(N2CCCC2)CC1	CVAKNHIXTWLGJO-UHFFFAOYSA-N	InChI=1S/C30H32ClN7OS/c1-36-14-9-33-30(36)40-28-6-5-21(15-24(28)31)35-29-20(18-32)19-34-25-17-26(27(39-2)16-23(25)29)38-12-7-22(8-13-38)37-10-3-4-11-37/h5-6,9,14-17,19,22H,3-4,7-8,10-13H2,1-2H3,(H,34,35)	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	CHEMBL2964	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens
CHEMBL3935857	SERABELISIB	Nc1nc2cc(-c3ccc4ncc(C(=O)N5CCOCC5)n4c3)ccc2o1	BLGWHBSBBJNKJO-UHFFFAOYSA-N	InChI=1S/C19H17N5O3/c20-19-22-14-9-12(1-3-16(14)27-19)13-2-4-17-21-10-15(24(17)11-13)18(25)23-5-7-26-8-6-23/h1-4,9-11H,5-8H2,(H2,20,22)	PI3-kinase p110-alpha subunit inhibitor	INHIBITOR	CHEMBL4005	PI3-kinase p110-alpha subunit	Homo sapiens
CHEMBL3348923	MLN-2480	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1	VWMJHAFYPMOMGF-ZCFIWIBFSA-N	InChI=1S/C17H12Cl2F3N7O2S/c1-6(28-15(31)12-11(19)13(23)27-5-26-12)16-25-4-9(32-16)14(30)29-10-2-7(17(20,21)22)8(18)3-24-10/h2-6H,1H3,(H,28,31)(H2,23,26,27)(H,24,29,30)/t6-/m1/s1	RAF serine/threonine protein kinase inhibitor	INHIBITOR	CHEMBL3559685	RAF serine/threonine protein kinase	Homo sapiens
CHEMBL259084	MLN-8054	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1	HHFBDROWDBDFBR-UHFFFAOYSA-N	InChI=1S/C25H15ClF2N4O2/c26-15-6-9-17-18(10-15)23(21-19(27)2-1-3-20(21)28)29-11-14-12-30-25(32-22(14)17)31-16-7-4-13(5-8-16)24(33)34/h1-10,12H,11H2,(H,33,34)(H,30,31,32)	Serine/threonine-protein kinase Aurora-A inhibitor	INHIBITOR	CHEMBL4722	Serine/threonine-protein kinase Aurora-A	Homo sapiens
CHEMBL1738758	ONVANSERTIB	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1	QHLVBNKYJGBCQJ-UHFFFAOYSA-N	InChI=1S/C24H27F3N8O3/c1-33-6-8-34(9-7-33)15-3-5-18(38-24(25,26)27)17(12-15)30-23-29-13-14-2-4-16-20(22(28)37)32-35(10-11-36)21(16)19(14)31-23/h3,5,12-13,36H,2,4,6-11H2,1H3,(H2,28,37)(H,29,30,31)	Serine/threonine-protein kinase PLK1 inhibitor	INHIBITOR	CHEMBL3024	Serine/threonine-protein kinase PLK1	Homo sapiens
CHEMBL2219421	RECILISIB	O=C(O)c1ccc(/C=C/S(=O)(=O)Cc2ccc(Cl)cc2)cc1	KBEKQQJUNVQLDZ-MDZDMXLPSA-N	InChI=1S/C16H13ClO4S/c17-15-7-3-13(4-8-15)11-22(20,21)10-9-12-1-5-14(6-2-12)16(18)19/h1-10H,11H2,(H,18,19)/b10-9+	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL4071161	TIRABRUTINIB	CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	SEJLPXCPMNSRAM-GOSISDBHSA-N	InChI=1S/C25H22N6O3/c1-2-6-21(32)29-14-13-18(15-29)31-24-22(23(26)27-16-28-24)30(25(31)33)17-9-11-20(12-10-17)34-19-7-4-3-5-8-19/h3-5,7-12,16,18H,13-15H2,1H3,(H2,26,27,28)/t18-/m1/s1	Tyrosine-protein kinase BTK inhibitor	INHIBITOR	CHEMBL5251	Tyrosine-protein kinase BTK	Homo sapiens
CHEMBL3989868	TUCATINIB	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1	SDEAXTCZPQIFQM-UHFFFAOYSA-N	InChI=1S/C26H24N8O2/c1-16-10-17(5-7-22(16)36-19-8-9-34-23(12-19)28-15-30-34)31-24-20-11-18(4-6-21(20)27-14-29-24)32-25-33-26(2,3)13-35-25/h4-12,14-15H,13H2,1-3H3,(H,32,33)(H,27,29,31)	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL1614710	OSI-930	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12	FGTCROZDHDSNIO-UHFFFAOYSA-N	InChI=1S/C22H16F3N3O2S/c23-22(24,25)30-16-7-5-15(6-8-16)28-21(29)20-19(10-12-31-20)27-13-14-9-11-26-18-4-2-1-3-17(14)18/h1-12,27H,13H2,(H,28,29)	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL1614710	OSI-930	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12	FGTCROZDHDSNIO-UHFFFAOYSA-N	InChI=1S/C22H16F3N3O2S/c23-22(24,25)30-16-7-5-15(6-8-16)28-21(29)20-19(10-12-31-20)27-13-14-9-11-26-18-4-2-1-3-17(14)18/h1-12,27H,13H2,(H,28,29)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL1684984	PA-799	CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21	JEGHXKRHKHPBJD-UHFFFAOYSA-N	InChI=1S/C15H19N7O3S/c1-26(23,24)22-3-2-11-12(10-8-17-14(16)18-9-10)19-15(20-13(11)22)21-4-6-25-7-5-21/h8-9H,2-7H2,1H3,(H2,16,17,18)	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL2141712	PALOMID-529	COc1ccc(COc2cc3oc(=O)c4cc(C(C)O)ccc4c3cc2OC)cc1	YEAHTLOYHVWAKW-UHFFFAOYSA-N	InChI=1S/C24H22O6/c1-14(25)16-6-9-18-19-11-22(28-3)23(12-21(19)30-24(26)20(18)10-16)29-13-15-4-7-17(27-2)8-5-15/h4-12,14,25H,13H2,1-3H3	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL3545196	PD-0166285	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1.Cl.Cl	NADLBPWBFGTESN-UHFFFAOYSA-N	InChI=1S/C26H27Cl2N5O2.2ClH/c1-4-33(5-2)13-14-35-19-11-9-18(10-12-19)30-26-29-16-17-15-20(25(34)32(3)24(17)31-26)23-21(27)7-6-8-22(23)28;;/h6-12,15-16H,4-5,13-14H2,1-3H3,(H,29,30,31);2*1H	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL3545196	PD-0166285	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1.Cl.Cl	NADLBPWBFGTESN-UHFFFAOYSA-N	InChI=1S/C26H27Cl2N5O2.2ClH/c1-4-33(5-2)13-14-35-19-11-9-18(10-12-19)30-26-29-16-17-15-20(25(34)32(3)24(17)31-26)23-21(27)7-6-8-22(23)28;;/h6-12,15-16H,4-5,13-14H2,1-3H3,(H,29,30,31);2*1H	Fibroblast growth factor receptor 1 inhibitor	INHIBITOR	CHEMBL3650	Fibroblast growth factor receptor 1	Homo sapiens
CHEMBL3545196	PD-0166285	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1.Cl.Cl	NADLBPWBFGTESN-UHFFFAOYSA-N	InChI=1S/C26H27Cl2N5O2.2ClH/c1-4-33(5-2)13-14-35-19-11-9-18(10-12-19)30-26-29-16-17-15-20(25(34)32(3)24(17)31-26)23-21(27)7-6-8-22(23)28;;/h6-12,15-16H,4-5,13-14H2,1-3H3,(H,29,30,31);2*1H	Platelet-derived growth factor receptor beta inhibitor	INHIBITOR	CHEMBL1913	Platelet-derived growth factor receptor beta	Homo sapiens
CHEMBL3545196	PD-0166285	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1.Cl.Cl	NADLBPWBFGTESN-UHFFFAOYSA-N	InChI=1S/C26H27Cl2N5O2.2ClH/c1-4-33(5-2)13-14-35-19-11-9-18(10-12-19)30-26-29-16-17-15-20(25(34)32(3)24(17)31-26)23-21(27)7-6-8-22(23)28;;/h6-12,15-16H,4-5,13-14H2,1-3H3,(H,29,30,31);2*1H	Tyrosine-protein kinase SRC inhibitor	INHIBITOR	CHEMBL267	Tyrosine-protein kinase SRC	Homo sapiens
CHEMBL3545137	PF-00477736	Cn1cc(-c2nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3-c2c[nH][nH]c4=O)cn1	YFNWWNRZJGMDBR-UHFFFAOYSA-N	InChI=1S/C22H25N7O2/c1-29-11-13(9-25-29)20-16-10-24-28-21(30)15-7-14(8-17(27-20)18(15)16)26-22(31)19(23)12-5-3-2-4-6-12/h7-12,19,24H,2-6,23H2,1H3,(H,26,31)(H,28,30)	Serine/threonine-protein kinase Chk1 inhibitor	INHIBITOR	CHEMBL4630	Serine/threonine-protein kinase Chk1	Homo sapiens
CHEMBL1084546	PF-00562271	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O	MZDKLVOWGIOKTN-UHFFFAOYSA-N	InChI=1S/C21H20F3N7O3S/c1-31(35(2,33)34)19-12(4-3-7-25-19)10-26-18-15(21(22,23)24)11-27-20(30-18)28-14-5-6-16-13(8-14)9-17(32)29-16/h3-8,11H,9-10H2,1-2H3,(H,29,32)(H2,26,27,28,30)	Focal adhesion kinase 1 inhibitor	INHIBITOR	CHEMBL2695	Focal adhesion kinase 1	Homo sapiens
CHEMBL1938400	PF-03715455	CC(C)(C)c1cc(NC(=O)NCc2ccccc2Sc2ccc3nnc(-c4ccccc4SCCO)n3c2)n(-c2ccc(O)c(Cl)c2)n1	VGEXRDWWPSGZDH-UHFFFAOYSA-N	InChI=1S/C35H34ClN7O3S2/c1-35(2,3)30-19-32(43(41-30)23-12-14-27(45)26(36)18-23)38-34(46)37-20-22-8-4-6-10-28(22)48-24-13-15-31-39-40-33(42(31)21-24)25-9-5-7-11-29(25)47-17-16-44/h4-15,18-19,21,44-45H,16-17,20H2,1-3H3,(H2,37,38,46)	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL3128043	PF-03758309	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1	AYCPARAPKDAOEN-LJQANCHMSA-N	InChI=1S/C25H30N8OS/c1-15-26-18-11-12-35-20(18)23(27-15)29-22-17-13-33(25(2,3)21(17)30-31-22)24(34)28-19(14-32(4)5)16-9-7-6-8-10-16/h6-12,19H,13-14H2,1-5H3,(H,28,34)(H2,26,27,29,30,31)/t19-/m1/s1	Serine/threonine-protein kinase PAK 4 inhibitor	INHIBITOR	CHEMBL4482	Serine/threonine-protein kinase PAK 4	Homo sapiens
CHEMBL2001019	PF-04217903	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1	PDMUGYOXRHVNMO-UHFFFAOYSA-N	InChI=1S/C19H16N8O/c28-7-6-26-12-15(9-22-26)17-10-21-18-19(23-17)27(25-24-18)11-13-3-4-16-14(8-13)2-1-5-20-16/h1-5,8-10,12,28H,6-7,11H2	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL3655081	ABROCITINIB	CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1	IUEWXNHSKRWHDY-PHIMTYICSA-N	InChI=1S/C14H21N5O2S/c1-3-6-22(20,21)18-10-7-11(8-10)19(2)14-12-4-5-15-13(12)16-9-17-14/h4-5,9-11,18H,3,6-8H2,1-2H3,(H,15,16,17)/t10-,11+	Tyrosine-protein kinase JAK1 inhibitor	INHIBITOR	CHEMBL2835	Tyrosine-protein kinase JAK1	Homo sapiens
CHEMBL1230607	PHA-793887	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C	HUXYBQXJVXOMKX-UHFFFAOYSA-N	InChI=1S/C19H31N5O2/c1-12(2)10-15(25)20-17-14-11-24(19(3,4)16(14)21-22-17)18(26)13-6-8-23(5)9-7-13/h12-13H,6-11H2,1-5H3,(H2,20,21,22,25)	Cyclin-dependent kinase inhibitor	INHIBITOR	CHEMBL3559691	Cyclin-dependent kinase	Homo sapiens
CHEMBL1963502	PKI-166	C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccccc1	XRYJULCDUUATMC-CYBMUJFWSA-N	InChI=1S/C20H18N4O/c1-13(14-5-3-2-4-6-14)23-19-17-11-18(24-20(17)22-12-21-19)15-7-9-16(25)10-8-15/h2-13,25H,1H3,(H2,21,22,23,24)/t13-/m1/s1	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL1258517	PKI-179	O=C(Nc1ccncc1)Nc1ccc(-c2nc(N3CCOCC3)nc(N3C4CCC3COC4)n2)cc1	WXUUCRLKXQMWRY-UHFFFAOYSA-N	InChI=1S/C25H28N8O3/c34-25(28-19-7-9-26-10-8-19)27-18-3-1-17(2-4-18)22-29-23(32-11-13-35-14-12-32)31-24(30-22)33-20-5-6-21(33)16-36-15-20/h1-4,7-10,20-21H,5-6,11-16H2,(H2,26,27,28,34)	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL1258517	PKI-179	O=C(Nc1ccncc1)Nc1ccc(-c2nc(N3CCOCC3)nc(N3C4CCC3COC4)n2)cc1	WXUUCRLKXQMWRY-UHFFFAOYSA-N	InChI=1S/C25H28N8O3/c34-25(28-19-7-9-26-10-8-19)27-18-3-1-17(2-4-18)22-29-23(32-11-13-35-14-12-32)31-24(30-22)33-20-5-6-21(33)16-36-15-20/h1-4,7-10,20-21H,5-6,11-16H2,(H2,26,27,28,34)	PI3-kinase p110-alpha subunit inhibitor	INHIBITOR	CHEMBL4005	PI3-kinase p110-alpha subunit	Homo sapiens
CHEMBL1766582	R-1487	Cl.Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21	RQHSAIGGUWVOBG-UHFFFAOYSA-N	InChI=1S/C19H18F2N4O3.ClH/c1-25-17-11(10-22-19(24-17)23-13-4-6-27-7-5-13)8-16(18(25)26)28-15-3-2-12(20)9-14(15)21;/h2-3,8-10,13H,4-7H2,1H3,(H,22,23,24);1H	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL384304	RG-547	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N	JRNJNYBQQYBCLE-UHFFFAOYSA-N	InChI=1S/C18H21F2N5O4S/c1-29-13-4-3-12(19)15(20)14(13)16(26)11-9-22-18(24-17(11)21)23-10-5-7-25(8-6-10)30(2,27)28/h3-4,9-10H,5-8H2,1-2H3,(H3,21,22,23,24)	Cyclin-dependent kinase 1 inhibitor	INHIBITOR	CHEMBL308	Cyclin-dependent kinase 1	Homo sapiens
CHEMBL384304	RG-547	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N	JRNJNYBQQYBCLE-UHFFFAOYSA-N	InChI=1S/C18H21F2N5O4S/c1-29-13-4-3-12(19)15(20)14(13)16(26)11-9-22-18(24-17(11)21)23-10-5-7-25(8-6-10)30(2,27)28/h3-4,9-10H,5-8H2,1-2H3,(H3,21,22,23,24)	Cyclin-dependent kinase 2 inhibitor	INHIBITOR	CHEMBL301	Cyclin-dependent kinase 2	Homo sapiens
CHEMBL384304	RG-547	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N	JRNJNYBQQYBCLE-UHFFFAOYSA-N	InChI=1S/C18H21F2N5O4S/c1-29-13-4-3-12(19)15(20)14(13)16(26)11-9-22-18(24-17(11)21)23-10-5-7-25(8-6-10)30(2,27)28/h3-4,9-10H,5-8H2,1-2H3,(H3,21,22,23,24)	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	CHEMBL331	Cyclin-dependent kinase 4	Homo sapiens
CHEMBL2106468	TRICETAMIDE	CCN(CC)C(=O)CNC(=O)c1cc(OC)c(OC)c(OC)c1	NLRFFZRHTICQBO-UHFFFAOYSA-N	InChI=1S/C16H24N2O5/c1-6-18(7-2)14(19)10-17-16(20)11-8-12(21-3)15(23-5)13(9-11)22-4/h8-9H,6-7,10H2,1-5H3,(H,17,20)	Tyrosine-protein kinase JAK1 inhibitor	INHIBITOR	CHEMBL2835	Tyrosine-protein kinase JAK1	Homo sapiens
CHEMBL2106468	TRICETAMIDE	CCN(CC)C(=O)CNC(=O)c1cc(OC)c(OC)c(OC)c1	NLRFFZRHTICQBO-UHFFFAOYSA-N	InChI=1S/C16H24N2O5/c1-6-18(7-2)14(19)10-17-16(20)11-8-12(21-3)15(23-5)13(9-11)22-4/h8-9H,6-7,10H2,1-5H3,(H,17,20)	Tyrosine-protein kinase JAK3 inhibitor	INHIBITOR	CHEMBL2148	Tyrosine-protein kinase JAK3	Homo sapiens
CHEMBL2331680	RG-7603	CCNC(=O)Nc1ccc(-c2nc3c(c(N4CCOC[C@@H]4C)n2)CCN(C2COC2)C3)cc1	RGJOJUGRHPQXGF-INIZCTEOSA-N	InChI=1S/C24H32N6O3/c1-3-25-24(31)26-18-6-4-17(5-7-18)22-27-21-12-29(19-14-33-15-19)9-8-20(21)23(28-22)30-10-11-32-13-16(30)2/h4-7,16,19H,3,8-15H2,1-2H3,(H2,25,26,31)/t16-/m0/s1	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL3545083	RGB-286638	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1	XLSYZSRXVVCHLS-UHFFFAOYSA-N	InChI=1S/C29H35N7O4/c1-39-16-13-34-9-11-35(12-10-34)19-20-5-7-21(8-6-20)26-25-27(32-31-26)22-3-2-4-23(24(22)28(25)37)30-29(38)33-36-14-17-40-18-15-36/h2-8H,9-19H2,1H3,(H,31,32)(H2,30,33,38)	Cyclin-dependent kinase 1 inhibitor	INHIBITOR	CHEMBL308	Cyclin-dependent kinase 1	Homo sapiens
CHEMBL3545083	RGB-286638	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1	XLSYZSRXVVCHLS-UHFFFAOYSA-N	InChI=1S/C29H35N7O4/c1-39-16-13-34-9-11-35(12-10-34)19-20-5-7-21(8-6-20)26-25-27(32-31-26)22-3-2-4-23(24(22)28(25)37)30-29(38)33-36-14-17-40-18-15-36/h2-8H,9-19H2,1H3,(H,31,32)(H2,30,33,38)	Cyclin-dependent kinase 2 inhibitor	INHIBITOR	CHEMBL301	Cyclin-dependent kinase 2	Homo sapiens
CHEMBL3545083	RGB-286638	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1	XLSYZSRXVVCHLS-UHFFFAOYSA-N	InChI=1S/C29H35N7O4/c1-39-16-13-34-9-11-35(12-10-34)19-20-5-7-21(8-6-20)26-25-27(32-31-26)22-3-2-4-23(24(22)28(25)37)30-29(38)33-36-14-17-40-18-15-36/h2-8H,9-19H2,1H3,(H,31,32)(H2,30,33,38)	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	CHEMBL331	Cyclin-dependent kinase 4	Homo sapiens
CHEMBL3545083	RGB-286638	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1	XLSYZSRXVVCHLS-UHFFFAOYSA-N	InChI=1S/C29H35N7O4/c1-39-16-13-34-9-11-35(12-10-34)19-20-5-7-21(8-6-20)26-25-27(32-31-26)22-3-2-4-23(24(22)28(25)37)30-29(38)33-36-14-17-40-18-15-36/h2-8H,9-19H2,1H3,(H,31,32)(H2,30,33,38)	Cyclin-dependent kinase 5 inhibitor	INHIBITOR	CHEMBL4036	Cyclin-dependent kinase 5	Homo sapiens
CHEMBL3545083	RGB-286638	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1	XLSYZSRXVVCHLS-UHFFFAOYSA-N	InChI=1S/C29H35N7O4/c1-39-16-13-34-9-11-35(12-10-34)19-20-5-7-21(8-6-20)26-25-27(32-31-26)22-3-2-4-23(24(22)28(25)37)30-29(38)33-36-14-17-40-18-15-36/h2-8H,9-19H2,1H3,(H,31,32)(H2,30,33,38)	Cyclin-dependent kinase 7 inhibitor	INHIBITOR	CHEMBL3055	Cyclin-dependent kinase 7	Homo sapiens
CHEMBL3545083	RGB-286638	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1	XLSYZSRXVVCHLS-UHFFFAOYSA-N	InChI=1S/C29H35N7O4/c1-39-16-13-34-9-11-35(12-10-34)19-20-5-7-21(8-6-20)26-25-27(32-31-26)22-3-2-4-23(24(22)28(25)37)30-29(38)33-36-14-17-40-18-15-36/h2-8H,9-19H2,1H3,(H,31,32)(H2,30,33,38)	Cyclin-dependent kinase 9 inhibitor	INHIBITOR	CHEMBL3116	Cyclin-dependent kinase 9	Homo sapiens
CHEMBL203567	RO-3201195	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1	IJDQETGUEUJVTB-HNNXBMFYSA-N	InChI=1S/C19H18FN3O4/c20-13-4-6-14(7-5-13)23-19(21)17(9-22-23)18(26)12-2-1-3-16(8-12)27-11-15(25)10-24/h1-9,15,24-25H,10-11,21H2/t15-/m0/s1	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL1614766	RO-4987655	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F	FIMYFEGKMOCQKT-UHFFFAOYSA-N	InChI=1S/C20H19F3IN3O5/c21-14-9-12(24)3-4-15(14)25-19-13(20(30)26-31-7-5-28)8-11(17(22)18(19)23)10-27-16(29)2-1-6-32-27/h3-4,8-9,25,28H,1-2,5-7,10H2,(H,26,30)	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3587	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens
CHEMBL1614766	RO-4987655	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F	FIMYFEGKMOCQKT-UHFFFAOYSA-N	InChI=1S/C20H19F3IN3O5/c21-14-9-12(24)3-4-15(14)25-19-13(20(30)26-31-7-5-28)8-11(17(22)18(19)23)10-27-16(29)2-1-6-32-27/h3-4,8-9,25,28H,1-2,5-7,10H2,(H,26,30)	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	CHEMBL2964	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens
CHEMBL190333	RWJ-67657	OCCC#Cc1nc(-c2ccc(F)cc2)c(-c2ccncc2)n1CCCc1ccccc1	QSUSKMBNZQHHPA-UHFFFAOYSA-N	InChI=1S/C27H24FN3O/c28-24-13-11-22(12-14-24)26-27(23-15-17-29-18-16-23)31(25(30-26)10-4-5-20-32)19-6-9-21-7-2-1-3-8-21/h1-3,7-8,11-18,32H,5-6,9,19-20H2	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL190333	RWJ-67657	OCCC#Cc1nc(-c2ccc(F)cc2)c(-c2ccncc2)n1CCCc1ccccc1	QSUSKMBNZQHHPA-UHFFFAOYSA-N	InChI=1S/C27H24FN3O/c28-24-13-11-22(12-14-24)26-27(23-15-17-29-18-16-23)31(25(30-26)10-4-5-20-32)19-6-9-21-7-2-1-3-8-21/h1-3,7-8,11-18,32H,5-6,9,19-20H2	MAP kinase p38 beta inhibitor	INHIBITOR	CHEMBL3961	MAP kinase p38 beta	Homo sapiens
CHEMBL2386889	SCH-900776	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1	GMIZZEXBPRLVIV-SECBINFHSA-N	InChI=1S/C15H18BrN7/c1-22-8-10(6-19-22)11-7-20-23-14(17)12(16)13(21-15(11)23)9-3-2-4-18-5-9/h6-9,18H,2-5,17H2,1H3/t9-/m1/s1	Serine/threonine-protein kinase Chk1 inhibitor	INHIBITOR	CHEMBL4630	Serine/threonine-protein kinase Chk1	Homo sapiens
CHEMBL1614702	SCIO-323	COc1cc2c(cc1C(=O)N1CCC(Cc3ccc(F)cc3)CC1)c(C(=O)C(=O)N(C)C)cn2C	JBNWDYGOTHQHOZ-UHFFFAOYSA-N	InChI=1S/C27H30FN3O4/c1-29(2)27(34)25(32)22-16-30(3)23-15-24(35-4)21(14-20(22)23)26(33)31-11-9-18(10-12-31)13-17-5-7-19(28)8-6-17/h5-8,14-16,18H,9-13H2,1-4H3	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL1090173	SD-0006	O=C(CO)N1CCC(c2n[nH]c(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1	CATQHDWESBRRQA-UHFFFAOYSA-N	InChI=1S/C20H20ClN5O2/c21-15-3-1-13(2-4-15)19-18(16-5-8-22-12-23-16)20(25-24-19)14-6-9-26(10-7-14)17(28)11-27/h1-5,8,12,14,27H,6-7,9-11H2,(H,24,25)	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL2326966	SF-1126	N=C(N)NCCC[C@H](NC(=O)CCC(=O)OC[N+]1(c2cc(=O)c3cccc(-c4ccccc4)c3o2)CCOCC1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)[O-]	SVNJBEMPMKWDCO-KCHLEUMXSA-N	InChI=1S/C39H48N8O14/c40-39(41)42-13-5-10-26(36(55)43-20-31(51)45-27(18-33(52)53)37(56)46-28(21-48)38(57)58)44-30(50)11-12-34(54)60-22-47(14-16-59-17-15-47)32-19-29(49)25-9-4-8-24(35(25)61-32)23-6-2-1-3-7-23/h1-4,6-9,19,26-28,48H,5,10-18,20-22H2,(H9-,40,41,42,43,44,45,46,50,51,52,53,55,56,57,58)/t26-,27-,28-/m0/s1	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL2326966	SF-1126	N=C(N)NCCC[C@H](NC(=O)CCC(=O)OC[N+]1(c2cc(=O)c3cccc(-c4ccccc4)c3o2)CCOCC1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)[O-]	SVNJBEMPMKWDCO-KCHLEUMXSA-N	InChI=1S/C39H48N8O14/c40-39(41)42-13-5-10-26(36(55)43-20-31(51)45-27(18-33(52)53)37(56)46-28(21-48)38(57)58)44-30(50)11-12-34(54)60-22-47(14-16-59-17-15-47)32-19-29(49)25-9-4-8-24(35(25)61-32)23-6-2-1-3-7-23/h1-4,6-9,19,26-28,48H,5,10-18,20-22H2,(H9-,40,41,42,43,44,45,46,50,51,52,53,55,56,57,58)/t26-,27-,28-/m0/s1	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL1952329	SGI-1776	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1	MHXGEROHKGDZGO-UHFFFAOYSA-N	InChI=1S/C20H22F3N5O/c1-27-9-7-14(8-10-27)12-24-18-5-6-19-25-13-17(28(19)26-18)15-3-2-4-16(11-15)29-20(21,22)23/h2-6,11,13-14H,7-10,12H2,1H3,(H,24,26)	Serine/threonine-protein kinase PIM inhibitor	INHIBITOR	CHEMBL3559682	Serine/threonine-protein kinase PIM	Homo sapiens
CHEMBL1236107	SGX-523	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1	BCZUAADEACICHN-UHFFFAOYSA-N	InChI=1S/C18H13N7S/c1-24-11-13(10-20-24)16-6-7-17-21-22-18(25(17)23-16)26-14-4-5-15-12(9-14)3-2-8-19-15/h2-11H,1H3	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL482767	SNS-314	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1	FAYAUAZLLLJJGH-UHFFFAOYSA-N	InChI=1S/C18H15ClN6OS2/c19-11-2-1-3-12(8-11)24-17(26)25-18-21-9-13(28-18)4-6-20-16-15-14(5-7-27-15)22-10-23-16/h1-3,5,7-10H,4,6H2,(H,20,22,23)(H2,21,24,25,26)	Serine/threonine-protein kinase Aurora inhibitor	INHIBITOR	CHEMBL3430911	Serine/threonine-protein kinase Aurora	Homo sapiens
CHEMBL258805	SU-9516	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2	QNUKRWAIZMBVCU-WCIBSUBMSA-N	InChI=1S/C13H11N3O2/c1-18-9-2-3-12-10(5-9)11(13(17)16-12)4-8-6-14-7-15-8/h2-7H,1H3,(H,14,15)(H,16,17)/b11-4-	Cyclin-dependent kinase 2 inhibitor	INHIBITOR	CHEMBL301	Cyclin-dependent kinase 2	Homo sapiens
CHEMBL1614707	MUBRITINIB	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1	ZTFBIUXIQYRUNT-MDWZMJQESA-N	InChI=1S/C25H23F3N4O2/c26-25(27,28)21-9-4-20(5-10-21)8-13-24-30-22(18-34-24)17-33-23-11-6-19(7-12-23)3-1-2-15-32-16-14-29-31-32/h4-14,16,18H,1-3,15,17H2/b13-8+	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL1614725	TAK-285	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21	ZYQXEVJIFYIBHZ-UHFFFAOYSA-N	InChI=1S/C26H25ClF3N5O3/c1-25(2,37)14-22(36)31-9-11-35-10-8-20-23(35)24(33-15-32-20)34-17-6-7-21(19(27)13-17)38-18-5-3-4-16(12-18)26(28,29)30/h3-8,10,12-13,15,37H,9,11,14H2,1-2H3,(H,31,36)(H,32,33,34)	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL1614725	TAK-285	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21	ZYQXEVJIFYIBHZ-UHFFFAOYSA-N	InChI=1S/C26H25ClF3N5O3/c1-25(2,37)14-22(36)31-9-11-35-10-8-20-23(35)24(33-15-32-20)34-17-6-7-21(19(27)13-17)38-18-5-3-4-16(12-18)26(28,29)30/h3-8,10,12-13,15,37H,9,11,14H2,1-2H3,(H,31,36)(H,32,33,34)	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL2180604	TAK-593	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1	DZFZXPPHBWCXPQ-UHFFFAOYSA-N	InChI=1S/C23H23N7O3/c1-13-4-7-16(11-17(13)24-23(32)18-10-14(2)27-29(18)3)33-21-9-8-20-25-19(12-30(20)28-21)26-22(31)15-5-6-15/h4,7-12,15H,5-6H2,1-3H3,(H,24,32)(H,26,31)	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL2180604	TAK-593	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1	DZFZXPPHBWCXPQ-UHFFFAOYSA-N	InChI=1S/C23H23N7O3/c1-13-4-7-16(11-17(13)24-23(32)18-10-14(2)27-29(18)3)33-21-9-8-20-25-19(12-30(20)28-21)26-22(31)15-5-6-15/h4,7-12,15H,5-6H2,1-3H3,(H,24,32)(H,26,31)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL1615025	TAK-733	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21	RCLQNICOARASSR-SECBINFHSA-N	InChI=1S/C17H15F2IN4O4/c1-23-15-12(16(27)24(7-21-15)5-9(26)6-25)14(13(19)17(23)28)22-11-3-2-8(20)4-10(11)18/h2-4,7,9,22,25-26H,5-6H2,1H3/t9-/m1/s1	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3587	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens
CHEMBL1615025	TAK-733	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21	RCLQNICOARASSR-SECBINFHSA-N	InChI=1S/C17H15F2IN4O4/c1-23-15-12(16(27)24(7-21-15)5-9(26)6-25)14(13(19)17(23)28)22-11-3-2-8(20)4-10(11)18/h2-4,7,9,22,25-26H,5-6H2,1H3/t9-/m1/s1	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	CHEMBL2964	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens
CHEMBL3544932	TAK-901	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1	WKDACQVEJIVHMZ-UHFFFAOYSA-N	InChI=1S/C28H32N4O3S/c1-5-36(34,35)21-8-6-7-19(14-21)23-15-22(28(33)30-20-9-11-32(4)12-10-20)18(3)26-25(23)24-13-17(2)16-29-27(24)31-26/h6-8,13-16,20H,5,9-12H2,1-4H3,(H,29,31)(H,30,33)	Serine/threonine-protein kinase Aurora-B inhibitor	INHIBITOR	CHEMBL2185	Serine/threonine-protein kinase Aurora-B	Homo sapiens
CHEMBL2392545	TAK-960	COc1cc(C(=O)NC2CCN(C)CC2)c(F)cc1Nc1ncc2c(n1)N(C1CCCC1)CC(F)(F)C(=O)N2C	GWRSATNRNFYMDI-UHFFFAOYSA-N	InChI=1S/C27H34F3N7O3/c1-35-10-8-16(9-11-35)32-24(38)18-12-22(40-3)20(13-19(18)28)33-26-31-14-21-23(34-26)37(17-6-4-5-7-17)15-27(29,30)25(39)36(21)2/h12-14,16-17H,4-11,15H2,1-3H3,(H,32,38)(H,31,33,34)	Serine/threonine-protein kinase PLK1 inhibitor	INHIBITOR	CHEMBL3024	Serine/threonine-protein kinase PLK1	Homo sapiens
CHEMBL1944698	ZOTIRACICLIB	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1	VXBAJLGYBMTJCY-NSCUHMNNSA-N	InChI=1S/C23H24N4O/c1-27-13-3-2-4-14-28-21-10-6-8-19(16-21)22-11-12-24-23(26-22)25-20-9-5-7-18(15-20)17-27/h2-3,5-12,15-16H,4,13-14,17H2,1H3,(H,24,25,26)/b3-2+	Cyclin-dependent kinase 1 inhibitor	INHIBITOR	CHEMBL308	Cyclin-dependent kinase 1	Homo sapiens
CHEMBL1944698	ZOTIRACICLIB	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1	VXBAJLGYBMTJCY-NSCUHMNNSA-N	InChI=1S/C23H24N4O/c1-27-13-3-2-4-14-28-21-10-6-8-19(16-21)22-11-12-24-23(26-22)25-20-9-5-7-18(15-20)17-27/h2-3,5-12,15-16H,4,13-14,17H2,1H3,(H,24,25,26)/b3-2+	Cyclin-dependent kinase 2 inhibitor	INHIBITOR	CHEMBL301	Cyclin-dependent kinase 2	Homo sapiens
CHEMBL1944698	ZOTIRACICLIB	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1	VXBAJLGYBMTJCY-NSCUHMNNSA-N	InChI=1S/C23H24N4O/c1-27-13-3-2-4-14-28-21-10-6-8-19(16-21)22-11-12-24-23(26-22)25-20-9-5-7-18(15-20)17-27/h2-3,5-12,15-16H,4,13-14,17H2,1H3,(H,24,25,26)/b3-2+	Cyclin-dependent kinase 7 inhibitor	INHIBITOR	CHEMBL3055	Cyclin-dependent kinase 7	Homo sapiens
CHEMBL1944698	ZOTIRACICLIB	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1	VXBAJLGYBMTJCY-NSCUHMNNSA-N	InChI=1S/C23H24N4O/c1-27-13-3-2-4-14-28-21-10-6-8-19(16-21)22-11-12-24-23(26-22)25-20-9-5-7-18(15-20)17-27/h2-3,5-12,15-16H,4,13-14,17H2,1H3,(H,24,25,26)/b3-2+	Cyclin-dependent kinase 9 inhibitor	INHIBITOR	CHEMBL3116	Cyclin-dependent kinase 9	Homo sapiens
CHEMBL1944698	ZOTIRACICLIB	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1	VXBAJLGYBMTJCY-NSCUHMNNSA-N	InChI=1S/C23H24N4O/c1-27-13-3-2-4-14-28-21-10-6-8-19(16-21)22-11-12-24-23(26-22)25-20-9-5-7-18(15-20)17-27/h2-3,5-12,15-16H,4,13-14,17H2,1H3,(H,24,25,26)/b3-2+	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL1944698	ZOTIRACICLIB	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1	VXBAJLGYBMTJCY-NSCUHMNNSA-N	InChI=1S/C23H24N4O/c1-27-13-3-2-4-14-28-21-10-6-8-19(16-21)22-11-12-24-23(26-22)25-20-9-5-7-18(15-20)17-27/h2-3,5-12,15-16H,4,13-14,17H2,1H3,(H,24,25,26)/b3-2+	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	CHEMBL2971	Tyrosine-protein kinase JAK2	Homo sapiens
CHEMBL3989869	UMBRALISIB TOSYLATE	CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F.Cc1ccc(S(=O)(=O)O)cc1	KYJWUPZPSXZEPG-NTISSMGPSA-N	InChI=1S/C31H24F3N5O3.C7H8O3S/c1-15(2)41-24-9-7-18(12-22(24)34)27-26-30(35)36-14-37-31(26)39(38-27)16(3)29-25(17-5-4-6-19(32)11-17)28(40)21-13-20(33)8-10-23(21)42-29;1-6-2-4-7(5-3-6)11(8,9)10/h4-16H,1-3H3,(H2,35,36,37);2-5H,1H3,(H,8,9,10)/t16-;/m0./s1	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	CHEMBL3130	PI3-kinase p110-delta subunit	Homo sapiens
CHEMBL1079593	VS-5584	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1[C@@H]1CCOc2c(F)cccc21	DBXGGXLBTWZXBB-MRXNPFEDSA-N	InChI=1S/C21H14F2N6O2/c22-11-4-5-14-17(8-11)28(10-25-14)20-24-9-15-19(27-20)29(21(30)26-15)16-6-7-31-18-12(16)2-1-3-13(18)23/h1-5,8-10,16H,6-7H2,(H,26,30)/t16-/m1/s1	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL1079593	VS-5584	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1[C@@H]1CCOc2c(F)cccc21	DBXGGXLBTWZXBB-MRXNPFEDSA-N	InChI=1S/C21H14F2N6O2/c22-11-4-5-14-17(8-11)28(10-25-14)20-24-9-15-19(27-20)29(21(30)26-15)16-6-7-31-18-12(16)2-1-3-13(18)23/h1-5,8-10,16H,6-7H2,(H,26,30)/t16-/m1/s1	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL3989870	BERZOSERTIB	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1	JZCWLJDSIRUGIN-UHFFFAOYSA-N	InChI=1S/C24H25N5O3S/c1-15(2)33(30,31)19-10-8-18(9-11-19)21-14-27-24(25)23(28-21)22-12-20(29-32-22)17-6-4-16(5-7-17)13-26-3/h4-12,14-15,26H,13H2,1-3H3,(H2,25,27)	Serine-protein kinase ATR inhibitor	INHIBITOR	CHEMBL5024	Serine-protein kinase ATR	Homo sapiens
CHEMBL405130	WHI-P131	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC	HOZUXBLMYUPGPZ-UHFFFAOYSA-N	InChI=1S/C16H15N3O3/c1-21-14-7-12-13(8-15(14)22-2)17-9-18-16(12)19-10-3-5-11(20)6-4-10/h3-9,20H,1-2H3,(H,17,18,19)	Tyrosine-protein kinase JAK3 inhibitor	INHIBITOR	CHEMBL2148	Tyrosine-protein kinase JAK3	Homo sapiens
CHEMBL4113131	ENSARTINIB	C[C@H]1CN(C(=O)c2ccc(NC(=O)c3cc(O[C@H](C)c4c(Cl)ccc(F)c4Cl)c(N)nn3)cc2)C[C@@H](C)N1	GLYMPHUVMRFTFV-QLFBSQMISA-N	InChI=1S/C26H27Cl2FN6O3/c1-13-11-35(12-14(2)31-13)26(37)16-4-6-17(7-5-16)32-25(36)20-10-21(24(30)34-33-20)38-15(3)22-18(27)8-9-19(29)23(22)28/h4-10,13-15,31H,11-12H2,1-3H3,(H2,30,34)(H,32,36)/t13-,14+,15-/m1/s1	ALK tyrosine kinase receptor inhibitor	INHIBITOR	CHEMBL4247	ALK tyrosine kinase receptor	Homo sapiens
CHEMBL3545328	XL-019	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1	ISOCDPQFIXDIMS-UHFFFAOYSA-N	InChI=1S/C25H28N6O2/c32-24(23-2-1-12-26-23)28-19-5-3-18(4-6-19)22-11-13-27-25(30-22)29-20-7-9-21(10-8-20)31-14-16-33-17-15-31/h3-11,13,23,26H,1-2,12,14-17H2,(H,28,32)(H,27,29,30)	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	CHEMBL2971	Tyrosine-protein kinase JAK2	Homo sapiens
CHEMBL3545085	XL-228	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1	ALKJNCZNEOTEMP-UHFFFAOYSA-N	InChI=1S/C22H31N9O/c1-14(2)17-10-16(32-29-17)13-23-22-25-19(24-20-11-18(27-28-20)15-4-5-15)12-21(26-22)31-8-6-30(3)7-9-31/h10-12,14-15H,4-9,13H2,1-3H3,(H3,23,24,25,26,27,28)	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	CHEMBL1862	Tyrosine-protein kinase ABL	Homo sapiens
CHEMBL3545085	XL-228	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1	ALKJNCZNEOTEMP-UHFFFAOYSA-N	InChI=1S/C22H31N9O/c1-14(2)17-10-16(32-29-17)13-23-22-25-19(24-20-11-18(27-28-20)15-4-5-15)12-21(26-22)31-8-6-30(3)7-9-31/h10-12,14-15H,4-9,13H2,1-3H3,(H3,23,24,25,26,27,28)	Insulin-like growth factor I receptor inhibitor	INHIBITOR	CHEMBL1957	Insulin-like growth factor I receptor	Homo sapiens
CHEMBL3545085	XL-228	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1	ALKJNCZNEOTEMP-UHFFFAOYSA-N	InChI=1S/C22H31N9O/c1-14(2)17-10-16(32-29-17)13-23-22-25-19(24-20-11-18(27-28-20)15-4-5-15)12-21(26-22)31-8-6-30(3)7-9-31/h10-12,14-15H,4-9,13H2,1-3H3,(H3,23,24,25,26,27,28)	SRC inhibitor	INHIBITOR	CHEMBL2363074	SRC	Homo sapiens
CHEMBL571948	Y-39983	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1	JTVBXQAYBIJXRP-SNVBAGLBSA-N	InChI=1S/C16H16N4O/c1-10(17)11-2-4-12(5-3-11)16(21)20-14-7-9-19-15-13(14)6-8-18-15/h2-10H,17H2,1H3,(H2,18,19,20,21)/t10-/m1/s1	Rho-associated protein kinase inhibitor	INHIBITOR	CHEMBL2111459	Rho-associated protein kinase	Homo sapiens
CHEMBL3544937	ZD-4190	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1.Cl	IOFHDGSCWJNVRZ-UHFFFAOYSA-N	InChI=1S/C19H16BrFN6O2.ClH/c1-28-17-9-13-16(10-18(17)29-7-6-27-5-4-24-26-27)22-11-23-19(13)25-15-3-2-12(20)8-14(15)21;/h2-5,8-11H,6-7H2,1H3,(H,22,23,25);1H	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL1206245	BRICICLIB	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(OP(=O)(O)O)c2)c(OC)c1	LXENKEWVEVKKGV-BQYQJAHWSA-N	InChI=1S/C19H23O10PS/c1-25-14-10-17(27-3)15(18(11-14)28-4)7-8-31(23,24)12-13-5-6-16(26-2)19(9-13)29-30(20,21)22/h5-11H,12H2,1-4H3,(H2,20,21,22)/b8-7+	G1/S-specific cyclin D1 inhibitor	INHIBITOR	CHEMBL3610	G1/S-specific cyclin D1	Homo sapiens
CHEMBL1084617	TEMANOGREL	COc1cccc(C(=O)Nc2ccc(OCCN3CCOCC3)c(-c3ccnn3C)c2)c1	ZEOQUKRCASTCFR-UHFFFAOYSA-N	InChI=1S/C24H28N4O4/c1-27-22(8-9-25-27)21-17-19(26-24(29)18-4-3-5-20(16-18)30-2)6-7-23(21)32-15-12-28-10-13-31-14-11-28/h3-9,16-17H,10-15H2,1-2H3,(H,26,29)	Serotonin 2a (5-HT2a) receptor inverse agonist	INVERSE AGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1829335	IRDABISANT	C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)[nH]n2)cc1	XUKROCVZGZNGSI-CQSZACIVSA-N	InChI=1S/C18H23N3O2/c1-14-4-2-11-21(14)12-3-13-23-16-7-5-15(6-8-16)17-9-10-18(22)20-19-17/h5-10,14H,2-4,11-13H2,1H3,(H,20,22)/t14-/m1/s1	Histamine H3 receptor antagonist	ANTAGONIST	CHEMBL264	Histamine H3 receptor	Homo sapiens
CHEMBL2106003	CIPRALISANT MALEATE	CC(C)(C)CCC#C[C@@H]1C[C@H]1c1c[nH]cn1.O=C(O)/C=C\C(=O)O	QIQWRCNAPQJQLL-COALEZEGSA-N	InChI=1S/C14H20N2.C4H4O4/c1-14(2,3)7-5-4-6-11-8-12(11)13-9-15-10-16-13;5-3(6)1-2-4(7)8/h9-12H,5,7-8H2,1-3H3,(H,15,16);1-2H,(H,5,6)(H,7,8)/b;2-1-/t11-,12-;/m1./s1	Histamine H3 receptor agonist	AGONIST	CHEMBL264	Histamine H3 receptor	Homo sapiens
CHEMBL2205230	TAK-441	CCc1cc2c(c(OCC(F)(F)F)c(C(=O)NC3CCN(C(=O)CO)CC3)n2C)c(=O)n1CC(=O)c1ccccc1	ZADWXQMNNVICKB-UHFFFAOYSA-N	InChI=1S/C28H31F3N4O6/c1-3-19-13-20-23(27(40)35(19)14-21(37)17-7-5-4-6-8-17)25(41-16-28(29,30)31)24(33(20)2)26(39)32-18-9-11-34(12-10-18)22(38)15-36/h4-8,13,18,36H,3,9-12,14-16H2,1-2H3,(H,32,39)	Smoothened homolog antagonist	ANTAGONIST	CHEMBL5971	Smoothened homolog	Homo sapiens
CHEMBL3133037	LEQ506	Cc1c(Cc2ccccc2)nnc(N2CCN(c3cnc(C(C)(C)O)cn3)[C@H](C)C2)c1C	POERAARDVFVDLO-QGZVFWFLSA-N	InChI=1S/C25H32N6O/c1-17-16-30(11-12-31(17)23-15-26-22(14-27-23)25(4,5)32)24-19(3)18(2)21(28-29-24)13-20-9-7-6-8-10-20/h6-10,14-15,17,32H,11-13,16H2,1-5H3/t17-/m1/s1	Smoothened homolog antagonist	ANTAGONIST	CHEMBL5971	Smoothened homolog	Homo sapiens
CHEMBL375611	LY404039	N[C@@]1(C(=O)O)CS(=O)(=O)[C@H]2[C@H](C(=O)O)[C@H]21	AVDUGNCTZRCAHH-MDASVERJSA-N	InChI=1S/C7H9NO6S/c8-7(6(11)12)1-15(13,14)4-2(3(4)7)5(9)10/h2-4H,1,8H2,(H,9,10)(H,11,12)/t2-,3-,4+,7+/m1/s1	Metabotropic glutamate receptor 2 agonist	AGONIST	CHEMBL5137	Metabotropic glutamate receptor 2	Homo sapiens
CHEMBL375611	LY404039	N[C@@]1(C(=O)O)CS(=O)(=O)[C@H]2[C@H](C(=O)O)[C@H]21	AVDUGNCTZRCAHH-MDASVERJSA-N	InChI=1S/C7H9NO6S/c8-7(6(11)12)1-15(13,14)4-2(3(4)7)5(9)10/h2-4H,1,8H2,(H,9,10)(H,11,12)/t2-,3-,4+,7+/m1/s1	Metabotropic glutamate receptor 3 agonist	AGONIST	CHEMBL2888	Metabotropic glutamate receptor 3	Homo sapiens
CHEMBL3358920	ETRASIMOD	O=C(O)C[C@H]1CCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21	MVGWUTBTXDYMND-QGZVFWFLSA-N	InChI=1S/C26H26F3NO3/c27-26(28,29)22-11-15(5-8-19(22)16-3-1-2-4-16)14-33-18-7-10-23-21(13-18)20-9-6-17(12-24(31)32)25(20)30-23/h5,7-8,10-11,13,16-17,30H,1-4,6,9,12,14H2,(H,31,32)/t17-/m1/s1	Sphingosine 1-phosphate receptor Edg-1 agonist	AGONIST	CHEMBL4333	Sphingosine 1-phosphate receptor Edg-1	Homo sapiens
CHEMBL4175981	OLORINAB	CC(C)(C)[C@@H](CO)NC(=O)c1nn(-c2c[n+]([O-])ccn2)c2c1C[C@@H]1C[C@H]21	ACSQLTBPYZSGBA-GMXVVIOVSA-N	InChI=1S/C18H23N5O3/c1-18(2,3)13(9-24)20-17(25)15-12-7-10-6-11(10)16(12)23(21-15)14-8-22(26)5-4-19-14/h4-5,8,10-11,13,24H,6-7,9H2,1-3H3,(H,20,25)/t10-,11-,13+/m0/s1	Cannabinoid CB2 receptor agonist	AGONIST	CHEMBL253	Cannabinoid CB2 receptor	Homo sapiens
CHEMBL197669	ST1535	CCCCc1nc(N)c2nc(-n3nccn3)n(C)c2n1	CYYQMAWUIRPCNW-UHFFFAOYSA-N	InChI=1S/C12H16N8/c1-3-4-5-8-16-10(13)9-11(17-8)19(2)12(18-9)20-14-6-7-15-20/h6-7H,3-5H2,1-2H3,(H2,13,16,17)	Adenosine A2a receptor antagonist	ANTAGONIST	CHEMBL251	Adenosine A2a receptor	Homo sapiens
CHEMBL2062154	CI-988	C[C@](Cc1c[nH]c2ccccc12)(NC(=O)OC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)NC[C@H](NC(=O)CCC(=O)O)c1ccccc1	FVQSSYMRZKLFDR-QRCSZXLUSA-N	InChI=1S/C35H42N4O6/c1-35(18-26-19-36-28-10-6-5-9-27(26)28,39-34(44)45-32-24-14-21-13-22(16-24)17-25(32)15-21)33(43)37-20-29(23-7-3-2-4-8-23)38-30(40)11-12-31(41)42/h2-10,19,21-22,24-25,29,32,36H,11-18,20H2,1H3,(H,37,43)(H,38,40)(H,39,44)(H,41,42)/t21-,22+,24-,25+,29-,32?,35+/m0/s1	Cholecystokinin B receptor antagonist	ANTAGONIST	CHEMBL298	Cholecystokinin B receptor	Homo sapiens
CHEMBL1915540	PF-03893787	CN[C@@H]1CCN(c2cc(NCC3CC3)nc(N)n2)C1	ISBHYKVAFKTATD-SNVBAGLBSA-N	InChI=1S/C13H22N6/c1-15-10-4-5-19(8-10)12-6-11(17-13(14)18-12)16-7-9-2-3-9/h6,9-10,15H,2-5,7-8H2,1H3,(H3,14,16,17,18)/t10-/m1/s1	Histamine H4 receptor antagonist	ANTAGONIST	CHEMBL3759	Histamine H4 receptor	Homo sapiens
CHEMBL3545388	SERIDOPIDINE	CCN1CCC(c2cc(F)cc(S(C)(=O)=O)c2)CC1	PHRDGRSMZPOCAB-UHFFFAOYSA-N	InChI=1S/C14H20FNO2S/c1-3-16-6-4-11(5-7-16)12-8-13(15)10-14(9-12)19(2,17)18/h8-11H,3-7H2,1-2H3	Dopamine D2 receptor modulator	MODULATOR	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL3545010	ORDOPIDINE	CCN1CCC(c2cccc(S(C)(=O)=O)c2F)CC1	UKUPJASJNQDHPH-UHFFFAOYSA-N	InChI=1S/C14H20FNO2S/c1-3-16-9-7-11(8-10-16)12-5-4-6-13(14(12)15)19(2,17)18/h4-6,11H,3,7-10H2,1-2H3	Dopamine D2 receptor modulator	MODULATOR	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL3234681	TEDALINAB	CC(C)(C)NC(=O)c1nn(-c2ccc(F)cc2F)c2c1[C@H]1CC[C@@H]2C1	NTPZXHMTJGOMCJ-WDEREUQCSA-N	InChI=1S/C19H21F2N3O/c1-19(2,3)22-18(25)16-15-10-4-5-11(8-10)17(15)24(23-16)14-7-6-12(20)9-13(14)21/h6-7,9-11H,4-5,8H2,1-3H3,(H,22,25)/t10-,11+/m0/s1	Cannabinoid CB2 receptor agonist	AGONIST	CHEMBL253	Cannabinoid CB2 receptor	Homo sapiens
CHEMBL3545330	MSX-122	c1cnc(NCc2ccc(CNc3ncccn3)cc2)nc1	PXZXYRKDDXKDTK-UHFFFAOYSA-N	InChI=1S/C16H16N6/c1-7-17-15(18-8-1)21-11-13-3-5-14(6-4-13)12-22-16-19-9-2-10-20-16/h1-10H,11-12H2,(H,17,18,21)(H,19,20,22)	C-X-C chemokine receptor type 4 antagonist	ANTAGONIST	CHEMBL2107	C-X-C chemokine receptor type 4	Homo sapiens
CHEMBL3545011	GS-9667	O[C@@H]1[C@@H](CSc2ccccc2F)O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4O)ncnc32)[C@@H]1O	IZRXENCTXNMAMI-DIJFLQFKSA-N	InChI=1S/C21H24FN5O4S/c22-11-4-1-2-7-15(11)32-8-14-17(29)18(30)21(31-14)27-10-25-16-19(23-9-24-20(16)27)26-12-5-3-6-13(12)28/h1-2,4,7,9-10,12-14,17-18,21,28-30H,3,5-6,8H2,(H,23,24,26)/t12-,13-,14-,17-,18-,21-/m1/s1	Adenosine A1 receptor partial agonist	PARTIAL AGONIST	CHEMBL226	Adenosine A1 receptor	Homo sapiens
CHEMBL440115	FK453	O=C(/C=C/c1c(-c2ccccc2)nn2ccccc12)N1CCCC[C@@H]1CCO	OPLOPFHUHFGKMJ-JXOMPUQVSA-N	InChI=1S/C23H25N3O2/c27-17-14-19-10-4-6-15-25(19)22(28)13-12-20-21-11-5-7-16-26(21)24-23(20)18-8-2-1-3-9-18/h1-3,5,7-9,11-13,16,19,27H,4,6,10,14-15,17H2/b13-12+/t19-/m1/s1	Adenosine A1 receptor antagonist	ANTAGONIST	CHEMBL226	Adenosine A1 receptor	Homo sapiens
CHEMBL260933	GS 6201	CCCn1c(=O)c2[nH]c(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)nc2n(CC)c1=O	KOYXXLLNCXWUNF-UHFFFAOYSA-N	InChI=1S/C21H21F3N6O2/c1-3-8-30-19(31)16-18(29(4-2)20(30)32)27-17(26-16)14-10-25-28(12-14)11-13-6-5-7-15(9-13)21(22,23)24/h5-7,9-10,12H,3-4,8,11H2,1-2H3,(H,26,27)	Adenosine A2b receptor antagonist	ANTAGONIST	CHEMBL255	Adenosine A2b receptor	Homo sapiens
CHEMBL1672627	LAS101057	O=C(Nc1cnc(-c2ccncc2F)c(-c2cccnc2)n1)C1CC1	XUYURJQIMYCWBB-UHFFFAOYSA-N	InChI=1S/C18H14FN5O/c19-14-9-21-7-5-13(14)17-16(12-2-1-6-20-8-12)23-15(10-22-17)24-18(25)11-3-4-11/h1-2,5-11H,3-4H2,(H,23,24,25)	Adenosine A2b receptor antagonist	ANTAGONIST	CHEMBL255	Adenosine A2b receptor	Homo sapiens
CHEMBL2104927	FIGOPITANT	CN(CCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)[C@H](c1ccccc1)N1CCN(CC2CC2)CC1	HUTHJVYJUPXHDF-DEOSSOPVSA-N	InChI=1S/C27H31F6N3O/c1-34(10-9-20-15-22(26(28,29)30)17-23(16-20)27(31,32)33)25(37)24(21-5-3-2-4-6-21)36-13-11-35(12-14-36)18-19-7-8-19/h2-6,15-17,19,24H,7-14,18H2,1H3/t24-/m0/s1	Neurokinin 1 receptor antagonist	ANTAGONIST	CHEMBL249	Neurokinin 1 receptor	Homo sapiens
CHEMBL2369989	ATILMOTIN	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)[N+](C)(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)[O-])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O	DUQRILZXKXSRIY-RUBJUKRASA-N	InChI=1S/C86H134N20O19/c1-13-51(8)71(103-81(121)65-30-23-41-105(65)85(125)70(50(6)7)102-82(122)66(106(10,11)12)46-54-26-18-15-19-27-54)83(123)101-64(44-53-24-16-14-17-25-53)80(120)104-72(52(9)107)84(124)100-63(45-55-31-33-56(108)34-32-55)74(114)93-47-68(110)94-59(36-38-69(111)112)76(116)99-62(43-49(4)5)79(119)97-60(35-37-67(88)109)77(117)96-58(29-22-40-92-86(90)91)75(115)98-61(42-48(2)3)78(118)95-57(73(89)113)28-20-21-39-87/h14-19,24-27,31-34,48-52,57-66,70-72,107H,13,20-23,28-30,35-47,87H2,1-12H3,(H21-,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124)/t51-,52+,57-,58+,59-,60-,61-,62-,63-,64-,65-,66-,70-,71-,72-/m0/s1	Motilin receptor agonist	AGONIST	CHEMBL2203	Motilin receptor	Homo sapiens
CHEMBL1980391	RG-1530	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2	UOVCGJXDGOGOCZ-UHFFFAOYSA-N	InChI=1S/C18H14ClFN4O/c1-9-16-18(24-23-9)21-14-8-15(25-2)13(20)7-11(14)17(22-16)10-5-3-4-6-12(10)19/h3-8H,1-2H3,(H2,21,23,24)	Fibroblast growth factor receptor 1 inhibitor	INHIBITOR	CHEMBL3650	Fibroblast growth factor receptor 1	Homo sapiens
CHEMBL1980391	RG-1530	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2	UOVCGJXDGOGOCZ-UHFFFAOYSA-N	InChI=1S/C18H14ClFN4O/c1-9-16-18(24-23-9)21-14-8-15(25-2)13(20)7-11(14)17(22-16)10-5-3-4-6-12(10)19/h3-8H,1-2H3,(H2,21,23,24)	Fibroblast growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL4142	Fibroblast growth factor receptor 2	Homo sapiens
CHEMBL1980391	RG-1530	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2	UOVCGJXDGOGOCZ-UHFFFAOYSA-N	InChI=1S/C18H14ClFN4O/c1-9-16-18(24-23-9)21-14-8-15(25-2)13(20)7-11(14)17(22-16)10-5-3-4-6-12(10)19/h3-8H,1-2H3,(H2,21,23,24)	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL1980391	RG-1530	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2	UOVCGJXDGOGOCZ-UHFFFAOYSA-N	InChI=1S/C18H14ClFN4O/c1-9-16-18(24-23-9)21-14-8-15(25-2)13(20)7-11(14)17(22-16)10-5-3-4-6-12(10)19/h3-8H,1-2H3,(H2,21,23,24)	Platelet-derived growth factor receptor beta inhibitor	INHIBITOR	CHEMBL1913	Platelet-derived growth factor receptor beta	Homo sapiens
CHEMBL1980391	RG-1530	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2	UOVCGJXDGOGOCZ-UHFFFAOYSA-N	InChI=1S/C18H14ClFN4O/c1-9-16-18(24-23-9)21-14-8-15(25-2)13(20)7-11(14)17(22-16)10-5-3-4-6-12(10)19/h3-8H,1-2H3,(H2,21,23,24)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL1980391	RG-1530	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2	UOVCGJXDGOGOCZ-UHFFFAOYSA-N	InChI=1S/C18H14ClFN4O/c1-9-16-18(24-23-9)21-14-8-15(25-2)13(20)7-11(14)17(22-16)10-5-3-4-6-12(10)19/h3-8H,1-2H3,(H2,21,23,24)	Serine/threonine-protein kinase Aurora-A inhibitor	INHIBITOR	CHEMBL4722	Serine/threonine-protein kinase Aurora-A	Homo sapiens
CHEMBL1980391	RG-1530	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2	UOVCGJXDGOGOCZ-UHFFFAOYSA-N	InChI=1S/C18H14ClFN4O/c1-9-16-18(24-23-9)21-14-8-15(25-2)13(20)7-11(14)17(22-16)10-5-3-4-6-12(10)19/h3-8H,1-2H3,(H2,21,23,24)	Serine/threonine-protein kinase PLK4 inhibitor	INHIBITOR	CHEMBL3788	Serine/threonine-protein kinase PLK4	Homo sapiens
CHEMBL229430	AMG-517	CC(=O)Nc1nc2c(Oc3cc(-c4ccc(C(F)(F)F)cc4)ncn3)cccc2s1	YUTIXVXZQIQWGY-UHFFFAOYSA-N	InChI=1S/C20H13F3N4O2S/c1-11(28)26-19-27-18-15(3-2-4-16(18)30-19)29-17-9-14(24-10-25-17)12-5-7-13(8-6-12)20(21,22)23/h2-10H,1H3,(H,26,27,28)	Vanilloid receptor antagonist	ANTAGONIST	CHEMBL4794	Vanilloid receptor	Homo sapiens
CHEMBL398338	ABT-102	CC(C)(C)c1ccc2c(c1)CC[C@H]2NC(=O)Nc1cccc2[nH]ncc12	TYOYXJNGINZFET-GOSISDBHSA-N	InChI=1S/C21H24N4O/c1-21(2,3)14-8-9-15-13(11-14)7-10-18(15)24-20(26)23-17-5-4-6-19-16(17)12-22-25-19/h4-6,8-9,11-12,18H,7,10H2,1-3H3,(H,22,25)(H2,23,24,26)/t18-/m1/s1	Vanilloid receptor antagonist	ANTAGONIST	CHEMBL4794	Vanilloid receptor	Homo sapiens
CHEMBL504652	TC-2216	c1cncc(N2CCC3(CCCN3)C2)c1	NXIPMBQVNTWEEX-UHFFFAOYSA-N	InChI=1S/C12H17N3/c1-3-11(9-13-6-1)15-8-5-12(10-15)4-2-7-14-12/h1,3,6,9,14H,2,4-5,7-8,10H2	Neuronal acetylcholine receptor; alpha4/beta2 antagonist	ANTAGONIST	CHEMBL1907589	Neuronal acetylcholine receptor; alpha4/beta2	Homo sapiens
CHEMBL1783256	AZD6280	CCCNC(=O)c1nnc2c(-c3cc(OC)ccc3OC)cccc2c1N	NVWCZRPXYVDQEE-UHFFFAOYSA-N	InChI=1S/C20H22N4O3/c1-4-10-22-20(25)19-17(21)14-7-5-6-13(18(14)23-24-19)15-11-12(26-2)8-9-16(15)27-3/h5-9,11H,4,10H2,1-3H3,(H2,21,23)(H,22,25)	GABA receptor alpha-2 subunit positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL4956	GABA receptor alpha-2 subunit	Homo sapiens
CHEMBL1783256	AZD6280	CCCNC(=O)c1nnc2c(-c3cc(OC)ccc3OC)cccc2c1N	NVWCZRPXYVDQEE-UHFFFAOYSA-N	InChI=1S/C20H22N4O3/c1-4-10-22-20(25)19-17(21)14-7-5-6-13(18(14)23-24-19)15-11-12(26-2)8-9-16(15)27-3/h5-9,11H,4,10H2,1-3H3,(H2,21,23)(H,22,25)	GABA receptor alpha-3 subunit positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL3026	GABA receptor alpha-3 subunit	Homo sapiens
CHEMBL3678076	EVENAMIDE	CCCCOc1cccc(CCNCC(=O)N(C)C)c1	GRHBODILPPXVKN-UHFFFAOYSA-N	InChI=1S/C16H26N2O2/c1-4-5-11-20-15-8-6-7-14(12-15)9-10-17-13-16(19)18(2)3/h6-8,12,17H,4-5,9-11,13H2,1-3H3	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL429317	AVL-3288	Cc1cc(/C(=C/Nc2ccc(Cl)cc2)C(=O)Nc2ccc(Cl)cc2)on1	VMAKIACTLSBBIY-BOPFTXTBSA-N	InChI=1S/C19H15Cl2N3O2/c1-12-10-18(26-24-12)17(11-22-15-6-2-13(20)3-7-15)19(25)23-16-8-4-14(21)5-9-16/h2-11,22H,1H3,(H,23,25)/b17-11-	Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2492	Neuronal acetylcholine receptor protein alpha-7 subunit	Homo sapiens
CHEMBL214268	PHA-543613	O=C(N[C@H]1CN2CCC1CC2)c1cc2ccoc2cn1	IPKZCLGGYKRDES-ZDUSSCGKSA-N	InChI=1S/C15H17N3O2/c19-15(12-7-11-3-6-20-14(11)8-16-12)17-13-9-18-4-1-10(13)2-5-18/h3,6-8,10,13H,1-2,4-5,9H2,(H,17,19)/t13-/m0/s1	Neuronal acetylcholine receptor protein alpha-7 subunit agonist	AGONIST	CHEMBL2492	Neuronal acetylcholine receptor protein alpha-7 subunit	Homo sapiens
CHEMBL2151570	ABT-107	c1cc2cc(-c3ccc(O[C@H]4CN5CCC4CC5)nn3)ccc2[nH]1	LUKNJAQKVPBDSC-SFHVURJKSA-N	InChI=1S/C19H20N4O/c1-2-16-15(5-8-20-16)11-14(1)17-3-4-19(22-21-17)24-18-12-23-9-6-13(18)7-10-23/h1-5,8,11,13,18,20H,6-7,9-10,12H2/t18-/m0/s1	Neuronal acetylcholine receptor protein alpha-7 subunit agonist	AGONIST	CHEMBL2492	Neuronal acetylcholine receptor protein alpha-7 subunit	Homo sapiens
CHEMBL2181753	AM-211	CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)NCc1ccccc1	OPXIRFWNLBDKQB-UHFFFAOYSA-N	InChI=1S/C27H27F3N2O4/c1-3-32(26(35)31-16-18-7-5-4-6-8-18)17-20-15-21(27(28,29)30)10-11-22(20)23-13-19(14-25(33)34)9-12-24(23)36-2/h4-13,15H,3,14,16-17H2,1-2H3,(H,31,35)(H,33,34)	G protein-coupled receptor 44 antagonist	ANTAGONIST	CHEMBL5071	G protein-coupled receptor 44	Homo sapiens
CHEMBL561132	MK-7246	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1	JTCAGRAKUAAYDY-OAHLLOKOSA-N	InChI=1S/C21H21FN2O4S/c1-23(29(27,28)16-9-6-14(22)7-10-16)15-8-11-20-18(12-21(25)26)17-4-2-3-5-19(17)24(20)13-15/h2-7,9-10,15H,8,11-13H2,1H3,(H,25,26)/t15-/m1/s1	G protein-coupled receptor 44 antagonist	ANTAGONIST	CHEMBL5071	G protein-coupled receptor 44	Homo sapiens
CHEMBL3330650	RG-7420	O=C(NOCCO)c1ccc2cncn2c1Nc1ccc(I)cc1F	RFWVETIZUQEJEF-UHFFFAOYSA-N	InChI=1S/C16H14FIN4O3/c17-13-7-10(18)1-4-14(13)20-15-12(16(24)21-25-6-5-23)3-2-11-8-19-9-22(11)15/h1-4,7-9,20,23H,5-6H2,(H,21,24)	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3587	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens
CHEMBL29919	ELPETRIGINE	Nc1cnc(-c2cc(Cl)cc(Cl)c2Cl)c(N)n1	NNXUYJFHOVCRSM-UHFFFAOYSA-N	InChI=1S/C10H7Cl3N4/c11-4-1-5(8(13)6(12)2-4)9-10(15)17-7(14)3-16-9/h1-3H,(H4,14,15,17)	Sodium channel protein type II alpha subunit blocker	BLOCKER	CHEMBL4187	Sodium channel protein type II alpha subunit	Homo sapiens
CHEMBL29919	ELPETRIGINE	Nc1cnc(-c2cc(Cl)cc(Cl)c2Cl)c(N)n1	NNXUYJFHOVCRSM-UHFFFAOYSA-N	InChI=1S/C10H7Cl3N4/c11-4-1-5(8(13)6(12)2-4)9-10(15)17-7(14)3-16-9/h1-3H,(H4,14,15,17)	Sodium channel protein type III alpha subunit blocker	BLOCKER	CHEMBL5163	Sodium channel protein type III alpha subunit	Homo sapiens
CHEMBL29919	ELPETRIGINE	Nc1cnc(-c2cc(Cl)cc(Cl)c2Cl)c(N)n1	NNXUYJFHOVCRSM-UHFFFAOYSA-N	InChI=1S/C10H7Cl3N4/c11-4-1-5(8(13)6(12)2-4)9-10(15)17-7(14)3-16-9/h1-3H,(H4,14,15,17)	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL29919	ELPETRIGINE	Nc1cnc(-c2cc(Cl)cc(Cl)c2Cl)c(N)n1	NNXUYJFHOVCRSM-UHFFFAOYSA-N	InChI=1S/C10H7Cl3N4/c11-4-1-5(8(13)6(12)2-4)9-10(15)17-7(14)3-16-9/h1-3H,(H4,14,15,17)	Voltage-gated N-type calcium channel alpha-1B subunit blocker	BLOCKER	CHEMBL4478	Voltage-gated N-type calcium channel alpha-1B subunit	Homo sapiens
CHEMBL29919	ELPETRIGINE	Nc1cnc(-c2cc(Cl)cc(Cl)c2Cl)c(N)n1	NNXUYJFHOVCRSM-UHFFFAOYSA-N	InChI=1S/C10H7Cl3N4/c11-4-1-5(8(13)6(12)2-4)9-10(15)17-7(14)3-16-9/h1-3H,(H4,14,15,17)	Voltage-gated P/Q-type calcium channel alpha-1A subunit blocker	BLOCKER	CHEMBL4266	Voltage-gated P/Q-type calcium channel alpha-1A subunit	Homo sapiens
CHEMBL29741	IRAMPANEL	CN(C)CCOc1ccccc1-c1nc(-c2ccccc2)no1	QZULPCPLWGCGSL-UHFFFAOYSA-N	InChI=1S/C18H19N3O2/c1-21(2)12-13-22-16-11-7-6-10-15(16)18-19-17(20-23-18)14-8-4-3-5-9-14/h3-11H,12-13H2,1-2H3	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	CHEMBL2096670	Glutamate receptor ionotropic AMPA	Homo sapiens
CHEMBL29741	IRAMPANEL	CN(C)CCOc1ccccc1-c1nc(-c2ccccc2)no1	QZULPCPLWGCGSL-UHFFFAOYSA-N	InChI=1S/C18H19N3O2/c1-21(2)12-13-22-16-11-7-6-10-15(16)18-19-17(20-23-18)14-8-4-3-5-9-14/h3-11H,12-13H2,1-2H3	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL2104449	SARAKALIM	CC(=O)N(O)CC1=C(n2ccccc2=O)c2cc(C(F)(F)F)ccc2OC1(C)C	FXRJKZVWFJSKGI-UHFFFAOYSA-N	InChI=1S/C20H19F3N2O4/c1-12(26)25(28)11-15-18(24-9-5-4-6-17(24)27)14-10-13(20(21,22)23)7-8-16(14)29-19(15,2)3/h4-10,28H,11H2,1-3H3	Sulfonylurea receptors; K-ATP channels opener	OPENER	CHEMBL2095152	Sulfonylurea receptors; K-ATP channels	Homo sapiens
CHEMBL2110814	DELUCEMINE	CNCCC(c1cccc(F)c1)c1cccc(F)c1	MUGNLPWYHGOJEG-UHFFFAOYSA-N	InChI=1S/C16H17F2N/c1-19-9-8-16(12-4-2-6-14(17)10-12)13-5-3-7-15(18)11-13/h2-7,10-11,16,19H,8-9H2,1H3	Glutamate [NMDA] receptor antagonist	ANTAGONIST	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL2364618	MAVATREP	CC(C)(O)c1ccccc1-c1ccc2[nH]c(/C=C/c3ccc(C(F)(F)F)cc3)nc2c1	ORDHXXHTBUZRCN-NTEUORMPSA-N	InChI=1S/C25H21F3N2O/c1-24(2,31)20-6-4-3-5-19(20)17-10-13-21-22(15-17)30-23(29-21)14-9-16-7-11-18(12-8-16)25(26,27)28/h3-15,31H,1-2H3,(H,29,30)/b14-9+	Vanilloid receptor antagonist	ANTAGONIST	CHEMBL4794	Vanilloid receptor	Homo sapiens
CHEMBL3545210	SR16234	CCN(CC)Cc1ccc(OCC[C@H]2CCC3C4C(CC[C@@]32C)c2ccc(O)cc2C[C@H]4C)c(OC)c1.O=C(O)CC(O)(CC(=O)O)C(=O)O	VOHOCSJONOJOSD-RQIKCBEZSA-N	InChI=1S/C33H47NO3.C6H8O7/c1-6-34(7-2)21-23-8-13-30(31(19-23)36-5)37-17-15-25-9-12-29-32-22(3)18-24-20-26(35)10-11-27(24)28(32)14-16-33(25,29)4;7-3(8)1-6(13,5(11)12)2-4(9)10/h8,10-11,13,19-20,22,25,28-29,32,35H,6-7,9,12,14-18,21H2,1-5H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t22-,25-,28?,29?,32?,33-;/m1./s1	Estrogen receptor alpha antagonist	ANTAGONIST	CHEMBL206	Estrogen receptor alpha	Homo sapiens
CHEMBL2107341	FISPEMIFENE	OCCOCCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1	NKZTZAQIKKGTDB-QPLCGJKRSA-N	InChI=1S/C26H27ClO3/c27-16-15-25(21-7-3-1-4-8-21)26(22-9-5-2-6-10-22)23-11-13-24(14-12-23)30-20-19-29-18-17-28/h1-14,28H,15-20H2/b26-25-	Estrogen receptor modulator	MODULATOR	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL6318	IDOXIFENE	CC/C(=C(\c1ccc(I)cc1)c1ccc(OCCN2CCCC2)cc1)c1ccccc1	JJKOTMDDZAJTGQ-DQSJHHFOSA-N	InChI=1S/C28H30INO/c1-2-27(22-8-4-3-5-9-22)28(23-10-14-25(29)15-11-23)24-12-16-26(17-13-24)31-21-20-30-18-6-7-19-30/h3-5,8-17H,2,6-7,18-21H2,1H3/b28-27-	Estrogen receptor modulator	MODULATOR	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL3545274	MK-6913	CC(C)(C)n1nnc2c3c(ccc21)C1=CC(=O)CC[C@@]1(CCOc1ccccc1)C3	LYLIIGQPIKTONH-RUZDIDTESA-N	InChI=1S/C25H27N3O2/c1-24(2,3)28-22-10-9-19-20(23(22)26-27-28)16-25(12-11-17(29)15-21(19)25)13-14-30-18-7-5-4-6-8-18/h4-10,15H,11-14,16H2,1-3H3/t25-/m1/s1	Estrogen receptor agonist	AGONIST	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL1232583	INDEGLITAZAR	COc1ccc(S(=O)(=O)n2cc(CCC(=O)O)c3cc(OC)ccc32)cc1	YMPALHOKRBVHOJ-UHFFFAOYSA-N	InChI=1S/C19H19NO6S/c1-25-14-4-7-16(8-5-14)27(23,24)20-12-13(3-10-19(21)22)17-11-15(26-2)6-9-18(17)20/h4-9,11-12H,3,10H2,1-2H3,(H,21,22)	Peroxisome proliferator-activated receptor agonist	AGONIST	CHEMBL3559683	Peroxisome proliferator-activated receptor	Homo sapiens
CHEMBL2104984	SODELGLITAZAR	Cc1cc(SCc2sc(-c3ccc(C(F)(F)F)cc3F)nc2C)ccc1OC(C)(C)C(=O)O	ZUGQWAYOWCBWGM-UHFFFAOYSA-N	InChI=1S/C23H21F4NO3S2/c1-12-9-15(6-8-18(12)31-22(3,4)21(29)30)32-11-19-13(2)28-20(33-19)16-7-5-14(10-17(16)24)23(25,26)27/h5-10H,11H2,1-4H3,(H,29,30)	Peroxisome proliferator-activated receptor agonist	AGONIST	CHEMBL3559683	Peroxisome proliferator-activated receptor	Homo sapiens
CHEMBL75133	IRX-4204	CC(/C=C/[C@@H]1C[C@]1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)=C\C(=O)O	BOOOLEGQBVUTKC-NVQSDHBMSA-N	InChI=1S/C24H32O2/c1-16(13-21(25)26)7-8-18-15-24(18,6)17-9-10-19-20(14-17)23(4,5)12-11-22(19,2)3/h7-10,13-14,18H,11-12,15H2,1-6H3,(H,25,26)/b8-7+,16-13+/t18-,24-/m1/s1	Retinoid X receptor agonist	AGONIST	CHEMBL2363070	Retinoid X receptor	Homo sapiens
CHEMBL3545333	MK-0773	CN1C(=O)C(F)=C[C@]2(C)C3CC[C@@]4(C)C(CC[C@@H]4C(=O)NCc4nc5ncccc5[nH]4)C3CCC12	GBEUKTWTUSPHEE-PAWGCEJPSA-N	InChI=1S/C27H34FN5O2/c1-26-11-10-17-15(6-9-21-27(17,2)13-19(28)25(35)33(21)3)16(26)7-8-18(26)24(34)30-14-22-31-20-5-4-12-29-23(20)32-22/h4-5,12-13,15-18,21H,6-11,14H2,1-3H3,(H,30,34)(H,29,31,32)/t15?,16?,17?,18-,21?,26+,27-/m1/s1	Androgen Receptor modulator	MODULATOR	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL3590187	CLASCOTERONE	CCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	GPNHMOZDMYNCPO-PDUMRIMRSA-N	InChI=1S/C24H34O5/c1-4-21(28)29-24(20(27)14-25)12-9-19-17-6-5-15-13-16(26)7-10-22(15,2)18(17)8-11-23(19,24)3/h13,17-19,25H,4-12,14H2,1-3H3/t17-,18+,19+,22+,23+,24+/m1/s1	Androgen Receptor antagonist	ANTAGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL2105738	GALETERONE	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2n1cnc2ccccc21	PAFKTGFSEFKSQG-PAASFTFBSA-N	InChI=1S/C26H32N2O/c1-25-13-11-18(29)15-17(25)7-8-19-20-9-10-24(26(20,2)14-12-21(19)25)28-16-27-22-5-3-4-6-23(22)28/h3-7,10,16,18-21,29H,8-9,11-15H2,1-2H3/t18-,19-,20-,21-,25-,26-/m0/s1	Androgen Receptor antagonist	ANTAGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL2105738	GALETERONE	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2n1cnc2ccccc21	PAFKTGFSEFKSQG-PAASFTFBSA-N	InChI=1S/C26H32N2O/c1-25-13-11-18(29)15-17(25)7-8-19-20-9-10-24(26(20,2)14-12-21(19)25)28-16-27-22-5-3-4-6-23(22)28/h3-7,10,16,18-21,29H,8-9,11-15H2,1-2H3/t18-,19-,20-,21-,25-,26-/m0/s1	Cytochrome P450 17A1 inhibitor	INHIBITOR	CHEMBL3522	Cytochrome P450 17A1	Homo sapiens
CHEMBL3581693	BRILANESTRANT	CC/C(=C(/c1ccc(/C=C/C(=O)O)cc1)c1ccc2[nH]ncc2c1)c1ccc(F)cc1Cl	BURHGPHDEVGCEZ-KJGLQBJMSA-N	InChI=1S/C26H20ClFN2O2/c1-2-21(22-10-9-20(28)14-23(22)27)26(18-8-11-24-19(13-18)15-29-30-24)17-6-3-16(4-7-17)5-12-25(31)32/h3-15H,2H2,1H3,(H,29,30)(H,31,32)/b12-5+,26-21+	Estrogen receptor alpha antagonist	ANTAGONIST	CHEMBL206	Estrogen receptor alpha	Homo sapiens
CHEMBL3545017	GTX-758	O=C(c1ccc(O)c(F)c1)N(c1ccc(O)cc1)c1ccc(F)cc1	FBCQEUMZZNVQKD-UHFFFAOYSA-N	InChI=1S/C19H13F2NO3/c20-13-2-4-14(5-3-13)22(15-6-8-16(23)9-7-15)19(25)12-1-10-18(24)17(21)11-12/h1-11,23-24H	Estrogen receptor alpha agonist	AGONIST	CHEMBL206	Estrogen receptor alpha	Homo sapiens
CHEMBL2137046	AFIMOXIFENE	CCC(=C(c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	TXUZVZSFRXZGTL-UHFFFAOYSA-N	InChI=1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3	Estrogen receptor modulator	MODULATOR	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL2137046	AFIMOXIFENE	CCC(=C(c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	TXUZVZSFRXZGTL-UHFFFAOYSA-N	InChI=1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3	Estrogen-related receptor gamma antagonist	ANTAGONIST	CHEMBL4245	Estrogen-related receptor gamma	Homo sapiens
CHEMBL450940	PRINABEREL	C=Cc1cc(O)cc2nc(-c3ccc(O)c(F)c3)oc12	MQIMZDXIAHJKQP-UHFFFAOYSA-N	InChI=1S/C15H10FNO3/c1-2-8-5-10(18)7-12-14(8)20-15(17-12)9-3-4-13(19)11(16)6-9/h2-7,18-19H,1H2	Estrogen receptor beta agonist	AGONIST	CHEMBL242	Estrogen receptor beta	Homo sapiens
CHEMBL278703	ERTEBEREL	Oc1ccc([C@@H]2Oc3ccc(O)cc3[C@@H]3CCC[C@@H]32)cc1	XIESSJVMWNJCGZ-VKJFTORMSA-N	InChI=1S/C18H18O3/c19-12-6-4-11(5-7-12)18-15-3-1-2-14(15)16-10-13(20)8-9-17(16)21-18/h4-10,14-15,18-20H,1-3H2/t14-,15+,18+/m1/s1	Estrogen receptor beta agonist	AGONIST	CHEMBL242	Estrogen receptor beta	Homo sapiens
CHEMBL198877	AUS-131	Oc1ccc([C@H]2COc3cc(O)ccc3C2)cc1	ADFCQWZHKCXPAJ-GFCCVEGCSA-N	InChI=1S/C15H14O3/c16-13-4-1-10(2-5-13)12-7-11-3-6-14(17)8-15(11)18-9-12/h1-6,8,12,16-17H,7,9H2/t12-/m1/s1	Estrogen receptor beta agonist	AGONIST	CHEMBL242	Estrogen receptor beta	Homo sapiens
CHEMBL3137304	DAGROCORAT	Cc1ncccc1NC(=O)c1ccc2c(c1)CC[C@@H]1C[C@@](O)(C(F)(F)F)CC[C@@]21Cc1ccccc1	QJJBNCHSWFGXML-KEKPKEOLSA-N	InChI=1S/C29H29F3N2O2/c1-19-25(8-5-15-33-19)34-26(35)22-10-12-24-21(16-22)9-11-23-18-28(36,29(30,31)32)14-13-27(23,24)17-20-6-3-2-4-7-20/h2-8,10,12,15-16,23,36H,9,11,13-14,17-18H2,1H3,(H,34,35)/t23-,27+,28-/m1/s1	Glucocorticoid receptor modulator	MODULATOR	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL3545391	ORG-34517	CC#C[C@]1(O)CCC2C3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc4c(c3)OCO4)C[C@@]21C	DFELGYQKEOCHOA-RBXNTRDFSA-N	InChI=1S/C28H30O4/c1-3-11-28(30)12-10-23-21-7-4-17-13-19(29)6-8-20(17)26(21)22(15-27(23,28)2)18-5-9-24-25(14-18)32-16-31-24/h5,9,13-14,21-23,30H,4,6-8,10,12,15-16H2,1-2H3/t21?,22-,23?,27+,28+/m1/s1	Glucocorticoid receptor antagonist	ANTAGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL2181927	FINERENONE	CCOc1ncc(C)c2c1[C@H](c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2	BTBHLEZXCOBLCY-QGZVFWFLSA-N	InChI=1S/C21H22N4O3/c1-5-28-21-18-17(14-7-6-13(9-22)8-15(14)27-4)16(20(23)26)12(3)25-19(18)11(2)10-24-21/h6-8,10,17,25H,5H2,1-4H3,(H2,23,26)/t17-/m1/s1	Mineralocorticoid receptor antagonist	ANTAGONIST	CHEMBL1994	Mineralocorticoid receptor	Homo sapiens
CHEMBL146032	LONAPRISAN	CC(=O)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C(F)(F)C(F)(F)F)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1	VHZPUDNSVGRVMB-RXDLHWJPSA-N	InChI=1S/C28H29F5O3/c1-15(34)16-3-5-17(6-4-16)22-14-25(2)23(11-12-26(25,36)27(29,30)28(31,32)33)21-9-7-18-13-19(35)8-10-20(18)24(21)22/h3-6,13,21-23,36H,7-12,14H2,1-2H3/t21-,22+,23-,25-,26-/m0/s1	Progesterone receptor antagonist	ANTAGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL2105694	TELAPRISTONE ACETATE	COCC(=O)[C@@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C	JVBGZFRPTRKSBB-MJBQOYBXSA-N	InChI=1S/C31H39NO5/c1-19(33)37-31(28(35)18-36-5)15-14-27-25-12-8-21-16-23(34)11-13-24(21)29(25)26(17-30(27,31)2)20-6-9-22(10-7-20)32(3)4/h6-7,9-10,16,25-27H,8,11-15,17-18H2,1-5H3/t25-,26+,27-,30-,31-/m0/s1	Progesterone receptor modulator	MODULATOR	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL1908373	ONAPRISTONE	CN(C)c1ccc([C@H]2C[C@]3(C)[C@@H](CC[C@]3(O)CCCO)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1	IEXUMDBQLIVNHZ-YOUGDJEHSA-N	InChI=1S/C29H39NO3/c1-28-18-25(19-5-8-21(9-6-19)30(2)3)27-23-12-10-22(32)17-20(23)7-11-24(27)26(28)13-15-29(28,33)14-4-16-31/h5-6,8-9,17,24-26,31,33H,4,7,10-16,18H2,1-3H3/t24-,25+,26-,28+,29+/m0/s1	Progesterone receptor antagonist	ANTAGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL424133	LY-518674	Cc1ccc(Cn2nc(CCCc3ccc(OC(C)(C)C(=O)O)cc3)nc2O)cc1	PNHFDVSKDSLUFH-UHFFFAOYSA-N	InChI=1S/C23H27N3O4/c1-16-7-9-18(10-8-16)15-26-22(29)24-20(25-26)6-4-5-17-11-13-19(14-12-17)30-23(2,3)21(27)28/h7-14H,4-6,15H2,1-3H3,(H,27,28)(H,24,25,29)	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	CHEMBL239	Peroxisome proliferator-activated receptor alpha	Homo sapiens
CHEMBL219586	GW590735	Cc1nc(-c2ccc(C(F)(F)F)cc2)sc1C(=O)NCc1ccc(OC(C)(C)C(=O)O)cc1	ILUPZUOBHCUBKB-UHFFFAOYSA-N	InChI=1S/C23H21F3N2O4S/c1-13-18(33-20(28-13)15-6-8-16(9-7-15)23(24,25)26)19(29)27-12-14-4-10-17(11-5-14)32-22(2,3)21(30)31/h4-11H,12H2,1-3H3,(H,27,29)(H,30,31)	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	CHEMBL239	Peroxisome proliferator-activated receptor alpha	Homo sapiens
CHEMBL93747	NETOGLITAZONE	O=C1NC(=O)C(Cc2ccc3cc(OCc4ccccc4F)ccc3c2)S1	PKWDZWYVIHVNKS-UHFFFAOYSA-N	InChI=1S/C21H16FNO3S/c22-18-4-2-1-3-16(18)12-26-17-8-7-14-9-13(5-6-15(14)11-17)10-19-20(24)23-21(25)27-19/h1-9,11,19H,10,12H2,(H,23,24,25)	Peroxisome proliferator-activated receptor gamma modulator	MODULATOR	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL107367	FARGLITAZAR	Cc1oc(-c2ccccc2)nc1CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1	ZZCHHVUQYRMYLW-HKBQPEDESA-N	InChI=1S/C34H30N2O5/c1-23-29(36-33(41-23)26-12-6-3-7-13-26)20-21-40-27-18-16-24(17-19-27)22-31(34(38)39)35-30-15-9-8-14-28(30)32(37)25-10-4-2-5-11-25/h2-19,31,35H,20-22H2,1H3,(H,38,39)/t31-/m0/s1	Peroxisome proliferator-activated receptor gamma agonist	AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL181954	NAVEGLITAZAR	CO[C@@H](Cc1ccc(OCCCOc2ccc(Oc3ccccc3)cc2)cc1)C(=O)O	OKJHGOPITGTTIM-DEOSSOPVSA-N	InChI=1S/C25H26O6/c1-28-24(25(26)27)18-19-8-10-20(11-9-19)29-16-5-17-30-21-12-14-23(15-13-21)31-22-6-3-2-4-7-22/h2-4,6-15,24H,5,16-18H2,1H3,(H,26,27)/t24-/m0/s1	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	CHEMBL239	Peroxisome proliferator-activated receptor alpha	Homo sapiens
CHEMBL181954	NAVEGLITAZAR	CO[C@@H](Cc1ccc(OCCCOc2ccc(Oc3ccccc3)cc2)cc1)C(=O)O	OKJHGOPITGTTIM-DEOSSOPVSA-N	InChI=1S/C25H26O6/c1-28-24(25(26)27)18-19-8-10-20(11-9-19)29-16-5-17-30-21-12-14-23(15-13-21)31-22-6-3-2-4-7-22/h2-4,6-15,24H,5,16-18H2,1H3,(H,26,27)/t24-/m0/s1	Peroxisome proliferator-activated receptor gamma agonist	AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL230158	SELADELPAR	CCO[C@H](COc1ccc(C(F)(F)F)cc1)CSc1ccc(OCC(=O)O)c(C)c1	JWHYSEDOYMYMNM-QGZVFWFLSA-N	InChI=1S/C21H23F3O5S/c1-3-27-17(11-28-16-6-4-15(5-7-16)21(22,23)24)13-30-18-8-9-19(14(2)10-18)29-12-20(25)26/h4-10,17H,3,11-13H2,1-2H3,(H,25,26)/t17-/m1/s1	Peroxisome proliferator-activated receptor delta agonist	AGONIST	CHEMBL3979	Peroxisome proliferator-activated receptor delta	Homo sapiens
CHEMBL490029	MK-0533	CC[C@@H](Oc1cccc(-n2c(C)c(C(=O)c3ccc(OC)cc3)c3ccc(OC(F)(F)F)cc32)c1)C(=O)O	STWITCBWQHTJFJ-XMMPIXPASA-N	InChI=1S/C28H24F3NO6/c1-4-24(27(34)35)37-20-7-5-6-18(14-20)32-16(2)25(26(33)17-8-10-19(36-3)11-9-17)22-13-12-21(15-23(22)32)38-28(29,30)31/h5-15,24H,4H2,1-3H3,(H,34,35)/t24-/m1/s1	Peroxisome proliferator-activated receptor gamma modulator	MODULATOR	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL1236924	INT131	O=S(=O)(Nc1cc(Cl)c(Oc2cnc3ccccc3c2)c(Cl)c1)c1ccc(Cl)cc1Cl	NMRWDFUZLLQSBN-UHFFFAOYSA-N	InChI=1S/C21H12Cl4N2O3S/c22-13-5-6-20(16(23)8-13)31(28,29)27-14-9-17(24)21(18(25)10-14)30-15-7-12-3-1-2-4-19(12)26-11-15/h1-11,27H	Peroxisome proliferator-activated receptor gamma modulator	MODULATOR	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL3545278	ATX08-001	CCCCCS(=O)(=O)NC(=O)c1ccc2nc(C)n(Cc3ccc(Cl)cc3Cl)c2c1	UYGZODVVDUIDDQ-UHFFFAOYSA-N	InChI=1S/C21H23Cl2N3O3S/c1-3-4-5-10-30(28,29)25-21(27)15-7-9-19-20(11-15)26(14(2)24-19)13-16-6-8-17(22)12-18(16)23/h6-9,11-12H,3-5,10,13H2,1-2H3,(H,25,27)	Peroxisome proliferator-activated receptor gamma modulator	MODULATOR	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL3545279	EFATUTAZONE HYDROCHLORIDE	Cc1cc(Oc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)cc(C)c1N.Cl.Cl	WFIOHOJEIMQCEG-UHFFFAOYSA-N	InChI=1S/C27H26N4O4S.2ClH/c1-15-10-20(11-16(2)25(15)28)35-19-8-9-21-22(13-19)31(3)24(29-21)14-34-18-6-4-17(5-7-18)12-23-26(32)30-27(33)36-23;;/h4-11,13,23H,12,14,28H2,1-3H3,(H,30,32,33);2*1H	Peroxisome proliferator-activated receptor gamma agonist	AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL2103824	ARHALOFENATE	CC(=O)NCCOC(=O)[C@H](Oc1cccc(C(F)(F)F)c1)c1ccc(Cl)cc1	BJBCSGQLZQGGIQ-QGZVFWFLSA-N	InChI=1S/C19H17ClF3NO4/c1-12(25)24-9-10-27-18(26)17(13-5-7-15(20)8-6-13)28-16-4-2-3-14(11-16)19(21,22)23/h2-8,11,17H,9-10H2,1H3,(H,24,25)/t17-/m1/s1	Peroxisome proliferator-activated receptor gamma modulator	MODULATOR	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL2103824	ARHALOFENATE	CC(=O)NCCOC(=O)[C@H](Oc1cccc(C(F)(F)F)c1)c1ccc(Cl)cc1	BJBCSGQLZQGGIQ-QGZVFWFLSA-N	InChI=1S/C19H17ClF3NO4/c1-12(25)24-9-10-27-18(26)17(13-5-7-15(20)8-6-13)28-16-4-2-3-14(11-16)19(21,22)23/h2-8,11,17H,9-10H2,1H3,(H,24,25)/t17-/m1/s1	Solute carrier family 22 member 12 inhibitor	INHIBITOR	CHEMBL6120	Solute carrier family 22 member 12	Homo sapiens
CHEMBL107430	NRX195183	CC1(C)CCC(C)(C)c2c1cc(C(=O)Nc1cc(F)c(C(=O)O)c(F)c1)c(O)c2Cl	PNAWUIKCVQSLFG-UHFFFAOYSA-N	InChI=1S/C22H22ClF2NO4/c1-21(2)5-6-22(3,4)16-12(21)9-11(18(27)17(16)23)19(28)26-10-7-13(24)15(20(29)30)14(25)8-10/h7-9,27H,5-6H2,1-4H3,(H,26,28)(H,29,30)	Retinoic acid receptor alpha agonist	AGONIST	CHEMBL2055	Retinoic acid receptor alpha	Homo sapiens
CHEMBL2105648	PALOVAROTENE	CC1(C)CCC(C)(C)c2cc(Cn3cccn3)c(/C=C/c3ccc(C(=O)O)cc3)cc21	YTFHCXIPDIHOIA-DHZHZOJOSA-N	InChI=1S/C27H30N2O2/c1-26(2)12-13-27(3,4)24-17-22(18-29-15-5-14-28-29)21(16-23(24)26)11-8-19-6-9-20(10-7-19)25(30)31/h5-11,14-17H,12-13,18H2,1-4H3,(H,30,31)/b11-8+	Retinoic acid receptor gamma agonist	AGONIST	CHEMBL2003	Retinoic acid receptor gamma	Homo sapiens
CHEMBL1716091	SDX-101	CCc1cccc2c3c([nH]c12)[C@@](CC)(CC(=O)O)OCC3	NNYBQONXHNTVIJ-QGZVFWFLSA-N	InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)/t17-/m1/s1	Retinoid X receptor alpha modulator	MODULATOR	CHEMBL2061	Retinoid X receptor alpha	Homo sapiens
CHEMBL457748	MB07811	Cc1cc(OC[P@@]2(=O)OCC[C@@H](c3cccc(Cl)c3)O2)cc(C)c1Cc1ccc(O)c(C(C)C)c1	LGGPZDRLTDGYSQ-JADSYQMUSA-N	InChI=1S/C28H32ClO5P/c1-18(2)25-14-21(8-9-27(25)30)15-26-19(3)12-24(13-20(26)4)32-17-35(31)33-11-10-28(34-35)22-6-5-7-23(29)16-22/h5-9,12-14,16,18,28,30H,10-11,15,17H2,1-4H3/t28-,35+/m0/s1	Thyroid hormone receptor beta-1 agonist	AGONIST	CHEMBL1947	Thyroid hormone receptor beta-1	Homo sapiens
CHEMBL2105107	INECALCITOL	C[C@H](CC#CC(C)(C)O)[C@H]1CC[C@@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C	HHGRMHMXKPQNGF-WNSNRMDMSA-N	InChI=1S/C26H40O3/c1-18(7-5-13-25(2,3)29)23-11-12-24-20(8-6-14-26(23,24)4)10-9-19-15-21(27)17-22(28)16-19/h9-10,18,21-24,27-29H,6-8,11-12,14-17H2,1-4H3/b20-10+/t18-,21-,22-,23-,24-,26-/m1/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL605525	DP001	C=C1[C@H](O)CC(=C/C=C2\CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@@H](C)CCCC(C)(C)O)C[C@H]1O	UHMPCVGLSKFXHR-NAQZCRMNSA-N	InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)22-12-13-23-21(9-7-15-27(22,23)5)11-10-20-16-24(28)19(2)25(29)17-20/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b21-11+/t18-,22+,23-,24+,25+,27+/m0/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL2104955	BECOCALCIDIOL	C=C1[C@H](O)CC(=C/C=C2\CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@@H](C)CC)C[C@H]1O	QSLUXQQUPXBIHH-YHSKWIAJSA-N	InChI=1S/C23H36O2/c1-5-15(2)19-10-11-20-18(7-6-12-23(19,20)4)9-8-17-13-21(24)16(3)22(25)14-17/h8-9,15,19-22,24-25H,3,5-7,10-14H2,1-2,4H3/b18-9+/t15-,19+,20-,21+,22+,23+/m0/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL2105705	LUNACALCIPOL	C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@H](C)C/C=C/S(=O)(=O)C(C)(C)C)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O	RFQHCLMGLJGZNV-UXXOMSPDSA-N	InChI=1S/C28H42O4S/c1-19(9-8-16-33(31,32)27(3,4)5)24-13-14-25-21(10-7-15-28(24,25)6)11-12-22-17-23(29)18-26(30)20(22)2/h8,11-13,16,19,23,25-26,29-30H,2,7,9-10,14-15,17-18H2,1,3-6H3/b16-8+,21-11+,22-12-/t19-,23-,25+,26+,28-/m1/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL3545094	ELOCALCITOL	C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@@H](C)C/C=C/C(O)(CC)CC)=CCC23)C[C@@H](O)C[C@@H]1O	XDBOQJCMEXOPMU-BAHYQGKPSA-N	InChI=1S/C29H44O3/c1-6-29(32,7-2)17-8-10-20(3)25-14-15-26-22(11-9-16-28(25,26)5)12-13-23-18-24(30)19-27(31)21(23)4/h8,12-14,17,20,24,26-27,30-32H,4,6-7,9-11,15-16,18-19H2,1-3,5H3/b17-8+,22-12+,23-13-/t20-,24+,26?,27-,28+/m0/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL565612	SOTRASTAURIN	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1	OAVGBZOFDPFGPJ-UHFFFAOYSA-N	InChI=1S/C25H22N6O2/c1-30-10-12-31(13-11-30)25-27-19-9-5-3-7-16(19)22(28-25)21-20(23(32)29-24(21)33)17-14-26-18-8-4-2-6-15(17)18/h2-9,14,26H,10-13H2,1H3,(H,29,32,33)	Protein kinase C (PKC) inhibitor	INHIBITOR	CHEMBL2093867	Protein kinase C (PKC)	Homo sapiens
CHEMBL587723	AEE-788	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1	OONFNUWBHFSNBT-HXUWFJFHSA-N	InChI=1S/C27H32N6/c1-3-32-13-15-33(16-14-32)18-21-9-11-23(12-10-21)25-17-24-26(28-19-29-27(24)31-25)30-20(2)22-7-5-4-6-8-22/h4-12,17,19-20H,3,13-16,18H2,1-2H3,(H2,28,29,30,31)/t20-/m1/s1	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL587723	AEE-788	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1	OONFNUWBHFSNBT-HXUWFJFHSA-N	InChI=1S/C27H32N6/c1-3-32-13-15-33(16-14-32)18-21-9-11-23(12-10-21)25-17-24-26(28-19-29-27(24)31-25)30-20(2)22-7-5-4-6-8-22/h4-12,17,19-20H,3,13-16,18H2,1-2H3,(H2,28,29,30,31)/t20-/m1/s1	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL587723	AEE-788	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1	OONFNUWBHFSNBT-HXUWFJFHSA-N	InChI=1S/C27H32N6/c1-3-32-13-15-33(16-14-32)18-21-9-11-23(12-10-21)25-17-24-26(28-19-29-27(24)31-25)30-20(2)22-7-5-4-6-8-22/h4-12,17,19-20H,3,13-16,18H2,1-2H3,(H2,28,29,30,31)/t20-/m1/s1	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL587723	AEE-788	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1	OONFNUWBHFSNBT-HXUWFJFHSA-N	InChI=1S/C27H32N6/c1-3-32-13-15-33(16-14-32)18-21-9-11-23(12-10-21)25-17-24-26(28-19-29-27(24)31-25)30-20(2)22-7-5-4-6-8-22/h4-12,17,19-20H,3,13-16,18H2,1-2H3,(H2,28,29,30,31)/t20-/m1/s1	Vascular endothelial growth factor receptor 1 inhibitor	INHIBITOR	CHEMBL1868	Vascular endothelial growth factor receptor 1	Homo sapiens
CHEMBL3545335	AG-13958	Cc1cc(C(=O)Nc2cc(Nc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2F)n(C)n1	JXSVVZKPEDIRTN-DHZHZOJOSA-N	InChI=1S/C26H22FN7O/c1-16-13-25(34(2)33-16)26(35)30-24-15-19(7-10-21(24)27)29-18-6-9-20-22(31-32-23(20)14-18)11-8-17-5-3-4-12-28-17/h3-15,29H,1-2H3,(H,30,35)(H,31,32)/b11-8+	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL3545311	BRIGATINIB	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1	AILRADAXUVEEIR-UHFFFAOYSA-N	InChI=1S/C29H39ClN7O2P/c1-35-15-17-37(18-16-35)21-11-13-36(14-12-21)22-9-10-24(26(19-22)39-2)33-29-31-20-23(30)28(34-29)32-25-7-5-6-8-27(25)40(3,4)38/h5-10,19-21H,11-18H2,1-4H3,(H2,31,32,33,34)	ALK tyrosine kinase receptor inhibitor	INHIBITOR	CHEMBL4247	ALK tyrosine kinase receptor	Homo sapiens
CHEMBL3545311	BRIGATINIB	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1	AILRADAXUVEEIR-UHFFFAOYSA-N	InChI=1S/C29H39ClN7O2P/c1-35-15-17-37(18-16-35)21-11-13-36(14-12-21)22-9-10-24(26(19-22)39-2)33-29-31-20-23(30)28(34-29)32-25-7-5-6-8-27(25)40(3,4)38/h5-10,19-21H,11-18H2,1-4H3,(H2,31,32,33,34)	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL3545065	VEROSUDIL	CN(C)C(C(=O)Nc1ccc2c(=O)[nH]ccc2c1)c1ccsc1	VDYRZXYYQMMFJW-UHFFFAOYSA-N	InChI=1S/C17H17N3O2S/c1-20(2)15(12-6-8-23-10-12)17(22)19-13-3-4-14-11(9-13)5-7-18-16(14)21/h3-10,15H,1-2H3,(H,18,21)(H,19,22)	Rho-associated protein kinase inhibitor	INHIBITOR	CHEMBL2111459	Rho-associated protein kinase	Homo sapiens
CHEMBL2103842	VARLITINIB	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1	UWXSAYUXVSFDBQ-CYBMUJFWSA-N	InChI=1S/C22H19ClN6O2S/c1-13-10-31-22(27-13)29-14-2-4-18-16(8-14)21(26-12-25-18)28-15-3-5-19(17(23)9-15)30-11-20-24-6-7-32-20/h2-9,12-13H,10-11H2,1H3,(H,27,29)(H,25,26,28)/t13-/m1/s1	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL2103842	VARLITINIB	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1	UWXSAYUXVSFDBQ-CYBMUJFWSA-N	InChI=1S/C22H19ClN6O2S/c1-13-10-31-22(27-13)29-14-2-4-18-16(8-14)21(26-12-25-18)28-15-3-5-19(17(23)9-15)30-11-20-24-6-7-32-20/h2-9,12-13H,10-11H2,1H3,(H,27,29)(H,25,26,28)/t13-/m1/s1	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL1088750	ARRY-797	CC(C)Cn1ncc2cc(Oc3ccc(F)cc3F)c(C(=O)NCCN(C)C)cc21	IFGWYHGYNVGVRB-UHFFFAOYSA-N	InChI=1S/C22H26F2N4O2/c1-14(2)13-28-19-11-17(22(29)25-7-8-27(3)4)21(9-15(19)12-26-28)30-20-6-5-16(23)10-18(20)24/h5-6,9-12,14H,7-8,13H2,1-4H3,(H,25,29)	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL3545213	BENTAMAPIMOD	N#CC(c1ccnc(OCc2ccc(CN3CCOCC3)cc2)n1)c1nc2ccccc2s1	XCPPIJCBCWUBNT-UHFFFAOYSA-N	InChI=1S/C25H23N5O2S/c26-15-20(24-28-22-3-1-2-4-23(22)33-24)21-9-10-27-25(29-21)32-17-19-7-5-18(6-8-19)16-30-11-13-31-14-12-30/h1-10,20H,11-14,16-17H2	c-Jun N-terminal kinase, JNK inhibitor	INHIBITOR	CHEMBL2096667	c-Jun N-terminal kinase, JNK	Homo sapiens
CHEMBL2107832	PIMASERTIB	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F	VIUAUNHCRHHYNE-JTQLQIEISA-N	InChI=1S/C15H15FIN3O3/c16-12-5-9(17)1-2-13(12)20-14-7-18-4-3-11(14)15(23)19-6-10(22)8-21/h1-5,7,10,20-22H,6,8H2,(H,19,23)/t10-/m0/s1	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3587	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens
CHEMBL2107832	PIMASERTIB	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F	VIUAUNHCRHHYNE-JTQLQIEISA-N	InChI=1S/C15H15FIN3O3/c16-12-5-9(17)1-2-13(12)20-14-7-18-4-3-11(14)15(23)19-6-10(22)8-21/h1-5,7,10,20-22H,6,8H2,(H,19,23)/t10-/m0/s1	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	CHEMBL2964	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens
CHEMBL3137308	PEFICITINIB	NC(=O)c1cnc2[nH]ccc2c1N[C@H]1[C@H]2CC3C[C@@H]1C[C@](O)(C3)C2	DREIJXJRTLTGJC-ZLBJMMTISA-N	InChI=1S/C18H22N4O2/c19-16(23)13-8-21-17-12(1-2-20-17)15(13)22-14-10-3-9-4-11(14)7-18(24,5-9)6-10/h1-2,8-11,14,24H,3-7H2,(H2,19,23)(H2,20,21,22)/t9?,10-,11+,14-,18-	Janus Kinase (JAK) inhibitor	INHIBITOR	CHEMBL2363062	Janus Kinase (JAK)	Homo sapiens
CHEMBL445813	AT-7519	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl	OVPNQJVDAFNBDN-UHFFFAOYSA-N	InChI=1S/C16H17Cl2N5O2/c17-10-2-1-3-11(18)13(10)15(24)22-12-8-20-23-14(12)16(25)21-9-4-6-19-7-5-9/h1-3,8-9,19H,4-7H2,(H,20,23)(H,21,25)(H,22,24)	Cyclin-dependent kinase inhibitor	INHIBITOR	CHEMBL3559691	Cyclin-dependent kinase	Homo sapiens
CHEMBL495727	AT-9283	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1	LOLPPWBBNUVNQZ-UHFFFAOYSA-N	InChI=1S/C19H23N7O2/c27-19(21-13-2-3-13)24-16-10-20-25-17(16)18-22-14-4-1-12(9-15(14)23-18)11-26-5-7-28-8-6-26/h1,4,9-10,13H,2-3,5-8,11H2,(H,20,25)(H,22,23)(H2,21,24,27)	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	CHEMBL1862	Tyrosine-protein kinase ABL	Homo sapiens
CHEMBL495727	AT-9283	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1	LOLPPWBBNUVNQZ-UHFFFAOYSA-N	InChI=1S/C19H23N7O2/c27-19(21-13-2-3-13)24-16-10-20-25-17(16)18-22-14-4-1-12(9-15(14)23-18)11-26-5-7-28-8-6-26/h1,4,9-10,13H,2-3,5-8,11H2,(H,20,25)(H,22,23)(H2,21,24,27)	Serine/threonine-protein kinase Aurora-A inhibitor	INHIBITOR	CHEMBL4722	Serine/threonine-protein kinase Aurora-A	Homo sapiens
CHEMBL495727	AT-9283	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1	LOLPPWBBNUVNQZ-UHFFFAOYSA-N	InChI=1S/C19H23N7O2/c27-19(21-13-2-3-13)24-16-10-20-25-17(16)18-22-14-4-1-12(9-15(14)23-18)11-26-5-7-28-8-6-26/h1,4,9-10,13H,2-3,5-8,11H2,(H,20,25)(H,22,23)(H2,21,24,27)	Serine/threonine-protein kinase Aurora-B inhibitor	INHIBITOR	CHEMBL2185	Serine/threonine-protein kinase Aurora-B	Homo sapiens
CHEMBL495727	AT-9283	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1	LOLPPWBBNUVNQZ-UHFFFAOYSA-N	InChI=1S/C19H23N7O2/c27-19(21-13-2-3-13)24-16-10-20-25-17(16)18-22-14-4-1-12(9-15(14)23-18)11-26-5-7-28-8-6-26/h1,4,9-10,13H,2-3,5-8,11H2,(H,20,25)(H,22,23)(H2,21,24,27)	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL495727	AT-9283	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1	LOLPPWBBNUVNQZ-UHFFFAOYSA-N	InChI=1S/C19H23N7O2/c27-19(21-13-2-3-13)24-16-10-20-25-17(16)18-22-14-4-1-12(9-15(14)23-18)11-26-5-7-28-8-6-26/h1,4,9-10,13H,2-3,5-8,11H2,(H,20,25)(H,22,23)(H2,21,24,27)	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	CHEMBL2971	Tyrosine-protein kinase JAK2	Homo sapiens
CHEMBL495727	AT-9283	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1	LOLPPWBBNUVNQZ-UHFFFAOYSA-N	InChI=1S/C19H23N7O2/c27-19(21-13-2-3-13)24-16-10-20-25-17(16)18-22-14-4-1-12(9-15(14)23-18)11-26-5-7-28-8-6-26/h1,4,9-10,13H,2-3,5-8,11H2,(H,20,25)(H,22,23)(H2,21,24,27)	Tyrosine-protein kinase JAK3 inhibitor	INHIBITOR	CHEMBL2148	Tyrosine-protein kinase JAK3	Homo sapiens
CHEMBL283120	AXL-1717	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC	YJGVMLPVUAXIQN-HAEOHBJNSA-N	InChI=1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19+,20-/m0/s1	Insulin-like growth factor I receptor inhibitor	INHIBITOR	CHEMBL1957	Insulin-like growth factor I receptor	Homo sapiens
CHEMBL1231124	AZD-1480	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1	PDOQBOJDRPLBQU-QMMMGPOBSA-N	InChI=1S/C14H14ClFN8/c1-7-3-11(24-23-7)21-13-10(15)6-19-14(22-13)20-8(2)12-17-4-9(16)5-18-12/h3-6,8H,1-2H3,(H3,19,20,21,22,23,24)/t8-/m0/s1	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	CHEMBL2971	Tyrosine-protein kinase JAK2	Homo sapiens
CHEMBL1976040	ADAVOSERTIB	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1	BKWJAKQVGHWELA-UHFFFAOYSA-N	InChI=1S/C27H32N8O2/c1-5-13-34-25(36)21-18-28-26(29-19-9-11-20(12-10-19)33-16-14-32(4)15-17-33)31-24(21)35(34)23-8-6-7-22(30-23)27(2,3)37/h5-12,18,37H,1,13-17H2,2-4H3,(H,28,29,31)	Serine/threonine-protein kinase WEE1 inhibitor	INHIBITOR	CHEMBL5491	Serine/threonine-protein kinase WEE1	Homo sapiens
CHEMBL3184679	AZD-4547	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1	VRQMAABPASPXMW-UHFFFAOYSA-N	InChI=1S/C26H33N5O3/c1-17-15-31(16-18(2)27-17)22-9-6-20(7-10-22)26(32)28-25-13-21(29-30-25)8-5-19-11-23(33-3)14-24(12-19)34-4/h6-7,9-14,17-18,27H,5,8,15-16H2,1-4H3,(H2,28,29,30,32)	Fibroblast growth factor receptor inhibitor	INHIBITOR	CHEMBL2095217	Fibroblast growth factor receptor	Homo sapiens
CHEMBL3334567	SAVOLITINIB	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21	XYDNMOZJKOGZLS-NSHDSACASA-N	InChI=1S/C17H15N9/c1-11(12-3-4-15-18-5-6-25(15)10-12)26-17-16(22-23-26)19-8-14(21-17)13-7-20-24(2)9-13/h3-11H,1-2H3/t11-/m0/s1	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL1614701	SELUMETINIB	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21	CYOHGALHFOKKQC-UHFFFAOYSA-N	InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3587	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens
CHEMBL1614701	SELUMETINIB	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21	CYOHGALHFOKKQC-UHFFFAOYSA-N	InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	CHEMBL2964	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens
CHEMBL2408045	SAPITINIB	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1	DFJSJLGUIXFDJP-UHFFFAOYSA-N	InChI=1S/C23H25ClFN5O3/c1-26-21(31)12-30-8-6-14(7-9-30)33-20-10-15-18(11-19(20)32-2)27-13-28-23(15)29-17-5-3-4-16(24)22(17)25/h3-5,10-11,13-14H,6-9,12H2,1-2H3,(H,26,31)(H,27,28,29)	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL2408045	SAPITINIB	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1	DFJSJLGUIXFDJP-UHFFFAOYSA-N	InChI=1S/C23H25ClFN5O3/c1-26-21(31)12-30-8-6-14(7-9-30)33-20-10-15-18(11-19(20)32-2)27-13-28-23(15)29-17-5-3-4-16(24)22(17)25/h3-5,10-11,13-14H,6-9,12H2,1-2H3,(H,26,31)(H,27,28,29)	Receptor tyrosine-protein kinase erbB-3 inhibitor	INHIBITOR	CHEMBL5838	Receptor tyrosine-protein kinase erbB-3	Homo sapiens
CHEMBL2408045	SAPITINIB	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1	DFJSJLGUIXFDJP-UHFFFAOYSA-N	InChI=1S/C23H25ClFN5O3/c1-26-21(31)12-30-8-6-14(7-9-30)33-20-10-15-18(11-19(20)32-2)27-13-28-23(15)29-17-5-3-4-16(24)22(17)25/h3-5,10-11,13-14H,6-9,12H2,1-2H3,(H,26,31)(H,27,28,29)	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL2079588	TELATINIB	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1	QFCXANHHBCGMAS-UHFFFAOYSA-N	InChI=1S/C20H16ClN5O3/c1-22-19(27)16-10-12(6-8-23-16)11-29-20-17-15(7-9-28-17)18(25-26-20)24-14-4-2-13(21)3-5-14/h2-10H,11H2,1H3,(H,22,27)(H,24,25)	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL2079588	TELATINIB	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1	QFCXANHHBCGMAS-UHFFFAOYSA-N	InChI=1S/C20H16ClN5O3/c1-22-19(27)16-10-12(6-8-23-16)11-29-20-17-15(7-9-28-17)18(25-26-20)24-14-4-2-13(21)3-5-14/h2-10H,11H2,1H3,(H,22,27)(H,24,25)	Platelet-derived growth factor receptor beta inhibitor	INHIBITOR	CHEMBL1913	Platelet-derived growth factor receptor beta	Homo sapiens
CHEMBL2079588	TELATINIB	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1	QFCXANHHBCGMAS-UHFFFAOYSA-N	InChI=1S/C20H16ClN5O3/c1-22-19(27)16-10-12(6-8-23-16)11-29-20-17-15(7-9-28-17)18(25-26-20)24-14-4-2-13(21)3-5-14/h2-10H,11H2,1H3,(H,22,27)(H,24,25)	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL2079588	TELATINIB	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1	QFCXANHHBCGMAS-UHFFFAOYSA-N	InChI=1S/C20H16ClN5O3/c1-22-19(27)16-10-12(6-8-23-16)11-29-20-17-15(7-9-28-17)18(25-26-20)24-14-4-2-13(21)3-5-14/h2-10H,11H2,1H3,(H,22,27)(H,24,25)	Vascular endothelial growth factor receptor 3 inhibitor	INHIBITOR	CHEMBL1955	Vascular endothelial growth factor receptor 3	Homo sapiens
CHEMBL1236682	REFAMETINIB	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1	RDSACQWTXKSHJT-NSHDSACASA-N	InChI=1S/C19H20F3IN2O5S/c1-30-15-7-13(21)16(22)18(24-14-3-2-10(23)6-12(14)20)17(15)25-31(28,29)19(4-5-19)8-11(27)9-26/h2-3,6-7,11,24-27H,4-5,8-9H2,1H3/t11-/m0/s1	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3587	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens
CHEMBL1236682	REFAMETINIB	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1	RDSACQWTXKSHJT-NSHDSACASA-N	InChI=1S/C19H20F3IN2O5S/c1-30-15-7-13(21)16(22)18(24-14-3-2-10(23)6-12(14)20)17(15)25-31(28,29)19(4-5-19)8-11(27)9-26/h2-3,6-7,11,24-27H,4-5,8-9H2,1H3/t11-/m0/s1	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	CHEMBL2964	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens
CHEMBL1879463	DACTOLISIB	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21	JOGKUKXHTYWRGZ-UHFFFAOYSA-N	InChI=1S/C30H23N5O/c1-30(2,18-31)22-9-11-23(12-10-22)35-28-24-15-19(21-14-20-6-4-5-7-25(20)32-16-21)8-13-26(24)33-17-27(28)34(3)29(35)36/h4-17H,1-3H3	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL1879463	DACTOLISIB	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21	JOGKUKXHTYWRGZ-UHFFFAOYSA-N	InChI=1S/C30H23N5O/c1-30(2,18-31)22-9-11-23(12-10-22)35-28-24-15-19(21-14-20-6-4-5-7-25(20)32-16-21)8-13-26(24)33-17-27(28)34(3)29(35)36/h4-17H,1-3H3	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL3545096	BGT-226	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1.O=C(O)/C=C\C(=O)O	YUXMAKUNSXIEKN-BTJKTKAUSA-N	InChI=1S/C28H25F3N6O2.C4H4O4/c1-35-24-16-33-22-6-3-17(18-4-8-25(39-2)34-15-18)13-20(22)26(24)37(27(35)38)19-5-7-23(21(14-19)28(29,30)31)36-11-9-32-10-12-36;5-3(6)1-2-4(7)8/h3-8,13-16,32H,9-12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL3545096	BGT-226	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1.O=C(O)/C=C\C(=O)O	YUXMAKUNSXIEKN-BTJKTKAUSA-N	InChI=1S/C28H25F3N6O2.C4H4O4/c1-35-24-16-33-22-6-3-17(18-4-8-25(39-2)34-15-18)13-20(22)26(24)37(27(35)38)19-5-7-23(21(14-19)28(29,30)31)36-11-9-32-10-12-36;5-3(6)1-2-4(7)8/h3-8,13-16,32H,9-12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL513909	BI-2536	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1	XQVVPGYIWAGRNI-JOCHJYFZSA-N	InChI=1S/C28H39N7O3/c1-5-22-27(37)34(3)23-17-29-28(32-25(23)35(22)20-8-6-7-9-20)31-21-11-10-18(16-24(21)38-4)26(36)30-19-12-14-33(2)15-13-19/h10-11,16-17,19-20,22H,5-9,12-15H2,1-4H3,(H,30,36)(H,29,31,32)/t22-/m1/s1	Serine/threonine-protein kinase PLK1 inhibitor	INHIBITOR	CHEMBL3024	Serine/threonine-protein kinase PLK1	Homo sapiens
CHEMBL2017974	BUPARLISIB	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1	CWHUFRVAEUJCEF-UHFFFAOYSA-N	InChI=1S/C18H21F3N6O2/c19-18(20,21)13-9-15(22)23-11-12(13)14-10-16(26-1-5-28-6-2-26)25-17(24-14)27-3-7-29-8-4-27/h9-11H,1-8H2,(H2,22,23)	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL1230065	BMS-582949	CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C	GDTQLZHHDRRBEB-UHFFFAOYSA-N	InChI=1S/C22H26N6O2/c1-4-9-23-22(30)17-11-28-19(14(17)3)20(24-12-25-28)27-18-10-15(6-5-13(18)2)21(29)26-16-7-8-16/h5-6,10-12,16H,4,7-9H2,1-3H3,(H,23,30)(H,26,29)(H,24,25,27)	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL3545396	BMS-690514	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1	CSGQVNMSRKWUSH-IAGOWNOFSA-N	InChI=1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23)/t16-,17-/m1/s1	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL3545396	BMS-690514	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1	CSGQVNMSRKWUSH-IAGOWNOFSA-N	InChI=1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23)/t16-,17-/m1/s1	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL3545396	BMS-690514	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1	CSGQVNMSRKWUSH-IAGOWNOFSA-N	InChI=1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23)/t16-,17-/m1/s1	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL3545396	BMS-690514	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1	CSGQVNMSRKWUSH-IAGOWNOFSA-N	InChI=1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23)/t16-,17-/m1/s1	Receptor protein-tyrosine kinase erbB-4 inhibitor	INHIBITOR	CHEMBL3009	Receptor protein-tyrosine kinase erbB-4	Homo sapiens
CHEMBL575448	BMS-754807	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1	LQVXSNNAFNGRAH-QHCPKHFHSA-N	InChI=1S/C23H24FN9O/c1-23(21(34)26-15-7-8-18(24)25-13-15)9-3-10-32(23)22-28-20(17-4-2-11-33(17)31-22)27-19-12-16(29-30-19)14-5-6-14/h2,4,7-8,11-14H,3,5-6,9-10H2,1H3,(H,26,34)(H2,27,28,29,30,31)/t23-/m0/s1	Insulin-like growth factor I receptor inhibitor	INHIBITOR	CHEMBL1957	Insulin-like growth factor I receptor	Homo sapiens
CHEMBL575448	BMS-754807	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1	LQVXSNNAFNGRAH-QHCPKHFHSA-N	InChI=1S/C23H24FN9O/c1-23(21(34)26-15-7-8-18(24)25-13-15)9-3-10-32(23)22-28-20(17-4-2-11-33(17)31-22)27-19-12-16(29-30-19)14-5-6-14/h2,4,7-8,11-14H,3,5-6,9-10H2,1H3,(H,26,34)(H2,27,28,29,30,31)/t23-/m0/s1	Insulin receptor inhibitor	INHIBITOR	CHEMBL1981	Insulin receptor	Homo sapiens
CHEMBL460702	BMS-777607	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1	VNBRGSXVFBYQNN-UHFFFAOYSA-N	InChI=1S/C25H19ClF2N4O4/c1-2-35-19-10-12-32(16-6-3-14(27)4-7-16)25(34)21(19)24(33)31-15-5-8-18(17(28)13-15)36-20-9-11-30-23(29)22(20)26/h3-13H,2H2,1H3,(H2,29,30)(H,31,33)	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL3544943	BMS-863233	Cl.O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12	UNDKJUKLBNARIZ-UHFFFAOYSA-N	InChI=1S/C14H12ClN3O2.ClH/c15-7-3-4-10-8(6-7)11-12(20-10)14(19)18-13(17-11)9-2-1-5-16-9;/h3-4,6,9,16H,1-2,5H2,(H,17,18,19);1H	Cell division cycle 7-related protein kinase inhibitor	INHIBITOR	CHEMBL5443	Cell division cycle 7-related protein kinase	Homo sapiens
CHEMBL3545215	BMS-911543	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21	JCINBYQJBYJGDM-UHFFFAOYSA-N	InChI=1S/C23H28N8O/c1-5-30-17(23(32)31(14-6-7-14)15-8-9-15)11-16-20-19(24-12-28(20)3)21(26-22(16)30)25-18-10-13(2)29(4)27-18/h10-12,14-15H,5-9H2,1-4H3,(H,25,26,27)	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	CHEMBL2971	Tyrosine-protein kinase JAK2	Homo sapiens
CHEMBL2396661	ALPELISIB	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1	STUWGJZDJHPWGZ-LBPRGKRZSA-N	InChI=1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1	PI3-kinase p110-alpha subunit inhibitor	INHIBITOR	CHEMBL4005	PI3-kinase p110-alpha subunit	Homo sapiens
CHEMBL3545337	C-1311	CCN(CC)CCNc1ccc2ncn3c4ccc(O)cc4c(=O)c1c23.Cl.Cl.O	XJYNBZQTAZDMHZ-UHFFFAOYSA-N	InChI=1S/C20H22N4O2.2ClH.H2O/c1-3-23(4-2)10-9-21-15-6-7-16-19-18(15)20(26)14-11-13(25)5-8-17(14)24(19)12-22-16;;;/h5-8,11-12,21,25H,3-4,9-10H2,1-2H3;2*1H;1H2	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL3545337	C-1311	CCN(CC)CCNc1ccc2ncn3c4ccc(O)cc4c(=O)c1c23.Cl.Cl.O	XJYNBZQTAZDMHZ-UHFFFAOYSA-N	InChI=1S/C20H22N4O2.2ClH.H2O/c1-3-23(4-2)10-9-21-15-6-7-16-19-18(15)20(26)14-11-13(25)5-8-17(14)24(19)12-22-16;;;/h5-8,11-12,21,25H,3-4,9-10H2,1-2H3;2*1H;1H2	DNA topoisomerase II inhibitor	INHIBITOR	CHEMBL2094255	DNA topoisomerase II	Homo sapiens
CHEMBL1614713	CC-401	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1	XDJCLCLBSGGNKS-UHFFFAOYSA-N	InChI=1S/C22H24N6O/c1-2-9-28(10-3-1)11-12-29-18-6-4-5-16(13-18)21-19-14-17(22-23-15-24-27-22)7-8-20(19)25-26-21/h4-8,13-15H,1-3,9-12H2,(H,25,26)(H,23,24,27)	c-Jun N-terminal kinase 1 inhibitor	INHIBITOR	CHEMBL2276	c-Jun N-terminal kinase 1	Homo sapiens
CHEMBL1614713	CC-401	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1	XDJCLCLBSGGNKS-UHFFFAOYSA-N	InChI=1S/C22H24N6O/c1-2-9-28(10-3-1)11-12-29-18-6-4-5-16(13-18)21-19-14-17(22-23-15-24-27-22)7-8-20(19)25-26-21/h4-8,13-15H,1-3,9-12H2,(H,25,26)(H,23,24,27)	c-Jun N-terminal kinase 2 inhibitor	INHIBITOR	CHEMBL4179	c-Jun N-terminal kinase 2	Homo sapiens
CHEMBL1614713	CC-401	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1	XDJCLCLBSGGNKS-UHFFFAOYSA-N	InChI=1S/C22H24N6O/c1-2-9-28(10-3-1)11-12-29-18-6-4-5-16(13-18)21-19-14-17(22-23-15-24-27-22)7-8-20(19)25-26-21/h4-8,13-15H,1-3,9-12H2,(H,25,26)(H,23,24,27)	c-Jun N-terminal kinase 3 inhibitor	INHIBITOR	CHEMBL2637	c-Jun N-terminal kinase 3	Homo sapiens
CHEMBL1950289	TANZISERTIB	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1	IBGLGMOPHJQDJB-IHRRRGAJSA-N	InChI=1S/C21H23F3N6O2/c22-11-7-15(23)18(16(24)8-11)28-21-27-17-9-25-20(26-12-1-3-14(31)4-2-12)29-19(17)30(21)13-5-6-32-10-13/h7-9,12-14,31H,1-6,10H2,(H,27,28)(H,25,26,29)/t12-,13-,14-/m0/s1	c-Jun N-terminal kinase 1 inhibitor	INHIBITOR	CHEMBL2276	c-Jun N-terminal kinase 1	Homo sapiens
CHEMBL1950289	TANZISERTIB	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1	IBGLGMOPHJQDJB-IHRRRGAJSA-N	InChI=1S/C21H23F3N6O2/c22-11-7-15(23)18(16(24)8-11)28-21-27-17-9-25-20(26-12-1-3-14(31)4-2-12)29-19(17)30(21)13-5-6-32-10-13/h7-9,12-14,31H,1-6,10H2,(H,27,28)(H,25,26,29)/t12-,13-,14-/m0/s1	c-Jun N-terminal kinase 2 inhibitor	INHIBITOR	CHEMBL4179	c-Jun N-terminal kinase 2	Homo sapiens
CHEMBL1950289	TANZISERTIB	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1	IBGLGMOPHJQDJB-IHRRRGAJSA-N	InChI=1S/C21H23F3N6O2/c22-11-7-15(23)18(16(24)8-11)28-21-27-17-9-25-20(26-12-1-3-14(31)4-2-12)29-19(17)30(21)13-5-6-32-10-13/h7-9,12-14,31H,1-6,10H2,(H,27,28)(H,25,26,29)/t12-,13-,14-/m0/s1	c-Jun N-terminal kinase 3 inhibitor	INHIBITOR	CHEMBL2637	c-Jun N-terminal kinase 3	Homo sapiens
CHEMBL105442	CI-1040	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl	GFMMXOIFOQCCGU-UHFFFAOYSA-N	InChI=1S/C17H14ClF2IN2O2/c18-12-7-10(21)3-6-14(12)22-16-11(4-5-13(19)15(16)20)17(24)23-25-8-9-1-2-9/h3-7,9,22H,1-2,8H2,(H,23,24)	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3587	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens
CHEMBL105442	CI-1040	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl	GFMMXOIFOQCCGU-UHFFFAOYSA-N	InChI=1S/C17H14ClF2IN2O2/c18-12-7-10(21)3-6-14(12)22-16-11(4-5-13(19)15(16)20)17(24)23-25-8-9-1-2-9/h3-7,9,22H,1-2,8H2,(H,23,24)	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	CHEMBL2964	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens
CHEMBL2107779	SEMAPIMOD	C/C(=N\NC(=N)N)c1cc(NC(=O)CCCCCCCCC(=O)Nc2cc(/C(C)=N/NC(=N)N)cc(/C(C)=N/NC(=N)N)c2)cc(/C(C)=N/NC(=N)N)c1	PWDYHMBTPGXCSN-VCBMUGGBSA-N	InChI=1S/C34H52N18O2/c1-19(45-49-31(35)36)23-13-24(20(2)46-50-32(37)38)16-27(15-23)43-29(53)11-9-7-5-6-8-10-12-30(54)44-28-17-25(21(3)47-51-33(39)40)14-26(18-28)22(4)48-52-34(41)42/h13-18H,5-12H2,1-4H3,(H,43,53)(H,44,54)(H4,35,36,49)(H4,37,38,50)(H4,39,40,51)(H4,41,42,52)/b45-19+,46-20+,47-21+,48-22+	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL3545308	ROCILETINIB	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1	HUFOZJXAKZVRNJ-UHFFFAOYSA-N	InChI=1S/C27H28F3N7O3/c1-4-24(39)32-18-6-5-7-19(14-18)33-25-21(27(28,29)30)16-31-26(35-25)34-22-9-8-20(15-23(22)40-3)37-12-10-36(11-13-37)17(2)38/h4-9,14-16H,1,10-13H2,2-3H3,(H,32,39)(H2,31,33,34,35)	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL2105728	CRENOLANIB	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1	DYNHJHQFHQTFTP-UHFFFAOYSA-N	InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL2105728	CRENOLANIB	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1	DYNHJHQFHQTFTP-UHFFFAOYSA-N	InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL4297182	PEGCANTRATINIB	COCCN1C(=O)O[C@@]2(C[C@H]3O[C@]2(C)n2c4ccccc4c4c5c(c6c7ccccc7n3c6c42)C(=O)NC5)C1=O	SHWPFRVVBIKGAT-LYWBODIJSA-N	InChI=1S/C30H24N4O6/c1-29-30(27(36)32(11-12-38-2)28(37)40-30)13-20(39-29)33-18-9-5-3-7-15(18)22-23-17(14-31-26(23)35)21-16-8-4-6-10-19(16)34(29)25(21)24(22)33/h3-10,20H,11-14H2,1-2H3,(H,31,35)/t20-,29+,30+/m1/s1	Nerve growth factor receptor Trk-A inhibitor	INHIBITOR	CHEMBL2815	Nerve growth factor receptor Trk-A	Homo sapiens
CHEMBL1230165	SILMITASERTIB	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12	MUOKSQABCJCOPU-UHFFFAOYSA-N	InChI=1S/C19H12ClN3O2/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18/h1-10H,(H,22,23)(H,24,25)	Casein kinase II alpha inhibitor	INHIBITOR	CHEMBL3629	Casein kinase II alpha	Homo sapiens
CHEMBL14762	SELICICLIB	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	BTIHMVBBUGXLCJ-OAHLLOKOSA-N	InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1	Cyclin-dependent kinase 2 inhibitor	INHIBITOR	CHEMBL301	Cyclin-dependent kinase 2	Homo sapiens
CHEMBL14762	SELICICLIB	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	BTIHMVBBUGXLCJ-OAHLLOKOSA-N	InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1	Cyclin-dependent kinase 7 inhibitor	INHIBITOR	CHEMBL3055	Cyclin-dependent kinase 7	Homo sapiens
CHEMBL14762	SELICICLIB	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	BTIHMVBBUGXLCJ-OAHLLOKOSA-N	InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1	Cyclin-dependent kinase 9 inhibitor	INHIBITOR	CHEMBL3116	Cyclin-dependent kinase 9	Homo sapiens
CHEMBL14762	SELICICLIB	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	BTIHMVBBUGXLCJ-OAHLLOKOSA-N	InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1	Cyclin-dependent kinase 1 inhibitor	INHIBITOR	CHEMBL308	Cyclin-dependent kinase 1	Homo sapiens
CHEMBL14762	SELICICLIB	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	BTIHMVBBUGXLCJ-OAHLLOKOSA-N	InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1	Cyclin-dependent kinase 5 inhibitor	INHIBITOR	CHEMBL4036	Cyclin-dependent kinase 5	Homo sapiens
CHEMBL1738757	REBASTINIB	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1	WVXNSAVVKYZVOE-UHFFFAOYSA-N	InChI=1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40)	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	CHEMBL1862	Tyrosine-protein kinase ABL	Homo sapiens
CHEMBL2220486	LUCITANIB	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12	CUDVHEFYRIWYQD-UHFFFAOYSA-N	InChI=1S/C26H25N3O4/c1-28-25(30)19-5-3-4-16-12-17(6-7-18(16)19)33-22-8-11-29-21-14-24(23(31-2)13-20(21)22)32-15-26(27)9-10-26/h3-8,11-14H,9-10,15,27H2,1-2H3,(H,28,30)	Fibroblast growth factor receptor 1 inhibitor	INHIBITOR	CHEMBL3650	Fibroblast growth factor receptor 1	Homo sapiens
CHEMBL2220486	LUCITANIB	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12	CUDVHEFYRIWYQD-UHFFFAOYSA-N	InChI=1S/C26H25N3O4/c1-28-25(30)19-5-3-4-16-12-17(6-7-18(16)19)33-22-8-11-29-21-14-24(23(31-2)13-20(21)22)32-15-26(27)9-10-26/h3-8,11-14H,9-10,15,27H2,1-2H3,(H,28,30)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL2220486	LUCITANIB	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12	CUDVHEFYRIWYQD-UHFFFAOYSA-N	InChI=1S/C26H25N3O4/c1-28-25(30)19-5-3-4-16-12-17(6-7-18(16)19)33-22-8-11-29-21-14-24(23(31-2)13-20(21)22)32-15-26(27)9-10-26/h3-8,11-14H,9-10,15,27H2,1-2H3,(H,28,30)	Fibroblast growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL4142	Fibroblast growth factor receptor 2	Homo sapiens
CHEMBL1097999	E-6201	CCNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O	MWUFVYLAWAXDHQ-HMNLTAHHSA-N	InChI=1S/C21H27NO6/c1-4-22-15-10-14-6-5-7-16(23)20(26)17(24)9-8-12(2)13(3)28-21(27)19(14)18(25)11-15/h5-6,8-13,16,20,22-23,25-26H,4,7H2,1-3H3/b6-5+,9-8-/t12-,13+,16+,20+/m1/s1	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3587	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens
CHEMBL1097999	E-6201	CCNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O	MWUFVYLAWAXDHQ-HMNLTAHHSA-N	InChI=1S/C21H27NO6/c1-4-22-15-10-14-6-5-7-16(23)20(26)17(24)9-8-12(2)13(3)28-21(27)19(14)18(25)11-15/h5-6,8-13,16,20,22-23,25-26H,4,7H2,1-3H3/b6-5+,9-8-/t12-,13+,16+,20+/m1/s1	Mitogen-activated protein kinase kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3956	Mitogen-activated protein kinase kinase kinase 1	Homo sapiens
CHEMBL3039525	GOLVATINIB	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1	UQRCJCNVNUFYDX-UHFFFAOYSA-N	InChI=1S/C33H37F2N7O4/c1-40-16-18-41(19-17-40)24-9-14-42(15-10-24)32(45)39-29-21-26(8-13-36-29)46-25-6-7-28(27(35)20-25)38-31(44)33(11-12-33)30(43)37-23-4-2-22(34)3-5-23/h2-8,13,20-21,24H,9-12,14-19H2,1H3,(H,37,43)(H,38,44)(H,36,39,45)	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL3039525	GOLVATINIB	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1	UQRCJCNVNUFYDX-UHFFFAOYSA-N	InChI=1S/C33H37F2N7O4/c1-40-16-18-41(19-17-40)24-9-14-42(15-10-24)32(45)39-29-21-26(8-13-36-29)46-25-6-7-28(27(35)20-25)38-31(44)33(11-12-33)30(43)37-23-4-2-22(34)3-5-23/h2-8,13,20-21,24H,9-12,14-19H2,1H3,(H,37,43)(H,38,44)(H,36,39,45)	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL607707	PELITINIB	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C	WVUNYSQLFKLYNI-AATRIKPKSA-N	InChI=1S/C24H23ClFN5O2/c1-4-33-22-12-20-17(11-21(22)30-23(32)6-5-9-31(2)3)24(15(13-27)14-28-20)29-16-7-8-19(26)18(25)10-16/h5-8,10-12,14H,4,9H2,1-3H3,(H,28,29)(H,30,32)/b6-5+	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL482968	ENMD-2076	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1	BLQYVHBZHAISJM-CMDGGOBGSA-N	InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+	Serine/threonine-protein kinase Aurora-A inhibitor	INHIBITOR	CHEMBL4722	Serine/threonine-protein kinase Aurora-A	Homo sapiens
CHEMBL482968	ENMD-2076	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1	BLQYVHBZHAISJM-CMDGGOBGSA-N	InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+	Serine/threonine-protein kinase Aurora-B inhibitor	INHIBITOR	CHEMBL2185	Serine/threonine-protein kinase Aurora-B	Homo sapiens
CHEMBL482968	ENMD-2076	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1	BLQYVHBZHAISJM-CMDGGOBGSA-N	InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL482968	ENMD-2076	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1	BLQYVHBZHAISJM-CMDGGOBGSA-N	InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+	Fibroblast growth factor receptor 3 inhibitor	INHIBITOR	CHEMBL2742	Fibroblast growth factor receptor 3	Homo sapiens
CHEMBL482968	ENMD-2076	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1	BLQYVHBZHAISJM-CMDGGOBGSA-N	InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL482968	ENMD-2076	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1	BLQYVHBZHAISJM-CMDGGOBGSA-N	InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL482968	ENMD-2076	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1	BLQYVHBZHAISJM-CMDGGOBGSA-N	InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	CHEMBL1844	Macrophage colony stimulating factor receptor	Homo sapiens
CHEMBL3301607	FILGOTINIB	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1	RIJLVEAXPNLDTC-UHFFFAOYSA-N	InChI=1S/C21H23N5O3S/c27-20(17-8-9-17)23-21-22-19-3-1-2-18(26(19)24-21)16-6-4-15(5-7-16)14-25-10-12-30(28,29)13-11-25/h1-7,17H,8-14H2,(H,23,24,27)	Tyrosine-protein kinase JAK1 inhibitor	INHIBITOR	CHEMBL2835	Tyrosine-protein kinase JAK1	Homo sapiens
CHEMBL3265032	ENTOSPLETINIB	c1cn2cc(-c3ccc4cn[nH]c4c3)nc(Nc3ccc(N4CCOCC4)cc3)c2n1	XSMSNFMDVXXHGJ-UHFFFAOYSA-N	InChI=1S/C23H21N7O/c1-2-17-14-25-28-20(17)13-16(1)21-15-30-8-7-24-23(30)22(27-21)26-18-3-5-19(6-4-18)29-9-11-31-12-10-29/h1-8,13-15H,9-12H2,(H,25,28)(H,26,27)	Tyrosine-protein kinase SYK inhibitor	INHIBITOR	CHEMBL2599	Tyrosine-protein kinase SYK	Homo sapiens
CHEMBL1230609	FORETINIB	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1	CXQHYVUVSFXTMY-UHFFFAOYSA-N	InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL1230609	FORETINIB	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1	CXQHYVUVSFXTMY-UHFFFAOYSA-N	InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL1230609	FORETINIB	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1	CXQHYVUVSFXTMY-UHFFFAOYSA-N	InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL1230609	FORETINIB	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1	CXQHYVUVSFXTMY-UHFFFAOYSA-N	InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL1230609	FORETINIB	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1	CXQHYVUVSFXTMY-UHFFFAOYSA-N	InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)	Tyrosine-protein kinase TIE-2 inhibitor	INHIBITOR	CHEMBL4128	Tyrosine-protein kinase TIE-2	Homo sapiens
CHEMBL1230609	FORETINIB	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1	CXQHYVUVSFXTMY-UHFFFAOYSA-N	InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL2219422	AFURESERTIB	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl	AFJRDFWMXUECEW-LBPRGKRZSA-N	InChI=1S/C18H17Cl2FN4OS/c1-25-16(14(19)9-23-25)13-7-15(27-17(13)20)18(26)24-12(8-22)6-10-3-2-4-11(21)5-10/h2-5,7,9,12H,6,8,22H2,1H3,(H,24,26)/t12-/m0/s1	Serine/threonine-protein kinase AKT inhibitor	INHIBITOR	CHEMBL2111353	Serine/threonine-protein kinase AKT	Homo sapiens
CHEMBL3137336	UPROSERTIB	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl	AXTAPYRUEKNRBA-JTQLQIEISA-N	InChI=1S/C18H16Cl2F2N4O2/c1-26-16(12(19)8-24-26)11-6-15(28-17(11)20)18(27)25-10(7-23)4-9-2-3-13(21)14(22)5-9/h2-3,5-6,8,10H,4,7,23H2,1H3,(H,25,27)/t10-/m0/s1	Serine/threonine-protein kinase AKT inhibitor	INHIBITOR	CHEMBL2111353	Serine/threonine-protein kinase AKT	Homo sapiens
CHEMBL3301606	SOLCITINIB	CC1(C)CN(C(=O)c2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)C1	MPYACSQFXVMWNO-UHFFFAOYSA-N	InChI=1S/C22H23N5O2/c1-22(2)12-26(13-22)20(29)16-10-6-14(7-11-16)17-4-3-5-18-23-21(25-27(17)18)24-19(28)15-8-9-15/h3-7,10-11,15H,8-9,12-13H2,1-2H3,(H,24,25,28)	Tyrosine-protein kinase JAK1 inhibitor	INHIBITOR	CHEMBL2835	Tyrosine-protein kinase JAK1	Homo sapiens
CHEMBL2103838	DILMAPIMOD	Cc1cc(F)ccc1-c1nc(NC(CO)CO)nc2c1ccc(=O)n2-c1c(F)cccc1F	ORVNHOYNEHYKJG-UHFFFAOYSA-N	InChI=1S/C23H19F3N4O3/c1-12-9-13(24)5-6-15(12)20-16-7-8-19(33)30(21-17(25)3-2-4-18(21)26)22(16)29-23(28-20)27-14(10-31)11-32/h2-9,14,31-32H,10-11H2,1H3,(H,27,28,29)	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL3545154	POZIOTINIB	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1	LPFWVDIFUFFKJU-UHFFFAOYSA-N	InChI=1S/C23H21Cl2FN4O3/c1-3-20(31)30-8-6-13(7-9-30)33-19-10-14-17(11-18(19)32-2)27-12-28-23(14)29-16-5-4-15(24)21(25)22(16)26/h3-5,10-13H,1,6-9H2,2H3,(H,27,28,29)	Epidermal growth factor receptor inhibitor	INHIBITOR	CHEMBL2363049	Epidermal growth factor receptor	Homo sapiens
CHEMBL206834	BAFETINIB	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1	ZGBAJMQHJDFTQJ-DEOSSOPVSA-N	InChI=1S/C30H31F3N8O/c1-19-4-7-23(13-27(19)39-29-36-10-8-26(38-29)22-14-34-18-35-15-22)37-28(42)20-5-6-21(25(12-20)30(31,32)33)16-41-11-9-24(17-41)40(2)3/h4-8,10,12-15,18,24H,9,11,16-17H2,1-3H3,(H,37,42)(H,36,38,39)/t24-/m0/s1	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	CHEMBL1862	Tyrosine-protein kinase ABL	Homo sapiens
CHEMBL206834	BAFETINIB	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1	ZGBAJMQHJDFTQJ-DEOSSOPVSA-N	InChI=1S/C30H31F3N8O/c1-19-4-7-23(13-27(19)39-29-36-10-8-26(38-29)22-14-34-18-35-15-22)37-28(42)20-5-6-21(25(12-20)30(31,32)33)16-41-11-9-24(17-41)40(2)3/h4-8,10,12-15,18,24H,9,11,16-17H2,1-3H3,(H,37,42)(H,36,38,39)/t24-/m0/s1	Tyrosine-protein kinase Lyn inhibitor	INHIBITOR	CHEMBL3905	Tyrosine-protein kinase Lyn	Homo sapiens
CHEMBL3039502	DUVELISIB	C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1	SJVQHLPISAIATJ-ZDUSSCGKSA-N	InChI=1S/C22H17ClN6O/c1-13(28-21-19-20(25-11-24-19)26-12-27-21)17-10-14-6-5-9-16(23)18(14)22(30)29(17)15-7-3-2-4-8-15/h2-13H,1H3,(H2,24,25,26,27,28)/t13-/m0/s1	PI3-kinase p110-gamma subunit inhibitor	INHIBITOR	CHEMBL3267	PI3-kinase p110-gamma subunit	Homo sapiens
CHEMBL3039502	DUVELISIB	C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1	SJVQHLPISAIATJ-ZDUSSCGKSA-N	InChI=1S/C22H17ClN6O/c1-13(28-21-19-20(25-11-24-19)26-12-27-21)17-10-14-6-5-9-16(23)18(14)22(30)29(17)15-7-3-2-4-8-15/h2-13H,1H3,(H2,24,25,26,27,28)/t13-/m0/s1	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	CHEMBL3130	PI3-kinase p110-delta subunit	Homo sapiens
CHEMBL3545155	JI-101	COc1ccc(Br)cc1NC(=O)Nc1cccc2c1ccn2Cc1ccnc(N)c1	ZXBFYBLSJMEBEP-UHFFFAOYSA-N	InChI=1S/C22H20BrN5O2/c1-30-20-6-5-15(23)12-18(20)27-22(29)26-17-3-2-4-19-16(17)8-10-28(19)13-14-7-9-25-21(24)11-14/h2-12H,13H2,1H3,(H2,24,25)(H2,26,27,29)	Ephrin type-B receptor 4 inhibitor	INHIBITOR	CHEMBL5147	Ephrin type-B receptor 4	Homo sapiens
CHEMBL3545155	JI-101	COc1ccc(Br)cc1NC(=O)Nc1cccc2c1ccn2Cc1ccnc(N)c1	ZXBFYBLSJMEBEP-UHFFFAOYSA-N	InChI=1S/C22H20BrN5O2/c1-30-20-6-5-15(23)12-18(20)27-22(29)26-17-3-2-4-19-16(17)8-10-28(19)13-14-7-9-25-21(24)11-14/h2-12H,13H2,1H3,(H2,24,25)(H2,26,27,29)	Platelet-derived growth factor receptor beta inhibitor	INHIBITOR	CHEMBL1913	Platelet-derived growth factor receptor beta	Homo sapiens
CHEMBL3545155	JI-101	COc1ccc(Br)cc1NC(=O)Nc1cccc2c1ccn2Cc1ccnc(N)c1	ZXBFYBLSJMEBEP-UHFFFAOYSA-N	InChI=1S/C22H20BrN5O2/c1-30-20-6-5-15(23)12-18(20)27-22(29)26-17-3-2-4-19-16(17)8-10-28(19)13-14-7-9-25-21(24)11-14/h2-12H,13H2,1H3,(H2,24,25)(H2,26,27,29)	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL571546	KX2-391	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1	HUNGUWOZPQBXGX-UHFFFAOYSA-N	InChI=1S/C26H29N3O3/c30-26(28-19-21-4-2-1-3-5-21)18-24-9-6-23(20-27-24)22-7-10-25(11-8-22)32-17-14-29-12-15-31-16-13-29/h1-11,20H,12-19H2,(H,28,30)	Tyrosine-protein kinase SRC inhibitor	INHIBITOR	CHEMBL267	Tyrosine-protein kinase SRC	Homo sapiens
CHEMBL362558	LY-2090314	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2	HRJWTAWVFDCTGO-UHFFFAOYSA-N	InChI=1S/C28H25FN6O3/c29-18-12-17-15-34(28(38)32-7-3-1-4-8-32)11-10-33-16-20(19(13-18)25(17)33)23-24(27(37)31-26(23)36)21-14-30-22-6-2-5-9-35(21)22/h2,5-6,9,12-14,16H,1,3-4,7-8,10-11,15H2,(H,31,36,37)	Glycogen synthase kinase-3 beta inhibitor	INHIBITOR	CHEMBL262	Glycogen synthase kinase-3 beta	Homo sapiens
CHEMBL362558	LY-2090314	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2	HRJWTAWVFDCTGO-UHFFFAOYSA-N	InChI=1S/C28H25FN6O3/c29-18-12-17-15-34(28(38)32-7-3-1-4-8-32)11-10-33-16-20(19(13-18)25(17)33)23-24(27(37)31-26(23)36)21-14-30-22-6-2-5-9-35(21)22/h2,5-6,9,12-14,16H,1,3-4,7-8,10-11,15H2,(H,31,36,37)	Glycogen synthase kinase-3 alpha inhibitor	INHIBITOR	CHEMBL2850	Glycogen synthase kinase-3 alpha	Homo sapiens
CHEMBL2364611	GALUNISERTIB	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1	IVRXNBXKWIJUQB-UHFFFAOYSA-N	InChI=1S/C22H19N5O/c1-13-4-2-5-18(25-13)21-20(19-6-3-11-27(19)26-21)15-9-10-24-17-8-7-14(22(23)28)12-16(15)17/h2,4-5,7-10,12H,3,6,11H2,1H3,(H2,23,28)	TGF-beta receptor type I inhibitor	INHIBITOR	CHEMBL4439	TGF-beta receptor type I	Homo sapiens
CHEMBL2364626	RALIMETINIB	CC(C)(C)Cn1c(N)nc2ccc(-c3[nH]c(C(C)(C)C)nc3-c3ccc(F)cc3)nc21	XPPBBJCBDOEXDN-UHFFFAOYSA-N	InChI=1S/C24H29FN6/c1-23(2,3)13-31-20-17(28-22(31)26)12-11-16(27-20)19-18(14-7-9-15(25)10-8-14)29-21(30-19)24(4,5)6/h7-12H,13H2,1-6H3,(H2,26,28)(H,29,30)	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL3039517	RABUSERTIB	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1	SYYBDNPGDKKJDU-ZDUSSCGKSA-N	InChI=1S/C18H22BrN5O3/c1-11-5-16(27-10-13-8-20-3-4-26-13)15(6-14(11)19)23-18(25)24-17-9-21-12(2)7-22-17/h5-7,9,13,20H,3-4,8,10H2,1-2H3,(H2,22,23,24,25)/t13-/m0/s1	Serine/threonine-protein kinase Chk1 inhibitor	INHIBITOR	CHEMBL4630	Serine/threonine-protein kinase Chk1	Homo sapiens
CHEMBL2107823	GANDOTINIB	Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1	SQSZANZGUXWJEA-UHFFFAOYSA-N	InChI=1S/C23H25ClFN7O/c1-14-9-21(29-28-14)27-22-11-17(13-31-5-7-33-8-6-31)23-26-15(2)20(32(23)30-22)10-16-3-4-18(24)12-19(16)25/h3-4,9,11-12H,5-8,10,13H2,1-2H3,(H2,27,28,29,30)	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	CHEMBL2971	Tyrosine-protein kinase JAK2	Homo sapiens
CHEMBL3301610	ABEMACICLIB	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1	UZWDCWONPYILKI-UHFFFAOYSA-N	InChI=1S/C27H32F2N8/c1-5-35-8-10-36(11-9-35)16-19-6-7-24(30-14-19)33-27-31-15-22(29)25(34-27)20-12-21(28)26-23(13-20)37(17(2)3)18(4)32-26/h6-7,12-15,17H,5,8-11,16H2,1-4H3,(H,30,31,33,34)	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	CHEMBL331	Cyclin-dependent kinase 4	Homo sapiens
CHEMBL3301610	ABEMACICLIB	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1	UZWDCWONPYILKI-UHFFFAOYSA-N	InChI=1S/C27H32F2N8/c1-5-35-8-10-36(11-9-35)16-19-6-7-24(30-14-19)33-27-31-15-22(29)25(34-27)20-12-21(28)26-23(13-20)37(17(2)3)18(4)32-26/h6-7,12-15,17H,5,8-11,16H2,1-4H3,(H,30,31,33,34)	Cyclin-dependent kinase 6 inhibitor	INHIBITOR	CHEMBL2508	Cyclin-dependent kinase 6	Homo sapiens
CHEMBL572878	TOZASERTIB	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1	GCIKSSRWRFVXBI-UHFFFAOYSA-N	InChI=1S/C23H28N8OS/c1-15-13-20(29-28-15)25-19-14-21(31-11-9-30(2)10-12-31)27-23(26-19)33-18-7-5-17(6-8-18)24-22(32)16-3-4-16/h5-8,13-14,16H,3-4,9-12H2,1-2H3,(H,24,32)(H2,25,26,27,28,29)	Serine/threonine-protein kinase Aurora inhibitor	INHIBITOR	CHEMBL3430911	Serine/threonine-protein kinase Aurora	Homo sapiens
CHEMBL1079175	MK-2206	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1	ULDXWLCXEDXJGE-UHFFFAOYSA-N	InChI=1S/C25H21N5O/c26-25(12-4-13-25)18-9-7-17(8-10-18)22-19(16-5-2-1-3-6-16)15-20-21(27-22)11-14-30-23(20)28-29-24(30)31/h1-3,5-11,14-15H,4,12-13,26H2,(H,29,31)	Serine/threonine-protein kinase AKT inhibitor	INHIBITOR	CHEMBL2111353	Serine/threonine-protein kinase AKT	Homo sapiens
CHEMBL1822792	MK-2461	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1	JGEBLDKNWBUGRZ-HXUWFJFHSA-N	InChI=1S/C24H25N5O5S/c1-28-13-18(12-26-28)17-9-22-23(25-11-17)6-4-16-3-5-19(10-21(16)24(22)30)27-35(31,32)29(2)14-20-15-33-7-8-34-20/h3-6,9-13,20,27H,7-8,14-15H2,1-2H3/t20-/m1/s1	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL124660	TANDUTINIB	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1	UXXQOJXBIDBUAC-UHFFFAOYSA-N	InChI=1S/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38)	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL124660	TANDUTINIB	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1	UXXQOJXBIDBUAC-UHFFFAOYSA-N	InChI=1S/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38)	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL124660	TANDUTINIB	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1	UXXQOJXBIDBUAC-UHFFFAOYSA-N	InChI=1S/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38)	Platelet-derived growth factor receptor beta inhibitor	INHIBITOR	CHEMBL1913	Platelet-derived growth factor receptor beta	Homo sapiens
CHEMBL2103851	AMUVATINIB	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1	FOFDIMHVKGYHRU-UHFFFAOYSA-N	InChI=1S/C23H21N5O3S/c32-23(24-12-15-5-6-18-19(11-15)30-14-29-18)28-9-7-27(8-10-28)22-21-20(25-13-26-22)16-3-1-2-4-17(16)31-21/h1-6,11,13H,7-10,12,14H2,(H,24,32)	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL2103851	AMUVATINIB	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1	FOFDIMHVKGYHRU-UHFFFAOYSA-N	InChI=1S/C23H21N5O3S/c32-23(24-12-15-5-6-18-19(11-15)30-14-29-18)28-9-7-27(8-10-28)22-21-20(25-13-26-22)16-3-1-2-4-17(16)31-21/h1-6,11,13H,7-10,12,14H2,(H,24,32)	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL2103851	AMUVATINIB	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1	FOFDIMHVKGYHRU-UHFFFAOYSA-N	InChI=1S/C23H21N5O3S/c32-23(24-12-15-5-6-18-19(11-15)30-14-29-18)28-9-7-27(8-10-28)22-21-20(25-13-26-22)16-3-1-2-4-17(16)31-21/h1-6,11,13H,7-10,12,14H2,(H,24,32)	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL2103851	AMUVATINIB	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1	FOFDIMHVKGYHRU-UHFFFAOYSA-N	InChI=1S/C23H21N5O3S/c32-23(24-12-15-5-6-18-19(11-15)30-14-29-18)28-9-7-27(8-10-28)22-21-20(25-13-26-22)16-3-1-2-4-17(16)31-21/h1-6,11,13H,7-10,12,14H2,(H,24,32)	Platelet-derived growth factor receptor alpha inhibitor	INHIBITOR	CHEMBL2007	Platelet-derived growth factor receptor alpha	Homo sapiens
CHEMBL3545157	TIDEGLUSIB	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1	PMJIHLSCWIDGMD-UHFFFAOYSA-N	InChI=1S/C19H14N2O2S/c22-18-20(13-14-7-2-1-3-8-14)19(23)24-21(18)17-12-6-10-15-9-4-5-11-16(15)17/h1-12H,13H2	Glycogen synthase kinase-3 beta inhibitor	INHIBITOR	CHEMBL262	Glycogen synthase kinase-3 beta	Homo sapiens
CHEMBL3120215	OSI-027	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12	JROFGZPOBKIAEW-HAQNSBGRSA-N	InChI=1S/C21H22N6O3/c1-30-15-4-2-3-13-9-14(25-16(13)15)17-18-19(22)23-10-24-27(18)20(26-17)11-5-7-12(8-6-11)21(28)29/h2-4,9-12,25H,5-8H2,1H3,(H,28,29)(H2,22,23,24)/t11-,12-	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL253969	OSI-632	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1	HXHAJRMTJXHJJZ-UHFFFAOYSA-N	InChI=1S/C20H24BrF2N5O3S/c21-12-9-14(22)13(15(23)10-12)11-31-18-16(17(24)29)19(32-27-18)26-20(30)25-5-1-2-6-28-7-3-4-8-28/h9-10H,1-8,11H2,(H2,24,29)(H2,25,26,30)	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL3545283	RIVICICLIB	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C1CO	QLUYMIVVAYRECT-UHFFFAOYSA-N	InChI=1S/C21H20ClNO5/c1-23-7-6-12(14(23)10-24)19-15(25)8-16(26)20-17(27)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,14,24-26H,6-7,10H2,1H3	Cyclin-dependent kinase 1 inhibitor	INHIBITOR	CHEMBL308	Cyclin-dependent kinase 1	Homo sapiens
CHEMBL3545283	RIVICICLIB	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C1CO	QLUYMIVVAYRECT-UHFFFAOYSA-N	InChI=1S/C21H20ClNO5/c1-23-7-6-12(14(23)10-24)19-15(25)8-16(26)20-17(27)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,14,24-26H,6-7,10H2,1H3	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	CHEMBL331	Cyclin-dependent kinase 4	Homo sapiens
CHEMBL3545283	RIVICICLIB	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C1CO	QLUYMIVVAYRECT-UHFFFAOYSA-N	InChI=1S/C21H20ClNO5/c1-23-7-6-12(14(23)10-24)19-15(25)8-16(26)20-17(27)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,14,24-26H,6-7,10H2,1H3	Cyclin-dependent kinase 9 inhibitor	INHIBITOR	CHEMBL3116	Cyclin-dependent kinase 9	Homo sapiens
CHEMBL507361	PD-0325901	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F	SUDAHWBOROXANE-SECBINFHSA-N	InChI=1S/C16H14F3IN2O4/c17-11-3-2-10(16(25)22-26-7-9(24)6-23)15(14(11)19)21-13-4-1-8(20)5-12(13)18/h1-5,9,21,23-24H,6-7H2,(H,22,25)/t9-/m1/s1	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3587	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens
CHEMBL507361	PD-0325901	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F	SUDAHWBOROXANE-SECBINFHSA-N	InChI=1S/C16H14F3IN2O4/c17-11-3-2-10(16(25)22-26-7-9(24)6-23)15(14(11)19)21-13-4-1-8(20)5-12(13)18/h1-5,9,21,23-24H,6-7H2,(H,22,25)/t9-/m1/s1	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	CHEMBL2964	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens
CHEMBL1234354	PF-04691502	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1	XDLYKKIQACFMJG-WKILWMFISA-N	InChI=1S/C22H27N5O4/c1-13-17-11-18(14-3-8-19(30-2)24-12-14)21(29)27(20(17)26-22(23)25-13)15-4-6-16(7-5-15)31-10-9-28/h3,8,11-12,15-16,28H,4-7,9-10H2,1-2H3,(H2,23,25,26)/t15-,16-	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL1234354	PF-04691502	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1	XDLYKKIQACFMJG-WKILWMFISA-N	InChI=1S/C22H27N5O4/c1-13-17-11-18(14-3-8-19(30-2)24-12-14)21(29)27(20(17)26-22(23)25-13)15-4-6-16(7-5-15)31-10-9-28/h3,8,11-12,15-16,28H,4-7,9-10H2,1-2H3,(H2,23,25,26)/t15-,16-	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL592445	GEDATOLISIB	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1	DWZAEMINVBZMHQ-UHFFFAOYSA-N	InChI=1S/C32H41N9O4/c1-38(2)27-11-13-39(14-12-27)29(42)24-5-9-26(10-6-24)34-32(43)33-25-7-3-23(4-8-25)28-35-30(40-15-19-44-20-16-40)37-31(36-28)41-17-21-45-22-18-41/h3-10,27H,11-22H2,1-2H3,(H2,33,34,43)	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL592445	GEDATOLISIB	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1	DWZAEMINVBZMHQ-UHFFFAOYSA-N	InChI=1S/C32H41N9O4/c1-38(2)27-11-13-39(14-12-27)29(42)24-5-9-26(10-6-24)34-32(43)33-25-7-3-23(4-8-25)28-35-30(40-15-19-44-20-16-40)37-31(36-28)41-17-21-45-22-18-41/h3-10,27H,11-22H2,1-2H3,(H2,33,34,43)	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL1088751	PH-797804	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1	KCAJXIDMCNPGHZ-UHFFFAOYSA-N	InChI=1S/C22H19BrF2N2O3/c1-12-4-5-14(21(28)26-3)9-18(12)27-13(2)8-19(20(23)22(27)29)30-11-15-6-7-16(24)10-17(15)25/h4-10H,11H2,1-3H3,(H,26,28)	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL402548	DANUSERTIB	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1	XKFTZKGMDDZMJI-HSZRJFAPSA-N	InChI=1S/C26H30N6O3/c1-30-12-14-31(15-13-30)20-10-8-19(9-11-20)25(33)27-24-21-16-32(17-22(21)28-29-24)26(34)23(35-2)18-6-4-3-5-7-18/h3-11,23H,12-17H2,1-2H3,(H2,27,28,29,33)/t23-/m1/s1	Serine/threonine-protein kinase Aurora inhibitor	INHIBITOR	CHEMBL3430911	Serine/threonine-protein kinase Aurora	Homo sapiens
CHEMBL564829	MILCICLIB	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2	RXZMYLDMFYNEIM-UHFFFAOYSA-N	InChI=1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29)	Cyclin-dependent kinase 1 inhibitor	INHIBITOR	CHEMBL308	Cyclin-dependent kinase 1	Homo sapiens
CHEMBL564829	MILCICLIB	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2	RXZMYLDMFYNEIM-UHFFFAOYSA-N	InChI=1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29)	Cyclin-dependent kinase 2 inhibitor	INHIBITOR	CHEMBL301	Cyclin-dependent kinase 2	Homo sapiens
CHEMBL564829	MILCICLIB	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2	RXZMYLDMFYNEIM-UHFFFAOYSA-N	InChI=1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29)	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	CHEMBL331	Cyclin-dependent kinase 4	Homo sapiens
CHEMBL564829	MILCICLIB	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2	RXZMYLDMFYNEIM-UHFFFAOYSA-N	InChI=1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29)	Nerve growth factor receptor Trk-A inhibitor	INHIBITOR	CHEMBL2815	Nerve growth factor receptor Trk-A	Homo sapiens
CHEMBL3813873	PEXIDARTINIB	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1	JGWRKYUXBBNENE-UHFFFAOYSA-N	InChI=1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29)	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	CHEMBL1844	Macrophage colony stimulating factor receptor	Homo sapiens
CHEMBL3813873	PEXIDARTINIB	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1	JGWRKYUXBBNENE-UHFFFAOYSA-N	InChI=1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29)	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL3813873	PEXIDARTINIB	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1	JGWRKYUXBBNENE-UHFFFAOYSA-N	InChI=1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29)	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL411907	SONOLISIB	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C	QIUASFSNWYMDFS-NILGECQDSA-N	InChI=1S/C29H35NO8/c1-7-11-30(12-8-2)14-17-23-26(34)25(33)22-18-9-10-20(32)28(18,4)13-19(37-16(3)31)24(22)29(23,5)21(15-36-6)38-27(17)35/h7-8,14,18-19,21,34H,1-2,9-13,15H2,3-6H3/b17-14+/t18-,19+,21+,28-,29-/m0/s1	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL1090089	PAMAPIMOD	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21	JYYLVUFNAHSSFE-UHFFFAOYSA-N	InChI=1S/C19H20F2N4O4/c1-25-17-11(10-22-19(24-17)23-13(4-6-26)5-7-27)8-16(18(25)28)29-15-3-2-12(20)9-14(15)21/h2-3,8-10,13,26-27H,4-7H2,1H3,(H,22,23,24)	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL3545340	R-343	CNC(=O)COc1cccc(Nc2ncc(F)c(Nc3ccc4c(c3)NC(=O)C(F)(F)O4)n2)c1.O=C(O)c1ccc2ccccc2c1O	ILIHENOWEIBEQV-UHFFFAOYSA-N	InChI=1S/C21H17F3N6O4.C11H8O3/c1-25-17(31)10-33-13-4-2-3-11(7-13)28-20-26-9-14(22)18(30-20)27-12-5-6-16-15(8-12)29-19(32)21(23,24)34-16;12-10-8-4-2-1-3-7(8)5-6-9(10)11(13)14/h2-9H,10H2,1H3,(H,25,31)(H,29,32)(H2,26,27,28,30);1-6,12H,(H,13,14)	Tyrosine-protein kinase SYK inhibitor	INHIBITOR	CHEMBL2599	Tyrosine-protein kinase SYK	Homo sapiens
CHEMBL475251	R-406	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC	NHHQJBCNYHBUSI-UHFFFAOYSA-N	InChI=1S/C22H23FN6O5/c1-22(2)20(30)28-19-13(34-22)6-7-16(27-19)26-18-12(23)10-24-21(29-18)25-11-8-14(31-3)17(33-5)15(9-11)32-4/h6-10H,1-5H3,(H3,24,25,26,27,28,29,30)	Tyrosine-protein kinase SYK inhibitor	INHIBITOR	CHEMBL2599	Tyrosine-protein kinase SYK	Homo sapiens
CHEMBL558752	RAF-265	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21	YABJJWZLRMPFSI-UHFFFAOYSA-N	InChI=1S/C24H16F6N6O/c1-36-19-7-6-15(10-17(19)34-22(36)33-14-4-2-13(3-5-14)23(25,26)27)37-16-8-9-31-18(11-16)21-32-12-20(35-21)24(28,29)30/h2-12H,1H3,(H,32,35)(H,33,34)	Serine/threonine-protein kinase B-raf inhibitor	INHIBITOR	CHEMBL5145	Serine/threonine-protein kinase B-raf	Homo sapiens
CHEMBL558752	RAF-265	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21	YABJJWZLRMPFSI-UHFFFAOYSA-N	InChI=1S/C24H16F6N6O/c1-36-19-7-6-15(10-17(19)34-22(36)33-14-4-2-13(3-5-14)23(25,26)27)37-16-8-9-31-18(11-16)21-32-12-20(35-21)24(28,29)30/h2-12H,1H3,(H,32,35)(H,33,34)	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL521851	PICTILISIB	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1	LHNIIDJUOCFXAP-UHFFFAOYSA-N	InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27)	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL1922094	APITOLISIB	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12	YOVVNQKCSKSHKT-HNNXBMFYSA-N	InChI=1S/C23H30N8O3S/c1-14-17(13-29-3-5-31(6-4-29)22(33)15(2)32)35-19-18(14)27-20(16-11-25-23(24)26-12-16)28-21(19)30-7-9-34-10-8-30/h11-12,15,32H,3-10,13H2,1-2H3,(H2,24,25,26)/t15-/m0/s1	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL1922094	APITOLISIB	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12	YOVVNQKCSKSHKT-HNNXBMFYSA-N	InChI=1S/C23H30N8O3S/c1-14-17(13-29-3-5-31(6-4-29)22(33)15(2)32)35-19-18(14)27-20(16-11-25-23(24)26-12-16)28-21(19)30-7-9-34-10-8-30/h11-12,15,32H,3-10,13H2,1-2H3,(H2,24,25,26)/t15-/m0/s1	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL2177390	IPATASERTIB	CC(C)NC[C@@H](C(=O)N1CCN(c2ncnc3c2[C@H](C)C[C@H]3O)CC1)c1ccc(Cl)cc1	GRZXWCHAXNAUHY-NSISKUIASA-N	InChI=1S/C24H32ClN5O2/c1-15(2)26-13-19(17-4-6-18(25)7-5-17)24(32)30-10-8-29(9-11-30)23-21-16(3)12-20(31)22(21)27-14-28-23/h4-7,14-16,19-20,26,31H,8-13H2,1-3H3/t16-,19-,20-/m1/s1	Serine/threonine-protein kinase AKT inhibitor	INHIBITOR	CHEMBL2111353	Serine/threonine-protein kinase AKT	Homo sapiens
CHEMBL2387080	TASELISIB	Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C(C)(C)C(N)=O)c4)cc2OCC3)n(C(C)C)n1	BEUQXVWXFDOSAQ-UHFFFAOYSA-N	InChI=1S/C24H28N8O2/c1-14(2)32-22(27-15(3)29-32)19-13-30-8-9-34-20-10-16(6-7-18(20)21(30)28-19)17-11-26-31(12-17)24(4,5)23(25)33/h6-7,10-14H,8-9H2,1-5H3,(H2,25,33)	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL3360203	PILARALISIB	COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1	QINPEPAQOBZPOF-UHFFFAOYSA-N	InChI=1S/C25H25ClN6O4S/c1-25(2,27)24(33)28-15-7-6-8-17(13-15)37(34,35)32-23-22(29-19-9-4-5-10-20(19)30-23)31-21-14-16(36-3)11-12-18(21)26/h4-14H,27H2,1-3H3,(H,28,33)(H,29,31)(H,30,32)	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL3545366	VOXTALISIB	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21	RGHYDLZMTYDBDT-UHFFFAOYSA-N	InChI=1S/C13H14N6O/c1-3-19-11-8(7(2)16-13(14)17-11)6-9(12(19)20)10-4-5-15-18-10/h4-6H,3H2,1-2H3,(H,15,18)(H2,14,16,17)	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL3545366	VOXTALISIB	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21	RGHYDLZMTYDBDT-UHFFFAOYSA-N	InChI=1S/C13H14N6O/c1-3-19-11-8(7(2)16-13(14)17-11)6-9(12(19)20)10-4-5-15-18-10/h4-6H,3H2,1-2H3,(H,15,18)(H2,14,16,17)	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL3545341	SAR-407899	Cl.O=c1[nH]ccc2cc(OC3CCNCC3)ccc12	KMNVOGVCCZNVNU-UHFFFAOYSA-N	InChI=1S/C14H16N2O2.ClH/c17-14-13-2-1-12(9-10(13)3-8-16-14)18-11-4-6-15-7-5-11;/h1-3,8-9,11,15H,4-7H2,(H,16,17);1H	Rho-associated protein kinase inhibitor	INHIBITOR	CHEMBL2111459	Rho-associated protein kinase	Homo sapiens
CHEMBL514201	TALMAPIMOD	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1	ZMELOYOKMZBMRB-DLBZAZTESA-N	InChI=1S/C27H30ClFN4O3/c1-16-13-33(17(2)12-32(16)14-18-6-8-19(29)9-7-18)26(35)21-10-20-22(25(34)27(36)30(3)4)15-31(5)24(20)11-23(21)28/h6-11,15-17H,12-14H2,1-5H3/t16-,17+/m0/s1	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL363648	TAK-715	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1	HEKAIDKUDLCBRU-UHFFFAOYSA-N	InChI=1S/C24H21N3OS/c1-3-21-27-22(18-11-7-8-16(2)14-18)23(29-21)19-12-13-25-20(15-19)26-24(28)17-9-5-4-6-10-17/h4-15H,3H2,1-2H3,(H,25,26,28)	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL230011	TG100-115	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1	UJIAQDJKSXQLIT-UHFFFAOYSA-N	InChI=1S/C18H14N6O2/c19-16-15-17(24-18(20)23-16)22-14(10-4-2-6-12(26)8-10)13(21-15)9-3-1-5-11(25)7-9/h1-8,25-26H,(H4,19,20,22,23,24)	PI3-kinase p110-gamma subunit inhibitor	INHIBITOR	CHEMBL3267	PI3-kinase p110-gamma subunit	Homo sapiens
CHEMBL230011	TG100-115	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1	UJIAQDJKSXQLIT-UHFFFAOYSA-N	InChI=1S/C18H14N6O2/c19-16-15-17(24-18(20)23-16)22-14(10-4-2-6-12(26)8-10)13(21-15)9-3-1-5-11(25)7-9/h1-8,25-26H,(H4,19,20,22,23,24)	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	CHEMBL3130	PI3-kinase p110-delta subunit	Homo sapiens
CHEMBL403989	TG100-801	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12	JMGXJHWTVBGOKG-UHFFFAOYSA-N	InChI=1S/C33H30ClN5O3/c1-22-19-24(28-21-27(13-14-29(28)34)42-32(40)23-7-3-2-4-8-23)20-30-31(22)36-33(38-37-30)35-25-9-11-26(12-10-25)41-18-17-39-15-5-6-16-39/h2-4,7-14,19-21H,5-6,15-18H2,1H3,(H,35,36,38)	SRC inhibitor	INHIBITOR	CHEMBL2363074	SRC	Homo sapiens
CHEMBL403989	TG100-801	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12	JMGXJHWTVBGOKG-UHFFFAOYSA-N	InChI=1S/C33H30ClN5O3/c1-22-19-24(28-21-27(13-14-29(28)34)42-32(40)23-7-3-2-4-8-23)20-30-31(22)36-33(38-37-30)35-25-9-11-26(12-10-25)41-18-17-39-15-5-6-16-39/h2-4,7-14,19-21H,5-6,15-18H2,1H3,(H,35,36,38)	Ephrin type-B receptor 4 inhibitor	INHIBITOR	CHEMBL5147	Ephrin type-B receptor 4	Homo sapiens
CHEMBL403989	TG100-801	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12	JMGXJHWTVBGOKG-UHFFFAOYSA-N	InChI=1S/C33H30ClN5O3/c1-22-19-24(28-21-27(13-14-29(28)34)42-32(40)23-7-3-2-4-8-23)20-30-31(22)36-33(38-37-30)35-25-9-11-26(12-10-25)41-18-17-39-15-5-6-16-39/h2-4,7-14,19-21H,5-6,15-18H2,1H3,(H,35,36,38)	Fibroblast growth factor receptor 1 inhibitor	INHIBITOR	CHEMBL3650	Fibroblast growth factor receptor 1	Homo sapiens
CHEMBL403989	TG100-801	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12	JMGXJHWTVBGOKG-UHFFFAOYSA-N	InChI=1S/C33H30ClN5O3/c1-22-19-24(28-21-27(13-14-29(28)34)42-32(40)23-7-3-2-4-8-23)20-30-31(22)36-33(38-37-30)35-25-9-11-26(12-10-25)41-18-17-39-15-5-6-16-39/h2-4,7-14,19-21H,5-6,15-18H2,1H3,(H,35,36,38)	Fibroblast growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL4142	Fibroblast growth factor receptor 2	Homo sapiens
CHEMBL403989	TG100-801	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12	JMGXJHWTVBGOKG-UHFFFAOYSA-N	InChI=1S/C33H30ClN5O3/c1-22-19-24(28-21-27(13-14-29(28)34)42-32(40)23-7-3-2-4-8-23)20-30-31(22)36-33(38-37-30)35-25-9-11-26(12-10-25)41-18-17-39-15-5-6-16-39/h2-4,7-14,19-21H,5-6,15-18H2,1H3,(H,35,36,38)	Platelet-derived growth factor receptor beta inhibitor	INHIBITOR	CHEMBL1913	Platelet-derived growth factor receptor beta	Homo sapiens
CHEMBL403989	TG100-801	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12	JMGXJHWTVBGOKG-UHFFFAOYSA-N	InChI=1S/C33H30ClN5O3/c1-22-19-24(28-21-27(13-14-29(28)34)42-32(40)23-7-3-2-4-8-23)20-30-31(22)36-33(38-37-30)35-25-9-11-26(12-10-25)41-18-17-39-15-5-6-16-39/h2-4,7-14,19-21H,5-6,15-18H2,1H3,(H,35,36,38)	Vascular endothelial growth factor receptor 1 inhibitor	INHIBITOR	CHEMBL1868	Vascular endothelial growth factor receptor 1	Homo sapiens
CHEMBL403989	TG100-801	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12	JMGXJHWTVBGOKG-UHFFFAOYSA-N	InChI=1S/C33H30ClN5O3/c1-22-19-24(28-21-27(13-14-29(28)34)42-32(40)23-7-3-2-4-8-23)20-30-31(22)36-33(38-37-30)35-25-9-11-26(12-10-25)41-18-17-39-15-5-6-16-39/h2-4,7-14,19-21H,5-6,15-18H2,1H3,(H,35,36,38)	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL574737	UCN-01	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O	PBCZSGKMGDDXIJ-KRUBCLEUSA-N	InChI=1S/C28H26N4O4/c1-28-25(35-3)15(29-2)12-18(36-28)31-16-10-6-4-8-13(16)19-21-22(27(34)30-26(21)33)20-14-9-5-7-11-17(14)32(28)24(20)23(19)31/h4-11,15,18,25,27,29,34H,12H2,1-3H3,(H,30,33)/t15-,18-,25-,27+,28+/m1/s1	Cyclin-dependent kinase 2 inhibitor	INHIBITOR	CHEMBL301	Cyclin-dependent kinase 2	Homo sapiens
CHEMBL574737	UCN-01	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O	PBCZSGKMGDDXIJ-KRUBCLEUSA-N	InChI=1S/C28H26N4O4/c1-28-25(35-3)15(29-2)12-18(36-28)31-16-10-6-4-8-13(16)19-21-22(27(34)30-26(21)33)20-14-9-5-7-11-17(14)32(28)24(20)23(19)31/h4-11,15,18,25,27,29,34H,12H2,1-3H3,(H,30,33)/t15-,18-,25-,27+,28+/m1/s1	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	CHEMBL331	Cyclin-dependent kinase 4	Homo sapiens
CHEMBL574737	UCN-01	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O	PBCZSGKMGDDXIJ-KRUBCLEUSA-N	InChI=1S/C28H26N4O4/c1-28-25(35-3)15(29-2)12-18(36-28)31-16-10-6-4-8-13(16)19-21-22(27(34)30-26(21)33)20-14-9-5-7-11-17(14)32(28)24(20)23(19)31/h4-11,15,18,25,27,29,34H,12H2,1-3H3,(H,30,33)/t15-,18-,25-,27+,28+/m1/s1	Cyclin-dependent kinase 6 inhibitor	INHIBITOR	CHEMBL2508	Cyclin-dependent kinase 6	Homo sapiens
CHEMBL574737	UCN-01	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O	PBCZSGKMGDDXIJ-KRUBCLEUSA-N	InChI=1S/C28H26N4O4/c1-28-25(35-3)15(29-2)12-18(36-28)31-16-10-6-4-8-13(16)19-21-22(27(34)30-26(21)33)20-14-9-5-7-11-17(14)32(28)24(20)23(19)31/h4-11,15,18,25,27,29,34H,12H2,1-3H3,(H,30,33)/t15-,18-,25-,27+,28+/m1/s1	Serine/threonine-protein kinase Chk1 inhibitor	INHIBITOR	CHEMBL4630	Serine/threonine-protein kinase Chk1	Homo sapiens
CHEMBL574737	UCN-01	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O	PBCZSGKMGDDXIJ-KRUBCLEUSA-N	InChI=1S/C28H26N4O4/c1-28-25(35-3)15(29-2)12-18(36-28)31-16-10-6-4-8-13(16)19-21-22(27(34)30-26(21)33)20-14-9-5-7-11-17(14)32(28)24(20)23(19)31/h4-11,15,18,25,27,29,34H,12H2,1-3H3,(H,30,33)/t15-,18-,25-,27+,28+/m1/s1	3-phosphoinositide dependent protein kinase-1 inhibitor	INHIBITOR	CHEMBL2534	3-phosphoinositide dependent protein kinase-1	Homo sapiens
CHEMBL574737	UCN-01	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O	PBCZSGKMGDDXIJ-KRUBCLEUSA-N	InChI=1S/C28H26N4O4/c1-28-25(35-3)15(29-2)12-18(36-28)31-16-10-6-4-8-13(16)19-21-22(27(34)30-26(21)33)20-14-9-5-7-11-17(14)32(28)24(20)23(19)31/h4-11,15,18,25,27,29,34H,12H2,1-3H3,(H,30,33)/t15-,18-,25-,27+,28+/m1/s1	Protein kinase C (PKC) inhibitor	INHIBITOR	CHEMBL2093867	Protein kinase C (PKC)	Homo sapiens
CHEMBL462018	TRICIRIBINE PHOSPHATE	Cn1nc(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23	URLYINUFLXOMHP-HTVVRFAVSA-N	InChI=1S/C13H17N6O7P/c1-18-11-7-5(10(14)17-18)2-19(12(7)16-4-15-11)13-9(21)8(20)6(26-13)3-25-27(22,23)24/h2,4,6,8-9,13,20-21H,3H2,1H3,(H2,14,17)(H2,22,23,24)/t6-,8-,9-,13-/m1/s1	Serine/threonine-protein kinase AKT inhibitor	INHIBITOR	CHEMBL2111353	Serine/threonine-protein kinase AKT	Homo sapiens
CHEMBL3137331	DEFACTINIB	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1	FWLMVFUGMHIOAA-UHFFFAOYSA-N	InChI=1S/C20H21F3N8O3S/c1-24-18(32)12-4-6-13(7-5-12)29-19-28-10-14(20(21,22)23)16(30-19)27-11-15-17(26-9-8-25-15)31(2)35(3,33)34/h4-10H,11H2,1-3H3,(H,24,32)(H2,27,28,29,30)	Focal adhesion kinase 1 inhibitor	INHIBITOR	CHEMBL2695	Focal adhesion kinase 1	Homo sapiens
CHEMBL3137331	DEFACTINIB	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1	FWLMVFUGMHIOAA-UHFFFAOYSA-N	InChI=1S/C20H21F3N8O3S/c1-24-18(32)12-4-6-13(7-5-12)29-19-28-10-14(20(21,22)23)16(30-19)27-11-15-17(26-9-8-25-15)31(2)35(3,33)34/h4-10H,11H2,1-3H3,(H,24,32)(H2,27,28,29,30)	Protein tyrosine kinase 2 beta inhibitor	INHIBITOR	CHEMBL5469	Protein tyrosine kinase 2 beta	Homo sapiens
CHEMBL3039513	DECERNOTINIB	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F	ASUGUQWIHMTFJL-QGZVFWFLSA-N	InChI=1S/C18H19F3N6O/c1-3-17(2,16(28)25-10-18(19,20)21)27-13-6-8-23-15(26-13)12-9-24-14-11(12)5-4-7-22-14/h4-9H,3,10H2,1-2H3,(H,22,24)(H,25,28)(H,23,26,27)/t17-/m1/s1	Tyrosine-protein kinase JAK3 inhibitor	INHIBITOR	CHEMBL2148	Tyrosine-protein kinase JAK3	Homo sapiens
CHEMBL1090090	VX-702	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F	FYSRKRZDBHOFAY-UHFFFAOYSA-N	InChI=1S/C19H12F4N4O2/c20-9-4-5-10(14(23)8-9)16-11(18(24)28)6-7-15(26-16)27(19(25)29)17-12(21)2-1-3-13(17)22/h1-8H,(H2,24,28)(H2,25,29)	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL119385	NEFLAMAPIMOD	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl	VEPKQEUBKLEPRA-UHFFFAOYSA-N	InChI=1S/C19H9Cl2F2N3OS/c20-11-2-1-3-12(21)17(11)18-14-5-7-16(25-26(14)9-24-19(18)27)28-15-6-4-10(22)8-13(15)23/h1-9H	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL3545027	XL-281	COC(=O)Nc1nc2cc(C3(O)c4ccccc4C(=O)N3c3cc(Cl)ccc3C)ccc2[nH]1	MMNNTJYFHUDSKL-UHFFFAOYSA-N	InChI=1S/C24H19ClN4O4/c1-13-7-9-15(25)12-20(13)29-21(30)16-5-3-4-6-17(16)24(29,32)14-8-10-18-19(11-14)27-22(26-18)28-23(31)33-2/h3-12,32H,1-2H3,(H2,26,27,28,31)	Serine/threonine-protein kinase B-raf inhibitor	INHIBITOR	CHEMBL5145	Serine/threonine-protein kinase B-raf	Homo sapiens
CHEMBL3545027	XL-281	COC(=O)Nc1nc2cc(C3(O)c4ccccc4C(=O)N3c3cc(Cl)ccc3C)ccc2[nH]1	MMNNTJYFHUDSKL-UHFFFAOYSA-N	InChI=1S/C24H19ClN4O4/c1-13-7-9-15(25)12-20(13)29-21(30)16-5-3-4-6-17(16)24(29,32)14-8-10-18-19(11-14)27-22(26-18)28-23(31)33-2/h3-12,32H,1-2H3,(H2,26,27,28,31)	Serine/threonine-protein kinase RAF inhibitor	INHIBITOR	CHEMBL1906	Serine/threonine-protein kinase RAF	Homo sapiens
CHEMBL3544983	TESEVATINIB	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1	HVXKQKFEHMGHSL-QKDCVEJESA-N	InChI=1S/C24H25Cl2FN4O2/c1-31-9-14-5-13(6-15(14)10-31)11-33-21-8-19-16(7-20(21)32-2)24(29-12-28-19)30-18-4-3-17(25)22(26)23(18)27/h3-4,7-8,12-15H,5-6,9-11H2,1-2H3,(H,28,29,30)/t13-,14-,15+	Ephrin type-B receptor 4 inhibitor	INHIBITOR	CHEMBL5147	Ephrin type-B receptor 4	Homo sapiens
CHEMBL3544983	TESEVATINIB	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1	HVXKQKFEHMGHSL-QKDCVEJESA-N	InChI=1S/C24H25Cl2FN4O2/c1-31-9-14-5-13(6-15(14)10-31)11-33-21-8-19-16(7-20(21)32-2)24(29-12-28-19)30-18-4-3-17(25)22(26)23(18)27/h3-4,7-8,12-15H,5-6,9-11H2,1-2H3,(H,28,29,30)/t13-,14-,15+	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL3544983	TESEVATINIB	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1	HVXKQKFEHMGHSL-QKDCVEJESA-N	InChI=1S/C24H25Cl2FN4O2/c1-31-9-14-5-13(6-15(14)10-31)11-33-21-8-19-16(7-20(21)32-2)24(29-12-28-19)30-18-4-3-17(25)22(26)23(18)27/h3-4,7-8,12-15H,5-6,9-11H2,1-2H3,(H,28,29,30)/t13-,14-,15+	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL586701	ZSTK-474	Cc1ccc(C2Sc3ccccc3N=C3C2=C(O)c2ccccc23)cc1	SFUWDBKYNKBXQU-UHFFFAOYSA-N	InChI=1S/C23H17NOS/c1-14-10-12-15(13-11-14)23-20-21(16-6-2-3-7-17(16)22(20)25)24-18-8-4-5-9-19(18)26-23/h2-13,23,25H,1H3	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL1852688	INFIGRATINIB	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1	QADPYRIHXKWUSV-UHFFFAOYSA-N	InChI=1S/C26H31Cl2N7O3/c1-5-34-10-12-35(13-11-34)18-8-6-17(7-9-18)31-21-15-22(30-16-29-21)33(2)26(36)32-25-23(27)19(37-3)14-20(38-4)24(25)28/h6-9,14-16H,5,10-13H2,1-4H3,(H,32,36)(H,29,30,31)	Fibroblast growth factor receptor inhibitor	INHIBITOR	CHEMBL2095217	Fibroblast growth factor receptor	Homo sapiens
CHEMBL3402762	TEPOTINIB	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1	AHYMHWXQRWRBKT-UHFFFAOYSA-N	InChI=1S/C29H28N6O2/c1-34-12-10-21(11-13-34)20-37-26-17-31-29(32-18-26)25-7-3-5-23(15-25)19-35-28(36)9-8-27(33-35)24-6-2-4-22(14-24)16-30/h2-9,14-15,17-18,21H,10-13,19-20H2,1H3	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL3188267	CAPMATINIB	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F	LIOLIMKSCNQPLV-UHFFFAOYSA-N	InChI=1S/C23H17FN6O/c1-25-22(31)18-6-5-16(11-19(18)24)21-13-28-23-27-12-17(30(23)29-21)10-14-4-7-20-15(9-14)3-2-8-26-20/h2-9,11-13H,10H2,1H3,(H,25,31)	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL4297181	SAMOTOLISIB	CO[C@@H](C)Cn1c(=O)n(C)c2cnc3ccc(-c4cncc(C(C)(C)O)c4)cc3c21	ACCFLVVUVBJNGT-AWEZNQCLSA-N	InChI=1S/C23H26N4O3/c1-14(30-5)13-27-21-18-9-15(16-8-17(11-24-10-16)23(2,3)29)6-7-19(18)25-12-20(21)26(4)22(27)28/h6-12,14,29H,13H2,1-5H3/t14-/m0/s1	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL4297181	SAMOTOLISIB	CO[C@@H](C)Cn1c(=O)n(C)c2cnc3ccc(-c4cncc(C(C)(C)O)c4)cc3c21	ACCFLVVUVBJNGT-AWEZNQCLSA-N	InChI=1S/C23H26N4O3/c1-14(30-5)13-27-21-18-9-15(16-8-17(11-24-10-16)23(2,3)29)6-7-19(18)25-12-20(21)26(4)22(27)28/h6-12,14,29H,13H2,1-5H3/t14-/m0/s1	PI3-kinase class I inhibitor	INHIBITOR	CHEMBL3559703	PI3-kinase class I	Homo sapiens
CHEMBL2103799	COBIPROSTONE	CC[C@H](C)CC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(=O)O)O1	SDDSJMXGJNWMJY-BRHAQHMBSA-N	InChI=1S/C21H34F2O5/c1-3-14(2)13-20(22,23)21(27)11-10-16-15(17(24)12-18(16)28-21)8-6-4-5-7-9-19(25)26/h14-16,18,27H,3-13H2,1-2H3,(H,25,26)/t14-,15+,16+,18+,21+/m0/s1	Chloride channel protein 2 activator	ACTIVATOR	CHEMBL1628478	Chloride channel protein 2	Homo sapiens
CHEMBL105060	DNK333	CN(C(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](/C=C/C(=O)N[C@@H]1CCCCNC1=O)Cc1ccc(Cl)c(Cl)c1	BHCJHYIMNHXLOM-WVDRJWPYSA-N	InChI=1S/C27H25Cl2F6N3O3/c1-38(25(41)16-12-17(26(30,31)32)14-18(13-16)27(33,34)35)19(10-15-5-7-20(28)21(29)11-15)6-8-23(39)37-22-4-2-3-9-36-24(22)40/h5-8,11-14,19,22H,2-4,9-10H2,1H3,(H,36,40)(H,37,39)/b8-6+/t19-,22+/m0/s1	Neurokinin 1 receptor antagonist	ANTAGONIST	CHEMBL249	Neurokinin 1 receptor	Homo sapiens
CHEMBL1215661	PRUVANSERIN	N#Cc1c[nH]c2c(C(=O)N3CCN(CCc4ccc(F)cc4)CC3)cccc12	AQRLDDAFYYAIJP-UHFFFAOYSA-N	InChI=1S/C22H21FN4O/c23-18-6-4-16(5-7-18)8-9-26-10-12-27(13-11-26)22(28)20-3-1-2-19-17(14-24)15-25-21(19)20/h1-7,15,25H,8-13H2	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL1287935	VERUCERFONT	CC[C@H](Nc1cc(C)nc2c(-c3ccc(OC)cc3C)c(C)nn12)c1nc(C)no1	VKHVAUKFLBBZFJ-SFHVURJKSA-N	InChI=1S/C22H26N6O2/c1-7-18(22-24-15(5)27-30-22)25-19-11-13(3)23-21-20(14(4)26-28(19)21)17-9-8-16(29-6)10-12(17)2/h8-11,18,25H,7H2,1-6H3/t18-/m0/s1	Corticotropin releasing factor receptor 1 antagonist	ANTAGONIST	CHEMBL1800	Corticotropin releasing factor receptor 1	Homo sapiens
CHEMBL1631540	GSK163090	Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1	ANGUXJDGJCHGOG-UHFFFAOYSA-N	InChI=1S/C25H29N5O/c1-19-8-9-22-23(27-19)6-3-7-24(22)29-16-14-28(15-17-29)12-10-20-4-2-5-21(18-20)30-13-11-26-25(30)31/h2-9,18H,10-17H2,1H3,(H,26,31)	Serotonin 1a (5-HT1a) receptor antagonist	ANTAGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL1631540	GSK163090	Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1	ANGUXJDGJCHGOG-UHFFFAOYSA-N	InChI=1S/C25H29N5O/c1-19-8-9-22-23(27-19)6-3-7-24(22)29-16-14-28(15-17-29)12-10-20-4-2-5-21(18-20)30-13-11-26-25(30)31/h2-9,18H,10-17H2,1H3,(H,26,31)	Serotonin 1b (5-HT1b) receptor antagonist	ANTAGONIST	CHEMBL1898	Serotonin 1b (5-HT1b) receptor	Homo sapiens
CHEMBL1631540	GSK163090	Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1	ANGUXJDGJCHGOG-UHFFFAOYSA-N	InChI=1S/C25H29N5O/c1-19-8-9-22-23(27-19)6-3-7-24(22)29-16-14-28(15-17-29)12-10-20-4-2-5-21(18-20)30-13-11-26-25(30)31/h2-9,18H,10-17H2,1H3,(H,26,31)	Serotonin 1d (5-HT1d) receptor antagonist	ANTAGONIST	CHEMBL1983	Serotonin 1d (5-HT1d) receptor	Homo sapiens
CHEMBL1631540	GSK163090	Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1	ANGUXJDGJCHGOG-UHFFFAOYSA-N	InChI=1S/C25H29N5O/c1-19-8-9-22-23(27-19)6-3-7-24(22)29-16-14-28(15-17-29)12-10-20-4-2-5-21(18-20)30-13-11-26-25(30)31/h2-9,18H,10-17H2,1H3,(H,26,31)	Serotonin transporter antagonist	ANTAGONIST	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL1823681	ETILEVODOPA	CCOC(=O)[C@@H](N)Cc1ccc(O)c(O)c1	NULMGOSOSZBEQL-QMMMGPOBSA-N	InChI=1S/C11H15NO4/c1-2-16-11(15)8(12)5-7-3-4-9(13)10(14)6-7/h3-4,6,8,13-14H,2,5,12H2,1H3/t8-/m0/s1	Dopamine D3 receptor agonist	AGONIST	CHEMBL234	Dopamine D3 receptor	Homo sapiens
CHEMBL1933349	MK-0893	COc1ccc2cc(-c3cc(-c4cc(Cl)cc(Cl)c4)nn3[C@@H](C)c3ccc(C(=O)NCCC(=O)O)cc3)ccc2c1	DNTVJEMGHBIUMW-IBGZPJMESA-N	InChI=1S/C32H27Cl2N3O4/c1-19(20-3-5-21(6-4-20)32(40)35-12-11-31(38)39)37-30(18-29(36-37)25-14-26(33)17-27(34)15-25)24-8-7-23-16-28(41-2)10-9-22(23)13-24/h3-10,13-19H,11-12H2,1-2H3,(H,35,40)(H,38,39)/t19-/m0/s1	Glucagon receptor antagonist	ANTAGONIST	CHEMBL1985	Glucagon receptor	Homo sapiens
CHEMBL1940832	MILVETEROL	O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O	BMKINZUHKYLSKI-DQEYMECFSA-N	InChI=1S/C25H29N3O4/c29-17-28-22-14-20(8-11-23(22)30)24(31)15-26-13-12-18-6-9-21(10-7-18)27-16-25(32)19-4-2-1-3-5-19/h1-11,14,17,24-27,30-32H,12-13,15-16H2,(H,28,29)/t24-,25-/m0/s1	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1950651	EVODENOSON	COC(=O)N1CCC(CC#Cc2nc(N)c3ncn([C@@H]4O[C@H](C(=O)NC5CC5)[C@@H](O)[C@H]4O)c3n2)CC1	SQJXTUJMBYVDBB-RQXXJAGISA-N	InChI=1S/C23H29N7O6/c1-35-23(34)29-9-7-12(8-10-29)3-2-4-14-27-19(24)15-20(28-14)30(11-25-15)22-17(32)16(31)18(36-22)21(33)26-13-5-6-13/h11-13,16-18,22,31-32H,3,5-10H2,1H3,(H,26,33)(H2,24,27,28)/t16-,17+,18-,22+/m0/s1	Adenosine A2a receptor agonist	AGONIST	CHEMBL251	Adenosine A2a receptor	Homo sapiens
CHEMBL2012520	LY377604	CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12	RBSGUQYXRDKPAE-QFIPXVFZSA-N	InChI=1S/C31H32N4O4/c1-31(2,16-20-10-13-23(14-11-20)39-28-15-12-21(17-33-28)30(32)37)34-18-22(36)19-38-27-9-5-8-26-29(27)24-6-3-4-7-25(24)35-26/h3-15,17,22,34-36H,16,18-19H2,1-2H3,(H2,32,37)/t22-/m0/s1	Beta-3 adrenergic receptor agonist	AGONIST	CHEMBL246	Beta-3 adrenergic receptor	Homo sapiens
CHEMBL2012520	LY377604	CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12	RBSGUQYXRDKPAE-QFIPXVFZSA-N	InChI=1S/C31H32N4O4/c1-31(2,16-20-10-13-23(14-11-20)39-28-15-12-21(17-33-28)30(32)37)34-18-22(36)19-38-27-9-5-8-26-29(27)24-6-3-4-7-25(24)35-26/h3-15,17,22,34-36H,16,18-19H2,1-2H3,(H2,32,37)/t22-/m0/s1	Beta-2 adrenergic receptor antagonist	ANTAGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL2012520	LY377604	CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12	RBSGUQYXRDKPAE-QFIPXVFZSA-N	InChI=1S/C31H32N4O4/c1-31(2,16-20-10-13-23(14-11-20)39-28-15-12-21(17-33-28)30(32)37)34-18-22(36)19-38-27-9-5-8-26-29(27)24-6-3-4-7-25(24)35-26/h3-15,17,22,34-36H,16,18-19H2,1-2H3,(H2,32,37)/t22-/m0/s1	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL2037511	EPELSIBAN	CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C	UWHCWRQFNKUYCG-QUZACWSFSA-N	InChI=1S/C30H38N4O4/c1-5-18(2)26-28(35)32-25(23-16-21-8-6-7-9-22(21)17-23)29(36)34(26)27(24-11-10-19(3)31-20(24)4)30(37)33-12-14-38-15-13-33/h6-11,18,23,25-27H,5,12-17H2,1-4H3,(H,32,35)/t18-,25+,26+,27+/m0/s1	Oxytocin receptor antagonist	ANTAGONIST	CHEMBL2049	Oxytocin receptor	Homo sapiens
CHEMBL2043437	GLASDEGIB	CN1CC[C@@H](NC(=O)Nc2ccc(C#N)cc2)C[C@@H]1c1nc2ccccc2[nH]1	SFNSLLSYNZWZQG-VQIMIIECSA-N	InChI=1S/C21H22N6O/c1-27-11-10-16(24-21(28)23-15-8-6-14(13-22)7-9-15)12-19(27)20-25-17-4-2-3-5-18(17)26-20/h2-9,16,19H,10-12H2,1H3,(H,25,26)(H2,23,24,28)/t16-,19-/m1/s1	Smoothened homolog antagonist	ANTAGONIST	CHEMBL5971	Smoothened homolog	Homo sapiens
CHEMBL208427	SOLABEGRON	O=C(O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1	LLDXOPKUNJTIRF-QFIPXVFZSA-N	InChI=1S/C23H23ClN2O3/c24-20-8-2-6-18(13-20)22(27)15-25-10-11-26-21-9-3-5-17(14-21)16-4-1-7-19(12-16)23(28)29/h1-9,12-14,22,25-27H,10-11,15H2,(H,28,29)/t22-/m0/s1	Beta-3 adrenergic receptor agonist	AGONIST	CHEMBL246	Beta-3 adrenergic receptor	Homo sapiens
CHEMBL2087337	VELUSETRAG	CC(C)n1c(=O)c(C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3C[C@@H](O)CN(C)S(C)(=O)=O)cc2ccccc21	HXLOHDZQBKCUCR-WOZUAGRISA-N	InChI=1S/C25H36N4O5S/c1-16(2)29-23-8-6-5-7-17(23)11-22(25(29)32)24(31)26-18-12-19-9-10-20(13-18)28(19)15-21(30)14-27(3)35(4,33)34/h5-8,11,16,18-21,30H,9-10,12-15H2,1-4H3,(H,26,31)/t18-,19+,20-,21-/m0/s1	Serotonin 4 (5-HT4) receptor agonist	AGONIST	CHEMBL1875	Serotonin 4 (5-HT4) receptor	Homo sapiens
CHEMBL2308782	DAROTROPIUM BROMIDE	C[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](CC(C#N)(c1ccccc1)c1ccccc1)C2.[Br-]	CWRNUVNMUYSOFQ-ABHLOGGPSA-M	InChI=1S/C24H29N2.BrH/c1-26(2)22-13-14-23(26)16-19(15-22)17-24(18-25,20-9-5-3-6-10-20)21-11-7-4-8-12-21;/h3-12,19,22-23H,13-17H2,1-2H3;1H/q+1;/p-1/t19-,22-,23+;	Muscarinic acetylcholine receptor antagonist	ANTAGONIST	CHEMBL2094109	Muscarinic acetylcholine receptor	Homo sapiens
CHEMBL2103828	ELINOGREL	CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F	LGSDFTPAICUONK-UHFFFAOYSA-N	InChI=1S/C20H15ClFN5O5S2/c1-23-15-9-14-12(8-13(15)22)18(28)27(20(30)25-14)11-4-2-10(3-5-11)24-19(29)26-34(31,32)17-7-6-16(21)33-17/h2-9,23H,1H3,(H,25,30)(H2,24,26,29)	Purinergic receptor P2Y12 antagonist	ANTAGONIST	CHEMBL2001	Purinergic receptor P2Y12	Homo sapiens
CHEMBL2103858	NARONAPRIDE	COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCN(CCCCCC(=O)O[C@H]2CN3CCC2CC3)C[C@@H]1OC	VGDDOIZXGFJDRC-VJTSUQJLSA-N	InChI=1S/C27H41ClN4O5/c1-35-23-15-21(29)20(28)14-19(23)27(34)30-22-9-13-31(17-25(22)36-2)10-5-3-4-6-26(33)37-24-16-32-11-7-18(24)8-12-32/h14-15,18,22,24-25H,3-13,16-17,29H2,1-2H3,(H,30,34)/t22-,24+,25+/m1/s1	Serotonin 4 (5-HT4) receptor agonist	AGONIST	CHEMBL1875	Serotonin 4 (5-HT4) receptor	Homo sapiens
CHEMBL2103862	BAVISANT	O=C(c1ccc(CN2CCOCC2)cc1)N1CCN(C2CC2)CC1	BGBVSGSIXIIREO-UHFFFAOYSA-N	InChI=1S/C19H27N3O2/c23-19(22-9-7-21(8-10-22)18-5-6-18)17-3-1-16(2-4-17)15-20-11-13-24-14-12-20/h1-4,18H,5-15H2	Histamine H3 receptor antagonist	ANTAGONIST	CHEMBL264	Histamine H3 receptor	Homo sapiens
CHEMBL2103880	CERLAPIRDINE	CN(C)CCCOc1ccc2[nH]nc(S(=O)(=O)c3cccc4ccccc34)c2c1	NXQGEDVQXVTCDA-UHFFFAOYSA-N	InChI=1S/C22H23N3O3S/c1-25(2)13-6-14-28-17-11-12-20-19(15-17)22(24-23-20)29(26,27)21-10-5-8-16-7-3-4-9-18(16)21/h3-5,7-12,15H,6,13-14H2,1-2H3,(H,23,24)	Serotonin 6 (5-HT6) receptor antagonist	ANTAGONIST	CHEMBL3371	Serotonin 6 (5-HT6) receptor	Homo sapiens
CHEMBL2104986	TEDATIOXETINE	Cc1ccc(Sc2ccccc2C2CCNCC2)cc1	CVASBKDYSQKLSO-UHFFFAOYSA-N	InChI=1S/C18H21NS/c1-14-6-8-16(9-7-14)20-18-5-3-2-4-17(18)15-10-12-19-13-11-15/h2-9,15,19H,10-13H2,1H3	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL2104986	TEDATIOXETINE	Cc1ccc(Sc2ccccc2C2CCNCC2)cc1	CVASBKDYSQKLSO-UHFFFAOYSA-N	InChI=1S/C18H21NS/c1-14-6-8-16(9-7-14)20-18-5-3-2-4-17(18)15-10-12-19-13-11-15/h2-9,15,19H,10-13H2,1H3	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL2104986	TEDATIOXETINE	Cc1ccc(Sc2ccccc2C2CCNCC2)cc1	CVASBKDYSQKLSO-UHFFFAOYSA-N	InChI=1S/C18H21NS/c1-14-6-8-16(9-7-14)20-18-5-3-2-4-17(18)15-10-12-19-13-11-15/h2-9,15,19H,10-13H2,1H3	Dopamine transporter inhibitor	INHIBITOR	CHEMBL238	Dopamine transporter	Homo sapiens
CHEMBL2104986	TEDATIOXETINE	Cc1ccc(Sc2ccccc2C2CCNCC2)cc1	CVASBKDYSQKLSO-UHFFFAOYSA-N	InChI=1S/C18H21NS/c1-14-6-8-16(9-7-14)20-18-5-3-2-4-17(18)15-10-12-19-13-11-15/h2-9,15,19H,10-13H2,1H3	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL2104986	TEDATIOXETINE	Cc1ccc(Sc2ccccc2C2CCNCC2)cc1	CVASBKDYSQKLSO-UHFFFAOYSA-N	InChI=1S/C18H21NS/c1-14-6-8-16(9-7-14)20-18-5-3-2-4-17(18)15-10-12-19-13-11-15/h2-9,15,19H,10-13H2,1H3	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL2104986	TEDATIOXETINE	Cc1ccc(Sc2ccccc2C2CCNCC2)cc1	CVASBKDYSQKLSO-UHFFFAOYSA-N	InChI=1S/C18H21NS/c1-14-6-8-16(9-7-14)20-18-5-3-2-4-17(18)15-10-12-19-13-11-15/h2-9,15,19H,10-13H2,1H3	Alpha-1a adrenergic receptor antagonist	ANTAGONIST	CHEMBL229	Alpha-1a adrenergic receptor	Homo sapiens
CHEMBL2104986	TEDATIOXETINE	Cc1ccc(Sc2ccccc2C2CCNCC2)cc1	CVASBKDYSQKLSO-UHFFFAOYSA-N	InChI=1S/C18H21NS/c1-14-6-8-16(9-7-14)20-18-5-3-2-4-17(18)15-10-12-19-13-11-15/h2-9,15,19H,10-13H2,1H3	Serotonin 3 (5-HT3) receptor antagonist	ANTAGONIST	CHEMBL2094132	Serotonin 3 (5-HT3) receptor	Homo sapiens
CHEMBL2104991	VABICASERIN HYDROCHLORIDE	Cl.c1cc2c3c(c1)[C@H]1CCC[C@H]1CN3CCNC2	PYPPENBDXAWXJC-QNTKWALQSA-N	InChI=1S/C15H20N2.ClH/c1-3-11-9-16-7-8-17-10-12-4-2-5-13(12)14(6-1)15(11)17;/h1,3,6,12-13,16H,2,4-5,7-10H2;1H/t12-,13-;/m0./s1	Serotonin 2c (5-HT2c) receptor agonist	AGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL2104991	VABICASERIN HYDROCHLORIDE	Cl.c1cc2c3c(c1)[C@H]1CCC[C@H]1CN3CCNC2	PYPPENBDXAWXJC-QNTKWALQSA-N	InChI=1S/C15H20N2.ClH/c1-3-11-9-16-7-8-17-10-12-4-2-5-13(12)14(6-1)15(11)17;/h1,3,6,12-13,16H,2,4-5,7-10H2;1H/t12-,13-;/m0./s1	Serotonin 2b (5-HT2b) receptor antagonist	ANTAGONIST	CHEMBL1833	Serotonin 2b (5-HT2b) receptor	Homo sapiens
CHEMBL2104991	VABICASERIN HYDROCHLORIDE	Cl.c1cc2c3c(c1)[C@H]1CCC[C@H]1CN3CCNC2	PYPPENBDXAWXJC-QNTKWALQSA-N	InChI=1S/C15H20N2.ClH/c1-3-11-9-16-7-8-17-10-12-4-2-5-13(12)14(6-1)15(11)17;/h1,3,6,12-13,16H,2,4-5,7-10H2;1H/t12-,13-;/m0./s1	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL2104992	VESTIPITANT MESYLATE	CS(=O)(=O)O.Cc1cc(F)ccc1[C@H]1CNCCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	BHECXGHXWKHZOY-DXPOFMJKSA-N	InChI=1S/C23H24F7N3O.CH4O3S/c1-13-8-18(24)4-5-19(13)20-12-31-6-7-33(20)21(34)32(3)14(2)15-9-16(22(25,26)27)11-17(10-15)23(28,29)30;1-5(2,3)4/h4-5,8-11,14,20,31H,6-7,12H2,1-3H3;1H3,(H,2,3,4)/t14-,20-;/m1./s1	Neurokinin 1 receptor antagonist	ANTAGONIST	CHEMBL249	Neurokinin 1 receptor	Homo sapiens
CHEMBL2105667	ORVEPITANT	Cc1cc(F)ccc1[C@H]1C[C@@H](N2CCN3C(=O)CC[C@H]3C2)CCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	XWNBGDJPEXZSQM-VZOBGQTKSA-N	InChI=1S/C31H35F7N4O2/c1-18-12-23(32)4-6-26(18)27-16-24(40-10-11-41-25(17-40)5-7-28(41)43)8-9-42(27)29(44)39(3)19(2)20-13-21(30(33,34)35)15-22(14-20)31(36,37)38/h4,6,12-15,19,24-25,27H,5,7-11,16-17H2,1-3H3/t19-,24+,25+,27-/m1/s1	Neurokinin 1 receptor antagonist	ANTAGONIST	CHEMBL249	Neurokinin 1 receptor	Homo sapiens
CHEMBL3989805	ELZASONAN HYDROCHLORIDE	CN1CCN(c2ccccc2/C=C2\SCCN(c3ccc(Cl)c(Cl)c3)C2=O)CC1.Cl	NMTRXBJYASHMND-UXTSPRGOSA-N	InChI=1S/C22H23Cl2N3OS.ClH/c1-25-8-10-26(11-9-25)20-5-3-2-4-16(20)14-21-22(28)27(12-13-29-21)17-6-7-18(23)19(24)15-17;/h2-7,14-15H,8-13H2,1H3;1H/b21-14-;	Serotonin 1b (5-HT1b) receptor antagonist	ANTAGONIST	CHEMBL1898	Serotonin 1b (5-HT1b) receptor	Homo sapiens
CHEMBL3989805	ELZASONAN HYDROCHLORIDE	CN1CCN(c2ccccc2/C=C2\SCCN(c3ccc(Cl)c(Cl)c3)C2=O)CC1.Cl	NMTRXBJYASHMND-UXTSPRGOSA-N	InChI=1S/C22H23Cl2N3OS.ClH/c1-25-8-10-26(11-9-25)20-5-3-2-4-16(20)14-21-22(28)27(12-13-29-21)17-6-7-18(23)19(24)15-17;/h2-7,14-15H,8-13H2,1H3;1H/b21-14-;	Serotonin 1d (5-HT1d) receptor antagonist	ANTAGONIST	CHEMBL1983	Serotonin 1d (5-HT1d) receptor	Homo sapiens
CHEMBL2107371	SELODENOSON	CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O	GWVQGVCXFNYGFP-PFHKOEEOSA-N	InChI=1S/C17H24N6O4/c1-2-18-16(26)13-11(24)12(25)17(27-13)23-8-21-10-14(19-7-20-15(10)23)22-9-5-3-4-6-9/h7-9,11-13,17,24-25H,2-6H2,1H3,(H,18,26)(H,19,20,22)/t11-,12+,13-,17+/m0/s1	Adenosine A1 receptor agonist	AGONIST	CHEMBL226	Adenosine A1 receptor	Homo sapiens
CHEMBL3989819	NAXIFYLLINE	CCCn1c(=O)c2nc([C@H]3C[C@H]4C[C@@H]3[C@@H]3O[C@H]43)[nH]c2n(CCC)c1=O	OQCJPFYWFGUHIN-GJKBLCTNSA-N	InChI=1S/C18H24N4O3/c1-3-5-21-16-12(17(23)22(6-4-2)18(21)24)19-15(20-16)11-8-9-7-10(11)14-13(9)25-14/h9-11,13-14H,3-8H2,1-2H3,(H,19,20)/t9-,10+,11+,13-,14+/m1/s1	Adenosine A1 receptor antagonist	ANTAGONIST	CHEMBL226	Adenosine A1 receptor	Homo sapiens
CHEMBL2107826	VIBEGRON	O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)[C@@H]1CCc2nccc(=O)n21	DJXRIQMCROIRCZ-XOEOCAAJSA-N	InChI=1S/C26H28N4O3/c31-24-14-15-27-23-13-12-22(30(23)24)26(33)29-19-8-6-17(7-9-19)16-20-10-11-21(28-20)25(32)18-4-2-1-3-5-18/h1-9,14-15,20-22,25,28,32H,10-13,16H2,(H,29,33)/t20-,21+,22-,25+/m0/s1	Beta-3 adrenergic receptor agonist	AGONIST	CHEMBL246	Beta-3 adrenergic receptor	Homo sapiens
CHEMBL2104864	APLINDORE FUMARATE	O=C(O)/C=C/C(=O)O.O=C1Cc2c(ccc3c2O[C@@H](CNCc2ccccc2)CO3)N1	GELJVTSEGKGLDF-QDSMGTAFSA-N	InChI=1S/C18H18N2O3.C4H4O4/c21-17-8-14-15(20-17)6-7-16-18(14)23-13(11-22-16)10-19-9-12-4-2-1-3-5-12;5-3(6)1-2-4(7)8/h1-7,13,19H,8-11H2,(H,20,21);1-2H,(H,5,6)(H,7,8)/b;2-1+/t13-;/m0./s1	Dopamine D2 receptor partial agonist	PARTIAL AGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL2110727	CENICRIVIROC	CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1	PNDKCRDVVKJPKG-WHERJAGFSA-N	InChI=1S/C41H52N4O4S/c1-5-7-22-48-23-24-49-38-15-10-32(11-16-38)33-12-19-40-35(25-33)26-34(9-8-21-44(40)28-31(3)4)41(46)43-36-13-17-39(18-14-36)50(47)29-37-27-42-30-45(37)20-6-2/h10-19,25-27,30-31H,5-9,20-24,28-29H2,1-4H3,(H,43,46)/b34-26+/t50-/m0/s1	C-C chemokine receptor type 5 antagonist	ANTAGONIST	CHEMBL274	C-C chemokine receptor type 5	Homo sapiens
CHEMBL2110727	CENICRIVIROC	CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1	PNDKCRDVVKJPKG-WHERJAGFSA-N	InChI=1S/C41H52N4O4S/c1-5-7-22-48-23-24-49-38-15-10-32(11-16-38)33-12-19-40-35(25-33)26-34(9-8-21-44(40)28-31(3)4)41(46)43-36-13-17-39(18-14-36)50(47)29-37-27-42-30-45(37)20-6-2/h10-19,25-27,30-31H,5-9,20-24,28-29H2,1-4H3,(H,43,46)/b34-26+/t50-/m0/s1	C-C chemokine receptor type 2 antagonist	ANTAGONIST	CHEMBL4015	C-C chemokine receptor type 2	Homo sapiens
CHEMBL2142592	TALADEGIB	CN(C(=O)c1ccc(F)cc1C(F)(F)F)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1	SZBGQDXLNMELTB-UHFFFAOYSA-N	InChI=1S/C26H24F4N6O/c1-34(25(37)20-8-7-16(27)15-21(20)26(28,29)30)17-10-13-36(14-11-17)24-19-6-4-3-5-18(19)23(32-33-24)22-9-12-31-35(22)2/h3-9,12,15,17H,10-11,13-14H2,1-2H3	Smoothened homolog antagonist	ANTAGONIST	CHEMBL5971	Smoothened homolog	Homo sapiens
CHEMBL2151197	PF-03654746	CCNC(=O)[C@H]1C[C@@](F)(c2ccc(CN3CCCC3)c(F)c2)C1	SXMBKHYDZOCBMT-PPUGGXLSSA-N	InChI=1S/C18H24F2N2O/c1-2-21-17(23)14-10-18(20,11-14)15-6-5-13(16(19)9-15)12-22-7-3-4-8-22/h5-6,9,14H,2-4,7-8,10-12H2,1H3,(H,21,23)/t14-,18-	Histamine H3 receptor antagonist	ANTAGONIST	CHEMBL264	Histamine H3 receptor	Homo sapiens
CHEMBL2103864	NAVARIXIN	CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1.O	AFTCWZSEWTXWTL-BTQNPOSSSA-N	InChI=1S/C21H23N3O5.H2O/c1-5-13(15-10-9-11(2)29-15)22-16-17(20(27)19(16)26)23-14-8-6-7-12(18(14)25)21(28)24(3)4;/h6-10,13,22-23,25H,5H2,1-4H3;1H2/t13-;/m1./s1	Interleukin-8 receptor A antagonist	ANTAGONIST	CHEMBL4029	Interleukin-8 receptor A	Homo sapiens
CHEMBL2103864	NAVARIXIN	CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1.O	AFTCWZSEWTXWTL-BTQNPOSSSA-N	InChI=1S/C21H23N3O5.H2O/c1-5-13(15-10-9-11(2)29-15)22-16-17(20(27)19(16)26)23-14-8-6-7-12(18(14)25)21(28)24(3)4;/h6-10,13,22-23,25H,5H2,1-4H3;1H2/t13-;/m1./s1	Interleukin-8 receptor B antagonist	ANTAGONIST	CHEMBL2434	Interleukin-8 receptor B	Homo sapiens
CHEMBL2178422	RIMEGEPANT	N[C@@H]1c2cccnc2[C@H](OC(=O)N2CCC(n3c(=O)[nH]c4ncccc43)CC2)CC[C@H]1c1cccc(F)c1F	KRNAOFGYEFKHPB-ANJVHQHFSA-N	InChI=1S/C28H28F2N6O3/c29-20-6-1-4-17(23(20)30)18-8-9-22(25-19(24(18)31)5-2-12-32-25)39-28(38)35-14-10-16(11-15-35)36-21-7-3-13-33-26(21)34-27(36)37/h1-7,12-13,16,18,22,24H,8-11,14-15,31H2,(H,33,34,37)/t18-,22+,24-/m0/s1	Calcitonin gene-related peptide type 1 receptor antagonist	ANTAGONIST	CHEMBL3798	Calcitonin gene-related peptide type 1 receptor	Homo sapiens
CHEMBL2178579	ELUBRIXIN	O=C(Nc1ccc(Cl)c(S(=O)(=O)N2CCNCC2)c1O)Nc1cccc(F)c1Cl	YQYFEGTYCUQBEI-UHFFFAOYSA-N	InChI=1S/C17H17Cl2FN4O4S/c18-10-4-5-13(23-17(26)22-12-3-1-2-11(20)14(12)19)15(25)16(10)29(27,28)24-8-6-21-7-9-24/h1-5,21,25H,6-9H2,(H2,22,23,26)	Interleukin-8 receptor B antagonist	ANTAGONIST	CHEMBL2434	Interleukin-8 receptor B	Homo sapiens
CHEMBL2206292	PF-03654764	CC(C)CNC(=O)[C@H]1C[C@@](F)(c2ccc(CN3CCCC3)c(F)c2)C1	DJRDLCHHQYHQQK-UKIBZPOASA-N	InChI=1S/C20H28F2N2O/c1-14(2)12-23-19(25)16-10-20(22,11-16)17-6-5-15(18(21)9-17)13-24-7-3-4-8-24/h5-6,9,14,16H,3-4,7-8,10-13H2,1-2H3,(H,23,25)/t16-,20-	Histamine H3 receptor antagonist	ANTAGONIST	CHEMBL264	Histamine H3 receptor	Homo sapiens
CHEMBL2364619	METHYLSAMIDORPHAN	C[N@+]1(CC2CC2)CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c13	ATCVVCBJNHXIEX-ZAHKBLQYSA-O	InChI=1S/C22H28N2O4/c1-24(12-13-2-3-13)9-8-21-11-15(25)6-7-22(21,28)17(24)10-14-4-5-16(20(23)27)19(26)18(14)21/h4-5,13,17,28H,2-3,6-12H2,1H3,(H2-,23,26,27)/p+1/t17-,21-,22-,24-/m1/s1	Mu opioid receptor antagonist	ANTAGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL2364638	UBROGEPANT	C[C@@H]1[C@H](c2ccccc2)C[C@H](NC(=O)c2cnc3c(c2)C[C@@]2(C3)C(=O)Nc3ncccc32)C(=O)N1CC(F)(F)F	DDOOFTLHJSMHLN-ZQHRPCGSSA-N	InChI=1S/C29H26F3N5O3/c1-16-20(17-6-3-2-4-7-17)11-22(26(39)37(16)15-29(30,31)32)35-25(38)19-10-18-12-28(13-23(18)34-14-19)21-8-5-9-33-24(21)36-27(28)40/h2-10,14,16,20,22H,11-13,15H2,1H3,(H,35,38)(H,33,36,40)/t16-,20-,22+,28+/m1/s1	Calcitonin gene-related peptide type 1 receptor antagonist	ANTAGONIST	CHEMBL3798	Calcitonin gene-related peptide type 1 receptor	Homo sapiens
CHEMBL291657	SSR125543	C#CCN(c1nc(-c2cc(C)c(OC)cc2Cl)c(C)s1)[C@@H](CC1CC1)c1ccc(C)c(F)c1	IEAKXXNRGSLYTQ-DEOSSOPVSA-N	InChI=1S/C27H28ClFN2OS/c1-6-11-31(24(13-19-8-9-19)20-10-7-16(2)23(29)14-20)27-30-26(18(4)33-27)21-12-17(3)25(32-5)15-22(21)28/h1,7,10,12,14-15,19,24H,8-9,11,13H2,2-5H3/t24-/m0/s1	Corticotropin releasing factor receptor 1 antagonist	ANTAGONIST	CHEMBL1800	Corticotropin releasing factor receptor 1	Homo sapiens
CHEMBL3039518	BATEFENTEROL	COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12	URWYQGVSPQJGGB-DHUJRADRSA-N	InChI=1S/C40H42ClN5O7/c1-52-36-22-33(31(41)21-26(36)23-42-24-35(48)29-11-13-34(47)39-30(29)12-14-37(49)45-39)43-38(50)17-20-46-18-15-27(16-19-46)53-40(51)44-32-10-6-5-9-28(32)25-7-3-2-4-8-25/h2-14,21-22,27,35,42,47-48H,15-20,23-24H2,1H3,(H,43,50)(H,44,51)(H,45,49)/t35-/m0/s1	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL3039518	BATEFENTEROL	COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12	URWYQGVSPQJGGB-DHUJRADRSA-N	InChI=1S/C40H42ClN5O7/c1-52-36-22-33(31(41)21-26(36)23-42-24-35(48)29-11-13-34(47)39-30(29)12-14-37(49)45-39)43-38(50)17-20-46-18-15-27(16-19-46)53-40(51)44-32-10-6-5-9-28(32)25-7-3-2-4-8-25/h2-14,21-22,27,35,42,47-48H,15-20,23-24H2,1H3,(H,43,50)(H,44,51)(H,45,49)/t35-/m0/s1	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	CHEMBL211	Muscarinic acetylcholine receptor M2	Homo sapiens
CHEMBL3039518	BATEFENTEROL	COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12	URWYQGVSPQJGGB-DHUJRADRSA-N	InChI=1S/C40H42ClN5O7/c1-52-36-22-33(31(41)21-26(36)23-42-24-35(48)29-11-13-34(47)39-30(29)12-14-37(49)45-39)43-38(50)17-20-46-18-15-27(16-19-46)53-40(51)44-32-10-6-5-9-28(32)25-7-3-2-4-8-25/h2-14,21-22,27,35,42,47-48H,15-20,23-24H2,1H3,(H,43,50)(H,44,51)(H,45,49)/t35-/m0/s1	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL3039520	LASMIDITAN	CN1CCC(C(=O)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2)CC1	XEDHVZKDSYZQBF-UHFFFAOYSA-N	InChI=1S/C19H18F3N3O2/c1-25-7-5-11(6-8-25)18(26)15-3-2-4-16(23-15)24-19(27)17-13(21)9-12(20)10-14(17)22/h2-4,9-11H,5-8H2,1H3,(H,23,24,27)	Serotonin 1f (5-HT1f) receptor agonist	AGONIST	CHEMBL1805	Serotonin 1f (5-HT1f) receptor	Homo sapiens
CHEMBL3039530	ABEDITEROL	O=c1ccc2c([C@@H](O)CNCCCCCCOCC(F)(F)c3ccccc3)ccc(O)c2[nH]1	SFYAXIFVXBKRPK-QFIPXVFZSA-N	InChI=1S/C25H30F2N2O4/c26-25(27,18-8-4-3-5-9-18)17-33-15-7-2-1-6-14-28-16-22(31)19-10-12-21(30)24-20(19)11-13-23(32)29-24/h3-5,8-13,22,28,30-31H,1-2,6-7,14-17H2,(H,29,32)/t22-/m0/s1	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL3039531	DANIRIXIN	Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCCNC2)c1O	NGYNBSHYFOFVLS-LBPRGKRZSA-N	InChI=1S/C19H21ClFN3O4S/c1-11-14(21)5-2-6-15(11)23-19(26)24-16-8-7-13(20)18(17(16)25)29(27,28)12-4-3-9-22-10-12/h2,5-8,12,22,25H,3-4,9-10H2,1H3,(H2,23,24,26)/t12-/m0/s1	Interleukin-8 receptor B antagonist	ANTAGONIST	CHEMBL2434	Interleukin-8 receptor B	Homo sapiens
CHEMBL3087515	MAVOGLURANT	COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#Cc1cccc(C)c1	ZFPZEYHRWGMJCV-ZHALLVOQSA-N	InChI=1S/C19H23NO3/c1-14-5-3-6-15(13-14)8-11-19(22)10-4-7-17-16(19)9-12-20(17)18(21)23-2/h3,5-6,13,16-17,22H,4,7,9-10,12H2,1-2H3/t16-,17-,19-/m1/s1	Metabotropic glutamate receptor 5 antagonist	ANTAGONIST	CHEMBL3227	Metabotropic glutamate receptor 5	Homo sapiens
CHEMBL3092650	GSK239512	O=C1CCCN1c1ccc(Oc2ccc3c(c2)CCN(C2CCC2)CC3)nc1	YFRBKEVUUCQYOW-UHFFFAOYSA-N	InChI=1S/C23H27N3O2/c27-23-5-2-12-26(23)20-7-9-22(24-16-20)28-21-8-6-17-10-13-25(19-3-1-4-19)14-11-18(17)15-21/h6-9,15-16,19H,1-5,10-14H2	Histamine H3 receptor antagonist	ANTAGONIST	CHEMBL264	Histamine H3 receptor	Homo sapiens
CHEMBL3137313	AXELOPRAN	NC(=O)c1cccc([C@@H]2C[C@@H]3CC[C@H](C2)N3CCN(CC2CCCCC2)C(=O)[C@@H](O)CO)c1	ATLYLVPZNWDJBW-KIHHCIJBSA-N	InChI=1S/C26H39N3O4/c27-25(32)20-8-4-7-19(13-20)21-14-22-9-10-23(15-21)29(22)12-11-28(26(33)24(31)17-30)16-18-5-2-1-3-6-18/h4,7-8,13,18,21-24,30-31H,1-3,5-6,9-12,14-17H2,(H2,27,32)/t21-,22+,23-,24-/m0/s1	Mu opioid receptor antagonist	ANTAGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL3301593	DECOGLURANT	Nc1ccc(C#Cc2cnn3c(C(F)(F)F)cc(-c4ccc(C(F)(F)F)cc4)nc23)cn1	DMJHZVARRXJSEG-UHFFFAOYSA-N	InChI=1S/C21H11F6N5/c22-20(23,24)15-6-4-13(5-7-15)16-9-17(21(25,26)27)32-19(31-16)14(11-30-32)3-1-12-2-8-18(28)29-10-12/h2,4-11H,(H2,28,29)	Metabotropic glutamate receptor 2 modulator	MODULATOR	CHEMBL5137	Metabotropic glutamate receptor 2	Homo sapiens
CHEMBL3301593	DECOGLURANT	Nc1ccc(C#Cc2cnn3c(C(F)(F)F)cc(-c4ccc(C(F)(F)F)cc4)nc23)cn1	DMJHZVARRXJSEG-UHFFFAOYSA-N	InChI=1S/C21H11F6N5/c22-20(23,24)15-6-4-13(5-7-15)16-9-17(21(25,26)27)32-19(31-16)14(11-30-32)3-1-12-2-8-18(28)29-10-12/h2,4-11H,(H2,28,29)	Metabotropic glutamate receptor 3 modulator	MODULATOR	CHEMBL2888	Metabotropic glutamate receptor 3	Homo sapiens
CHEMBL3301604	RALINEPAG	O=C(O)COC[C@H]1CC[C@H](COC(=O)N(c2ccccc2)c2ccc(Cl)cc2)CC1	NPDKXVKJRHPDQT-IYARVYRRSA-N	InChI=1S/C23H26ClNO5/c24-19-10-12-21(13-11-19)25(20-4-2-1-3-5-20)23(28)30-15-18-8-6-17(7-9-18)14-29-16-22(26)27/h1-5,10-13,17-18H,6-9,14-16H2,(H,26,27)/t17-,18-	Prostanoid IP receptor agonist	AGONIST	CHEMBL1995	Prostanoid IP receptor	Homo sapiens
CHEMBL3301626	BASIMGLURANT	Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(F)cc1	UPZWINBEAHDTLA-UHFFFAOYSA-N	InChI=1S/C18H13ClFN3/c1-12-17(8-3-14-9-10-21-18(19)11-14)22-13(2)23(12)16-6-4-15(20)5-7-16/h4-7,9-11H,1-2H3	Metabotropic glutamate receptor 5 modulator	MODULATOR	CHEMBL3227	Metabotropic glutamate receptor 5	Homo sapiens
CHEMBL392149	TECADENOSON	OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCOC4)ncnc32)[C@H](O)[C@@H]1O	OESBDSFYJMDRJY-BAYCTPFLSA-N	InChI=1S/C14H19N5O5/c20-3-8-10(21)11(22)14(24-8)19-6-17-9-12(15-5-16-13(9)19)18-7-1-2-23-4-7/h5-8,10-11,14,20-22H,1-4H2,(H,15,16,18)/t7-,8-,10-,11-,14-/m1/s1	Adenosine A1 receptor agonist	AGONIST	CHEMBL226	Adenosine A1 receptor	Homo sapiens
CHEMBL412262	IBIPINABANT	CN/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1C[C@H](c2ccccc2)C(c2ccc(Cl)cc2)=N1	AXJQVVLKUYCICH-OAQYLSRUSA-N	InChI=1S/C23H20Cl2N4O2S/c1-26-23(28-32(30,31)20-13-11-19(25)12-14-20)29-15-21(16-5-3-2-4-6-16)22(27-29)17-7-9-18(24)10-8-17/h2-14,21H,15H2,1H3,(H,26,28)/t21-/m1/s1	Cannabinoid CB1 receptor antagonist	ANTAGONIST	CHEMBL218	Cannabinoid CB1 receptor	Homo sapiens
CHEMBL426084	SAMIDORPHAN	NC(=O)c1ccc2c(c1O)[C@]13CCN(CC4CC4)[C@H](C2)[C@]1(O)CCC(=O)C3	RYIDHLJADOKWFM-MAODMQOUSA-N	InChI=1S/C21H26N2O4/c22-19(26)15-4-3-13-9-16-21(27)6-5-14(24)10-20(21,17(13)18(15)25)7-8-23(16)11-12-1-2-12/h3-4,12,16,25,27H,1-2,5-11H2,(H2,22,26)/t16-,20-,21-/m1/s1	Mu opioid receptor antagonist	ANTAGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL429736	RETOSIBAN	CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(C)n1	PLVGDGRBPMVYPB-FDUHJNRSSA-N	InChI=1S/C27H34N4O5/c1-4-16(2)23-25(32)29-22(20-13-18-7-5-6-8-19(18)14-20)26(33)31(23)24(21-15-36-17(3)28-21)27(34)30-9-11-35-12-10-30/h5-8,15-16,20,22-24H,4,9-14H2,1-3H3,(H,29,32)/t16-,22+,23+,24+/m0/s1	Oxytocin receptor antagonist	ANTAGONIST	CHEMBL2049	Oxytocin receptor	Homo sapiens
CHEMBL447664	VIPADENANT	Cc1cc(Cn2nnc3c(-c4ccco4)nc(N)nc32)ccc1N	HQSBCDPYXDGTCL-UHFFFAOYSA-N	InChI=1S/C16H15N7O/c1-9-7-10(4-5-11(9)17)8-23-15-14(21-22-23)13(19-16(18)20-15)12-3-2-6-24-12/h2-7H,8,17H2,1H3,(H2,18,19,20)	Adenosine A2a receptor antagonist	ANTAGONIST	CHEMBL251	Adenosine A2a receptor	Homo sapiens
CHEMBL447955	SERLOPITANT	C[C@@H](O[C@H]1CC[C@@H]2CN(C3=CC(=O)CC3)C[C@H]2[C@@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	FLNYCRJBCNNHRH-OIYLJQICSA-N	InChI=1S/C29H28F7NO2/c1-16(19-10-20(28(31,32)33)12-21(11-19)29(34,35)36)39-26-9-4-18-14-37(23-7-8-24(38)13-23)15-25(18)27(26)17-2-5-22(30)6-3-17/h2-3,5-6,10-13,16,18,25-27H,4,7-9,14-15H2,1H3/t16-,18-,25-,26+,27+/m1/s1	Neurokinin 1 receptor antagonist	ANTAGONIST	CHEMBL249	Neurokinin 1 receptor	Homo sapiens
CHEMBL476323	MK-0249	Cc1nc2cccc(C(F)(F)F)c2c(=O)n1-c1ccc(OCCCN2CCCC2)cc1	DDDZBLNULGDPGA-UHFFFAOYSA-N	InChI=1S/C23H24F3N3O2/c1-16-27-20-7-4-6-19(23(24,25)26)21(20)22(30)29(16)17-8-10-18(11-9-17)31-15-5-14-28-12-2-3-13-28/h4,6-11H,2-3,5,12-15H2,1H3	Histamine H3 receptor inverse agonist	INVERSE AGONIST	CHEMBL264	Histamine H3 receptor	Homo sapiens
CHEMBL489095	CAMICINAL	C[C@H]1CN(Cc2ccc(CC(=O)N3CCC(Nc4cccc(F)c4)CC3)cc2)CCN1	RZKDEGZIFSJVNA-IBGZPJMESA-N	InChI=1S/C25H33FN4O/c1-19-17-29(14-11-27-19)18-21-7-5-20(6-8-21)15-25(31)30-12-9-23(10-13-30)28-24-4-2-3-22(26)16-24/h2-8,16,19,23,27-28H,9-15,17-18H2,1H3/t19-/m0/s1	Motilin receptor agonist	AGONIST	CHEMBL2203	Motilin receptor	Homo sapiens
CHEMBL514270	EMICERFONT	COc1ccc(N2CCc3c(-n4ccc(N5CCNC5=O)n4)cc(C)nc32)c(C)c1	JFHJGXQFESYQGY-UHFFFAOYSA-N	InChI=1S/C22H24N6O2/c1-14-12-16(30-3)4-5-18(14)26-9-6-17-19(13-15(2)24-21(17)26)28-10-7-20(25-28)27-11-8-23-22(27)29/h4-5,7,10,12-13H,6,8-9,11H2,1-3H3,(H,23,29)	Corticotropin releasing factor receptor 1 antagonist	ANTAGONIST	CHEMBL1800	Corticotropin releasing factor receptor 1	Homo sapiens
CHEMBL517140	GSK189254	CNC(=O)c1ccc(Oc2ccc3c(c2)CCN(C2CCC2)CC3)nc1	WROHEWWOCPRMIA-UHFFFAOYSA-N	InChI=1S/C21H25N3O2/c1-22-21(25)17-6-8-20(23-14-17)26-19-7-5-15-9-11-24(18-3-2-4-18)12-10-16(15)13-19/h5-8,13-14,18H,2-4,9-12H2,1H3,(H,22,25)	Histamine H3 receptor antagonist	ANTAGONIST	CHEMBL264	Histamine H3 receptor	Homo sapiens
CHEMBL538867	PATIDEGIB	CC1=C2C[C@H]3[C@@H](CC[C@@H]4C[C@H](NS(C)(=O)=O)CC[C@]34C)[C@@H]2CC[C@@]2(C1)O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C	HZLFFNCLTRVYJG-WWGOJCOQSA-N	InChI=1S/C29H48N2O3S/c1-17-12-26-27(30-16-17)19(3)29(34-26)11-9-22-23-7-6-20-13-21(31-35(5,32)33)8-10-28(20,4)25(23)14-24(22)18(2)15-29/h17,19-23,25-27,30-31H,6-16H2,1-5H3/t17-,19+,20+,21+,22-,23-,25-,26+,27-,28-,29-/m0/s1	Smoothened homolog antagonist	ANTAGONIST	CHEMBL5971	Smoothened homolog	Homo sapiens
CHEMBL3545029	ABT-288	CN1CC2CCN(c3ccc(-c4ccc(-n5ncccc5=O)cc4)cc3)C2C1	GNIRITULTPTAQW-UHFFFAOYSA-N	InChI=1S/C23H24N4O/c1-25-15-19-12-14-26(22(19)16-25)20-8-4-17(5-9-20)18-6-10-21(11-7-18)27-23(28)3-2-13-24-27/h2-11,13,19,22H,12,14-16H2,1H3	Histamine H3 receptor antagonist	ANTAGONIST	CHEMBL264	Histamine H3 receptor	Homo sapiens
CHEMBL3545403	BMS-833923	CNCc1ccc(C)c(NC(=O)c2ccc(Nc3nc(-c4ccccc4)c4ccccc4n3)cc2)c1	KLRRGBHZCJLIEL-UHFFFAOYSA-N	InChI=1S/C30H27N5O/c1-20-12-13-21(19-31-2)18-27(20)33-29(36)23-14-16-24(17-15-23)32-30-34-26-11-7-6-10-25(26)28(35-30)22-8-4-3-5-9-22/h3-18,31H,19H2,1-2H3,(H,33,36)(H,32,34,35)	Smoothened homolog antagonist	ANTAGONIST	CHEMBL5971	Smoothened homolog	Homo sapiens
CHEMBL3989871	AVACOPAN	Cc1ccc(NC(=O)[C@H]2CCCN(C(=O)c3c(C)cccc3F)[C@H]2c2ccc(NC3CCCC3)cc2)cc1C(F)(F)F	PUKBOVABABRILL-YZNIXAGQSA-N	InChI=1S/C33H35F4N3O2/c1-20-12-15-25(19-27(20)33(35,36)37)39-31(41)26-10-6-18-40(32(42)29-21(2)7-5-11-28(29)34)30(26)22-13-16-24(17-14-22)38-23-8-3-4-9-23/h5,7,11-17,19,23,26,30,38H,3-4,6,8-10,18H2,1-2H3,(H,39,41)/t26-,30-/m0/s1	C5a anaphylatoxin chemotactic receptor antagonist	ANTAGONIST	CHEMBL2373	C5a anaphylatoxin chemotactic receptor	Homo sapiens
CHEMBL4297183	BALOVAPTAN	CN1Cc2cc(Cl)ccc2-n2c(nnc2[C@H]2CC[C@H](Oc3ccccn3)CC2)C1	GMPZPHGHNDMRKL-RZDIXWSQSA-N	InChI=1S/C22H24ClN5O/c1-27-13-16-12-17(23)7-10-19(16)28-20(14-27)25-26-22(28)15-5-8-18(9-6-15)29-21-4-2-3-11-24-21/h2-4,7,10-12,15,18H,5-6,8-9,13-14H2,1H3/t15-,18-	Vasopressin V1a receptor antagonist	ANTAGONIST	CHEMBL1889	Vasopressin V1a receptor	Homo sapiens
CHEMBL3544984	TRADIPITANT	O=C(c1ccccc1Cl)c1cccnc1-c1nnn(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1-c1ccncc1	CAVRKWRKTNINFF-UHFFFAOYSA-N	InChI=1S/C28H16ClF6N5O/c29-22-6-2-1-4-20(22)26(41)21-5-3-9-37-23(21)24-25(17-7-10-36-11-8-17)40(39-38-24)15-16-12-18(27(30,31)32)14-19(13-16)28(33,34)35/h1-14H,15H2	Neurokinin 1 receptor antagonist	ANTAGONIST	CHEMBL249	Neurokinin 1 receptor	Homo sapiens
CHEMBL4297184	CIFORADENANT	Cc1ccc(-c2nc(N)nc3c2nnn3Cc2cccc(CO[C@H]3CCOC3)n2)o1	KURQKNMKCGYWRJ-HNNXBMFYSA-N	InChI=1S/C20H21N7O3/c1-12-5-6-16(30-12)17-18-19(24-20(21)23-17)27(26-25-18)9-13-3-2-4-14(22-13)10-29-15-7-8-28-11-15/h2-6,15H,7-11H2,1H3,(H2,21,23,24)/t15-/m0/s1	Adenosine A2a receptor antagonist	ANTAGONIST	CHEMBL251	Adenosine A2a receptor	Homo sapiens
CHEMBL3545289	AZD2207	C[C@@H](NC(=O)Cc1c(Cl)ccc(NCC(F)(F)c2cccc[n+]2O)[n+]1O)c1cccc(Cl)c1	GNYWBETUYIZBHL-CQSZACIVSA-P	InChI=1S/C22H20Cl2F2N4O3/c1-14(15-5-4-6-16(23)11-15)28-21(31)12-18-17(24)8-9-20(30(18)33)27-13-22(25,26)19-7-2-3-10-29(19)32/h2-11,14,33H,12-13H2,1H3,(H-,28,31,32)/p+2/t14-/m1/s1	Cannabinoid CB1 receptor antagonist	ANTAGONIST	CHEMBL218	Cannabinoid CB1 receptor	Homo sapiens
CHEMBL1198855	RONACALERET	CC(C)(CC1Cc2ccccc2C1)NC[C@@H](O)COc1cc(CCC(=O)O)cc(F)c1F	FQJISUPNMFRIFZ-HXUWFJFHSA-N	InChI=1S/C25H31F2NO4/c1-25(2,13-17-9-18-5-3-4-6-19(18)10-17)28-14-20(29)15-32-22-12-16(7-8-23(30)31)11-21(26)24(22)27/h3-6,11-12,17,20,28-29H,7-10,13-15H2,1-2H3,(H,30,31)/t20-/m1/s1	Calcium sensing receptor antagonist	ANTAGONIST	CHEMBL1878	Calcium sensing receptor	Homo sapiens
CHEMBL1272307	SB-649868	Cc1nc(C(=O)N2CCCC[C@H]2CNC(=O)c2cccc3occc23)c(-c2ccc(F)cc2)s1	ZJXIUGNEAIHSBI-IBGZPJMESA-N	InChI=1S/C26H24FN3O3S/c1-16-29-23(24(34-16)17-8-10-18(27)11-9-17)26(32)30-13-3-2-5-19(30)15-28-25(31)21-6-4-7-22-20(21)12-14-33-22/h4,6-12,14,19H,2-3,5,13,15H2,1H3,(H,28,31)/t19-/m0/s1	Orexin receptor 1 antagonist	ANTAGONIST	CHEMBL5113	Orexin receptor 1	Homo sapiens
CHEMBL1272307	SB-649868	Cc1nc(C(=O)N2CCCC[C@H]2CNC(=O)c2cccc3occc23)c(-c2ccc(F)cc2)s1	ZJXIUGNEAIHSBI-IBGZPJMESA-N	InChI=1S/C26H24FN3O3S/c1-16-29-23(24(34-16)17-8-10-18(27)11-9-17)26(32)30-13-3-2-5-19(30)15-28-25(31)21-6-4-7-22-20(21)12-14-33-22/h4,6-12,14,19H,2-3,5,13,15H2,1H3,(H,28,31)/t19-/m0/s1	Orexin receptor 2 antagonist	ANTAGONIST	CHEMBL4792	Orexin receptor 2	Homo sapiens
CHEMBL225411	GW842166X	O=C(NCC1CCOCC1)c1cnc(Nc2ccc(Cl)cc2Cl)nc1C(F)(F)F	TWQYWUXBZHPIIV-UHFFFAOYSA-N	InChI=1S/C18H17Cl2F3N4O2/c19-11-1-2-14(13(20)7-11)26-17-25-9-12(15(27-17)18(21,22)23)16(28)24-8-10-3-5-29-6-4-10/h1-2,7,9-10H,3-6,8H2,(H,24,28)(H,25,26,27)	Cannabinoid CB2 receptor agonist	AGONIST	CHEMBL253	Cannabinoid CB2 receptor	Homo sapiens
CHEMBL1951914	AZD5672	CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1	QOSMEMHKXNNIGG-SSEXGKCCSA-N	InChI=1S/C31H43F2N3O5S2/c1-4-36(31(37)19-23-5-7-29(8-6-23)42(2,38)39)28-11-14-34(15-12-28)16-13-30(25-20-26(32)22-27(33)21-25)24-9-17-35(18-10-24)43(3,40)41/h5-8,20-22,24,28,30H,4,9-19H2,1-3H3/t30-/m1/s1	C-C chemokine receptor type 5 antagonist	ANTAGONIST	CHEMBL274	C-C chemokine receptor type 5	Homo sapiens
CHEMBL1914489	AZD1981	CC(=O)Nc1cccc2c1c(Sc1ccc(Cl)cc1)c(C)n2CC(=O)O	JWYIGNODXSRKGP-UHFFFAOYSA-N	InChI=1S/C19H17ClN2O3S/c1-11-19(26-14-8-6-13(20)7-9-14)18-15(21-12(2)23)4-3-5-16(18)22(11)10-17(24)25/h3-9H,10H2,1-2H3,(H,21,23)(H,24,25)	G protein-coupled receptor 44 antagonist	ANTAGONIST	CHEMBL5071	G protein-coupled receptor 44	Homo sapiens
CHEMBL2178570	AZD4818	CC(=O)Nc1ccc(O)cc1OC[C@@](C)(O)CNC1CCN(Cc2ccc(Cl)cc2)CC1	RKWKLTLIBREDHD-DEOSSOPVSA-N	InChI=1S/C24H32ClN3O4/c1-17(29)27-22-8-7-21(30)13-23(22)32-16-24(2,31)15-26-20-9-11-28(12-10-20)14-18-3-5-19(25)6-4-18/h3-8,13,20,26,30-31H,9-12,14-16H2,1-2H3,(H,27,29)/t24-/m0/s1	C-C chemokine receptor type 1 antagonist	ANTAGONIST	CHEMBL2413	C-C chemokine receptor type 1	Homo sapiens
CHEMBL3545407	TRABODENOSON	O=[N+]([O-])OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O	AQLVRTWKJDTWQQ-SDBHATRESA-N	InChI=1S/C15H20N6O6/c22-11-9(5-26-21(24)25)27-15(12(11)23)20-7-18-10-13(16-6-17-14(10)20)19-8-3-1-2-4-8/h6-9,11-12,15,22-23H,1-5H2,(H,16,17,19)/t9-,11-,12-,15-/m1/s1	Adenosine A1 receptor agonist	AGONIST	CHEMBL226	Adenosine A1 receptor	Homo sapiens
CHEMBL431733	NAMODENOSON	CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc32)[C@H](O)[C@@H]1O	IPSYPUKKXMNCNQ-PFHKOEEOSA-N	InChI=1S/C18H18ClIN6O4/c1-21-16(29)13-11(27)12(28)17(30-13)26-7-23-10-14(24-18(19)25-15(10)26)22-6-8-3-2-4-9(20)5-8/h2-5,7,11-13,17,27-28H,6H2,1H3,(H,21,29)(H,22,24,25)/t11-,12+,13-,17+/m0/s1	Adenosine A3 receptor agonist	AGONIST	CHEMBL256	Adenosine A3 receptor	Homo sapiens
CHEMBL244243	SRX246	C[C@@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1cccc(C(F)(F)F)c1	ZPKHVQNRKMCYGL-AFAPVMNMSA-N	InChI=1S/C43H48F3N5O5/c1-29(32-16-11-17-33(26-32)43(44,45)46)47-40(53)36(27-38(52)49-24-20-34(21-25-49)48-22-9-4-10-23-48)50-35(19-18-30-12-5-2-6-13-30)39(41(50)54)51-37(28-56-42(51)55)31-14-7-3-8-15-31/h2-3,5-8,11-19,26,29,34-37,39H,4,9-10,20-25,27-28H2,1H3,(H,47,53)/b19-18+/t29-,35-,36-,37-,39+/m1/s1	Vasopressin V1a receptor antagonist	ANTAGONIST	CHEMBL1889	Vasopressin V1a receptor	Homo sapiens
CHEMBL1910936	MK3207	O=C(CN1C(=O)C2(CCCC2)NC[C@H]1c1cc(F)cc(F)c1)Nc1ccc2c(c1)C[C@@]1(C2)C(=O)Nc2ncccc21	AZAANWYREOQRFB-SETSBSEESA-N	InChI=1S/C31H29F2N5O3/c32-21-10-19(11-22(33)13-21)25-16-35-31(7-1-2-8-31)29(41)38(25)17-26(39)36-23-6-5-18-14-30(15-20(18)12-23)24-4-3-9-34-27(24)37-28(30)40/h3-6,9-13,25,35H,1-2,7-8,14-17H2,(H,36,39)(H,34,37,40)/t25-,30+/m0/s1	Calcitonin gene-related peptide type 1 receptor antagonist	ANTAGONIST	CHEMBL3798	Calcitonin gene-related peptide type 1 receptor	Homo sapiens
CHEMBL207197	OLCEGEPANT	NCCCC[C@H](NC(=O)[C@@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(N2Cc3ccccc3NC2=O)CC1)C(=O)N1CCN(c2ccncc2)CC1	ITIXDWVDFFXNEG-JHOUSYSJSA-N	InChI=1S/C38H47Br2N9O5/c39-29-21-25(22-30(40)34(29)50)23-33(45-37(53)48-15-10-28(11-16-48)49-24-26-5-1-2-6-31(26)44-38(49)54)35(51)43-32(7-3-4-12-41)36(52)47-19-17-46(18-20-47)27-8-13-42-14-9-27/h1-2,5-6,8-9,13-14,21-22,28,32-33,50H,3-4,7,10-12,15-20,23-24,41H2,(H,43,51)(H,44,54)(H,45,53)/t32-,33+/m0/s1	Calcitonin gene-related peptide type 1 receptor antagonist	ANTAGONIST	CHEMBL3798	Calcitonin gene-related peptide type 1 receptor	Homo sapiens
CHEMBL3137332	FEVIPIPRANT	Cc1c(CC(=O)O)c2cccnc2n1Cc1ccc(S(C)(=O)=O)cc1C(F)(F)F	GFPPXZDRVCSVNR-UHFFFAOYSA-N	InChI=1S/C19H17F3N2O4S/c1-11-15(9-17(25)26)14-4-3-7-23-18(14)24(11)10-12-5-6-13(29(2,27)28)8-16(12)19(20,21)22/h3-8H,9-10H2,1-2H3,(H,25,26)	G protein-coupled receptor 44 antagonist	ANTAGONIST	CHEMBL5071	G protein-coupled receptor 44	Homo sapiens
CHEMBL2442750	QAV680	Cc1c(CC(=O)O)c2cccnc2n1Cc1ccc(S(C)(=O)=O)cc1	YOPFAMROKXHVCQ-UHFFFAOYSA-N	InChI=1S/C18H18N2O4S/c1-12-16(10-17(21)22)15-4-3-9-19-18(15)20(12)11-13-5-7-14(8-6-13)25(2,23)24/h3-9H,10-11H2,1-2H3,(H,21,22)	G protein-coupled receptor 44 antagonist	ANTAGONIST	CHEMBL5071	G protein-coupled receptor 44	Homo sapiens
CHEMBL560993	OC000459	Cc1c(Cc2ccc3ccccc3n2)c2cc(F)ccc2n1CC(=O)O	FATGTHLOZSXOBC-UHFFFAOYSA-N	InChI=1S/C21H17FN2O2/c1-13-17(11-16-8-6-14-4-2-3-5-19(14)23-16)18-10-15(22)7-9-20(18)24(13)12-21(25)26/h2-10H,11-12H2,1H3,(H,25,26)	G protein-coupled receptor 44 antagonist	ANTAGONIST	CHEMBL5071	G protein-coupled receptor 44	Homo sapiens
CHEMBL3545367	LEMBOREXANT	Cc1ncc(OC[C@@]2(c3cccc(F)c3)C[C@H]2C(=O)Nc2ccc(F)cn2)c(C)n1	MUGXRYIUWFITCP-PGRDOPGGSA-N	InChI=1S/C22H20F2N4O2/c1-13-19(11-25-14(2)27-13)30-12-22(15-4-3-5-16(23)8-15)9-18(22)21(29)28-20-7-6-17(24)10-26-20/h3-8,10-11,18H,9,12H2,1-2H3,(H,26,28,29)/t18-,22+/m0/s1	Orexin receptor 1 antagonist	ANTAGONIST	CHEMBL5113	Orexin receptor 1	Homo sapiens
CHEMBL3545367	LEMBOREXANT	Cc1ncc(OC[C@@]2(c3cccc(F)c3)C[C@H]2C(=O)Nc2ccc(F)cn2)c(C)n1	MUGXRYIUWFITCP-PGRDOPGGSA-N	InChI=1S/C22H20F2N4O2/c1-13-19(11-25-14(2)27-13)30-12-22(15-4-3-5-16(23)8-15)9-18(22)21(29)28-20-7-6-17(24)10-26-20/h3-8,10-11,18H,9,12H2,1-2H3,(H,26,28,29)/t18-,22+/m0/s1	Orexin receptor 2 antagonist	ANTAGONIST	CHEMBL4792	Orexin receptor 2	Homo sapiens
CHEMBL2103829	FAXELADOL	CN(C)C[C@@H]1CCCC[C@H]1c1cccc(O)c1	JIRYWFYYBBRJAN-ZFWWWQNUSA-N	InChI=1S/C15H23NO/c1-16(2)11-13-6-3-4-9-15(13)12-7-5-8-14(17)10-12/h5,7-8,10,13,15,17H,3-4,6,9,11H2,1-2H3/t13-,15-/m0/s1	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL2103829	FAXELADOL	CN(C)C[C@@H]1CCCC[C@H]1c1cccc(O)c1	JIRYWFYYBBRJAN-ZFWWWQNUSA-N	InChI=1S/C15H23NO/c1-16(2)11-13-6-3-4-9-15(13)12-7-5-8-14(17)10-12/h5,7-8,10,13,15,17H,3-4,6,9,11H2,1-2H3/t13-,15-/m0/s1	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL2103829	FAXELADOL	CN(C)C[C@@H]1CCCC[C@H]1c1cccc(O)c1	JIRYWFYYBBRJAN-ZFWWWQNUSA-N	InChI=1S/C15H23NO/c1-16(2)11-13-6-3-4-9-15(13)12-7-5-8-14(17)10-12/h5,7-8,10,13,15,17H,3-4,6,9,11H2,1-2H3/t13-,15-/m0/s1	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL3989680	AXOMADOL	COc1cccc(C2(O)CC(O)CCC2CN(C)C)c1	LQJLLAOISDVBJM-UHFFFAOYSA-N	InChI=1S/C16H25NO3/c1-17(2)11-13-7-8-14(18)10-16(13,19)12-5-4-6-15(9-12)20-3/h4-6,9,13-14,18-19H,7-8,10-11H2,1-3H3	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL3989680	AXOMADOL	COc1cccc(C2(O)CC(O)CCC2CN(C)C)c1	LQJLLAOISDVBJM-UHFFFAOYSA-N	InChI=1S/C16H25NO3/c1-17(2)11-13-7-8-14(18)10-16(13,19)12-5-4-6-15(9-12)20-3/h4-6,9,13-14,18-19H,7-8,10-11H2,1-3H3	Delta opioid receptor agonist	AGONIST	CHEMBL236	Delta opioid receptor	Homo sapiens
CHEMBL3989680	AXOMADOL	COc1cccc(C2(O)CC(O)CCC2CN(C)C)c1	LQJLLAOISDVBJM-UHFFFAOYSA-N	InChI=1S/C16H25NO3/c1-17(2)11-13-7-8-14(18)10-16(13,19)12-5-4-6-15(9-12)20-3/h4-6,9,13-14,18-19H,7-8,10-11H2,1-3H3	Kappa opioid receptor agonist	AGONIST	CHEMBL237	Kappa opioid receptor	Homo sapiens
CHEMBL539423	SPARSENTAN	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)Nc2noc(C)c2C)c(COCC)c1	WRFHGDPIDHPWIQ-UHFFFAOYSA-N	InChI=1S/C32H40N4O5S/c1-5-7-14-29-33-32(17-10-11-18-32)31(37)36(29)20-24-15-16-26(25(19-24)21-40-6-2)27-12-8-9-13-28(27)42(38,39)35-30-22(3)23(4)41-34-30/h8-9,12-13,15-16,19H,5-7,10-11,14,17-18,20-21H2,1-4H3,(H,34,35)	Endothelin receptor ET-A antagonist	ANTAGONIST	CHEMBL252	Endothelin receptor ET-A	Homo sapiens
CHEMBL539423	SPARSENTAN	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)Nc2noc(C)c2C)c(COCC)c1	WRFHGDPIDHPWIQ-UHFFFAOYSA-N	InChI=1S/C32H40N4O5S/c1-5-7-14-29-33-32(17-10-11-18-32)31(37)36(29)20-24-15-16-26(25(19-24)21-40-6-2)27-12-8-9-13-28(27)42(38,39)35-30-22(3)23(4)41-34-30/h8-9,12-13,15-16,19H,5-7,10-11,14,17-18,20-21H2,1-4H3,(H,34,35)	Type-1 angiotensin II receptor antagonist	ANTAGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL3301609	TOREFORANT	Cc1cc(C)c2nc(-c3cnc(NCCCC4CCN(C)CC4)nc3C)[nH]c2c1	FCRFVPZAXGJLPW-UHFFFAOYSA-N	InChI=1S/C23H32N6/c1-15-12-16(2)21-20(13-15)27-22(28-21)19-14-25-23(26-17(19)3)24-9-5-6-18-7-10-29(4)11-8-18/h12-14,18H,5-11H2,1-4H3,(H,27,28)(H,24,25,26)	Histamine H4 receptor antagonist	ANTAGONIST	CHEMBL3759	Histamine H4 receptor	Homo sapiens
CHEMBL1096146	PONESIMOD	CCC/N=C1\S/C(=C\c2ccc(OC[C@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C	LPAUOXUZGSBGDU-STDDISTJSA-N	InChI=1S/C23H25ClN2O4S/c1-3-10-25-23-26(19-7-5-4-6-15(19)2)22(29)21(31-23)12-16-8-9-20(18(24)11-16)30-14-17(28)13-27/h4-9,11-12,17,27-28H,3,10,13-14H2,1-2H3/b21-12-,25-23-/t17-/m1/s1	Sphingosine 1-phosphate receptor Edg-1 agonist	AGONIST	CHEMBL4333	Sphingosine 1-phosphate receptor Edg-1	Homo sapiens
CHEMBL3545035	REVEXEPRIDE	COCCCN1CC[C@@H](CNC(=O)c2cc(Cl)c(N)c3c2OC(C)(C)C3)[C@H](O)C1	FOUUNSGQVBGYQM-SUMWQHHRSA-N	InChI=1S/C21H32ClN3O4/c1-21(2)10-15-18(23)16(22)9-14(19(15)29-21)20(27)24-11-13-5-7-25(12-17(13)26)6-4-8-28-3/h9,13,17,26H,4-8,10-12,23H2,1-3H3,(H,24,27)/t13-,17+/m0/s1	Serotonin 4 (5-HT4) receptor agonist	AGONIST	CHEMBL1875	Serotonin 4 (5-HT4) receptor	Homo sapiens
CHEMBL1800159	RELUGOLIX	CONC(=O)Nc1ccc(-c2sc3c(c2CN(C)C)c(=O)n(-c2ccc(OC)nn2)c(=O)n3Cc2c(F)cccc2F)cc1	AOMXMOCNKJTRQP-UHFFFAOYSA-N	InChI=1S/C29H27F2N7O5S/c1-36(2)14-19-24-26(39)38(22-12-13-23(42-3)34-33-22)29(41)37(15-18-20(30)6-5-7-21(18)31)27(24)44-25(19)16-8-10-17(11-9-16)32-28(40)35-43-4/h5-13H,14-15H2,1-4H3,(H2,32,35,40)	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL1254771	SAFOTIBANT	COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1	AMTQCENHQIDBHQ-UHFFFAOYSA-N	InChI=1S/C25H34N4O5S/c1-18-14-22(33-5)15-19(2)24(18)35(31,32)29(4)12-13-34-17-23(30)28(3)16-20-6-8-21(9-7-20)25-26-10-11-27-25/h6-9,14-15H,10-13,16-17H2,1-5H3,(H,26,27)	Bradykinin B1 receptor antagonist	ANTAGONIST	CHEMBL4308	Bradykinin B1 receptor	Homo sapiens
CHEMBL232943	MK0686	COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1	WZZIQHIQMWJNLU-LLVKDONJSA-N	InChI=1S/C22H19ClF4N2O4/c1-11(28-19(31)21(8-9-21)29-20(32)22(25,26)27)13-7-6-12(10-16(13)24)14-4-3-5-15(23)17(14)18(30)33-2/h3-7,10-11H,8-9H2,1-2H3,(H,28,31)(H,29,32)/t11-/m1/s1	Bradykinin B1 receptor antagonist	ANTAGONIST	CHEMBL4308	Bradykinin B1 receptor	Homo sapiens
CHEMBL2103878	ODELEPRAN	NC(=O)c1ccc(Oc2ccc(CNCCC3CCOCC3)cc2F)nc1	QWNDOCKIKKQJNN-UHFFFAOYSA-N	InChI=1S/C20H24FN3O3/c21-17-11-15(12-23-8-5-14-6-9-26-10-7-14)1-3-18(17)27-19-4-2-16(13-24-19)20(22)25/h1-4,11,13-14,23H,5-10,12H2,(H2,22,25)	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	CHEMBL2095181	Opioid receptors; mu/kappa/delta	Homo sapiens
CHEMBL324547	NETAZEPIDE	CNc1cccc(NC(=O)N[C@@H]2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1	YDZYKNJZCVIKPP-VWLOTQADSA-N	InChI=1S/C28H30N6O3/c1-28(2,3)23(35)17-34-22-14-6-5-12-20(22)24(21-13-7-8-15-30-21)32-25(26(34)36)33-27(37)31-19-11-9-10-18(16-19)29-4/h5-16,25,29H,17H2,1-4H3,(H2,31,33,37)/t25-/m0/s1	Cholecystokinin B receptor antagonist	ANTAGONIST	CHEMBL298	Cholecystokinin B receptor	Homo sapiens
CHEMBL3545408	NALTALIMIDE	O=C1c2ccccc2C(=O)N1[C@@H]1CC[C@@]2(O)C3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)C1O5	DHAITNWJDOSRBU-RCSSWNHXSA-N	InChI=1S/C28H28N2O5/c31-20-8-7-16-13-21-28(34)10-9-19(30-25(32)17-3-1-2-4-18(17)26(30)33)24-27(28,22(16)23(20)35-24)11-12-29(21)14-15-5-6-15/h1-4,7-8,15,19,21,24,31,34H,5-6,9-14H2/t19-,21?,24?,27+,28-/m1/s1	Mu opioid receptor partial agonist	PARTIAL AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL189475	LADARIXIN	C[C@@H](C(=O)NS(C)(=O)=O)c1ccc(OS(=O)(=O)C(F)(F)F)cc1	DDLPYOCJHQSVSZ-SSDOTTSWSA-N	InChI=1S/C11H12F3NO6S2/c1-7(10(16)15-22(2,17)18)8-3-5-9(6-4-8)21-23(19,20)11(12,13)14/h3-7H,1-2H3,(H,15,16)/t7-/m1/s1	Interleukin-8 receptor A modulator	MODULATOR	CHEMBL4029	Interleukin-8 receptor A	Homo sapiens
CHEMBL189475	LADARIXIN	C[C@@H](C(=O)NS(C)(=O)=O)c1ccc(OS(=O)(=O)C(F)(F)F)cc1	DDLPYOCJHQSVSZ-SSDOTTSWSA-N	InChI=1S/C11H12F3NO6S2/c1-7(10(16)15-22(2,17)18)8-3-5-9(6-4-8)21-23(19,20)11(12,13)14/h3-7H,1-2H3,(H,15,16)/t7-/m1/s1	Interleukin-8 receptor B modulator	MODULATOR	CHEMBL2434	Interleukin-8 receptor B	Homo sapiens
CHEMBL541758	FASITIBANT CHLORIDE	Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)NC4(C(=O)N5CCN(C(=O)[C@@H](N)CCC[N+](C)(C)C)CC5)CCOCC4)c3Cl)c2n1.[Cl-]	ZNHJDJYKDVGQSH-JMAPEOGHSA-M	InChI=1S/C36H49Cl2N6O6S.ClH/c1-24-22-25(2)40-33-26(24)8-6-10-30(33)50-23-27-28(37)11-12-31(32(27)38)51(47,48)41-36(13-20-49-21-14-36)35(46)43-17-15-42(16-18-43)34(45)29(39)9-7-19-44(3,4)5;/h6,8,10-12,22,29,41H,7,9,13-21,23,39H2,1-5H3;1H/q+1;/p-1/t29-;/m0./s1	Bradykinin B2 receptor antagonist	ANTAGONIST	CHEMBL3157	Bradykinin B2 receptor	Homo sapiens
CHEMBL3545224	BURIXAFOR	Nc1cc(N2CCN(CCP(=O)(O)O)CC2)nc(NCC2CCC(CNCCCNC3CCCCC3)CC2)n1	QLVSJMZJSABWRX-UHFFFAOYSA-N	InChI=1S/C27H51N8O3P/c28-25-19-26(35-15-13-34(14-16-35)17-18-39(36,37)38)33-27(32-25)31-21-23-9-7-22(8-10-23)20-29-11-4-12-30-24-5-2-1-3-6-24/h19,22-24,29-30H,1-18,20-21H2,(H2,36,37,38)(H3,28,31,32,33)	C-X-C chemokine receptor type 4 antagonist	ANTAGONIST	CHEMBL2107	C-X-C chemokine receptor type 4	Homo sapiens
CHEMBL1950553	SONEDENOSON	Nc1nc(OCCc2ccc(Cl)cc2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	WUCQGGOGHZRELS-LSCFUAHRSA-N	InChI=1S/C18H20ClN5O5/c19-10-3-1-9(2-4-10)5-6-28-18-22-15(20)12-16(23-18)24(8-21-12)17-14(27)13(26)11(7-25)29-17/h1-4,8,11,13-14,17,25-27H,5-7H2,(H2,20,22,23)/t11-,13-,14-,17-/m1/s1	Adenosine A2a receptor agonist	AGONIST	CHEMBL251	Adenosine A2a receptor	Homo sapiens
CHEMBL3545163	AMP579	CCNC(=O)[C@H]1CC(n2ccc3c(NC(CC)Cc4sccc4Cl)ncnc32)[C@H](O)[C@@H]1O	CKQOOYMMAAPDKH-NXKGBEFYSA-N	InChI=1S/C22H28ClN5O3S/c1-3-12(9-17-15(23)6-8-32-17)27-20-13-5-7-28(21(13)26-11-25-20)16-10-14(18(29)19(16)30)22(31)24-4-2/h5-8,11-12,14,16,18-19,29-30H,3-4,9-10H2,1-2H3,(H,24,31)(H,25,26,27)/t12?,14-,16?,18+,19-/m0/s1	Adenosine A1 receptor agonist	AGONIST	CHEMBL226	Adenosine A1 receptor	Homo sapiens
CHEMBL3545163	AMP579	CCNC(=O)[C@H]1CC(n2ccc3c(NC(CC)Cc4sccc4Cl)ncnc32)[C@H](O)[C@@H]1O	CKQOOYMMAAPDKH-NXKGBEFYSA-N	InChI=1S/C22H28ClN5O3S/c1-3-12(9-17-15(23)6-8-32-17)27-20-13-5-7-28(21(13)26-11-25-20)16-10-14(18(29)19(16)30)22(31)24-4-2/h5-8,11-12,14,16,18-19,29-30H,3-4,9-10H2,1-2H3,(H,24,31)(H,25,26,27)/t12?,14-,16?,18+,19-/m0/s1	Adenosine A2a receptor agonist	AGONIST	CHEMBL251	Adenosine A2a receptor	Homo sapiens
CHEMBL1096896	UK432097	CCNC(=O)[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(C(=O)NCCNC(=O)NC4CCN(c5ccccn5)CC4)nc32)[C@H](O)[C@@H]1O	ZOTHAEBAWXWVID-HXEFRTELSA-N	InChI=1S/C40H47N11O6/c1-2-41-37(54)33-31(52)32(53)39(57-33)51-24-46-30-34(45-23-28(25-11-5-3-6-12-25)26-13-7-4-8-14-26)48-35(49-36(30)51)38(55)43-19-20-44-40(56)47-27-16-21-50(22-17-27)29-15-9-10-18-42-29/h3-15,18,24,27-28,31-33,39,52-53H,2,16-17,19-23H2,1H3,(H,41,54)(H,43,55)(H2,44,47,56)(H,45,48,49)/t31-,32+,33-,39+/m0/s1	Adenosine A2a receptor agonist	AGONIST	CHEMBL251	Adenosine A2a receptor	Homo sapiens
CHEMBL592435	DERENOFYLLINE	OC1CCC(Nc2nc(-c3ccccc3)nc3[nH]ccc23)CC1	RBZNJGHIKXAKQE-UHFFFAOYSA-N	InChI=1S/C18H20N4O/c23-14-8-6-13(7-9-14)20-18-15-10-11-19-17(15)21-16(22-18)12-4-2-1-3-5-12/h1-5,10-11,13-14,23H,6-9H2,(H2,19,20,21,22)	Adenosine A1 receptor antagonist	ANTAGONIST	CHEMBL226	Adenosine A1 receptor	Homo sapiens
CHEMBL3545036	RASEGLURANT	Cc1cc(C)c(N)c(C#Cc2cccc(F)c2)n1	MEDCLNYIYBERKO-UHFFFAOYSA-N	InChI=1S/C15H13FN2/c1-10-8-11(2)18-14(15(10)17)7-6-12-4-3-5-13(16)9-12/h3-5,8-9H,17H2,1-2H3	Metabotropic glutamate receptor 5 modulator	MODULATOR	CHEMBL3227	Metabotropic glutamate receptor 5	Homo sapiens
CHEMBL3545164	AZD2066	C[C@@H](Oc1nnc(-c2ccncc2)n1C)c1cc(-c2cccc(Cl)c2)on1	SXWHYTICXCLKDG-GFCCVEGCSA-N	InChI=1S/C19H16ClN5O2/c1-12(16-11-17(27-24-16)14-4-3-5-15(20)10-14)26-19-23-22-18(25(19)2)13-6-8-21-9-7-13/h3-12H,1-2H3/t12-/m1/s1	Metabotropic glutamate receptor 5 modulator	MODULATOR	CHEMBL3227	Metabotropic glutamate receptor 5	Homo sapiens
CHEMBL598172	NELOTANSERIN	COc1ccc(NC(=O)Nc2ccc(F)cc2F)cc1-c1c(Br)cnn1C	COSPVUFTLGQDQL-UHFFFAOYSA-N	InChI=1S/C18H15BrF2N4O2/c1-25-17(13(19)9-22-25)12-8-11(4-6-16(12)27-2)23-18(26)24-15-5-3-10(20)7-14(15)21/h3-9H,1-2H3,(H2,23,24,26)	Serotonin 2a (5-HT2a) receptor inverse agonist	INVERSE AGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL2346738	DIPRAGLURANT	Fc1ccc2nc(CCC#Cc3ccccn3)cn2c1	LZXMUJCJAWVHPZ-UHFFFAOYSA-N	InChI=1S/C16H12FN3/c17-13-8-9-16-19-15(12-20(16)11-13)7-2-1-5-14-6-3-4-10-18-14/h3-4,6,8-12H,2,7H2	Metabotropic glutamate receptor 5 modulator	MODULATOR	CHEMBL3227	Metabotropic glutamate receptor 5	Homo sapiens
CHEMBL3544947	BURAPITANT	CC(C)(C(N)=O)C1CCN(CCC2(c3ccc(Cl)c(Cl)c3)CN(C(=O)Cc3cc(C(F)(F)F)cc(C(F)(F)F)c3)CCO2)CC1	ZLNYUCXXSDDIFU-UHFFFAOYSA-N	InChI=1S/C31H35Cl2F6N3O3/c1-28(2,27(40)44)20-5-8-41(9-6-20)10-7-29(21-3-4-24(32)25(33)17-21)18-42(11-12-45-29)26(43)15-19-13-22(30(34,35)36)16-23(14-19)31(37,38)39/h3-4,13-14,16-17,20H,5-12,15,18H2,1-2H3,(H2,40,44)	Neurokinin 1 receptor antagonist	ANTAGONIST	CHEMBL249	Neurokinin 1 receptor	Homo sapiens
CHEMBL3545165	AFACIFENACIN	O=C1Nc2ccccc2C(c2ccccc2)N1C1CCN(Cc2cccc(OC(F)(F)F)c2)CC1	IJUMFEAYOMCXAQ-UHFFFAOYSA-N	InChI=1S/C27H26F3N3O2/c28-27(29,30)35-22-10-6-7-19(17-22)18-32-15-13-21(14-16-32)33-25(20-8-2-1-3-9-20)23-11-4-5-12-24(23)31-26(33)34/h1-12,17,21,25H,13-16,18H2,(H,31,34)	Muscarinic acetylcholine receptor antagonist	ANTAGONIST	CHEMBL2094109	Muscarinic acetylcholine receptor	Homo sapiens
CHEMBL3545165	AFACIFENACIN	O=C1Nc2ccccc2C(c2ccccc2)N1C1CCN(Cc2cccc(OC(F)(F)F)c2)CC1	IJUMFEAYOMCXAQ-UHFFFAOYSA-N	InChI=1S/C27H26F3N3O2/c28-27(29,30)35-22-10-6-7-19(17-22)18-32-15-13-21(14-16-32)33-25(20-8-2-1-3-9-20)23-11-4-5-12-24(23)31-26(33)34/h1-12,17,21,25H,13-16,18H2,(H,31,34)	Sodium channel protein type X alpha subunit blocker	BLOCKER	CHEMBL5451	Sodium channel protein type X alpha subunit	Homo sapiens
CHEMBL3545165	AFACIFENACIN	O=C1Nc2ccccc2C(c2ccccc2)N1C1CCN(Cc2cccc(OC(F)(F)F)c2)CC1	IJUMFEAYOMCXAQ-UHFFFAOYSA-N	InChI=1S/C27H26F3N3O2/c28-27(29,30)35-22-10-6-7-19(17-22)18-32-15-13-21(14-16-32)33-25(20-8-2-1-3-9-20)23-11-4-5-12-24(23)31-26(33)34/h1-12,17,21,25H,13-16,18H2,(H,31,34)	Sodium channel protein type XI alpha subunit blocker	BLOCKER	CHEMBL5167	Sodium channel protein type XI alpha subunit	Homo sapiens
CHEMBL2016681	VELNEPERIT	CC(C)(C)S(=O)(=O)N[C@H]1CC[C@H](C(=O)Nc2ccc(C(F)(F)F)cn2)CC1	WGEWUYACXPEFPO-AULYBMBSSA-N	InChI=1S/C17H24F3N3O3S/c1-16(2,3)27(25,26)23-13-7-4-11(5-8-13)15(24)22-14-9-6-12(10-21-14)17(18,19)20/h6,9-11,13,23H,4-5,7-8H2,1-3H3,(H,21,22,24)/t11-,13-	Neuropeptide Y receptor type 5 antagonist	ANTAGONIST	CHEMBL4561	Neuropeptide Y receptor type 5	Homo sapiens
CHEMBL1779046	TARAFENACIN	O=C(O[C@H]1CN2CCC1CC2)N(Cc1cc(F)c(F)c(F)c1)c1cccc(F)c1	UXZDMXYRRQJIBJ-IBGZPJMESA-N	InChI=1S/C21H20F4N2O2/c22-15-2-1-3-16(10-15)27(11-13-8-17(23)20(25)18(24)9-13)21(28)29-19-12-26-6-4-14(19)5-7-26/h1-3,8-10,14,19H,4-7,11-12H2/t19-/m0/s1	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL3545166	DRINABANT	CS(=O)(=O)N(c1cc(F)cc(F)c1)C1CN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)C1	IQQBRKLVEALROM-UHFFFAOYSA-N	InChI=1S/C23H20Cl2F2N2O2S/c1-32(30,31)29(21-11-19(26)10-20(27)12-21)22-13-28(14-22)23(15-2-6-17(24)7-3-15)16-4-8-18(25)9-5-16/h2-12,22-23H,13-14H2,1H3	Cannabinoid CB1 receptor antagonist	ANTAGONIST	CHEMBL218	Cannabinoid CB1 receptor	Homo sapiens
CHEMBL45305	BEFIRADOL	Cc1ccc(CNCC2(F)CCN(C(=O)c3ccc(F)c(Cl)c3)CC2)nc1	PKZXLMVXBZICTF-UHFFFAOYSA-N	InChI=1S/C20H22ClF2N3O/c1-14-2-4-16(25-11-14)12-24-13-20(23)6-8-26(9-7-20)19(27)15-3-5-18(22)17(21)10-15/h2-5,10-11,24H,6-9,12-13H2,1H3	Serotonin 1a (5-HT1a) receptor agonist	AGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL3183740	TRELANSERIN	NC(=O)Cn1c(=O)cc(CCN2CCN(c3nccc4sccc34)CC2)c2ccc(F)cc21	JDLYOFUDIKMYBL-UHFFFAOYSA-N	InChI=1S/C24H24FN5O2S/c25-17-1-2-18-16(13-23(32)30(15-22(26)31)20(18)14-17)4-7-28-8-10-29(11-9-28)24-19-5-12-33-21(19)3-6-27-24/h1-3,5-6,12-14H,4,7-11,15H2,(H2,26,31)	Serotonin 1b (5-HT1b) receptor antagonist	ANTAGONIST	CHEMBL1898	Serotonin 1b (5-HT1b) receptor	Homo sapiens
CHEMBL3183740	TRELANSERIN	NC(=O)Cn1c(=O)cc(CCN2CCN(c3nccc4sccc34)CC2)c2ccc(F)cc21	JDLYOFUDIKMYBL-UHFFFAOYSA-N	InChI=1S/C24H24FN5O2S/c25-17-1-2-18-16(13-23(32)30(15-22(26)31)20(18)14-17)4-7-28-8-10-29(11-9-28)24-19-5-12-33-21(19)3-6-27-24/h1-3,5-6,12-14H,4,7-11,15H2,(H2,26,31)	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL582857	NELIVAPTAN	COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3ccccc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1	NJXZWIIMWNEOGJ-WEWKHQNJSA-N	InChI=1S/C30H32ClN3O8S/c1-32(2)28(36)24-15-19(35)17-33(24)30(21-8-6-7-9-25(21)41-4)22-14-18(31)10-12-23(22)34(29(30)37)43(38,39)27-13-11-20(40-3)16-26(27)42-5/h6-14,16,19,24,35H,15,17H2,1-5H3/t19-,24+,30+/m1/s1	Vasopressin V1b receptor antagonist	ANTAGONIST	CHEMBL1921	Vasopressin V1b receptor	Homo sapiens
CHEMBL539843	VAPITADINE DIHYDROCHLORIDE	Cl.Cl.NC(=O)c1cnc2n1CCc1ccccc1C21CCNCC1	BOYLPLUVCXUHDJ-UHFFFAOYSA-N	InChI=1S/C17H20N4O.2ClH/c18-15(22)14-11-20-16-17(6-8-19-9-7-17)13-4-2-1-3-12(13)5-10-21(14)16;;/h1-4,11,19H,5-10H2,(H2,18,22);2*1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL3235279	CAPADENOSON	N#Cc1c(N)nc(SCc2csc(-c3ccc(Cl)cc3)n2)c(C#N)c1-c1ccc(OCCO)cc1	CITWCLNVRIKQAF-UHFFFAOYSA-N	InChI=1S/C25H18ClN5O2S2/c26-17-5-1-16(2-6-17)24-30-18(13-34-24)14-35-25-21(12-28)22(20(11-27)23(29)31-25)15-3-7-19(8-4-15)33-10-9-32/h1-8,13,32H,9-10,14H2,(H2,29,31)	Adenosine A1 receptor partial agonist	PARTIAL AGONIST	CHEMBL226	Adenosine A1 receptor	Homo sapiens
CHEMBL189676	SURINABANT	CCc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)cc1	HMXDWDSNPRNUKI-UHFFFAOYSA-N	InChI=1S/C23H23BrCl2N4O/c1-2-18-21(23(31)28-29-12-4-3-5-13-29)27-30(20-11-10-17(25)14-19(20)26)22(18)15-6-8-16(24)9-7-15/h6-11,14H,2-5,12-13H2,1H3,(H,28,31)	Cannabinoid CB1 receptor antagonist	ANTAGONIST	CHEMBL218	Cannabinoid CB1 receptor	Homo sapiens
CHEMBL2103856	ATOPAXAR	CCOc1cc2c(c(F)c1OCC)C(=N)N(CC(=O)c1cc(N3CCOCC3)c(OC)c(C(C)(C)C)c1)C2	QWKAUGRRIXBIPO-UHFFFAOYSA-N	InChI=1S/C29H38FN3O5/c1-7-37-23-15-19-16-33(28(31)24(19)25(30)27(23)38-8-2)17-22(34)18-13-20(29(3,4)5)26(35-6)21(14-18)32-9-11-36-12-10-32/h13-15,31H,7-12,16-17H2,1-6H3	Proteinase-activated receptor 1 antagonist	ANTAGONIST	CHEMBL3974	Proteinase-activated receptor 1	Homo sapiens
CHEMBL261244	REGRELOR DISODIUM	CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])[O-])[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21.[Na+].[Na+]	MKQKPLQMNCXTJE-VEZQGTPESA-L	InChI=1S/C22H25N6O8P.2Na/c1-2-23-22(29)27-19-16-20(25-11-24-19)28(12-26-16)21-18-17(14(34-21)10-33-37(30,31)32)35-15(36-18)9-8-13-6-4-3-5-7-13;;/h3-9,11-12,14-15,17-18,21H,2,10H2,1H3,(H2,30,31,32)(H2,23,24,25,27,29);;/q;2*+1/p-2/b9-8+;;/t14-,15+,17-,18-,21-;;/m1../s1	Purinergic receptor P2Y12 antagonist	ANTAGONIST	CHEMBL2001	Purinergic receptor P2Y12	Homo sapiens
CHEMBL303960	RIVENPROST	COCc1cccc(C[C@H](O)/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2CCSCCCC(=O)OC)c1	FBQUXLIJKPWCAO-AZIFJQEOSA-N	InChI=1S/C24H34O6S/c1-29-16-18-6-3-5-17(13-18)14-19(25)8-9-20-21(23(27)15-22(20)26)10-12-31-11-4-7-24(28)30-2/h3,5-6,8-9,13,19-22,25-26H,4,7,10-12,14-16H2,1-2H3/b9-8+/t19-,20-,21-,22-/m1/s1	Prostanoid EP4 receptor agonist	AGONIST	CHEMBL1836	Prostanoid EP4 receptor	Homo sapiens
CHEMBL2027925	CAPESEROD	Nc1c(Cl)cc(-c2nn(C3CCN(CCc4ccccc4)CC3)c(=O)o2)c2c1OCCO2	MDBNTXARNGRHEV-UHFFFAOYSA-N	InChI=1S/C23H25ClN4O4/c24-18-14-17(20-21(19(18)25)31-13-12-30-20)22-26-28(23(29)32-22)16-7-10-27(11-8-16)9-6-15-4-2-1-3-5-15/h1-5,14,16H,6-13,25H2	Serotonin 4 (5-HT4) receptor partial agonist	PARTIAL AGONIST	CHEMBL1875	Serotonin 4 (5-HT4) receptor	Homo sapiens
CHEMBL2218893	BEDORADRINE SULFATE	CN(C)C(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(O)c(CCO)c1)CC2.CN(C)C(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1ccc(O)c(CCO)c1)CC2.O=S(=O)(O)O	VPCOODFYDJWLHD-YMZXMBPUSA-N	InChI=1S/2C24H32N2O5.H2O4S/c2*1-26(2)24(30)15-31-21-7-4-16-3-6-20(12-19(16)13-21)25-14-23(29)17-5-8-22(28)18(11-17)9-10-27;1-5(2,3)4/h2*4-5,7-8,11,13,20,23,25,27-29H,3,6,9-10,12,14-15H2,1-2H3;(H2,1,2,3,4)/t2*20-,23-;/m00./s1	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL345237	PICLOZOTAN	O=C1c2ccccc2OC=C(Cl)N1CCCCN1CC=C(c2ccccn2)CC1	URMTUEWUIGOJBW-UHFFFAOYSA-N	InChI=1S/C23H24ClN3O2/c24-22-17-29-21-9-2-1-7-19(21)23(28)27(22)14-6-5-13-26-15-10-18(11-16-26)20-8-3-4-12-25-20/h1-4,7-10,12,17H,5-6,11,13-16H2	Serotonin 1a (5-HT1a) receptor agonist	AGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL3668014	LINZAGOLIX	COc1cc(F)c(-n2c(=O)[nH]c3csc(C(=O)O)c3c2=O)cc1OCc1c(OC)ccc(F)c1F	BMAAMIIYNNPHAB-UHFFFAOYSA-N	InChI=1S/C22H15F3N2O7S/c1-32-14-4-3-10(23)18(25)9(14)7-34-16-6-13(11(24)5-15(16)33-2)27-20(28)17-12(26-22(27)31)8-35-19(17)21(29)30/h3-6,8H,7H2,1-2H3,(H,26,31)(H,29,30)	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL567303	PALOSURAN	Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1	WYJCYXOCHXWTHG-UHFFFAOYSA-N	InChI=1S/C25H30N4O2/c1-19-17-23(21-9-5-6-10-22(21)27-19)28-24(30)26-13-16-29-14-11-25(31,12-15-29)18-20-7-3-2-4-8-20/h2-10,17,31H,11-16,18H2,1H3,(H2,26,27,28,30)	Urotensin II receptor antagonist	ANTAGONIST	CHEMBL3764	Urotensin II receptor	Homo sapiens
CHEMBL1094785	CARMOTEROL	COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1	IHOXNOQMRZISPV-YJYMSZOUSA-N	InChI=1S/C21H24N2O4/c1-13(11-14-3-5-15(27-2)6-4-14)22-12-19(25)16-7-9-18(24)21-17(16)8-10-20(26)23-21/h3-10,13,19,22,24-25H,11-12H2,1-2H3,(H,23,26)/t13-,19+/m1/s1	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL22055	SUFUGOLIX	CONC(=O)Nc1ccc(-c2sc3c(c2CN(C)Cc2ccccc2)c(=O)n(-c2ccccc2)c(=O)n3Cc2c(F)cccc2F)cc1	UCQSBGOFELXYIN-UHFFFAOYSA-N	InChI=1S/C36H31F2N5O4S/c1-41(20-23-10-5-3-6-11-23)21-28-31-33(44)43(26-12-7-4-8-13-26)36(46)42(22-27-29(37)14-9-15-30(27)38)34(31)48-32(28)24-16-18-25(19-17-24)39-35(45)40-47-2/h3-19H,20-22H2,1-2H3,(H2,39,40,45)	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL1628569	ROBALZOTAN	NC(=O)c1ccc(F)c2c1C[C@@H](N(C1CCC1)C1CCC1)CO2	MQTUXRKNJYPMCG-CYBMUJFWSA-N	InChI=1S/C18H23FN2O2/c19-16-8-7-14(18(20)22)15-9-13(10-23-17(15)16)21(11-3-1-4-11)12-5-2-6-12/h7-8,11-13H,1-6,9-10H2,(H2,20,22)/t13-/m1/s1	Serotonin 1a (5-HT1a) receptor antagonist	ANTAGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL2107760	NEBENTAN	COc1ccccc1Oc1c(NS(=O)(=O)/C=C/c2ccccc2)nc(-c2ncccn2)nc1OC	LONWRQOYFPYMQD-DTQAZKPQSA-N	InChI=1S/C24H21N5O5S/c1-32-18-11-6-7-12-19(18)34-20-21(29-35(30,31)16-13-17-9-4-3-5-10-17)27-23(28-24(20)33-2)22-25-14-8-15-26-22/h3-16H,1-2H3,(H,27,28,29)/b16-13+	Endothelin receptor ET-A antagonist	ANTAGONIST	CHEMBL252	Endothelin receptor ET-A	Homo sapiens
CHEMBL257978	DABUZALGRON	Cc1c(OCC2=NCCN2)ccc(Cl)c1NS(C)(=O)=O	FOYWMEJSRSBQGB-UHFFFAOYSA-N	InChI=1S/C12H16ClN3O3S/c1-8-10(19-7-11-14-5-6-15-11)4-3-9(13)12(8)16-20(2,17)18/h3-4,16H,5-7H2,1-2H3,(H,14,15)	Alpha-1a adrenergic receptor partial agonist	PARTIAL AGONIST	CHEMBL229	Alpha-1a adrenergic receptor	Homo sapiens
CHEMBL2107572	TECALCET HYDROCHLORIDE	COc1cccc([C@@H](C)NCCCc2ccccc2Cl)c1.Cl	YJXUXANREVNZLH-PFEQFJNWSA-N	InChI=1S/C18H22ClNO.ClH/c1-14(16-8-5-10-17(13-16)21-2)20-12-6-9-15-7-3-4-11-18(15)19;/h3-5,7-8,10-11,13-14,20H,6,9,12H2,1-2H3;1H/t14-;/m1./s1	Calcium sensing receptor modulator	MODULATOR	CHEMBL1878	Calcium sensing receptor	Homo sapiens
CHEMBL279260	RAFABEGRON	C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1	FHEYFIGWYQJVDR-ACJLOTCBSA-N	InChI=1S/C21H23ClN2O4/c1-13(23-11-18(25)14-4-2-5-16(22)9-14)8-15-10-24-21-17(15)6-3-7-19(21)28-12-20(26)27/h2-7,9-10,13,18,23-25H,8,11-12H2,1H3,(H,26,27)/t13-,18+/m1/s1	Beta-3 adrenergic receptor agonist	AGONIST	CHEMBL246	Beta-3 adrenergic receptor	Homo sapiens
CHEMBL2218898	BARUSIBAN	CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCSCC[C@@H](C(=O)N(C)[C@H](CO)CCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O	UGNGRKKDUVKQDF-IHOMMZCZSA-N	InChI=1S/C40H63N9O8S/c1-6-23(3)34-38(55)46-31(20-32(42)51)36(53)45-29(40(57)49(5)26(22-50)11-10-16-41)14-17-58-18-15-33(52)44-30(19-25-21-43-28-13-9-8-12-27(25)28)37(54)47-35(24(4)7-2)39(56)48-34/h8-9,12-13,21,23-24,26,29-31,34-35,43,50H,6-7,10-11,14-20,22,41H2,1-5H3,(H2,42,51)(H,44,52)(H,45,53)(H,46,55)(H,47,54)(H,48,56)/t23-,24+,26+,29+,30-,31+,34+,35+/m1/s1	Oxytocin receptor antagonist	ANTAGONIST	CHEMBL2049	Oxytocin receptor	Homo sapiens
CHEMBL2107725	ANATIBANT	Cc1cc(C)c2cccc(OCc3c(Cl)ccc(S(=O)(=O)N4CCC[C@H]4C(=O)NCCCNC(=O)c4ccc(C(=N)N)cc4)c3Cl)c2n1	XUHBBTKJWIBQMY-MHZLTWQESA-N	InChI=1S/C34H36Cl2N6O5S/c1-20-18-21(2)41-31-24(20)6-3-8-28(31)47-19-25-26(35)13-14-29(30(25)36)48(45,46)42-17-4-7-27(42)34(44)40-16-5-15-39-33(43)23-11-9-22(10-12-23)32(37)38/h3,6,8-14,18,27H,4-5,7,15-17,19H2,1-2H3,(H3,37,38)(H,39,43)(H,40,44)/t27-/m0/s1	Bradykinin B2 receptor antagonist	ANTAGONIST	CHEMBL3157	Bradykinin B2 receptor	Homo sapiens
CHEMBL281764	TABIMORELIN	CNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1ccc2ccccc2c1)N(C)C(=O)/C=C/CC(C)(C)N	WURGZWOTGMLDJP-ZCYANPAGSA-N	InChI=1S/C32H40N4O3/c1-32(2,33)19-11-16-29(37)35(4)28(22-24-17-18-25-14-9-10-15-26(25)20-24)31(39)36(5)27(30(38)34-3)21-23-12-7-6-8-13-23/h6-18,20,27-28H,19,21-22,33H2,1-5H3,(H,34,38)/b16-11+/t27-,28-/m1/s1	Ghrelin receptor agonist	AGONIST	CHEMBL4616	Ghrelin receptor	Homo sapiens
CHEMBL281764	TABIMORELIN	CNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1ccc2ccccc2c1)N(C)C(=O)/C=C/CC(C)(C)N	WURGZWOTGMLDJP-ZCYANPAGSA-N	InChI=1S/C32H40N4O3/c1-32(2,33)19-11-16-29(37)35(4)28(22-24-17-18-25-14-9-10-15-26(25)20-24)31(39)36(5)27(30(38)34-3)21-23-12-7-6-8-13-23/h6-18,20,27-28H,19,21-22,33H2,1-5H3,(H,34,38)/b16-11+/t27-,28-/m1/s1	Cytochrome P450 3A4 inhibitor	INHIBITOR	CHEMBL340	Cytochrome P450 3A4	Homo sapiens
CHEMBL41194	PRATOSARTAN	CCCc1nc2c(n1Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)CCCC2	KCTFTBCZZUBAKN-UHFFFAOYSA-N	InChI=1S/C25H26N6O/c1-2-7-23-26-21-10-5-6-11-22(32)24(21)31(23)16-17-12-14-18(15-13-17)19-8-3-4-9-20(19)25-27-29-30-28-25/h3-4,8-9,12-15H,2,5-7,10-11,16H2,1H3,(H,27,28,29,30)	Type-1 angiotensin II receptor antagonist	ANTAGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL41194	PRATOSARTAN	CCCc1nc2c(n1Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)CCCC2	KCTFTBCZZUBAKN-UHFFFAOYSA-N	InChI=1S/C25H26N6O/c1-2-7-23-26-21-10-5-6-11-22(32)24(21)31(23)16-17-12-14-18(15-13-17)19-8-3-4-9-20(19)25-27-29-30-28-25/h3-4,8-9,12-15H,2,5-7,10-11,16H2,1H3,(H,27,28,29,30)	Solute carrier family 22 member 12 inhibitor	INHIBITOR	CHEMBL6120	Solute carrier family 22 member 12	Homo sapiens
CHEMBL41194	PRATOSARTAN	CCCc1nc2c(n1Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)CCCC2	KCTFTBCZZUBAKN-UHFFFAOYSA-N	InChI=1S/C25H26N6O/c1-2-7-23-26-21-10-5-6-11-22(32)24(21)31(23)16-17-12-14-18(15-13-17)19-8-3-4-9-20(19)25-27-29-30-28-25/h3-4,8-9,12-15H,2,5-7,10-11,16H2,1H3,(H,27,28,29,30)	Solute carrier family 22 member 6 inhibitor	INHIBITOR	CHEMBL1641347	Solute carrier family 22 member 6	Homo sapiens
CHEMBL41194	PRATOSARTAN	CCCc1nc2c(n1Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)CCCC2	KCTFTBCZZUBAKN-UHFFFAOYSA-N	InChI=1S/C25H26N6O/c1-2-7-23-26-21-10-5-6-11-22(32)24(21)31(23)16-17-12-14-18(15-13-17)19-8-3-4-9-20(19)25-27-29-30-28-25/h3-4,8-9,12-15H,2,5-7,10-11,16H2,1H3,(H,27,28,29,30)	Solute carrier family 22 member 8 inhibitor	INHIBITOR	CHEMBL1641348	Solute carrier family 22 member 8	Homo sapiens
CHEMBL2110618	MINOPAFANT	CCCCCCCCCCCCCCCCCCNC(=O)OC1CCN(C(=O)OC[C@H](COC(=O)N(Cc2cccc[n+]2CC)C(=O)c2ccccc2OC)OC)CC1	HGOAIWZFTWACBD-RRHRGVEJSA-O	InChI=1S/C46H72N4O9/c1-5-7-8-9-10-11-12-13-14-15-16-17-18-19-20-24-31-47-44(52)59-39-29-33-49(34-30-39)45(53)57-36-40(55-3)37-58-46(54)50(35-38-26-23-25-32-48(38)6-2)43(51)41-27-21-22-28-42(41)56-4/h21-23,25-28,32,39-40H,5-20,24,29-31,33-37H2,1-4H3/p+1/t40-/m1/s1	Platelet activating factor receptor antagonist	ANTAGONIST	CHEMBL250	Platelet activating factor receptor	Homo sapiens
CHEMBL2106710	FADOLMIDINE HYDROCHLORIDE	Cl.Oc1ccc2c(c1)C(Cc1c[nH]cn1)CC2	OYKZVKWXOWICFI-UHFFFAOYSA-N	InChI=1S/C13H14N2O.ClH/c16-12-4-3-9-1-2-10(13(9)6-12)5-11-7-14-8-15-11;/h3-4,6-8,10,16H,1-2,5H2,(H,14,15);1H	Adrenergic receptor alpha-2 agonist	AGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL431651	ENRASENTAN	CCCOc1ccc2c(c1)[C@@H](c1ccc(OC)cc1OCCO)[C@H](C(=O)O)[C@H]2c1ccc2c(c1)OCO2	GLCKXJLCYIJMRB-UPRLRBBYSA-N	InChI=1S/C29H30O8/c1-3-11-34-19-6-7-20-22(14-19)27(21-8-5-18(33-2)15-24(21)35-12-10-30)28(29(31)32)26(20)17-4-9-23-25(13-17)37-16-36-23/h4-9,13-15,26-28,30H,3,10-12,16H2,1-2H3,(H,31,32)/t26-,27+,28+/m0/s1	Endothelin receptor ET-A antagonist	ANTAGONIST	CHEMBL252	Endothelin receptor ET-A	Homo sapiens
CHEMBL431651	ENRASENTAN	CCCOc1ccc2c(c1)[C@@H](c1ccc(OC)cc1OCCO)[C@H](C(=O)O)[C@H]2c1ccc2c(c1)OCO2	GLCKXJLCYIJMRB-UPRLRBBYSA-N	InChI=1S/C29H30O8/c1-3-11-34-19-6-7-20-22(14-19)27(21-8-5-18(33-2)15-24(21)35-12-10-30)28(29(31)32)26(20)17-4-9-23-25(13-17)37-16-36-23/h4-9,13-15,26-28,30H,3,10-12,16H2,1-2H3,(H,31,32)/t26-,27+,28+/m0/s1	Endothelin receptor ET-B antagonist	ANTAGONIST	CHEMBL1785	Endothelin receptor ET-B	Homo sapiens
CHEMBL1742420	AMELUBANT	CCOC(=O)NC(=N)c1ccc(OCc2cccc(COc3ccc(C(C)(C)c4ccc(O)cc4)cc3)c2)cc1	SBVYURPQULDJTI-UHFFFAOYSA-N	InChI=1S/C33H34N2O5/c1-4-38-32(37)35-31(34)25-8-16-29(17-9-25)39-21-23-6-5-7-24(20-23)22-40-30-18-12-27(13-19-30)33(2,3)26-10-14-28(36)15-11-26/h5-20,36H,4,21-22H2,1-3H3,(H2,34,35,37)	Leukotriene B4 receptor 1 antagonist	ANTAGONIST	CHEMBL3911	Leukotriene B4 receptor 1	Homo sapiens
CHEMBL329123	ETALOCIB	CCCc1c(OCCCOc2cc(O)c(-c3ccc(F)cc3)cc2CC)cccc1Oc1ccccc1C(=O)O	YFIZRWPXUYFCSN-UHFFFAOYSA-N	InChI=1S/C33H33FO6/c1-3-9-25-29(12-7-13-30(25)40-31-11-6-5-10-26(31)33(36)37)38-18-8-19-39-32-21-28(35)27(20-22(32)4-2)23-14-16-24(34)17-15-23/h5-7,10-17,20-21,35H,3-4,8-9,18-19H2,1-2H3,(H,36,37)	Leukotriene B4 receptor 1 antagonist	ANTAGONIST	CHEMBL3911	Leukotriene B4 receptor 1	Homo sapiens
CHEMBL329123	ETALOCIB	CCCc1c(OCCCOc2cc(O)c(-c3ccc(F)cc3)cc2CC)cccc1Oc1ccccc1C(=O)O	YFIZRWPXUYFCSN-UHFFFAOYSA-N	InChI=1S/C33H33FO6/c1-3-9-25-29(12-7-13-30(25)40-31-11-6-5-10-26(31)33(36)37)38-18-8-19-39-32-21-28(35)27(20-22(32)4-2)23-14-16-24(34)17-15-23/h5-7,10-17,20-21,35H,3-4,8-9,18-19H2,1-2H3,(H,36,37)	Peroxisome proliferator-activated receptor gamma agonist	AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL522302	VOFOPITANT	COc1ccc(-n2nnnc2C(F)(F)F)cc1CN[C@H]1CCCN[C@H]1c1ccccc1	XILNRORTJVDYRH-HKUYNNGSSA-N	InChI=1S/C21H23F3N6O/c1-31-18-10-9-16(30-20(21(22,23)24)27-28-29-30)12-15(18)13-26-17-8-5-11-25-19(17)14-6-3-2-4-7-14/h2-4,6-7,9-10,12,17,19,25-26H,5,8,11,13H2,1H3/t17-,19-/m0/s1	Neurokinin 1 receptor antagonist	ANTAGONIST	CHEMBL249	Neurokinin 1 receptor	Homo sapiens
CHEMBL10188	TALNETANT	CC[C@H](NC(=O)c1c(O)c(-c2ccccc2)nc2ccccc12)c1ccccc1	BIAVGWDGIJKWRM-FQEVSTJZSA-N	InChI=1S/C25H22N2O2/c1-2-20(17-11-5-3-6-12-17)27-25(29)22-19-15-9-10-16-21(19)26-23(24(22)28)18-13-7-4-8-14-18/h3-16,20,28H,2H2,1H3,(H,27,29)/t20-/m0/s1	Neurokinin 3 receptor antagonist	ANTAGONIST	CHEMBL4429	Neurokinin 3 receptor	Homo sapiens
CHEMBL419667	RELCOVAPTAN	COc1ccc(S(=O)(=O)N2c3ccc(Cl)cc3[C@](O)(c3ccccc3Cl)[C@@H]2C(=O)N2CCC[C@H]2C(N)=O)cc1OC	CEBYCSRFKCEUSW-NAYZPBBASA-N	InChI=1S/C28H27Cl2N3O7S/c1-39-23-12-10-17(15-24(23)40-2)41(37,38)33-21-11-9-16(29)14-19(21)28(36,18-6-3-4-7-20(18)30)25(33)27(35)32-13-5-8-22(32)26(31)34/h3-4,6-7,9-12,14-15,22,25,36H,5,8,13H2,1-2H3,(H2,31,34)/t22-,25-,28+/m0/s1	Vasopressin V1a receptor antagonist	ANTAGONIST	CHEMBL1889	Vasopressin V1a receptor	Homo sapiens
CHEMBL419667	RELCOVAPTAN	COc1ccc(S(=O)(=O)N2c3ccc(Cl)cc3[C@](O)(c3ccccc3Cl)[C@@H]2C(=O)N2CCC[C@H]2C(N)=O)cc1OC	CEBYCSRFKCEUSW-NAYZPBBASA-N	InChI=1S/C28H27Cl2N3O7S/c1-39-23-12-10-17(15-24(23)40-2)41(37,38)33-21-11-9-16(29)14-19(21)28(36,18-6-3-4-7-20(18)30)25(33)27(35)32-13-5-8-22(32)26(31)34/h3-4,6-7,9-12,14-15,22,25,36H,5,8,13H2,1-2H3,(H2,31,34)/t22-,25-,28+/m0/s1	Oxytocin receptor antagonist	ANTAGONIST	CHEMBL2049	Oxytocin receptor	Homo sapiens
CHEMBL2106841	NONABINE	CCCCCC(C)C(C)c1cc(O)c2c(c1)OC(C)(C)C=C2c1ccncc1	YHUDSHIRWOVVCV-UHFFFAOYSA-N	InChI=1S/C25H33NO2/c1-6-7-8-9-17(2)18(3)20-14-22(27)24-21(19-10-12-26-13-11-19)16-25(4,5)28-23(24)15-20/h10-18,27H,6-9H2,1-5H3	Cannabinoid CB1 receptor agonist	AGONIST	CHEMBL218	Cannabinoid CB1 receptor	Homo sapiens
CHEMBL2106841	NONABINE	CCCCCC(C)C(C)c1cc(O)c2c(c1)OC(C)(C)C=C2c1ccncc1	YHUDSHIRWOVVCV-UHFFFAOYSA-N	InChI=1S/C25H33NO2/c1-6-7-8-9-17(2)18(3)20-14-22(27)24-21(19-10-12-26-13-11-19)16-25(4,5)28-23(24)15-20/h10-18,27H,6-9H2,1-5H3	Cannabinoid CB2 receptor agonist	AGONIST	CHEMBL253	Cannabinoid CB2 receptor	Homo sapiens
CHEMBL1256717	ITRIGLUMIDE	Cc1cc(C)c(NC(=O)C[C@H](CC(=O)O)c2cccc3ccccc23)c(C(=O)N2CCC3(CCCC3)CC2)c1	MFOOVZCXWVAWOV-RUZDIDTESA-N	InChI=1S/C33H38N2O4/c1-22-18-23(2)31(28(19-22)32(39)35-16-14-33(15-17-35)12-5-6-13-33)34-29(36)20-25(21-30(37)38)27-11-7-9-24-8-3-4-10-26(24)27/h3-4,7-11,18-19,25H,5-6,12-17,20-21H2,1-2H3,(H,34,36)(H,37,38)/t25-/m1/s1	Cholecystokinin B receptor antagonist	ANTAGONIST	CHEMBL298	Cholecystokinin B receptor	Homo sapiens
CHEMBL3989481	FRAKEFAMIDE	C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O	GTPHQORJKFJIRB-JTQLPTLWSA-N	InChI=1S/C30H34FN5O5/c1-18(34-29(40)24(32)15-20-9-13-23(37)14-10-20)28(39)36-26(17-21-7-11-22(31)12-8-21)30(41)35-25(27(33)38)16-19-5-3-2-4-6-19/h2-14,18,24-26,37H,15-17,32H2,1H3,(H2,33,38)(H,34,40)(H,35,41)(H,36,39)/t18-,24+,25+,26+/m1/s1	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL515966	EZLOPITANT	COc1ccc(C(C)C)cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1	XPNMCDYOYIKVGB-CONSDPRKSA-N	InChI=1S/C31H38N2O/c1-22(2)26-14-15-28(34-3)27(20-26)21-32-30-25-16-18-33(19-17-25)31(30)29(23-10-6-4-7-11-23)24-12-8-5-9-13-24/h4-15,20,22,25,29-32H,16-19,21H2,1-3H3/t30-,31-/m0/s1	Neurokinin 1 receptor antagonist	ANTAGONIST	CHEMBL249	Neurokinin 1 receptor	Homo sapiens
CHEMBL1742428	DONITRIPTAN	N#Cc1ccc(N2CCN(C(=O)COc3ccc4[nH]cc(CCN)c4c3)CC2)cc1	SOHCKWZVTCTQBG-UHFFFAOYSA-N	InChI=1S/C23H25N5O2/c24-8-7-18-15-26-22-6-5-20(13-21(18)22)30-16-23(29)28-11-9-27(10-12-28)19-3-1-17(14-25)2-4-19/h1-6,13,15,26H,7-12,16,24H2	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	CHEMBL1898	Serotonin 1b (5-HT1b) receptor	Homo sapiens
CHEMBL1742428	DONITRIPTAN	N#Cc1ccc(N2CCN(C(=O)COc3ccc4[nH]cc(CCN)c4c3)CC2)cc1	SOHCKWZVTCTQBG-UHFFFAOYSA-N	InChI=1S/C23H25N5O2/c24-8-7-18-15-26-22-6-5-20(13-21(18)22)30-16-23(29)28-11-9-27(10-12-28)19-3-1-17(14-25)2-4-19/h1-6,13,15,26H,7-12,16,24H2	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	CHEMBL1983	Serotonin 1d (5-HT1d) receptor	Homo sapiens
CHEMBL1742428	DONITRIPTAN	N#Cc1ccc(N2CCN(C(=O)COc3ccc4[nH]cc(CCN)c4c3)CC2)cc1	SOHCKWZVTCTQBG-UHFFFAOYSA-N	InChI=1S/C23H25N5O2/c24-8-7-18-15-26-22-6-5-20(13-21(18)22)30-16-23(29)28-11-9-27(10-12-28)19-3-1-17(14-25)2-4-19/h1-6,13,15,26H,7-12,16,24H2	G protein-coupled receptor 44 antagonist	ANTAGONIST	CHEMBL5071	G protein-coupled receptor 44	Homo sapiens
CHEMBL1090488	PF-00446687	C[C@H]1CN(C(=O)[C@@H]2CN(C(C)(C)C)C[C@H]2c2ccc(F)cc2F)C[C@@H](C)[C@]1(O)c1ccccc1	WHPJOAUPIZDJNX-AGGGUQDCSA-N	InChI=1S/C28H36F2N2O2/c1-18-14-31(15-19(2)28(18,34)20-9-7-6-8-10-20)26(33)24-17-32(27(3,4)5)16-23(24)22-12-11-21(29)13-25(22)30/h6-13,18-19,23-24,34H,14-17H2,1-5H3/t18-,19+,23-,24+,28-/m0/s1	Melanocortin receptor 4 agonist	AGONIST	CHEMBL259	Melanocortin receptor 4	Homo sapiens
CHEMBL3301624	SETMELANOTIDE	CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](C)NC1=O	HDHDTKMUACZDAA-PHNIDTBTSA-N	InChI=1S/C49H68N18O9S2/c1-26-41(70)63-37(20-30-22-55-25-59-30)46(75)64-35(18-28-10-4-3-5-11-28)44(73)62-34(15-9-17-57-49(53)54)43(72)65-36(19-29-21-58-32-13-7-6-12-31(29)32)45(74)66-38(40(50)69)23-77-78-24-39(47(76)60-26)67-42(71)33(61-27(2)68)14-8-16-56-48(51)52/h3-7,10-13,21-22,25-26,33-39,58H,8-9,14-20,23-24H2,1-2H3,(H2,50,69)(H,55,59)(H,60,76)(H,61,68)(H,62,73)(H,63,70)(H,64,75)(H,65,72)(H,66,74)(H,67,71)(H4,51,52,56)(H4,53,54,57)/t26-,33+,34+,35-,36+,37+,38+,39+/m1/s1	Melanocortin receptor 4 agonist	AGONIST	CHEMBL259	Melanocortin receptor 4	Homo sapiens
CHEMBL2105635	DAVALINTIDE	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@H](C)O)[C@H](C)O	SLYFITHISHUGLZ-LWZDQURMSA-N	InChI=1S/C152H248N50O49S2/c1-66(2)48-91(189-143(245)113(70(9)10)195-140(242)103-64-253-252-63-102(193-122(224)83(154)24-18-19-43-153)139(241)188-97(56-108(158)216)135(237)200-115(73(13)206)144(246)174-71(11)121(223)196-116(74(14)207)148(250)194-103)123(225)171-59-110(218)175-84(25-20-44-168-150(161)162)124(226)183-94(51-69(7)8)132(234)192-101(62-204)138(240)180-87(37-40-105(155)213)126(228)178-89(39-42-112(220)221)127(229)185-93(50-68(5)6)131(233)186-95(54-80-58-167-65-173-80)133(235)177-85(26-21-45-169-151(163)164)125(227)184-92(49-67(3)4)130(232)179-88(38-41-106(156)214)129(231)199-119(77(17)210)147(249)191-99(53-79-31-35-82(212)36-32-79)149(251)202-47-23-28-104(202)141(243)181-86(27-22-46-170-152(165)166)128(230)198-118(76(16)209)146(248)190-98(57-109(159)217)136(238)197-114(72(12)205)142(244)172-60-111(219)176-100(61-203)137(239)187-96(55-107(157)215)134(236)201-117(75(15)208)145(247)182-90(120(160)222)52-78-29-33-81(211)34-30-78/h29-36,58,65-77,83-104,113-119,203-212H,18-28,37-57,59-64,153-154H2,1-17H3,(H2,155,213)(H2,156,214)(H2,157,215)(H2,158,216)(H2,159,217)(H2,160,222)(H,167,173)(H,171,225)(H,172,244)(H,174,246)(H,175,218)(H,176,219)(H,177,235)(H,178,228)(H,179,232)(H,180,240)(H,181,243)(H,182,247)(H,183,226)(H,184,227)(H,185,229)(H,186,233)(H,187,239)(H,188,241)(H,189,245)(H,190,248)(H,191,249)(H,192,234)(H,193,224)(H,194,250)(H,195,242)(H,196,223)(H,197,238)(H,198,230)(H,199,231)(H,200,237)(H,201,236)(H,220,221)(H4,161,162,168)(H4,163,164,169)(H4,165,166,170)/t71-,72+,73-,74-,75+,76-,77-,83-,84-,85-,86-,87-,88+,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,113-,114-,115-,116-,117-,118-,119-/m0/s1	Calcitonin gene-related peptide type 1 receptor agonist	AGONIST	CHEMBL3798	Calcitonin gene-related peptide type 1 receptor	Homo sapiens
CHEMBL2105635	DAVALINTIDE	CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@H](C)O)[C@H](C)O	SLYFITHISHUGLZ-LWZDQURMSA-N	InChI=1S/C152H248N50O49S2/c1-66(2)48-91(189-143(245)113(70(9)10)195-140(242)103-64-253-252-63-102(193-122(224)83(154)24-18-19-43-153)139(241)188-97(56-108(158)216)135(237)200-115(73(13)206)144(246)174-71(11)121(223)196-116(74(14)207)148(250)194-103)123(225)171-59-110(218)175-84(25-20-44-168-150(161)162)124(226)183-94(51-69(7)8)132(234)192-101(62-204)138(240)180-87(37-40-105(155)213)126(228)178-89(39-42-112(220)221)127(229)185-93(50-68(5)6)131(233)186-95(54-80-58-167-65-173-80)133(235)177-85(26-21-45-169-151(163)164)125(227)184-92(49-67(3)4)130(232)179-88(38-41-106(156)214)129(231)199-119(77(17)210)147(249)191-99(53-79-31-35-82(212)36-32-79)149(251)202-47-23-28-104(202)141(243)181-86(27-22-46-170-152(165)166)128(230)198-118(76(16)209)146(248)190-98(57-109(159)217)136(238)197-114(72(12)205)142(244)172-60-111(219)176-100(61-203)137(239)187-96(55-107(157)215)134(236)201-117(75(15)208)145(247)182-90(120(160)222)52-78-29-33-81(211)34-30-78/h29-36,58,65-77,83-104,113-119,203-212H,18-28,37-57,59-64,153-154H2,1-17H3,(H2,155,213)(H2,156,214)(H2,157,215)(H2,158,216)(H2,159,217)(H2,160,222)(H,167,173)(H,171,225)(H,172,244)(H,174,246)(H,175,218)(H,176,219)(H,177,235)(H,178,228)(H,179,232)(H,180,240)(H,181,243)(H,182,247)(H,183,226)(H,184,227)(H,185,229)(H,186,233)(H,187,239)(H,188,241)(H,189,245)(H,190,248)(H,191,249)(H,192,234)(H,193,224)(H,194,250)(H,195,242)(H,196,223)(H,197,238)(H,198,230)(H,199,231)(H,200,237)(H,201,236)(H,220,221)(H4,161,162,168)(H4,163,164,169)(H4,165,166,170)/t71-,72+,73-,74-,75+,76-,77-,83-,84-,85-,86-,87-,88+,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,113-,114-,115-,116-,117-,118-,119-/m0/s1	Amylin receptor AMY1, CALCR/RAMP1 agonist	AGONIST	CHEMBL2111189	Amylin receptor AMY1, CALCR/RAMP1	Homo sapiens
CHEMBL1817709	SELEPRESSIN	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCC(N)=O)NC1=O	JCVQBJTWWDYUFQ-MRUTUVJXSA-N	InChI=1S/C46H73N13O11S2/c1-5-26(4)38-45(69)54-30(14-9-17-35(48)60)41(65)56-32(21-36(49)61)42(66)57-33(24-72-71-23-28(47)39(63)55-31(43(67)58-38)20-27-12-7-6-8-13-27)46(70)59-19-11-16-34(59)44(68)53-29(15-10-18-51-25(2)3)40(64)52-22-37(50)62/h6-8,12-13,25-26,28-34,38,51H,5,9-11,14-24,47H2,1-4H3,(H2,48,60)(H2,49,61)(H2,50,62)(H,52,64)(H,53,68)(H,54,69)(H,55,63)(H,56,65)(H,57,66)(H,58,67)/t26-,28-,29-,30-,31-,32-,33-,34-,38-/m0/s1	Vasopressin V1a receptor agonist	AGONIST	CHEMBL1889	Vasopressin V1a receptor	Homo sapiens
CHEMBL3545347	TXA127	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)O	PVHLMTREZMEJCG-GDTLVBQBSA-N	InChI=1S/C41H62N12O11/c1-5-22(4)33(38(61)50-29(17-24-19-45-20-47-24)39(62)53-15-7-9-30(53)40(63)64)52-36(59)28(16-23-10-12-25(54)13-11-23)49-37(60)32(21(2)3)51-35(58)27(8-6-14-46-41(43)44)48-34(57)26(42)18-31(55)56/h10-13,19-22,26-30,32-33,54H,5-9,14-18,42H2,1-4H3,(H,45,47)(H,48,57)(H,49,60)(H,50,61)(H,51,58)(H,52,59)(H,55,56)(H,63,64)(H4,43,44,46)/t22-,26-,27-,28-,29-,30-,32-,33-/m0/s1	Proto-oncogene Mas agonist	AGONIST	CHEMBL3559701	Proto-oncogene Mas	Homo sapiens
CHEMBL2105864	LABRADIMIL	COc1ccc(C[C@@H](CN[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](Cc2cccs2)NC(=O)CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CCCN=C(N)N)cc1	IDXCXSCCZNCXCL-XMADEQCMSA-N	InChI=1S/C49H75N15O12S/c1-76-31-14-12-28(13-15-31)21-29(24-57-34(47(74)75)9-3-17-56-49(53)54)59-43(70)37-10-4-18-62(37)45(72)36(27-65)61-41(68)35(23-32-7-6-20-77-32)60-40(67)25-58-42(69)39-22-30(66)26-64(39)46(73)38-11-5-19-63(38)44(71)33(50)8-2-16-55-48(51)52/h6-7,12-15,20,29-30,33-39,57,65-66H,2-5,8-11,16-19,21-27,50H2,1H3,(H,58,69)(H,59,70)(H,60,67)(H,61,68)(H,74,75)(H4,51,52,55)(H4,53,54,56)/t29-,30+,33-,34-,35-,36-,37-,38-,39-/m0/s1	Bradykinin B2 receptor agonist	AGONIST	CHEMBL3157	Bradykinin B2 receptor	Homo sapiens
CHEMBL3544949	CTCE-9908	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(C)C)C(N)=O	VUYRSKROGTWHDC-HZGLMRDYSA-N	InChI=1S/C86H147N27O23/c1-45(2)35-58(104-81(133)64(43-116)110-83(135)68(47(5)6)112-66(120)39-99-71(123)53(89)17-9-12-30-87)75(127)108-62(41-114)79(131)106-60(37-49-22-26-51(118)27-23-49)77(129)102-56(20-15-33-97-85(92)93)73(125)96-32-14-11-19-55(70(91)122)101-74(126)57(21-16-34-98-86(94)95)103-78(130)61(38-50-24-28-52(119)29-25-50)107-80(132)63(42-115)109-76(128)59(36-46(3)4)105-82(134)65(44-117)111-84(136)69(48(7)8)113-67(121)40-100-72(124)54(90)18-10-13-31-88/h22-29,45-48,53-65,68-69,114-119H,9-21,30-44,87-90H2,1-8H3,(H2,91,122)(H,96,125)(H,99,123)(H,100,124)(H,101,126)(H,102,129)(H,103,130)(H,104,133)(H,105,134)(H,106,131)(H,107,132)(H,108,127)(H,109,128)(H,110,135)(H,111,136)(H,112,120)(H,113,121)(H4,92,93,97)(H4,94,95,98)/t53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,68-,69-/m0/s1	C-X-C chemokine receptor type 4 antagonist	ANTAGONIST	CHEMBL2107	C-X-C chemokine receptor type 4	Homo sapiens
CHEMBL448343	LESOGABERAN	NC[C@@H](F)C[PH](=O)O	LJNUIEQATDYXJH-GSVOUGTGSA-N	InChI=1S/C3H9FNO2P/c4-3(1-5)2-8(6)7/h3,8H,1-2,5H2,(H,6,7)/t3-/m1/s1	GABA-B receptor 1 agonist	AGONIST	CHEMBL2064	GABA-B receptor 1	Homo sapiens
CHEMBL448343	LESOGABERAN	NC[C@@H](F)C[PH](=O)O	LJNUIEQATDYXJH-GSVOUGTGSA-N	InChI=1S/C3H9FNO2P/c4-3(1-5)2-8(6)7/h3,8H,1-2,5H2,(H,6,7)/t3-/m1/s1	GABA-B receptor 2 agonist	AGONIST	CHEMBL5034	GABA-B receptor 2	Homo sapiens
CHEMBL3622820	ITACITINIB	N#CCC1(n2cc(-c3ncnc4[nH]ccc34)cn2)CN(C2CCN(C(=O)c3ccnc(C(F)(F)F)c3F)CC2)C1	KTBSXLIQKWEBRB-UHFFFAOYSA-N	InChI=1S/C26H23F4N9O/c27-20-18(1-7-32-22(20)26(28,29)30)24(40)37-9-3-17(4-10-37)38-13-25(14-38,5-6-31)39-12-16(11-36-39)21-19-2-8-33-23(19)35-15-34-21/h1-2,7-8,11-12,15,17H,3-5,9-10,13-14H2,(H,33,34,35)	Tyrosine-protein kinase JAK1 inhibitor	INHIBITOR	CHEMBL2835	Tyrosine-protein kinase JAK1	Homo sapiens
CHEMBL3301622	GILTERITINIB	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1	GYQYAJJFPNQOOW-UHFFFAOYSA-N	InChI=1S/C29H44N8O3/c1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36/h5-6,19-20,22H,4,7-18H2,1-3H3,(H2,30,38)(H2,31,32,34)	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL3301622	GILTERITINIB	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1	GYQYAJJFPNQOOW-UHFFFAOYSA-N	InChI=1S/C29H44N8O3/c1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36/h5-6,19-20,22H,4,7-18H2,1-3H3,(H2,30,38)(H2,31,32,34)	Tyrosine-protein kinase receptor UFO inhibitor	INHIBITOR	CHEMBL4895	Tyrosine-protein kinase receptor UFO	Homo sapiens
CHEMBL207433	SB-705498	O=C(Nc1ccccc1Br)N[C@@H]1CCN(c2ccc(C(F)(F)F)cn2)C1	JYILLRHXRVTRSH-GFCCVEGCSA-N	InChI=1S/C17H16BrF3N4O/c18-13-3-1-2-4-14(13)24-16(26)23-12-7-8-25(10-12)15-6-5-11(9-22-15)17(19,20)21/h1-6,9,12H,7-8,10H2,(H2,23,24,26)/t12-/m1/s1	Vanilloid receptor antagonist	ANTAGONIST	CHEMBL4794	Vanilloid receptor	Homo sapiens
CHEMBL3545039	AZD1386	Cc1cc(Cl)cc2c1N(Cc1cccc(C(F)(F)F)c1)C(=O)C21NC(=O)NC1=O	DXDVSYALLVVBOV-UHFFFAOYSA-N	InChI=1S/C19H13ClF3N3O3/c1-9-5-12(20)7-13-14(9)26(16(28)18(13)15(27)24-17(29)25-18)8-10-3-2-4-11(6-10)19(21,22)23/h2-7H,8H2,1H3,(H2,24,25,27,29)	Vanilloid receptor antagonist	ANTAGONIST	CHEMBL4794	Vanilloid receptor	Homo sapiens
CHEMBL1783282	AZD7325	CCCNC(=O)c1nnc2c(-c3c(F)cccc3OC)cccc2c1N	KYDURMHFWXCKMW-UHFFFAOYSA-N	InChI=1S/C19H19FN4O2/c1-3-10-22-19(25)18-16(21)12-7-4-6-11(17(12)23-24-18)15-13(20)8-5-9-14(15)26-2/h4-9H,3,10H2,1-2H3,(H2,21,23)(H,22,25)	GABA receptor alpha-2 subunit positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL4956	GABA receptor alpha-2 subunit	Homo sapiens
CHEMBL1783282	AZD7325	CCCNC(=O)c1nnc2c(-c3c(F)cccc3OC)cccc2c1N	KYDURMHFWXCKMW-UHFFFAOYSA-N	InChI=1S/C19H19FN4O2/c1-3-10-22-19(25)18-16(21)12-7-4-6-11(17(12)23-24-18)15-13(20)8-5-9-14(15)26-2/h4-9H,3,10H2,1-2H3,(H2,21,23)(H,22,25)	GABA receptor alpha-3 subunit positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL3026	GABA receptor alpha-3 subunit	Homo sapiens
CHEMBL3545040	AZD7009	CC(C)(C)OC(=O)NCCN1CC2CN(C[C@H](O)COc3ccc(C#N)cc3)CC(C1)O2	JRHUUZPSMQIWBQ-PELRDEGISA-N	InChI=1S/C23H34N4O5/c1-23(2,3)32-22(29)25-8-9-26-12-20-14-27(15-21(13-26)31-20)11-18(28)16-30-19-6-4-17(10-24)5-7-19/h4-7,18,20-21,28H,8-9,11-16H2,1-3H3,(H,25,29)/t18-,20?,21?/m0/s1	HERG blocker	BLOCKER	CHEMBL240	HERG	Homo sapiens
CHEMBL3545040	AZD7009	CC(C)(C)OC(=O)NCCN1CC2CN(C[C@H](O)COc3ccc(C#N)cc3)CC(C1)O2	JRHUUZPSMQIWBQ-PELRDEGISA-N	InChI=1S/C23H34N4O5/c1-23(2,3)32-22(29)25-8-9-26-12-20-14-27(15-21(13-26)31-20)11-18(28)16-30-19-6-4-17(10-24)5-7-19/h4-7,18,20-21,28H,8-9,11-16H2,1-3H3,(H,25,29)/t18-,20?,21?/m0/s1	Sodium channel protein type V alpha subunit blocker	BLOCKER	CHEMBL1980	Sodium channel protein type V alpha subunit	Homo sapiens
CHEMBL3545169	AZD1305	CC(C)(C)OC(=O)NCCN1CC2CN(CCOc3ccc(C#N)cc3F)CC(C1)O2	BLLNYXOLLAVTRF-UHFFFAOYSA-N	InChI=1S/C22H31FN4O4/c1-22(2,3)31-21(28)25-6-7-26-12-17-14-27(15-18(13-26)30-17)8-9-29-20-5-4-16(11-24)10-19(20)23/h4-5,10,17-18H,6-9,12-15H2,1-3H3,(H,25,28)	HERG blocker	BLOCKER	CHEMBL240	HERG	Homo sapiens
CHEMBL3545169	AZD1305	CC(C)(C)OC(=O)NCCN1CC2CN(CCOc3ccc(C#N)cc3F)CC(C1)O2	BLLNYXOLLAVTRF-UHFFFAOYSA-N	InChI=1S/C22H31FN4O4/c1-22(2,3)31-21(28)25-6-7-26-12-17-14-27(15-18(13-26)30-17)8-9-29-20-5-4-16(11-24)10-19(20)23/h4-5,10,17-18H,6-9,12-15H2,1-3H3,(H,25,28)	Sodium channel protein type V alpha subunit blocker	BLOCKER	CHEMBL1980	Sodium channel protein type V alpha subunit	Homo sapiens
CHEMBL3545169	AZD1305	CC(C)(C)OC(=O)NCCN1CC2CN(CCOc3ccc(C#N)cc3F)CC(C1)O2	BLLNYXOLLAVTRF-UHFFFAOYSA-N	InChI=1S/C22H31FN4O4/c1-22(2,3)31-21(28)25-6-7-26-12-17-14-27(15-18(13-26)30-17)8-9-29-20-5-4-16(11-24)10-19(20)23/h4-5,10,17-18H,6-9,12-15H2,1-3H3,(H,25,28)	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL188462	ISPRONICLINE	CN[C@@H](C)C/C=C/c1cncc(OC(C)C)c1	RPCVIAXDAUMJJP-PZBABLGHSA-N	InChI=1S/C14H22N2O/c1-11(2)17-14-8-13(9-16-10-14)7-5-6-12(3)15-4/h5,7-12,15H,6H2,1-4H3/b7-5+/t12-/m0/s1	Neuronal acetylcholine receptor; alpha4/beta2 partial agonist	PARTIAL AGONIST	CHEMBL1907589	Neuronal acetylcholine receptor; alpha4/beta2	Homo sapiens
CHEMBL467084	LANICEMINE	N[C@@H](Cc1ccccn1)c1ccccc1	FWUQWDCOOWEXRY-ZDUSSCGKSA-N	InChI=1S/C13H14N2/c14-13(11-6-2-1-3-7-11)10-12-8-4-5-9-15-12/h1-9,13H,10,14H2/t13-/m0/s1	Glutamate [NMDA] receptor blocker	BLOCKER	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL2151437	AZD0328	c1cnc2c(c1)C[C@@]1(CN3CCC1CC3)O2	OCKIPDMKGPYYJS-ZDUSSCGKSA-N	InChI=1S/C13H16N2O/c1-2-10-8-13(16-12(10)14-5-1)9-15-6-3-11(13)4-7-15/h1-2,5,11H,3-4,6-9H2/t13-/m0/s1	Neuronal acetylcholine receptor protein alpha-7 subunit agonist	AGONIST	CHEMBL2492	Neuronal acetylcholine receptor protein alpha-7 subunit	Homo sapiens
CHEMBL1207366	GW468816	O=C(O)C1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1	XDKRVNKVAKCFGW-FOCLMDBBSA-N	InChI=1S/C20H17ClN2O3/c21-12-6-7-14-16(11-18(20(25)26)22-17(14)10-12)15-8-9-23(19(15)24)13-4-2-1-3-5-13/h1-7,10,18,22H,8-9,11H2,(H,25,26)/b16-15+	Glutamate [NMDA] receptor antagonist	ANTAGONIST	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL2068839	RISLENEMDAZ	Cc1ccc(COC(=O)N2CC[C@H](CNc3ncccn3)[C@H](F)C2)cc1	RECBFDWSXWAXHY-IAGOWNOFSA-N	InChI=1S/C19H23FN4O2/c1-14-3-5-15(6-4-14)13-26-19(25)24-10-7-16(17(20)12-24)11-23-18-21-8-2-9-22-18/h2-6,8-9,16-17H,7,10-13H2,1H3,(H,21,22,23)/t16-,17-/m1/s1	Glutamate NMDA receptor; GRIN1/GRIN2B antagonist	ANTAGONIST	CHEMBL1907603	Glutamate NMDA receptor; GRIN1/GRIN2B	Homo sapiens
CHEMBL3545349	EVT-101	Cc1nccn1Cc1cc(-c2ccc(F)c(C(F)F)c2)cnn1.Cl.Cl	OJBLXSPBJMGZDN-UHFFFAOYSA-N	InChI=1S/C16H13F3N4.2ClH/c1-10-20-4-5-23(10)9-13-6-12(8-21-22-13)11-2-3-15(17)14(7-11)16(18)19;;/h2-8,16H,9H2,1H3;2*1H	Glutamate NMDA receptor; GRIN1/GRIN2B antagonist	ANTAGONIST	CHEMBL1907603	Glutamate NMDA receptor; GRIN1/GRIN2B	Homo sapiens
CHEMBL3989872	APIMOSTINEL	C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@@]1(Cc1ccccc1)C(=O)N[C@H](C(N)=O)[C@@H](C)O	DVBUEXCIEIAXPM-PJUQSVSOSA-N	InChI=1S/C25H37N5O6/c1-15(31)19(26)23(35)29-12-6-10-18(29)22(34)30-13-7-11-25(30,14-17-8-4-3-5-9-17)24(36)28-20(16(2)32)21(27)33/h3-5,8-9,15-16,18-20,31-32H,6-7,10-14,26H2,1-2H3,(H2,27,33)(H,28,36)/t15-,16-,18+,19+,20+,25-/m1/s1	Glutamate [NMDA] receptor partial agonist	PARTIAL AGONIST	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL3544917	RAPASTINEL	C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)[C@@H](C)O	GIBQQARAXHVEGD-BSOLPCOYSA-N	InChI=1S/C18H31N5O6/c1-9(24)13(19)18(29)23-8-4-6-12(23)17(28)22-7-3-5-11(22)16(27)21-14(10(2)25)15(20)26/h9-14,24-25H,3-8,19H2,1-2H3,(H2,20,26)(H,21,27)/t9-,10-,11+,12+,13+,14+/m1/s1	Glutamate [NMDA] receptor partial agonist	PARTIAL AGONIST	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL1255840	NEBOGLAMINE	CC1(C)CCC(NC(=O)[C@@H](N)CCC(=O)O)CC1	VCRGLZYPNNAVRP-JTQLQIEISA-N	InChI=1S/C13H24N2O3/c1-13(2)7-5-9(6-8-13)15-12(18)10(14)3-4-11(16)17/h9-10H,3-8,14H2,1-2H3,(H,15,18)(H,16,17)/t10-/m0/s1	Glutamate [NMDA] receptor positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL3545351	AV-101	Nc1cc(Cl)ccc1C(=O)CC(N)C(=O)O	HQLHZNDJQSRKDT-UHFFFAOYSA-N	InChI=1S/C10H11ClN2O3/c11-5-1-2-6(7(12)3-5)9(14)4-8(13)10(15)16/h1-3,8H,4,12-13H2,(H,15,16)	Glutamate [NMDA] receptor antagonist	ANTAGONIST	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL3545108	AZD9056	O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(CCCNCCCO)ccc1Cl	HSQAARMBHJCUOK-UHFFFAOYSA-N	InChI=1S/C24H35ClN2O2/c25-22-5-4-17(3-1-6-26-7-2-8-28)12-21(22)23(29)27-16-24-13-18-9-19(14-24)11-20(10-18)15-24/h4-5,12,18-20,26,28H,1-3,6-11,13-16H2,(H,27,29)	P2X purinoceptor 7 antagonist	ANTAGONIST	CHEMBL4805	P2X purinoceptor 7	Homo sapiens
CHEMBL3716057	GEFAPIXANT	COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1S(N)(=O)=O	HLWURFKMDLAKOD-UHFFFAOYSA-N	InChI=1S/C14H19N5O4S/c1-7(2)8-4-10(22-3)12(24(17,20)21)5-9(8)23-11-6-18-14(16)19-13(11)15/h4-7H,1-3H3,(H2,17,20,21)(H4,15,16,18,19)	P2X purinoceptor 3 antagonist	ANTAGONIST	CHEMBL2998	P2X purinoceptor 3	Homo sapiens
CHEMBL1823817	CE-224535	COC[C@H](O)Cn1c(=O)cnn(-c2ccc(Cl)c(C(=O)NCC3(O)CCCCCC3)c2)c1=O	FUCKCIVGBCBZNP-MRXNPFEDSA-N	InChI=1S/C22H29ClN4O6/c1-33-13-16(28)12-26-19(29)11-25-27(21(26)31)15-6-7-18(23)17(10-15)20(30)24-14-22(32)8-4-2-3-5-9-22/h6-7,10-11,16,28,32H,2-5,8-9,12-14H2,1H3,(H,24,30)/t16-/m1/s1	P2X purinoceptor 7 antagonist	ANTAGONIST	CHEMBL4805	P2X purinoceptor 7	Homo sapiens
CHEMBL1258006	BRADANICLINE	O=C(N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1)c1cc2ccccc2o1	OXKRFEWMSWPKKV-GHTZIAJQSA-N	InChI=1S/C22H23N3O2/c26-22(20-13-17-5-1-2-6-19(17)27-20)24-21-16-7-10-25(11-8-16)18(21)12-15-4-3-9-23-14-15/h1-6,9,13-14,16,18,21H,7-8,10-12H2,(H,24,26)/t18-,21+/m0/s1	Neuronal acetylcholine receptor protein alpha-7 subunit agonist	AGONIST	CHEMBL2492	Neuronal acetylcholine receptor protein alpha-7 subunit	Homo sapiens
CHEMBL17350	TRAXOPRODIL	C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(c2ccccc2)CC1	QEMSVZNTSXPFJA-HNAYVOBHSA-N	InChI=1S/C20H25NO3/c1-15(19(23)16-7-9-18(22)10-8-16)21-13-11-20(24,12-14-21)17-5-3-2-4-6-17/h2-10,15,19,22-24H,11-14H2,1H3/t15-,19+/m0/s1	Glutamate NMDA receptor; GRIN1/GRIN2B antagonist	ANTAGONIST	CHEMBL1907603	Glutamate NMDA receptor; GRIN1/GRIN2B	Homo sapiens
CHEMBL3545231	ABT-126	c1ccc(-c2nnc(O[C@@H]3C4CC5C[C@H]3CN(C5)C4)s2)cc1	QZDCYUCETTWCMO-CDFKWJNJSA-N	InChI=1S/C17H19N3OS/c1-2-4-12(5-3-1)16-18-19-17(22-16)21-15-13-6-11-7-14(15)10-20(8-11)9-13/h1-5,11,13-15H,6-10H2/t11?,13-,14?,15-/m0/s1	Neuronal acetylcholine receptor protein alpha-7 subunit agonist	AGONIST	CHEMBL2492	Neuronal acetylcholine receptor protein alpha-7 subunit	Homo sapiens
CHEMBL3544913	VIXOTRIGINE	NC(=O)[C@@H]1CC[C@H](c2ccc(OCc3ccccc3F)cc2)N1	JESCETIFNOFKEU-SJORKVTESA-N	InChI=1S/C18H19FN2O2/c19-15-4-2-1-3-13(15)11-23-14-7-5-12(6-8-14)16-9-10-17(21-16)18(20)22/h1-8,16-17,21H,9-11H2,(H2,20,22)/t16-,17+/m1/s1	Sodium channel protein type IX alpha subunit blocker	BLOCKER	CHEMBL4296	Sodium channel protein type IX alpha subunit	Homo sapiens
CHEMBL3545232	AQW051	Cc1ccc(-c2ccc(OC3CN4CCC3CC4)cn2)cc1	NPDLTEZXGWRMLQ-UHFFFAOYSA-N	InChI=1S/C19H22N2O/c1-14-2-4-15(5-3-14)18-7-6-17(12-20-18)22-19-13-21-10-8-16(19)9-11-21/h2-7,12,16,19H,8-11,13H2,1H3	Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist	PARTIAL AGONIST	CHEMBL2492	Neuronal acetylcholine receptor protein alpha-7 subunit	Homo sapiens
CHEMBL3545291	JNJ-39393406	CN(C)C(=O)CCn1nc(Nc2ccc3c(c2)OC(F)(F)O3)nc1-c1ccncc1	IURMHZBQEYNQOH-UHFFFAOYSA-N	InChI=1S/C19H18F2N6O3/c1-26(2)16(28)7-10-27-17(12-5-8-22-9-6-12)24-18(25-27)23-13-3-4-14-15(11-13)30-19(20,21)29-14/h3-6,8-9,11H,7,10H2,1-2H3,(H,23,25)	Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2492	Neuronal acetylcholine receptor protein alpha-7 subunit	Homo sapiens
CHEMBL559478	SSR180711	O=C(Oc1ccc(Br)cc1)N1CCN2CCC1CC2	RXLOZRCLQMJJLC-UHFFFAOYSA-N	InChI=1S/C14H17BrN2O2/c15-11-1-3-13(4-2-11)19-14(18)17-10-9-16-7-5-12(17)6-8-16/h1-4,12H,5-10H2	Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist	PARTIAL AGONIST	CHEMBL2492	Neuronal acetylcholine receptor protein alpha-7 subunit	Homo sapiens
CHEMBL127071	POZANICLINE	Cc1ncccc1OC[C@@H]1CCCN1	YRVIKLBSVVNSHF-JTQLQIEISA-N	InChI=1S/C11H16N2O/c1-9-11(5-3-6-12-9)14-8-10-4-2-7-13-10/h3,5-6,10,13H,2,4,7-8H2,1H3/t10-/m0/s1	Nicotinic acetylcholine receptor alpha4/beta2/alpha5 partial agonist	PARTIAL AGONIST	CHEMBL3038461	Nicotinic acetylcholine receptor alpha4/beta2/alpha5	Homo sapiens
CHEMBL127071	POZANICLINE	Cc1ncccc1OC[C@@H]1CCCN1	YRVIKLBSVVNSHF-JTQLQIEISA-N	InChI=1S/C11H16N2O/c1-9-11(5-3-6-12-9)14-8-10-4-2-7-13-10/h3,5-6,10,13H,2,4,7-8H2,1H3/t10-/m0/s1	Neuronal acetylcholine receptor; alpha6/beta2 partial agonist	PARTIAL AGONIST	CHEMBL2109237	Neuronal acetylcholine receptor; alpha6/beta2	Homo sapiens
CHEMBL2104964	TEBANICLINE TOSYLATE	Cc1ccc(S(=O)(=O)O)cc1.Clc1ccc(OC[C@H]2CCN2)cn1	JCPWIGCGJUGLJQ-OGFXRTJISA-N	InChI=1S/C9H11ClN2O.C7H8O3S/c10-9-2-1-8(5-12-9)13-6-7-3-4-11-7;1-6-2-4-7(5-3-6)11(8,9)10/h1-2,5,7,11H,3-4,6H2;2-5H,1H3,(H,8,9,10)/t7-;/m1./s1	Neuronal acetylcholine receptor; alpha4/beta2 agonist	AGONIST	CHEMBL1907589	Neuronal acetylcholine receptor; alpha4/beta2	Homo sapiens
CHEMBL238465	SOFINICLINE	Clc1cc(N2C[C@@H]3CN[C@@H]3C2)cnc1Cl	MBQYQLWSBRANKQ-IMTBSYHQSA-N	InChI=1S/C10H11Cl2N3/c11-8-1-7(3-14-10(8)12)15-4-6-2-13-9(6)5-15/h1,3,6,9,13H,2,4-5H2/t6-,9+/m0/s1	Neuronal acetylcholine receptor; alpha4/beta2 agonist	AGONIST	CHEMBL1907589	Neuronal acetylcholine receptor; alpha4/beta2	Homo sapiens
CHEMBL2179529	AZD1446	O=C(c1ccc(Cl)o1)N1CC2CNCC2C1	GTUIQNHJSXQMKW-UHFFFAOYSA-N	InChI=1S/C11H13ClN2O2/c12-10-2-1-9(16-10)11(15)14-5-7-3-13-4-8(7)6-14/h1-2,7-8,13H,3-6H2	Neuronal acetylcholine receptor; alpha4/beta2 agonist	AGONIST	CHEMBL1907589	Neuronal acetylcholine receptor; alpha4/beta2	Homo sapiens
CHEMBL3545042	SELURAMPANEL	CC(C)c1cc2[nH]c(=O)n(NS(C)(=O)=O)c(=O)c2cc1-c1ccnn1C	MCECSFFXUPEPDB-UHFFFAOYSA-N	InChI=1S/C16H19N5O4S/c1-9(2)10-8-13-12(7-11(10)14-5-6-17-20(14)3)15(22)21(16(23)18-13)19-26(4,24)25/h5-9,19H,1-4H3,(H,18,23)	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	CHEMBL2096670	Glutamate receptor ionotropic AMPA	Homo sapiens
CHEMBL3545042	SELURAMPANEL	CC(C)c1cc2[nH]c(=O)n(NS(C)(=O)=O)c(=O)c2cc1-c1ccnn1C	MCECSFFXUPEPDB-UHFFFAOYSA-N	InChI=1S/C16H19N5O4S/c1-9(2)10-8-13-12(7-11(10)14-5-6-17-20(14)3)15(22)21(16(23)18-13)19-26(4,24)25/h5-9,19H,1-4H3,(H,18,23)	Glutamate receptor ionotropic kainate antagonist	ANTAGONIST	CHEMBL2109241	Glutamate receptor ionotropic kainate	Homo sapiens
CHEMBL119549	ANDOLAST	O=C(Nc1ccc(-c2nn[nH]n2)cc1)c1ccc(-c2nn[nH]n2)cc1	VXEBMQZDPONDFB-UHFFFAOYSA-N	InChI=1S/C15H11N9O/c25-15(11-3-1-9(2-4-11)13-17-21-22-18-13)16-12-7-5-10(6-8-12)14-19-23-24-20-14/h1-8H,(H,16,25)(H,17,18,21,22)(H,19,20,23,24)	Calcium-activated potassium channel subunit alpha-1 activator	ACTIVATOR	CHEMBL4304	Calcium-activated potassium channel subunit alpha-1	Homo sapiens
CHEMBL182066	RADIPRODIL	O=C(Nc1ccc2[nH]c(=O)oc2c1)C(=O)N1CCC(Cc2ccc(F)cc2)CC1	GKGRZLGAQZPEHO-UHFFFAOYSA-N	InChI=1S/C21H20FN3O4/c22-15-3-1-13(2-4-15)11-14-7-9-25(10-8-14)20(27)19(26)23-16-5-6-17-18(12-16)29-21(28)24-17/h1-6,12,14H,7-11H2,(H,23,26)(H,24,28)	Glutamate NMDA receptor; GRIN1/GRIN2B antagonist	ANTAGONIST	CHEMBL1907603	Glutamate NMDA receptor; GRIN1/GRIN2B	Homo sapiens
CHEMBL3544914	TEZACAFTOR	CC(C)(CO)c1cc2cc(NC(=O)C3(c4ccc5c(c4)OC(F)(F)O5)CC3)c(F)cc2n1C[C@@H](O)CO	MJUVRTYWUMPBTR-MRXNPFEDSA-N	InChI=1S/C26H27F3N2O6/c1-24(2,13-33)22-8-14-7-18(17(27)10-19(14)31(22)11-16(34)12-32)30-23(35)25(5-6-25)15-3-4-20-21(9-15)37-26(28,29)36-20/h3-4,7-10,16,32-34H,5-6,11-13H2,1-2H3,(H,30,35)/t16-/m1/s1	Cystic fibrosis transmembrane conductance regulator positive modulator	POSITIVE MODULATOR	CHEMBL4051	Cystic fibrosis transmembrane conductance regulator	Homo sapiens
CHEMBL222460	BMS-223131	O=c1[nH]c2ccc(C(F)(F)F)cc2c(-c2cc(Cl)ccc2O)c1CCO	QESHSZWKJULSAR-UHFFFAOYSA-N	InChI=1S/C18H13ClF3NO3/c19-10-2-4-15(25)13(8-10)16-11(5-6-24)17(26)23-14-3-1-9(7-12(14)16)18(20,21)22/h1-4,7-8,24-25H,5-6H2,(H,23,26)	Calcium-activated potassium channel subunit alpha-1 activator	ACTIVATOR	CHEMBL4304	Calcium-activated potassium channel subunit alpha-1	Homo sapiens
CHEMBL3989703	TEZAMPANEL	O.O=C(O)[C@@H]1C[C@H]2C[C@@H](CCc3nn[nH]n3)CC[C@H]2CN1	LNDYQNTTYXLTNH-RTBBDAMFSA-N	InChI=1S/C13H21N5O2.H2O/c19-13(20)11-6-10-5-8(1-3-9(10)7-14-11)2-4-12-15-17-18-16-12;/h8-11,14H,1-7H2,(H,19,20)(H,15,16,17,18);1H2/t8-,9+,10-,11+;/m1./s1	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	CHEMBL2096670	Glutamate receptor ionotropic AMPA	Homo sapiens
CHEMBL3989703	TEZAMPANEL	O.O=C(O)[C@@H]1C[C@H]2C[C@@H](CCc3nn[nH]n3)CC[C@H]2CN1	LNDYQNTTYXLTNH-RTBBDAMFSA-N	InChI=1S/C13H21N5O2.H2O/c19-13(20)11-6-10-5-8(1-3-9(10)7-14-11)2-4-12-15-17-18-16-12;/h8-11,14H,1-7H2,(H,19,20)(H,15,16,17,18);1H2/t8-,9+,10-,11+;/m1./s1	Glutamate receptor ionotropic kainate antagonist	ANTAGONIST	CHEMBL2109241	Glutamate receptor ionotropic kainate	Homo sapiens
CHEMBL604710	Z160	O=C(CC(c1ccccc1)c1ccccc1)N1CCN(C(c2ccccc2)c2ccccc2)CC1	VCPMZDWBEWTGNW-UHFFFAOYSA-N	InChI=1S/C32H32N2O/c35-31(25-30(26-13-5-1-6-14-26)27-15-7-2-8-16-27)33-21-23-34(24-22-33)32(28-17-9-3-10-18-28)29-19-11-4-12-20-29/h1-20,30,32H,21-25H2	Voltage-gated N-type calcium channel alpha-1B subunit blocker	BLOCKER	CHEMBL4478	Voltage-gated N-type calcium channel alpha-1B subunit	Homo sapiens
CHEMBL426559	LAROPIPRANT	CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3	NXFFJDQHYLNEJK-CYBMUJFWSA-N	InChI=1S/C21H19ClFNO4S/c1-29(27,28)18-10-15(23)9-17-16-7-4-13(8-19(25)26)20(16)24(21(17)18)11-12-2-5-14(22)6-3-12/h2-3,5-6,9-10,13H,4,7-8,11H2,1H3,(H,25,26)/t13-/m1/s1	Prostanoid DP receptor antagonist	ANTAGONIST	CHEMBL4427	Prostanoid DP receptor	Homo sapiens
CHEMBL1951575	VIDUPIPRANT	CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3CC3)cc2Cl)c1	PFWVGKROPKKEDW-UHFFFAOYSA-N	InChI=1S/C28H27Cl2FN2O6S/c1-28(2,3)32-27(36)17-6-8-23(39-24-14-21(31)18(11-19(24)29)13-26(34)35)22(12-17)33-40(37,38)25-9-7-16(10-20(25)30)15-4-5-15/h6-12,14-15,33H,4-5,13H2,1-3H3,(H,32,36)(H,34,35)	Prostanoid DP receptor antagonist	ANTAGONIST	CHEMBL4427	Prostanoid DP receptor	Homo sapiens
CHEMBL1951575	VIDUPIPRANT	CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3CC3)cc2Cl)c1	PFWVGKROPKKEDW-UHFFFAOYSA-N	InChI=1S/C28H27Cl2FN2O6S/c1-28(2,3)32-27(36)17-6-8-23(39-24-14-21(31)18(11-19(24)29)13-26(34)35)22(12-17)33-40(37,38)25-9-7-16(10-20(25)30)15-4-5-15/h6-12,14-15,33H,4-5,13H2,1-3H3,(H,32,36)(H,34,35)	G protein-coupled receptor 44 antagonist	ANTAGONIST	CHEMBL5071	G protein-coupled receptor 44	Homo sapiens
CHEMBL1688243	INCB-9471	CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C	ZMCJFJZOSKEMOM-DNKZPPIMSA-N	InChI=1S/C30H40F3N5O2/c1-6-40-25-16-22-15-23(30(31,32)33)7-8-24(22)27(25)38-14-13-37(17-19(38)2)29(5)9-11-36(12-10-29)28(39)26-20(3)34-18-35-21(26)4/h7-8,15,18-19,25,27H,6,9-14,16-17H2,1-5H3/t19-,25+,27+/m0/s1	C-C chemokine receptor type 5 antagonist	ANTAGONIST	CHEMBL274	C-C chemokine receptor type 5	Homo sapiens
CHEMBL3545233	PAVINETANT	CC[C@H](NC(=O)c1c(NS(C)(=O)=O)c(-c2ccccc2)nc2ccccc12)c1ccccc1	QYTBBBAHNIWFOD-NRFANRHFSA-N	InChI=1S/C26H25N3O3S/c1-3-21(18-12-6-4-7-13-18)28-26(30)23-20-16-10-11-17-22(20)27-24(19-14-8-5-9-15-19)25(23)29-33(2,31)32/h4-17,21,29H,3H2,1-2H3,(H,28,30)/t21-/m0/s1	Neurokinin 3 receptor antagonist	ANTAGONIST	CHEMBL4429	Neurokinin 3 receptor	Homo sapiens
CHEMBL3137316	FOSDAGROCORAT	Cc1ncccc1NC(=O)c1ccc2c(c1)CC[C@@H]1C[C@@](OP(=O)(O)O)(C(F)(F)F)CC[C@@]21Cc1ccccc1	BVXLAHSJXXSWFF-KEKPKEOLSA-N	InChI=1S/C29H30F3N2O5P/c1-19-25(8-5-15-33-19)34-26(35)22-10-12-24-21(16-22)9-11-23-18-28(29(30,31)32,39-40(36,37)38)14-13-27(23,24)17-20-6-3-2-4-7-20/h2-8,10,12,15-16,23H,9,11,13-14,17-18H2,1H3,(H,34,35)(H2,36,37,38)/t23-,27+,28-/m1/s1	Glucocorticoid receptor modulator	MODULATOR	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL3787344	NAZARTINIB	Cc1cc(C(=O)Nc2nc3cccc(Cl)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1	IOMMMLWIABWRKL-WUTDNEBXSA-N	InChI=1S/C26H31ClN6O2/c1-18-16-19(12-13-28-18)25(35)30-26-29-22-10-6-9-21(27)24(22)33(26)20-8-4-5-15-32(17-20)23(34)11-7-14-31(2)3/h6-7,9-13,16,20H,4-5,8,14-15,17H2,1-3H3,(H,29,30,35)/b11-7+/t20-/m1/s1	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL3809489	BEMCENTINIB	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2	KXMZDGSRSGHMMK-VWLOTQADSA-N	InChI=1S/C30H34N8/c31-29-33-30(32-24-13-10-20-11-14-25(15-12-22(20)18-24)37-16-3-4-17-37)36-38(29)27-19-23-8-5-7-21-6-1-2-9-26(21)28(23)35-34-27/h1-2,6,9-10,13,18-19,25H,3-5,7-8,11-12,14-17H2,(H3,31,32,33,36)/t25-/m0/s1	Tyrosine-protein kinase receptor UFO inhibitor	INHIBITOR	CHEMBL4895	Tyrosine-protein kinase receptor UFO	Homo sapiens
CHEMBL41306	CNS-5161	CSc1cccc(N(C)C(=N)Nc2cc(SC)ccc2Cl)c1	JHVHEDNLONERHY-UHFFFAOYSA-N	InChI=1S/C16H18ClN3S2/c1-20(11-5-4-6-12(9-11)21-2)16(18)19-15-10-13(22-3)7-8-14(15)17/h4-10H,1-3H3,(H2,18,19)	Glutamate [NMDA] receptor blocker	BLOCKER	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL2103869	DASOLAMPANEL	O=C(O)[C@@H]1C[C@H]2C[C@@H](Oc3cccc(Cl)c3-c3nnn[nH]3)CC[C@H]2CN1	LAKQPSQCICNZII-NOHGZBONSA-N	InChI=1S/C17H20ClN5O3/c18-12-2-1-3-14(15(12)16-20-22-23-21-16)26-11-5-4-9-8-19-13(17(24)25)7-10(9)6-11/h1-3,9-11,13,19H,4-8H2,(H,24,25)(H,20,21,22,23)/t9-,10+,11-,13-/m0/s1	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	CHEMBL2096670	Glutamate receptor ionotropic AMPA	Homo sapiens
CHEMBL2103869	DASOLAMPANEL	O=C(O)[C@@H]1C[C@H]2C[C@@H](Oc3cccc(Cl)c3-c3nnn[nH]3)CC[C@H]2CN1	LAKQPSQCICNZII-NOHGZBONSA-N	InChI=1S/C17H20ClN5O3/c18-12-2-1-3-14(15(12)16-20-22-23-21-16)26-11-5-4-9-8-19-13(17(24)25)7-10(9)6-11/h1-3,9-11,13,19H,4-8H2,(H,24,25)(H,20,21,22,23)/t9-,10+,11-,13-/m0/s1	Glutamate receptor ionotropic kainate 1 antagonist	ANTAGONIST	CHEMBL1918	Glutamate receptor ionotropic kainate 1	Homo sapiens
CHEMBL2107762	NERISPIRDINE	CCCN(c1ccncc1F)n1cc(C)c2ccccc21	BTDHTARYCBHHPJ-UHFFFAOYSA-N	InChI=1S/C17H18FN3/c1-3-10-20(17-8-9-19-11-15(17)18)21-12-13(2)14-6-4-5-7-16(14)21/h4-9,11-12H,3,10H2,1-2H3	Voltage-gated potassium channel blocker	BLOCKER	CHEMBL2362996	Voltage-gated potassium channel	Homo sapiens
CHEMBL2107762	NERISPIRDINE	CCCN(c1ccncc1F)n1cc(C)c2ccccc21	BTDHTARYCBHHPJ-UHFFFAOYSA-N	InChI=1S/C17H18FN3/c1-3-10-20(17-8-9-19-11-15(17)18)21-12-13(2)14-6-4-5-7-16(14)21/h4-9,11-12H,3,10H2,1-2H3	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL3989682	BECAMPANEL	CN(CP(=O)(O)O)c1cc([N+](=O)[O-])cc2[nH]c(=O)c(=O)[nH]c12	DDOAQMGXVXFNSH-UHFFFAOYSA-N	InChI=1S/C10H11N4O7P/c1-13(4-22(19,20)21)7-3-5(14(17)18)2-6-8(7)12-10(16)9(15)11-6/h2-3H,4H2,1H3,(H,11,15)(H,12,16)(H2,19,20,21)	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	CHEMBL2096670	Glutamate receptor ionotropic AMPA	Homo sapiens
CHEMBL1276138	FARAMPATOR	O=C(c1ccc2nonc2c1)N1CCCCC1	XFVRBYKKGGDPAJ-UHFFFAOYSA-N	InChI=1S/C12H13N3O2/c16-12(15-6-2-1-3-7-15)9-4-5-10-11(8-9)14-17-13-10/h4-5,8H,1-3,6-7H2	Glutamate receptor ionotropic AMPA positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2096670	Glutamate receptor ionotropic AMPA	Homo sapiens
CHEMBL1277001	MIBAMPATOR	CC(C)S(=O)(=O)NC[C@H](C)c1ccc(-c2ccc(CCNS(C)(=O)=O)cc2)cc1	ULRDYYKSPCRXAJ-KRWDZBQOSA-N	InChI=1S/C21H30N2O4S2/c1-16(2)29(26,27)23-15-17(3)19-9-11-21(12-10-19)20-7-5-18(6-8-20)13-14-22-28(4,24)25/h5-12,16-17,22-23H,13-15H2,1-4H3/t17-/m0/s1	Glutamate receptor ionotropic AMPA positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2096670	Glutamate receptor ionotropic AMPA	Homo sapiens
CHEMBL2105160	NAMINIDIL	C[C@@H](N/C(=N\C#N)Nc1ccc(C#N)cc1)C(C)(C)C	PGYDRGZVXVVZQC-LLVKDONJSA-N	InChI=1S/C15H19N5/c1-11(15(2,3)4)19-14(18-10-17)20-13-7-5-12(9-16)6-8-13/h5-8,11H,1-4H3,(H2,18,19,20)/t11-/m1/s1	Sulfonylurea receptors; K-ATP channels opener	OPENER	CHEMBL2095152	Sulfonylurea receptors; K-ATP channels	Homo sapiens
CHEMBL593430	ATAGABALIN	C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C	IUVMAUQEZFTTFB-YUMQZZPRSA-N	InChI=1S/C10H19NO2/c1-7-3-10(6-11,4-8(7)2)5-9(12)13/h7-8H,3-6,11H2,1-2H3,(H,12,13)/t7-,8-/m0/s1	Voltage-gated calcium channel modulator	MODULATOR	CHEMBL2363032	Voltage-gated calcium channel	Homo sapiens
CHEMBL111659	ALTINICLINE	C#Cc1cncc([C@@H]2CCCN2C)c1	NUPUDYKEEJNZRG-LBPRGKRZSA-N	InChI=1S/C12H14N2/c1-3-10-7-11(9-13-8-10)12-5-4-6-14(12)2/h1,7-9,12H,4-6H2,2H3/t12-/m0/s1	Neuronal acetylcholine receptor; alpha4/beta2 agonist	AGONIST	CHEMBL1907589	Neuronal acetylcholine receptor; alpha4/beta2	Homo sapiens
CHEMBL2103791	ADIPIPLON	CCCc1c(Cn2ccnc2-c2ncccc2F)ncn2nc(C)nc12	UAMAIHOEGLEXSV-UHFFFAOYSA-N	InChI=1S/C18H18FN7/c1-3-5-13-15(22-11-26-17(13)23-12(2)24-26)10-25-9-8-21-18(25)16-14(19)6-4-7-20-16/h4,6-9,11H,3,5,10H2,1-2H3	GABA-A receptor; anion channel partial agonist	PARTIAL AGONIST	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL2107801	RESEQUINIL	COc1cccc(-c2nccc3[nH]c(=O)c(-c4noc(C)n4)cc23)c1	JQOFKKWHXGQABB-UHFFFAOYSA-N	InChI=1S/C18H14N4O3/c1-10-20-17(22-25-10)14-9-13-15(21-18(14)23)6-7-19-16(13)11-4-3-5-12(8-11)24-2/h3-9H,1-2H3,(H,21,23)	GABA-A receptor; anion channel inverse agonist	INVERSE AGONIST	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL356388	ETAZOLATE	CCOC(=O)c1cnc2c(cnn2CC)c1NN=C(C)C	OPQRBXUBWHDHPQ-UHFFFAOYSA-N	InChI=1S/C14H19N5O2/c1-5-19-13-10(8-16-19)12(18-17-9(3)4)11(7-15-13)14(20)21-6-2/h7-8H,5-6H2,1-4H3,(H,15,18)	GABA receptor beta-3 subunit positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL1847	GABA receptor beta-3 subunit	Homo sapiens
CHEMBL487	DROLOXIFENE	CC/C(=C(/c1ccc(OCCN(C)C)cc1)c1cccc(O)c1)c1ccccc1	ZQZFYGIXNQKOAV-OCEACIFDSA-N	InChI=1S/C26H29NO2/c1-4-25(20-9-6-5-7-10-20)26(22-11-8-12-23(28)19-22)21-13-15-24(16-14-21)29-18-17-27(2)3/h5-16,19,28H,4,17-18H2,1-3H3/b26-25+	Estrogen receptor modulator	MODULATOR	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL68055	ACOLBIFENE	CC1=C(c2ccc(O)cc2)[C@H](c2ccc(OCCN3CCCCC3)cc2)Oc2cc(O)ccc21	DUYNJNWVGIWJRI-LJAQVGFWSA-N	InChI=1S/C29H31NO4/c1-20-26-14-11-24(32)19-27(26)34-29(28(20)21-5-9-23(31)10-6-21)22-7-12-25(13-8-22)33-18-17-30-15-3-2-4-16-30/h5-14,19,29,31-32H,2-4,15-18H2,1H3/t29-/m0/s1	Estrogen receptor modulator	MODULATOR	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL4297185	DAROLUTAMIDE	CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1	BLIJXOOIHRSQRB-PXYINDEMSA-N	InChI=1S/C19H19ClN6O2/c1-11(22-19(28)18-8-17(12(2)27)23-24-18)10-26-6-5-16(25-26)13-3-4-14(9-21)15(20)7-13/h3-8,11-12,27H,10H2,1-2H3,(H,22,28)(H,23,24)/t11-,12?/m0/s1	Androgen Receptor antagonist	ANTAGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL1738889	ENOBOSARM	C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	JNGVJMBLXIUVRD-SFHVURJKSA-N	InChI=1S/C19H14F3N3O3/c1-18(27,11-28-15-6-2-12(9-23)3-7-15)17(26)25-14-5-4-13(10-24)16(8-14)19(20,21)22/h2-8,27H,11H2,1H3,(H,25,26)/t18-/m0/s1	Androgen Receptor modulator	MODULATOR	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL3183409	APALUTAMIDE	CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F	HJBWBFZLDZWPHF-UHFFFAOYSA-N	InChI=1S/C21H15F4N5O2S/c1-27-17(31)13-4-3-11(8-15(13)22)30-19(33)29(18(32)20(30)5-2-6-20)12-7-14(21(23,24)25)16(9-26)28-10-12/h3-4,7-8,10H,2,5-6H2,1H3,(H,27,31)	Androgen Receptor antagonist	ANTAGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL566315	OBETICHOLIC ACID	CC[C@@H]1[C@@H]2C[C@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]3[C@H](C)CCC(=O)O)[C@@H]2[C@@H]1O	ZXERDUOLZKYMJM-ZWECCWDJSA-N	InChI=1S/C26H44O4/c1-5-17-21-14-16(27)10-12-26(21,4)20-11-13-25(3)18(15(2)6-9-22(28)29)7-8-19(25)23(20)24(17)30/h15-21,23-24,27,30H,5-14H2,1-4H3,(H,28,29)/t15-,16-,17-,18-,19+,20+,21+,23+,24-,25-,26-/m1/s1	Bile acid receptor FXR agonist	AGONIST	CHEMBL2047	Bile acid receptor FXR	Homo sapiens
CHEMBL2103876	MAPRACORAT	Cc1ccc2c(NC[C@](O)(CC(C)(C)c3cc(F)cc4c3OCC4)C(F)(F)F)cccc2n1	VJGFOYBQOIPQFY-XMMPIXPASA-N	InChI=1S/C25H26F4N2O2/c1-15-7-8-18-20(5-4-6-21(18)31-15)30-14-24(32,25(27,28)29)13-23(2,3)19-12-17(26)11-16-9-10-33-22(16)19/h4-8,11-12,30,32H,9-10,13-14H2,1-3H3/t24-/m1/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL267431	ASOPRISNIL	COC[C@]1(OC)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(/C=N/O)cc3)C[C@@]21C	GJMNAFGEUJBOCE-MEQIQULJSA-N	InChI=1S/C28H35NO4/c1-27-15-24(19-6-4-18(5-7-19)16-29-31)26-22-11-9-21(30)14-20(22)8-10-23(26)25(27)12-13-28(27,33-3)17-32-2/h4-7,14,16,23-25,31H,8-13,15,17H2,1-3H3/b29-16+/t23-,24+,25-,27-,28+/m0/s1	Progesterone receptor modulator	MODULATOR	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL592054	IMIGLITAZAR	Cc1oc(-c2ccccc2)nc1COc1ccc(CO/N=C(\CCC(=O)O)c2ccccc2)cc1	ULVDFHLHKNJICZ-QCWLDUFUSA-N	InChI=1S/C28H26N2O5/c1-20-26(29-28(35-20)23-10-6-3-7-11-23)19-33-24-14-12-21(13-15-24)18-34-30-25(16-17-27(31)32)22-8-4-2-5-9-22/h2-15H,16-19H2,1H3,(H,31,32)/b30-25+	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	CHEMBL239	Peroxisome proliferator-activated receptor alpha	Homo sapiens
CHEMBL592054	IMIGLITAZAR	Cc1oc(-c2ccccc2)nc1COc1ccc(CO/N=C(\CCC(=O)O)c2ccccc2)cc1	ULVDFHLHKNJICZ-QCWLDUFUSA-N	InChI=1S/C28H26N2O5/c1-20-26(29-28(35-20)23-10-6-3-7-11-23)19-33-24-14-12-21(13-15-24)18-34-30-25(16-17-27(31)32)22-8-4-2-5-9-22/h2-15H,16-19H2,1H3,(H,31,32)/b30-25+	Peroxisome proliferator-activated receptor gamma agonist	AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL519504	ALEGLITAZAR	CO[C@@H](Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)c2ccsc12)C(=O)O	DAYKLWSKQJBGCS-NRFANRHFSA-N	InChI=1S/C24H23NO5S/c1-15-19(25-23(30-15)16-6-4-3-5-7-16)10-12-29-20-9-8-17(14-21(28-2)24(26)27)22-18(20)11-13-31-22/h3-9,11,13,21H,10,12,14H2,1-2H3,(H,26,27)/t21-/m0/s1	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	CHEMBL239	Peroxisome proliferator-activated receptor alpha	Homo sapiens
CHEMBL519504	ALEGLITAZAR	CO[C@@H](Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)c2ccsc12)C(=O)O	DAYKLWSKQJBGCS-NRFANRHFSA-N	InChI=1S/C24H23NO5S/c1-15-19(25-23(30-15)16-6-4-3-5-7-16)10-12-29-20-9-8-17(14-21(28-2)24(26)27)22-18(20)11-13-31-22/h3-9,11,13,21H,10,12,14H2,1-2H3,(H,26,27)/t21-/m0/s1	Peroxisome proliferator-activated receptor gamma agonist	AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL186179	MURAGLITAZAR	COc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCCc3nc(-c4ccccc4)oc3C)cc2)cc1	IRLWJILLXJGJTD-UHFFFAOYSA-N	InChI=1S/C29H28N2O7/c1-20-26(30-28(37-20)22-6-4-3-5-7-22)16-17-36-24-10-8-21(9-11-24)18-31(19-27(32)33)29(34)38-25-14-12-23(35-2)13-15-25/h3-15H,16-19H2,1-2H3,(H,32,33)	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	CHEMBL239	Peroxisome proliferator-activated receptor alpha	Homo sapiens
CHEMBL186179	MURAGLITAZAR	COc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCCc3nc(-c4ccccc4)oc3C)cc2)cc1	IRLWJILLXJGJTD-UHFFFAOYSA-N	InChI=1S/C29H28N2O7/c1-20-26(30-28(37-20)22-6-4-3-5-7-22)16-17-36-24-10-8-21(9-11-24)18-31(19-27(32)33)29(34)38-25-14-12-23(35-2)13-15-25/h3-15H,16-19H2,1-2H3,(H,32,33)	Peroxisome proliferator-activated receptor gamma agonist	AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL282686	TESAGLITAZAR	CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)O	CXGTZJYQWSUFET-IBGZPJMESA-N	InChI=1S/C20H24O7S/c1-3-25-19(20(21)22)14-16-6-8-17(9-7-16)26-13-12-15-4-10-18(11-5-15)27-28(2,23)24/h4-11,19H,3,12-14H2,1-2H3,(H,21,22)/t19-/m0/s1	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	CHEMBL239	Peroxisome proliferator-activated receptor alpha	Homo sapiens
CHEMBL282686	TESAGLITAZAR	CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)O	CXGTZJYQWSUFET-IBGZPJMESA-N	InChI=1S/C20H24O7S/c1-3-25-19(20(21)22)14-16-6-8-17(9-7-16)26-13-12-15-4-10-18(11-5-15)27-28(2,23)24/h4-11,19H,3,12-14H2,1-2H3,(H,21,22)/t19-/m0/s1	Peroxisome proliferator-activated receptor gamma agonist	AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL2103991	BALAGLITAZONE	Cn1c(COc2ccc(CC3SC(=O)NC3=O)cc2)nc2ccccc2c1=O	IETKPTYAGKZLKY-UHFFFAOYSA-N	InChI=1S/C20H17N3O4S/c1-23-17(21-15-5-3-2-4-14(15)19(23)25)11-27-13-8-6-12(7-9-13)10-16-18(24)22-20(26)28-16/h2-9,16H,10-11H2,1H3,(H,22,24,26)	Peroxisome proliferator-activated receptor gamma partial agonist	PARTIAL AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL2104753	RIVOGLITAZONE	COc1ccc2nc(COc3ccc(CC4SC(=O)NC4=O)cc3)n(C)c2c1	XMSXOLDPMGMWTH-UHFFFAOYSA-N	InChI=1S/C20H19N3O4S/c1-23-16-10-14(26-2)7-8-15(16)21-18(23)11-27-13-5-3-12(4-6-13)9-17-19(24)22-20(25)28-17/h3-8,10,17H,9,11H2,1-2H3,(H,22,24,25)	Peroxisome proliferator-activated receptor gamma agonist	AGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL1762621	BARDOXOLONE METHYL	COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@](C)(CC[C@H]4C(C)(C)C(=O)C(C#N)=C[C@]34C)[C@]1(C)CC2	WPTTVJLTNAWYAO-KPOXMGGZSA-N	InChI=1S/C32H43NO4/c1-27(2)11-13-32(26(36)37-8)14-12-31(7)24(20(32)17-27)21(34)15-23-29(5)16-19(18-33)25(35)28(3,4)22(29)9-10-30(23,31)6/h15-16,20,22,24H,9-14,17H2,1-8H3/t20-,22-,24-,29-,30+,31+,32-/m0/s1	Peroxisome proliferator-activated receptor gamma antagonist	ANTAGONIST	CHEMBL235	Peroxisome proliferator-activated receptor gamma	Homo sapiens
CHEMBL1762621	BARDOXOLONE METHYL	COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@](C)(CC[C@H]4C(C)(C)C(=O)C(C#N)=C[C@]34C)[C@]1(C)CC2	WPTTVJLTNAWYAO-KPOXMGGZSA-N	InChI=1S/C32H43NO4/c1-27(2)11-13-32(26(36)37-8)14-12-31(7)24(20(32)17-27)21(34)15-23-29(5)16-19(18-33)25(35)28(3,4)22(29)9-10-30(23,31)6/h15-16,20,22,24H,9-14,17H2,1-8H3/t20-,22-,24-,29-,30+,31+,32-/m0/s1	Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor	INHIBITOR	CHEMBL1991	Inhibitor of nuclear factor kappa B kinase beta subunit	Homo sapiens
CHEMBL1762621	BARDOXOLONE METHYL	COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@](C)(CC[C@H]4C(C)(C)C(=O)C(C#N)=C[C@]34C)[C@]1(C)CC2	WPTTVJLTNAWYAO-KPOXMGGZSA-N	InChI=1S/C32H43NO4/c1-27(2)11-13-32(26(36)37-8)14-12-31(7)24(20(32)17-27)21(34)15-23-29(5)16-19(18-33)25(35)28(3,4)22(29)9-10-30(23,31)6/h15-16,20,22,24H,9-14,17H2,1-8H3/t20-,22-,24-,29-,30+,31+,32-/m0/s1	Keap1/Nrf2 inhibitor	INHIBITOR	CHEMBL3038498	Keap1/Nrf2	Homo sapiens
CHEMBL2035874	EPROTIROME	CC(C)c1cc(Oc2c(Br)cc(NC(=O)CC(=O)O)cc2Br)ccc1O	VPCSYAVXDAUHLT-UHFFFAOYSA-N	InChI=1S/C18H17Br2NO5/c1-9(2)12-7-11(3-4-15(12)22)26-18-13(19)5-10(6-14(18)20)21-16(23)8-17(24)25/h3-7,9,22H,8H2,1-2H3,(H,21,23)(H,24,25)	Thyroid hormone receptor beta-1 agonist	AGONIST	CHEMBL1947	Thyroid hormone receptor beta-1	Homo sapiens
CHEMBL1908376	SEOCALCITOL	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/C=C/C(O)(CC)CC)C[C@@H](O)C[C@@H]1O	LVLLALCJVJNGQQ-SEODYNFXSA-N	InChI=1S/C30H46O3/c1-6-30(33,7-2)18-9-8-11-21(3)26-15-16-27-23(12-10-17-29(26,27)5)13-14-24-19-25(31)20-28(32)22(24)4/h8-9,11,13-14,18,21,25-28,31-33H,4,6-7,10,12,15-17,19-20H2,1-3,5H3/b11-8+,18-9+,23-13+,24-14-/t21-,25-,26-,27+,28+,29-/m1/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL3989862	PEFCALCITOL	C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@H](C)OCC(=O)NCC(F)(F)C(F)(F)F)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O	SVCSMAZYWOQCBW-NVJMFHFGSA-N	InChI=1S/C26H34F5NO4/c1-15-18(11-19(33)12-22(15)34)7-6-17-5-4-10-24(3)20(8-9-21(17)24)16(2)36-13-23(35)32-14-25(27,28)26(29,30)31/h6-8,16,19,21-22,33-34H,1,4-5,9-14H2,2-3H3,(H,32,35)/b17-6+,18-7-/t16-,19+,21-,22-,24+/m0/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL1908391	MASITINIB	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1	WJEOLQLKVOPQFV-UHFFFAOYSA-N	InChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32)	Fibroblast growth factor receptor 3 inhibitor	INHIBITOR	CHEMBL2742	Fibroblast growth factor receptor 3	Homo sapiens
CHEMBL1908391	MASITINIB	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1	WJEOLQLKVOPQFV-UHFFFAOYSA-N	InChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32)	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL1908391	MASITINIB	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1	WJEOLQLKVOPQFV-UHFFFAOYSA-N	InChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32)	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL223360	LINIFANIB	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1	MPVGZUGXCQEXTM-UHFFFAOYSA-N	InChI=1S/C21H18FN5O/c1-12-5-10-16(22)18(11-12)25-21(28)24-14-8-6-13(7-9-14)15-3-2-4-17-19(15)20(23)27-26-17/h2-11H,1H3,(H3,23,26,27)(H2,24,25,28)	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	CHEMBL1844	Macrophage colony stimulating factor receptor	Homo sapiens
CHEMBL223360	LINIFANIB	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1	MPVGZUGXCQEXTM-UHFFFAOYSA-N	InChI=1S/C21H18FN5O/c1-12-5-10-16(22)18(11-12)25-21(28)24-14-8-6-13(7-9-14)15-3-2-4-17-19(15)20(23)27-26-17/h2-11H,1H3,(H3,23,26,27)(H2,24,25,28)	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL223360	LINIFANIB	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1	MPVGZUGXCQEXTM-UHFFFAOYSA-N	InChI=1S/C21H18FN5O/c1-12-5-10-16(22)18(11-12)25-21(28)24-14-8-6-13(7-9-14)15-3-2-4-17-19(15)20(23)27-26-17/h2-11H,1H3,(H3,23,26,27)(H2,24,25,28)	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL223360	LINIFANIB	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1	MPVGZUGXCQEXTM-UHFFFAOYSA-N	InChI=1S/C21H18FN5O/c1-12-5-10-16(22)18(11-12)25-21(28)24-14-8-6-13(7-9-14)15-3-2-4-17-19(15)20(23)27-26-17/h2-11H,1H3,(H3,23,26,27)(H2,24,25,28)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL576982	QUIZARTINIB	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1	CVWXJKQAOSCOAB-UHFFFAOYSA-N	InChI=1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36)	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	CHEMBL1844	Macrophage colony stimulating factor receptor	Homo sapiens
CHEMBL576982	QUIZARTINIB	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1	CVWXJKQAOSCOAB-UHFFFAOYSA-N	InChI=1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36)	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL576982	QUIZARTINIB	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1	CVWXJKQAOSCOAB-UHFFFAOYSA-N	InChI=1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36)	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL576982	QUIZARTINIB	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1	CVWXJKQAOSCOAB-UHFFFAOYSA-N	InChI=1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36)	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL576982	QUIZARTINIB	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1	CVWXJKQAOSCOAB-UHFFFAOYSA-N	InChI=1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36)	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	CHEMBL2041	Tyrosine-protein kinase receptor RET	Homo sapiens
CHEMBL2103882	TIVANTINIB	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12	UCEQXRCJXIVODC-PMACEKPBSA-N	InChI=1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m0/s1	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL217092	SARACATINIB	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1	OUKYUETWWIPKQR-UHFFFAOYSA-N	InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	CHEMBL1862	Tyrosine-protein kinase ABL	Homo sapiens
CHEMBL217092	SARACATINIB	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1	OUKYUETWWIPKQR-UHFFFAOYSA-N	InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)	Tyrosine-protein kinase SRC inhibitor	INHIBITOR	CHEMBL267	Tyrosine-protein kinase SRC	Homo sapiens
CHEMBL415049	BARASERTIB	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O	GBJVVSCPOBPEIT-UHFFFAOYSA-N	InChI=1S/C26H31FN7O6P/c1-2-34(10-12-40-41(36,37)38)9-4-11-39-21-7-8-22-23(16-21)28-17-29-26(22)31-24-14-20(32-33-24)15-25(35)30-19-6-3-5-18(27)13-19/h3,5-8,13-14,16-17H,2,4,9-12,15H2,1H3,(H,30,35)(H2,36,37,38)(H2,28,29,31,32,33)	Serine/threonine-protein kinase Aurora-B inhibitor	INHIBITOR	CHEMBL2185	Serine/threonine-protein kinase Aurora-B	Homo sapiens
CHEMBL491473	CEDIRANIB	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1	XXJWYDDUDKYVKI-UHFFFAOYSA-N	InChI=1S/C25H27FN4O3/c1-16-12-17-19(29-16)6-7-21(24(17)26)33-25-18-13-22(31-2)23(14-20(18)27-15-28-25)32-11-5-10-30-8-3-4-9-30/h6-7,12-15,29H,3-5,8-11H2,1-2H3	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL491473	CEDIRANIB	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1	XXJWYDDUDKYVKI-UHFFFAOYSA-N	InChI=1S/C25H27FN4O3/c1-16-12-17-19(29-16)6-7-21(24(17)26)33-25-18-13-22(31-2)23(14-20(18)27-15-28-25)32-11-5-10-30-8-3-4-9-30/h6-7,12-15,29H,3-5,8-11H2,1-2H3	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL491473	CEDIRANIB	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1	XXJWYDDUDKYVKI-UHFFFAOYSA-N	InChI=1S/C25H27FN4O3/c1-16-12-17-19(29-16)6-7-21(24(17)26)33-25-18-13-22(31-2)23(14-20(18)27-15-28-25)32-11-5-10-30-8-3-4-9-30/h6-7,12-15,29H,3-5,8-11H2,1-2H3	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL3353410	OSIMERTINIB	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C	DUYJMQONPNNFPI-UHFFFAOYSA-N	InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL1233528	VOLASERTIB	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C	SXNJFOWDRLKDSF-STROYTFGSA-N	InChI=1S/C34H50N8O3/c1-6-28-33(44)39(4)29-20-35-34(38-31(29)42(28)22(2)3)37-27-14-9-24(19-30(27)45-5)32(43)36-25-10-12-26(13-11-25)41-17-15-40(16-18-41)21-23-7-8-23/h9,14,19-20,22-23,25-26,28H,6-8,10-13,15-18,21H2,1-5H3,(H,36,43)(H,35,37,38)/t25-,26-,28-/m1/s1	Serine/threonine-protein kinase PLK1 inhibitor	INHIBITOR	CHEMBL3024	Serine/threonine-protein kinase PLK1	Homo sapiens
CHEMBL377300	BRIVANIB	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1	WCWUXEGQKLTGDX-LLVKDONJSA-N	InChI=1S/C19H19FN4O3/c1-10-6-13-14(23-10)4-5-15(17(13)20)27-19-18-12(3)16(26-8-11(2)25)7-24(18)22-9-21-19/h4-7,9,11,23,25H,8H2,1-3H3/t11-/m1/s1	Fibroblast growth factor receptor inhibitor	INHIBITOR	CHEMBL2095217	Fibroblast growth factor receptor	Homo sapiens
CHEMBL377300	BRIVANIB	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1	WCWUXEGQKLTGDX-LLVKDONJSA-N	InChI=1S/C19H19FN4O3/c1-10-6-13-14(23-10)4-5-15(17(13)20)27-19-18-12(3)16(26-8-11(2)25)7-24(18)22-9-21-19/h4-7,9,11,23,25H,8H2,1-3H3/t11-/m1/s1	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL270995	BRIVANIB ALANINATE	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1	LTEJRLHKIYCEOX-OCCSQVGLSA-N	InChI=1S/C22H24FN5O4/c1-11-7-15-16(27-11)5-6-17(19(15)23)32-21-20-13(3)18(8-28(20)26-10-25-21)30-9-12(2)31-22(29)14(4)24/h5-8,10,12,14,27H,9,24H2,1-4H3/t12-,14+/m1/s1	Fibroblast growth factor receptor inhibitor	INHIBITOR	CHEMBL2095217	Fibroblast growth factor receptor	Homo sapiens
CHEMBL270995	BRIVANIB ALANINATE	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1	LTEJRLHKIYCEOX-OCCSQVGLSA-N	InChI=1S/C22H24FN5O4/c1-11-7-15-16(27-11)5-6-17(19(15)23)32-21-20-13(3)18(8-28(20)26-10-25-21)30-9-12(2)31-22(29)14(4)24/h5-8,10,12,14,27H,9,24H2,1-4H3/t12-,14+/m1/s1	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL290352	CEP-1347	CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O	SCMLRESZJCKCTC-KMYQRJGFSA-N	InChI=1S/C33H33N3O5S2/c1-5-42-15-17-7-9-22-19(11-17)26-27-21(14-34-30(27)37)25-20-12-18(16-43-6-2)8-10-23(20)36-29(25)28(26)35(22)24-13-33(39,31(38)40-4)32(36,3)41-24/h7-12,24,39H,5-6,13-16H2,1-4H3,(H,34,37)/t24-,32+,33+/m1/s1	Mitogen-activated protein kinase kinase kinase 11 inhibitor	INHIBITOR	CHEMBL2708	Mitogen-activated protein kinase kinase kinase 11	Homo sapiens
CHEMBL290352	CEP-1347	CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O	SCMLRESZJCKCTC-KMYQRJGFSA-N	InChI=1S/C33H33N3O5S2/c1-5-42-15-17-7-9-22-19(11-17)26-27-21(14-34-30(27)37)25-20-12-18(16-43-6-2)8-10-23(20)36-29(25)28(26)35(22)24-13-33(39,31(38)40-4)32(36,3)41-24/h7-12,24,39H,5-6,13-16H2,1-4H3,(H,34,37)/t24-,32+,33+/m1/s1	Mitogen-activated protein kinase kinase kinase 10 inhibitor	INHIBITOR	CHEMBL2873	Mitogen-activated protein kinase kinase kinase 10	Homo sapiens
CHEMBL290352	CEP-1347	CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O	SCMLRESZJCKCTC-KMYQRJGFSA-N	InChI=1S/C33H33N3O5S2/c1-5-42-15-17-7-9-22-19(11-17)26-27-21(14-34-30(27)37)25-20-12-18(16-43-6-2)8-10-23(20)36-29(25)28(26)35(22)24-13-33(39,31(38)40-4)32(36,3)41-24/h7-12,24,39H,5-6,13-16H2,1-4H3,(H,34,37)/t24-,32+,33+/m1/s1	Mitogen-activated protein kinase kinase kinase 9 inhibitor	INHIBITOR	CHEMBL2872	Mitogen-activated protein kinase kinase kinase 9	Homo sapiens
CHEMBL290352	CEP-1347	CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O	SCMLRESZJCKCTC-KMYQRJGFSA-N	InChI=1S/C33H33N3O5S2/c1-5-42-15-17-7-9-22-19(11-17)26-27-21(14-34-30(27)37)25-20-12-18(16-43-6-2)8-10-23(20)36-29(25)28(26)35(22)24-13-33(39,31(38)40-4)32(36,3)41-24/h7-12,24,39H,5-6,13-16H2,1-4H3,(H,34,37)/t24-,32+,33+/m1/s1	Mitogen-activated protein kinase kinase kinase 13 inhibitor	INHIBITOR	CHEMBL1163124	Mitogen-activated protein kinase kinase kinase 13	Homo sapiens
CHEMBL290352	CEP-1347	CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O	SCMLRESZJCKCTC-KMYQRJGFSA-N	InChI=1S/C33H33N3O5S2/c1-5-42-15-17-7-9-22-19(11-17)26-27-21(14-34-30(27)37)25-20-12-18(16-43-6-2)8-10-23(20)36-29(25)28(26)35(22)24-13-33(39,31(38)40-4)32(36,3)41-24/h7-12,24,39H,5-6,13-16H2,1-4H3,(H,34,37)/t24-,32+,33+/m1/s1	Mitogen-activated protein kinase kinase kinase 12 inhibitor	INHIBITOR	CHEMBL1908389	Mitogen-activated protein kinase kinase kinase 12	Homo sapiens
CHEMBL603469	LESTAURTINIB	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O	UIARLYUEJFELEN-LROUJFHJSA-N	InChI=1S/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18-,25+,26+/m1/s1	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL603469	LESTAURTINIB	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O	UIARLYUEJFELEN-LROUJFHJSA-N	InChI=1S/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18-,25+,26+/m1/s1	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	CHEMBL2971	Tyrosine-protein kinase JAK2	Homo sapiens
CHEMBL603469	LESTAURTINIB	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O	UIARLYUEJFELEN-LROUJFHJSA-N	InChI=1S/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18-,25+,26+/m1/s1	Nerve growth factor receptor Trk-A inhibitor	INHIBITOR	CHEMBL2815	Nerve growth factor receptor Trk-A	Homo sapiens
CHEMBL603469	LESTAURTINIB	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O	UIARLYUEJFELEN-LROUJFHJSA-N	InChI=1S/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18-,25+,26+/m1/s1	Neurotrophic tyrosine kinase receptor type 2 inhibitor	INHIBITOR	CHEMBL4898	Neurotrophic tyrosine kinase receptor type 2	Homo sapiens
CHEMBL603469	LESTAURTINIB	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O	UIARLYUEJFELEN-LROUJFHJSA-N	InChI=1S/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18-,25+,26+/m1/s1	NT-3 growth factor receptor inhibitor	INHIBITOR	CHEMBL5608	NT-3 growth factor receptor	Homo sapiens
CHEMBL603469	LESTAURTINIB	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O	UIARLYUEJFELEN-LROUJFHJSA-N	InChI=1S/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18-,25+,26+/m1/s1	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	CHEMBL2041	Tyrosine-protein kinase receptor RET	Homo sapiens
CHEMBL545315	CANERTINIB DIHYDROCHLORIDE	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1.Cl.Cl	JZZFDCXSFTVOJY-UHFFFAOYSA-N	InChI=1S/C24H25ClFN5O3.2ClH/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16;;/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29);2*1H	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL545315	CANERTINIB DIHYDROCHLORIDE	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1.Cl.Cl	JZZFDCXSFTVOJY-UHFFFAOYSA-N	InChI=1S/C24H25ClFN5O3.2ClH/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16;;/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29);2*1H	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL545315	CANERTINIB DIHYDROCHLORIDE	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1.Cl.Cl	JZZFDCXSFTVOJY-UHFFFAOYSA-N	InChI=1S/C24H25ClFN5O3.2ClH/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16;;/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29);2*1H	Receptor protein-tyrosine kinase erbB-4 inhibitor	INHIBITOR	CHEMBL3009	Receptor protein-tyrosine kinase erbB-4	Homo sapiens
CHEMBL1078178	MOMELOTINIB	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1	ZVHNDZWQTBEVRY-UHFFFAOYSA-N	InChI=1S/C23H22N6O2/c24-10-12-25-22(30)18-3-1-17(2-4-18)21-9-11-26-23(28-21)27-19-5-7-20(8-6-19)29-13-15-31-16-14-29/h1-9,11H,12-16H2,(H,25,30)(H,26,27,28)	Tyrosine-protein kinase JAK1 inhibitor	INHIBITOR	CHEMBL2835	Tyrosine-protein kinase JAK1	Homo sapiens
CHEMBL1078178	MOMELOTINIB	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1	ZVHNDZWQTBEVRY-UHFFFAOYSA-N	InChI=1S/C23H22N6O2/c24-10-12-25-22(30)18-3-1-17(2-4-18)21-9-11-26-23(28-21)27-19-5-7-20(8-6-19)29-13-15-31-16-14-29/h1-9,11H,12-16H2,(H,25,30)(H,26,27,28)	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	CHEMBL2971	Tyrosine-protein kinase JAK2	Homo sapiens
CHEMBL1088752	LOSMAPIMOD	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1	KKYABQBFGDZVNQ-UHFFFAOYSA-N	InChI=1S/C22H26FN3O2/c1-13-17(9-15(10-18(13)23)21(28)26-16-6-7-16)19-8-5-14(11-24-19)20(27)25-12-22(2,3)4/h5,8-11,16H,6-7,12H2,1-4H3,(H,25,27)(H,26,28)	MAP kinase p38 alpha inhibitor	INHIBITOR	CHEMBL260	MAP kinase p38 alpha	Homo sapiens
CHEMBL1088752	LOSMAPIMOD	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1	KKYABQBFGDZVNQ-UHFFFAOYSA-N	InChI=1S/C22H26FN3O2/c1-13-17(9-15(10-18(13)23)21(28)26-16-6-7-16)19-8-5-14(11-24-19)20(27)25-12-22(2,3)4/h5,8-11,16H,6-7,12H2,1-4H3,(H,25,27)(H,26,28)	MAP kinase p38 beta inhibitor	INHIBITOR	CHEMBL3961	MAP kinase p38 beta	Homo sapiens
CHEMBL3545413	FLUMATINIB	Cc1ncc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1	BJCJYEYYYGBROF-UHFFFAOYSA-N	InChI=1S/C29H29F3N8O/c1-19-26(38-28-34-9-7-25(37-28)21-4-3-8-33-16-21)15-23(17-35-19)36-27(41)20-5-6-22(24(14-20)29(30,31)32)18-40-12-10-39(2)11-13-40/h3-9,14-17H,10-13,18H2,1-2H3,(H,36,41)(H,34,37,38)	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	CHEMBL1862	Tyrosine-protein kinase ABL	Homo sapiens
CHEMBL180022	NERATINIB	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C	JWNPDZNEKVCWMY-VQHVLOKHSA-N	InChI=1S/C30H29ClN6O3/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38)/b9-7+	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL180022	NERATINIB	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C	JWNPDZNEKVCWMY-VQHVLOKHSA-N	InChI=1S/C30H29ClN6O3/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38)/b9-7+	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL428690	ALVOCIDIB	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1	BIIVYFLTOXDAOV-YVEFUNNKSA-N	InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1	Cyclin-dependent kinase 2 inhibitor	INHIBITOR	CHEMBL301	Cyclin-dependent kinase 2	Homo sapiens
CHEMBL428690	ALVOCIDIB	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1	BIIVYFLTOXDAOV-YVEFUNNKSA-N	InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	CHEMBL331	Cyclin-dependent kinase 4	Homo sapiens
CHEMBL428690	ALVOCIDIB	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1	BIIVYFLTOXDAOV-YVEFUNNKSA-N	InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1	Cyclin-dependent kinase 6 inhibitor	INHIBITOR	CHEMBL2508	Cyclin-dependent kinase 6	Homo sapiens
CHEMBL428690	ALVOCIDIB	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1	BIIVYFLTOXDAOV-YVEFUNNKSA-N	InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1	Cyclin-dependent kinase 9 inhibitor	INHIBITOR	CHEMBL3116	Cyclin-dependent kinase 9	Homo sapiens
CHEMBL428690	ALVOCIDIB	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1	BIIVYFLTOXDAOV-YVEFUNNKSA-N	InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1	Cyclin-dependent kinase 1 inhibitor	INHIBITOR	CHEMBL308	Cyclin-dependent kinase 1	Homo sapiens
CHEMBL428690	ALVOCIDIB	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1	BIIVYFLTOXDAOV-YVEFUNNKSA-N	InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1	Cyclin-dependent kinase 7 inhibitor	INHIBITOR	CHEMBL3055	Cyclin-dependent kinase 7	Homo sapiens
CHEMBL2105759	BARICITINIB	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1	XUZMWHLSFXCVMG-UHFFFAOYSA-N	InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)	Tyrosine-protein kinase JAK1 inhibitor	INHIBITOR	CHEMBL2835	Tyrosine-protein kinase JAK1	Homo sapiens
CHEMBL2105759	BARICITINIB	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1	XUZMWHLSFXCVMG-UHFFFAOYSA-N	InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	CHEMBL2971	Tyrosine-protein kinase JAK2	Homo sapiens
CHEMBL1289494	TIVOZANIB	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC	SPMVMDHWKHCIDT-UHFFFAOYSA-N	InChI=1S/C22H19ClN4O5/c1-12-8-21(27-32-12)26-22(28)25-16-5-4-13(9-15(16)23)31-18-6-7-24-17-11-20(30-3)19(29-2)10-14(17)18/h4-11H,1-3H3,(H2,25,26,27,28)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL3545110	RIBOCICLIB	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1	RHXHGRAEPCAFML-UHFFFAOYSA-N	InChI=1S/C23H30N8O/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28)	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	CHEMBL331	Cyclin-dependent kinase 4	Homo sapiens
CHEMBL3545110	RIBOCICLIB	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1	RHXHGRAEPCAFML-UHFFFAOYSA-N	InChI=1S/C23H30N8O/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28)	Cyclin-dependent kinase 6 inhibitor	INHIBITOR	CHEMBL2508	Cyclin-dependent kinase 6	Homo sapiens
CHEMBL3301612	ENCORAFENIB	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1	CMJCXYNUCSMDBY-ZDUSSCGKSA-N	InChI=1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H,27,32)(H,25,26,28)/t13-/m0/s1	Serine/threonine-protein kinase B-raf inhibitor	INHIBITOR	CHEMBL5145	Serine/threonine-protein kinase B-raf	Homo sapiens
CHEMBL300138	ENZASTAURIN	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21	AXRCEOKUDYDWLF-UHFFFAOYSA-N	InChI=1S/C32H29N5O2/c1-35-19-25(23-9-2-4-11-27(23)35)29-30(32(39)34-31(29)38)26-20-37(28-12-5-3-10-24(26)28)22-13-16-36(17-14-22)18-21-8-6-7-15-33-21/h2-12,15,19-20,22H,13-14,16-18H2,1H3,(H,34,38,39)	Protein kinase C beta inhibitor	INHIBITOR	CHEMBL3045	Protein kinase C beta	Homo sapiens
CHEMBL91829	RUBOXISTAURIN	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1	ZCBUQCWBWNUWSU-SFHVURJKSA-N	InChI=1S/C28H28N4O3/c1-30(2)15-18-11-12-31-16-21(19-7-3-5-9-23(19)31)25-26(28(34)29-27(25)33)22-17-32(13-14-35-18)24-10-6-4-8-20(22)24/h3-10,16-18H,11-15H2,1-2H3,(H,29,33,34)/t18-/m0/s1	Protein kinase C beta inhibitor	INHIBITOR	CHEMBL3045	Protein kinase C beta	Homo sapiens
CHEMBL3187723	BINIMETINIB	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21	ACWZRVQXLIRSDF-UHFFFAOYSA-N	InChI=1S/C17H15BrF2N4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3587	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens
CHEMBL3187723	BINIMETINIB	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21	ACWZRVQXLIRSDF-UHFFFAOYSA-N	InChI=1S/C17H15BrF2N4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	CHEMBL2964	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens
CHEMBL2103840	DINACICLIB	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12	PIMQWRZWLQKKBJ-SFHVURJKSA-N	InChI=1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1	Cyclin-dependent kinase 1 inhibitor	INHIBITOR	CHEMBL308	Cyclin-dependent kinase 1	Homo sapiens
CHEMBL2103840	DINACICLIB	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12	PIMQWRZWLQKKBJ-SFHVURJKSA-N	InChI=1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1	Cyclin-dependent kinase 2 inhibitor	INHIBITOR	CHEMBL301	Cyclin-dependent kinase 2	Homo sapiens
CHEMBL2103840	DINACICLIB	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12	PIMQWRZWLQKKBJ-SFHVURJKSA-N	InChI=1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1	Cyclin-dependent kinase 5 inhibitor	INHIBITOR	CHEMBL4036	Cyclin-dependent kinase 5	Homo sapiens
CHEMBL2103840	DINACICLIB	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12	PIMQWRZWLQKKBJ-SFHVURJKSA-N	InChI=1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1	Cyclin-dependent kinase 9 inhibitor	INHIBITOR	CHEMBL3116	Cyclin-dependent kinase 9	Homo sapiens
CHEMBL483158	ALISERTIB	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O	ZLHFILGSQDJULK-UHFFFAOYSA-N	InChI=1S/C27H20ClFN4O4/c1-36-21-5-3-4-20(29)23(21)25-19-10-15(28)6-8-17(19)24-14(12-30-25)13-31-27(33-24)32-16-7-9-18(26(34)35)22(11-16)37-2/h3-11,13H,12H2,1-2H3,(H,34,35)(H,31,32,33)	Serine/threonine-protein kinase Aurora-A inhibitor	INHIBITOR	CHEMBL4722	Serine/threonine-protein kinase Aurora-A	Homo sapiens
CHEMBL2013119	RIGOSERTIB SODIUM	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)[O-])c2)c(OC)c1.[Na+]	VLQLUZFVFXYXQE-USRGLUTNSA-M	InChI=1S/C21H25NO8S.Na/c1-27-15-10-19(29-3)16(20(11-15)30-4)7-8-31(25,26)13-14-5-6-18(28-2)17(9-14)22-12-21(23)24;/h5-11,22H,12-13H2,1-4H3,(H,23,24);/q;+1/p-1/b8-7+;	Proteinase-activated receptor 1 inhibitor	INHIBITOR	CHEMBL3974	Proteinase-activated receptor 1	Homo sapiens
CHEMBL1091644	LINSITINIB	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1	PKCDDUHJAFVJJB-VLZXCDOPSA-N	InChI=1S/C26H23N5O/c1-26(32)14-19(15-26)25-30-22(23-24(27)28-11-12-31(23)25)18-8-7-17-9-10-20(29-21(17)13-18)16-5-3-2-4-6-16/h2-13,19,32H,14-15H2,1H3,(H2,27,28)/t19-,26+	Insulin-like growth factor I receptor inhibitor	INHIBITOR	CHEMBL1957	Insulin-like growth factor I receptor	Homo sapiens
CHEMBL1091644	LINSITINIB	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1	PKCDDUHJAFVJJB-VLZXCDOPSA-N	InChI=1S/C26H23N5O/c1-26(32)14-19(15-26)25-30-22(23-24(27)28-11-12-31(23)25)18-8-7-17-9-10-20(29-21(17)13-18)16-5-3-2-4-6-16/h2-13,19,32H,14-15H2,1H3,(H2,27,28)/t19-,26+	Insulin receptor inhibitor	INHIBITOR	CHEMBL1981	Insulin receptor	Homo sapiens
CHEMBL2105719	DACOMITINIB	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O	BSPLGGCPNTZPIH-IPZCTEOASA-N	InChI=1S/C24H25ClFN5O2.H2O/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31;/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29);1H2/b6-5+;	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL2105719	DACOMITINIB	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O	BSPLGGCPNTZPIH-IPZCTEOASA-N	InChI=1S/C24H25ClFN5O2.H2O/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31;/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29);1H2/b6-5+;	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL2105719	DACOMITINIB	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O	BSPLGGCPNTZPIH-IPZCTEOASA-N	InChI=1S/C24H25ClFN5O2.H2O/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31;/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29);1H2/b6-5+;	Receptor protein-tyrosine kinase erbB-4 inhibitor	INHIBITOR	CHEMBL3009	Receptor protein-tyrosine kinase erbB-4	Homo sapiens
CHEMBL608533	MIDOSTAURIN	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	BMGQWWVMWDBQGC-IIFHNQTCSA-N	InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL608533	MIDOSTAURIN	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	BMGQWWVMWDBQGC-IIFHNQTCSA-N	InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL608533	MIDOSTAURIN	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	BMGQWWVMWDBQGC-IIFHNQTCSA-N	InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL608533	MIDOSTAURIN	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	BMGQWWVMWDBQGC-IIFHNQTCSA-N	InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1	Protein kinase C (PKC) inhibitor	INHIBITOR	CHEMBL2093867	Protein kinase C (PKC)	Homo sapiens
CHEMBL608533	MIDOSTAURIN	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	BMGQWWVMWDBQGC-IIFHNQTCSA-N	InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL101253	VATALANIB	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1	YCOYDOIWSSHVCK-UHFFFAOYSA-N	InChI=1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25)	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL101253	VATALANIB	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1	YCOYDOIWSSHVCK-UHFFFAOYSA-N	InChI=1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25)	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL101253	VATALANIB	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1	YCOYDOIWSSHVCK-UHFFFAOYSA-N	InChI=1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL101253	VATALANIB	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1	YCOYDOIWSSHVCK-UHFFFAOYSA-N	InChI=1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25)	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	CHEMBL1844	Macrophage colony stimulating factor receptor	Homo sapiens
CHEMBL2103830	FOSTAMATINIB	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC	GKDRMWXFWHEQQT-UHFFFAOYSA-N	InChI=1S/C23H26FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29)	Tyrosine-protein kinase SYK inhibitor	INHIBITOR	CHEMBL2599	Tyrosine-protein kinase SYK	Homo sapiens
CHEMBL2146883	COBIMETINIB	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1	BSMCAPRUBJMWDF-KRWDZBQOSA-N	InChI=1S/C21H21F3IN3O2/c22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17/h4-7,9,17,26-27,30H,1-3,8,10-11H2/t17-/m0/s1	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	CHEMBL3587	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens
CHEMBL2146883	COBIMETINIB	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1	BSMCAPRUBJMWDF-KRWDZBQOSA-N	InChI=1S/C21H21F3IN3O2/c22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17/h4-7,9,17,26-27,30H,1-3,8,10-11H2/t17-/m0/s1	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	CHEMBL2964	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens
CHEMBL1287853	FEDRATINIB	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1	JOOXLOJCABQBSG-UHFFFAOYSA-N	InChI=1S/C27H36N6O3S/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31)	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL1287853	FEDRATINIB	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1	JOOXLOJCABQBSG-UHFFFAOYSA-N	InChI=1S/C27H36N6O3S/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31)	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	CHEMBL2971	Tyrosine-protein kinase JAK2	Homo sapiens
CHEMBL2035187	PACRITINIB	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1	HWXVIOGONBBTBY-ONEGZZNKSA-N	InChI=1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3+	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	CHEMBL2971	Tyrosine-protein kinase JAK2	Homo sapiens
CHEMBL2035187	PACRITINIB	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1	HWXVIOGONBBTBY-ONEGZZNKSA-N	InChI=1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3+	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL3545235	SIMOTINIB	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CC2(CC2)C2(C1)OCCO2	OXWUWXCJDBRCCG-UHFFFAOYSA-N	InChI=1S/C25H26ClFN4O4/c1-32-21-12-20-17(23(29-15-28-20)30-16-2-3-19(27)18(26)10-16)11-22(21)33-7-6-31-13-24(4-5-24)25(14-31)34-8-9-35-25/h2-3,10-12,15H,4-9,13-14H2,1H3,(H,28,29,30)	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL276711	SEMAXANIB	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1	WUWDLXZGHZSWQZ-WQLSENKSSA-N	InChI=1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)18/h3-8,16H,1-2H3,(H,17,18)/b12-8-	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL276711	SEMAXANIB	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1	WUWDLXZGHZSWQZ-WQLSENKSSA-N	InChI=1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)18/h3-8,16H,1-2H3,(H,17,18)/b12-8-	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL274654	ORANTINIB	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O	NHFDRBXTEDBWCZ-ZROIWOOFSA-N	InChI=1S/C18H18N2O3/c1-10-12(7-8-17(21)22)11(2)19-16(10)9-14-13-5-3-4-6-15(13)20-18(14)23/h3-6,9,19H,7-8H2,1-2H3,(H,20,23)(H,21,22)/b14-9-	Fibroblast growth factor receptor inhibitor	INHIBITOR	CHEMBL2095217	Fibroblast growth factor receptor	Homo sapiens
CHEMBL274654	ORANTINIB	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O	NHFDRBXTEDBWCZ-ZROIWOOFSA-N	InChI=1S/C18H18N2O3/c1-10-12(7-8-17(21)22)11(2)19-16(10)9-14-13-5-3-4-6-15(13)20-18(14)23/h3-6,9,19H,7-8H2,1-2H3,(H,20,23)(H,21,22)/b14-9-	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL274654	ORANTINIB	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O	NHFDRBXTEDBWCZ-ZROIWOOFSA-N	InChI=1S/C18H18N2O3/c1-10-12(7-8-17(21)22)11(2)19-16(10)9-14-13-5-3-4-6-15(13)20-18(14)23/h3-6,9,19H,7-8H2,1-2H3,(H,20,23)(H,21,22)/b14-9-	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL522892	DOVITINIB	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1	PIQCTGMSNWUMAF-UHFFFAOYSA-N	InChI=1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11H,7-10H2,1H3,(H,24,25)(H3,23,26,29)	Fibroblast growth factor receptor 3 inhibitor	INHIBITOR	CHEMBL2742	Fibroblast growth factor receptor 3	Homo sapiens
CHEMBL522892	DOVITINIB	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1	PIQCTGMSNWUMAF-UHFFFAOYSA-N	InChI=1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11H,7-10H2,1H3,(H,24,25)(H3,23,26,29)	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL522892	DOVITINIB	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1	PIQCTGMSNWUMAF-UHFFFAOYSA-N	InChI=1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11H,7-10H2,1H3,(H,24,25)(H3,23,26,29)	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL522892	DOVITINIB	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1	PIQCTGMSNWUMAF-UHFFFAOYSA-N	InChI=1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11H,7-10H2,1H3,(H,24,25)(H3,23,26,29)	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL522892	DOVITINIB	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1	PIQCTGMSNWUMAF-UHFFFAOYSA-N	InChI=1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11H,7-10H2,1H3,(H,24,25)(H3,23,26,29)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL3545414	RIVOCERANIB MESYLATE	CS(=O)(=O)O.N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1	FYJROXRIVQPKRY-UHFFFAOYSA-N	InChI=1S/C24H23N5O.CH4O3S/c25-17-24(11-1-2-12-24)19-5-7-20(8-6-19)29-23(30)21-4-3-13-27-22(21)28-16-18-9-14-26-15-10-18;1-5(2,3)4/h3-10,13-15H,1-2,11-12,16H2,(H,27,28)(H,29,30);1H3,(H,2,3,4)	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	CHEMBL279	Vascular endothelial growth factor receptor 2	Homo sapiens
CHEMBL405821	SENICAPOC	NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1	SCTZUZTYRMOMKT-UHFFFAOYSA-N	InChI=1S/C20H15F2NO/c21-17-10-6-15(7-11-17)20(19(23)24,14-4-2-1-3-5-14)16-8-12-18(22)13-9-16/h1-13H,(H2,23,24)	Intermediate conductance calcium-activated potassium channel protein 4 blocker	BLOCKER	CHEMBL4305	Intermediate conductance calcium-activated potassium channel protein 4	Homo sapiens
CHEMBL1208155	ELAGOLIX	COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(C[C@H](NCCCC(=O)O)c3ccccc3)c2=O)c1F	HEAUOKZIVMZVQL-VWLOTQADSA-N	InChI=1S/C32H30F5N3O5/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42)/t25-/m0/s1	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL1628688	ZIBOTENTAN	COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(-c2nnco2)cc1	FJHHZXWJVIEFGJ-UHFFFAOYSA-N	InChI=1S/C19H16N6O4S/c1-12-10-21-17(19(23-12)28-2)25-30(26,27)15-4-3-9-20-16(15)13-5-7-14(8-6-13)18-24-22-11-29-18/h3-11H,1-2H3,(H,21,25)	Endothelin receptor ET-A antagonist	ANTAGONIST	CHEMBL252	Endothelin receptor ET-A	Homo sapiens
CHEMBL1668019	APLAVIROC HYDROCHLORIDE	CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2.Cl	QNNBMSGFNQRUEH-PQQSRXGVSA-N	InChI=1S/C33H43N3O6.ClH/c1-2-3-19-36-30(38)28(29(37)24-7-5-4-6-8-24)34-32(41)33(36)17-20-35(21-18-33)22-23-9-13-26(14-10-23)42-27-15-11-25(12-16-27)31(39)40;/h9-16,24,28-29,37H,2-8,17-22H2,1H3,(H,34,41)(H,39,40);1H/t28-,29-;/m1./s1	C-C chemokine receptor type 5 antagonist	ANTAGONIST	CHEMBL274	C-C chemokine receptor type 5	Homo sapiens
CHEMBL1672054	CASOPITANT	CC(=O)N1CCN([C@H]2CCN(C(=O)N(C)[C@H](C)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)[C@@H](c3ccc(F)cc3C)C2)CC1	XGGTZCKQRWXCHW-WMTVXVAQSA-N	InChI=1S/C30H35F7N4O2/c1-18-13-24(31)5-6-26(18)27-17-25(40-11-9-39(10-12-40)20(3)42)7-8-41(27)28(43)38(4)19(2)21-14-22(29(32,33)34)16-23(15-21)30(35,36)37/h5-6,13-16,19,25,27H,7-12,17H2,1-4H3/t19-,25+,27-/m1/s1	Neurokinin 1 receptor antagonist	ANTAGONIST	CHEMBL249	Neurokinin 1 receptor	Homo sapiens
CHEMBL191413	REPARIXIN	CC(C)Cc1ccc([C@@H](C)C(=O)NS(C)(=O)=O)cc1	KQDRVXQXKZXMHP-LLVKDONJSA-N	InChI=1S/C14H21NO3S/c1-10(2)9-12-5-7-13(8-6-12)11(3)14(16)15-19(4,17)18/h5-8,10-11H,9H2,1-4H3,(H,15,16)/t11-/m1/s1	Interleukin-8 receptor A modulator	MODULATOR	CHEMBL4029	Interleukin-8 receptor A	Homo sapiens
CHEMBL191413	REPARIXIN	CC(C)Cc1ccc([C@@H](C)C(=O)NS(C)(=O)=O)cc1	KQDRVXQXKZXMHP-LLVKDONJSA-N	InChI=1S/C14H21NO3S/c1-10(2)9-12-5-7-13(8-6-12)11(3)14(16)15-19(4,17)18/h5-8,10-11H,9H2,1-4H3,(H,15,16)/t11-/m1/s1	Interleukin-8 receptor B modulator	MODULATOR	CHEMBL2434	Interleukin-8 receptor B	Homo sapiens
CHEMBL1923502	ULIMORELIN HYDROCHLORIDE	C[C@@H]1CN[C@@H](C2CC2)C(=O)N(C)[C@H](C)C(=O)N[C@H](Cc2ccc(F)cc2)C(=O)NCCCc2ccccc2O1.Cl.O	ZWIXEQBDJMFCMN-DHHNQDMHSA-N	InChI=1S/C30H39FN4O4.ClH.H2O/c1-19-18-33-27(23-12-13-23)30(38)35(3)20(2)28(36)34-25(17-21-10-14-24(31)15-11-21)29(37)32-16-6-8-22-7-4-5-9-26(22)39-19;;/h4-5,7,9-11,14-15,19-20,23,25,27,33H,6,8,12-13,16-18H2,1-3H3,(H,32,37)(H,34,36);1H;1H2/t19-,20-,25-,27+;;/m1../s1	Ghrelin receptor agonist	AGONIST	CHEMBL4616	Ghrelin receptor	Homo sapiens
CHEMBL1950554	BINODENOSON	Nc1nc(N/N=C/C2CCCCC2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	XJFMHMFFBSOEPR-DNZQAUTHSA-N	InChI=1S/C17H25N7O4/c18-14-11-15(22-17(21-14)23-20-6-9-4-2-1-3-5-9)24(8-19-11)16-13(27)12(26)10(7-25)28-16/h6,8-10,12-13,16,25-27H,1-5,7H2,(H3,18,21,22,23)/b20-6+/t10-,12-,13-,16-/m1/s1	Adenosine A2a receptor agonist	AGONIST	CHEMBL251	Adenosine A2a receptor	Homo sapiens
CHEMBL1950649	APADENOSON	CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CC[C@H]4CC[C@H](C(=O)OC)CC4)nc32)[C@H](O)[C@@H]1O	FLEVIENZILQUKB-XTWQNQIISA-N	InChI=1S/C23H30N6O6/c1-3-25-21(32)18-16(30)17(31)22(35-18)29-11-26-15-19(24)27-14(28-20(15)29)6-4-5-12-7-9-13(10-8-12)23(33)34-2/h11-13,16-18,22,30-31H,3,5,7-10H2,1-2H3,(H,25,32)(H2,24,27,28)/t12-,13-,16-,17+,18-,22+/m0/s1	Adenosine A2a receptor agonist	AGONIST	CHEMBL251	Adenosine A2a receptor	Homo sapiens
CHEMBL209821	NALUZOTAN	CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1	SPWZXWDPAWDKQE-UHFFFAOYSA-N	InChI=1S/C23H38N4O3S/c1-20(28)25-22-10-7-11-23(18-22)27-16-14-26(15-17-27)13-6-5-12-24-31(29,30)19-21-8-3-2-4-9-21/h7,10-11,18,21,24H,2-6,8-9,12-17,19H2,1H3,(H,25,28)	Serotonin 1a (5-HT1a) receptor agonist	AGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL2103794	ANAMORELIN HYDROCHLORIDE	CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1.Cl	VFYAEUWJFGTGGO-GHTUPXNNSA-N	InChI=1S/C31H42N6O3.ClH/c1-30(2,32)28(39)34-26(18-23-20-33-25-15-10-9-14-24(23)25)27(38)37-17-11-16-31(21-37,29(40)36(5)35(3)4)19-22-12-7-6-8-13-22;/h6-10,12-15,20,26,33H,11,16-19,21,32H2,1-5H3,(H,34,39);1H/t26-,31-;/m1./s1	Ghrelin receptor agonist	AGONIST	CHEMBL4616	Ghrelin receptor	Homo sapiens
CHEMBL562668	OTENABANT	CCNC1(C(N)=O)CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1	UNAZAADNBYXMIV-UHFFFAOYSA-N	InChI=1S/C25H25Cl2N7O/c1-2-31-25(24(28)35)11-13-33(14-12-25)22-20-23(30-15-29-22)34(17-9-7-16(26)8-10-17)21(32-20)18-5-3-4-6-19(18)27/h3-10,15,31H,2,11-14H2,1H3,(H2,28,35)	Cannabinoid CB1 receptor antagonist	ANTAGONIST	CHEMBL218	Cannabinoid CB1 receptor	Homo sapiens
CHEMBL2105747	TOZADENANT	COc1ccc(N2CCOCC2)c2sc(NC(=O)N3CCC(C)(O)CC3)nc12	XNBRWUQWSKXMPW-UHFFFAOYSA-N	InChI=1S/C19H26N4O4S/c1-19(25)5-7-23(8-6-19)18(24)21-17-20-15-14(26-2)4-3-13(16(15)28-17)22-9-11-27-12-10-22/h3-4,25H,5-12H2,1-2H3,(H,20,21,24)	Adenosine A2a receptor antagonist	ANTAGONIST	CHEMBL251	Adenosine A2a receptor	Homo sapiens
CHEMBL2105755	NALDEMEDINE	CC(C)(NC(=O)C1=C(O)[C@@H]2Oc3c(O)ccc4c3[C@@]23CCN(CC2CC2)[C@H](C4)[C@]3(O)C1)c1nc(-c2ccccc2)no1	AXQACEQYCPKDMV-RZAWKFBISA-N	InChI=1S/C32H34N4O6/c1-30(2,29-33-27(35-42-29)18-6-4-3-5-7-18)34-28(39)20-15-32(40)22-14-19-10-11-21(37)25-23(19)31(32,26(41-25)24(20)38)12-13-36(22)16-17-8-9-17/h3-7,10-11,17,22,26,37-38,40H,8-9,12-16H2,1-2H3,(H,34,39)/t22-,26+,31+,32-/m1/s1	Mu opioid receptor antagonist	ANTAGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL2107339	ESMIRTAZAPINE MALEATE	CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1.O=C(O)/C=C\C(=O)O	RPUBHMMISKEXSR-MLCLTIQSSA-N	InChI=1S/C17H19N3.C4H4O4/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20;5-3(6)1-2-4(7)8/h2-8,16H,9-12H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t16-;/m1./s1	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL2107339	ESMIRTAZAPINE MALEATE	CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1.O=C(O)/C=C\C(=O)O	RPUBHMMISKEXSR-MLCLTIQSSA-N	InChI=1S/C17H19N3.C4H4O4/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20;5-3(6)1-2-4(7)8/h2-8,16H,9-12H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t16-;/m1./s1	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL2107339	ESMIRTAZAPINE MALEATE	CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1.O=C(O)/C=C\C(=O)O	RPUBHMMISKEXSR-MLCLTIQSSA-N	InChI=1S/C17H19N3.C4H4O4/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20;5-3(6)1-2-4(7)8/h2-8,16H,9-12H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t16-;/m1./s1	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL2107339	ESMIRTAZAPINE MALEATE	CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1.O=C(O)/C=C\C(=O)O	RPUBHMMISKEXSR-MLCLTIQSSA-N	InChI=1S/C17H19N3.C4H4O4/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20;5-3(6)1-2-4(7)8/h2-8,16H,9-12H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t16-;/m1./s1	Adrenergic receptor alpha-2 antagonist	ANTAGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL2107349	LECOZOTAN HYDROCHLORIDE	C[C@H](CN(C(=O)c1ccc(C#N)cc1)c1ccccn1)N1CCN(c2cccc3c2OCCO3)CC1.Cl	GXYZREDEYDFJPT-ZMBIFBSDSA-N	InChI=1S/C28H29N5O3.ClH/c1-21(31-13-15-32(16-14-31)24-5-4-6-25-27(24)36-18-17-35-25)20-33(26-7-2-3-12-30-26)28(34)23-10-8-22(19-29)9-11-23;/h2-12,21H,13-18,20H2,1H3;1H/t21-;/m1./s1	Serotonin 1a (5-HT1a) receptor antagonist	ANTAGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL2107384	VICRIVIROC MALEATE	COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C.O=C(O)/C=C\C(=O)O	GXINKQQWHLIBJA-UCIBKFKQSA-N	InChI=1S/C28H38F3N5O2.C4H4O4/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3;5-3(6)1-2-4(7)8/h6-9,18-19,24H,10-17H2,1-5H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t19-,24-;/m0./s1	C-C chemokine receptor type 5 antagonist	ANTAGONIST	CHEMBL274	C-C chemokine receptor type 5	Homo sapiens
CHEMBL2110730	POMAGLUMETAD METHIONIL	CSCC[C@H](N)C(=O)N[C@@]1(C(=O)O)CS(=O)(=O)[C@H]2[C@H](C(=O)O)[C@H]21	VOYCNOJFAJAILW-CAMHOICYSA-N	InChI=1S/C12H18N2O7S2/c1-22-3-2-5(13)9(15)14-12(11(18)19)4-23(20,21)8-6(7(8)12)10(16)17/h5-8H,2-4,13H2,1H3,(H,14,15)(H,16,17)(H,18,19)/t5-,6+,7+,8-,12-/m0/s1	Metabotropic glutamate receptor 2 agonist	AGONIST	CHEMBL5137	Metabotropic glutamate receptor 2	Homo sapiens
CHEMBL2110730	POMAGLUMETAD METHIONIL	CSCC[C@H](N)C(=O)N[C@@]1(C(=O)O)CS(=O)(=O)[C@H]2[C@H](C(=O)O)[C@H]21	VOYCNOJFAJAILW-CAMHOICYSA-N	InChI=1S/C12H18N2O7S2/c1-22-3-2-5(13)9(15)14-12(11(18)19)4-23(20,21)8-6(7(8)12)10(16)17/h5-8H,2-4,13H2,1H3,(H,14,15)(H,16,17)(H,18,19)/t5-,6+,7+,8-,12-/m0/s1	Metabotropic glutamate receptor 3 agonist	AGONIST	CHEMBL2888	Metabotropic glutamate receptor 3	Homo sapiens
CHEMBL2146110	SARIZOTAN HYDROCHLORIDE	Cl.Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1	QDLVYMYXOLGZOD-ZMBIFBSDSA-N	InChI=1S/C22H21FN2O.ClH/c23-20-8-5-17(6-9-20)19-11-16(12-24-14-19)13-25-15-21-10-7-18-3-1-2-4-22(18)26-21;/h1-6,8-9,11-12,14,21,25H,7,10,13,15H2;1H/t21-;/m1./s1	Serotonin 1a (5-HT1a) receptor agonist	AGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL2146110	SARIZOTAN HYDROCHLORIDE	Cl.Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1	QDLVYMYXOLGZOD-ZMBIFBSDSA-N	InChI=1S/C22H21FN2O.ClH/c23-20-8-5-17(6-9-20)19-11-16(12-24-14-19)13-25-15-21-10-7-18-3-1-2-4-22(18)26-21;/h1-6,8-9,11-12,14,21,25H,7,10,13,15H2;1H/t21-;/m1./s1	Dopamine D2 receptor partial agonist	PARTIAL AGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL2146110	SARIZOTAN HYDROCHLORIDE	Cl.Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1	QDLVYMYXOLGZOD-ZMBIFBSDSA-N	InChI=1S/C22H21FN2O.ClH/c23-20-8-5-17(6-9-20)19-11-16(12-24-14-19)13-25-15-21-10-7-18-3-1-2-4-22(18)26-21;/h1-6,8-9,11-12,14,21,25H,7,10,13,15H2;1H/t21-;/m1./s1	Dopamine D3 receptor agonist	AGONIST	CHEMBL234	Dopamine D3 receptor	Homo sapiens
CHEMBL2146110	SARIZOTAN HYDROCHLORIDE	Cl.Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1	QDLVYMYXOLGZOD-ZMBIFBSDSA-N	InChI=1S/C22H21FN2O.ClH/c23-20-8-5-17(6-9-20)19-11-16(12-24-14-19)13-25-15-21-10-7-18-3-1-2-4-22(18)26-21;/h1-6,8-9,11-12,14,21,25H,7,10,13,15H2;1H/t21-;/m1./s1	Dopamine D4 receptor agonist	AGONIST	CHEMBL219	Dopamine D4 receptor	Homo sapiens
CHEMBL2178578	VERCIRNON	CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(Cl)cc2C(=O)c2cc[n+]([O-])cc2)cc1	JRWROCIMSDXGOZ-UHFFFAOYSA-N	InChI=1S/C22H21ClN2O4S/c1-22(2,3)16-4-7-18(8-5-16)30(28,29)24-20-9-6-17(23)14-19(20)21(26)15-10-12-25(27)13-11-15/h4-14,24H,1-3H3	C-C chemokine receptor type 9 antagonist	ANTAGONIST	CHEMBL5815	C-C chemokine receptor type 9	Homo sapiens
CHEMBL220360	TARANABANT	C[C@H](NC(=O)C(C)(C)Oc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1	QLYKJCMUNUWAGO-GAJHUEQPSA-N	InChI=1S/C27H25ClF3N3O2/c1-17(34-25(35)26(2,3)36-24-12-9-21(16-33-24)27(29,30)31)23(14-18-7-10-22(28)11-8-18)20-6-4-5-19(13-20)15-32/h4-13,16-17,23H,14H2,1-3H3,(H,34,35)/t17-,23+/m0/s1	Cannabinoid CB1 receptor inverse agonist	INVERSE AGONIST	CHEMBL218	Cannabinoid CB1 receptor	Homo sapiens
CHEMBL2336071	SIPONIMOD	CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1	KIHYPELVXPAIDH-HNSNBQBZSA-N	InChI=1S/C29H35F3N2O3/c1-3-21-14-23(10-11-24(21)15-34-16-25(17-34)28(35)36)19(2)33-37-18-20-9-12-26(22-7-5-4-6-8-22)27(13-20)29(30,31)32/h9-14,22,25H,3-8,15-18H2,1-2H3,(H,35,36)/b33-19+	Sphingosine 1-phosphate receptor Edg-1 agonist	AGONIST	CHEMBL4333	Sphingosine 1-phosphate receptor Edg-1	Homo sapiens
CHEMBL2364612	LATANOPROSTENE BUNOD	O=C(CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1)OCCCCO[N+](=O)[O-]	LOVMMUBRQUFEAH-UIEAZXIASA-N	InChI=1S/C27H41NO8/c29-22(15-14-21-10-4-3-5-11-21)16-17-24-23(25(30)20-26(24)31)12-6-1-2-7-13-27(32)35-18-8-9-19-36-28(33)34/h1,3-6,10-11,22-26,29-31H,2,7-9,12-20H2/b6-1-/t22-,23+,24+,25-,26+/m0/s1	Prostanoid FP receptor agonist	AGONIST	CHEMBL1987	Prostanoid FP receptor	Homo sapiens
CHEMBL236593	TELCAGEPANT	O=C(N[C@@H]1CC[C@@H](c2cccc(F)c2F)CN(CC(F)(F)F)C1=O)N1CCC(n2c(O)nc3ncccc32)CC1	CGDZXLJGHVKVIE-DNVCBOLYSA-N	InChI=1S/C26H27F5N6O3/c27-18-4-1-3-17(21(18)28)15-6-7-19(23(38)36(13-15)14-26(29,30)31)33-24(39)35-11-8-16(9-12-35)37-20-5-2-10-32-22(20)34-25(37)40/h1-5,10,15-16,19H,6-9,11-14H2,(H,33,39)(H,32,34,40)/t15-,19-/m1/s1	Calcitonin gene-related peptide type 1 receptor antagonist	ANTAGONIST	CHEMBL3798	Calcitonin gene-related peptide type 1 receptor	Homo sapiens
CHEMBL240624	PRELADENANT	COCCOc1ccc(N2CCN(CCn3ncc4c3nc(N)n3nc(-c5ccco5)nc43)CC2)cc1	DTYWJKSSUANMHD-UHFFFAOYSA-N	InChI=1S/C25H29N9O3/c1-35-15-16-36-19-6-4-18(5-7-19)32-11-8-31(9-12-32)10-13-33-23-20(17-27-33)24-28-22(21-3-2-14-37-21)30-34(24)25(26)29-23/h2-7,14,17H,8-13,15-16H2,1H3,(H2,26,29)	Adenosine A2a receptor antagonist	ANTAGONIST	CHEMBL251	Adenosine A2a receptor	Homo sapiens
CHEMBL278623	MACIMORELIN	CC(C)(N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)NC=O	UJVDJAPJQWZRFR-DHIUTWEWSA-N	InChI=1S/C26H30N6O3/c1-26(2,27)25(35)31-22(11-16-13-28-20-9-5-3-7-18(16)20)24(34)32-23(30-15-33)12-17-14-29-21-10-6-4-8-19(17)21/h3-10,13-15,22-23,28-29H,11-12,27H2,1-2H3,(H,30,33)(H,31,35)(H,32,34)/t22-,23-/m1/s1	Ghrelin receptor agonist	AGONIST	CHEMBL4616	Ghrelin receptor	Homo sapiens
CHEMBL3039511	BEVENOPRAN	COc1cc(CNCCC2CCOCC2)ccc1Oc1cnc(C(N)=O)cn1	ZGCYVRNZWGUXNQ-UHFFFAOYSA-N	InChI=1S/C20H26N4O4/c1-26-18-10-15(11-22-7-4-14-5-8-27-9-6-14)2-3-17(18)28-19-13-23-16(12-24-19)20(21)25/h2-3,10,12-14,22H,4-9,11H2,1H3,(H2,21,25)	Mu opioid receptor antagonist	ANTAGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL3137314	ESUBERAPROST	CC#CC[C@H](C)[C@H](O)/C=C/[C@@H]1[C@H]2c3cccc(CCCC(=O)O)c3O[C@H]2C[C@H]1O	CTPOHARTNNSRSR-NOQAJONNSA-N	InChI=1S/C24H30O5/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28)/b13-12+/t15-,17-,19+,20+,21-,23-/m0/s1	Prostanoid IP receptor agonist	AGONIST	CHEMBL1995	Prostanoid IP receptor	Homo sapiens
CHEMBL3286580	IDALOPIRDINE	Fc1ccc2c(CCNCc3cccc(OCC(F)(F)C(F)F)c3)c[nH]c2c1	YBAWYTYNMZWMMJ-UHFFFAOYSA-N	InChI=1S/C20H19F5N2O/c21-15-4-5-17-14(11-27-18(17)9-15)6-7-26-10-13-2-1-3-16(8-13)28-12-20(24,25)19(22)23/h1-5,8-9,11,19,26-27H,6-7,10,12H2	Serotonin 6 (5-HT6) receptor antagonist	ANTAGONIST	CHEMBL3371	Serotonin 6 (5-HT6) receptor	Homo sapiens
CHEMBL414157	TONAPOFYLLINE	CCCn1c(=O)c2nc(C34CCC(CCC(=O)O)(CC3)CC4)[nH]c2n(CCC)c1=O	ZWTVVWUOTJRXKM-UHFFFAOYSA-N	InChI=1S/C22H32N4O4/c1-3-13-25-17-16(18(29)26(14-4-2)20(25)30)23-19(24-17)22-10-7-21(8-11-22,9-12-22)6-5-15(27)28/h3-14H2,1-2H3,(H,23,24)(H,27,28)	Adenosine A1 receptor antagonist	ANTAGONIST	CHEMBL226	Adenosine A1 receptor	Homo sapiens
CHEMBL462605	PITOLISANT	Clc1ccc(CCCOCCCN2CCCCC2)cc1	NNACHAUCXXVJSP-UHFFFAOYSA-N	InChI=1S/C17H26ClNO/c18-17-9-7-16(8-10-17)6-4-14-20-15-5-13-19-11-2-1-3-12-19/h7-10H,1-6,11-15H2	Histamine H3 receptor inverse agonist	INVERSE AGONIST	CHEMBL264	Histamine H3 receptor	Homo sapiens
CHEMBL482950	PEXACERFONT	CC[C@@H](C)Nc1nc(C)nc2c(-c3ccc(OC)nc3C)c(C)nn12	LBWQSAZEYIZZCE-SNVBAGLBSA-N	InChI=1S/C18H24N6O/c1-7-10(2)19-18-22-13(5)21-17-16(12(4)23-24(17)18)14-8-9-15(25-6)20-11(14)3/h8-10H,7H2,1-6H3,(H,19,21,22)/t10-/m1/s1	Corticotropin releasing factor receptor 1 antagonist	ANTAGONIST	CHEMBL1800	Corticotropin releasing factor receptor 1	Homo sapiens
CHEMBL52333	ROLOFYLLINE	CCCn1c(=O)c2nc(C34CC5CC(CC3C5)C4)[nH]c2n(CCC)c1=O	PJBFVWGQFLYWCB-UHFFFAOYSA-N	InChI=1S/C20H28N4O2/c1-3-5-23-16-15(17(25)24(6-4-2)19(23)26)21-18(22-16)20-10-12-7-13(11-20)9-14(20)8-12/h12-14H,3-11H2,1-2H3,(H,21,22)	Adenosine A1 receptor antagonist	ANTAGONIST	CHEMBL226	Adenosine A1 receptor	Homo sapiens
CHEMBL545437	AMIBEGRON HYDROCHLORIDE	CCOC(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1cccc(Cl)c1)CC2.Cl	NQIZCDQCNYCVAS-RQBPZYBGSA-N	InChI=1S/C22H26ClNO4.ClH/c1-2-27-22(26)14-28-20-9-7-15-6-8-19(11-17(15)12-20)24-13-21(25)16-4-3-5-18(23)10-16;/h3-5,7,9-10,12,19,21,24-25H,2,6,8,11,13-14H2,1H3;1H/t19-,21-;/m0./s1	Beta-3 adrenergic receptor agonist	AGONIST	CHEMBL246	Beta-3 adrenergic receptor	Homo sapiens
CHEMBL2106068	ATRASENTAN HYDROCHLORIDE	CCCCN(CCCC)C(=O)CN1C[C@H](c2ccc3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1c1ccc(OC)cc1.Cl	IJFUJIFSUKPWCZ-SQMFDTLJSA-N	InChI=1S/C29H38N2O6.ClH/c1-4-6-14-30(15-7-5-2)26(32)18-31-17-23(21-10-13-24-25(16-21)37-19-36-24)27(29(33)34)28(31)20-8-11-22(35-3)12-9-20;/h8-13,16,23,27-28H,4-7,14-15,17-19H2,1-3H3,(H,33,34);1H/t23-,27-,28+;/m1./s1	Endothelin receptor ET-A antagonist	ANTAGONIST	CHEMBL252	Endothelin receptor ET-A	Homo sapiens
CHEMBL3989873	PICLIDENOSON	CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4ccc(I)cc4)ncnc32)[C@H](O)[C@@H]1O	JTZRECOPNKCRTE-MOROJQBDSA-N	InChI=1S/C18H19IN6O4/c1-20-17(28)14-12(26)13(27)18(29-14)25-8-24-11-15(22-7-23-16(11)25)21-6-9-2-4-10(19)5-3-9/h2-5,7-8,12-14,18,26-27H,6H2,1H3,(H,20,28)(H,21,22,23)/t12-,13+,14-,18+/m0/s1	Adenosine A3 receptor agonist	AGONIST	CHEMBL256	Adenosine A3 receptor	Homo sapiens
CHEMBL2364605	CEBRANOPADOL	CN(C)[C@]1(c2ccccc2)CC[C@]2(CC1)OCCc1c3cc(F)ccc3[nH]c12	CSMVOZKEWSOFER-RQNOJGIXSA-N	InChI=1S/C24H27FN2O/c1-27(2)23(17-6-4-3-5-7-17)11-13-24(14-12-23)22-19(10-15-28-24)20-16-18(25)8-9-21(20)26-22/h3-9,16,26H,10-15H2,1-2H3/t23-,24-	Nociceptin receptor agonist	AGONIST	CHEMBL2014	Nociceptin receptor	Homo sapiens
CHEMBL2364605	CEBRANOPADOL	CN(C)[C@]1(c2ccccc2)CC[C@]2(CC1)OCCc1c3cc(F)ccc3[nH]c12	CSMVOZKEWSOFER-RQNOJGIXSA-N	InChI=1S/C24H27FN2O/c1-27(2)23(17-6-4-3-5-7-17)11-13-24(14-12-23)22-19(10-15-28-24)20-16-18(25)8-9-21(20)26-22/h3-9,16,26H,10-15H2,1-2H3/t23-,24-	Opioid receptors; mu/kappa/delta agonist	AGONIST	CHEMBL2095181	Opioid receptors; mu/kappa/delta	Homo sapiens
CHEMBL2448613	PIMAVANSERIN TARTRATE	CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1.CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1.O=C(O)C(O)C(O)C(=O)O	RGSULKHNAKTFIZ-UHFFFAOYSA-N	InChI=1S/2C25H34FN3O2.C4H6O6/c2*1-19(2)18-31-24-10-6-20(7-11-24)16-27-25(30)29(23-12-14-28(3)15-13-23)17-21-4-8-22(26)9-5-21;5-1(3(7)8)2(6)4(9)10/h2*4-11,19,23H,12-18H2,1-3H3,(H,27,30);1-2,5-6H,(H,7,8)(H,9,10)	Serotonin 2a (5-HT2a) receptor inverse agonist	INVERSE AGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL266125	IBODUTANT	Cc1ccc2cc(C(=O)NC3(C(=O)N[C@H](Cc4ccccc4)C(=O)NCC4CCN(CC5CCOCC5)CC4)CCCC3)sc2c1	YQYSVMKCMIUCHY-WJOKGBTCSA-N	InChI=1S/C37H48N4O4S/c1-26-9-10-30-23-33(46-32(30)21-26)35(43)40-37(15-5-6-16-37)36(44)39-31(22-27-7-3-2-4-8-27)34(42)38-24-28-11-17-41(18-12-28)25-29-13-19-45-20-14-29/h2-4,7-10,21,23,28-29,31H,5-6,11-20,22,24-25H2,1H3,(H,38,42)(H,39,44)(H,40,43)/t31-/m1/s1	Neurokinin 2 receptor antagonist	ANTAGONIST	CHEMBL2327	Neurokinin 2 receptor	Homo sapiens
CHEMBL74355	VOLINANSERIN	COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC	HXTGXYRHXAGCFP-OAQYLSRUSA-N	InChI=1S/C22H28FNO3/c1-26-20-5-3-4-19(22(20)27-2)21(25)17-11-14-24(15-12-17)13-10-16-6-8-18(23)9-7-16/h3-9,17,21,25H,10-15H2,1-2H3/t21-/m1/s1	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL61780	TEZOSENTAN	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)C)cn2)nc(-c2ccnc(-c3nn[nH]n3)c2)nc1OCCO	TUYWTLTWNJOZNY-UHFFFAOYSA-N	InChI=1S/C27H27N9O6S/c1-16(2)18-8-9-22(29-15-18)43(38,39)34-26-23(42-21-7-5-4-6-20(21)40-3)27(41-13-12-37)31-24(30-26)17-10-11-28-19(14-17)25-32-35-36-33-25/h4-11,14-16,37H,12-13H2,1-3H3,(H,30,31,34)(H,32,33,35,36)	Endothelin receptor ET-A antagonist	ANTAGONIST	CHEMBL252	Endothelin receptor ET-A	Homo sapiens
CHEMBL61780	TEZOSENTAN	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)C)cn2)nc(-c2ccnc(-c3nn[nH]n3)c2)nc1OCCO	TUYWTLTWNJOZNY-UHFFFAOYSA-N	InChI=1S/C27H27N9O6S/c1-16(2)18-8-9-22(29-15-18)43(38,39)34-26-23(42-21-7-5-4-6-20(21)40-3)27(41-13-12-37)31-24(30-26)17-10-11-28-19(14-17)25-32-35-36-33-25/h4-11,14-16,37H,12-13H2,1-3H3,(H,30,31,34)(H,32,33,35,36)	Endothelin receptor ET-B antagonist	ANTAGONIST	CHEMBL1785	Endothelin receptor ET-B	Homo sapiens
CHEMBL2107786	TERUTROBAN	Cc1ccc2c(c1CCC(=O)O)CC[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)C2	HWEOXFSBSQIWSY-MRXNPFEDSA-N	InChI=1S/C20H22ClNO4S/c1-13-2-3-14-12-16(6-9-19(14)18(13)10-11-20(23)24)22-27(25,26)17-7-4-15(21)5-8-17/h2-5,7-8,16,22H,6,9-12H2,1H3,(H,23,24)/t16-/m1/s1	Thromboxane A2 receptor antagonist	ANTAGONIST	CHEMBL2069	Thromboxane A2 receptor	Homo sapiens
CHEMBL2107777	SATAVAPTAN	CCOc1ccc2c(c1)[C@]1(CC[C@H](CCN3CCOCC3)CC1)C(=O)N2S(=O)(=O)c1ccc(C(=O)NC(C)(C)C)cc1OC	CDSBFDCCJJDFCV-CKZSCMLPSA-N	InChI=1S/C33H45N3O7S/c1-6-43-25-8-9-27-26(22-25)33(14-11-23(12-15-33)13-16-35-17-19-42-20-18-35)31(38)36(27)44(39,40)29-10-7-24(21-28(29)41-5)30(37)34-32(2,3)4/h7-10,21-23H,6,11-20H2,1-5H3,(H,34,37)/t23-,33+	Vasopressin V2 receptor antagonist	ANTAGONIST	CHEMBL1790	Vasopressin V2 receptor	Homo sapiens
CHEMBL3989834	AVOSENTAN	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccncc2)nc1OC	YBWLTKFZAOSWSM-UHFFFAOYSA-N	InChI=1S/C23H21N5O5S/c1-15-8-9-19(25-14-15)34(29,30)28-22-20(33-18-7-5-4-6-17(18)31-2)23(32-3)27-21(26-22)16-10-12-24-13-11-16/h4-14H,1-3H3,(H,26,27,28)	Endothelin receptor ET-A antagonist	ANTAGONIST	CHEMBL252	Endothelin receptor ET-A	Homo sapiens
CHEMBL2107773	RITOBEGRON	Cc1cc(OCC(=O)O)c(C)cc1CCN[C@@H](C)[C@H](O)c1ccc(O)cc1	VMMYRRFPMAGXNP-BTYIYWSLSA-N	InChI=1S/C21H27NO5/c1-13-11-19(27-12-20(24)25)14(2)10-17(13)8-9-22-15(3)21(26)16-4-6-18(23)7-5-16/h4-7,10-11,15,21-23,26H,8-9,12H2,1-3H3,(H,24,25)/t15-,21-/m0/s1	Beta-3 adrenergic receptor agonist	AGONIST	CHEMBL246	Beta-3 adrenergic receptor	Homo sapiens
CHEMBL3989686	IFERANSERIN	CN1CCCC[C@H]1CCc1ccccc1NC(=O)/C=C/c1ccccc1	UXIPFQUBOVWAQW-UEBLJOKOSA-N	InChI=1S/C23H28N2O/c1-25-18-8-7-12-21(25)16-15-20-11-5-6-13-22(20)24-23(26)17-14-19-9-3-2-4-10-19/h2-6,9-11,13-14,17,21H,7-8,12,15-16,18H2,1H3,(H,24,26)/b17-14+/t21-/m0/s1	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL109648	CLAZOSENTAN	COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccnc(-c3nn[nH]n3)c2)nc1OCCO	LFWCJABOXHSRGC-UHFFFAOYSA-N	InChI=1S/C25H23N9O6S/c1-15-7-8-20(27-14-15)41(36,37)32-24-21(40-19-6-4-3-5-18(19)38-2)25(39-12-11-35)29-22(28-24)16-9-10-26-17(13-16)23-30-33-34-31-23/h3-10,13-14,35H,11-12H2,1-2H3,(H,28,29,32)(H,30,31,33,34)	Endothelin receptor ET-A antagonist	ANTAGONIST	CHEMBL252	Endothelin receptor ET-A	Homo sapiens
CHEMBL506981	REMINERTANT	COc1cccc(OC)c1-c1cc(C(=O)NC2(C(=O)O)C3CC4CC(C3)CC2C4)nn1-c1ccnc2cc(Cl)ccc12	DYLJVOXRWLXDIG-UHFFFAOYSA-N	InChI=1S/C32H31ClN4O5/c1-41-27-4-3-5-28(42-2)29(27)26-16-24(36-37(26)25-8-9-34-23-15-21(33)6-7-22(23)25)30(38)35-32(31(39)40)19-11-17-10-18(13-19)14-20(32)12-17/h3-9,15-20H,10-14H2,1-2H3,(H,35,38)(H,39,40)	Neurotensin receptor 1 antagonist	ANTAGONIST	CHEMBL4123	Neurotensin receptor 1	Homo sapiens
CHEMBL1742408	OSEMOZOTAN	c1ccc2c(c1)OC[C@H](CNCCCOc1ccc3c(c1)OCO3)O2	MEEQBDCQPIZMLY-HNNXBMFYSA-N	InChI=1S/C19H21NO5/c1-2-5-18-16(4-1)22-12-15(25-18)11-20-8-3-9-21-14-6-7-17-19(10-14)24-13-23-17/h1-2,4-7,10,15,20H,3,8-9,11-13H2/t15-/m0/s1	Serotonin 1a (5-HT1a) receptor agonist	AGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL49429	LIXIVAPTAN	Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1	PPHTXRNHTVLQED-UHFFFAOYSA-N	InChI=1S/C27H21ClFN3O2/c1-17-8-9-19(29)13-23(17)26(33)30-20-10-11-22(24(28)14-20)27(34)32-16-21-6-4-12-31(21)15-18-5-2-3-7-25(18)32/h2-14H,15-16H2,1H3,(H,30,33)	Vasopressin V2 receptor antagonist	ANTAGONIST	CHEMBL1790	Vasopressin V2 receptor	Homo sapiens
CHEMBL23261	DARUSENTAN	COc1cc(OC)nc(O[C@H](C(=O)O)C(OC)(c2ccccc2)c2ccccc2)n1	FEJVSJIALLTFRP-LJQANCHMSA-N	InChI=1S/C22H22N2O6/c1-27-17-14-18(28-2)24-21(23-17)30-19(20(25)26)22(29-3,15-10-6-4-7-11-15)16-12-8-5-9-13-16/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1	Endothelin receptor ET-A antagonist	ANTAGONIST	CHEMBL252	Endothelin receptor ET-A	Homo sapiens
CHEMBL23261	DARUSENTAN	COc1cc(OC)nc(O[C@H](C(=O)O)C(OC)(c2ccccc2)c2ccccc2)n1	FEJVSJIALLTFRP-LJQANCHMSA-N	InChI=1S/C22H22N2O6/c1-27-17-14-18(28-2)24-21(23-17)30-19(20(25)26)22(29-3,15-10-6-4-7-11-15)16-12-8-5-9-13-16/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1	Endothelin receptor ET-B antagonist	ANTAGONIST	CHEMBL1785	Endothelin receptor ET-B	Homo sapiens
CHEMBL2070241	BREMELANOTIDE	CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O	FFHBJDQSGDNCIV-MFVUMRCOSA-N	InChI=1S/C50H68N14O10/c1-3-4-16-35(58-29(2)65)43(67)64-41-25-42(66)54-20-11-10-18-37(49(73)74)60-46(70)39(23-31-26-56-34-17-9-8-15-33(31)34)62-44(68)36(19-12-21-55-50(51)52)59-45(69)38(22-30-13-6-5-7-14-30)61-47(71)40(63-48(41)72)24-32-27-53-28-57-32/h5-9,13-15,17,26-28,35-41,56H,3-4,10-12,16,18-25H2,1-2H3,(H,53,57)(H,54,66)(H,58,65)(H,59,69)(H,60,70)(H,61,71)(H,62,68)(H,63,72)(H,64,67)(H,73,74)(H4,51,52,55)/t35-,36-,37-,38+,39-,40-,41-/m0/s1	Melanocortin receptor 4 agonist	AGONIST	CHEMBL259	Melanocortin receptor 4	Homo sapiens
CHEMBL3545184	VELCALCETIDE	CC(=O)N[C@H](CSSC[C@H](N)C(=O)O)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(N)=O	ANIAZGVDEUQPRI-ZJQCGQFWSA-N	InChI=1S/C38H73N21O10S2/c1-18(28(62)56-22(27(40)61)8-4-12-49-35(41)42)53-30(64)23(9-5-13-50-36(43)44)58-32(66)25(11-7-15-52-38(47)48)59-31(65)24(10-6-14-51-37(45)46)57-29(63)19(2)54-33(67)26(55-20(3)60)17-71-70-16-21(39)34(68)69/h18-19,21-26H,4-17,39H2,1-3H3,(H2,40,61)(H,53,64)(H,54,67)(H,55,60)(H,56,62)(H,57,63)(H,58,66)(H,59,65)(H,68,69)(H4,41,42,49)(H4,43,44,50)(H4,45,46,51)(H4,47,48,52)/t18-,19-,21+,22-,23-,24-,25-,26-/m1/s1	Calcium sensing receptor agonist	AGONIST	CHEMBL1878	Calcium sensing receptor	Homo sapiens
CHEMBL2103975	VAPREOTIDE	CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(N)=O)NC1=O	SWXOGPJRIDTIRL-KTJGOPLGSA-N	InChI=1S/C57H70N12O9S2/c1-32(2)49-57(78)68-48(55(76)64-44(50(60)71)26-35-28-61-41-16-8-6-14-38(35)41)31-80-79-30-47(67-51(72)40(59)24-33-12-4-3-5-13-33)56(77)65-45(25-34-19-21-37(70)22-20-34)53(74)66-46(27-36-29-62-42-17-9-7-15-39(36)42)54(75)63-43(52(73)69-49)18-10-11-23-58/h3-9,12-17,19-22,28-29,32,40,43-49,61-62,70H,10-11,18,23-27,30-31,58-59H2,1-2H3,(H2,60,71)(H,63,75)(H,64,76)(H,65,77)(H,66,74)(H,67,72)(H,68,78)(H,69,73)/t40-,43+,44+,45-,46+,47+,48+,49+/m1/s1	Somatostatin receptor 2 agonist	AGONIST	CHEMBL1804	Somatostatin receptor 2	Homo sapiens
CHEMBL2103975	VAPREOTIDE	CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(N)=O)NC1=O	SWXOGPJRIDTIRL-KTJGOPLGSA-N	InChI=1S/C57H70N12O9S2/c1-32(2)49-57(78)68-48(55(76)64-44(50(60)71)26-35-28-61-41-16-8-6-14-38(35)41)31-80-79-30-47(67-51(72)40(59)24-33-12-4-3-5-13-33)56(77)65-45(25-34-19-21-37(70)22-20-34)53(74)66-46(27-36-29-62-42-17-9-7-15-39(36)42)54(75)63-43(52(73)69-49)18-10-11-23-58/h3-9,12-17,19-22,28-29,32,40,43-49,61-62,70H,10-11,18,23-27,30-31,58-59H2,1-2H3,(H2,60,71)(H,63,75)(H,64,76)(H,65,77)(H,66,74)(H,67,72)(H,68,78)(H,69,73)/t40-,43+,44+,45-,46+,47+,48+,49+/m1/s1	Somatostatin receptor 3 agonist	AGONIST	CHEMBL2028	Somatostatin receptor 3	Homo sapiens
CHEMBL2103975	VAPREOTIDE	CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(N)=O)NC1=O	SWXOGPJRIDTIRL-KTJGOPLGSA-N	InChI=1S/C57H70N12O9S2/c1-32(2)49-57(78)68-48(55(76)64-44(50(60)71)26-35-28-61-41-16-8-6-14-38(35)41)31-80-79-30-47(67-51(72)40(59)24-33-12-4-3-5-13-33)56(77)65-45(25-34-19-21-37(70)22-20-34)53(74)66-46(27-36-29-62-42-17-9-7-15-39(36)42)54(75)63-43(52(73)69-49)18-10-11-23-58/h3-9,12-17,19-22,28-29,32,40,43-49,61-62,70H,10-11,18,23-27,30-31,58-59H2,1-2H3,(H2,60,71)(H,63,75)(H,64,76)(H,65,77)(H,66,74)(H,67,72)(H,68,78)(H,69,73)/t40-,43+,44+,45-,46+,47+,48+,49+/m1/s1	Somatostatin receptor 5 agonist	AGONIST	CHEMBL1792	Somatostatin receptor 5	Homo sapiens
CHEMBL3544954	ZOPTARELIN DOXORUBICIN	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)COC(=O)CCCC(=O)NCCCC[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1	OOUACICUAVTCEC-LZHWUUGESA-N	InChI=1S/C91H117N19O26/c1-44(2)31-58(83(125)104-57(17-11-29-98-90(94)95)89(131)110-30-12-18-63(110)88(130)100-40-67(93)114)105-81(123)55(16-7-8-28-97-68(115)20-10-21-70(117)134-42-66(113)91(132)36-52-73(65(37-91)136-71-35-53(92)76(118)45(3)135-71)80(122)75-74(78(52)120)77(119)51-14-9-19-64(133-4)72(51)79(75)121)103-84(126)59(32-46-22-24-49(112)25-23-46)106-87(129)62(41-111)109-85(127)60(33-47-38-99-54-15-6-5-13-50(47)54)107-86(128)61(34-48-39-96-43-101-48)108-82(124)56-26-27-69(116)102-56/h5-6,9,13-15,19,22-25,38-39,43-45,53,55-63,65,71,76,99,111-112,118,120,122,132H,7-8,10-12,16-18,20-21,26-37,40-42,92H2,1-4H3,(H2,93,114)(H,96,101)(H,97,115)(H,100,130)(H,102,116)(H,103,126)(H,104,125)(H,105,123)(H,106,129)(H,107,128)(H,108,124)(H,109,127)(H4,94,95,98)/t45-,53-,55+,56-,57-,58-,59-,60-,61-,62-,63-,65-,71-,76+,91-/m0/s1	Gonadotropin-releasing hormone receptor agonist	AGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL596802	PRIDOPIDINE	CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1	YGKUEOZJFIXDGI-UHFFFAOYSA-N	InChI=1S/C15H23NO2S/c1-3-9-16-10-7-13(8-11-16)14-5-4-6-15(12-14)19(2,17)18/h4-6,12-13H,3,7-11H2,1-2H3	Dopamine D2 receptor modulator	MODULATOR	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL2151572	ENCENICLINE	O=C(N[C@H]1CN2CCC1CC2)c1cc2cccc(Cl)c2s1	SSRDSYXGYPJKRR-ZDUSSCGKSA-N	InChI=1S/C16H17ClN2OS/c17-12-3-1-2-11-8-14(21-15(11)12)16(20)18-13-9-19-6-4-10(13)5-7-19/h1-3,8,10,13H,4-7,9H2,(H,18,20)/t13-/m0/s1	Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist	PARTIAL AGONIST	CHEMBL2492	Neuronal acetylcholine receptor protein alpha-7 subunit	Homo sapiens
CHEMBL2107771	RALFINAMIDE	C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O	BHJIBOFHEFDSAU-LBPRGKRZSA-N	InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-6-8-15(9-7-13)22-11-14-4-2-3-5-16(14)18/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1	Voltage-gated N-type calcium channel alpha-1B subunit blocker	BLOCKER	CHEMBL4478	Voltage-gated N-type calcium channel alpha-1B subunit	Homo sapiens
CHEMBL2107771	RALFINAMIDE	C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O	BHJIBOFHEFDSAU-LBPRGKRZSA-N	InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-6-8-15(9-7-13)22-11-14-4-2-3-5-16(14)18/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1	Monoamine oxidase B inhibitor	INHIBITOR	CHEMBL2039	Monoamine oxidase B	Homo sapiens
CHEMBL2107771	RALFINAMIDE	C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O	BHJIBOFHEFDSAU-LBPRGKRZSA-N	InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-6-8-15(9-7-13)22-11-14-4-2-3-5-16(14)18/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL2107771	RALFINAMIDE	C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O	BHJIBOFHEFDSAU-LBPRGKRZSA-N	InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-6-8-15(9-7-13)22-11-14-4-2-3-5-16(14)18/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1	Glutamate [NMDA] receptor antagonist	ANTAGONIST	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL2103881	DEXMECAMYLAMINE	CN[C@@]1(C)[C@@H]2CC[C@@H](C2)C1(C)C	IMYZQPCYWPFTAG-NGZCFLSTSA-N	InChI=1S/C11H21N/c1-10(2)8-5-6-9(7-8)11(10,3)12-4/h8-9,12H,5-7H2,1-4H3/t8-,9+,11-/m0/s1	Neuronal acetylcholine receptor; alpha4/beta2 antagonist	ANTAGONIST	CHEMBL1907589	Neuronal acetylcholine receptor; alpha4/beta2	Homo sapiens
CHEMBL266510	FLINDOKALNER	COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(C(F)(F)F)ccc21	ULYONBAOIMCNEH-HNNXBMFYSA-N	InChI=1S/C16H10ClF4NO2/c1-24-13-5-3-9(17)7-11(13)15(18)10-4-2-8(16(19,20)21)6-12(10)22-14(15)23/h2-7H,1H3,(H,22,23)/t15-/m0/s1	Calcium-activated potassium channel subunit alpha-1 opener	OPENER	CHEMBL4304	Calcium-activated potassium channel subunit alpha-1	Homo sapiens
CHEMBL266510	FLINDOKALNER	COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(C(F)(F)F)ccc21	ULYONBAOIMCNEH-HNNXBMFYSA-N	InChI=1S/C16H10ClF4NO2/c1-24-13-5-3-9(17)7-11(13)15(18)10-4-2-8(16(19,20)21)6-12(10)22-14(15)23/h2-7H,1H3,(H,22,23)/t15-/m0/s1	Voltage-gated potassium channel subunit Kv7.5 activator	ACTIVATOR	CHEMBL2925	Voltage-gated potassium channel subunit Kv7.5	Homo sapiens
CHEMBL266510	FLINDOKALNER	COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(C(F)(F)F)ccc21	ULYONBAOIMCNEH-HNNXBMFYSA-N	InChI=1S/C16H10ClF4NO2/c1-24-13-5-3-9(17)7-11(13)15(18)10-4-2-8(16(19,20)21)6-12(10)22-14(15)23/h2-7H,1H3,(H,22,23)/t15-/m0/s1	Voltage-gated potassium channel subunit Kv7.4 activator	ACTIVATOR	CHEMBL3576	Voltage-gated potassium channel subunit Kv7.4	Homo sapiens
CHEMBL266510	FLINDOKALNER	COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(C(F)(F)F)ccc21	ULYONBAOIMCNEH-HNNXBMFYSA-N	InChI=1S/C16H10ClF4NO2/c1-24-13-5-3-9(17)7-11(13)15(18)10-4-2-8(16(19,20)21)6-12(10)22-14(15)23/h2-7H,1H3,(H,22,23)/t15-/m0/s1	Voltage-gated potassium channel subunit Kv7.2 activator	ACTIVATOR	CHEMBL2476	Voltage-gated potassium channel subunit Kv7.2	Homo sapiens
CHEMBL266510	FLINDOKALNER	COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(C(F)(F)F)ccc21	ULYONBAOIMCNEH-HNNXBMFYSA-N	InChI=1S/C16H10ClF4NO2/c1-24-13-5-3-9(17)7-11(13)15(18)10-4-2-8(16(19,20)21)6-12(10)22-14(15)23/h2-7H,1H3,(H,22,23)/t15-/m0/s1	Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) activator	ACTIVATOR	CHEMBL2221348	Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3)	Homo sapiens
CHEMBL266510	FLINDOKALNER	COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(C(F)(F)F)ccc21	ULYONBAOIMCNEH-HNNXBMFYSA-N	InChI=1S/C16H10ClF4NO2/c1-24-13-5-3-9(17)7-11(13)15(18)10-4-2-8(16(19,20)21)6-12(10)22-14(15)23/h2-7H,1H3,(H,22,23)/t15-/m0/s1	Voltage-gated potassium channel KCNQ3/KCNQ4 activator	ACTIVATOR	CHEMBL3707192	Voltage-gated potassium channel KCNQ3/KCNQ4	Homo sapiens
CHEMBL2386081	SETIPIPRANT	O=C(O)Cn1c2c(c3cc(F)ccc31)CN(C(=O)c1cccc3ccccc13)CC2	IHAXLPDVOWLUOS-UHFFFAOYSA-N	InChI=1S/C24H19FN2O3/c25-16-8-9-21-19(12-16)20-13-26(11-10-22(20)27(21)14-23(28)29)24(30)18-7-3-5-15-4-1-2-6-17(15)18/h1-9,12H,10-11,13-14H2,(H,28,29)	G protein-coupled receptor 44 antagonist	ANTAGONIST	CHEMBL5071	G protein-coupled receptor 44	Homo sapiens
CHEMBL3545043	ASAPIPRANT	CC(C)Oc1ccc(S(=O)(=O)N2CCN(c3ccc(-c4ncco4)c(OCC(=O)O)c3)CC2)cc1	ZMZNWNTZRWXTJU-UHFFFAOYSA-N	InChI=1S/C24H27N3O7S/c1-17(2)34-19-4-6-20(7-5-19)35(30,31)27-12-10-26(11-13-27)18-3-8-21(24-25-9-14-32-24)22(15-18)33-16-23(28)29/h3-9,14-15,17H,10-13,16H2,1-2H3,(H,28,29)	Prostanoid DP receptor antagonist	ANTAGONIST	CHEMBL4427	Prostanoid DP receptor	Homo sapiens
CHEMBL572881	MOTESANIB	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21	RAHBGWKEPAQNFF-UHFFFAOYSA-N	InChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28)	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL572881	MOTESANIB	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21	RAHBGWKEPAQNFF-UHFFFAOYSA-N	InChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28)	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	CHEMBL2041	Tyrosine-protein kinase receptor RET	Homo sapiens
CHEMBL572881	MOTESANIB	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21	RAHBGWKEPAQNFF-UHFFFAOYSA-N	InChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL572881	MOTESANIB	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21	RAHBGWKEPAQNFF-UHFFFAOYSA-N	InChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28)	Platelet-derived growth factor receptor inhibitor	INHIBITOR	CHEMBL2095189	Platelet-derived growth factor receptor	Homo sapiens
CHEMBL3306803	LUMATEPERONE	CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12	HOIIHACBCFLJET-SFTDATJTSA-N	InChI=1S/C24H28FN3O/c1-26-14-15-28-21-11-13-27(16-20(21)19-4-2-5-22(26)24(19)28)12-3-6-23(29)17-7-9-18(25)10-8-17/h2,4-5,7-10,20-21H,3,6,11-16H2,1H3/t20-,21-/m0/s1	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL3306803	LUMATEPERONE	CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12	HOIIHACBCFLJET-SFTDATJTSA-N	InChI=1S/C24H28FN3O/c1-26-14-15-28-21-11-13-27(16-20(21)19-4-2-5-22(26)24(19)28)12-3-6-23(29)17-7-9-18(25)10-8-17/h2,4-5,7-10,20-21H,3,6,11-16H2,1H3/t20-,21-/m0/s1	Dopamine D2 receptor partial agonist	PARTIAL AGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL3306803	LUMATEPERONE	CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12	HOIIHACBCFLJET-SFTDATJTSA-N	InChI=1S/C24H28FN3O/c1-26-14-15-28-21-11-13-27(16-20(21)19-4-2-5-22(26)24(19)28)12-3-6-23(29)17-7-9-18(25)10-8-17/h2,4-5,7-10,20-21H,3,6,11-16H2,1H3/t20-,21-/m0/s1	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL3545257	MIROGABALIN BESYLATE	CCC1=C[C@@H]2[C@H](C1)C[C@]2(CN)CC(=O)O.O=S(=O)(O)c1ccccc1	OKJXJRVWXYRSAN-TXULWXBWSA-N	InChI=1S/C12H19NO2.C6H6O3S/c1-2-8-3-9-5-12(7-13,6-11(14)15)10(9)4-8;7-10(8,9)6-4-2-1-3-5-6/h4,9-10H,2-3,5-7,13H2,1H3,(H,14,15);1-5H,(H,7,8,9)/t9-,10-,12-;/m1./s1	Voltage-gated calcium channel alpha2/delta subunit 1 modulator	MODULATOR	CHEMBL1919	Voltage-gated calcium channel alpha2/delta subunit 1	Homo sapiens
CHEMBL3545257	MIROGABALIN BESYLATE	CCC1=C[C@@H]2[C@H](C1)C[C@]2(CN)CC(=O)O.O=S(=O)(O)c1ccccc1	OKJXJRVWXYRSAN-TXULWXBWSA-N	InChI=1S/C12H19NO2.C6H6O3S/c1-2-8-3-9-5-12(7-13,6-11(14)15)10(9)4-8;7-10(8,9)6-4-2-1-3-5-6/h4,9-10H,2-3,5-7,13H2,1H3,(H,14,15);1-5H,(H,7,8,9)/t9-,10-,12-;/m1./s1	Voltage-gated calcium channel alpha2/delta subunit 2 modulator	MODULATOR	CHEMBL3896	Voltage-gated calcium channel alpha2/delta subunit 2	Homo sapiens
CHEMBL2103836	IMAGABALIN	CCC[C@@H](C)C[C@H](N)CC(=O)O	JXEHXYFSIOYTAH-SFYZADRCSA-N	InChI=1S/C9H19NO2/c1-3-4-7(2)5-8(10)6-9(11)12/h7-8H,3-6,10H2,1-2H3,(H,11,12)/t7-,8+/m1/s1	Voltage-gated calcium channel modulator	MODULATOR	CHEMBL2363032	Voltage-gated calcium channel	Homo sapiens
CHEMBL262075	INDIPLON	CC(=O)N(C)c1cccc(-c2ccnc3c(C(=O)c4cccs4)cnn23)c1	CBIAWPMZSFFRGN-UHFFFAOYSA-N	InChI=1S/C20H16N4O2S/c1-13(25)23(2)15-6-3-5-14(11-15)17-8-9-21-20-16(12-22-24(17)20)19(26)18-7-4-10-27-18/h3-12H,1-2H3	GABA receptor alpha-1 subunit positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL1962	GABA receptor alpha-1 subunit	Homo sapiens
CHEMBL312443	GABOXADOL	Oc1noc2c1CCNC2	ZXRVKCBLGJOCEE-UHFFFAOYSA-N	InChI=1S/C6H8N2O2/c9-6-4-1-2-7-3-5(4)10-8-6/h7H,1-3H2,(H,8,9)	GABA-A receptor; agonist GABA site agonist	AGONIST	CHEMBL2109244	GABA-A receptor; agonist GABA site	Homo sapiens
CHEMBL3039514	ELBASVIR	COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2ccc3c(c2)O[C@@H](c2ccccc2)n2c-3cc3cc(-c4c[nH]c([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)n4)ccc32)c[nH]1)C(C)C	BVAZQCUMNICBAQ-PZHYSIFUSA-N	InChI=1S/C49H55N9O7/c1-27(2)41(54-48(61)63-5)45(59)56-20-10-14-37(56)43-50-25-34(52-43)30-17-19-36-32(22-30)23-39-33-18-16-31(24-40(33)65-47(58(36)39)29-12-8-7-9-13-29)35-26-51-44(53-35)38-15-11-21-57(38)46(60)42(28(3)4)55-49(62)64-6/h7-9,12-13,16-19,22-28,37-38,41-42,47H,10-11,14-15,20-21H2,1-6H3,(H,50,52)(H,51,53)(H,54,61)(H,55,62)/t37-,38-,41-,42-,47-/m0/s1	Nonstructural protein 5A inhibitor	INHIBITOR	CHEMBL3307224	Nonstructural protein 5A	Hepatitis C virus
CHEMBL2063090	GRAZOPREVIR	C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)O[C@@H]1C[C@H]1CCCCCc1nc3ccc(OC)cc3nc1O2)C(=O)NS(=O)(=O)C1CC1	OBMNJSNZOWALQB-NCQNOWPTSA-N	InChI=1S/C38H50N6O9S/c1-6-22-19-38(22,35(47)43-54(49,50)25-13-14-25)42-32(45)29-18-24-20-44(29)34(46)31(37(2,3)4)41-36(48)53-30-16-21(30)10-8-7-9-11-27-33(52-24)40-28-17-23(51-5)12-15-26(28)39-27/h6,12,15,17,21-22,24-25,29-31H,1,7-11,13-14,16,18-20H2,2-5H3,(H,41,48)(H,42,45)(H,43,47)/t21-,22-,24-,29+,30-,31-,38-/m1/s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL607400	BRIVARACETAM	CCC[C@@H]1CC(=O)N([C@@H](CC)C(N)=O)C1	MSYKRHVOOPPJKU-BDAKNGLRSA-N	InChI=1S/C11H20N2O2/c1-3-5-8-6-10(14)13(7-8)9(4-2)11(12)15/h8-9H,3-7H2,1-2H3,(H2,12,15)/t8-,9+/m1/s1	Synaptic vesicle glycoprotein 2A modulator	MODULATOR	CHEMBL1998	Synaptic vesicle glycoprotein 2A	Homo sapiens
CHEMBL3137309	VENETOCLAX	CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1	LQBVNQSMGBZMKD-UHFFFAOYSA-N	InChI=1S/C45H50ClN7O7S/c1-45(2)15-11-33(39(26-45)31-3-5-34(46)6-4-31)29-51-17-19-52(20-18-51)35-7-9-38(42(24-35)60-36-23-32-12-16-47-43(32)49-28-36)44(54)50-61(57,58)37-8-10-40(41(25-37)53(55)56)48-27-30-13-21-59-22-14-30/h3-10,12,16,23-25,28,30,48H,11,13-15,17-22,26-27,29H2,1-2H3,(H,47,49)(H,50,54)	Apoptosis regulator Bcl-2 inhibitor	INHIBITOR	CHEMBL4860	Apoptosis regulator Bcl-2	Homo sapiens
CHEMBL1255654	TETRACAINE HYDROCHLORIDE	CCCCNc1ccc(C(=O)OCCN(C)C)cc1.Cl	PPWHTZKZQNXVAE-UHFFFAOYSA-N	InChI=1S/C15H24N2O2.ClH/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3;/h6-9,16H,4-5,10-12H2,1-3H3;1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL1201341	ECHOTHIOPHATE	CCOP(=O)(OCC)SCC[N+](C)(C)C	BJOLKYGKSZKIGU-UHFFFAOYSA-N	InChI=1S/C9H23NO3PS/c1-6-12-14(11,13-7-2)15-9-8-10(3,4)5/h6-9H2,1-5H3/q+1	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL220	Acetylcholinesterase	Homo sapiens
CHEMBL1083390	INTEPIRDINE	O=S(=O)(c1ccccc1)c1cnc2c(N3CCNCC3)cccc2c1	JJZFWROHYSMCMU-UHFFFAOYSA-N	InChI=1S/C19H19N3O2S/c23-25(24,16-6-2-1-3-7-16)17-13-15-5-4-8-18(19(15)21-14-17)22-11-9-20-10-12-22/h1-8,13-14,20H,9-12H2	Serotonin 6 (5-HT6) receptor antagonist	ANTAGONIST	CHEMBL3371	Serotonin 6 (5-HT6) receptor	Homo sapiens
CHEMBL2111110	TEDISAMIL	C1CCC2(C1)[C@H]1CN(CC3CC3)C[C@@H]2CN(CC2CC2)C1	CTIRHWCPXYGDGF-HDICACEKSA-N	InChI=1S/C19H32N2/c1-2-8-19(7-1)17-11-20(9-15-3-4-15)12-18(19)14-21(13-17)10-16-5-6-16/h15-18H,1-14H2/t17-,18+	Voltage-gated potassium channel blocker	BLOCKER	CHEMBL2362996	Voltage-gated potassium channel	Homo sapiens
CHEMBL2107359	PAFURAMIDINE MALEATE	CONC(=N)c1ccc(-c2ccc(-c3ccc(C(=N)NOC)cc3)o2)cc1.O=C(O)/C=C\C(=O)O	SWMNGXODFOCPKQ-BTJKTKAUSA-N	InChI=1S/C20H20N4O3.C4H4O4/c1-25-23-19(21)15-7-3-13(4-8-15)17-11-12-18(27-17)14-5-9-16(10-6-14)20(22)24-26-2;5-3(6)1-2-4(7)8/h3-12H,1-2H3,(H2,21,23)(H2,22,24);1-2H,(H,5,6)(H,7,8)/b;2-1-	Kinetoplast DNA inhibitor	INHIBITOR	CHEMBL2366047	Kinetoplast DNA	Trypanosoma brucei
CHEMBL1516	OLMESARTAN	CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1	VTRAEEWXHOVJFV-UHFFFAOYSA-N	InChI=1S/C24H26N6O3/c1-4-7-19-25-21(24(2,3)33)20(23(31)32)30(19)14-15-10-12-16(13-11-15)17-8-5-6-9-18(17)22-26-28-29-27-22/h5-6,8-13,33H,4,7,14H2,1-3H3,(H,31,32)(H,26,27,28,29)	Type-1 angiotensin II receptor antagonist	ANTAGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL289228	TIPIFARNIB	Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C	PLHJCIYEEKOWNM-HHHXNRCGSA-N	InChI=1S/C27H22Cl2N4O/c1-32-16-31-15-25(32)27(30,18-6-9-20(28)10-7-18)19-8-11-24-23(13-19)22(14-26(34)33(24)2)17-4-3-5-21(29)12-17/h3-16H,30H2,1-2H3/t27-/m1/s1	Protein farnesyltransferase inhibitor	INHIBITOR	CHEMBL2094108	Protein farnesyltransferase	Homo sapiens
CHEMBL2103778	CILANSETRON	Cc1nccn1C[C@H]1CCc2c(c3cccc4c3n2CCC4)C1=O	NCNFDKWULDWJDS-OAHLLOKOSA-N	InChI=1S/C20H21N3O/c1-13-21-9-11-22(13)12-15-7-8-17-18(20(15)24)16-6-2-4-14-5-3-10-23(17)19(14)16/h2,4,6,9,11,15H,3,5,7-8,10,12H2,1H3/t15-/m1/s1	Serotonin 3 (5-HT3) receptor antagonist	ANTAGONIST	CHEMBL2111332	Serotonin 3 (5-HT3) receptor	Homo sapiens
CHEMBL348475	TARIQUIDAR	COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cc(OC)c(OC)cc3NC(=O)c3cnc4ccccc4c3)cc1)CC2	LGGHDPFKSSRQNS-UHFFFAOYSA-N	InChI=1S/C38H38N4O6/c1-45-33-18-25-14-16-42(23-28(25)19-34(33)46-2)15-13-24-9-11-29(12-10-24)40-38(44)30-20-35(47-3)36(48-4)21-32(30)41-37(43)27-17-26-7-5-6-8-31(26)39-22-27/h5-12,17-22H,13-16,23H2,1-4H3,(H,40,44)(H,41,43)	P-glycoprotein 1 inhibitor	INHIBITOR	CHEMBL4302	P-glycoprotein 1	Homo sapiens
CHEMBL395091	ESKETAMINE	CN[C@]1(c2ccccc2Cl)CCCCC1=O	YQEZLKZALYSWHR-ZDUSSCGKSA-N	InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3/t13-/m0/s1	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL2103793	AGATOLIMOD SODIUM	Cc1cn([C@H]2C[C@H](O)[C@@H](COP([O-])(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP([O-])(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3CO)O2)c(=O)[nH]c1=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]	QUWFSKKBMDKAHK-SBOJBMMISA-A	InChI=1S/C236H303N70O133P23S23.23Na/c1-91-47-287(223(333)269-193(91)309)157-23-105(308)130(394-157)62-370-440(347,463)418-107-25-158(283-19-15-153(237)253-219(283)329)395-131(107)63-372-457(364,480)434-123-41-175(301-85-247-181-187(301)257-213(241)263-207(181)323)412-148(123)80-388-452(359,475)429-118-36-170(296-56-100(10)202(318)278-232(296)342)400-136(118)68-376-442(349,465)419-109-27-160(285-21-17-155(239)255-221(285)331)397-133(109)65-374-459(366,482)436-125-43-177(303-87-249-183-189(303)259-215(243)265-209(183)325)413-149(125)81-389-455(362,478)432-121-39-173(299-59-103(13)205(321)281-235(299)345)407-143(121)75-383-447(354,470)424-114-32-166(292-52-96(6)198(314)274-228(292)338)403-139(114)71-379-445(352,468)422-113-31-165(291-51-95(5)197(313)273-227(291)337)406-142(113)74-382-450(357,473)427-117-35-169(295-55-99(9)201(317)277-231(295)341)410-146(117)78-386-462(369,485)439-128-46-180(306-90-252-186-192(306)262-218(246)268-212(186)328)416-152(128)84-392-454(361,477)431-120-38-172(298-58-102(12)204(320)280-234(298)344)402-138(120)70-378-444(351,467)421-110-28-161(286-22-18-156(240)256-222(286)332)398-134(110)66-375-460(367,483)437-126-44-178(304-88-250-184-190(304)260-216(244)266-210(184)326)414-150(126)82-390-456(363,479)433-122-40-174(300-60-104(14)206(322)282-236(300)346)408-144(122)76-384-448(355,471)425-115-33-167(293-53-97(7)199(315)275-229(293)339)404-140(115)72-380-446(353,469)423-112-30-164(290-50-94(4)196(312)272-226(290)336)405-141(112)73-381-449(356,472)426-116-34-168(294-54-98(8)200(316)276-230(294)340)409-145(116)77-385-461(368,484)438-127-45-179(305-89-251-185-191(305)261-217(245)267-211(185)327)415-151(127)83-391-453(360,476)430-119-37-171(297-57-101(11)203(319)279-233(297)343)401-137(119)69-377-443(350,466)420-108-26-159(284-20-16-154(238)254-220(284)330)396-132(108)64-373-458(365,481)435-124-42-176(302-86-248-182-188(302)258-214(242)264-208(182)324)411-147(124)79-387-451(358,474)428-111-29-163(289-49-93(3)195(311)271-225(289)335)399-135(111)67-371-441(348,464)417-106-24-162(393-129(106)61-307)288-48-92(2)194(310)270-224(288)334;;;;;;;;;;;;;;;;;;;;;;;/h15-22,47-60,85-90,105-152,157-180,307-308H,23-46,61-84H2,1-14H3,(H,347,463)(H,348,464)(H,349,465)(H,350,466)(H,351,467)(H,352,468)(H,353,469)(H,354,470)(H,355,471)(H,356,472)(H,357,473)(H,358,474)(H,359,475)(H,360,476)(H,361,477)(H,362,478)(H,363,479)(H,364,480)(H,365,481)(H,366,482)(H,367,483)(H,368,484)(H,369,485)(H2,237,253,329)(H2,238,254,330)(H2,239,255,331)(H2,240,256,332)(H,269,309,333)(H,270,310,334)(H,271,311,335)(H,272,312,336)(H,273,313,337)(H,274,314,338)(H,275,315,339)(H,276,316,340)(H,277,317,341)(H,278,318,342)(H,279,319,343)(H,280,320,344)(H,281,321,345)(H,282,322,346)(H3,241,257,263,323)(H3,242,258,264,324)(H3,243,259,265,325)(H3,244,260,266,326)(H3,245,261,267,327)(H3,246,262,268,328);;;;;;;;;;;;;;;;;;;;;;;/q;23*+1/p-23/t105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129+,130+,131+,132+,133+,134+,135+,136+,137+,138+,139+,140+,141+,142+,143+,144+,145+,146+,147+,148+,149+,150+,151+,152+,157+,158+,159+,160+,161+,162+,163+,164+,165+,166+,167+,168+,169+,170+,171+,172+,173+,174+,175+,176+,177+,178+,179+,180+,440?,441?,442?,443?,444?,445?,446?,447?,448?,449?,450?,451?,452?,453?,454?,455?,456?,457?,458?,459?,460?,461?,462?;;;;;;;;;;;;;;;;;;;;;;;/m0......................./s1	Toll-like receptor 9 agonist	AGONIST	CHEMBL5804	Toll-like receptor 9	Homo sapiens
CHEMBL1800807	ANACETRAPIB	COc1cc(F)c(C(C)C)cc1-c1ccc(C(F)(F)F)cc1CN1C(=O)O[C@H](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@@H]1C	MZZLGJHLQGUVPN-HAWMADMCSA-N	InChI=1S/C30H25F10NO3/c1-14(2)22-11-23(25(43-4)12-24(22)31)21-6-5-18(28(32,33)34)9-17(21)13-41-15(3)26(44-27(41)42)16-7-19(29(35,36)37)10-20(8-16)30(38,39)40/h5-12,14-15,26H,13H2,1-4H3/t15-,26-/m0/s1	Cholesteryl ester transfer protein inhibitor	INHIBITOR	CHEMBL3572	Cholesteryl ester transfer protein	Homo sapiens
CHEMBL57242	AZILSARTAN	CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2noc(O)n2)cc1	KGSXMPPBFPAXLY-UHFFFAOYSA-N	InChI=1S/C25H20N4O5/c1-2-33-24-26-20-9-5-8-19(23(30)31)21(20)29(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-27-25(32)34-28-22/h3-13H,2,14H2,1H3,(H,30,31)(H,27,28,32)	Type-1 angiotensin II receptor antagonist	ANTAGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL2103796	BERUBICIN HYDROCHLORIDE	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](OCc2ccccc2)[C@H](C)O1.Cl	GPMIHHFZKBVWAZ-LMMKTYIZSA-N	InChI=1S/C34H35NO11.ClH/c1-16-33(44-15-17-7-4-3-5-8-17)20(35)11-24(45-16)46-22-13-34(42,23(37)14-36)12-19-26(22)32(41)28-27(30(19)39)29(38)18-9-6-10-21(43-2)25(18)31(28)40;/h3-10,16,20,22,24,33,36,39,41-42H,11-15,35H2,1-2H3;1H/t16-,20-,22-,24-,33+,34-;/m0./s1	DNA topoisomerase II inhibitor	INHIBITOR	CHEMBL2094255	DNA topoisomerase II	Homo sapiens
CHEMBL512351	BETRIXABAN	COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1	XHOLNRLADUSQLD-UHFFFAOYSA-N	InChI=1S/C23H22ClN5O3/c1-29(2)21(25)14-4-6-15(7-5-14)22(30)27-19-10-9-17(32-3)12-18(19)23(31)28-20-11-8-16(24)13-26-20/h4-13,25H,1-3H3,(H,27,30)(H,26,28,31)	Coagulation factor X inhibitor	INHIBITOR	CHEMBL244	Coagulation factor X	Homo sapiens
CHEMBL313006	DALCETRAPIB	CCC(CC)CC1(C(=O)Nc2ccccc2SC(=O)C(C)C)CCCCC1	YZQLWPMZQVHJED-UHFFFAOYSA-N	InChI=1S/C23H35NO2S/c1-5-18(6-2)16-23(14-10-7-11-15-23)22(26)24-19-12-8-9-13-20(19)27-21(25)17(3)4/h8-9,12-13,17-18H,5-7,10-11,14-16H2,1-4H3,(H,24,26)	Cholesteryl ester transfer protein inhibitor	INHIBITOR	CHEMBL3572	Cholesteryl ester transfer protein	Homo sapiens
CHEMBL2103810	EZATIOSTAT HYDROCHLORIDE	CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c1ccccc1.Cl	XJDYQYNYISTAMO-GFDYFVENSA-N	InChI=1S/C27H35N3O6S.ClH/c1-3-35-26(33)21(28)15-16-23(31)29-22(18-37-17-19-11-7-5-8-12-19)25(32)30-24(27(34)36-4-2)20-13-9-6-10-14-20;/h5-14,21-22,24H,3-4,15-18,28H2,1-2H3,(H,29,31)(H,30,32);1H/t21-,22-,24+;/m0./s1	Glutathione S-transferase Pi inhibitor	INHIBITOR	CHEMBL3902	Glutathione S-transferase Pi	Homo sapiens
CHEMBL49642	INDIBULIN	O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12	SOLIIYNRSAWTSQ-UHFFFAOYSA-N	InChI=1S/C22H16ClN3O2/c23-16-7-5-15(6-8-16)13-26-14-19(18-3-1-2-4-20(18)26)21(27)22(28)25-17-9-11-24-12-10-17/h1-12,14H,13H2,(H,24,25,28)	Tubulin inhibitor	INHIBITOR	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL2103815	LARAZOTIDE ACETATE	CC(=O)O.CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C	NYGCNONRVCGHAT-UFIKZEAMSA-N	InChI=1S/C32H55N9O10.C2H4O2/c1-16(2)12-20(38-30(49)26(17(3)4)39-24(44)14-35-23(43)13-33)28(47)40-27(18(5)6)31(50)37-19(9-10-22(34)42)32(51)41-11-7-8-21(41)29(48)36-15-25(45)46;1-2(3)4/h16-21,26-27H,7-15,33H2,1-6H3,(H2,34,42)(H,35,43)(H,36,48)(H,37,50)(H,38,49)(H,39,44)(H,40,47)(H,45,46);1H3,(H,3,4)/t19-,20-,21-,26-,27-;/m0./s1	Neuronal acetylcholine receptor; alpha3/beta4 partial agonist	PARTIAL AGONIST	CHEMBL1907594	Neuronal acetylcholine receptor; alpha3/beta4	Homo sapiens
CHEMBL481611	ODANACATIB	CC(C)(F)C[C@H](N[C@@H](c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1	FWIVDMJALNEADT-SFTDATJTSA-N	InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1	Cathepsin K inhibitor	INHIBITOR	CHEMBL268	Cathepsin K	Homo sapiens
CHEMBL459505	TALAROZOLE	CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1	SNFYYXUGUBUECJ-UHFFFAOYSA-N	InChI=1S/C21H23N5S/c1-3-15(4-2)20(26-14-22-13-23-26)16-9-11-17(12-10-16)24-21-25-18-7-5-6-8-19(18)27-21/h5-15,20H,3-4H2,1-2H3,(H,24,25)	Cytochrome P450 26A1 inhibitor	INHIBITOR	CHEMBL5141	Cytochrome P450 26A1	Homo sapiens
CHEMBL48361	DABIGATRAN	Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21	YBSJFWOBGCMAKL-UHFFFAOYSA-N	InChI=1S/C25H25N7O3/c1-31-20-10-7-17(25(35)32(13-11-23(33)34)21-4-2-3-12-28-21)14-19(20)30-22(31)15-29-18-8-5-16(6-9-18)24(26)27/h2-10,12,14,29H,11,13,15H2,1H3,(H3,26,27)(H,33,34)	Thrombin inhibitor	INHIBITOR	CHEMBL204	Thrombin	Homo sapiens
CHEMBL2103826	DAVUNETIDE	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O	DWLTUUXCVGVRAV-XWRHUKJGSA-N	InChI=1S/C36H60N10O12/c1-6-18(4)28(35(56)46-14-8-9-23(46)31(52)41-21(36(57)58)11-12-25(38)48)44-30(51)22(16-47)42-33(54)27(17(2)3)43-32(53)24-10-7-13-45(24)34(55)19(5)40-29(50)20(37)15-26(39)49/h17-24,27-28,47H,6-16,37H2,1-5H3,(H2,38,48)(H2,39,49)(H,40,50)(H,41,52)(H,42,54)(H,43,53)(H,44,51)(H,57,58)/t18-,19-,20-,21-,22-,23-,24-,27-,28-/m0/s1	Tubulin stabiliser	STABILISER	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL515387	GOSOGLIPTIN	O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1	QWEWGXUTRTXFRF-KBPBESRZSA-N	InChI=1S/C17H24F2N6O/c18-17(19)2-5-25(12-17)15(26)14-10-13(11-22-14)23-6-8-24(9-7-23)16-20-3-1-4-21-16/h1,3-4,13-14,22H,2,5-12H2/t13-,14-/m0/s1	Dipeptidyl peptidase IV inhibitor	INHIBITOR	CHEMBL284	Dipeptidyl peptidase IV	Homo sapiens
CHEMBL2103831	NAPROXCINOD	COc1ccc2cc([C@H](C)C(=O)OCCCCO[N+](=O)[O-])ccc2c1	AKFJWRDCWYYTIG-ZDUSSCGKSA-N	InChI=1S/C18H21NO6/c1-13(18(20)24-9-3-4-10-25-19(21)22)14-5-6-16-12-17(23-2)8-7-15(16)11-14/h5-8,11-13H,3-4,9-10H2,1-2H3/t13-/m0/s1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL889	PALIFOSFAMIDE	O=P(O)(NCCCl)NCCCl	BKCJZNIZRWYHBN-UHFFFAOYSA-N	InChI=1S/C4H11Cl2N2O2P/c5-1-3-7-11(9,10)8-4-2-6/h1-4H2,(H3,7,8,9,10)	DNA cross-linking agent	CROSS-LINKING AGENT	CHEMBL2311221	DNA	Homo sapiens
CHEMBL2103832	PARDOPRUNOX	CN1CCN(c2cccc3[nH]c(=O)oc23)CC1	YVPUUUDAZYFFQT-UHFFFAOYSA-N	InChI=1S/C12H15N3O2/c1-14-5-7-15(8-6-14)10-4-2-3-9-11(10)17-12(16)13-9/h2-4H,5-8H2,1H3,(H,13,16)	Dopamine receptors; D2 & D3 partial agonist	PARTIAL AGONIST	CHEMBL2095169	Dopamine receptors; D2 & D3	Homo sapiens
CHEMBL148674	VARESPLADIB	CCc1c(C(=O)C(N)=O)c2c(OCC(=O)O)cccc2n1Cc1ccccc1	BHLXTPHDSZUFHR-UHFFFAOYSA-N	InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25)	Phospholipase A2 group IIA inhibitor	INHIBITOR	CHEMBL3474	Phospholipase A2 group IIA	Homo sapiens
CHEMBL2103837	TAFAMIDIS	O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1	TXEIIPDJKFWEEC-UHFFFAOYSA-N	InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H,(H,18,19)	Transthyretin stabiliser	STABILISER	CHEMBL3194	Transthyretin	Homo sapiens
CHEMBL2103839	RIDAFOROLIMUS	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C	BUROJSBIWGDYCN-GAUTUEMISA-N	InChI=1S/C53H84NO14P/c1-32-18-14-13-15-19-33(2)44(63-8)30-40-23-21-38(7)53(61,67-40)50(58)51(59)54-25-17-16-20-41(54)52(60)66-45(35(4)28-39-22-24-43(46(29-39)64-9)68-69(11,12)62)31-42(55)34(3)27-37(6)48(57)49(65-10)47(56)36(5)26-32/h13-15,18-19,27,32,34-36,38-41,43-46,48-49,57,61H,16-17,20-26,28-31H2,1-12H3/b15-13+,18-14+,33-19+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL2103844	PIXANTRONE DIMALEATE	NCCNc1ccc(NCCN)c2c1C(=O)c1ccncc1C2=O.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O	SVAGFBGXEWPNJC-SPIKMXEPSA-N	InChI=1S/C17H19N5O2.2C4H4O4/c18-4-7-21-12-1-2-13(22-8-5-19)15-14(12)16(23)10-3-6-20-9-11(10)17(15)24;2*5-3(6)1-2-4(7)8/h1-3,6,9,21-22H,4-5,7-8,18-19H2;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-	DNA cross-linking agent	CROSS-LINKING AGENT	CHEMBL2311221	DNA	Homo sapiens
CHEMBL2103846	ULIPRISTAL	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C	HKDLNTKNLJPAIY-WKWWZUSTSA-N	InChI=1S/C28H35NO3/c1-17(30)28(32)14-13-25-23-11-7-19-15-21(31)10-12-22(19)26(23)24(16-27(25,28)2)18-5-8-20(9-6-18)29(3)4/h5-6,8-9,15,23-25,32H,7,10-14,16H2,1-4H3/t23-,24+,25-,27-,28-/m0/s1	Progesterone receptor modulator	MODULATOR	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL2103847	TOSEDOSTAT	CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)[C@H](O)C(=O)NO	FWFGIHPGRQZWIW-SQNIBIBYSA-N	InChI=1S/C21H30N2O6/c1-13(2)12-16(18(24)20(26)23-28)19(25)22-17(14-8-4-3-5-9-14)21(27)29-15-10-6-7-11-15/h3-5,8-9,13,15-18,24,28H,6-7,10-12H2,1-2H3,(H,22,25)(H,23,26)/t16-,17+,18+/m1/s1	Aminopeptidase inhibitor	INHIBITOR	CHEMBL3831223	Aminopeptidase	Homo sapiens
CHEMBL2103849	UDENAFIL	CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc2c(CCC)nn(C)c2c(=O)[nH]1	IYFNEFQTYQPVOC-UHFFFAOYSA-N	InChI=1S/C25H36N6O4S/c1-5-8-20-22-23(31(4)29-20)25(32)28-24(27-22)19-16-18(10-11-21(19)35-15-6-2)36(33,34)26-13-12-17-9-7-14-30(17)3/h10-11,16-17,26H,5-9,12-15H2,1-4H3,(H,27,28,32)	Phosphodiesterase 5A inhibitor	INHIBITOR	CHEMBL1827	Phosphodiesterase 5A	Homo sapiens
CHEMBL2103852	CROLIBULIN	COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC	JXONINOYTKKXQQ-CQSZACIVSA-N	InChI=1S/C18H17BrN4O3/c1-24-13-6-8(5-11(19)17(13)25-2)14-9-3-4-12(21)15(22)16(9)26-18(23)10(14)7-20/h3-6,14H,21-23H2,1-2H3/t14-/m1/s1	Tubulin inhibitor	INHIBITOR	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL286738	IROSUSTAT	NS(=O)(=O)Oc1ccc2c3c(c(=O)oc2c1)CCCCC3	DSLPMJSGSBLWRE-UHFFFAOYSA-N	InChI=1S/C14H15NO5S/c15-21(17,18)20-9-6-7-11-10-4-2-1-3-5-12(10)14(16)19-13(11)8-9/h6-8H,1-5H2,(H2,15,17,18)	Steryl-sulfatase inhibitor	INHIBITOR	CHEMBL3559	Steryl-sulfatase	Homo sapiens
CHEMBL2103855	TELOTRISTAT	Cc1ccn(-c2cc(Cl)ccc2[C@@H](Oc2cc(-c3ccc(C[C@H](N)C(=O)O)cc3)nc(N)n2)C(F)(F)F)n1	NCLGDOBQAWBXRA-PGRDOPGGSA-N	InChI=1S/C25H22ClF3N6O3/c1-13-8-9-35(34-13)20-11-16(26)6-7-17(20)22(25(27,28)29)38-21-12-19(32-24(31)33-21)15-4-2-14(3-5-15)10-18(30)23(36)37/h2-9,11-12,18,22H,10,30H2,1H3,(H,36,37)(H2,31,32,33)/t18-,22+/m0/s1	Tryptophan 5-hydroxylase inhibitor	INHIBITOR	CHEMBL3831287	Tryptophan 5-hydroxylase	Homo sapiens
CHEMBL2103857	EDIVOXETINE	COc1ccc(F)cc1C[C@@](O)(C1CCOCC1)[C@@H]1CNCCO1	CPBHSHYQQLFAPW-ZWKOTPCHSA-N	InChI=1S/C18H26FNO4/c1-22-16-3-2-15(19)10-13(16)11-18(21,14-4-7-23-8-5-14)17-12-20-6-9-24-17/h2-3,10,14,17,20-21H,4-9,11-12H2,1H3/t17-,18+/m0/s1	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL218650	DELAMANID	C[C@]1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1	XDAOLTSRNUSPPH-XMMPIXPASA-N	InChI=1S/C25H25F3N4O6/c1-24(15-31-14-22(32(33)34)29-23(31)38-24)16-35-18-4-2-17(3-5-18)30-12-10-20(11-13-30)36-19-6-8-21(9-7-19)37-25(26,27)28/h2-9,14,20H,10-13,15-16H2,1H3/t24-/m1/s1	Mycobacterium tuberculosis H37Rv inhibitor	INHIBITOR	CHEMBL2111188	Mycobacterium tuberculosis H37Rv	Mycobacterium tuberculosis H37Rv
CHEMBL1922660	FIBOFLAPON	CCOc1ccc(-c2ccc(Cn3c(CC(C)(C)C(=O)O)c(SC(C)(C)C)c4cc(OCc5ccc(C)cn5)ccc43)cc2)cn1	DFQGDHBGRSTTHX-UHFFFAOYSA-N	InChI=1S/C38H43N3O4S/c1-8-44-34-18-14-28(22-40-34)27-12-10-26(11-13-27)23-41-32-17-16-30(45-24-29-15-9-25(2)21-39-29)19-31(32)35(46-37(3,4)5)33(41)20-38(6,7)36(42)43/h9-19,21-22H,8,20,23-24H2,1-7H3,(H,42,43)	5-lipoxygenase activating protein inhibitor	INHIBITOR	CHEMBL4550	5-lipoxygenase activating protein	Homo sapiens
CHEMBL552212	LEXIBULIN	CCC[C@H](Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)ncc1C)c1cccnc1	MTJHLONVHHPNSI-IBGZPJMESA-N	InChI=1S/C24H30N6O2/c1-5-8-19(18-9-7-12-25-15-18)28-22-16(3)14-27-23(30-22)17-10-11-20(21(13-17)32-4)29-24(31)26-6-2/h7,9-15,19H,5-6,8H2,1-4H3,(H2,26,29,31)(H,27,28,30)/t19-/m0/s1	Tubulin inhibitor	INHIBITOR	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL2103867	PLECANATIDE	CC(C)C[C@H](NC(=O)[C@@H]1CSSC[C@@H]2NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(N)=O)CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC2=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N1)C(=O)O	NSPHQWLKCGGCQR-DLJDZFDSSA-N	InChI=1S/C65H104N18O26S4/c1-25(2)15-34-55(98)80-41-24-113-110-21-38(58(101)77-37(65(108)109)16-26(3)4)71-44(87)20-69-62(105)50(30(10)84)83-61(104)40(78-51(94)29(9)70-63(106)48(27(5)6)81-57(100)35(18-43(68)86)76-64(107)49(28(7)8)82-60(41)103)23-112-111-22-39(59(102)73-32(53(96)75-34)11-13-45(88)89)79-54(97)33(12-14-46(90)91)72-56(99)36(19-47(92)93)74-52(95)31(66)17-42(67)85/h25-41,48-50,84H,11-24,66H2,1-10H3,(H2,67,85)(H2,68,86)(H,69,105)(H,70,106)(H,71,87)(H,72,99)(H,73,102)(H,74,95)(H,75,96)(H,76,107)(H,77,101)(H,78,94)(H,79,97)(H,80,98)(H,81,100)(H,82,103)(H,83,104)(H,88,89)(H,90,91)(H,92,93)(H,108,109)/t29-,30+,31-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,48-,49-,50-/m0/s1	Heat-stable enterotoxin receptor agonist	AGONIST	CHEMBL1795197	Heat-stable enterotoxin receptor	Homo sapiens
CHEMBL1922673	FIBOFLAPON SODIUM	CCOc1ccc(-c2ccc(Cn3c(CC(C)(C)C(=O)[O-])c(SC(C)(C)C)c4cc(OCc5ccc(C)cn5)ccc43)cc2)cn1.[Na+]	NOJNFULGOQGBKB-UHFFFAOYSA-M	InChI=1S/C38H43N3O4S.Na/c1-8-44-34-18-14-28(22-40-34)27-12-10-26(11-13-27)23-41-32-17-16-30(45-24-29-15-9-25(2)21-39-29)19-31(32)35(46-37(3,4)5)33(41)20-38(6,7)36(42)43;/h9-19,21-22H,8,20,23-24H2,1-7H3,(H,42,43);/q;+1/p-1	5-lipoxygenase activating protein inhibitor	INHIBITOR	CHEMBL4550	5-lipoxygenase activating protein	Homo sapiens
CHEMBL2017179	EVACETRAPIB	Cc1cc(C)c2c(c1)[C@@H](N(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1nnn(C)n1)CCCN2C[C@H]1CC[C@H](C(=O)O)CC1	IHIUGIVXARLYHP-YBXDKENTSA-N	InChI=1S/C31H36F6N6O2/c1-18-11-19(2)27-25(12-18)26(5-4-10-42(27)16-20-6-8-22(9-7-20)28(44)45)43(29-38-40-41(3)39-29)17-21-13-23(30(32,33)34)15-24(14-21)31(35,36)37/h11-15,20,22,26H,4-10,16-17H2,1-3H3,(H,44,45)/t20-,22-,26-/m0/s1	Cholesteryl ester transfer protein inhibitor	INHIBITOR	CHEMBL3572	Cholesteryl ester transfer protein	Homo sapiens
CHEMBL2103879	GANETESPIB	CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O	RVAQIUULWULRNW-UHFFFAOYSA-N	InChI=1S/C20H20N4O3/c1-11(2)14-9-15(18(26)10-17(14)25)19-21-22-20(27)24(19)13-4-5-16-12(8-13)6-7-23(16)3/h4-11,25-26H,1-3H3,(H,22,27)	Heat shock protein HSP90 inhibitor	INHIBITOR	CHEMBL2095165	Heat shock protein HSP90	Homo sapiens
CHEMBL117287	PRUCALOPRIDE	COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1	ZPMNHBXQOOVQJL-UHFFFAOYSA-N	InChI=1S/C18H26ClN3O3/c1-24-9-2-6-22-7-3-12(4-8-22)21-18(23)14-11-15(19)16(20)13-5-10-25-17(13)14/h11-12H,2-10,20H2,1H3,(H,21,23)	Serotonin 4 (5-HT4) receptor agonist	AGONIST	CHEMBL1875	Serotonin 4 (5-HT4) receptor	Homo sapiens
CHEMBL2103883	AVATROMBOPAG	O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1	OFZJKCQENFPZBH-UHFFFAOYSA-N	InChI=1S/C29H34Cl2N6O3S2/c30-20-15-23(41-17-20)24-27(37-12-10-35(11-13-37)21-4-2-1-3-5-21)42-29(33-24)34-26(38)19-14-22(31)25(32-16-19)36-8-6-18(7-9-36)28(39)40/h14-18,21H,1-13H2,(H,39,40)(H,33,34,38)	Thrombopoietin receptor agonist	AGONIST	CHEMBL1864	Thrombopoietin receptor	Homo sapiens
CHEMBL2103884	OPROZOMIB	COC[C@H](NC(=O)c1cnc(C)s1)C(=O)N[C@@H](COC)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1	SWZXEVABPLUDIO-WSZYKNRRSA-N	InChI=1S/C25H32N4O7S/c1-15-26-11-20(37-15)24(33)29-19(13-35-4)23(32)28-18(12-34-3)22(31)27-17(21(30)25(2)14-36-25)10-16-8-6-5-7-9-16/h5-9,11,17-19H,10,12-14H2,1-4H3,(H,27,31)(H,28,32)(H,29,33)/t17-,18-,19-,25+/m0/s1	26S proteosome inhibitor	INHIBITOR	CHEMBL2364701	26S proteasome	Homo sapiens
CHEMBL298734	LONAFARNIB	NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1	DHMTURDWPRKSOA-RUZDIDTESA-N	InChI=1S/C27H31Br2ClN4O2/c28-20-12-19-2-1-18-13-21(30)14-22(29)24(18)25(26(19)32-15-20)17-5-9-33(10-6-17)23(35)11-16-3-7-34(8-4-16)27(31)36/h12-17,25H,1-11H2,(H2,31,36)/t25-/m1/s1	Protein farnesyltransferase inhibitor	INHIBITOR	CHEMBL2094108	Protein farnesyltransferase	Homo sapiens
CHEMBL3301672	ERITORAN TETRASODIUM	CCCCCC/C=C\CCCCCCCCCC(=O)N[C@H]1[C@H](OC[C@H]2O[C@H](OP(=O)([O-])[O-])[C@H](NC(=O)CC(=O)CCCCCCCCCCC)[C@@H](OCCCCCCCCCC)[C@@H]2O)O[C@H](COC)[C@@H](OP(=O)([O-])[O-])[C@@H]1OCC[C@@H](CCCCCCC)OC.[Na+].[Na+].[Na+].[Na+]	FEMINZOAAWPBPP-RHMAUSBNSA-J	InChI=1S/C66H126N2O19P2.4Na/c1-7-11-15-19-22-25-26-27-28-29-30-32-34-38-42-46-57(70)67-60-64(82-49-47-54(80-6)45-41-36-18-14-10-4)62(86-88(73,74)75)56(51-79-5)85-65(60)83-52-55-61(72)63(81-48-43-39-35-24-21-17-13-9-3)59(66(84-55)87-89(76,77)78)68-58(71)50-53(69)44-40-37-33-31-23-20-16-12-8-2;;;;/h25-26,54-56,59-66,72H,7-24,27-52H2,1-6H3,(H,67,70)(H,68,71)(H2,73,74,75)(H2,76,77,78);;;;/q;4*+1/p-4/b26-25-;;;;/t54-,55-,56-,59-,60-,61-,62-,63-,64-,65-,66-;;;;/m1..../s1	Toll-like receptor 4/MD-2 antagonist	ANTAGONIST	CHEMBL3038512	Toll-like receptor 4/MD-2	Homo sapiens
CHEMBL2104967	FIRATEGRAST	CCOCc1cc(OC)c(-c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(=O)O)cc2)c(OC)c1	YLFZHHDVRSYTKT-NRFANRHFSA-N	InChI=1S/C27H27F2NO6/c1-4-36-15-17-13-22(34-2)24(23(14-17)35-3)18-10-8-16(9-11-18)12-21(27(32)33)30-26(31)25-19(28)6-5-7-20(25)29/h5-11,13-14,21H,4,12,15H2,1-3H3,(H,30,31)(H,32,33)/t21-/m0/s1	Integrin alpha-4/beta-1 antagonist	ANTAGONIST	CHEMBL1907599	Integrin alpha-4/beta-1	Homo sapiens
CHEMBL2104981	RILAPLADIB	COCCN1CCC(N(Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)C(=O)Cn2c(SCc3cccc(F)c3F)cc(=O)c3ccccc32)CC1	NNBGCSGCRSCFEA-UHFFFAOYSA-N	InChI=1S/C40H38F5N3O3S/c1-51-22-21-46-19-17-32(18-20-46)47(24-27-9-11-28(12-10-27)29-13-15-31(16-14-29)40(43,44)45)37(50)25-48-35-8-3-2-6-33(35)36(49)23-38(48)52-26-30-5-4-7-34(41)39(30)42/h2-16,23,32H,17-22,24-26H2,1H3	LDL-associated phospholipase A2 inhibitor	INHIBITOR	CHEMBL3514	LDL-associated phospholipase A2	Homo sapiens
CHEMBL90983	TERAMEPROCOL	COc1ccc(C[C@H](C)[C@H](C)Cc2ccc(OC)c(OC)c2)cc1OC	ORQFDHFZSMXRLM-IYBDPMFKSA-N	InChI=1S/C22H30O4/c1-15(11-17-7-9-19(23-3)21(13-17)25-5)16(2)12-18-8-10-20(24-4)22(14-18)26-6/h7-10,13-16H,11-12H2,1-6H3/t15-,16+	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL3989496	TEZACITABINE	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)/C2=C\F)c(=O)n1.O	XPYQFIISZQCINN-QVXDJYSKSA-N	InChI=1S/C10H12FN3O4.H2O/c11-3-5-8(16)6(4-15)18-9(5)14-2-1-7(12)13-10(14)17;/h1-3,6,8-9,15-16H,4H2,(H2,12,13,17);1H2/b5-3+;/t6-,8+,9-;/m1./s1	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	CHEMBL2095215	Ribonucleoside-diphosphate reductase RR1	Homo sapiens
CHEMBL235191	TACEDINALINE	CC(=O)Nc1ccc(C(=O)Nc2ccccc2N)cc1	VAZAPHZUAVEOMC-UHFFFAOYSA-N	InChI=1S/C15H15N3O2/c1-10(19)17-12-8-6-11(7-9-12)15(20)18-14-5-3-2-4-13(14)16/h2-9H,16H2,1H3,(H,17,19)(H,18,20)	Histone deacetylase inhibitor	INHIBITOR	CHEMBL2093865	Histone deacetylase	Homo sapiens
CHEMBL1908371	IDRAPARINUX SODIUM	CO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@H]2O[C@@H](C(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]4O[C@H](C(=O)[O-])[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](OC)[C@H](OC)[C@H]5OC)[C@H](OC)[C@H]4OC)[C@H](OS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])[C@H](OC)[C@H]2OC)[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]	MVPQUSQUURLQKF-ABIFMKGDSA-E	InChI=1S/C38H64O49S7.9Na/c1-64-15-12(9-72-88(43,44)45)76-35(27(68-5)18(15)65-2)80-21-19(66-3)28(69-6)37(82-25(21)32(39)40)79-17-14(11-74-90(49,50)51)77-38(31(87-94(61,62)63)24(17)85-92(55,56)57)81-22-20(67-4)29(70-7)36(83-26(22)33(41)42)78-16-13(10-73-89(46,47)48)75-34(71-8)30(86-93(58,59)60)23(16)84-91(52,53)54;;;;;;;;;/h12-31,34-38H,9-11H2,1-8H3,(H,39,40)(H,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54)(H,55,56,57)(H,58,59,60)(H,61,62,63);;;;;;;;;/q;9*+1/p-9/t12-,13-,14-,15-,16-,17-,18+,19+,20+,21+,22+,23+,24+,25+,26-,27-,28-,29-,30-,31-,34+,35-,36+,37-,38-;;;;;;;;;/m1........./s1	Coagulation factor X inhibitor	INHIBITOR	CHEMBL244	Coagulation factor X	Homo sapiens
CHEMBL2110725	VINFLUNINE	CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32	NMDYYWFGPIMTKO-KLCPSUAYSA-N	InChI=1S/C45H54F2N4O8/c1-8-42-14-11-16-51-17-15-43(36(42)51)30-19-31(34(56-5)20-33(30)49(4)37(43)45(55,40(54)58-7)38(42)59-25(2)52)44(39(53)57-6)21-26-18-27(41(3,46)47)23-50(22-26)24-29-28-12-9-10-13-32(28)48-35(29)44/h9-14,19-20,26-27,36-38,48,55H,8,15-18,21-24H2,1-7H3/t26-,27+,36-,37+,38+,42+,43+,44-,45-/m0/s1	Tubulin inhibitor	INHIBITOR	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL429876	CILENGITIDE	CC(C)[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc2ccccc2)C(=O)N1C	AMLYAMJWYAIXIA-VWNVYAMZSA-N	InChI=1S/C27H40N8O7/c1-15(2)22-25(41)33-17(10-7-11-30-27(28)29)23(39)31-14-20(36)32-18(13-21(37)38)24(40)34-19(26(42)35(22)3)12-16-8-5-4-6-9-16/h4-6,8-9,15,17-19,22H,7,10-14H2,1-3H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30)/t17-,18-,19+,22-/m0/s1	Integrin alpha-V/beta-3 antagonist	ANTAGONIST	CHEMBL1907598	Integrin alpha-V/beta-3	Homo sapiens
CHEMBL325424	ALEPLASININ	Cc1cccc(-c2ccc3c(c2)c(C(=O)C(=O)O)cn3Cc2ccc(C(C)(C)C)cc2)c1	HSXLMAFNWCSZGP-UHFFFAOYSA-N	InChI=1S/C28H27NO3/c1-18-6-5-7-20(14-18)21-10-13-25-23(15-21)24(26(30)27(31)32)17-29(25)16-19-8-11-22(12-9-19)28(2,3)4/h5-15,17H,16H2,1-4H3,(H,31,32)	Plasminogen activator inhibitor-1 inhibitor	INHIBITOR	CHEMBL3475	Plasminogen activator inhibitor-1	Homo sapiens
CHEMBL591118	CARMEGLIPTIN	COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@@H](CF)CC3=O)CN1CC2	GUYMHFIHHOEFOA-ZCPGHIKRSA-N	InChI=1S/C20H28FN3O3/c1-26-18-6-13-3-4-23-11-17(24-10-12(9-21)5-20(24)25)15(22)8-16(23)14(13)7-19(18)27-2/h6-7,12,15-17H,3-5,8-11,22H2,1-2H3/t12-,15+,16+,17+/m1/s1	Dipeptidyl peptidase IV inhibitor	INHIBITOR	CHEMBL284	Dipeptidyl peptidase IV	Homo sapiens
CHEMBL27759	ENTINOSTAT	Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1	INVTYAOGFAGBOE-UHFFFAOYSA-N	InChI=1S/C21H20N4O3/c22-18-5-1-2-6-19(18)25-20(26)17-9-7-15(8-10-17)13-24-21(27)28-14-16-4-3-11-23-12-16/h1-12H,13-14,22H2,(H,24,27)(H,25,26)	Histone deacetylase inhibitor	INHIBITOR	CHEMBL2093865	Histone deacetylase	Homo sapiens
CHEMBL315985	ESLICARBAZEPINE	NC(=O)N1c2ccccc2C[C@H](O)c2ccccc21	BMPDWHIDQYTSHX-AWEZNQCLSA-N	InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m0/s1	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL289351	FOSBRETABULIN DISODIUM	COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)([O-])[O-].[Na+].[Na+]	VXNQMUVMEIGUJW-XNOMRPDFSA-L	InChI=1S/C18H21O8P.2Na/c1-22-14-8-7-12(9-15(14)26-27(19,20)21)5-6-13-10-16(23-2)18(25-4)17(11-13)24-3;;/h5-11H,1-4H3,(H2,19,20,21);;/q;2*+1/p-2/b6-5-;;	Tubulin inhibitor	INHIBITOR	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL2105643	FOSBRETABULIN TROMETHAMINE	COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O.NC(CO)(CO)CO	FIDMEHCRMLKKPZ-YSMBQZINSA-N	InChI=1S/C18H21O8P.C4H11NO3/c1-22-14-8-7-12(9-15(14)26-27(19,20)21)5-6-13-10-16(23-2)18(25-4)17(11-13)24-3;5-4(1-6,2-7)3-8/h5-11H,1-4H3,(H2,19,20,21);6-8H,1-3,5H2/b6-5-;	Tubulin disrupting agent	DISRUPTING AGENT	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL272980	MOCETINOSTAT	Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1	HRNLUBSXIHFDHP-UHFFFAOYSA-N	InChI=1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29)	Histone deacetylase 1 inhibitor	INHIBITOR	CHEMBL325	Histone deacetylase 1	Homo sapiens
CHEMBL2028665	REMOGLIFLOZIN ETABONATE	CCOC(=O)OC[C@H]1O[C@@H](Oc2nn(C(C)C)c(C)c2Cc2ccc(OC(C)C)cc2)[C@H](O)[C@@H](O)[C@@H]1O	UAOCLDQAQNNEAX-ABMICEGHSA-N	InChI=1S/C26H38N2O9/c1-7-33-26(32)34-13-20-21(29)22(30)23(31)25(36-20)37-24-19(16(6)28(27-24)14(2)3)12-17-8-10-18(11-9-17)35-15(4)5/h8-11,14-15,20-23,25,29-31H,7,12-13H2,1-6H3/t20-,21-,22+,23-,25+/m1/s1	Sodium/glucose cotransporter 2 inhibitor	INHIBITOR	CHEMBL3884	Sodium/glucose cotransporter 2	Homo sapiens
CHEMBL377559	RETASPIMYCIN HYDROCHLORIDE	C=CCNc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)N2.Cl	OIRUWDYJGMHDHJ-AFXVCOSJSA-N	InChI=1S/C31H45N3O8.ClH/c1-8-12-33-26-21-13-17(2)14-25(41-7)27(36)19(4)15-20(5)29(42-31(32)39)24(40-6)11-9-10-18(3)30(38)34-22(28(21)37)16-23(26)35;/h8-11,15-17,19,24-25,27,29,33,35-37H,1,12-14H2,2-7H3,(H2,32,39)(H,34,38);1H/b11-9-,18-10+,20-15+;/t17-,19+,24+,25+,27-,29+;/m1./s1	Heat shock protein HSP90 inhibitor	INHIBITOR	CHEMBL2095165	Heat shock protein HSP90	Homo sapiens
CHEMBL2304041	SAGOPILONE	C=CC[C@H]1C(=O)C(C)(C)[C@@H](O)CC(=O)O[C@H](c2ccc3sc(C)nc3c2)C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@@H]1O	BFZKMNSQCNVFGM-UCEYFQQTSA-N	InChI=1S/C30H41NO6S/c1-7-9-20-27(34)17(2)10-8-13-30(6)25(37-30)15-22(19-11-12-23-21(14-19)31-18(3)38-23)36-26(33)16-24(32)29(4,5)28(20)35/h7,11-12,14,17,20,22,24-25,27,32,34H,1,8-10,13,15-16H2,2-6H3/t17-,20+,22-,24-,25-,27-,30+/m0/s1	Tubulin stabiliser	STABILISER	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL2105659	VARESPLADIB METHYL	CCc1c(C(=O)C(N)=O)c2c(OCC(=O)OC)cccc2n1Cc1ccccc1	VJYDOJXJUCJUHL-UHFFFAOYSA-N	InChI=1S/C22H22N2O5/c1-3-15-20(21(26)22(23)27)19-16(24(15)12-14-8-5-4-6-9-14)10-7-11-17(19)29-13-18(25)28-2/h4-11H,3,12-13H2,1-2H3,(H2,23,27)	Phospholipase A2 group IIA inhibitor	INHIBITOR	CHEMBL3474	Phospholipase A2 group IIA	Homo sapiens
CHEMBL2105661	LITRONESIB	CCNCCS(=O)(=O)NC[C@@]1(c2ccccc2)SC(NC(=O)C(C)(C)C)=NN1C(=O)C(C)(C)C	YVAFBXLHPINSIK-QHCPKHFHSA-N	InChI=1S/C23H37N5O4S2/c1-8-24-14-15-34(31,32)25-16-23(17-12-10-9-11-13-17)28(19(30)22(5,6)7)27-20(33-23)26-18(29)21(2,3)4/h9-13,24-25H,8,14-16H2,1-7H3,(H,26,27,29)/t23-/m0/s1	Kinesin-like protein 1 inhibitor	INHIBITOR	CHEMBL4581	Kinesin-like protein 1	Homo sapiens
CHEMBL2105665	ELACYTARABINE	CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@@H](O)[C@@H]1O	FLFGNMFWNBOBGE-FNNZEKJRSA-N	InChI=1S/C27H45N3O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-23(31)35-20-21-24(32)25(33)26(36-21)30-19-18-22(28)29-27(30)34/h9-10,18-19,21,24-26,32-33H,2-8,11-17,20H2,1H3,(H2,28,29,34)/b10-9+/t21-,24-,25+,26-/m1/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL190412	TEGLARINAD CHLORIDE	COCCOCCOCCOCCOC(=O)OC[n+]1ccc(N/C(=N/CCCCCCOc2ccc(Cl)cc2)NC#N)cc1.[Cl-]	DAHMXVAETAAQOZ-UHFFFAOYSA-N	InChI=1S/C30H42ClN5O8.ClH/c1-38-16-17-39-18-19-40-20-21-41-22-23-43-30(37)44-25-36-13-10-27(11-14-36)35-29(34-24-32)33-12-4-2-3-5-15-42-28-8-6-26(31)7-9-28;/h6-11,13-14H,2-5,12,15-23,25H2,1H3,(H,33,34);1H	Nicotinamide phosphoribosyltransferase inhibitor	INHIBITOR	CHEMBL1744525	Nicotinamide phosphoribosyltransferase	Homo sapiens
CHEMBL371405	MARIZOMIB	C[C@@]12OC(=O)[C@]1([C@@H](O)[C@@H]1C=CCCC1)NC(=O)[C@@H]2CCCl	NGWSFRIPKNWYAO-SHTIJGAHSA-N	InChI=1S/C15H20ClNO4/c1-14-10(7-8-16)12(19)17-15(14,13(20)21-14)11(18)9-5-3-2-4-6-9/h3,5,9-11,18H,2,4,6-8H2,1H3,(H,17,19)/t9-,10+,11+,14+,15+/m1/s1	20S proteosome inhibitor	INHIBITOR	CHEMBL3831201	20S proteasome	Homo sapiens
CHEMBL1800955	OMECAMTIV MECARBIL	COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1	RFUBTTPMWSKEIW-UHFFFAOYSA-N	InChI=1S/C20H24FN5O3/c1-14-6-7-16(12-22-14)23-19(27)24-17-5-3-4-15(18(17)21)13-25-8-10-26(11-9-25)20(28)29-2/h3-7,12H,8-11,13H2,1-2H3,(H2,23,24,27)	Cardiac myosin activator	ACTIVATOR	CHEMBL3831286	Cardiac myosin	Homo sapiens
CHEMBL1096380	PLINABULIN	CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O	UNRCMCRRFYFGFX-TYPNBTCFSA-N	InChI=1S/C19H20N4O2/c1-19(2,3)16-13(20-11-21-16)10-15-18(25)22-14(17(24)23-15)9-12-7-5-4-6-8-12/h4-11H,1-3H3,(H,20,21)(H,22,25)(H,23,24)/b14-9-,15-10-	Tubulin inhibitor	INHIBITOR	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL506871	VELIPARIB	C[C@]1(c2nc3cccc(C(N)=O)c3[nH]2)CCCN1	JNAHVYVRKWKWKQ-CYBMUJFWSA-N	InChI=1S/C13H16N4O/c1-13(6-3-7-15-13)12-16-9-5-2-4-8(11(14)18)10(9)17-12/h2,4-5,15H,3,6-7H2,1H3,(H2,14,18)(H,16,17)/t13-/m1/s1	PARP 1, 2 and 3 inhibitor	INHIBITOR	CHEMBL3390820	PARP 1, 2 and 3	Homo sapiens
CHEMBL2105671	AFEGOSTAT TARTRATE	O=C(O)C(O)C(O)C(=O)O.OC[C@H]1CNC[C@@H](O)[C@@H]1O	ULBPPCHRAVUQMC-RWOHWRPJSA-N	InChI=1S/C6H13NO3.C4H6O6/c8-3-4-1-7-2-5(9)6(4)10;5-1(3(7)8)2(6)4(9)10/h4-10H,1-3H2;1-2,5-6H,(H,7,8)(H,9,10)/t4-,5-,6-;/m1./s1	Beta-glucocerebrosidase stabiliser	STABILISER	CHEMBL2179	Beta-glucocerebrosidase	Homo sapiens
CHEMBL2105675	TAFAMIDIS MEGLUMINE	CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1	DQJDBUPLRMRBAB-WZTVWXICSA-N	InChI=1S/C14H7Cl2NO3.C7H17NO5/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13;1-8-2-4(10)6(12)7(13)5(11)3-9/h1-6H,(H,18,19);4-13H,2-3H2,1H3/t;4-,5+,6+,7+/m.0/s1	Transthyretin stabiliser	STABILISER	CHEMBL3194	Transthyretin	Homo sapiens
CHEMBL460785	DUVOGLUSTAT HYDROCHLORIDE	Cl.OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O	ZJIHMALTJRDNQI-VFQQELCFSA-N	InChI=1S/C6H13NO4.ClH/c8-2-3-5(10)6(11)4(9)1-7-3;/h3-11H,1-2H2;1H/t3-,4+,5-,6-;/m1./s1	Lysosomal alpha-glucosidase stabiliser	STABILISER	CHEMBL2608	Lysosomal alpha-glucosidase	Homo sapiens
CHEMBL2105681	SAPACITABINE	CCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2C#N)c(=O)n1	LBGFKUUHOPIEMA-PEARBKPGSA-N	InChI=1S/C26H42N4O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-23(32)28-22-16-17-30(26(34)29-22)25-20(18-27)24(33)21(19-31)35-25/h16-17,20-21,24-25,31,33H,2-15,19H2,1H3,(H,28,29,32,34)/t20-,21+,24-,25+/m0/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL2105683	NAPROXEN ETEMESIL	COc1ccc2cc([C@H](C)C(=O)OCCS(C)(=O)=O)ccc2c1	JGBUBSOKFSVXKS-LBPRGKRZSA-N	InChI=1S/C17H20O5S/c1-12(17(18)22-8-9-23(3,19)20)13-4-5-15-11-16(21-2)7-6-14(15)10-13/h4-7,10-12H,8-9H2,1-3H3/t12-/m0/s1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1095032	LETAXABAN	O=C([C@H](O)CS(=O)(=O)c1ccc2cc(Cl)ccc2c1)N1CCC(N2CCCNC2=O)CC1	GEHAEMCVKDPMKO-HXUWFJFHSA-N	InChI=1S/C22H26ClN3O5S/c23-17-4-2-16-13-19(5-3-15(16)12-17)32(30,31)14-20(27)21(28)25-10-6-18(7-11-25)26-9-1-8-24-22(26)29/h2-5,12-13,18,20,27H,1,6-11,14H2,(H,24,29)/t20-/m1/s1	Coagulation factor X inhibitor	INHIBITOR	CHEMBL244	Coagulation factor X	Homo sapiens
CHEMBL301742	ARBACLOFEN	NC[C@H](CC(=O)O)c1ccc(Cl)cc1	KPYSYYIEGFHWSV-QMMMGPOBSA-N	InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)/t8-/m0/s1	GABA-B receptor agonist	AGONIST	CHEMBL2111463	GABA-B receptor	Homo sapiens
CHEMBL2105711	TOFOGLIFLOZIN	CCc1ccc(Cc2ccc3c(c2)[C@]2(OC3)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1.O	ZXOCGDDVNPDRIW-NHFZGCSJSA-N	InChI=1S/C22H26O6.H2O/c1-2-13-3-5-14(6-4-13)9-15-7-8-16-12-27-22(17(16)10-15)21(26)20(25)19(24)18(11-23)28-22;/h3-8,10,18-21,23-26H,2,9,11-12H2,1H3;1H2/t18-,19-,20+,21-,22+;/m1./s1	Sodium/glucose cotransporter 2 inhibitor	INHIBITOR	CHEMBL3884	Sodium/glucose cotransporter 2	Homo sapiens
CHEMBL2105721	NIVOCASAN	CC(C)[C@@]1(C(=O)N[C@H]2CC(=O)O[C@]2(O)CF)CC(c2nccc3ccccc23)=NO1	VYFGDLGHHBUDTQ-ZLGUVYLKSA-N	InChI=1S/C21H22FN3O5/c1-12(2)20(19(27)24-16-9-17(26)29-21(16,28)11-22)10-15(25-30-20)18-14-6-4-3-5-13(14)7-8-23-18/h3-8,12,16,28H,9-11H2,1-2H3,(H,24,27)/t16-,20+,21+/m0/s1	Caspase-8 inhibitor	INHIBITOR	CHEMBL3776	Caspase-8	Homo sapiens
CHEMBL1173055	RUCAPARIB	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1	HMABYWSNWIZPAG-UHFFFAOYSA-N	InChI=1S/C19H18FN3O/c1-21-10-11-2-4-12(5-3-11)18-14-6-7-22-19(24)15-8-13(20)9-16(23-18)17(14)15/h2-5,8-9,21,23H,6-7,10H2,1H3,(H,22,24)	PARP 1, 2 and 3 inhibitor	INHIBITOR	CHEMBL3390820	PARP 1, 2 and 3	Homo sapiens
CHEMBL3989801	FORIGERIMOD ACETATE	CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](COP(=O)(O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)CC)C(C)C	AAYJNPGTWYJOET-VURLEEIPSA-N	InChI=1S/C117H181N34O32PS.C2H4O2/c1-9-64(5)94(149-97(161)75(120)24-18-47-128-115(121)122)112(176)144-85(56-71-57-127-62-133-71)106(170)139-80(44-51-185-8)103(167)148-93(63(3)4)110(174)143-83(54-69-32-38-73(154)39-33-69)105(169)146-87(60-152)108(172)138-77(25-14-16-45-118)100(164)137-78(28-20-49-130-117(125)126)101(165)147-88(61-183-184(180,181)182)99(163)132-58-90(156)135-81(26-15-17-46-119)113(177)151-50-21-29-89(151)109(173)140-76(27-19-48-129-116(123)124)98(162)131-59-91(157)136-82(53-68-30-36-72(153)37-31-68)104(168)134-66(7)96(160)142-84(52-67-22-12-11-13-23-67)107(171)150-95(65(6)10-2)111(175)141-79(42-43-92(158)159)102(166)145-86(114(178)179)55-70-34-40-74(155)41-35-70;1-2(3)4/h11-13,22-23,30-41,57,62-66,75-89,93-95,152-155H,9-10,14-21,24-29,42-56,58-61,118-120H2,1-8H3,(H,127,133)(H,131,162)(H,132,163)(H,134,168)(H,135,156)(H,136,157)(H,137,164)(H,138,172)(H,139,170)(H,140,173)(H,141,175)(H,142,160)(H,143,174)(H,144,176)(H,145,166)(H,146,169)(H,147,165)(H,148,167)(H,149,161)(H,150,171)(H,158,159)(H,178,179)(H4,121,122,128)(H4,123,124,129)(H4,125,126,130)(H2,180,181,182);1H3,(H,3,4)/t64-,65-,66-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,93-,94-,95-;/m0./s1	Heat shock cognate 71 kDa protein inhibitor	INHIBITOR	CHEMBL1275223	Heat shock cognate 71 kDa protein	Homo sapiens
CHEMBL1921976	ORTERONEL	CNC(=O)c1ccc2cc([C@@]3(O)CCn4cncc43)ccc2c1	OZPFIJIOIVJZMN-SFHVURJKSA-N	InChI=1S/C18H17N3O2/c1-19-17(22)14-3-2-13-9-15(5-4-12(13)8-14)18(23)6-7-21-11-20-10-16(18)21/h2-5,8-11,23H,6-7H2,1H3,(H,19,22)/t18-/m0/s1	Cytochrome P450 17A1 inhibitor	INHIBITOR	CHEMBL3522	Cytochrome P450 17A1	Homo sapiens
CHEMBL1094636	NIRAPARIB	NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12	PCHKPVIQAHNQLW-CQSZACIVSA-N	InChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	CHEMBL5366	Poly [ADP-ribose] polymerase 2	Homo sapiens
CHEMBL2105754	TRELAGLIPTIN SUCCINATE	Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O.O=C(O)CCC(=O)O	OGCNTTUPLQTBJI-XFULWGLBSA-N	InChI=1S/C18H20FN5O2.C4H6O4/c1-22-17(25)8-16(23-6-2-3-15(21)11-23)24(18(22)26)10-13-7-14(19)5-4-12(13)9-20;5-3(6)1-2-4(7)8/h4-5,7-8,15H,2-3,6,10-11,21H2,1H3;1-2H2,(H,5,6)(H,7,8)/t15-;/m1./s1	Dipeptidyl peptidase IV inhibitor	INHIBITOR	CHEMBL284	Dipeptidyl peptidase IV	Homo sapiens
CHEMBL1770248	ERTUGLIFLOZIN	CCOc1ccc(Cc2cc([C@]34OC[C@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1	MCIACXAZCBVDEE-CUUWFGFTSA-N	InChI=1S/C22H25ClO7/c1-2-28-16-6-3-13(4-7-16)9-14-10-15(5-8-17(14)23)22-20(27)18(25)19(26)21(11-24,30-22)12-29-22/h3-8,10,18-20,24-27H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22-/m0/s1	Sodium/glucose cotransporter 2 inhibitor	INHIBITOR	CHEMBL3884	Sodium/glucose cotransporter 2	Homo sapiens
CHEMBL2105762	OMARIGLIPTIN	CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2	MKMPWKUAHLTIBJ-ISTRZQFTSA-N	InChI=1S/C17H20F2N4O3S/c1-27(24,25)23-7-10-6-22(8-16(10)21-23)12-5-15(20)17(26-9-12)13-4-11(18)2-3-14(13)19/h2-4,7,12,15,17H,5-6,8-9,20H2,1H3/t12-,15+,17-/m1/s1	Dipeptidyl peptidase IV inhibitor	INHIBITOR	CHEMBL284	Dipeptidyl peptidase IV	Homo sapiens
CHEMBL2105765	LIPEGFILGRASTIM	COCCOC(=O)NCC(=O)N[C@@H]1[C@@H](O)C[C@](OC[C@H]2O[C@H](O[C@H](C)[C@H](N)C(=O)O)[C@H](NC(C)=O)[C@@H](O)[C@H]2O)(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO	GAQMWPRWVIGRRV-IVDGIBIRSA-N	InChI=1S/C27H46N4O19/c1-10(16(28)23(40)41)48-24-18(30-11(2)33)21(39)20(38)14(49-24)9-47-27(25(42)43)6-12(34)17(22(50-27)19(37)13(35)8-32)31-15(36)7-29-26(44)46-5-4-45-3/h10,12-14,16-22,24,32,34-35,37-39H,4-9,28H2,1-3H3,(H,29,44)(H,30,33)(H,31,36)(H,40,41)(H,42,43)/t10-,12+,13-,14-,16+,17-,18-,19-,20+,21-,22-,24+,27-/m1/s1	Granulocyte colony stimulating factor receptor agonist	AGONIST	CHEMBL1996	Granulocyte colony stimulating factor receptor	Homo sapiens
CHEMBL431770	ISTRADEFYLLINE	CCn1c(=O)c2c(nc(/C=C/c3ccc(OC)c(OC)c3)n2C)n(CC)c1=O	IQVRBWUUXZMOPW-PKNBQFBNSA-N	InChI=1S/C20H24N4O4/c1-6-23-18-17(19(25)24(7-2)20(23)26)22(3)16(21-18)11-9-13-8-10-14(27-4)15(12-13)28-5/h8-12H,6-7H2,1-5H3/b11-9+	Adenosine A2a receptor antagonist	ANTAGONIST	CHEMBL251	Adenosine A2a receptor	Homo sapiens
CHEMBL416146	ETORICOXIB	Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1	MNJVRJDLRVPLFE-UHFFFAOYSA-N	InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3	Cyclooxygenase-2 inhibitor	INHIBITOR	CHEMBL230	Cyclooxygenase-2	Homo sapiens
CHEMBL218166	BIFEPRUNOX	O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1	CYGODHVAJQTCBG-UHFFFAOYSA-N	InChI=1S/C24H23N3O2/c28-24-25-21-10-5-11-22(23(21)29-24)27-14-12-26(13-15-27)17-18-6-4-9-20(16-18)19-7-2-1-3-8-19/h1-11,16H,12-15,17H2,(H,25,28)	Serotonin 1a (5-HT1a) receptor partial agonist	PARTIAL AGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL2106798	NERAMEXANE MESYLATE	CC1(C)CC(C)(C)CC(C)(N)C1.CS(=O)(=O)O	CLUKHUGGXSIGRX-UHFFFAOYSA-N	InChI=1S/C11H23N.CH4O3S/c1-9(2)6-10(3,4)8-11(5,12)7-9;1-5(2,3)4/h6-8,12H2,1-5H3;1H3,(H,2,3,4)	Neuronal acetylcholine receptor; alpha9/alpha10 antagonist	ANTAGONIST	CHEMBL2109238	Neuronal acetylcholine receptor; alpha9/alpha10	Homo sapiens
CHEMBL2107312	ARBACLOFEN PLACARBIL	CC(C)C(=O)O[C@@H](OC(=O)NC[C@H](CC(=O)O)c1ccc(Cl)cc1)C(C)C	JXTAALBWJQJLGN-KSSFIOAISA-N	InChI=1S/C19H26ClNO6/c1-11(2)17(24)26-18(12(3)4)27-19(25)21-10-14(9-16(22)23)13-5-7-15(20)8-6-13/h5-8,11-12,14,18H,9-10H2,1-4H3,(H,21,25)(H,22,23)/t14-,18-/m0/s1	GABA-B receptor agonist	AGONIST	CHEMBL2111463	GABA-B receptor	Homo sapiens
CHEMBL2107313	BECATECARIN	CCN(CC)CCN1C(=O)c2c(c3c4cccc(Cl)c4n([C@@H]4O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]4O)c3c3[nH]c4c(Cl)cccc4c23)C1=O	JSKFWUPVIZYJMR-UDOAKELVSA-N	InChI=1S/C33H34Cl2N4O7/c1-4-37(5-2)12-13-38-31(43)22-20-15-8-6-10-17(34)24(15)36-25(20)27-21(23(22)32(38)44)16-9-7-11-18(35)26(16)39(27)33-29(42)28(41)30(45-3)19(14-40)46-33/h6-11,19,28-30,33,36,40-42H,4-5,12-14H2,1-3H3/t19-,28-,29-,30-,33-/m1/s1	DNA topoisomerase I inhibitor	INHIBITOR	CHEMBL1781	DNA topoisomerase I	Homo sapiens
CHEMBL1767407	DENUFOSOL TETRASODIUM	Nc1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)O2)c(=O)n1.[Na+].[Na+].[Na+].[Na+]	PASYJVRFGUDDEW-WMUGRWSXSA-J	InChI=1S/C18H27N5O21P4.4Na/c19-11-1-3-22(17(28)20-11)13-5-8(24)9(40-13)6-38-45(30,31)42-47(34,35)44-48(36,37)43-46(32,33)39-7-10-14(26)15(27)16(41-10)23-4-2-12(25)21-18(23)29;;;;/h1-4,8-10,13-16,24,26-27H,5-7H2,(H,30,31)(H,32,33)(H,34,35)(H,36,37)(H2,19,20,28)(H,21,25,29);;;;/q;4*+1/p-4/t8-,9+,10+,13+,14+,15+,16+;;;;/m0..../s1	Purinergic receptor P2Y2 agonist	AGONIST	CHEMBL4398	Purinergic receptor P2Y2	Homo sapiens
CHEMBL550755	FORODESINE HYDROCHLORIDE	Cl.O=c1[nH]cnc2c([C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)c[nH]c12	WEIAMZKHBCLFOG-QPAIBFMUSA-N	InChI=1S/C11H14N4O4.ClH/c16-2-5-9(17)10(18)7(15-5)4-1-12-8-6(4)13-3-14-11(8)19;/h1,3,5,7,9-10,12,15-18H,2H2,(H,13,14,19);1H/t5-,7+,9-,10+;/m1./s1	Purine nucleoside phosphorylase inhibitor	INHIBITOR	CHEMBL4338	Purine nucleoside phosphorylase	Homo sapiens
CHEMBL2107354	MIFAMURTIDE	CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC.O.[Na+]	SARBMGXGWXCXFW-GJHVZSAVSA-M	InChI=1S/C59H109N6O19P.Na.H2O/c1-7-9-11-13-15-17-19-21-23-25-27-29-31-33-50(69)79-40-46(83-51(70)34-32-30-28-26-24-22-20-18-16-14-12-10-8-2)41-81-85(77,78)80-38-37-61-56(73)42(3)62-49(68)36-35-47(55(60)72)65-57(74)43(4)63-58(75)44(5)82-54-52(64-45(6)67)59(76)84-48(39-66)53(54)71;;/h42-44,46-48,52-54,59,66,71,76H,7-41H2,1-6H3,(H2,60,72)(H,61,73)(H,62,68)(H,63,75)(H,64,67)(H,65,74)(H,77,78);;1H2/q;+1;/p-1/t42-,43-,44+,46+,47+,48+,52+,53+,54+,59?;;/m0../s1	Nucleotide-binding oligomerization domain-containing protein 2 other	OTHER	CHEMBL1293266	Nucleotide-binding oligomerization domain-containing protein 2	Homo sapiens
CHEMBL2107358	OBATOCLAX MESYLATE	COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O	ZFKXDVMHNXPEIY-PEZBNFGJSA-N	InChI=1S/C20H19N3O.CH4O3S/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17;1-5(2,3)4/h4-11,21-22H,1-3H3;1H3,(H,2,3,4)/b19-10-;	Apoptosis regulator Bcl-2 inhibitor	INHIBITOR	CHEMBL4860	Apoptosis regulator Bcl-2	Homo sapiens
CHEMBL190083	TARENFLURBIL	C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1	SYTBZMRGLBWNTM-SNVBAGLBSA-N	InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/t10-/m1/s1	Gamma-secretase modulator	MODULATOR	CHEMBL2094135	Gamma-secretase	Homo sapiens
CHEMBL197672	EMRICASAN	C[C@H](NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)COc1c(F)c(F)cc(F)c1F	SCVHJVCATBPIHN-SJCJKPOMSA-N	InChI=1S/C26H27F4N3O7/c1-12(31-24(38)25(39)32-16-8-6-5-7-13(16)26(2,3)4)23(37)33-17(10-19(35)36)18(34)11-40-22-20(29)14(27)9-15(28)21(22)30/h5-9,12,17H,10-11H2,1-4H3,(H,31,38)(H,32,39)(H,33,37)(H,35,36)/t12-,17-/m0/s1	Caspase inhibitor	INHIBITOR	CHEMBL3831289	Caspase	Homo sapiens
CHEMBL180101	ESREBOXETINE	CCOc1ccccc1O[C@@H](c1ccccc1)[C@@H]1CNCCO1	CBQGYUDMJHNJBX-OALUTQOASA-N	InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m0/s1	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL520733	SEMAGACESTAT	CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCc2ccccc21	PKXWXXPNHIWQHW-RCBQFDQVSA-N	InChI=1S/C19H27N3O4/c1-11(2)16(23)18(25)20-12(3)17(24)21-15-14-8-6-5-7-13(14)9-10-22(4)19(15)26/h5-8,11-12,15-16,23H,9-10H2,1-4H3,(H,20,25)(H,21,24)/t12-,15-,16-/m0/s1	Gamma-secretase inhibitor	INHIBITOR	CHEMBL2094135	Gamma-secretase	Homo sapiens
CHEMBL1835207	APRICOXIB	CCOc1ccc(-c2cc(C)cn2-c2ccc(S(N)(=O)=O)cc2)cc1	JTMITOKKUMVWRT-UHFFFAOYSA-N	InChI=1S/C19H20N2O3S/c1-3-24-17-8-4-15(5-9-17)19-12-14(2)13-21(19)16-6-10-18(11-7-16)25(20,22)23/h4-13H,3H2,1-2H3,(H2,20,22,23)	Cyclooxygenase-2 inhibitor	INHIBITOR	CHEMBL230	Cyclooxygenase-2	Homo sapiens
CHEMBL68117	VOSAROXIN	CN[C@H]1CN(c2ccc3c(=O)c(C(=O)O)cn(-c4nccs4)c3n2)C[C@@H]1OC	XZAFZXJXZHRNAQ-STQMWFEESA-N	InChI=1S/C18H19N5O4S/c1-19-12-8-22(9-13(12)27-2)14-4-3-10-15(24)11(17(25)26)7-23(16(10)21-14)18-20-5-6-28-18/h3-7,12-13,19H,8-9H2,1-2H3,(H,25,26)/t12-,13-/m0/s1	DNA topoisomerase II inhibitor	INHIBITOR	CHEMBL2094255	DNA topoisomerase II	Homo sapiens
CHEMBL257704	EPLIVANSERIN	CN(C)CCO/N=C(/C=C/c1ccc(O)cc1)c1ccccc1F	VAIOZOCLKVMIMN-PRJWTAEASA-N	InChI=1S/C19H21FN2O2/c1-22(2)13-14-24-21-19(17-5-3-4-6-18(17)20)12-9-15-7-10-16(23)11-8-15/h3-12,23H,13-14H2,1-2H3/b12-9+,21-19-	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	CHEMBL224	Serotonin 2a (5-HT2a) receptor	Homo sapiens
CHEMBL492399	VERUBULIN	COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1	SNHCRNMVYDHVDT-UHFFFAOYSA-N	InChI=1S/C17H17N3O/c1-12-18-16-7-5-4-6-15(16)17(19-12)20(2)13-8-10-14(21-3)11-9-13/h4-11H,1-3H3	Tubulin disrupting agent	DISRUPTING AGENT	CHEMBL2095182	Tubulin	Homo sapiens
CHEMBL1090771	AVAGACESTAT	NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1	XEAOPVUAMONVLA-QGZVFWFLSA-N	InChI=1S/C20H17ClF4N4O4S/c21-14-3-5-15(6-4-14)34(31,32)29(17(18(26)30)7-8-20(23,24)25)10-13-2-1-12(9-16(13)22)19-27-11-33-28-19/h1-6,9,11,17H,7-8,10H2,(H2,26,30)/t17-/m1/s1	Gamma-secretase inhibitor	INHIBITOR	CHEMBL2094135	Gamma-secretase	Homo sapiens
CHEMBL396778	SAFINAMIDE	C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O	NEMGRZFTLSKBAP-LBPRGKRZSA-N	InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1	Monoamine oxidase B inhibitor	INHIBITOR	CHEMBL2039	Monoamine oxidase B	Homo sapiens
CHEMBL1171829	BITOPERTIN	C[C@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ncc(C(F)(F)F)cc2F)CC1)C(F)(F)F	YUUGYIUSCYNSQR-LBPRGKRZSA-N	InChI=1S/C21H20F7N3O4S/c1-12(20(23,24)25)35-17-4-3-14(36(2,33)34)10-15(17)19(32)31-7-5-30(6-8-31)18-16(22)9-13(11-29-18)21(26,27)28/h3-4,9-12H,5-8H2,1-2H3/t12-/m0/s1	Glycine transporter 1 inhibitor	INHIBITOR	CHEMBL2337	Glycine transporter 1	Homo sapiens
CHEMBL18901	EFAPROXIRAL	Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(=O)O)cc2)c1	BNFRJXLZYUTIII-UHFFFAOYSA-N	InChI=1S/C20H23NO4/c1-13-9-14(2)11-16(10-13)21-18(22)12-15-5-7-17(8-6-15)25-20(3,4)19(23)24/h5-11H,12H2,1-4H3,(H,21,22)(H,23,24)	Hemoglobin HbA negative modulator	NEGATIVE MODULATOR	CHEMBL2095168	Hemoglobin HbA	Homo sapiens
CHEMBL463981	BEGACESTAT	O=S(=O)(N[C@H](CO)C(C(F)(F)F)C(F)(F)F)c1ccc(Cl)s1	PSXOKXJMVRSARX-SCSAIBSYSA-N	InChI=1S/C9H8ClF6NO3S2/c10-5-1-2-6(21-5)22(19,20)17-4(3-18)7(8(11,12)13)9(14,15)16/h1-2,4,7,17-18H,3H2/t4-/m1/s1	Gamma-secretase inhibitor	INHIBITOR	CHEMBL2094135	Gamma-secretase	Homo sapiens
CHEMBL204021	DARAPLADIB	CCN(CC)CCN(Cc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)C(=O)Cn1c(SCc2ccc(F)cc2)nc(=O)c2c1CCC2	WDPFJWLDPVQCAJ-UHFFFAOYSA-N	InChI=1S/C36H38F4N4O2S/c1-3-42(4-2)20-21-43(22-25-8-12-27(13-9-25)28-14-16-29(17-15-28)36(38,39)40)33(45)23-44-32-7-5-6-31(32)34(46)41-35(44)47-24-26-10-18-30(37)19-11-26/h8-19H,3-7,20-24H2,1-2H3	LDL-associated phospholipase A2 inhibitor	INHIBITOR	CHEMBL3514	LDL-associated phospholipase A2	Homo sapiens
CHEMBL167731	PIXANTRONE	NCCNc1ccc(NCCN)c2c1C(=O)c1ccncc1C2=O	PEZPMAYDXJQYRV-UHFFFAOYSA-N	InChI=1S/C17H19N5O2/c18-4-7-21-12-1-2-13(22-8-5-19)15-14(12)16(23)10-3-6-20-9-11(10)17(15)24/h1-3,6,9,21-22H,4-5,7-8,18-19H2	DNA cross-linking agent	CROSS-LINKING AGENT	CHEMBL2311221	DNA	Homo sapiens
CHEMBL3989689	SQUALAMINE LACTATE	CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@H](NCCCNCCCCN)C[C@@H]1C[C@H]3O)OS(=O)(=O)O.C[C@H](O)C(=O)O.O	ZPYIELFRIYUVQP-BHBJEIPNSA-N	InChI=1S/C34H65N3O5S.C3H6O3.H2O/c1-23(2)31(42-43(39,40)41)12-9-24(3)27-10-11-28-32-29(14-16-34(27,28)5)33(4)15-13-26(21-25(33)22-30(32)38)37-20-8-19-36-18-7-6-17-35;1-2(4)3(5)6;/h23-32,36-38H,6-22,35H2,1-5H3,(H,39,40,41);2,4H,1H3,(H,5,6);1H2/t24-,25-,26+,27-,28+,29+,30-,31-,32+,33+,34-;2-;/m10./s1	Sodium/hydrogen exchanger 3 inhibitor	INHIBITOR	CHEMBL3273	Sodium/hydrogen exchanger 3	Homo sapiens
CHEMBL109480	TANESPIMYCIN	C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O	AYUNIORJHRXIBJ-TXHRRWQRSA-N	InChI=1S/C31H43N3O8/c1-8-12-33-26-21-13-17(2)14-25(41-7)27(36)19(4)15-20(5)29(42-31(32)39)24(40-6)11-9-10-18(3)30(38)34-22(28(21)37)16-23(26)35/h8-11,15-17,19,24-25,27,29,33,36H,1,12-14H2,2-7H3,(H2,32,39)(H,34,38)/b11-9-,18-10+,20-15+/t17-,19+,24+,25+,27-,29+/m1/s1	Heat shock protein HSP90 inhibitor	INHIBITOR	CHEMBL2095165	Heat shock protein HSP90	Homo sapiens
CHEMBL142703	VILDAGLIPTIN	N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2	SYOKIDBDQMKNDQ-XWTIBIIYSA-N	InChI=1S/C17H25N3O2/c18-9-14-2-1-3-20(14)15(21)10-19-16-5-12-4-13(6-16)8-17(22,7-12)11-16/h12-14,19,22H,1-8,10-11H2/t12?,13?,14-,16?,17?/m0/s1	Dipeptidyl peptidase IV inhibitor	INHIBITOR	CHEMBL284	Dipeptidyl peptidase IV	Homo sapiens
CHEMBL481958	AMRUBICIN HYDROCHLORIDE	CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O.Cl	BHMLHEQFWVQAJS-IITOGVPQSA-N	InChI=1S/C25H25NO9.ClH/c1-10(27)25(26)7-13-18(16(8-25)35-17-6-14(28)15(29)9-34-17)24(33)20-19(23(13)32)21(30)11-4-2-3-5-12(11)22(20)31;/h2-5,14-17,28-29,32-33H,6-9,26H2,1H3;1H/t14-,15+,16-,17-,25-;/m0./s1	DNA topoisomerase II alpha inhibitor	INHIBITOR	CHEMBL1806	DNA topoisomerase II alpha	Homo sapiens
CHEMBL443684	NAVITOCLAX	CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1	JLYAXFNOILIKPP-KXQOOQHDSA-N	InChI=1S/C47H55ClF3N5O6S3/c1-46(2)20-18-42(34-8-12-37(48)13-9-34)36(31-46)32-55-22-24-56(25-23-55)39-14-10-35(11-15-39)45(57)53-65(60,61)41-16-17-43(44(30-41)64(58,59)47(49,50)51)52-38(19-21-54-26-28-62-29-27-54)33-63-40-6-4-3-5-7-40/h3-17,30,38,52H,18-29,31-33H2,1-2H3,(H,53,57)/t38-/m1/s1	Apoptosis regulator Bcl-2 inhibitor	INHIBITOR	CHEMBL4860	Apoptosis regulator Bcl-2	Homo sapiens
CHEMBL1215923	BIMOSIAMOSE	O=C(O)Cc1cccc(-c2cc(CCCCCCc3ccc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c(-c4cccc(CC(=O)O)c4)c3)ccc2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)c1	RYWCQJDEHXJHRI-XJMXIVSISA-N	InChI=1S/C46H54O16/c47-23-35-39(53)41(55)43(57)45(61-35)59-33-15-13-25(19-31(33)29-11-5-9-27(17-29)21-37(49)50)7-3-1-2-4-8-26-14-16-34(60-46-44(58)42(56)40(54)36(24-48)62-46)32(20-26)30-12-6-10-28(18-30)22-38(51)52/h5-6,9-20,35-36,39-48,53-58H,1-4,7-8,21-24H2,(H,49,50)(H,51,52)/t35-,36-,39-,40-,41+,42+,43+,44+,45+,46+/m1/s1	Selectin inhibitor	INHIBITOR	CHEMBL3831288	Selectin	Homo sapiens
CHEMBL73822	APAZIQUONE	Cn1c(/C=C/CO)c(CO)c2c1C(=O)C=C(N1CC1)C2=O	MXPOCMVWFLDDLZ-NSCUHMNNSA-N	InChI=1S/C15H16N2O4/c1-16-10(3-2-6-18)9(8-19)13-14(16)12(20)7-11(15(13)21)17-4-5-17/h2-3,7,18-19H,4-6,8H2,1H3/b3-2+	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL435224	LAPAQUISTAT ACETATE	COc1cccc([C@H]2O[C@H](CC(=O)N3CCC(CC(=O)O)CC3)C(=O)N(CC(C)(C)COC(C)=O)c3ccc(Cl)cc32)c1OC	CMLUGNQVANVZHY-POURPWNDSA-N	InChI=1S/C33H41ClN2O9/c1-20(37)44-19-33(2,3)18-36-25-10-9-22(34)16-24(25)30(23-7-6-8-26(42-4)31(23)43-5)45-27(32(36)41)17-28(38)35-13-11-21(12-14-35)15-29(39)40/h6-10,16,21,27,30H,11-15,17-19H2,1-5H3,(H,39,40)/t27-,30-/m1/s1	Squalene synthetase inhibitor	INHIBITOR	CHEMBL3338	Squalene synthetase	Homo sapiens
CHEMBL490665	NALFURAFINE HYDROCHLORIDE	CN(C(=O)/C=C/c1ccoc1)[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5.Cl	DJSFYNINGIMKAG-FQJQBBMWSA-N	InChI=1S/C28H32N2O5.ClH/c1-29(23(32)7-4-18-9-13-34-16-18)20-8-10-28(33)22-14-19-5-6-21(31)25-24(19)27(28,26(20)35-25)11-12-30(22)15-17-2-3-17;/h4-7,9,13,16-17,20,22,26,31,33H,2-3,8,10-12,14-15H2,1H3;1H/b7-4+;/t20-,22-,26+,27+,28-;/m1./s1	Kappa opioid receptor agonist	AGONIST	CHEMBL237	Kappa opioid receptor	Homo sapiens
CHEMBL2107818	ALDOXORUBICIN	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(CO)=N/NC(=O)CCCCCN1C(=O)C=CC1=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1	OBMJQRLIQQTJLR-USGQOSEYSA-N	InChI=1S/C37H42N4O13/c1-17-32(46)20(38)13-27(53-17)54-22-15-37(51,23(16-42)39-40-24(43)9-4-3-5-12-41-25(44)10-11-26(41)45)14-19-29(22)36(50)31-30(34(19)48)33(47)18-7-6-8-21(52-2)28(18)35(31)49/h6-8,10-11,17,20,22,27,32,42,46,48,50-51H,3-5,9,12-16,38H2,1-2H3,(H,40,43)/b39-23+/t17-,20-,22-,27-,32+,37-/m0/s1	DNA topoisomerase II alpha inhibitor	INHIBITOR	CHEMBL1806	DNA topoisomerase II alpha	Homo sapiens
CHEMBL2107821	EMIXUSTAT	NCC[C@@H](O)c1cccc(OCC2CCCCC2)c1	WJIGGYYSZBWCGC-MRXNPFEDSA-N	InChI=1S/C16H25NO2/c17-10-9-16(18)14-7-4-8-15(11-14)19-12-13-5-2-1-3-6-13/h4,7-8,11,13,16,18H,1-3,5-6,9-10,12,17H2/t16-/m1/s1	Retinoid isomerohydrolase inhibitor	INHIBITOR	CHEMBL3831182	Retinoid isomerohydrolase	Homo sapiens
CHEMBL2107829	EMIXUSTAT HYDROCHLORIDE	Cl.NCC[C@@H](O)c1cccc(OCC2CCCCC2)c1	BPZWRYOUJMDQSY-PKLMIRHRSA-N	InChI=1S/C16H25NO2.ClH/c17-10-9-16(18)14-7-4-8-15(11-14)19-12-13-5-2-1-3-6-13;/h4,7-8,11,13,16,18H,1-3,5-6,9-10,12,17H2;1H/t16-;/m1./s1	Retinoid isomerohydrolase inhibitor	INHIBITOR	CHEMBL3831182	Retinoid isomerohydrolase	Homo sapiens
CHEMBL2364609	ESKETAMINE HYDROCHLORIDE	CN[C@]1(c2ccccc2Cl)CCCCC1=O.Cl	VCMGMSHEPQENPE-ZOWNYOTGSA-N	InChI=1S/C13H16ClNO.ClH/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14;/h2-3,6-7,15H,4-5,8-9H2,1H3;1H/t13-;/m0./s1	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL1829174	FASIGLIFAM	Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3c(c2)OC[C@H]3CC(=O)O)c1	BZCALJIHZVNMGJ-HSZRJFAPSA-N	InChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1	Free fatty acid receptor 1 positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL4422	Free fatty acid receptor 1	Homo sapiens
CHEMBL2364614	LIAFENSINE	CN1Cc2cc(-c3ccc(N)nn3)ccc2[C@H](c2ccc3ccccc3c2)C1	VCIBGDSRPUOBOG-QFIPXVFZSA-N	InChI=1S/C24H22N4/c1-28-14-20-13-19(23-10-11-24(25)27-26-23)8-9-21(20)22(15-28)18-7-6-16-4-2-3-5-17(16)12-18/h2-13,22H,14-15H2,1H3,(H2,25,27)/t22-/m0/s1	Monoamine transporter inhibitor	INHIBITOR	CHEMBL2363064	Monoamine transporter	Homo sapiens
CHEMBL1231160	PEVONEDISTAT	NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O	MPUQHZXIXSTTDU-QXGSTGNESA-N	InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18-,19-/m0/s1	NEDD8 activating enzyme inhibitor	INHIBITOR	CHEMBL3831283	NEDD8 activating enzyme	Homo sapiens
CHEMBL2364624	PRADIGASTAT	O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(Nc4ccc(C(F)(F)F)nc4)cn3)cc2)CC1	GXALXAKNHIROPE-QAQDUYKDSA-N	InChI=1S/C25H24F3N3O2/c26-25(27,28)23-12-10-21(15-30-23)31-20-9-11-22(29-14-20)19-7-5-18(6-8-19)17-3-1-16(2-4-17)13-24(32)33/h5-12,14-17,31H,1-4,13H2,(H,32,33)/t16-,17-	Diacylglycerol O-acyltransferase 1 inhibitor	INHIBITOR	CHEMBL6009	Diacylglycerol O-acyltransferase 1	Homo sapiens
CHEMBL3707446	RIVIPANSEL	C[C@@H]1O[C@@H](O[C@@H]2[C@@H](NC(=O)c3cc(=O)[nH]c(=O)[nH]3)C[C@@H](C(=O)NCCNC(=O)COCCOCC(=O)Nc3cc(S(=O)(=O)O)cc4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)C[C@H]2O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)O)[C@H]2OC(=O)c2ccccc2)[C@@H](O)[C@H](O)[C@@H]1O	VXBNTHRZPJLRSS-PTCSXESPSA-N	InChI=1S/C58H74N6O31S3/c1-27-45(69)47(71)48(72)56(90-27)95-49-35(62-53(74)36-23-41(66)64-58(78)63-36)19-31(20-37(49)92-57-51(94-55(77)29-10-6-3-7-11-29)50(46(70)39(24-65)93-57)91-38(54(75)76)16-28-8-4-2-5-9-28)52(73)60-13-12-59-42(67)25-88-14-15-89-26-43(68)61-34-21-32(96(79,80)81)17-30-18-33(97(82,83)84)22-40(44(30)34)98(85,86)87/h3,6-7,10-11,17-18,21-23,27-28,31,35,37-39,45-51,56-57,65,69-72H,2,4-5,8-9,12-16,19-20,24-26H2,1H3,(H,59,67)(H,60,73)(H,61,68)(H,62,74)(H,75,76)(H,79,80,81)(H,82,83,84)(H,85,86,87)(H2,63,64,66,78)/t27-,31+,35-,37+,38-,39+,45+,46-,47+,48-,49+,50-,51+,56-,57+/m0/s1	P-selectin antagonist	ANTAGONIST	CHEMBL5378	P-selectin	Homo sapiens
CHEMBL2364639	VALBENAZINE	COc1cc2c(cc1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2	GEJDGVNQKABXKG-CFKGEZKQSA-N	InChI=1S/C24H38N2O4/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3/t17-,19-,20-,23+/m1/s1	Synaptic vesicular amine transporter inhibitor	INHIBITOR	CHEMBL1893	Synaptic vesicular amine transporter	Homo sapiens
CHEMBL1812161	VATIQUINONE	CC(C)=CCC/C(C)=C/CC/C(C)=C/CC[C@@](C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O	LNOVHERIIMJMDG-XZXLULOTSA-N	InChI=1S/C29H44O3/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8,32)19-17-26-25(7)27(30)23(5)24(6)28(26)31/h12,14,16,32H,9-11,13,15,17-19H2,1-8H3/b21-14+,22-16+/t29-/m1/s1	Quinone reductase 1) modulator	MODULATOR	CHEMBL3623	Quinone reductase 1)	Homo sapiens
CHEMBL2048028	LIFITEGRAST	CS(=O)(=O)c1cccc(C[C@H](NC(=O)c2c(Cl)cc3c(c2Cl)CCN(C(=O)c2ccc4ccoc4c2)C3)C(=O)O)c1	JFOZKMSJYSPYLN-QHCPKHFHSA-N	InChI=1S/C29H24Cl2N2O7S/c1-41(38,39)20-4-2-3-16(11-20)12-23(29(36)37)32-27(34)25-22(30)13-19-15-33(9-7-21(19)26(25)31)28(35)18-6-5-17-8-10-40-24(17)14-18/h2-6,8,10-11,13-14,23H,7,9,12,15H2,1H3,(H,32,34)(H,36,37)/t23-/m0/s1	Integrin alpha-L/beta-2 (LFA-1) antagonist	ANTAGONIST	CHEMBL2364172	Integrin alpha-L/beta-2 (LFA-1)	Homo sapiens
CHEMBL3039507	SOTAGLIFLOZIN	CCOc1ccc(Cc2cc([C@@H]3O[C@H](SC)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1	QKDRXGFQVGOQKS-CRSSMBPESA-N	InChI=1S/C21H25ClO5S/c1-3-26-15-7-4-12(5-8-15)10-14-11-13(6-9-16(14)22)20-18(24)17(23)19(25)21(27-20)28-2/h4-9,11,17-21,23-25H,3,10H2,1-2H3/t17-,18-,19+,20+,21-/m1/s1	Sodium/glucose cotransporter 1 inhibitor	INHIBITOR	CHEMBL4979	Sodium/glucose cotransporter 1	Homo sapiens
CHEMBL3039515	ELOBIXIBAT	CCCCC1(CCCC)CN(c2ccccc2)c2cc(SC)c(OCC(=O)N[C@@H](C(=O)NCC(=O)O)c3ccccc3)cc2S(=O)(=O)C1	XFLQIRAKKLNXRQ-UUWRZZSWSA-N	InChI=1S/C36H45N3O7S2/c1-4-6-18-36(19-7-5-2)24-39(27-16-12-9-13-17-27)28-20-30(47-3)29(21-31(28)48(44,45)25-36)46-23-32(40)38-34(26-14-10-8-11-15-26)35(43)37-22-33(41)42/h8-17,20-21,34H,4-7,18-19,22-25H2,1-3H3,(H,37,43)(H,38,40)(H,41,42)/t34-/m1/s1	Ileal bile acid transporter inhibitor	INHIBITOR	CHEMBL2778	Ileal bile acid transporter	Homo sapiens
CHEMBL3039521	VINTAFOLIDE	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)CC[C@H](NC(=O)c5ccc(NCc6cnc7[nH]c(N)nc(=O)c7n6)cc5)C(=O)O)C(=O)O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1	KUZYSQSABONDME-QRLOMCMNSA-N	InChI=1S/C86H109N21O26S2/c1-6-82(129)35-42-36-85(78(127)132-5,64-47(21-26-106(39-42)41-82)46-12-8-9-13-50(46)95-64)49-30-48-57(34-58(49)131-4)105(3)75-84(48)23-27-107-25-11-22-83(7-2,74(84)107)76(125)86(75,130)77(126)103-104-81(128)133-28-29-134-135-40-56(73(123)124)100-70(119)55(33-62(113)114)99-69(118)54(32-61(111)112)98-67(116)51(14-10-24-90-79(87)88)96-68(117)53(31-60(109)110)94-59(108)20-19-52(72(121)122)97-66(115)43-15-17-44(18-16-43)91-37-45-38-92-65-63(93-45)71(120)102-80(89)101-65/h8-9,11-13,15-18,22,30,34,38,42,51-56,74-76,91,95,125,129-130H,6-7,10,14,19-21,23-29,31-33,35-37,39-41H2,1-5H3,(H,94,108)(H,96,117)(H,97,115)(H,98,116)(H,99,118)(H,100,119)(H,103,126)(H,104,128)(H,109,110)(H,111,112)(H,113,114)(H,121,122)(H,123,124)(H4,87,88,90)(H3,89,92,101,102,120)/t42-,51-,52-,53-,54-,55-,56-,74-,75+,76+,82-,83+,84+,85-,86-/m0/s1	Folate receptor alpha binding agent	BINDING AGENT	CHEMBL2121	Folate receptor alpha	Homo sapiens
CHEMBL3039522	BIRINAPANT	CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c(-c2[nH]c3cc(F)ccc3c2C[C@@H]2C[C@H](O)CN2C(=O)[C@H](CC)NC(=O)[C@H](C)NC)[nH]c2cc(F)ccc12	PKWRMUKBEYJEIX-DXXQBUJASA-N	InChI=1S/C42H56F2N8O6/c1-7-33(49-39(55)21(3)45-5)41(57)51-19-27(53)15-25(51)17-31-29-11-9-23(43)13-35(29)47-37(31)38-32(30-12-10-24(44)14-36(30)48-38)18-26-16-28(54)20-52(26)42(58)34(8-2)50-40(56)22(4)46-6/h9-14,21-22,25-28,33-34,45-48,53-54H,7-8,15-20H2,1-6H3,(H,49,55)(H,50,56)/t21-,22-,25-,26-,27-,28-,33-,34-/m0/s1	cIAP1/cIAP2 inhibitor	INHIBITOR	CHEMBL3038465	cIAP1/cIAP2	Homo sapiens
CHEMBL3039529	TIRASEMTIV	C#Cc1cnc2nc(O)n(C(CC)CC)c2n1	RSQGZEAXODVTOL-UHFFFAOYSA-N	InChI=1S/C12H14N4O/c1-4-8-7-13-10-11(14-8)16(12(17)15-10)9(5-2)6-3/h1,7,9H,5-6H2,2-3H3,(H,13,15,17)	Fast skeletal troponin complex activator	ACTIVATOR	CHEMBL3831282	Fast skeletal troponin complex	Homo sapiens
CHEMBL166863	POLMACOXIB	CC1(C)OC(c2ccc(S(N)(=O)=O)cc2)=C(c2cccc(F)c2)C1=O	IJWPAFMIFNSIGD-UHFFFAOYSA-N	InChI=1S/C18H16FNO4S/c1-18(2)17(21)15(12-4-3-5-13(19)10-12)16(24-18)11-6-8-14(9-7-11)25(20,22)23/h3-10H,1-2H3,(H2,20,22,23)	Cyclooxygenase-2 inhibitor	INHIBITOR	CHEMBL230	Cyclooxygenase-2	Homo sapiens
CHEMBL2338329	ROXADUSTAT	Cc1nc(C(=O)NCC(=O)O)c(O)c2ccc(Oc3ccccc3)cc12	YOZBGTLTNGAVFU-UHFFFAOYSA-N	InChI=1S/C19H16N2O5/c1-11-15-9-13(26-12-5-3-2-4-6-12)7-8-14(15)18(24)17(21-11)19(25)20-10-16(22)23/h2-9,24H,10H2,1H3,(H,20,25)(H,22,23)	Hypoxia-inducible factor prolyl hydroxylase inhibitor	INHIBITOR	CHEMBL3831261	Hypoxia-inducible factor prolyl hydroxylase	Homo sapiens
CHEMBL3137318	TALAZOPARIB TOSYLATE	Cc1ccc(S(=O)(=O)O)cc1.Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1	QUQKKHBYEFLEHK-QNBGGDODSA-N	InChI=1S/C19H14F2N6O.C7H8O3S/c1-27-18(22-8-23-27)15-16(9-2-4-10(20)5-3-9)24-13-7-11(21)6-12-14(13)17(15)25-26-19(12)28;1-6-2-4-7(5-3-6)11(8,9)10/h2-8,15-16,24H,1H3,(H,26,28);2-5H,1H3,(H,8,9,10)/t15-,16-;/m1./s1	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	CHEMBL5366	Poly [ADP-ribose] polymerase 2	Homo sapiens
CHEMBL3137320	TALAZOPARIB	Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1	HWGQMRYQVZSGDQ-HZPDHXFCSA-N	InChI=1S/C19H14F2N6O/c1-27-18(22-8-23-27)15-16(9-2-4-10(20)5-3-9)24-13-7-11(21)6-12-14(13)17(15)25-26-19(12)28/h2-8,15-16,24H,1H3,(H,26,28)/t15-,16-/m1/s1	Poly [ADP-ribose] polymerase-1 inhibitor	INHIBITOR	CHEMBL3105	Poly [ADP-ribose] polymerase-1	Homo sapiens
CHEMBL3137322	DIANHYDROGALACTITOL	O[C@H]([C@@H]1CO1)[C@@H](O)[C@H]1CO1	AAFJXZWCNVJTMK-GUCUJZIJSA-N	InChI=1S/C6H10O4/c7-5(3-1-9-3)6(8)4-2-10-4/h3-8H,1-2H2/t3-,4+,5+,6-	DNA cross-linking agent	CROSS-LINKING AGENT	CHEMBL2311221	DNA	Homo sapiens
CHEMBL1186894	AMRUBICIN	CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O	VJZITPJGSQKZMX-XDPRQOKASA-N	InChI=1S/C25H25NO9/c1-10(27)25(26)7-13-18(16(8-25)35-17-6-14(28)15(29)9-34-17)24(33)20-19(23(13)32)21(30)11-4-2-3-5-12(11)22(20)31/h2-5,14-17,28-29,32-33H,6-9,26H2,1H3/t14-,15+,16-,17-,25-/m0/s1	DNA topoisomerase II alpha inhibitor	INHIBITOR	CHEMBL1806	DNA topoisomerase II alpha	Homo sapiens
CHEMBL3301595	DASOTRALINE	N[C@@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21	SRPXSILJHWNFMK-MEDUHNTESA-N	InChI=1S/C16H15Cl2N/c17-14-7-5-10(9-15(14)18)11-6-8-16(19)13-4-2-1-3-12(11)13/h1-5,7,9,11,16H,6,8,19H2/t11-,16+/m0/s1	Monoamine transporter inhibitor	INHIBITOR	CHEMBL2363064	Monoamine transporter	Homo sapiens
CHEMBL3301627	TENAPANOR HYDROCHLORIDE	CN1Cc2c(Cl)cc(Cl)cc2[C@H](c2cccc(S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)c2)C1.Cl.Cl	VFRAXTZDILCRKY-OWRGXFNZSA-N	InChI=1S/C50H66Cl4N8O10S2.2ClH/c1-61-31-43(41-27-37(51)29-47(53)45(41)33-61)35-7-5-9-39(25-35)73(65,66)59-15-19-71-23-21-69-17-13-57-49(63)55-11-3-4-12-56-50(64)58-14-18-70-22-24-72-20-16-60-74(67,68)40-10-6-8-36(26-40)44-32-62(2)34-46-42(44)28-38(52)30-48(46)54;;/h5-10,25-30,43-44,59-60H,3-4,11-24,31-34H2,1-2H3,(H2,55,57,63)(H2,56,58,64);2*1H/t43-,44-;;/m0../s1	Sodium/hydrogen exchanger 3 inhibitor	INHIBITOR	CHEMBL3273	Sodium/hydrogen exchanger 3	Homo sapiens
CHEMBL3544911	PREXASERTIB	COc1cccc(OCCCN)c1-c1cc(Nc2cnc(C#N)cn2)n[nH]1	DOTGPNHGTYJDEP-UHFFFAOYSA-N	InChI=1S/C18H19N7O2/c1-26-14-4-2-5-15(27-7-3-6-19)18(14)13-8-16(25-24-13)23-17-11-21-12(9-20)10-22-17/h2,4-5,8,10-11H,3,6-7,19H2,1H3,(H2,22,23,24,25)	Serine/threonine-protein kinase Chk1 inhibitor	INHIBITOR	CHEMBL4630	Serine/threonine-protein kinase Chk1	Homo sapiens
CHEMBL260046	EVOFOSFAMIDE	Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+](=O)[O-]	UGJWRPJDTDGERK-UHFFFAOYSA-N	InChI=1S/C9H16Br2N5O4P/c1-15-8(6-12-9(15)16(17)18)7-20-21(19,13-4-2-10)14-5-3-11/h6H,2-5,7H2,1H3,(H2,13,14,19)	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL3544988	DAPRODUSTAT	O=C(O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O	RUEYEZADQJCKGV-UHFFFAOYSA-N	InChI=1S/C19H27N3O6/c23-14(24)11-20-16(25)15-17(26)21(12-7-3-1-4-8-12)19(28)22(18(15)27)13-9-5-2-6-10-13/h12-13,15H,1-11H2,(H,20,25)(H,23,24)	Hypoxia-inducible factor prolyl hydroxylase inhibitor	INHIBITOR	CHEMBL3831261	Hypoxia-inducible factor prolyl hydroxylase	Homo sapiens
CHEMBL2443262	OLICERIDINE	COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1	DMNOVGJWPASQDL-OAQYLSRUSA-N	InChI=1S/C22H30N2O2S/c1-25-18-7-15-27-19(18)16-23-13-10-21(20-6-2-5-12-24-20)11-14-26-22(17-21)8-3-4-9-22/h2,5-7,12,15,23H,3-4,8-11,13-14,16-17H2,1H3/t21-/m1/s1	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL3545185	SELINEXOR	O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1	DEVSOMFAQLZNKR-RJRFIUFISA-N	InChI=1S/C17H11F6N7O/c18-16(19,20)11-5-10(6-12(7-11)17(21,22)23)15-26-9-30(29-15)4-1-14(31)28-27-13-8-24-2-3-25-13/h1-9H,(H,25,27)(H,28,31)/b4-1-	Exportin-1 inhibitor	INHIBITOR	CHEMBL5661	Exportin-1	Homo sapiens
CHEMBL1241348	FALDAPREVIR	C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3csc(NC(=O)C(C)C)n3)nc3c(Br)c(OC)ccc23)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)O	LLGDPTDZOVKFDU-XUHJSTDZSA-N	InChI=1S/C40H49BrN6O9S/c1-8-21-17-40(21,36(51)52)46-34(49)27-15-23(18-47(27)35(50)32(39(4,5)6)44-38(53)56-22-11-9-10-12-22)55-29-16-25(26-19-57-37(43-26)45-33(48)20(2)3)42-31-24(29)13-14-28(54-7)30(31)41/h8,13-14,16,19-23,27,32H,1,9-12,15,17-18H2,2-7H3,(H,44,53)(H,46,49)(H,51,52)(H,43,45,48)/t21-,23-,27+,32-,40-/m1/s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL1808388	BEXAGLIFLOZIN	OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(OCCOC4CC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O	BTCRKOKVYTVOLU-SJSRKZJXSA-N	InChI=1S/C24H29ClO7/c25-19-8-3-15(24-23(29)22(28)21(27)20(13-26)32-24)12-16(19)11-14-1-4-17(5-2-14)30-9-10-31-18-6-7-18/h1-5,8,12,18,20-24,26-29H,6-7,9-11,13H2/t20-,21-,22+,23-,24+/m1/s1	Sodium/glucose cotransporter 2 inhibitor	INHIBITOR	CHEMBL3884	Sodium/glucose cotransporter 2	Homo sapiens
CHEMBL3545369	EPACADOSTAT	NS(=O)(=O)NCCNc1nonc1/C(=N/O)Nc1ccc(F)c(Br)c1	FBKMWOJEPMPVTQ-UHFFFAOYSA-N	InChI=1S/C11H13BrFN7O4S/c12-7-5-6(1-2-8(7)13)17-11(18-21)9-10(20-24-19-9)15-3-4-16-25(14,22)23/h1-2,5,16,21H,3-4H2,(H,15,20)(H,17,18)(H2,14,22,23)	Indoleamine 2,3-dioxygenase inhibitor	INHIBITOR	CHEMBL4685	Indoleamine 2,3-dioxygenase	Homo sapiens
CHEMBL484785	CRISABOROLE	N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1	USZAGAREISWJDP-UHFFFAOYSA-N	InChI=1S/C14H10BNO3/c16-8-10-1-3-12(4-2-10)19-13-5-6-14-11(7-13)9-18-15(14)17/h1-7,17H,9H2	Phosphodiesterase 4 inhibitor	INHIBITOR	CHEMBL2093863	Phosphodiesterase 4	Homo sapiens
CHEMBL190461	CANNABIDIOL	C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)cc1O	QHMBSVQNZZTUGM-ZWKOTPCHSA-N	InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1	Cannabinoid CB1 receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	CHEMBL218	Cannabinoid CB1 receptor	Homo sapiens
CHEMBL1808388	BEXAGLIFLOZIN	OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(OCCOC4CC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O	BTCRKOKVYTVOLU-SJSRKZJXSA-N	InChI=1S/C24H29ClO7/c25-19-8-3-15(24-23(29)22(28)21(27)20(13-26)32-24)12-16(19)11-14-1-4-17(5-2-14)30-9-10-31-18-6-7-18/h1-5,8,12,18,20-24,26-29H,6-7,9-11,13H2/t20-,21-,22+,23-,24+/m1/s1	Sodium/glucose cotransporter 2 inhibitor	INHIBITOR	CHEMBL3884	Sodium/glucose cotransporter 2	Homo sapiens
CHEMBL2105665	ELACYTARABINE	CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@@H](O)[C@@H]1O	FLFGNMFWNBOBGE-FNNZEKJRSA-N	InChI=1S/C27H45N3O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-23(31)35-20-21-24(32)25(33)26(36-21)30-19-18-22(28)29-27(30)34/h9-10,18-19,21,24-26,32-33H,2-8,11-17,20H2,1H3,(H2,28,29,34)/b10-9+/t21-,24-,25+,26-/m1/s1	RNA inhibitor	INHIBITOR	CHEMBL2311222	RNA	Homo sapiens
CHEMBL2106798	NERAMEXANE MESYLATE	CC1(C)CC(C)(C)CC(C)(N)C1.CS(=O)(=O)O	CLUKHUGGXSIGRX-UHFFFAOYSA-N	InChI=1S/C11H23N.CH4O3S/c1-9(2)6-10(3,4)8-11(5,12)7-9;1-5(2,3)4/h6-8,12H2,1-5H3;1H3,(H,2,3,4)	Glutamate [NMDA] receptor antagonist	ANTAGONIST	CHEMBL2094124	Glutamate [NMDA] receptor	Homo sapiens
CHEMBL2107358	OBATOCLAX MESYLATE	COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O	ZFKXDVMHNXPEIY-PEZBNFGJSA-N	InChI=1S/C20H19N3O.CH4O3S/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17;1-5(2,3)4/h4-11,21-22H,1-3H3;1H3,(H,2,3,4)/b19-10-;	Apoptosis regulator Bcl-X inhibitor	INHIBITOR	CHEMBL4625	Apoptosis regulator Bcl-X	Homo sapiens
CHEMBL2107358	OBATOCLAX MESYLATE	COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O	ZFKXDVMHNXPEIY-PEZBNFGJSA-N	InChI=1S/C20H19N3O.CH4O3S/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17;1-5(2,3)4/h4-11,21-22H,1-3H3;1H3,(H,2,3,4)/b19-10-;	Apoptosis regulator Bcl-W inhibitor	INHIBITOR	CHEMBL4677	Apoptosis regulator Bcl-W	Homo sapiens
CHEMBL2107358	OBATOCLAX MESYLATE	COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O	ZFKXDVMHNXPEIY-PEZBNFGJSA-N	InChI=1S/C20H19N3O.CH4O3S/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17;1-5(2,3)4/h4-11,21-22H,1-3H3;1H3,(H,2,3,4)/b19-10-;	Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitor	INHIBITOR	CHEMBL4361	Induced myeloid leukemia cell differentiation protein Mcl-1	Homo sapiens
CHEMBL2107358	OBATOCLAX MESYLATE	COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O	ZFKXDVMHNXPEIY-PEZBNFGJSA-N	InChI=1S/C20H19N3O.CH4O3S/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17;1-5(2,3)4/h4-11,21-22H,1-3H3;1H3,(H,2,3,4)/b19-10-;	Bcl-2-related protein A1 inhibitor	INHIBITOR	CHEMBL6044	Bcl-2-related protein A1	Homo sapiens
CHEMBL2107358	OBATOCLAX MESYLATE	COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O	ZFKXDVMHNXPEIY-PEZBNFGJSA-N	InChI=1S/C20H19N3O.CH4O3S/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17;1-5(2,3)4/h4-11,21-22H,1-3H3;1H3,(H,2,3,4)/b19-10-;	Bcl-2-like protein 10 inhibitor	INHIBITOR	CHEMBL5988	Bcl-2-like protein 10	Homo sapiens
CHEMBL166863	POLMACOXIB	CC1(C)OC(c2ccc(S(N)(=O)=O)cc2)=C(c2cccc(F)c2)C1=O	IJWPAFMIFNSIGD-UHFFFAOYSA-N	InChI=1S/C18H16FNO4S/c1-18(2)17(21)15(12-4-3-5-13(19)10-12)16(24-18)11-6-8-14(9-7-11)25(20,22)23/h3-10H,1-2H3,(H2,20,22,23)	Carbonic anhydrase II inhibitor	INHIBITOR	CHEMBL205	Carbonic anhydrase II	Homo sapiens
CHEMBL166863	POLMACOXIB	CC1(C)OC(c2ccc(S(N)(=O)=O)cc2)=C(c2cccc(F)c2)C1=O	IJWPAFMIFNSIGD-UHFFFAOYSA-N	InChI=1S/C18H16FNO4S/c1-18(2)17(21)15(12-4-3-5-13(19)10-12)16(24-18)11-6-8-14(9-7-11)25(20,22)23/h3-10H,1-2H3,(H2,20,22,23)	Carbonic anhydrase I inhibitor	INHIBITOR	CHEMBL261	Carbonic anhydrase I	Homo sapiens
CHEMBL2103832	PARDOPRUNOX	CN1CCN(c2cccc3[nH]c(=O)oc23)CC1	YVPUUUDAZYFFQT-UHFFFAOYSA-N	InChI=1S/C12H15N3O2/c1-14-5-7-15(8-6-14)10-4-2-3-9-11(10)17-12(16)13-9/h2-4H,5-8H2,1H3,(H,13,16)	Serotonin 1a (5-HT1a) receptor agonist	AGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL3707446	RIVIPANSEL	C[C@@H]1O[C@@H](O[C@@H]2[C@@H](NC(=O)c3cc(=O)[nH]c(=O)[nH]3)C[C@@H](C(=O)NCCNC(=O)COCCOCC(=O)Nc3cc(S(=O)(=O)O)cc4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)C[C@H]2O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)O)[C@H]2OC(=O)c2ccccc2)[C@@H](O)[C@H](O)[C@@H]1O	VXBNTHRZPJLRSS-PTCSXESPSA-N	InChI=1S/C58H74N6O31S3/c1-27-45(69)47(71)48(72)56(90-27)95-49-35(62-53(74)36-23-41(66)64-58(78)63-36)19-31(20-37(49)92-57-51(94-55(77)29-10-6-3-7-11-29)50(46(70)39(24-65)93-57)91-38(54(75)76)16-28-8-4-2-5-9-28)52(73)60-13-12-59-42(67)25-88-14-15-89-26-43(68)61-34-21-32(96(79,80)81)17-30-18-33(97(82,83)84)22-40(44(30)34)98(85,86)87/h3,6-7,10-11,17-18,21-23,27-28,31,35,37-39,45-51,56-57,65,69-72H,2,4-5,8-9,12-16,19-20,24-26H2,1H3,(H,59,67)(H,60,73)(H,61,68)(H,62,74)(H,75,76)(H,79,80,81)(H,82,83,84)(H,85,86,87)(H2,63,64,66,78)/t27-,31+,35-,37+,38-,39+,45+,46-,47+,48-,49+,50-,51+,56-,57+/m0/s1	Selectin E antagonist	ANTAGONIST	CHEMBL3890	Selectin E	Homo sapiens
CHEMBL3707446	RIVIPANSEL	C[C@@H]1O[C@@H](O[C@@H]2[C@@H](NC(=O)c3cc(=O)[nH]c(=O)[nH]3)C[C@@H](C(=O)NCCNC(=O)COCCOCC(=O)Nc3cc(S(=O)(=O)O)cc4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)C[C@H]2O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)O)[C@H]2OC(=O)c2ccccc2)[C@@H](O)[C@H](O)[C@@H]1O	VXBNTHRZPJLRSS-PTCSXESPSA-N	InChI=1S/C58H74N6O31S3/c1-27-45(69)47(71)48(72)56(90-27)95-49-35(62-53(74)36-23-41(66)64-58(78)63-36)19-31(20-37(49)92-57-51(94-55(77)29-10-6-3-7-11-29)50(46(70)39(24-65)93-57)91-38(54(75)76)16-28-8-4-2-5-9-28)52(73)60-13-12-59-42(67)25-88-14-15-89-26-43(68)61-34-21-32(96(79,80)81)17-30-18-33(97(82,83)84)22-40(44(30)34)98(85,86)87/h3,6-7,10-11,17-18,21-23,27-28,31,35,37-39,45-51,56-57,65,69-72H,2,4-5,8-9,12-16,19-20,24-26H2,1H3,(H,59,67)(H,60,73)(H,61,68)(H,62,74)(H,75,76)(H,79,80,81)(H,82,83,84)(H,85,86,87)(H2,63,64,66,78)/t27-,31+,35-,37+,38-,39+,45+,46-,47+,48-,49+,50-,51+,56-,57+/m0/s1	Leukocyte adhesion molecule-1 antagonist	ANTAGONIST	CHEMBL3161	Leukocyte adhesion molecule-1	Homo sapiens
CHEMBL3039507	SOTAGLIFLOZIN	CCOc1ccc(Cc2cc([C@@H]3O[C@H](SC)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1	QKDRXGFQVGOQKS-CRSSMBPESA-N	InChI=1S/C21H25ClO5S/c1-3-26-15-7-4-12(5-8-15)10-14-11-13(6-9-16(14)22)20-18(24)17(23)19(25)21(27-20)28-2/h4-9,11,17-21,23-25H,3,10H2,1-2H3/t17-,18-,19+,20+,21-/m1/s1	Sodium/glucose cotransporter 2 inhibitor	INHIBITOR	CHEMBL3884	Sodium/glucose cotransporter 2	Homo sapiens
CHEMBL3137320	TALAZOPARIB	Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1	HWGQMRYQVZSGDQ-HZPDHXFCSA-N	InChI=1S/C19H14F2N6O/c1-27-18(22-8-23-27)15-16(9-2-4-10(20)5-3-9)24-13-7-11(21)6-12-14(13)17(15)25-26-19(12)28/h2-8,15-16,24H,1H3,(H,26,28)/t15-,16-/m1/s1	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	CHEMBL5366	Poly [ADP-ribose] polymerase 2	Homo sapiens
CHEMBL68117	VOSAROXIN	CN[C@H]1CN(c2ccc3c(=O)c(C(=O)O)cn(-c4nccs4)c3n2)C[C@@H]1OC	XZAFZXJXZHRNAQ-STQMWFEESA-N	InChI=1S/C18H19N5O4S/c1-19-12-8-22(9-13(12)27-2)14-4-3-10-15(24)11(17(25)26)7-23(16(10)21-14)18-20-5-6-28-18/h3-7,12-13,19H,8-9H2,1-2H3,(H,25,26)/t12-,13-/m0/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL3137318	TALAZOPARIB TOSYLATE	Cc1ccc(S(=O)(=O)O)cc1.Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1	QUQKKHBYEFLEHK-QNBGGDODSA-N	InChI=1S/C19H14F2N6O.C7H8O3S/c1-27-18(22-8-23-27)15-16(9-2-4-10(20)5-3-9)24-13-7-11(21)6-12-14(13)17(15)25-26-19(12)28;1-6-2-4-7(5-3-6)11(8,9)10/h2-8,15-16,24H,1H3,(H,26,28);2-5H,1H3,(H,8,9,10)/t15-,16-;/m1./s1	Poly [ADP-ribose] polymerase-1 inhibitor	INHIBITOR	CHEMBL3105	Poly [ADP-ribose] polymerase-1	Homo sapiens
CHEMBL2104967	FIRATEGRAST	CCOCc1cc(OC)c(-c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(=O)O)cc2)c(OC)c1	YLFZHHDVRSYTKT-NRFANRHFSA-N	InChI=1S/C27H27F2NO6/c1-4-36-15-17-13-22(34-2)24(23(14-17)35-3)18-10-8-16(9-11-18)12-21(27(32)33)30-26(31)25-19(28)6-5-7-20(25)29/h5-11,13-14,21H,4,12,15H2,1-3H3,(H,30,31)(H,32,33)/t21-/m0/s1	Integrin alpha-4/beta-7 antagonist	ANTAGONIST	CHEMBL2095184	Integrin alpha-4/beta-7	Homo sapiens
CHEMBL272980	MOCETINOSTAT	Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1	HRNLUBSXIHFDHP-UHFFFAOYSA-N	InChI=1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29)	Histone deacetylase 2 inhibitor	INHIBITOR	CHEMBL1937	Histone deacetylase 2	Homo sapiens
CHEMBL272980	MOCETINOSTAT	Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1	HRNLUBSXIHFDHP-UHFFFAOYSA-N	InChI=1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29)	Histone deacetylase 3 inhibitor	INHIBITOR	CHEMBL1829	Histone deacetylase 3	Homo sapiens
CHEMBL272980	MOCETINOSTAT	Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1	HRNLUBSXIHFDHP-UHFFFAOYSA-N	InChI=1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29)	Histone deacetylase 11 inhibitor	INHIBITOR	CHEMBL3310	Histone deacetylase 11	Homo sapiens
CHEMBL272980	MOCETINOSTAT	Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1	HRNLUBSXIHFDHP-UHFFFAOYSA-N	InChI=1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29)	Histone deacetylase 8 inhibitor	INHIBITOR	CHEMBL3192	Histone deacetylase 8	Homo sapiens
CHEMBL443684	NAVITOCLAX	CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1	JLYAXFNOILIKPP-KXQOOQHDSA-N	InChI=1S/C47H55ClF3N5O6S3/c1-46(2)20-18-42(34-8-12-37(48)13-9-34)36(31-46)32-55-22-24-56(25-23-55)39-14-10-35(11-15-39)45(57)53-65(60,61)41-16-17-43(44(30-41)64(58,59)47(49,50)51)52-38(19-21-54-26-28-62-29-27-54)33-63-40-6-4-3-5-7-40/h3-17,30,38,52H,18-29,31-33H2,1-2H3,(H,53,57)/t38-/m1/s1	Apoptosis regulator Bcl-X inhibitor	INHIBITOR	CHEMBL4625	Apoptosis regulator Bcl-X	Homo sapiens
CHEMBL443684	NAVITOCLAX	CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1	JLYAXFNOILIKPP-KXQOOQHDSA-N	InChI=1S/C47H55ClF3N5O6S3/c1-46(2)20-18-42(34-8-12-37(48)13-9-34)36(31-46)32-55-22-24-56(25-23-55)39-14-10-35(11-15-39)45(57)53-65(60,61)41-16-17-43(44(30-41)64(58,59)47(49,50)51)52-38(19-21-54-26-28-62-29-27-54)33-63-40-6-4-3-5-7-40/h3-17,30,38,52H,18-29,31-33H2,1-2H3,(H,53,57)/t38-/m1/s1	Apoptosis regulator Bcl-W inhibitor	INHIBITOR	CHEMBL4677	Apoptosis regulator Bcl-W	Homo sapiens
CHEMBL2105721	NIVOCASAN	CC(C)[C@@]1(C(=O)N[C@H]2CC(=O)O[C@]2(O)CF)CC(c2nccc3ccccc23)=NO1	VYFGDLGHHBUDTQ-ZLGUVYLKSA-N	InChI=1S/C21H22FN3O5/c1-12(2)20(19(27)24-16-9-17(26)29-21(16,28)11-22)10-15(25-30-20)18-14-6-4-3-5-13(14)7-8-23-18/h3-8,12,16,28H,9-11H2,1-2H3,(H,24,27)/t16-,20+,21+/m0/s1	Caspase-1 inhibitor	INHIBITOR	CHEMBL4801	Caspase-1	Homo sapiens
CHEMBL2105721	NIVOCASAN	CC(C)[C@@]1(C(=O)N[C@H]2CC(=O)O[C@]2(O)CF)CC(c2nccc3ccccc23)=NO1	VYFGDLGHHBUDTQ-ZLGUVYLKSA-N	InChI=1S/C21H22FN3O5/c1-12(2)20(19(27)24-16-9-17(26)29-21(16,28)11-22)10-15(25-30-20)18-14-6-4-3-5-13(14)7-8-23-18/h3-8,12,16,28H,9-11H2,1-2H3,(H,24,27)/t16-,20+,21+/m0/s1	Caspase-9 inhibitor	INHIBITOR	CHEMBL2273	Caspase-9	Homo sapiens
CHEMBL3544911	PREXASERTIB	COc1cccc(OCCCN)c1-c1cc(Nc2cnc(C#N)cn2)n[nH]1	DOTGPNHGTYJDEP-UHFFFAOYSA-N	InChI=1S/C18H19N7O2/c1-26-14-4-2-5-15(27-7-3-6-19)18(14)13-8-16(25-24-13)23-17-11-21-12(9-20)10-22-17/h2,4-5,8,10-11H,3,6-7,19H2,1H3,(H2,22,23,24,25)	Serine/threonine-protein kinase Chk2 inhibitor	INHIBITOR	CHEMBL2527	Serine/threonine-protein kinase Chk2	Homo sapiens
CHEMBL429876	CILENGITIDE	CC(C)[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc2ccccc2)C(=O)N1C	AMLYAMJWYAIXIA-VWNVYAMZSA-N	InChI=1S/C27H40N8O7/c1-15(2)22-25(41)33-17(10-7-11-30-27(28)29)23(39)31-14-20(36)32-18(13-21(37)38)24(40)34-19(26(42)35(22)3)12-16-8-5-4-6-9-16/h4-6,8-9,15,17-19,22H,7,10-14H2,1-3H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30)/t17-,18-,19+,22-/m0/s1	Integrin alpha-V/beta-5 antagonist	ANTAGONIST	CHEMBL2096675	Integrin alpha-V/beta-5	Homo sapiens
CHEMBL2105659	VARESPLADIB METHYL	CCc1c(C(=O)C(N)=O)c2c(OCC(=O)OC)cccc2n1Cc1ccccc1	VJYDOJXJUCJUHL-UHFFFAOYSA-N	InChI=1S/C22H22N2O5/c1-3-15-20(21(26)22(23)27)19-16(24(15)12-14-8-5-4-6-9-14)10-7-11-17(19)29-13-18(25)28-2/h4-11H,3,12-13H2,1-2H3,(H2,23,27)	Group X secretory phospholipase A2 inhibitor	INHIBITOR	CHEMBL4342	Group X secretory phospholipase A2	Homo sapiens
CHEMBL2105659	VARESPLADIB METHYL	CCc1c(C(=O)C(N)=O)c2c(OCC(=O)OC)cccc2n1Cc1ccccc1	VJYDOJXJUCJUHL-UHFFFAOYSA-N	InChI=1S/C22H22N2O5/c1-3-15-20(21(26)22(23)27)19-16(24(15)12-14-8-5-4-6-9-14)10-7-11-17(19)29-13-18(25)28-2/h4-11H,3,12-13H2,1-2H3,(H2,23,27)	Phospholipase A2 group V inhibitor	INHIBITOR	CHEMBL4323	Phospholipase A2 group V	Homo sapiens
CHEMBL1169	AMINOSALICYLIC ACID	Nc1ccc(C(=O)O)c(O)c1	WUBBRNOQWQTFEX-UHFFFAOYSA-N	InChI=1S/C7H7NO3/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,9H,8H2,(H,10,11)	Dihydrofolate reductase inhibitor	INHIBITOR	CHEMBL6065	Dihydrofolate reductase	Mycobacterium tuberculosis
CHEMBL468	THALIDOMIDE	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	UEJJHQNACJXSKW-UHFFFAOYSA-N	InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)	CRL4(CRBN) E3 ubiquitin ligase inhibitor	INHIBITOR	CHEMBL3833061	CRL4(CRBN) E3 ubiquitin ligase	Homo sapiens
CHEMBL848	LENALIDOMIDE	Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O	GOTYRUGSSMKFNF-UHFFFAOYSA-N	InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)	CRL4(CRBN) E3 ubiquitin ligase inhibitor	INHIBITOR	CHEMBL3833061	CRL4(CRBN) E3 ubiquitin ligase	Homo sapiens
CHEMBL43452	POMALIDOMIDE	Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O	UVSMNLNDYGZFPF-UHFFFAOYSA-N	InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18)	CRL4(CRBN) E3 ubiquitin ligase inhibitor	INHIBITOR	CHEMBL3833061	CRL4(CRBN) E3 ubiquitin ligase	Homo sapiens
CHEMBL296913	PARECOXIB SODIUM	CCC(=O)[N-]S(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1.[Na+]	HQPVVKXJNZEAFW-UHFFFAOYSA-M	InChI=1S/C19H18N2O4S.Na/c1-3-17(22)21-26(23,24)16-11-9-14(10-12-16)18-13(2)25-20-19(18)15-7-5-4-6-8-15;/h4-12H,3H2,1-2H3,(H,21,22);/q;+1/p-1	Cyclooxygenase-2 inhibitor	INHIBITOR	CHEMBL230	Cyclooxygenase-2	Homo sapiens
CHEMBL2051955	LEVOSIMENDAN	C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1	WHXMKTBCFHIYNQ-SECBINFHSA-N	InChI=1S/C14H12N6O/c1-9-6-13(21)19-20-14(9)10-2-4-11(5-3-10)17-18-12(7-15)8-16/h2-5,9,17H,6H2,1H3,(H,19,21)/t9-/m1/s1	Phosphodiesterase 3 inhibitor	INHIBITOR	CHEMBL2094125	Phosphodiesterase 3	Homo sapiens
CHEMBL1568698	GANAXOLONE	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C	PGTVWKLGGCQMBR-FLBATMFCSA-N	InChI=1S/C22H36O2/c1-14(23)17-7-8-18-16-6-5-15-13-20(2,24)11-12-21(15,3)19(16)9-10-22(17,18)4/h15-19,24H,5-13H2,1-4H3/t15-,16-,17+,18-,19-,20+,21-,22+/m0/s1	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL413376	SURAMIN HEXASODIUM	Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)[O-])c5cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c45)ccc3C)c2)c1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]	VAPNKLKDKUDFHK-UHFFFAOYSA-H	InChI=1S/C51H40N6O23S6.6Na/c1-25-9-11-29(49(60)54-37-13-15-41(83(69,70)71)35-21-33(81(63,64)65)23-43(45(35)37)85(75,76)77)19-39(25)56-47(58)27-5-3-7-31(17-27)52-51(62)53-32-8-4-6-28(18-32)48(59)57-40-20-30(12-10-26(40)2)50(61)55-38-14-16-42(84(72,73)74)36-22-34(82(66,67)68)24-44(46(36)38)86(78,79)80;;;;;;/h3-24H,1-2H3,(H,54,60)(H,55,61)(H,56,58)(H,57,59)(H2,52,53,62)(H,63,64,65)(H,66,67,68)(H,69,70,71)(H,72,73,74)(H,75,76,77)(H,78,79,80);;;;;;/q;6*+1/p-6	Acidic fibroblast growth factor inhibitor	INHIBITOR	CHEMBL2120	Acidic fibroblast growth factor	Homo sapiens
CHEMBL59356	ATRELEUTON	C[C@H](C#Cc1ccc(Cc2ccc(F)cc2)s1)N(O)C(N)=O	MMSNEKOTSJRTRI-LLVKDONJSA-N	InChI=1S/C16H15FN2O2S/c1-11(19(21)16(18)20)2-7-14-8-9-15(22-14)10-12-3-5-13(17)6-4-12/h3-6,8-9,11,21H,10H2,1H3,(H2,18,20)/t11-/m1/s1	Arachidonate 5-lipoxygenase inhibitor	INHIBITOR	CHEMBL215	Arachidonate 5-lipoxygenase	Homo sapiens
CHEMBL458875	CLEVUDINE	Cc1cn([C@H]2O[C@@H](CO)[C@H](O)[C@H]2F)c(=O)[nH]c1=O	GBBJCSTXCAQSSJ-XQXXSGGOSA-N	InChI=1S/C10H13FN2O5/c1-4-2-13(10(17)12-8(4)16)9-6(11)7(15)5(3-14)18-9/h2,5-7,9,14-15H,3H2,1H3,(H,12,16,17)/t5-,6+,7-,9-/m0/s1	Protein P inhibitor	INHIBITOR	CHEMBL3833482	Protein P	Hepatitis B virus genotype A2 subtype adw2 (strain Rutter 1979)(HBV-A)
CHEMBL118218	IROFULVEN	CC1=C(CO)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1	NICJCIQSJJKZAH-AWEZNQCLSA-N	InChI=1S/C15H18O3/c1-8-6-10-12(11(8)7-16)9(2)15(4-5-15)14(3,18)13(10)17/h6,16,18H,4-5,7H2,1-3H3/t14-/m0/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL19236	MOXONIDINE	COc1nc(C)nc(Cl)c1NC1=NCCN1	WPNJAUFVNXKLIM-UHFFFAOYSA-N	InChI=1S/C9H12ClN5O/c1-5-13-7(10)6(8(14-5)16-2)15-9-11-3-4-12-9/h3-4H2,1-2H3,(H2,11,12,15)	Nischarin agonist	AGONIST	CHEMBL3923	Nischarin	Homo sapiens
CHEMBL279785	MARIMASTAT	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	OCSMOTCMPXTDND-OUAUKWLOSA-N	InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1	Matrix metalloproteinase 9 inhibitor	INHIBITOR	CHEMBL321	Matrix metalloproteinase 9	Homo sapiens
CHEMBL515408	MARIBAVIR	CC(C)Nc1nc2cc(Cl)c(Cl)cc2n1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O	KJFBVJALEQWJBS-XUXIUFHCSA-N	InChI=1S/C15H19Cl2N3O4/c1-6(2)18-15-19-9-3-7(16)8(17)4-10(9)20(15)14-13(23)12(22)11(5-21)24-14/h3-4,6,11-14,21-23H,5H2,1-2H3,(H,18,19)/t11-,12-,13-,14-/m0/s1	Serine/threonine-protein kinase BGLF4 inhibitor	INHIBITOR	CHEMBL3833483	Serine/threonine-protein kinase BGLF4	Epstein-Barr virus (strain GD1) (HHV-4) (Human herpesvirus 4)
CHEMBL476960	VOGLIBOSE	OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O	FZNCGRZWXLXZSZ-CIQUZCHMSA-N	InChI=1S/C10H21NO7/c12-2-5(3-13)11-6-1-10(18,4-14)9(17)8(16)7(6)15/h5-9,11-18H,1-4H2/t6-,7-,8+,9-,10-/m0/s1	Alpha glucosidase inhibitor	INHIBITOR	CHEMBL3833502	Alpha glucosidase	Homo sapiens
CHEMBL298406	ECOPIPAM	CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21	DMJWENQHWZZWDF-PKOBYXMFSA-N	InChI=1S/C19H20ClNO/c1-21-9-8-13-10-16(20)18(22)11-15(13)19-14-5-3-2-4-12(14)6-7-17(19)21/h2-5,10-11,17,19,22H,6-9H2,1H3/t17-,19+/m0/s1	Dopamine D1 receptor antagonist	ANTAGONIST	CHEMBL2056	Dopamine D1 receptor	Homo sapiens
CHEMBL175	DEXIBUPROFEN	CC(C)Cc1ccc([C@H](C)C(=O)O)cc1	HEFNNWSXXWATRW-JTQLQIEISA-N	InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/t10-/m0/s1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL14370	REBOXETINE	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	CBQGYUDMJHNJBX-UHFFFAOYSA-N	InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL432162	TASOSARTAN	Cc1nc(C)c2c(n1)N(Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)CC2	ADXGNEYLLLSOAR-UHFFFAOYSA-N	InChI=1S/C23H21N7O/c1-14-18-11-12-21(31)30(23(18)25-15(2)24-14)13-16-7-9-17(10-8-16)19-5-3-4-6-20(19)22-26-28-29-27-22/h3-10H,11-13H2,1-2H3,(H,26,27,28,29)	Type-1 angiotensin II receptor antagonist	ANTAGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL1512580	XALIPRODEN	FC(F)(F)c1cccc(C2=CCN(CCc3ccc4ccccc4c3)CC2)c1	WJJYZXPHLSLMGE-UHFFFAOYSA-N	InChI=1S/C24H22F3N/c25-24(26,27)23-7-3-6-22(17-23)20-11-14-28(15-12-20)13-10-18-8-9-19-4-1-2-5-21(19)16-18/h1-9,11,16-17H,10,12-15H2	Serotonin 1a (5-HT1a) receptor agonist	AGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL306823	SODIUM DICHLOROACETATE	O=C([O-])C(Cl)Cl.[Na+]	LUPNKHXLFSSUGS-UHFFFAOYSA-M	InChI=1S/C2H2Cl2O2.Na/c3-1(4)2(5)6;/h1H,(H,5,6);/q;+1/p-1	Pyruvate dehydrogenase kinase inhibitor	INHIBITOR	CHEMBL2096665	Pyruvate dehydrogenase kinase	Homo sapiens
CHEMBL2104745	PAGOCLONE	CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1	HIUPRQPBWVEQJJ-UHFFFAOYSA-N	InChI=1S/C23H22ClN3O2/c1-14(2)7-10-16(28)13-19-17-5-3-4-6-18(17)23(29)27(19)21-12-9-15-8-11-20(24)25-22(15)26-21/h3-6,8-9,11-12,14,19H,7,10,13H2,1-2H3	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL281398	TERBOGREL	CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1	XUTLOCQNGLJNSA-RGVLZGJSSA-N	InChI=1S/C23H27N5O2/c1-23(2,3)28-22(26-16-24)27-19-10-6-8-17(14-19)20(11-4-5-12-21(29)30)18-9-7-13-25-15-18/h6-11,13-15H,4-5,12H2,1-3H3,(H,29,30)(H2,26,27,28)/b20-11+	Thromboxane A2 receptor antagonist	ANTAGONIST	CHEMBL2069	Thromboxane A2 receptor	Homo sapiens
CHEMBL225071	RALTITREXED	Cc1nc(=O)c2cc(CN(C)c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)s3)ccc2[nH]1	IVTVGDXNLFLDRM-HNNXBMFYSA-N	InChI=1S/C21H22N4O6S/c1-11-22-14-4-3-12(9-13(14)19(28)23-11)10-25(2)17-7-6-16(32-17)20(29)24-15(21(30)31)5-8-18(26)27/h3-4,6-7,9,15H,5,8,10H2,1-2H3,(H,24,29)(H,26,27)(H,30,31)(H,22,23,28)/t15-/m0/s1	Thymidylate synthase inhibitor	INHIBITOR	CHEMBL1952	Thymidylate synthase	Homo sapiens
CHEMBL355200	ENILURACIL	C#Cc1cnc(O)nc1O	JOZGNYDSEBIJDH-UHFFFAOYSA-N	InChI=1S/C6H4N2O2/c1-2-4-3-7-6(10)8-5(4)9/h1,3H,(H2,7,8,9,10)	Dihydropyrimidine dehydrogenase inhibitor	INHIBITOR	CHEMBL3172	Dihydropyrimidine dehydrogenase	Homo sapiens
CHEMBL2105872	IBUTAMOREN MESYLATE	CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12.CS(=O)(=O)O	DUGMCDWNXXFHDE-VZYDHVRKSA-N	InChI=1S/C27H36N4O5S.CH4O3S/c1-26(2,28)25(33)29-22(18-36-17-20-9-5-4-6-10-20)24(32)30-15-13-27(14-16-30)19-31(37(3,34)35)23-12-8-7-11-21(23)27;1-5(2,3)4/h4-12,22H,13-19,28H2,1-3H3,(H,29,33);1H3,(H,2,3,4)/t22-;/m1./s1	Ghrelin receptor agonist	AGONIST	CHEMBL4616	Ghrelin receptor	Homo sapiens
CHEMBL29609	PLECONARIL	Cc1cc(CCCOc2c(C)cc(-c3noc(C(F)(F)F)n3)cc2C)on1	KQOXLKOJHVFTRN-UHFFFAOYSA-N	InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3	VP1 capsid protein disrupting agent	DISRUPTING AGENT	CHEMBL3833484	VP1 capsid protein	Human rhinovirus sp.
CHEMBL1206690	PARECOXIB	CCC(=O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1	TZRHLKRLEZJVIJ-UHFFFAOYSA-N	InChI=1S/C19H18N2O4S/c1-3-17(22)21-26(23,24)16-11-9-14(10-12-16)18-13(2)25-20-19(18)15-7-5-4-6-8-15/h4-12H,3H2,1-2H3,(H,21,22)	Cyclooxygenase-2 inhibitor	INHIBITOR	CHEMBL230	Cyclooxygenase-2	Homo sapiens
CHEMBL359164	TROXACITABINE	Nc1ccn([C@@H]2CO[C@H](CO)O2)c(=O)n1	RXRGZNYSEHTMHC-BQBZGAKWSA-N	InChI=1S/C8H11N3O4/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7-/m0/s1	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	CHEMBL2363042	DNA polymerase (alpha/delta/epsilon)	Homo sapiens
CHEMBL1016	CANDESARTAN	CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1	HTQMVQVXFRQIKW-UHFFFAOYSA-N	InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)	Type-1 angiotensin II receptor antagonist	ANTAGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL70972	SERATRODAST	CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O	ZBVKEHDGYSLCCC-UHFFFAOYSA-N	InChI=1S/C22H26O4/c1-14-15(2)22(26)20(16(3)21(14)25)18(17-10-6-4-7-11-17)12-8-5-9-13-19(23)24/h4,6-7,10-11,18H,5,8-9,12-13H2,1-3H3,(H,23,24)	Thromboxane A2 receptor antagonist	ANTAGONIST	CHEMBL2069	Thromboxane A2 receptor	Homo sapiens
CHEMBL226267	ARZOXIFENE	COc1ccc(-c2sc3cc(O)ccc3c2Oc2ccc(OCCN3CCCCC3)cc2)cc1	MCGDSOGUHLTADD-UHFFFAOYSA-N	InChI=1S/C28H29NO4S/c1-31-22-8-5-20(6-9-22)28-27(25-14-7-21(30)19-26(25)34-28)33-24-12-10-23(11-13-24)32-18-17-29-15-3-2-4-16-29/h5-14,19,30H,2-4,15-18H2,1H3	Estrogen receptor modulator	MODULATOR	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL515408	MARIBAVIR	CC(C)Nc1nc2cc(Cl)c(Cl)cc2n1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O	KJFBVJALEQWJBS-XUXIUFHCSA-N	InChI=1S/C15H19Cl2N3O4/c1-6(2)18-15-19-9-3-7(16)8(17)4-10(9)20(15)14-13(23)12(22)11(5-21)24-14/h3-4,6,11-14,21-23H,5H2,1-2H3,(H,18,19)/t11-,12-,13-,14-/m0/s1	Phosphotransferase pUL97 inhibitor	INHIBITOR	CHEMBL1287608	Phosphotransferase pUL97	Human herpesvirus 5
CHEMBL218166	BIFEPRUNOX	O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1	CYGODHVAJQTCBG-UHFFFAOYSA-N	InChI=1S/C24H23N3O2/c28-24-25-21-10-5-11-22(23(21)29-24)27-14-12-26(13-15-27)17-18-6-4-9-20(16-18)19-7-2-1-3-8-19/h1-11,16H,12-15,17H2,(H,25,28)	Dopamine D2 receptor partial agonist	PARTIAL AGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL1094636	NIRAPARIB	NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12	PCHKPVIQAHNQLW-CQSZACIVSA-N	InChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1	Poly [ADP-ribose] polymerase-1 inhibitor	INHIBITOR	CHEMBL3105	Poly [ADP-ribose] polymerase-1	Homo sapiens
CHEMBL2107313	BECATECARIN	CCN(CC)CCN1C(=O)c2c(c3c4cccc(Cl)c4n([C@@H]4O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]4O)c3c3[nH]c4c(Cl)cccc4c23)C1=O	JSKFWUPVIZYJMR-UDOAKELVSA-N	InChI=1S/C33H34Cl2N4O7/c1-4-37(5-2)12-13-38-31(43)22-20-15-8-6-10-17(34)24(15)36-25(20)27-21(23(22)32(38)44)16-9-7-11-18(35)26(16)39(27)33-29(42)28(41)30(45-3)19(14-40)46-33/h6-11,19,28-30,33,36,40-42H,4-5,12-14H2,1-3H3/t19-,28-,29-,30-,33-/m1/s1	DNA topoisomerase II inhibitor	INHIBITOR	CHEMBL2094255	DNA topoisomerase II	Homo sapiens
CHEMBL119625	ZONAMPANEL	O=C(O)Cn1c(=O)c(=O)[nH]c2cc([N+](=O)[O-])c(-n3ccnc3)cc21	SPXYHZRWPRQLNS-UHFFFAOYSA-N	InChI=1S/C13H9N5O6/c19-11(20)5-17-8-4-9(16-2-1-14-6-16)10(18(23)24)3-7(8)15-12(21)13(17)22/h1-4,6H,5H2,(H,15,21)(H,19,20)	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	CHEMBL2096670	Glutamate receptor ionotropic AMPA	Homo sapiens
CHEMBL281398	TERBOGREL	CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1	XUTLOCQNGLJNSA-RGVLZGJSSA-N	InChI=1S/C23H27N5O2/c1-23(2,3)28-22(26-16-24)27-19-10-6-8-17(14-19)20(11-4-5-12-21(29)30)18-9-7-13-25-15-18/h6-11,13-15H,4-5,12H2,1-3H3,(H,29,30)(H2,26,27,28)/b20-11+	Thromboxane-A synthase inhibitor	INHIBITOR	CHEMBL1835	Thromboxane-A synthase	Homo sapiens
CHEMBL3545062	VELPATASVIR	COC[C@H]1C[C@@H](c2nc(-c3ccc4c(c3)COc3cc5c(ccc6nc([C@@H]7CC[C@H](C)N7C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c65)cc3-4)c[nH]2)N(C(=O)[C@H](NC(=O)OC)c2ccccc2)C1	FHCUMDQMBHQXKK-CDIODLITSA-N	InChI=1S/C49H54N8O8/c1-26(2)41(54-48(60)63-5)47(59)57-27(3)12-17-38(57)45-51-36-16-14-30-20-35-33-15-13-31(19-32(33)25-65-40(35)21-34(30)43(36)53-45)37-22-50-44(52-37)39-18-28(24-62-4)23-56(39)46(58)42(55-49(61)64-6)29-10-8-7-9-11-29/h7-11,13-16,19-22,26-28,38-39,41-42H,12,17-18,23-25H2,1-6H3,(H,50,52)(H,51,53)(H,54,60)(H,55,61)/t27-,28-,38-,39-,41-,42+/m0/s1	Nonstructural protein 5A inhibitor	INHIBITOR	CHEMBL3307224	Nonstructural protein 5A	Hepatitis C virus
CHEMBL3833368	RUCAPARIB CAMSYLATE	CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)O)C(=O)C2.CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1	INBJJAFXHQQSRW-STOWLHSFSA-N	InChI=1S/C19H18FN3O.C10H16O4S/c1-21-10-11-2-4-12(5-3-11)18-14-6-7-22-19(24)15-8-13(20)9-16(23-18)17(14)15;1-9(2)7-3-4-10(9,8(11)5-7)6-15(12,13)14/h2-5,8-9,21,23H,6-7,10H2,1H3,(H,22,24);7H,3-6H2,1-2H3,(H,12,13,14)/t;7-,10-/m.1/s1	PARP 1, 2 and 3 inhibitor	INHIBITOR	CHEMBL3390820	PARP 1, 2 and 3	Homo sapiens
CHEMBL3707266	RIBOCICLIB SUCCINATE	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1.O=C(O)CCC(=O)O	NHANOMFABJQAAH-UHFFFAOYSA-N	InChI=1S/C23H30N8O.C4H6O4/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30;5-3(6)1-2-4(7)8/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28);1-2H2,(H,5,6)(H,7,8)	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	CHEMBL331	Cyclin-dependent kinase 4	Homo sapiens
CHEMBL3707266	RIBOCICLIB SUCCINATE	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1.O=C(O)CCC(=O)O	NHANOMFABJQAAH-UHFFFAOYSA-N	InChI=1S/C23H30N8O.C4H6O4/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30;5-3(6)1-2-4(7)8/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28);1-2H2,(H,5,6)(H,7,8)	Cyclin-dependent kinase 6 inhibitor	INHIBITOR	CHEMBL2508	Cyclin-dependent kinase 6	Homo sapiens
CHEMBL48582	SAFINAMIDE MESYLATE	CS(=O)(=O)O.C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O	YKOCHIUQOBQIAC-YDALLXLXSA-N	InChI=1S/C17H19FN2O2.CH4O3S/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14;1-5(2,3)4/h2-9,12,20H,10-11H2,1H3,(H2,19,21);1H3,(H,2,3,4)/t12-;/m0./s1	Monoamine oxidase B inhibitor	INHIBITOR	CHEMBL2039	Monoamine oxidase B	Homo sapiens
CHEMBL3039508	NALDEMEDINE TOSYLATE	CC(C)(NC(=O)C1=C(O)[C@@H]2Oc3c(O)ccc4c3[C@@]23CCN(CC2CC2)[C@H](C4)[C@]3(O)C1)c1nc(-c2ccccc2)no1.Cc1ccc(S(=O)(=O)O)cc1	WCYDLROFMZJJLE-RTMHEQJQSA-N	InChI=1S/C32H34N4O6.C7H8O3S/c1-30(2,29-33-27(35-42-29)18-6-4-3-5-7-18)34-28(39)20-15-32(40)22-14-19-10-11-21(37)25-23(19)31(32,26(41-25)24(20)38)12-13-36(22)16-17-8-9-17;1-6-2-4-7(5-3-6)11(8,9)10/h3-7,10-11,17,22,26,37-38,40H,8-9,12-16H2,1-2H3,(H,34,39);2-5H,1H3,(H,8,9,10)/t22-,26+,31+,32-;/m1./s1	Mu opioid receptor antagonist	ANTAGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL2105695	TELOTRISTAT ETHYL	CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1	MDSQOJYHHZBZKA-GBXCKJPGSA-N	InChI=1S/C27H26ClF3N6O3/c1-3-39-25(38)20(32)12-16-4-6-17(7-5-16)21-14-23(35-26(33)34-21)40-24(27(29,30)31)19-9-8-18(28)13-22(19)37-11-10-15(2)36-37/h4-11,13-14,20,24H,3,12,32H2,1-2H3,(H2,33,34,35)/t20-,24+/m0/s1	Tryptophan 5-hydroxylase inhibitor	INHIBITOR	CHEMBL3831287	Tryptophan 5-hydroxylase	Homo sapiens
CHEMBL1201891	DEFLAZACORT	CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C	FBHSPRKOSMHSIF-GRMWVWQJSA-N	InChI=1S/C25H31NO6/c1-13-26-25(20(30)12-31-14(2)27)21(32-13)10-18-17-6-5-15-9-16(28)7-8-23(15,3)22(17)19(29)11-24(18,25)4/h7-9,17-19,21-22,29H,5-6,10-12H2,1-4H3/t17-,18-,19-,21+,22+,23-,24-,25+/m0/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL3707374	AMISELIMOD HYDROCHLORIDE	CCCCCCCOc1ccc(CCC(N)(CO)CO)cc1C(F)(F)F.Cl	GEDVJGOVRLHFQG-UHFFFAOYSA-N	InChI=1S/C19H30F3NO3.ClH/c1-2-3-4-5-6-11-26-17-8-7-15(12-16(17)19(20,21)22)9-10-18(23,13-24)14-25;/h7-8,12,24-25H,2-6,9-11,13-14,23H2,1H3;1H	Sphingosine 1-phosphate receptor modulator	MODULATOR	CHEMBL2363041	Sphingosine 1-phosphate receptor	Homo sapiens
CHEMBL4204869	ELENBECESTAT	C[C@H]1OC[C@]2(c3cc(NC(=O)c4cnc(C(F)F)cn4)ccc3F)N=C(N)SC[C@H]12	AACUJFVOHGRMTR-DPXNYUHVSA-N	InChI=1S/C19H18F3N5O2S/c1-9-12-7-30-18(23)27-19(12,8-29-9)11-4-10(2-3-13(11)20)26-17(28)15-6-24-14(5-25-15)16(21)22/h2-6,9,12,16H,7-8H2,1H3,(H2,23,27)(H,26,28)/t9-,12-,19-/m1/s1	Beta-secretase 1 inhibitor	INHIBITOR	CHEMBL4822	Beta-secretase 1	Homo sapiens
CHEMBL1540	PENCICLOVIR	Nc1nc(O)c2ncn(CCC(CO)CO)c2n1	JNTOCHDNEULJHD-UHFFFAOYSA-N	InChI=1S/C10H15N5O3/c11-10-13-8-7(9(18)14-10)12-5-15(8)2-1-6(3-16)4-17/h5-6,16-17H,1-4H2,(H3,11,13,14,18)	Human herpesvirus 1 DNA polymerase inhibitor	INHIBITOR	CHEMBL1872	Human herpesvirus 1 DNA polymerase	Herpes simplex virus (type 1 / strain 17)
CHEMBL656	OXYCODONE	COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314	BRUQQQPBMZOVGD-XFKAJCMBSA-N	InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1	Mu opioid receptor agonist	AGONIST	CHEMBL233	Mu opioid receptor	Homo sapiens
CHEMBL94081	ALCLOFENAC	C=CCOc1ccc(CC(=O)O)cc1Cl	ARHWPKZXBHOEEE-UHFFFAOYSA-N	InChI=1S/C11H11ClO3/c1-2-5-15-10-4-3-8(6-9(10)12)7-11(13)14/h2-4,6H,1,5,7H2,(H,13,14)	Cyclooxygenase-1 inhibitor	INHIBITOR	CHEMBL221	Cyclooxygenase-1	Homo sapiens
CHEMBL54349	ALPIDEM	CCCN(CCC)C(=O)Cc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12	JRTIDHTUMYMPRU-UHFFFAOYSA-N	InChI=1S/C21H23Cl2N3O/c1-3-11-25(12-4-2)20(27)13-18-21(15-5-7-16(22)8-6-15)24-19-10-9-17(23)14-26(18)19/h5-10,14H,3-4,11-13H2,1-2H3	Translocator protein partial agonist	PARTIAL AGONIST	CHEMBL5742	Translocator protein	Homo sapiens
CHEMBL418995	AMINEPTINE	O=C(O)CCCCCCNC1c2ccccc2CCc2ccccc21	ONNOFKFOZAJDHT-UHFFFAOYSA-N	InChI=1S/C22H27NO2/c24-21(25)13-3-1-2-8-16-23-22-19-11-6-4-9-17(19)14-15-18-10-5-7-12-20(18)22/h4-7,9-12,22-23H,1-3,8,13-16H2,(H,24,25)	Dopamine D1 and D2 receptor antagonist	ANTAGONIST	CHEMBL2111341	Dopamine D1 and D2 receptor	Homo sapiens
CHEMBL345524	ANTRAFENINE	O=C(OCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccccc1Nc1ccnc2cc(C(F)(F)F)ccc12	NWGGKKGAFZIVBJ-UHFFFAOYSA-N	InChI=1S/C30H26F6N4O2/c31-29(32,33)20-4-3-5-22(18-20)40-14-12-39(13-15-40)16-17-42-28(41)24-6-1-2-7-25(24)38-26-10-11-37-27-19-21(30(34,35)36)8-9-23(26)27/h1-11,18-19H,12-17H2,(H,37,38)	Prostaglandin-H2 D-isomerase inhibitor	INHIBITOR	CHEMBL3430865	Prostaglandin-H2 D-isomerase	Homo sapiens
CHEMBL515914	AZARIBINE	CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O	QQOBRRFOVWGIMD-OJAKKHQRSA-N	InChI=1S/C14H17N3O9/c1-6(18)23-5-9-11(24-7(2)19)12(25-8(3)20)13(26-9)17-14(22)16-10(21)4-15-17/h4,9,11-13H,5H2,1-3H3,(H,16,21,22)/t9-,11-,12-,13-/m1/s1	Uridine 5'-monophosphate synthase inhibitor	INHIBITOR	CHEMBL5216	Uridine 5'-monophosphate synthase	Homo sapiens
CHEMBL1089221	BENDAZAC	O=C(O)COc1nn(Cc2ccccc2)c2ccccc12	BYFMCKSPFYVMOU-UHFFFAOYSA-N	InChI=1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)	Xanthine dehydrogenase inhibitor	INHIBITOR	CHEMBL1929	Xanthine dehydrogenase	Homo sapiens
CHEMBL400599	BENFLUOREX	CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1	CJAVTWRYCDNHSM-UHFFFAOYSA-N	InChI=1S/C19H20F3NO2/c1-14(12-15-6-5-9-17(13-15)19(20,21)22)23-10-11-25-18(24)16-7-3-2-4-8-16/h2-9,13-14,23H,10-12H2,1H3	Acyl coenzyme A:cholesterol acyltransferase 1 inhibitor	INHIBITOR	CHEMBL2782	Acyl coenzyme A:cholesterol acyltransferase 1	Homo sapiens
CHEMBL340978	BENOXAPROFEN	CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1	MITFXPHMIHQXPI-UHFFFAOYSA-N	InChI=1S/C16H12ClNO3/c1-9(16(19)20)11-4-7-14-13(8-11)18-15(21-14)10-2-5-12(17)6-3-10/h2-9H,1H3,(H,19,20)	Arachidonate 12-lipoxygenase inhibitor	INHIBITOR	CHEMBL3687	Arachidonate 12-lipoxygenase	Homo sapiens
CHEMBL232201	BENZIODARONE	CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1	CZCHIEJNWPNBDE-UHFFFAOYSA-N	InChI=1S/C17H12I2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3	Calmodulin inhibitor	INHIBITOR	CHEMBL6093	Calmodulin	Homo sapiens
CHEMBL127516	BUTAMBEN	CCCCOC(=O)c1ccc(N)cc1	IUWVALYLNVXWKX-UHFFFAOYSA-N	InChI=1S/C11H15NO2/c1-2-3-8-14-11(13)9-4-6-10(12)7-5-9/h4-7H,2-3,8,12H2,1H3	Transient receptor potential cation channel subfamily V member 4 inhibitor	INHIBITOR	CHEMBL3119	Transient receptor potential cation channel subfamily V member 4	Homo sapiens
CHEMBL3142541	BUTAMBEN PICRATE	CCCCOC(=O)c1ccc(N)cc1.CCCCOC(=O)c1ccc(N)cc1.O=[N+]([O-])c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1	ATAGSVCDFKGYPE-UHFFFAOYSA-N	InChI=1S/2C11H15NO2.C6H3N3O7/c2*1-2-3-8-14-11(13)9-4-6-10(12)7-5-9;10-6-4(8(13)14)1-3(7(11)12)2-5(6)9(15)16/h2*4-7H,2-3,8,12H2,1H3;1-2,10H	Transient receptor potential cation channel subfamily A member 1 inhibitor	INHIBITOR	CHEMBL6007	Transient receptor potential cation channel subfamily A member 1	Homo sapiens
CHEMBL1463345	CANRENONE	C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@]21CCC(=O)O1	UJVLDDZCTMKXJK-WNHSNXHDSA-N	InChI=1S/C22H28O3/c1-20-9-5-15(23)13-14(20)3-4-16-17(20)6-10-21(2)18(16)7-11-22(21)12-8-19(24)25-22/h3-4,13,16-18H,5-12H2,1-2H3/t16-,17+,18+,20+,21+,22-/m1/s1	Mineralocorticoid receptor antagonist	ANTAGONIST	CHEMBL1994	Mineralocorticoid receptor	Homo sapiens
CHEMBL1256696	CARBETAPENTANE CITRATE	CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1.O=C(O)CC(O)(CC(=O)O)C(=O)O	AKJDEXBCRLOVTH-UHFFFAOYSA-N	InChI=1S/C20H31NO3.C6H8O7/c1-3-21(4-2)14-15-23-16-17-24-19(22)20(12-8-9-13-20)18-10-6-5-7-11-18;7-3(8)1-6(13,5(11)12)2-4(9)10/h5-7,10-11H,3-4,8-9,12-17H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)	Sigma opioid receptor agonist	AGONIST	CHEMBL287	Sigma opioid receptor	Homo sapiens
CHEMBL110691	CHLORMADINONE ACETATE	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	QMBJSIBWORFWQT-DFXBJWIESA-N	InChI=1S/C23H29ClO4/c1-13(25)23(28-14(2)26)10-7-18-16-12-20(24)19-11-15(27)5-8-21(19,3)17(16)6-9-22(18,23)4/h11-12,16-18H,5-10H2,1-4H3/t16-,17+,18+,21-,22+,23+/m1/s1	Progesterone receptor modulator	MODULATOR	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL13376	CLOMETACIN	COc1ccc2c(C(=O)c3ccc(Cl)cc3)c(C)n(CC(=O)O)c2c1	DGMZLCLHHVYDIS-UHFFFAOYSA-N	InChI=1S/C19H16ClNO4/c1-11-18(19(24)12-3-5-13(20)6-4-12)15-8-7-14(25-2)9-16(15)21(11)10-17(22)23/h3-9H,10H2,1-2H3,(H,22,23)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL141305	CYCLOFENIL	CC(=O)Oc1ccc(C(=C2CCCCC2)c2ccc(OC(C)=O)cc2)cc1	GVOUFPWUYJWQSK-UHFFFAOYSA-N	InChI=1S/C23H24O4/c1-16(24)26-21-12-8-19(9-13-21)23(18-6-4-3-5-7-18)20-10-14-22(15-11-20)27-17(2)25/h8-15H,3-7H2,1-2H3	Estrogen receptor modulator	MODULATOR	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL53418	DANTHRON	O=C1c2cccc(O)c2C(=O)c2c(O)cccc21	QBPFLULOKWLNNW-UHFFFAOYSA-N	InChI=1S/C14H8O4/c15-9-5-1-3-7-11(9)14(18)12-8(13(7)17)4-2-6-10(12)16/h1-6,15-16H	Retinoid X receptor alpha antagonist	ANTAGONIST	CHEMBL2061	Retinoid X receptor alpha	Homo sapiens
CHEMBL1887891	DEXFENFLURAMINE HYDROCHLORIDE	CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1.Cl	ZXKXJHAOUFHNAS-FVGYRXGTSA-N	InChI=1S/C12H16F3N.ClH/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15;/h4-6,8-9,16H,3,7H2,1-2H3;1H/t9-;/m0./s1	Serotonin (5-HT) receptor agonist	AGONIST	CHEMBL2096904	Serotonin (5-HT) receptor	Homo sapiens
CHEMBL3188576	DIHYDROSTREPTOMYCIN SULFATE	CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O.CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O	CZWJCQXZZJHHRH-YCRXJPFRSA-N	InChI=1S/2C21H41N7O12.3H2O4S/c2*1-5-21(36,4-30)16(40-17-9(26-2)13(34)10(31)6(3-29)38-17)18(37-5)39-15-8(28-20(24)25)11(32)7(27-19(22)23)12(33)14(15)35;3*1-5(2,3)4/h2*5-18,26,29-36H,3-4H2,1-2H3,(H4,22,23,27)(H4,24,25,28);3*(H2,1,2,3,4)/t2*5-,6-,7+,8-,9-,10-,11+,12-,13-,14+,15+,16-,17-,18-,21+;;;/m00.../s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1204165	DILEVALOL HYDROCHLORIDE	C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(C(N)=O)c1.Cl	WQVZLXWQESQGIF-WJKBNZMCSA-N	InChI=1S/C19H24N2O3.ClH/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24;/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24);1H/t13-,18+;/m1./s1	Adrenergic receptor beta antagonist	ANTAGONIST	CHEMBL2094118	Adrenergic receptor beta	Homo sapiens
CHEMBL3989803	DIPYRONE	Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.O.[Na+]	UNZIDPIPYUMVPA-UHFFFAOYSA-M	InChI=1S/C13H17N3O4S.Na.H2O/c1-10-12(14(2)9-21(18,19)20)13(17)16(15(10)3)11-7-5-4-6-8-11;;/h4-8H,9H2,1-3H3,(H,18,19,20);;1H2/q;+1;/p-1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1742471	EBROTIDINE	N=C(N)Nc1nc(CSCCN/C=N/S(=O)(=O)c2ccc(Br)cc2)cs1	ZQHFZHPUZXNPMF-UHFFFAOYSA-N	InChI=1S/C14H17BrN6O2S3/c15-10-1-3-12(4-2-10)26(22,23)19-9-18-5-6-24-7-11-8-25-14(20-11)21-13(16)17/h1-4,8-9H,5-7H2,(H,18,19)(H4,16,17,20,21)	Histamine H2 receptor antagonist	ANTAGONIST	CHEMBL1941	Histamine H2 receptor	Homo sapiens
CHEMBL2106155	ENCAINIDE HYDROCHLORIDE	COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1.Cl	OJIIZIWOLTYOBS-UHFFFAOYSA-N	InChI=1S/C22H28N2O2.ClH/c1-24-16-6-5-8-19(24)13-10-17-7-3-4-9-21(17)23-22(25)18-11-14-20(26-2)15-12-18;/h3-4,7,9,11-12,14-15,19H,5-6,8,10,13,16H2,1-2H3,(H,23,25);1H	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL15677	FENCLOFENAC	O=C(O)Cc1ccccc1Oc1ccc(Cl)cc1Cl	IDKAXRLETRCXKS-UHFFFAOYSA-N	InChI=1S/C14H10Cl2O3/c15-10-5-6-13(11(16)8-10)19-12-4-2-1-3-9(12)7-14(17)18/h1-6,8H,7H2,(H,17,18)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL2106217	FENFLURAMINE HYDROCHLORIDE	CCNC(C)Cc1cccc(C(F)(F)F)c1.Cl	ZXKXJHAOUFHNAS-UHFFFAOYSA-N	InChI=1S/C12H16F3N.ClH/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15;/h4-6,8-9,16H,3,7H2,1-2H3;1H	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	CHEMBL1983	Serotonin 1d (5-HT1d) receptor	Homo sapiens
CHEMBL32800	FENOTEROL	CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1	LSLYOANBFKQKPT-UHFFFAOYSA-N	InChI=1S/C17H21NO4/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13/h2-5,7-9,11,17-22H,6,10H2,1H3	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL13280	FLUNITRAZEPAM	CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21	PPTYJKAXVCCBDU-UHFFFAOYSA-N	InChI=1S/C16H12FN3O3/c1-19-14-7-6-10(20(22)23)8-12(14)16(18-9-15(19)21)11-4-2-3-5-13(11)17/h2-8H,9H2,1H3	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL146095	GLAFENINE	O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12	GWOFUCIGLDBNKM-UHFFFAOYSA-N	InChI=1S/C19H17ClN2O4/c20-12-5-6-14-17(7-8-21-18(14)9-12)22-16-4-2-1-3-15(16)19(25)26-11-13(24)10-23/h1-9,13,23-24H,10-11H2,(H,21,22)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL341812	IBUFENAC	CC(C)Cc1ccc(CC(=O)O)cc1	CYWFCPPBTWOZSF-UHFFFAOYSA-N	InChI=1S/C12H16O2/c1-9(2)7-10-3-5-11(6-4-10)8-12(13)14/h3-6,9H,7-8H2,1-2H3,(H,13,14)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL276520	INDALPINE	c1ccc2c(CCC3CCNCC3)c[nH]c2c1	SADQVAVFGNTEOD-UHFFFAOYSA-N	InChI=1S/C15H20N2/c1-2-4-15-14(3-1)13(11-17-15)6-5-12-7-9-16-10-8-12/h1-4,11-12,16-17H,5-10H2	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL15870	INDOPROFEN	CC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1	RJMIEHBSYVWVIN-UHFFFAOYSA-N	InChI=1S/C17H15NO3/c1-11(17(20)21)12-6-8-14(9-7-12)18-10-13-4-2-3-5-15(13)16(18)19/h2-9,11H,10H2,1H3,(H,20,21)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL53292	ISOXICAM	Cc1cc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)no1	YYUAYBYLJSNDCX-UHFFFAOYSA-N	InChI=1S/C14H13N3O5S/c1-8-7-11(16-22-8)15-14(19)12-13(18)9-5-3-4-6-10(9)23(20,21)17(12)2/h3-7,18H,1-2H3,(H,15,16,19)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL404108	LUMIRACOXIB	Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1	KHPKQFYUPIUARC-UHFFFAOYSA-N	InChI=1S/C15H13ClFNO2/c1-9-5-6-13(10(7-9)8-14(19)20)18-15-11(16)3-2-4-12(15)17/h2-7,18H,8H2,1H3,(H,19,20)	Cyclooxygenase-2 inhibitor	INHIBITOR	CHEMBL230	Cyclooxygenase-2	Homo sapiens
CHEMBL1909283	MEBANAZINE	CC(NN)c1ccccc1	HHRZAEJMHSGZNP-UHFFFAOYSA-N	InChI=1S/C8H12N2/c1-7(10-9)8-5-3-2-4-6-8/h2-7,10H,9H2,1H3	Monoamine oxidase inhibitor	INHIBITOR	CHEMBL2095205	Monoamine oxidase	Homo sapiens
CHEMBL1712842	MEPAZINE ACETATE	CC(=O)O.CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1	COBIOCPXKOZHSU-UHFFFAOYSA-N	InChI=1S/C19H22N2S.C2H4O2/c1-20-12-6-7-15(13-20)14-21-16-8-2-4-10-18(16)22-19-11-5-3-9-17(19)21;1-2(3)4/h2-5,8-11,15H,6-7,12-14H2,1H3;1H3,(H,3,4)	Mucosa-associated lymphoid tissue lymphoma translocation protein 1 inhibitor	INHIBITOR	CHEMBL3632452	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	Homo sapiens
CHEMBL1418176	METHANDROSTENOLONE	C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O	XWALNWXLMVGSFR-HLXURNFRSA-N	InChI=1S/C20H28O2/c1-18-9-6-14(21)12-13(18)4-5-15-16(18)7-10-19(2)17(15)8-11-20(19,3)22/h6,9,12,15-17,22H,4-5,7-8,10-11H2,1-3H3/t15-,16+,17+,18+,19+,20+/m1/s1	Androgen Receptor agonist	AGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL3187246	METHAPYRILENE FUMARATE	CN(C)CCN(Cc1cccs1)c1ccccn1.CN(C)CCN(Cc1cccs1)c1ccccn1.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O	OLGIEIJNOQGBSS-VQYXCCSOSA-N	InChI=1S/2C14H19N3S.3C4H4O4/c2*1-16(2)9-10-17(12-13-6-5-11-18-13)14-7-3-4-8-15-14;3*5-3(6)1-2-4(7)8/h2*3-8,11H,9-10,12H2,1-2H3;3*1-2H,(H,5,6)(H,7,8)/b;;3*2-1+	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL1255739	METHAPYRILENE HYDROCHLORIDE	CN(C)CCN(Cc1cccs1)c1ccccn1.Cl	BONORRGKLJBGRV-UHFFFAOYSA-N	InChI=1S/C14H19N3S.ClH/c1-16(2)9-10-17(12-13-6-5-11-18-13)14-7-3-4-8-15-14;/h3-8,11H,9-10,12H2,1-2H3;1H	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL282052	METHAQUALONE	Cc1ccccc1-n1c(C)nc2ccccc2c1=O	JEYCTXHKTXCGPB-UHFFFAOYSA-N	InChI=1S/C16H14N2O/c1-11-7-3-6-10-15(11)18-12(2)17-14-9-5-4-8-13(14)16(18)19/h3-10H,1-2H3	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL2106829	METHAQUALONE HYDROCHLORIDE	Cc1ccccc1-n1c(C)nc2ccccc2c1=O.Cl	KJUHIXIWKSVBKB-UHFFFAOYSA-N	InChI=1S/C16H14N2O.ClH/c1-11-7-3-6-10-15(11)18-12(2)17-14-9-5-4-8-13(14)16(18)19;/h3-10H,1-2H3;1H	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL278819	MINAPRINE	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	LDMWSLGGVTVJPG-UHFFFAOYSA-N	InChI=1S/C17H22N4O/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21/h2-6,13H,7-12H2,1H3,(H,18,20)	Serotonin 2 (5-HT2) receptor antagonist	ANTAGONIST	CHEMBL2093870	Serotonin 2 (5-HT2) receptor	Rattus norvegicus
CHEMBL1364551	MINAPRINE HYDROCHLORIDE	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1.Cl.Cl	GNUCGROXDZMCJI-UHFFFAOYSA-N	InChI=1S/C17H22N4O.2ClH/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21;;/h2-6,13H,7-12H2,1H3,(H,18,20);2*1H	Serotonin 2 (5-HT2) receptor antagonist	ANTAGONIST	CHEMBL2093870	Serotonin 2 (5-HT2) receptor	Rattus norvegicus
CHEMBL159226	MOXISYLYTE	CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C	VRYMTAVOXVTQEF-UHFFFAOYSA-N	InChI=1S/C16H25NO3/c1-11(2)14-10-15(20-13(4)18)12(3)9-16(14)19-8-7-17(5)6/h9-11H,7-8H2,1-6H3	Adrenergic receptor alpha antagonist	ANTAGONIST	CHEMBL2095203	Adrenergic receptor alpha	Homo sapiens
CHEMBL1256841	NIALAMIDE	O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	NOIIUHRQUVNIDD-UHFFFAOYSA-N	InChI=1S/C16H18N4O2/c21-15(18-12-13-4-2-1-3-5-13)8-11-19-20-16(22)14-6-9-17-10-7-14/h1-7,9-10,19H,8,11-12H2,(H,18,21)(H,20,22)	Monoamine oxidase inhibitor	INHIBITOR	CHEMBL2095205	Monoamine oxidase	Homo sapiens
CHEMBL1909285	NITREFAZOLE	Cc1nc([N+](=O)[O-])cn1-c1ccc([N+](=O)[O-])cc1	NMTBSNPBIGRZBL-UHFFFAOYSA-N	InChI=1S/C10H8N4O4/c1-7-11-10(14(17)18)6-12(7)8-2-4-9(5-3-8)13(15)16/h2-6H,1H3	Alcohol dehydrogenase inhibitor	INHIBITOR	CHEMBL2096668	Alcohol dehydrogenase	Homo sapiens
CHEMBL1256842	NOMIFENSINE MALEATE	CN1Cc2c(N)cccc2C(c2ccccc2)C1.O=C(O)/C=C\C(=O)O	GEOCVSMCLVIOEV-BTJKTKAUSA-N	InChI=1S/C16H18N2.C4H4O4/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18;5-3(6)1-2-4(7)8/h2-9,14H,10-11,17H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-	Monoamine transporter inhibitor	INHIBITOR	CHEMBL2363064	Monoamine transporter	Homo sapiens
CHEMBL1334033	PERHEXILINE MALEATE	C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1.O=C(O)/C=C\C(=O)O	JDZOTSLZMQDFLG-BTJKTKAUSA-N	InChI=1S/C19H35N.C4H4O4/c1-3-9-16(10-4-1)19(17-11-5-2-6-12-17)15-18-13-7-8-14-20-18;5-3(6)1-2-4(7)8/h16-20H,1-15H2;1-2H,(H,5,6)(H,7,8)/b;2-1-	Carnitine O-palmitoyltransferase 1, muscle isoform inhibitor	INHIBITOR	CHEMBL2216739	Carnitine O-palmitoyltransferase 1, muscle isoform	Homo sapiens
CHEMBL1909286	PHENOXYPROPAZINE	CC(COc1ccccc1)NN	QNEXFJFTGQBXBJ-UHFFFAOYSA-N	InChI=1S/C9H14N2O/c1-8(11-10)7-12-9-5-3-2-4-6-9/h2-6,8,11H,7,10H2,1H3	Monoamine oxidase inhibitor	INHIBITOR	CHEMBL2095205	Monoamine oxidase	Homo sapiens
CHEMBL188952	PIRPROFEN	CC(C(=O)O)c1ccc(N2CC=CC2)c(Cl)c1	PIDSZXPFGCURGN-UHFFFAOYSA-N	InChI=1S/C13H14ClNO2/c1-9(13(16)17)10-4-5-12(11(14)8-10)15-6-2-3-7-15/h2-5,8-9H,6-7H2,1H3,(H,16,17)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL24072	PRENYLAMINE	CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1	IFFPICMESYHZPQ-UHFFFAOYSA-N	InChI=1S/C24H27N/c1-20(19-21-11-5-2-6-12-21)25-18-17-24(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,20,24-25H,17-19H2,1H3	Sodium channel protein type V alpha subunit blocker	BLOCKER	CHEMBL1980	Sodium channel protein type V alpha subunit	Homo sapiens
CHEMBL316561	PROGLUMIDE	CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1	DGMKFQYCZXERLX-UHFFFAOYSA-N	InChI=1S/C18H26N2O4/c1-3-12-20(13-4-2)18(24)15(10-11-16(21)22)19-17(23)14-8-6-5-7-9-14/h5-9,15H,3-4,10-13H2,1-2H3,(H,19,23)(H,21,22)	Cholecystokinin receptor antagonist	ANTAGONIST	CHEMBL2095185	Cholecystokinin receptor	Homo sapiens
CHEMBL16476	PRONETALOL	CC(C)NCC(O)c1ccc2ccccc2c1	HRSANNODOVBCST-UHFFFAOYSA-N	InChI=1S/C15H19NO/c1-11(2)16-10-15(17)14-8-7-12-5-3-4-6-13(12)9-14/h3-9,11,15-17H,10H2,1-2H3	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL2105345	PROPANIDID	CCCOC(=O)Cc1ccc(OCC(=O)N(CC)CC)c(OC)c1	KEJXLQUPYHWCNM-UHFFFAOYSA-N	InChI=1S/C18H27NO5/c1-5-10-23-18(21)12-14-8-9-15(16(11-14)22-4)24-13-17(20)19(6-2)7-3/h8-9,11H,5-7,10,12-13H2,1-4H3	Butyrylcholinesterase inhibitor	INHIBITOR	CHEMBL1914	Butyrylcholinesterase	Homo sapiens
CHEMBL2105233	PROXIBARBAL	C=CCC1(CC(C)O)C(=O)NC(=O)NC1=O	VNLMRPAWAMPLNZ-UHFFFAOYSA-N	InChI=1S/C10H14N2O4/c1-3-4-10(5-6(2)13)7(14)11-9(16)12-8(10)15/h3,6,13H,1,4-5H2,2H3,(H2,11,12,14,15,16)	Diamine oxidase activator	ACTIVATOR	CHEMBL2118	Diamine oxidase	Homo sapiens
CHEMBL2104793	PYROVALERONE HYDROCHLORIDE	CCCC(C(=O)c1ccc(C)cc1)N1CCCC1.Cl	MWRACNBZNVAJHE-UHFFFAOYSA-N	InChI=1S/C16H23NO.ClH/c1-3-6-15(17-11-4-5-12-17)16(18)14-9-7-13(2)8-10-14;/h7-10,15H,3-6,11-12H2,1-2H3;1H	Monoamine transporters; Norepinephrine & dopamine inhibitor	INHIBITOR	CHEMBL2096990	Monoamine transporters; Norepinephrine & dopamine	Homo sapiens
CHEMBL22242	REMOXIPRIDE	CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC	GUJRSXAPGDDABA-NSHDSACASA-N	InChI=1S/C16H23BrN2O3/c1-4-19-9-5-6-11(19)10-18-16(20)14-13(21-2)8-7-12(17)15(14)22-3/h7-8,11H,4-6,9-10H2,1-3H3,(H,18,20)/t11-/m0/s1	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL3989556	REMOXIPRIDE HYDROCHLORIDE	CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC.Cl.O	SPFVHFBNXPARTR-IDMXKUIJSA-N	InChI=1S/C16H23BrN2O3.ClH.H2O/c1-4-19-9-5-6-11(19)10-18-16(20)14-13(21-2)8-7-12(17)15(14)22-3;;/h7-8,11H,4-6,9-10H2,1-3H3,(H,18,20);1H;1H2/t11-;;/m0../s1	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL111	RIMONABANT	Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1	JZCPYUJPEARBJL-UHFFFAOYSA-N	InChI=1S/C22H21Cl3N4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)	Cannabinoid CB1 receptor antagonist	ANTAGONIST	CHEMBL218	Cannabinoid CB1 receptor	Homo sapiens
CHEMBL12713	SERTINDOLE	O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1	GZKLJWGUPQBVJQ-UHFFFAOYSA-N	InChI=1S/C24H26ClFN4O/c25-18-1-6-23-21(15-18)22(16-30(23)20-4-2-19(26)3-5-20)17-7-10-28(11-8-17)13-14-29-12-9-27-24(29)31/h1-6,15-17H,7-14H2,(H,27,31)	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL282724	SITAXENTAN	Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2	PHWXUGHIIBDVKD-UHFFFAOYSA-N	InChI=1S/C18H15ClN2O6S2/c1-9-5-13-14(26-8-25-13)7-11(9)6-12(22)17-15(3-4-28-17)29(23,24)21-18-16(19)10(2)20-27-18/h3-5,7,21H,6,8H2,1-2H3	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	CHEMBL2096678	Endothelin receptor, ET-A/ET-B	Homo sapiens
CHEMBL2105740	SITAXENTAN SODIUM	Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)[N-]c1onc(C)c1Cl)OCO2.[Na+]	MDTNUYUCUYPIHE-UHFFFAOYSA-N	InChI=1S/C18H14ClN2O6S2.Na/c1-9-5-13-14(26-8-25-13)7-11(9)6-12(22)17-15(3-4-28-17)29(23,24)21-18-16(19)10(2)20-27-18;/h3-5,7H,6,8H2,1-2H3;/q-1;+1	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	CHEMBL2096678	Endothelin receptor, ET-A/ET-B	Homo sapiens
CHEMBL70046	SORIVUDINE	O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)cc1/C=C/Br	GCQYYIHYQMVWLT-HQNLTJAPSA-N	InChI=1S/C11H13BrN2O6/c12-2-1-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-15)20-10/h1-3,6-8,10,15-17H,4H2,(H,13,18,19)/b2-1+/t6-,7-,8+,10-/m1/s1	DNA polymerase catalytic subunit inhibitor	INHIBITOR	CHEMBL5944	DNA polymerase catalytic subunit	Human herpesvirus 1 (strain KOS) (HHV-1) (Human herpes simplex virus1)
CHEMBL62193	SULFADIMETHOXINE	COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1	ZZORFUFYDOWNEF-UHFFFAOYSA-N	InChI=1S/C12H14N4O4S/c1-19-11-7-10(14-12(15-11)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL2107253	SULFADIMETHOXINE SODIUM	COc1cc([N-]S(=O)(=O)c2ccc(N)cc2)nc(OC)n1.[Na+]	DQDZQHMCPDUUPC-UHFFFAOYSA-N	InChI=1S/C12H13N4O4S.Na/c1-19-11-7-10(14-12(15-11)20-2)16-21(17,18)9-5-3-8(13)4-6-9;/h3-7H,13H2,1-2H3;/q-1;+1	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL268869	SULFAMETHOXYPYRIDAZINE	COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1	VLYWMPOKSSWJAL-UHFFFAOYSA-N	InChI=1S/C11H12N4O3S/c1-18-11-7-6-10(13-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15)	Bacterial dihydropteroate synthase inhibitor	INHIBITOR	CHEMBL2364668	Bacterial dihydropteroate synthase	Bacteria
CHEMBL404849	SULOCTIDIL	CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1	BFCDFTHTSVTWOG-UHFFFAOYSA-N	InChI=1S/C20H35NOS/c1-5-6-7-8-9-10-15-21-17(4)20(22)18-11-13-19(14-12-18)23-16(2)3/h11-14,16-17,20-22H,5-10,15H2,1-4H3	Voltage-gated calcium channel blocker	BLOCKER	CHEMBL2363032	Voltage-gated calcium channel	Homo sapiens
CHEMBL2107495	TEMAFLOXACIN HYDROCHLORIDE	CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1.Cl	DDVJEYDLTXRYAJ-UHFFFAOYSA-N	InChI=1S/C21H18F3N3O3.ClH/c1-11-9-26(5-4-25-11)19-8-18-13(7-16(19)24)20(28)14(21(29)30)10-27(18)17-3-2-12(22)6-15(17)23;/h2-3,6-8,10-11,25H,4-5,9H2,1H3,(H,29,30);1H	Bacterial DNA gyrase inhibitor	INHIBITOR	CHEMBL2311224	Bacterial DNA gyrase	Bacteria
CHEMBL17157	TERFENADINE	CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1	GUGOEEXESWIERI-UHFFFAOYSA-N	InChI=1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL539770	TERODILINE HYDROCHLORIDE	CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C.Cl	RNGHAJVBYQPLAZ-UHFFFAOYSA-N	InChI=1S/C20H27N.ClH/c1-16(21-20(2,3)4)15-19(17-11-7-5-8-12-17)18-13-9-6-10-14-18;/h5-14,16,19,21H,15H2,1-4H3;1H	Muscarinic acetylcholine receptor antagonist	ANTAGONIST	CHEMBL2094109	Muscarinic acetylcholine receptor	Homo sapiens
CHEMBL2105527	TETRAZEPAM	CN1C(=O)CN=C(C2=CCCCC2)c2cc(Cl)ccc21	IQWYAQCHYZHJOS-UHFFFAOYSA-N	InChI=1S/C16H17ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h5,7-9H,2-4,6,10H2,1H3	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL2105458	THENALIDINE	CN1CCC(N(Cc2cccs2)c2ccccc2)CC1	KLOHYVOVXOUKQI-UHFFFAOYSA-N	InChI=1S/C17H22N2S/c1-18-11-9-16(10-12-18)19(14-17-8-5-13-20-17)15-6-3-2-4-7-15/h2-8,13,16H,9-12,14H2,1H3	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL436	TOLRESTAT	COc1ccc2c(C(=S)N(C)CC(=O)O)cccc2c1C(F)(F)F	LUBHDINQXIHVLS-UHFFFAOYSA-N	InChI=1S/C16H14F3NO3S/c1-20(8-13(21)22)15(24)11-5-3-4-10-9(11)6-7-12(23-2)14(10)16(17,18)19/h3-7H,8H2,1-2H3,(H,21,22)	Aldose reductase inhibitor	INHIBITOR	CHEMBL1900	Aldose reductase	Homo sapiens
CHEMBL187709	TRIPARANOL	CCN(CC)CCOc1ccc(C(O)(Cc2ccc(Cl)cc2)c2ccc(C)cc2)cc1	SYHDSBBKRLVLFF-UHFFFAOYSA-N	InChI=1S/C27H32ClNO2/c1-4-29(5-2)18-19-31-26-16-12-24(13-17-26)27(30,23-10-6-21(3)7-11-23)20-22-8-14-25(28)15-9-22/h6-17,30H,4-5,18-20H2,1-3H3	Delta(24)-sterol reductase inhibitor	INHIBITOR	CHEMBL2331059	Delta(24)-sterol reductase	Homo sapiens
CHEMBL2105581	VERALIPRIDE	C=CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)cc(OC)c1OC	RYJXBGGBZJGVQF-UHFFFAOYSA-N	InChI=1S/C17H25N3O5S/c1-4-7-20-8-5-6-12(20)11-19-17(21)14-9-13(26(18,22)23)10-15(24-2)16(14)25-3/h4,9-10,12H,1,5-8,11H2,2-3H3,(H,19,21)(H2,18,22,23)	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL522038	XIMELAGATRAN	CCOC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(/C(N)=N\O)cc1)C1CCCCC1	ZXIBCJHYVWYIKI-PZJWPPBQSA-N	InChI=1S/C24H35N5O5/c1-2-34-20(30)15-26-21(17-6-4-3-5-7-17)24(32)29-13-12-19(29)23(31)27-14-16-8-10-18(11-9-16)22(25)28-33/h8-11,17,19,21,26,33H,2-7,12-15H2,1H3,(H2,25,28)(H,27,31)/t19-,21+/m0/s1	Thrombin inhibitor	INHIBITOR	CHEMBL204	Thrombin	Homo sapiens
CHEMBL2355333	ZIMELDINE HYDROCHLORIDE	CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1.Cl.Cl.O	WFUAVXYXJOQWAZ-GVKRCPFFSA-N	InChI=1S/C16H17BrN2.2ClH.H2O/c1-19(2)11-9-16(14-4-3-10-18-12-14)13-5-7-15(17)8-6-13;;;/h3-10,12H,11H2,1-2H3;2*1H;1H2/b16-9-;;;	Serotonin (5-HT) receptor antagonist	ANTAGONIST	CHEMBL2096904	Serotonin (5-HT) receptor	Homo sapiens
CHEMBL189171	ACEMETACIN	COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1	FSQKKOOTNAMONP-UHFFFAOYSA-N	InChI=1S/C21H18ClNO6/c1-12-16(10-20(26)29-11-19(24)25)17-9-15(28-2)7-8-18(17)23(12)21(27)13-3-5-14(22)6-4-13/h3-9H,10-11H2,1-2H3,(H,24,25)	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL10878	AGOMELATINE	COc1ccc2cccc(CCNC(C)=O)c2c1	YJYPHIXNFHFHND-UHFFFAOYSA-N	InChI=1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17)	Melatonin receptor agonist	AGONIST	CHEMBL2094268	Melatonin receptor	Homo sapiens
CHEMBL3305985	ALCURONIUM	C=CC[N@@+]12CC[C@@]34c5ccccc5N5/C=C6/[C@H]7C[C@H]8[C@@]9(CC[N@@+]8(CC=C)C/C7=C/CO)c7ccccc7N(/C=C(/[C@@H](C[C@@H]31)/C(=C\CO)C2)[C@H]54)[C@@H]69	MUQUYTSLDVKIOF-CHJKCJHBSA-N	InChI=1S/C44H50N4O2/c1-3-17-47-19-15-43-35-9-5-7-11-37(35)45-26-34-32-24-40-44(16-20-48(40,18-4-2)28-30(32)14-22-50)36-10-6-8-12-38(36)46(42(34)44)25-33(41(43)45)31(23-39(43)47)29(27-47)13-21-49/h3-14,25-26,31-32,39-42,49-50H,1-2,15-24,27-28H2/q+2/b29-13-,30-14-,33-25-,34-26-/t31-,32-,39-,40-,41-,42-,43+,44+,47-,48-/m0/s1	Muscarinic acetylcholine receptor M2 positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL211	Muscarinic acetylcholine receptor M2	Homo sapiens
CHEMBL1601669	ALFACALCIDOL	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O	OFHCOWSQAMBJIW-AVJTYSNKSA-N	InChI=1S/C27H44O2/c1-18(2)8-6-9-19(3)24-13-14-25-21(10-7-15-27(24,25)5)11-12-22-16-23(28)17-26(29)20(22)4/h11-12,18-19,23-26,28-29H,4,6-10,13-17H2,1-3,5H3/b21-11+,22-12-/t19-,23-,24-,25+,26+,27-/m1/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL2105618	ALLYLESTRENOL	C=CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCCC4[C@H]3CC[C@@]21C	ATXHVCQZZJYMCF-XZCODKSBSA-N	InChI=1S/C21H32O/c1-3-12-21(22)14-11-19-18-9-8-15-6-4-5-7-16(15)17(18)10-13-20(19,21)2/h3,6,16-19,22H,1,4-5,7-14H2,2H3/t16?,17-,18-,19+,20+,21+/m1/s1	Estrogen receptor agonist	AGONIST	CHEMBL2093866	Estrogen receptor	Homo sapiens
CHEMBL243712	AMISULPRIDE	CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC	NTJOBXMMWNYJFB-UHFFFAOYSA-N	InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)	Serotonin (5-HT) receptor antagonist	ANTAGONIST	CHEMBL2096904	Serotonin (5-HT) receptor	Homo sapiens
CHEMBL43	AMSACRINE	COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12	XCPGHVQEEXUHNC-UHFFFAOYSA-N	InChI=1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23)	DNA topoisomerase II inhibitor	INHIBITOR	CHEMBL2094255	DNA topoisomerase II	Homo sapiens
CHEMBL277474	ANTIPYRINE	Cc1cc(=O)n(-c2ccccc2)n1C	VEQOALNAAJBPNY-UHFFFAOYSA-N	InChI=1S/C11H12N2O/c1-9-8-11(14)13(12(9)2)10-6-4-3-5-7-10/h3-8H,1-2H3	Cyclooxygenase-1 inhibitor	INHIBITOR	CHEMBL221	Cyclooxygenase-1	Homo sapiens
CHEMBL1565476	APAZONE	CCCC1C(=O)N2C(N(C)C)=Nc3ccc(C)cc3N2C1=O	MPHPHYZQRGLTBO-UHFFFAOYSA-N	InChI=1S/C16H20N4O2/c1-5-6-11-14(21)19-13-9-10(2)7-8-12(13)17-16(18(3)4)20(19)15(11)22/h7-9,11H,5-6H2,1-4H3	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1096979	BENSERAZIDE	NC(CO)C(=O)NNCc1ccc(O)c(O)c1O	BNQDCRGUHNALGH-UHFFFAOYSA-N	InChI=1S/C10H15N3O5/c11-6(4-14)10(18)13-12-3-5-1-2-7(15)9(17)8(5)16/h1-2,6,12,14-17H,3-4,11H2,(H,13,18)	DOPA decarboxylase inhibitor	INHIBITOR	CHEMBL1843	DOPA decarboxylase	Homo sapiens
CHEMBL388590	BENZBROMARONE	CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1	WHQCHUCQKNIQEC-UHFFFAOYSA-N	InChI=1S/C17H12Br2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3	Solute carrier family 22 member 12 inhibitor	INHIBITOR	CHEMBL6120	Solute carrier family 22 member 12	Homo sapiens
CHEMBL12610	BENZYDAMINE	CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12	CNBGNNVCVSKAQZ-UHFFFAOYSA-N	InChI=1S/C19H23N3O/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16/h3-7,9-12H,8,13-15H2,1-2H3	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL1528134	BENZYDAMINE HYDROCHLORIDE	CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12.Cl	HNNIWKQLJSNAEQ-UHFFFAOYSA-N	InChI=1S/C19H23N3O.ClH/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16;/h3-7,9-12H,8,13-15H2,1-2H3;1H	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL24441	BETAHISTINE	CNCCc1ccccn1	UUQMNUMQCIQDMZ-UHFFFAOYSA-N	InChI=1S/C8H12N2/c1-9-7-5-8-4-2-3-6-10-8/h2-4,6,9H,5,7H2,1H3	Histamine H3 receptor antagonist	ANTAGONIST	CHEMBL264	Histamine H3 receptor	Homo sapiens
CHEMBL264374	BEZAFIBRATE	CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O	IIBYAHWJQTYFKB-UHFFFAOYSA-N	InChI=1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24)	Peroxisome proliferator-activated receptor agonist	AGONIST	CHEMBL3559683	Peroxisome proliferator-activated receptor	Homo sapiens
CHEMBL1742423	BILASTINE	CCOCCn1c(C2CCN(CCc3ccc(C(C)(C)C(=O)O)cc3)CC2)nc2ccccc21	ACCMWZWAEFYUGZ-UHFFFAOYSA-N	InChI=1S/C28H37N3O3/c1-4-34-20-19-31-25-8-6-5-7-24(25)29-26(31)22-14-17-30(18-15-22)16-13-21-9-11-23(12-10-21)28(2,3)27(32)33/h5-12,22H,4,13-20H2,1-3H3,(H,32,33)	Histamine H1 receptor inverse agonist	INVERSE AGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL277062	BROMAZEPAM	O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1	VMIYHDSEFNYJSL-UHFFFAOYSA-N	InChI=1S/C14H10BrN3O/c15-9-4-5-11-10(7-9)14(17-8-13(19)18-11)12-3-1-2-6-16-12/h1-7H,8H2,(H,18,19)	GABA receptor alpha-2 subunit positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL4956	GABA receptor alpha-2 subunit	Homo sapiens
CHEMBL28218	BROMPERIDOL	O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1	RKLNONIVDFXQRX-UHFFFAOYSA-N	InChI=1S/C21H23BrFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL2110824	BUSERELIN	CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1	CUWODFFVMXJOKD-UVLQAERKSA-N	InChI=1S/C60H86N16O13/c1-7-64-57(87)48-15-11-23-76(48)58(88)41(14-10-22-65-59(61)62)69-51(81)42(24-33(2)3)70-56(86)47(31-89-60(4,5)6)75-52(82)43(25-34-16-18-37(78)19-17-34)71-55(85)46(30-77)74-53(83)44(26-35-28-66-39-13-9-8-12-38(35)39)72-54(84)45(27-36-29-63-32-67-36)73-50(80)40-20-21-49(79)68-40/h8-9,12-13,16-19,28-29,32-33,40-48,66,77-78H,7,10-11,14-15,20-27,30-31H2,1-6H3,(H,63,67)(H,64,87)(H,68,79)(H,69,81)(H,70,86)(H,71,85)(H,72,84)(H,73,80)(H,74,83)(H,75,82)(H4,61,62,65)/t40-,41-,42-,43-,44-,45-,46-,47+,48-/m0/s1	Gonadotropin-releasing hormone receptor agonist	AGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL559180	ISOXSUPRINE HYDROCHLORIDE	CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1.Cl	QVPSGVSNYPRFAS-UHFFFAOYSA-N	InChI=1S/C18H23NO3.ClH/c1-13(12-22-17-6-4-3-5-7-17)19-14(2)18(21)15-8-10-16(20)11-9-15;/h3-11,13-14,18-21H,12H2,1-2H3;1H	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	CHEMBL2094251	Adrenergic receptor alpha-1	Homo sapiens
CHEMBL254328	ABIRATERONE	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2c1cccnc1	GZOSMCIZMLWJML-VJLLXTKPSA-N	InChI=1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3/t18-,19-,21-,22-,23-,24+/m0/s1	Cytochrome P450 17A1 inhibitor	INHIBITOR	CHEMBL3522	Cytochrome P450 17A1	Homo sapiens
CHEMBL3989767	CALCITONIN	CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O	BBBFJLBPOGFECG-VJVYQDLKSA-N	InChI=1S/C145H240N44O48S2/c1-65(2)45-86(175-139(232)110(70(11)12)183-136(229)99-63-239-238-62-79(148)117(210)178-96(59-191)134(227)174-92(52-104(151)202)131(224)172-90(49-69(9)10)129(222)180-98(61-193)135(228)187-114(74(16)197)142(235)181-99)118(211)158-55-106(204)162-80(25-18-20-40-146)120(213)169-89(48-68(7)8)128(221)179-97(60-192)133(226)167-83(34-37-102(149)200)122(215)165-85(36-39-109(207)208)123(216)171-88(47-67(5)6)127(220)173-91(51-77-54-156-64-161-77)130(223)164-81(26-19-21-41-147)121(214)170-87(46-66(3)4)126(219)166-84(35-38-103(150)201)125(218)186-113(73(15)196)141(234)177-94(50-76-30-32-78(199)33-31-76)143(236)189-44-24-29-101(189)137(230)168-82(27-22-42-157-145(154)155)124(217)185-112(72(14)195)140(233)176-93(53-105(152)203)132(225)184-111(71(13)194)138(231)160-56-107(205)163-95(58-190)119(212)159-57-108(206)182-115(75(17)198)144(237)188-43-23-28-100(188)116(153)209/h30-33,54,64-75,79-101,110-115,190-199H,18-29,34-53,55-63,146-148H2,1-17H3,(H2,149,200)(H2,150,201)(H2,151,202)(H2,152,203)(H2,153,209)(H,156,161)(H,158,211)(H,159,212)(H,160,231)(H,162,204)(H,163,205)(H,164,223)(H,165,215)(H,166,219)(H,167,226)(H,168,230)(H,169,213)(H,170,214)(H,171,216)(H,172,224)(H,173,220)(H,174,227)(H,175,232)(H,176,233)(H,177,234)(H,178,210)(H,179,221)(H,180,222)(H,181,235)(H,182,206)(H,183,229)(H,184,225)(H,185,217)(H,186,218)(H,187,228)(H,207,208)(H4,154,155,157)/t71-,72-,73-,74-,75-,79+,80+,81+,82+,83+,84+,85+,86+,87+,88+,89+,90+,91+,92+,93+,94+,95+,96+,97+,98+,99+,100+,101+,110+,111+,112+,113+,114+,115+/m1/s1	Calcitonin receptor agonist	AGONIST	CHEMBL1832	Calcitonin receptor	Homo sapiens
CHEMBL1371200	CANRENOATE POTASSIUM	C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@]2(O)CCC(=O)[O-].[K+]	JTZQCHFUGHIPDF-RYVBEKKQSA-M	InChI=1S/C22H30O4.K/c1-20-9-5-15(23)13-14(20)3-4-16-17(20)6-10-21(2)18(16)7-11-22(21,26)12-8-19(24)25;/h3-4,13,16-18,26H,5-12H2,1-2H3,(H,24,25);/q;+1/p-1/t16-,17+,18+,20+,21+,22-;/m1./s1	Mineralocorticoid receptor antagonist	ANTAGONIST	CHEMBL1994	Mineralocorticoid receptor	Homo sapiens
CHEMBL46917	CARBARIL	CNC(=O)Oc1cccc2ccccc12	CVXBEEMKQHEXEN-UHFFFAOYSA-N	InChI=1S/C12H11NO2/c1-13-12(14)15-11-8-4-6-9-5-2-3-7-10(9)11/h2-8H,1H3,(H,13,14)	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL2362988	Acetylcholinesterase	Pediculus humanus capitis
CHEMBL499915	CARBENOXOLONE	CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C	OBZHEBDUNPOCJG-WBXJDKIVSA-N	InChI=1S/C34H50O7/c1-29(2)23-10-13-34(7)27(32(23,5)12-11-24(29)41-26(38)9-8-25(36)37)22(35)18-20-21-19-31(4,28(39)40)15-14-30(21,3)16-17-33(20,34)6/h18,21,23-24,27H,8-17,19H2,1-7H3,(H,36,37)(H,39,40)/t21-,23-,24-,27+,30+,31-,32-,33+,34+/m0/s1	11-beta-hydroxysteroid dehydrogenase inhibitor	INHIBITOR	CHEMBL3542430	11-beta-hydroxysteroid dehydrogenase	Homo sapiens
CHEMBL3301668	CARBETOCIN	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O	NSTRIRCPWQHTIA-DTRKZRJBSA-N	InChI=1S/C45H69N11O12S/c1-6-25(4)38-44(66)51-28(15-16-34(46)57)40(62)52-31(21-35(47)58)41(63)54-32(23-69-18-8-10-37(60)50-30(42(64)55-38)20-26-11-13-27(68-5)14-12-26)45(67)56-17-7-9-33(56)43(65)53-29(19-24(2)3)39(61)49-22-36(48)59/h11-14,24-25,28-33,38H,6-10,15-23H2,1-5H3,(H2,46,57)(H2,47,58)(H2,48,59)(H,49,61)(H,50,60)(H,51,66)(H,52,62)(H,53,65)(H,54,63)(H,55,64)/t25-,28-,29-,30-,31-,32-,33-,38-/m0/s1	Oxytocin receptor agonist	AGONIST	CHEMBL2049	Oxytocin receptor	Homo sapiens
CHEMBL508102	CARBIMAZOLE	CCOC(=O)n1ccn(C)c1=S	CFOYWRHIYXMDOT-UHFFFAOYSA-N	InChI=1S/C7H10N2O2S/c1-3-11-7(10)9-5-4-8(2)6(9)12/h4-5H,3H2,1-2H3	Thyroid peroxidase inhibitor	INHIBITOR	CHEMBL1839	Thyroid peroxidase	Homo sapiens
CHEMBL1146	CEFAMANDOLE	Cn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](O)c3ccccc3)[C@H]2SC1	OLVCFLKTBJRLHI-AXAPSJFSSA-N	InChI=1S/C18H18N6O5S2/c1-23-18(20-21-22-23)31-8-10-7-30-16-11(15(27)24(16)12(10)17(28)29)19-14(26)13(25)9-5-3-2-4-6-9/h2-6,11,13,16,25H,7-8H2,1H3,(H,19,26)(H,28,29)/t11-,13-,16-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL2303613	CEFODIZIME	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(C)c(CC(=O)O)s3)CS[C@H]12)c1csc(N)n1	XDZKBRJLTGRPSS-BGZQYGJUSA-N	InChI=1S/C20H20N6O7S4/c1-7-10(3-11(27)28)37-20(22-7)36-5-8-4-34-17-13(16(30)26(17)14(8)18(31)32)24-15(29)12(25-33-2)9-6-35-19(21)23-9/h6,13,17H,3-5H2,1-2H3,(H2,21,23)(H,24,29)(H,27,28)(H,31,32)/b25-12-/t13-,17-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL65794	CEFPIROME	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3cccc4c3CCC4)CS[C@H]12)c1csc(N)n1	DKOQGJHPHLTOJR-WHRDSVKCSA-N	InChI=1S/C22H22N6O5S2/c1-33-26-15(13-10-35-22(23)24-13)18(29)25-16-19(30)28-17(21(31)32)12(9-34-20(16)28)8-27-7-3-5-11-4-2-6-14(11)27/h3,5,7,10,16,20H,2,4,6,8-9H2,1H3,(H3-,23,24,25,29,31,32)/b26-15-/t16-,20-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL3351077	CEFSULODIN	NC(=O)c1cc[n+](CC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)[C@@H](c4ccccc4)S(=O)(=O)[O-])[C@H]3SC2)cc1	SYLKGLMBLAAGSC-QLVMHMETSA-N	InChI=1S/C22H20N4O8S2/c23-18(27)13-6-8-25(9-7-13)10-14-11-35-21-15(20(29)26(21)16(14)22(30)31)24-19(28)17(36(32,33)34)12-4-2-1-3-5-12/h1-9,15,17,21H,10-11H2,(H4-,23,24,27,28,30,31,32,33,34)/t15-,17-,21-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL27810	CELIPROLOL	CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1	JOATXPAWOHTVSZ-UHFFFAOYSA-N	InChI=1S/C20H33N3O4/c1-7-23(8-2)19(26)22-15-9-10-18(17(11-15)14(3)24)27-13-16(25)12-21-20(4,5)6/h9-11,16,21,25H,7-8,12-13H2,1-6H3,(H,22,26)	Beta-2 adrenergic receptor partial agonist	PARTIAL AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL2110774	CHLORPHENOXAMINE	CN(C)CCOC(C)(c1ccccc1)c1ccc(Cl)cc1	KKHPNPMTPORSQE-UHFFFAOYSA-N	InChI=1S/C18H22ClNO/c1-18(21-14-13-20(2)3,15-7-5-4-6-8-15)16-9-11-17(19)12-10-16/h4-12H,13-14H2,1-3H3	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL515606	CILAZAPRIL	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](C(=O)O)N2C1=O	HHHKFGXWKKUNCY-FHWLQOOXSA-N	InChI=1S/C22H31N3O5/c1-2-30-22(29)18(13-12-16-8-4-3-5-9-16)23-17-10-6-14-24-15-7-11-19(21(27)28)25(24)20(17)26/h3-5,8-9,17-19,23H,2,6-7,10-15H2,1H3,(H,27,28)/t17-,18-,19-/m0/s1	Angiotensin-converting enzyme inhibitor	INHIBITOR	CHEMBL1808	Angiotensin-converting enzyme	Homo sapiens
CHEMBL557555	CIPROFIBRATE	CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O	KPSRODZRAIWAKH-UHFFFAOYSA-N	InChI=1S/C13H14Cl2O3/c1-12(2,11(16)17)18-9-5-3-8(4-6-9)10-7-13(10,14)15/h3-6,10H,7H2,1-2H3,(H,16,17)	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	CHEMBL239	Peroxisome proliferator-activated receptor alpha	Homo sapiens
CHEMBL325109	CLEBOPRIDE	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1	BVPWJMCABCPUQY-UHFFFAOYSA-N	InChI=1S/C20H24ClN3O2/c1-26-19-12-18(22)17(21)11-16(19)20(25)23-15-7-9-24(10-8-15)13-14-5-3-2-4-6-14/h2-6,11-12,15H,7-10,13,22H2,1H3,(H,23,25)	Serotonin 4 (5-HT4) receptor agonist	AGONIST	CHEMBL1875	Serotonin 4 (5-HT4) receptor	Homo sapiens
CHEMBL49080	CLENBUTEROL	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1	STJMRWALKKWQGH-UHFFFAOYSA-N	InChI=1S/C12H18Cl2N2O/c1-12(2,3)16-6-10(17)7-4-8(13)11(15)9(14)5-7/h4-5,10,16-17H,6,15H2,1-3H3	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL315795	CLOMETHIAZOLE	Cc1ncsc1CCCl	PCLITLDOTJTVDJ-UHFFFAOYSA-N	InChI=1S/C6H8ClNS/c1-5-6(2-3-7)9-4-8-5/h4H,2-3H2,1H3	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL304902	CLOTHIAPINE	CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1	KAAZGXDPUNNEFN-UHFFFAOYSA-N	InChI=1S/C18H18ClN3S/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3	Serotonin 2 (5-HT2) receptor antagonist	ANTAGONIST	CHEMBL2095200	Serotonin 2 (5-HT2) receptor	Homo sapiens
CHEMBL2105842	CORTIVAZOL	CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C=C(C)C4=Cc5c(cnn5-c5ccccc5)C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C	RKHQGWMMUURILY-UHRZLXHJSA-N	InChI=1S/C32H38N2O5/c1-18-11-23-25-12-19(2)32(38,28(37)17-39-20(3)35)31(25,5)15-27(36)29(23)30(4)14-21-16-33-34(26(21)13-24(18)30)22-9-7-6-8-10-22/h6-11,13,16,19,23,25,27,29,36,38H,12,14-15,17H2,1-5H3/t19-,23+,25+,27+,29-,30+,31+,32+/m1/s1	Glucocorticoid receptor agonist	AGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL139835	CYPROTERONE ACETATE	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C	UWFYSQMTEOIJJG-FDTZYFLXSA-N	InChI=1S/C24H29ClO4/c1-12(26)24(29-13(2)27)8-6-16-14-10-20(25)19-11-21(28)15-9-18(15)23(19,4)17(14)5-7-22(16,24)3/h10-11,14-18H,5-9H2,1-4H3/t14-,15+,16-,17-,18-,22-,23-,24-/m0/s1	Androgen Receptor antagonist	ANTAGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL2110900	DAPOXETINE	CN(C)[C@@H](CCOc1cccc2ccccc12)c1ccccc1	USRHYDPUVLEVMC-FQEVSTJZSA-N	InChI=1S/C21H23NO/c1-22(2)20(18-10-4-3-5-11-18)15-16-23-21-14-8-12-17-9-6-7-13-19(17)21/h3-14,20H,15-16H2,1-2H3/t20-/m0/s1	Serotonin transporter inhibitor	INHIBITOR	CHEMBL228	Serotonin transporter	Homo sapiens
CHEMBL169901	DEBRISOQUIN	N=C(N)N1CCc2ccccc2C1	JWPGJSVJDAJRLW-UHFFFAOYSA-N	InChI=1S/C10H13N3/c11-10(12)13-6-5-8-3-1-2-4-9(8)7-13/h1-4H,5-7H2,(H3,11,12)	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL75435	DEXKETOPROFEN	C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1	DKYWVDODHFEZIM-NSHDSACASA-N	InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)/t11-/m0/s1	Cyclooxygenase inhibitor	INHIBITOR	CHEMBL2094253	Cyclooxygenase	Homo sapiens
CHEMBL3833389	DEXTROMORAMIDE	C[C@@H](CC(C(=O)N1CCCC1)(c1ccccc1)c1ccccc1)N1CCOCC1	XHKXWINHANRSNT-NRFANRHFSA-N	InChI=1S/C25H32N2O2/c1-21(26-16-18-29-19-17-26)20-25(22-10-4-2-5-11-22,23-12-6-3-7-13-23)24(28)27-14-8-9-15-27/h2-7,10-13,21H,8-9,14-20H2,1H3/t21-/m0/s1	Opioid receptors; mu/kappa/delta agonist	AGONIST	CHEMBL2095181	Opioid receptors; mu/kappa/delta	Homo sapiens
CHEMBL1442422	DIBENZEPIN	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	QPGGEKPRGVJKQB-UHFFFAOYSA-N	InChI=1S/C18H21N3O/c1-19(2)12-13-21-17-11-7-6-10-16(17)20(3)15-9-5-4-8-14(15)18(21)22/h4-11H,12-13H2,1-3H3	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL22108	DIMETHINDENE	CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1	MVMQESMQSYOVGV-UHFFFAOYSA-N	InChI=1S/C20H24N2/c1-15(19-10-6-7-12-21-19)20-17(11-13-22(2)3)14-16-8-4-5-9-18(16)20/h4-10,12,15H,11,13-14H2,1-3H3	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL397420	ACENOCOUMAROL	CC(=O)CC(c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O	VABCILAOYCMVPS-UHFFFAOYSA-N	InChI=1S/C19H15NO6/c1-11(21)10-15(12-6-8-13(9-7-12)20(24)25)17-18(22)14-4-2-3-5-16(14)26-19(17)23/h2-9,15,22H,10H2,1H3	Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor	INHIBITOR	CHEMBL1930	Vitamin k epoxide reductase complex subunit 1 isoform 1	Homo sapiens
CHEMBL382301	ATOSIBAN	CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1	VWXRQYYUEIYXCZ-OBIMUBPZSA-N	InChI=1S/C43H67N11O12S2/c1-5-23(3)35-41(63)53-36(24(4)55)42(64)50-29(20-32(45)56)38(60)51-30(43(65)54-17-8-10-31(54)40(62)49-27(9-7-16-44)37(59)47-21-33(46)57)22-68-67-18-15-34(58)48-28(39(61)52-35)19-25-11-13-26(14-12-25)66-6-2/h11-14,23-24,27-31,35-36,55H,5-10,15-22,44H2,1-4H3,(H2,45,56)(H2,46,57)(H,47,59)(H,48,58)(H,49,62)(H,50,64)(H,51,60)(H,52,61)(H,53,63)/t23-,24+,27-,28+,29-,30-,31-,35-,36-/m0/s1	Oxytocin receptor antagonist	ANTAGONIST	CHEMBL2049	Oxytocin receptor	Homo sapiens
CHEMBL253371	ALVERINE	CCN(CCCc1ccccc1)CCCc1ccccc1	ZPFXAOWNKLFJDN-UHFFFAOYSA-N	InChI=1S/C20H27N/c1-2-21(17-9-15-19-11-5-3-6-12-19)18-10-16-20-13-7-4-8-14-20/h3-8,11-14H,2,9-10,15-18H2,1H3	Serotonin 1a (5-HT1a) receptor antagonist	ANTAGONIST	CHEMBL214	Serotonin 1a (5-HT1a) receptor	Homo sapiens
CHEMBL297302	BENPERIDOL	O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1	FEBOTPHFXYHVPL-UHFFFAOYSA-N	InChI=1S/C22H24FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-10,18H,3,6,11-15H2,(H,24,28)	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL93645	ACECLOFENAC	O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl	MNIPYSSQXLZQLJ-UHFFFAOYSA-N	InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)	Cyclooxygenase-2 inhibitor	INHIBITOR	CHEMBL230	Cyclooxygenase-2	Homo sapiens
CHEMBL43064	CINNARIZINE	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1	DERZBLKQOCDDDZ-JLHYYAGUSA-N	InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+	Voltage-gated L-type calcium channel blocker	BLOCKER	CHEMBL2095229	Voltage-gated L-type calcium channel	Homo sapiens
CHEMBL1697737	CLOTIAZEPAM	CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl	CHBRHODLKOZEPZ-UHFFFAOYSA-N	InChI=1S/C16H15ClN2OS/c1-3-10-8-12-15(11-6-4-5-7-13(11)17)18-9-14(20)19(2)16(12)21-10/h4-8H,3,9H2,1-2H3	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL3184437	DICHLOROBENZYL ALCOHOL	OCc1ccc(Cl)cc1Cl	DBHODFSFBXJZNY-UHFFFAOYSA-N	InChI=1S/C7H6Cl2O/c8-6-2-1-5(4-10)7(9)3-6/h1-3,10H,4H2	Sodium channel alpha subunit blocker	BLOCKER	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL2356023	DIHYDROTACHYSTEROL	CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3\C[C@@H](O)CC[C@@H]3C)CCC[C@@]21C	ILYCWAKSDCYMBB-OPCMSESCSA-N	InChI=1S/C28H46O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-22,25-27,29H,7-8,11,14-18H2,1-6H3/b10-9+,23-12+,24-13+/t20-,21-,22+,25-,26+,27-,28+/m0/s1	Vitamin D receptor agonist	AGONIST	CHEMBL1977	Vitamin D receptor	Homo sapiens
CHEMBL2051955	LEVOSIMENDAN	C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1	WHXMKTBCFHIYNQ-SECBINFHSA-N	InChI=1S/C14H12N6O/c1-9-6-13(21)19-20-14(9)10-2-4-11(5-3-10)17-18-12(7-15)8-16/h2-5,9,17H,6H2,1H3,(H,19,21)/t9-/m1/s1	Troponin, cardiac muscle positive modulator	POSITIVE MODULATOR	CHEMBL2095202	Troponin, cardiac muscle	Homo sapiens
CHEMBL279785	MARIMASTAT	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	OCSMOTCMPXTDND-OUAUKWLOSA-N	InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1	Matrix metalloproteinase-1 inhibitor	INHIBITOR	CHEMBL332	Matrix metalloproteinase-1	Homo sapiens
CHEMBL279785	MARIMASTAT	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	OCSMOTCMPXTDND-OUAUKWLOSA-N	InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1	Matrix metalloproteinase 12 inhibitor	INHIBITOR	CHEMBL4393	Matrix metalloproteinase 12	Homo sapiens
CHEMBL279785	MARIMASTAT	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	OCSMOTCMPXTDND-OUAUKWLOSA-N	InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1	Matrix metalloproteinase-2 inhibitor	INHIBITOR	CHEMBL333	Matrix metalloproteinase-2	Homo sapiens
CHEMBL279785	MARIMASTAT	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	OCSMOTCMPXTDND-OUAUKWLOSA-N	InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1	Matrix metalloproteinase 3 inhibitor	INHIBITOR	CHEMBL283	Matrix metalloproteinase 3	Homo sapiens
CHEMBL279785	MARIMASTAT	CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C	OCSMOTCMPXTDND-OUAUKWLOSA-N	InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1	Matrix metalloproteinase 7 inhibitor	INHIBITOR	CHEMBL4073	Matrix metalloproteinase 7	Homo sapiens
CHEMBL3142541	BUTAMBEN PICRATE	CCCCOC(=O)c1ccc(N)cc1.CCCCOC(=O)c1ccc(N)cc1.O=[N+]([O-])c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1	ATAGSVCDFKGYPE-UHFFFAOYSA-N	InChI=1S/2C11H15NO2.C6H3N3O7/c2*1-2-3-8-14-11(13)9-4-6-10(12)7-5-9;10-6-4(8(13)14)1-3(7(11)12)2-5(6)9(15)16/h2*4-7H,2-3,8,12H2,1H3;1-2,10H	Transient receptor potential cation channel subfamily V member 4 inhibitor	INHIBITOR	CHEMBL3119	Transient receptor potential cation channel subfamily V member 4	Homo sapiens
CHEMBL127516	BUTAMBEN	CCCCOC(=O)c1ccc(N)cc1	IUWVALYLNVXWKX-UHFFFAOYSA-N	InChI=1S/C11H15NO2/c1-2-3-8-14-11(13)9-4-6-10(12)7-5-9/h4-7H,2-3,8,12H2,1H3	Transient receptor potential cation channel subfamily A member 1 inhibitor	INHIBITOR	CHEMBL6007	Transient receptor potential cation channel subfamily A member 1	Homo sapiens
CHEMBL2106217	FENFLURAMINE HYDROCHLORIDE	CCNC(C)Cc1cccc(C(F)(F)F)c1.Cl	ZXKXJHAOUFHNAS-UHFFFAOYSA-N	InChI=1S/C12H16F3N.ClH/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15;/h4-6,8-9,16H,3,7H2,1-2H3;1H	Serotonin 2c (5-HT2c) receptor agonist	AGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL2106217	FENFLURAMINE HYDROCHLORIDE	CCNC(C)Cc1cccc(C(F)(F)F)c1.Cl	ZXKXJHAOUFHNAS-UHFFFAOYSA-N	InChI=1S/C12H16F3N.ClH/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15;/h4-6,8-9,16H,3,7H2,1-2H3;1H	Sigma opioid receptor antagonist	ANTAGONIST	CHEMBL287	Sigma opioid receptor	Homo sapiens
CHEMBL2105345	PROPANIDID	CCCOC(=O)Cc1ccc(OCC(=O)N(CC)CC)c(OC)c1	KEJXLQUPYHWCNM-UHFFFAOYSA-N	InChI=1S/C18H27NO5/c1-5-10-23-18(21)12-14-8-9-15(16(11-14)22-4)24-13-17(20)19(6-2)7-3/h8-9,11H,5-7,10,12-13H2,1-4H3	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL220	Acetylcholinesterase	Homo sapiens
CHEMBL1334033	PERHEXILINE MALEATE	C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1.O=C(O)/C=C\C(=O)O	JDZOTSLZMQDFLG-BTJKTKAUSA-N	InChI=1S/C19H35N.C4H4O4/c1-3-9-16(10-4-1)19(17-11-5-2-6-12-17)15-18-13-7-8-14-20-18;5-3(6)1-2-4(7)8/h16-20H,1-15H2;1-2H,(H,5,6)(H,7,8)/b;2-1-	Carnitine palmitoyltransferase 2 inhibitor	INHIBITOR	CHEMBL3238	Carnitine palmitoyltransferase 2	Homo sapiens
CHEMBL1334033	PERHEXILINE MALEATE	C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1.O=C(O)/C=C\C(=O)O	JDZOTSLZMQDFLG-BTJKTKAUSA-N	InChI=1S/C19H35N.C4H4O4/c1-3-9-16(10-4-1)19(17-11-5-2-6-12-17)15-18-13-7-8-14-20-18;5-3(6)1-2-4(7)8/h16-20H,1-15H2;1-2H,(H,5,6)(H,7,8)/b;2-1-	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL24072	PRENYLAMINE	CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1	IFFPICMESYHZPQ-UHFFFAOYSA-N	InChI=1S/C24H27N/c1-20(19-21-11-5-2-6-12-21)25-18-17-24(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,20,24-25H,17-19H2,1H3	Calmodulin inhibitor	INHIBITOR	CHEMBL6093	Calmodulin	Homo sapiens
CHEMBL1742471	EBROTIDINE	N=C(N)Nc1nc(CSCCN/C=N/S(=O)(=O)c2ccc(Br)cc2)cs1	ZQHFZHPUZXNPMF-UHFFFAOYSA-N	InChI=1S/C14H17BrN6O2S3/c15-10-1-3-12(4-2-10)26(22,23)19-9-18-5-6-24-7-11-8-25-14(20-11)21-13(16)17/h1-4,8-9H,5-7H2,(H,18,19)(H4,16,17,20,21)	Urease inhibitor	INHIBITOR	CHEMBL5325	Urease	Helicobacter pylori
CHEMBL2105233	PROXIBARBAL	C=CCC1(CC(C)O)C(=O)NC(=O)NC1=O	VNLMRPAWAMPLNZ-UHFFFAOYSA-N	InChI=1S/C10H14N2O4/c1-3-4-10(5-6(2)13)7(14)11-9(16)12-8(10)15/h3,6,13H,1,4-5H2,2H3,(H2,11,12,14,15,16)	Monoamine oxidase A activator	ACTIVATOR	CHEMBL1951	Monoamine oxidase A	Homo sapiens
CHEMBL12713	SERTINDOLE	O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1	GZKLJWGUPQBVJQ-UHFFFAOYSA-N	InChI=1S/C24H26ClFN4O/c25-18-1-6-23-21(15-18)22(16-30(23)20-4-2-19(26)3-5-20)17-7-10-28(11-8-17)13-14-29-12-9-27-24(29)31/h1-6,15-17H,7-14H2,(H,27,31)	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	CHEMBL2094251	Adrenergic receptor alpha-1	Homo sapiens
CHEMBL12713	SERTINDOLE	O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1	GZKLJWGUPQBVJQ-UHFFFAOYSA-N	InChI=1S/C24H26ClFN4O/c25-18-1-6-23-21(15-18)22(16-30(23)20-4-2-19(26)3-5-20)17-7-10-28(11-8-17)13-14-29-12-9-27-24(29)31/h1-6,15-17H,7-14H2,(H,27,31)	Serotonin 2 receptors; 5-HT2a & 5-HT2c antagonist	ANTAGONIST	CHEMBL2096662	Serotonin 2 receptors; 5-HT2a & 5-HT2c	Homo sapiens
CHEMBL539770	TERODILINE HYDROCHLORIDE	CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C.Cl	RNGHAJVBYQPLAZ-UHFFFAOYSA-N	InChI=1S/C20H27N.ClH/c1-16(21-20(2,3)4)15-19(17-11-7-5-8-12-17)18-13-9-6-10-14-18;/h5-14,16,19,21H,15H2,1-4H3;1H	Voltage-gated calcium channel blocker	BLOCKER	CHEMBL2363032	Voltage-gated calcium channel	Homo sapiens
CHEMBL1364551	MINAPRINE HYDROCHLORIDE	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1.Cl.Cl	GNUCGROXDZMCJI-UHFFFAOYSA-N	InChI=1S/C17H22N4O.2ClH/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21;;/h2-6,13H,7-12H2,1H3,(H,18,20);2*1H	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL220	Acetylcholinesterase	Homo sapiens
CHEMBL1364551	MINAPRINE HYDROCHLORIDE	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1.Cl.Cl	GNUCGROXDZMCJI-UHFFFAOYSA-N	InChI=1S/C17H22N4O.2ClH/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21;;/h2-6,13H,7-12H2,1H3,(H,18,20);2*1H	Dopamine D1 and D2 receptor agonist	AGONIST	CHEMBL2111341	Dopamine D1 and D2 receptor	Homo sapiens
CHEMBL1364551	MINAPRINE HYDROCHLORIDE	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1.Cl.Cl	GNUCGROXDZMCJI-UHFFFAOYSA-N	InChI=1S/C17H22N4O.2ClH/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21;;/h2-6,13H,7-12H2,1H3,(H,18,20);2*1H	Monoamine oxidase A inhibitor	INHIBITOR	CHEMBL1951	Monoamine oxidase A	Homo sapiens
CHEMBL1364551	MINAPRINE HYDROCHLORIDE	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1.Cl.Cl	GNUCGROXDZMCJI-UHFFFAOYSA-N	InChI=1S/C17H22N4O.2ClH/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21;;/h2-6,13H,7-12H2,1H3,(H,18,20);2*1H	Muscarinic acetylcholine receptor M1 agonist	AGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL278819	MINAPRINE	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	LDMWSLGGVTVJPG-UHFFFAOYSA-N	InChI=1S/C17H22N4O/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21/h2-6,13H,7-12H2,1H3,(H,18,20)	Acetylcholinesterase inhibitor	INHIBITOR	CHEMBL220	Acetylcholinesterase	Homo sapiens
CHEMBL278819	MINAPRINE	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	LDMWSLGGVTVJPG-UHFFFAOYSA-N	InChI=1S/C17H22N4O/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21/h2-6,13H,7-12H2,1H3,(H,18,20)	Dopamine D1 and D2 receptor agonist	AGONIST	CHEMBL2111341	Dopamine D1 and D2 receptor	Homo sapiens
CHEMBL278819	MINAPRINE	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	LDMWSLGGVTVJPG-UHFFFAOYSA-N	InChI=1S/C17H22N4O/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21/h2-6,13H,7-12H2,1H3,(H,18,20)	Monoamine oxidase A inhibitor	INHIBITOR	CHEMBL1951	Monoamine oxidase A	Homo sapiens
CHEMBL278819	MINAPRINE	Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	LDMWSLGGVTVJPG-UHFFFAOYSA-N	InChI=1S/C17H22N4O/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21/h2-6,13H,7-12H2,1H3,(H,18,20)	Muscarinic acetylcholine receptor M1 agonist	AGONIST	CHEMBL216	Muscarinic acetylcholine receptor M1	Homo sapiens
CHEMBL1204165	DILEVALOL HYDROCHLORIDE	C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(C(N)=O)c1.Cl	WQVZLXWQESQGIF-WJKBNZMCSA-N	InChI=1S/C19H24N2O3.ClH/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24;/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24);1H/t13-,18+;/m1./s1	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL1442422	DIBENZEPIN	CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21	QPGGEKPRGVJKQB-UHFFFAOYSA-N	InChI=1S/C18H21N3O/c1-19(2)12-13-21-17-11-7-6-10-16(17)20(3)15-9-5-4-8-14(15)18(21)22/h4-11H,12-13H2,1-3H3	Norepinephrine transporter inhibitor	INHIBITOR	CHEMBL222	Norepinephrine transporter	Homo sapiens
CHEMBL27810	CELIPROLOL	CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1	JOATXPAWOHTVSZ-UHFFFAOYSA-N	InChI=1S/C20H33N3O4/c1-7-23(8-2)19(26)22-15-9-10-18(17(11-15)14(3)24)27-13-16(25)12-21-20(4,5)6/h9-11,16,21,25H,7-8,12-13H2,1-6H3,(H,22,26)	Adrenergic receptor alpha-2 antagonist	ANTAGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL27810	CELIPROLOL	CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1	JOATXPAWOHTVSZ-UHFFFAOYSA-N	InChI=1S/C20H33N3O4/c1-7-23(8-2)19(26)22-15-9-10-18(17(11-15)14(3)24)27-13-16(25)12-21-20(4,5)6/h9-11,16,21,25H,7-8,12-13H2,1-6H3,(H,22,26)	Beta-1 adrenergic receptor antagonist	ANTAGONIST	CHEMBL213	Beta-1 adrenergic receptor	Homo sapiens
CHEMBL253371	ALVERINE	CCN(CCCc1ccccc1)CCCc1ccccc1	ZPFXAOWNKLFJDN-UHFFFAOYSA-N	InChI=1S/C20H27N/c1-2-21(17-9-15-19-11-5-3-6-12-19)18-10-16-20-13-7-4-8-14-20/h3-8,11-14H,2,9-10,15-18H2,1H3	Hepatocyte nuclear factor 4-alpha activator	ACTIVATOR	CHEMBL5398	Hepatocyte nuclear factor 4-alpha	Homo sapiens
CHEMBL24441	BETAHISTINE	CNCCc1ccccn1	UUQMNUMQCIQDMZ-UHFFFAOYSA-N	InChI=1S/C8H12N2/c1-9-7-5-8-4-2-3-6-10-8/h2-4,6,9H,5,7H2,1H3	Histamine H1 receptor agonist	AGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL2105618	ALLYLESTRENOL	C=CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCCC4[C@H]3CC[C@@]21C	ATXHVCQZZJYMCF-XZCODKSBSA-N	InChI=1S/C21H32O/c1-3-12-21(22)14-11-19-18-9-8-15-6-4-5-7-16(15)17(18)10-13-20(19,21)2/h3,6,16-19,22H,1,4-5,7-14H2,2H3/t16?,17-,18-,19+,20+,21+/m1/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL254328	ABIRATERONE	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2c1cccnc1	GZOSMCIZMLWJML-VJLLXTKPSA-N	InChI=1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3/t18-,19-,21-,22-,23-,24+/m0/s1	Androgen Receptor antagonist	ANTAGONIST	CHEMBL1871	Androgen Receptor	Homo sapiens
CHEMBL254328	ABIRATERONE	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2c1cccnc1	GZOSMCIZMLWJML-VJLLXTKPSA-N	InChI=1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3/t18-,19-,21-,22-,23-,24+/m0/s1	Steroid 5-alpha-reductase inhibitor	INHIBITOR	CHEMBL2363075	Steroid 5-alpha-reductase	Homo sapiens
CHEMBL10878	AGOMELATINE	COc1ccc2cccc(CCNC(C)=O)c2c1	YJYPHIXNFHFHND-UHFFFAOYSA-N	InChI=1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17)	Serotonin 2c (5-HT2c) receptor antagonist	ANTAGONIST	CHEMBL225	Serotonin 2c (5-HT2c) receptor	Homo sapiens
CHEMBL559180	ISOXSUPRINE HYDROCHLORIDE	CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1.Cl	QVPSGVSNYPRFAS-UHFFFAOYSA-N	InChI=1S/C18H23NO3.ClH/c1-13(12-22-17-6-4-3-5-7-17)19-14(2)18(21)15-8-10-16(20)11-9-15;/h3-11,13-14,18-21H,12H2,1-2H3;1H	Beta-2 adrenergic receptor agonist	AGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL43064	CINNARIZINE	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1	DERZBLKQOCDDDZ-JLHYYAGUSA-N	InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+	Histamine H1 receptor antagonist	ANTAGONIST	CHEMBL231	Histamine H1 receptor	Homo sapiens
CHEMBL243712	AMISULPRIDE	CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC	NTJOBXMMWNYJFB-UHFFFAOYSA-N	InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)	Dopamine receptors; D2 & D3 antagonist	ANTAGONIST	CHEMBL2095169	Dopamine receptors; D2 & D3	Homo sapiens
CHEMBL325109	CLEBOPRIDE	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1	BVPWJMCABCPUQY-UHFFFAOYSA-N	InChI=1S/C20H24ClN3O2/c1-26-19-12-18(22)17(21)11-16(19)20(25)23-15-7-9-24(10-8-15)13-14-5-3-2-4-6-14/h2-6,11-12,15H,7-10,13,22H2,1H3,(H,23,25)	Dopamine D2 receptor antagonist	ANTAGONIST	CHEMBL217	Dopamine D2 receptor	Homo sapiens
CHEMBL304902	CLOTHIAPINE	CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1	KAAZGXDPUNNEFN-UHFFFAOYSA-N	InChI=1S/C18H18ClN3S/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3	Dopamine D4 receptor antagonist	ANTAGONIST	CHEMBL219	Dopamine D4 receptor	Homo sapiens
CHEMBL304902	CLOTHIAPINE	CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1	KAAZGXDPUNNEFN-UHFFFAOYSA-N	InChI=1S/C18H18ClN3S/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3	Serotonin 3 (5-HT3) receptor antagonist	ANTAGONIST	CHEMBL2094132	Serotonin 3 (5-HT3) receptor	Homo sapiens
CHEMBL139835	CYPROTERONE ACETATE	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C	UWFYSQMTEOIJJG-FDTZYFLXSA-N	InChI=1S/C24H29ClO4/c1-12(26)24(29-13(2)27)8-6-16-14-10-20(25)19-11-21(28)15-9-18(15)23(19,4)17(14)5-7-22(16,24)3/h10-11,14-18H,5-9H2,1-4H3/t14-,15+,16-,17-,18-,22-,23-,24-/m0/s1	Glucocorticoid receptor antagonist	ANTAGONIST	CHEMBL2034	Glucocorticoid receptor	Homo sapiens
CHEMBL139835	CYPROTERONE ACETATE	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C	UWFYSQMTEOIJJG-FDTZYFLXSA-N	InChI=1S/C24H29ClO4/c1-12(26)24(29-13(2)27)8-6-16-14-10-20(25)19-11-21(28)15-9-18(15)23(19,4)17(14)5-7-22(16,24)3/h10-11,14-18H,5-9H2,1-4H3/t14-,15+,16-,17-,18-,22-,23-,24-/m0/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL70046	SORIVUDINE	O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)cc1/C=C/Br	GCQYYIHYQMVWLT-HQNLTJAPSA-N	InChI=1S/C11H13BrN2O6/c12-2-1-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-15)20-10/h1-3,6-8,10,15-17H,4H2,(H,13,18,19)/b2-1+/t6-,7-,8+,10-/m1/s1	DNA polymerase inhibitor	INHIBITOR	CHEMBL4859	DNA polymerase	Varicella-zoster virus (strain Dumas) (HHV-3) (Human herpesvirus 3)
CHEMBL16476	PRONETALOL	CC(C)NCC(O)c1ccc2ccccc2c1	HRSANNODOVBCST-UHFFFAOYSA-N	InChI=1S/C15H19NO/c1-11(2)16-10-15(17)14-8-7-12-5-3-4-6-13(12)9-14/h3-9,11,15-17H,10H2,1-2H3	Beta-2 adrenergic receptor antagonist	ANTAGONIST	CHEMBL210	Beta-2 adrenergic receptor	Homo sapiens
CHEMBL3707348	ACALABRUTINIB	CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12	WDENQIQQYWYTPO-IBGZPJMESA-N	InChI=1S/C26H23N7O2/c1-2-6-21(34)32-15-5-7-19(32)25-31-22(23-24(27)29-14-16-33(23)25)17-9-11-18(12-10-17)26(35)30-20-8-3-4-13-28-20/h3-4,8-14,16,19H,5,7,15H2,1H3,(H2,27,29)(H,28,30,35)/t19-/m0/s1	Tyrosine-protein kinase BTK inhibitor	INHIBITOR	CHEMBL5251	Tyrosine-protein kinase BTK	Homo sapiens
CHEMBL3545068	COPANLISIB HYDROCHLORIDE	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21.Cl.Cl	STGQPVQAAFJJFX-UHFFFAOYSA-N	InChI=1S/C23H28N8O4.2ClH/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15;;/h3-4,13-14H,2,5-12H2,1H3,(H2,24,26,27)(H,28,29,32);2*1H	PI3-kinase p110-alpha subunit inhibitor	INHIBITOR	CHEMBL4005	PI3-kinase p110-alpha subunit	Homo sapiens
CHEMBL178	DAUNORUBICIN	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1	STQGQHZAVUOBTE-VGBVRHCVSA-N	InChI=1S/C27H29NO10/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3/t10-,14-,16-,17-,22+,27-/m0/s1	DNA inhibitor	INHIBITOR	CHEMBL2311221	DNA	Homo sapiens
CHEMBL2105638	DELAFLOXACIN MEGLUMINE	CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.Nc1nc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(O)C4)c(Cl)c32)c(F)cc1F	AHJGUEMIZPMAMR-WZTVWXICSA-N	InChI=1S/C18H12ClF3N4O4.C7H17NO5/c19-12-13-7(1-9(20)14(12)25-3-6(27)4-25)15(28)8(18(29)30)5-26(13)17-11(22)2-10(21)16(23)24-17;1-8-2-4(10)6(12)7(13)5(11)3-9/h1-2,5-6,27H,3-4H2,(H2,23,24)(H,29,30);4-13H,2-3H2,1H3/t;4-,5+,6+,7+/m.0/s1	Bacterial DNA gyrase inhibitor	INHIBITOR	CHEMBL2311224	Bacterial DNA gyrase	Bacteria
CHEMBL3137326	DUTETRABENAZINE	[2H]C([2H])([2H])Oc1cc2c(cc1OC([2H])([2H])[2H])C1CC(=O)C(CC(C)C)CN1CC2	MKJIEFSOBYUXJB-LIJFRPJRSA-N	InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/i3D3,4D3	Synaptic vesicular amine transporter inhibitor	INHIBITOR	CHEMBL1893	Synaptic vesicular amine transporter	Homo sapiens
CHEMBL3989931	ENASIDENIB MESYLATE	CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1.CS(=O)(=O)O	ORZHZQZYWXEDDL-UHFFFAOYSA-N	InChI=1S/C19H17F6N7O.CH4O3S/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25;1-5(2,3)4/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32);1H3,(H,2,3,4)	Isocitrate dehydrogenase [NADP], mitochondrial inhibitor	INHIBITOR	CHEMBL3991501	Isocitrate dehydrogenase [NADP], mitochondrial	Homo sapiens
CHEMBL3545363	GLECAPREVIR	CC(C)(C)[C@@H]1NC(=O)O[C@@H]2CCC[C@H]2OC/C=C/C(F)(F)c2nc3ccccc3nc2O[C@@H]2C[C@@H](C(=O)N[C@]3(C(=O)NS(=O)(=O)C4(C)CC4)C[C@H]3C(F)F)N(C2)C1=O	MLSQGNCUYAMAHD-ITNVBOSISA-N	InChI=1S/C38H46F4N6O9S/c1-35(2,3)28-32(50)48-19-20(17-24(48)30(49)46-37(18-21(37)29(39)40)33(51)47-58(53,54)36(4)14-15-36)56-31-27(43-22-9-5-6-10-23(22)44-31)38(41,42)13-8-16-55-25-11-7-12-26(25)57-34(52)45-28/h5-6,8-10,13,20-21,24-26,28-29H,7,11-12,14-19H2,1-4H3,(H,45,52)(H,46,49)(H,47,51)/b13-8+/t20-,21+,24+,25-,26-,28-,37-/m1/s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL1241951	LETERMOVIR	COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1	FWYSMLBETOMXAG-QHCPKHFHSA-N	InChI=1S/C29H28F4N4O4/c1-40-20-6-3-5-19(16-20)35-11-13-36(14-12-35)28-34-27-21(7-4-8-22(27)30)23(17-26(38)39)37(28)24-15-18(29(31,32)33)9-10-25(24)41-2/h3-10,15-16,23H,11-14,17H2,1-2H3,(H,38,39)/t23-/m0/s1	DNA terminase inhibitor	INHIBITOR	CHEMBL3991482	DNA terminase	Human cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5)
CHEMBL3545123	PIBRENTASVIR	COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2cc([C@H]3CC[C@H](c4cc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)[nH]c5cc4F)N3c3cc(F)c(N4CCC(c5ccc(F)cc5)CC4)c(F)c3)c(F)cc2[nH]1)[C@@H](C)OC	VJYSBPDEJWLKKJ-NLIMODCCSA-N	InChI=1S/C57H65F5N10O8/c1-29(77-3)49(67-56(75)79-5)54(73)70-19-7-9-47(70)52-63-41-25-35(37(59)27-43(41)65-52)45-15-16-46(72(45)34-23-39(61)51(40(62)24-34)69-21-17-32(18-22-69)31-11-13-33(58)14-12-31)36-26-42-44(28-38(36)60)66-53(64-42)48-10-8-20-71(48)55(74)50(30(2)78-4)68-57(76)80-6/h11-14,23-30,32,45-50H,7-10,15-22H2,1-6H3,(H,63,65)(H,64,66)(H,67,75)(H,68,76)/t29-,30-,45-,46-,47+,48+,49+,50+/m1/s1	Nonstructural protein 5A inhibitor	INHIBITOR	CHEMBL3307224	Nonstructural protein 5A	Hepatitis C virus
CHEMBL3989923	PITAVASTATIN MAGNESIUM	O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Mg+2]	MPAZKXHCZWDZDY-FFNUKLMVSA-L	InChI=1S/2C25H24FNO4.Mg/c2*26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31;/h2*1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31);/q;;+2/p-2/b2*12-11+;/t2*18-,19-;/m11./s1	HMG-CoA reductase inhibitor	INHIBITOR	CHEMBL402	HMG-CoA reductase	Homo sapiens
CHEMBL3989920	PITAVASTATIN SODIUM	O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Na+]	NBDQGOCGYHMDSJ-NRFPMOEYSA-M	InChI=1S/C25H24FNO4.Na/c26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31;/h1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31);/q;+1/p-1/b12-11+;/t18-,19-;/m1./s1	HMG-CoA reductase inhibitor	INHIBITOR	CHEMBL402	HMG-CoA reductase	Homo sapiens
CHEMBL498847	SECNIDAZOLE	Cc1ncc([N+](=O)[O-])n1CC(C)O	KPQZUUQMTUIKBP-UHFFFAOYSA-N	InChI=1S/C7H11N3O3/c1-5(11)4-9-6(2)8-3-7(9)10(12)13/h3,5,11H,4H2,1-2H3	DNA inhibitor	INHIBITOR	CHEMBL2364041	DNA	Bacteria
CHEMBL3348963	TELOTRISTAT ETIPRATE	CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1.O=C(O)CNC(=O)c1ccccc1	XSFPZBUIBYMVEA-CELUQASASA-N	InChI=1S/C27H26ClF3N6O3.C9H9NO3/c1-3-39-25(38)20(32)12-16-4-6-17(7-5-16)21-14-23(35-26(33)34-21)40-24(27(29,30)31)19-9-8-18(28)13-22(19)37-11-10-15(2)36-37;11-8(12)6-10-9(13)7-4-2-1-3-5-7/h4-11,13-14,20,24H,3,12,32H2,1-2H3,(H2,33,34,35);1-5H,6H2,(H,10,13)(H,11,12)/t20-,24+;/m0./s1	Tryptophan 5-hydroxylase inhibitor	INHIBITOR	CHEMBL3831287	Tryptophan 5-hydroxylase	Homo sapiens
CHEMBL3317857	VABORBACTAM	O=C(O)C[C@@H]1CC[C@H](NC(=O)Cc2cccs2)B(O)O1	IOOWNWLVCOUUEX-WPRPVWTQSA-N	InChI=1S/C12H16BNO5S/c15-11(7-9-2-1-5-20-9)14-10-4-3-8(6-12(16)17)19-13(10)18/h1-2,5,8,10,18H,3-4,6-7H2,(H,14,15)(H,16,17)/t8-,10-/m0/s1	Carbepenem-hydrolyzing beta-lactamase KPC inhibitor	INHIBITOR	CHEMBL6132	Carbepenem-hydrolyzing beta-lactamase KPC	Klebsiella pneumoniae
CHEMBL3707248	VALBENAZINE TOSYLATE	COc1cc2c(cc1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1	BXGKAGLZHGYAMW-TZYFFPFWSA-N	InChI=1S/C24H38N2O4.2C7H8O3S/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4;2*1-6-2-4-7(5-3-6)11(8,9)10/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3;2*2-5H,1H3,(H,8,9,10)/t17-,19-,20-,23+;;/m1../s1	Synaptic vesicular amine transporter inhibitor	INHIBITOR	CHEMBL1893	Synaptic vesicular amine transporter	Homo sapiens
CHEMBL3707372	VOXILAPREVIR	CC[C@H]1[C@@H](C(=O)N[C@]2(C(=O)NS(=O)(=O)C3(C)CC3)C[C@H]2C(C)C)N2C[C@@H]1Oc1nc3cc(OC)ccc3nc1C(F)(F)CCCC[C@@H]1C[C@H]1OC(=O)N[C@@H](C(C)(C)C)C2=O	MKDALIOACIEUJM-XCFCBFDASA-N	InChI=1S/C42H58F2N6O9S/c1-9-25-30-21-50(31(25)34(51)48-41(20-26(41)22(2)3)37(53)49-60(55,56)40(7)16-17-40)36(52)33(39(4,5)6)47-38(54)59-29-18-23(29)12-10-11-15-42(43,44)32-35(58-30)46-28-19-24(57-8)13-14-27(28)45-32/h13-14,19,22-23,25-26,29-31,33H,9-12,15-18,20-21H2,1-8H3,(H,47,54)(H,48,51)(H,49,53)/t23-,25-,26+,29-,30+,31+,33-,41-/m1/s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL3989932	ANGIOTENSIN II ACETATE	CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O	VBTZKFAHKJXHBA-PIONDTTLSA-N	InChI=1S/C50H71N13O12.C2H4O2/c1-5-28(4)41(47(72)59-36(23-31-25-54-26-56-31)48(73)63-20-10-14-38(63)45(70)60-37(49(74)75)22-29-11-7-6-8-12-29)62-44(69)35(21-30-15-17-32(64)18-16-30)58-46(71)40(27(2)3)61-43(68)34(13-9-19-55-50(52)53)57-42(67)33(51)24-39(65)66;1-2(3)4/h6-8,11-12,15-18,25-28,33-38,40-41,64H,5,9-10,13-14,19-24,51H2,1-4H3,(H,54,56)(H,57,67)(H,58,71)(H,59,72)(H,60,70)(H,61,68)(H,62,69)(H,65,66)(H,74,75)(H4,52,53,55);1H3,(H,3,4)/t28-,33-,34-,35-,36-,37-,38-,40-,41-;/m0./s1	Type-1 angiotensin II receptor agonist	AGONIST	CHEMBL227	Type-1 angiotensin II receptor	Homo sapiens
CHEMBL2364617	MACIMORELIN ACETATE	CC(=O)O.CC(C)(N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)NC=O	WVDSKQXKCDZXLH-OHIDFYLOSA-N	InChI=1S/C26H30N6O3.C2H4O2/c1-26(2,27)25(35)31-22(11-16-13-28-20-9-5-3-7-18(16)20)24(34)32-23(30-15-33)12-17-14-29-21-10-6-4-8-19(17)21;1-2(3)4/h3-10,13-15,22-23,28-29H,11-12,27H2,1-2H3,(H,30,33)(H,31,35)(H,32,34);1H3,(H,3,4)/t22-,23-;/m1./s1	Ghrelin receptor agonist	AGONIST	CHEMBL4616	Ghrelin receptor	Homo sapiens
CHEMBL3545126	NETARSUDIL DIMESYLATE	CS(=O)(=O)O.CS(=O)(=O)O.Cc1ccc(C(=O)OCC2=CCC([C@@H](CN)C(=O)Nc3ccc4cnccc4c3)C=C2)c(C)c1	RIYFCYMNMHPKGL-DCHFXQLBSA-N	InChI=1S/C28H29N3O3.2CH4O3S/c1-18-3-10-25(19(2)13-18)28(33)34-17-20-4-6-21(7-5-20)26(15-29)27(32)31-24-9-8-23-16-30-12-11-22(23)14-24;2*1-5(2,3)4/h3-6,8-14,16,21,26H,7,15,17,29H2,1-2H3,(H,31,32);2*1H3,(H,2,3,4)/t21?,26-;;/m1../s1	Rho-associated protein kinase inhibitor	INHIBITOR	CHEMBL2111459	Rho-associated protein kinase	Homo sapiens
CHEMBL3990047	OZENOXACIN	CNc1ncc(-c2ccc3c(=O)c(C(=O)O)cn(C4CC4)c3c2C)cc1C	XPIJWUTXQAGSLK-UHFFFAOYSA-N	InChI=1S/C21H21N3O3/c1-11-8-13(9-23-20(11)22-3)15-6-7-16-18(12(15)2)24(14-4-5-14)10-17(19(16)25)21(26)27/h6-10,14H,4-5H2,1-3H3,(H,22,23)(H,26,27)	DNA gyrase inhibitor	INHIBITOR	CHEMBL3991502	DNA gyrase	Streptococcus pyogenes serotype M3 (strain ATCC BAA-595 / MGAS315)
CHEMBL3989866	BICTEGRAVIR	O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c(O)c1=O)C(=O)N1[C@H]3CC[C@H](C3)O[C@@H]1C2	SOLUWJRYJLAZCX-LYOVBCGYSA-N	InChI=1S/C21H18F3N3O5/c22-9-3-14(23)12(15(24)4-9)6-25-20(30)13-7-26-8-16-27(10-1-2-11(5-10)32-16)21(31)17(26)19(29)18(13)28/h3-4,7,10-11,16,29H,1-2,5-6,8H2,(H,25,30)/t10-,11+,16+/m0/s1	Human immunodeficiency virus type 1 integrase inhibitor	INHIBITOR	CHEMBL3471	Human immunodeficiency virus type 1 integrase	Human immunodeficiency virus 1
CHEMBL2107825	TENOFOVIR ALAFENAMIDE	CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1	LDEKQSIMHVQZJK-CAQYMETFSA-N	InChI=1S/C21H29N6O5P/c1-14(2)31-21(28)16(4)26-33(29,32-17-8-6-5-7-9-17)13-30-15(3)10-27-12-25-18-19(22)23-11-24-20(18)27/h5-9,11-12,14-16H,10,13H2,1-4H3,(H,26,29)(H2,22,23,24)/t15-,16+,33+/m1/s1	Human immunodeficiency virus type 1 reverse transcriptase inhibitor	INHIBITOR	CHEMBL247	Human immunodeficiency virus type 1 reverse transcriptase	Human immunodeficiency virus 1
CHEMBL110458	MIGALASTAT	OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O	LXBIFEVIBLOUGU-DPYQTVNSSA-N	InChI=1S/C6H13NO4/c8-2-3-5(10)6(11)4(9)1-7-3/h3-11H,1-2H2/t3-,4+,5+,6-/m1/s1	Alpha-galactosidase A stabiliser	STABILISER	CHEMBL2524	Alpha-galactosidase A	Homo sapiens
CHEMBL178	DAUNORUBICIN	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1	STQGQHZAVUOBTE-VGBVRHCVSA-N	InChI=1S/C27H29NO10/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3/t10-,14-,16-,17-,22+,27-/m0/s1	DNA topoisomerase II alpha inhibitor	INHIBITOR	CHEMBL1806	DNA topoisomerase II alpha	Homo sapiens
CHEMBL3545068	COPANLISIB HYDROCHLORIDE	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21.Cl.Cl	STGQPVQAAFJJFX-UHFFFAOYSA-N	InChI=1S/C23H28N8O4.2ClH/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15;;/h3-4,13-14H,2,5-12H2,1H3,(H2,24,26,27)(H,28,29,32);2*1H	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	CHEMBL3130	PI3-kinase p110-delta subunit	Homo sapiens
CHEMBL2105638	DELAFLOXACIN MEGLUMINE	CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.Nc1nc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(O)C4)c(Cl)c32)c(F)cc1F	AHJGUEMIZPMAMR-WZTVWXICSA-N	InChI=1S/C18H12ClF3N4O4.C7H17NO5/c19-12-13-7(1-9(20)14(12)25-3-6(27)4-25)15(28)8(18(29)30)5-26(13)17-11(22)2-10(21)16(23)24-17;1-8-2-4(10)6(12)7(13)5(11)3-9/h1-2,5-6,27H,3-4H2,(H2,23,24)(H,29,30);4-13H,2-3H2,1H3/t;4-,5+,6+,7+/m.0/s1	Topoisomerase IV inhibitor	INHIBITOR	CHEMBL2363076	Topoisomerase IV	Bacteria
CHEMBL3990047	OZENOXACIN	CNc1ncc(-c2ccc3c(=O)c(C(=O)O)cn(C4CC4)c3c2C)cc1C	XPIJWUTXQAGSLK-UHFFFAOYSA-N	InChI=1S/C21H21N3O3/c1-11-8-13(9-23-20(11)22-3)15-6-7-16-18(12(15)2)24(14-4-5-14)10-17(19(16)25)21(26)27/h6-10,14H,4-5H2,1-3H3,(H,22,23)(H,26,27)	Topoisomerase IV inhibitor	INHIBITOR	CHEMBL3038508	Topoisomerase IV	Staphylococcus aureus
CHEMBL3990047	OZENOXACIN	CNc1ncc(-c2ccc3c(=O)c(C(=O)O)cn(C4CC4)c3c2C)cc1C	XPIJWUTXQAGSLK-UHFFFAOYSA-N	InChI=1S/C21H21N3O3/c1-11-8-13(9-23-20(11)22-3)15-6-7-16-18(12(15)2)24(14-4-5-14)10-17(19(16)25)21(26)27/h6-10,14H,4-5H2,1-3H3,(H,22,23)(H,26,27)	DNA gyrase inhibitor	INHIBITOR	CHEMBL3038482	DNA gyrase	Staphylococcus aureus
CHEMBL3990047	OZENOXACIN	CNc1ncc(-c2ccc3c(=O)c(C(=O)O)cn(C4CC4)c3c2C)cc1C	XPIJWUTXQAGSLK-UHFFFAOYSA-N	InChI=1S/C21H21N3O3/c1-11-8-13(9-23-20(11)22-3)15-6-7-16-18(12(15)2)24(14-4-5-14)10-17(19(16)25)21(26)27/h6-10,14H,4-5H2,1-3H3,(H,22,23)(H,26,27)	DNA topoisomerase IV inhibitor	INHIBITOR	CHEMBL3991503	DNA topoisomerase IV	Streptococcus pyogenes serotype M3 (strain ATCC BAA-595 / MGAS315)
CHEMBL1200699	DOXYCYCLINE	C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O	XQTWDDCIUJNLTR-CVHRZJFOSA-N	InChI=1S/C22H24N2O8.H2O/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;/h4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);1H2/t7-,10+,14+,15-,17-,22-;/m0./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL3989740	DOXYCYCLINE HYCLATE	CCO.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl.Cl.O	HALQELOKLVRWRI-VDBOFHIQSA-N	InChI=1S/2C22H24N2O8.C2H6O.2ClH.H2O/c2*1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;1-2-3;;;/h2*4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);3H,2H2,1H3;2*1H;1H2/t2*7-,10+,14+,15-,17-,22-;;;;/m00..../s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL2325741	CAPIVASERTIB	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1	JDUBGYFRJFOXQC-KRWDZBQOSA-N	InChI=1S/C21H25ClN6O2/c22-15-3-1-14(2-4-15)17(6-12-29)27-20(30)21(23)7-10-28(11-8-21)19-16-5-9-24-18(16)25-13-26-19/h1-5,9,13,17,29H,6-8,10-12,23H2,(H,27,30)(H,24,25,26)/t17-/m0/s1	Serine/threonine-protein kinase AKT inhibitor	INHIBITOR	CHEMBL2111353	Serine/threonine-protein kinase AKT	Homo sapiens
CHEMBL3989914	GLESATINIB	COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4F)c3s2)nc1	YRCHYHRCBXNYNU-UHFFFAOYSA-N	InChI=1S/C31H27F2N5O3S2/c1-40-13-12-34-17-20-4-8-24(36-18-20)28-16-25-30(43-28)27(10-11-35-25)41-26-9-7-22(15-23(26)33)37-31(42)38-29(39)14-19-2-5-21(32)6-3-19/h2-11,15-16,18,34H,12-14,17H2,1H3,(H2,37,38,39,42)	Hepatocyte growth factor receptor inhibitor	INHIBITOR	CHEMBL3717	Hepatocyte growth factor receptor	Homo sapiens
CHEMBL3989914	GLESATINIB	COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4F)c3s2)nc1	YRCHYHRCBXNYNU-UHFFFAOYSA-N	InChI=1S/C31H27F2N5O3S2/c1-40-13-12-34-17-20-4-8-24(36-18-20)28-16-25-30(43-28)27(10-11-35-25)41-26-9-7-22(15-23(26)33)37-31(42)38-29(39)14-19-2-5-21(32)6-3-19/h2-11,15-16,18,34H,12-14,17H2,1H3,(H2,37,38,39,42)	Macrophage-stimulating protein receptor inhibitor	INHIBITOR	CHEMBL2689	Macrophage-stimulating protein receptor	Homo sapiens
CHEMBL3989914	GLESATINIB	COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4F)c3s2)nc1	YRCHYHRCBXNYNU-UHFFFAOYSA-N	InChI=1S/C31H27F2N5O3S2/c1-40-13-12-34-17-20-4-8-24(36-18-20)28-16-25-30(43-28)27(10-11-35-25)41-26-9-7-22(15-23(26)33)37-31(42)38-29(39)14-19-2-5-21(32)6-3-19/h2-11,15-16,18,34H,12-14,17H2,1H3,(H2,37,38,39,42)	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	CHEMBL2095227	Vascular endothelial growth factor receptor	Homo sapiens
CHEMBL3989914	GLESATINIB	COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4F)c3s2)nc1	YRCHYHRCBXNYNU-UHFFFAOYSA-N	InChI=1S/C31H27F2N5O3S2/c1-40-13-12-34-17-20-4-8-24(36-18-20)28-16-25-30(43-28)27(10-11-35-25)41-26-9-7-22(15-23(26)33)37-31(42)38-29(39)14-19-2-5-21(32)6-3-19/h2-11,15-16,18,34H,12-14,17H2,1H3,(H2,37,38,39,42)	Tyrosine-protein kinase TIE-2 inhibitor	INHIBITOR	CHEMBL4128	Tyrosine-protein kinase TIE-2	Homo sapiens
CHEMBL2336325	VISTUSERTIB	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1	JUSFANSTBFGBAF-IRXDYDNUSA-N	InChI=1S/C25H30N6O3/c1-16-14-33-11-9-30(16)23-20-7-8-21(18-5-4-6-19(13-18)24(32)26-3)27-22(20)28-25(29-23)31-10-12-34-15-17(31)2/h4-8,13,16-17H,9-12,14-15H2,1-3H3,(H,26,32)/t16-,17-/m0/s1	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	CHEMBL2842	Serine/threonine-protein kinase mTOR	Homo sapiens
CHEMBL429910	DAPAGLIFLOZIN	CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1	JVHXJTBJCFBINQ-ADAARDCZSA-N	InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1	Sodium/glucose cotransporter 2 inhibitor	INHIBITOR	CHEMBL3884	Sodium/glucose cotransporter 2	Homo sapiens
CHEMBL471737	IVABRADINE	COc1cc2c(cc1OC)CC(=O)N(CCCN(C)C[C@H]1Cc3cc(OC)c(OC)cc31)CC2	ACRHBAYQBXXRTO-OAQYLSRUSA-N	InChI=1S/C27H36N2O5/c1-28(17-21-11-20-14-25(33-4)26(34-5)16-22(20)21)8-6-9-29-10-7-18-12-23(31-2)24(32-3)13-19(18)15-27(29)30/h12-14,16,21H,6-11,15,17H2,1-5H3/t21-/m1/s1	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker	BLOCKER	CHEMBL1250417	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	Homo sapiens
CHEMBL1790041	RANITIDINE	CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1	VMXUWOKSQNHOCA-UHFFFAOYSA-N	InChI=1S/C13H22N4O3S/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3/h4-5,9,14-15H,6-8,10H2,1-3H3	Histamine H2 receptor antagonist	ANTAGONIST	CHEMBL1941	Histamine H2 receptor	Homo sapiens
CHEMBL655	MIDAZOLAM	Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2	DDLIGBOFAVUZHB-UHFFFAOYSA-N	InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL95889	BETAINE	C[N+](C)(C)CC(=O)O	KWIUHFFTVRNATP-UHFFFAOYSA-O	InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3/p+1	Betaine-homocysteine S-methyltransferase substrate	SUBSTRATE	CHEMBL3391661	Betaine-homocysteine S-methyltransferase	Homo sapiens
CHEMBL354077	AMIFAMPRIDINE	Nc1ccncc1N	OYTKINVCDFNREN-UHFFFAOYSA-N	InChI=1S/C5H7N3/c6-4-1-2-8-3-5(4)7/h1-3H,7H2,(H2,6,8)	Voltage-gated potassium channel blocker	BLOCKER	CHEMBL2362996	Voltage-gated potassium channel	Homo sapiens
CHEMBL766	CILASTATIN	CC1(C)C[C@@H]1C(=O)N/C(=C\CCCCSC[C@H](N)C(=O)O)C(=O)O	DHSUYTOATWAVLW-WFVMDLQDSA-N	InChI=1S/C16H26N2O5S/c1-16(2)8-10(16)13(19)18-12(15(22)23)6-4-3-5-7-24-9-11(17)14(20)21/h6,10-11H,3-5,7-9,17H2,1-2H3,(H,18,19)(H,20,21)(H,22,23)/b12-6-/t10-,11+/m1/s1	Renal dipeptidase inhibitor	INHIBITOR	CHEMBL1989	Renal dipeptidase	Homo sapiens
CHEMBL3301611	AMIFAMPRIDINE PHOSPHATE	Nc1ccncc1N.O=P(O)(O)O	KAICRBBQCRKMPO-UHFFFAOYSA-N	InChI=1S/C5H7N3.H3O4P/c6-4-1-2-8-3-5(4)7;1-5(2,3)4/h1-3H,7H2,(H2,6,8);(H3,1,2,3,4)	Voltage-gated potassium channel blocker	BLOCKER	CHEMBL2362996	Voltage-gated potassium channel	Homo sapiens
CHEMBL2105758	AVATROMBOPAG MALEATE	O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1.O=C(O)/C=C\C(=O)O	MISPBGHDNZYFNM-BTJKTKAUSA-N	InChI=1S/C29H34Cl2N6O3S2.C4H4O4/c30-20-15-23(41-17-20)24-27(37-12-10-35(11-13-37)21-4-2-1-3-5-21)42-29(33-24)34-26(38)19-14-22(31)25(32-16-19)36-8-6-18(7-9-36)28(39)40;5-3(6)1-2-4(7)8/h14-18,21H,1-13H2,(H,39,40)(H,33,34,38);1-2H,(H,5,6)(H,7,8)/b;2-1-	Thrombopoietin receptor agonist	AGONIST	CHEMBL1864	Thrombopoietin receptor	Homo sapiens
CHEMBL2364608	DORAVIRINE	Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(Cl)cc(C#N)c3)c2=O)n[nH]c1=O	ZIAOVIPSKUPPQW-UHFFFAOYSA-N	InChI=1S/C17H11ClF3N5O3/c1-25-13(23-24-16(25)28)8-26-3-2-12(17(19,20)21)14(15(26)27)29-11-5-9(7-22)4-10(18)6-11/h2-6H,8H2,1H3,(H,24,28)	Reverse transcriptase negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	CHEMBL2366516	Reverse transcriptase	Human immunodeficiency virus 1
CHEMBL3989516	FOSTAMATINIB DISODIUM	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)([O-])[O-])C(=O)C(C)(C)O4)n2)cc(OC)c1OC.O.O.O.O.O.O.[Na+].[Na+]	ZQGJCHHKJNSPMS-UHFFFAOYSA-L	InChI=1S/C23H26FN6O9P.2Na.6H2O/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4;;;;;;;;/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29);;;6*1H2/q;2*+1;;;;;;/p-2	Tyrosine-protein kinase SYK inhibitor	INHIBITOR	CHEMBL2599	Tyrosine-protein kinase SYK	Homo sapiens
CHEMBL3301603	GILTERITINIB FUMARATE	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1.CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O	UJOUWHLYTQFUCU-WXXKFALUSA-N	InChI=1S/2C29H44N8O3.C4H4O4/c2*1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36;5-3(6)1-2-4(7)8/h2*5-6,19-20,22H,4,7-18H2,1-3H3,(H2,30,38)(H2,31,32,34);1-2H,(H,5,6)(H,7,8)/b;;2-1+	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL4297534	GLASDEGIB MALEATE	CN1CC[C@@H](NC(=O)Nc2ccc(C#N)cc2)C[C@@H]1c1nc2ccccc2[nH]1.O=C(O)/C=C\C(=O)O	VJCVKWFBWAVYOC-UIXXXISESA-N	InChI=1S/C21H22N6O.C4H4O4/c1-27-11-10-16(24-21(28)23-15-8-6-14(13-22)7-9-15)12-19(27)20-25-17-4-2-3-5-18(17)26-20;5-3(6)1-2-4(7)8/h2-9,16,19H,10-12H2,1H3,(H,25,26)(H2,23,24,28);1-2H,(H,5,6)(H,7,8)/b;2-1-/t16-,19-;/m1./s1	Smoothened homolog antagonist	ANTAGONIST	CHEMBL5971	Smoothened homolog	Homo sapiens
CHEMBL3989958	IVOSIDENIB	N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1	WIJZXSAJMHAVGX-DHLKQENFSA-N	InChI=1S/C28H22ClF3N6O3/c29-21-4-2-1-3-20(21)25(26(40)36-18-11-28(31,32)12-18)37(19-10-17(30)14-34-15-19)27(41)22-5-6-24(39)38(22)23-9-16(13-33)7-8-35-23/h1-4,7-10,14-15,18,22,25H,5-6,11-12H2,(H,36,40)/t22-,25-/m0/s1	Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor	INHIBITOR	CHEMBL2007625	Isocitrate dehydrogenase [NADP] cytoplasmic	Homo sapiens
CHEMBL2107831	LUSUTROMBOPAG	CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC	NOZIJMHMKORZBA-KJCUYJGMSA-N	InChI=1S/C29H32Cl2N2O5S/c1-5-6-7-8-12-38-18(3)20-10-9-11-21(26(20)37-4)25-16-39-29(32-25)33-27(34)19-14-23(30)22(24(31)15-19)13-17(2)28(35)36/h9-11,13-16,18H,5-8,12H2,1-4H3,(H,35,36)(H,32,33,34)/b17-13+/t18-/m0/s1	Thrombopoietin receptor agonist	AGONIST	CHEMBL1864	Thrombopoietin receptor	Homo sapiens
CHEMBL2105748	PRUCALOPRIDE SUCCINATE	COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1.O=C(O)CCC(=O)O	QZRSNVSQLGRAID-UHFFFAOYSA-N	InChI=1S/C18H26ClN3O3.C4H6O4/c1-24-9-2-6-22-7-3-12(4-8-22)21-18(23)14-11-15(19)16(20)13-5-10-25-17(13)14;5-3(6)1-2-4(7)8/h11-12H,2-10,20H2,1H3,(H,21,23);1-2H2,(H,5,6)(H,7,8)	Serotonin 4 (5-HT4) receptor agonist	AGONIST	CHEMBL1875	Serotonin 4 (5-HT4) receptor	Homo sapiens
CHEMBL3833319	REVEFENACIN	CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1	FYDWDCIFZSGNBU-UHFFFAOYSA-N	InChI=1S/C35H43N5O4/c1-38(34(42)29-13-11-26(12-14-29)25-40-19-15-28(16-20-40)33(36)41)23-24-39-21-17-30(18-22-39)44-35(43)37-32-10-6-5-9-31(32)27-7-3-2-4-8-27/h2-14,28,30H,15-25H2,1H3,(H2,36,41)(H,37,43)	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	CHEMBL245	Muscarinic acetylcholine receptor M3	Homo sapiens
CHEMBL3989919	FOSNETUPITANT CHLORIDE HYDROCHLORIDE	Cc1ccccc1-c1cc(N2CC[N+](C)(COP(=O)(O)O)CC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1.Cl.[Cl-]	LBTQUZNIWCWBNN-UHFFFAOYSA-N	InChI=1S/C31H35F6N4O5P.2ClH/c1-20-8-6-7-9-24(20)25-17-27(40-10-12-41(5,13-11-40)19-46-47(43,44)45)38-18-26(25)39(4)28(42)29(2,3)21-14-22(30(32,33)34)16-23(15-21)31(35,36)37;;/h6-9,14-18H,10-13,19H2,1-5H3,(H-,43,44,45);2*1H	Neurokinin 1 receptor antagonist	ANTAGONIST	CHEMBL249	Neurokinin 1 receptor	Homo sapiens
CHEMBL4297503	BALOXAVIR MARBOXIL	COC(=O)OCOc1c2n(ccc1=O)N([C@@H]1c3ccccc3SCc3c1ccc(F)c3F)[C@@H]1COCCN1C2=O	RZVPBGBYGMDSBG-GGAORHGYSA-N	InChI=1S/C27H23F2N3O7S/c1-36-27(35)39-14-38-25-19(33)8-9-31-24(25)26(34)30-10-11-37-12-21(30)32(31)23-15-6-7-18(28)22(29)17(15)13-40-20-5-3-2-4-16(20)23/h2-9,21,23H,10-14H2,1H3/t21-,23+/m1/s1	Polymerase acidic protein inhibitor	INHIBITOR	CHEMBL1169598	Polymerase acidic protein	Influenza A virus (A/Puerto Rico/8/1934(H1N1))
CHEMBL4297503	BALOXAVIR MARBOXIL	COC(=O)OCOc1c2n(ccc1=O)N([C@@H]1c3ccccc3SCc3c1ccc(F)c3F)[C@@H]1COCCN1C2=O	RZVPBGBYGMDSBG-GGAORHGYSA-N	InChI=1S/C27H23F2N3O7S/c1-36-27(35)39-14-38-25-19(33)8-9-31-24(25)26(34)30-10-11-37-12-21(30)32(31)23-15-6-7-18(28)22(29)17(15)13-40-20-5-3-2-4-16(20)23/h2-9,21,23H,10-14H2,1H3/t21-,23+/m1/s1	Polymerase acidic protein inhibitor	INHIBITOR	CHEMBL2028641	Polymerase acidic protein	Influenza B virus (B/Lee/40)
CHEMBL207538	BREXANOLONE	CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C	AURFZBICLPNKBZ-SYBPFIFISA-N	InChI=1S/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15+,16-,17+,18-,19-,20-,21+/m0/s1	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL1788132	LOFEXIDINE HYDROCHLORIDE	CC(Oc1c(Cl)cccc1Cl)C1=NCCN1.Cl	DWWHMKBNNNZGHF-UHFFFAOYSA-N	InChI=1S/C11H12Cl2N2O.ClH/c1-7(11-14-5-6-15-11)16-10-8(12)3-2-4-9(10)13;/h2-4,7H,5-6H2,1H3,(H,14,15);1H	Adrenergic receptor alpha-2 agonist	AGONIST	CHEMBL2095158	Adrenergic receptor alpha-2	Homo sapiens
CHEMBL3286830	LORLATINIB	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21	IIXWYSCJSQVBQM-LLVKDONJSA-N	InChI=1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1	ALK tyrosine kinase receptor inhibitor	INHIBITOR	CHEMBL4247	ALK tyrosine kinase receptor	Homo sapiens
CHEMBL3286830	LORLATINIB	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21	IIXWYSCJSQVBQM-LLVKDONJSA-N	InChI=1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1	EML4-ALK  inhibitor	INHIBITOR	CHEMBL3883330	EML4-ALK 	Homo sapiens
CHEMBL2219414	ERAVACYCLINE DIHYDROCHLORIDE	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)c(NC(=O)CN5CCCC5)cc(F)c4C[C@H]3C[C@@H]12.Cl.Cl	JYCNMRVZELJVAW-RZVFYPHASA-N	InChI=1S/C27H31FN4O8.2ClH/c1-31(2)20-13-8-11-7-12-14(28)9-15(30-16(33)10-32-5-3-4-6-32)21(34)18(12)22(35)17(11)24(37)27(13,40)25(38)19(23(20)36)26(29)39;;/h9,11,13,20,34,36-37,40H,3-8,10H2,1-2H3,(H2,29,39)(H,30,33);2*1H/t11-,13-,20-,27-;;/m0../s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL1257073	TECOVIRIMAT	O=C(NN1C(=O)[C@H]2[C@H]3C=C[C@H]([C@@H]4C[C@H]34)[C@H]2C1=O)c1ccc(C(F)(F)F)cc1	CSKDFZIMJXRJGH-VWLPUNTISA-N	InChI=1S/C19H15F3N2O3/c20-19(21,22)9-3-1-8(2-4-9)16(25)23-24-17(26)14-10-5-6-11(13-7-12(10)13)15(14)18(24)27/h1-6,10-15H,7H2,(H,23,25)/t10-,11+,12+,13-,14-,15+	Envelope phospholipase F13 (p37) inhibitor	INHIBITOR	CHEMBL4296170	Envelope phospholipase F13 (p37)	Vaccinia virus (strain Western Reserve) (VACV) (Vaccinia virus (strainWR))
CHEMBL2105680	RIFAMYCIN SODIUM	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c([O-])c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C.[Na+]	YVOFSHPIJOYKSH-NLYBMVFSSA-M	InChI=1S/C37H47NO12.Na/c1-16-11-10-12-17(2)36(46)38-23-15-24(40)26-27(32(23)44)31(43)21(6)34-28(26)35(45)37(8,50-34)48-14-13-25(47-9)18(3)33(49-22(7)39)20(5)30(42)19(4)29(16)41;/h10-16,18-20,25,29-30,33,40-44H,1-9H3,(H,38,46);/q;+1/p-1/b11-10+,14-13+,17-12-;/t16-,18+,19+,20+,25-,29-,30+,33+,37-;/m0./s1	DNA-directed RNA polymerase inhibitor	INHIBITOR	CHEMBL4296169	DNA-directed RNA polymerase	Escherichia coli
CHEMBL3545376	ERDAFITINIB	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1	OLAHOMJCDNXHFI-UHFFFAOYSA-N	InChI=1S/C25H30N6O2/c1-17(2)26-8-9-31(20-10-21(32-4)13-22(11-20)33-5)19-6-7-23-24(12-19)29-25(15-27-23)18-14-28-30(3)16-18/h6-7,10-17,26H,8-9H2,1-5H3	Fibroblast growth factor receptor inhibitor	INHIBITOR	CHEMBL2095217	Fibroblast growth factor receptor	Homo sapiens
CHEMBL4298150	SIPONIMOD FUMARATE	CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1.CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1.O=C(O)/C=C/C(=O)O	JNLIKIBISICTMS-PEJBKAKVSA-N	InChI=1S/2C29H35F3N2O3.C4H4O4/c2*1-3-21-14-23(10-11-24(21)15-34-16-25(17-34)28(35)36)19(2)33-37-18-20-9-12-26(22-7-5-4-6-8-22)27(13-20)29(30,31)32;5-3(6)1-2-4(7)8/h2*9-14,22,25H,3-8,15-18H2,1-2H3,(H,35,36);1-2H,(H,5,6)(H,7,8)/b2*33-19+;2-1+	Sphingosine 1-phosphate receptor Edg-1 agonist	AGONIST	CHEMBL4333	Sphingosine 1-phosphate receptor Edg-1	Homo sapiens
CHEMBL3989867	BICTEGRAVIR SODIUM	O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c([O-])c1=O)C(=O)N1[C@H]3CC[C@H](C3)O[C@@H]1C2.[Na+]	WJNFBIVCQMPPJC-FQYDJHLKSA-M	InChI=1S/C21H18F3N3O5.Na/c22-9-3-14(23)12(15(24)4-9)6-25-20(30)13-7-26-8-16-27(10-1-2-11(5-10)32-16)21(31)17(26)19(29)18(13)28;/h3-4,7,10-11,16,29H,1-2,5-6,8H2,(H,25,30);/q;+1/p-1/t10-,11+,16+;/m0./s1	Human immunodeficiency virus type 1 integrase inhibitor	INHIBITOR	CHEMBL3471	Human immunodeficiency virus type 1 integrase	Human immunodeficiency virus 1
CHEMBL3989939	LAROTRECTINIB SULFATE	O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1.O=S(=O)(O)O	PXHANKVTFWSDSG-QLOBERJESA-N	InChI=1S/C21H22F2N6O2.H2O4S/c22-13-3-4-16(23)15(10-13)18-2-1-7-28(18)19-6-9-29-20(26-19)17(11-24-29)25-21(31)27-8-5-14(30)12-27;1-5(2,3)4/h3-4,6,9-11,14,18,30H,1-2,5,7-8,12H2,(H,25,31);(H2,1,2,3,4)/t14-,18+;/m0./s1	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	CHEMBL3559684	Neurotrophic tyrosine kinase receptor	Homo sapiens
CHEMBL4297533	BREMELANOTIDE ACETATE	CC(=O)O.CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O	MAYUSRUHXFWITM-GBRHMYBBSA-N	InChI=1S/C50H68N14O10.C2H4O2/c1-3-4-16-35(58-29(2)65)43(67)64-41-25-42(66)54-20-11-10-18-37(49(73)74)60-46(70)39(23-31-26-56-34-17-9-8-15-33(31)34)62-44(68)36(19-12-21-55-50(51)52)59-45(69)38(22-30-13-6-5-7-14-30)61-47(71)40(63-48(41)72)24-32-27-53-28-57-32;1-2(3)4/h5-9,13-15,17,26-28,35-41,56H,3-4,10-12,16,18-25H2,1-2H3,(H,53,57)(H,54,66)(H,58,65)(H,59,69)(H,60,70)(H,61,71)(H,62,68)(H,63,72)(H,64,67)(H,73,74)(H4,51,52,55);1H3,(H,3,4)/t35-,36-,37-,38+,39-,40-,41-;/m0./s1	Melanocortin receptor 4 agonist	AGONIST	CHEMBL259	Melanocortin receptor 4	Homo sapiens
CHEMBL3989973	PEXIDARTINIB HYDROCHLORIDE	Cl.FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1	CJLUYLRKLUYCEK-UHFFFAOYSA-N	InChI=1S/C20H15ClF3N5.ClH/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24;/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29);1H	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	CHEMBL1844	Macrophage colony stimulating factor receptor	Homo sapiens
CHEMBL3301605	RELEBACTAM	O.O=C(NC1CCNCC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O	TWFRCSHLWKJBQH-UXQCFNEQSA-N	InChI=1S/C12H20N4O6S.H2O/c17-11(14-8-3-5-13-6-4-8)10-2-1-9-7-15(10)12(18)16(9)22-23(19,20)21;/h8-10,13H,1-7H2,(H,14,17)(H,19,20,21);1H2/t9-,10+;/m1./s1	Beta-lactamase SHV-1 inhibitor	INHIBITOR	CHEMBL5094	Beta-lactamase SHV-1	Klebsiella pneumoniae
CHEMBL2107355	MIGALASTAT HYDROCHLORIDE	Cl.OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O	ZJIHMALTJRDNQI-OLALXQGDSA-N	InChI=1S/C6H13NO4.ClH/c8-2-3-5(10)6(11)4(9)1-7-3;/h3-11H,1-2H2;1H/t3-,4+,5+,6-;/m1./s1	Alpha-galactosidase A stabiliser	STABILISER	CHEMBL2524	Alpha-galactosidase A	Homo sapiens
CHEMBL2103854	OMADACYCLINE TOSYLATE	CN(C)c1cc(CNCC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O.Cc1ccc(S(=O)(=O)O)cc1	SETFNHZTVGTBHC-XGLFQKEBSA-N	InChI=1S/C29H40N4O7.C7H8O3S/c1-28(2,3)12-31-11-14-10-17(32(4)5)15-8-13-9-16-21(33(6)7)24(36)20(27(30)39)26(38)29(16,40)25(37)18(13)23(35)19(15)22(14)34;1-6-2-4-7(5-3-6)11(8,9)10/h10,13,16,21,31,34,36-37,40H,8-9,11-12H2,1-7H3,(H2,30,39);2-5H,1H3,(H,8,9,10)/t13-,16-,21-,29-;/m0./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL2364623	PLAZOMICIN SULFATE	CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CCN)OC[C@]1(C)O.O=S(=O)(O)O	SFTBRKHJMASSAP-BGJNVEJLSA-N	InChI=1S/C25H48N6O10.H2O4S/c1-25(37)11-38-24(18(35)21(25)29-2)41-20-15(31-22(36)16(33)5-6-26)9-14(28)19(17(20)34)40-23-13(27)4-3-12(39-23)10-30-7-8-32;1-5(2,3)4/h3,13-21,23-24,29-30,32-35,37H,4-11,26-28H2,1-2H3,(H,31,36);(H2,1,2,3,4)/t13-,14+,15-,16+,17+,18-,19-,20+,21-,23-,24-,25+;/m1./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL3707377	SEGESTERONE ACETATE	C=C1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]2(C)[C@@]1(OC(C)=O)C(C)=O	CKFBRGLGTWAVLG-GOMYTPFNSA-N	InChI=1S/C23H30O4/c1-13-11-21-20-7-5-16-12-17(26)6-8-18(16)19(20)9-10-22(21,4)23(13,14(2)24)27-15(3)25/h12,18-21H,1,5-11H2,2-4H3/t18-,19+,20+,21-,22-,23-/m0/s1	Progesterone receptor agonist	AGONIST	CHEMBL208	Progesterone receptor	Homo sapiens
CHEMBL502182	ELAGOLIX SODIUM	COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(C[C@H](NCCCC(=O)[O-])c3ccccc3)c2=O)c1F.[Na+]	DQYGXRQUFSRDCH-UQIIZPHYSA-M	InChI=1S/C32H30F5N3O5.Na/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33;/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42);/q;+1/p-1/t25-;/m0./s1	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	CHEMBL1855	Gonadotropin-releasing hormone receptor	Homo sapiens
CHEMBL3301605	RELEBACTAM	O.O=C(NC1CCNCC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O	TWFRCSHLWKJBQH-UXQCFNEQSA-N	InChI=1S/C12H20N4O6S.H2O/c17-11(14-8-3-5-13-6-4-8)10-2-1-9-7-15(10)12(18)16(9)22-23(19,20)21;/h8-10,13H,1-7H2,(H,14,17)(H,19,20,21);1H2/t9-,10+;/m1./s1	Bacterial beta-lactamase TEM inhibitor	INHIBITOR	CHEMBL2364670	Bacterial beta-lactamase TEM	Bacteria
CHEMBL3301605	RELEBACTAM	O.O=C(NC1CCNCC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O	TWFRCSHLWKJBQH-UXQCFNEQSA-N	InChI=1S/C12H20N4O6S.H2O/c17-11(14-8-3-5-13-6-4-8)10-2-1-9-7-15(10)12(18)16(9)22-23(19,20)21;/h8-10,13H,1-7H2,(H,14,17)(H,19,20,21);1H2/t9-,10+;/m1./s1	Beta-lactamase inhibitor	INHIBITOR	CHEMBL5031	Beta-lactamase	Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG12228)
CHEMBL3301605	RELEBACTAM	O.O=C(NC1CCNCC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O	TWFRCSHLWKJBQH-UXQCFNEQSA-N	InChI=1S/C12H20N4O6S.H2O/c17-11(14-8-3-5-13-6-4-8)10-2-1-9-7-15(10)12(18)16(9)22-23(19,20)21;/h8-10,13H,1-7H2,(H,14,17)(H,19,20,21);1H2/t9-,10+;/m1./s1	Beta-lactamase inhibitor	INHIBITOR	CHEMBL2725	Beta-lactamase	Enterobacter cloacae
CHEMBL3301605	RELEBACTAM	O.O=C(NC1CCNCC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O	TWFRCSHLWKJBQH-UXQCFNEQSA-N	InChI=1S/C12H20N4O6S.H2O/c17-11(14-8-3-5-13-6-4-8)10-2-1-9-7-15(10)12(18)16(9)22-23(19,20)21;/h8-10,13H,1-7H2,(H,14,17)(H,19,20,21);1H2/t9-,10+;/m1./s1	Carbapenem-hydrolyzing beta-lactamase KPC inhibitor	INHIBITOR	CHEMBL3562180	Carbapenem-hydrolyzing beta-lactamase KPC	Klebsiella oxytoca
CHEMBL3301605	RELEBACTAM	O.O=C(NC1CCNCC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O	TWFRCSHLWKJBQH-UXQCFNEQSA-N	InChI=1S/C12H20N4O6S.H2O/c17-11(14-8-3-5-13-6-4-8)10-2-1-9-7-15(10)12(18)16(9)22-23(19,20)21;/h8-10,13H,1-7H2,(H,14,17)(H,19,20,21);1H2/t9-,10+;/m1./s1	Beta-lactamase CTX-M inhibitor	INHIBITOR	CHEMBL6131	Beta-lactamase CTX-M	Escherichia coli
CHEMBL2096646	AMINOSALICYLATE SODIUM	Nc1ccc(C(=O)[O-])c(O)c1.O.O.[Na+]	GMUQJDAYXZXBOT-UHFFFAOYSA-M	InChI=1S/C7H7NO3.Na.2H2O/c8-4-1-2-5(7(10)11)6(9)3-4;;;/h1-3,9H,8H2,(H,10,11);;2*1H2/q;+1;;/p-1	Dihydrofolate reductase inhibitor	INHIBITOR	CHEMBL6065	Dihydrofolate reductase	Mycobacterium tuberculosis
CHEMBL1200584	AMINOSALICYLATE POTASSIUM	Nc1ccc(C(=O)[O-])c(O)c1.[K+]	PRZJIMSXCLZGLT-UHFFFAOYSA-M	InChI=1S/C7H7NO3.K/c8-4-1-2-5(7(10)11)6(9)3-4;/h1-3,9H,8H2,(H,10,11);/q;+1/p-1	Dihydrofolate reductase inhibitor	INHIBITOR	CHEMBL6065	Dihydrofolate reductase	Mycobacterium tuberculosis
CHEMBL3218576	COPANLISIB	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21	PZBCKZWLPGJMAO-UHFFFAOYSA-N	InChI=1S/C23H28N8O4/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15/h3-4,13-14H,2,5-12H2,1H3,(H2,24,26,27)(H,28,29,32)	PI3-kinase p110-alpha subunit inhibitor	INHIBITOR	CHEMBL4005	PI3-kinase p110-alpha subunit	Homo sapiens
CHEMBL3218576	COPANLISIB	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21	PZBCKZWLPGJMAO-UHFFFAOYSA-N	InChI=1S/C23H28N8O4/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15/h3-4,13-14H,2,5-12H2,1H3,(H2,24,26,27)(H,28,29,32)	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	CHEMBL3130	PI3-kinase p110-delta subunit	Homo sapiens
CHEMBL2110732	DACOMITINIB	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1	LVXJQMNHJWSHET-AATRIKPKSA-N	InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL2110732	DACOMITINIB	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1	LVXJQMNHJWSHET-AATRIKPKSA-N	InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL2110732	DACOMITINIB	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1	LVXJQMNHJWSHET-AATRIKPKSA-N	InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+	Receptor protein-tyrosine kinase erbB-4 inhibitor	INHIBITOR	CHEMBL3009	Receptor protein-tyrosine kinase erbB-4	Homo sapiens
CHEMBL3301603	GILTERITINIB FUMARATE	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1.CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O	UJOUWHLYTQFUCU-WXXKFALUSA-N	InChI=1S/2C29H44N8O3.C4H4O4/c2*1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36;5-3(6)1-2-4(7)8/h2*5-6,19-20,22H,4,7-18H2,1-3H3,(H2,30,38)(H2,31,32,34);1-2H,(H,5,6)(H,7,8)/b;;2-1+	Tyrosine-protein kinase receptor UFO inhibitor	INHIBITOR	CHEMBL4895	Tyrosine-protein kinase receptor UFO	Homo sapiens
CHEMBL216981	NAVARIXIN	CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1	RXIUEIPPLAFSDF-CYBMUJFWSA-N	InChI=1S/C21H23N3O5/c1-5-13(15-10-9-11(2)29-15)22-16-17(20(27)19(16)26)23-14-8-6-7-12(18(14)25)21(28)24(3)4/h6-10,13,22-23,25H,5H2,1-4H3/t13-/m1/s1	Interleukin-8 receptor A antagonist	ANTAGONIST	CHEMBL4029	Interleukin-8 receptor A	Homo sapiens
CHEMBL180022	NERATINIB	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C	JWNPDZNEKVCWMY-VQHVLOKHSA-N	InChI=1S/C30H29ClN6O3/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38)/b9-7+	Receptor protein-tyrosine kinase erbB-4 inhibitor	INHIBITOR	CHEMBL3009	Receptor protein-tyrosine kinase erbB-4	Homo sapiens
CHEMBL3989921	NERATINIB MALEATE	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C.O=C(O)/C=C\C(=O)O	VXZCUHNJXSIJIM-MEBGWEOYSA-N	InChI=1S/C30H29ClN6O3.C4H4O4/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22;5-3(6)1-2-4(7)8/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38);1-2H,(H,5,6)(H,7,8)/b9-7+;2-1-	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	CHEMBL1824	Receptor protein-tyrosine kinase erbB-2	Homo sapiens
CHEMBL3989921	NERATINIB MALEATE	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C.O=C(O)/C=C\C(=O)O	VXZCUHNJXSIJIM-MEBGWEOYSA-N	InChI=1S/C30H29ClN6O3.C4H4O4/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22;5-3(6)1-2-4(7)8/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38);1-2H,(H,5,6)(H,7,8)/b9-7+;2-1-	Epidermal growth factor receptor erbB1 inhibitor	INHIBITOR	CHEMBL203	Epidermal growth factor receptor erbB1	Homo sapiens
CHEMBL3989921	NERATINIB MALEATE	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C.O=C(O)/C=C\C(=O)O	VXZCUHNJXSIJIM-MEBGWEOYSA-N	InChI=1S/C30H29ClN6O3.C4H4O4/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22;5-3(6)1-2-4(7)8/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38);1-2H,(H,5,6)(H,7,8)/b9-7+;2-1-	Receptor protein-tyrosine kinase erbB-4 inhibitor	INHIBITOR	CHEMBL3009	Receptor protein-tyrosine kinase erbB-4	Homo sapiens
CHEMBL3989922	NIRAPARIB TOSYLATE	Cc1ccc(S(=O)(=O)O)cc1.NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12.O	ACNPUCQQZDAPJH-FMOMHUKBSA-N	InChI=1S/C19H20N4O.C7H8O3S.H2O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14;1-6-2-4-7(5-3-6)11(8,9)10;/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24);2-5H,1H3,(H,8,9,10);1H2/t14-;;/m1../s1	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	CHEMBL5366	Poly [ADP-ribose] polymerase 2	Homo sapiens
CHEMBL3989922	NIRAPARIB TOSYLATE	Cc1ccc(S(=O)(=O)O)cc1.NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12.O	ACNPUCQQZDAPJH-FMOMHUKBSA-N	InChI=1S/C19H20N4O.C7H8O3S.H2O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14;1-6-2-4-7(5-3-6)11(8,9)10;/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24);2-5H,1H3,(H,8,9,10);1H2/t14-;;/m1../s1	Poly [ADP-ribose] polymerase-1 inhibitor	INHIBITOR	CHEMBL3105	Poly [ADP-ribose] polymerase-1	Homo sapiens
CHEMBL3989973	PEXIDARTINIB HYDROCHLORIDE	Cl.FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1	CJLUYLRKLUYCEK-UHFFFAOYSA-N	InChI=1S/C20H15ClF3N5.ClH/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24;/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29);1H	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL3989973	PEXIDARTINIB HYDROCHLORIDE	Cl.FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1	CJLUYLRKLUYCEK-UHFFFAOYSA-N	InChI=1S/C20H15ClF3N5.ClH/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24;/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29);1H	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL3581647	BIRABRESIB	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2	GNMUEVRJHCWKTO-FQEVSTJZSA-N	InChI=1S/C25H22ClN5O2S/c1-13-14(2)34-25-22(13)23(16-4-6-17(26)7-5-16)28-20(24-30-29-15(3)31(24)25)12-21(33)27-18-8-10-19(32)11-9-18/h4-11,20,32H,12H2,1-3H3,(H,27,33)/t20-/m0/s1	Bromodomain and extra-terminal motif (BET) inhibitor	INHIBITOR	CHEMBL4296614	Bromodomain and extra-terminal motif (BET)	Homo sapiens
CHEMBL1232461	MOLIBRESIB	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21	AAAQFGUYHFJNHI-SFHVURJKSA-N	InChI=1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m0/s1	Bromodomain and extra-terminal motif (BET) inhibitor	INHIBITOR	CHEMBL4296614	Bromodomain and extra-terminal motif (BET)	Homo sapiens
CHEMBL4085457	PF-06651600	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C	CBRJPFGIXUFMTM-WDEREUQCSA-N	InChI=1S/C15H19N5O/c1-3-13(21)20-8-11(5-4-10(20)2)19-15-12-6-7-16-14(12)17-9-18-15/h3,6-7,9-11H,1,4-5,8H2,2H3,(H2,16,17,18,19)/t10-,11+/m0/s1	Tyrosine-protein kinase JAK3 inhibitor	INHIBITOR	CHEMBL2148	Tyrosine-protein kinase JAK3	Homo sapiens
CHEMBL4085457	PF-06651600	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C	CBRJPFGIXUFMTM-WDEREUQCSA-N	InChI=1S/C15H19N5O/c1-3-13(21)20-8-11(5-4-10(20)2)19-15-12-6-7-16-14(12)17-9-18-15/h3,6-7,9-11H,1,4-5,8H2,2H3,(H2,16,17,18,19)/t10-,11+/m0/s1	TEC family kinase inhibitor	INHIBITOR	CHEMBL4296642	TEC family kinase	Homo sapiens
CHEMBL4297458	BMS-986158	Cc1nnn(C)c1-c1cnc2c3ccc(C(C)(C)O)cc3n([C@H](c3ccccc3)C3CCOCC3)c2c1	KGERZPVQIRYWRK-GDLZYMKVSA-N	InChI=1S/C30H33N5O2/c1-19-28(34(4)33-32-19)22-16-26-27(31-18-22)24-11-10-23(30(2,3)36)17-25(24)35(26)29(20-8-6-5-7-9-20)21-12-14-37-15-13-21/h5-11,16-18,21,29,36H,12-15H2,1-4H3/t29-/m1/s1	Bromodomain and extra-terminal motif (BET) inhibitor	INHIBITOR	CHEMBL4296614	Bromodomain and extra-terminal motif (BET)	Homo sapiens
CHEMBL2393130	APABETALONE	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1	NETXMUIMUZJUTB-UHFFFAOYSA-N	InChI=1S/C20H22N2O5/c1-11-7-13(8-12(2)18(11)27-6-5-23)19-21-15-9-14(25-3)10-16(26-4)17(15)20(24)22-19/h7-10,23H,5-6H2,1-4H3,(H,21,22,24)	Bromodomain and extra-terminal motif (BET) inhibitor	INHIBITOR	CHEMBL4296614	Bromodomain and extra-terminal motif (BET)	Homo sapiens
CHEMBL4297423	RO-6870810	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCN1CCN(C)CC1)c1nnc(C)n1-2	PKQXLRYFPSZKDU-QFIPXVFZSA-N	InChI=1S/C27H34ClN7OS/c1-17-18(2)37-27-24(17)25(20-6-8-21(28)9-7-20)30-22(26-32-31-19(3)35(26)27)16-23(36)29-10-5-11-34-14-12-33(4)13-15-34/h6-9,22H,5,10-16H2,1-4H3,(H,29,36)/t22-/m0/s1	Bromodomain and extra-terminal motif (BET) inhibitor	INHIBITOR	CHEMBL4296614	Bromodomain and extra-terminal motif (BET)	Homo sapiens
CHEMBL573677	RGX-104	C[C@H](CCOc1cccc(CC(=O)O)c1)N(Cc1cccc(C(F)(F)F)c1Cl)CC(c1ccccc1)c1ccccc1	ZLJZDYOBXVOTSA-XMMPIXPASA-N	InChI=1S/C34H33ClF3NO3/c1-24(18-19-42-29-16-8-10-25(20-29)21-32(40)41)39(22-28-15-9-17-31(33(28)35)34(36,37)38)23-30(26-11-4-2-5-12-26)27-13-6-3-7-14-27/h2-17,20,24,30H,18-19,21-23H2,1H3,(H,40,41)/t24-/m1/s1	Liver X receptor agonist	AGONIST	CHEMBL3706564	Liver X receptor	Homo sapiens
CHEMBL3989949	CENOBAMATE	NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl	GFHAXPJGXSQLPT-VIFPVBQESA-N	InChI=1S/C10H10ClN5O2/c11-8-4-2-1-3-7(8)9(18-10(12)17)5-16-14-6-13-15-16/h1-4,6,9H,5H2,(H2,12,17)/t9-/m0/s1	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	CHEMBL2093872	GABA-A receptor; anion channel	Homo sapiens
CHEMBL3989949	CENOBAMATE	NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl	GFHAXPJGXSQLPT-VIFPVBQESA-N	InChI=1S/C10H10ClN5O2/c11-8-4-2-1-3-7(8)9(18-10(12)17)5-16-14-6-13-15-16/h1-4,6,9H,5H2,(H2,12,17)/t9-/m0/s1	Sodium channel alpha subunit inhibitor	INHIBITOR	CHEMBL2331043	Sodium channel alpha subunit	Homo sapiens
CHEMBL4101807	VOXELOTOR	CC(C)n1nccc1-c1ncccc1COc1cccc(O)c1C=O	FWCVZAQENIZVMY-UHFFFAOYSA-N	InChI=1S/C19H19N3O3/c1-13(2)22-16(8-10-21-22)19-14(5-4-9-20-19)12-25-18-7-3-6-17(24)15(18)11-23/h3-11,13,24H,12H2,1-2H3	Hemoglobin HbA positive modulator	POSITIVE MODULATOR	CHEMBL2095168	Hemoglobin HbA	Homo sapiens
CHEMBL4297213	AFAMELANOTIDE ACETATE	CC(=O)O.CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C	LBIUKNXYUXOWFF-CRYSLBJVSA-N	InChI=1S/C78H111N21O19.C2H4O2/c1-5-6-19-52(91-75(116)61(41-101)97-72(113)57(34-46-24-26-49(103)27-25-46)94-74(115)60(40-100)88-44(4)102)68(109)92-54(28-29-64(105)106)70(111)96-59(36-48-38-83-42-87-48)73(114)93-56(33-45-16-8-7-9-17-45)71(112)90-53(22-14-31-84-78(81)82)69(110)95-58(35-47-37-85-51-20-11-10-18-50(47)51)67(108)86-39-63(104)89-55(21-12-13-30-79)77(118)99-32-15-23-62(99)76(117)98-65(43(2)3)66(80)107;1-2(3)4/h7-11,16-18,20,24-27,37-38,42-43,52-62,65,85,100-101,103H,5-6,12-15,19,21-23,28-36,39-41,79H2,1-4H3,(H2,80,107)(H,83,87)(H,86,108)(H,88,102)(H,89,104)(H,90,112)(H,91,116)(H,92,109)(H,93,114)(H,94,115)(H,95,110)(H,96,111)(H,97,113)(H,98,117)(H,105,106)(H4,81,82,84);1H3,(H,3,4)/t52-,53-,54-,55-,56+,57-,58-,59-,60-,61-,62-,65-;/m0./s1	Melanocortin receptor 1 agonist	AGONIST	CHEMBL3795	Melanocortin receptor 1	Homo sapiens
CHEMBL3707313	TRIFAROTENE	CC(C)(C)c1cc(-c2cc(-c3ccc(C(=O)O)cc3)ccc2OCCO)ccc1N1CCCC1	MFBCDACCJCDGBA-UHFFFAOYSA-N	InChI=1S/C29H33NO4/c1-29(2,3)25-19-23(10-12-26(25)30-14-4-5-15-30)24-18-22(11-13-27(24)34-17-16-31)20-6-8-21(9-7-20)28(32)33/h6-13,18-19,31H,4-5,14-17H2,1-3H3,(H,32,33)	Retinoic acid receptor gamma agonist	AGONIST	CHEMBL2003	Retinoic acid receptor gamma	Homo sapiens
CHEMBL3545309	LEFAMULIN ACETATE	C=C[C@]1(C)C[C@@H](OC(=O)CS[C@@H]2CC[C@@H](N)C[C@H]2O)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O.CC(=O)O	WSMXIQXWHPSVDE-ZPJPNJFZSA-N	InChI=1S/C28H45NO5S.C2H4O2/c1-6-26(4)14-22(34-23(32)15-35-21-8-7-18(29)13-20(21)31)27(5)16(2)9-11-28(17(3)25(26)33)12-10-19(30)24(27)28;1-2(3)4/h6,16-18,20-22,24-25,31,33H,1,7-15,29H2,2-5H3;1H3,(H,3,4)/t16-,17+,18-,20-,21-,22-,24+,25+,26-,27+,28+;/m1./s1	Bacterial 70S ribosome inhibitor	INHIBITOR	CHEMBL2363135	Bacterial 70S ribosome	Bacteria
CHEMBL3039526	LASMIDITAN SUCCINATE	CN1CCC(C(=O)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2)CC1.CN1CCC(C(=O)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2)CC1.O=C(O)CCC(=O)O	MSOIHUHNGPOCTH-UHFFFAOYSA-N	InChI=1S/2C19H18F3N3O2.C4H6O4/c2*1-25-7-5-11(6-8-25)18(26)15-3-2-4-16(23-15)24-19(27)17-13(21)9-12(20)10-14(17)22;5-3(6)1-2-4(7)8/h2*2-4,9-11H,5-8H2,1H3,(H,23,24,27);1-2H2,(H,5,6)(H,7,8)	Serotonin 1f (5-HT1f) receptor agonist	AGONIST	CHEMBL1805	Serotonin 1f (5-HT1f) receptor	Homo sapiens
CHEMBL3622821	UPADACITINIB	CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12	WYQFJHHDOKWSHR-MNOVXSKESA-N	InChI=1S/C17H19F3N6O/c1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15/h3-6,10-11,21H,2,7-9H2,1H3,(H,24,27)/t10-,11+/m1/s1	Janus Kinase (JAK) inhibitor	INHIBITOR	CHEMBL2363062	Janus Kinase (JAK)	Homo sapiens
CHEMBL3989974	CEFIDEROCOL	CC(C)(O/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(CCNC(=O)c4ccc(O)c(O)c4Cl)CCCC3)CS[C@H]12)c1csc(N)n1)C(=O)O	DBPPRLRVDVJOCL-FQRUVTKNSA-N	InChI=1S/C30H34ClN7O10S2/c1-30(2,28(46)47)48-36-19(16-13-50-29(32)34-16)24(42)35-20-25(43)37-21(27(44)45)14(12-49-26(20)37)11-38(8-3-4-9-38)10-7-33-23(41)15-5-6-17(39)22(40)18(15)31/h5-6,13,20,26H,3-4,7-12H2,1-2H3,(H7-,32,33,34,35,36,39,40,41,42,44,45,46,47)/t20-,26-/m1/s1	Bacterial penicillin-binding protein inhibitor	INHIBITOR	CHEMBL2354204	Bacterial penicillin-binding protein	Bacteria
CHEMBL4297216	FEDRATINIB HYDROCHLORIDE	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cl.Cl.O	QAFZLTVOFJHYDF-UHFFFAOYSA-N	InChI=1S/C27H36N6O3S.2ClH.H2O/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4;;;/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31);2*1H;1H2	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	CHEMBL2971	Tyrosine-protein kinase JAK2	Homo sapiens
CHEMBL4297216	FEDRATINIB HYDROCHLORIDE	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cl.Cl.O	QAFZLTVOFJHYDF-UHFFFAOYSA-N	InChI=1S/C27H36N6O3S.2ClH.H2O/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4;;;/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31);2*1H;1H2	Tyrosine-protein kinase receptor FLT3 inhibitor	INHIBITOR	CHEMBL1974	Tyrosine-protein kinase receptor FLT3	Homo sapiens
CHEMBL1983268	ENTRECTINIB	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1	HAYYBYPASCDWEQ-UHFFFAOYSA-N	InChI=1S/C31H34F2N6O2/c1-38-8-10-39(11-9-38)25-3-4-26(29(19-25)34-24-6-12-41-13-7-24)31(40)35-30-27-17-20(2-5-28(27)36-37-30)14-21-15-22(32)18-23(33)16-21/h2-5,15-19,24,34H,6-14H2,1H3,(H2,35,36,37,40)	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	CHEMBL3559684	Neurotrophic tyrosine kinase receptor	Homo sapiens
CHEMBL1983268	ENTRECTINIB	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1	HAYYBYPASCDWEQ-UHFFFAOYSA-N	InChI=1S/C31H34F2N6O2/c1-38-8-10-39(11-9-38)25-3-4-26(29(19-25)34-24-6-12-41-13-7-24)31(40)35-30-27-17-20(2-5-28(27)36-37-30)14-21-15-22(32)18-23(33)16-21/h2-5,15-19,24,34H,6-14H2,1H3,(H2,35,36,37,40)	Proto-oncogene tyrosine-protein kinase ROS inhibitor	INHIBITOR	CHEMBL5568	Proto-oncogene tyrosine-protein kinase ROS	Homo sapiens
CHEMBL1983268	ENTRECTINIB	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1	HAYYBYPASCDWEQ-UHFFFAOYSA-N	InChI=1S/C31H34F2N6O2/c1-38-8-10-39(11-9-38)25-3-4-26(29(19-25)34-24-6-12-41-13-7-24)31(40)35-30-27-17-20(2-5-28(27)36-37-30)14-21-15-22(32)18-23(33)16-21/h2-5,15-19,24,34H,6-14H2,1H3,(H2,35,36,37,40)	ALK tyrosine kinase receptor inhibitor	INHIBITOR	CHEMBL4247	ALK tyrosine kinase receptor	Homo sapiens
CHEMBL4298128	ELEXACAFTOR	Cc1nn(C)cc1S(=O)(=O)NC(=O)c1ccc(-n2ccc(OCC(C)(C)C(F)(F)F)n2)nc1N1C[C@@H](C)CC1(C)C	MVRHVFSOIWFBTE-INIZCTEOSA-N	InChI=1S/C26H34F3N7O4S/c1-16-12-25(5,6)35(13-16)22-18(23(37)33-41(38,39)19-14-34(7)31-17(19)2)8-9-20(30-22)36-11-10-21(32-36)40-15-24(3,4)26(27,28)29/h8-11,14,16H,12-13,15H2,1-7H3,(H,33,37)/t16-/m0/s1	Cystic fibrosis transmembrane conductance regulator positive modulator	POSITIVE MODULATOR	CHEMBL4051	Cystic fibrosis transmembrane conductance regulator	Homo sapiens
CHEMBL3936761	ZANUBRUTINIB	C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1	RNOAOAWBMHREKO-QFIPXVFZSA-N	InChI=1S/C27H29N5O3/c1-2-23(33)31-16-13-18(14-17-31)22-12-15-29-27-24(26(28)34)25(30-32(22)27)19-8-10-21(11-9-19)35-20-6-4-3-5-7-20/h2-11,18,22,29H,1,12-17H2,(H2,28,34)/t22-/m0/s1	Tyrosine-protein kinase BTK inhibitor	INHIBITOR	CHEMBL5251	Tyrosine-protein kinase BTK	Homo sapiens
CHEMBL4164059	PITOLISANT HYDROCHLORIDE	Cl.Clc1ccc(CCCOCCCN2CCCCC2)cc1	XLFKECRRMPOAQS-UHFFFAOYSA-N	InChI=1S/C17H26ClNO.ClH/c18-17-9-7-16(8-10-17)6-4-14-20-15-5-13-19-11-2-1-3-12-19;/h7-10H,1-6,11-15H2;1H	Histamine H3 receptor inverse agonist	INVERSE AGONIST	CHEMBL264	Histamine H3 receptor	Homo sapiens
CHEMBL3707393	OSILODROSTAT PHOSPHATE	N#Cc1ccc([C@H]2CCc3cncn32)c(F)c1.O=P(O)(O)O	FMCPYRDGUZBOJZ-BTQNPOSSSA-N	InChI=1S/C13H10FN3.H3O4P/c14-12-5-9(6-15)1-3-11(12)13-4-2-10-7-16-8-17(10)13;1-5(2,3)4/h1,3,5,7-8,13H,2,4H2;(H3,1,2,3,4)/t13-;/m1./s1	Cytochrome P450 11B1 inhibitor	INHIBITOR	CHEMBL1908	Cytochrome P450 11B1	Homo sapiens
CHEMBL3707246	OZANIMOD HYDROCHLORIDE	CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NCCO)no2)cc1C#N.Cl	HAOOCAKHSFYDBU-BDQAORGHSA-N	InChI=1S/C23H24N4O3.ClH/c1-14(2)29-21-9-6-15(12-16(21)13-24)23-26-22(27-30-23)19-5-3-4-18-17(19)7-8-20(18)25-10-11-28;/h3-6,9,12,14,20,25,28H,7-8,10-11H2,1-2H3;1H/t20-;/m0./s1	Sphingosine 1-phosphate receptor Edg-1 modulator	MODULATOR	CHEMBL4333	Sphingosine 1-phosphate receptor Edg-1	Homo sapiens
CHEMBL1651956	ALISPORIVIR	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N(CC)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C	OLROWHGDTNFZBH-XEMWPYQTSA-N	InChI=1S/C63H113N11O12/c1-26-29-30-40(16)52(75)51-56(79)66-44(27-2)59(82)68(20)43(19)58(81)74(28-3)49(38(12)13)55(78)67-48(37(10)11)62(85)69(21)45(31-34(4)5)54(77)64-41(17)53(76)65-42(18)57(80)70(22)46(32-35(6)7)60(83)71(23)47(33-36(8)9)61(84)72(24)50(39(14)15)63(86)73(51)25/h26,29,34-52,75H,27-28,30-33H2,1-25H3,(H,64,77)(H,65,76)(H,66,79)(H,67,78)/b29-26+/t40-,41+,42-,43-,44+,45+,46+,47+,48+,49+,50+,51+,52-/m1/s1	Cyclophilin A inhibitor	INHIBITOR	CHEMBL1949	Cyclophilin A	Homo sapiens
CHEMBL294029	RAVUCONAZOLE	C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@](O)(Cn1cncn1)c1ccc(F)cc1F	OPAHEYNNJWPQPX-RCDICMHDSA-N	InChI=1S/C22H17F2N5OS/c1-14(21-28-20(10-31-21)16-4-2-15(9-25)3-5-16)22(30,11-29-13-26-12-27-29)18-7-6-17(23)8-19(18)24/h2-8,10,12-14,30H,11H2,1H3/t14-,22+/m0/s1	Cytochrome P450 51 inhibitor	INHIBITOR	CHEMBL1780	Cytochrome P450 51	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
CHEMBL3545313	BEMPEDOIC ACID	CC(C)(CCCCCC(O)CCCCCC(C)(C)C(=O)O)C(=O)O	HYHMLYSLQUKXKP-UHFFFAOYSA-N	InChI=1S/C19H36O5/c1-18(2,16(21)22)13-9-5-7-11-15(20)12-8-6-10-14-19(3,4)17(23)24/h15,20H,5-14H2,1-4H3,(H,21,22)(H,23,24)	ATP-citrate synthase inhibitor	INHIBITOR	CHEMBL3720	ATP-citrate synthase	Homo sapiens
CHEMBL4065616	REMDESIVIR	CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](O)[C@@H]1O)Oc1ccccc1	RWWYLEGWBNMMLJ-YSOARWBDSA-N	InChI=1S/C27H35N6O8P/c1-4-18(5-2)13-38-26(36)17(3)32-42(37,41-19-9-7-6-8-10-19)39-14-21-23(34)24(35)27(15-28,40-21)22-12-11-20-25(29)30-16-31-33(20)22/h6-12,16-18,21,23-24,34-35H,4-5,13-14H2,1-3H3,(H,32,37)(H2,29,30,31)/t17-,21+,23+,24+,27-,42-/m0/s1	RNA-directed RNA polymerase L inhibitor	INHIBITOR	CHEMBL4303062	RNA-directed RNA polymerase L	Zaire ebolavirus (strain Mayinga-76) (ZEBOV) (Zaire Ebola virus)
CHEMBL4204794	AVAPRITINIB	Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1	DWYRIWUZIJHQKQ-SANMLTNESA-N	InChI=1S/C26H27FN10/c1-26(28,20-3-5-22(27)6-4-20)21-13-29-25(30-14-21)36-9-7-35(8-10-36)24-23-11-18(16-37(23)33-17-31-24)19-12-32-34(2)15-19/h3-6,11-17H,7-10,28H2,1-2H3/t26-/m0/s1	Stem cell growth factor receptor inhibitor	INHIBITOR	CHEMBL1936	Stem cell growth factor receptor	Homo sapiens
CHEMBL4204794	AVAPRITINIB	Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1	DWYRIWUZIJHQKQ-SANMLTNESA-N	InChI=1S/C26H27FN10/c1-26(28,20-3-5-22(27)6-4-20)21-13-29-25(30-14-21)36-9-7-35(8-10-36)24-23-11-18(16-37(23)33-17-31-24)19-12-32-34(2)15-19/h3-6,11-17H,7-10,28H2,1-2H3/t26-/m0/s1	Platelet-derived growth factor receptor alpha inhibitor	INHIBITOR	CHEMBL2007	Platelet-derived growth factor receptor alpha	Homo sapiens
CHEMBL2364629	RIMEGEPANT SULFATE	N[C@@H]1c2cccnc2[C@H](OC(=O)N2CCC(n3c(=O)[nH]c4ncccc43)CC2)CC[C@H]1c1cccc(F)c1F.N[C@@H]1c2cccnc2[C@H](OC(=O)N2CCC(n3c(=O)[nH]c4ncccc43)CC2)CC[C@H]1c1cccc(F)c1F.O.O.O.O=S(=O)(O)O	SOGUOEZRYKUOHR-CQZKMDJHSA-N	InChI=1S/2C28H28F2N6O3.H2O4S.3H2O/c2*29-20-6-1-4-17(23(20)30)18-8-9-22(25-19(24(18)31)5-2-12-32-25)39-28(38)35-14-10-16(11-15-35)36-21-7-3-13-33-26(21)34-27(36)37;1-5(2,3)4;;;/h2*1-7,12-13,16,18,22,24H,8-11,14-15,31H2,(H,33,34,37);(H2,1,2,3,4);3*1H2/t2*18-,22+,24-;;;;/m00..../s1	Calcitonin gene-related peptide type 1 receptor antagonist	ANTAGONIST	CHEMBL3798	Calcitonin gene-related peptide type 1 receptor	Homo sapiens
CHEMBL1523964	EPHEDRINE SULFATE	CN[C@@H](C)[C@H](O)c1ccccc1.CN[C@@H](C)[C@H](O)c1ccccc1.O=S(=O)(O)O	CAVQBDOACNULDN-KHFUBBAMSA-N	InChI=1S/2C10H15NO.H2O4S/c2*1-8(11-2)10(12)9-6-4-3-5-7-9;1-5(2,3)4/h2*3-8,10-12H,1-2H3;(H2,1,2,3,4)/t2*8-,10-;/m00./s1	Adrenergic receptor agonist	AGONIST	CHEMBL2331074	Adrenergic receptor	Homo sapiens
CHEMBL70663	DAPIVIRINE	Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1	ILAYIAGXTHKHNT-UHFFFAOYSA-N	InChI=1S/C20H19N5/c1-13-10-14(2)19(15(3)11-13)24-18-8-9-22-20(25-18)23-17-6-4-16(12-21)5-7-17/h4-11H,1-3H3,(H2,22,23,24,25)	Reverse transcriptase inhibitor	INHIBITOR	CHEMBL2366516	Reverse transcriptase	Human immunodeficiency virus 1
CHEMBL551978	DROTAVERINE	CCOc1ccc(/C=C2\NCCc3cc(OCC)c(OCC)cc32)cc1OCC	OMFNSKIUKYOYRG-MOSHPQCFSA-N	InChI=1S/C24H31NO4/c1-5-26-21-10-9-17(14-22(21)27-6-2)13-20-19-16-24(29-8-4)23(28-7-3)15-18(19)11-12-25-20/h9-10,13-16,25H,5-8,11-12H2,1-4H3/b20-13-	Phosphodiesterase 4 inhibitor	INHIBITOR	CHEMBL2093863	Phosphodiesterase 4	Homo sapiens
CHEMBL3188386	WNT-974	Cc1cc(-c2ncc(CC(=O)Nc3ccc(-c4cnccn4)cn3)cc2C)ccn1	XXYGTCZJJLTAGH-UHFFFAOYSA-N	InChI=1S/C23H20N6O/c1-15-9-17(12-28-23(15)18-5-6-25-16(2)10-18)11-22(30)29-21-4-3-19(13-27-21)20-14-24-7-8-26-20/h3-10,12-14H,11H2,1-2H3,(H,27,29,30)	Probable protein-cysteine N-palmitoyltransferase porcupine inhibitor	INHIBITOR	CHEMBL1255163	Probable protein-cysteine N-palmitoyltransferase porcupine	Homo sapiens
CHEMBL297884	CILUPREVIR	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)C[C@H]5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(C)C)n3)nc2c1	PJZPDFUUXKKDNB-KNINVFKUSA-N	InChI=1S/C40H50N6O8S/c1-23(2)41-38-43-32(22-55-38)31-19-34(28-16-15-26(52-3)17-30(28)42-31)53-27-18-33-35(47)45-40(37(49)50)20-24(40)11-7-5-4-6-8-14-29(36(48)46(33)21-27)44-39(51)54-25-12-9-10-13-25/h7,11,15-17,19,22-25,27,29,33H,4-6,8-10,12-14,18,20-21H2,1-3H3,(H,41,43)(H,44,51)(H,45,47)(H,49,50)/b11-7-/t24-,27-,29+,33+,40-/m1/s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL2105750	SOVAPREVIR	C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3ccccc3)nc3cc(OC)ccc23)CN1C(=O)[C@@H](CC(=O)N1CCCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1	MHFMTUBUVQZIRE-WINRQGAFSA-N	InChI=1S/C43H53N5O8S/c1-6-28-25-43(28,41(52)46-57(53,54)31-16-17-31)45-39(50)36-22-30(26-48(36)40(51)33(42(2,3)4)23-38(49)47-19-11-8-12-20-47)56-37-24-34(27-13-9-7-10-14-27)44-35-21-29(55-5)15-18-32(35)37/h6-7,9-10,13-15,18,21,24,28,30-31,33,36H,1,8,11-12,16-17,19-20,22-23,25-26H2,2-5H3,(H,45,50)(H,46,52)/t28-,30-,33-,36+,43-/m1/s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL2013174	VEDROPREVIR	CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3csc(NC(C)C)n3)nc3c(Cl)c(OCCN4CCOCC4)ccc23)CN1C(=O)[C@@H](NC(=O)O[C@@H]1C[C@@H]2C[C@@H]2C1)C(C)(C)C)C(=O)O	OTXAMWFYPMNDME-FQQWJMKMSA-N	InChI=1S/C45H60ClN7O9S/c1-7-27-21-45(27,41(56)57)51-39(54)33-19-29(22-53(33)40(55)38(44(4,5)6)50-43(58)62-28-17-25-16-26(25)18-28)61-35-20-31(32-23-63-42(49-32)47-24(2)3)48-37-30(35)8-9-34(36(37)46)60-15-12-52-10-13-59-14-11-52/h8-9,20,23-29,33,38H,7,10-19,21-22H2,1-6H3,(H,47,49)(H,50,58)(H,51,54)(H,56,57)/t25-,26+,27-,28+,29-,33+,38-,45-/m1/s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL4297647	FURAPREVIR	CC(C)Oc1ccc(-c2nc(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6(C)CC6)C[C@H]5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)c3oc4ccccc4c3n2)cc1	GZRNOYTVBWWFLJ-NTPALUMKSA-N	InChI=1S/C47H56N6O10S/c1-28(2)60-32-21-19-29(20-22-32)40-49-38-34-16-11-12-18-37(34)63-39(38)42(50-40)61-33-25-36-41(54)51-47(44(56)52-64(58,59)46(3)23-24-46)26-30(47)13-7-5-4-6-8-17-35(43(55)53(36)27-33)48-45(57)62-31-14-9-10-15-31/h7,11-13,16,18-22,28,30-31,33,35-36H,4-6,8-10,14-15,17,23-27H2,1-3H3,(H,48,57)(H,51,54)(H,52,56)/b13-7-/t30-,33-,35+,36+,47-/m1/s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL1255891	NARLAPREVIR	CCCC[C@H](NC(=O)[C@@H]1[C@@H]2[C@H](CN1C(=O)[C@@H](NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1	RICZEKWVNZFTNZ-LFGITCQGSA-N	InChI=1S/C36H61N5O7S/c1-10-11-15-24(27(42)30(44)37-22-16-17-22)38-29(43)26-25-23(35(25,8)9)20-41(26)31(45)28(33(2,3)4)39-32(46)40-36(18-13-12-14-19-36)21-49(47,48)34(5,6)7/h22-26,28H,10-21H2,1-9H3,(H,37,44)(H,38,43)(H2,39,40,46)/t23-,24-,25-,26-,28+/m0/s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL2105735	ASUNAPREVIR	C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2ncc(OC)c3ccc(Cl)cc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1	XRWSZZJLZRKHHD-WVWIJVSJSA-N	InChI=1S/C35H46ClN5O9S/c1-9-19-16-35(19,31(44)40-51(46,47)22-11-12-22)39-28(42)25-15-21(49-29-24-14-20(36)10-13-23(24)26(48-8)17-37-29)18-41(25)30(43)27(33(2,3)4)38-32(45)50-34(5,6)7/h9-10,13-14,17,19,21-22,25,27H,1,11-12,15-16,18H2,2-8H3,(H,38,45)(H,39,42)(H,40,44)/t19-,21-,25+,27-,35-/m1/s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL599872	VANIPREVIR	C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1	HPAPGONEMPZXMM-ONAXAZCASA-N	InChI=1S/C38H53N5O9S/c1-7-25-18-38(25,33(46)41-53(49,50)27-14-15-27)40-31(44)29-17-26-20-43(29)32(45)30(36(2,3)4)39-34(47)51-22-37(5,6)16-9-8-11-23-12-10-13-24-19-42(21-28(23)24)35(48)52-26/h7,10,12-13,25-27,29-30H,1,8-9,11,14-22H2,2-6H3,(H,39,47)(H,40,44)(H,41,46)/t25-,26-,29+,30-,38-/m1/s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL206031	BRECANAVIR	Cc1nc(COc2ccc(C[C@H](NC(=O)O[C@H]3CO[C@H]4OCC[C@@H]34)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc4c(c3)OCO4)cc2)cs1	JORVRJNILJXMMG-OLNQLETPSA-N	InChI=1S/C33H41N3O10S2/c1-20(2)14-36(48(39,40)25-8-9-29-30(13-25)45-19-44-29)15-28(37)27(35-33(38)46-31-17-43-32-26(31)10-11-41-32)12-22-4-6-24(7-5-22)42-16-23-18-47-21(3)34-23/h4-9,13,18,20,26-28,31-32,37H,10-12,14-17,19H2,1-3H3,(H,35,38)/t26-,27-,28+,31-,32+/m0/s1	HIV-1 protease inhibitor	INHIBITOR	CHEMBL4296312	HIV-1 protease	Human immunodeficiency virus
CHEMBL322241	TELINAVIR	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)C(=O)NC(C)(C)C	ZILOOGIOHVCEKS-HZFUHODCSA-N	InChI=1S/C33H44N6O5/c1-21(2)19-39(32(44)38-33(3,4)5)20-28(40)26(17-22-11-7-6-8-12-22)36-31(43)27(18-29(34)41)37-30(42)25-16-15-23-13-9-10-14-24(23)35-25/h6-16,21,26-28,40H,17-20H2,1-5H3,(H2,34,41)(H,36,43)(H,37,42)(H,38,44)/t26-,27-,28+/m0/s1	HIV-1 protease inhibitor	INHIBITOR	CHEMBL4296312	HIV-1 protease	Human immunodeficiency virus
CHEMBL258734	DANOPREVIR	CC(C)(C)OC(=O)N[C@H]1CCCCC/C=C\[C@@H]2C[C@@]2(C(=O)NS(=O)(=O)C2CC2)NC(=O)[C@@H]2C[C@@H](OC(=O)N3Cc4cccc(F)c4C3)CN2C1=O	ZVTDLPBHTSMEJZ-JSZLBQEHSA-N	InChI=1S/C35H46FN5O9S/c1-34(2,3)50-32(45)37-27-13-8-6-4-5-7-11-22-17-35(22,31(44)39-51(47,48)24-14-15-24)38-29(42)28-16-23(19-41(28)30(27)43)49-33(46)40-18-21-10-9-12-26(36)25(21)20-40/h7,9-12,22-24,27-28H,4-6,8,13-20H2,1-3H3,(H,37,45)(H,38,42)(H,39,44)/b11-7-/t22-,23-,27+,28+,35-/m1/s1	Hepatitis C virus serine protease, NS3/NS4A inhibitor	INHIBITOR	CHEMBL2095231	Hepatitis C virus serine protease, NS3/NS4A	Hepatitis C virus
CHEMBL1214598	UMIFENOVIR	CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12	KCFYEAOKVJSACF-UHFFFAOYSA-N	InChI=1S/C22H25BrN2O3S/c1-5-28-22(27)20-18(13-29-14-9-7-6-8-10-14)25(4)17-11-16(23)21(26)15(19(17)20)12-24(2)3/h6-11,26H,5,12-13H2,1-4H3	Hemagglutinin negative modulator	NEGATIVE MODULATOR	CHEMBL3559640	Hemagglutinin	Influenza A virus
CHEMBL2106041	AVIPTADIL	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)[C@H](O)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O	OIDGWOIMPADMGM-GXSWRUKYSA-N	InChI=1S/C145H232N40O43S/c1-19-74(13)114(141(224)175-94(55-71(7)8)130(213)178-102(144(227)228)62-109(153)195)183-138(221)104(67-187)180-133(216)99(61-108(152)194)172-129(212)93(54-70(5)6)169-131(214)95(57-80-37-41-83(189)42-38-80)170-124(207)87(34-25-28-49-147)163-123(206)88(35-26-29-50-148)166-139(222)112(72(9)10)181-118(201)76(15)159-121(204)91(47-52-229-18)165-126(209)90(45-46-106(150)192)164-122(205)86(33-24-27-48-146)162-117(200)75(14)160-127(210)92(53-69(3)4)168-125(208)89(36-30-51-157-145(154)155)167-143(226)116(105(191)20-2)185-136(219)96(58-81-39-43-84(190)44-40-81)171-132(215)98(60-107(151)193)173-134(217)101(64-111(198)199)177-142(225)115(78(17)188)184-135(218)97(56-79-31-22-21-23-32-79)176-140(223)113(73(11)12)182-119(202)77(16)161-128(211)100(63-110(196)197)174-137(220)103(66-186)179-120(203)85(149)59-82-65-156-68-158-82/h21-23,31-32,37-44,65,68-78,85-105,112-116,186-191H,19-20,24-30,33-36,45-64,66-67,146-149H2,1-18H3,(H2,150,192)(H2,151,193)(H2,152,194)(H2,153,195)(H,156,158)(H,159,204)(H,160,210)(H,161,211)(H,162,200)(H,163,206)(H,164,205)(H,165,209)(H,166,222)(H,167,226)(H,168,208)(H,169,214)(H,170,207)(H,171,215)(H,172,212)(H,173,217)(H,174,220)(H,175,224)(H,176,223)(H,177,225)(H,178,213)(H,179,203)(H,180,216)(H,181,201)(H,182,202)(H,183,221)(H,184,218)(H,185,219)(H,196,197)(H,198,199)(H,227,228)(H4,154,155,157)/t74-,75-,76-,77-,78+,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105+,112-,113-,114-,115-,116-/m0/s1	Adrenergic receptor alpha antagonist	ANTAGONIST	CHEMBL2095203	Adrenergic receptor alpha	Homo sapiens
